Report	O
Status	O
:	O
Final	O
.	O

Type	O
:	O
Surgical	O
Pathology	O
.	O

Specimen	O
Type	O
:	O
Peritoneum	O
.	O

Procedure	O
Date	O
:	O
Resident	O
:	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
A	O
.	O

LEFT	O
PELVIC	O
SIDE	O
WALL	O
DEPOSIT	O
:	O
Fibrovascular	O
tissue	O
with	O
chronic	O
inflammation	O
.	O
and	O
foreign	O
body	O
giant	O
cell	O
reaction	O
,	O
negative	O
.	O
for	O
tumor	O
.	O

B	O
.	O

RIGHT	O
RETROPERITONEAL	O
MASS	O
.	O

DEDIFFERENTIATED	O
LIPOSARCOMA	O
.	O

5	B
cm	I
.	O

Mitoses	O
number	O
40	O
:	O
10	O
HPF	O
.	O

No	O
necrosis	O
identified	O
.	O

C	O
.	O

OMENTAL	O
NODULE	O
:	O
DEDIFFERENTIATED	O
LIPOSARCOMA	O
involving	O
.	O
fibroadipose	O
tissue	O
.	O

D	O
.	O

ILEUM	O
AND	O
RIGHT	O
COLON	O
:	O
DEDIFFERENTIATED	O
LIPOSARCOMA	O
,	O
1	B
.	I
9	I
cm	I
,	O
involving	O
the	O
wall	O
.	O
of	O
the	O
small	O
intestine	O
,	O
invading	O
into	O
the	O
submucosa	O
.	O

Colonic	O
and	O
ileal	O
resection	O
margins	O
are	O
negative	O
for	O
tumor	O
.	O

Four	O
lymph	O
nodes	O
,	O
negative	O
for	O
tumor	O
(	O
0	O
:	O
4	O
)	O
.	O

E	O
.	O

SMALL	O
BOWEL	O
MESENTERY	O
LYMPH	O
NODES	O
:	O
Three	O
lymph	O
nodes	O
,	O
negative	O
for	O
tumor	O
(	O
0	O
:	O
3	O
)	O
.	O

CLINICAL	O
DATA	O
:	O
History	O
:	O
Dedif	O
LPS	O
.	O

Operation	O
:	O
Resection	O
of	O
duodenal	O
liposarcoma	O
,	O
sm	O
bowel	O
resection	O
.	O

Operative	O
Findings	O
:	O
Not	O
provided	O
.	O

Clinical	O
Diagnosis	O
:	O
Duodenal	O
liposarcoma	O
.	O

TISSUE	O
SUBMITTED	O
:	O
A	O
.	O

LT	O
pelvic	O
side	O
wall	O
deposit	O
.	O

B	O
.	O

RT	O
retroperitoneal	O
mass	O
-	O
short	O
sup	O
-	O
long	O
lat	O
-	O
tissue	O
bank	O
.	O

C	O
.	O

Omental	O
nodule	O
.	O

D	O
.	O

Ileum	O
+	O
RT	O
colon	O
.	O

E	O
.	O

Sm	O
bowel	O
mesentery	O
lymph	O
node	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
in	O
five	O
parts	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
unit	O
number	O
.	O

Part	O
A	O
,	O
"	O
#	O
1	O
.	O

Left	O
pelvic	O
sidewall	O
deposits	O
"	O
,	O
consists	O
of	O
soft	O
tissue	O
fragments	O
.	O
of	O
2	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

Micro	O
A1	O
:	O
Soft	O
tissue	O
fragments	O
,	O
1	O
frag	O
,	O
.	O

Part	O
B	O
,	O
"	O
#	O
2	O
.	O

Right	O
retroperitoneal	O
mass	O
stitch	O
superior	O
,	O
long	O
posterior	O
tissue	O
.	O

bank	O
"	O
,	O
consists	O
of	O
a	O
35	O
.	O
5	O
-	O
g	O
tan	O
/	O
yellow	O
lobulated	O
multifocally	O
disrupted	O
.	O
oriented	O
soft	O
tissue	O
mass	O
(	O
5	O
x	O
5	O
x	O
4	O
.	O
5	O
cm	O
)	O
with	O
a	O
short	O
stitch	O
superior	O
and	O
.	O
long	O
stitch	O
lateral	O
.	O

The	O
excision	O
appears	O
marginal	O
grossly	O
.	O

The	O
specimen	O
is	O
.	O
inked	O
per	O
protocol	O
.	O

There	O
is	O
on	O
the	O
lateral	O
aspect	O
of	O
the	O
specimen	O
additional	O
.	O
fatty	O
piece	O
attached	O
measuring	O
2	O
.	O
7	O
x	O
2	O
.	O
1	O
x	O
0	O
.	O
6	O
cm	O
.	O

There	O
is	O
a	O
tan	O
/	O
white	O
.	O
lobulated	O
firm	O
cut	O
surface	O
of	O
the	O
tumor	O
.	O

Representative	O
section	O
of	O
the	O
tumor	O
.	O

Page	O
:	O
1	O
of	O
2	O
.	O

la	O
.	O

is	O
submitted	O
for	O
cytogenetics	O
and	O
tissue	O
bank	O
and	O
for	O
.	O
lab	O
.	O

Photograph	O
is	O
taken	O
.	O

Micro	O
B1	O
:	O
Medial	O
inferior	O
lateral	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
B2	O
:	O
Anterior	O
medial	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
B3	O
:	O
Posterior	O
inferior	O
margin	O
.	O

1	O
frag	O
,	O
.	O

Micro	O
B4	O
:	O
Lateral	O
margin	O
,	O
2	O
frag	O
,	O
.	O

Micro	O
B5	O
:	O
Medial	O
superior	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
B6	O
:	O
Anterior	O
inferior	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
B7	O
:	O
Superior	O
resection	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
B8	O
-	O
B10	O
:	O
Additional	O
tumor	O
sampling	O
,	O
3	O
frags	O
,	O
.	O

Part	O
C	O
,	O
"	O
#	O
3	O
.	O

Omental	O
nodule	O
"	O
,	O
consists	O
of	O
a	O
white	O
firm	O
nodule	O
of	O
1	O
.	O
2	O
cm	O
in	O
.	O
diameter	O
.	O

Micro	O
C1	O
-	O
C2	O
:	O
Nodule	O
bisected	O
,	O
2	O
frags	O
,	O
.	O

Part	O
D	O
,	O
"	O
#	O
4	O
.	O

Ileum	O
and	O
right	O
colon	O
frozen	O
section	O
"	O
,	O
consists	O
of	O
a	O
segment	O
of	O
.	O
ileum	O
measuring	O
34	O
.	O
0	O
cm	O
in	O
length	O
x	O
3	O
.	O
0	O
cm	O
in	O
diameter	O
with	O
a	O
right	O
colon	O
of	O
.	O

12	O
.	O
0	O
cm	O
in	O
length	O
x	O
8	O
.	O
0	O
cm	O
in	O
diameter	O
with	O
a	O
radial	O
resection	O
margin	O
of	O
6	O
.	O
0	O
.	O

cm	O
.	O

The	O
mucosa	O
of	O
the	O
bowel	O
is	O
unremarkable	O
.	O

There	O
is	O
mesenteric	O
nodule	O
in	O
.	O
the	O
terminal	O
ileum	O
measuring	O
1	O
.	O
6	O
cm	O
in	O
diameter	O
pushing	O
the	O
submucosa	O
located	O
.	O
at	O
20	O
.	O
0	O
cm	O
from	O
the	O
ileal	O
resection	O
margin	O
and	O
11	O
.	O
0	O
cm	O
from	O
the	O
ICV	O
.	O

Micro	O
D1	O
:	O
Ileal	O
resection	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
D2	O
:	O
Colon	O
resection	O
margin	O
,	O
1	O
frag	O
,	O
.	O

Micor	O
D3	O
:	O
Radial	O
resection	O
margin	O
,	O
2	O
frags	O
,	O
.	O

Micor	O
D4	O
:	O
Lymph	O
node	O
?	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
D5	O
:	O
Lymph	O
node	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
D6	O
:	O
Lymph	O
node	O
,	O
2	O
frags	O
,	O
.	O

Micro	O
D7	O
-	O
D8	O
:	O
Ileal	O
mesenteric	O
mass	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
D9	O
-	O
D10	O
:	O
colonic	O
mucosa	O
,	O
4	O
frags	O
.	O

Micro	O
D11	O
-	O
D14	O
:	O
Ileal	O
mucosa	O
,	O
8	O
frags	O
,	O
.	O

Part	O
E	O
,	O
"	O
#	O
5	O
.	O

Small	O
bowel	O
mesentery	O
lymph	O
node	O
"	O
,	O
consists	O
of	O
a	O
lymph	O
node	O
of	O
1	O
.	O
3	O
.	O

x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
with	O
fibroadipose	O
tissue	O
measuring	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
in	O
.	O
aggregate	O
.	O

Micro	O
E1	O
:	O
Lymph	O
node	O
and	O
fibroadipose	O
tissue	O
,	O
3	O
frags	O
,	O
.	O

By	O
his	O
/	O
her	O
signature	O
below	O
,	O
the	O
senior	O
physician	O
certifies	O
that	O
he	O
/	O
she	O
.	O
personally	O
conducted	O
a	O
microscopic	O
examination	O
(	O
"	O
gross	O
only	O
"	O
exam	O
if	O
so	O
stated	O
)	O
.	O
of	O
the	O
described	O
specimen	O
(	O
s	O
)	O
and	O
rendered	O
or	O
confirmed	O
the	O
diagnosis	O
(	O
es	O
)	O
.	O
related	O
thereto	O
.	O

Final	O
Diagnosis	O
by	O
.	O

Gender	O
:	O
F	O
.	O

Examination	O
result	O
No	O
.	O

Unit	O
in	O
charge	O
:	O
(	O
.	O
Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
Stomach	O
cancer	O
.	O
Date	O
of	O
admission	O
:	O
(	O
urgency	O
:	O
Standard	O
)	O
.	O
Material	O
:	O
1	O
)	O
Material	O
:	O
stomach	O
,	O
stomach	O
with	O
the	O
tumour	O
.	O

Method	O
of	O
collection	O
:	O
Total	O
organ	O
resection	O
.	O

Histopathological	O
diagnosis	O
:	O
Stomach	O
adenocarcinoma	O
mucinous	O
with	O
metastases	O
to	O
lymph	O
nodes	O
(	O
G3	O
,	O
pT2	O
,	O
pNI	O
)	O
.	O

(	O
8140	O
/	O
3	O
T	O
-	O
63000	O
)	O
.	O

Macroscopic	O
description	O
:	O
The	O
specimen	O
containing	O
the	O
stomach	O
,	O
incised	O
along	O
the	O
lesser	O
curvature	O
sized	O
1	O
9	O
x	O
13	O
cm	O
.	O

Tumour	O
with	O
.	O
ulceration	O
sized	O
7x5x2	B
cm	I
in	O
the	O
pyloric	O
region	O
.	O

Distance	O
from	O
the	O
proximal	O
end	O
:	O
12	O
cm	O
,	O
from	O
distal	O
end	O
:	O
0	O
.	O
5	O
cm	O
.	O

Microscopic	O
description	O
:	O
Gastric	O
adenocarcinoma	O
mucocellulare	O
(	O
G3	O
,	O
diffuse	O
type	O
acc	O
.	O
to	O
Lauren	O
class	O
.	O
)	O
.	O

The	O
lesion	O
invades	O
the	O
.	O
submucosa	O
and	O
the	O
muscular	O
layer	O
of	O
the	O
stomach	O
wall	O
.	O

Incision	O
lines	O
free	O
of	O
neoplastic	O
lesions	O
.	O

Metastases	O
to	O
3	O
/	O
10	O
lymph	O
nodes	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATE	O
:	O
1	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
F	O
.	O

BIRTHDATE	O
:	O
ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
PROCEDURE	O
:	O
with	O
.	O
history	O
of	O
dysphagia	O
,	O
heartburn	O
,	O
regurg	O
and	O
weight	O
.	O
loss	O
.	O

Adenocarcinoma	O
of	O
distal	O
esophagus	O
.	O

Operative	O
Procedure	O
:	O
Esophagectomy	O
.	O

PROCEDURE	O
:	O
1	O
.	O

"	O
Thoracic	O
esophagus	O
.	O

A	O
15	O
cm	O
long	O
segment	O
of	O
esophagus	O
and	O
2	O
x	O
3	O
cm	O
.	O
proximal	O
stomach	O
.	O

The	O
specimen	O
is	O
received	O
open	O
.	O

Near	O
the	O
GE	O
junction	O
there	O
is	O
.	O

a	O
3	O
.	O
5	O
x	O
2	O
cm	O
ulcerated	O
mass	O
with	O
depth	O
of	O
invasion	O
1	O
.	O
3	O
cm	O
all	O
the	O
way	O
through	O
.	O
muscularis	O
propria	O
and	O
closely	O
approximating	O
to	O
serosal	O
surface	O
.	O

The	O
mass	O
.	O
occupies	O
70	O
%	O
of	O
the	O
lumen	O
circumference	O
and	O
with	O
marked	O
Lumen	O
occlusion	O
.	O

Tumor	O
.	O
closely	O
approximates	O
the	O
distal	O
gastric	O
surgical	O
margin	O
within	O
0	O
.	O
2	O
cm	O
.	O

The	O
.	O
remaining	O
esophagus	O
and	O
stomach	O
are	O
grossly	O
unremarkable	O
.	O

Several	O
gross	O
.	O
positive	O
lymph	O
nodes	O
identified	O
,	O
up	O
to	O
1	O
cm	O
in	O
greatest	O
dimension	O
with	O
no	O
.	O
obvious	O
actual	O
capsular	O
extension	O
.	O

1A	O
-	O
B	O
.	O

Tumor	O
with	O
deepest	O
invasion	O
and	O
adjacent	O
gastric	O
mucosa	O
.	O

1C	O
-	O
D	O
.	O

Tumor	O
with	O
deepest	O
invasion	O
with	O
adjacent	O
esophagus	O
.	O

1E	O
.	O

Tumor	O
with	O
closest	O
distal	O
surgical	O
margin	O
after	O
shaving	O
the	O
stapled	O
.	O
mucosa	O
.	O

1F	O
.	O

Shaved	O
stapled	O
gastric	O
mucosa	O
.	O

1G	O
.	O

Normal	O
appearing	O
GE	O
junction	O
overlying	O
the	O
tumor	O
.	O

1H	O
.	O

Normal	O
appearing	O
esophagus	O
and	O
unremarkable	O
gastric	O
mucosa	O
.	O

11	O
.	O

Grossly	O
positive	O
Lymph	O
nodes	O
.	O

Sectioned	O
.	O

1J	O
.	O

Two	O
grossly	O
positive	O
lymph	O
nodes	O
.	O

Larger	O
bisected	O
and	O
inked	O
yellow	O
.	O

1K	O
.	O

Grossly	O
unremarkable	O
lymph	O
nodes	O
.	O

1L	O
.	O

Grossly	O
unremarkable	O
lymph	O
nodes	O
.	O

2	O
.	O

"	O
Proximal	O
cervical	O
margin	O
.	O
"	O
A	O
0	O
.	O
5	O
cm	O
long	O
segment	O
of	O
unremarkable	O
.	O
esophagus	O
.	O

3	O
.	O

"	O
Lesser	O
curve	O
lymph	O
node	O
.	O
"	O
Two	O
0	O
.	O
3	O
to	O
0	O
.	O
5	O
cm	O
lymph	O
nodes	O
.	O

PROCEDURE	O
:	O
VERIFIED	O
8Y	O
:	O
ESOPHAGEAL	O
,	O
CARDIAC	O
AND	O
GASTROESOPHAGEAL	O
JUNCTION	O
CARCINOMA	O
:	O
Type	O
of	O
carcinoma	O
:	O
Adenocarcinoma	O
.	O

If	O
adenocarcinoma	O
,	O
is	O
it	O
arising	O
in	O
Barrett	O
'	O
s	O
mucosa	O
,	O
gastric	O
cardia	O
,	O
or	O
.	O

GE	O
.	O
junction	O
:	O
GE	O
junction	O
.	O

Depth	O
of	O
invasion	O
:	O
Adventitia	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

2	O
.	O

REPORT	O
DATE	O
:	O
PATIENT	O
NBR	O
:	O
SEX	O
:	O
F	O
.	O

ADM	O
DATE	O
:	O
BIRTHDATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
Number	O
of	O
positive	O
Lymph	O
nodes	O
,	O
the	O
total	O
number	O
sampled	O
is	O
irrelevant	O
:	O
7	O
/	O
10	O
.	O

Extranodal	O
metastasis	O
:	O
None	O
.	O

Pattern	O
of	O
invasion	O
:	O
Infiltrative	O
.	O

Esophageal	O
and	O
gastric	O
resection	O
margins	O
involved	O
:	O
No	O
.	O

Deep	O
resection	O
margin	O
involved	O
:	O
No	O
.	O

TNM	O
classification	O
:	O
T3	O
N1	O
Mx	O
.	O

PROCEDURE	O
:	O
1	O
.	O

Esophagus	O
and	O
proximal	O
stomach	O
,	O
resection	O
:	O
Adenocarcinoma	O
arising	O
at	O
the	O
.	O

GE	O
junction	O
with	O
extension	O
to	O
perigastric	O
and	O
eriesophageal	O
adipose	O
tissue	O
.	O

Free	O
margins	O
of	O
excision	O
.	O

Seven	O
of	O
10	O
Lymph	O
nodes	O
positive	O
for	O
carcinoma	O
.	O

See	O
.	O
template	O
.	O

2	O
.	O

Segment	O
of	O
esophagus	O
,	O
resection	O
:	O
Negative	O
for	O
carcinoma	O
.	O

3	O
.	O

Lymph	O
node	O
of	O
Lesser	O
curvature	O
of	O
stomach	O
,	O
excision	O
:	O
One	O
of	O
two	O
lymph	O
.	O
nodes	O
positive	O
for	O
carcinoma	O
.	O

1	O
,	O
.	O
,	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
examined	O
and	O
.	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

Code	O
:	O
END	O
OF	O
PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

CLINICAL	O
HISTORY	O
:	O
Outside	O
hospital	O
left	O
ovarian	O
mass	O
increased	O
CA125	O
,	O
abdominal	O
swelling	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Omentum	O
"	O
,	O
received	O
fresh	O
for	O
frozen	O
and	O
placed	O
in	O
formalin	O
on	O
'	O
.	O

at	O
.	O

is	O
a	O
19	O
x	O
9	O
x	O
2	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
that	O
is	O
firm	O
,	O
.	O
solid	O
and	O
multinodular	O
.	O

Sectioning	O
of	O
the	O
specimen	O
reveals	O
a	O
tan	O
-	O
yellow	O
,	O
firm	O
.	O
parenchyma	O
with	O
some	O
mucous	O
.	O

A	O
representative	O
section	O
was	O
submitted	O
in	O
frozen	O
.	O
in	O
AF1	O
and	O
submitted	O
in	O
A1	O
.	O

Another	O
representative	O
section	O
will	O
be	O
submitted	O
.	O
as	O
A2	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
was	O
sent	O
for	O
research	O
.	O

B	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
.	O
formalin	O
on	O
.	O

a	O
92	O
.	O
6	O
gram	O
,	O
previously	O
opened	O
hysterectomy	O
.	O
specimen	O
with	O
uterus	O
and	O
cervix	O
,	O
bilateral	O
tubes	O
,	O
and	O
ovaries	O
.	O

The	O
uterus	O
is	O
.	O

4	O
.	O
5	O
cm	O
from	O
cornu	O
to	O
cornu	O
,	O
2	O
.	O
1	O
cm	O
from	O
anterior	O
to	O
posterior	O
,	O
and	O
9	O
.	O
1	O
cm	O
from	O
.	O
superior	O
to	O
inferior	O
.	O

The	O
cervix	O
measures	O
2	O
.	O
7	O
cm	O
in	O
diameter	O
with	O
a	O
1	O
.	O
1	O
cm	O
.	O
round	O
patent	O
os	O
.	O

The	O
endometrium	O
is	O
grossly	O
unremarkable	O
.	O

The	O
anterior	O
.	O
endometrium	O
measures	O
1	O
.	O
1	O
cm	O
from	O
cornu	O
to	O
cornu	O
and	O
4	O
.	O
5	O
cm	O
in	O
length	O
.	O

The	O
.	O
posterior	O
endometrium	O
is	O
0	O
.	O
9	O
cm	O
from	O
cornu	O
to	O
cornu	O
and	O
4	O
.	O
1	O
cm	O
in	O
length	O
.	O

The	O
.	O
ectocervix	O
is	O
tan	O
smooth	O
and	O
glistening	O
with	O
areas	O
of	O
pinpoint	O
hemorrhage	O
.	O

The	O
.	O
endocervical	O
canal	O
also	O
has	O
a	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
clear	O
mucous	O
deposit	O
.	O

The	O
.	O
uterine	O
serosa	O
is	O
smooth	O
tan	O
and	O
glistening	O
with	O
multiple	O
nodular	O
adhesions	O
.	O
that	O
range	O
in	O
size	O
from	O
0	O
.	O
2	O
to	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

There	O
is	O
also	O
an	O
adherent	O
.	O
tan	O
-	O
brown	O
cauterized	O
mass	O
that	O
is	O
adhesed	O
to	O
the	O
serosa	O
,	O
fallopian	O
tube	O
,	O
and	O
.	O
left	O
ovary	O
.	O

The	O
right	O
fallopian	O
tube	O
is	O
also	O
studded	O
with	O
multiple	O
0	O
.	O
1	O
to	O
0	O
.	O
3	O
.	O

cm	O
nodules	O
.	O

The	O
left	O
ovary	O
is	O
extensively	O
adherent	O
to	O
uterus	O
.	O

It	O
is	O
4	O
.	O
1	O
.	O

x	O
.	O

3	O
.	O
2	O
x	O
2	O
.	O
5	O
cm	O
and	O
is	O
tan	O
-	O
white	O
and	O
cerebriform	O
with	O
a	O
disrupted	O
capsule	O
that	O
.	O
has	O
tumor	O
grossly	O
extending	O
out	O
of	O
the	O
capsule	O
.	O

The	O
right	O
fallopian	O
tube	O
is	O
.	O
studded	O
with	O
grossly	O
apparent	O
tumor	O
nodules	O
that	O
range	O
in	O
size	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O
3	O
.	O

cm	O
.	O

The	O
left	O
and	O
right	O
parametria	O
are	O
also	O
grossly	O
studded	O
with	O
tumor	O
nodules	O
.	O
that	O
range	O
in	O
size	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O

cm	O
in	O
diameter	O
.	O

The	O
tumor	O
grossly	O
appears	O
.	O
to	O
be	O
adherent	O
to	O
the	O
tube	O
and	O
uterus	O
,	O
and	O
possibly	O
invades	O
the	O
myometrium	O
.	O

The	O
disrupted	O
capsule	O
with	O
the	O
tumor	O
extruding	O
from	O
it	O
is	O
inked	O
.	O

The	O
left	O
.	O
fimbriated	O
tube	O
is	O
6	O
.	O
1	O
cm	O
long	O
x	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
with	O
a	O
pinpoint	O
patent	O
.	O
lumen	O
,	O
but	O
the	O
tube	O
is	O
stenosed	O
and	O
strictured	O
.	O

The	O
right	O
fimbriated	O
tube	O
is	O
.	O

4	O
.	O
1	O
cm	O
long	O
x	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
with	O
a	O
pinpoint	O
patent	O
lumen	O
and	O
a	O
strictured	O
.	O
tube	O
.	O

The	O
right	O
ovary	O
is	O
tan	O
-	O
white	O
and	O
cerebriform	O
and	O
is	O
2	O
.	O
5	O
x	O
1	O
.	O
9	O
x	O
1	O
.	O
2	O
cm	O
.	O

The	O
outer	O
surface	O
of	O
the	O
right	O
ovary	O
does	O
not	O
appear	O
to	O
be	O
grossly	O
involved	O
.	O

The	O
right	O
ovary	O
on	O
sectioning	O
is	O
firm	O
tan	O
-	O
white	O
with	O
a	O
hemorrhagic	O
center	O
.	O

The	O
.	O
left	O
ovary	O
on	O
sectioning	O
reveals	O
a	O
heterogeneous	O
parenchyma	O
that	O
is	O
.	O
hemorrhagic	O
,	O
necrotic	O
,	O
and	O
with	O
tumor	O
grossly	O
extending	O
outside	O
the	O
capsule	O
.	O

BLOCK	O
SUMMARY	O
:	O
B1	O
-	O
representative	O
section	O
of	O
anterior	O
cervix	O
.	O

B2	O
-	O
-	O
representative	O
section	O
of	O
posterior	O
cervix	O
.	O

B3	O
-	O
anterior	O
full	O
thickness	O
endometrium	O
.	O

B4	O
-	O
possible	O
tumor	O
to	O
normal	O
myometrium	O
,	O
anterior	O
.	O

B5	O
-	O
posterior	O
full	O
thickness	O
with	O
additional	O
section	O
to	O
serosal	O
nodule	O
.	O

B6	O
-	O
left	O
parametrium	O
.	O

B7	O
-	O
right	O
parametrium	O
.	O

B8	O
-	O
left	O
fallopian	O
tube	O
.	O

B9	O
-	O
right	O
fallopian	O
tube	O
.	O

B10	O
-	O
11	O
-	O
right	O
ovary	O
.	O

B12	O
-	O
15	O
-	O
left	O
ovary	O
with	O
capsule	O
disruption	O
.	O

B17	O
-	O
18	O
-	O
adherent	O
left	O
ovary	O
to	O
uterus	O
.	O

C	O
.	O

"	O
Left	O
gutter	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
5	O
.	O
5	O
x	O
4	O
.	O
2	O
x	O
2	O
.	O
5	O
cm	O
fragment	O
of	O
yellow	O
fibroadipose	O
tissue	O
with	O
some	O
.	O
vessels	O
present	O
.	O

The	O
specimen	O
is	O
firm	O
and	O
nodular	O
with	O
some	O
areas	O
of	O
.	O
cauterized	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
C1	O
-	O
2	O
.	O

D	O
.	O

"	O
Omentum	O
#	O
2	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
12	O
x	O
11	O
.	O
5	O
x	O
2	O
.	O
4	O
cm	O
aggregate	O
of	O
yellow	O
fibroadipose	O
tissue	O
with	O
some	O
.	O
solid	O
nodular	O
areas	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
B1	O
.	O

E	O
.	O

"	O
Small	O
bowel	O
nodule	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
5	O
x	O
2	O
.	O
9	O
x	O
2	O
.	O
4	O
cm	O
fragment	O
of	O
tan	O
-	O
white	O
tissue	O
that	O
is	O
firm	O
and	O
.	O
has	O
a	O
large	O
nodular	O
area	O
that	O
covers	O
most	O
of	O
the	O
specimen	O
.	O

A	O
representative	O
.	O
section	O
is	O
submitted	O
in	O
E1	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Omentum	O
"	O
AF1	O
(	O
rep	O
)	O
-	O
adenocarcinoma	O
with	O
papillary	O
features	O
(	O
Dr	O
.	O
MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
Exploratory	O
laparotomy	O
,	O
total	O
abdominal	O
hysterectomy	O
,	O
bilateral	O
.	O
salpingo	O
-	O
oophorectomy	O
,	O
infragastric	O
omentectomy	O
,	O
removal	O
abdominal	O
wall	O
mass	O
,	O
.	O
and	O
optimal	O
tumor	O
debulking	O
to	O
less	O
than	O
1	O
cm	O
of	O
maximal	O
residual	O
disease	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pT3c	O
pNX	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

OMENTUM	O
(	O
RESECTION	O
)	O
:	O
INVOLVED	O
BY	O
HIGH	O
GRADE	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

B	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
AND	O
OVARIES	O
(	O
TOTAL	O
HYSTERECTOMY	O
.	O
AND	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
LEFT	O
OVARY	O
:	O
TYPE	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

SEE	O
NOTE	O
.	O

TUMOR	O
GRADE	O
:	O
HIGH	O
GRADE	O
.	O

TUMOR	O
SIZE	O
:	O
4	B
.	I
1	I
X	I
3	I
.	I
2	I
X	I
2	I
.	I
5	I
CM	I
.	O

SEROSA	O
:	O
DISRUPTED	O
CAPSULE	O
WITH	O
TUMOR	O
PRESENT	O
MOSTLY	O
ON	O
SURFACE	O
,	O
BUT	O
ALSO	O
.	O

WITHIN	O
PARENCHYMA	O
.	O

SEE	O
NOTE	O
.	O

UTERUS	O
:	O
CERVIX	O
:	O
NO	O
DIAGNOSTIC	O
ABNORMALITY	O
.	O

ENDOMETRIUM	O
:	O
ATROPHIC	O
.	O

LEFT	O
FALLOPIAN	O
TUBE	O
:	O
ACUTE	O
SALPINGITIS	O
AND	O
SEROSITIS	O
.	O

RIGHT	O
OVARY	O
SURFACE	O
SEROSAL	O
ADHESIONS	O
AND	O
MESOTHELIAL	O
HYPERPLASIA	O
WITH	O
.	O

DETACHED	O
FRAGMENTS	O
OF	O
CARCINOMA	O
.	O

SPECIMENS	O
WITH	O
METASTATIC	O
/	O
IMPLANTED	O
TUMOR	O
:	O
RIGHT	O
FALLOPIAN	O
TUBE	O
,	O
LEFT	O
.	O

PARAMETRIUM	O
,	O
MYOMETRIUM	O
AND	O
SEROSA	O
.	O

NOTE	O
:	O
The	O
tumor	O
seen	O
in	O
the	O
left	O
ovary	O
involves	O
predominantly	O
the	O
ovarian	O
.	O
surface	O
with	O
only	O
limited	O
parenchymal	O
involvement	O
.	O

Per	O
clinical	O
history	O
,	O
the	O
.	O
bulk	O
of	O
this	O
tumor	O
is	O
present	O
within	O
the	O
peritoneum	O
/	O
omentum	O
.	O

According	O
to	O
.	O
criteria	O
,	O
a	O
tumor	O
mass	O
greater	O
than	O
5	O
mm	O
involving	O
the	O
ovarian	O
parenchyma	O
.	O
should	O
be	O
staged	O
as	O
an	O
ovarian	O
primary	O
,	O
which	O
is	O
the	O
case	O
in	O
this	O
material	O
.	O

Having	O
said	O
that	O
,	O
we	O
suspect	O
that	O
in	O
this	O
particular	O
case	O
,	O
a	O
peritoneal	O
origin	O
.	O

is	O
more	O
likely	O
.	O

Clinical	O
correlation	O
is	O
highly	O
recommended	O
.	O

C	O
.	O

LEFT	O
GUTTER	O
(	O
RESECTION	O
)	O
:	O
INVOLVED	O
BY	O
HIGH	O
GRADE	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

D	O
.	O

OMENTUM	O
#	O
2	O
(	O
RESECTION	O
)	O
:	O
INVOLVED	O
BY	O
HIGH	O
GRADE	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

E	O
.	O

SMALL	O
BOWEL	O
NODULE	O
(	O
RESECTION	O
)	O
:	O
INVOLVED	O
BY	O
HIGH	O
GRADE	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Attending	O
MD	O
:	O

Procedure	O
:	O
adrenalectomy	O
.	O

Gross	O
description	O
:	O
14x9	O
X	O
5cm	O
,	O
336g	O
.	O

Reference	O
Pathology	O
only	O
:	O
Diagnosis	O
:	O
adrenocortical	O
carcinoma	O
,	O
with	O
unusually	O
high	O
proliferation	O
rate	O
,	O
KI67	O
60	O
%	O
.	O

Weiss	O
score	O
:	O
8	O
.	O

Hough	O
score	O
:	O
4	O
.	O
89	O
.	O

Van	O
Slooten	O
score	O
:	O
22	O
.	O
7	O
.	O

'	O
nternal	O
Sample	O
ID	O
:	O
Diagnosis	O
:	O
This	O
is	O
a	O
moderately	O
differentiated	O
adenocarcinoma	O
of	O
the	O
sigmoid	O
colon	O
with	O
.	O
histopathological	O
grade	O
G2	O
differentiation	O
,	O
with	O
erosions	O
of	O
the	O
inner	O
tumor	O
surface	O
,	O
with	O
.	O
peritumorous	O
,	O
chronic	O
recurrent	O
concomitant	O
inflammation	O
,	O
with	O
tumor	O
infiltration	O
of	O
the	O
.	O
parietal	O
layers	O
of	O
the	O
sigmoid	O
colon	O
extending	O
to	O
the	O
outer	O
layers	O
of	O
the	O
tunica	O
muscularis	O
,	O
.	O
with	O
chronic	O
lymphadenitis	O
of	O
the	O
tumor	O
-	O
free	O
lymph	O
nodes	O
(	O
0	O
/	O
12	O
)	O
and	O
tumor	O
-	O
free	O
overview	O
.	O
sections	O
from	O
the	O
resection	O
margins	O
and	O
from	O
the	O
region	O
of	O
the	O
vascular	O
ligature	O
.	O

According	O
to	O
these	O
section	O
preparations	O
,	O
the	O
tumor	O
spread	O
of	O
the	O
sigmoid	O
colon	O
carcinoma	O
.	O
corresponds	O
to	O
a	O
tumor	O
stage	O
of	O
pT2	O
,	O
pNo	O
,	O
MX	O
,	O
R0	O
.	O

CLINICAL	O
HISTORY	O
:	O
Malignant	O
neocorpus	O
uteri	O
-	O
182	O
.	O
0	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
(	O
AF1	O
-	O
2	O
)	O
"	O
.	O

Received	O
fresh	O
is	O
.	O

a	O
.	O

99	O
gram	O
uterus	O
(	O
9	O
x	O
6	O
x	O
3	O
cm	O
)	O
with	O
attached	O
left	O
ovary	O
(	O
1	O
.	O
9	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
8	O
cm	O
)	O
,	O
.	O
left	O
fimbriated	O
fallopian	O
tube	O
(	O
3	O
.	O
6	O
cm	O
long	O
x	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
,	O
right	O
ovary	O
.	O

(	O
2	O
.	O
6	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
2	O
cm	O
)	O
and	O
right	O
fimbriated	O
fallopian	O
tube	O
(	O
3	O
.	O
2	O
cm	O
long	O
x	O
0	O
.	O
5	O
cm	O
.	O
in	O
diameter	O
)	O
The	O
endometrial	O
cavity	O
is	O
2	O
.	O
7	O
cm	O
from	O
cornu	O
to	O
cornu	O
and	O
.	O
expands	O
4	O
.	O
8	O
cm	O
and	O
contains	O
an	O
ill	O
-	O
defined	O
fundal	O
soft	O
gray	O
-	O
tan	O
endometrial	O
.	O
mass	O
(	O
1	O
.	O
3	O
x	O
1	O
x	O
0	O
.	O
7	O
cm	O
)	O
that	O
slightly	O
traces	O
into	O
the	O
anterior	O
and	O
posterior	O
.	O
endometrium	O
,	O
4	O
.	O
5	O
cm	O
and	O
3	O
.	O
1	O
cm	O
from	O
the	O
anterior	O
and	O
posterior	O
lower	O
uterine	O
.	O
segments	O
respectively	O
.	O

The	O
mass	O
penetrates	O
0	O
.	O
2	O
cm	O
into	O
a	O
1	O
.	O
5	O
cm	O
thick	O
.	O
trabeculated	O
myometrium	O
that	O
contains	O
a	O
single	O
white	O
whorled	O
intramural	O
nodule	O
.	O

(	O
1	O
x	O
1	O
x	O
0	O
.	O
9	O
cm	O
)	O
.	O

The	O
mass	O
was	O
partially	O
frozen	O
as	O
representative	O
AF1	O
.	O

The	O
.	O
remainder	O
of	O
the	O
endometrium	O
is	O
red	O
-	O
tan	O
and	O
diffusely	O
coarse	O
(	O
0	O
.	O
1	O
cm	O
thick	O
)	O
.	O
with	O
a	O
second	O
soft	O
gray	O
-	O
tan	O
mass	O
(	O
1	O
.	O
6	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
)	O
that	O
is	O
1	O
.	O
1	O
cm	O
from	O
the	O
.	O
lower	O
uterine	O
segment	O
.	O

The	O
second	O
mass	O
extends	O
0	O
.	O
2	O
cm	O
into	O
the	O
underlying	O
.	O
myometrium	O
.	O

The	O
uterine	O
serosa	O
is	O
pink	O
-	O
tan	O
,	O
smooth	O
and	O
glistening	O
.	O

The	O
.	O
exocervix	O
is	O
red	O
-	O
white	O
and	O
smooth	O
with	O
diffuse	O
erythema	O
surrounding	O
a	O
1	O
cm	O
.	O
cervical	O
-	O
-	O
os	O
-	O
that	O
-	O
leads	O
into	O
-	O
a	O
-	O
2	O
.	O
5	O
cm	O
trabeculated	O
endocervical	O
canal	O
.	O

The	O
.	O
left	O
and	O
right	O
ovary	O
are	O
grossly	O
unremarkable	O
.	O

The	O
left	O
and	O
right	O
fimbriated	O
.	O
fallopian	O
tubes	O
are	O
both	O
discontinuous	O
and	O
grossly	O
unremarkable	O
.	O

BLOCK	O
SUMMARY	O
:	O
A1	O
-	O
frozen	O
section	O
remnant	O
from	O
AF1	O
.	O

A2	O
-	O
.	O
anterior	O
endomyometrium	O
full	O
thickness	O
with	O
mass	O
.	O

A3	O
-	O
posterior	O
endomyometrium	O
full	O
thickness	O
with	O
mass	O
.	O

A4	O
-	O
.	O
anterior	O
endomyometrium	O
full	O
thickness	O
with	O
second	O
mass	O
.	O

A5	O
-	O
.	O
perpendicular	O
section	O
of	O
anterior	O
lower	O
uterine	O
segment	O
with	O
second	O
mas	O
.	O

A6	O
-	O
.	O
perpendicular	O
section	O
of	O
posterior	O
lower	O
uterine	O
segment	O
.	O

A7	O
-	O
.	O
intramural	O
nodule	O
.	O

A8	O
-	O
.	O
anterior	O
cervix	O
.	O

A9	O
-	O
posterior	O
cervix	O
.	O

A10	O
-	O
left	O
tube	O
and	O
ovary	O
.	O

All	O
-	O
right	O
tube	O
and	O
ovary	O
.	O

A12	O
-	O
remnant	O
from	O
AF2	O
which	O
is	O
the	O
deep	O
tissue	O
to	O
from	O
AF1	O
which	O
was	O
not	O
.	O
frozen	O
due	O
to	O
"	O
chucking	O
out	O
"	O
during	O
frozen	O
section	O
.	O

B	O
.	O

"	O
Left	O
pelvic	O
lymph	O
node	O
"	O
.	O

Received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
9	O
.	O
3	O
.	O

x	O
5	O
.	O
8	O
x	O
2	O
.	O
4	O
cm	O
aggregate	O
of	O
adipose	O
tissue	O
that	O
has	O
eight	O
lymph	O
node	O
.	O
candidates	O
ranging	O
from	O
0	O
.	O

x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
up	O
to	O
2	O
.	O
1	O
x	O
1	O
.	O
7	O
x	O
1	O
.	O
6	O
cm	O
.	O

Each	O
.	O
lymph	O
node	O
has	O
a	O
fatty	O
cut	O
surface	O
.	O

BLOCK	O
SUMMARY	O
:	O
B1	O
-	O
.	O
two	O
lymph	O
node	O
candidates	O
,	O
one	O
is	O
inked	O
black	O
and	O
bisected	O
.	O

B2	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

B3	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

B4	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

B5	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

B6	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

B7	O
-	O
8	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
serially	O
sectioned	O
.	O

C	O
.	O

"	O
Right	O
pelvic	O
lymph	O
nodes	O
"	O
.	O

Received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
.	O

7	O
.	O
3	O
x	O
5	O
.	O
2	O
x	O
1	O
.	O
8	O
cm	O
aggregate	O
of	O
adipose	O
tissue	O
that	O
has	O
eleven	O
lymph	O
node	O
.	O
candidates	O
ranging	O
from	O
1	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
up	O
to	O
2	O
.	O
1	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
.	O

Each	O
lymph	O
.	O
node	O
has	O
a	O
fatty	O
cut	O
surface	O
.	O

BLOCK	O
SUMMARY	O
:	O
C1	O
-	O
.	O
three	O
lymph	O
node	O
candidates	O
.	O

C2	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
.	O

C3	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
.	O

C4	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
.	O

C5	O
-	O
.	O
two	O
lymph	O
node	O
candidates	O
,	O
each	O
bisected	O
and	O
one	O
inked	O
black	O
.	O

C6	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

C7	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

C8	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
bisected	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
"	O
:	O
AF1	O
(	O
mass	O
at	O
fundus	O
)	O
:	O
adenocarcinoma	O
with	O
mucinous	O
features	O
,	O
.	O

FIGO	O
grade	O
1	O
,	O
?	O
2	O
at	O
most	O
.	O

AF2	O
not	O
frozen	O
.	O

MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
HYSTERECTOMY	O
,	O
OOPHORECTOMY	O
&	O
LYMPHADENECTOMY	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT1B	O
pNO	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
-	O
the	O
-	O
-	O
Commission	O
on	O
Cancer	O
.	O
-	O
Pathology	O
stage	O
-	O
is	O
-	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

UTERUS	O
:	O
99	O
GRAMS	O
.	O

ENDOMETRIUM	O
:	O
TUMOR	O
SITE	O
:	O
FUNDUS	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
ENDOMETRIOID	O
ADENOCARCINOMA	O
.	O

FIGO	O
GRADE	O
:	O
1	O
.	O

TUMOR	O
SIZE	O
:	O
1	B
.	I
3	I
x	I
1	I
x	I
0	I
.	I
7	I
CM	I
.	O

MAXIMUM	O
DEPTH	O
OF	O
MYOMETRIAL	O
INVASION	O
:	O
0	O
.	O
2	O
CM	O
,	O
IN	O
A	O
1	O
.	O
5	O
THICK	O
WALL	O
.	O

LYMPHATIC	O
/	O
VASCULAR	O
INVASION	O
:	O
NEGATIVE	O
.	O

ADJACENT	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIUM	O
:	O
ATROPHIC	O
.	O

REMAINING	O
MYOMETRIUM	O
:	O
LEIOMYOMA	O
,	O
SMALL	O
.	O

CERVIX	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

SEROSA	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

SPECIMEN	O
MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

THE	O
FOLLOWING	O
SPECIMENS	O
ARE	O
FREE	O
OF	O
TUMOR	O
:	O
A	O
.	O

OVARIES	O
AND	O
FALLOPIAN	O
TUBES	O
,	O
BILATERAL	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

B	O
.	O

LEFT	O
PELVIC	O
LYMPH	O
NODES	O
:	O
NO	O
TUMOR	O
IN	O
7	O
LYMPH	O
NODES	O
(	O
0	O
/	O
7	O
)	O
.	O

C	O
.	O

RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
:	O
NO	O
TUMOR	O
IN	O
11	O
LYMPH	O
NODES	O
(	O
0	O
/	O
11	O
)	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

CI	O
ADDENDUM	O
1	O
:	O
Please	O
see	O
Image	O
Cytometry	O
Report	O
.	O
or	O
results	O
of	O
supplementary	O
.	O
tests	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
MUCOSA	O
,	O
RIGHT	O
DEEP	O
MARGIN	O
,	O
EXCISION	O
:	O
INVOLVED	O
BY	O
SQUAMOUS	O
CELL	O
.	O

CARCINOMA	O
.	O

2	O
)	O
SOFT	O
TISSUE	O
,	O
POSTERIOR	O
MUCOSAL	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
WITH	O
.	O

CHRONIC	O
INFLAMMATION	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

3	O
)	O
SOFT	O
TISSUE	O
,	O
LEFT	O
MUCOSAL	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
WITH	O
CHRONIC	O
.	O

INFLAMMATION	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

4	O
)	O
SOFT	O
TISSUE	O
,	O
NEW	O
DEEP	O
RIGHT	O
MARGIN	O
,	O
EXCISION	O
:	O
FIBROADIPOSE	O
TISSUE	O
,	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

5	O
)	O
LYMPH	O
NODE	O
,	O
RIGHT	O
NECK	O
LEVELS	O
2	O
-	O
5	O
,	O
EXCISION	O
:	O
1	O
OF	O
33	O
LYMPH	O
NODES	O
.	O

INVOLVED	O
BY	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
LARGEST	O
FOCUS	O
MEASURING	O
2	B
.	I
4	I
CM	I
,	O
.	O

(	O
1	O
/	O
33	O
)	O
,	O
NEGATIVE	O
FOR	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

6	O
)	O
SALIVARY	O
GLAND	O
AND	O
LYMPH	O
NODE	O
,	O
RIGHT	O
NECK	O
LEVEL	O
1	O
,	O
EXCISION	O
:	O
BENIGN	O
.	O

SALIVARY	O
GLAND	O
,	O
4	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
4	O
)	O
.	O

7	O
)	O
PALATE	O
,	O
EXCISION	O
:	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MODERATELY	O
TO	O
.	O

POORLY	O
-	O
DIFFERENTIATED	O
,	O
3	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
,	O
INVOLVING	O
THE	O
DEEP	O
.	O

(	O
BLACK	O
)	O
TISSUE	O
EDGE	O
;	O
PERINEURAL	O
INVASION	O
PRESENT	O
;	O
BENIGN	O
SALIVARY	O
GLAND	O
,	O
.	O

(	O
SEE	O
COMMENT	O
#	O
1	O
)	O
.	O

8	O
)	O
SOFT	O
TISSUE	O
,	O
ADDITIONAL	O
RIGHT	O
DEEP	O
MARGIN	O
,	O
EXCISION	O
:	O
BENIGN	O
SALIVARY	O
.	O

GLAND	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
,	O
(	O
SEE	O
COMMENT	O
#	O
1	O
)	O
.	O

COMMENT	O
#	O
1	O
:	O
Although	O
tumor	O
is	O
present	O
at	O
the	O
deep	O
tissue	O
edge	O
of	O
specimen	O
.	O

#	O
7	O
,	O
specimen	O
#	O
8	O
(	O
additional	O
R	O
deep	O
margin	O
)	O
supersedes	O
this	O
area	O
,	O
thus	O
the	O
.	O
final	O
margin	O
is	O
negative	O
for	O
malignancy	O
.	O

These	O
findings	O
correspond	O
to	O
AJCC	O
.	O

Edition	O
pathologic	O
Stage	O
III	O
(	O
pT2	O
,	O
pN1	O
,	O
pMn	O
/	O
a	O
)	O
.	O

Upper	O
Aerodigestive	O
Tract	O
-	O
including	O
Minor	O
Salivary	O
Glands	O
,	O
Lip	O
,	O
Oral	O
.	O
cavity	O
,	O
Nasal	O
Cavity	O
,	O
Paranasal	O
Sinuses	O
,	O
Oropharynx	O
,	O
Nasopharynx	O
,	O
and	O
.	O

Hypopharynx	O
Summary	O
of	O
Findings	O
:	O
Specimen	O
Type	O
:	O
palatectomy	O
with	O
selective	O
right	O
neck	O
level	O
1	O
-	O
5	O
dissection	O
.	O

Tumor	O
Site	O
:	O
palate	O
.	O

Tumor	O
Size	O
:	O
3	B
.	I
5	I
cm	I
.	O

Laterality	O
:	O
Right	O
.	O

Margins	O
:	O
All	O
final	O
margins	O
negative	O
for	O
malignancy	O
.	O

Histologic	O
Type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
Grade	O
:	O
moderately	O
to	O
poorly	O
differentiated	O
.	O

Pathologic	O
Staging	O
(	O
pTMN	O
)	O
III	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pN1	O
.	O

Number	O
examined	O
:	O
33	O
.	O

Numbered	O
involved	O
:	O
1	O
.	O

Extracapsular	O
extension	O
:	O
No	O
.	O

Perineural	O
invasion	O
:	O
Yes	O
.	O

CLINICAL	O
DATA	O
.	O

Clinical	O
Features	O
:	O
Unspecified	O
.	O

Operator	O
:	O
Operation	O
:	O
Unspecified	O
.	O

Operative	O
Findings	O
:	O
Unspecified	O
.	O

Operative	O
Diagnosis	O
:	O
Unspecified	O
.	O

Tissue	O
Submitted	O
:	O
1	O
)	O
deep	O
right	O
margin	O
;	O
2	O
)	O
posterior	O
mucosal	O
.	O
margin	O
;	O
3	O
)	O
left	O
mucosal	O
margin	O
;	O
4	O
)	O
new	O
deep	O
.	O
right	O
margin	O
;	O
5	O
)	O
right	O
neck	O
levels	O
2	O
-	O
5	O
;	O
.	O

6	O
)	O
right	O
neck	O
level	O
1	O
;	O
7	O
)	O
palate	O
;	O
.	O

8	O
)	O
additional	O
right	O
deep	O
tissue	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
SOURCE	O
:	O
Deep	O
Right	O
Margin	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
medical	O
record	O
number	O
along	O
with	O
the	O
designation	O
"	O
deep	O
right	O
.	O

margin	O
"	O
and	O
consists	O
of	O
a	O
0	O
.	O
6	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
piece	O
of	O
red	O
soft	O
tissue	O
.	O

The	O
.	O
entire	O
specimen	O
is	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O

Summary	O
of	O
sections	O
:	O
1AFSC	O
,	O
entire	O
specimen	O
,	O
1	O
/	O
1	O
.	O

2	O
)	O
SOURCE	O
:	O
Posterior	O
Mucosal	O
Margin	O
.	O

Received	O
fresh	O
and	O
submitted	O
for	O
frozen	O
section	O
is	O
a	O
3	O
.	O
5	O
x	O
0	O
.	O
2	O
X	O
0	O
.	O
1	O
cm	O
.	O
piece	O
of	O
red	O
-	O
tan	O
tissue	O
with	O
a	O
mucosal	O
surface	O
.	O

The	O
tissue	O
is	O
submitted	O
.	O
entirely	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
2AFSC	O
,	O
1	O
/	O
1	O
.	O

3	O
)	O
SOURCE	O
:	O
Left	O
Mucosal	O
Margin	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
and	O
submitted	O
for	O
frozen	O
section	O
labeled	O
.	O

"	O
left	O
mucosal	O
margin	O
"	O
are	O
2	O
strips	O
of	O
tissue	O
with	O
a	O
mucosal	O
surface	O
,	O
each	O
.	O
measuring	O
1	O
.	O
0	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
.	O

The	O
tissue	O
is	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
3AFSC	O
,	O
2	O
/	O
1	O
.	O

4	O
)	O
SOURCE	O
:	O
New	O
Deep	O
Right	O
Margin	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
medical	O
record	O
number	O
,	O
as	O
well	O
as	O
the	O
designation	O
"	O
new	O
deep	O
right	O
.	O

margin	O
"	O
and	O
consists	O
of	O
two	O
pieces	O
of	O
cauterized	O
red	O
,	O
soft	O
tissue	O
which	O
.	O
measures	O
4	O
.	O
0	O
X	O
3	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
and	O
4	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
.	O

The	O
entire	O
specimen	O
is	O
.	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O

Summary	O
of	O
sections	O
:	O
4AFSC	O
,	O
tissue	O
for	O
frozen	O
section	O
diagnosis	O
,	O
2	O
/	O
1	O
.	O

5	O
)	O
SOURCE	O
:	O
Right	O
Neck	O
Levels	O
2	O
-	O
5	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
neck	O
level	O
2	O
-	O
5	O
stitch	O
superior	O
"	O
is	O
a	O
radical	O
.	O
neck	O
dissection	O
with	O
a	O
possible	O
submandibular	O
gland	O
,	O
a	O
stitch	O
through	O
the	O
.	O
superior	O
margin	O
.	O

The	O
gland	O
measures	O
3	O
.	O
0	O
X	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
cm	O
.	O

The	O
remainder	O
of	O
.	O
the	O
neck	O
measures	O
10	O
.	O
0	O
X	O
6	O
.	O
0	O
X	O
2	O
.	O
2	O
cm	O
.	O

Multiple	O
metallic	O
clips	O
are	O
.	O
identified	O
.	O

No	O
jugular	O
vein	O
is	O
grossly	O
identified	O
attached	O
to	O
the	O
specimen	O
.	O

The	O
metallic	O
clips	O
are	O
removed	O
.	O

The	O
outer	O
surface	O
of	O
the	O
gland	O
is	O
inked	O
.	O

The	O
cut	O
surfaces	O
of	O
the	O
submandibular	O
gland	O
are	O
pale	O
yellow	O
-	O
white	O
,	O
vaguely	O
.	O
nodular	O
with	O
a	O
cystic	O
area	O
measuring	O
1	O
.	O
4	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
7	O
cm	O
.	O

The	O
cystic	O
area	O
.	O
contains	O
brown	O
-	O
tan	O
grumous	O
material	O
.	O

Multiple	O
candidate	O
lymph	O
nodes	O
are	O
.	O
recovered	O
.	O

Summary	O
of	O
sections	O
:	O
5A	O
-	O
5C	O
,	O
submandibular	O
gland	O
,	O
1	O
/	O
1	O
each	O
,	O
level	O
3	O
lymph	O
.	O
nodes	O
,	O
superior	O
to	O
inferior	O
5D	O
,	O
1	O
possible	O
lymph	O
node	O
,	O
2	O
/	O
1	O
;	O
5E	O
,	O
1	O
possible	O
.	O
lymph	O
node	O
,	O
2	O
/	O
1	O
;	O
5F	O
,	O
1	O
possible	O
lymph	O
node	O
,	O
5	O
/	O
1	O
;	O
5G	O
,	O
2	O
possible	O
lymph	O
.	O
nodes	O
,	O
2	O
/	O
1	O
;	O
level	O
4	O
,	O
superior	O
to	O
inferior	O
possible	O
candidate	O
lymph	O
nodes	O
;	O
.	O

5H	O
,	O
2	O
possible	O
lymph	O
nodes	O
,	O
2	O
/	O
1	O
;	O
5I	O
,	O
1	O
possible	O
lymph	O
node	O
bisected	O
,	O
2	O
/	O
1	O
;	O
.	O

5J	O
,	O
1	O
possible	O
lymph	O
node	O
bisected	O
,	O
2	O
/	O
1	O
;	O
5K	O
,	O
1	O
possible	O
lymph	O
node	O
.	O
trisected	O
,	O
3	O
/	O
1	O
;	O
5L	O
,	O
1	O
possible	O
lymph	O
node	O
bisected	O
,	O
2	O
/	O
1	O
;	O
5M	O
,	O
2	O
possible	O
.	O
lymph	O
nodes	O
,	O
2	O
/	O
1	O
each	O
,	O
level	O
5	O
lymph	O
nodes	O
superior	O
to	O
inferior	O
5N	O
-	O
5W	O
,	O
1	O
.	O
possible	O
lymph	O
node	O
in	O
each	O
cassette	O
bisected	O
,	O
2	O
/	O
1	O
each	O
;	O
5X	O
,	O
2	O
possible	O
.	O
candidate	O
lymph	O
nodes	O
,	O
2	O
/	O
1	O
;	O
5Y	O
,	O
1	O
lymph	O
node	O
bisected	O
,	O
2	O
/	O
1	O
.	O

6	O
)	O
SOURCE	O
:	O
Right	O
Neck	O
Level	O
1	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
right	O
neck	O
level	O
1	O
"	O
is	O
a	O
5	O
cm	O
X	O
3	O
cm	O
.	O

X	O
2	O
cm	O
piece	O
of	O
yellow	O
lobulated	O
tissue	O
when	O
palpated	O
reveals	O
4	O
candidate	O
.	O
lymph	O
nodes	O
.	O

Bisecting	O
these	O
lymph	O
nodes	O
reveals	O
a	O
firm	O
white	O
area	O
with	O
a	O
.	O
small	O
portion	O
of	O
grossly	O
normal	O
appearing	O
lymph	O
node	O
parenchyma	O
.	O

Summary	O
of	O
sections	O
:	O
6A	O
,	O
2	O
lymph	O
nodes	O
bisected	O
,	O
4	O
/	O
1	O
;	O
6B	O
,	O
1	O
bisected	O
lymph	O
.	O
node	O
with	O
1	O
smaller	O
lymph	O
node	O
,	O
3	O
/	O
1	O
.	O

7	O
)	O
SOURCE	O
:	O
Palate	O
.	O

Received	O
fresh	O
in	O
container	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
.	O
number	O
and	O
palate	O
,	O
is	O
a	O
4	O
.	O
5	O
X	O
4	O
.	O
0	O
X	O
1	O
.	O
2	O
cm	O
palate	O
excision	O
.	O

A	O
stitch	O
is	O
.	O
placed	O
to	O
indicate	O
the	O
anterior	O
margin	O
.	O

There	O
is	O
a	O
3	O
.	O
5	O
cm	O
X	O
2	O
.	O
7	O
cm	O
.	O
exophytic	O
lesion	O
on	O
the	O
mucosal	O
surface	O
of	O
the	O
palate	O
excision	O
.	O

This	O
lesion	O
.	O

is	O
centrally	O
located	O
within	O
the	O
mucosal	O
surface	O
and	O
is	O
grossly	O
0	O
.	O
2	O
cm	O
from	O
.	O
the	O
posterior	O
margin	O
as	O
its	O
closest	O
margin	O
.	O

It	O
is	O
located	O
0	O
.	O
3	O
cm	O
from	O
.	O
anterior	O
margin	O
,	O
0	O
.	O
7	O
cm	O
from	O
superior	O
margin	O
,	O
and	O
0	O
.	O
3	O
cm	O
from	O
inferior	O
.	O
margin	O
.	O

The	O
deep	O
margin	O
has	O
significant	O
cautery	O
artifact	O
.	O

The	O
specimen	O
is	O
.	O
inked	O
in	O
the	O
following	O
fashion	O
:	O
Deep	O
cut	O
surface	O
black	O
,	O
anterior	O
red	O
,	O
.	O
posterior	O
orange	O
,	O
superior	O
yellow	O
,	O
inferior	O
blue	O
.	O

Summary	O
of	O
sections	O
:	O
The	O
specimen	O
is	O
then	O
serially	O
sectioned	O
from	O
anterior	O
.	O
to	O
posterior	O
to	O
reveal	O
the	O
exophytic	O
mass	O
extending	O
into	O
the	O
deep	O
tissue	O
,	O
.	O
abutting	O
the	O
black	O
inked	O
margin	O
.	O

Grossly	O
,	O
the	O
specimen	O
appears	O
not	O
to	O
.	O
involve	O
the	O
remaining	O
margin	O
.	O

Representative	O
sections	O
of	O
each	O
margin	O
with	O
.	O
closest	O
tumor	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
7A	O
,	O
anterior	O
and	O
posterior	O
margin	O
,	O
2	O
/	O
1	O
;	O
7B	O
,	O
tumor	O
to	O
.	O
deep	O
black	O
margin	O
,	O
2	O
/	O
1	O
;	O
7C	O
,	O
tumor	O
closest	O
to	O
yellow	O
inked	O
margin	O
,	O
1	O
/	O
1	O
;	O
7D	O
,	O
.	O
tumor	O
closest	O
to	O
blue	O
inked	O
margin	O
,	O
1	O
/	O
1	O
;	O
7E	O
,	O
representative	O
tumor	O
to	O
blue	O
.	O
inked	O
and	O
black	O
margin	O
(	O
this	O
is	O
not	O
closest	O
margin	O
)	O
,	O
2	O
/	O
1	O
.	O

8	O
)	O
SOURCE	O
:	O
Additional	O
Right	O
Deep	O
Tissue	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
additional	O
"	O
are	O
aggregates	O
of	O
tissue	O
.	O
measuring	O
3	O
.	O
0	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
6	O
cm	O
.	O

The	O
tissue	O
has	O
cautery	O
artifact	O
associated	O
.	O
with	O
submitted	O
tissue	O
.	O

Tissue	O
is	O
submitted	O
entirely	O
over	O
two	O
cassettes	O
.	O

Summary	O
of	O
sections	O
:	O
8A	O
-	O
8B	O
,	O
M	O
/	O
1	O
each	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

SURGICAL	O
PATHOLOGY	O
INTRAOPERATIVE	O
CONSULTATION	O
.	O

1	O
)	O
SOURCE	O
:	O
Deep	O
Right	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
INVOLVED	O
BY	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

2	O
)	O
SOURCE	O
:	O
Posterior	O
Mucosal	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

J	O
.	O

3	O
)	O
SOURCE	O
:	O
Left	O
Mucosal	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

4	O
)	O
SOURCE	O
:	O
New	O
Deep	O
Right	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

SNOMED	O
:	O
T	O
-	O
01000	O
,	O
T	O
-	O
01000	O
,	O
M	O
-	O
80103	O
-	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
LEFT	O
DISTAL	O
URETER	O
.	O

INK	O
AT	O
MARGIN	O
:	O
Segment	O
of	O
ureter	O
,	O
no	O
tumor	O
present	O
.	O

(	O
B	O
)	O
RIGHT	O
DISTAL	O
URETER	O
,	O
INK	O
AT	O
MARGIN	O
:	O
Segment	O
of	O
ureter	O
,	O
no	O
tumor	O
present	O
.	O

(	O
C	O
)	O
BLADDER	O
,	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
:	O
BLADDER	O
-	O
.	O

UROTHELIAL	O
CARCINOMA	O
NON	O
-	O
PAPILLARY	O
TYPE	O
,	O
HIGH	O
GRADE	O
WITH	O
FOCAL	O
.	O

SQUAMOUS	O
DIFFERENTIATION	O
.	O

TUMOR	O
INVADES	O
BLADDER	O
WALL	O
TRANSMURALLY	O
AND	O
EXTENDS	O
TO	O
.	O

PERIVESICAL	O
FAT	O
.	O

Serosal	O
surface	O
,	O
free	O
of	O
tumor	O
.	O

No	O
lymphovascular	O
invasion	O
is	O
identified	O
.	O

Resection	O
margins	O
,	O
free	O
of	O
tumor	O
.	O

PROSTATE	O
-	O
.	O

UROTHELIAL	O
CARCINOMA	O
EXTENDS	O
TO	O
THE	O
PERIURETHRAL	O
PROSTATIC	O
.	O

DUCTS	O
AND	O
SHOWS	O
SUPERFICIAL	O
.	O

INVASION	O
OF	O
THE	O
PERIDUCTAL	O
STROMA	O
.	O

Prostatic	O
tissue	O
with	O
glandular	O
atrophy	O
,	O
paribasal	O
cell	O
hyperplasia	O
with	O
atypia	O
consistent	O
.	O
with	O
treatment	O
effect	O
.	O

No	O
evidence	O
of	O
residual	O
prostatic	O
carcinoma	O
.	O

Prostatic	O
tissue	O
with	O
chronic	O
and	O
focally	O
acute	O
inflammation	O
.	O

(	O
D	O
)	O
LEFT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODES	O
:	O
Four	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
4	O
)	O
.	O

(	O
E	O
)	O
LEFT	O
OBTURATOR	O
LYMPH	O
NODES	O
:	O
Nine	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
9	O
)	O
.	O

(	O
F	O
)	O
LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODES	O
:	O
Four	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
4	O
)	O
.	O

(	O
G	O
)	O
RIGHT	O
OBTURATOR	O
LYMPH	O
NODES	O
:	O
Eight	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
8	O
)	O
.	O

(	O
H	O
)	O
RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODES	O
:	O
Four	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
4	O
)	O
.	O

(	O
I	O
)	O
RIGHT	O
COMMON	O
ILIAC	O
LYMPH	O
NODES	O
:	O
One	O
lymph	O
node	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
1	O
)	O
.	O

(	O
J	O
)	O
LEFT	O
URETER	O
,	O
FINAL	O
MARGIN	O
:	O
Wall	O
of	O
ureter	O
with	O
unremarkable	O
urothelium	O
.	O

(	O
K	O
)	O
RIGHT	O
URETER	O
,	O
FINAL	O
MARGIN	O
:	O
Wall	O
of	O
ureter	O
with	O
unremarkable	O
urothelium	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
LEFT	O
DISTAL	O
URETER	O
-	O
A	O
segment	O
of	O
ureter	O
(	O
0	O
.	O
8	O
cm	O
in	O
length	O
)	O
with	O
marked	O
true	O
.	O
margin	O
.	O

The	O
margin	O
submitted	O
en	O
face	O
for	O
frozen	O
in	O
A	O
.	O

FS	O
/	O
DX	O
:	O
URETER	O
.	O

NEGATIVE	O
FOR	O
CARCINOMA	O
OR	O
HIGH	O
-	O
GRADE	O
.	O

DYSPLASIA	O
.	O

BAC	O
:	O
(	O
B	O
)	O
RIGHT	O
DISTAL	O
URETER	O
-	O
A	O
1	O
.	O
5	O
cm	O
segment	O
of	O
ureter	O
with	O
true	O
margin	O
marked	O
.	O

The	O
.	O
margin	O
submitted	O
en	O
face	O
for	O
frozen	O
section	O
in	O
B	O
.	O

FS	O
/	O
DX	O
:	O
URETER	O
.	O

NEGATIVE	O
FOR	O
CARCINOMA	O
OR	O
HIGH	O
-	O
GRADE	O
.	O

DYSPLASIA	O
.	O

BAC	O
:	O
(	O
C	O
)	O
BLADDER	O
,	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
-	O
A	O
radical	O
cystoprostatectomy	O
.	O
specimen	O
consisting	O
of	O
a	O
urinary	O
bladder	O
(	O
12	O
x	O
10	O
x	O
2	O
cm	O
opened	O
)	O
,	O
prostate	O
gland	O
(	O
4	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
3	O
.	O
cm	O
)	O
,	O
seminal	O
vesicles	O
and	O
attached	O
perivesical	O
adipose	O
tissue	O
measuring	O
overall	O
16	O
x	O
14	O
x	O
4	O
cm	O
.	O

Located	O
in	O
the	O
left	O
lateral	O
wall	O
and	O
anterior	O
wall	O
of	O
the	O
bladder	O
is	O
an	O
exophytic	O
tumor	O
(	O
5	B
.	I
5	I
x	I
3	I
.	I
9	I
.	I
cm	I
)	O
.	O

The	O
tumor	O
invades	O
into	O
the	O
bladder	O
wall	O
and	O
extends	O
into	O
the	O
perivesical	O
fat	O
.	O

The	O
tumor	O
.	O
does	O
not	O
extend	O
to	O
the	O
inked	O
margin	O
of	O
the	O
specimen	O
.	O

The	O
right	O
and	O
left	O
ureteral	O
orifices	O
are	O
not	O
.	O
involved	O
by	O
tumor	O
.	O

The	O
prostatic	O
tissue	O
is	O
firm	O
.	O

No	O
gross	O
lesions	O
are	O
identified	O
within	O
the	O
prostate	O
.	O

Tissue	O
is	O
.	O
submitted	O
for	O
tumor	O
bank	O
.	O

Representative	O
section	O
of	O
bladder	O
wall	O
and	O
attached	O
prostate	O
are	O
.	O
submitted	O
as	O
per	O
enclosed	O
map	O
of	O
cystoprostatectomy	O
specimen	O
.	O

SECTION	O
CODE	O
:	O
C1	O
-	O
C47	O
,	O
sections	O
of	O
the	O
bladder	O
including	O
tumor	O
submitted	O
.	O
sequentially	O
from	O
the	O
dome	O
to	O
the	O
bladder	O
base	O
;	O
C48	O
-	O
C57	O
,	O
sections	O
of	O
the	O
prostate	O
gland	O
.	O
including	O
seminal	O
vesicles	O
;	O
C58	O
,	O
urethral	O
margin	O
.	O

(	O
D	O
)	O
LEFT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
-	O
A	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
2	O
cm	O
aggregate	O
of	O
.	O
fibroadipose	O
tissue	O
.	O

The	O
tissue	O
is	O
dissected	O
to	O
reveal	O
five	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
5	O
.	O

x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
-	O
2	O
.	O
0	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
.	O

SECTION	O
CODE	O
:	O
D1	O
,	O
two	O
possible	O
lymph	O
nodes	O
;	O
D2	O
,	O
two	O
possible	O
lymph	O
nodes	O
;	O
D3	O
,	O
.	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
.	O

(	O
E	O
)	O
LEFT	O
OBTURATOR	O
LYMPH	O
NODE	O
-	O
A	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
aggregate	O
of	O
fibroadipose	O
.	O
tissue	O
.	O

The	O
tissue	O
is	O
dissected	O
to	O
reveal	O
ten	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
.	O

cm	O
-	O
2	O
.	O
2	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
7	O
cm	O
.	O

SECTION	O
CODE	O
:	O
E1	O
,	O
two	O
possible	O
lymph	O
nodes	O
;	O
E2	O
,	O
three	O
possible	O
lymph	O
nodes	O
;	O
E3	O
,	O
.	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
;	O
E4	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
;	O
E5	O
,	O
.	O
one	O
possible	O
lymph	O
nodes	O
serially	O
sectioned	O
;	O
E6	O
,	O
one	O
possible	O
lymph	O
nodes	O
serially	O
sectioned	O
;	O
.	O

E7	O
,	O
E8	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
.	O

(	O
F	O
)	O
LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODES	O
-	O
A	O
3	O
.	O
0	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
fibroadipose	O
.	O
tissue	O
.	O

The	O
tissue	O
is	O
dissected	O
to	O
reveal	O
four	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
.	O

cm	O
-	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

SECTION	O
CODE	O
:	O
F1	O
,	O
three	O
possible	O
lymph	O
nodes	O
;	O
F2	O
,	O
F3	O
,	O
one	O
possible	O
lymph	O
node	O
.	O
serially	O
sectioned	O
.	O

Entire	O
specimen	O
is	O
submitted	O
.	O

(	O
G	O
)	O
RIGHT	O
OBTURATOR	O
LYMPH	O
NODE	O
-	O
A	O
5	O
.	O
0	O
x	O
5	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
fibroadipose	O
.	O
tissue	O
.	O

The	O
tissue	O
is	O
dissected	O
to	O
reveal	O
eight	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
.	O

cm	O
-	O
3	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

SECTION	O
CODE	O
:	O
G1	O
,	O
one	O
possible	O
lymph	O
node	O
;	O
G2	O
,	O
two	O
possible	O
lymph	O
nodes	O
;	O
G3	O
,	O
two	O
.	O
possible	O
lymph	O
nodes	O
;	O
G4	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
;	O
G5	O
,	O
one	O
possible	O
lymph	O
.	O
node	O
serially	O
sectioned	O
;	O
G6	O
,	O
G7	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
.	O

(	O
H	O
)	O
RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
-	O
A	O
4	O
.	O
7	O
x	O
4	O
.	O
0	O
x	O
1	O
.	O
8	O
cm	O
aggregate	O
of	O
.	O
fibroadipose	O
tissue	O
.	O

The	O
tissue	O
was	O
dissected	O
to	O
reveal	O
five	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
.	O

0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
-	O
2	O
.	O
5	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
8	O
cm	O
.	O

SECTION	O
CODE	O
:	O
H1	O
,	O
one	O
possible	O
lymph	O
node	O
;	O
H2	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
.	O
sectioned	O
;	O
H3	O
,	O
one	O
possible	O
node	O
serially	O
sectioned	O
;	O
H4	O
,	O
H5	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
.	O
sectioned	O
;	O
H6	O
,	O
H7	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
.	O

(	O
I	O
)	O
RIGHT	O
COMMON	O
ILIAC	O
LYMPH	O
NODE	O
-	O
A	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
3	O
cm	O
lymph	O
node	O
.	O

SECTION	O
CODE	O
:	O
Il	O
and	O
I2	O
,	O
one	O
possible	O
lymph	O
node	O
serially	O
sectioned	O
.	O

Entire	O
.	O
specimen	O
is	O
submitted	O
.	O

(	O
J	O
)	O
LEFT	O
URETER	O
,	O
FINAL	O
MARGIN	O
-	O
A	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
portion	O
of	O
ureter	O
that	O
is	O
oriented	O
by	O
the	O
.	O
surgeon	O
with	O
a	O
suture	O
.	O

The	O
side	O
where	O
the	O
suture	O
is	O
inked	O
blue	O
and	O
the	O
opposite	O
side	O
is	O
inked	O
.	O
black	O
.	O

SECTION	O
CODE	O
:	O
J1	O
,	O
side	O
with	O
the	O
suture	O
,	O
en	O
face	O
;	O
J2	O
,	O
side	O
opposite	O
suture	O
,	O
en	O
face	O
.	O

(	O
K	O
)	O
RIGHT	O
URETER	O
,	O
FINAL	O
MARGIN	O
-	O
A	O
2	O
.	O
0	O
x	O
0	O
.	O
2	O
cm	O
portion	O
of	O
ureter	O
that	O
is	O
oriented	O
by	O
.	O
the	O
surgeon	O
with	O
a	O
suture	O
on	O
one	O
end	O
.	O

The	O
side	O
where	O
the	O
suture	O
is	O
inked	O
blue	O
and	O
the	O
opposite	O
.	O
side	O
is	O
inked	O
black	O
.	O

SECTION	O
CODE	O
:	O
K1	O
,	O
side	O
with	O
suture	O
,	O
en	O
face	O
;	O
K2	O
,	O
side	O
opposite	O
suture	O
,	O
en	O
face	O
.	O

CLINICAL	O
HISTORY	O
.	O

None	O
given	O
.	O

Microscopic	O
Description	O
:	O
Sections	O
demonstrate	O
sheets	O
of	O
poorly	O
cohesive	O
,	O
large	O
cells	O
.	O

These	O
have	O
large	O
atypical	O
,	O
somewhat	O
open	O
.	O
nuclei	O
,	O
usually	O
with	O
multiple	O
nucleoli	O
.	O

They	O
have	O
only	O
a	O
modest	O
amount	O
of	O
cytoplasm	O
.	O

Numerous	O
mitotic	O
.	O
figures	O
are	O
seen	O
.	O

Individual	O
apoptotic	O
cells	O
are	O
seen	O
without	O
frank	O
necrosis	O
.	O

The	O
tumor	O
has	O
an	O
expansive	O
.	O
interface	O
with	O
the	O
surrounding	O
parenchyma	O
but	O
an	O
angiocentric	O
pattern	O
is	O
also	O
appreciated	O
.	O

Areas	O
of	O
.	O
apparent	O
glial	O
and	O
fibrous	O
scarring	O
are	O
also	O
noted	O
.	O

Diagnosis	O
:	O
Brainstem	O
Tumor	O
:	O
diffuse	O
Large	O
Cell	O
Lymphoma	O
,	O
B	O
-	O
cell	O
type	O
.	O

PERMANENT	O
CHART	O
COPY	O
.	O

NEUROPATHOLOGY	O
REPORT	O
.	O

GROSS	O
DESCRIPTION	O
:	O
MICROSCOPIC	O
DESCRIPTION	O
:	O
1	O
,	O
2	O
.	O

Sections	O
demonstrate	O
sheets	O
of	O
poorly	O
cohesive	O
,	O
large	O
cells	O
.	O

These	O
have	O
.	O
large	O
atypical	O
,	O
somewhat	O
open	O
nuclei	O
,	O
usually	O
with	O
multiple	O
nucleoli	O
.	O

They	O
.	O
have	O
only	O
a	O
modest	O
amount	O
of	O
cytoplasm	O
.	O

Numerous	O
mitotic	O
figures	O
are	O
seen	O
.	O

Individual	O
apoptotic	O
cells	O
are	O
seen	O
without	O
frank	O
necrosis	O
.	O

The	O
tumor	O
has	O
an	O
.	O
expansive	O
interface	O
with	O
the	O
surrounding	O
parenchyma	O
but	O
an	O
angiocentric	O
.	O
pattern	O
is	O
also	O
appreciated	O
.	O

Areas	O
of	O
apparent	O
glial	O
and	O
fibrous	O
scarring	O
are	O
.	O
also	O
noted	O
.	O

The	O
neoplastic	O
cells	O
are	O
immunoreactive	O
for	O
CD45	O
and	O
CD20	O
,	O
confirming	O
B	O
-	O
cell	O
.	O
lymphocytic	O
origin	O
.	O

They	O
are	O
negative	O
for	O
GFAP	O
,	O
S	O
-	O
100	O
and	O
cytokeratin	O
8	O
/	O
18	O
.	O

The	O
neoplastic	O
cells	O
demonstrate	O
aberrant	O
expression	O
of	O
the	O
T	O
-	O
cell	O
marker	O
CD43	O
.	O
but	O
are	O
negative	O
for	O
CD3	O
and	O
CD45	O
ro	O
.	O

They	O
demonstrate	O
BCL2	O
and	O
BCL6	O
.	O
positivity	O
but	O
are	O
negative	O
for	O
CD10	O
.	O

Overall	O
,	O
the	O
immunophenotype	O
is	O
.	O
consistent	O
with	O
a	O
diffuse	O
large	O
cell	O
B	O
-	O
cell	O
lymphoma	O
.	O

DIAGNOSIS	O
:	O
(	O
PROVISIONAL	O
)	O
.	O

1	O
,	O
2	O
.	O

BRAINSTEM	O
TUMOR	O
,	O
BIOPSIES	O
:	O
DIFFUSE	O
CELL	O
B	O
-	O
CELL	O
TYPE	O
.	O

The	O
LARGE	O
tumor	O
LYMPHOMA	O
,	O
is	O
negative	O
for	O
test	O
co3	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LEFI	O
BREAST	O
,	O
SEGMENTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
NOTTINGHAM	O
SCORE	O
8	O
/	O
9	O
(	O
TUBULES	O
3	O
,	O
NUCLEI	O
3	O
,	O
MITOSIS	O
2	O
)	O
,	O
2	B
.	I
6	I
CM	I
.	O

B	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
MICROPAPILLARY	O
AND	O
SOLID	O
TYPES	O
WITH	O
COMEDO	O
NECROSIS	O
,	O
NUCLEAR	O
.	O

GRADE	O
3	O
,	O
REPRESENTING	O
5	O
%	O
OF	O
THE	O
TUMOR	O
VOLUME	O
.	O

C	O
.	O

LYMPHOVASCULAR	O
SPACE	O
INVOLVEMENT	O
SEEN	O
.	O

D	O
.	O

INVASIVE	O
CARCINOMA	O
IS	O
0	O
.	O
1	O
CM	O
FROM	O
INFERIOR	O
MARGIN	O
.	O

E	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
IS	O
<	O
0	O
.	O
1	O
CM	O
(	O
1MM	O
)	O
FROM	O
INFERIOR	O
MARGIN	O
.	O

F	O
.	O

MARGINS	O
FREE	O
OF	O
LESION	O
.	O

G	O
.	O

MICROCALCIFICATION	O
ASSOCIATED	O
WITH	O
BENIGN	O
CHANGES	O
AND	O
TUMOR	O
.	O

H	O
.	O

CHANGES	O
CONSISTENT	O
WITH	O
BIOPSY	O
SITE	O
.	O

I	O
.	O

PROLIFERATIVE	O
FIBROCYSTIC	O
CHANGES	O
WITH	O
ATYPICAL	O
DUCTAL	O
EPITHELIAL	O
HYPERPLASIA	O
AND	O
.	O

COLUMNAR	O
CELL	O
CHANGES	O
.	O

J	O
.	O

MICROSCOPIC	O
PERIPHERAL	O
PAPILLOMA	O
AND	O
SCLEROSING	O
ADENOSIS	O
.	O

K	O
.	O

SKIN	O
NOT	O
REMARKABLE	O
.	O

PART	O
2	O
:	O
LEFT	O
AXILLA	O
,	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
EXCISION	O
-	O
.	O

A	O
.	O

ONE	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
.	O
9	O
CM	O
)	O
.	O

B	O
.	O

NO	O
EXTRACAPSULAR	O
EXTENSION	O
SEEN	O
.	O

PART	O
3	O
:	O
LEFT	O
AXILLA	O
,	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
,	O
EXCISION	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
WITH	O
RARE	O
CLUSTERS	O
OF	O
METASTATIC	O
TUMOR	O
CELLS	O
IN	O
PERIPHERAL	O
SINUS	O
.	O

PART	O
4	O
:	O
LEFT	O
AXILLA	O
,	O
LYMPH	O
NODE	O
EXCISION	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
WITH	O
EXTENSIVE	O
THERMAL	O
EFFECT	O
,	O
PROBABLY	O
FREE	O
OF	O
TUMOR	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Left	O
.	O

PROCEDURE	O
:	O
Segmental	O
.	O

Lower	O
outer	O
quadrant	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
2	B
.	I
6	I
cm	I
.	O

TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitotic	O
activity	O
score	O
:	O
2	O
.	O

Total	O
Nottingham	O
score	O
:	O
8	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
3	O
.	O

DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
CALCIFICATION	O
:	O
Yes	O
,	O
benign	O
zones	O
.	O

TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Yes	O
,	O
malignant	O
zones	O
.	O

Soia	O
.	O

Micropapillary	O
.	O

Comedo	O
.	O

DCIS	O
admixed	O
and	O
outside	O
of	O
invasive	O
carcinoma	O
component	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Percent	O
of	O
tumor	O
occupied	O
by	O
in	O
situ	O
component	O
:	O
5	O
%	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
Distance	O
of	O
invasive	O
tumor	O
to	O
closest	O
margin	O
:	O
1	O
mm	O
.	O

PAGET	O
'	O
S	O
DISEASE	O
OF	O
NIPPLE	O
:	O
Distance	O
of	O
in	O
situ	O
disease	O
to	O
closest	O
margin	O
:	O
0	O
.	O
7	O
mm	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
2	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
3	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
.	O

SENTINEL	O
NODE	O
METASTASIS	O
:	O
SIZE	O
OF	O
NODAL	O
METASTASES	O
:	O
LYMPH	O
NODE	O
METASTASIS	O
(	O
-	O
ES	O
)	O
WITH	O
EXTRACAPSULAR	O
EXTENSION	O
:	O
Diameter	O
of	O
largest	O
lymph	O
node	O
metastasis	O
:	O
9	O
mm	O
.	O

SKIN	O
INVOLVED	O
(	O
ULCERATION	O
)	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
ADH	O
,	O
Papilloma	O
,	O
FCD	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT2	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1a	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
positive	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
positive	O
.	O

PATIENT	O
HISTORY	O
:	O
SPECIMENS	O
TAKEN	O
BY	O
PATH	O
DATE	O
of	O
LMP	O
:	O
(	O
NOT	O
LISTED	O
ON	O
REQUISITION	O
)	O
.	O

DATE	O
or	O
LAST	O
DELIVERY	O
:	O
PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
RIGHT	O
BREAST	O
CANCER	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
SAME	O
.	O

OPERATIVE	O
PROCEDURE	O
:	O
R	O
SENTINEL	O
LYMPH	O
NODE	O
,	O
R	O
SEGMENTAL	O
MASTECTOMY	O
.	O

CLINICAL	O
HISTORY	O
:	O
SPECIMENS	O
TAKEN	O
BY	O
PATH	O
.	O

MATERIAL	O
SUBMITTED	O
:	O
A	O
)	O
RIGHT	O
SENTINEL	O
LYMPH	O
NODE	O
,	O
PROCUREMENT	O
BY	O
SURGICAL	O
PROCEDURE	O
.	O

B	O
)	O
RIGHT	O
BREAST	O
BICPSY	O
/	O
TISSUE	O
,	O
PROCUREMENT	O
BY	O
SURGICAL	O
PROCEDURE	O
.	O

Long	O
-	O
lat	O
,	O
med	O
-	O
med	O
,	O
sht	O
-	O
superior	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
R	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
:	O
One	O
lymph	O
node	O
,	O
0	O
.	O
8	O
by	O
0	O
.	O
6	O
by	O
0	O
.	O
5	O
cm	O
.	O

Touch	O
Prep	O
.	O

Diagnosis	O
:	O
Negative	O
.	O

ADDENDA	O
:	O
Addendum	O
.	O

FISH	O
analysis	O
using	O
DNA	O
probe	O
for	O
Her	O
-	O
2	O
/	O
neu	O
gene	O
showed	O
that	O
,	O
the	O
ratio	O
of	O
Her	O
-	O
2	O
/	O
neu	O
signals	O
to	O
chromosome	O
17	O
.	O
centromere	O
signais	O
is	O
0	O
.	O
94	O
(	O
>	O
2	O
.	O
0	O
ratio	O
is	O
considered	O
amplified	O
)	O
.	O

Therefore	O
,	O
Her	O
-	O
2	O
/	O
neu	O
gene	O
is	O
not	O
amplified	O
.	O

Bv	O
Pathologi	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
submitted	O
material	O
(	O
s	O
)	O
and	O
the	O
above	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

Addendum	O
.	O

MATERIAL	O
SUBMITTED	O
:	O
BLOCK	O
"	O
B3	O
"	O
FOR	O
ER	O
/	O
PR	O
AND	O
HER	O
-	O
2	O
/	O
NEU	O
(	O
BREAST	O
CANCER	O
)	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
ESTROGEN	O
/	O
PROGESTERONT	O
RECEPTORS	O
AND	O
HER	O
-	O
2	O
/	O
NEU	O
PERFORMED	O
ON	O
RIGHT	O
BREAST	O
TISSUE	O
.	O

ESTROGEN	O
RECEPTOR	O
(	O
0	O
-	O
40	O
%	O
;	O
1	O
+	O
40	O
%	O
;	O
2	O
+	O
10	O
%	O
;	O
3	O
+	O
10	O
%	O
)	O
HSCORE	O
OF	O
90	O
.	O

ESTROGEN	O
RECEPTOR	O
IS	O
INTERPRETED	O
AS	O
.	O

POSITIVE	O
.	O

PROGESTERONS	O
RECEPTOR	O
(	O
0	O
-	O
70	O
%	O
;	O
1	O
+	O
10	O
%	O
;	O
2	O
+	O
10	O
%	O
;	O
3	O
+	O
10	O
%	O
)	O
HSCORE	O
OF	O
60	O
.	O

PROGESTERONI	O
RECEPTOR	O
IS	O
INTERPRETED	O
AS	O
.	O

POSITIVE	O
.	O

HER	O
-	O
2	O
/	O
NEU	O
-	O
DAKO	O
HERCEPTEST	O
.	O

A	O
WEAK	O
TO	O
MODERATE	O
COMPLETE	O
MEMBRANE	O
STAINING	O
IS	O
OBSERVED	O
IN	O
MORE	O
THAN	O
10	O
%	O
OF	O
THE	O
.	O

TUMOR	O
CELLS	O
.	O

HER	O
-	O
2	O
/	O
NEU	O
IS	O
INTERPRETED	O
AS	O
POSITIVE	O
(	O
SCORE	O
2	O
+	O
)	O
.	O

HSCORE	O
:	O
<	O
=	O
15	O
NEGATIVE	O
.	O

>	O
15	O
<	O
=	O
30	O
BORDERLINE	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
FINAL	O
DIAGNOSIS	O
:	O
A	O
)	O
RIGHT	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
:	O
-	O
MICROMIETASTATIC	O
DUCTAL	O
CARCINOMA	O
OF	O
THE	O
BREAST	O
(	O
SEE	O
NOTE	O
)	O
.	O

B	O
)	O
RIGHT	O
SEGMENTAL	O
MASTECTOMY	O
:	O
INFILTRATING	O
MODERATELY	O
DIFFERENTIATED	O
DUCTAL	O
CARCINOMA	O
)	O
NOTTINGHAM	O
SCORE	O
6	O
/	O
9	O
(	O
TUBULES	O
=	O
3	O
,	O
NUCLEI	O
=	O
2	O
,	O
.	O
MITOSIS	O
-	O
1	O
)	O
SIZE	O
2	B
.	I
5	I
BY	I
2	I
.	I
0	I
BY	I
1	I
.	I
5	I
CX	I
.	O

-	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
NON	O
-	O
COMEDO	O
TYPE	O
,	O
SOLID	O
AND	O
CRIBRIFORK	O
)	O
NUCLEAR	O
GRADK	O
1	O
,	O
CONSTITUTES	O
5	O
%	O
or	O
.	O

ENTIRE	O
.	O

TUMOR	O
MASS	O
.	O

-	O
SEVERAL	O
MICROSCOPIC	O
FOCI	O
OF	O
INFILTRATING	O
ADENOCARCINOMA	O
,	O
UP	O
TO	O
0	B
.	I
5	I
CM	I
,	O
IN	O
THE	O
REMAINING	O
BREAST	O
TISSUE	O
.	O

#	O
9	O
,	O
#	O
12	O
)	O
.	O

-	O
LATERAL	O
AND	O
INFERIOR	O
SURGICAL	O
MARGINS	O
POSITIVE	O
FOR	O
INVASIVE	O
TUMOR	O
.	O

-	O
INTRADUCTAL	O
PAPILLOMA	O
AND	O
PROLIFERATIVE	O
FIBROCYSTIC	O
CHANGES	O
IN	O
THE	O
REMAINING	O
BREAST	O
TISSUE	O
.	O

FOCAL	O
NECROSIS	O
AND	O
GRANULATION	O
TISSUL	O
,	O
STATUS	O
-	O
POST	O
CORE	O
BIOPSY	O
or	O
BREAST	O
(	O
CROSS	O
REFER	O
.	O

NOTE	O
:	O
Minute	O
clusters	O
of	O
metastatic	O
ductal	O
carcinoma	O
was	O
found	O
in	O
serial	O
section	O
"	O
Al	O
"	O
,	O
but	O
it	O
ie	O
best	O
.	O
visualized	O
with	O
the	O
immunoperoxidase	O
stain	O
AB1	O
/	O
AR3	O
in	O
serial	O
section	O
A2	O
.	O

The	O
immunostain	O
was	O
repeated	O
and	O
.	O
the	O
presence	O
of	O
metastatic	O
neoplastic	O
cells	O
in	O
the	O
lymph	O
node	O
section	O
"	O
Al	O
"	O
was	O
confirmed	O
by	O
.	O
immunostaining	O
(	O
"	O
A26A3	O
"	O
)	O
.	O

The	O
later	O
serial	O
sections	O
of	O
the	O
lymph	O
nodes	O
are	O
negative	O
.	O

The	O
touch	O
prep	O
of	O
.	O
the	O
.	O

sentinel	O
node	O
was	O
re	O
-	O
reviewed	O
and	O
no	O
malignant	O
cells	O
are	O
identified	O
ER	O
/	O
PR	O
immunoperoxidase	O
assay	O
and	O
Her	O
-	O
.	O

2	O
/	O
NEU	O
testing	O
will	O
be	O
performed	O
on	O
block	O
"	O
B3	O
"	O
.	O

The	O
special	O
stains	O
and	O
/	O
or	O
immunoperoxidase	O
tests	O
used	O
in	O
thi	O
~	O
ase	O
hatra	O
bean	O
and	O
their	O
performance	O
.	O
characterietics	O
determined	O
by	O
the	O
Department	O
of	O
Pathology	O
at	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

SPECIMEN	O
:	O
Sex	O
:	O
F	O
.	O

Date	O
Collected	O
:	O
Date	O
Received	O
:	O
Clinical	O
History	O
/	O
Diagnosis	O
:	O
Left	O
breast	O
cancer	O
.	O

Source	O
of	O
Specimen	O
(	O
s	O
)	O
:	O
1	O
:	O
Sentinel	O
Nodes	O
-	O
left	O
axilla	O
.	O

2	O
:	O
left	O
breast	O
lumpectomy	O
.	O

3	O
:	O
Margin	O
-	O
final	O
medial	O
.	O

Gross	O
Description	O
:	O
Received	O
in	O
three	O
parts	O
.	O

Source	O
of	O
Tissue	O
:	O
1	O
.	O

Labeled	O
#	O
1	O
,	O
"	O
sentinel	O
node	O
left	O
axilla	O
"	O
.	O

Touch	O
Preparation	O
Evaluation	O
:	O
1TP	O
-	O
NO	O
TUMOR	O
SEEN	O
PER	O
.	O

(	O
VERIFIED	O
)	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
/	O
touch	O
.	O
impression	O
in	O
a	O
container	O
labeled	O
"	O
sentinel	O
node	O
left	O
axilla	O
"	O
.	O

It	O
consists	O
of	O
a	O
tan	O
to	O
light	O
.	O
brown	O
rubbery	O
lymph	O
node	O
measuring	O
1	O
.	O
6	O
x	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
cm	O
.	O

There	O
is	O
a	O
stitch	O
at	O
one	O
end	O
.	O
marking	O
the	O
bluest	O
portion	O
.	O

The	O
node	O
is	O
sectioned	O
.	O

Touch	O
impression	O
of	O
the	O
bluest	O
.	O
end	O
was	O
submitted	O
as	O
1TPA	O
and	O
the	O
tissue	O
is	O
subsequently	O
submitted	O
in	O
1A	O
.	O

Touch	O
impression	O
of	O
the	O
opposite	O
end	O
was	O
submitted	O
as	O
1TPB	O
and	O
.	O
subsequently	O
the	O
tissue	O
is	O
submitted	O
in	O
1B	O
.	O

Source	O
of	O
Tissue	O
:	O
2	O
.	O

Labeled	O
#	O
2	O
,	O
"	O
left	O
breast	O
lumpectomy	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
left	O
breast	O
lumpectomy	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
7	O
.	O
4	O
x	O
7	O
.	O
4	O
x	O
3	O
.	O
5	O
cm	O
ovoid	O
rubbery	O
fragment	O
of	O
fibroadipose	O
tissue	O
.	O

There	O
is	O
a	O
.	O
short	O
stitch	O
marking	O
the	O
superior	O
and	O
a	O
long	O
marking	O
the	O
lateral	O
.	O

The	O
anterior	O
is	O
.	O
inked	O
blue	O
and	O
the	O
remaining	O
margins	O
are	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
.	O
sectioned	O
disclosing	O
a	O
large	O
firm	O
tan	O
lesion	O
with	O
moderately	O
defined	O
.	O
borders	O
measuring	O
3	O
.	O
8	O
x	O
2	O
.	O
6	O
x	O
1	O
.	O
9	O
cm	O
.	O

The	O
lesion	O
occupies	O
an	O
appreciable	O
.	O
amount	O
of	O
the	O
lumpectomy	O
specimen	O
.	O

Laterally	O
in	O
the	O
tumor	O
there	O
is	O
.	O
inspissated	O
blood	O
consistent	O
with	O
previous	O
biopsy	O
site	O
changes	O
.	O

The	O
.	O
lesion	O
comes	O
very	O
close	O
to	O
the	O
medial	O
,	O
superior	O
,	O
and	O
anterior	O
resection	O
.	O
margins	O
.	O

Also	O
adjacently	O
the	O
breast	O
parenchyma	O
is	O
fibrous	O
and	O
there	O
is	O
a	O
.	O

0	O
.	O
4	O
cm	O
blue	O
dome	O
cyst	O
noted	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O

2A	O
-	O
K	O
.	O

Designation	O
of	O
Sections	O
:	O
2A	O
-	O
2C	O
-	O
breast	O
tissue	O
with	O
tumor	O
in	O
relationship	O
.	O
to	O
anterior	O
margin	O
,	O
2D	O
-	O
2F	O
-	O
breast	O
tissue	O
with	O
tumor	O
in	O
relationship	O
to	O
.	O
posterior	O
margin	O
,	O
2G	O
-	O
additional	O
sections	O
of	O
tumor	O
,	O
no	O
margins	O
are	O
.	O
represented	O
with	O
biopsy	O
site	O
,	O
2H	O
-	O
perpendicular	O
sections	O
of	O
superior	O
.	O
resection	O
margin	O
,	O
2I	O
-	O
perpendicular	O
sections	O
of	O
medial	O
resection	O
margin	O
.	O

[	O
Note	O
:	O
specimen	O
3	O
presumably	O
supercedes	O
this	O
margin	O
.	O
]	O
,	O
2J	O
-	O
perpendicular	O
.	O
sections	O
of	O
inferior	O
margin	O
,	O
2K	O
-	O
perpendicular	O
sections	O
of	O
lateral	O
margin	O
.	O

Source	O
of	O
Tissue	O
:	O
3	O
.	O

Labeled	O
#	O
3	O
,	O
"	O
final	O
medial	O
margin	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
final	O
medial	O
margin	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
fragment	O
of	O
fibroadipose	O
tissue	O
measuring	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

There	O
is	O
a	O
.	O
stitch	O
marking	O
the	O
final	O
margin	O
which	O
is	O
inked	O
black	O
prior	O
to	O
sectioning	O
.	O

Sections	O
disclose	O
no	O
obvious	O
residual	O
lesional	O
tissue	O
.	O

Entirely	O
submitted	O
.	O
in	O
3A	O
and	O
3B	O
.	O

Final	O
Diagnosis	O
:	O
1	O
.	O

Sentinel	O
lymph	O
node	O
,	O
left	O
axilla	O
,	O
excision	O
:	O
-	O
One	O
lymph	O
node	O
with	O
no	O
tumor	O
seen	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
Negative	O
immunohistochemical	O
staining	O
for	O
cytokeratin	O
AE1	O
/	O
AE3	O
.	O

2	O
.	O

Left	O
breast	O
,	O
lumpectomy	O
:	O
Invasive	O
and	O
in	O
situ	O
lobular	O
carcinoma	O
.	O

-	O
Invasive	O
lobular	O
carcinoma	O
,	O
3	B
.	I
8	I
cm	I
in	O
greatest	O
dimension	O
grossly	O
,	O
grade	O
.	O

II	O
-	O
III	O
.	O

Lobular	O
carcinoma	O
in	O
situ	O
,	O
nuclear	O
grade	O
II	O
-	O
III	O
,	O
comprising	O
.	O
approximately	O
5	O
%	O
of	O
the	O
tumor	O
mass	O
.	O

-	O
Lymphovascular	O
invasion	O
is	O
not	O
identified	O
.	O

-	O
Invasive	O
carcinoma	O
is	O
less	O
than	O
1mm	O
to	O
the	O
inked	O
closest	O
medial	O
margin	O
.	O

(	O
see	O
specimen	O
3	O
for	O
final	O
medial	O
margin	O
status	O
)	O
,	O
and	O
remaining	O
margins	O
.	O
with	O
no	O
tumor	O
seen	O
.	O

-	O
Changes	O
consistent	O
with	O
prior	O
biopsy	O
site	O
seen	O
.	O

Non	O
-	O
neoplastic	O
breast	O
tissue	O
shows	O
fibrocystic	O
changes	O
with	O
.	O
microcalcifications	O
.	O

3	O
.	O

Left	O
breast	O
,	O
final	O
medial	O
margin	O
,	O
excision	O
:	O
-	O
Benign	O
breast	O
tissue	O
,	O
no	O
tumor	O
seen	O
.	O

Note	O
:	O
Case	O
reviewed	O
with	O
.	O
who	O
concurs	O
with	O
the	O
.	O
diagnosis	O
.	O

Procedures	O
/	O
Addenda	O
.	O

Addendum	O
Date	O
Ordered	O
:	O
Date	O
Complete	O
:	O
Addendum	O
Diagnosis	O
.	O

Specimen	O
sent	O
tc	O
.	O
for	O
additional	O
.	O
testing	O
.	O

Antibody	O
/	O
Tests	O
.	O

Prognostic	O
.	O

Grouping	O
.	O

DNA	O
INDEX	O
/	O
PLOIDY	O
.	O

1	O
.	O
59	O
Aneuploid	O
.	O

S	O
-	O
Phase	O
.	O

See	O
Below	O
.	O

Ki	O
-	O
67	O
(	O
MIB	O
-	O
1	O
)	O
.	O

<	O
10	O
%	O
.	O

Favorable	O
.	O

An	O
accurate	O
S	O
-	O
phase	O
fraction	O
(	O
SPF	O
)	O
value	O
cannot	O
be	O
determined	O
due	O
to	O
DNA	O
.	O

aneuploid	O
/	O
tetraploidy	O
cell	O
population	O
<	O
20	O
%	O
of	O
total	O
cells	O
analyzed	O
.	O

INVASIVE	O
BREAST	O
CANCER	O
TEMPLATE	O
:	O
Excisions	O
and	O
Mastectomies	O
.	O

Specimen	O
Type	O
.	O

Excision	O
.	O

Lymph	O
Node	O
Sampling	O
.	O

Sentinel	O
lymph	O
node	O
only	O
.	O

Specimen	O
Size	O
(	O
for	O
excisions	O
less	O
than	O
total	O
mastectomy	O
)	O
.	O

Greatest	O
dimension	O
:	O
7	O
.	O
4	O
cm	O
.	O

Laterality	O
.	O

Left	O
.	O

Tumor	O
Site	O
(	O
s	O
)	O
.	O

Not	O
specified	O
.	O

Invasive	O
Component	O
.	O

Solitary	O
.	O

Greatest	O
dimension	O
:	O
3	B
.	I
8	I
cm	I
(	O
grossly	O
)	O
.	O

Histologic	O
Type	O
(	O
s	O
)	O
.	O

Lobular	O
carcinoma	O
in	O
situ	O
.	O

Invasive	O
lobular	O
.	O

Invasive	O
Lobular	O
Carcinoma	O
Type	O
.	O

Classical	O
,	O
singet	O
-	O
ring	O
,	O
and	O
pleomorphic	O
.	O

Invasion	O
.	O

Invasion	O
confined	O
to	O
breast	O
parenchyma	O
.	O

Angiolymphatic	O
Invasion	O
.	O

Absent	O
.	O

Microcalcifications	O
Associated	O
with	O
Carcinoma	O
In	O
Situ	O
.	O

Margins	O
.	O

Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
and	O
in	O
situ	O
carcinoma	O
.	O

Regional	O
Lymph	O
Nodes	O
.	O

1	O
regional	O
lymph	O
node	O
examined	O
.	O

No	O
regional	O
lymph	O
node	O
metastasis	O
histologically	O
and	O
by	O
.	O
immunohistochemical	O
staining	O
for	O
cytokeratin	O
AE1	O
/	O
AE3	O
(	O
NO	O
)	O
.	O

Ancillary	O
Immunopathology	O
Studies	O
(	O
performed	O
on	O
.	O

ER	O
.	O

Positive	O
.	O

PR	O
.	O

Positive	O
.	O

Her2	O
-	O
Neu	O
.	O

Negative	O
(	O
score	O
0	O
)	O
.	O

pTNM	O
:	O
T2	O
NO	O
Mx	O
.	O

Result	O
date	O
:	O
Clinical	O
History	O
.	O

Prostate	O
cancer	O
.	O

Specimen	O
.	O

#	O
1	O
.	O

Prostate	O
.	O

#	O
2	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
.	O

#	O
3	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
.	O

Gross	O
Examination	O
.	O

#	O
1	O
.	O

Received	O
fresh	O
and	O
labeled	O
prostate	O
,	O
is	O
a	O
35	O
gram	O
,	O
4	O
.	O
0	O
cm	O
(	O
right	O
to	O
left	O
)	O
.	O

X	O
3	O
.	O
7	O
cm	O
(	O
apex	O
to	O
base	O
)	O
X	O
3	O
.	O
5	O
cm	O
(	O
anterior	O
to	O
posterior	O
)	O
prostate	O
with	O
attached	O
.	O
right	O
and	O
left	O
seminal	O
vesicles	O
(	O
2	O
.	O
5	O
X	O
1	O
.	O
2	O
X	O
0	O
.	O
8	O
cm	O
,	O
3	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
0	O
.	O
8	O
cm	O
,	O
.	O
respectively	O
)	O
.	O

There	O
are	O
portions	O
of	O
attached	O
right	O
and	O
left	O
vasa	O
deferentia	O
.	O

(	O
each	O
0	O
.	O
5	O
cm	O
long	O
)	O
.	O

Also	O
present	O
within	O
the	O
specimen	O
container	O
there	O
is	O
a	O
2	O
.	O
5	O
X	O
.	O

1	O
.	O
5	O
X	O
up	O
to	O
0	O
.	O
7	O
cm	O
aggregate	O
of	O
three	O
irregular	O
fragments	O
of	O
tubular	O
rubbery	O
,	O
.	O
grey	O
tan	O
tissue	O
.	O

The	O
right	O
half	O
of	O
the	O
prostate	O
is	O
inked	O
black	O
and	O
the	O
left	O
.	O
half	O
is	O
inked	O
blue	O
.	O

The	O
prostate	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
to	O
.	O
demonstrate	O
a	O
1	O
.	O
5	O
cm	O
ill	O
-	O
defined	O
focal	O
firm	O
area	O
of	O
pale	O
tan	O
discoloration	O
.	O
within	O
the	O
mid	O
aspect	O
of	O
the	O
left	O
posterior	O
prostate	O
,	O
coming	O
to	O
within	O
0	O
.	O
1	O
cm	O
of	O
.	O
the	O
blue	O
inked	O
outer	O
surface	O
.	O

The	O
parenchyma	O
otherwise	O
consists	O
of	O
tan	O
,	O
rubbery	O
.	O
glistening	O
parenchyma	O
with	O
a	O
moderate	O
amount	O
of	O
periurethral	O
nodularity	O
.	O

There	O
.	O
are	O
no	O
additional	O
abnormalities	O
identified	O
.	O

A	O
total	O
of	O
thirty	O
-	O
four	O
sections	O
are	O
submitted	O
in	O
fifteen	O
cassettes	O
"	O
A	O
-	O
O	O
"	O
.	O

Block	O
summary	O
:	O
"	O
A	O
"	O
,	O
right	O
apex	O
longitudinally	O
sectioned	O
;	O
"	O
B	O
"	O
,	O
left	O
apex	O
.	O
longitudinally	O
sectioned	O
;	O
"	O
C	O
"	O
,	O
right	O
bladder	O
neck	O
longitudinally	O
sectioned	O
;	O
"	O
D	O
"	O
,	O
.	O
left	O
bladder	O
neck	O
longitudinally	O
sectioned	O
;	O
"	O
E	O
-	O
G	O
"	O
,	O
right	O
posterior	O
prostate	O
,	O
.	O
from	O
apex	O
to	O
base	O
respectively	O
;	O
"	O
H	O
-	O
J	O
"	O
,	O
left	O
posterior	O
prostate	O
,	O
from	O
apex	O
to	O
.	O
base	O
respectively	O
;	O
"	O
K	O
"	O
,	O
right	O
lateral	O
prostate	O
;	O
"	O
L	O
"	O
,	O
left	O
lateral	O
prostate	O
;	O
"	O
M	O
"	O
,	O
.	O
anterior	O
prostate	O
;	O
"	O
N	O
"	O
,	O
right	O
seminal	O
vesicle	O
and	O
prostate	O
,	O
including	O
right	O
vas	O
;	O
.	O

"	O
O	O
"	O
,	O
left	O
seminal	O
vesicle	O
and	O
prostate	O
,	O
including	O
left	O
vas	O
.	O

Following	O
explicit	O
.	O
written	O
consent	O
of	O
the	O
patient	O
,	O
tissue	O
is	O
taken	O
for	O
the	O
Cancer	O
Genome	O
Atlas	O
.	O

Project	O
.	O

#	O
2	O
.	O

Labeled	O
right	O
pelvic	O
lymph	O
node	O
,	O
is	O
a	O
3	O
.	O
2	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
8	O
cm	O
portion	O
of	O
tan	O
.	O
yellow	O
fibroadipose	O
tissue	O
.	O

Within	O
the	O
tissue	O
there	O
is	O
a	O
0	O
.	O
8	O
cm	O
lymph	O
node	O
.	O
candidate	O
.	O

The	O
candidate	O
is	O
bisected	O
and	O
submitted	O
as	O
two	O
sections	O
in	O
one	O
.	O
cassette	O
.	O

#	O
3	O
.	O

Labeled	O
left	O
pelvic	O
lymph	O
node	O
,	O
is	O
a	O
4	O
.	O
0	O
X	O
2	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
.	O
multiple	O
irregular	O
fragments	O
of	O
tan	O
yellow	O
fibroadipose	O
tissue	O
.	O

Within	O
the	O
.	O
tissue	O
there	O
are	O
two	O
lymph	O
node	O
candidates	O
,	O
0	O
.	O
4	O
and	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

The	O
candidates	O
are	O
submitted	O
as	O
five	O
sections	O
in	O
three	O
:	O
"	O
A	O
-	O
C	O
"	O
.	O

Block	O
summary	O
"	O
A	O
"	O
,	O
one	O
candidate	O
;	O
"	O
B	O
,	O
C	O
"	O
,	O
larger	O
candidate	O
,	O
sectioned	O
.	O

OR	O
Consultation	O
.	O

#	O
1	O
.	O

PROSTATE	O
,	O
RADICAL	O
PROSTATECTOMY	O
:	O
TISSUE	O
TRIAGE	O
FOR	O
.	O

Signature	O
Line	O
.	O

Microscopic	O
Examination	O
.	O

#	O
1	O
-	O
#	O
3	O
Microscopic	O
examination	O
performed	O
.	O

Comment	O
.	O

Portions	O
of	O
this	O
case	O
have	O
been	O
reviewed	O
in	O
consultation	O
with	O
one	O
additional	O
.	O
departmental	O
pathologist	O
.	O

Final	O
Diagnosis	O
.	O

#	O
1	O
.	O

PROSTATE	O
GLAND	O
PROSTATIC	O
ADENOCARCINOMA	O
.	O

GLEASON	O
SCORE	O
:	O
4	O
+	O
3	O
=	O
7	O
.	O

TUMOR	O
SIZE	O
:	O
AT	O
LEAST	O
2	B
.	I
0	I
X	I
1	I
.	I
0	I
CM	I
(	O
AS	O
MEASURED	O
ON	O
GLASS	O
SLIDE	O
"	O
I	O
"	O
)	O
.	O

PERCENT	O
PROSTATE	O
INVOLVEMENT	O
,	O
ESTIMATE	O
:	O
25	O
%	O
OF	O
EXAMINED	O
SECTIONS	O
.	O

TUMOR	O
LOCATION	O
BILATERAL	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
MULTIFOCAL	O
.	O

SURGICAL	O
MARGIN	O
STATUS	O
:	O
NEGATIVE	O
.	O

SEMINAL	O
VESICLE	O
AND	O
VASA	O
DEFERENTIA	O
STATUS	O
:	O
BILATERAL	O
INVOLVEMENT	O
.	O

BY	O
CARCINOMA	O
.	O

LYMPHATIC	O
(	O
SMALL	O
VESSEL	O
)	O
INVASION	O
:	O
ABSENT	O
.	O

VENOUS	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
:	O
ABSENT	O
.	O

#	O
2	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
:	O
BENIGN	O
LYMPH	O
NODE	O
.	O

#	O
3	O
LEFT	O
PELVIC	O
LYMPH	O
NODES	O
:	O
BENIGN	O
LYMPH	O
NODES	O
(	O
x	O
2	O
)	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
TNM	O
CLASSIFICATION	O
)	O
:	O
pT3b	O
pNO	O
.	O

DIAGNOSIS	O
:	O
1	O
,	O
.	O
5	O
)	O
PHARYNX	O
,	O
LARYNX	O
,	O
PHARYNGOLARYNGECTOMY	O
:	O
MODERATELY	O
DIFFERENTIATED	O
.	O

KERATINIZING	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
OF	O
THE	O
EPIGLOTTIS	O
,	O
2	B
.	I
3	I
CM	I
IN	O
GREATEST	O
.	O

EXTENT	O
,	O
INVOLVING	O
THE	O
ANTERIOR	O
COMMISURE	O
,	O
RIGHT	O
AND	O
LEFT	O
FALSE	O
VOCAL	O
FOLDS	O
,	O
.	O

AND	O
THE	O
PRE	O
-	O
EPIGLOTTIS	O
,	O
EXTENSION	O
INTO	O
THE	O
EPIGLOTTIC	O
CARTILAGE	O
;	O
FOCALLY	O
.	O

INVOLVING	O
THE	O
SUPERIOR	O
INKED	O
LEFT	O
ANTERIOR	O
SOFT	O
TISSUE	O
RESECTION	O
MARGIN	O
,	O
.	O

ALL	O
OTHER	O
MARGINS	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
SEE	O
COMMENT	O
)	O
.	O

2	O
)	O
MARGIN	O
,	O
POSTERIOR	O
CRICOID	O
,	O
EXCISION	O
:	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

3	O
)	O
MARGIN	O
,	O
LEFT	O
HYPOPHARYNX	O
,	O
EXCISION	O
:	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

4	O
)	O
MARGIN	O
,	O
RIGHT	O
HYPOPHARYNX	O
,	O
EXCISION	O
:	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

6	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
LEVEL	O
4	O
,	O
DISSECTION	O
:	O
19	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

7	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
LEVEL	O
2A	O
,	O
3	O
,	O
DISSECTION	O
:	O
43	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
.	O

FOR	O
MALIGNANCY	O
.	O

8	O
)	O
LYMPH	O
NODES	O
,	O
RIGHT	O
NECK	O
LEVEL	O
2	O
,	O
3	O
,	O
4	O
,	O
DISSECTION	O
:	O
1	O
OF	O
40	O
LYMPH	O
NODES	O
.	O

INVOLVED	O
BY	O
METASTATIC	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

9	O
)	O
LYMPH	O
NODES	O
,	O
LEVEL	O
1A	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
2	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

COMMENT	O
:	O
These	O
findings	O
correspond	O
to	O
AJCC	O
6TH	O
Edition	O
Pathologic	O
Stage	O
III	O
.	O

(	O
pT3N1Mn	O
/	O
a	O
)	O
.	O

CLINICAL	O
DATA	O
.	O

Clinical	O
Features	O
:	O
Unspecified	O
.	O

Operator	O
:	O
Operation	O
:	O
Unspecified	O
.	O

Operative	O
Findings	O
:	O
Unspecified	O
.	O

Operative	O
Diagnosis	O
:	O
Unspecified	O
.	O

Tissue	O
Submitted	O
:	O
1	O
)	O
epiglottis	O
,	O
2	O
)	O
post	O
cricoid	O
,	O
3	O
)	O
left	O
.	O
hypopharynx	O
,	O
4	O
)	O
right	O
hypopharynx	O
,	O
5	O
)	O
.	O
pharyngolaryngectomy	O
;	O
6	O
)	O
left	O
neck	O
level	O
.	O

4	O
;	O
7	O
)	O
left	O
neck	O
levels	O
2A	O
,	O
3	O
;	O
8	O
)	O
right	O
neck	O
.	O
levels	O
2	O
,	O
3	O
,	O
4	O
;	O
9	O
)	O
neck	O
dissection	O
level	O
1A	O
.	O

INSTRUCTIONS	O
TO	O
PATHOLOGIST	O
:	O
Frozen	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
SOURCE	O
:	O
Epiglottis	O
.	O

Received	O
fresh	O
labeled	O
,	O
"	O
epiglottis	O
,	O
"	O
is	O
a	O
0	O
.	O
6	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
3	O
cm	O
piece	O
of	O
.	O
tan	O
-	O
white	O
tissue	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
1AFSC	O
,	O
1	O
/	O
1	O
.	O

2	O
)	O
SOURCE	O
:	O
Post	O
Cricoid	O
.	O

The	O
specimen	O
labeled	O
"	O
post	O
cricoid	O
,	O
"	O
is	O
received	O
fresh	O
and	O
is	O
comprised	O
of	O
.	O

a	O
2	O
.	O
4	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
strip	O
of	O
pink	O
-	O
tan	O
mucosa	O
.	O

The	O
specimen	O
is	O
submitted	O
.	O
entirely	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
2AFSC	O
,	O
entirely	O
submitted	O
,	O
1	O
/	O
1	O
.	O

3	O
)	O
SOURCE	O
:	O
Left	O
Hypopharynx	O
.	O

The	O
specimen	O
labeled	O
"	O
left	O
hypopharynx	O
,	O
"	O
is	O
received	O
fresh	O
and	O
is	O
comprised	O
.	O
of	O
a	O
2	O
.	O
7	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
strip	O
of	O
tan	O
-	O
pink	O
mucosa	O
.	O

The	O
specimen	O
is	O
inked	O
.	O
black	O
,	O
and	O
submitted	O
entirely	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
3AFSC	O
,	O
1	O
/	O
1	O
.	O

4	O
)	O
SOURCE	O
:	O
Right	O
Hypopharynx	O
.	O

The	O
specimen	O
labeled	O
"	O
right	O
hypopharynx	O
,	O
"	O
is	O
received	O
fresh	O
and	O
is	O
.	O
comprised	O
of	O
two	O
pieces	O
of	O
tissue	O
,	O
one	O
measuring	O
1	O
.	O
8	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
,	O
the	O
.	O
second	O
measuring	O
1	O
.	O
4	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
.	O

The	O
first	O
piece	O
of	O
tissue	O
does	O
not	O
.	O
have	O
an	O
easily	O
identifiable	O
mucosal	O
surface	O
.	O

The	O
second	O
strip	O
of	O
tissue	O
.	O
does	O
have	O
an	O
identifiable	O
mucosal	O
surface	O
.	O

Each	O
of	O
these	O
pieces	O
of	O
tissue	O
.	O
are	O
inked	O
blue	O
,	O
and	O
the	O
specimen	O
is	O
submitted	O
entirely	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
4AFSC	O
,	O
entirely	O
submitted	O
,	O
2	O
/	O
1	O
.	O

5	O
)	O
SOURCE	O
:	O
Pharyngolaryngectomy	O
.	O

The	O
specimen	O
labeled	O
"	O
pharyngolaryngectomy	O
"	O
is	O
received	O
fresh	O
and	O
is	O
.	O
comprised	O
of	O
a	O
laryngectomy	O
with	O
attached	O
epiglottis	O
,	O
thyroid	O
cartilage	O
.	O
with	O
extension	O
of	O
the	O
mucosa	O
and	O
trachea	O
inferior	O
to	O
the	O
thyroid	O
cartilage	O
.	O

The	O
thyroid	O
gland	O
is	O
not	O
present	O
with	O
the	O
specimen	O
.	O

The	O
specimen	O
measures	O
.	O

8	O
.	O
0	O
cm	O
superior	O
to	O
inferior	O
X	O
5	O
.	O
0	O
cm	O
left	O
to	O
right	O
X	O
4	O
.	O
8	O
cm	O
anterior	O
to	O
.	O
posterior	O
.	O

The	O
specimen	O
has	O
been	O
opened	O
prior	O
to	O
receipt	O
along	O
the	O
.	O
posterior	O
aspect	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
anterior	O
-	O
orange	O
,	O
.	O
posterior	O
-	O
black	O
,	O
superior	O
-	O
yellow	O
,	O
inferior	O
-	O
green	O
,	O
right	O
-	O
red	O
,	O
left	O
-	O
blue	O
.	O

Examination	O
of	O
the	O
specimen	O
shows	O
a	O
2	O
.	O
3	O
X	O
1	O
.	O
8	O
cm	O
ulcerated	O
lesion	O
on	O
the	O
.	O
posterior	O
face	O
of	O
the	O
epiglottis	O
present	O
centrally	O
,	O
extending	O
to	O
the	O
left	O
.	O
and	O
right	O
(	O
more	O
prominently	O
leftward	O
)	O
,	O
and	O
towards	O
the	O
epiglottic	O
vocal	O
.	O
folds	O
.	O

The	O
right	O
and	O
left	O
superior	O
vocal	O
folds	O
are	O
involved	O
,	O
medially	O
,	O
with	O
.	O
the	O
left	O
involved	O
laterally	O
.	O

The	O
anterior	O
commissure	O
is	O
involved	O
.	O

On	O
.	O
sectioning	O
,	O
the	O
lesion	O
penetrates	O
0	O
.	O
4	O
cm	O
deep	O
from	O
the	O
mucosal	O
surface	O
.	O

There	O
is	O
a	O
prominent	O
0	O
.	O
8	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
7	O
cm	O
nodule	O
in	O
the	O
left	O
anterior	O
.	O
superior	O
portion	O
of	O
the	O
specimen	O
abutting	O
the	O
anterior	O
superior	O
margin	O
.	O

There	O
is	O
no	O
gross	O
tumor	O
involvement	O
of	O
the	O
thyroid	O
cartilage	O
.	O

The	O
tumor	O
.	O
mass	O
has	O
borders	O
and	O
comes	O
within	O
0	O
.	O
3	O
cm	O
of	O
the	O
hyoid	O
bone	O
,	O
which	O
is	O
.	O
present	O
with	O
the	O
specimen	O
.	O

The	O
tumor	O
mass	O
does	O
appear	O
to	O
wrap	O
around	O
the	O
.	O
superior	O
aspect	O
of	O
the	O
thyroid	O
cartilage	O
.	O

There	O
is	O
no	O
apparent	O
extension	O
.	O
inferior	O
to	O
the	O
vocal	O
folds	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
5A	O
,	O
inferior	O
margin	O
,	O
1	O
/	O
1	O
;	O
5B	O
,	O
anterior	O
commissure	O
,	O
.	O

1	O
/	O
1	O
;	O
5C	O
,	O
right	O
superior	O
margin	O
with	O
epiglottis	O
,	O
1	O
/	O
1	O
;	O
5D	O
,	O
right	O
medial	O
vocal	O
.	O
folds	O
,	O
1	O
/	O
1	O
;	O
5E	O
,	O
right	O
lateral	O
vocal	O
folds	O
,	O
1	O
/	O
1	O
;	O
5F	O
,	O
right	O
aryepiglottic	O
.	O
mucosa	O
,	O
1	O
/	O
1	O
;	O
5G	O
,	O
left	O
anterior	O
superior	O
margin	O
with	O
prominent	O
nodule	O
,	O
2	O
/	O
1	O
.	O

(	O
single	O
section	O
bisected	O
)	O
;	O
2	O
/	O
1	O
;	O
5H	O
,	O
left	O
medial	O
vocal	O
fold	O
with	O
closest	O
.	O
approach	O
to	O
hyoid	O
bone	O
,	O
1	O
/	O
1	O
;	O
5I	O
,	O
left	O
lateral	O
vocal	O
fold	O
,	O
1	O
/	O
1	O
;	O
5J	O
,	O
left	O
.	O
aryepiglottic	O
mucosa	O
,	O
1	O
/	O
1	O
;	O
5K	O
,	O
right	O
and	O
left	O
soft	O
tissue	O
margins	O
,	O
2	O
/	O
1	O
;	O
5L	O
,	O
.	O
anterior	O
and	O
posterior	O
soft	O
tissue	O
margins	O
,	O
2	O
/	O
1	O
.	O

NOTE	O
:	O
Appropriate	O
sections	O
.	O
are	O
decalcified	O
.	O

6	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Level	O
4	O
.	O

The	O
specimen	O
labeled	O
"	O
left	O
neck	O
level	O
4	O
"	O
is	O
received	O
in	O
saline	O
,	O
and	O
is	O
.	O
comprised	O
of	O
a	O
5	O
.	O
2	O
X	O
4	O
.	O
2	O
X	O
0	O
.	O
5	O
cm	O
collection	O
of	O
fibroadipose	O
tissue	O
.	O
containing	O
lymph	O
node	O
candidates	O
.	O

Lymph	O
node	O
candidates	O
range	O
in	O
.	O
measurement	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
and	O
21	O
lymph	O
node	O
.	O
candidates	O
are	O
removed	O
.	O

These	O
lymph	O
node	O
candidates	O
are	O
submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
6A	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
;	O
6B	O
,	O
lymph	O
node	O
.	O
candidates	O
,	O
m	O
/	O
1	O
;	O
6C	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
.	O

7	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Levels	O
2A	O
&	O
3	O
.	O

The	O
specimen	O
labeled	O
"	O
left	O
neck	O
levels	O
2A	O
,	O
3	O
"	O
is	O
received	O
in	O
saline	O
and	O
is	O
.	O
comprised	O
of	O
a	O
13	O
.	O
5	O
X	O
4	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
collection	O
of	O
fibroadipose	O
tissue	O
.	O
containing	O
lymph	O
nodes	O
and	O
vessels	O
,	O
with	O
suture	O
ties	O
investing	O
the	O
vascular	O
.	O
end	O
.	O

The	O
specimen	O
is	O
dissected	O
to	O
reveal	O
the	O
presence	O
of	O
numerous	O
lymph	O
.	O
node	O
candidates	O
measuring	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
extent	O
.	O

The	O
lymph	O
.	O
node	O
candidates	O
are	O
submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
7A	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
;	O
7B	O
,	O
lymph	O
node	O
.	O
candidates	O
,	O
M	O
/	O
1	O
;	O
7C	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
;	O
7D	O
,	O
lymph	O
node	O
candidates	O
,	O
.	O

6	O
/	O
1	O
;	O
7E	O
,	O
two	O
lymph	O
nodes	O
,	O
each	O
bisected	O
,	O
one	O
inked	O
black	O
,	O
4	O
/	O
1	O
.	O

8	O
)	O
SOURCE	O
:	O
Right	O
Neck	O
Level	O
2	O
,	O
3	O
,	O
&	O
4	O
.	O

The	O
specimen	O
labeled	O
"	O
right	O
neck	O
level	O
2	O
,	O
3	O
,	O
4	O
"	O
is	O
received	O
fresh	O
and	O
is	O
.	O
comprised	O
of	O
a	O
15	O
.	O
2	O
X	O
5	O
.	O
2	O
X	O
0	O
.	O
6	O
cm	O
collection	O
of	O
fibroadipose	O
tissue	O
.	O
containing	O
lymph	O
nodes	O
and	O
vessels	O
.	O

The	O
specimen	O
is	O
dissected	O
to	O
reveal	O
the	O
.	O
presence	O
of	O
numerous	O
lymph	O
nodes	O
measuring	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O
2	O
cm	O
.	O

Lymph	O
node	O
.	O
candidates	O
are	O
submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
8A	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
;	O
8B	O
,	O
lymph	O
node	O
.	O
candidates	O
,	O
M	O
/	O
1	O
;	O
8C	O
,	O
lymph	O
node	O
candidates	O
,	O
M	O
/	O
1	O
;	O
8D	O
,	O
lymph	O
node	O
candidates	O
,	O
.	O

M	O
/	O
1	O
;	O
8E	O
,	O
lymph	O
node	O
candidates	O
,	O
2	O
/	O
1	O
;	O
8F	O
,	O
single	O
lymph	O
node	O
,	O
bisected	O
,	O
2	O
/	O
1	O
.	O

9	O
)	O
SOURCE	O
:	O
Neck	O
Dissection	O
Level	O
1A	O
.	O

The	O
specimen	O
labeled	O
"	O
neck	O
dissection	O
level	O
1A	O
"	O
is	O
received	O
in	O
saline	O
and	O
.	O

is	O
comprised	O
of	O
a	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
X	O
0	O
.	O
5	O
cm	O
collection	O
of	O
fibroadipose	O
tissue	O
.	O
containing	O
lymph	O
node	O
candidates	O
.	O

The	O
specimen	O
is	O
divided	O
to	O
reveal	O
the	O
.	O
presence	O
of	O
possible	O
lymph	O
nodes	O
measuring	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
.	O

is	O
submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
9A	O
,	O
2	O
/	O
1	O
;	O
9B	O
,	O
2	O
/	O
1	O
;	O
9C	O
,	O
2	O
/	O
1	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

SURGICAL	O
PATHOLOGY	O
INTRAOPERATIVE	O
CONSULTATION	O
.	O

1	O
)	O
SOURCE	O
:	O
Epiglottis	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

2	O
)	O
SOURCE	O
:	O
Post	O
Cricoid	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

3	O
)	O
SOURCE	O
:	O
Left	O
Hypopharynx	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

4	O
)	O
SOURCE	O
:	O
Right	O
Hypopharynx	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

The	O
following	O
special	O
studies	O
were	O
performed	O
on	O
this	O
case	O
and	O
the	O
.	O
interpretation	O
is	O
incorporated	O
in	O
the	O
diagnostic	O
report	O
above	O
:	O
1xDECALCIFICATION	O
.	O

In	O
some	O
tests	O
,	O
analyte	O
specific	O
reagents	O
(	O
ASRs	O
)	O
are	O
used	O
.	O

In	O
the	O
case	O
of	O
.	O

an	O
ASR	O
,	O
this	O
test	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
.	O
determined	O
by	O
this	O
laboratory	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

US	O
Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
test	O
is	O
used	O
for	O
clinical	O
.	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
.	O

(	O
CLIA	O
'	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
.	O
clinical	O
laboratory	O
testing	O
.	O

Observation	O
Date	O
.	O

Last	O
Edited	O
Date	O
.	O

Diagnosis	O
.	O

A	O
.	O

Lymph	O
node	O
,	O
#	O
7	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
6	O
)	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
#	O
8	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
#	O
9	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

D	O
.	O

Lymph	O
node	O
,	O
#	O
10	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
9	O
)	O
.	O

E	O
.	O

"	O
Lymph	O
node	O
"	O
,	O
#	O
2	O
,	O
excision	O
:	O
-	O
Benign	O
adipose	O
tissue	O
,	O
no	O
lymph	O
node	O
is	O
identified	O
.	O

F	O
.	O

.	O
Lymph	O
node	O
,	O
#	O
4	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
umor	O
(	O
0	O
/	O
10	O
)	O
.	O

G	O
.	O
Bronchial	O
margin	O
,	O
excision	O
:	O
-	O
Negative	O
for	O
tumor	O
.	O

H	O
.	O

Lung	O
,	O
right	O
upper	O
lobe	O
,	O
lobectomy	O
:	O
-	O
Squamous	O
cell	O
carcinoma	O
,	O
moderately	O
differentiated	O
,	O
comprise	O
90	O
%	O
of	O
the	O
tumor	O
.	O

-	O
Adenocarcinoma	O
,	O
comprise	O
10	O
%	O
of	O
the	O
tumor	O
,	O
adenosquamous	O
carcinoma	O
(	O
slides	O
H6	O
)	O
.	O

-	O
Tumor	O
measures	O
3	B
.	I
5cm	I
in	O
greatest	O
dimension	O
.	O

-	O
Surgical	O
margins	O
and	O
pleura	O
free	O
of	O
tumor	O
.	O

-	O
pT2aNO	O
.	O

(	O
Electronically	O
signed	O
by	O
)	O
.	O

Clinical	O
Information	O
.	O

The	O
patient	O
is	O
a	O
.	O
male	O
with	O
a	O
clinical	O
history	O
of	O
lung	O
cancer	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

GFS1	O
:	O
Bronchial	O
margin	O
,	O
biopsy	O
:	O
-	O
Negative	O
for	O
tumor	O
.	O

HFS1	O
:	O
Lung	O
,	O
right	O
upper	O
lobe	O
,	O
excision	O
:	O
-	O
Squamous	O
cell	O
carcinoma	O
.	O

Per	O
Dr	O
.	O
Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
eight	O
containers	O
,	O
each	O
labeled	O
with	O
the	O
patients	O
name	O
and	O
medical	O
.	O
record	O
number	O
.	O

The	O
first	O
container	O
is	O
further	O
labeled	O
"	O
#	O
1	O
-	O
#	O
7	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
multiple	O
.	O
pieces	O
of	O
lymphoid	O
tissue	O
measuring	O
2x	O
1	O
.	O
5	O
X	O
0	O
,	O
6	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
.	O
entirety	O
.	O

The	O
second	O
container	O
is	O
further	O
labeled	O
"	O
#	O
2	O
-	O
#	O
8	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
two	O
pieces	O
of	O
.	O
lymphoid	O
tissue	O
measuring	O
0	O
.	O
6	O
X	O
0	O
.	O
5	O
.	O

X	O
0	O
.	O
4	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
entirety	O
.	O

The	O
third	O
container	O
is	O
further	O
labeled	O
"	O
#	O
3	O
-	O
#	O
9	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
lymphoid	O
.	O
adipose	O
tissue	O
measuring	O
0	O
.	O
9	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

One	O
lymph	O
node	O
is	O
identified	O
.	O

The	O
fourth	O
container	O
is	O
.	O
further	O
labeled	O
"	O
#	O
4	O
-	O
#	O
10	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
multiple	O
pieces	O
of	O
lymphoid	O
adipose	O
tissue	O
.	O
measuring	O
2	O
.	O
5	O
x	O
2	O
X	O
1	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

Multiple	O
lymph	O
node	O
fragments	O
are	O
identified	O
.	O

The	O
fifth	O
container	O
is	O
further	O
labeled	O
"	O
#	O
5	O
-	O
#	O
2	O
lymph	O
node	O
.	O
"	O
It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
soft	O
tissue	O
.	O
measuring	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
entirety	O
.	O

The	O
sixth	O
container	O
is	O
further	O
.	O
labeled	O
"	O
#	O
6	O
-	O
#	O
4	O
lymph	O
node	O
.	O
'	O
It	O
consists	O
of	O
lymphoid	O
adipose	O
tissue	O
measuring	O
3	O
.	O
5	O
X	O
1	O
.	O
2	O
X	O
2	O
.	O
3	O
.	O

cm	O
in	O
.	O
greatest	O
dimensions	O
.	O

Multiple	O
possible	O
lymph	O
nodes	O
are	O
identified	O
.	O

The	O
seventh	O
container	O
is	O
further	O
.	O
labeled	O
"	O
#	O
7	O
-	O
bronchial	O
margin	O
.	O
'	O
It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
tan	O
-	O
pink	O
soft	O
tissue	O
.	O
measuring	O
0	O
.	O
6	O
X	O
.	O

0	O
.	O
2	O
X	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
will	O
be	O
entirely	O
submitted	O
for	O
frozen	O
and	O
now	O
resubmitted	O
for	O
permanent	O
.	O

The	O
.	O
eighth	O
.	O

specimen	O
is	O
labeled	O
"	O
right	O
upper	O
lobe	O
.	O
"	O
It	O
contains	O
a	O
single	O
lung	O
specimen	O
that	O
has	O
been	O
.	O
previously	O
incised	O
and	O
.	O
partly	O
inked	O
measuring	O
15	O
X	O
7	O
.	O
5	O
X	O
3	O
.	O
5	O
cm	O
.	O

On	O
examination	O
of	O
the	O
specimen	O
the	O
.	O
lesion	O
is	O
a	O
totally	O
circumscribed	O
white	O
tan	O
in	O
.	O
coloration	O
with	O
areas	O
of	O
hemorrhage	O
with	O
green	O
-	O
tan	O
.	O
exudate	O
,	O
possibly	O
reflective	O
of	O
necrosis	O
.	O

The	O
lesional	O
area	O
measures	O
3	O
.	O
5	O
X	O
3	O
X	O
3	O
cm	O
.	O

The	O
lesional	O
.	O
area	O
is	O
approximately	O
1	O
cm	O
from	O
the	O
vascular	O
resection	O
margin	O
and	O
approximately	O
1	O
cm	O
from	O
the	O
bronchial	O
.	O
margin	O
.	O

The	O
closest	O
the	O
tumor	O
to	O
a	O
surgical	O
resection	O
margin	O
is	O
0	O
.	O
4	O
cm	O
.	O

The	O
tissue	O
immediately	O
.	O
underneath	O
the	O
surgical	O
staple	O
.	O
line	O
is	O
inked	O
green	O
.	O

On	O
serially	O
sectioning	O
through	O
the	O
rest	O
of	O
the	O
lung	O
.	O
specimen	O
no	O
other	O
apparent	O
gross	O
abnormality	O
is	O
.	O
identified	O
.	O

Representative	O
sections	O
of	O
the	O
lesional	O
.	O
area	O
are	O
submitted	O
per	O
the	O
block	O
summary	O
.	O

There	O
was	O
a	O
representative	O
section	O
of	O
the	O
lesion	O
that	O
was	O
.	O
originally	O
submitted	O
fresh	O
for	O
frozen	O
section	O
is	O
now	O
entirely	O
.	O
resubmitted	O
for	O
permanent	O
section	O
in	O
.	O
cassette	O
H1	O
.	O

Dr	O
.	O
Block	O
Summary	O
.	O

A1	O
-	O
.	O

#	O
7	O
Lymph	O
node	O
.	O

B1	O
-	O
.	O

#	O
8	O
Lymph	O
node	O
.	O

C1	O
-	O
.	O

#	O
9	O
Lymph	O
node	O
.	O

D1	O
-	O
D2	O
#	O
10	O
Lymph	O
node	O
(	O
D2	O
one	O
lymph	O
node	O
bisected	O
)	O
.	O

E1	O
-	O
.	O

#	O
2	O
Lymph	O
node	O
.	O

F1	O
-	O
F2	O
.	O

#	O
4	O
Lymph	O
node	O
(	O
F1	O
multiple	O
lymph	O
node	O
,	O
F2	O
remaining	O
adipose	O
tissue	O
)	O
.	O

G1	O
-	O
.	O

Bronchial	O
margin	O
.	O

H1	O
-	O
.	O

Right	O
upper	O
lobe	O
lesion	O
.	O

H2	O
-	O
.	O

Vascular	O
and	O
bronchial	O
margin	O
.	O

H3	O
-	O
H4	O
Tumor	O
in	O
relation	O
to	O
surgical	O
staple	O
line	O
and	O
pleura	O
.	O

H5	O
-	O
H6	O
.	O

Tumor	O
in	O
relation	O
to	O
pleura	O
.	O

H7	O
-	O
.	O

Tumor	O
in	O
relation	O
to	O
bronchus	O
.	O

Microscopic	O
Description	O
.	O

A	O
microscopic	O
examination	O
has	O
been	O
performed	O
.	O

SP	O
Synoptic	O
Report	O
.	O

H	O
:	O
Thorax	O
Lung	O
.	O

SPECIMEN	O
:	O
Lobe	O
(	O
s	O
)	O
of	O
lung	O
:	O
right	O
upper	O
lobe	O
.	O

PROCEDURE	O
:	O
Lobectomy	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
.	O

SPECIMEN	O
LATERALITY	O
:	O
Right	O
.	O

TUMOR	O
SITE	O
:	O
Upper	O
lobe	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
5	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenosquamous	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

TUMOR	O
EXTENSION	O
:	O
Not	O
identified	O
.	O

BRONCHIAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

VASCULAR	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

PARENCHYMAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

PARIETAL	O
PLEURAL	O
MARGIN	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

CHEST	O
WALL	O
MARGIN	O
:	O
Not	O
applicable	O
.	O

OTHER	O
ATTACHED	O
TISSUE	O
MARGIN	O
.	O

TREATMENT	O
EFFECT	O
:	O
Not	O
applicable	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Not	O
identified	O
.	O

LYMPH	O
NODES	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2a	O
:	O
Tumor	O
>	O
3	O
cm	O
,	O
and	O
<	O
5	O
cm	O
in	O
greatest	O
dimension	O
surrounded	O
by	O
.	O
lung	O
or	O
visceral	O
pleura	O
,	O
without	O
bronchoscopic	O
evidence	O
of	O
.	O
invasion	O
in	O
the	O
main	O
bronchus	O
;	O
or	O
Tumor	O
.	O

<	O
5	O
cm	O
in	O
greatest	O
dimension	O
with	O
any	O
of	O
the	O
following	O
:	O
involves	O
main	O
bronchus	O
,	O
2	O
cm	O
or	O
more	O
distal	O
.	O
to	O
the	O
carina	O
;	O
invades	O
the	O
visceral	O
pleura	O
;	O
associated	O
with	O
atelectasis	O
or	O
.	O
obstructive	O
pneumonitis	O
that	O
.	O
extends	O
to	O
the	O
hilar	O
region	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

surgical	O
Pathology	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
B1	O
B2	O
C1	O
D1	O
E1	O
.	O

Tissue	O
from	O
left	O
lower	O
lobe	O
lung	O
(	O
12	O
.	O
57	O
grams	O
;	O
5	O
x	O
1	O
.	O
7	O
x	O
1	O
.	O
5	O
cm	O
)	O
,	O
.	O
superior	O
(	O
right	O
lower	O
paratracheal	O
)	O
and	O
inferior	O
(	O
subcarinal	O
)	O
.	O
mediastinal	O
Tymph	O
nodes	O
.	O

DIAGNOSIS	O
:	O
Lung	O
,	O
left	O
lower	O
lobe	O
,	O
wedge	O
excision	O
:	O
Invasive	O
grade	O
3	O
(	O
of	O
4	O
)	O
.	O
adenocarcinoma	O
forming	O
a	O
peripheral	O
2	B
.	I
1	I
x	I
2	I
x	I
1	I
cm	I
mass	O
.	O

The	O
.	O
visceral	O
pleura	O
is	O
not	O
involved	O
.	O

The	O
surgical	O
margin	O
of	O
resection	O
.	O

is	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
superior	O
(	O
right	O
lower	O
paratracheal	O
)	O
and	O
inferior	O
.	O

(	O
subcarinal	O
)	O
mediastinal	O
,	O
excision	O
:	O
Multiple	O
superior	O
(	O
8	O
right	O
.	O
lower	O
paratracheal	O
)	O
and	O
inferior	O
(	O
4	O
subcarinal	O
)	O
mediastinal	O
Tymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Patient	O
.	O

Identifier	O
:	O
TISSUE	O
DESCRIPTION	O
:	O
Right	O
kidney	O
(	O
14	O
.	O
5	O
x	O
7	O
.	O
5	O
x	O
6	O
.	O
5	O
cm	O
)	O
wich	O
8	O
.	O
5	O
cm	O
right	O
ureter	O
.	O

DIAGNOSIS	O
:	O
Kidney	O
,	O
right	O
,	O
nephrectomy	O
:	O
Grade	O
3	O
(	O
of	O
4	O
)	O
renal	O
cell	O
carcinana	O
,	O
.	O
clear	O
cell	O
type	O
,	O
forms	O
a	O
B	O
x	O
8	O
x	O
6	O
cm	O
mass	O
located	O
in	O
the	O
superior	O
.	O
mid	O
kidney	O
The	O
tumor	O
exhibits	O
extension	O
into	O
perineghric	O
fat	O
.	O

The	O
.	O
renal	O
vein	O
is	O
free	O
of	O
involvement	O
Coagulative	O
tumor	O
necrosis	O
is	O
.	O
present	O
.	O

The	O
surgical	O
margins	O
are	O
negative	O
.	O

No	O
renal	O
hilar	O
1ympt	O
.	O
nodes	O
are	O
identified	O
.	O

No	O
adrenal	O
gland	O
is	O
present	O
.	O

Gender	O
:	O
M	O
.	O

Examination	O
result	O
No	O
.	O

Surgery	O
and	O
Laryngological	O
Oncology	O
Dept	O
.	O

Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
Laryngeal	O
carcinoma	O
(	O
Hist	O
.	O
pat	O
.	O
:	O
Ca	O
planoepitheliale	O
verrucosae	O
)	O
.	O

Date	O
of	O
admission	O
:	O
(	O
urgency	O
:	O
intraoperative	O
)	O
.	O

Material	O
:	O
1	O
)	O
Material	O
:	O
tumour	O
of	O
the	O
larynx	O
.	O

Please	O
examine	O
the	O
marked	O
margins	O
.	O

Method	O
of	O
collection	O
:	O
Collection	O
of	O
specimens	O
for	O
.	O
laboratory	O
examination	O
.	O

Histopathological	O
Diagnosis	O
.	O

Invasive	O
squamous	O
carcinoma	O
of	O
the	O
larynx	O
,	O
keratinizing	O
.	O

Carcinoma	O
planoepitheliale	O
keratodes	O
invasivum	O
(	O
verrucosum	O
)	O
laryngis	O
.	O

G1	O
,	O
pT2	O
,	O
pNO	O
(	O
Delphian	O
)	O
.	O
codes	O
according	O
to	O
ICD	O
-	O
O	O
-	O
3	O
or	O
SNOMED	O
.	O

Macroscopic	O
description	O
:	O
Surgical	O
specimen	O
sized	O
9	O
x	O
5	O
.	O
5	O
x	O
5cm	O
,	O
including	O
larynx	O
with	O
the	O
hyoid	O
bone	O
.	O

Tumour	O
sized	O
2	B
.	I
6	I
x	I
2	I
.	I
6	I
x	I
1	I
.	I
0	I
cm	I
in	O
the	O
glottis	O
region	O
,	O
.	O
right	O
side	O
,	O
infiltrating	O
the	O
subglottal	O
and	O
supraglottal	O
regions	O
.	O

Microscopic	O
description	O
:	O
Carcinoma	O
planoepitheliale	O
keratodes	O
invasivum	O
(	O
verrucosum	O
)	O
G1	O
glotis	O
.	O

The	O
tumour	O
invading	O
the	O
subglottal	O
and	O
supraglottal	O
regions	O
.	O

Surgical	O
incision	O
lines	O
off	O
cancer	O
invaded	O
area	O
.	O

No	O
signs	O
of	O
vascular	O
and	O
nerve	O
invasion	O
found	O
.	O

Sinus	O
histiocytosis	O
lymphonodorum	O
No	O
I	O
(	O
Delphian	O
)	O
.	O

Results	O
of	O
intraoperative	O
examination	O
:	O
Neoplastic	O
lesions	O
not	O
found	O
.	O

Final	O
reply	O
to	O
be	O
given	O
after	O
the	O
analysis	O
of	O
paraffin	O
specimens	O
.	O

Gross	O
Description	O
:	O
Lymph	O
node	O
is	O
enlarged	O
with	O
1	O
.	O
5x1x1cm	O
in	O
size	O
,	O
soft	O
,	O
dark	O
brown	O
and	O
gray	O
surface	O
.	O

Microscopic	O
Description	O
:	O
Tumor	O
architectures	O
are	O
replaced	O
by	O
diffuse	O
pattern	O
.	O

The	O
tumor	O
cells	O
are	O
.	O
composed	O
of	O
small	O
or	O
enlarged	O
transformed	O
lymphoid	O
cells	O
with	O
irregular	O
hyperchromatic	O
nuclei	O
Tumor	O
.	O
cells	O
are	O
oval	O
or	O
round	O
in	O
shape	O
with	O
scant	O
cytoplasm	O
.	O

Nucleoli	O
is	O
single	O
or	O
multiple	O
.	O

Mitotic	O
figures	O
are	O
.	O
commnon	O
.	O

Diagnosis	O
Details	O
:	O
Malignant	O
lymphoma	O
,	O
large	O
B	O
cell	O
,	O
diffuse	O
type	O
.	O

Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
Diagnosis	O
:	O
Diffuse	O
large	O
B	O
-	O
cell	O
lymphoma	O
.	O

Tumor	O
location	O
:	O
Lymph	O
node	O
,	O
cervical	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
5	I
X	I
1x	I
1cm	I
.	O

Tumor	O
markers	O
:	O
CD20	O
(	O
+	O
)	O
,	O
CD3	O
(	O
-	O
)	O
.	O

SPECIMENS	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
LEFT	O
AXILLA	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
LEFT	O
AXILLA	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
LEFT	O
AXILLA	O
.	O

D	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
4	O
LEFT	O
AXILLA	O
.	O

E	O
.	O

LEFT	O
BREAST	O
.	O

F	O
.	O

ADDITIONAL	O
SKIN	O
UPPER	O
SUPERIOR	O
FLAP	O
.	O

G	O
.	O

RIGHT	O
BREAST	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
LEFT	O
AXILLA	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
LEFT	O
AXILLA	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
LEFT	O
AXILLA	O
.	O

D	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
4	O
LEFT	O
AXILLA	O
.	O

E	O
.	O

LEFT	O
BREAST	O
.	O

F	O
.	O

ADDITIONAL	O
SKIN	O
UPPER	O
SUPERIOR	O
FLAP	O
.	O

G	O
.	O

RIGHT	O
BREAST	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
:	O
TPA	O
-	O
TPD	O
:	O
sentinel	O
nodes	O
#	O
1	O
-	O
#	O
4	O
,	O
left	O
axilla	O
:	O
All	O
negative	O
for	O
tumor	O
cells	O
on	O
touch	O
prep	O
,	O
called	O
to	O
Dr	O
.	O
at	O
.	O
by	O
Dr	O
.	O
GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
of	O
a	O
fragment	O
of	O
beige	O
tan	O
soft	O
tissue	O
measuring	O
1	O
.	O

x	O
.	O

1	O
x	O
0	O
.	O
3	O
cm	O
.	O

Touch	O
preparations	O
are	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
cassette	O
A1	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
of	O
a	O
fragment	O
of	O
beige	O
tan	O
soft	O
tissue	O
measuring	O
1	O
.	O

x	O
1	O
x	O
0	O
.	O
3	O
cm	O
.	O

Touch	O
preparations	O
are	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
cassette	O
B1	O
and	O
.	O

B2	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
are	O
two	O
possible	O
lymph	O
nodes	O
measuring	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
each	O
.	O

Both	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
separately	O
in	O
C1	O
and	O
C2	O
.	O

D	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
4	O
LEFT	O
AXILLA	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
of	O
a	O
fragment	O
of	O
beige	O
tan	O
soft	O
tissue	O
measuring	O
.	O

0	O
.	O
7	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

Touch	O
preparations	O
are	O
performed	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
cassette	O
.	O

D1	O
.	O

E	O
.	O

LEFT	O
BREAST	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
and	O
designated	O
"	O
Part	O
E	O
.	O
,	O
left	O
breast	O
"	O
is	O
an	O
.	O
orientated	O
399g	O
,	O
18	O
x	O
17	O
x	O
3	O
cm	O
mastectomy	O
specimen	O
with	O
a	O
5	O
.	O
2	O
x	O
3	O
.	O
3	O
cm	O
skin	O
ellipse	O
,	O
and	O
1	O
.	O
2cm	O
.	O
everted	O
nipple	O
.	O

Ink	O
code	O
:	O
Anterior	O
/	O
superior	O
-	O
blue	O
,	O
anterior	O
/	O
inferior	O
-	O
orange	O
,	O
posterior	O
-	O
black	O
.	O

Specimen	O
is	O
.	O
serially	O
sectioned	O
into	O
9	O
slices	O
from	O
medial	O
to	O
lateral	O
with	O
nipple	O
in	O
slice	O
3	O
revealing	O
a	O
3	O
.	O
5	O
x	O
3	O
.	O
1	O
x	O
2	O
cm	O
.	O
firm	O
beige	O
spiculated	O
mass	O
at	O
the	O
12	O
o	O
'	O
clock	O
position	O
(	O
slices	O
5	O
-	O
7	O
)	O
closest	O
to	O
the	O
anterior	O
margin	O
at	O
0	O
.	O
9cm	O
.	O
and	O
located	O
2	O
.	O
2cm	O
from	O
the	O
deep	O
margin	O
.	O

Tissue	O
is	O
procured	O
.	O

Representatively	O
submitted	O
:	O
E1	O
:	O
Perpendicular	O
sections	O
,	O
nipple	O
.	O

E2	O
:	O
Bisected	O
nipple	O
base	O
.	O

E3	O
:	O
Sections	O
of	O
skin	O
.	O

E4	O
:	O
Tumor	O
,	O
slice	O
5	O
.	O

E5	O
-	O
E8	O
:	O
Tumor	O
,	O
slice	O
6	O
.	O

E9	O
:	O
Overlying	O
deep	O
margin	O
,	O
slice	O
6	O
.	O

E10	O
:	O
Tumor	O
,	O
slice	O
7	O
.	O

E11	O
:	O
Tumor	O
and	O
closest	O
anterior	O
margin	O
,	O
slice	O
7	O
.	O

E12	O
:	O
Additional	O
tumor	O
,	O
slice	O
7	O
.	O

E13	O
:	O
Upper	O
outer	O
quadrant	O
.	O

E14	O
:	O
Lower	O
outer	O
quadrant	O
.	O

E15	O
:	O
Upper	O
inner	O
quadrant	O
.	O

E16	O
:	O
Lower	O
inner	O
quadrant	O
.	O

F	O
.	O

ADDITIONAL	O
SKIN	O
UPPER	O
SUPERIOR	O
FLAP	O
.	O

Received	O
in	O
formalin	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
is	O
a	O
brown	O
tan	O
crescent	O
.	O
shaped	O
excision	O
of	O
skin	O
measuring	O
6	O
.	O
1	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

A	O
suture	O
designates	O
superior	O
.	O

The	O
specimen	O
.	O

is	O
.	O
inked	O
as	O
follows	O
:	O
Superior	O
-	O
blue	O
,	O
inferior	O
-	O
orange	O
,	O
deep	O
-	O
black	O
.	O

The	O
surface	O
of	O
the	O
skin	O
demonstrates	O
no	O
.	O
obvious	O
gross	O
abnormality	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
and	O
submitted	O
.	O
entirely	O
for	O
microscopic	O
evaluation	O
.	O

Cassettes	O
are	O
submitted	O
as	O
follows	O
:	O
F1	O
:	O
Medial	O
tip	O
.	O

F2	O
-	O
F6	O
:	O
Serial	O
sections	O
.	O

F7	O
:	O
Lateral	O
tip	O
.	O

G	O
.	O

RIGHT	O
BREAST	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
and	O
"	O
Right	O
Breast	O
-	O
Stitch	O
marks	O
axillary	O
tail	O
"	O
is	O
an	O
.	O
oriented	O
339g	O
,	O
23	O
x	O
14	O
x	O
3cm	O
simple	O
mastectomy	O
with	O
5	O
x	O
3cm	O
tan	O
pink	O
skin	O
ellipse	O
,	O
and	O
a	O
1	O
.	O
3cm	O
.	O
centrally	O
located	O
,	O
raised	O
nipple	O
.	O

Ink	O
Code	O
:	O
Anterior	O
-	O
Superior	O
:	O
Blue	O
,	O
Anterior	O
-	O
Inferior	O
:	O
Orange	O
,	O
Posterior	O
:	O
Black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
lateral	O
to	O
medial	O
into	O
15	O
slices	O
.	O

The	O
nipple	O
is	O
located	O
in	O
.	O
slice	O
12	O
.	O

The	O
cut	O
surfaces	O
reveal	O
a	O
blue	O
dome	O
cyst	O
0	O
.	O
8	O
x	O
0	O
.	O
4cm	O
in	O
the	O
LC	O
of	O
slice	O
12	O
,	O
more	O
than	O
1cm	O
.	O
from	O
the	O
closest	O
deep	O
margin	O
.	O

No	O
lesions	O
are	O
grossly	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O
as	O
follows	O
:	O
G1	O
:	O
nipple	O
slice	O
12	O
.	O

G2	O
:	O
skin	O
slice	O
12	O
.	O

G3	O
:	O
UOQ	O
slice	O
8	O
.	O

G4	O
:	O
UOQ	O
slice	O
9	O
.	O

G5	O
:	O
LOQ	O
slice	O
7	O
.	O

G6	O
:	O
LOQ	O
slice	O
10	O
.	O

G7	O
:	O
blue	O
dome	O
cyst	O
LC	O
slice	O
12	O
.	O

G8	O
:	O
LC	O
with	O
inferior	O
margin	O
slice	O
12	O
.	O

G9	O
:	O
UC	O
slice	O
12	O
.	O

G10	O
:	O
UIQ	O
slice	O
13	O
.	O

G11	O
:	O
UIQ	O
slice	O
14	O
.	O

G12	O
:	O
LIQ	O
slice	O
13	O
.	O

G13	O
:	O
LIQ	O
slice	O
14	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
,	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
1	O
)	O
.	O

B	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
,	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
1	O
)	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
:	O
-	O
TWO	O
LYMPH	O
NODES	O
,	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
2	O
)	O
.	O

D	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
4	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
,	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
1	O
)	O
.	O

E	O
.	O

BREAST	O
,	O
LEFT	O
,	O
MASTECTOMY	O
:	O
-	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
.	O

(	O
SBR	O
GRADE	O
3	O
)	O
(	O
SEE	O
NOTE	O
)	O
.	O

-	O
TUMOR	O
MEASURES	O
3	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

-	O
MARGINS	O
,	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
,	O
SOLID	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
3	O
,	O
.	O

WITH	O
NECROSIS	O
,	O
MICROCALCIFICATIONS	O
AND	O
ASSOCIATED	O
.	O

LYMPHOID	O
INFILTRATE	O
.	O

-	O
SKIN	O
AND	O
NIPPLE	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

NOTE	O
:	O
Biomarkers	O
and	O
lymphvascular	O
invasion	O
status	O
will	O
be	O
reported	O
in	O
an	O
addendum	O
.	O

F	O
.	O

SKIN	O
,	O
UPPER	O
SUPERIOR	O
FLAP	O
,	O
EXCISION	O
:	O
-	O
BASAL	O
CELL	O
CARCINOMA	O
,	O
SUPERFICIAL	O
TYPE	O
(	O
SEE	O
NOTE	O
)	O
.	O

-	O
MARGINS	O
,	O
FREE	O
OF	O
TUMOR	O
.	O

NOTE	O
:	O
The	O
basal	O
cell	O
carcinoma	O
is	O
focally	O
2	O
mm	O
from	O
the	O
superior	O
margin	O
.	O

G	O
.	O

BREAST	O
,	O
RIGHT	O
,	O
PROPHYLACTIC	O
MASTECTOMY	O
:	O
-	O
SMALL	O
FIBROADENOMA	O
,	O
PSEUDOLACTATIONAL	O
CHANGE	O
,	O
APOCRINE	O
.	O

METAPLASIA	O
,	O
STROMAL	O
FIBROSIS	O
,	O
AND	O
MICROCALCIFICATIONS	O
.	O

-	O
BENIGN	O
SKIN	O
AND	O
NIPPLE	O
.	O

SYNOPTIC	O
REPORT	O
-	O
BREAST	O
.	O

Specimen	O
Type	O
:	O
Mastectomy	O
.	O

Needle	O
Localization	O
:	O
No	O
.	O

Laterality	O
:	O
Left	O
.	O

Invasive	O
Tumor	O
:	O
Present	O
.	O

Multifocality	O
:	O
No	O
.	O

WHO	O
CLASSIFICATION	O
.	O

Invasive	O
ductal	O
carcinoma	O
,	O
NOS	O
8500	O
/	O
3	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
5cm	I
.	O

Tumor	O
Site	O
:	O
12	O
:	O
00	O
.	O

Margins	O
:	O
Negative	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
0	O
.	O
5cm	O
.	O
anterior	O
superior	O
.	O

Tubular	O
Score	O
:	O
3	O
.	O

Nuclear	O
Grade	O
:	O
3	O
.	O

Mitotic	O
Score	O
:	O
3	O
.	O

Modified	O
Scarff	O
Bloom	O
Richardson	O
Grade	O
:	O
3	O
.	O

Necrosis	O
:	O
Present	O
.	O

Lobular	O
neoplasia	O
:	O
None	O
.	O

Lymph	O
nodes	O
:	O
Sentinel	O
lymph	O
node	O
only	O
.	O

Lymph	O
node	O
status	O
:	O
Negative	O
0	O
/	O
5	O
.	O

DCIS	O
present	O
.	O

Margins	O
uninvolved	O
by	O
DCIS	O
:	O
0	O
.	O
5cm	O
from	O
anterior	O
superior	O
margin	O
.	O

DCIS	O
Quantity	O
:	O
Estimate	O
40	O
%	O
.	O

DCIS	O
Type	O
:	O
Solid	O
.	O

DCIS	O
Location	O
:	O
Associated	O
with	O
invasive	O
tumor	O
.	O

Nuclear	O
grade	O
:	O
High	O
.	O

Necrosis	O
:	O
Present	O
.	O

Location	O
of	O
CA	O
+	O
+	O
:	O
DCIS	O
.	O

Pathological	O
staging	O
(	O
pTN	O
)	O
:	O
pT	O
2N0	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
None	O
given	O
.	O

ADDENDUM	O
:	O
NOTE	O
:	O
A	O
CD31	O
stain	O
was	O
performed	O
on	O
block	O
E6	O
and	O
is	O
negative	O
,	O
showing	O
no	O
evidence	O
of	O
.	O
lymphvascular	O
invasion	O
.	O

SYNOPTIC	O
REPORT	O
-	O
BREAST	O
,	O
ER	O
/	O
PR	O
RESULTS	O
.	O

Specimen	O
:	O
Surgical	O
Excision	O
.	O

Block	O
Number	O
:	O
E10	O
.	O

ER	O
:	O
Negative	O
Allred	O
Score	O
:	O
0	O
=	O
Proportion	O
Score	O
0	O
+	O
Intensity	O
Score	O
0	O
.	O

PR	O
:	O
Negative	O
Allred	O
Score	O
:	O
0	O
=	O
Proportion	O
Score	O
0	O
+	O
Intensity	O
Score	O
0	O
.	O

COMMENT	O
:	O
The	O
Allred	O
score	O
for	O
estrogen	O
and	O
progesterone	O
receptors	O
is	O
calculated	O
by	O
adding	O
the	O
sum	O
of	O
the	O
.	O
proportion	O
score	O
(	O
0	O
=	O
no	O
staining	O
,	O
1	O
=	O
<	O
1	O
%	O
of	O
cells	O
staining	O
,	O
2	O
=	O
1	O
-	O
10	O
%	O
of	O
cells	O
staining	O
,	O
3	O
=	O
11	O
-	O
30	O
%	O
of	O
.	O
cells	O
staining	O
,	O
4	O
=	O
31	O
-	O
60	O
%	O
of	O
cells	O
staining	O
,	O
5	O
=	O
>	O
60	O
%	O
of	O
cells	O
staining	O
)	O
to	O
the	O
intensity	O
score	O
(	O
1	O
=	O
weak	O
.	O
intensity	O
of	O
staining	O
,	O
2	O
=	O
intermediate	O
intensity	O
of	O
staining	O
,	O
3	O
=	O
strong	O
intensity	O
of	O
staining	O
)	O
,	O
with	O
a	O
scoring	O
.	O
range	O
from	O
0	O
to	O
8	O
.	O

ER	O
/	O
PR	O
positive	O
is	O
defined	O
as	O
an	O
Allred	O
score	O
of	O
>	O
2	O
and	O
ER	O
/	O
PR	O
negative	O
is	O
defined	O
as	O
an	O
Allred	O
score	O
.	O
of	O
less	O
than	O
or	O
equal	O
to	O
2	O
.	O

METHODOLOGY	O
:	O
Tissue	O
was	O
fixed	O
in	O
10	O
%	O
neutral	O
buffered	O
formalin	O
for	O
no	O
less	O
than	O
8	O
and	O
no	O
longer	O
than	O
24	O
hours	O
.	O

Immunohistochemistry	O
was	O
performed	O
using	O
the	O
mouse	O
anti	O
-	O
human	O
ER	O
(	O
ER	O
1D5	O
,	O
1	O
:	O
100	O
)	O
and	O
PR	O
(	O
PGR	O
.	O
136	O
,	O
1	O
:	O
100	O
)	O
provided	O
by	O
Dakc	O
.	O
bllowing	O
the	O
manufacturer	O
s	O
instructions	O
.	O

This	O
.	O
assay	O
was	O
not	O
modified	O
.	O

Interpretation	O
of	O
the	O
ER	O
/	O
PR	O
immunohistochemical	O
stain	O
is	O
guided	O
by	O
published	O
.	O
results	O
in	O
the	O
medical	O
literature	O
,	O
information	O
provided	O
by	O
the	O
reagent	O
manufacturer	O
and	O
by	O
internal	O
.	O
review	O
of	O
staining	O
performance	O
.	O

SYNOPTIC	O
REPORT	O
-	O
BREAST	O
HER	O
-	O
2	O
RESULTS	O
.	O

Specimen	O
:	O
Surgical	O
Excision	O
.	O

Block	O
Number	O
:	O
E10	O
.	O

Interpretation	O
:	O
EQUIVOCAL	O
.	O

Intensity	O
:	O
2	O
+	O
.	O

%	O
Tumor	O
Staining	O
:	O
15	O
%	O
.	O

Fish	O
Ordered	O
:	O
Yes	O
,	O
on	O
Date	O
.	O

METHODOLOGY	O
:	O
Tissue	O
was	O
fixed	O
in	O
10	O
%	O
neutral	O
buffered	O
formalin	O
for	O
no	O
less	O
than	O
8	O
and	O
no	O
longer	O
than	O
24	O
hours	O
.	O

Her2	O
analysis	O
was	O
performed	O
using	O
the	O
FDA	O
approved	O
Dako	O
HercepTest	O
(	O
TM	O
)	O
test	O
kit	O
.	O

C	O
.	O
using	O
rabbit	O
anti	O
-	O
human	O
HER2	O
.	O

This	O
assay	O
was	O
not	O
modified	O
.	O

External	O
kit	O
-	O
slides	O
.	O
provided	O
by	O
the	O
manufacturer	O
(	O
cell	O
lines	O
with	O
high	O
,	O
low	O
and	O
negative	O
HER2	O
protein	O
expression	O
)	O
and	O
in	O
-	O
.	O
house	O
known	O
HER2	O
amplified	O
control	O
tissue	O
were	O
evaluated	O
along	O
with	O
the	O
test	O
tissue	O
.	O

Adequate	O
,	O
well	O
.	O
preserved	O
,	O
clear	O
-	O
cut	O
invasive	O
carcinoma	O
was	O
identified	O
for	O
HER2	O
evaluation	O
.	O

Interpretation	O
of	O
the	O
HER2	O
.	O
immunohistochemical	O
stain	O
is	O
guided	O
by	O
published	O
results	O
in	O
the	O
medical	O
literature	O
,	O
information	O
provided	O
.	O
by	O
the	O
reagent	O
manufacturer	O
and	O
by	O
internal	O
review	O
of	O
staining	O
performance	O
.	O

This	O
assay	O
has	O
been	O
validated	O
according	O
to	O
the	O
.	O
int	O
recommendations	O
and	O
guidelines	O
from	O
.	O

ASCO	O
and	O
CAP	O
and	O
from	O
the	O
NCCN	O
HER2	O
testing	O
in	O
Breast	O
Cancer	O
Task	O
Force	O
.	O

The	O
Pathology	O
.	O

Department	O
takes	O
full	O
responsibility	O
for	O
this	O
test	O
'	O
s	O
performance	O
.	O

PathVysion	O
HER	O
-	O
2	O
DNA	O
Probe	O
Kit	O
.	O

Analytical	O
Interpretation	O
of	O
Results	O
:	O
HER	O
-	O
2	O
NOT	O
AMPLIFIED	O
.	O

Clinical	O
Interpretation	O
of	O
results	O
.	O

Amplification	O
of	O
the	O
HER	O
-	O
2	O
gene	O
was	O
evaluated	O
with	O
interphase	O
fluorescence	O
in	O
-	O
situ	O
.	O
hybridization	O
(	O
FISH	O
)	O
on	O
formalin	O
-	O
fixed	O
paraffin	O
embedded	O
tissue	O
sections	O
using	O
a	O
chromosome	O
.	O

17	O
.	O
centromeric	O
probe	O
and	O
a	O
HER	O
-	O
2	O
probe	O
that	O
spans	O
the	O
entire	O
HER	O
-	O
2	O
gene	O
in	O
the	O
.	O
by	O
Dr	O
.	O
A	O
majority	O
of	O
tumors	O
cells	O
displayed	O
2	O
chromosome	O
17	O
.	O
signals	O
and	O
2	O
HER	O
-	O
2	O
signals	O
,	O
with	O
a	O
HER	O
-	O
2	O
/	O
CEP	O
17	O
Ratio	O
<	O
/	O
=	O
2	O
.	O
0	O
,	O
consistent	O
with	O
no	O
.	O
amplification	O
of	O
the	O
HER2	O
/	O
neu	O
gene	O
.	O

Block	O
used	O
E10	O
.	O

Source	O
of	O
case	O
:	O
Tissue	O
fixation	O
.	O
formalin	O
-	O
fixed	O
tissue	O
.	O

Outside	O
Case	O
No	O
:	O
NA	O
.	O

Tissue	O
source	O
.	O
breast	O
Results	O
interpreted	O
:	O
HER2	O
/	O
CEP17	O
ratio	O
:	O
1	O
.	O
03	O
.	O

This	O
ratio	O
is	O
derived	O
by	O
dividing	O
the	O
total	O
number	O
of	O
LSI	O
HER	O
-	O
2	O
/	O
neu	O
signals	O
by	O
the	O
total	O
number	O
of	O
.	O

CEP17	O
signals	O
in	O
at	O
least	O
20	O
interphase	O
nuclei	O
with	O
nonoverlapping	O
nuclei	O
in	O
the	O
neoplastic	O
.	O
mammary	O
epithelial	O
cells	O
.	O

Cells	O
with	O
no	O
signals	O
or	O
with	O
signals	O
of	O
only	O
one	O
color	O
are	O
disregarded	O
.	O

Method	O
of	O
ratio	O
enumeration	O
:	O
manual	O
count	O
.	O

Limitations	O
.	O

The	O
Vysis	O
PathVysion	O
Kit	O
is	O
not	O
intended	O
for	O
use	O
to	O
screen	O
for	O
or	O
diagnose	O
breast	O
cancer	O
.	O

It	O
is	O
.	O
intended	O
to	O
be	O
used	O
as	O
an	O
adjunct	O
to	O
other	O
prognostic	O
factors	O
currently	O
used	O
to	O
predict	O
disease	O
-	O
free	O
.	O
and	O
overall	O
survival	O
in	O
stage	O
II	O
,	O
node	O
-	O
positive	O
breast	O
cancer	O
patients	O
.	O

In	O
making	O
decisions	O
regarding	O
.	O
adjuvant	O
CAF	O
treatment	O
,	O
all	O
other	O
available	O
clinical	O
information	O
should	O
also	O
be	O
taken	O
into	O
.	O
consideration	O
,	O
such	O
as	O
tumor	O
size	O
,	O
number	O
of	O
involved	O
lymph	O
nodes	O
,	O
and	O
steroid	O
receptor	O
status	O
.	O
treatment	O
decision	O
for	O
stage	O
II	O
,	O
node	O
-	O
positive	O
breast	O
cancer	O
patients	O
should	O
be	O
based	O
on	O
HER	O
-	O
.	O

2	O
/	O
neu	O
.	O
gene	O
amplification	O
status	O
alone	O
.	O

Overview	O
of	O
this	O
test	O
.	O

FDA	O
APPROVED	O
REAGENT	O
.	O

PathVysion	O
HER	O
-	O
2	O
DNA	O
Probe	O
Kit	O
is	O
FDA	O
approved	O
for	O
selection	O
of	O
.	O
patients	O
for	O
whom	O
Herceptin	O
therapy	O
is	O
being	O
considered	O
.	O

These	O
tests	O
were	O
performed	O
in	O
the	O
.	O
under	O
the	O
direction	O
.	O
of	O
Dr	O
.	O
The	O
results	O
of	O
these	O
studies	O
should	O
always	O
be	O
interpreted	O
in	O
the	O
context	O
of	O
the	O
.	O
clinical	O
,	O
morphological	O
,	O
and	O
immunophenotypic	O
diagnosis	O
.	O

Microscopic	O
/	O
Diagnostic	O
Dictation	O
:	O
Pathologist	O
,	O
1	O
.	O

Final	O
Review	O
:	O
Pathologist	O
,	O
.	O

Final	O
Review	O
:	O
Pathologist	O
,	O
.	O

Final	O
:	O
Pathologist	O
,	O
r	O
.	O

Addendum	O
:	O
Pathologiat	O
.	O

Addendum	O
Final	O
:	O
Pathologist	O
,	O
.	O

Addendum	O
:	O
Pathologist	O
,	O
.	O

Addendum	O
Final	O
:	O
Pathologist	O
.	O

I	O
.	O

Gynecology	O
.	O

MRN	O
:	O
Hospital	O
#	O
.	O

M	O
.	O
D	O
.	O

DIAGNOSIS	O
:	O
inconclusive	O
DEOVIX	O
RADICAL	O
.	O

SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MOCERATELY	O
CIFFERENTIATED	O
,	O
2	B
.	I
5	I
CM	I
IN	O
CREATEST	O
.	O

DIMENSION	O
.	O

TUMOR	O
INVADES	O
TO	O
A	O
DEPTH	O
OF	O
0	O
.	O
7	O
CM	O
(	O
TOTAL	O
WALL	O
THICKNESS	O
1	O
.	O
8	O
CM	O
)	O
.	O

-	O
NO	O
LYMPHVASCULAR	O
SPACE	O
INVASION	O
is	O
INENTIFIED	O
.	O

-	O
RESECTION	O
MARGING	O
ARE	O
FREE	O
OF	O
CARCINCMA	O
.	O

PARAMETRIA	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

LYMPH	O
NODES	O
,	O
PARAMETRIA	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
ELEVEN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
11	O
)	O
.	O

VAGINA	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

.	O
NO	O
DYSPLASIA	O
OR	O
CARCINOMA	O
IDENTIFIED	O
.	O

UTERUS	O
,	O
ENDOMETRIUM	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
SECRETORY	O
ENDOMETRIUM	O
.	O

UTERUS	O
,	O
MYOMETRIUM	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

OVARIES	O
,	O
RIGHT	O
AND	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

.	O
PARA	O
-	O
OVARIAN	O
ADHESIONS	O
.	O

FALLOPIAN	O
TUBES	O
,	O
RIGHT	O
AND	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
PERITUBAL	O
ADHESIONS	O
.	O

-	O
HYDROSALPINX	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
EXTERNAL	O
ILIAC	O
,	O
EXCISION	O
(	O
FS1	O
)	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
EXTERNAL	O
ILIAC	O
,	O
EXCISION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
FIVE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
5	O
)	O
.	O

Male	O
.	O

Clinical	O
diagnosis	O
:	O
Anaplastic	O
Squamous	O
cell	O
carcinoma	O
of	O
the	O
esophagus	O
.	O

Sample	O
:	O
histology	O
#	O
.	O

Gross	O
description	O
:	O
Esophageal	O
fragment	O
with	O
gastric	O
25x20x20	O
.	O

Section	O
.	O
reveals	O
gray	O
tumor	O
mass	O
1	B
cm	I
in	O
thickness	O
.	O

Paraesophageal	O
lymphatic	O
node	O
.	O

1	O
,	O
5x0	O
,	O
4	O
cm	O
with	O
dark	O
-	O
red	O
surface	O
.	O

Microscopic	O
description	O
:	O
Sections	O
reveal	O
ulcerative	O
infiltrated	O
tumor	O
,	O
.	O
anaplastic	O
squamous	O
cell	O
carcinoma	O
with	O
heavy	O
lymphoid	O
infiltration	O
.	O

Surgical	O
.	O
borders	O
are	O
clear	O
.	O

Paraesophageal	O
lymphatic	O
node	O
shows	O
metastatic	O
cells	O
.	O

Paragastric	O
lymphatic	O
nodes	O
and	O
greater	O
omentum	O
show	O
no	O
sign	O
of	O
metastasis	O
.	O

Final	O
diagnosis	O
:	O
Anaplastic	O
Squamous	O
cell	O
carcinoma	O
of	O
the	O
esophagus	O
.	O

Confidential	O
.	O

Final	O
Diagnosis	O
.	O

Yeast	O
,	O
left	O
,	O
wide	O
local	O
excision	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
Nottingham	O
grade	O
III	O
(	O
of	O
III	O
)	O
,	O
forming	O
a	O
2	B
.	I
7	I
x	I
2	I
.	I
7	I
x	I
1	I
.	I
5	I
cm	I
mass	O
.	O

(	O
AJCC	O
pT2	O
)	O
.	O

The	O
margins	O
,	O
including	O
the	O
separately	O
submitted	O
superior	O
margin	O
,	O
are	O
negative	O
for	O
tumor	O
.	O

The	O
closest	O
margin	O
.	O

(	O
superior	O
)	O
is	O
free	O
by	O
1	O
.	O
5	O
cm	O
.	O

Lymph	O
nodes	O
,	O
left	O
axillary	O
sentinel	O
,	O
excision	O
:	O
Multiple	O
(	O
2	O
)	O
left	O
axillary	O
sentinel	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
[	O
AJCCpNO	O
(	O
i	O
-	O
.	O
sn	O
)	O
]	O
.	O

Blue	O
dye	O
is	O
identified	O
in	O
both	O
left	O
axillary	O
sentinel	O
lymph	O
nodes	O
.	O

Immunohistochemical	O
cytokeratin	O
stain	O
was	O
performed	O
on	O
.	O
the	O
paraffin	O
embedded	O
sentinel	O
lymph	O
node	O
tissue	O
and	O
confirms	O
the	O
H	O
&	O
E	O
impression	O
.	O

CLINICAL	O
DIAGNOSIS	O
:	O
HCC	O
.	O

Specimen	O
:	O
liver	O
.	O

Gross	O
Photo	O
:	O
GROSS	O
:	O
1	O
.	O

Specimen	O
:	O
Liver	O
:	O
13	O
.	O
0	O
X	O
7	O
.	O
5	O
x	O
4	O
.	O
5	O
cm	O
,	O
185	O
.	O
0	O
gm	O
,	O
unfixed	O
.	O

2	O
.	O

Tumor	O
location	O
:	O
segment	O
8	O
.	O

Tumor	O
number	O
:	O
one	O
.	O

Tumor	O
size	O
:	O
4	B
.	I
0	I
X	I
3	I
.	I
0	I
X	I
3	I
.	I
8	I
cm	I
.	O

3	O
.	O

Satellite	O
nodule	O
:	O
no	O
.	O
4	O
.	O

Gross	O
type	O
.	O

HCC	O
:	O
expanding	O
nodular	O
.	O

5	O
.	O

Tumor	O
necrosis	O
:	O
no	O
.	O
6	O
.	O

Hemorrhage	O
/	O
peliosis	O
:	O
no	O
.	O
7	O
.	O

Portal	O
vein	O
invasion	O
:	O
no	O
.	O
8	O
.	O

Bile	O
duct	O
invasion	O
:	O
no	O
.	O

Gross	O
photo	O
present	O
.	O

Blocks	O
.	O

TB	O
,	O
T1	O
-	O
4	O
,	O
tumor	O
mass	O
X	O
5	O
.	O

RM	O
,	O
resection	O
margin	O
X	O
1	O
.	O

NB	O
,	O
A	O
,	O
non	O
-	O
tumorous	O
liver	O
parenchyme	O
x	O
2	O
.	O

MICROSCOPIC	O
:	O
1	O
.	O

Hepatocellular	O
carcinoma	O
:	O
yes	O
.	O

-	O
1	O
.	O

Differentiation	O
.	O

The	O
worst	O
differentiation	O
III	O
.	O

The	O
major	O
differentiation	O
II	O
.	O

1	O
-	O
2	O
.	O

Histologic	O
type	O
:	O
trabecular	O
,	O
pseudoglandular	O
.	O

1	O
-	O
3	O
.	O

Cell	O
type	O
:	O
hepatic	O
.	O

1	O
-	O
4	O
.	O

Fatty	O
change	O
:	O
no	O
.	O
2	O
.	O

Fibrous	O
capsule	O
formation	O
:	O
complete	O
capsule	O
.	O

3	O
.	O

Capsular	O
infiltration	O
:	O
no	O
.	O
4	O
.	O

Septum	O
formation	O
:	O
no	O
.	O
5	O
.	O

Surgical	O
resection	O
margin	O
invasion	O
:	O
no	O
,	O
margin	O
of	O
the	O
clearence	O
(	O
1	O
.	O
0	O
cm	O
)	O
.	O

6	O
.	O

Serosal	O
invasion	O
:	O
no	O
.	O
7	O
.	O

Portal	O
vein	O
invasion	O
:	O
no	O
.	O
8	O
.	O

Bile	O
duct	O
invasion	O
:	O
no	O
.	O
9	O
.	O

Hepatic	O
vein	O
invasion	O
:	O
no	O
.	O
10	O
.	O

Hepatic	O
artery	O
invasion	O
:	O
no	O
.	O
11	O
.	O

Microvessel	O
invasion	O
:	O
no	O
.	O
12	O
.	O

Intrahepatic	O
metastasis	O
:	O
no	O
.	O
13	O
.	O

Multicentric	O
occurrence	O
:	O
no	O
.	O

Non	O
-	O
tumor	O
liver	O
pathology	O
.	O

1	O
.	O

Chronic	O
hepatitis	O
:	O
yes	O
.	O

1	O
-	O
1	O
.	O

Etiology	O
:	O
HBV	O
.	O

1	O
-	O
2	O
.	O

Grade	O
,	O
lobular	O
:	O
minimal	O
.	O

1	O
-	O
3	O
.	O

Grade	O
,	O
portoperiportal	O
:	O
minimal	O
.	O

1	O
-	O
4	O
.	O

Stage	O
(	O
fibrosis	O
)	O
:	O
cirrhosis	O
.	O

1	O
-	O
5	O
.	O

Cirrhosis	O
:	O
micronodular	O
.	O

2	O
.	O

Dysplastic	O
nodule	O
:	O
no	O
.	O
3	O
.	O

Ductal	O
epithelial	O
dysplasia	O
:	O
no	O
.	O
4	O
.	O

Other	O
liver	O
diseases	O
:	O
no	O
.	O

SPECIAL	O
STAIN	O
:	O
Trichrome	O
(	O
+	O
stage	O
(	O
3	O
-	O
4	O
)	O
)	O
.	O

NOT	O
reported	O
.	O

Gross	O
:	O
Tunica	O
vaginalis	O
,	O
inguinal	O
,	O
ligation	O
,	O
Hernial	O
sac	O
.	O

Stomach	O
,	O
angle	O
,	O
scopic	O
,	O
chronic	O
gastritis	O
,	O
H	O
.	O
pylori	O
,	O
associated	O
.	O

Stomach	O
,	O
angle	O
,	O
scopic	O
,	O
ulcer	O
.	O

Liver	O
,	O
ectomy	O
,	O
hepatocellular	O
carcinoma	O
,	O
cirrhosis	O
.	O

T56000	O
,	O
P10	O
,	O
M81703	O
,	O
M49500	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
segment	O
8	O
,	O
segmentectomy	O
:	O
Hepatocellular	O
carcinoma	O
,	O
moderately	O
differentiated	O
.	O

Cirrhosis	O
,	O
micronodular	O
.	O

Suggestion	O
:	O

PATIENT	O
HISTORY	O
:	O
CHIEF	O
COMPLAINT	O
/	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
(	O
INCLUDING	O
PREOP	O
AND	O
POSTOP	O
DIAGNOSIS	O
)	O
:	O
Thyroid	O
nodule	O
.	O

PROCEDURE	O
:	O
Thyroidectomy	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
TO	O
ANSWER	O
:	O
.	O
Not	O
answered	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
ON	O
THIS	O
SPECIMEN	O
:	O
No	O
.	O

PRIOR	O
CANCER	O
/	O
MALIGNANCYITUMOR	O
:	O
No	O
.	O

CHEMORADIATION	O
THERAPY	O
:	O
No	O
.	O

HISTORY	O
OF	O
ORGAN	O
TRANSPLANT	O
:	O
No	O
.	O

HISTORY	O
OF	O
IMMUNOSUPPRESSION	O
:	O
No	O
.	O

ANY	O
OTHER	O
UNDERLYING	O
DISEASES	O
:	O
No	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
THYROID	O
GLAND	O
,	O
LEFT	O
LOBE	O
.	O

LOBECTOMY	O
(	O
14	O
GRAMS	O
)	O
-	O
.	O

A	O
.	O

PAPILLARY	O
THYROID	O
CARCINOMA	O
,	O
3	B
.	I
3	I
CM	I
,	O
WITH	O
DOMINANT	O
FOLLICULAR	O
GROWTH	O
PATTERN	O
(	O
see	O
.	O
comment	O
)	O
.	O

B	O
.	O

EXTRATHYROIDAL	O
EXTENSION	O
IS	O
ABSENT	O
.	O

C	O
.	O

VASCULAR	O
INVASION	O
IS	O
ABSENT	O
.	O

D	O
.	O

CARCINOMA	O
IS	O
0	O
.	O
1	O
CM	O
FROM	O
MARGIN	O
.	O

E	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
T2	O
.	O

PART	O
2	O
:	O
THYROID	O
GLAND	O
,	O
RIGHT	O
LOBE	O
,	O
LOBECTOMY	O
(	O
2	O
.	O
6	O
AND	O
0	O
.	O
7	O
GRAMS	O
)	O
-	O
.	O

BENIGN	O
THYROID	O
TISSUE	O
.	O

COMMENT	O
:	O
Previously	O
,	O
fine	O
needle	O
aspiration	O
of	O
the	O
left	O
thyrold	O
lobe	O
.	O
was	O
shown	O
to	O
be	O
positive	O
for	O
HRAS	O
.	O
mutation	O
(	O
see	O
addendum	O
for	O
.	O
r	O
further	O
details	O
)	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
THYROID	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Total	O
Thyroidectomy	O
.	O

TUMOR	O
SITE	O
:	O
Left	O
Lobe	O
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

TUMOR	O
SIZE	O
(	O
largest	O
nodule	O
)	O
:	O
Greatest	O
Dimension	O
:	O
3	B
.	I
3	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
:	O
Papillary	O
carcinoma	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNX	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

EXTRATHYROIDAL	O
EXTENSION	O
:	O
Not	O
identified	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Distance	O
of	O
invasive	O
carcinoma	O
to	O
closest	O
margin	O
:	O
1	O
mm	O
.	O

Not	O
identified	O
.	O

PATIENT	O
HISTORY	O
:	O
The	O
patient	O
is	O
a	O
.	O
with	O
a	O
history	O
of	O
PSA	O
value	O
of	O
15	O
,	O
.	O

The	O
patient	O
also	O
has	O
a	O
history	O
of	O
biopsy	O
on	O
.	O
this	O
biopsy	O
reveals	O
:	O
right	O
apex	O
=	O
Gleason	O
grade	O
.	O

4	O
+	O
4	O
=	O
8	O
;	O
right	O
mid	O
=	O
Gleason	O
grade	O
4	O
+	O
4	O
=	O
8	O
;	O
right	O
base	O
=	O
Gleason	O
grade	O
4	O
+	O
3	O
=	O
7	O
;	O
left	O
base	O
=	O
Gleason	O
grade	O
4	O
+	O
3	O
=	O
7	O
;	O
left	O
mid	O
=	O
.	O

Gleason	O
grade	O
4	O
+	O
3	O
=	O
7	O
;	O
left	O
apex	O
=	O
Gleason	O
grade	O
4	O
+	O
4	O
=	O
8	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Prostate	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Radical	O
prostatectomy	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

METASTATIC	O
CARCINOMA	O
IN	O
ONE	O
OF	O
SIX	O
(	O
1	O
/	O
6	O
)	O
LYMPH	O
NODES	O
EXAMINED	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

METASTATIC	O
CARCINOMA	O
IN	O
TWO	O
OF	O
SIX	O
(	O
2	O
/	O
6	O
)	O
LYMPH	O
NODES	O
EXAMINED	O
.	O

PART	O
3	O
:	O
PROSTATE	O
AND	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
RADICAL	O
PROSTATECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
POORLY	O
-	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
4	O
+	O
4	O
=	O
8	O
WITH	O
TERTIARY	O
.	O

GLEASON	O
PATTERN	O
3	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
BOTH	O
THE	O
RIGHT	O
AND	O
LEFT	O
LOBES	O
AND	O
HAS	O
A	O
GREATEST	O
NODULAR	O
DIAMETER	O
.	O

OF	O
2	B
.	I
6	I
CM	I
.	O

C	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
70	O
%	O
OF	O
THE	O
EXAMINED	O
PROSTATE	O
VOLUME	O
.	O

D	O
.	O

THE	O
CARCINOMA	O
SHOWS	O
SHOWS	O
ESTABLISHED	O
EXTRACAPSULAR	O
EXTENSION	O
IN	O
THE	O
RIGHT	O
AND	O
LEFT	O
.	O

POSTERIOR	O
BASE	O
REGIONS	O
AND	O
FOCALLY	O
INVOLVES	O
THE	O
INKED	O
SURGICAL	O
MARGINS	O
IN	O
THESE	O
REGIONS	O
.	O

(	O
SLIDES	O
3W	O
,	O
3X	O
,	O
3BB	O
)	O
.	O

E	O
.	O

BILATERAL	O
SEMINAL	O
VESICLES	O
ARE	O
INVOLVED	O
BY	O
CARCINOMA	O
.	O

F	O
.	O

ALL	O
OTHER	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

G	O
.	O

PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

I	O
.	O

HIGH	O
GRADE	O
PROSTATIC	O
INTRAEPITHELIAL	O
NEOPLASIA	O
IS	O
IDENTIFIED	O
.	O

J	O
.	O

PATHOLOGIC	O
TNM	O
STAGE	O
:	O
p3b	O
N1	O
MX	O
,	O
.	O

K	O
.	O

TNM	O
HISTOLOGIC	O
GRADE	O
=	O
G3	O
-	O
4	O
.	O

L	O
.	O

BENIGN	O
PROSTATIC	O
HYPERTROPHY	O
AND	O
CHRONIC	O
MODERATELY	O
ACTIVE	O
PROSTATITIS	O
ARE	O
NOTED	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
PROSTATE	O
TUMORS	O
.	O

CLINICAL	O
DATA	O
:	O
PSA	O
value	O
:	O
15	O
.	O

INVASIVE	O
CA	O
IDENTIFIED	O
?	O
:	O
TUMOR	O
HISTOLOGY	O
:	O
Adenocarcinoma	O
NOS	O
.	O

PRIMARY	O
GLEASON	O
GRADE	O
:	O
4	O
.	O

SECONDARY	O
GLEASON	O
GRADE	O
:	O
4	O
.	O

GLEASON	O
SUM	O
SCORE	O
:	O
8	O
.	O

GLEASON	O
4	O
/	O
5	O
PERCENTAGE	O
:	O
90	O
%	O
.	O

WEIGHT	O
OF	O
PROSTATE	O
:	O
52	O
.	O
81gm	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
2	B
.	I
4	I
cm	I
.	O

LOBE	O
LATERALITY	O
:	O
Right	O
and	O
Left	O
Lobes	O
.	O

PERCENT	O
OF	O
SPECIMEN	O
INVOLVED	O
BY	O
TUMOR	O
:	O
>	O
25	O
%	O
.	O

MULTIFOCAL	O
DISEASE	O
:	O
HIGH	O
GRADE	O
PIN	O
:	O
Yes	O
-	O
multifocal	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
Yes	O
-	O
Established	O
(	O
>	O
0	O
.	O
8mm	O
)	O
.	O

PERINEURAL	O
INVASION	O
:	O
ANGIOLYMPHATIC	O
INVASION	O
:	O
SEMINAL	O
VESICLE	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
Widespread	O
tumor	O
involvement	O
at	O
margin	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
12	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
3	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
Unknown	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3b	O
-	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
-	O
4	O
,	O
Poorly	O
differentiated	O
/	O
undifferentiated	O
.	O

Report	O
for	O
.	O

TEST	O
:	O
Surgical	O
Pathology	O
.	O

Collected	O
Date	O
&	O
Time	O
:	O
Result	O
Name	O
.	O

Reference	O
Range	O
.	O

Patient	O
Name	O
:	O
:	O
(	O
Age	O
:	O
Gender	O
:	O
M	O
.	O

Physician	O
(	O
s	O
)	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Right	O
external	O
iliac	O
and	O
obturator	O
lymph	O
nodes	O
.	O

B	O
:	O
Prostate	O
.	O

Pathologic	O
Diagnosis	O
.	O

Lymph	O
nodes	O
,	O
right	O
external	O
iliac	O
and	O
obturator	O
,	O
excision	O
(	O
A	O
)	O
:	O
2	O
lymph	O
nodes	O
,	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
2	O
)	O
.	O

Prostate	O
,	O
excision	O
(	O
B	O
)	O
:	O
Prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
4	O
+	O
5	O
=	O
9	O
.	O

High	O
-	O
grade	O
prostatic	O
intraepithelial	O
neoplasia	O
.	O

Note	O
:	O
The	O
prostatic	O
adenocarcinoma	O
is	O
centered	O
in	O
the	O
right	O
lobe	O
.	O
of	O
the	O
prostate	O
and	O
demonstrates	O
a	O
majority	O
of	O
Gleason	O
4	O
pattern	O
.	O
with	O
a	O
secondary	O
Gleason	O
5	O
pattern	O
.	O

Focally	O
,	O
the	O
right	O
posterior	O
.	O
lateral	O
margin	O
of	O
the	O
prostate	O
is	O
involved	O
by	O
adenocarcinoma	O
.	O

Along	O
the	O
posterior	O
and	O
posterolateral	O
margins	O
on	O
the	O
right	O
side	O
,	O
.	O
the	O
tumor	O
is	O
present	O
within	O
a	O
fraction	O
of	O
a	O
millimeter	O
of	O
the	O
.	O
inked	O
margin	O
of	O
excision	O
.	O

SURGICAL	O
PATHOLOGY	O
CANCER	O
CASE	O
SUMMARY	O
CHECKLIST	O
:	O
PROSTATE	O
GLAND	O
,	O
.	O

RADICAL	O
PROSTATECTOMY	O
.	O

Procedure	O
:	O
Radical	O
prostatectomy	O
.	O

Prostate	O
Size	O
:	O
Weight	O
:	O
34	O
g	O
.	O

Size	O
:	O
4	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
3	O
cm	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Pelvic	O
lymph	O
node	O
dissection	O
.	O

Histologic	O
Type	O
:	O
Adenocarcinoma	O
,	O
acinar	O
,	O
NOS	O
.	O

Histologic	O
Grade	O
/	O
Gleason	O
Pattern	O
:	O
Primary	O
Pattern	O
:	O
Grade	O
4	O
.	O

Secondary	O
Pattern	O
:	O
Grade	O
5	O
.	O

Tertiary	O
Pattern	O
:	O
Grade	O
3	O
.	O

Total	O
Gleason	O
Score	O
:	O
4	O
+	O
5	O
=	O
9	O
.	O

Tumor	O
Quantitation	O
:	O
Proportion	O
of	O
prostate	O
involved	O
by	O
tumor	O
:	O
Approximately	O
40	O
%	O
.	O

Extraprostatic	O
Extension	O
:	O
Not	O
identified	O
.	O

Seminal	O
Vesicle	O
Invasion	O
:	O
Not	O
identified	O
.	O

Margins	O
:	O
Margins	O
involved	O
by	O
invasive	O
carcinoma	O
,	O
unifocal	O
,	O
right	O
.	O
posterolateral	O
.	O

Treatment	O
Effect	O
on	O
Carcinoma	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Present	O
.	O

Pathologic	O
Staging	O
:	O
Primary	O
Tumor	O
:	O
pT2c	O
.	O

Regional	O
lymph	O
nodes	O
:	O
pNO	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
2	O
.	O

Number	O
of	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
metastasis	O
:	O
Not	O
applicable	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
.	O
for	O
is	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
.	O

is	O
based	O
solely	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
.	O
and	O
does	O
not	O
incorporate	O
other	O
relevant	O
data	O
.	O

Pathology	O
stage	O
is	O
.	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
the	O
clinical	O
.	O
stage	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
.	O
operative	O
report	O
.	O

Primarv	O
Pathologist	O
:	O
Clinical	O
History	O
.	O

Prostate	O
cancer	O
,	O
additional	O
information	O
is	O
provided	O
.	O

Intraoperative	O
Consultation	O
.	O

A	O
.	O

Right	O
external	O
iliac	O
obturator	O
lymph	O
nodes	O
:	O
Four	O
benign	O
.	O
lvmph	O
nodes	O
.	O

(	O
microscopic	O
evaluation	O
)	O
.	O

Ph	O
.	O
D	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
right	O
external	O
.	O
iliac	O
obturator	O
lymph	O
nodes	O
"	O
is	O
a	O
6	O
.	O
0	O
x	O
5	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
.	O
fat	O
.	O

There	O
are	O
four	O
lymph	O
nodes	O
dissected	O
out	O
,	O
ranging	O
from	O
0	O
.	O
7	O
.	O
to	O
4	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
submitted	O
.	O
as	O
follows	O
:	O
A1FS	O
-	O
4	O
.	O
5	O
cm	O
lymph	O
node	O
inked	O
black	O
and	O
bisected	O
.	O

A2FS	O
-	O
three	O
lymph	O
nodes	O
(	O
one	O
orange	O
,	O
one	O
yellow	O
,	O
one	O
blue	O
)	O
.	O

B	O
.	O

Received	O
in	O
formalin	O
labeled	O
"	O
prostate	O
"	O
is	O
a	O
34	O
g	O
,	O
4	O
.	O
0	O
cm	O
.	O
from	O
left	O
to	O
right	O
,	O
3	O
.	O
3	O
cm	O
from	O
anterior	O
to	O
posterior	O
,	O
3	O
.	O
5	O
cm	O
.	O
from	O
apex	O
to	O
bladder	O
neck	O
margin	O
prostatectomy	O
specimen	O
with	O
.	O
attached	O
right	O
seminal	O
vesicle	O
(	O
4	O
.	O
0	O
x	O
1	O
.	O
x	O
0	O
.	O
3	O
cm	O
)	O
,	O
right	O
vas	O
.	O
deferens	O
(	O
3	O
.	O
2	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
)	O
,	O
left	O
seminal	O
vesicle	O
(	O
3	O
.	O
2	O
x	O
1	O
.	O
7	O
x	O
.	O
0	O
.	O
6	O
cm	O
)	O
,	O
left	O
vas	O
deferens	O
(	O
3	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
)	O
.	O

The	O
prostate	O
is	O
.	O
inked	O
as	O
follows	O
:	O
right	O
prostate	O
is	O
inked	O
blue	O
,	O
left	O
prostate	O
is	O
.	O
inked	O
black	O
,	O
and	O
bladder	O
neck	O
margin	O
is	O
inked	O
yellow	O
.	O

The	O
prostate	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
bladder	O
neck	O
.	O
margin	O
to	O
reveal	O
a	O
2	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
firm	O
white	O
-	O
tan	O
.	O
lesion	O
located	O
in	O
the	O
right	O
anterior	O
and	O
right	O
posterior	O
prostate	O
.	O
that	O
extends	O
from	O
apex	O
to	O
bladder	O
neck	O
margin	O
.	O

The	O
lesion	O
.	O
grossly	O
approaches	O
the	O
apex	O
margin	O
.	O

There	O
are	O
no	O
other	O
discrete	O
.	O
nodules	O
or	O
masses	O
grossly	O
identified	O
.	O

85	O
%	O
of	O
the	O
specimen	O
is	O
.	O
submitted	O
in	O
cassettes	O
B1	O
through	O
B20	O
.	O

Sections	O
are	O
submitted	O
as	O
.	O
follows	O
:	O
B1	O
,	O
B2	O
-	O
right	O
apex	O
perpendicularly	O
cut	O
.	O

B3	O
,	O
B4	O
-	O
left	O
apex	O
perpendicularly	O
cut	O
.	O

B5	O
,	O
B6	O
-	O
right	O
bladder	O
neck	O
margin	O
perpendicularly	O
cut	O
.	O

B7	O
,	O
B8	O
-	O
left	O
bladder	O
neck	O
margin	O
perpendicularly	O
cut	O
.	O

B9	O
-	O
right	O
seminal	O
vesicle	O
insertion	O
point	O
and	O
cross	O
-	O
section	O
.	O
through	O
right	O
seminal	O
vesicle	O
and	O
vas	O
deferens	O
.	O

B10	O
-	O
left	O
seminal	O
vesicle	O
insertion	O
point	O
and	O
cross	O
-	O
section	O
.	O
through	O
left	O
seminal	O
vesicle	O
and	O
vas	O
deferens	O
.	O

B11	O
-	O
right	O
anterior	O
prostate	O
.	O

B12	O
-	O
B15	O
-	O
right	O
posterior	O
prostate	O
from	O
apex	O
to	O
bladder	O
neck	O
.	O
margin	O
.	O

B16	O
-	O
left	O
anterior	O
prostate	O
.	O

B17	O
-	O
B20	O
-	O
left	O
posterior	O
prostate	O
from	O
apex	O
to	O
bladder	O
neck	O
.	O
margin	O
.	O

Microscopic	O
Description	O
.	O

Microscopic	O
examination	O
has	O
been	O
performed	O
on	O
all	O
slides	O
.	O

The	O
.	O
pathologic	O
diagnosis	O
encompasses	O
the	O
essential	O
microscopic	O
.	O
findings	O
of	O
this	O
case	O
.	O

Interpretation	O
performed	O
at	O
.	O

If	O
imsunohistochemistry	O
or	O
in	O
situ	O
hybridization	O
was	O
used	O
the	O
.	O
following	O
applies	O
:	O
This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O

It	O
.	O
characteristic	O
determined	O
by	O
.	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O

S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
does	O
not	O
require	O
this	O
test	O
to	O
go	O
.	O
through	O
premarket	O
FDA	O
review	O
.	O

This	O
test	O
is	O
used	O
for	O
clinical	O
.	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
.	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
.	O

Laboratory	O
Improvement	O
Amendments	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
.	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

All	O
special	O
stains	O
.	O
used	O
have	O
adequate	O
controls	O
.	O

MRN	O
#	O
:	O
Ref	O
Phyame	O
.	O

SPECIMEN	O
INFORMATION	O
.	O

Acct	O
.	O
/	O
Reg	O
#	O
:	O
DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Pelvic	O
lymph	O
nodes	O
,	O
biopsy	O
:	O
Two	O
benign	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

B	O
.	O

Prostate	O
,	O
radical	O
prostatectomy	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

2	O
.	O

Prostate	O
size	O
:	O
4	O
.	O
8x4	O
.	O
5x4	O
.	O
3cm	O
.	O

3	O
.	O

Tumor	O
quantitation	O
:	O
Tumor	O
involves	O
both	O
lobes	O
.	O

4	O
.	O

Gleason	O
grade	O
:	O
a	O
.	O

Primary	O
pattern	O
:	O
3	O
/	O
5	O
,	O
.	O

b	O
.	O

Secondary	O
pattern	O
:	O
3	O
/	O
5	O
.	O

c	O
.	O

Total	O
Gleason	O
score	O
:	O
6	O
/	O
10	O
.	O

5	O
.	O

Extraprostatic	O
extension	O
:	O
No	O
.	O
6	O
.	O

Seminal	O
vesicle	O
involvement	O
:	O
No	O
.	O
7	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
No	O
.	O
8	O
.	O

High	O
grade	O
PIN	O
:	O
Yes	O
,	O
extensive	O
.	O

9	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
.	O

10	O
.	O

Perineural	O
invasion	O
:	O
Yes	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

All	O
margins	O
are	O
free	O
of	O
carcinoma	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
received	O
:	O
2	O
.	O

2	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
carcinoma	O
:	O
0	O
(	O
0	O
/	O
2	O
)	O
.	O

Other	O
:	O
1	O
.	O

Other	O
significant	O
findings	O
:	O
High	O
grade	O
PIN	O
and	O
benign	O
prostatic	O
hyperplasia	O
.	O

2	O
.	O

pTNM	O
stage	O
:	O
T2c	O
NO	O
Mx	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
.	O

B	O
.	O

Prostate	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
two	O
formalin	O
filled	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

A	O
.	O

Additionally	O
labeled	O
#	O
1	O
and	O
contains	O
a	O
4	O
,	O
8	O
x	O
4	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
yellow	O
-	O
tan	O
fibrofatty	O
soft	O
tissue	O
.	O

On	O
palpation	O
,	O
two	O
firm	O
fatty	O
possible	O
lymph	O
.	O
nodes	O
.	O

are	O
.	O
identified	O
0	O
.	O
9	O
and	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
largest	O
is	O
inked	O
.	O

Both	O
pieces	O
are	O
bisected	O
and	O
all	O
tissue	O
is	O
submitted	O
in	O
cassette	O
A	O
labeled	O
.	O

B	O
.	O

Additionally	O
labeled	O
#	O
2	O
and	O
contains	O
a	O
44	O
.	O
9	O
gram	O
,	O
4	O
.	O
8	O
x	O
4	O
.	O
5	O
x	O
4	O
.	O
3	O
cm	O
prostate	O
received	O
with	O
attached	O
bilateral	O
adnexa	O
having	O
overall	O
dimensions	O
of	O
3	O
.	O
5	O
.	O

x	O
3	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
.	O

Prostatic	O
capsule	O
is	O
pink	O
-	O
tan	O
and	O
shaggy	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
right	O
side	O
-	O
blue	O
;	O
and	O
left	O
side	O
-	O
black	O
.	O

The	O
base	O
and	O
apical	O
.	O
margins	O
are	O
coned	O
and	O
serially	O
sectioned	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
to	O
reveal	O
a	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
well	O
.	O
circumscribed	O
yellow	O
-	O
tan	O
firm	O
nodule	O
located	O
in	O
the	O
posterior	O
aspect	O
and	O
approaching	O
to	O
within	O
0	O
.	O
3	O
cm	O
of	O
the	O
inked	O
capsule	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
.	O
surface	O
is	O
pink	O
-	O
tan	O
and	O
focally	O
cystic	O
with	O
diffuse	O
periurethral	O
nodularity	O
.	O

No	O
additional	O
discrete	O
lesions	O
are	O
identified	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
in	O
cassettes	O
B1	O
-	O
18	O
labeled	O
.	O
designated	O
as	O
follows	O
:	O
1	O
-	O
right	O
prostate	O
/	O
seminal	O
vesicle	O
junction	O
;	O
2	O
-	O
left	O
prostate	O
/	O
seminal	O
vesicle	O
.	O
junction	O
;	O
.	O

3	O
-	O
4	O
-	O
apical	O
.	O
margin	O
,	O
.	O
perpendicular	O
,	O
.	O

5	O
-	O
6	O
-	O
pase	O
margin	O
,	O
perpendicular	O
;	O
7	O
-	O
9	O
-	O
right	O
anterior	O
,	O
apex	O
to	O
base	O
;	O
10	O
-	O
12	O
-	O
right	O
posterior	O
,	O
apex	O
to	O
base	O
;	O
13	O
-	O
.	O

15	O
-	O
left	O
.	O
anterior	O
,	O
apex	O
to	O
base	O
;	O
16	O
-	O
18	O
-	O
left	O
posterior	O
,	O
apex	O
to	O
base	O
,	O
Additionally	O
,	O
a	O
yellow	O
and	O
green	O
cassette	O
are	O
submitted	O
for	O
Genomics	O
research	O
each	O
.	O
labeled	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
SENTINEL	O
#	O
1	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
FREE	O
OF	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
SENTINEL	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
FREE	O
OF	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
3	O
:	O
BREAST	O
,	O
LEFT	O
,	O
SEGMENTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

(	O
NEILTRATING	O
DUCIAL	O
CARCINOMA	O
(	O
3A	O
,	O
3B	O
,	O
3C	O
,	O
3D	O
,	O
3E	O
,	O
AND	O
3F	O
)	O
.	O

THE	O
TUMOR	O
COMES	O
TO	O
WITHIN	O
1	O
.	O
0	O
MM	O
.	O

FROM	O
THE	O
NEAREST	O
ANTERIOR	O
RESECTION	O
MARGIN	O
(	O
3A	O
AND	O
3B	O
)	O
.	O

B	O
.	O

THE	O
TUMOR	O
SIZE	O
IS	O
1	B
.	I
5	I
X	I
1	I
.	I
2	I
X	I
1	I
.	I
1	I
CM	I
.	O

C	O
.	O

NOTTINGHAM	O
SCORE	O
IS	O
6	O
/	O
9	O
(	O
TUBULES	O
3	O
,	O
NUCLEI	O
2	O
,	O
MITOSIS	O
1	O
)	O
.	O

D	O
.	O

LYMPHOVASCULAR	O
PERMEATION	O
IS	O
NOT	O
APPRECIATED	O
.	O

E	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
CRIBRIFORM	O
AND	O
SOLID	O
TYPES	O
,	O
NUCLEAR	O
GRADE	O
2	O
,	O
REPRESENTING	O
.	O

ABOUT	O
2	O
%	O
OF	O
TUMOR	O
VOLUME	O
.	O

F	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
IS	O
ADMIXED	O
WITH	O
INVASIVE	O
TUMOR	O
AND	O
COMES	O
TO	O
WITHIN	O
1	O
.	O
0	O
MM	O
FROM	O
.	O

THE	O
NEAREST	O
ANTERIOR	O
RESECTION	O
MARGIN	O
.	O

G	O
.	O

CHANGES	O
CONSISTENT	O
WITH	O
PREVIOUS	O
BIOPSY	O
SITE	O
,	O
SEE	O
PRIOR	O
.	O

H	O
.	O

FIBROCYSTIC	O
CHANGES	O
WITH	O
FIBROADENOMATOID	O
CHANGES	O
,	O
DUCTAL	O
EPITHELIAL	O
HYPERPLASIA	O
,	O
.	O

COLUMNAR	O
CELL	O
CHANGES	O
AND	O
ASSOCIATED	O
MULTIFOCAL	O
MICROCALCIFICATIONS	O
.	O

I	O
.	O

IMMUNOHISTOCHEMICAL	O
STAINING	O
FOR	O
ESTROGEN	O
RECEPTOR	O
,	O
PROGESTERONE	O
RECEPTOR	O
AND	O
HER	O
-	O
.	O

2	O
/	O
NEU	O
WERE	O
PREVIOUSLY	O
PERFORMED	O
ON	O
.	O

AND	O
WERE	O
REPORTED	O
AS	O
FOLLOWS	O
:	O
ESTROGEN	O
RECEPTOR	O
-	O
POSITIVE	O
,	O
PROGESTERONE	O
RECEPTOR	O
-	O
POSITIVE	O
,	O
HER	O
-	O
2	O
/	O
NEU	O
-	O
NEGATIVE	O
.	O

(	O
SCORE	O
+	O
1	O
)	O
.	O

PART	O
4	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
SENTINEL	O
#	O
3	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
FREE	O
OF	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
5	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
SENTINEL	O
#	O
4	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
FREE	O
OF	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Left	O
.	O

PROCEDURE	O
:	O
Segmental	O
.	O

Not	O
specified	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
1	B
.	I
5	I
cm	I
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
2	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitotic	O
activity	O
score	O
:	O
1	O
.	O

Total	O
Nottingham	O
score	O
:	O
6	O
.	O

Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
2	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
Not	O
applicable	O
.	O

CALCIFICATION	O
:	O
Yes	O
,	O
benign	O
zones	O
.	O

TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Cribriform	O
,	O
Solid	O
,	O
DCIS	O
admixed	O
with	O
invasive	O
carcinoma	O
,	O
Percent	O
of	O
tumor	O
occupied	O
.	O
by	O
in	O
situ	O
component	O
:	O
2	O
%	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Distance	O
of	O
invasive	O
tumor	O
to	O
closest	O
margin	O
:	O
1	O
mm	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
Distance	O
of	O
in	O
situ	O
disease	O
to	O
closest	O
margin	O
:	O
1	O
mm	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
0	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
4	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
.	O

T	O
PATHOLOGIC	O
:	O
NON	O
-	O
NEOPLASTIC	O
STAGE	O
,	O
BREAST	O
TISSUE	O
:	O
Fibroadenoma	O
,	O
FCD	O
.	O

pT1c	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNo	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
pMX	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
positive	O
.	O
positive	O
.	O

HER2	O
/	O
NEU	O
:	O
zero	O
or	O
1	O
+	O
.	O

JA	O
-	O
28	O
-	O
1757	O
-	O
.	O

Department	O
of	O
Pathology	O
&	O
Laboratory	O
.	O

Medicine	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

Reason	O
for	O
Addendum	O
#	O
1	O
:	O
Additional	O
studies	O
/	O
stains	O
/	O
opinion	O
(	O
s	O
)	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

B	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
,	O
NCI	O
#	O
1	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

30	O
%	O
of	O
tumor	O
necrosis	O
.	O

80	O
%	O
of	O
tumor	O
cellularity	O
.	O

C	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
NCI	O
#	O
2	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

70	O
%	O
of	O
tumor	O
necrosis	O
.	O

90	O
%	O
of	O
viable	O
tumor	O
cellularity	O
.	O

D	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
NCI	O
#	O
3	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

80	O
%	O
of	O
tumor	O
necrosis	O
.	O

10	O
%	O
of	O
viable	O
tumor	O
cellularity	O
.	O

E	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
NCI	O
#	O
4	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

90	O
%	O
of	O
tumor	O
necrosis	O
.	O

5	O
%	O
of	O
viable	O
tumor	O
cellularity	O
.	O

F	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
BIOPSY	O
NCI	O
#	O
5	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

30	O
%	O
of	O
tumor	O
cellularity	O
.	O

90	O
%	O
of	O
tumor	O
necrosis	O
.	O

G	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISION	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

H	O
.	O

BRAIN	O
,	O
RIGHT	O
TEMPORAL	O
,	O
EXCISIONAL	O
BIOPSY	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

COMMENT	O
:	O
Patient	O
Case	O
(	O
s	O
)	O
.	O

PATIENT	O
Dot	O
RISULIS	O
.	O

DR	O
.	O

NURSE	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

A	O
high	O
percentage	O
of	O
tumor	O
cells	O
(	O
greater	O
than	O
20	O
%	O
)	O
immunostainino	O
for	O
MGMT	O
has	O
been	O
reported	O
to	O
.	O

be	O
.	O
associated	O
.	O
with	O
a	O
relatively	O
diminished	O
response	O
to	O
Temodar	O
.	O

Hence	O
,	O
the	O
low	O
5	O
%	O
result	O
in	O
.	O
this	O
case	O
suggests	O
a	O
likelihood	O
of	O
this	O
tumor	O
being	O
responsive	O
to	O
Temodar	O
.	O

Recent	O
studies	O
have	O
shown	O
that	O
co	O
-	O
expression	O
of	O
EGFRvIII	O
and	O
PTEN	O
as	O
detected	O
by	O
immunostaining	O
was	O
.	O
significantly	O
correlated	O
with	O
a	O
clinical	O
response	O
of	O
glioblastomas	O
to	O
EGFR	O
kinase	O
inhibitors	O
.	O

Hence	O
the	O
preserved	O
expression	O
of	O
PTEN	O
in	O
this	O
case	O
,	O
when	O
combined	O
with	O
EGFRvIII	O
.	O
mutation	O
,	O
permits	O
a	O
possibility	O
of	O
this	O
tumor	O
being	O
responsive	O
to	O
EGFR	O
-	O
kinase	O
inhibitors	O
.	O

Retained	O
expression	O
of	O
PTEN	O
was	O
found	O
in	O
be	O
associated	O
with	O
.	O
grade	O
aliomas	O
)	O
.	O

n	O
.	O

Molecular	O
subclasses	O
of	O
high	O
-	O
grade	O
glioma	O
.	O
predict	O
prognosis	O
,	O
delineate	O
a	O
pattern	O
of	O
disease	O
progression	O
,	O
and	O
resemble	O
stages	O
in	O
neurogenesis	O
.	O

Cancer	O
Cell	O
,	O
.	O

Recent	O
studies	O
indicated	O
an	O
adverse	O
prognostic	O
significance	O
of	O
increased	O
expression	O
of	O
laminin	O
heta	O
1	O
and	O
decreased	O
.	O
expression	O
of	O
laminin	O
beta	O
2	O
predicting	O
a	O
worse	O
survival	O
of	O
patients	O
with	O
gliomas	O
.	O
between	O
laminin	O
-	O
8	O
and	O
glial	O
tumor	O
grade	O
,	O
recurrence	O
,	O
and	O
patient	O
survival	O
.	O

Accordingly	O
,	O
elevated	O
expression	O
of	O
B1	O
and	O
32	O
in	O
this	O
tumor	O
suggest	O
the	O
tumor	O
aggress	O
	O
veness	O
intermediate	O
between	O
.	O
the	O
Bill	O
(	O
or	O
normal	O
)	O
/	O
22	O
normal	O
(	O
or	O
ii	O
)	O
(	O
the	O
most	O
favorable	O
prognosis	O
)	O
and	O
Bill	O
/	O
(	O
least	O
favorable	O
prognosis	O
)	O
.	O

Presence	O
of	O
activated	O
(	O
phosphorylated	O
)	O
p42	O
/	O
44	O
Mitogen	O
-	O
Activated	O
Protein	O
Kinase	O
(	O
pMAPK	O
)	O
has	O
been	O
shown	O
to	O
be	O
.	O
associated	O
with	O
a	O
relative	O
resistance	O
of	O
glioblastoma	O
multiforme	O
to	O
radiation	O
therapy	O
.	O

Prognostic	O
Associations	O
of	O
Activated	O
Mitogen	O
-	O
Activated	O
Protein	O
Kinase	O
and	O
Akt	O
Pathways	O
in	O
.	O

Glioblastoma	O
.	O

Clin	O
Cancer	O
Res	O
.	O

Correspondingly	O
,	O
a	O
high	O
percentage	O
of	O
tumor	O
cells	O
immunoreactive	O
to	O
pMAPK	O
antibody	O
in	O
this	O
case	O
predicts	O
a	O
.	O
relative	O
resistance	O
to	O
radiation	O
therapy	O
.	O

The	O
use	O
of	O
these	O
tests	O
in	O
guiding	O
therapy	O
has	O
limitations	O
.	O

Review	O
of	O
the	O
relevant	O
literature	O
and	O
clinical	O
correlation	O
is	O
.	O
advised	O
.	O

These	O
test	O
results	O
do	O
not	O
obligate	O
or	O
preclude	O
use	O
of	O
the	O
relevant	O
therapeutic	O
agents	O
.	O

IDC2a	O
:	O
Selected	O
slides	O
were	O
reviewed	O
in	O
consultation	O
with	O
.	O

HISTORY	O
:	O
Tumor	O
brain	O
.	O

MICROSCOPIC	O
:	O
This	O
extensively	O
necrotizing	O
malignant	O
infiltrating	O
glioma	O
features	O
nuclear	O
pleomorphism	O
,	O
scattered	O
mitotic	O
activity	O
,	O
.	O
focal	O
microvascular	O
endothelial	O
proliferation	O
.	O

IMMUNOSTAINS	O
:	O
MGMT	O
(	O
G1	O
)	O
:	O
Up	O
to	O
5	O
%	O
of	O
tumor	O
nuclei	O
are	O
positive	O
.	O

PTEN	O
(	O
G1	O
)	O
:	O
Retained	O
(	O
1	O
-	O
2	O
+	O
in	O
80	O
%	O
of	O
tumor	O
cells	O
)	O
.	O

pMAPK	O
(	O
G1	O
)	O
:	O
40	O
%	O
of	O
tumor	O
nuclei	O
are	O
positive	O
and	O
70	O
%	O
of	O
tumor	O
cytoplasm	O
is	O
positive	O
.	O

Laminin	O
beta	O
-	O
1	O
(	O
8	O
/	O
411	O
)	O
(	O
G1	O
)	O
:	O
Upregulated	O
(	O
3	O
+	O
in	O
endothelial	O
cells	O
)	O
.	O

Laminin	O
beta	O
-	O
2	O
(	O
9	O
/	O
421	O
)	O
(	O
G1	O
)	O
:	O
Upregulated	O
(	O
2	O
+	O
in	O
endothelial	O
cells	O
)	O
.	O

GROSS	O
:	O
A	O
.	O

RIGHT	O
TEMPORAL	O
BRAIN	O
TUMOR	O
FS	O
1	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
right	O
temporal	O
brain	O
tumor	O
FS	O
1	O
"	O
,	O
is	O
a	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
piece	O
of	O
soft	O
tan	O
.	O
tissue	O
.	O

Specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O

Entirely	O
submitted	O
.	O

A1	O
.	O

Frozen	O
section	O
control	O
for	O
FS	O
#	O
1	O
(	O
specimen	O
A	O
)	O
-	O
1	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

PATIENT	O
:	O
&	O
.	O

B	O
.	O

RIGHT	O
TEMPORAL	O
NCI	O
#	O
1	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
#	O
1	O
NCI	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
.	O
research	O
tissue	O
procurement	O
is	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
4	O
cm	O
portion	O
of	O
pink	O
-	O
tan	O
,	O
focally	O
hemorrhagic	O
tissue	O
.	O

Specimen	O
is	O
.	O
entirely	O
submitted	O
.	O

B1	O
,	O
1	O
.	O

C	O
.	O

RIGHT	O
TEMPORAL	O
NCI	O
#	O
2	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
NCI	O
#	O
2	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
.	O
research	O
tissue	O
procurement	O
and	O
is	O
subsequently	O
fixed	O
in	O
formalin	O
and	O
is	O
a	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
light	O
tan	O
focally	O
.	O
hemorrhagic	O
tissue	O
fragment	O
.	O

Specimen	O
is	O
entirely	O
submitted	O
.	O

CI	O
.	O

1	O
.	O

D	O
.	O

RIGHT	O
TEMPORAL	O
NCI	O
#	O
3	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
NCI	O
#	O
3	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
.	O
research	O
tissue	O
procurement	O
and	O
is	O
subsequently	O
fixed	O
in	O
formalin	O
and	O
is	O
a	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
light	O
tan	O
tissue	O
.	O
fragment	O
.	O

Specimen	O
is	O
entirely	O
submitted	O
.	O

D1	O
.	O

1	O
.	O

E	O
.	O

RIGHT	O
TEMPORAL	O
NCI	O
#	O
4	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
NCI	O
#	O
4	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
.	O
research	O
tissue	O
procurement	O
and	O
is	O
subsequently	O
fixed	O
in	O
formalin	O
and	O
is	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
light	O
tan	O
focally	O
.	O
hemorrhagic	O
tissue	O
fragment	O
.	O

Specimen	O
is	O
entirely	O
submitted	O
.	O

E1	O
.	O

1	O
.	O

F	O
.	O

RIGHT	O
TEMPORAL	O
NCI	O
#	O
5	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
NCI	O
#	O
5	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
research	O
tissue	O
.	O
procurement	O
and	O
is	O
subsequently	O
fixed	O
in	O
formalin	O
and	O
is	O
a	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
portion	O
of	O
hemorrhagic	O
light	O
tan	O
.	O
tissue	O
.	O

Specimen	O
is	O
entirely	O
submitted	O
.	O

F1	O
.	O

I	O
.	O

G	O
.	O

RIGHT	O
TEMPORAL	O
FOR	O
PERMANENTS	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
are	O
two	O
portions	O
of	O
light	O
tan	O
.	O
hemorrhagic	O
somewhat	O
friable	O
tissue	O
.	O

Tissues	O
serially	O
sectioned	O
and	O
entirely	O
submitted	O
.	O

G1	O
,	O
G2	O
.	O

2	O
each	O
.	O

H	O
.	O

RIGHT	O
TEMPORAL	O
.	O

Labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
temporal	O
"	O
,	O
and	O
received	O
in	O
formalin	O
are	O
three	O
pieces	O
of	O
semi	O
-	O
firm	O
friable	O
.	O
pink	O
-	O
white	O
soft	O
tissue	O
ranging	O
in	O
size	O
from	O
0	O
.	O
7	O
up	O
to	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

Tissues	O
are	O
entirely	O
submitted	O
.	O

H1	O
,	O
H2	O
.	O

4	O
,	O
3	O
.	O

OPERATIVE	O
CALL	O
.	O

OPERATIVE	O
CONSULT	O
(	O
FROZEN	O
)	O
:	O
A	O
.	O

RIGHT	O
TEMPORAL	O
FS	O
:	O
Glioma	O
.	O

If	O
this	O
report	O
includes	O
inmmunohistochemical	O
test	O
results	O
.	O
please	O
note	O
the	O
following	O
:	O
Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

Numavone	O
.	O

?	O
mical	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
.	O
and	O
Laboratory	O
Medicine	O
.	O

Those	O
inmunolistochemical	O
tests	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
.	O
and	O
FDA	O
approval	O
is	O
not	O
required	O
.	O

I	O
have	O
personally	O
examined	O
the	O
specimen	O
,	O
interpreted	O
the	O
results	O
,	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

ADDENDUM	O
.	O

FISH	O
(	O
FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
)	O
for	O
EGFR	O
.	O

Number	O
of	O
cells	O
analyzed	O
:	O
40	O
.	O

Ratio	O
of	O
EGFR	O
/	O
CEP	O
:	O
8	O
.	O
3	O
.	O

Percentage	O
of	O
cells	O
with	O
>	O
4	O
copies	O
of	O
EGFR	O
:	O
10	O
%	O
.	O

Amplification	O
:	O
YES	O
.	O

High	O
Level	O
of	O
Polysomy	O
:	O
NO	O
.	O

INTERPRETATION	O
:	O
1	O
.	O

Samples	O
are	O
interpreted	O
as	O
Positive	O
if	O
:	O
a	O
.	O

EGFR	O
to	O
CEP	O
7	O
signal	O
ratio	O
is	O
>	O
2	O
.	O
0	O
in	O
>	O
10	O
%	O
of	O
analyzed	O
cells	O
.	O

b	O
.	O

When	O
high	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
EGFR	O
in	O
40	O
%	O
of	O
cells	O
)	O
is	O
present	O
.	O

2	O
.	O

Samples	O
are	O
interpreted	O
as	O
Negative	O
if	O
EGFR	O
to	O
CEP	O
7	O
signal	O
ratio	O
is	O
<	O
2	O
.	O
0	O
or	O
in	O
the	O
absence	O
of	O
high	O
.	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
EGFR	O
)	O
.	O

3	O
,	O
.	O

Samples	O
are	O
considered	O
inconclusive	O
,	O
requiring	O
consult	O
with	O
the	O
pathologist	O
,	O
when	O
EGFR	O
to	O
CEP	O
7	O
.	O
signal	O
ratio	O
is	O
2	O
.	O
0	O
in	O
<	O
10	O
%	O
of	O
analyzed	O
cells	O
or	O
when	O
high	O
level	O
of	O
polysomy	O
(	O
>	O
four	O
copies	O
of	O
.	O
EGFR	O
)	O
is	O
present	O
in	O
<	O
40	O
%	O
of	O
cells	O
.	O

These	O
cases	O
also	O
need	O
to	O
be	O
co	O
-	O
read	O
.	O

REFERENCES	O
.	O

Addendum	O
-	O
Please	O
See	O
End	O
of	O
Report	O
.	O

1	O
have	O
personally	O
examined	O
the	O
specimen	O
,	O
interpreted	O
the	O
results	O
.	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

SURGICI	O
.	O

A	O
/	O
S	O
:	O
Rec	O
:	O
Col	O
:	O
Attending	O
MD	O
:	O
Copies	O
To	O
:	O
DIAGNOSIS	O
:	O
1	O
.	O

OMENTUM	O
,	O
BIOPSY	O
:	O
-	O
-	O
Infiltrating	O
serous	O
papillary	O
adenocarcinoma	O
.	O

-	O
High	O
grade	O
.	O

2	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
,	O
ovary	O
.	O

-	O
High	O
grade	O
.	O

-	O
Psammoma	O
bodies	O
.	O

-	O
Unremarkable	O
fallopian	O
tube	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
,	O
ovary	O
.	O

-	O
High	O
grade	O
.	O

-	O
Tumor	O
invades	O
fallopian	O
tube	O
from	O
serosa	O
up	O
to	O
the	O
outer	O
.	O
portions	O
of	O
mucosa	O
.	O

-	O
-	O
Psammoma	O
bodies	O
.	O

4	O
.	O

UTERUS	O
AND	O
CERVIX	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
invading	O
uterine	O
wall	O
serosa	O
.	O
and	O
outer	O
portions	O
of	O
myometrium	O
.	O

-	O
Psammoma	O
bodies	O
.	O

-	O
Adenomyomatous	O
polyp	O
,	O
endometrial	O
/	O
endocervical	O
polyp	O
.	O

-	O
Leiomyoma	O
,	O
subserosal	O
,	O
minute	O
.	O

-	O
Benign	O
endocervical	O
mucosa	O
with	O
focal	O
squamous	O
metaplasia	O
,	O
.	O
nabothian	O
cyst	O
and	O
mild	O
chronic	O
non	O
-	O
specific	O
inflammation	O
.	O

5	O
.	O

PELVIC	O
MASS	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
.	O

-	O
High	O
grade	O
.	O

6	O
.	O

SIGMOID	O
MASS	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
.	O

-	O
High	O
grade	O
.	O

7	O
.	O

ANTERIOR	O
LIVER	O
TUMOR	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
,	O
metastatic	O
.	O

8	O
.	O

POSTERIOR	O
LIVER	O
TUMOR	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
,	O
metastatic	O
.	O

9	O
.	O

RIGHT	O
RETROPERITONEAL	O
TUMOR	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
.	O

10	O
.	O

OMENTUM	O
TUMOR	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
.	O

-	O
Psammoma	O
bodies	O
.	O

11	O
.	O

ABDOMINAL	O
TUMOR	O
:	O
-	O
Serous	O
papillary	O
adenocarcinoma	O
,	O
metastatic	O
.	O

-	O
Psammoma	O
bodies	O
.	O

HISTORY	O
:	O
Pelvic	O
mass	O
;	O
ovarian	O
carcinoma	O
.	O

MICROSCOPIC	O
:	O
See	O
Diagnosis	O
.	O

GROSS	O
:	O
1	O
:	O
OMENTUM	O
.	O

Labeled	O
"	O
omentum	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
5	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O
firm	O
,	O
yellow	O
,	O
nodular	O
adipose	O
tissue	O
with	O
red	O
-	O
brown	O
discoloration	O
.	O

Cut	O
surface	O
is	O
yellow	O
-	O
tan	O
,	O
firm	O
and	O
remarkable	O
for	O
two	O
white	O
.	O
circular	O
nodules	O
measuring	O
0	O
.	O
6	O
and	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

A	O
.	O

Representative	O
sections	O
-	O
3	O
.	O

2	O
:	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
"	O
right	O
tube	O
and	O
ovary	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
7	O
.	O
0	O
cm	O
.	O
in	O
length	O
,	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
segment	O
of	O
fallopian	O
tube	O
with	O
.	O
fimbriated	O
end	O
.	O

The	O
serosa	O
is	O
pink	O
-	O
tan	O
and	O
focally	O
hyperemic	O
.	O

Cut	O
.	O
surface	O
reveals	O
a	O
0	O
.	O
1	O
cm	O
wall	O
with	O
a	O
patent	O
pinpoint	O
lumen	O
.	O

Attached	O
.	O

is	O
a	O
3	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
ovary	O
with	O
a	O
pink	O
-	O
tan	O
,	O
focally	O
hyperemic	O
,	O
.	O
firm	O
,	O
nodular	O
cortical	O
surface	O
.	O

The	O
cut	O
surface	O
is	O
remarkable	O
for	O
.	O
pink	O
-	O
tan	O
,	O
friable	O
tissue	O
;	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
subcortical	O
,	O
smooth	O
-	O
.	O
walled	O
cyst	O
;	O
a	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
firm	O
,	O
white	O
,	O
homogeneous	O
nodule	O
and	O
.	O

a	O
.	O
scant	O
amount	O
of	O
normal	O
variegated	O
,	O
pink	O
-	O
tan	O
ovarian	O
parenchyma	O
with	O
.	O
two	O
corpora	O
albicantia	O
.	O

The	O
mesovarium	O
is	O
markedly	O
hemorrhagic	O
.	O

Representative	O
sections	O
submitted	O
.	O

B	O
.	O
cross	O
section	O
of	O
ovary	O
including	O
friable	O
tissue	O
,	O
firm	O
white	O
.	O
tissue	O
,	O
cyst	O
,	O
normal	O
ovarian	O
parenchyma	O
with	O
corpus	O
albicans	O
-	O
1	O
.	O

C	O
.	O

Cross	O
section	O
of	O
ovary	O
with	O
fallopian	O
tube	O
-	O
2	O
.	O

3	O
:	O
LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
left	O
tube	O
and	O
ovary	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
60	O
gram	O
,	O
.	O

7	O
.	O
0	O
x	O
5	O
.	O
0	O
x	O
4	O
.	O
5	O
cm	O
ovary	O
with	O
a	O
pink	O
-	O
tan	O
distended	O
cortical	O
surface	O
.	O
with	O
numerous	O
(	O
greater	O
than	O
ten	O
)	O
pink	O
-	O
tan	O
,	O
friable	O
tumor	O
studs	O
.	O
ranging	O
from	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
up	O
to	O
3	O
.	O
0	O
x	O
2	O
.	O
8	O
x	O
2	O
.	O
0	O
cm	O
.	O

The	O
cut	O
.	O
surface	O
is	O
remarkable	O
for	O
both	O
solid	O
and	O
cystic	O
areas	O
.	O

The	O
largest	O
.	O
cyst	O
measures	O
4	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
4	O
.	O
0	O
cm	O
and	O
is	O
remarkable	O
for	O
30	O
CC	O
of	O
amber	O
.	O
serous	O
fluid	O
and	O
multiple	O
yellow	O
-	O
pink	O
papillary	O
excrescences	O
.	O
extending	O
from	O
the	O
inner	O
lining	O
of	O
the	O
cyst	O
wall	O
.	O

Attached	O
is	O
a	O
.	O

3	O
.	O
0	O
cm	O
in	O
length	O
,	O
0	O
.	O
4	O
cm	O
in	O
average	O
diameter	O
segment	O
of	O
fallopian	O
.	O
tube	O
with	O
pink	O
-	O
tan	O
focally	O
hyperemic	O
serosa	O
.	O

Fimbriated	O
end	O
is	O
.	O
present	O
.	O

Cut	O
surface	O
reveals	O
a	O
0	O
.	O
1	O
cm	O
wall	O
with	O
patent	O
pinpoint	O
.	O
lumen	O
.	O

Also	O
present	O
is	O
a	O
moderate	O
amount	O
of	O
pink	O
-	O
tan	O
,	O
moderately	O
.	O
hemorrhagic	O
mesovarium	O
tissue	O
.	O

Representative	O
sections	O
submitted	O
.	O

D	O
.	O

Cross	O
section	O
of	O
cystic	O
and	O
solid	O
area	O
of	O
tumor	O
,	O
fallopian	O
.	O
tube	O
-	O
2	O
.	O

E	O
.	O

Cross	O
section	O
of	O
cystic	O
and	O
solid	O
tumor	O
and	O
fallopian	O
tube	O
-	O
3	O
.	O

4	O
:	O
UTERUS	O
AND	O
CERVIX	O
.	O

Labeled	O
"	O
uterus	O
and	O
cervix	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
75	O
gram	O
.	O
symmetric	O
uterus	O
with	O
cervix	O
and	O
without	O
bilateral	O
adnexa	O
,	O
measuring	O
.	O

4	O
.	O
0	O
cm	O
cornu	O
to	O
cornu	O
,	O
7	O
.	O
0	O
cm	O
superior	O
to	O
inferior	O
and	O
4	O
.	O
0	O
cm	O
.	O
anterior	O
to	O
posterior	O
.	O

The	O
serosa	O
is	O
pink	O
-	O
tan	O
and	O
focally	O
disrupted	O
.	O
by	O
a	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
area	O
of	O
hemorrhage	O
on	O
the	O
anterior	O
surface	O
,	O
.	O
multiple	O
cysts	O
ranging	O
from	O
0	O
.	O
2	O
up	O
to	O
0	O
.	O
7	O
cm	O
in	O
diameter	O
and	O
patchy	O
.	O
areas	O
of	O
grey	O
-	O
tan	O
fibrinous	O
exudate	O
.	O

There	O
is	O
a	O
0	O
.	O
5	O
x	O
0	O
,	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O
tan	O
-	O
white	O
subserosal	O
spherical	O
nodule	O
on	O
the	O
posterior	O
corpus	O
which	O
.	O
on	O
cut	O
section	O
has	O
a	O
tan	O
-	O
white	O
,	O
homogeneous	O
,	O
whorled	O
surface	O
without	O
.	O
hemorrhage	O
,	O
calcification	O
or	O
necrosis	O
.	O

The	O
cervix	O
measures	O
3	O
.	O
3	O
.	O

x	O
.	O

2	O
.	O
8	O
cm	O
in	O
area	O
with	O
a	O
0	O
.	O
7	O
cm	O
in	O
width	O
anterior	O
vaginal	O
cuff	O
and	O
.	O

1	O
.	O
5	O
cm	O
in	O
width	O
posterior	O
vaginal	O
cuff	O
.	O

The	O
ectocervical	O
mucosa	O
is	O
.	O
tan	O
-	O
pink	O
and	O
moderately	O
hyperemic	O
.	O

The	O
os	O
measures	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
,	O
is	O
.	O
round	O
and	O
has	O
a	O
pink	O
-	O
tan	O
,	O
firm	O
,	O
nodular	O
polyp	O
extending	O
2	O
.	O
0	O
cm	O
from	O
.	O
the	O
opening	O
.	O

The	O
specimen	O
is	O
bivalved	O
to	O
reveal	O
a	O
2	O
.	O
5	O
cm	O
in	O
length	O
,	O
.	O

1	O
.	O
0	O
cm	O
in	O
width	O
endocervical	O
canal	O
with	O
a	O
tan	O
-	O
pink	O
,	O
smooth	O
mucosa	O
.	O

The	O
endometrial	O
cavity	O
measures	O
3	O
.	O
7	O
cm	O
in	O
length	O
,	O
1	O
.	O
7	O
cm	O
in	O
width	O
.	O

The	O
endometrial	O
lining	O
measures	O
0	O
.	O
1	O
cm	O
in	O
thickness	O
and	O
is	O
tan	O
-	O
pink	O
.	O
and	O
lush	O
.	O

The	O
lining	O
is	O
significant	O
for	O
a	O
6	O
.	O
5	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
5	O
cm	O
polyp	O
.	O
which	O
extends	O
from	O
the	O
anterior	O
lower	O
uterine	O
segment	O
through	O
the	O
.	O
endocervical	O
canal	O
with	O
multiple	O
foci	O
of	O
adhesions	O
and	O
then	O
continues	O
.	O
out	O
through	O
the	O
cervical	O
os	O
,	O
extending	O
2	O
.	O
0	O
cm	O
from	O
the	O
opening	O
.	O

Also	O
.	O
present	O
is	O
a	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
white	O
endometrial	O
polyp	O
extending	O
.	O
from	O
the	O
posterior	O
lower	O
uterine	O
segment	O
.	O

The	O
myometrium	O
measures	O
.	O

1	O
.	O
6	O
cm	O
in	O
maximum	O
thickness	O
and	O
is	O
tan	O
-	O
pink	O
.	O

No	O
lesions	O
are	O
grossly	O
.	O
identified	O
.	O

Representative	O
sections	O
submitted	O
.	O

F	O
.	O

Anterior	O
ectocervix	O
-	O
1	O
.	O

G	O
.	O

Anterior	O
lower	O
uterine	O
segment	O
including	O
base	O
of	O
large	O
polyp	O
.	O
and	O
area	O
of	O
disruption	O
on	O
serosa	O
of	O
hemorrhage	O
and	O
fibrinous	O
.	O
adhesions	O
-	O
1	O
.	O

H	O
.	O

Continuation	O
of	O
large	O
polyp	O
-	O
.	O

I	O
.	O

Full	O
thickness	O
myometrium	O
of	O
anterior	O
corpus	O
-	O
1	O
.	O

J	O
.	O

Posterior	O
ectocervix	O
and	O
vaginal	O
cuff	O
-	O
1	O
.	O

K	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
with	O
small	O
polyp	O
-	O
1	O
.	O

L	O
.	O

Full	O
thickness	O
myometrium	O
,	O
posterior	O
corpus	O
-	O
1	O
.	O

M	O
.	O

Subserosal	O
nodule	O
-	O
1	O
.	O

N	O
.	O

Cross	O
section	O
of	O
serosa	O
at	O
anterior	O
corpus	O
in	O
area	O
of	O
.	O
hemorrhage	O
and	O
fibrous	O
adhesions	O
-	O
1	O
.	O

5	O
:	O
PELVIC	O
MASS	O
.	O

Labeled	O
"	O
pelvic	O
mass	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
x	O
.	O

0	O
.	O
7	O
cm	O
pink	O
-	O
tan	O
,	O
friable	O
,	O
papillary	O
fragment	O
of	O
tissue	O
with	O
foci	O
of	O
.	O
hemorrhage	O
and	O
yellow	O
fibrinous	O
adhesions	O
.	O

o	O
.	O

All	O
embedded	O
-	O
1	O
.	O

6	O
:	O
SIGMOID	O
MASS	O
.	O

Labeled	O
"	O
sigmoid	O
mass	O
"	O
,	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
for	O
.	O
intraoperative	O
frozen	O
section	O
diagnosis	O
and	O
subsequently	O
fixed	O
in	O
.	O
formalin	O
,	O
are	O
two	O
soft	O
,	O
pink	O
-	O
tan	O
2	O
.	O
0	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
3	O
cm	O
and	O
1	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
.	O

0	O
.	O
9	O
cm	O
fragments	O
of	O
tissue	O
.	O

Representative	O
sections	O
submitted	O
.	O

P	O
.	O

Frozen	O
section	O
remnant	O
-	O
.	O

Q	O
.	O

Cross	O
sections	O
of	O
fragments	O
-	O
2	O
.	O

7	O
:	O
ANTERIOR	O
LIVER	O
TUMOR	O
.	O

Labeled	O
anterior	O
liver	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
7	B
.	I
0	I
x	I
.	I

7	B
.	I
0	I
x	I
4	I
.	I
0	I
cm	I
tan	O
-	O
pink	O
,	O
focally	O
hemorrhagic	O
,	O
friable	O
aggregate	O
of	O
.	O
papillary	O
tissue	O
and	O
blood	O
clot	O
.	O

R	O
.	O

Representative	O
sections	O
-	O
2	O
.	O

POSTERIOR	O
LIVER	O
TUMOR	O
.	O

Labeled	O
posterior	O
liver	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	B
.	I
0	I
x	I
.	I

3	B
.	I
0	I
x	I
2	I
.	I
5	I
cm	I
aggregate	O
of	O
pink	O
-	O
tan	O
friable	O
papillary	O
tissue	O
.	O

S	O
.	O

Representative	O
sections	O
-	O
2	O
.	O

9	O
:	O
RIGHT	O
RETROPERITONEAL	O
TUMOR	O
.	O

Labeled	O
"	O
right	O
peritoneal	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
7	B
.	I
0	I
x	I
.	I

6	B
.	I
0	I
x	I
2	I
.	I
5	I
cm	I
aggregate	O
of	O
tan	O
-	O
pink	O
friable	O
papillary	O
tissue	O
fragments	O
.	O
and	O
blood	O
clot	O
.	O

T	O
.	O

Representative	O
sections	O
-	O
2	O
.	O

10	O
:	O
OMENTUM	O
TUMOR	O
.	O

Labeled	O
"	O
omentum	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
an	O
8	B
.	I
0	I
x	I
5	I
.	I
0	I
x	I
.	I

3	B
.	I
5	I
cm	I
aggregate	O
of	O
pink	O
-	O
tan	O
friable	O
nodular	O
adipose	O
tissue	O
with	O
red	O
-	O
.	O
brown	O
discoloration	O
and	O
adherent	O
blood	O
clot	O
.	O

Cross	O
section	O
reveals	O
a	O
.	O

5	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
yellow	O
-	O
white	O
,	O
firm	O
nodular	O
mass	O
surrounded	O
by	O
the	O
.	O

Male	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Liver	O
,	O
portion	O
of	O
segment	O
V	O
,	O
subsegmental	O
resection	O
:	O
Hepatocellular	O
carcinoma	O
,	O
well	O
-	O
differentiated	O
,	O
5	B
.	I
3	I
cm	I
in	O
greatest	O
.	O
dimension	O
.	O

Resection	O
margin	O
negative	O
for	O
tumor	O
(	O
tumor	O
free	O
margin	O
,	O
.	O
0	O
.	O
3	O
cm	O
)	O
.	O

.	O
Vascular	O
invasion	O
is	O
absent	O
.	O

AJCC	O
stage	O
(	O
with	O
available	O
surgical	O
material	O
)	O
:	O
pT1	O
(	O
7th	O
edition	O
)	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
the	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
the	O
.	O
specimen	O
(	O
s	O
)	O
.	O

Hematoxylin	O
and	O
Eosin	O
(	O
H	O
&	O
E	O
)	O
permanent	O
sections	O
are	O
.	O
reviewed	O
to	O
confirm	O
these	O
findings	O
.	O

Any	O
substantive	O
changes	O
.	O
identified	O
on	O
permanent	O
section	O
review	O
will	O
be	O
reflected	O
in	O
a	O
.	O
revised	O
report	O
.	O

Interpreted	O
by	O
:	O
ADDENDUM	O
:	O
The	O
background	O
liver	O
parenchyma	O
shows	O
marked	O
steatosis	O
and	O
zone	O
.	O

3	O
.	O
congestion	O
.	O

A	O
trichrome	O
stain	O
shows	O
no	O
significant	O
fibrosis	O
.	O

A	O
.	O

PAS	O
-	O
D	O
stain	O
shows	O
no	O
cytoplasmic	O
globules	O
within	O
hepatocytes	O
.	O

An	O
.	O
iron	O
stain	O
is	O
negative	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Nck	O
:	O
contents	O
left	O
neck	O
.	O

2	O
.	O

Oral	O
cavity	O
:	O
It	O
.	O
oral	O
major	O
resection	O
-	O
short	O
medial	O
long	O
anterior	O
.	O

3	O
.	O

Oral	O
Cavity	O
:	O
t	O
.	O
posterior	O
margin	O
.	O

4	O
.	O

Oral	O
avity	O
:	O
It	O
.	O
anterior	O
margin	O
.	O

5	O
.	O

Oral	O
Cavity	O
:	O
It	O
.	O
lateral	O
mucosa	O
margin	O
.	O

6	O
.	O

Oral	O
Cavity	O
:	O
deep	O
muscle	O
margin	O
.	O

7	O
.	O

Surgical	O
Waste	O
.	O

8	O
.	O

Neck	O
:	O
contents	O
rt	O
neck	O
.	O

9	O
.	O

Lymph	O
node	O
:	O
lt	O
.	O
facial	O
node	O
.	O

10	O
.	O

Lymph	O
node	O
:	O
It	O
neck	O
III	O
node	O
.	O

11	O
.	O

Lymph	O
node	O
:	O
It	O
facial	O
node	O
.	O

Diagnosis	O
.	O

1	O
.	O

Contents	O
left	O
neck	O
.	O

Metastatic	O
squamous	O
cell	O
carcinoma	O
involving	O
six	O
of	O
thirty	O
-	O
five	O
lymph	O
nodes	O
(	O
6	O
/	O
35	O
)	O
.	O

a	O
.	O

The	O
involved	O
lymph	O
nodes	O
are	O
in	O
levels	O
I	O
,	O
II	O
,	O
and	O
III	O
.	O

b	O
.	O

The	O
largest	O
involved	O
lymph	O
node	O
measures	O
3	O
.	O
1	O
cm	O
.	O

C	O
.	O

Extranodal	O
invasion	O
is	O
present	O
.	O

Submandibular	O
gland	O
with	O
no	O
pathologic	O
changes	O
.	O

2	O
.	O

Oral	O
cavity	O
;	O
left	O
oral	O
resection	O
.	O

Squamous	O
cell	O
carcinoma	O
,	O
moderately	O
differentiated	O
.	O

a	O
.	O

Maximum	O
tumor	O
diameter	O
5	B
.	I
5	I
cm	I
.	O

b	O
.	O

Tumor	O
thickness	O
2	B
.	I
5	I
cm	I
.	O

C	O
.	O

Perineural	O
invasion	O
is	O
present	O
.	O

d	O
.	O

No	O
lymphovascular	O
invasion	O
.	O

e	O
.	O

The	O
tumor	O
is	O
close	O
to	O
deep	O
tongue	O
and	O
posterior	O
soft	O
tissue	O
margins	O
(	O
0	O
.	O
2	O
cm	O
)	O
.	O

The	O
remaining	O
.	O
margins	O
are	O
negative	O
for	O
tumor	O
.	O

3	O
.	O

Left	O
posterior	O
margin	O
.	O

Negative	O
for	O
tumor	O
.	O

4	O
.	O

Left	O
anterior	O
margin	O
.	O

Negative	O
for	O
tumor	O
.	O

5	O
.	O

Left	O
lateral	O
mucosa	O
margin	O
.	O

Negative	O
for	O
tumor	O
.	O

6	O
.	O

Deep	O
muscle	O
margin	O
.	O

Negative	O
for	O
tumor	O
.	O

7	O
.	O

Surgical	O
waste	O
.	O

Skin	O
and	O
soft	O
tissues	O
with	O
no	O
pathologic	O
changes	O
.	O

(	O
Gross	O
examination	O
only	O
)	O
.	O

8	O
.	O

Contents	O
right	O
neck	O
.	O

Metastatic	O
squamous	O
cell	O
carcinoma	O
involving	O
two	O
of	O
twenty	O
-	O
one	O
lymph	O
nodes	O
(	O
2	O
/	O
21	O
)	O
.	O

a	O
.	O

The	O
involved	O
lymph	O
nodes	O
are	O
in	O
levels	O
Il	O
and	O
III	O
.	O

b	O
.	O

The	O
largest	O
involved	O
lymph	O
node	O
measures	O
1	O
.	O
0	O
cm	O
.	O

C	O
.	O

No	O
extranodal	O
invasion	O
present	O
.	O

Submandibular	O
gland	O
with	O
no	O
pathologic	O
changes	O
.	O

9	O
.	O

Left	O
facial	O
lymph	O
node	O
.	O

One	O
lymph	O
node	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

10	O
.	O

Left	O
neck	O
III	O
lymph	O
node	O
.	O

Soft	O
tissues	O
with	O
no	O
pathologic	O
changes	O
.	O

11	O
.	O

Left	O
facial	O
lymph	O
node	O
.	O

Two	O
lymph	O
nodes	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

Synoptic	O
Data	O
.	O

Specimen	O
Type	O
:	O
Resection	O
:	O
left	O
oral	O
resection	O
.	O

Tumor	O
Site	O
:	O
Oral	O
Cavity	O
.	O

Histologic	O
Type	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
conventional	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
5	B
.	I
5	I
cm	I
.	O

Tumor	O
thickness	O
:	O
2	B
.	I
5	I
cm	I
.	O

Histologic	O
Grade	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

Venous	O
/	O
Lymphatic	O
(	O
Large	O
/	O
Small	O
Vessel	O
)	O
Invasion	O
(	O
V	O
/	O
L	O
)	O
:	O
Absent	O
.	O

Perineural	O
Invasion	O
:	O
Present	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
tumor	O
.	O

Pathologic	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT3	O
:	O
Tumor	O
or	O
lip	O
or	O
oral	O
cavity	O
more	O
than	O
4	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

pN2c	O
:	O
Metastasis	O
in	O
bilateral	O
or	O
contralateral	O
lymph	O
nodes	O
,	O
.	O
none	O
more	O
than	O
6	O
cm	O
in	O
greatest	O
dimension	O
for	O
all	O
.	O
aerodigestive	O
sites	O
except	O
nasopharynx	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
59	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
8	O
.	O

Extra	O
-	O
capsular	O
extension	O
of	O
nodal	O
tumor	O
:	O
Present	O
.	O

pMX	O
:	O
Distant	O
metastasis	O
cannot	O
be	O
assessed	O
.	O

Gross	O
Description	O
.	O

1	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
contents	O
left	O
neck	O
of	O
"	O
.	O

It	O
consists	O
of	O
.	O

an	O
oriented	O
left	O
neck	O
dissection	O
with	O
overall	O
dimensions	O
of	O
17	O
.	O
0	O
X	O
1	O
.	O
2	O
X	O
13	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
.	O
includes	O
levels	O
IA	O
to	O
IV	O
.	O

There	O
is	O
a	O
portion	O
of	O
muscle	O
measuring	O
4	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
0	O
.	O
5	O
cm	O
.	O

The	O
.	O
submandibular	O
gland	O
measures	O
3	O
.	O
7	O
X	O
3	O
.	O
0	O
X	O
0	O
.	O
9	O
cm	O
and	O
is	O
unremarkable	O
.	O

Multiple	O
lymph	O
nodes	O
.	O
ranging	O
from	O
0	O
.	O
2	O
to	O
3	O
.	O
1	O
cm	O
are	O
identified	O
in	O
multiple	O
levels	O
with	O
the	O
largest	O
node	O
being	O
in	O
level	O
IIA	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

1A	O
-	O
1B	O
multiple	O
lymph	O
nodes	O
per	O
block	O
,	O
level	O
IA	O
.	O

1C	O
.	O
submandibular	O
gland	O
.	O

1D	O
.	O
multiple	O
lymph	O
nodes	O
,	O
level	O
IB	O
.	O

1E	O
.	O
muscle	O
.	O

1F	O
.	O
largest	O
lymph	O
node	O
level	O
IIA	O
.	O

1G	O
.	O
one	O
lymph	O
node	O
level	O
Il	O
.	O

1H	O
.	O
multiple	O
lymph	O
nodes	O
level	O
Il	O
.	O

1I	O
-	O
1J	O
.	O
multiple	O
lymph	O
nodes	O
per	O
block	O
level	O
llb	O
.	O

1K	O
.	O
one	O
lymph	O
node	O
level	O
llb	O
.	O

1L	O
.	O
one	O
lymph	O
node	O
level	O
llb	O
.	O

1M	O
-	O
1N	O
multiple	O
lymph	O
nodes	O
per	O
block	O
level	O
III	O
.	O

10	O
.	O
one	O
lymph	O
node	O
level	O
III	O
.	O

1P	O
.	O
one	O
lymph	O
node	O
level	O
III	O
.	O

1Q	O
.	O
multiple	O
lymph	O
nodes	O
,	O
level	O
IV	O
.	O

2	O
.	O

The	O
specimen	O
is	O
labeled	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
oral	O
major	O
resection	O
short	O
-	O
medial	O
long	O
.	O

anterior	O
"	O
.	O

It	O
consists	O
of	O
an	O
oriented	O
portion	O
of	O
left	O
tongue	O
,	O
floor	O
of	O
mouth	O
with	O
overall	O
dimensions	O
.	O
of	O
6	O
.	O
5	O
cm	O
SI	O
X	O
3	O
.	O
9	O
cm	O
ML	O
X	O
8	O
.	O
1	O
cm	O
AP	O
.	O

The	O
portion	O
of	O
tongue	O
measures	O
2	O
.	O
2	O
cm	O
X	O
SI	O
3	O
.	O
4	O
cm	O
ML	O
X	O
.	O

8	O
.	O
1	O
cm	O
AP	O
.	O

The	O
floor	O
of	O
mouth	O
measures	O
2	O
.	O
0	O
cm	O
SI	O
X	O
4	O
.	O
0	O
cm	O
ML	O
X	O
6	O
.	O
0	O
cm	O
AP	O
cm	O
.	O

There	O
is	O
a	O
.	O
tumor	O
involving	O
the	O
tongue	O
and	O
floor	O
of	O
mouth	O
.	O

The	O
tumor	O
measures	O
3	B
.	I
5	I
cm	I
SI	I
X	I
2	I
.	I
5	I
cm	I
ML	I
X	I
5	I
.	I
5	I
.	I

cm	B
AP	O
.	O

The	O
tumor	O
has	O
an	O
ulcerated	O
center	O
with	O
rolled	O
edges	O
.	O

The	O
cut	O
surface	O
is	O
white	O
-	O
tan	O
.	O

It	O
is	O
.	O
located	O
at	O
0	O
.	O
5	O
cm	O
from	O
the	O
lateral	O
margin	O
,	O
1	O
.	O
4	O
cm	O
from	O
the	O
medial	O
margin	O
,	O
1	O
.	O
2	O
cm	O
from	O
the	O
deep	O
.	O
margin	O
,	O
0	O
.	O
5	O
cm	O
from	O
the	O
anterior	O
(	O
floor	O
of	O
mouth	O
)	O
margin	O
,	O
and	O
0	O
.	O
6	O
cm	O
from	O
the	O
posterior	O
(	O
junction	O
.	O
of	O
tongue	O
and	O
floor	O
of	O
mouth	O
)	O
margin	O
.	O

The	O
remaining	O
tongue	O
mucosa	O
is	O
unremarkable	O
.	O

Tissue	O
is	O
.	O
taken	O
for	O
the	O
for	O
the	O
tissue	O
bank	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

2A	O
.	O
anterior	O
floor	O
of	O
mouth	O
margin	O
with	O
tumor	O
.	O

2B	O
.	O
posterior	O
margin	O
(	O
junction	O
of	O
tongue	O
and	O
floor	O
of	O
mouth	O
)	O
with	O
tumor	O
.	O

2C	O
.	O
medial	O
margin	O
with	O
tumor	O
.	O

2D	O
.	O
lateral	O
floor	O
of	O
mouth	O
margin	O
with	O
tumor	O
.	O

2E	O
.	O
dorsum	O
of	O
tongue	O
with	O
tumor	O
.	O

2F	O
.	O
deep	O
margin	O
with	O
tumor	O
.	O

2G	O
.	O
tumor	O
with	O
medial	O
margin	O
.	O

2H	O
.	O
lateral	O
margin	O
with	O
tumor	O
and	O
sublingual	O
gland	O
.	O

3	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
posterior	O
tongue	O
"	O
.	O

It	O
consists	O
of	O
a	O
.	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
5	O
X	O
0	O
.	O
9	O
X	O
0	O
.	O
6	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
for	O
frozen	O
.	O
section	O
.	O

3A	O
.	O
frozen	O
section	O
control	O
.	O

4	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
anterior	O
tongue	O
"	O
.	O

It	O
consists	O
of	O
a	O
.	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
4	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
for	O
frozen	O
.	O
section	O
.	O

4A	O
.	O
frozen	O
section	O
control	O
.	O

5	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
lateral	O
margin	O
mucosa	O
"	O
.	O

It	O
consists	O
.	O
of	O
a	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
1	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
for	O
.	O
frozen	O
section	O
.	O

5A	O
.	O
frozen	O
section	O
control	O
.	O

6	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
deep	O
muscle	O
margin	O
"	O
.	O

It	O
consists	O
of	O
a	O
.	O
fragment	O
of	O
tissue	O
measuring	O
1	O
.	O
0	O
X	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
for	O
frozen	O
.	O
section	O
.	O

6A	O
.	O
frozen	O
section	O
control	O
.	O

7	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
surgical	O
waste	O
"	O
.	O

It	O
consists	O
of	O
multiple	O
.	O
pieces	O
of	O
adipose	O
tissue	O
,	O
seven	O
with	O
skin	O
on	O
one	O
aspect	O
,	O
ranging	O
in	O
size	O
from	O
3	O
.	O
0	O
to	O
10	O
.	O
5	O
cm	O
.	O

Also	O
received	O
is	O
muscle	O
.	O

All	O
of	O
the	O
pieces	O
are	O
grossly	O
appear	O
unremarkable	O
.	O

No	O
sections	O
are	O
.	O
taken	O
for	O
microscopic	O
examination	O
.	O

8	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
contents	O
RT	O
neck	O
"	O
.	O

It	O
consists	O
of	O
an	O
.	O
oriented	O
right	O
neck	O
dissection	O
with	O
overall	O
dimensions	O
of	O
10	O
.	O
0	O
SI	O
X	O
2	O
.	O
2	O
ML	O
X	O
8	O
.	O
7	O
AP	O
cm	O
.	O

The	O
.	O
specimen	O
includes	O
levels	O
I	O
to	O
III	O
.	O

The	O
submandibular	O
gland	O
measures	O
4	O
.	O
5	O
X	O
2	O
.	O
8	O
X	O
1	O
.	O
8	O
cm	O
and	O
is	O
.	O
unremarkable	O
.	O

Multiple	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O
5	O
cm	O
are	O
identified	O
in	O
multiple	O
levels	O
.	O
with	O
the	O
largest	O
nodes	O
in	O
level	O
II	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

8A	O
.	O
submandibular	O
gland	O
.	O

8B	O
-	O
8C	O
multiple	O
lymph	O
nodes	O
per	O
block	O
level	O
I	O
.	O

8D	O
-	O
8H	O
multiple	O
lymph	O
nodes	O
per	O
block	O
level	O
Il	O
.	O

8I	O
.	O
one	O
lymph	O
node	O
level	O
Il	O
.	O

8J	O
.	O
one	O
lymph	O
node	O
level	O
Il	O
.	O

8K	O
.	O
multiple	O
lymph	O
nodes	O
level	O
III	O
.	O

9	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
facial	O
node	O
#	O
16	O
"	O
.	O

It	O
contains	O
two	O
.	O
pieces	O
of	O
adipose	O
tissue	O
,	O
measuring	O
0	O
.	O
7	O
and	O
1	O
.	O
8	O
cm	O
each	O
in	O
maximum	O
dimension	O
.	O

A	O
single	O
lymph	O
.	O
node	O
,	O
is	O
identified	O
within	O
the	O
largest	O
piece	O
of	O
adipose	O
tissue	O
.	O

9A	O
.	O
one	O
lymph	O
node	O
.	O

10	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
level	O
III	O
node	O
neck	O
"	O
.	O

It	O
consists	O
of	O
.	O

a	O
piece	O
of	O
adipose	O
tissue	O
measuring	O
1	O
.	O
5	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
1	O
cm	O
.	O

No	O
lymph	O
nodes	O
are	O
grossly	O
identified	O
.	O

10A	O
.	O
specimen	O
in	O
toto	O
.	O

11	O
.	O

The	O
specimen	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
LT	O
facial	O
node	O
#	O
2	O
"	O
.	O

It	O
consists	O
of	O
a	O
.	O
piece	O
of	O
adipose	O
tissue	O
measuring	O
1	O
.	O
8	O
X	O
1	O
.	O
2	O
X	O
0	O
.	O
4	O
cm	O
.	O

Multiple	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
3	O
to	O
.	O

0	O
.	O
7	O
cm	O
in	O
maximum	O
dimension	O
are	O
identified	O
.	O

11A	O
.	O
multiple	O
lymph	O
nodes	O
.	O

Quick	O
Section	O
Diagnosis	O
.	O

3	O
.	O

Left	O
posterior	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

4	O
.	O

Left	O
anterior	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

5	O
.	O

Left	O
lateral	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

6	O
.	O

Deep	O
muscle	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

IAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Soft	O
tissue	O
,	O
right	O
lateral	O
margin	O
of	O
prostatectomy	O
,	O
biopsy	O
:	O
No	O
malignancy	O
identified	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
pelvic	O
,	O
resection	O
;	O
negative	O
for	O
malignancy	O
,	O
nine	O
nodes	O
.	O

C	O
.	O

Prostate	O
gland	O
,	O
radical	O
prostatectomy	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
,	O
conventional	O
type	O
.	O

2	O
.	O

Prostate	O
size	O
:	O
35	O
.	O
7	O
grams	O
.	O

3	O
.	O

Tumor	O
.	O
quantitation	O
:	O
Malignancy	O
is	O
present	O
peripherally	O
and	O
in	O
the	O
apex	O
,	O
bilaterally	O
,	O
and	O
accounts	O
for	O
an	O
estimated	O
25	O
%	O
of	O
the	O
total	O
prostate	O
volume	O
.	O

4	O
.	O

Gleason	O
grade	O
:	O
a	O
.	O

Primary	O
pattern	O
:	O
3	O
/	O
5	O
.	O

b	O
.	O

Secondary	O
pattern	O
:	O
4	O
/	O
5	O
.	O

C	O
.	O

Total	O
Gleason	O
score	O
:	O
7	O
/	O
10	O
.	O

5	O
.	O

Extraprostatic	O
extension	O
:	O
Not	O
identified	O
.	O

6	O
.	O

Seminal	O
vesicle	O
involvement	O
:	O
Not	O
identified	O
.	O

7	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

8	O
.	O

High	O
grade	O
PIN	O
:	O
Present	O
focally	O
.	O

9	O
.	O

Perineural	O
invasion	O
:	O
Present	O
,	O
and	O
extensive	O
.	O

9	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

Malignancy	O
extends	O
to	O
the	O
inked	O
left	O
posterior	O
apical	O
margin	O
.	O

2	O
.	O

Malignancy	O
extends	O
to	O
less	O
than	O
0	O
.	O
05	O
cm	O
in	O
multiple	O
additional	O
areas	O
,	O
bilaterally	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O

See	O
part	O
B	O
.	O

Other	O
:	O
1	O
.	O

pTNM	O
stage	O
:	O
pT2c	O
,	O
NO	O
.	O

COMMENTS	O
:	O
No	O
prior	O
material	O
for	O
review	O
and	O
comparison	O
is	O
identified	O
in	O
our	O
files	O
.	O

Correlation	O
with	O
previous	O
biopsy	O
material	O
is	O
suggested	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Prostate	O
cancer	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Right	O
lateral	O
margin	O
.	O

B	O
.	O

Pelvic	O
lymph	O
nodes	O
.	O

C	O
.	O

Prostate	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
three	O
formalin	O
filled	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

A	O
.	O

Additionally	O
labeled	O
right	O
lateral	O
margin	O
and	O
contains	O
a	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
pink	O
-	O
tan	O
rubbery	O
,	O
cauterized	O
soft	O
tissue	O
.	O

The	O
specimen	O
is	O
trisected	O
and	O
.	O
entirely	O
submitted	O
in	O
cassette	O
A	O
labelec	O
.	O

B	O
.	O

Additionally	O
labeled	O
pelvic	O
lymph	O
node	O
and	O
contains	O
two	O
yellow	O
-	O
tan	O
fibrofatty	O
soft	O
tissues	O
2	O
.	O
8	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
3	O
cm	O
and	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
.	O

Designation	O
is	O
not	O
.	O
offered	O
or	O
possible	O
.	O

On	O
section	O
and	O
palpation	O
,	O
multiple	O
firm	O
fatty	O
possible	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
from	O
0	O
.	O
1	O
up	O
to	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

They	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
B1	O
-	O
4	O
labeled	O
.	O
designated	O
as	O
follows	O
:	O
B1	O
-	O
-	O
five	O
whole	O
possible	O
lymph	O
nodes	O
;	O
B2	O
-	O
-	O
four	O
whole	O
possible	O
.	O
lymph	O
nodes	O
;	O
B3	O
-	O
4	O
-	O
-	O
one	O
whole	O
possible	O
lymph	O
node	O
,	O
senally	O
sectioned	O
.	O

C	O
.	O

Additionally	O
labeled	O
prostate	O
and	O
contains	O
a	O
35	O
.	O
7	O
gram	O
,	O
4	O
.	O
3	O
x	O
4	O
.	O
3	O
x	O
3	O
.	O
5	O
cm	O
prostate	O
received	O
with	O
attached	O
bilateral	O
adnexa	O
which	O
has	O
overall	O
.	O
dimensions	O
of	O
4	O
.	O
8	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
prostatic	O
capsule	O
is	O
pink	O
-	O
tan	O
and	O
shaggy	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
right	O
side	O
-	O
blue	O
and	O
left	O
side	O
-	O
black	O
.	O

The	O
base	O
and	O
apical	O
margins	O
are	O
coned	O
and	O
serially	O
sectioned	O
.	O

The	O
remainder	O
of	O
the	O
gland	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
to	O
reveal	O
a	O
pink	O
-	O
tan	O
.	O
focally	O
cystir	O
cut	O
eurface	O
with	O
diffuse	O
periurethral	O
nodularity	O
.	O

Discrete	O
masses	O
are	O
not	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
C1	O
-	O
.	O

18	O
labeled	O
.	O
designated	O
as	O
follows	O
:	O
1	O
-	O
right	O
prostate	O
/	O
seminal	O
vesicle	O
junction	O
;	O
2	O
-	O
-	O
left	O
prostate	O
/	O
seminal	O
vesicle	O
junction	O
;	O
3	O
and	O
4	O
-	O
-	O
apical	O
margin	O
,	O
.	O
perpendicular	O
;	O
5	O
anu	O
6	O
-	O
-	O
base	O
margin	O
,	O
perpendicular	O
;	O
7	O
-	O
9	O
-	O
-	O
right	O
anterior	O
,	O
apex	O
to	O
base	O
;	O
10	O
-	O
12	O
-	O
-	O
right	O
posterior	O
,	O
apex	O
to	O
base	O
;	O
13	O
-	O
15	O
-	O
-	O
left	O
anterior	O
,	O
apex	O
to	O
.	O
base	O
;	O
16	O
-	O
18	O
-	O
-	O
left	O
posterior	O
,	O
apex	O
to	O
base	O
.	O

Additionally	O
,	O
a	O
yellow	O
and	O
green	O
cassette	O
are	O
submitted	O
for	O
.	O
esearch	O
each	O
labeled	O
.	O

Surgical	O
Pathology	O
:	O
Final	O
.	O

OUID	O
:	O
CA834E5F	O
-	O
30DC	O
-	O
46CF	O
-	O
AF33	O
-	O
AD11226FC09E	O
.	O

CLINICAL	O
HISTORY	O
:	O
Bilateral	O
carcinoma	O
of	O
the	O
breast	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Medial	O
margin	O
right	O
breast	O
biopsy	O
"	O
,	O
fresh	O
.	O

The	O
specimen	O
consists	O
of	O
3	O
.	O
7	O
x	O
.	O

2	O
.	O
2	O
x	O
0	O
.	O
6	O
cm	O
disc	O
of	O
firm	O
white	O
,	O
unremarkable	O
breast	O
tissue	O
;	O
four	O
sutures	O
.	O
denote	O
the	O
true	O
margin	O
,	O
which	O
is	O
inked	O
black	O
.	O

Serial	O
radial	O
sections	O
are	O
.	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
A1	O
frozen	O
section	O
remnant	O
Af1	O
.	O

A2	O
frozen	O
section	O
remnant	O
AF2	O
.	O

A3	O
frozen	O
section	O
remnant	O
AF3	O
.	O

A4	O
additional	O
tissue	O
.	O

B	O
.	O

"	O
Right	O
breast	O
biopsy	O
sample	O
"	O
.	O

Contains	O
an	O
irregular	O
10	O
x	O
0	O
.	O
5	O
x	O
1	O
.	O
7	O
cm	O
disc	O
.	O
tan	O
-	O
brown	O
coarsely	O
papillary	O
tissue	O
.	O

Portions	O
are	O
submitted	O
for	O
ER	O
/	O
PR	O
and	O
for	O
.	O
tissue	O
.	O

bank	O
and	O
for	O
frozen	O
section	O
.	O

Frozen	O
section	O
remnant	O
submitted	O
in	O
Block	O
.	O

B1	O
.	O

C	O
.	O

"	O
Left	O
breast	O
tumor	O
,	O
wide	O
reexcision	O
,	O
long	O
suture	O
lateral	O
,	O
short	O
suture	O
.	O

superior	O
"	O
,	O
fresh	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
4	O
.	O
5	O
x	O
4	O
.	O
3	O
x	O
2	O
.	O
2	O
cm	O
wide	O
.	O
reexcision	O
of	O
the	O
breast	O
.	O

The	O
long	O
suture	O
denotes	O
the	O
lateral	O
aspect	O
of	O
the	O
.	O
specimen	O
and	O
a	O
short	O
suture	O
the	O
superior	O
.	O

The	O
superior	O
pole	O
of	O
the	O
tissue	O
is	O
.	O
inked	O
black	O
,	O
and	O
the	O
inferior	O
blue	O
.	O

On	O
cut	O
section	O
,	O
there	O
is	O
a	O
1	B
.	I
3	I
x	I
1	I
.	I
3	I
x	I
1	I
cm	I
round	O
,	O
white	O
,	O
firm	O
,	O
gritty	O
,	O
.	O
sharply	O
-	O
circumscribed	O
tumor	O
in	O
the	O
superior	O
portion	O
of	O
the	O
resection	O
.	O

The	O
.	O
tumor	O
extends	O
to	O
within	O
2	O
mm	O
of	O
the	O
superior	O
margin	O
,	O
and	O
does	O
not	O
approach	O
.	O
closely	O
to	O
any	O
other	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
breast	O
consists	O
of	O
firm	O
,	O
.	O
white	O
and	O
tan	O
admixed	O
breast	O
parenchyma	O
.	O

Tissue	O
is	O
divided	O
into	O
deep	O
(	O
towards	O
.	O
chest	O
wall	O
)	O
and	O
superficial	O
(	O
towards	O
skin	O
)	O
halves	O
and	O
submitted	O
from	O
medial	O
to	O
.	O
lateral	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
C1	O
frozen	O
section	O
remnant	O
Cfl	O
.	O

C2	O
-	O
C8	O
superficial	O
half	O
from	O
medial	O
to	O
lateral	O
.	O

C9	O
-	O
C15	O
deep	O
half	O
from	O
medial	O
to	O
lateral	O
.	O

D	O
.	O

"	O
Right	O
axillary	O
dissection	O
and	O
wide	O
reexcision	O
"	O
,	O
fresh	O
.	O

The	O
specimen	O
.	O
consists	O
of	O
an	O
excisional	O
breast	O
biopsy	O
and	O
attached	O
axillary	O
dissection	O
.	O

The	O
.	O
biopsy	O
is	O
incised	O
,	O
to	O
obtain	O
tissue	O
for	O
frozen	O
section	O
,	O
ER	O
/	O
PR	O
,	O
and	O
tissue	O
.	O
bank	O
,	O
prior	O
to	O
receipt	O
by	O
pathology	O
.	O

The	O
biopsy	O
measures	O
6	O
.	O
7	O
x	O
6	O
.	O
5	O
x	O
3	O
.	O
2	O
cm	O
.	O

The	O
axillary	O
tail	O
measures	O
10	O
x	O
2	O
.	O
3	O
x	O
0	O
.	O
9	O
cm	O
.	O

The	O
medial	O
surface	O
(	O
not	O
a	O
true	O
.	O
margin	O
)	O
is	O
inked	O
in	O
red	O
,	O
the	O
inferior	O
margin	O
black	O
and	O
the	O
superior	O
margin	O
in	O
.	O
blue	O
.	O

On	O
cut	O
section	O
,	O
there	O
is	O
a	O
4	B
.	I
5	I
x	I
2	I
.	I
3	I
x	I
2	I
.	I
5	I
cm	I
white	O
firm	O
tumor	O
,	O
composed	O
of	O
.	O
tan	O
-	O
yellow	O
loose	O
aggregates	O
of	O
tumor	O
.	O

The	O
tumor	O
approaches	O
to	O
within	O
3	O
mm	O
of	O
.	O
the	O
inked	O
superior	O
margin	O
of	O
resection	O
and	O
to	O
within	O
1	O
cm	O
of	O
the	O
superior	O
and	O
.	O

5	O
mm	O
of	O
the	O
inferior	O
margin	O
.	O

Tumor	O
approaches	O
to	O
within	O
4	O
mm	O
of	O
the	O
deep	O
.	O
margin	O
of	O
resection	O
.	O

The	O
remainder	O
of	O
the	O
breast	O
is	O
unremarkable	O
.	O

The	O
axillary	O
dissection	O
is	O
divided	O
into	O
low	O
,	O
mid	O
and	O
distal	O
level	O
.	O

There	O
are	O
.	O
numerous	O
lymph	O
nodes	O
,	O
ranging	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
4	O
cm	O
,	O
none	O
grossly	O
involved	O
by	O
.	O
tumor	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
of	O
2	O
.	O

D1	O
-	O
D5	O
Anterior	O
(	O
superficial	O
)	O
tumor	O
from	O
lateral	O
to	O
medial	O
.	O

D6	O
-	O
D10	O
Posterior	O
(	O
deep	O
)	O
tumor	O
from	O
lateral	O
to	O
medial	O
.	O

D11	O
-	O
Lower	O
lymph	O
node	O
candidate	O
.	O

D12	O
-	O
One	O
mid	O
-	O
level	O
lymph	O
node	O
,	O
bisected	O
.	O

D13	O
-	O
Five	O
mid	O
-	O
level	O
lymph	O
node	O
candidates	O
.	O

D14	O
-	O
Four	O
distal	O
lymph	O
node	O
candidates	O
.	O

D15	O
-	O
Highest	O
lymph	O
node	O
.	O

E	O
.	O

"	O
Left	O
axillary	O
dissection	O
,	O
silk	O
on	O
apex	O
"	O
,	O
fresh	O
.	O

The	O
specimen	O
consists	O
of	O
.	O

a	O
6	O
x	O
9	O
x	O
1	O
.	O
7	O
cm	O
lymph	O
node	O
dissection	O
,	O
with	O
a	O
black	O
suture	O
at	O
one	O
pole	O
.	O

The	O
.	O
lymph	O
node	O
dissection	O
is	O
divided	O
into	O
three	O
sections	O
,	O
lower	O
,	O
middle	O
and	O
.	O
distal	O
.	O

Numerous	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
7	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

None	O
grossly	O
contains	O
tumor	O
.	O

BLOCK	O
SUMMARY	O
:	O
E1	O
Lower	O
nodes	O
,	O
3	O
lymph	O
node	O
candidates	O
.	O

E2	O
Three	O
lymph	O
node	O
candidates	O
,	O
lower	O
node	O
.	O

E3	O
Middle	O
nodes	O
,	O
2	O
lymph	O
node	O
candidates	O
.	O

E4	O
Middle	O
nodes	O
,	O
2	O
lymph	O
node	O
candidates	O
.	O

E5	O
Three	O
lymph	O
node	O
candidates	O
,	O
upper	O
lobe	O
.	O

E6	O
Upper	O
nodes	O
,	O
1	O
lymph	O
node	O
candidate	O
.	O

E7	O
Upper	O
node	O
,	O
1	O
lymph	O
node	O
candidates	O
,	O
bisected	O
.	O

E8	O
Highest	O
apical	O
node	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
AF1	O
-	O
Af3	O
:	O
"	O
Medial	O
margin	O
right	O
breast	O
biopsy	O
"	O
:	O
Inked	O
margin	O
free	O
of	O
carcinoma	O
.	O

(	O
KR	O
)	O
.	O

Bf1	O
:	O
"	O
Right	O
breast	O
biopsy	O
sample	O
"	O
:	O
Carcinoma	O
.	O

Cf1	O
:	O
"	O
Left	O
breast	O
biopsy	O
"	O
:	O
Carcinoma	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
MEDIAL	O
MARGIN	O
RIGHT	O
BREAST	O
BIOPSY	O
"	O
:	O
BENIGN	O
BREAST	O
TISSUE	O
.	O

B	O
.	O

"	O
RIGHT	O
BREAST	O
BIOPSY	O
"	O
:	O
POORLY	O
-	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
.	O

C	O
.	O

"	O
LEFT	O
BREAST	O
TUMOR	O
,	O
WIDE	O
RE	O
-	O
EXCISION	O
"	O
:	O
INVASIVE	O
AND	O
INTRADUCTAL	O
ADENOCARCINOMA	O
.	O

1	B
.	I
3	I
x	I
1	I
.	I
3	I
x	I
1	I
.	I
3	I
CM	I
.	O

NSABP	O
HISTOLOGIC	O
GRADE	O
3	O
,	O
NUCLEAR	O
GRADE	O
3	O
.	O

NON	O
-	O
COMEDO	O
TYPE	O
INTRADUCTAL	O
COMPONENT	O
COMPRISES	O
5	O
%	O
OF	O
TUMOR	O
.	O

VASCULAR	O
SPACE	O
INVASION	O
IDENTIFIED	O
(	O
C13	O
)	O
.	O

INKED	O
MARGINS	O
OF	O
RESECTION	O
FREE	O
OF	O
TUMOR	O
.	O

EXTENDING	O
TO	O
WITHIN	O
1	O
MM	O
OF	O
INKED	O
SUPERIOR	O
MARGIN	O
OF	O
RESECTION	O
(	O
C14	O
)	O
.	O

ASSOCIATED	O
WITH	O
MICROCALCIFICATION	O
.	O

REMAINDER	O
OF	O
BREAST	O
WITH	O
APOCRINE	O
METAPLASIA	O
AND	O
MICROCYST	O
FORMATION	O
.	O

D	O
.	O

"	O
RIGHT	O
AXILLARY	O
RESECTION	O
OF	O
BREAST	O
AND	O
WIDE	O
RE	O
-	O
EXCISION	O
"	O
:	O
INVASIVE	O
AND	O
INTRADUCTAL	O
CARCINOMA	O
.	O

4	B
.	I
5	I
x	I
2	I
.	I
3	I
x	I
2	I
.	I
5	I
CM	I
.	O

NSABP	O
HISTOLOGIC	O
GRADE	O
3	O
,	O
NUCLEAR	O
GRADE	O
2	O
.	O

NON	O
-	O
COMEDO	O
TYPE	O
INTRADUCTAL	O
CARCINOMA	O
COMPRISES	O
5	O
%	O
OF	O
TUMOR	O
.	O

INTRADUCTAL	O
CARCINOMA	O
EXTENDS	O
BEYOND	O
TUMOR	O
MASS	O
.	O

VASCULAR	O
SPACE	O
INVASION	O
NOT	O
IDENTIFIED	O
.	O

TUMOR	O
APPROACHES	O
TO	O
WITHIN	O
100	O
MICRONS	O
OF	O
INKED	O
MARGIN	O
OF	O
RESECTION	O
.	O

(	O
D7	O
,	O
D8	O
,	O
D9	O
,	O
D10	O
,	O
D6	O
)	O
,	O
SEE	O
NOTE	O
.	O

REMAINDER	O
OF	O
BREAST	O
WITH	O
MICROCYST	O
FORMATION	O
AND	O
FIBROADENOMATOUS	O
CHANGE	O
.	O

10	O
REGIONAL	O
LYMPH	O
NODES	O
WITH	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
10	O
)	O
.	O

E	O
.	O

"	O
LEFT	O
AXILLARY	O
DISSECTION	O
"	O
:	O
8	O
LYMPH	O
NODES	O
WITH	O
NO	O
TUMOR	O
SEEN	O
(	O
0	O
/	O
8	O
)	O
.	O

NOTE	O
:	O
FOCALLY	O
,	O
CAUTERY	O
ARTIFACT	O
EXTENDS	O
TO	O
TUMOR	O
inal	O
.	O

2	O
of	O
2	O
.	O

Surgical	O
Pathology	O
Site	O
Code	O
,	O
Endometrium	O
(	O
54	O
.	O
1	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
A2	O
A3	O
A4	O
A5	O
A6	O
A7	O
B1	O
B2	O
C1	O
C2	O
C3	O
C4	O
C5	O
D1	O
E1	O
.	O

E2	O
E3	O
E4	O
.	O

F1	O
F2	O
G1	O
G2	O
G3	O
G4	O
.	O

Uterus	O
(	O
82	O
.	O
21	O
grams	O
)	O
,	O
right	O
ovary	O
(	O
2	O
.	O
9	O
X	O
2	O
.	O
5	O
X	O
0	O
.	O
7	O
cm	O
)	O
.	O
with	O
7	O
.	O
5	O
cm	O
.	O
segment	O
of	O
right	O
fallopian	O
tube	O
,	O
and	O
separately	O
submitted	O
.	O
left	O
ovary	O
.	O

(	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
3	O
cm	O
)	O
with	O
4	O
.	O
0	O
cm	O
segment	O
of	O
left	O
fallopian	O
.	O
tube	O
,	O
.	O
right	O
and	O
left	O
pelvic	O
lymph	O
nodes	O
(	O
laparoscopically	O
)	O
.	O
right	O
and	O
left	O
.	O
para	O
-	O
aortic	O
lymph	O
nodes	O
above	O
and	O
below	O
the	O
inferior	O
.	O
mesenteric	O
.	O

artery	O
(	O
laparoscopically	O
)	O
.	O

DIAGNOSIS	O
:	O
Uterus	O
,	O
hysterectomy	O
:	O
Endometrial	O
adenocarcinoma	O
,	O
.	O
endometrioid	O
.	O

type	O
,	O
FIGO	O
grade	O
II	O
(	O
of	O
III	O
)	O
endometrioid	O
type	O
,	O
forming	O
a	O
.	O
polypoid	O
.	O

mass	O
(	O
7	O
.	O
5	O
x	O
2	O
.	O
5	O
X	O
1	O
.	O
3	O
cm	O
)	O
The	O
tumor	O
,	O
which	O
demonstrates	O
.	O
focal	O
.	O

squamous	O
differentiation	O
,	O
invades	O
the	O
myometrium	O
to	O
a	O
.	O
maximal	O
depth	O
.	O
of	O
0	O
.	O
5	O
cm	O
(	O
2	O
.	O
0	O
cm	O
total	O
myometrial	O
thickness	O
)	O
and	O
extends	O
.	O
to	O
involve	O
.	O
the	O
lower	O
uterine	O
segment	O
.	O

The	O
cervix	O
is	O
uninvolved	O
.	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
right	O
salpingo	O
-	O
oophorectomy	O
:	O
diagnostic	O
abnormalities	O
.	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
left	O
salpingo	O
-	O
oophorectomy	O
:	O
:	O
No	O
.	O
diagnostic	O
.	O

abnormalities	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
(	O
5	O
)	O
.	O
right	O
.	O

pelvic	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
(	O
10	O
)	O
.	O
left	O
.	O

pelvic	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
right	O
and	O
left	O
para	O
-	O
aortic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
.	O

(	O
5	O
above	O
the	O
inferior	O
mesenteric	O
artery	O
and	O
1	O
below	O
the	O
.	O
inferior	O
.	O
mesenteric	O
artery	O
)	O
para	O
-	O
aortic	O
lymph	O
nodes	O
are	O
negative	O
.	O
for	O
tumor	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
.	O

gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
.	O
the	O
.	O

specimen	O
(	O
s	O
)	O
.	O

Sex	O
:	O
Female	O
.	O

Diagnosis	O
:	O
Breast	O
Cancer	O
Histological	O
description	O
:	O
Infiltrative	O
ductal	O
carcinoma	O
.	O

Anatomic	O
Site	O
:	O
Right	O
Breast	O
Tumor	O
location	O
:	O
Primary	O
.	O

Tissue	O
Specification	O
:	O
Tumor	O
Specimen	O
Matrix	O
:	O
Tissue	O
Specimen	O
Format	O
:	O
Frozen	O
.	O

Container	O
:	O
cryomold	O
Type	O
of	O
Procurement	O
:	O
Radical	O
mastectomy	O
Grade	O
:	O
3	O
.	O

T	O
Stage	O
:	O
2	O
N	O
Stage	O
:	O
0	O
M	O
Stage	O
:	O
0	O
Treatment	O
:	O
none	O
.	O

Treatment	O
Details	O
:	O
n	O
/	O
a	O
.	O

Normal	O
Sample	O
.	O

Anatomic	O
Site	O
:	O
Blood	O
Sample	O
Type	O
:	O
Normal	O
Type	O
of	O
Procurement	O
:	O
blood	O
draw	O
.	O

Matrix	O
:	O
Blood	O
Specimen	O
Format	O
:	O
frozen	O
Container	O
:	O
tube	O
.	O

SPECIMENS	O
:	O
A	O
.	O

RIGHT	O
RENAL	O
TUMOR	O
BASE	O
.	O

B	O
.	O

RIGHT	O
KIDNEY	O
TUMOR	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

RIGHT	O
RENAL	O
TUMOR	O
BASE	O
.	O

B	O
.	O

RIGHT	O
KIDNEY	O
TUMOR	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
:	O
FSA	O
-	O
right	O
renal	O
tumor	O
base	O
:	O
No	O
malignancy	O
identified	O
.	O

Diagnosis	O
called	O
by	O
Dr	O
.	O
to	O
Dr	O
.	O
at	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
TUMOR	O
BASE	O
,	O
EXCISION	O
:	O
-	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

B	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
PARTIAL	O
NEPHRECTOMY	O
:	O
-	O
PAPILLARY	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
TYPE	O
2	O
.	O

-	O
TUMOR	O
SIZE	O
:	O
2	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

-	O
SURGICAL	O
RESECTION	O
MARGIN	O
IS	O
INVOLVED	O
BY	O
CARCINOMA	O
.	O

-	O
SEE	O
SYNOPTIC	O
REPORT	O
.	O

COMMENT	O
;	O
.	O

The	O
surface	O
inked	O
orange	O
is	O
not	O
real	O
margin	O
as	O
per	O
conversation	O
with	O
Dr	O
.	O
on	O
.	O

SYNOPTIC	O
REPORT	O
-	O
KIDNEY	O
(	O
PARTIAL	O
OR	O
RADICAL	O
)	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
A	O
:	O
RIGHT	O
RENAL	O
TUMOR	O
BASE	O
.	O

B	O
:	O
RIGHT	O
KIDNEY	O
TUMOR	O
.	O

Specimen	O
Type	O
:	O
Partial	O
nephrectomy	O
.	O

Without	O
adrenal	O
gland	O
.	O

Laterality	O
:	O
Right	O
.	O

Tumor	O
Site	O
:	O
Not	O
specified	O
.	O

Focality	O
:	O
Unifocal	O
.	O

Tumor	O
Size	O
(	O
largest	O
tumor	O
if	O
multiple	O
)	O
:	O
Greatest	O
dimension	O
:	O
2	B
.	I
5cm	I
.	O

Macroscopic	O
Extent	O
of	O
Tumor	O
:	O
Tumor	O
limited	O
to	O
kidney	O
.	O

WHO	O
CLASSIFICATION	O
.	O

Papillary	O
renal	O
cell	O
carcinoma	O
8260	O
/	O
3	O
.	O

Histologic	O
Grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
G2	O
:	O
Nuclei	O
slightly	O
irregular	O
,	O
approximately	O
15	O
u	O
;	O
.	O
nucleoli	O
evident	O
.	O

Invasion	O
of	O
Vascular	O
/	O
Lymphatic	O
:	O
Absent	O
.	O

Perinephric	O
Tissue	O
Invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Include	O
:	O
Renal	O
parenchymal	O
margin	O
(	O
partial	O
nephrectomy	O
only	O
)	O
.	O

Adrenal	O
Gland	O
:	O
Not	O
present	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
None	O
sampled	O
.	O

Additional	O
Findings	O
:	O
None	O
identified	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT	O
1a	O
N	O
x	O
M	O
x	O
.	O

Pathological	O
staging	O
is	O
based	O
on	O
the	O
AJCC	O
Cancer	O
Staging	O
Manual	O
,	O
7th	O
Edition	O
.	O

pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

SUMMARY	O
OF	O
IMMUNOHISTOCHEMISTRY	O
/	O
SPECIAL	O
STAINS	O
.	O

Material	O
:	O
Block	O
B2	O
.	O

Population	O
:	O
Tumor	O
Cells	O
.	O

Stain	O
/	O
Marker	O
:	O
Result	O
:	O
Comment	O
:	O
CYTOKERATIN	O
7	O
.	O

Positive	O
.	O

CD	O
10	O
.	O

Positive	O
.	O

Material	O
:	O
Block	O
B5	O
.	O

Population	O
:	O
Tumor	O
Cells	O
.	O

Stain	O
/	O
Marker	O
:	O
Result	O
:	O
Comment	O
:	O
RACEMACE	O
Positive	O
.	O

Carbonic	O
Anhydrase	O
IX	O
.	O

Positive	O
Equivocal	O
.	O

The	O
interpretation	O
of	O
the	O
above	O
immunohistochemistry	O
stain	O
or	O
stains	O
is	O
guided	O
by	O
published	O
results	O
in	O
.	O
the	O
medical	O
literature	O
,	O
provided	O
package	O
information	O
from	O
the	O
manufacturer	O
and	O
by	O
internal	O
review	O
of	O
.	O
staining	O
performance	O
and	O
assay	O
validation	O
within	O
the	O
.	O

The	O
use	O
.	O
of	O
one	O
or	O
more	O
reagents	O
in	O
the	O
above	O
tests	O
is	O
regulated	O
as	O
an	O
analyte	O
specific	O
reagent	O
(	O
ASR	O
)	O
.	O

These	O
.	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristic	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
.	O

FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

Special	O
stains	O
and	O
/	O
or	O
immunohistochemical	O
stains	O
were	O
performed	O
with	O
appropriately	O
stained	O
positive	O
.	O

and	O
/	O
or	O
negative	O
controls	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

RIGHT	O
RENAL	O
TUMOR	O
BASE	O
.	O

Received	O
fresh	O
labeled	O
the	O
patient	O
'	O
s	O
identification	O
and	O
"	O
right	O
renal	O
tumor	O
base	O
"	O
is	O
a	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
.	O
piece	O
of	O
red	O
-	O
tan	O
soft	O
tissue	O
;	O
submitted	O
in	O
the	O
frozen	O
section	O
diagnosis	O
,	O
FSA	O
.	O

B	O
.	O

RIGHT	O
KIDNEY	O
TUMOR	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
and	O
"	O
right	O
kidney	O
tumor	O
"	O
is	O
a	O
9	O
g	O
,	O
3	O
.	O
7	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
3	O
.	O

cm	O
piece	O
of	O
kidney	O
with	O
1	O
.	O
3	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
piece	O
of	O
attached	O
perinephric	O
fat	O
.	O

The	O
surface	O
has	O
a	O
1	O
.	O
5	O
x	O
1	O
.	O

cm	O
defect	O
.	O

The	O
specimen	O
is	O
oriented	O
by	O
Dr	O
.	O
.	O

The	O
true	O
margin	O
(	O
surrounding	O
the	O
defect	O
)	O
is	O
inked	O
black	O
and	O
.	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
inked	O
orange	O
.	O

On	O
sectioning	O
,	O
there	O
is	O
a	O
well	O
-	O
circumscribed	O
mottled	O
tan	O
.	O
and	O
brown	O
nodule	O
,	O
2	B
.	I
5	I
x	I
2	I
.	I
3	I
x	I
1	I
.	I
8	I
cm	I
,	O
which	O
abuts	O
the	O
true	O
margin	O
.	O

Photographs	O
are	O
taken	O
and	O
tissue	O
is	O
.	O
procured	O
;	O
submitted	O
entirely	O
,	O
B1	O
-	O
B8	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
Given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Right	O
renal	O
mass	O
.	O

Microscopic	O
/	O
Diagnostic	O
Dictation	O
:	O
Final	O
Review	O
:	O
.	O

Pathologist	O
.	O

Final	O
:	O
Pathologist	O
,	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
with	O
3	O
,	O
9	O
x	O
3	O
cm	O
hypervascular	O
right	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
tumor	O
.	O

2	O
:	O
SP	O
:	O
Deep	O
margin	O
#	O
2	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

KIDNEY	O
,	O
RIGHT	O
;	O
PARTIAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
CELL	O
)	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
III	O
/	O
IV	O
.	O

-	O
THE	O
PATTERN	O
OF	O
GROWTH	O
IS	O
SOLID	O
.	O

-	O
THE	O
TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
3	B
.	I
9	I
CM	I
.	O

-	O
THE	O
TUMOR	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

.	O
THE	O
SURGICAL	O
MARGIN	O
IS	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

2	O
)	O
.	O

MARGIN	O
,	O
DEEP	O
#	O
2	O
;	O
BIOPSY	O
:	O
-	O
BENIGN	O
RENAL	O
PARENCHYMA	O
.	O

1	O
)	O
.	O

The	O
specimen	O
Is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
,	O
"	O
Right	O
kidney	O
tumor	O
,	O
stitch	O
marks	O
deep	O
margin	O
"	O
.	O
consists	O
of	O
a	O
partial	O
nephrectomy	O
specimen	O
measuring	O
5	O
.	O
0	O
X	O
4	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
area	O
with	O
the	O
black	O
stitch	O
is	O
inked	O
blue	O
.	O

Cut	O
.	O
section	O
the	O
specimen	O
shows	O
a	O
3	O
.	O
9	O
X	O
3	O
.	O
8	O
x	O
3	O
.	O
8	O
cm	O
round	O
,	O
well	O
encapsulated	O
,	O
hemorrhagic	O
orange	O
tumor	O
mass	O
located	O
0	O
.	O
2	O
cm	O
from	O
.	O
the	O
resected	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
kidney	O
parenchyma	O
is	O
brown	O
tan	O
and	O
unremarkable	O
.	O

Representatives	O
sections	O
are	O
.	O
frozen	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

A	O
sample	O
of	O
the	O
tumor	O
Is	O
given	O
to	O
.	O

Summary	O
of	O
sections	O
:	O
FSCA	O
-	O
frozen	O
section	O
control	O
A	O
(	O
tumor	O
)	O
.	O

FSCB	O
-	O
frozen	O
section	O
control	O
B	O
(	O
margin	O
)	O
.	O

T	O
-	O
tumor	O
.	O

RS	O
-	O
representative	O
section	O
of	O
uninvolved	O
parenchyma	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
,	O
"	O
Deep	O
margin	O
#	O
2	O
"	O
.	O

It	O
consists	O
of	O
a	O
piece	O
of	O
gray	O
.	O

(	O
an	O
soft	O
tissue	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O
The	O
specimen	O
is	O
entirely	O
frozen	O
.	O
Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O
Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
tumor	O
.	O
Block	O
.	O
Sect	O
.	O
Site	O
.	O
PCs	O
.	O
fsca	O
.	O
1	O
.	O
1	O
.	O
fscb	O
.	O
1	O
.	O
rs	O
.	O
1	O
.	O
4	O
.	O
Part	O
2	O
:	O
SP	O
:	O
Deep	O
margin	O
#	O
2	O
.	O
Block	O
.	O
Sect	O
.	O
Site	O
.	O
PCs	O
.	O
1	O
.	O
fsc	O
.	O
1	O
.	O
Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O
1A	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
TUMOR	O
:	O
CORTICAL	O
CELL	O
NEOPLASM	O
,	O
FAVOR	O
RENAL	O
CARCINOMA	O
/	O
CLEAR	O
.	O

CELL	O
CONVENTIONAL	O
TYPE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

1B	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
MARGIN	O
:	O
BENIGN	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
,	O
.	O

2	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

M	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
LYMPH	O
NODE	O
,	O
4R	O
,	O
LYMPHADENECTOMY	O
:	O
Two	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
2	O
)	O
.	O

(	O
B	O
)	O
LYMPH	O
NODE	O
,	O
STATION	O
7	O
,	O
LYMPHADENECTOMY	O
:	O
One	O
lymph	O
node	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
1	O
)	O
.	O

(	O
C	O
)	O
DIAPHRAGM	O
,	O
BIOPSY	O
:	O
Portion	O
of	O
diaphragm	O
,	O
no	O
tumor	O
present	O
.	O

(	O
D	O
)	O
RIGHT	O
LIVER	O
,	O
BIOPSY	O
:	O
Liver	O
parenchyma	O
with	O
fibrosis	O
,	O
no	O
tumor	O
present	O
.	O

(	O
E	O
)	O
RIGHT	O
PLEURA	O
,	O
BIOPSY	O
:	O
EPITHELIOID	O
MALIGNANT	O
MESOTHELIOMA	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
.	O

4R	O
LYMPH	O
NODE	O
-	O
Received	O
are	O
two	O
possible	O
lymph	O
nodes	O
measuring	O
0	O
.	O
6	O
to	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
.	O
submitted	O
entirely	O
in	O
A	O
.	O

(	O
B	O
)	O
.	O

STATION	O
.	O

7	O
LYMPH	O
NODE	O
-	O
Received	O
is	O
one	O
possible	O
lymph	O
node	O
measuring	O
0	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
.	O
submitted	O
entirely	O
in	O
B	O
.	O

(	O
C	O
)	O
.	O

BIOPSY	O
OF	O
DIAPHRAGM	O
-	O
Received	O
is	O
a	O
single	O
fragment	O
of	O
tan	O
-	O
pink	O
soft	O
tissue	O
measuring	O
0	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
submitted	O
entirely	O
in	O
C	O
.	O

(	O
D	O
)	O
RIGHT	O
LIVER	O
BIOPSY	O
-	O
Received	O
are	O
two	O
fragments	O
of	O
tan	O
-	O
pink	O
soft	O
tissue	O
both	O
measuring	O
0	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimen	O
submitted	O
entirely	O
in	O
D	O
.	O

(	O
E	O
)	O
.	O

RIGHT	O
.	O

PLEURAL	O
TUMOR	O
-	O
A	O
single	O
(	O
2	B
.	I
3	I
X	I
1	I
.	I
1	I
x	I
0	I
.	I
9	I
cm	I
)	O
portion	O
of	O
pink	O
-	O
tan	O
to	O
white	O
fibrous	O
tissue	O
that	O
is	O
entirely	O
submitted	O
for	O
.	O
frozen	O
section	O
evaluation	O
in	O
E	O
.	O

FS	O
/	O
DX	O
:	O
POSITIVE	O
MALIGNANT	O
MESOTHELIOMA	O
.	O

CLINICAL	O
HISTORY	O
.	O

Mesothelioma	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
2900	O
,	O
M	O
-	O
90503	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
-	O
-	O
-	O
.	O

Page	O
:	O
2	O
.	O

M	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
y	O
/	O
o	O
femnle	O
with	O
left	O
breast	O
cancer	O
on	O
core	O
biopsy	O
IDC	O
/	O
DCIS	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
one	O
.	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
one	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
one	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

4	O
:	O
SP	O
:	O
Left	O
breast	O
.	O

5	O
:	O
SP	O
:	O
Levels	O
one	O
and	O
two	O
left	O
axillary	O
contents	O
(	O
.	O
6	O
:	O
SP	O
:	O
Level	O
two	O
left	O
axillary	O
contents	O
.	O
7	O
:	O
SP	O
:	O
Level	O
three	O
left	O
axillary	O
contents	O
.	O
DIAGNOSIS	O
:	O
1	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
1	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
METASTATIC	O
CARCINOMA	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
.	O

-	O
THERE	O
IS	O
EXTRANODAL	O
CAPSULAR	O
EXTENSION	O
OF	O
CARCINOMA	O
(	O
<	O
2	O
MN	O
)	O
.	O

2	O
)	O
.	O

LYMPH	O
NODES	O
,	O
SENTINEL	O
#	O
2	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
METASTATIC	O
CARCINOMA	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
,	O
2	O
.	O
1	O
MM	O
FOCUS	O
,	O
SEE	O
NOTE	O
.	O

THERE	O
IS	O
NO	O
EXTRANODAL	O
EXTENSION	O
OF	O
CARCINOMA	O
.	O

NOTE	O
:	O
THE	O
CARCINOMA	O
IS	O
NO	O
LONGER	O
PRESENT	O
ON	O
DEEPER	O
H	O
&	O
E	O
STAINED	O
SECTIONS	O
.	O

3	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
3	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

4	O
)	O
.	O

BREAST	O
,	O
LEFT	O
;	O
TOTAL	O
MASTECTOMY	O
:	O
-	O
INVASIVE	O
POORLY	O
DIFFERENTIATED	O
DUCTAL	O
CARCINOMA	O
,	O
NOS	O
TYPE	O
,	O
HISTOLOGIC	O
.	O

GRADE	O
III	O
/	O
III	O
(	O
SLIGHT	O
OR	O
NO	O
TUBULE	O
FORMATION	O
)	O
NUCLEAR	O
GRADE	O
III	O
/	O
III	O
(	O
MARKED	O
.	O
VARIATION	O
IN	O
SIZE	O
AND	O
SHAPE	O
)	O
MEASURING	O
5	B
.	I
0	I
CM	I
IN	O
LARGEST	O
DIMENSION	O
GROSSLY	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
IS	O
ALSO	O
IDENTIFIED	O
,	O
SOLID	O
AND	O
CRIBRIFORM	O
.	O

TYPES	O
,	O
WITH	O
HIGH	O
NUCLEAR	O
GRADE	O
AND	O
MODERATE	O
NECROSIS	O
.	O

THE	O
DCIS	O
CONSTITUTES	O
<	O
=	O
25	O
%	O
OF	O
THE	O
TOTAL	O
TUMOR	O
MASS	O
,	O
AND	O
IS	O
PRESENT	O
.	O

ADMIXED	O
WITH	O
AND	O
AWAY	O
FROM	O
THE	O
INVASIVE	O
COMPONENT	O
.	O

-	O
THE	O
INVASIVE	O
CARCINOMA	O
IS	O
LOCATED	O
IN	O
THE	O
UPPER	O
OUTER	O
QUADRANT	O
AND	O
UPPER	O
.	O

INNER	O
QUADRANT	O
.	O

THE	O
DCIS	O
IS	O
LOCATED	O
IN	O
THE	O
UPPER	O
INNER	O
QUADRANT	O
AND	O
LOWER	O
INNER	O
QUADRANT	O
.	O

-	O
NO	O
INVOLVEMENT	O
OF	O
THE	O
NIPPLE	O
BY	O
EITHER	O
IN	O
SITU	O
OR	O
INVASIVE	O
CARCINOMA	O
IS	O
.	O

IDENTIFIED	O
.	O

NO	O
CALCIFICATIONS	O
ARE	O
IDENTIFIED	O
IN	O
EITHER	O
THE	O
INVASIVE	O
OR	O
IN	O
SITU	O
.	O

COMPONENT	O
.	O

-	O
CALCIFICATIONS	O
ARE	O
PRESENT	O
IN	O
THE	O
BENIGN	O
BREAST	O
PARENCHYMA	O
.	O

-	O
EXTENSIVE	O
VASCULAR	O
INVASION	O
IS	O
PRESENT	O
.	O

-	O
POSITIVE	O
PERINEURAL	O
INVASION	O
.	O

-	O
NO	O
INVOLVEMENT	O
OF	O
THE	O
SURGICAL	O
MARGINS	O
BY	O
EITHER	O
INVASIVE	O
OR	O
IN	O
SITU	O
.	O

CARCINOMA	O
IS	O
IDENTIFIED	O
.	O

NO	O
SKIN	O
INVOLVEMENT	O
BY	O
CARCINOMA	O
IS	O
IDENTIFIED	O
.	O

-	O
THE	O
ATTACHED	O
SKELETAL	O
MUSCLE	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

THE	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
SHOWS	O
BIOPSY	O
SITE	O
CHANGES	O
,	O
FIBROCYSTIC	O
.	O

CHANGES	O
AND	O
FIBROADENOMATOUS	O
CHANGES	O
.	O

-	O
THE	O
LYMPH	O
NODE	O
STATUS	O
IS	O
AS	O
FOLLOWS	O
(	O
EXPRESSED	O
AS	O
THE	O
NUMBER	O
OF	O
POSITIVE	O
.	O
LYMPH	O
NODES	O
IN	O
RELATION	O
TO	O
THE	O
TOTAL	O
NUMBER	O
OF	O
LYMPH	O
NODES	O
EXAMINED	O
)	O
:	O
LEVEL	O
.	O

I	O
:	O
0	O
/	O
1	O
.	O

5	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEVELS	O
I	O
AND	O
II	O
LEFT	O
AXILLARY	O
CONTENTS	O
;	O
EXCISION	O
:	O
-	O
MICROMETASTATIC	O
CARCINOMA	O
IN	O
ONE	O
OUT	O
OF	O
EIGHTEEN	O
LYMPH	O
NODES	O
(	O
1	O
/	O
18	O
)	O
.	O

-	O
THERE	O
IS	O
NO	O
EXTRANODAL	O
EXTENSION	O
OF	O
CARCINOMA	O
.	O

6	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
II	O
LEFT	O
AXILLARY	O
CONTENTS	O
;	O
EXCISION	O
:	O
-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

7	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
III	O
LEFT	O
AXILLARY	O
CONTENTS	O
;	O
EXCISION	O
:	O
FOUR	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
4	O
)	O
.	O

NOTE	O
:	O
RESULTS	O
OF	O
SPECIAL	O
STAINS	O
(	O
ER	O
,	O
PR	O
,	O
HER2	O
-	O
neu	O
)	O
WILL	O
BE	O
REPORTED	O
AS	O
AN	O
.	O

ADDENDUM	O
.	O

SUMMARY	O
OF	O
LYMPH	O
NODES	O
:	O
3	O
/	O
26	O
.	O

TUMOR	O
STAGE	O
:	O
T2	O
,	O
pN1a	O
,	O
MX	O
STAGE	O
GROUPING	O
IIB	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
.	O

AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

M	O
.	O
D	O
.	O
,	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

RECUT	O
.	O
level	O
.	O

ER	O
-	O
C	O
.	O

PR	O
-	O
C	O
.	O

HER2	O
-	O
0	O
.	O

NEG	O
CONT	O
.	O

IMM	O
RECUT	O
.	O

NEG	O
-	O
HER2	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
labeled	O
.	O

"	O
Sentinel	O
node	O
number	O
one	O
,	O
level	O
1	O
,	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
single	O
.	O
lymph	O
node	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
.	O

Entirely	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
-	O
frozen	O
section	O
control	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
labeled	O
.	O

"	O
Sentinel	O
node	O
number	O
two	O
,	O
level	O
1	O
,	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
two	O
lymph	O
.	O
nodes	O
measuring	O
1	O
.	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
and	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
larger	O
lymph	O
.	O
node	O
is	O
inked	O
black	O
.	O

Entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
-	O
frozen	O
section	O
control	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
labeled	O
.	O

"	O
Sentinel	O
node	O
number	O
three	O
,	O
level	O
1	O
,	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
single	O
.	O
lymph	O
node	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
.	O

Lymph	O
node	O
is	O
bisected	O
.	O

Entirely	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
-	O
frozen	O
section	O
control	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
,	O
"	O
left	O
breast	O
,	O
stitch	O
marks	O
.	O
axillary	O
tail	O
"	O
and	O
consists	O
of	O
a	O
breast	O
with	O
attached	O
axillary	O
tail	O
.	O

The	O
.	O
breast	O
measures	O
28	O
.	O
0	O
x	O
25	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
with	O
overlying	O
skin	O
ellipse	O
measuring	O
.	O

22	O
.	O
0	O
x	O
10	O
.	O
0	O
cm	O
.	O

Situated	O
eccentrically	O
on	O
the	O
skin	O
surface	O
is	O
a	O
nipple	O
.	O
measuring	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
cm	O
and	O
areola	O
measuring	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
.	O

A	O
suture	O
.	O
demarcates	O
the	O
axillary	O
tail	O
which	O
measures	O
6	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
.	O

The	O
posterior	O
.	O
surface	O
of	O
the	O
breast	O
is	O
inked	O
black	O
,	O
anterior	O
superior	O
-	O
blue	O
,	O
anterior	O
.	O
inferior	O
-	O
green	O
and	O
the	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
firm	O
.	O
white	O
mass	O
measuring	O
5	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
,	O
and	O
located	O
in	O
the	O
upper	O
inner	O
.	O
quadrant	O
extending	O
to	O
the	O
upper	O
outer	O
quadrant	O
,	O
measuring	O
2	O
.	O
0	O
cm	O
from	O
the	O
.	O
closest	O
deep	O
margin	O
.	O

The	O
remaining	O
breast	O
tissue	O
shows	O
a	O
fibrofatty	O
cut	O
.	O
surface	O
.	O

The	O
axillary	O
tissue	O
is	O
dissected	O
to	O
reveal	O
a	O
lymph	O
node	O
.	O

Representative	O
sections	O
are	O
submitted	O
,	O
including	O
the	O
lymph	O
node	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
nipple	O
.	O

NB	O
-	O
nipple	O
base	O
.	O

S	O
skim	O
.	O

D	O
-	O
deep	O
margin	O
.	O

T	O
-	O
tumor	O
.	O

UIQ	O
-	O
upper	O
inner	O
quadrant	O
.	O

LIQ	O
-	O
lower	O
inner	O
quadrant	O
.	O

UOQ	O
-	O
upper	O
outer	O
quadrant	O
.	O

LOQ	O
-	O
lower	O
outer	O
quadrant	O
.	O

AA	O
-	O
axillary	O
tail	O
.	O

AALN	O
-	O
a	O
bisected	O
lymph	O
node	O
in	O
axillary	O
area	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Levels	O
1	O
and	O
2	O
left	O
axillary	O
.	O

contents	O
"	O
.	O

It	O
consists	O
of	O
a	O
3	O
x	O
2	O
x	O
1	O
cm	O
portion	O
of	O
fibroadipose	O
tissue	O
.	O

Multiple	O
lymph	O
nodes	O
identified	O
measuring	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
1	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

All	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

6	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
level	O
2	O
,	O
left	O
axillary	O
.	O

contents	O
"	O
and	O
consists	O
of	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
portion	O
of	O
fatty	O
tissue	O
.	O

Entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

7	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
level	O
3	O
,	O
left	O
axillary	O
.	O

contents	O
"	O
and	O
consists	O
of	O
two	O
lymph	O
nodes	O
measuring	O
0	O
.	O
5	O
cm	O
and	O
1	O
.	O
3	O
cm	O
in	O
.	O
maximum	O
dimension	O
.	O

Entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
node	O
.	O

BLN	O
-	O
bisected	O
lymph	O
node	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
one	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
one	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
one	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Left	O
breast	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

aa	O
.	O

1	O
.	O
aaln	O
.	O

2	O
.	O

d	O
.	O

2	O
.	O

3	O
.	O
liq	O
.	O

3	O
.	O

2	O
.	O
loq	O
.	O

2	O
.	O

1	O
.	O

n	O
.	O

1	O
.	O

1	O
.	O

nb	O
.	O

1	O
.	O

1	O
.	O

s	O
.	O

1	O
.	O

10	O
.	O

10	O
.	O

2	O
.	O
uiq	O
.	O

2	O
.	O

2	O
.	O
uog	O
.	O

2	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Levels	O
one	O
and	O
two	O
left	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

6	O
.	O

LN	O
.	O

18	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Level	O
two	O
left	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

u	O
.	O

1	O
.	O

Part	O
7	O
:	O
SP	O
:	O
Level	O
three	O
left	O
axillary	O
contents	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
bln	O
.	O

1	O
.	O

1	O
.	O

In	O
.	O

1	O
.	O

Procedures	O
/	O
Addenda	O
:	O
Addendum	O
.	O

Date	O
Complete	O
:	O
Addendum	O
Diagnosis	O
.	O

ADDENDUM	O
REPORT	O
.	O

SITE	O
:	O
LEFT	O
BREAST	O
(	O
PART	O
4	O
)	O
.	O

ER	O
:	O
95	O
%	O
NUCLEAR	O
STAINING	O
WITH	O
MODERATE	O
INTENSITY	O
.	O

PR	O
:	O
<	O
5	O
%	O
NUCLEAR	O
STAINING	O
WITH	O
MODERATE	O
INTENSITY	O
.	O

HER2	O
/	O
NEU	O
(	O
HERCEPTEST	O
)	O
:	O
NEGATIVE	O
(	O
STAINING	O
INTENSITY	O
OF	O
0	O
)	O
.	O

CONTROLS	O
ARE	O
SATISFACTORY	O
.	O

.	O
M	O
.	O
D	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
.	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
METASTATIC	O
CARCINOM	O
'	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

2	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
METASTATIC	O
CARCINOMA	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

3	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
LYMPH	O
NODE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

Final	O
Diagnosis	O
.	O

A	O
.	O

LYMPH	O
NODE	O
,	O
HEPATIC	O
ARTERY	O
,	O
EXCISION	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

B	O
.	O

PANCREAS	O
AND	O
SPLEEN	O
,	O
SUBTOTAL	O
PANCREATECTOMY	O
AND	O
SPLENECTOMY	O
:	O
Pancreatic	O
endocrine	O
neoplasm	O
,	O
grade	O
2	O
.	O

Tumor	O
size	O
:	O
3	B
x	I
2	I
.	I
5	I
:	I
cm	I
.	O

Surgical	O
margins	O
:	O
Free	O
of	O
tumor	O
.	O

Necrosis	O
:	O
present	O
.	O

Mitotic	O
rate	O
:	O
7	O
/	O
10	O
HPFs	O
.	O

Fifteen	O
regional	O
lymph	O
nodes	O
with	O
no	O
evidence	O
of	O
metastasis	O
.	O

Unremarkable	O
spleen	O
.	O

See	O
Key	O
Pathological	O
Findings	O
.	O

C	O
.	O

ACCESSORY	O
SPLEEN	O
,	O
"	O
SPLENULE	O
"	O
,	O
EXCISION	O
:	O
Unremarkable	O
splenic	O
parenchyma	O
.	O

D	O
.	O

GALLBLADDER	O
,	O
CHOLECYSTECTOMY	O
:	O
Chronic	O
cholecystitis	O
and	O
cholesterolosis	O
.	O

No	O
evidence	O
of	O
dysplasia	O
or	O
malignancy	O
.	O

I	O
,	O
.	O
the	O
attending	O
pathologiat	O
,	O
personally	O
reviewed	O
all	O
.	O
aliues	O
and	O
/	O
or	O
materials	O
and	O
rendered	O
the	O
final	O
diagnosis	O
.	O

Electronically	O
.	O

Key	O
Pathological	O
Findings	O
.	O

B	O
:	O
Pancreas	O
Endocrine	O
.	O

SPECIMEN	O
:	O
Tail	O
of	O
pancreas	O
.	O

Spleen	O
.	O

SPECIMEN	O
:	O
Splenectomy	O
.	O

TUMOR	O
SITE	O
:	O
Pancreatic	O
fail	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
0	I
cm	I
.	O

Additional	O
dimensions	O
:	O
2	B
.	I
5x2	I
.	I
0	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Well	O
-	O
differentiated	O
neuroendocrine	O
tumor	O
.	O

WORLD	O
HEALTH	O
ORGANIZATION	O
CLASSIFICATION	O
:	O
Well	O
-	O
differentiated	O
endocrine	O
tumor	O
,	O
uncertain	O
behavior	O
.	O

FUNCTIONAL	O
TYPE	O
:	O
Cannot	O
be	O
assessed	O
.	O

MITOTIC	O
ACTIVITY	O
:	O
Greater	O
than	O
or	O
equal	O
to	O
2	O
mitoses	O
/	O
10	O
HPF	O
to	O
10	O
mitoses	O
/	O
10	O
HPF	O
;	O
number	O
of	O
mitoses	O
per	O
10	O
.	O

HPF	O
:	O
7	O
mitoses	O
/	O
10	O
high	O
power	O
fields	O
.	O

Ki67	O
LABELING	O
INDEX	O
:	O
3	O
%	O
-	O
20	O
%	O
Ki67	O
-	O
positive	O
cells	O
.	O

TUMOR	O
NECROSIS	O
:	O
Present	O
.	O

MICROSCOPIC	O
TUMOR	O
EXTENSION	O
:	O
Tumor	O
is	O
confined	O
to	O
pancreas	O
.	O

MARGINS	O
:	O
Margina	O
uninvolved	O
by	O
tumor	O
.	O

Distance	O
of	O
tumor	O
from	O
closest	O
margin	O
:	O
0	O
.	O
2	O
mm	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Present	O
.	O

PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
limited	O
to	O
the	O
pancreas	O
,	O
more	O
than	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
fymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
16	O
.	O

Number	O
involved	O
:	O
0	O
.	O

DISTANT	O
METASTASIS	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
PANIN	O
lla	O
.	O

ANCILLARY	O
STUDIES	O
:	O
The	O
neoplastic	O
cells	O
are	O
positive	O
for	O
synaptophysin	O
,	O
focally	O
positive	O
for	O
chromogranin	O
by	O
.	O
immunohistochemistry	O
.	O

The	O
Ki	O
-	O
67	O
immunostain	O
is	O
positive	O
in	O
approximately	O
15	O
%	O
of	O
the	O
.	O
neoplastic	O
cells	O
.	O

COMMENT	O
(	O
S	O
)	O
.	O

B2	O
-	O
7	O
adequate	O
for	O
molecular	O
studies	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
.	O

HEPATIC	O
ARTERY	O
LYMPH	O
NODE	O
.	O

B	O
.	O

SUBTOTAL	O
PANCREATECTOMY	O
AND	O
SPLENECTOMY	O
FS	O
.	O

C	O
.	O

SPLENULE	O
.	O

D	O
.	O

GALLBLADDER	O
GROSSLY	O
CHECK	O
FOR	O
POLYP	O
.	O

Clinical	O
History	O
.	O

Y	O
/	O
O	O
FEMALE	O
MORBID	O
OBESITY	O
,	O
HM	O
-	O
ASTHMA	O
.	O

Preoperative	O
Diagnosis	O
.	O

PANCREATIC	O
NEUROENDOCRINE	O
TUMOR	O
.	O

Intraoperative	O
Consultation	O
.	O

FSB1	O
SUBTOTAL	O
PANCREATECTOMY	O
AND	O
SPLENECTOMY	O
:	O
Pancreatic	O
margin	O
,	O
no	O
evidence	O
of	O
malignancy	O
.	O

GROSS	O
EXAMINATION	O
.	O

D	O
.	O

GALLBLADDER	O
GROSSLY	O
CHECK	O
FOR	O
POLYP	O
:	O
Partially	O
calcified	O
mucosal	O
polyps	O
,	O
measuring	O
3	O
mm	O
to	O
5	O
mm	O
.	O

FSD1	O
GALLBLADDER	O
GROSSLY	O
CHECK	O
FOR	O
POLYP	O
:	O
Largest	O
polyp	O
no	O
evidence	O
of	O
malignancy	O
.	O

Intradepartmental	O
Consultation	O
:	O
The	O
case	O
was	O
also	O
reviewed	O
by	O
.	O

MD	O
,	O
who	O
concurs	O
.	O
with	O
the	O
above	O
interpretation	O
(	O
FSD1	O
)	O
.	O

Comment	O
:	O
These	O
frozen	O
section	O
diagnoses	O
/	O
results	O
were	O
communicated	O
to	O
and	O
acknowledged	O
by	O
Dr	O
.	O
I	O
.	O
D	O
.	O
,	O
have	O
performed	O
the	O
intraoperative	O
consultations	O
and	O
issued	O
the	O
above	O
.	O
diagnosis	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Specimen	O
A	O
is	O
received	O
fresh	O
labeled	O
"	O
hepatic	O
artery	O
lymph	O
node	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
.	O

a	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
,	O
moderately	O
firm	O
gray	O
tan	O
irregular	O
lymph	O
node	O
which	O
is	O
serially	O
sectioned	O
and	O
entirely	O
.	O
submitted	O
as	O
A1	O
-	O
A2	O
.	O

B	O
.	O

Specimen	O
B	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
analysis	O
labeled	O
"	O
subtotal	O
pancreatectomy	O
and	O
.	O
spienectomy	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
a	O
subtotal	O
pancreatectomy	O
(	O
8	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
)	O
attached	O
to	O
a	O
.	O
grossly	O
unremarkable	O
spleen	O
(	O
14	O
.	O
0	O
x	O
8	O
.	O
0	O
x	O
6	O
.	O
0	O
cm	O
)	O
.	O

Both	O
specimens	O
are	O
adherent	O
to	O
a	O
moderate	O
.	O
amount	O
of	O
fat	O
.	O

The	O
pancreatic	O
margin	O
of	O
resection	O
is	O
stapled	O
.	O

The	O
staples	O
are	O
removed	O
and	O
the	O
.	O
underlying	O
tissue	O
is	O
removed	O
tangentially	O
and	O
entirely	O
submitted	O
on	O
frozen	O
section	O
as	O
FSB1	O
.	O

The	O
.	O
pancreatic	O
duct	O
is	O
markedly	O
dilated	O
but	O
is	O
probe	O
-	O
patent	O
for	O
approximately	O
2	O
cm	O
where	O
it	O
is	O
filled	O
with	O
.	O

a	O
.	O
soft	O
brown	O
tan	O
protruding	O
tissue	O
(	O
possible	O
tumor	O
)	O
.	O

The	O
end	O
of	O
the	O
pancreas	O
which	O
attaches	O
to	O
the	O
.	O
spleen	O
is	O
markedly	O
indurated	O
and	O
exhibits	O
a	O
gray	O
white	O
smooth	O
ill	O
-	O
defined	O
mass	O
(	O
3	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O
abutting	O
the	O
soft	O
tissue	O
margin	O
of	O
resection	O
and	O
is	O
approximately	O
4	O
cm	O
from	O
the	O
pancreatic	O
margin	O
of	O
.	O
resection	O
.	O

The	O
mass	O
at	O
this	O
point	O
totally	O
occludes	O
the	O
pancreatic	O
duct	O
.	O

The	O
mass	O
occupies	O
.	O
approximately	O
75	O
%	O
of	O
the	O
pancreas	O
.	O

The	O
random	O
pancreatic	O
parenchyma	O
is	O
lobulated	O
gray	O
tan	O
grossly	O
.	O
unremarkable	O
.	O

The	O
capsule	O
of	O
the	O
spleen	O
is	O
brown	O
tan	O
and	O
intact	O
.	O

The	O
cut	O
surface	O
exhibits	O
a	O
soft	O
red	O
brown	O
tissue	O
.	O
with	O
grossly	O
unremarkable	O
parenchyma	O
.	O

Sectioning	O
of	O
the	O
adipose	O
tissue	O
isolates	O
no	O
definitive	O
fymph	O
.	O
nodes	O
.	O

A	O
representative	O
section	O
of	O
the	O
tumor	O
is	O
submitted	O
to	O
Tissue	O
Procurement	O
Laboratory	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
:	O
B2	O
:	O
Mirror	O
image	O
of	O
tumor	O
submitted	O
to	O
Tissue	O
Bank	O
.	O

B3	O
-	O
B6	O
:	O
Sections	O
of	O
tumor	O
showing	O
relationship	O
to	O
soft	O
tissue	O
margin	O
of	O
resection	O
.	O

B7	O
-	O
B8	O
:	O
Sections	O
of	O
tumor	O
showing	O
relationship	O
to	O
pancreatic	O
duct	O
.	O

B9	O
:	O
Grossly	O
unremarkable	O
pancreatic	O
parenchyma	O
.	O

B10	O
:	O
Grossly	O
unremarkable	O
spleen	O
.	O

B11	O
-	O
B26	O
:	O
Representative	O
sections	O
of	O
adipose	O
tissue	O
.	O

c	O
.	O

Specimen	O
C	O
is	O
received	O
fresh	O
labeled	O
"	O
splenule	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
what	O
grossly	O
.	O
appears	O
to	O
be	O
a	O
lobule	O
of	O
spienic	O
tissue	O
partially	O
covered	O
by	O
adipose	O
tissue	O
(	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O

The	O
.	O
overlying	O
adipose	O
tissue	O
is	O
marked	O
with	O
black	O
ink	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
reveals	O
a	O
.	O
red	O
brown	O
grossly	O
unremarkable	O
splenic	O
parenchyma	O
.	O

Representative	O
sections	O
submitted	O
as	O
C1	O
.	O

D	O
.	O

Specimen	O
D	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
analysis	O
labeled	O
"	O
gallbladder	O
grossly	O
check	O
for	O
.	O
polyps	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
club	O
-	O
shaped	O
gallbladder	O
(	O
8	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
)	O
.	O

Te	O
external	O
surface	O
.	O

is	O
green	O
yellow	O
,	O
wrinkled	O
with	O
a	O
small	O
amount	O
of	O
attached	O
fibroadipose	O
tissue	O
.	O

The	O
lumen	O
is	O
filled	O
with	O
.	O

a	O
.	O
green	O
vicile	O
bile	O
.	O

No	O
calculi	O
grossly	O
appreciated	O
.	O

There	O
are	O
several	O
adherent	O
soft	O
lesions	O
(	O
possible	O
.	O
polyps	O
)	O
ranging	O
from	O
0	O
.	O
2	O
cm	O
to	O
0	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

A	O
representative	O
section	O
of	O
these	O
.	O
lesions	O
is	O
submitted	O
for	O
frozen	O
section	O
as	O
FSD1	O
.	O

The	O
remainder	O
of	O
the	O
mucosal	O
surface	O
is	O
.	O
green	O
-	O
yellow	O
,	O
velvet	O
-	O
like	O
and	O
grossly	O
unremarkable	O
.	O

Permanent	O
representative	O
sections	O
are	O
submitted	O
.	O
as	O
D2	O
-	O
D3	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

4R	O
LYMPH	O
NODE	O
.	O

B	O
.	O

LEVEL	O
7	O
.	O

C	O
.	O

4L	O
LYMPH	O
NODE	O
.	O

D	O
.	O

RIGHT	O
LEVEL	O
4	O
LNODE	O
.	O

E	O
.	O

RIGHT	O
UPPER	O
LOBE	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
RUL	O
small	O
cell	O
lung	O
ca	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
:	O
FSA	O
-	O
FSD	O
:	O
Lymph	O
nodes	O
-	O
negative	O
for	O
tumor	O
.	O

FSE	O
:	O
Bronchial	O
margin	O
-	O
negative	O
for	O
tumor	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

4R	O
LYMPH	O
NODE	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
is	O
a	O
tan	O
-	O
pink	O
lymph	O
node	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
.	O
submitted	O
entirely	O
for	O
frozen	O
section	O
in	O
FSA1	O
.	O

B	O
.	O

LEVEL	O
7	O
.	O

Is	O
a	O
tan	O
-	O
pink	O
aggregate	O
of	O
lymphoid	O
tissue	O
0	O
.	O
7	O
x	O
0	O
,	O
4	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
.	O
for	O
frozen	O
section	O
in	O
FSB1	O
.	O

C	O
.	O

4L	O
LYMPH	O
NODE	O
.	O

Is	O
an	O
aggregate	O
of	O
lymphoid	O
tissue	O
0	O
,	O
5	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
for	O
.	O
frozen	O
section	O
in	O
FSC1	O
.	O

D	O
.	O

RIGHT	O
LEVEL	O
4	O
LYMPH	O
NODE	O
.	O

Is	O
a	O
tan	O
-	O
pink	O
aggregate	O
of	O
lymphoid	O
tissue	O
0	O
.	O
8	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
.	O
for	O
frozen	O
section	O
in	O
FSD1	O
.	O

E	O
.	O
LUNG	O
,	O
RIGHT	O
UPPER	O
LOBE	O
,	O
LOBECTOMY	O
;	O
.	O

Received	O
fresh	O
and	O
labeled	O
with	O
the	O
patient	O
name	O
.	O
right	O
upper	O
lobe	O
"	O
,	O
is	O
a	O
.	O

121	O
-	O
gram	O
lobectomy	O
specimen	O
measuring	O
14	O
.	O
5	O
x	O
10	O
.	O
7	O
x	O
2	O
.	O
3	O
cm	O
.	O

There	O
is	O
a	O
defect	O
on	O
the	O
pleural	O
.	O
surface	O
exposing	O
a	O
mass	O
measuring	O
3	O
.	O
0	O
x	O
2	O
.	O
5x1	O
.	O
5	O
cm	O
.	O

The	O
mass	O
is	O
hemorrhagic	O
and	O
necrotic	O
.	O

It	O
.	O
extends	O
to	O
within	O
0	O
.	O
3	O
cm	O
of	O
the	O
pleural	O
margin	O
and	O
1	O
.	O
2	O
cm	O
from	O
the	O
bronchial	O
margin	O
.	O

A	O
shave	O
.	O
section	O
is	O
taken	O
of	O
the	O
bronchial	O
margin	O
for	O
frozen	O
section	O
.	O

The	O
bronchi	O
are	O
opened	O
and	O
they	O
.	O
have	O
a	O
smooth	O
tan	O
appearance	O
.	O

The	O
lung	O
is	O
sectioned	O
and	O
the	O
parenchyma	O
has	O
a	O
variegated	O
pink	O
.	O
and	O
anthracotic	O
appearance	O
as	O
well	O
as	O
areas	O
of	O
congestion	O
.	O

Possible	O
anthracotic	O
lymph	O
nodes	O
are	O
.	O
identified	O
.	O

Portions	O
of	O
mass	O
were	O
submitted	O
for	O
tissue	O
procurement	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
as	O
follows	O
:	O
FSE1	O
:	O
Shave	O
section	O
of	O
bronchial	O
margin	O
.	O

E2	O
-	O
E5	O
:	O
Sections	O
of	O
mass	O
including	O
relationship	O
to	O
normal	O
appearing	O
parenchyma	O
and	O
.	O
pleural	O
margin	O
.	O

E6	O
:	O
Additional	O
portions	O
of	O
uninvolved	O
parenchyma	O
.	O

E7	O
:	O
Possible	O
lymph	O
nodes	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

4R	O
RIGHT	O
LYMPH	O
NODE	O
.	O

-	O
ANTHRACOSIS	O
OF	O
ONE	O
LYMPH	O
NODE	O
-	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

B	O
.	O

LEVEL	O
7	O
LYMPH	O
NODE	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
-	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

C	O
.	O

4L	O
LEFT	O
LYMPH	O
NODE	O
:	O
-	O
ONE	O
LYMPH	O
NODE	O
-	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

D	O
.	O

RIGHT	O
LEVEL	O
4	O
LYMPH	O
NODE	O
:	O
ONE	O
LYMPH	O
NODE	O
-	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

E	O
.	O

LUNG	O
,	O
RIGHT	O
UPPER	O
LOBE	O
,	O
LOBECTOMY	O
SPECIMEN	O
:	O
-	O
NON	O
SMALL	O
CELL	O
CARCINOMA	O
(	O
CONSISTENT	O
WITH	O
MODERATE	O
TO	O
.	O
POORLY	O
DIFFERENTIATED	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
)	O
WITH	O
AREAS	O
OF	O
.	O

NECROSIS	O
OF	O
UPPER	O
LOBE	O
OF	O
RIGHT	O
LUNG	O
.	O

-	O
SIZE	O
OF	O
TUMOR	O
3	B
.	I
0	I
X	I
2	I
.	I
5	I
X	I
1	I
.	I
5	I
CM	I
.	O

-	O
CONGESTION	O
AND	O
FOCAL	O
ATELECTATIC	O
CHANGE	O
.	O

-	O
SIX	O
PERIBRONCHIAL	O
LYMPH	O
NODES	O
-	O
(	O
0	O
/	O
6	O
)	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

-	O
MARGINS	O
OF	O
RESECTION	O
-	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SYNOPTIC	O
REPORT	O
-	O
LUNG	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
E	O
:	O
RIGHT	O
UPPER	O
LOBE	O
.	O

Surgical	O
Procedure	O
:	O
Lobectomy	O
.	O

Laterality	O
:	O
Right	O
.	O

Tumor	O
Site	O
:	O
Upper	O
lobe	O
.	O

Tumor	O
Location	O
:	O
Central	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
:	O
3cm	B
.	O

Additional	O
dimensions	O
:	O
2	B
.	I
5cm	I
x	I
1	I
.	I
5cm	I
.	O

WHO	O
CLASSIFICATION	O
.	O

Squamous	O
cell	O
carcinoma	O
.	O

Comment	O
(	O
s	O
)	O
:	O
Non	O
small	O
cell	O
carcinoma	O
.	O

Histologic	O
Grade	O
:	O
poorly	O
to	O
moderately	O
differentiated	O
.	O

Angiolymphatic	O
Invasion	O
:	O
Absent	O
.	O

Bronchial	O
Margins	O
:	O
Bronchial	O
margins	O
uninvolved	O
.	O

Tumor	O
Distance	O
from	O
margin	O
:	O
1	O
.	O
2cm	O
.	O

Visceral	O
Pleural	O
Involvement	O
:	O
Absent	O
.	O

Satellite	O
Tumor	O
(	O
s	O
)	O
:	O
Absent	O
.	O

Lymph	O
Node	O
Involvement	O
:	O
N1	O
:	O
Ipsilateral	O
Hilar	O
and	O
/	O
or	O
Peribronchial	O
(	O
levels	O
10	O
-	O
14	O
)	O
.	O

Negative	O
016	O
.	O

N2	O
:	O
Ipsilateral	O
Mediastinal	O
and	O
/	O
or	O
Subcarinal	O
(	O
Levels	O
1	O
-	O
9	O
)	O
.	O

Negative	O
0	O
/	O
3	O
.	O

N3	O
:	O
Contralateral	O
Mediastinal	O
/	O
Hilar	O
,	O
Scalene	O
or	O
Supraclavicular	O
.	O

Negative	O
0	O
/	O
1	O
.	O

Non	O
-	O
Neoplastic	O
Lung	O
:	O
Emphysematous	O
changes	O
.	O
congestion	O
and	O
focal	O
atelectatic	O
change	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
None	O
identified	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT	O
1	O
.	O

M	O
x	O
.	O

Infiltrating	O
Lobular	O
Carcinoma	O
.	O

CATEGORY	O
:	O
BREAST	O
INVASIVE	O
CARCINOMA	O
-	O
INFILTRATING	O
LOBULAR	O
.	O

CARCINOMA	O
.	O

FROM	O
PRIMARY	O
BREAST	O
SURGERY	O
.	O

CLINICAL	O
HX	O
-	O
Invasive	O
lobular	O
carcinoma	O
.	O

RIGHT	O
BREAST	O
,	O
MASTECTOMY	O
-	O
Invasive	O
lobular	O
carcinoma	O
,	O
focally	O
pleomorphic	O
type	O
,	O
.	O

3	B
.	I
0cm	I
in	O
greatest	O
microscopic	O
dimension	O
,	O
associated	O
with	O
extensive	O
duct	O
carcinoma	O
in	O
-	O
situ	O
.	O

(	O
DCIS	O
)	O
,	O
intermediate	O
nuclear	O
grade	O
,	O
solid	O
type	O
with	O
comedo	O
necrosis	O
.	O

[	O
Nottingham	O
histologic	O
.	O
grading	O
system	O
utilized	O
-	O
SBR	O
score	O
7	O
;	O
architectural	O
grade	O
3	O
,	O
nuclear	O
grade	O
2	O
,	O
mitotic	O
grade	O
2	O
)	O
.	O

No	O
.	O
lymphatic	O
invasion	O
is	O
identified	O
.	O

Deep	O
margin	O
negative	O
for	O
tumor	O
.	O

Vessel	O
wall	O
calcifications	O
.	O

Intraductal	O
papilloma	O
,	O
radial	O
scar	O
and	O
fibrocystic	O
changes	O
including	O
sclerosing	O
adenosis	O
.	O

Skin	O
and	O
.	O
nipple	O
,	O
unremarkable	O
.	O

Prior	O
biopsy	O
site	O
changes	O
.	O

RIGHT	O
AXILLARY	O
CONTENTS	O
,	O
EXCISION	O
-	O
Metastatic	O
carcinoma	O
present	O
in	O
two	O
of	O
the	O
.	O
thirteen	O
lymph	O
nodes	O
(	O
2	O
/	O
13	O
)	O
.	O

Largest	O
metastatic	O
focus	O
measures	O
4mm	O
in	O
greatest	O
microscopic	O
.	O
dimension	O
.	O

No	O
extranodal	O
extension	O
is	O
identified	O
.	O

Comment	O
:	O
AJCC	O
pathologic	O
stage	O
pT2N1aMx	O
.	O

Synoptic	O
summary	O
will	O
follow	O
as	O
an	O
addendum	O
.	O

ADDENDUM	O
1	O
:	O
RIGHT	O
BREAST	O
,	O
MASTECTOMY	O
-	O
Immunohistochemical	O
stain	O
for	O
HER	O
-	O
2	O
-	O
NEU	O
oncoprotein	O
.	O

is	O
negative	O
(	O
performed	O
on	O
formalin	O
-	O
fixed	O
paraffin	O
embedded	O
sections	O
by	O
manual	O
semiquantitative	O
.	O
morphometric	O
analysis	O
with	O
appropriate	O
positive	O
and	O
negative	O
controls	O
)	O
.	O

No	O
membranous	O
staining	O
.	O

is	O
seen	O
.	O

The	O
HER	O
-	O
2	O
-	O
NEU	O
procedure	O
was	O
performed	O
using	O
monoclonal	O
antibody	O
4B5	O
and	O
DAB	O
.	O
detection	O
system	O
.	O

(	O
Staining	O
interpretation	O
:	O
Weak	O
=	O
1	O
+	O
;	O
Moderate	O
=	O
2	O
+	O
;	O
Strong	O
=	O
3	O
+	O
.	O
)	O
.	O

NOTE	O
.	O

This	O
evaluation	O
was	O
performed	O
according	O
to	O
ASCO	O
/	O
CAP	O
guidelines	O
:	O
Positive	O
HER2	O
/	O
neu	O
.	O
cases	O
are	O
those	O
with	O
strong	O
and	O
complete	O
membrane	O
staining	O
(	O
3	O
+	O
)	O
in	O
greater	O
than	O
30	O
%	O
of	O
invasive	O
.	O
cancer	O
cells	O
.	O

Negative	O
cases	O
are	O
defined	O
as	O
those	O
with	O
no	O
staining	O
(	O
0	O
)	O
or	O
weak	O
,	O
incomplete	O
.	O
membrane	O
staining	O
(	O
1	O
+	O
)	O
in	O
any	O
proportion	O
of	O
cells	O
.	O

Equivocal	O
cases	O
are	O
those	O
cases	O
with	O
strong	O
.	O
staining	O
in	O
less	O
than	O
or	O
equal	O
to	O
30	O
%	O
of	O
cells	O
,	O
or	O
less	O
than	O
strong	O
but	O
complete	O
membrane	O
staining	O
.	O

(	O
2	O
+	O
)	O
in	O
at	O
least	O
10	O
%	O
of	O
cells	O
.	O

Immunohistochemical	O
stains	O
were	O
performed	O
on	O
formalin	O
-	O
fixed	O
.	O
paraffin	O
embedded	O
tissue	O
with	O
appropriate	O
positive	O
and	O
negative	O
controls	O
.	O

ADDENDUM	O
2	O
.	O

Specimen	O
Type	O
-	O
Mastectomy	O
.	O

Lymph	O
node	O
Sampling	O
-	O
Axillary	O
dissection	O
.	O

Specimen	O
Size	O
.	O

Greatest	O
dimension	O
3cm	O
.	O

Histologic	O
Type	O
-	O
Invasive	O
lobular	O
.	O

Grading	O
System	O
-	O
Nottingham	O
.	O

Tubule	O
Formation	O
-	O
Minimal	O
less	O
than	O
10	O
%	O
(	O
score	O
=	O
3	O
)	O
.	O

Nuclear	O
Pleomorphism	O
-	O
Moderate	O
.	O
increase	O
in	O
size	O
,	O
etc	O
(	O
score	O
=	O
2	O
)	O
.	O

Mitotic	O
Count	O
-	O
40X	O
objective	O
field	O
with	O
a	O
field	O
area	O
of	O
0	O
.	O
152	O
.	O

mm2	O
:	O
6	O
to	O
10	O
mitoses	O
per	O
10	O
HPF	O
(	O
score	O
=	O
2	O
)	O
.	O

Total	O
Nottingham	O
Score	O
-	O
Grade	O
II	O
:	O
6	O
-	O
7	O
points	O
.	O

Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
5mm	O
.	O

Deep	O
Primary	O
.	O

Tumor	O
[	O
pT	O
]	O
:	O
pT2	O
-	O
Tumor	O
greater	O
than	O
or	O
equal	O
to	O
2	O
.	O
0	O
-	O
5	O
.	O
0cm	O
.	O

Regional	O
Nodes	O
[	O
pN	O
]	O
:	O
pN1a	O
:	O
Metastasis	O
in	O
1	O
to	O
3	O
axillary	O
lymph	O
nodes	O
(	O
at	O
least	O
1	O
tumor	O
deposit	O
greater	O
than	O
2	O
.	O
0mm	O
)	O
.	O

Number	O
.	O
involved	O
:	O
2	O
.	O

Number	O
examined	O
:	O
13	O
.	O

Distant	O
Metastasis	O
[	O
pM	O
]	O
:	O
pMX	O
-	O
cannot	O
be	O
assessed	O
.	O

FROM	O
DIAGNOSIS	O
.	O

CLINICAL	O
HX	O
-	O
Right	O
irregular	O
mass	O
,	O
Right	O
ax	O
tail	O
lymph	O
node	O
.	O

RIGHT	O
BREAST	O
,	O
10	O
:	O
00	O
.	O

MASS	O
,	O
CORE	O
BIOPSY	O
-	O
Invasive	O
,	O
lobular	O
carcinoma	O
with	O
focal	O
duct	O
carcinoma	O
in	O
situ	O
,	O
solid	O
.	O
type	O
,	O
low	O
nuclear	O
grade	O
.	O

Intraductal	O
papilloma	O
involved	O
by	O
lobular	O
carcinoma	O
in	O
-	O
situ	O
.	O

RIGHT	O
.	O

AXILLA	O
,	O
LYMPH	O
NODE	O
,	O
CORE	O
BIOPSY	O
-	O
Lymph	O
node	O
with	O
metastatic	O
carcinoma	O
.	O
histologically	O
identical	O
to	O
breast	O
carcinoma	O
.	O

COMMENT	O
.	O

Prognostic	O
/	O
predictive	O
markers	O
are	O
.	O
being	O
performed	O
and	O
results	O
will	O
follow	O
as	O
an	O
addendum	O
.	O

ADDENDUM	O
:	O
Results	O
of	O
.	O
immunoperoxidase	O
steroid	O
receptor	O
protein	O
determination	O
on	O
paraffin	O
sections	O
,	O
visually	O
evaluated	O
.	O
using	O
DAB	O
detection	O
system	O
and	O
monoclonal	O
antibodies	O
(	O
manual	O
semiquantitative	O
morphometric	O
.	O
7	O
.	O
analysis	O
)	O
:	O
ESTROGEN	O
RECEPTOR	O
PROTEIN	O
(	O
ER	O
-	O
clone	O
SP1	O
)	O
:	O
POSITIVE	O
;	O
PROGESTERONE	O
.	O

RECEPTOR	O
PROTEIN	O
(	O
PR	O
-	O
clone	O
1E2	O
)	O
:	O
POSITIVE	O
.	O

Estimated	O
percentage	O
of	O
nuclei	O
staining	O
.	O
positive	O
(	O
ER	O
)	O
:	O
100	O
;	O
Estimated	O
percentage	O
of	O
nuclei	O
staining	O
positive	O
(	O
PR	O
)	O
:	O
25	O
.	O

Intensity	O
of	O
.	O
staining	O
,	O
ER	O
:	O
3	O
+	O
(	O
strong	O
)	O
.	O

Intensity	O
of	O
staining	O
,	O
PR	O
:	O
3	O
+	O
(	O
strong	O
)	O
.	O

Immunohistochemical	O
stain	O
for	O
.	O

HER	O
-	O
2	O
-	O
NEU	O
oncoprotein	O
is	O
NEGATIVE	O
(	O
performed	O
on	O
formalin	O
-	O
fixed	O
paraffin	O
embedded	O
.	O
sections	O
by	O
manual	O
semiquanitative	O
morphometric	O
analysis	O
)	O
.	O

No	O
membranous	O
staining	O
is	O
seen	O
.	O

The	O
HER	O
-	O
2	O
-	O
NEU	O
procedure	O
was	O
performed	O
using	O
monoclonal	O
antibody	O
4B5	O
and	O
DAB	O
detection	O
.	O
system	O
.	O

8	O
.	O

De	O
-	O
Identified	O
Specimen	O
Code	O
:	O
M	O
.	O

SPECIMEN	O
SUBMITTED	O
:	O
Part	O
A	O
:	O
POSTERIOR	O
SEGMENT	O
RIGHT	O
.	O

UPPER	O
LOBE	O
.	O

Part	O
B	O
:	O
LEVEL	O
10	O
R	O
.	O

Final	O
Diagnosis	O
.	O

1	O
.	O

Right	O
lung	O
,	O
upper	O
lobe	O
,	O
wedge	O
excision	O
(	O
A	O
)	O
Adenocarcinoma	O
,	O
solid	O
predominant	O
(	O
40	O
%	O
)	O
with	O
.	O
acinar	O
(	O
40	O
%	O
)	O
,	O
and	O
lepidic	O
(	O
20	O
%	O
)	O
patterns	O
.	O

-	O
Mild	O
centrilobular	O
emphysema	O
.	O

-	O
See	O
comment	O
.	O

2	O
.	O

Lymph	O
node	O
,	O
level	O
10R	O
,	O
excision	O
(	O
B	O
)	O
Hylanized	O
lymph	O
node	O
,	O
negative	O
for	O
neoplasm	O
.	O

Diagnosis	O
Comment	O
:	O
1	O
.	O

The	O
tumor	O
measures	O
1	B
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

No	O
invasion	O
into	O
or	O
through	O
the	O
pleural	O
is	O
seen	O
.	O

The	O
.	O
parenchymal	O
margin	O
of	O
excision	O
is	O
negative	O
for	O
neoplasm	O
.	O

Further	O
studies	O
to	O
define	O
the	O
origin	O
of	O
this	O
.	O
adenocarcinoma	O
will	O
be	O
performed	O
and	O
the	O
results	O
of	O
those	O
studies	O
reported	O
as	O
an	O
addendum	O
.	O

Intraoperative	O
Diagnosis	O
:	O
A	O
.	O

Adenocarcinoma	O
.	O

Margin	O
negative	O
.	O

Clinical	O
Diagnosis	O
:	O
LUNG	O
NODULES	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
diagnosis	O
labeled	O
"	O
posterior	O
segment	O
right	O
upper	O
lobe	O
"	O
is	O
a	O
wedge	O
.	O
of	O
lung	O
measuring	O
14	O
.	O
8	O
X	O
5	O
.	O
2	O
x	O
2	O
.	O
7	O
cm	O
,	O
and	O
weighing	O
39	O
.	O
1	O
grams	O
.	O

A	O
staple	O
line	O
is	O
present	O
and	O
inked	O
.	O
orange	O
.	O

The	O
pleural	O
surface	O
displays	O
a	O
puckered	O
area	O
measuring	O
1	O
.	O
2	O
X	O
0	O
.	O
8	O
cm	O
and	O
is	O
located	O
3	O
.	O
2	O
cm	O
.	O
from	O
the	O
orange	O
inked	O
parenchymal	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
pleural	O
surface	O
is	O
smooth	O
and	O
.	O
glistening	O
.	O

The	O
puckered	O
area	O
is	O
inked	O
blue	O
.	O

Upon	O
sectioning	O
,	O
a	O
stellate	O
tan	O
-	O
gray	O
firm	O
nodule	O
is	O
identified	O
.	O
in	O
the	O
puckered	O
region	O
measuring	O
1	O
.	O
6	O
X	O
1	O
.	O
2	O
X	O
1	O
.	O
0	O
cm	O
,	O
and	O
extending	O
within	O
2	O
.	O
7	O
cm	O
of	O
the	O
parenchymal	O
.	O
line	O
of	O
resection	O
and	O
appears	O
to	O
extend	O
into	O
,	O
but	O
not	O
through	O
the	O
pleura	O
.	O

The	O
remainder	O
of	O
the	O
.	O
parenchyma	O
is	O
unremarkable	O
.	O

Other	O
masses	O
,	O
lesions	O
,	O
nodules	O
are	O
not	O
present	O
.	O

The	O
mass	O
is	O
totally	O
.	O
submitted	O
.	O

The	O
nodule	O
is	O
totally	O
submitted	O
as	O
follows	O
:	O
A1	O
nodule	O
with	O
closest	O
pleural	O
involvement	O
,	O
A2	O
.	O
perpendicular	O
line	O
of	O
resection	O
representative	O
section	O
,	O
A3	O
-	O
A5	O
nodule	O
with	O
pleural	O
surface	O
,	O
A6	O
remainder	O
.	O
of	O
nodule	O
totally	O
submitted	O
,	O
A7	O
additional	O
representative	O
section	O
of	O
parenchymal	O
margin	O
,	O
A8	O
.	O
representative	O
section	O
of	O
apparent	O
uninvolved	O
tissue	O
.	O

B	O
.	O

Received	O
fresh	O
is	O
a	O
tan	O
-	O
black	O
nodule	O
resembling	O
lymph	O
node	O
measuring	O
0	O
.	O
4	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
not	O
sectioned	O
.	O

Totally	O
submitted	O
in	O
one	O
cassette	O
.	O

Microscopic	O
:	O
{	O
Not	O
Entered	O
}	O
.	O

DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
Lymph	O
node	O
,	O
level	O
9	O
,	O
biopsy	O
:	O
Anthracosis	O
.	O

Negative	O
for	O
malignancy	O
(	O
two	O
small	O
lymph	O
nodes	O
)	O
.	O

Lymph	O
nodes	O
,	O
level	O
7	O
,	O
excisional	O
biopsy	O
:	O
Anthracosis	O
and	O
reactive	O
change	O
,	O
two	O
lymph	O
nodes	O
.	O

Both	O
are	O
negative	O
for	O
malignancy	O
.	O

Lung	O
,	O
right	O
lower	O
lobe	O
,	O
wedge	O
resection	O
:	O
Adenocarcinoma	O
,	O
poorly	O
differentiated	O
,	O
with	O
extensive	O
necrosis	O
.	O

Stapled	O
surgical	O
margin	O
is	O
free	O
of	O
malignancy	O
.	O

Malignancy	O
extends	O
to	O
within	O
0	O
.	O
1	O
mm	O
of	O
free	O
pleural	O
surface	O
.	O

Malignancy	O
is	O
1	B
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

Definite	O
lymphovascular	O
space	O
invasion	O
is	O
not	O
identified	O
.	O

COMMENTS	O
:	O
The	O
malignancy	O
is	O
poorly	O
differentiated	O
,	O
present	O
in	O
sheets	O
in	O
some	O
areas	O
.	O

Focally	O
,	O
however	O
,	O
definite	O
gland	O
formation	O
is	O
present	O
.	O

The	O
small	O
cell	O
compone	O
.	O

is	O
not	O
identified	O
.	O

The	O
frozen	O
section	O
diagnosis	O
is	O
confirmed	O
.	O

Staging	O
sheet	O
#	O
22	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
with	O
right	O
lung	O
masses	O
,	O
rule	O
out	O
malignancy	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Level	O
9	O
lymph	O
node	O
.	O

B	O
.	O

Level	O
7	O
lymph	O
node	O
.	O

C	O
.	O

Right	O
lower	O
lobe	O
lung	O
nodule	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
is	O
a	O
0	O
.	O
5	O
cm	O
soft	O
yellow	O
slightly	O
lobular	O
fragment	O
.	O

It	O
is	O
submitted	O
whole	O
in	O
one	O
cassette	O
.	O

is	O
a	O
1	O
.	O
1	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
2	O
cm	O
rubbery	O
brown	O
lymph	O
node	O
.	O

It	O
is	O
bisected	O
and	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O
and	O
RLL	O
nodule	O
is	O
a	O
6	O
.	O
3	O
gram	O
wedge	O
of	O
lung	O
tissue	O
,	O
4	O
.	O
5	O
X	O
1	O
.	O
5	O
X	O
0	O
.	O
7	O
cm	O
.	O

The	O
specimen	O
has	O
been	O
partially	O
sampled	O
for	O
frozen	O
section	O
.	O

The	O
.	O
margin	O
is	O
inked	O
stapled	O
.	O

The	O
pleura	O
is	O
gray	O
and	O
remarkable	O
for	O
an	O
area	O
of	O
firm	O
yellow	O
discoloration	O
and	O
nodularity	O
.	O

The	O
staple	O
is	O
removed	O
,	O
the	O
margin	O
is	O
inked	O
and	O
shaved	O
.	O

Further	O
sectioning	O
reveals	O
a	O
yellow	O
chalky	O
firm	O
nodule	O
,	O
1	O
.	O
6	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
.	O
nodule	O
.	O

is	O
.	O

0	O
.	O
2	O
.	O
from	O
the	O
shave	O
staple	O
margin	O
and	O
less	O
than	O
0	O
.	O
1	O
cm	O
from	O
the	O
inked	O
pleura	O
.	O

The	O
uninvolved	O
tissue	O
is	O
brown	O
and	O
spongy	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
1	O
-	O
-	O
frozen	O
section	O
residue	O
;	O
2	O
and	O
3	O
-	O
-	O
shave	O
staple	O
margin	O
;	O
4	O
to	O
6	O
-	O
-	O
perpendicular	O
sections	O
through	O
lesic	O
.	O

7	O
-	O
-	O
uninvolved	O
tissue	O
.	O

Cassette	O
A	O
research	O
tissue	O
labeled	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
:	O

PATIENT	O
HISTORY	O
.	O

The	O
patient	O
is	O
a	O
.	O
vith	O
a	O
history	O
of	O
PSA	O
value	O
of	O
8	O
.	O
85	O
.	O

The	O
patient	O
also	O
has	O
a	O
history	O
of	O
biopsy	O
on	O
.	O
his	O
biopsy	O
reveals	O
:	O
poorly	O
-	O
differentiated	O
prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
4	O
+	O
3	O
=	O
7	O
in	O
the	O
left	O
apex	O
,	O
teit	O
.	O
base	O
,	O
right	O
rapex	O
,	O
right	O
mid	O
and	O
right	O
base	O
of	O
the	O
prostate	O
and	O
poorly	O
-	O
differentiated	O
prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
-	O
3	O
+	O
4	O
.	O

=	O
.	O

7	O
in	O
the	O
left	O
mid	O
of	O
the	O
prostate	O
.	O

The	O
patient	O
also	O
has	O
a	O
history	O
of	O
a	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Prostate	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Radical	O
prostatectomy	O
.	O

ADDENDA	O
:	O
Addendum	O
.	O

Specimen	O
labeled	O
"	O
right	O
pedicle	O
margin	O
"	O
has	O
been	O
evaluated	O
with	O
multiple	O
levels	O
and	O
PSA	O
,	O
racemase	O
,	O
CK903	O
and	O
p63	O
.	O
iimmunohistochemical	O
stains	O
.	O

The	O
immunohistochemical	O
stains	O
show	O
PSA	O
expression	O
in	O
the	O
glands	O
,	O
confirming	O
prostatic	O
origin	O
.	O

Immunohistochemical	O
.	O
stains	O
show	O
expression	O
of	O
racemase	O
in	O
these	O
glands	O
.	O

Presence	O
of	O
basal	O
cells	O
is	O
confirmed	O
by	O
CK903	O
and	O
p63	O
.	O
immunohistochemical	O
stains	O
.	O

This	O
immunohistochemical	O
profile	O
suggests	O
these	O
glands	O
represent	O
high	O
grade	O
prostatic	O
intraepithellal	O
neoplasia	O
.	O

No	O
.	O
evidence	O
of	O
invasive	O
carcinoma	O
is	O
seen	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

A	O
.	O

METASTATIC	O
CARCINOMA	O
IN	O
1	O
OF	O
13	O
LYMPH	O
NODES	O
(	O
1	O
/	O
13	O
)	O
.	O

B	O
.	O

EXTRANODAL	O
EXTENSION	O
IS	O
PRESENT	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

METASTATIC	O
CARCINOMA	O
IN	O
1	O
OF	O
8	O
LYMPH	O
NODES	O
(	O
1	O
/	O
8	O
)	O
.	O

PART	O
3	O
:	O
PROSTATE	O
AND	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
RADICAL	O
PROSTATECTOMY	O
.	O

A	O
.	O

PROSTATE	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
4	O
+	O
5	O
=	O
9	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
BOTH	O
THE	O
RIGHT	O
AND	O
LEFT	O
LOBES	O
AND	O
HAS	O
A	O
GREATEST	O
NODULAR	O
DIAMETER	O
OF	O
.	O

2	O
CM	O
IN	O
ONE	O
HISTOLOGIC	O
SECTION	O
(	O
SLIDE	O
3U	O
)	O
.	O

C	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
35	O
%	O
OF	O
THE	O
EXAMINED	O
PROSTATE	O
VOLUME	O
.	O

D	O
.	O

EXTENSIVE	O
EXTRAPROSTATIC	O
EXTENSION	O
IS	O
PRESENT	O
.	O

E	O
.	O

BILATERAL	O
SEMINAL	O
VESICLES	O
ARE	O
INVOLVED	O
BY	O
CARCINOMA	O
,	O
.	O

F	O
.	O

THE	O
INKED	O
MARGINS	O
OF	O
RESECTION	O
ARE	O
FREE	O
OF	O
CARCINOMA	O
.	O

G	O
.	O

EXTENSIVE	O
PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

HIGH	O
GRADE	O
PROSTATIC	O
INTRAEPITHELIAL	O
NEOPLASIA	O
IS	O
IDENTIFIED	O
.	O

1	O
.	O

PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT3b	O
N1	O
MX	O
.	O

J	O
.	O

BACKGROUND	O
PROSTATE	O
TISSUE	O
WITH	O
NODULAR	O
HYPERPLASIA	O
AND	O
CHRONIC	O
INFLAMMATION	O
.	O

PART	O
4	O
:	O
RIGHT	O
PEDICLE	O
MARGIN	O
,	O
BIOPSY	O
-	O
.	O

A	O
.	O

FIBROVASCULAR	O
TISSUE	O
,	O
WITH	O
PROMINENT	O
CRUSH	O
ARTIFACT	O
,	O
AND	O
FOCAL	O
ATYPICAL	O
AREAS	O
.	O

B	O
.	O

IMMUNOHISTOCHEMICAL	O
STAINS	O
PENDING	O
,	O
REPORT	O
TO	O
FOLLOW	O
IN	O
AN	O
ADDENDUM	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
PROSTATE	O
TUMORS	O
.	O

CLINICAL	O
DATA	O
:	O
PSA	O
value	O
:	O
8	O
.	O
85	O
.	O

INVASIVE	O
CA	O
IDENTIFIED	O
?	O
:	O
TUMOR	O
HISTOLOGY	O
:	O
Adenocarcinoma	O
NOS	O
.	O

PRIMARY	O
GLEASON	O
GRADE	O
;	O
.	O

4	O
.	O

SECONDARY	O
GLEASON	O
GRADE	O
:	O
5	O
.	O

GLEASON	O
SUM	O
SCORE	O
:	O
9	O
.	O

GLEASON	O
4	O
/	O
5	O
PERCENTAGE	O
:	O
95	O
%	O
.	O

WEIGHT	O
OF	O
PROSTATE	O
:	O
41	O
.	O
11gm	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
2	B
cm	I
.	O

LOBE	O
LATERALITY	O
:	O
Right	O
and	O
Left	O
Lobes	O
.	O

PERCENT	O
OF	O
SPECIMEN	O
INVOLVED	O
BY	O
TUMOR	O
:	O
>	O
25	O
%	O
.	O

MULTIFOCAL	O
DISEASE	O
:	O
HIGH	O
GRADE	O
PIN	O
:	O
Yes	O
multifocal	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
Yes	O
-	O
Established	O
(	O
>	O
0	O
.	O
8mm	O
)	O
.	O

PERINEURAL	O
INVASION	O
:	O
ANGIOLYMPHATIC	O
INVASION	O
:	O
Unknown	O
.	O

SEMINAL	O
VESICLE	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
All	O
surgical	O
margins	O
free	O
of	O
tumor	O
.	O

RESIDUAL	O
TUMOR	O
:	O
LYMPH	O
NODES	O
EXAMINED	O
:	O
21	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
2	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
SIZE	O
OF	O
NODAL	O
METASTASIS	O
:	O
1	O
.	O
5mm	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3b	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
-	O
4	O
,	O
Poorly	O
differentiated	O
/	O
undifferentiated	O
.	O

DATUAL	O
onv	O
REDORT	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

A	O
-	O
C	O
.	O

LEFT	O
TEMPORAL	O
LOBE	O
OF	O
BRAIN	O
,	O
TUMOR	O
,	O
EPIDURAL	O
TISSUE	O
,	O
AND	O
DURA	O
:	O
-	O
-	O
GLIOBLASTOMA	O
WITH	O
EXTENSIVE	O
SPINDLE	O
CELL	O
DIFFERENTIATION	O
(	O
"	O
GLIOSARCOMA	O
"	O
)	O
.	O

INVOLVING	O
LEPTOMENINGES	O
,	O
DURA	O
MATER	O
,	O
AND	O
SKULL	O
.	O

Note	O
:	O
Immunohistochemical	O
stains	O
were	O
used	O
in	O
the	O
assessment	O
of	O
this	O
malignancy	O
.	O

By	O
the	O
signature	O
on	O
this	O
report	O
,	O
the	O
individual	O
or	O
group	O
listed	O
as	O
making	O
the	O
Final	O
Interpretation	O
/	O
Diagnosis	O
certifies	O
that	O
they	O
.	O
have	O
reviewed	O
this	O
case	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

A	O
.	O

Touch	O
Imprint	O
:	O
Meningioma	O
,	O
at	O
least	O
Grade	O
2	O
.	O

B	O
.	O

Touch	O
Imprint	O
:	O
Meningioma	O
,	O
at	O
least	O
Grade	O
2	O
.	O

Addendum	O
/	O
Procedures	O
:	O
ANCILLARY	O
TESTING	O
.	O

Date	O
Complete	O
:	O
Results	O
-	O
Comments	O
.	O

One	O
or	O
more	O
of	O
the	O
reagents	O
used	O
to	O
perform	O
assays	O
on	O
this	O
specimen	O
MAY	O
have	O
contained	O
components	O
.	O
considered	O
to	O
be	O
analyte	O
specific	O
reagents	O
(	O
ASR	O
'	O
s	O
)	O
.	O

ASR	O
'	O
s	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O
Food	O
.	O
and	O
Drug	O
Administration	O
.	O

These	O
assays	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
.	O
the	O
The	O
assays	O
were	O
performed	O
with	O
appropriate	O
positive	O
and	O
negative	O
controls	O
.	O

Clinical	O
History	O
:	O
LEFT	O
BRAIN	O
TUMOR	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
TUMOR	O
AND	O
EPIDURAL	O
TISSUE	O
.	O

B	O
:	O
DURA	O
.	O

C	O
:	O
TUMIOR	O
CEREBRAL	O
.	O

Gross	O
Description	O
:	O
A	O
:	O
Received	O
fresh	O
,	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
and	O
.	O

"	O
tumor	O
and	O
epidural	O
tissue	O
"	O
,	O
are	O
multiple	O
irregularly	O
-	O
shaped	O
fragments	O
of	O
tan	O
-	O
white	O
and	O
hemorrhagic	O
.	O
portions	O
of	O
membranous	O
and	O
rubbery	O
tissue	O
,	O
1	O
.	O
8	O
X	O
0	O
.	O
8	O
X	O
0	O
.	O
3	O
cm	O
in	O
aggregate	O
.	O

A	O
portion	O
of	O
the	O
.	O
fragments	O
are	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
in	O
two	O
cassettes	O
.	O

B	O
:	O
Received	O
fresh	O
,	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
and	O
.	O

"	O
dura	O
"	O
,	O
is	O
a	O
4	O
.	O
8	O
x	O
3	O
.	O
2	O
X	O
0	O
.	O
1	O
cm	O
tan	O
-	O
white	O
,	O
membranous	O
fragment	O
of	O
tissue	O
.	O

The	O
specimen	O
is	O
serially	O
.	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
three	O
cassettes	O
.	O

C	O
:	O
Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
number	O
,	O
are	O
multiple	O
irregular	O
,	O
opaque	O
.	O
white	O
to	O
pink	O
-	O
tan	O
,	O
soft	O
cerebriform	O
tissue	O
fragments	O
measuring	O
in	O
aggregate	O
4	O
.	O
0	O
X	O
3	O
.	O
0	O
:	O
X	O
1	O
.	O
1	O
cm	O
.	O

Submitted	O
entirely	O
in	O
three	O
cassettes	O
.	O

Summary	O
of	O
Cassettes	O
:	O
Specimen	O
.	O

Label	O
.	O

Site	O
.	O

A	O
.	O

1	O
.	O
frozen	O
section	O
.	O

2	O
.	O
remainder	O
of	O
the	O
specimen	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

10	O
.	O

REPORT	O
DATE	O
:	O
SEX	O
:	O
M	O
.	O

ADM	O
DATE	O
:	O
BIRTHDATE	O
:	O
OPER	O
DATE	O
:	O
PROCEDURE	O
:	O
SPHS	O
.	O

Liver	O
cancer	O
.	O

Operative	O
Procedure	O
/	O
Tissue	O
Submitted	O
:	O
Laparoscopic	O
assisted	O
.	O
liver	O
resection	O
.	O

PROCEDURE	O
:	O
SPGD	O
.	O

1	O
.	O

"	O
Gallbladder	O
.	O
"	O
Received	O
in	O
formalin	O
in	O
a	O
medium	O
container	O
is	O
a	O
previously	O
.	O
disrupted	O
11	O
.	O
8	O
x	O
4	O
.	O
6	O
x	O
1	O
.	O
6	O
cm	O
gallbladder	O
with	O
focally	O
adhesed	O
serosa	O
.	O

The	O
.	O

Lumen	O
is	O
devoid	O
of	O
content	O
.	O

The	O
mucosa	O
is	O
red	O
-	O
tan	O
,	O
velvety	O
with	O
a	O
0	O
.	O
2	O
cm	O
.	O
average	O
wall	O
thickness	O
.	O

The	O
cystic	O
duct	O
is	O
patent	O
and	O
there	O
are	O
no	O
separate	O
.	O
stones	O
in	O
the	O
container	O
.	O

1A	O
.	O

Gallbladder	O
.	O

2	O
.	O

"	O
Segment	O
5	O
-	O
6	O
liver	O
resection	O
,	O
gross	O
margins	O
.	O
"	O
A	O
5	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
4	O
.	O
8	O
cm	O
,	O
65	O
gm	O
.	O
resection	O
of	O
liver	O
with	O
nodular	O
capsular	O
surface	O
.	O

The	O
margin	O
is	O
inked	O
black	O
.	O

A	O
.	O

2	O
.	O
1	O
cm	O
nodule	O
is	O
1	O
.	O
9	O
cm	O
from	O
the	O
margin	O
.	O

The	O
nodular	O
mass	O
comes	O
to	O
within	O
0	O
.	O
1	O
.	O

cm	O
of	O
the	O
capsule	O
.	O

The	O
remaining	O
parenchyma	O
has	O
multiple	O
nodules	O
that	O
average	O
.	O

0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
diffuse	O
nodular	O
parenchyma	O
is	O
focally	O
.	O
fibrous	O
.	O

2A	O
-	O
D	O
.	O

Mass	O
with	O
nodular	O
parenchyma	O
and	O
surgical	O
margin	O
.	O

INTRAOPERATIVE	O
GROSS	O
:	O
PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATE	O
:	O
11	O
.	O

SEX	O
:	O
M	O
.	O

BIRTHDATE	O
:	O
ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
2	O
.	O

A	O
2	O
.	O
1	O
cm	O
nodule	O
is	O
1	O
.	O
9	O
cm	O
from	O
margin	O
.	O

PROCEDURE	O
:	O
SPMI	O
.	O

LIVER	O
:	O
HEPATOCELLULAR	O
CARCINOMA	O
.	O

WAS	O
THE	O
TUMOR	O
PREVIOUSLY	O
TREATED	O
?	O
:	O
No	O
.	O

TUMOR	O
TYPE	O
:	O
Ordinary	O
.	O

SINGLE	O
OR	O
MULTIPLE	O
MASSES	O
:	O
Single	O
.	O

MAXIMUM	O
DIAMETER	O
OF	O
LARGEST	O
MASS	O
:	O
2	O
.	O
1	O
cm	O
.	O

ARE	O
THE	O
MARGINS	O
OF	O
RESECTION	O
FREE	O
OF	O
TUMOR	O
?	O
:	O
Yes	O
.	O

VASCULAR	O
INVASION	O
?	O
:	O
No	O
.	O

INVASION	O
THROUGH	O
THE	O
CAPSULE	O
TO	O
THE	O
SEROSAL	O
SURFACE	O
?	O
:	O
No	O
.	O

LYMPH	O
NODE	O
METASTASES	O
?	O
:	O
Unknown	O
.	O

DISTANT	O
METASTASES	O
?	O
:	O
Unknown	O
.	O

IS	O
THE	O
LIVER	O
CIRRHOTIC	O
?	O
:	O
Yes	O
,	O
cryptogenic	O
.	O

pT1	O
NX	O
.	O

PROCEDURE	O
:	O
SPDX	O
.	O

1	O
.	O

Gallbladder	O
,	O
resection	O
:	O
No	O
significant	O
abnormality	O
.	O

2	O
.	O

Liver	O
,	O
segments	O
5	O
and	O
6	O
,	O
resection	O
:	O
Well	O
-	O
differentiated	O
hepatocellular	O
.	O
carcinoma	O
(	O
2	O
.	O
1cm	O
)	O
.	O

Margins	O
negative	O
.	O

Cryptogenic	O
cirrhosis	O
.	O

Please	O
see	O
.	O

TEMPLATE	O
for	O
details	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
,	O
CONVENTIONAL	O
TYPE	O
.	O

Location	O
:	O
Right	O
lobe	O
.	O

Multi	O
-	O
focal	O
:	O
No	O
.	O

Size	O
=	O
3	B
.	I
6	I
cm	I
.	O

Extrathyroidal	O
extension	O
:	O
Absent	O
.	O

Lymphovascular	O
invasion	O
:	O
Absent	O
.	O

Resection	O
Margins	O
:	O
Negative	O
.	O

Background	O
Thyroid	O
:	O
mild	O
chronic	O
lymphocytic	O
thyroiditis	O
.	O

Lymph	O
nodes	O
:	O
No	O
tumor	O
present	O
in	O
1	O
lymph	O
node	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
,	O
DOMINANT	O
NODULE	O
ON	O
RIGHT	O
-	O
an	O
asymmetric	O
thyroid	O
with	O
right	O
lobe	O
distended	O
(	O
4	O
.	O
0	O
x	O
3	O
.	O
1	O
.	O
x	O
.	O
2	O
.	O
0	O
.	O
cm	O
)	O
,	O
isthmus	O
(	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
0	O
.	O
3	O
cm	O
)	O
and	O
left	O
lobe	O
(	O
4	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
)	O
with	O
smooth	O
surface	O
overlying	O
the	O
entire	O
gland	O
.	O

The	O
right	O
lobe	O
is	O
replaced	O
by	O
a	O
pink	O
-	O
tan	O
nodule	O
filling	O
the	O
lobe	O
(	O
3	O
.	O
6	O
x	O
2	O
.	O
8	O
x	O
2	O
.	O
0	O
,	O
with	O
scant	O
rim	O
of	O
normal	O
parenchyma	O
.	O
grossly	O
identified	O
.	O

The	O
isthmus	O
and	O
left	O
lobes	O
are	O
unremarkable	O
without	O
extension	O
of	O
the	O
mass	O
into	O
this	O
region	O
.	O

SECTION	O
CODE	O
:	O
A1	O
-	O
3	O
,	O
Left	O
lobe	O
representative	O
superior	O
to	O
inferior	O
;	O
A4	O
-	O
5	O
,	O
isthmus	O
;	O
A6	O
-	O
A16	O
Right	O
lobe	O
from	O
superior	O
.	O
to	O
inferior	O
with	O
mass	O
.	O

CLINICAL	O
HISTORY	O
.	O

Papillary	O
thyroid	O
carcinoma	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
B6000	O
,	O
M	O
-	O
80503	O
,	O
M	O
-	O
B0630	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
specifically	O
cleared	O
or	O
.	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
i	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Kidney	O
,	O
right	O
,	O
tumor	O
#	O
1	O
,	O
excision	O
:	O
Renal	O
cell	O
carcinoma	O
with	O
features	O
of	O
papillary	O
RCC	O
type	O
1	O
with	O
solid	O
and	O
.	O
clear	O
cell	O
areas	O
;	O
see	O
note	O
.	O

2	O
.	O

Kidney	O
,	O
right	O
,	O
tumor	O
#	O
2	O
,	O
excision	O
:	O
Multiple	O
foci	O
of	O
renal	O
cell	O
carcinoma	O
with	O
features	O
of	O
papillary	O
RCC	O
type	O
1	O
with	O
.	O
solid	O
areas	O
;	O
see	O
note	O
.	O

NOTE	O
:	O
The	O
case	O
will	O
be	O
discussed	O
with	O
.	O
and	O
a	O
supplemental	O
report	O
will	O
follow	O
,	O
if	O
indicated	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Brief	O
Clinical	O
History	O
:	O
with	O
HPRC	O
and	O
right	O
renal	O
mass	O
.	O

Specimen	O
Taken	O
For	O
Protocol	O
:	O
01	O
-	O
Yes	O
Allocate	O
Order	O
to	O
Protocol	O
:	O
PROCEDURE	O
:	O
Operative	O
Findings	O
:	O
two	O
right	O
renal	O
masses	O
Post	O
-	O
Operative	O
Diagnosis	O
:	O
renal	O
mass	O
Pre	O
-	O
Operative	O
Diagnosis	O
:	O
renal	O
mass	O
.	O

SPECIMENS	O
SUBMITTED	O
:	O
1	O
.	O

TUMOR	O
,	O
#	O
1	O
.	O

2	O
.	O

TUMOR	O
,	O
#	O
2	O
Right	O
Kidney	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
for	O
procurement	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
.	O
further	O
described	O
as	O
follows	O
are	O
:	O
1	O
.	O

"	O
Tumor	O
#	O
1	O
"	O
is	O
a	O
1	B
.	I

1	B
X	I
1	I
.	I
1	I
x	I
1	I
cm	I
white	O
soft	O
tissue	O
fragment	O
.	O

The	O
cut	O
surface	O
is	O
tan	O
homogeneous	O
.	O

60	O
%	O
is	O
.	O
procured	O
for	O
the	O
.	O

a	O
0	O
.	O
1	O
CC	O
amount	O
is	O
procured	O
for	O
electron	O
microscopy	O
,	O
and	O
the	O
remainder	O
is	O
sent	O
to	O
Surgical	O
.	O

Pathology	O
.	O

At	O
Surgical	O
Pathology	O
,	O
the	O
specimen	O
is	O
received	O
and	O
matches	O
the	O
above	O
description	O
.	O

It	O
is	O
serially	O
.	O
sectioned	O
and	O
entirely	O
submitted	O
in	O
cassette	O
.	O
for	O
permanent	O
processing	O
.	O

2	O
.	O

"	O
Tumor	O
#	O
2	O
right	O
kidney	O
"	O
is	O
a	O
2	B
.	I
5	I
X	I
2	I
.	I
2	I
X	I
2	I
cm	I
soft	O
tissue	O
fragment	O
with	O
a	O
white	O
/	O
tan	O
,	O
variegated	O
cut	O
surface	O
.	O

Attached	O
normal	O
parenchyma	O
is	O
seen	O
.	O

35	O
%	O
is	O
procured	O
the	O
.	O

a	O
0	O
.	O
1	O
CC	O
fragment	O
is	O
sent	O
for	O
electron	O
.	O
microscopy	O
,	O
and	O
the	O
remainder	O
is	O
sent	O
to	O
.	O

At	O
.	O
the	O
specimen	O
is	O
received	O
.	O
and	O
matches	O
the	O
above	O
description	O
and	O
is	O
entirely	O
submitted	O
in	O
cassette	O
.	O
for	O
permanent	O
.	O
processing	O
.	O

The	O
above	O
procurement	O
was	O
performed	O
by	O
.	O

on	O
.	O

No	O
consultants	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
RIGHT	O
URETER	O
,	O
DISTAL	O
,	O
SHAVE	O
MARGIN	O
,	O
BIOPSY	O
-	O
.	O

A	O
.	O

BENIGN	O
URETER	O
.	O

B	O
.	O

NEGATIVE	O
FOR	O
NEOPLASIA	O
.	O

PART	O
2	O
:	O
LEFT	O
,	O
URETER	O
,	O
DISTAL	O
,	O
SHAVE	O
MARGIN	O
,	O
BIOPSY	O
-	O
.	O

A	O
.	O

BENIGN	O
URETER	O
.	O

B	O
.	O

NEGATIVE	O
FOR	O
NEOPLASIA	O
.	O

PART	O
3	O
:	O
URINARY	O
BLADDER	O
,	O
DISTAL	O
URETERS	O
,	O
PROSTATE	O
,	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
AND	O
BILATERAL	O
DISTAL	O
.	O

VASA	O
DEFERENTIA	O
,	O
RADICAL	O
CYSTOPROSTATECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
UROTHELIAL	O
CARCINOMA	O
,	O
HIGH	O
-	O
GRADE	O
(	O
2004	O
WHO	O
/	O
ISUP	O
)	O
(	O
SLIDES	O
3E	O
,	O
3F	O
,	O
3L	O
,	O
3R	O
,	O
3S	O
,	O
3T	O
,	O
3U	O
,	O
3V	O
)	O
,	O
.	O

ASSOCIATED	O
WITH	O
FOCAL	O
HIGH	O
-	O
GRADE	O
PAPILLARY	O
UROTHELIAL	O
CARCINOMA	O
(	O
SLIDES	O
3H	O
,	O
30	O
,	O
3S	O
)	O
.	O

TUMOR	O
.	O

MEASURES	O
3	B
.	I
5	I
x	I
1	I
.	I
5	I
x	I
0	I
.	I
4	I
CM	I
,	O
AND	O
IS	O
PRESENT	O
IN	O
THE	O
LEFT	O
LATERAL	O
WALL	O
AND	O
TRIGONE	O
.	O

CARCINOMA	O
.	O

INFILTRATES	O
INTO	O
THE	O
SUPERFICIAL	O
DETRUSOR	O
MUSCLE	O
(	O
INNER	O
HALF	O
)	O
.	O

B	O
.	O

UROTHELIAL	O
DYSPLASIA	O
THROUGH	O
CARCINOMA	O
IN	O
SITU	O
IS	O
PRESENT	O
IN	O
THE	O
RIGHT	O
URETERAL	O
OSTIUM	O
.	O

(	O
SLIDE	O
3G	O
)	O
,	O
LEFT	O
URETERAL	O
OSTIUM	O
(	O
SLIDE	O
3H	O
)	O
,	O
AND	O
ANTERIOR	O
WALL	O
/	O
DOME	O
(	O
SLIDE	O
3N	O
)	O
.	O

C	O
.	O

NO	O
DEFINITIVE	O
ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
(	O
SLIDE	O
3E	O
)	O
.	O

D	O
.	O

ALL	O
EXAMINED	O
SURGICAL	O
RESECTION	O
MARGINS	O
ARE	O
FREE	O
OF	O
UROTHELIAL	O
NEOPLASIA	O
.	O

E	O
.	O

TNM	O
PATHOLOGIC	O
STAGE	O
:	O
pT2a	O
NO	O
MX	O
(	O
SEE	O
SYNOPTIC	O
)	O
.	O

F	O
.	O

BACKGROUND	O
BLADDER	O
WITH	O
GRANULOMATOUS	O
INFLAMMATION	O
(	O
HISTORY	O
OF	O
BCG	O
THERAPY	O
)	O
AND	O
.	O

BIOPSY	O
SITE	O
CHANGES	O
.	O

G	O
.	O

BENIGN	O
PROSTATE	O
WITH	O
MULTIFOCAL	O
NECROTIZING	O
GRANULOMAS	O
(	O
HISTORY	O
OF	O
BCG	O
THERAPY	O
)	O
,	O
.	O

NODULAR	O
HYPERPLASIA	O
,	O
FOCAL	O
GLANDULAR	O
ATROPHY	O
,	O
AND	O
CHRONIC	O
INFLAMMATION	O
.	O

H	O
.	O

BENIGN	O
BILATERAL	O
SEMINAL	O
VESICLES	O
.	O

PART	O
4	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
EXCISION	O
.	O

A	O
.	O

NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
SEVENTEEN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
17	O
)	O
.	O

B	O
.	O

ONE	O
LYMPH	O
NODE	O
WITH	O
FEW	O
NON	O
-	O
NECROTIZING	O
GRANULOMAS	O
(	O
SLIDE	O
4B	O
)	O
.	O

PART	O
5	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
.	O

A	O
.	O

NO	O
EVIDENCE	O
OF	O
NEOPLASIA	O
IN	O
SIX	O
LYMPH	O
NODES	O
(	O
0	O
/	O
6	O
)	O
.	O

B	O
.	O

ONE	O
LYMPH	O
NODE	O
WITH	O
A	O
SMALL	O
NON	O
-	O
NECROTIZING	O
GRANULOMA	O
(	O
SLIDE	O
4K	O
)	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
.	O

PRIMARY	O
URINARY	O
BLADDER	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Radical	O
cystoprostatectomy	O
.	O

TUMOR	O
SITE	O
:	O
Trigone	O
,	O
Left	O
lateral	O
wall	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
1	B
.	I
5	I
x	I
0	I
.	I
4	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
:	O
Urothelial	O
(	O
transitional	O
cell	O
)	O
carcinoma	O
.	O

ASSOCIATED	O
EPITHELIAL	O
LESIONS	O
:	O
None	O
identified	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Urothelial	O
carcinoma	O
-	O
High	O
-	O
grade	O
.	O

TUMOR	O
CONFIGURATION	O
:	O
Papillary	O
,	O
Flat	O
,	O
Ulcerated	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
pT2a	O
.	O

pNO	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
23	O
.	O

Number	O
of	O
nodes	O
involved	O
:	O
o	O
.	O

pMX	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Margin	O
(	O
s	O
)	O
uninvolved	O
by	O
carcinoma	O
in	O
situ	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
(	O
LARGE	O
/	O
SMALL	O
)	O
VESSEL	O
INVASION	O
(	O
V	O
/	O
L	O
)	O
:	O
Absent	O
.	O

DIRECT	O
EXTENSION	O
OF	O
INVASIVE	O
TUMOR	O
:	O
None	O
identified	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Urothelial	O
carcinoma	O
in	O
situ	O
.	O

Therapy	O
-	O
related	O
changes	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
with	O
a	O
chest	O
wall	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Radical	O
resection	O
of	O
right	O
chest	O
wall	O
mass	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Soft	O
tissue	O
,	O
right	O
chest	O
wall	O
,	O
mass	O
;	O
radical	O
resection	O
:	O
-	O
Myxofibrosarcoma	O
,	O
high	O
grade	O
.	O

-	O
Tumor	O
measures	O
6	B
cm	I
in	O
greatest	O
dimension	O
.	O

-	O
Tumor	O
involves	O
deep	O
soft	O
tissue	O
and	O
skeletal	O
muscle	O
.	O

-	O
Mitoses	O
12	O
/	O
10	O
high	O
power	O
fields	O
.	O

-	O
Surgical	O
resection	O
margins	O
are	O
free	O
of	O
tumor	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Report	O
kiectronically	O
signed	O
Out	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
.	O
radical	O
resection	O
of	O
right	O
.	O
chest	O
wall	O
mass	O
Short	O
stitch	O
superior	O
margin	O
,	O
long	O
stitchlateral	O
.	O

.	O
and	O
it	O
.	O
consists	O
of	O
a	O
oriented	O
tissue	O
associated	O
with	O
skin	O
ellipse	O
(	O
11	O
.	O
5	O
x2	O
cm	O
)	O
and	O
.	O
skeletal	O
muscle	O
measuring	O
13	O
cm	O
from	O
medial	O
to	O
lateral	O
,	O
9	O
.	O
5	O
cm	O
from	O
.	O
superficial	O
to	O
deep	O
,	O
6	O
cm	O
from	O
superior	O
to	O
inferior	O
.	O

Ink	O
is	O
placed	O
as	O
:	O
deepblack	O
,	O
.	O
superiorblue	O
,	O
inferiorgreen	O
,	O
medial	O
red	O
,	O
lateral	O
yellow	O
.	O

Sectioning	O
along	O
deep	O
to	O
superficial	O
axis	O
reveals	O
a	O
6	O
x	O
5	O
.	O
8	O
x	O
5	O
.	O
4	O
cm	O
well	O
.	O
defined	O
intra	O
-	O
muscular	O
mass	O
.	O

It	O
is	O
3	O
cm	O
from	O
the	O
skin	O
,	O
0	O
.	O
5	O
cm	O
from	O
the	O
deep	O
,	O
.	O

0	O
.	O
4	O
cm	O
from	O
the	O
lateral	O
,	O
2	O
cm	O
from	O
the	O
medial	O
1	O
.	O
5	O
cm	O
from	O
the	O
superior	O
,	O
1	O
.	O
5	O
.	O

cm	O
from	O
inferior	O
.	O

The	O
cut	O
surface	O
is	O
white	O
and	O
homogenous	O
,	O
gelatinous	O
.	O
appearance	O
is	O
appreciated	O
.	O

A	O
small	O
portion	O
of	O
the	O
mass	O
is	O
submitted	O
for	O
.	O

TPS	O
,	O
gross	O
photos	O
were	O
taken	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
SXMtumor	O
and	O
superior	O
margin	O
.	O

IXMtumor	O
and	O
inferior	O
margin	O
.	O

MXMtumor	O
and	O
medial	O
margin	O
.	O

LXMtumor	O
and	O
lateral	O
margin	O
.	O

DXMtumor	O
and	O
deep	O
margin	O
.	O

-	O
-	O
-	O
tumor	O
.	O

SKakin	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Radical	O
resection	O
of	O
right	O
chest	O
wall	O
mass	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

DXM	O
.	O

3	O
.	O

2	O
.	O

IXM	O
.	O

3	O
.	O

2	O
.	O

LXM	O
.	O

3	O
.	O

2	O
.	O

MXM	O
.	O

3	O
.	O

2	O
.	O

SK	O
.	O

3	O
.	O

2	O
.	O

SXM	O
.	O

3	O
.	O

6	O
.	O

7	O
.	O
icirciel	O
:	O
me	O
.	O

Operative	O
Procedure	O
:	O
Right	O
thigh	O
soft	O
tissue	O
sarcoma	O
excision	O
.	O

Right	O
thigh	O
sarcoma	O
;	O
stitch	O
is	O
distal	O
.	O

Final	O
Pathologic	O
Diagnosis	O
:	O
Soft	O
tissue	O
,	O
right	O
thigh	O
,	O
resection	O
:	O
Pleomorphic	O
undifferentiated	O
sarcoma	O
(	O
8	B
.	I
5	I
cm	I
in	O
greatest	O
dimension	O
)	O
.	O

See	O
Synoptic	O
Report	O
and	O
Note	O
below	O
.	O

Synoptic	O
Report	O
.	O

Procedure	O
:	O
Resection	O
.	O

Tumor	O
site	O
:	O
Right	O
thigh	O
.	O

Tumor	O
size	O
:	O
8	B
.	I
5	I
cm	I
(	O
greatest	O
dimension	O
)	O
.	O

Macroscopic	O
extent	O
of	O
tumor	O
:	O
Intramuscular	O
.	O

Histologic	O
type	O
:	O
Undifferentiated	O
pleomorphic	O
sarcoma	O
.	O

Mitotic	O
rate	O
:	O
5	O
/	O
10	O
high	O
-	O
power	O
fields	O
(	O
HPF	O
)	O
.	O

Necrosis	O
:	O
Not	O
identified	O
.	O

Histologic	O
grade	O
:	O
High	O
grade	O
.	O

Margins	O
:	O
Sarcoma	O
extends	O
to	O
peripheral	O
margin	O
.	O

Pathologic	O
staging	O
(	O
pTNM	O
)	O
.	O

TNM	O
descriptors	O
:	O
None	O
known	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2b	O
:	O
Tumor	O
more	O
than	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
,	O
deep	O
tumor	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
pNx	O
Cannot	O
be	O
assessed	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
pMx	O
Cannot	O
be	O
assessed	O
.	O

Additional	O
pathologic	O
findings	O
:	O
None	O
.	O

Ancillary	O
studies	O
.	O

Immunohistochemistry	O
:	O
Not	O
performed	O
.	O

Cytogenetics	O
:	O
Not	O
performed	O
.	O

Molecular	O
Pathology	O
:	O
Not	O
performed	O
.	O

Preresection	O
treatment	O
:	O
No	O
known	O
therapy	O
.	O

Treatment	O
effect	O
:	O
Not	O
applicable	O
.	O

The	O
examination	O
of	O
this	O
case	O
material	O
and	O
the	O
preparation	O
of	O
this	O
report	O
were	O
.	O

Gross	O
Description	O
:	O
The	O
specimen	O
is	O
received	O
in	O
a	O
single	O
formalin	O
filled	O
container	O
labeled	O
with	O
the	O
.	O
patient	O
name	O
and	O
"	O
right	O
thigh	O
sarcoma	O
,	O
stitch	O
is	O
distal	O
"	O
and	O
.	O
consists	O
of	O
a	O
portion	O
of	O
ovoid	O
fibromuscular	O
soft	O
tissue	O
that	O
is	O
14	O
.	O
8	O
x	O
11	O
.	O
0	O
x	O
.	O

6	O
.	O
0	O
cm	O
.	O

There	O
is	O
a	O
black	O
stitch	O
marking	O
the	O
distal	O
aspect	O
.	O

This	O
will	O
be	O
.	O
designated	O
as	O
6	O
o	O
'	O
clock	O
.	O

The	O
specimen	O
has	O
been	O
previously	O
incised	O
one	O
peripheral	O
.	O
aspect	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
the	O
previously	O
incised	O
peripheral	O
.	O
aspect	O
is	O
inked	O
black	O
and	O
the	O
opposite	O
peripheral	O
aspect	O
in	O
blue	O
.	O

Sectioning	O
.	O
reveals	O
a	O
white	O
-	O
tan	O
somewhat	O
soft	O
mass	O
that	O
is	O
8	O
.	O
5	O
x	O
6	O
.	O
0	O
x	O
4	O
.	O
5	O
cm	O
.	O

This	O
lesion	O
.	O
measures	O
4	O
cm	O
from	O
the	O
distal	O
aspect	O
and	O
4	O
.	O
5	O
cm	O
from	O
the	O
proximal	O
aspect	O
.	O

The	O
.	O
mass	O
does	O
not	O
appear	O
to	O
be	O
encapsulated	O
;	O
however	O
the	O
previously	O
incised	O
aspect	O
.	O
of	O
the	O
specimen	O
has	O
an	O
overlying	O
fibrous	O
band	O
which	O
does	O
not	O
appear	O
to	O
be	O
.	O
penetrated	O
by	O
the	O
tumor	O
.	O

Otherwise	O
,	O
the	O
lesion	O
does	O
abut	O
the	O
fibrous	O
band	O
.	O

The	O
.	O
lesion	O
is	O
approximately	O
1	O
cm	O
from	O
the	O
nearest	O
not	O
previously	O
incised	O
peripheral	O
.	O
aspect	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
1	O
.	O
distal	O
tip	O
;	O
.	O

2	O
.	O
proximal	O
tip	O
;	O
.	O

3	O
-	O
10	O
representative	O
sections	O
of	O
mass	O
to	O
include	O
the	O
black	O
inked	O
surface	O
.	O
and	O
blue	O
inked	O
surface	O
.	O

Microscopic	O
Description	O
:	O
The	O
final	O
diagnosis	O
of	O
each	O
specimen	O
incorporates	O
the	O
microscopic	O
examination	O
.	O
findings	O
.	O

Gender	O
:	O
F	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
:	O
RIGHT	O
PELVIC	O
PERITONEUM	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
2	O
:	O
RIGHT	O
PERICOLIC	O
TISSUE	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

PART	O
3	O
:	O
LEFT	O
PERICOLIC	O
GUTTER	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
4	O
:	O
PELVIC	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
5	O
:	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
,	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

OVARY	O
WITH	O
HIGH	O
-	O
GRADE	O
SEROUS	O
CARCINOMA	O
(	O
7	B
CM	I
)	O
INVOLVING	O
FIMBRIATED	O
SEGMENT	O
OF	O
.	O

FALLOPIAN	O
TUBE	O
.	O

B	O
.	O

OVARIAN	O
SURFACE	O
INVOLVED	O
BY	O
TUMOR	O
.	O

C	O
.	O

LYMPHOVASCULAR	O
INVASI	O
	O
N	O
IS	O
IDENTIFIED	O
.	O

D	O
.	O

UNINVOLVED	O
FALLOPIAN	O
TUBE	O
,	O
HISTOLOGICALLY	O
UNREMARKABLE	O
.	O

E	O
.	O

RECEPTOR	O
STUDIES	O
:	O
ER	O
-	O
POSITIVE	O
,	O
PR	O
-	O
NEGATIVE	O
.	O

F	O
.	O

PELVIC	O
WASH	O
AND	O
DIAPHRAGMATIC	O
SCRAPINGS	O
ARE	O
NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
COMMENT	O
)	O
.	O

G	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
T2a	O
NO	O
Mx	O
.	O

H	O
.	O

FIGO	O
:	O
II	O
A	O
.	O

PART	O
6	O
:	O
POST	O
PERITONEUM	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

PART	O
7	O
:	O
UTERUS	O
WITH	O
RIGHT	O
OVARY	O
AND	O
RIGHT	O
FALLOPIAN	O
TUBE	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
AND	O
.	O

RIGHT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

ENDOMETRIAL	O
POLYP	O
.	O

B	O
.	O

INACTIVE	O
ENDOMETRIUM	O
.	O

C	O
.	O

CERVIX	O
WITH	O
SQUAMOUS	O
METAPLASIA	O
.	O

D	O
.	O

RIGHT	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
,	O
HISTOLOGICALLY	O
UNREMARKABLE	O
.	O

PART	O
8	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
BIOPSY	O
-	O
.	O

FIVE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
5	O
)	O
.	O

PART	O
9	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
BIOPSY	O
-	O
.	O

FIVE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
5	O
)	O
.	O

PART	O
10	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PERIAORTIC	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
11	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PERIAORTIC	O
,	O
BIOPSY	O
-	O
.	O

TWO	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
T	O
METASTATIC	O
UMOR	O
(	O
0	O
/	O
2	O
)	O
.	O

PART	O
12	O
:	O
OMENTUM	O
,	O
BIOPSY	O
-	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
(	O
SEE	O
COMMENT	O
)	O
.	O

MICROSCOPIC	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
OVARIAN	O
TUMORS	O
INCLUDING	O
BORDERLINE	O
TUMORS	O
.	O

TUMOR	O
LOCATION	O
:	O
Left	O
.	O

PROCEDURE	O
:	O
TAH	O
with	O
salpingo	O
-	O
oophorectomy	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
7	B
cm	I
.	O

TUMOR	O
TYPE	O
:	O
Papillary	O
serous	O
carcinoma	O
.	O

HISTOLOGIC	O
SILVERBERG	O
GRADE	O
:	O
Poorly	O
differentiated	O
(	O
8	O
-	O
9	O
pts	O
)	O
.	O

ARCHITECTURAL	O
PATTERN	O
:	O
Solid	O
(	O
3	O
)	O
.	O

CYTOLOGIC	O
ATYPIA	O
:	O
Marked	O
(	O
3	O
)	O
.	O

MITOTIC	O
COUNTS	O
/	O
10hpf	O
:	O
>	O
or	O
=	O
25	O
(	O
3	O
)	O
.	O

VASCULAR	O
INVASION	O
:	O
TUMOR	O
CAPSULE	O
:	O
Ruptured	O
.	O

SURFACE	O
IMPLANTS	O
:	O
Not	O
present	O
.	O

MALIGNANT	O
CELLS	O
IN	O
ASCITES	O
OR	O
.	O

PERITONEAL	O
WASHING	O
:	O
LYMPH	O
NODES	O
EXAMINED	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
:	O
13	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT2a	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
PATHOL	O
nair	O
.	O

nMV	O
.	O

Diagnosis	O
:	O
1	O
.	O
and	O
2	O
.	O

Bifocal	O
poorly	O
differentiated	O
invasive	O
ductal	O
carcinoma	O
(	O
tumor	O
diameters	O
:	O
2	B
.	I
8	I
and	O
.	O
0	B
.	I
8	I
cm	I
)	O
.	O

Concluding	O
tumor	O
classification	O
:	O
NOS	O
,	O
G	O
III	O
,	O
pT2	O
(	O
mult	O
)	O
NOLOVORO	O
.	O

Pathology	O
.	O
port	O
.	O

Pathology	O
,	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
(	O
4	B
.	I
5	I
CM	I
)	O
.	O

TUMOR	O
CONFINED	O
WITHIN	O
THYROID	O
TISSUE	O
.	O

No	O
extracapsular	O
extension	O
identified	O
.	O

Unremarkable	O
parathyroid	O
tissue	O
,	O
no	O
tumor	O
present	O
.	O

One	O
lymph	O
node	O
,	O
no	O
tumor	O
present	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
-	O
A	O
total	O
thyroidectomy	O
with	O
overall	O
measurements	O
,	O
8	O
.	O
0	O
x	O
5	O
.	O
0	O
x	O
3	O
.	O
5	O
cm	O
.	O

The	O
right	O
lobe	O
appears	O
.	O
unremarkable	O
and	O
measures	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
and	O
mostly	O
appears	O
fibrotic	O
.	O

The	O
left	O
lobe	O
measures	O
6	O
.	O
0	O
X	O
5	O
.	O
0	O
X	O
3	O
.	O
5	O
cm	O
and	O
.	O
contains	O
well	O
-	O
defined	O
friable	O
light	O
tan	O
and	O
soft	O
mass	O
measuring	O
4	O
.	O
5	O
x	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

The	O
tumor	O
abuts	O
the	O
external	O
surface	O
and	O
the	O
.	O
capsule	O
of	O
the	O
lobe	O
.	O

No	O
gross	O
involvement	O
of	O
the	O
surgical	O
margin	O
,	O
but	O
tumor	O
is	O
noted	O
.	O

The	O
tumor	O
also	O
appears	O
friable	O
and	O
.	O
papillary	O
in	O
nature	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
in	O
A1	O
-	O
A5	O
,	O
sequential	O
sectioning	O
of	O
the	O
right	O
lobe	O
from	O
superior	O
to	O
inferior	O
;	O
.	O

A5	O
,	O
A6	O
,	O
isthmus	O
;	O
A8	O
-	O
A22	O
,	O
sequential	O
sectioning	O
of	O
the	O
left	O
lobe	O
from	O
superior	O
inferior	O
including	O
tumor	O
and	O
adjacent	O
soft	O
.	O
tissue	O
.	O

CLINICAL	O
HISTORY	O
.	O

History	O
of	O
papillary	O
thyroid	O
cancer	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
B6000	O
,	O
M	O
-	O
80503	O
.	O

Released	O
by	O
:	O

Identifier	O
:	O
Tumor	O
Type	O
:	O
Thymoma	O
.	O

Pathology	O
Report	O
-	O
Summary	O
:	O
Material	O
:	O
tumor	O
:	O
8	B
.	I
0	I
X	I
8	I
.	I
0	I
X	I
3	I
.	I
0	I
cm	I
.	O
focal	O
invasion	O
through	O
capsule	O
.	O

Diagnosis	O
:	O
Type	O
A	O
-	O
Thymoma	O
(	O
with	O
focal	O
TypeA	O
/	O
B	O
)	O
.	O

pT2	O
,	O
pNO	O
(	O
0	O
/	O
7	O
)	O
.	O

Masaoka	O
:	O
II	O
.	O
1	O
.	O

Immunhistochemistry	O
.	O
epithelial	O
cells	O
positive	O
for	O
:	O
CK5	O
/	O
6	O
.	O
strong	O
membrane	O
staining	O
for	O
EGFR	O
.	O
epithelial	O
cells	O
negative	O
for	O
:	O
c	O
-	O
kit	O
,	O
CD5	O
.	O

CD1a	O
,	O
CD99	O
-	O
positive	O
immature	O
T	O
-	O
lymphocytes	O
,	O
partially	O
also	O
positive	O
for	O
CD5	O
.	O
sparsely	O
CD20	O
-	O
positive	O
lymphocytes	O
.	O

CORRECTED	O
.	O

Report	O
Type	O
.	O

Date	O
of	O
Event	O
.	O

M	O
.	O

Hosp	O
/	O
Group	O
.	O

Record	O
Status	O
.	O

ADDENDA	O
:	O
Addendum	O
.	O

PROBE	O
:	O
LSI	O
EGFR	O
/	O
CEP7	O
Jual	O
-	O
Color	O
Probe	O
.	O

Cytogenetic	O
Location	O
:	O
7p12	O
/	O
7p11	O
.	O
1	O
-	O
q11	O
.	O
1	O
.	O

EGFR	O
FISH	O
STUDIES	O
PERFORMED	O
ON	O
THE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
ARE	O
.	O

NEGATIVE	O
.	O

Number	O
of	O
cells	O
analyzed	O
:	O
71	O
.	O

Ratio	O
EGFR	O
/	O
CEP7	O
:	O
1	O
.	O
3	O
.	O

High	O
Polysomy	O
:	O
0	O
%	O
.	O

SNR	O
(	O
signal	O
to	O
nucleus	O
ratio	O
)	O
:	O
2	O
.	O
3	O
.	O

Low	O
Polysomy	O
:	O
13	O
(	O
18	O
.	O
3	O
%	O
)	O
.	O

Trisomy	O
:	O
9	O
(	O
12	O
.	O
7	O
%	O
)	O
.	O

Disomy	O
:	O
49	O
(	O
69	O
.	O
0	O
%	O
)	O
.	O

This	O
result	O
should	O
be	O
integrated	O
with	O
all	O
clinical	O
and	O
pathologic	O
data	O
.	O
in	O
the	O
.	O
determination	O
of	O
a	O
comprehensive	O
diagnostic	O
and	O
treatment	O
plan	O
.	O

EGFR	O
FISH	O
analysis	O
was	O
manually	O
performed	O
and	O
quantitatively	O
assessed	O
.	O
analysis	O
of	O
a	O
minimum	O
of	O
60	O
cells	O
using	O
the	O
EGFR	O
SpectrumOrange	O
and	O
.	O
the	O
CEP7	O
.	O

SpectrumGreen	O
probes	O
.	O

EGFR	O
FISH	O
positive	O
:	O
High	O
Polysomy	O
:	O
>	O
four	O
gene	O
copies	O
in	O
>	O
40	O
%	O
of	O
cells	O
.	O

Gene	O
Amplification	O
:	O
Ratio	O
gene	O
/	O
chromosome	O
more	O
than	O
two	O
or	O
>	O
15	O
gene	O
.	O
copies	O
in	O
.	O

>	O
10	O
%	O
of	O
cells	O
.	O

EGFR	O
FISH	O
negative	O
:	O
Disomy	O
<	O
two	O
gene	O
copies	O
in	O
more	O
than	O
90	O
%	O
of	O
the	O
cells	O
.	O

Trisomy	O
:	O
three	O
gene	O
copies	O
in	O
more	O
than	O
10	O
%	O
of	O
cells	O
.	O

Low	O
Polysomy	O
:	O
>	O
four	O
gene	O
copies	O
in	O
more	O
than	O
10	O
%	O
but	O
less	O
than	O
40	O
%	O
of	O
.	O
cells	O
.	O

References	O
:	O
Rogers	O
SJ	O
,	O
Box	O
C	O
,	O
Chambers	O
P	O
,	O
Barbachano	O
Y	O
,	O
Nutting	O
CM	O
,	O
Rhys	O
-	O
Evans	O
P	O
,	O
.	O

Workman	O
.	O

P	O
,	O
Harrington	O
KJ	O
,	O
Eccles	O
SA	O
.	O

Determinants	O
of	O
response	O
to	O
epidermal	O
.	O
growth	O
.	O

factor	O
receptor	O
tyrosine	O
kinase	O
inhibition	O
in	O
squamous	O
cell	O
carcinoma	O
.	O
of	O
the	O
.	O
head	O
and	O
neck	O
.	O

J	O
Pathol	O
.	O

2009	O
May	O
;	O
218	O
(	O
1	O
)	O
122	O
-	O
30	O
.	O

Chung	O
CH	O
,	O
Ely	O
K	O
,	O
McGavran	O
L	O
,	O
Varella	O
-	O
Garcia	O
M	O
,	O
Parker	O
J	O
,	O
Parker	O
N	O
,	O
.	O

Jarrett	O
.	O

C	O
,	O
Carter	O
J	O
,	O
Murphy	O
BA	O
,	O
Netterville	O
J	O
,	O
Burkey	O
BB	O
,	O
Sinard	O
R	O
,	O
Cmelak	O
A	O
,	O
.	O

Levy	O
.	O

S	O
,	O
Yarbrough	O
WG	O
,	O
Slebos	O
RJ	O
,	O
Hirsch	O
FR	O
.	O

Increased	O
epidermal	O
growth	O
factor	O
.	O
receptor	O
gene	O
copy	O
number	O
is	O
associated	O
with	O
poor	O
prognosis	O
in	O
head	O
and	O
.	O
neck	O
.	O

squamous	O
cell	O
carcinomas	O
.	O

J	O
Clin	O
Oncol	O
.	O

2006	O
Sep	O
1	O
;	O
24	O
(	O
25	O
)	O
:	O
4170	O
-	O
6	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
.	O
submitted	O
.	O

material	O
(	O
s	O
)	O
and	O
the	O
above	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

Addendum	O
.	O

Immunoperoxidase	O
stain	O
for	O
EGFR	O
is	O
positive	O
.	O

Immunoperoxidase	O
stain	O
.	O
for	O
p16	O
.	O

is	O
focally	O
positive	O
but	O
negative	O
as	O
a	O
surrogate	O
marker	O
for	O
HPV	O
.	O

In	O
-	O
.	O
situ	O
.	O

hybridization	O
for	O
HPV	O
is	O
negative	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
.	O
submitted	O
.	O

material	O
(	O
s	O
)	O
and	O
the	O
above	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
CERVICAL	O
,	O
LEVELS	O
2	O
,	O
3	O
,	O
AND	O
4	O
,	O
SELECTIVE	O
.	O

DISSECTION	O
.	O

TWENTY	O
-	O
EIGHT	O
LYMPH	O
NODES	O
,	O
NO	O
TUMOR	O
PRESENT	O
(	O
0	O
/	O
28	O
)	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
CERVICAL	O
,	O
LEVELS	O
2	O
,	O
3	O
,	O
AND	O
4	O
,	O
SELECTIVE	O
.	O

DISSECTION	O
.	O

A	O
.	O

MICROSCOPIC	O
FOCUS	O
OF	O
METASTATIC	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
IN	O
.	O

ONE	O
OUT	O
.	O

OF	O
THIRTY	O
-	O
TWO	O
LYMPH	O
NODES	O
(	O
1	O
/	O
32	O
)	O
.	O

B	O
.	O

THE	O
LYMPH	O
NODE	O
WITH	O
METASTATIC	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
IS	O
IN	O
.	O

LEVEL	O
3	O
.	O

AND	O
THERE	O
IS	O
NO	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

PART	O
3	O
:	O
LARYNX	O
,	O
TOTAL	O
LARYNGECTOMY	O
.	O

A	O
.	O

SUPRAGLOTTIC	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
.	O

NONKERATINIZING	O
.	O

(	O
2	B
.	I
5	I
CM	I
)	O
.	O

B	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
PRESENT	O
.	O

C	O
.	O

PERINEURAL	O
INVASION	O
ABSENT	O
.	O

D	O
.	O

RESECTION	O
MARGINS	O
ARE	O
FREE	O
OF	O
CARCINOMA	O
(	O
ALSO	O
SEE	O
PART	O
4	O
)	O
.	O

E	O
.	O

NINE	O
LYMPH	O
NODES	O
,	O
NO	O
TUMOR	O
PRESENT	O
(	O
0	O
/	O
9	O
)	O
.	O

F	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT1	O
N2	O
.	O

PART	O
4	O
:	O
LEFT	O
LATERAL	O
MARGIN	O
,	O
BIOPSY	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
.	O
submitted	O
.	O

tissue	O
.	O

Grossly	O
,	O
there	O
is	O
a	O
2	B
.	I
5	I
X	I
2	I
.	I
3	I
X	I
0	I
.	I
9	I
cm	I
tan	O
-	O
white	O
,	O
firm	O
,	O
.	O
exophytic	O
.	O

supraglottic	O
tumor	O
mainly	O
involving	O
the	O
right	O
side	O
.	O

Anterior	O
.	O
commissure	O
,	O
.	O
preepiglottic	O
soft	O
tissue	O
,	O
vocal	O
cords	O
,	O
and	O
aryepiglottic	O
folds	O
are	O
not	O
.	O
involved	O
.	O

The	O
rest	O
of	O
the	O
mucosa	O
is	O
unremarkable	O
.	O

There	O
are	O
two	O
possible	O
lymph	O
nodes	O
attached	O
to	O
the	O
left	O
side	O
of	O
the	O
.	O
larynx	O
.	O

measuring	O
in	O
greatest	O
dimension	O
1	O
.	O
8	O
cm	O
each	O
.	O

Multiple	O
possible	O
lymph	O
.	O
nodes	O
.	O
from	O
anterior	O
soft	O
tissue	O
are	O
identified	O
ranging	O
in	O
greatest	O
dimension	O
.	O
from	O
.	O

0	O
.	O
1	O
to	O
.	O
5	O
cm	O
.	O

The	O
tumor	O
is	O
entirely	O
submitted	O
.	O

Normal	O
tissue	O
and	O
tissue	O
from	O
tumor	O
is	O
banked	O
for	O
SPORE	O
Head	O
and	O
Neck	O
.	O

Tissue	O
.	O

Bank	O
.	O

Digital	O
imaging	O
photographs	O
are	O
taken	O
.	O

INK	O
CODE	O
:	O
Black	O
anterior	O
soft	O
tissue	O
.	O

Blue	O
pre	O
-	O
epiglottic	O
soft	O
tissue	O
.	O

Orange	O
area	O
under	O
hyoid	O
bone	O
,	O
not	O
true	O
margin	O
.	O

Red	O
banked	O
area	O
.	O

CASSETTE	O
CODE	O
:	O
3A	O
base	O
of	O
tongue	O
margin	O
,	O
shave	O
.	O

3B	O
left	O
lateral	O
edge	O
,	O
shave	O
,	O
.	O

3C	O
right	O
lateral	O
margin	O
,	O
shave	O
.	O

3D	O
inferior	O
margin	O
,	O
shave	O
(	O
including	O
superior	O
portion	O
of	O
the	O
.	O
tracheostomy	O
.	O
mucosal	O
site	O
)	O
.	O

3E	O
tracheostomy	O
skin	O
site	O
,	O
perpendicular	O
.	O

3F	O
tracheostomy	O
soft	O
tissue	O
opening	O
,	O
perpendicular	O
.	O

3G	O
.	O
representative	O
of	O
left	O
vocal	O
cords	O
.	O

3H	O
representative	O
of	O
right	O
vocal	O
cords	O
.	O

3I	O
-	O
J	O
.	O
tumor	O
and	O
preepiglottic	O
soft	O
tissue	O
,	O
right	O
to	O
left	O
.	O

3K	O
-	O
L	O
reminder	O
of	O
tumor	O
,	O
.	O

3M	O
-	O
N	O
one	O
lymph	O
node	O
in	O
each	O
,	O
bisected	O
(	O
attached	O
to	O
left	O
larynx	O
)	O
.	O

30	O
one	O
lymph	O
node	O
,	O
bisected	O
,	O
anterior	O
soft	O
tissue	O
.	O

3P	O
one	O
lymph	O
node	O
,	O
anterior	O
soft	O
tissue	O
.	O

3Q	O
possible	O
lymph	O
nodes	O
,	O
anterior	O
soft	O
tissue	O
.	O

Part	O
4	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
XX	O
.	O
and	O
.	O

"	O
left	O
lateral	O
margin	O
"	O
.	O

Received	O
are	O
two	O
,	O
pale	O
yellow	O
-	O
tan	O
soft	O
tissue	O
.	O
fragments	O
cervical	O
and	O
some	O
is	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
and	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
cm	O
.	O

A	O
.	O
frozen	O
.	O

section	O
is	O
performed	O
with	O
an	O
intraoperative	O
diagnosis	O
completed	O
.	O

The	O
.	O
specimen	O
.	O

is	O
entirely	O
submitted	O
for	O
processing	O
in	O
a	O
cassette	O
labeled	O
4AFS	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
4AFS	O
:	O
LARYNX	O
,	O
LEFT	O
LATERAL	O
MARGIN	O
,	O
(	O
frozen	O
section	O
)	O
-	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

MICROSCOPIC	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
diagnosis	O
.	O
material	O
(	O
s	O
)	O
and	O
the	O
final	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
4	O
parts	O
.	O

Part	O
1	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
.	O
and	O
.	O

"	O
right	O
neck	O
levels	O
2	O
,	O
3	O
,	O
4	O
"	O
.	O

Received	O
is	O
an	O
unoriented	O
,	O
irregular	O
mass	O
.	O

of	O
.	O
finely	O
lobulated	O
to	O
coarsely	O
lobulated	O
11	O
x	O
6	O
x	O
2	O
cm	O
adipose	O
tissue	O
.	O

The	O
.	O
specimen	O
is	O
divided	O
into	O
3	O
equal	O
segments	O
and	O
designated	O
as	O
levels	O
A	O
.	O

(	O
finely	O
.	O
lobulated	O
segment	O
)	O
through	O
C	O
.	O

Multiple	O
lymph	O
nodes	O
are	O
identified	O
.	O
ranging	O
in	O
.	O
size	O
from	O
0	O
.	O
1	O
to	O
2	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O

Section	O
code	O
:	O
1A	O
-	O
level	O
A	O
-	O
bisected	O
lymph	O
node	O
.	O

1B	O
-	O
level	O
A	O
-	O
bisected	O
lymph	O
node	O
.	O

1C	O
-	O
level	O
A	O
-	O
4	O
possible	O
lymph	O
nodes	O
.	O

1D	O
-	O
level	O
B	O
-	O
2	O
larger	O
lymph	O
nodes	O
.	O

1E	O
-	O
level	O
B	O
-	O
4	O
lymph	O
nodes	O
.	O

1F	O
-	O
level	O
B	O
-	O
2	O
bisected	O
lymph	O
nodes	O
.	O

1G	O
-	O
level	O
B	O
.	O

-	O
6	O
smallest	O
lymph	O
nodes	O
.	O

1H	O
-	O
level	O
C	O
-	O
4	O
possible	O
lymph	O
nodes	O
.	O

1I	O
-	O
level	O
C	O
-	O
3	O
possible	O
lymph	O
nodes	O
.	O

Part	O
2	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
.	O
and	O
.	O

"	O
left	O
neck	O
-	O
levels	O
2	O
,	O
3	O
,	O
4	O
(	O
tie	O
superior	O
)	O
"	O
Received	O
is	O
an	O
oriented	O
,	O
.	O
irregular	O
,	O
12	O
x	O
3	O
x	O
3	O
cm	O
,	O
adipose	O
neck	O
dissection	O
with	O
a	O
single	O
suture	O
.	O
designating	O
superior	O
.	O

The	O
specimen	O
is	O
subdivided	O
into	O
3	O
equal	O
segments	O
.	O
and	O
.	O

designated	O
as	O
levels	O
2	O
through	O
4	O
.	O

Multiple	O
lymph	O
nodes	O
are	O
identified	O
.	O
ranging	O
.	O
in	O
size	O
from	O
0	O
.	O
2	O
to	O
2	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Several	O
of	O
the	O
.	O
larger	O
lymph	O
.	O
nodes	O
within	O
level	O
2	O
appear	O
suspicious	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
.	O
submitted	O
.	O

Section	O
code	O
:	O
2A	O
-	O
2C	O
-	O
level	O
2	O
-	O
trisected	O
largest	O
lymph	O
node	O
.	O

2D	O
-	O
level	O
2	O
-	O
bisected	O
lymph	O
node	O
.	O

2E	O
-	O
level	O
2	O
-	O
two	O
bisected	O
lymph	O
nodes	O
(	O
one	O
LN	O
inked	O
blue	O
)	O
.	O

2F	O
-	O
level	O
2	O
-	O
two	O
possible	O
smaller	O
lymph	O
nodes	O
.	O

2G	O
-	O
level	O
3	O
-	O
bisected	O
lymph	O
node	O
.	O

2H	O
-	O
level	O
3	O
-	O
bisected	O
lymph	O
node	O
.	O

2I	O
-	O
level	O
3	O
-	O
four	O
possible	O
lymph	O
nodes	O
.	O

2J	O
-	O
level	O
3	O
-	O
three	O
smaller	O
possible	O
lymph	O
nodes	O
.	O

2K	O
-	O
level	O
4	O
-	O
-	O
four	O
possible	O
lymph	O
nodes	O
.	O

2L	O
-	O
level	O
4	O
-	O
five	O
possible	O
lymph	O
nodes	O
.	O

2M	O
-	O
level	O
4	O
-	O
seven	O
minute	O
possible	O
lymph	O
nodes	O
.	O

Part	O
3	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
.	O
and	O
.	O

"	O
larynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
total	O
laryngectomy	O
measuring	O
11	O
.	O
5	O
X	O
8	O
.	O
0	O
X	O
.	O

7	O
.	O
0	O
cm	O
.	O
with	O
attached	O
hyoid	O
bone	O
,	O
skin	O
(	O
4	O
.	O
0	O
x	O
3	O
.	O
5	O
cm	O
)	O
with	O
a	O
tracheostomy	O
site	O
,	O
.	O
and	O
.	O

fibroadipose	O
tissue	O
with	O
multiple	O
lymph	O
nodes	O
attached	O
the	O
anterior	O
.	O
soft	O
.	O

The	O
following	O
statement	O
applies	O
to	O
all	O
immunohistochemistry	O
,	O
Insitu	O
.	O

Hybridization	O
Assays	O
(	O
ISH	O
&	O
FISH	O
)	O
,	O
Molecular	O
Anatomic	O
Pathology	O
,	O
and	O
.	O

Immunofluorescent	O
Testing	O
:	O
The	O
testing	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O
the	O
.	O

Department	O
of	O
Pathology	O
,	O
as	O
required	O
by	O
.	O
the	O
CLIA	O
.	O

'	O
88	O
regulations	O
.	O

The	O
testing	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
the	O
.	O
specific	O
use	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
,	O
but	O
the	O
FDA	O
has	O
.	O
determined	O
such	O
approval	O
is	O
not	O
necessary	O
for	O
clinical	O
use	O
.	O

Tissue	O
.	O
fixation	O
.	O

ranges	O
from	O
a	O
minimum	O
of	O
2	O
to	O
a	O
maximum	O
of	O
84	O
hours	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
"	O
CLIA	O
"	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
complexity	O
.	O
clinical	O
.	O

testing	O
.	O

Pursuant	O
to	O
the	O
requirements	O
of	O
CLIA	O
,	O
ASR	O
'	O
s	O
used	O
in	O
this	O
.	O
laboratory	O
.	O

have	O
been	O
established	O
and	O
verified	O
for	O
accuracy	O
and	O
precision	O
.	O

Additional	O
.	O
information	O
about	O
this	O
type	O
of	O
test	O
is	O
available	O
upon	O
request	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
LARYNX	O
RESECTIONS	O
.	O

TYPE	O
OF	O
LARYNGECTOMY	O
:	O
Total	O
.	O

TUMOR	O
LATERALITY	O
:	O
Other	O
location	O
:	O
Primary	O
right	O
with	O
extension	O
.	O
across	O
.	O

midline	O
.	O

ATTACHED	O
STRUCTURES	O
:	O
Pyriform	O
sinus	O
,	O
Base	O
of	O
tongue	O
,	O
Tracheotomy	O
,	O
.	O

Skin	O
.	O

TUMOR	O
LOCATION	O
/	O
SEGMENT	O
:	O
Supraglottic	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
2	B
.	I
5	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
OF	O
TUMOR	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Moderately	O
differentiated	O
.	O

STRUCTURES	O
INVOLVED	O
BY	O
TUMOR	O
:	O
Epiglottis	O
.	O

LYMPH	O
NODES	O
:	O
Lymph	O
nodes	O
positive	O
,	O
Right	O
:	O
0	O
.	O

Total	O
number	O
of	O
right	O
sided	O
lymph	O
nodes	O
examined	O
:	O
28	O
.	O

Lymph	O
nodes	O
positive	O
,	O
Left	O
:	O
1	O
.	O

Total	O
number	O
of	O
left	O
sided	O
lymph	O
nodes	O
examined	O
:	O
32	O
.	O

Site	O
of	O
'	O
other	O
'	O
lymph	O
nodes	O
:	O
Anterior	O
soft	O
tissue	O
.	O

Lymph	O
nodes	O
positive	O
,	O
'	O
other	O
'	O
:	O
0	O
.	O

Total	O
number	O
of	O
'	O
other	O
'	O
lymph	O
nodes	O
examined	O
:	O
9	O
.	O

EXTRACAPSULAR	O
SPREAD	O
OF	O
LYMPH	O
NODE	O
METASTASES	O
.	O

INTRA	O
-	O
PERINEURAL	O
INVASION	O
:	O
Absent	O
.	O

VASCULAR	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
.	O

Free	O
(	O
2	O
mm	O
or	O
more	O
)	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
Supraglottis	O
,	O
pT1	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN2	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

PATIENT	O
HISTORY	O
:	O
As	O
a	O
negative	O
shorter	O
one	O
with	O
a	O
CHIEF	O
COMPLAINT	O
/	O
PRE	O
-	O
OP	O
/	O
POST	O
-	O
OP	O
.	O

DIAGNOSIS	O
:	O
Cancer	O
of	O
larynx	O
.	O

PROCEDURE	O
:	O
Laryngectomy	O
and	O
bilateral	O
neck	O
dissections	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Margins	O
and	O
nodes	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
Yes	O
-	O
squamous	O
cell	O
carcinoma	O
.	O

PRIOR	O
MALIGNANCY	O
:	O
No	O
.	O

CHEMORADIATION	O
:	O
No	O
.	O

ORGAN	O
TRANSPLANT	O
:	O
No	O
.	O

IMMUNOSUPPRESSION	O
No	O
.	O

OTHER	O
DISEASES	O
:	O
No	O
.	O

HISTO	O
TISSUE	O
SUMMARY	O
/	O
SLIDES	O
REVIEWED	O
:	O
Part	O
1	O
:	O
Neck	O
Dissection	O
,	O
Level	O
2	O
,	O
3	O
,	O
4	O
.	O

Stain	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

Part	O
2	O
:	O
Neck	O
Dissection	O
Levels	O
7	O
.	O

3	O
.	O

4	O
.	O

Stair	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

I	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

K	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

L	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

M	O
.	O

Part	O
3	O
:	O
Larynx	O
,	O
Total	O
Laryngectomy	O
.	O

Stain	O
/	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
Recut	O
x	O
.	O

1	O
.	O

IEGFR	O
x	O
1	O
.	O

IBNKNC	O
x	O
1	O
.	O

I	O
.	O

IBNKNC	O
x	O
1	O
.	O

IBNKNC	O
x	O
1	O
.	O

IBNKNC	O
X	O
1	O
.	O

IBNKNC	O
X	O
1	O
.	O

IBNKNC	O
X	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

HPV	O
X	O
1	O
.	O

IISH	O
X	O
1	O
.	O

IISH	O
x	O
1	O
.	O

P16	O
X	O
1	O
.	O

V	O
-	O
EGFR	O
X	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

K	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

M	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

N	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

O	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

P	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Q	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

R	O
.	O

Part	O
4	O
:	O
Left	O
Lateral	O
Margin	O
.	O

Stain	O
/	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

A	O
FS	O
.	O

TC1	O
.	O

CLINICAL	O
HISTORY	O
:	O
Malignant	O
neo	O
corpus	O
uteri	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Uterus	O
and	O
cervix	O
(	O
AF1	O
)	O
"	O
,	O
received	O
fresh	O
for	O
frozen	O
section	O
diagnosis	O
is	O
a	O
.	O

68	O
gm	O
,	O
8	O
x	O
5	O
.	O
5	O
x	O
3	O
cm	O
hysterectomy	O
specimen	O
with	O
attached	O
cervix	O
(	O
3	O
cm	O
in	O
.	O
length	O
x	O
3	O
cm	O
in	O
diameter	O
)	O
with	O
a	O
patent	O
os	O
of	O
0	O
.	O
6	O
cm	O
.	O

The	O
serosal	O
surface	O
is	O
.	O
pink	O
-	O
tan	O
and	O
grossly	O
unremarkable	O
.	O

The	O
paracervical	O
soft	O
tissue	O
is	O
inked	O
.	O
entirely	O
in	O
blue	O
and	O
the	O
specimen	O
is	O
opened	O
laterally	O
on	O
each	O
side	O
.	O

The	O
.	O
cervical	O
canal	O
(	O
2	O
.	O
5	O
cm	O
length	O
x	O
2	O
.	O
4	O
cm	O
wide	O
)	O
is	O
tan	O
-	O
pink	O
,	O
has	O
a	O
herringbone	O
.	O
pattern	O
.	O

The	O
endometrial	O
canal	O
(	O
4	O
.	O
5	O
cm	O
in	O
length	O
x	O
3	O
cm	O
from	O
cornu	O
to	O
cornu	O
)	O
.	O
demonstrates	O
a	O
large	O
,	O
contiguous	O
,	O
fungating	O
mass	O
on	O
the	O
posterior	O
portion	O
.	O

(	O
beginning	O
1	O
.	O
5	O
cm	O
superior	O
to	O
the	O
lower	O
uterine	O
segment	O
and	O
continuing	O
to	O
the	O
.	O
anterior	O
endometrium	O
approximately	O
2	O
.	O
6	O
cm	O
from	O
the	O
lower	O
uterine	O
segment	O
.	O

Both	O
.	O
lower	O
uterine	O
segments	O
are	O
grossly	O
uninvolved	O
.	O

Serial	O
sectioning	O
of	O
the	O
.	O
endometrium	O
demonstrates	O
a	O
focally	O
1	O
cm	O
thick	O
endometrium	O
overlying	O
a	O
1	O
.	O
1	O
cm	O
.	O
thick	O
myometrium	O
.	O

The	O
area	O
of	O
deepest	O
invasion	O
is	O
located	O
on	O
the	O
posterior	O
.	O
surface	O
and	O
appears	O
to	O
grossly	O
invade	O
0	O
.	O
8	O
cm	O
into	O
a	O
1	O
.	O
7	O
cm	O
myometrium	O
.	O

The	O
.	O
deepest	O
invasion	O
on	O
the	O
anterior	O
endometrium	O
is	O
0	O
.	O
3	O
cm	O
into	O
a	O
1	O
.	O
7	O
cm	O
.	O
myometrium	O
.	O

BLOCK	O
SUMMARY	O
:	O
A1	O
-	O
AF1	O
rep	O
of	O
deepest	O
invasion	O
.	O

A2	O
-	O
anterior	O
cervix	O
.	O

A3	O
-	O
posterior	O
cervix	O
.	O

A4	O
-	O
anterior	O
lower	O
uterine	O
segment	O
.	O

A5	O
-	O
posterior	O
lower	O
uterine	O
segment	O
.	O

A6	O
-	O
A7	O
representative	O
of	O
deepest	O
invasion	O
anterior	O
endomyometrium	O
.	O

A8	O
-	O
A9	O
representative	O
deepest	O
invasion	O
posterior	O
endomyometrium	O
.	O

B	O
.	O

"	O
Hernia	O
sac	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
.	O

a	O
9	O
.	O
5	O
x	O
9	O
x	O
3	O
.	O
2	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
.	O

The	O
specimen	O
is	O
.	O
sectioned	O
revealing	O
benign	O
fibroadipose	O
tissue	O
.	O

Representative	O
sections	O
.	O

in	O
.	O

B1	O
-	O
B3	O
.	O

C	O
.	O

"	O
Right	O
tube	O
and	O
ovary	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
an	O
8	O
gm	O
,	O
6	O
x	O
3	O
.	O
1	O
x	O
1	O
.	O
8	O
cm	O
tube	O
and	O
ovary	O
specimen	O
.	O

The	O
fallopian	O
.	O
tube	O
(	O
7	O
.	O
5	O
cm	O
in	O
length	O
x	O
0	O
.	O
cm	O
in	O
diameter	O
)	O
is	O
upon	O
sectioning	O
tan	O
-	O
white	O
and	O
.	O
grossly	O
unremarkable	O
.	O

The	O
fimbriae	O
is	O
also	O
grossly	O
unremarkable	O
.	O

The	O
right	O
.	O
ovary	O
(	O
2	O
.	O
5	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
9	O
cm	O
)	O
is	O
white	O
-	O
tan	O
,	O
cerebriform	O
and	O
upon	O
sectioning	O
.	O
demonstrates	O
a	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
corpus	O
albicans	O
.	O

BLOCK	O
SUMMARY	O
:	O
C1	O
-	O
tube	O
and	O
fimbriae	O
.	O

C2	O
-	O
ovary	O
.	O

D	O
.	O

"	O
Left	O
tube	O
and	O
ovary	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

s	O
an	O
11	O
gm	O
,	O
6	O
.	O
8	O
x	O
3	O
x	O
2	O
cm	O
tube	O
and	O
ovary	O
.	O

The	O
fallopian	O
tube	O
(	O
7	O
.	O
6	O
.	O
cm	O
in	O
length	O
x	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
)	O
appears	O
on	O
sectioning	O
grossly	O
unremarkable	O
.	O
the	O
attached	O
fimbriae	O
is	O
grossly	O
unremarkable	O
.	O

The	O
left	O
ovary	O
(	O
3	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
.	O
cm	O
)	O
is	O
white	O
-	O
tan	O
cerebriform	O
and	O
upon	O
sectioning	O
is	O
grossly	O
unremarkable	O
.	O

BLOCK	O
SUMMARY	O
:	O
D1	O
-	O
left	O
tube	O
and	O
fimbriae	O
.	O

D2	O
-	O
.	O
left	O
ovary	O
.	O

1	O
of	O
4	O
.	O

E	O
.	O

"	O
Left	O
pelvic	O
lymph	O
node	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
a	O
5	O
x	O
2	O
.	O
3	O
x	O
1	O
.	O
8	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
which	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Six	O
lymph	O
node	O
candidates	O
are	O
identified	O
.	O

Submitted	O
as	O
follows	O
:	O
E1	O
-	O
one	O
lymph	O
node	O
candidate	O
(	O
mostly	O
fat	O
)	O
.	O

E2	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

E3	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

E4	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
.	O

F	O
.	O

"	O
Left	O
common	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
a	O
1	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
cm	O
fragment	O
of	O
soft	O
brown	O
tissue	O
which	O
is	O
submitted	O
in	O
its	O
.	O
entirety	O
in	O
F1	O
.	O

G	O
.	O

"	O
Aortic	O
"	O
,	O
received	O
is	O
a	O
2	O
.	O
8	O
x	O
2	O
x	O
0	O
.	O
6	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
.	O
which	O
is	O
dissected	O
for	O
lymph	O
nodes	O
.	O

One	O
lymph	O
node	O
candidate	O
measuring	O
2	O
.	O
6	O
cm	O
.	O
in	O
length	O
x	O
0	O
.	O
4	O
cm	O
is	O
bisected	O
and	O
submitted	O
in	O
its	O
entirety	O
in	O
G1	O
and	O
G2	O
.	O

H	O
.	O

"	O
Rinht	O
pelvic	O
node	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
a	O
5	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
which	O
.	O

is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
2	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
.	O

BLOCK	O
SUMMARY	O
:	O
H1	O
-	O
three	O
lymph	O
nodes	O
.	O

H2	O
-	O
three	O
lymph	O
nodes	O
.	O

H3	O
-	O
two	O
lymph	O
nodes	O
.	O

H4	O
-	O
.	O
one	O
lymph	O
node	O
bisected	O
.	O

H5	O
-	O
.	O
one	O
lymph	O
node	O
bisected	O
.	O

I	O
.	O

"	O
Right	O
aortic	O
lymph	O
node	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

is	O
a	O
3	O
.	O
5	O
x	O
3	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
which	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Two	O
lymph	O
nodes	O
are	O
found	O
ranging	O
from	O
1	O
.	O
3	O
cm	O
in	O
.	O
greatest	O
dimension	O
to	O
0	O
.	O
5	O
cm	O
.	O

BLOCK	O
SUMMARY	O
:	O
Il	O
-	O
one	O
lymph	O
node	O
bisected	O
.	O

I2	O
-	O
.	O
one	O
lymph	O
.	O

Dr	O
.	O
slides	O
to	O
Dr	O
.	O
INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Uterus	O
and	O
cervix	O
"	O
:	O
AF1	O
(	O
rep	O
)	O
0	O
.	O
8	O
cm	O
into	O
a	O
1	O
.	O
7	O
cm	O
myometrium	O
,	O
.	O
endometrioid	O
adenocarcinoma	O
FIGO	O
grade	O
2	O
.	O

MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

Depth	O
of	O
invasion	O
is	O
best	O
seen	O
on	O
the	O
.	O
frozen	O
section	O
slide	O
(	O
AF1	O
)	O
,	O
as	O
the	O
tissue	O
did	O
not	O
survive	O
processing	O
intact	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
Total	O
hysterectomy	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pTla	O
pNO	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

UTERUS	O
AND	O
CERVIX	O
(	O
TOTAL	O
HYSTERECTOMY	O
)	O
:	O
UTERUS	O
:	O
68	O
GRAMS	O
.	O

CARCINOMA	O
OF	O
THE	O
ENDOMETRIUM	O
:	O
TUMOR	O
SITE	O
:	O
DIFFUSE	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
ENDOMETRIOID	O
ADENOCARCINOMA	O
WITH	O
SQUAMOUS	O
.	O

DIFFERENTIATION	O
.	O

FIGO	O
GRADE	O
;	O
2	O
.	O

TUMOR	O
SIZE	O
:	O
4	B
.	I
9	I
x	I
3	I
x	I
0	I
.	I
8	I
CM	I
.	O

MAXIMUM	O
DEPTH	O
OF	O
MYOMETRIAL	O
INVASION	O
:	O
0	O
.	O
8	O
CM	O
IN	O
A	O
1	O
.	O
7	O
CM	O
THICK	O
WALL	O
.	O

LYMPHATIC	O
/	O
VASCULAR	O
INVASION	O
:	O
ABSENT	O
.	O

ADJACENT	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIUM	O
:	O
ATROPHIC	O
.	O

REMAINING	O
MYOMETRIUM	O
:	O
UNREMARKABLE	O
.	O

CERVIX	O
:	O
FREE	O
OF	O
TUMOR	O
.	O

MULTIPLE	O
NABOTHIAN	O
CYSTS	O
.	O

SEROSA	O
:	O
FREE	O
OF	O
TUMOR	O
.	O

SPECIMEN	O
MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

B	O
.	O

HERNIA	O
SAC	O
(	O
HERNIORRHAPHY	O
)	O
:	O
MESOTHELIAL	O
LINED	O
FIBROADIPOSE	O
TISSUE	O
,	O
CONSISTENT	O
WITH	O
HERNIA	O
SAC	O
.	O

C	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
(	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
WITH	O
NO	O
SIGNIFICANT	O
PATHOLOGIC	O
ALTERATION	O
.	O

NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

D	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
(	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
WITH	O
NO	O
SIGNIFICANT	O
PATHOLOGIC	O
ALTERATION	O
.	O

NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

E	O
.	O

LEFT	O
PELVIC	O
LYMPH	O
NODE	O
(	O
BIOPSY	O
)	O
:	O
SIX	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
6	O
)	O
.	O

F	O
.	O

LEFT	O
COMMON	O
LYMPH	O
NODE	O
(	O
BIOPSY	O
)	O
:	O
TWO	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
2	O
)	O
.	O

G	O
.	O

AORTIC	O
LYMPH	O
NODE	O
(	O
BIOPSY	O
)	O
:	O
TWO	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
2	O
)	O
.	O

H	O
.	O

RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
(	O
BIOPSY	O
)	O
:	O
ELEVEN	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
11	O
)	O
.	O

SEE	O
COMMENT	O
.	O

I	O
.	O

RIGHT	O
AORTIC	O
LYMPH	O
NODE	O
(	O
BIOPSY	O
)	O
:	O
FIVE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
5	O
)	O
.	O

COMMENT	O
:	O
The	O
right	O
pelvic	O
nodes	O
(	O
part	O
H	O
)	O
have	O
a	O
prominent	O
histiocytic	O
.	O
infiltrate	O
.	O

Special	O
stains	O
for	O
fungi	O
and	O
acid	O
fast	O
bacilli	O
will	O
be	O
performed	O
.	O
and	O
the	O
results	O
reported	O
in	O
an	O
addendum	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

ADDENDUM	O
1	O
:	O
This	O
addendum	O
is	O
issued	O
to	O
report	O
the	O
results	O
of	O
special	O
stains	O
.	O

The	O
original	O
.	O
diagnoses	O
remain	O
unchanged	O
.	O

Special	O
stains	O
(	O
performed	O
on	O
block	O
H2	O
)	O
for	O
fungi	O
(	O
PAS	O
)	O
and	O
acid	O
-	O
fast	O
bacilli	O
.	O

(	O
TBC	O
)	O
are	O
NEGATIVE	O
.	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

CI	O
ADDENDUM	O
1	O
:	O
Please	O
see	O
Image	O
Cytometry	O
Report	O
.	O
for	O
results	O
of	O
supplementary	O
.	O
tests	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Consulting	O
MDs	O
:	O

Gross	O
Description	O
:	O
Tongue	O
tissue	O
up	O
to	O
8	O
cm	O
in	O
size	O
with	O
gray	O
dense	O
-	O
elastic	O
tumor	O
up	O
to	O
5	B
cm	I
in	O
size	O
,	O
.	O
with	O
ulceration	O
.	O

Microscopic	O
Description	O
:	O
Squamous	O
carcinoma	O
of	O
the	O
tongue	O
,	O
G	O
-	O
1	O
,	O
keratinizing	O
type	O
.	O

Fatty	O
tissue	O
from	O
.	O
the	O
left	O
side	O
is	O
with	O
hemorrhages	O
.	O

In	O
the	O
fatty	O
tissue	O
from	O
the	O
right	O
side	O
there	O
are	O
six	O
lymph	O
nodes	O
with	O
.	O
normal	O
morphological	O
structure	O
.	O

Diagnosis	O
Details	O
:	O
Tumor	O
Features	O
:	O
Indeterminate	O
,	O
Tumor	O
Extent	O
:	O
Localized	O
,	O
NOS	O
,	O
Venous	O
Invasion	O
:	O
Present	O
,	O
Margins	O
:	O
Absent	O
,	O
Treatment	O
Effect	O
:	O
Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
HEAD	O
&	O
NECK	O
CHECKLIST	O
.	O

Squamous	O
cell	O
carcinoma	O
,	O
keratinizing	O
of	O
the	O
oral	O
cavity	O
.	O

Tumor	O
size	O
:	O
5cm	B
.	O

Laterality	O
:	O
Midline	O
.	O

Gender	O
:	O
M	O
.	O

Examination	O
result	O
.	O

Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
Melanoma	O
of	O
the	O
nasal	O
cavity	O
right	O
side	O
.	O

Malignant	O
melanoma	O
ulcerating	O
.	O

Material	O
:	O
1	O
)	O
Material	O
:	O
nose	O
,	O
tumor	O
of	O
the	O
nose	O
.	O

Histopathological	O
Diagnosis	O
:	O
Malignant	O
melanoma	O
of	O
the	O
mucous	O
membrane	O
of	O
the	O
nose	O
pT4a	O
,	O
pNO	O
.	O

Macroscopic	O
description	O
:	O
Surgical	O
specimen	O
sized	O
5	O
x	O
6	O
x	O
1	O
.	O
2cm	O
,	O
including	O
cartilage	O
and	O
skin	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
in	O
length	O
.	O

Tumour	O
sized	O
3	B
.	I
5	I
x	I
3	I
X	I
1	I
.	I
5	I
.	O

cm	O
.	O

Microscopic	O
description	O
:	O
Malignant	O
melanoma	O
of	O
the	O
mucous	O
membrane	O
of	O
the	O
nose	O
.	O

Thickness	O
min	O
.	O
:	O
12mm	O
.	O

Surgical	O
incision	O
lines	O
off	O
cancer	O
invaded	O
area	O
.	O

No	O
signs	O
of	O
vascular	O
,	O
nerve	O
and	O
cartilage	O
invasion	O
found	O
.	O

Receive	O
Date	O
:	O
PHN	O
:	O
Final	O
Diagnosis	O
:	O
Hysterectomy	O
,	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
,	O
omentectomy	O
and	O
pelvic	O
/	O
peritoneal	O
.	O
washing	O
specimens	O
showing	O
:	O
1	O
.	O

High	O
-	O
grade	O
serous	O
carcinoma	O
of	O
left	O
ovary	O
with	O
implants	O
of	O
metastatic	O
.	O
serous	O
carcinoma	O
to	O
right	O
ovary	O
,	O
fallopian	O
tubes	O
,	O
serosal	O
surface	O
of	O
the	O
.	O
uterus	O
and	O
omentum	O
.	O

2	O
.	O

Benign	O
uterine	O
leiomyomas	O
.	O

3	O
.	O

Proliferative	O
endometrium	O
.	O

4	O
.	O

Benign	O
endo	O
-	O
and	O
exocervical	O
mucosa	O
.	O

5	O
.	O

Peritoneal	O
fluid	O
(	O
cytology	O
specimen	O
.	O

is	O
positive	O
for	O
serous	O
.	O
carcinoma	O
.	O

6	O
.	O

Please	O
see	O
Comment	O
.	O

Final	O
Diagnosis	O
Comment	O
:	O
This	O
unusual	O
tumour	O
shows	O
both	O
high	O
-	O
grade	O
and	O
low	O
-	O
grade	O
architectural	O
growth	O
.	O
patterns	O
;	O
however	O
,	O
on	O
closer	O
examination	O
it	O
has	O
a	O
high	O
mitotic	O
rate	O
throughout	O
and	O
is	O
.	O
best	O
classified	O
as	O
high	O
-	O
grade	O
serous	O
carcinoma	O
.	O

The	O
tumour	O
involves	O
both	O
ovaries	O
,	O
the	O
.	O
serosal	O
surface	O
of	O
the	O
uterus	O
and	O
omentum	O
.	O

No	O
fallopian	O
tube	O
mucosal	O
involvement	O
is	O
.	O
identified	O
.	O

Clinical	O
History	O
as	O
Provided	O
by	O
.	O
with	O
pelvic	O
mass	O
.	O

Cytology	O
.	O

A	O
.	O

Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

B	O
.	O

Omentum	O
.	O

Specimens	O
Received	O
:	O
A	O
:	O
urterus	O
+	O
cervix	O
+	O
bilateral	O
tubes	O
+	O
ovaries	O
.	O

B	O
:	O
omentum	O
.	O

Gross	O
Description	O
:	O
Two	O
specimens	O
are	O
received	O
,	O
both	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
demographics	O
.	O

Peritoneal	O
.	O
fluid	O
washing	O
for	O
cytology	O
(	O
cytology	O
7	O
.	O

is	O
also	O
received	O
.	O

Specimen	O
A	O
is	O
labelled	O
UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
TUBES	O
AND	O
OVARIES	O
.	O

It	O
.	O
consists	O
of	O
a	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
and	O
a	O
total	O
hysterectomy	O
specimen	O
.	O

The	O
.	O
left	O
ovary	O
is	O
completely	O
replaced	O
by	O
a	O
tan	O
complex	O
cystic	O
mass	O
with	O
solid	O
and	O
papillary	O
.	O
areas	O
measuring	O
approximately	O
15	O
cm	O
in	O
diameter	O
.	O

Multiple	O
tumour	O
implants	O
are	O
.	O
identified	O
on	O
the	O
serosal	O
surface	O
of	O
this	O
cyst	O
.	O

The	O
left	O
fallopian	O
tube	O
measures	O
4	O
cm	O
in	O
.	O
length	O
and	O
1	O
cm	O
in	O
diameter	O
.	O

Its	O
serosal	O
surface	O
is	O
also	O
involved	O
by	O
the	O
tumour	O
implants	O
,	O
.	O
with	O
possible	O
mural	O
and	O
luminal	O
involvement	O
.	O

The	O
right	O
ovary	O
measures	O
2	O
.	O
5	O
X	O
2	O
.	O
2	O
X	O
5	O
.	O
5	O
.	O

cm	O
,	O
and	O
it	O
is	O
partially	O
replaced	O
by	O
the	O
same	O
tumour	O
,	O
with	O
serosal	O
implants	O
identified	O
.	O

The	O
.	O
uterine	O
body	O
measures	O
5	O
.	O
6	O
X	O
5	O
X	O
4	O
cm	O
.	O

Its	O
posterior	O
surface	O
/	O
cul	O
-	O
de	O
-	O
sac	O
is	O
extensively	O
.	O
involved	O
by	O
tumour	O
implants	O
.	O

The	O
anterior	O
surface	O
is	O
also	O
involved	O
,	O
albeit	O
less	O
.	O
extensively	O
.	O

The	O
endometrium	O
appears	O
grossly	O
unremarkable	O
.	O

Several	O
leiomyomata	O
,	O
.	O
measuring	O
up	O
to	O
1	O
.	O
2	O
cm	O
,	O
are	O
identified	O
.	O

The	O
cervix	O
measures	O
4	O
.	O
5	O
cm	O
in	O
length	O
and	O
4	O
.	O
5	O
.	O

cm	O
in	O
diameter	O
.	O

It	O
appears	O
grossly	O
unremarkable	O
.	O

The	O
serosal	O
surfaces	O
of	O
the	O
right	O
and	O
.	O
left	O
adnexa	O
and	O
uterus	O
are	O
inked	O
blue	O
.	O

The	O
resection	O
margins	O
are	O
inked	O
black	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
A1	O
-	O
A2	O
-	O
sections	O
obtained	O
during	O
the	O
frozen	O
section	O
.	O

A3	O
-	O
A8	O
-	O
representative	O
sections	O
of	O
the	O
left	O
ovarian	O
mass	O
.	O

A9	O
-	O
left	O
fallopian	O
tube	O
.	O

A10	O
-	O
A12	O
-	O
right	O
ovary	O
.	O

A13	O
-	O
right	O
fallopian	O
tube	O
.	O

A14	O
-	O
A17	O
-	O
anterior	O
endomyometrium	O
,	O
from	O
superior	O
to	O
inferior	O
,	O
with	O
A15	O
-	O
A16	O
.	O
being	O
from	O
the	O
same	O
level	O
.	O

A18	O
-	O
anterior	O
junction	O
of	O
the	O
lower	O
uterine	O
segment	O
and	O
endocervix	O
.	O

A19	O
-	O
anterior	O
junction	O
of	O
the	O
endocervix	O
and	O
ectocervix	O
.	O

A20	O
-	O
A23	O
-	O
posterior	O
endomyometrium	O
,	O
from	O
superior	O
to	O
inferior	O
,	O
with	O
A20	O
-	O
A21	O
.	O
from	O
the	O
same	O
level	O
and	O
A22	O
-	O
A23	O
from	O
the	O
same	O
level	O
.	O

A24	O
-	O
A25	O
-	O
posterior	O
junction	O
of	O
the	O
lower	O
uterine	O
segment	O
and	O
endocervix	O
,	O
.	O
with	O
A25	O
being	O
from	O
cul	O
-	O
de	O
-	O
sac	O
.	O

A26	O
-	O
posterior	O
junction	O
of	O
the	O
endocervix	O
and	O
ectocervix	O
.	O

Specimen	O
B	O
is	O
labelled	O
OMENTUM	O
.	O

It	O
consists	O
of	O
a	O
fibrofatty	O
tissue	O
measuring	O
13	O
X	O
6	O
X	O
.	O

3	O
.	O
5	O
cm	O
.	O

Multiple	O
tumour	O
deposits	O
are	O
identified	O
in	O
this	O
specimen	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
B1	O
to	O
B4	O
.	O

Intraoperative	O
Consultation	O
:	O
FSA	O
/	O
1	O
,	O
2	O
.	O

Gross	O
Description	O
:	O
Large	O
left	O
sided	O
mass	O
,	O
cystic	O
,	O
multiple	O
with	O
solid	O
and	O
papillary	O
.	O
excrescences	O
with	O
serosal	O
implants	O
right	O
side	O
adnexal	O
and	O
elsewhere	O
on	O
uterus	O
.	O

F	O
/	O
S	O
:	O
cyst	O
(	O
L	O
)	O
-	O
A1	O
,	O
opposite	O
side	O
-	O
A2	O
.	O

Provisional	O
Diagnosis	O
:	O
Serous	O
carcinoma	O
,	O
variably	O
differentiated	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
AND	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

NO	O
EVIDENCE	O
OF	O
NEOPLASIA	O
IN	O
9	O
LYMPH	O
NODES	O
(	O
0	O
/	O
9	O
)	O
.	O

PART	O
2	O
:	O
PROSTATE	O
AND	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
RADICAL	O
PROSTATECTOMY	O
-	O
.	O

A	O
.	O

PROSTATE	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
3	O
+	O
4	O
=	O
7	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
BOTH	O
THE	O
RIGHT	O
AND	O
LEFT	O
LOBES	O
AND	O
HAS	O
A	O
GREATEST	O
NODULAR	O
DIAMETER	O
OF	O
.	O

2	O
.	O
0	O
CM	O
IN	O
ONE	O
HISTOLOGIC	O
SECTION	O
.	O

c	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
10	O
%	O
OF	O
THE	O
EXAMINED	O
PROSTATE	O
VOLUME	O
.	O

D	O
.	O

THE	O
CARCINOMA	O
SHOWS	O
EVIDENCE	O
OF	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

E	O
.	O

CARCINOMA	O
INVOLVES	O
BILATERAL	O
SEMINAL	O
VESICLES	O
.	O

F	O
.	O

ALL	O
EXAMINED	O
SURGICAL	O
RESECTION	O
MARGINS	O
ARE	O
FREE	O
OF	O
CARCINOMA	O
.	O

G	O
.	O

EXTENSIVE	O
PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

NO	O
ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

HIGH	O
GRADE	O
PROSTATIC	O
INTRAEPITHELIAL	O
NEOPLASIA	O
IS	O
IDENTIFIED	O
.	O

J	O
.	O

PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT3b	O
NO	O
MX	O
.	O

K	O
.	O

BACKGROUND	O
PROSTATE	O
TISSUE	O
WITH	O
NODULAR	O
HYPERPLASIA	O
AND	O
CHRONIC	O
INFLAMMATION	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
PROSTATE	O
TUMORS	O
.	O

INVASIVE	O
CA	O
IDENTIFIED	O
?	O
:	O
TUMOR	O
HISTOLOGY	O
:	O
Adenocarcinoma	O
NOS	O
.	O

PRIMARY	O
GLEASON	O
GRADE	O
:	O
3	O
.	O

SECONDARY	O
GLEASON	O
GRADE	O
:	O
4	O
.	O

GLEASON	O
SUM	O
SCORE	O
:	O
7	O
.	O

GLEASON	O
4	O
/	O
5	O
PERCENTAGE	O
:	O
20	O
%	O
.	O

WEIGHT	O
OF	O
PROSTATE	O
:	O
42	O
.	O
3gm	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
2	B
cm	I
.	O

LOBE	O
LATERALITY	O
:	O
Right	O
and	O
Left	O
Lobes	O
.	O

PERCENT	O
OF	O
SPECIMEN	O
INVOLVED	O
BY	O
TUMOR	O
:	O
5	O
-	O
25	O
%	O
.	O

MULTIFOCAL	O
DISEASE	O
:	O
HIGH	O
GRADE	O
PIN	O
:	O
Yes	O
-	O
multifocal	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
Yes	O
-	O
Established	O
(	O
>	O
0	O
.	O
8mm	O
)	O
.	O

PERINEURAL	O
INVASION	O
:	O
ANGIOLYMPHATIC	O
INVASION	O
:	O
SEMINAL	O
VESICLE	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
All	O
surgical	O
margins	O
free	O
of	O
tumor	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
9	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
0	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3b	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
-	O
4	O
,	O
Poorly	O
differentiated	O
/	O
undifferentiated	O
.	O

Report	O
Status	O
:	O
Type	O
:	O
Surgical	O
Pathology	O
.	O

Pathology	O
Repor	O
.	O

MUSCLE	O
BIOPSY	O
.	O

DIAGNOSIS	O
:	O
SPECIMEN	O
LABELED	O
"	O
OMENTAL	O
TUMOR	O
MASS	O
"	O
(	O
including	O
FSA	O
)	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
(	O
3	B
.	I
2	I
cm	I
)	O
.	O

SPECIMEN	O
LABELED	O
"	O
TUMOR	O
FROM	O
STOMACH	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
(	O
3	B
.	I
2	I
cm	I
)	O
.	O

SPECIMEN	O
LABELED	O
"	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
grade	O
2	O
of	O
3	O
involving	O
surface	O
of	O
ovary	O
.	O
and	O
fallopian	O
tube	O
,	O
and	O
minimally	O
invading	O
ovarian	O
parenchyma	O
.	O

Peritubal	O
adhesions	O
.	O

SPECIMEN	O
LABELED	O
"	O
LEFT	O
TUBE	O
AND	O
OVARY	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
involving	O
surface	O
of	O
ovary	O
and	O
fallopian	O
.	O
tube	O
.	O

SPECIMEN	O
LABELED	O
"	O
CUL	O
DE	O
SAC	O
TUMOR	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

SPECIMEN	O
LABELED	O
"	O
UTERUS	O
AND	O
CERVIX	O
"	O
(	O
98g	O
)	O
:	O
Cervix	O
:	O
Squamous	O
metaplasia	O
.	O

Endometrium	O
:	O
Inactive	O
endometrium	O
.	O

Endometrial	O
polyps	O
.	O

Myometrium	O
:	O
Leiomyomata	O
.	O

Adenomyosis	O
.	O

Serosa	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

SPECIMEN	O
LABELED	O
"	O
CUL	O
DE	O
SAC	O
TUMOR	O
II	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
,	O
.	O

SPECIMEN	O
LABELED	O
"	O
TUMOR	O
ON	O
APPENDIX	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

SPECIMEN	O
LABELED	O
"	O
APPENDIX	O
AND	O
TUMOR	O
"	O
:	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

SPECIMEN	O
LABELED	O
"	O
UMBILICAL	O
HERNIA	O
"	O
:	O
Fibroadipose	O
tissue	O
with	O
acute	O
and	O
chronic	O
inflammation	O
.	O

Note	O
:	O
The	O
tumor	O
distribution	O
favors	O
a	O
PRIMARY	O
PERITONEAL	O
SEROUS	O
CARCINOMA	O
.	O

CLINICAL	O
DATA	O
:	O
History	O
:	O
-	O
CA125	O
1500	O
,	O
ascites	O
,	O
omental	O
cake	O
,	O
?	O
ovarian	O
.	O
cancer	O
.	O

Clinical	O
Diagnosis	O
:	O
Ascites	O
.	O

TISSUE	O
SUBMITTED	O
:	O
1	O
.	O

Rectal	O
muscles	O
to	O
research	O
.	O

2	O
.	O

Omental	O
tumor	O
mass	O
(	O
FS	O
)	O
.	O

3	O
.	O

Tumor	O
from	O
stomach	O
.	O

4	O
.	O

Right	O
tube	O
and	O
ovary	O
.	O

5	O
.	O

Left	O
tube	O
and	O
ovary	O
.	O

6	O
.	O

Cul	O
de	O
sac	O
tumor	O
.	O

7	O
.	O

Uterus	O
and	O
cervix	O
.	O

Page	O
:	O
1	O
of	O
3	O
.	O

8	O
.	O

Cul	O
de	O
sac	O
tumor	O
II	O
.	O

9	O
.	O

Tumor	O
on	O
appendix	O
.	O

10	O
.	O

Appendix	O
and	O
tumor	O
.	O

11	O
.	O

Umbilical	O
hernia	O
sac	O
.	O

O	O
.	O
R	O
.	O

CONSULTATION	O
:	O
SPECIMEN	O
LABELED	O
"	O
#	O
2	O
OMENTAL	O
TUMOR	O
MASS	O
'	O
(	O
FSA	O
)	O
:	O
Poorly	O
differentiated	O
carcinoma	O
,	O
consistent	O
with	O
ovarian	O
origin	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
in	O
11	O
parts	O
,	O
each	O
Tabeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
unit	O
number	O
.	O

Part	O
1	O
,	O
"	O
rectus	O
muscles	O
"	O
,	O
consists	O
of	O
one	O
fragment	O
of	O
red	O
/	O
tan	O
/	O
brown	O
soft	O
tissue	O
.	O

(	O
2	O
.	O
5	O
x	O
2	O
.	O
3	O
x	O
1	O
.	O
5	O
cm	O
)	O
grossly	O
consistent	O
with	O
skeletal	O
muscle	O
.	O

The	O
entire	O
.	O
specimen	O
is	O
submitted	O
for	O
special	O
studies	O
.	O

Part	O
2	O
,	O
"	O
omental	O
tumor	O
mass	O
-	O
FS	O
"	O
,	O
consists	O
of	O
one	O
fragment	O
of	O
yellow	O
/	O
tan	O
/	O
pinl	O
.	O
fibroadipose	O
tissue	O
(	O
34	O
x	O
8	O
x	O
4	O
cm	O
)	O
with	O
multiple	O
firm	O
,	O
yellow	O
/	O
white	O
nodules	O
.	O

(	O
up	O
to	O
6	O
cm	O
)	O
A	O
representative	O
section	O
of	O
one	O
nodule	O
is	O
frozen	O
and	O
submitted	O
.	O

as	O
.	O

"	O
FSA	O
"	O
.	O

Representative	O
nodules	O
are	O
submitted	O
for	O
special	O
studies	O
and	O
tumor	O
.	O
bank	O
.	O

Some	O
of	O
the	O
nodules	O
have	O
areas	O
of	O
hemorrhage	O
and	O
necrosis	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
1	O
.	O

FSA	O
remnant	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
2	O
.	O
omental	O
tumor	O
mass	O
,	O
1	O
frag	O
,	O
.	O

Part	O
3	O
,	O
"	O
tumor	O
from	O
stomach	O
"	O
,	O
consists	O
of	O
a	O
5	O
x	O
4	O
x	O
4	O
cm	O
fragment	O
of	O
.	O

yellow	O
/	O
tan	O
/	O
white	O
fibroadipose	O
tissue	O
with	O
a	O
3	B
.	I
2	I
x	I
3	I
x	I
1	I
.	I
6	I
cm	I
firm	O
,	O
white	O
/	O
tan	O
,	O
.	O
ill	O
-	O
defined	O
mass	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
3	O
.	O

-	O
tumor	O
from	O
stomach	O
,	O
3	O
frags	O
,	O
.	O

Part	O
4	O
,	O
"	O
right	O
tube	O
and	O
ovary	O
"	O
,	O
consists	O
of	O
a	O
5	O
.	O
3	O
x	O
4	O
.	O
0	O
x	O
1	O
.	O
9	O
cm	O
ovary	O
and	O
.	O
fallopian	O
tube	O
.	O

The	O
fallopian	O
tube	O
(	O
approximately	O
5	O
.	O
8	O
x	O
1	O
.	O
1	O
cm	O
)	O
has	O
areas	O
of	O
.	O
edema	O
and	O
adhesions	O
to	O
a	O
3	O
.	O
1	O
x	O
1	O
.	O
6	O
x	O
1	O
.	O
4	O
cm	O
ovary	O
.	O

Ther	O
are	O
multiple	O
papillary	O
.	O
exarescences	O
in	O
the	O
adnexal	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
4	O
-	O
6	O
-	O
right	O
tube	O
and	O
ovary	O
,	O
1	O
-	O
2	O
frags	O
each	O
,	O
.	O

Part	O
5	O
,	O
"	O
left	O
tube	O
and	O
ovary	O
"	O
,	O
consists	O
of	O
a	O
5	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
fimbriated	O
edematous	O
.	O
fallopian	O
tube	O
,	O
a	O
2	O
.	O
6	O
x	O
1	O
.	O
4	O
X	O
1	O
.	O
3	O
cm	O
ovary	O
and	O
associated	O
adnexal	O
tissue	O
.	O

The	O
.	O
ovary	O
has	O
a	O
yellow	O
/	O
white	O
,	O
slightly	O
rough	O
,	O
nodular	O
surface	O
.	O

There	O
are	O
multiple	O
.	O
tan	O
,	O
papillary	O
excrescences	O
(	O
up	O
to	O
0	O
.	O
4	O
cm	O
)	O
throughout	O
the	O
adnexa	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
7	O
-	O
9	O
-	O
left	O
tube	O
and	O
ovary	O
,	O
1	O
-	O
2	O
frags	O
each	O
,	O
.	O

Part	O
6	O
,	O
"	O
cul	O
de	O
sac	O
tumor	O
"	O
,	O
consists	O
of	O
multiple	O
fragments	O
of	O
firm	O
,	O
.	O

yellow	O
/	O
white	O
,	O
hemorrhagic	O
tissue	O
(	O
6	B
x	I
5	I
x	I
2	I
cm	I
in	O
aggregate	O
)	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Micro	O
10	O
-	O
11	O
-	O
cul	O
de	O
sac	O
tumor	O
,	O
3	O
frags	O
each	O
,	O
.	O

Part	O
7	O
,	O
"	O
uterus	O
and	O
cervix	O
"	O
,	O
consists	O
of	O
a	O
98g	O
hysterectomy	O
specimen	O
(	O
9	O
x	O
6	O
x	O
4	O
.	O
cm	O
.	O
in	O
overall	O
dimensions	O
)	O
which	O
has	O
a	O
rough	O
,	O
nodular	O
,	O
focally	O
hemorrhagic	O
.	O
serosal	O
surface	O
and	O
a	O
subserosal	O
leiomyoma	O
(	O
2	B
cm	I
)	O
The	O
exocervix	O
(	O
3	O
.	O
1	O
cm	O
in	O
.	O
diameter	O
)	O
has	O
a	O
0	O
.	O

:	O
cm	O
slit	O
-	O
like	O
os	O
leading	O
to	O
a	O
2	O
.	O
4	O
x	O
1	O
.	O
0	O
cm	O
endocervical	O
.	O
canal	O
.	O

The	O
endocervix	O
has	O
a	O
tan	O
,	O
glistening	O
herringbone	O
-	O
lik	O
appearance	O
.	O

The	O
endometrium	O
(	O
4	O
.	O
4	O
cm	O
from	O
cornu	O
to	O
cornu	O
,	O
4	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
2	O
cm	O
in	O
.	O
thickness	O
)	O
is	O
tan	O
and	O
glistening	O
with	O
multiple	O
polyps	O
(	O
from	O
0	O
.	O
to	O
2	O
.	O
5	O
cm	O
)	O
.	O

The	O
myometrium	O
(	O
1	O
.	O
3	O
cm	O
in	O
average	O
thickness	O
)	O
has	O
an	O
intramural	O
leiomyoma	O
(	O
0	O
.	O
6	O
.	O
cm	O
)	O
Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
12	O
.	O
anterior	O
cervix	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
13	O
.	O
posterior	O
cervix	O
,	O
1	O
frag	O
.	O

Micro	O
14	O
.	O

LUS	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
15	O
-	O
16	O
.	O

-	O
anterior	O
endometrium	O
,	O
serosal	O
nodules	O
&	O
polyps	O
,	O
1	O
-	O
2	O
frags	O
each	O
,	O
.	O

Micro	O
17	O
.	O
posterior	O
endometrium	O
,	O
polyps	O
&	O
leios	O
,	O
1	O
frag	O
each	O
.	O

Page	O
:	O
2	O
of	O
3	O
.	O

Part	O
8	O
,	O
"	O
cul	O
de	O
sac	O
tumor	O
II	O
"	O
,	O
consists	O
of	O
two	O
fragments	O
of	O
white	O
/	O
tan	O
/	O
yellow	O
.	O
soft	O
tissue	O
with	O
a	O
papillary	O
,	O
friable	O
texture	O
(	O
in	O
aggregate	O
5	O
x	O
4	O
.	O
2	O
x	O
2	O
.	O
1	O
cm	O
)	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
19	O
.	O

-	O
cul	O
de	O
sac	O
tumor	O
II	O
,	O
3	O
frags	O
,	O
.	O

Part	O
9	O
,	O
"	O
tumor	O
on	O
appendix	O
"	O
,	O
consists	O
of	O
a	O
2	B
.	I
1	I
x	I
1	I
.	I
1	I
x	I
1	I
.	I
1	I
cm	I
fragment	O
o	O
.	O

white	O
/	O
tan	O
,	O
papillary	O
appearing	O
,	O
firm	O
tissue	O
.	O

Representative	O
sections	O
ar	O
.	O
submitted	O
.	O

Micro	O
20	O
.	O

-	O
tumor	O
on	O
appendix	O
,	O
2	O
frags	O
.	O

Part	O
10	O
,	O
"	O
appendix	O
and	O
tumor	O
"	O
,	O
consists	O
of	O
a	O
4	B
.	I
5	I
x	I
3	I
x	I
2	I
.	I
1	I
cm	I
multiloculated	O
.	O
cystic	O
mass	O
filled	O
with	O
green	O
and	O
tan	O
mucinous	O
fluid	O
.	O

Near	O
the	O
.	O

re	O
-	O
section	O
.	O
margin	O
is	O
a	O
1	O
x	O
1	O
x	O
1	O
cm	O
area	O
of	O
white	O
/	O
tan	O
,	O
nodular	O
,	O
firm	O
tissue	O
.	O

The	O
.	O
resection	O
margin	O
of	O
the	O
appendix	O
is	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
and	O
has	O
an	O
obliterated	O
.	O
lumen	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
21	O
.	O
resection	O
margin	O
&	O
possible	O
tip	O
,	O
2	O
frags	O
,	O
.	O

Micro	O
22	O
.	O
appendix	O
&	O
tumor	O
,	O
3	O
frags	O
,	O
.	O

Part	O
11	O
,	O
"	O
umbilical	O
hernia	O
sac	O
"	O
,	O
consists	O
of	O
a	O
3	O
.	O
9	O
x	O
2	O
.	O
6	O
x	O
0	O
.	O
7	O
cm	O
fragment	O
of	O
.	O

yellow	O
/	O
tan	O
,	O
hemorrhagic	O
soft	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Micro	O
23	O
.	O

-	O
umbilical	O
hernia	O
sac	O
,	O
3	O
frags	O
,	O
.	O

Reports	O
to	O
:	O
SPECIMEN	O
TYPE	O
:	O
MUSCLE	O
.	O

BIOPSY	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
SOFT	O
TISSUE	O
TUMOR	O
EXTENSIVE	O
RESECTION	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
SOFT	O
TISSUE	O
MASS	O
OR	O
SIMPLE	O
EXCISION	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
UTERUS	O
WITH	O
OR	O
WITHOUT	O
TUBES	O
&	O
OVARIES	O
,	O
NEOPLASTIC	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
SOFT	O
TISSUE	O
MASS	O
OR	O
SIMPLE	O
EXCISION	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
SOFT	O
TISSUE	O
BIOPSY	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
SOFT	O
TISSUE	O
BIOPSY	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
APPENDIX	O
,	O
OTHER	O
THAN	O
INCIDENTAL	O
.	O

ADDITIONAL	O
SPECIMEN	O
TYPE	O
:	O
HERNIA	O
SAC	O
(	O
ANY	O
LOCATION	O
)	O
.	O

Page	O
:	O
3	O
of	O
3	O
.	O

WholeBlood	O
.	O

Ovarian	O
Tumor	O
.	O
year	O
old	O
black	O
female	O
.	O

Collected	O
date	O
:	O
Diagnosis	O
.	O

Ovary	O
and	O
Fallopian	O
tube	O
,	O
left	O
,	O
excision	O
:	O
-	O
Papillary	O
serous	O
adenocarcinoma	O
.	O

-	O
Ovarian	O
capsule	O
is	O
intact	O
.	O

-	O
The	O
size	O
of	O
tumor	O
is	O
9	B
.	I
5	I
cm	I
in	O
maximum	O
dimension	O
.	O

-	O
Fallopian	O
tube	O
is	O
not	O
identified	O
.	O

Ovary	O
and	O
Fallopian	O
tube	O
,	O
right	O
,	O
excision	O
:	O
-	O
Papillary	O
serous	O
adenocarcinoma	O
.	O

-	O
Ovarian	O
capsule	O
is	O
intact	O
.	O

-	O
The	O
size	O
of	O
tumor	O
is	O
19	B
.	I
0	I
cm	I
in	O
maximum	O
dimension	O
.	O

-	O
Fallopian	O
tube	O
is	O
not	O
identified	O
.	O

Omentum	O
,	O
excision	O
:	O
-	O
No	O
evidence	O
of	O
malignancy	O
.	O

-	O
See	O
comment	O
.	O

Pathologist	O
Comment	O
.	O

Both	O
ovaries	O
show	O
significant	O
involvement	O
by	O
tumor	O
resulting	O
in	O
large	O
bilateral	O
tumor	O
masses	O
.	O

I	O
favor	O
.	O
synchronnous	O
tumors	O
because	O
capsules	O
seems	O
to	O
be	O
intact	O
.	O

However	O
metastatic	O
tumor	O
cannot	O
be	O
ruled	O
.	O
out	O
.	O

Synoptic	O
Report	O
.	O

SPECIMEN	O
;	O
.	O

Right	O
ovary	O
.	O

Left	O
ovary	O
.	O

Right	O
fallopian	O
tube	O
.	O

Left	O
fallopian	O
tube	O
.	O

Omentum	O
.	O

PROCEDURE	O
:	O
Bilateral	O
salpingo	O
-	O
oophorectomy	O
.	O

Omentectomy	O
.	O

LYMPH	O
NODE	O
SAMPLING	O
:	O
Not	O
performed	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Capsule	O
intact	O
.	O

Left	O
ovary	O
.	O

Capsule	O
intact	O
.	O

PRIMARY	O
TUMOR	O
SITE	O
:	O
Bilateral	O
ovarian	O
involvement	O
.	O

OVARIAN	O
SURFACE	O
INVOLVEMENT	O
:	O
Uncertain	O
/	O
cannot	O
be	O
determined	O
.	O

TUMOR	O
SIZE	O
:	O
Right	O
Ovary	O
-	O
Greatest	O
dimension	O
:	O
19	B
.	I
0	I
cm	I
.	O

Left	O
Ovary	O
-	O
Greatest	O
dimension	O
:	O
9	O
.	O
5	O
cm	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Serous	O
,	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
High	O
grade	O
.	O

EXTENT	O
OF	O
INVOLVEMENT	O
OF	O
OTHER	O
TISSUES	O
/	O
ORGANS	O
:	O
Right	O
ovary	O
:	O
Involved	O
.	O

Left	O
ovary	O
:	O
Involved	O
.	O

Right	O
fallopian	O
tube	O
:	O
Not	O
applicable	O
.	O

Left	O
fallopian	O
tube	O
:	O
Not	O
applicable	O
.	O

Omentum	O
:	O
Not	O
involved	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
[	O
FIGO	O
]	O
:	O
pT1b	O
[	O
IB	O
]	O
:	O
Tumor	O
limited	O
to	O
both	O
ovaries	O
;	O
capsule	O
intact	O
,	O
no	O
tumor	O
on	O
ovarian	O
surface	O
.	O

No	O
.	O
malignant	O
cells	O
in	O
ascites	O
or	O
peritoneal	O
washings	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Clinical	O
Information	O
.	O

The	O
patient	O
is	O
a	O
.	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
pelvic	O
pain	O
and	O
pelvic	O
mass	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

AFS1	O
:	O
Left	O
tube	O
and	O
ovary	O
,	O
excision	O
:	O
-	O
Positive	O
for	O
carcinoma	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
three	O
containers	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
.	O

The	O
first	O
container	O
is	O
labeled	O
,	O
"	O
left	O
tube	O
and	O
ovary	O
"	O
.	O

Received	O
is	O
a	O
frozen	O
section	O
cassettes	O
and	O
ovary	O
.	O
according	O
to	O
the	O
frozen	O
section	O
paperwork	O
it	O
is	O
a	O
4	O
.	O
0	O
x	O
3	O
.	O
5	O
papillary	O
mass	O
.	O

This	O
mass	O
appears	O
to	O
have	O
.	O
been	O
within	O
a	O
cyst	O
that	O
measures	O
approximately	O
8	O
.	O
0	O
cm	O
.	O

The	O
entire	O
specimen	O
measures	O
9	O
.	O
5	O
X	O
8	O
.	O
5	O
X	O
2	O
.	O
5	O
.	O

cm	O
.	O

Attached	O
to	O
the	O
papillary	O
lesion	O
,	O
the	O
section	O
of	O
firm	O
white	O
tissue	O
that	O
measures	O
8	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
.	O

The	O
second	O
container	O
is	O
labeled	O
,	O
"	O
right	O
tube	O
and	O
ovary	O
"	O
.	O

Received	O
is	O
the	O
ovary	O
and	O
possible	O
fallopian	O
tube	O
.	O
that	O
measures	O
5	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
ovary	O
has	O
been	O
opened	O
intraoperatively	O
and	O
appears	O
cystic	O
.	O

The	O
ovary	O
.	O
measures	O
14	O
.	O
5	O
x	O
7	O
.	O
5	O
X	O
2	O
.	O
5	O
cm	O
.	O

Within	O
the	O
open	O
cyst	O
,	O
the	O
papillary	O
lesion	O
that	O
measures	O
3	O
.	O
0	O
X	O
2	O
.	O
5	O
cm	O
.	O

The	O
.	O
outside	O
will	O
be	O
inked	O
.	O

The	O
cystic	O
region	O
measures	O
7	O
.	O
5	O
X	O
7	O
.	O
0	O
cm	O
.	O

Further	O
examination	O
of	O
the	O
cyst	O
reveals	O
.	O
there	O
are	O
multiple	O
papillary	O
regions	O
.	O

There	O
is	O
an	O
additional	O
section	O
that	O
measures	O
4	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

There	O
is	O
a	O
.	O
separate	O
cystic	O
area	O
that	O
measures	O
4	O
.	O
0	O
x	O
2	O
.	O
0	O
X	O
2	O
.	O
0	O
cm	O
.	O

The	O
cyst	O
contains	O
brown	O
fluid	O
as	O
well	O
as	O
what	O
.	O
appears	O
to	O
be	O
necrotic	O
material	O
.	O

The	O
third	O
container	O
is	O
labeled	O
,	O
"	O
omentum	O
"	O
.	O

Received	O
is	O
a	O
section	O
of	O
omentum	O
that	O
measures	O
25	O
.	O
0	O
x	O
8	O
.	O
0	O
x	O
.	O

2	O
.	O
0	O
cm	O
.	O

Section	O
through	O
the	O
omentum	O
reveals	O
multiple	O
small	O
sections	O
with	O
hemorrhage	O
and	O
firm	O
tissue	O
.	O

Representative	O
sections	O
will	O
be	O
submitted	O
.	O

Block	O
Summary	O
.	O

A1	O
-	O
A2	O
-	O
Frozen	O
sections	O
.	O

A3	O
-	O
A5	O
-	O
Full	O
thickness	O
section	O
through	O
papillary	O
lesion	O
and	O
outside	O
of	O
ovary	O
.	O

A6	O
-	O
Additional	O
section	O
through	O
papillary	O
lesion	O
.	O

A7	O
-	O
A8	O
-	O
Representative	O
sections	O
through	O
firm	O
white	O
tissue	O
.	O

A9	O
-	O
Section	O
through	O
possibly	O
hemorrhagic	O
/	O
necrotic	O
tissue	O
and	O
cyst	O
wall	O
.	O

A10	O
-	O
Additional	O
cystic	O
tissue	O
.	O

B1	O
-	O
Fallopian	O
tube	O
.	O

B2	O
-	O
B4	O
-	O
Representative	O
sections	O
through	O
papillary	O
lesion	O
.	O

B5	O
-	O
B6	O
-	O
Additional	O
sections	O
through	O
separate	O
papillary	O
lesion	O
.	O

B7	O
-	O
Representative	O
sections	O
through	O
second	O
cyst	O
.	O

B8	O
-	O
B9	O
-	O
Representative	O
sections	O
through	O
ovary	O
.	O

B10	O
-	O
Section	O
through	O
necrotic	O
tissue	O
.	O

C1	O
-	O
C5	O
-	O
Representative	O
sections	O
of	O
omentum	O
.	O

Microscopic	O
Description	O
.	O

Bilateral	O
ovaries	O
show	O
malignant	O
tumor	O
with	O
papillary	O
architecture	O
and	O
high	O
grade	O
cytologic	O
atypia	O
.	O
consistent	O
with	O
papillary	O
serous	O
adenocarcinoma	O
.	O

Bilateral	O
ovaries	O
are	O
involved	O
by	O
tumor	O
.	O

Fallopian	O
tubes	O
.	O
are	O
not	O
histologically	O
identified	O
.	O

Omentum	O
is	O
free	O
of	O
malignancy	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

A	O
.	O

LEFT	O
BRAIN	O
CYSTIC	O
TUMOR	O
,	O
REMOVAL	O
:	O
-	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
(	O
WHO	O
GRADE	O
IV	O
)	O
.	O

Note	O
:	O
The	O
tumor	O
demonstrates	O
focal	O
circumscription	O
with	O
pilomyxoid	O
degeneration	O
.	O

Necrosis	O
is	O
not	O
identified	O
,	O
.	O
however	O
,	O
microvascular	O
proliferation	O
is	O
prominent	O
.	O

B	O
.	O

SPECIMEN	O
LABELED	O
CYST	O
WALL	O
,	O
BIOPSY	O
:	O
-	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
.	O

Note	O
:	O
Immunohistochemical	O
stains	O
confirm	O
the	O
diagnosis	O
.	O

C	O
.	O

TEMPORAL	O
TIP	O
,	O
BIOPSY	O
:	O
-	O
-	O
CEREBRAL	O
CORTEX	O
DEMONSTRATING	O
MILD	O
ASTROCYTIC	O
HYPERCELLULARITY	O
.	O

One	O
or	O
more	O
of	O
the	O
reagents	O
used	O
to	O
perform	O
assays	O
on	O
this	O
specimen	O
MAY	O
have	O
contained	O
components	O
considered	O
.	O
to	O
be	O
analyte	O
specific	O
reagents	O
(	O
ASR	O
'	O
s	O
)	O
.	O

ASR	O
'	O
s	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

These	O
assays	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

The	O
assays	O
.	O
were	O
performed	O
with	O
appropriate	O
positive	O
and	O
negative	O
controls	O
.	O

By	O
the	O
signature	O
on	O
this	O
report	O
,	O
the	O
individual	O
or	O
group	O
listed	O
as	O
making	O
the	O
Final	O
Interpretation	O
/	O
Diagnosis	O
certifies	O
that	O
they	O
have	O
reviewed	O
this	O
case	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

A	O
&	O
B	O
:	O
Touch	O
Imprint	O
:	O
High	O
grade	O
glioma	O
.	O

Clinical	O
History	O
:	O
Left	O
brain	O
cystic	O
lesion	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
TUMOR	O
.	O

B	O
:	O
CYST	O
WALL	O
.	O

C	O
:	O
TEMPORAL	O
TIP	O
.	O

Gross	O
Description	O
:	O
A	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
hospital	O
number	O
,	O
are	O
multiple	O
,	O
.	O
irregular	O
fragments	O
of	O
tan	O
-	O
brown	O
and	O
gray	O
,	O
soft	O
tissue	O
,	O
measuring	O
approximately	O
3	O
.	O
5	O
X	O
3x	O
1	O
.	O
5	O
cm	O
.	O

A	O
touch	O
imprint	O
and	O
.	O
frozen	O
section	O
is	O
performed	O
on	O
this	O
tissue	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
total	O
of	O
five	O
cassettes	O
.	O

B	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
number	O
,	O
are	O
multiple	O
,	O
irregular	O
.	O
fragments	O
of	O
tan	O
-	O
brown	O
and	O
gray	O
,	O
soft	O
tissue	O
,	O
measuring	O
approximately	O
1	O
.	O
5	O
x	O
1	O
X	O
0	O
.	O
4	O
cm	O
in	O
aggregate	O
.	O

A	O
touch	O
imprint	O
.	O
and	O
frozen	O
section	O
are	O
performed	O
on	O
the	O
specimen	O
,	O
and	O
the	O
entire	O
specimen	O
is	O
submitted	O
in	O
two	O
cassettes	O
.	O

C	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
are	O
multiple	O
,	O
irregular	O
fragments	O
of	O
tan	O
-	O
gray	O
,	O
soft	O
tissue	O
,	O
measuring	O
.	O
approximately	O
1	O
.	O
5	O
)	O
0	O
.	O
8	O
X	O
0	O
.	O
4	O
cm	O
in	O
aggregate	O
.	O

A	O
frozen	O
section	O
and	O
touch	O
imprint	O
were	O
performed	O
and	O
submitted	O
in	O
.	O
one	O
cassette	O
.	O

Summary	O
of	O
Cassettes	O
:	O
A	O
.	O

1FS	O
.	O

2	O
-	O
5	O
.	O
remainder	O
of	O
the	O
specimen	O
.	O

B	O
.	O

1FS	O
.	O

2	O
.	O
remainder	O
of	O
the	O
specimen	O
.	O

C	O
.	O

1	O
.	O
entire	O
specimen	O
of	O
tan	O
-	O
gray	O
,	O
soft	O
tissue	O
.	O

Structured	O
findings	O
:	O
The	O
material	O
in	O
I	O
)	O
is	O
an	O
advanced	O
carcinoma	O
,	O
namely	O
a	O
mucinous	O
adenocarcinoma	O
of	O
the	O
colon	O
.	O
with	O
penetration	O
of	O
all	O
parietal	O
layers	O
and	O
vascular	O
infiltrates	O
(	O
G3	O
,	O
pT3	O
,	O
L1	O
,	O
V1	O
)	O
,	O
with	O
regard	O
to	O
.	O
the	O
resection	O
margins	O
of	O
the	O
mucosa	O
they	O
show	O
a	O
regular	O
mucosa	O
,	O
submucosa	O
and	O
muscularis	O
,	O
.	O
with	O
regard	O
to	O
the	O
radial	O
resection	O
margin	O
they	O
show	O
a	O
free	O
resection	O
margin	O
with	O
mature	O
fatty	O
.	O
connective	O
tissue	O
and	O
related	O
vascular	O
portions	O
,	O
.	O
with	O
regard	O
to	O
the	O
lymph	O
nodes	O
they	O
show	O
free	O
lymph	O
nodes	O
(	O
0	O
/	O
14	O
)	O
.	O

Findings	O
and	O
diagnosis	O
in	O
response	O
to	O
the	O
question	O
:	O
I	O
)	O
involves	O
regular	O
splenic	O
tissue	O
,	O
divided	O
into	O
red	O
and	O
white	O
pulp	O
with	O
the	O
appropriate	O
.	O
trabecular	O
structure	O
.	O

II	O
)	O
involves	O
free	O
fatty	O
tissue	O
and	O
free	O
lymph	O
nodes	O
.	O

III	O
)	O
involves	O
a	O
poorly	O
differentiated	O
advanced	O
gastric	O
carcinoma	O
.	O
in	O
this	O
case	O
an	O
.	O
invasive	O
adenocarcinoma	O
of	O
the	O
intestinal	O
type	O
,	O
.	O
with	O
infiltration	O
of	O
all	O
wall	O
layers	O
(	O
p	O
T	O
2b	O
)	O
,	O
.	O
with	O
extensive	O
lymphatic	O
vessel	O
penetration	O
(	O
L	O
1	O
-	O
.	O
also	O
below	O
)	O
,	O
.	O
with	O
free	O
resection	O
margins	O
in	O
the	O
mucosal	O
area	O
.	O

In	O
addition	O
,	O
in	O
eight	O
cut	O
surfaces	O
there	O
are	O
lymph	O
node	O
metastases	O
from	O
the	O
carcinoma	O
.	O
described	O
and	O
,	O
adjacent	O
to	O
these	O
,	O
indurated	O
fatty	O
connective	O
tissue	O
and	O
.	O
infiltration	O
of	O
the	O
omental	O
tissue	O
and	O
.	O
partially	O
also	O
of	O
the	O
serosa	O
(	O
p	O
T	O
3	O
)	O
.	O

IV	O
)	O
involves	O
regular	O
anastomotic	O
rings	O
,	O
here	O
of	O
the	O
small	O
bowel	O
type	O
with	O
appropriate	O
.	O
villous	O
and	O
crypt	O
relief	O
,	O
lined	O
with	O
cylinder	O
cells	O
and	O
goblet	O
cells	O
.	O

In	O
respect	O
of	O
the	O
pancreatic	O
situation	O
,	O
further	O
secondary	O
resections	O
will	O
follow	O
(	O
p	O
T	O
3	O
/	O
.	O
p	O
T	O
4	O
)	O
.	O

A	O
consultation	O
was	O
held	O
about	O
the	O
definitive	O
TNM	O
classification	O
.	O

This	O
is	O
defined	O
by	O
the	O
infiltration	O
of	O
the	O
omental	O
tissue	O
,	O
in	O
this	O
case	O
with	O
infiltration	O
of	O
the	O
.	O
peritoneum	O
and	O
,	O
additionally	O
to	O
the	O
initial	O
findings	O
,	O
with	O
infiltration	O
of	O
the	O
lymph	O
nodes	O
in	O
.	O
the	O
area	O
of	O
the	O
omentum	O
in	O
four	O
cut	O
surfaces	O
.	O

In	O
the	O
pancreas	O
these	O
are	O
inflammatory	O
reactive	O
changes	O
.	O

The	O
tumour	O
classification	O
is	O
as	O
follows	O
:	O
ICDO	O
-	O
DA	O
-	O
M	O
8140	O
/	O
3	O
.	O

pT3	O
,	O
p	O
N	O
1	O
,	O
L	O
1	O
.	O

In	O
respect	O
of	O
the	O
operative	O
specimen	O
a	O
clear	O
margin	O
of	O
healthy	O
tissue	O
was	O
removed	O
locally	O
.	O

(	O
cf	O
.	O
also	O
where	O
necessary	O
the	O
corresponding	O
operative	O
report	O
)	O
.	O

Amended	O
.	O

Physician	O
(	O
s	O
)	O
:	O
other	O
Related	O
Clinical	O
Data	O
:	O
DIAGNOSIS	O
:	O
OVARY	O
,	O
RIGHT	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
ADENOCARCINOMA	O
(	O
SEE	O
SYNOPSIS	O
)	O
.	O

-	O
THE	O
TUMOR	O
INVOLVES	O
THE	O
OVARIAN	O
SURFACE	O
AND	O
AND	O
PARAOVARIAN	O
SOFT	O
TISSUE	O
.	O

-	O
LYMPHATIC	O
-	O
VASCULAF	O
SPACE	O
INVASION	O
ARE	O
IDENTIFIED	O
.	O

OVARY	O
,	O
LEFT	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
ADENOCARCINOMA	O
(	O
SEE	O
SYNOPSIS	O
)	O
.	O

-	O
THE	O
TUMOR	O
INVOLVES	O
THE	O
OVARIAN	O
SURFACE	O
AND	O
AND	O
PARAOVARIAN	O
SOFT	O
TISSUE	O
.	O

-	O
LYMPHATIC	O
-	O
VASCULAR	O
SPACE	O
INVASION	O
ARE	O
IDENTIFIED	O
.	O

FALLOPIAN	O
TUBE	O
,	O
RIGHT	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

FALLOPIAN	O
TUBE	O
,	O
LEFT	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

UTERUS	O
WITH	O
CERVIX	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
INVOLVING	O
EXTENSIVELY	O
SEROSA	O
,	O
SUBSEROSAL	O
MYOMETRIUM	O
,	O
.	O

ECTOCERVIX	O
AND	O
FOCALLY	O
ENDOCERVIX	O
.	O

-	O
INACTIVE	O
ENDOMETRIUM	O
.	O

-	O
ADENOMYOSIS	O
.	O

BLADDER	O
MUCOSA	O
,	O
BIOPSY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

APPENDIX	O
,	O
APPENDECTOMY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

GASTROCOLIC	O
OMENTUM	O
,	O
EXCISION	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

RECTAL	O
PLAQUE	O
,	O
BIOPSY	O
.	O

-	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
WITH	O
NECROSIS	O
.	O

By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
upon	O
my	O
.	O
personal	O
.	O

examination	O
of	O
the	O
slides	O
(	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
the	O
diagnosis	O
)	O
.	O

Intraoperative	O
Consultation	O
:	O
An	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
Called	O
to	O
.	O
pick	O
-	O
up	O
uterus	O
/	O
cervix	O
/	O
right	O
and	O
left	O
tubes	O
and	O
ovaries	O
'	O
consisting	O
of	O
a	O
102	O
gram	O
corpus	O
.	O
uteri	O
and	O
cervix	O
with	O
bilateral	O
attached	O
fallopian	O
tubes	O
and	O
ovaries	O
.	O

The	O
ovaries	O
are	O
.	O
sectioned	O
and	O
tissue	O
is	O
procured	O
for	O
.	O
request	O
.	O

The	O
uterus	O
measures	O
6	O
.	O
8	O
cm	O
.	O
from	O
fundus	O
to	O
cervix	O
,	O
3	O
cm	O
from	O
cornu	O
to	O
cornu	O
,	O
and	O
4	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

All	O
.	O
for	O
permanents	O
,	O
.	O

Microscopic	O
Description	O
and	O
Comment	O
:	O
tantiates	O
the	O
above	O
cited	O
diagnosis	O
.	O

History	O
:	O
The	O
patient	O
is	O
a	O
.	O
of	O
unstated	O
race	O
,	O
with	O
ovarian	O
cancer	O
.	O

Operative	O
.	O
procedure	O
:	O
Evaluation	O
under	O
anesthesia	O
,	O
exploratory	O
laparotomy	O
,	O
transabdominal	O
hysterectomy	O
.	O

-	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
,	O
tumor	O
debulking	O
,	O
and	O
appendectomy	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
HYSTERECTOMY	O
,	O
BSO	O
.	O

B	O
:	O
BLADDER	O
SEROSA	O
.	O

C	O
:	O
APPENDIX	O
.	O

D	O
:	O
GASTRO	O
COLIC	O
OMENTUM	O
,	O
ROUTINE	O
.	O

E	O
:	O
RECTAL	O
PLAQUE	O
.	O

Gross	O
Description	O
.	O

The	O
specimens	O
are	O
received	O
in	O
five	O
containers	O
of	O
formalin	O
,	O
each	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
.	O

The	O
first	O
container	O
is	O
labelled	O
"	O
uterus	O
/	O
cervix	O
/	O
right	O
and	O
left	O
tubes	O
and	O
ovaries	O
.	O

It	O
.	O
consists	O
of	O
a	O
uterus	O
,	O
with	O
dimensions	O
consistent	O
with	O
those	O
in	O
intraoperative	O
consultation	O
,	O
.	O
attached	O
cervix	O
,	O
measuring	O
3	O
x	O
3	O
x	O
2	O
.	O
5	O
cm	O
,	O
left	O
and	O
right	O
fallopian	O
tubes	O
,	O
measuring	O
6	O
.	O
5	O
.	O

cm	O
and	O
6	O
cm	O
,	O
respectively	O
,	O
and	O
left	O
and	O
right	O
ovaries	O
measuring	O
3	O
x	O
2	O
.	O
5	O
x	O
1	O
cm	O
each	O
.	O

The	O
.	O
specimen	O
has	O
been	O
previously	O
bivalved	O
for	O
fixation	O
.	O

The	O
external	O
surface	O
of	O
cervix	O
and	O
.	O
uterus	O
shows	O
irregular	O
adhesions	O
.	O

No	O
recognizable	O
vaginal	O
cuff	O
or	O
parametrial	O
tissue	O
is	O
.	O
present	O
.	O

The	O
ectocervix	O
measures	O
3	O
x	O
1	O
cm	O
anteriorly	O
,	O
and	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
posteriorly	O
.	O

The	O
.	O
reconstituted	O
os	O
is	O
somewhat	O
irregular	O
,	O
measuring	O
0	O
.	O
5	O
cm	O
.	O

An	O
area	O
of	O
hemorrhage	O
,	O
otherwise	O
.	O
smooth	O
is	O
noted	O
along	O
the	O
posterior	O
ectocervix	O
measuring	O
1	O
x	O
1	O
cm	O
in	O
extent	O
.	O

The	O
cervical	O
.	O
canal	O
measuring	O
2	O
.	O
5	O
cm	O
in	O
length	O
shows	O
mucus	O
.	O

A	O
slight	O
irregularity	O
is	O
noted	O
along	O
the	O
.	O
anterior	O
endocervical	O
canal	O
with	O
attached	O
mucus	O
,	O
measuring	O
1	O
x	O
1	O
.	O
2	O
cm	O
.	O

The	O
endometrial	O
.	O
cavity	O
is	O
triangular	O
and	O
measures	O
2	O
.	O
5	O
x	O
2	O
cm	O
.	O

The	O
anterior	O
and	O
posterior	O
endomyometrium	O
.	O

is	O
diffusely	O
thickened	O
with	O
a	O
smooth	O
,	O
trabeculated	O
appearance	O
.	O

The	O
anterior	O
endomyometrium	O
.	O
measures	O
2	O
.	O
3	O
cm	O
in	O
thickness	O
and	O
the	O
posterior	O
endomyometrium	O
measures	O
2	O
.	O
7	O
cm	O
in	O
the	O
.	O
maximally	O
thickened	O
area	O
.	O

The	O
endometrial	O
-	O
myometrial	O
interface	O
is	O
grossly	O
obliterated	O
.	O

The	O
.	O
left	O
adnexal	O
structures	O
are	O
congested	O
and	O
edematous	O
in	O
appearance	O
.	O

Adhesions	O
are	O
grossly	O
.	O
identified	O
with	O
some	O
firm	O
areas	O
.	O

The	O
fimbriated	O
end	O
of	O
the	O
left	O
fallopian	O
tube	O
is	O
grossly	O
.	O
obliterated	O
and	O
shows	O
a	O
soft	O
,	O
grey	O
-	O
white	O
nodule	O
,	O
measuring	O
0	O
.	O
3	O
cm	O
in	O
immediate	O
vicinity	O
.	O

The	O
left	O
ovary	O
,	O
although	O
not	O
grossly	O
enlarged	O
,	O
has	O
a	O
nodular	O
,	O
granular	O
outer	O
surface	O
with	O
.	O
areas	O
showing	O
exudate	O
.	O

The	O
cut	O
surface	O
is	O
also	O
somewhat	O
nodular	O
and	O
firm	O
.	O

No	O
gross	O
extension	O
.	O
of	O
tumor	O
into	O
the	O
meso	O
-	O
ovarian	O
or	O
adjacent	O
,	O
middle	O
-	O
third	O
of	O
fallopian	O
tube	O
is	O
noted	O
.	O

The	O
.	O
right	O
fallopian	O
tube	O
is	O
thickened	O
along	O
the	O
middle	O
-	O
third	O
with	O
serosal	O
congestion	O
and	O
exudate	O
.	O
on	O
the	O
surface	O
.	O

The	O
fimbriated	O
end	O
is	O
obliterated	O
and	O
somewhat	O
firm	O
.	O

There	O
are	O
areas	O
of	O
.	O
congestion	O
and	O
firmness	O
with	O
exudate	O
-	O
like	O
deposits	O
in	O
the	O
left	O
adnexal	O
soft	O
tissue	O
.	O

The	O
.	O
right	O
ovary	O
is	O
similar	O
in	O
gross	O
appearance	O
to	O
the	O
left	O
ovary	O
.	O

Labelled	O
A1	O
-	O
A5	O
,	O
anterior	O
.	O
cervix	O
with	O
A1	O
.	O
and	O
_	O
A2	O
containing	O
the	O
nodular	O
_	O
thickening	O
;	O
A6	O
-	O
A8	O
,	O
posterior	O
cervix	O
;	O
A9	O
and	O
.	O

A10	O
,	O
synchronous	O
sections	O
of	O
anterior	O
endomyometriun	O
;	O
A11	O
and	O
A12	O
,	O
synchronous	O
sections	O
of	O
.	O
posterior	O
endomyometrium	O
;	O
A13	O
,	O
posterior	O
serosal	O
adhesions	O
on	O
uterine	O
corpus	O
;	O
A14	O
,	O
anterior	O
.	O
serosal	O
adhesions	O
;	O
A15	O
-	O
A17	O
,	O
left	O
ovary	O
and	O
fallopian	O
tube	O
;	O
A18	O
-	O
A20	O
,	O
right	O
ovary	O
,	O
right	O
.	O
adnexa	O
and	O
fallopian	O
tube	O
;	O
A21	O
-	O
A25	O
,	O
the	O
remaining	O
entire	O
cervix	O
;	O
A26	O
-	O
A33	O
,	O
the	O
remaining	O
.	O
entire	O
endometrium	O
.	O

The	O
second	O
container	O
is	O
labelled	O
"	O
bladder	O
serosa	O
"	O
and	O
contains	O
an	O
irregular	O
fragment	O
of	O
.	O
congested	O
,	O
soft	O
,	O
membranous	O
tissue	O
measuring	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Attached	O
adipose	O
tissue	O
.	O

is	O
noted	O
on	O
the	O
smooth	O
surface	O
.	O

The	O
opposite	O
surface	O
is	O
somewhat	O
rough	O
and	O
hemorrhagic	O
.	O

Serially	O
sectioned	O
.	O

Labelled	O
B1	O
and	O
B2	O
.	O

The	O
third	O
container	O
is	O
labelled	O
"	O
appendix	O
"	O
and	O
contains	O
an	O
appendix	O
with	O
attached	O
fat	O
,	O
.	O
measuring	O
6	O
cm	O
in	O
length	O
.	O

The	O
tip	O
is	O
swollen	O
and	O
congested	O
and	O
shows	O
grey	O
-	O
white	O
exudate	O
on	O
.	O
the	O
surface	O
.	O

It	O
measures	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
cut	O
surface	O
in	O
the	O
swollen	O
area	O
.	O
shows	O
an	O
obliterated	O
lumen	O
with	O
no	O
gross	O
evidence	O
of	O
tumor	O
involvement	O
.	O

Serial	O
sectioning	O
.	O
through	O
the	O
remaining	O
appendix	O
shows	O
a	O
thin	O
,	O
0	O
.	O
3	O
cm	O
appendix	O
with	O
obliterated	O
lumen	O
.	O

The	O
.	O
adjacent	O
ad	O
	O
pose	O
tissue	O
is	O
grossly	O
unremarkable	O
.	O

Labelled	O
C1	O
and	O
C2	O
,	O
entire	O
firm	O
area	O
around	O
.	O
putative	O
tip	O
;	O
C3	O
,	O
random	O
appendix	O
.	O

The	O
fourth	O
container	O
is	O
labelled	O
"	O
gastro	O
-	O
colic	O
omentum	O
.	O

It	O
consists	O
of	O
a	O
stretch	O
of	O
.	O
omentum	O
,	O
measuring	O
40	O
x	O
18	O
x	O
3	O
.	O
5	O
cm	O
in	O
maximum	O
dimensions	O
.	O

There	O
are	O
geographic	O
areas	O
of	O
.	O
thickening	O
and	O
omental	O
caking	O
,	O
involving	O
the	O
edges	O
of	O
the	O
omentum	O
.	O

Cut	O
sections	O
of	O
these	O
.	O
areas	O
show	O
grey	O
-	O
white	O
,	O
firm	O
cut	O
'	O
surface	O
with	O
areas	O
of	O
necrosis	O
.	O

Random	O
representative	O
.	O
sections	O
labelled	O
D1	O
-	O
D4	O
.	O

The	O
fifth	O
container	O
is	O
labelled	O
"	O
rectal	O
plaque	O
"	O
and	O
contains	O
multiple	O
plaque	O
-	O
like	O
,	O
.	O
hemorrhagic	O
fragments	O
measuring	O
1	O
.	O
5	O
CC	O
in	O
aggregate	O
.	O

Labelled	O
E1	O
.	O

Jar	O
0	O
.	O

Synopsis	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
OVARIAN	O
NEOPLASMS	O
.	O

1	O
.	O

A	O
neoplasm	O
is	O
PRESENT	O
.	O

2	O
.	O

The	O
HISTOLOGIC	O
DIAGNOSIS	O
is	O
.	O

Serous	O
adenocarcinoma	O
.	O

3	O
.	O

The	O
LOCATION	O
(	O
S	O
)	O
OF	O
THE	O
PRIMARY	O
TUMOR	O
(	O
S	O
)	O
is	O
/	O
are	O
:	O
Right	O
and	O
left	O
ovary	O
(	O
synchronous	O
primary	O
tumors	O
)	O
.	O

The	O
FIGO	O
GRADE	O
of	O
the	O
tumor	O
is	O
:	O
III	O
(	O
Tumor	O
composed	O
of	O
>	O
50	O
%	O
solid	O
cellular	O
nests	O
)	O
.	O

5	O
.	O

The	O
NUCLEAR	O
(	O
BRODERS	O
'	O
)	O
GRADE	O
of	O
the	O
tumor	O
is	O
:	O
G3	O
.	O

Poorly	O
-	O
differentiated	O
)	O
.	O

6	O
.	O

Tumor	O
IS	O
identified	O
on	O
the	O
ovarian	O
surface	O
(	O
s	O
)	O
.	O

7	O
.	O

Tumor	O
DOES	O
invade	O
the	O
mesovarium	O
.	O

8	O
.	O

Tumor	O
DOES	O
invade	O
the	O
adjacent	O
fallopian	O
tube	O
.	O

9	O
.	O

Tumor	O
DOES	O
invade	O
the	O
pelvic	O
soft	O
tissue	O
.	O

10	O
.	O

Tumor	O
involvement	O
of	O
the	O
pelvic	O
peritoneum	O
is	O
PRESENT	O
.	O

11	O
.	O

Metastatic	O
involvement	O
of	O
the	O
EXTRAPELVIC	O
PERITONEUM	O
is	O
PRESENT	O
.	O

12	O
.	O

Metastatic	O
involvement	O
of	O
the	O
omentum	O
is	O
PRESENT	O
.	O

13	O
.	O

The	O
maximum	O
dimension	O
of	O
tumor	O
implants	O
outside	O
the	O
true	O
pelvis	O
is	O
.	O

>	O
2	O
cm	O
.	O

15	O
.	O

Metastatic	O
involvement	O
of	O
the	O
endometrium	O
is	O
ABSENT	O
.	O

16	O
.	O

Regional	O
lymph	O
node	O
metastases	O
CANNOT	O
BE	O
EVALUATED	O
.	O

17	O
.	O

The	O
total	O
number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
is	O
0	O
.	O

18	O
.	O

The	O
total	O
number	O
of	O
metastatically	O
-	O
involved	O
regional	O
lymph	O
nodes	O
cannot	O
be	O
evaluated	O
.	O

19	O
.	O

DETAILED	O
STAGING	O
INFORMATION	O
:	O
Based	O
on	O
the	O
above	O
information	O
,	O
the	O
PRIMARY	O
TUMOR	O
is	O
.	O
classified	O
as	O
:	O
TNM	O
Scheme	O
.	O

FIGO	O
Scheme	O
.	O

Definition	O
.	O

T3c	O
.	O

IIIC	O
.	O

Macroscopic	O
peritoneal	O
.	O
metastasis	O
beyond	O
true	O
pelvis	O
measuring	O
>	O
2	O
cm	O
in	O
greatest	O
dimension	O
,	O
.	O

THE	O
REGIONAL	O
LYMPH	O
NODES	O
are	O
classified	O
as	O
:	O
NX	O
(	O
Nodal	O
status	O
cannot	O
be	O
assessed	O
)	O
.	O

THE	O
STATUS	O
OF	O
DISTANT	O
TUMOR	O
SITES	O
is	O
classified	O
as	O
:	O
MX	O
(	O
Status	O
cannot	O
be	O
assessed	O
)	O
.	O

20	O
.	O

The	O
FINAL	O
AJCC	O
/	O
UICC	O
/	O
FIGO	O
STAGE	O
IS	O
:	O
AJCC	O
/	O
UICC	O
/	O
FIGO	O
.	O

X	O
.	O

Insufficient	O
data	O
to	O
assign	O
stage	O
.	O

Amendments	O
.	O

Reason	O
:	O
This	O
case	O
is	O
being	O
amended	O
to	O
correct	O
the	O
Microscopic	O
description	O
field	O
.	O

SURG	O
PATH	O
#	O
:	O
SPECIMEN	O
CLASS	O
:	O
ALT	O
ID	O
#	O
:	O
SEX	O
:	O
F	O
.	O

DATE	O
RECEIVED	O
:	O
DATE	O
OF	O
PRINTING	O
:	O
Material	O
Received	O
:	O
A	O
:	O
left	O
breast	O
SLN	O
#	O
1	O
time	O
out	O
.	O

B	O
:	O
left	O
breast	O
SLN	O
#	O
2	O
time	O
out	O
.	O

C	O
:	O
left	O
breast	O
SLN	O
#	O
3	O
time	O
out	O
.	O

D	O
:	O
left	O
breast	O
SLN	O
#	O
4	O
time	O
out	O
.	O

E	O
:	O
left	O
breast	O
lumpectomy	O
time	O
out	O
.	O

F	O
:	O
additional	O
anterior	O
left	O
breast	O
tissue	O
.	O

History	O
:	O
year	O
-	O
old	O
female	O
with	O
history	O
of	O
invasive	O
lobular	O
carcinoma	O
of	O
the	O
breast	O
.	O

Final	O
Diagnosis	O
:	O
A	O
.	O

Lymph	O
node	O
(	O
1	O
)	O
,	O
"	O
left	O
breast	O
SLN	O
#	O
1	O
"	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
in	O
one	O
lymph	O
node	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Deeper	O
sections	O
and	O
a	O
pancytokeratin	O
immunostain	O
are	O
negative	O
in	O
support	O
of	O
the	O
above	O
diagnosis	O
.	O

B	O
.	O

Lymph	O
node	O
(	O
1	O
)	O
,	O
"	O
left	O
breast	O
SLN	O
#	O
2	O
"	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
in	O
one	O
lymph	O
node	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Deeper	O
sections	O
and	O
a	O
pancytokeratin	O
immunostain	O
are	O
negative	O
in	O
support	O
of	O
the	O
above	O
diagnosis	O
.	O

C	O
.	O

Lymph	O
node	O
(	O
1	O
)	O
,	O
"	O
left	O
breast	O
SLN	O
#	O
3	O
"	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
in	O
one	O
lymph	O
node	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Deeper	O
sections	O
and	O
a	O
pancytokeratin	O
immunostain	O
are	O
negative	O
in	O
support	O
of	O
the	O
above	O
diagnosis	O
.	O

D	O
.	O

Lymph	O
node	O
(	O
1	O
)	O
,	O
"	O
left	O
breast	O
SLN	O
#	O
4	O
"	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
in	O
one	O
lymph	O
node	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Deeper	O
sections	O
and	O
a	O
pancytokeratin	O
immunostain	O
are	O
negative	O
in	O
support	O
of	O
the	O
above	O
diagnosis	O
.	O

E	O
.	O

Breast	O
,	O
"	O
left	O
breast	O
lumpectomy	O
"	O
,	O
lumpectomy	O
:	O
Invasive	O
lobular	O
carcinoma	O
,	O
moderately	O
differentiated	O
.	O

See	O
comment	O
.	O

Lobular	O
carcinoma	O
in	O
-	O
situ	O
and	O
atypical	O
lobular	O
hyperplasia	O
.	O

Previous	O
biopsy	O
site	O
changes	O
.	O

F	O
.	O

Breast	O
,	O
"	O
additional	O
anterior	O
left	O
breast	O
tissue	O
"	O
,	O
excision	O
:	O
Microscopic	O
focus	O
of	O
invasive	O
lobular	O
carcinoma	O
.	O

See	O
comment	O
.	O

Lobular	O
carcinoma	O
in	O
-	O
situ	O
and	O
atypical	O
lobular	O
hyperplasia	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
Comment	O
:	O
INVASIVE	O
CARCINOMA	O
OF	O
THE	O
BREAST	O
.	O

Specimen	O
Type	O
:	O
Lumpectomy	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
Site	O
:	O
1	O
:	O
00	O
,	O
6	O
cm	O
FTN	O
.	O

Histologic	O
Type	O
:	O
Invasive	O
lobular	O
carcinoma	O
.	O

Size	O
of	O
Invasive	O
Component	O
:	O
1	B
.	I
5	I
cm	I
in	O
greatest	O
dimension	O
in	O
the	O
main	O
lumpectomy	O
.	O

0	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
in	O
the	O
separately	O
.	O
submitted	O
"	O
additional	O
anterior	O
left	O
breast	O
tissue	O
"	O
.	O

Tumor	O
Multicentricity	O
:	O
Yes	O
.	O

Surgical	O
Margins	O
:	O
The	O
carcinoma	O
is	O
focally	O
1	O
.	O
5	O
mm	O
from	O
the	O
anterior	O
margin	O
and	O
focally	O
1	O
.	O
75	O
mm	O
from	O
the	O
inferior	O
margin	O
in	O
.	O
the	O
.	O

main	O
lumpectomy	O
(	O
Specimen	O
E	O
)	O
;	O
all	O
other	O
margins	O
are	O
greater	O
than	O
0	O
.	O
2	O
cm	O
away	O
.	O

In	O
specimen	O
F	O
(	O
"	O
additional	O
anterior	O
left	O
breast	O
.	O
tissue	O
"	O
)	O
which	O
is	O
unoriented	O
,	O
carcinoma	O
is	O
present	O
at	O
one	O
shave	O
margin	O
/	O
tissue	O
edge	O
while	O
all	O
other	O
margins	O
are	O
0	O
.	O
2	O
cm	O
or	O
greater	O
.	O
away	O
.	O

Histologic	O
Grade	O
(	O
Nottingham	O
Histologic	O
Score	O
)	O
:	O
II	O
/	O
III	O
.	O

Tubule	O
Formation	O
:	O
3	O
.	O

Nuclear	O
Grade	O
:	O
2	O
.	O

Mitotic	O
Count	O
(	O
40x	O
objective	O
)	O
:	O
1	O
.	O

Total	O
Nottingham	O
Score	O
:	O
6	O
/	O
9	O
.	O

Ductal	O
Carcinoma	O
In	O
-	O
situ	O
(	O
DCIS	O
)	O
:	O
Absent	O
.	O

Lobular	O
Carcinoma	O
In	O
-	O
situ	O
(	O
LCIS	O
)	O
:	O
Present	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Absent	O
.	O

Nipple	O
Involvement	O
:	O
Not	O
applicable	O
.	O

Skin	O
Involvement	O
:	O
Not	O
applicable	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Sentinel	O
lymph	O
node	O
(	O
s	O
)	O
only	O
.	O

Total	O
number	O
of	O
involved	O
nodes	O
/	O
total	O
nodes	O
found	O
:	O
0	O
/	O
4	O
.	O

Non	O
-	O
neoplastic	O
Breast	O
Tissue	O
:	O
Focal	O
atypical	O
ductal	O
hyperplasia	O
.	O

Fibrosis	O
and	O
prior	O
biopsy	O
site	O
changes	O
.	O

Prognostic	O
markers	O
:	O
Ordered	O
on	O
prior	O
biopsy	O
.	O

See	O
.	O
for	O
addendum	O
.	O

Time	O
between	O
tumor	O
removal	O
and	O
placement	O
into	O
formalin	O
<	O
1	O
hour	O
:	O
Yes	O
.	O

Fixation	O
Time	O
between	O
6	O
-	O
48	O
hours	O
:	O
Yes	O
.	O

Pathologic	O
Staging	O
:	O
pT1c	O
snNo	O
(	O
i	O
-	O
)	O
.	O

Primary	O
Tumor	O
(	O
Invasive	O
Carcinoma	O
)	O
(	O
pT	O
)	O
.	O

pT1c	O
:	O
Tumor	O
10	O
mm	O
but	O
d20	O
mm	O
in	O
greatest	O
dimension	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
.	O

Modifier	O
(	O
required	O
only	O
if	O
applicable	O
)	O
.	O

(	O
sn	O
)	O
:	O
Only	O
sentinel	O
node	O
(	O
s	O
)	O
evaluated	O
.	O

If	O
6	O
or	O
more	O
sentinel	O
nodes	O
and	O
/	O
or	O
nonsentinel	O
nodes	O
are	O
removed	O
,	O
this	O
modifier	O
.	O
should	O
not	O
be	O
used	O
.	O

pNO	O
(	O
i	O
-	O
)	O
:	O
No	O
regional	O
lymph	O
node	O
metastases	O
histologically	O
,	O
negative	O
IHC	O
.	O

Distant	O
Metastasis	O
(	O
M	O
)	O
.	O

Not	O
applicable	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
as	O
it	O
reflects	O
only	O
current	O
pathologic	O
data	O
and	O
does	O
not	O
.	O
incorporate	O
full	O
knowledge	O
of	O
the	O
patient	O
'	O
s	O
clinical	O
status	O
and	O
/	O
or	O
prior	O
pathology	O
.	O

In	O
Specimen	O
F	O
,	O
immunohistochemical	O
stain	O
for	O
smooth	O
muscle	O
myosin	O
supports	O
the	O
diagnosis	O
.	O

Attestation	O
:	O
By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
I	O
have	O
personally	O
formulated	O
the	O
final	O
interpretation	O
expressed	O
in	O
this	O
report	O
and	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
.	O
upon	O
my	O
examination	O
of	O
the	O
slides	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
this	O
report	O
.	O

Interpreted	O
by	O
:	O
Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
Resident	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
"	O
left	O
female	O
breast	O
sentinel	O
lymph	O
node	O
#	O
1	O
out	O
at	O
.	O
are	O
two	O
tan	O
-	O
pink	O
.	O
lymph	O
nodes	O
measuring	O
0	O
.	O
9	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
6	O
cm	O
and	O
1	O
.	O
4	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
smaller	O
lymph	O
node	O
is	O
inked	O
black	O
.	O

Both	O
lymph	O
nodes	O
are	O
.	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
cassette	O
A1	O
.	O

B	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
"	O
female	O
left	O
breast	O
sentinel	O
lymph	O
node	O
#	O
2	O
time	O
out	O
.	O

"	O
is	O
a	O
2	O
.	O
3	O
x	O
1	O
.	O
8	O
x	O
.	O

0	O
.	O
6	O
cm	O
aggregate	O
of	O
yellow	O
-	O
tan	O
fibroadipose	O
tissue	O
that	O
is	O
palpated	O
to	O
reveal	O
two	O
possible	O
lymph	O
nodes	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
.	O

cm	O
and	O
1	O
.	O
5	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
smaller	O
lymph	O
node	O
is	O
inked	O
black	O
.	O

Both	O
lymph	O
nodes	O
are	O
serially	O
sectioned	O
and	O
submitted	O
.	O
entirely	O
in	O
cassette	O
B1	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
female	O
left	O
breast	O
sentinel	O
lymph	O
node	O
#	O
3	O
time	O
out	O
.	O

"	O
is	O
a	O
3	O
.	O
2	O
x	O
.	O

1	O
.	O
7	O
x	O
0	O
.	O
9	O
cm	O
aggregate	O
of	O
yellow	O
-	O
tan	O
fibroadipose	O
tissue	O
that	O
is	O
palpated	O
to	O
reveal	O
two	O
possible	O
fymph	O
nodes	O
measuring	O
0	O
.	O
5x	O
0	O
.	O
5	O
.	O

x	O
.	O

0	O
.	O
3	O
cm	O
and	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
smaller	O
lymph	O
node	O
is	O
inked	O
black	O
.	O

Both	O
lymph	O
nodes	O
are	O
serially	O
sectioned	O
and	O
.	O
submitted	O
.	O

entirely	O
in	O
cassette	O
C1	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
female	O
breast	O
sentinel	O
lymph	O
node	O
#	O
4	O
out	O
at	O
.	O

"	O
.	O

is	O
a	O
2	O
.	O
2	O
X	O
1	O
.	O
1	O
.	O

x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
yellow	O
-	O
tan	O
fibroadipose	O
tissue	O
that	O
is	O
palpated	O
to	O
reveal	O
one	O
possible	O
lymph	O
node	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
.	O

cm	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
cassette	O
D1	O
.	O

E	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
information	O
and	O
"	O
female	O
left	O
breast	O
lumpectomy	O
"	O
is	O
a	O
35	O
gm	O
lumpectomy	O
specimen	O
.	O
measuring	O
7	O
.	O
0	O
x	O
5	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
has	O
already	O
been	O
inked	O
by	O
the	O
surgeon	O
as	O
follows	O
:	O
Orange	O
-	O
Lateral	O
.	O

Yellow	O
-	O
Medial	O
.	O

Red	O
-	O
Superior	O
.	O

Blue	O
-	O
Inferior	O
.	O

Green	O
-	O
Anterior	O
.	O

Black	O
-	O
Posterior	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
lateral	O
to	O
medial	O
into	O
twelve	O
slices	O
.	O

In	O
slices	O
6	O
through	O
8	O
,	O
there	O
is	O
a	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
firm	O
.	O
white	O
well	O
circumscribed	O
mass	O
that	O
is	O
:	O
0	O
.	O
1	O
cm	O
from	O
the	O
anterior	O
margin	O
.	O

1	O
.	O
8	O
cm	O
from	O
the	O
posterior	O
margin	O
.	O

1	O
.	O
5	O
cm	O
from	O
the	O
superior	O
margin	O
.	O

2	O
.	O
2	O
cm	O
from	O
the	O
inferior	O
margin	O
.	O

2	O
.	O
0	O
cm	O
from	O
the	O
lateral	O
margin	O
.	O

1	O
.	O
6	O
cm	O
from	O
the	O
medial	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
breast	O
parenchyma	O
is	O
yellow	O
-	O
white	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
as	O
follows	O
:	O
E1	O
.	O

Slice	O
#	O
1	O
(	O
lateral	O
margin	O
)	O
.	O

E2	O
.	O

Slice	O
#	O
2	O
.	O

E3	O
-	O
4	O
.	O

Slice	O
#	O
3	O
bisected	O
.	O

E5	O
-	O
7	O
.	O

Slice	O
#	O
4	O
trisected	O
.	O

E8	O
-	O
9	O
.	O

Slice	O
#	O
5	O
bisected	O
.	O

E10	O
-	O
12	O
.	O

Slice	O
#	O
6	O
trisected	O
.	O

E13	O
-	O
14	O
.	O

Slice	O
#	O
7	O
bisected	O
.	O

E15	O
-	O
17	O
.	O

Slice	O
#	O
8	O
trisected	O
.	O

E18	O
-	O
20	O
.	O

Slice	O
#	O
9	O
trisected	O
.	O

E21	O
-	O
22	O
.	O

Slice	O
#	O
10	O
bisected	O
.	O

E23	O
-	O
24	O
.	O

Slice	O
#	O
11	O
bisected	O
.	O

E25	O
.	O

Slice	O
#	O
12	O
(	O
medial	O
margin	O
)	O
.	O

The	O
specimen	O
was	O
removed	O
from	O
the	O
patient	O
at	O
.	O
and	O
placed	O
in	O
formalin	O
at	O
.	O
on	O
and	O
not	O
removed	O
from	O
formalin	O
until	O
.	O

F	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
additional	O
anterior	O
left	O
breast	O
tissue	O
"	O
is	O
a	O
2	O
.	O
7	O
x	O
1	O
.	O
9	O
x	O
1	O
.	O
0	O
cm	O
piece	O
of	O
.	O
yellow	O
lobular	O
adipose	O
tissue	O
.	O

The	O
outer	O
surface	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
yellow	O
.	O
homogeneous	O
cut	O
surface	O
with	O
no	O
discrete	O
lesion	O
or	O
abnormalities	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
cassettes	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
F1	O
-	O
F3	O
.	O

The	O
breast	O
was	O
removed	O
from	O
the	O
patient	O
at	O
.	O
,	O
and	O
placed	O
in	O
formalin	O
immediately	O
in	O
the	O
OR	O
and	O
not	O
removed	O
from	O
.	O
formalin	O
until	O
.	O
on	O
today	O
'	O
s	O
date	O
.	O

If	O
immunohistochemical	O
stains	O
and	O
/	O
or	O
in	O
situ	O
hybridization	O
are	O
cited	O
in	O
this	O
report	O
,	O
the	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
.	O
in	O
compliance	O
with	O
CLIA	O
'	O
88	O
.	O
regulations	O
.	O

Some	O
of	O
these	O
tests	O
rely	O
on	O
the	O
use	O
of	O
"	O
analyte	O
specific	O
reagents	O
"	O
and	O
are	O
subject	O
to	O
specific	O
labeling	O
requirements	O
by	O
the	O
FDA	O
.	O

Known	O
.	O
positive	O
and	O
negative	O
control	O
tissues	O
demonstrate	O
appropriate	O
staining	O
.	O

This	O
testing	O
was	O
developed	O
by	O
the	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
FDA	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
.	O

is	O
not	O
necessary	O
.	O

Date	O
of	O
Printing	O
:	O

AGE	O
/	O
SX	O
:	O
ROOM	O
.	O

REG	O
DR	O
:	O
BED	O
:	O
DIS	O
:	O
TLOC	O
:	O
COLL	O
.	O

TIME	O
IN	O
FORMALIN	O
:	O
4	O
:	O
16	O
.	O
hrs	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Pre	O
-	O
Op	O
Diagnosis	O
:	O
Right	O
breast	O
CA	O
.	O

Remarks	O
:	O
Specimen	O
(	O
s	O
)	O
:	O
A	O
.	O

Right	O
breast	O
tissue	O
stitch	O
axillary	O
tail	O
.	O

B	O
.	O

Right	O
axillary	O
node	O
x2	O
.	O

C	O
.	O

#	O
1	O
sentinel	O
node	O
right	O
breast	O
.	O

D	O
.	O

IS	O
level	O
3	O
node	O
stitch	O
marks	O
highest	O
level	O
node	O
.	O

E	O
.	O

Axillary	O
contents	O
.	O

MICROSCOPI	O
DIAGNOSIS	O
.	O

A	O
.	O

RIGHT	O
BREAST	O
,	O
TOTAL	O
MASTECTOMY	O
:	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
.	O

INVASIVE	O
CARCINOMA	O
MEASURES	O
AT	O
LEAST	O
4	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
(	O
pT2	O
)	O
.	O

NOTTINGHAM	O
COMBINED	O
HISTOLOGIC	O
GRADE	O
2	O
OF	O
3	O
.	O

TUBULE	O
FORMATION	O
SCORE	O
3	O
OF	O
3	O
.	O

NUCLEAR	O
PLEOMORPHISM	O
SCORE	O
2	O
OF	O
3	O
.	O

MITOTIC	O
COUNT	O
SCORE	O
1	O
OF	O
3	O
.	O

SURGICAL	O
MARGINS	O
OF	O
RESECTION	O
FREE	O
OF	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
.	O

FOCI	O
OF	O
LOBULAR	O
CARCINOMA	O
IN	O
SITU	O
.	O

FOCI	O
OF	O
DUCT	O
CARCINOMA	O
IN	O
SITU	O
.	O

INTERMEDIATE	O
NUCLEAR	O
GRADE	O
,	O
NOT	O
EXTENSIVE	O
.	O

SEE	O
COMMENT	O
FOR	O
SURGICAL	O
PATHOLOGY	O
CANCER	O
CASE	O
SUMMARY	O
CHECKLIST	O
.	O

B	O
.	O

RIGHT	O
AXILLARY	O
LYMPH	O
NODES	O
X2	O
,	O
EXCISION	O
:	O
METASTATIC	O
BREAST	O
CARCINOMA	O
IN	O
TWO	O
OF	O
TWO	O
LYMPH	O
NODES	O
.	O

C	O
.	O

SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
EXCISION	O
:	O
NEGATIVE	O
.	O

NO	O
EVIDENCE	O
OF	O
METASTATIC	O
CARCINOMA	O
IN	O
THIS	O
SPECIMEN	O
.	O

D	O
.	O

LEVEL	O
3	O
AXILLARY	O
LYMPH	O
NODES	O
,	O
REGIONAL	O
RESECTION	O
.	O

NEGATIVE	O
.	O

NO	O
EVIDENCE	O
OF	O
METASTATIC	O
CARCINOMA	O
IN	O
SIX	O
HIGHEST	O
LEVEL	O
3	O
LYMPH	O
NODES	O
.	O

E	O
.	O

RIGHT	O
AXILLARY	O
LYMPH	O
NODES	O
,	O
REGIONAL	O
RESECTION	O
:	O
METASTATIC	O
BREAST	O
CARCINOMA	O
IN	O
ONE	O
OF	O
14	O
AXILLARY	O
LYMPH	O
NODES	O
.	O

COMMENT	O
(	O
S	O
)	O
.	O

SURGICAL	O
PATHOLOGY	O
CANCER	O
CASE	O
SUMMARY	O
CHECKLIST	O
-	O
CAP	O
APPROVED	O
.	O

Procedure	O
:	O
Total	O
mastectomy	O
.	O

RUN	O
DATE	O
.	O

RUN	O
TIME	O
.	O

RUN	O
USER	O
:	O
SPEC	O
#	O
:	O
COMMENT	O
(	O
S	O
)	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Sentinel	O
lymph	O
node	O
(	O
s	O
)	O
.	O
axillary	O
dissection	O
.	O

Specimen	O
Laterality	O
:	O
Right	O
.	O

Histologic	O
Type	O
of	O
Invasive	O
Carcinoma	O
:	O
Invasive	O
lobular	O
carcinoma	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
of	O
largest	O
focus	O
of	O
invasion	O
:	O
45	B
.	I

mm	B
.	O

Histologic	O
Grade	O
(	O
Nottingham	O
)	O
:	O
Glandular	O
/	O
Tubular	O
Differentiation	O
:	O
Score	O
3	O
.	O

Nuclear	O
Pleomorphism	O
:	O
Score	O
2	O
.	O

Mitotic	O
Rate	O
:	O
Scors	O
1	O
.	O

Overall	O
Grade	O
Grade	O
2	O
.	O

Ductal	O
Carcinoma	O
In	O
Situ	O
:	O
DCIS	O
is	O
present	O
;	O
negative	O
for	O
extensive	O
intraductal	O
.	O
component	O
(	O
EIC	O
)	O
.	O

Architectural	O
Patterns	O
:	O
Cribriform	O
,	O
solid	O
.	O

Nuclear	O
Grade	O
Grade	O
II	O
.	O

Necrosis	O
:	O
Present	O
,	O
focal	O
.	O

Lobular	O
Carcinoma	O
In	O
Situ	O
:	O
Present	O
.	O

Invasive	O
Carcinoma	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
.	O

Margins	O
:	O
carcinoma	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
1	O
0mm	O
.	O

DCIS	O
:	O
Margins	O
uninvolved	O
by	O
DCIS	O
.	O

Distance	O
from	O
closest	O
margin	O
>	O
10	O
mm	O
.	O

Lymph	O
Nodes	O
:	O
Number	O
of	O
sentinel	O
lymph	O
nodes	O
examined	O
:	O
1	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
(	O
sentinel	O
and	O
.	O
nonsentinel	O
)	O
:	O
23	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
macrometastases	O
(	O
>	O
2	O
mm	O
)	O
:	O
3	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
micrometastases	O
(	O
>	O
0	O
.	O
2	O
mm	O
.	O
to	O
2	O
mm	O
and	O
/	O
or	O
200	O
cells	O
)	O
:	O
0	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
isolated	O
tumor	O
cells	O
.	O

(	O
50	O
.	O
2	O
mm	O
and	O
<	O
200	O
cells	O
)	O
:	O
0	O
.	O

Number	O
of	O
lymph	O
nodes	O
without	O
tumor	O
cells	O
.	O
identified	O
20	O
.	O

Extranodal	O
Extension	O
:	O
Not	O
identified	O
.	O

Method	O
of	O
Evaluation	O
:	O
Hematolxylin	O
and	O
eosin	O
,	O
level	O
1	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
.	O

Not	O
identified	O
.	O

Dermal	O
Lymph	O
-	O
Vascular	O
Invasion	O
.	O

Not	O
identified	O
.	O

Pathologic	O
Staging	O
:	O
Primary	O
Tumor	O
:	O
pT2	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
pN1a	O
.	O

Distant	O
Metastasis	O
:	O
Not	O
applicable	O
.	O

Ancillary	O
Studies	O
:	O
ER	O
:	O
Positive	O
(	O
92	O
%	O
of	O
tumor	O
cells	O
with	O
nuclear	O
.	O
positivity	O
)	O
;	O
strong	O
.	O

PR	O
:	O
Negative	O
.	O

HER2	O
:	O
Positive	O
(	O
score	O
3	O
+	O
)	O
.	O

In	O
Situ	O
Hybridization	O
for	O
HER2	O
Not	O
amplified	O
.	O

RUN	O
DATE	O
:	O
RUN	O
TIME	O
:	O
Specimen	O
Inquiry	O
.	O

RUN	O
USER	O
:	O
SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
submitted	O
in	O
five	O
containers	O
.	O

A	O
.	O

The	O
first	O
specimen	O
submitted	O
in	O
the	O
fresh	O
state	O
is	O
labeled	O
"	O
right	O
breast	O
tissue	O
"	O
The	O
.	O
specimen	O
is	O
the	O
right	O
breast	O
,	O
total	O
mastectomy	O
specimen	O
Suture	O
marks	O
the	O
axillary	O
tail	O
of	O
.	O
the	O
breast	O
.	O

There	O
is	O
an	O
ellipse	O
of	O
white	O
skin	O
containing	O
the	O
nipple	O
.	O

This	O
measures	O
9	O
x	O
4	O
.	O
5	O
.	O

cm	O
The	O
breast	O
itself	O
measures	O
23	O
x	O
22	O
.	O
5	O
x	O
6	O
.	O
5	O
cm	O
.	O

There	O
is	O
a	O
firm	O
mass	O
palpable	O
beneath	O
.	O
the	O
surface	O
at	O
approximately	O
the	O
11	O
o	O
'	O
clock	O
position	O
The	O
overlying	O
superficial	O
margin	O
.	O
adjacent	O
to	O
the	O
skin	O
is	O
marked	O
with	O
black	O
ink	O
and	O
the	O
deep	O
margin	O
beneath	O
this	O
is	O
marked	O
.	O
with	O
blue	O
ink	O
.	O

On	O
cut	O
section	O
the	O
mass	O
measures	O
approximately	O
4	O
.	O
5	O
x	O
3	O
x	O
3	O
cm	O
.	O

The	O
edges	O
.	O
are	O
quite	O
difficult	O
to	O
discern	O
and	O
are	O
more	O
easily	O
palpated	O
than	O
visualized	O
In	O
the	O
center	O
.	O
of	O
the	O
specimen	O
there	O
is	O
a	O
small	O
focus	O
of	O
hemorrhage	O
consistent	O
with	O
previous	O
biopsy	O
.	O

	O
.	O
portion	O
of	O
this	O
mass	O
is	O
set	O
aside	O
for	O
tissue	O
banking	O
per	O
protocol	O
.	O

The	O
mass	O
extends	O
to	O
.	O
within	O
approximately	O
1	O
cm	O
of	O
the	O
overlying	O
superficial	O
margin	O
at	O
approximately	O
11	O
O	O
'	O
clock	O
.	O
at	O
its	O
closest	O
point	O
.	O

It	O
is	O
located	O
well	O
above	O
the	O
deep	O
margin	O
which	O
is	O
approximately	O
7	O
cm	O
.	O
beneath	O
the	O
mass	O
.	O

Cut	O
sections	O
through	O
the	O
remainder	O
of	O
the	O
breast	O
tissue	O
reveals	O
some	O
.	O
rubbery	O
white	O
parenchymal	O
breast	O
tissue	O
and	O
abundant	O
yellow	O
fat	O
.	O

There	O
.	O
are	O
.	O

other	O
.	O
nodules	O
or	O
mass	O
is	O
identified	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
:	O
A1	O
.	O
nipple	O
.	O

A2	O
-	O
5	O
-	O
.	O
mass	O
in	O
breast	O
.	O

A6	O
.	O
mass	O
in	O
breast	O
with	O
adjacent	O
tissue	O
.	O

A7	O
-	O
9	O
-	O
.	O
non	O
-	O
neoplastic	O
appearing	O
breast	O
tissue	O
.	O

B	O
.	O

The	O
.	O
second	O
specimen	O
is	O
received	O
in	O
the	O
fresh	O
state	O
in	O
the	O
operating	O
room	O
and	O
represents	O
.	O
two	O
axillary	O
lymph	O
nodes	O
,	O
one	O
measuring	O
2	O
x	O
1	O
.	O
5	O
x	O
1	O
cm	O
and	O
the	O
other	O
measuring	O
1	O
x	O
0	O
.	O
7	O
x	O
.	O

0	O
.	O
7	O
.	O

cm	O
.	O

The	O
cut	O
sections	O
are	O
hard	O
.	O

A	O
section	O
of	O
each	O
is	O
examined	O
by	O
frozen	O
section	O
.	O

These	O
are	O
submitted	O
in	O
block	O
B1	O
,	O
frozen	O
section	O
control	O
.	O

Additional	O
section	O
of	O
each	O
is	O
.	O
submitted	O
in	O
block	O
B2	O
.	O

C	O
.	O

The	O
.	O
third	O
specimen	O
initially	O
in	O
the	O
fresh	O
state	O
is	O
labeled	O
"	O
sentinel	O
node	O
#	O
1	O
"	O
and	O
is	O
a	O
.	O
piece	O
of	O
yellow	O
fat	O
measuring	O
2	O
.	O
5	O
x	O
2	O
x	O
1	O
cm	O
with	O
a	O
1	O
cm	O
round	O
moderately	O
firm	O
lymph	O
node	O
.	O
which	O
is	O
bisected	O
and	O
submitted	O
in	O
toto	O
in	O
block	O
C1	O
.	O

D	O
.	O

The	O
fourth	O
specimen	O
is	O
labeled	O
"	O
level	O
3	O
axillary	O
nodes	O
"	O
The	O
specimen	O
is	O
a	O
piece	O
of	O
.	O
yellow	O
fatty	O
tissue	O
measuring	O
9	O
x	O
3	O
x	O
1	O
.	O
!	O

cm	O
with	O
a	O
suture	O
marking	O
the	O
highest	O
level	O
3	O
.	O
lymph	O
node	O
.	O

There	O
are	O
five	O
additional	O
small	O
lymph	O
nodes	O
.	O

The	O
highest	O
node	O
is	O
submitted	O
in	O
.	O
block	O
D1	O
and	O
the	O
other	O
five	O
lymph	O
nodes	O
are	O
submitted	O
in	O
block	O
D2	O
.	O

E	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
"	O
right	O
axillary	O
contents	O
"	O
The	O
specimen	O
is	O
yellow	O
fatty	O
.	O
tissue	O
measuring	O
10	O
x	O
9	O
x	O
2	O
.	O
5	O
cm	O
.	O

Within	O
the	O
fatty	O
tissue	O
are	O
several	O
nodules	O
consistent	O
.	O
with	O
.	O

lymph	O
nodes	O
.	O

The	O
largest	O
of	O
these	O
measures	O
2	O
cm	O
in	O
diameter	O
and	O
on	O
cut	O
section	O
is	O
.	O
partially	O
replaced	O
by	O
very	O
hard	O
white	O
tissue	O
.	O

A	O
section	O
of	O
each	O
node	O
is	O
.	O
submitted	O
.	O

in	O
.	O
blocks	O
E1	O
through	O
E4	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

The	O
slides	O
are	O
examined	O
and	O
evaluated	O
.	O

RUN	O
DATE	O
.	O

RUN	O
TIME	O
.	O

Specimen	O
Inquiry	O
.	O

RUN	O
USER	O
.	O

SPEC	O
#	O
:	O
INTRAOPERATIVE	O
CONSULTATION	O
.	O

OPERATING	O
ROOM	O
CONSULTATIONS	O
:	O
	O
.	O

Portions	O
of	O
the	O
breast	O
mass	O
are	O
processed	O
for	O
tumor	O
tissue	O
banking	O
per	O
protocol	O
.	O

B	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
OF	O
RIGHT	O
AXILLARY	O
LYMPH	O
NODES	O
X2	O
:	O
METASTATIC	O
CARCINOMA	O
IN	O
TWO	O
LYMPH	O
NODES	O
.	O

PHOTO	O
DOCUMENTATION	O
.	O

Image	O
.	O

Image	O
.	O

Image	O
.	O

Image	O
.	O

Image	O
.	O

Image	O
.	O

(	O
signature	O
on	O
file	O
)	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
ESOPHAGUS	O
,	O
DISTAL	O
,	O
TUMOR	O
,	O
BIOPSY	O
:	O
INVASIVE	O
,	O
MODERATELY	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
.	O

No	O
distinctive	O
-	O
type	O
of	O
Barrett	O
mucosa	O
identified	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
DISTAL	O
ESOPHAGEAL	O
TUMOR	O
-	O
Multiple	O
light	O
gray	O
and	O
pink	O
fragments	O
of	O
soft	O
tissue	O
(	O
0	B
.	I
8	I
x	I
0	I
.	I
3	I
x	I
0	I
.	I
3	I
cm	I
in	O
aggregate	O
)	O
.	O

Entirely	O
submitted	O
in	O
A	O
.	O

BIOMARKER	O
TESTING	O
.	O

Tumor	O
block	O
:	O
A1	O
.	O

CLINICAL	O
HISTORY	O
.	O

Esophageal	O
carcinoma	O
.	O

SNOMED	O
CODES	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

.	O
These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
.	O

Gender	O
:	O
F	O
.	O

Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
Cancer	O
of	O
the	O
left	O
breast	O
.	O

Date	O
of	O
admission	O
:	O
Material	O
:	O
1	O
)	O
Material	O
:	O
Left	O
breast	O
.	O

Method	O
of	O
collection	O
:	O
total	O
organ	O
resection	O
.	O

Histopathological	O
diagnosis	O
:	O
Invasive	O
lobular	O
carcinoma	O
of	O
the	O
left	O
breast	O
(	O
NHG2	O
,	O
pT2	O
)	O
.	O

(	O
8520	O
/	O
3	O
T	O
-	O
04030	O
)	O
.	O

.	O
codes	O
according	O
to	O
ICD	O
-	O
O	O
-	O
3	O
or	O
SNOMED	O
.	O

Macroscopic	O
description	O
:	O
Left	O
breast	O
,	O
sized	O
21	O
.	O
2	O
x	O
12	O
.	O
3	O
x	O
5	O
.	O
4	O
cm	O
,	O
removed	O
without	O
axillary	O
tissues	O
and	O
with	O
a	O
skin	O
flap	O
of	O
18	O
.	O
2	O
x	O
8	O
.	O
3	O
cm	O
.	O

Weight	O
:	O
436g	O
.	O

Tumour	O
sized	O
4x2	B
,	O
2x1	B
,	O
6cm	B
found	O
on	O
the	O
boundary	O
of	O
upper	O
quadrants	O
,	O
placed	O
2	O
.	O
8	O
cm	O
from	O
the	O
upper	O
boundary	O
,	O
.	O

1	O
.	O
4cm	O
from	O
the	O
base	O
and	O
1	O
.	O
0cm	O
from	O
the	O
skin	O
.	O

Microscopic	O
description	O
:	O
Invasive	O
ductal	O
carcinoma	O
(	O
classical	O
type	O
)	O
-	O
NHG	O
2	O
(	O
3	O
+	O
2	O
+	O
1	O
:	O
0	O
mitoses	O
/	O
10	O
HPF	O
-	O
visual	O
area	O
:	O
0	O
.	O
55mm	O
:	O
0	O
.	O
55mm	O
)	O
.	O

The	O
.	O
nipple	O
without	O
pathological	O
lesions	O
.	O

Glandular	O
tissue	O
showing	O
parenchyma	O
atrophy	O
.	O

Results	O
of	O
intraoperative	O
examination	O
:	O
Estrogen	O
receptors	O
found	O
in	O
75	O
%	O
of	O
neoplastic	O
cell	O
nuclei	O
.	O

Progesterone	O
receptors	O
found	O
in	O
75	O
%	O
of	O
neoplastic	O
cell	O
.	O
nuclei	O
.	O

HER2	O
protein	O
stained	O
with	O
.	O

HER	O
-	O
2	O
/	O
neu	O
(	O
4B5	O
)	O
Rabbit	O
Monoclonal	O
Antibody	O
.	O

Negative	O
reaction	O
in	O
invasive	O
cancerous	O
cells	O
(	O
Score	O
=	O
1	O
+	O
)	O
.	O

The	O
expression	O
of	O
proliferating	O
nuclear	O
antigen	O
Ki	O
67	O
in	O
15	O
%	O
cellular	O
nuclei	O
.	O

Suraical	O
Pathology	O
Report	O
.	O
service	O
:	O
Gynecology	O
.	O

(	O
Age	O
:	O
Other	O
Related	O
Clinical	O
Data	O
:	O
DIAGNOSIS	O
:	O
UTERUS	O
,	O
ENDOMETRIUM	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

-	O
ADENOCARCINOMA	O
IS	O
CONFINED	O
TO	O
THE	O
ENDOMETRIUM	O
.	O

-	O
NO	O
LYMPHVASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
INVOLVING	O
ENDOCERVICAL	O
.	O

GLANDS	O
.	O

UTERUS	O
,	O
MYOMETRIUM	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
LEIOMYOMATA	O
WITH	O
CALCIFICATION	O
AND	O
HYALINIZATION	O
.	O

LARGEST	O
6	B
.	I
2	I
CM	I
.	O

OVARY	O
,	O
RIGHT	O
,	O
OOPHORECTOMY	O
.	O

NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

-	O
PARAOVARIAN	O
SOFT	O
TISSUE	O
WITH	O
ORGANIZING	O
THROMBUS	O
.	O

-	O
NO	O
FALLOPIAN	O
TUBE	O
IDENTIFIED	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
EXCISION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
FIVE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
5	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
FIVE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
5	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
PERIAORTIC	O
,	O
EXCISION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
FOUR	O
LYMPH	O
NODES	O
(	O
0	O
/	O
4	O
)	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
PERIAORTIC	O
,	O
EXCISION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
TWO	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

Intraoperative	O
Consultation	O
:	O
An	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
called	O
to	O
pick	O
-	O
up	O
uterus	O
,	O
cervix	O
,	O
right	O
ovary	O
and	O
tube	O
'	O
consisting	O
of	O
a	O
600	O
.	O
gram	O
uterus	O
,	O
measuring	O
15	O
cm	O
(	O
from	O
fundus	O
to	O
os	O
)	O
x	O
8	O
cm	O
(	O
cornu	O
to	O
cornu	O
)	O
x	O
10	O
.	O

cm	O
.	O

(	O
anterior	O
to	O
posterior	O
)	O
.	O

The	O
right	O
ovary	O
is	O
attached	O
and	O
no	O
definitive	O
tube	O
is	O
.	O
identified	O
intraoperatively	O
.	O
opened	O
to	O
show	O
a	O
5	O
cm	O
wide	O
x	O
7	O
cm	O
long	O
endometrial	O
.	O
cavity	O
with	O
tumor	O
in	O
the	O
fundic	O
area	O
.	O

Tumor	O
and	O
normal	O
(	O
serosa	O
)	O
taken	O
for	O
.	O

Shown	O
to	O
surgeon	O
.	O

Remainder	O
for	O
permanents	O
,	O
"	O
.	O

Microscopic	O
Description	O
and	O
Comment	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
cited	O
diagnosis	O
.	O

History	O
:	O
The	O
patient	O
is	O
a	O
year	O
old	O
woman	O
with	O
endometrial	O
cancer	O
.	O

Operative	O
.	O
procedure	O
:	O
Total	O
abdominal	O
hysterectomy	O
with	O
right	O
salpingo	O
-	O
oophorectomy	O
and	O
.	O
pelvic	O
lymph	O
node	O
dissection	O
.	O

specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
CERVIX	O
,	O
UTERUS	O
,	O
AND	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

B	O
:	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
.	O

C	O
:	O
LEFT	O
PELVIC	O
LYMPH	O
NODE	O
.	O

D	O
:	O
LEFT	O
PERI	O
AORTIC	O
LYMPH	O
NODE	O
.	O

E	O
:	O
RIGHT	O
PERI	O
AORTIC	O
LYMPH	O
NODE	O
.	O

Gross	O
Description	O
.	O

The	O
.	O
specimens	O
are	O
received	O
in	O
five	O
containers	O
of	O
formalin	O
,	O
each	O
labeled	O
.	O

The	O
first	O
container	O
is	O
labeled	O
"	O
cervix	O
,	O
uterus	O
,	O
right	O
tube	O
and	O
.	O
ovary	O
.	O

It	O
contains	O
a	O
600	O
gram	O
,	O
15	O
x	O
10	O
x	O
8	O
cm	O
previously	O
opened	O
uterus	O
which	O
.	O
has	O
a	O
shiny	O
light	O
brown	O
serosal	O
surface	O
without	O
focal	O
lesions	O
and	O
is	O
obviously	O
.	O
distorted	O
by	O
abundant	O
myometrial	O
nodules	O
.	O

The	O
cervix	O
measures	O
2	O
.	O
0	O
x	O
1	O
.	O
9	O
cm	O
.	O
and	O
.	O

has	O
a	O
shiny	O
white	O
-	O
tan	O
ectocervical	O
mucosa	O
without	O
focal	O
lesions	O
.	O

The	O
.	O
transformation	O
zone	O
is	O
grossly	O
unremarkable	O
and	O
the	O
endocervical	O
canal	O
measures	O
.	O

3	O
.	O
8	O
cm	O
in	O
length	O
and	O
also	O
has	O
a	O
shiny	O
brown	O
,	O
unremarkable	O
mucosa	O
.	O

The	O
.	O
endometrial	O
cavity	O
measures	O
7	O
.	O
0	O
cm	O
long	O
x	O
5	O
cm	O
wide	O
x	O
0	O
.	O
5	O
cm	O
in	O
depth	O
and	O
has	O
a	O
.	O
finely	O
folded	O
light	O
brown	O
endometrium	O
with	O
a	O
fungating	O
,	O
soft	O
and	O
irregular	O
tan	O
.	O
mass	O
over	O
the	O
most	O
superior	O
aspect	O
of	O
the	O
posterior	O
wall	O
and	O
over	O
the	O
fundus	O
and	O
.	O
most	O
superior	O
aspect	O
of	O
the	O
anterior	O
wall	O
.	O

There	O
is	O
no	O
gross	O
involvement	O
of	O
the	O
.	O
lower	O
uterine	O
segment	O
.	O

Numerous	O
sections	O
through	O
the	O
tumor	O
show	O
it	O
to	O
be	O
.	O
exophytic	O
without	O
obvious	O
invasion	O
into	O
the	O
underlying	O
myometrium	O
which	O
is	O
.	O
markedly	O
distorted	O
.	O

It	O
has	O
a	O
maximal	O
thickness	O
of	O
3	O
.	O
6	O
cm	O
and	O
has	O
numerous	O
white	O
.	O
whorled	O
nodules	O
(	O
>	O
10	O
)	O
throughout	O
with	O
several	O
underlying	O
the	O
endometrial	O
tumor	O
.	O
mass	O
and	O
ranging	O
from	O
0	O
.	O
4	O
up	O
to	O
6	O
.	O
2	O
cm	O
in	O
maximum	O
dimension	O
.	O

On	O
sectioning	O
.	O
there	O
is	O
no	O
evidence	O
of	O
necrosis	O
,	O
hemorrhage	O
,	O
or	O
cystic	O
change	O
.	O

Several	O
of	O
.	O
these	O
nodules	O
have	O
yellow	O
-	O
browr	O
gritty	O
apparent	O
calcification	O
.	O

The	O
attached	O
.	O
right	O
ovary	O
is	O
lobulated	O
and	O
light	O
tan	O
and	O
measures	O
3	O
.	O
4	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
.	O

It	O
has	O
.	O

a	O
variegated	O
tan	O
cut	O
surface	O
without	O
masses	O
or	O
focal	O
lesions	O
.	O

Examination	O
.	O
and	O
.	O

numerous	O
sections	O
though	O
the	O
surrounding	O
lobulated	O
broad	O
ligament	O
soft	O
tissue	O
.	O
show	O
dilated	O
veins	O
with	O
central	O
brown	O
thrombi	O
but	O
no	O
obvious	O
fallopian	O
tube	O
.	O

Labeled	O
A1	O
,	O
A2	O
-	O
anterior	O
cervix	O
and	O
lower	O
uterine	O
segment	O
,	O
respectively	O
;	O
A3	O
.	O
anterior	O
endomyometrium	O
with	O
tumor	O
(	O
partial	O
thickness	O
)	O
A4	O
,	O
A5	O
-	O
posterior	O
.	O
cervix	O
and	O
lower	O
uterine	O
segment	O
,	O
respectively	O
;	O
A6	O
-	O
posterior	O
endometrium	O
tumor	O
.	O

(	O
partial	O
thickness	O
)	O
:	O
A7	O
-	O
full	O
thickness	O
posterior	O
endometrium	O
with	O
tumor	O
;	O
A8	O
,	O
.	O

A9	O
.	O
continuous	O
fuli	O
thickness	O
sections	O
over	O
posterior	O
endomyometrium	O
with	O
tumor	O
.	O

(	O
top	O
to	O
bottom	O
)	O
;	O
A10	O
-	O
full	O
thickness	O
anterior	O
endometrium	O
with	O
tumor	O
;	O
A11	O
,	O
.	O

A12	O
.	O

-	O
myometrial	O
nodules	O
;	O
A13	O
-	O
right	O
ovary	O
;	O
A14	O
-	O
paraovarian	O
soft	O
tissue	O
.	O

Jar	O
.	O

3	O
.	O

The	O
second	O
container	O
is	O
labeled	O
"	O
#	O
2	O
,	O
right	O
pelvic	O
lymph	O
node	O
.	O

It	O
contains	O
.	O
four	O
.	O

pieces	O
of	O
lobulated	O
yellow	O
fibroadipose	O
tissue	O
,	O
measuring	O
9	O
.	O
5	O
x	O
6	O
.	O
5	O
x	O
3	O
.	O
8	O
cm	O
in	O
.	O
aggregate	O
which	O
are	O
dissected	O
to	O
show	O
numerous	O
large	O
and	O
fat	O
replaced	O
tan	O
-	O
brown	O
.	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
4	O
up	O
to	O
3	O
.	O
5	O
cm	O
.	O

Labeled	O
B1	O
to	O
B3	O
-	O
single	O
lymph	O
.	O
node	O
.	O
in	O
each	O
cassette	O
,	O
sectioned	O
;	O
B4	O
-	O
two	O
small	O
lymph	O
nodes	O
;	O
B5	O
to	O
87	O
-	O
entire	O
.	O
largest	O
single	O
lymph	O
node	O
.	O

Jar	O
1	O
.	O

The	O
third	O
container	O
is	O
labeled	O
"	O
#	O
3	O
,	O
left	O
pelvic	O
lymph	O
node	O
.	O
'	O
It	O
contains	O
.	O
four	O
.	O

pieces	O
of	O
lobulated	O
yellow	O
and	O
tan	O
fibroadipose	O
tissue	O
which	O
is	O
dissected	O
to	O
.	O
show	O
numerous	O
tan	O
-	O
brown	O
lymph	O
nodes	O
without	O
gross	O
sclerosis	O
,	O
some	O
of	O
which	O
are	O
.	O
quite	O
large	O
,	O
measuring	O
from	O
0	O
.	O
4	O
up	O
to	O
2	O
.	O
4	O
cm	O
in	O
maximum	O
dimension	O
.	O

Labeled	O
C1	O
.	O
four	O
small	O
Tymph	O
nodes	O
;	O
C2	O
,	O
C3	O
-	O
a	O
single	O
large	O
node	O
,	O
sectioned	O
;	O
C4	O
,	O
C5	O
-	O
another	O
.	O
single	O
large	O
node	O
,	O
sectioned	O
;	O
C6	O
-	O
single	O
sm	O
	O
ller	O
node	O
,	O
bisected	O
.	O

Jar	O
1	O
.	O

The	O
fourth	O
container	O
is	O
labeled	O
"	O
#	O
4	O
,	O
left	O
peri	O
-	O
aortic	O
lymph	O
node	O
.	O
'	O
It	O
contains	O
.	O
four	O
pieces	O
of	O
lobulated	O
yellow	O
and	O
brown	O
fibroadipose	O
tissue	O
which	O
are	O
.	O
dissected	O
to	O
show	O
several	O
tan	O
-	O
brown	O
Tymph	O
nodes	O
without	O
gross	O
sclerosis	O
ranging	O
.	O
from	O
0	O
.	O
4	O
up	O
to	O
1	O
.	O
2	O
cm	O
in	O
maximum	O
dimension	O
.	O

Labeled	O
D1	O
-	O
three	O
individual	O
Tymph	O
.	O
nodes	O
;	O
D2	O
-	O
single	O
larger	O
node	O
,	O
bisected	O
.	O

Jar	O
1	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
'	O
#	O
5	O
,	O
right	O
periaortic	O
lymph	O
node	O
.	O

It	O
contains	O
.	O
four	O
pieces	O
of	O
lobulated	O
yellow	O
and	O
tan	O
fibroadipose	O
tissue	O
measuring	O
3	O
.	O

8	O
x	O
3	O
.	O
1	O
.	O

x	O
0	O
.	O
9	O
cm	O
in	O
aggregate	O
which	O
are	O
dissected	O
to	O
show	O
two	O
tan	O
lymph	O
nodes	O
without	O
.	O
gross	O
sclerosis	O
measuring	O
0	O
.	O
5	O
and	O
1	O
.	O
1	O
cm	O
,	O
respectively	O
.	O

Labeled	O
E1	O
-	O
single	O
.	O
smaller	O
node	O
;	O
E2	O
-	O
single	O
larger	O
node	O
,	O
bisected	O
.	O

1ar	O
.	O

1	O
.	O
synopsis	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
ENDOMETRIAL	O
TUMORS	O
.	O

1	O
.	O

A	O
NEOPLASM	O
IS	O
:	O
Present	O
.	O

2	O
.	O

THE	O
HISTOLOGIC	O
DIAGNOSIS	O
IS	O
:	O
Adenocarcinoma	O
,	O
serous	O
papillary	O
type	O
.	O

3	O
.	O

THE	O
MAXIMUM	O
TUMOR	O
SIZE	O
IS	O
3	B
.	I
6	I
cm	I
.	O

4	O
.	O

THE	O
LENGTH	O
OF	O
THE	O
UTERINE	O
CAVITY	O
IS	O
.	O

7	O
.	O
0	O
cm	O
.	O

6	O
.	O

THE	O
NUCLEAR	O
GRADE	O
OF	O
THE	O
TUMOR	O
IS	O
:	O
NIII	O
.	O

7	O
.	O

INVASIVE	O
TUMOR	O
IS	O
:	O
Absent	O
(	O
intraendometrial	O
tumor	O
only	O
)	O
.	O

8	O
.	O

THE	O
TUMOR	O
INVADES	O
TO	O
A	O
DEPTH	O
OF	O
0	O
mm	O
WITH	O
.	O

A	O
MYOMETRIAL	O
THICKNESS	O
OF	O
20	O
mm	O
"	O
.	O

9	O
.	O

THE	O
ENDOCERVIX	O
IS	O
:	O
Involved	O
by	O
tumor	O
in	O
its	O
mucosal	O
aspect	O
only	O
.	O

10	O
.	O

LYMPHATIC	O
INVASION	O
BY	O
TUMOR	O
IS	O
:	O
Absent	O
.	O

11	O
.	O

VASCULAR	O
INVASION	O
BY	O
TUMOR	O
IS	O
:	O
Absent	O
.	O

12	O
.	O

RESIDUAL	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIAL	O
TISSUE	O
:	O
Shows	O
atrophy	O
.	O

13	O
.	O

THE	O
MYOMETRIUM	O
:	O
Shows	O
the	O
presence	O
of	O
leiomyomas	O
.	O

14	O
.	O

THE	O
RIGHT	O
OVARY	O
:	O
Is	O
free	O
of	O
tumor	O
.	O

15	O
.	O

THE	O
LEFT	O
OVARY	O
:	O
Is	O
not	O
evaluable	O
.	O

16	O
.	O

THE	O
RIGHT	O
FALLOPIAN	O
TUBE	O
.	O

Is	O
not	O
evaluable	O
.	O

17	O
.	O

THE	O
LEFT	O
FALLOPIAN	O
TUBE	O
:	O
Is	O
not	O
evaluable	O
.	O

18	O
.	O

THE	O
VAGINAL	O
CUFF	O
OF	O
EXCISION	O
IS	O
:	O
Not	O
evaluable	O
.	O

19	O
.	O

TUMOR	O
INVASION	O
OF	O
ADJACENT	O
STRUCTURES	O
IS	O
:	O
Absent	O
.	O

20	O
.	O

METASTASIS	O
TO	O
THE	O
OMENTUM	O
AND	O
PERITONEUM	O
IS	O
:	O
NOT	O
evaluable	O
.	O

21	O
.	O

"	O
T	O
"	O
DATA	O
-	O
THE	O
TUMOR	O
IS	O
:	O
TNM	O
Categories	O
.	O

FIGO	O
Stages	O
.	O

2a	O
.	O

IIA	O
.	O

Endocervical	O
glandular	O
involvement	O
only	O
.	O

22	O
.	O

THE	O
REGIONAL	O
LYMPH	O
NODES	O
:	O
Are	O
free	O
of	O
tumor	O
in	O
16	O
nodes	O
.	O

23	O
.	O

"	O
N	O
"	O
DATA	O
-	O
-	O
THE	O
REGIONAL	O
LYMPH	O
NODES	O
ARE	O
:	O
(	O
Free	O
of	O
metastases	O
)	O
.	O

24	O
.	O

"	O
M	O
"	O
DATA	O
-	O
-	O
DISTANT	O
METASTASES	O
ARE	O
:	O
MX	O
(	O
Not	O
evaluable	O
)	O
.	O

25	O
.	O

THE	O
OVERALL	O
PATHOLOGIC	O
AJCC	O
STAGE	O
OF	O
THE	O
TUMOR	O
IS	O
:	O
Stage	O
X	O
.	O
Insufficient	O
data	O
to	O
assign	O
a	O
stage	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
and	O
may	O
.	O
change	O
after	O
integration	O
of	O
clinical	O
data	O
not	O
provided	O
with	O
this	O
specimen	O
.	O
surgical	O
Pathology	O
Report	O
.	O

SURGICAL	O
PATHOLOGY	O
REPORT	O
-	O
CONSULT	O
.	O
service	O
:	O
Inside	O
/	O
outside	O
.	O

(	O
Age	O
:	O
Other	O
Related	O
Clinical	O
Data	O
:	O
DIAGNOSIS	O
.	O

UTERUS	O
,	O
ENDOCERVIX	O
,	O
CURETTINGS	O
(	O
.	O

DETACHED	O
CLUSTERS	O
OF	O
CARCINOMA	O
CELLS	O
.	O

ENDOCERVICAL	O
EPITHELIUM	O
WITH	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

UTERUS	O
,	O
ENDOMETRIUM	O
,	O
CURETTINGS	O
.	O

-	O
PREDOMINANTLY	O
BLOOD	O
CLOT	O
WTTH	O
DETACHED	O
CLUSTERS	O
OF	O
CARCINOMA	O
CELLS	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BIOPSY	O
.	O

-	O
BLOOD	O
CLOT	O
WITH	O
DETACHED	O
ATYPICAL	O
CELLS	O
.	O

-	O
ACUTE	O
AND	O
CHRONIC	O
CERVICITIS	O
,	O
MTID	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
THIN	O
PREPARATION	O
.	O

-	O
POSITIVE	O
FOR	O
MALIGNANCY	O
,	O
CONSISTENT	O
WITH	O
CARCINOMA	O
.	O

Microscopic	O
Description	O
and	O
Comment	O
.	O

The	O
cytologic	O
features	O
are	O
consistent	O
with	O
a	O
poorly	O
differentiated	O
.	O
adenocarcinoma	O
.	O

The	O
site	O
of	O
origin	O
,	O
endometrial	O
,	O
endocervical	O
or	O
extrauterine	O
.	O
cannot	O
be	O
ascertained	O
in	O
these	O
samples	O
.	O

History	O
.	O

The	O
patient	O
is	O
a	O
year	O
old	O
woman	O
with	O
postmenopausal	O
bleeding	O
.	O

Operative	O
.	O
procedure	O
:	O
Pap	O
smear	O
as	O
well	O
as	O
endocervical	O
and	O
endometrial	O
curettings	O
,	O
and	O
.	O
cervical	O
biopsies	O
.	O

Material	O
(	O
(	O
5	O
)	O
Received	O
.	O

Received	O
are	O
seven	O
slides	O
labeled	O
.	O

(	O
6	O
)	O
and	O
.	O

(	O
1	O
)	O
accompanied	O
by	O
a	O
.	O
corresponding	O
pathology	O
report	O
.	O

FINAL	O
CORRECTED	O
REPORT	O
DATED	O
.	O

REPLACES	O
ALL	O
PREVIOUS	O
VERSIONS	O
.	O

Final	O
,	O
Corrected	O
.	O

CORRECTED	O
REPORT	O
.	O

Cardiothoracic	O
Surgery	O
.	O

Takart	O
.	O

Accessioned	O
:	O
DIAGNOSIS	O
:	O
LUNG	O
,	O
"	O
PARIETAL	O
PLEURAL	O
DEPOSIT	O
,	O
"	O
BIOPSY	O
(	O
INCLUDING	O
FS1	O
)	O
.	O

-	O
ADENOCARCINOMA	O
.	O

-	O
HYALINIZED	O
GRANULOMAS	O
.	O

-	O
SEE	O
COMMENT	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
,	O
BIOPSY	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
HYALINIZED	O
GRANULOMA	O
.	O

-	O
NO	O
FUNGAL	O
FORMS	O
OR	O
MYCOBACTERIAL	O
SPECIES	O
IDENTIFIED	O
ON	O
GMS	O
,	O
AFB	O
OR	O
FITE	O
STAINS	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
11	O
,	O
BIOPSY	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
HYALINIZED	O
GRANULOMA	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
11	O
,	O
BIOPSY	O
(	O
INCLUDING	O
FS2	O
)	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
HYALINIZED	O
GRANULOMA	O
.	O

LUNG	O
.	O

LINGULA	O
,	O
RESECTION	O
(	O
INCLUDING	O
FS3	O
)	O
.	O

-	O
ADENOCARCINOMA	O
(	O
3	B
.	I
2	I
CM	I
)	O
.	O

INVASIVE	O
AND	O
POORLY	O
DIFFERENTIATED	O
.	O

-	O
TUMOR	O
INVADES	O
INTO	O
THE	O
VISCERAL	O
PLEURA	O
(	O
T2aN0Mia	O
.	O
STAGE	O
IV	O
)	O
.	O

-	O
ARTERIAL	O
INVASION	O
IDENTIFIED	O
.	O

-	O
NON	O
-	O
TUMORAL	O
LUNG	O
WITH	O
HYALINIZED	O
GRANULOMAS	O
.	O

.	O
SEE	O
SYNOPSIS	O
AND	O
COMMENTS	O
.	O

By	O
the	O
signature	O
.	O

!	O
attest	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
ypon	O
my	O
gersonal	O
.	O
examination	O
of	O
the	O
sides	O
(	O
and	O
/	O
or	O
other	O
material	O
in	O
the	O
diagrosis	O
)	O
.	O

"	O
.	O

Page	O
of	O
4	O
.	O

Intraoperative	O
Consultation	O
:	O
An	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
Brought	O
to	O
the	O
frozen	O
section	O
area	O
is	O
.	O

'	O
lingula	O
,	O
'	O
which	O
consists	O
of	O
a	O
pink	O
-	O
red	O
wedge	O
of	O
lung	O
,	O
measuring	O
13	O
x	O
12	O
.	O
5	O
x	O
3	O
cm	O
.	O

Staple	O
line	O
removed	O
and	O
inked	O
.	O
black	O
.	O

Sectioned	O
to	O
show	O
a	O
light	O
brown	O
-	O
tan	O
soft	O
mass	O
measuring	O
3	O
.	O
2	O
x	O
2	O
.	O
7	O
cm	O
,	O
located	O
approximately	O
0	O
.	O
5	O
cm	O
from	O
the	O
.	O
nearest	O
inked	O
margin	O
.	O

Portion	O
frozen	O
as	O
FS3	O
.	O

Tissue	O
taken	O
for	O
tuberculosis	O
test	O
.	O

Rest	O
for	O
permanents	O
,	O
"	O
by	O
.	O

FS1	O
:	O
Pleural	O
deposit	O
,	O
blopsy	O
.	O

-	O
"	O
Hyalinized	O
granulomas	O
,	O
focal	O
small	O
basophilic	O
nests	O
,	O
question	O
tumoriets	O
.	O
"	O
by	O
.	O

FS2	O
:	O
Level	O
11	O
lymph	O
nodes	O
.	O

-	O
"	O
Hyalinized	O
granulomas	O
,	O
focally	O
necrotizing	O
.	O

no	O
evidence	O
of	O
malignancy	O
,	O
"	O
by	O
.	O

FS3	O
:	O
Lingula	O
.	O
excision	O
.	O

"	O
Adenocarcinoma	O
,	O
inked	O
margin	O
free	O
of	O
tumor	O
,	O
"	O
by	O
.	O

Microscopic	O
Description	O
and	O
Comment	O
:	O
Sections	O
of	O
the	O
submitted	O
lingula	O
"	O
(	O
part	O
E	O
)	O
show	O
an	O
invasive	O
,	O
poorly	O
differentiated	O
adenocarcinoma	O
(	O
3	B
.	I
2	I
cm	I
)	O
which	O
has	O
.	O

an	O
infiltrative	O
and	O
poorly	O
circumscribed	O
border	O
,	O
involving	O
the	O
visceral	O
pleura	O
(	O
PL2	O
)	O
.	O

The	O
tumor	O
invades	O
into	O
but	O
not	O
.	O
through	O
the	O
visceral	O
pleura	O
(	O
blockE7	O
)	O
.	O

All	O
surgical	O
resection	O
margins	O
are	O
free	O
of	O
tumor	O
.	O

Of	O
note	O
,	O
multiple	O
intra	O
-	O
arterial	O
.	O
invasions	O
with	O
tumor	O
cells	O
colonizing	O
the	O
endothelial	O
wall	O
are	O
also	O
seen	O
.	O

A	O
provisional	O
primary	O
tumor	O
staging	O
is	O
provided	O
.	O
as	O
T2a	O
based	O
on	O
the	O
staging	O
information	O
from	O
the	O
"	O
l	O
	O
ngula	O
"	O
specimen	O
.	O

Additional	O
sections	O
of	O
the	O
specimen	O
"	O
pleural	O
deposit	O
"	O
(	O
part	O
A	O
)	O
show	O
focal	O
small	O
basophilic	O
nests	O
of	O
tumor	O
cels	O
with	O
.	O
some	O
features	O
of	O
neuroendocrine	O
differentiation	O
.	O

Small	O
amount	O
of	O
mature	O
adipose	O
tissue	O
is	O
also	O
present	O
.	O

At	O
deeper	O
.	O
level	O
,	O
some	O
of	O
these	O
areas	O
also	O
showed	O
tubular	O
and	O
acinar	O
architecture	O
.	O

These	O
tumor	O
cells	O
are	O
positive	O
for	O
TTF	O
-	O
1	O
and	O
.	O
are	O
negative	O
for	O
synaptophysin	O
and	O
chromogranin	O
,	O
confirming	O
their	O
malignant	O
nature	O
.	O

Per	O
discussion	O
with	O
.	O

we	O
understand	O
that	O
the	O
submitted	O
"	O
pleural	O
deposit	O
"	O
(	O
part	O
A	O
)	O
was	O
acquired	O
.	O
from	O
distant	O
parletal	O
pleural	O
site	O
(	O
M1a	O
)	O
.	O

This	O
report	O
is	O
ammended	O
to	O
Include	O
this	O
information	O
and	O
to	O
upstage	O
.	O
the	O
lesion	O
to	O
STAGE	O
IV	O
.	O

Numerous	O
granulomas	O
are	O
seen	O
(	O
part	O
B	O
,	O
part	O
C	O
,	O
part	O
D	O
,	O
part	O
E	O
)	O
.	O

GMS	O
,	O
FITE	O
,	O
AFB	O
are	O
performed	O
on	O
the	O
lymph	O
node	O
.	O
specimen	O
acquired	O
from	O
level	O
7	O
(	O
part	O
B	O
)	O
and	O
the	O
results	O
are	O
negative	O
.	O
also	O
reviewed	O
select	O
sections	O
and	O
concurs	O
with	O
final	O
diagnosis	O
.	O

History	O
:	O
The	O
patient	O
is	O
.	O
who	O
presents	O
with	O
a	O
pre	O
-	O
operative	O
diagnosis	O
of	O
lung	O
mass	O
.	O

Pre	O
-	O
operative	O
biopsy	O
show	O
.	O

no	O
evidence	O
of	O
maagnancy	O
in	O
multiple	O
lymph	O
nodes	O
.	O

Operative	O
procedure	O
:	O
Video	O
-	O
assisted	O
lingulectomy	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
PLEURAL	O
DEPOSIT	O
.	O

B	O
:	O
LYMPH	O
-	O
NOOE	O
,	O
LEVEL	O
-	O
1	O
.	O

C	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
11	O
.	O

D	O
:	O
LYMPH	O
NODE	O
,	O
LEVEL	O
11	O
.	O

E	O
:	O
LINGULA	O
.	O

Gross	O
Description	O
;	O
.	O

The	O
specimens	O
are	O
received	O
in	O
five	O
formalin	O
-	O
filled	O
containers	O
,	O
each	O
labaled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

The	O
first	O
container	O
is	O
additionally	O
labeled	O
"	O
pleural	O
deposit	O
;	O
FS1	O
.	O

It	O
contains	O
a	O
green	O
tissue	O
cassette	O
PST	O
,	O
.	O
which	O
holds	O
multiple	O
minute	O
brown	O
-	O
tan	O
frozen	O
section	O
tissue	O
remnants	O
,	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
1	O
cm	O
in	O
aggregate	O
.	O

Wrapped	O
.	O

Labeled	O
A1	O
(	O
FS1	O
)	O
.	O

Jar	O
0	O
.	O

The	O
second	O
container	O
is	O
labeled	O
"	O
level	O
7	O
lymph	O
nodes	O
.	O

It	O
contains	O
a	O
pink	O
-	O
tan	O
lymph	O
node	O
candidate	O
.	O
measuring	O
2	O
x	O
.	O

1	O
.	O

x	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

Bisected	O
to	O
show	O
no	O
grossly	O
identifiable	O
lesion	O
.	O

Labeled	O
B1	O
.	O

Jar	O
.	O

0	O
.	O

The	O
third	O
container	O
is	O
labeled	O
"	O
level	O
11	O
lymph	O
node	O
.	O
"	O
It	O
contains	O
one	O
single	O
pink	O
-	O
brown	O
lymph	O
node	O
candidate	O
,	O
.	O
measuring	O
0	O
.	O
9	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
.	O

Bisected	O
.	O

Labeled	O
C1	O
.	O

Jar	O
0	O
:	O
The	O
fourth	O
container	O
is	O
labeled	O
"	O
level	O
11	O
lymph	O
node	O
;	O
FS2	O
.	O
"	O
It	O
contains	O
a	O
green	O
tissue	O
cassette	O
labeled	O
"	O
FS2	O
,	O
"	O
which	O
.	O
holds	O
two	O
pieces	O
of	O
brown	O
-	O
pink	O
frozen	O
section	O
tissue	O
remnants	O
,	O
measuring	O
1	O
x	O
1	O
.	O
2x0	O
.	O
3	O
cm	O
and	O
1	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
3	O
cm	O
each	O
.	O

Labeled	O
D1	O
(	O
FS2	O
)	O
.	O

Jar	O
0	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
"	O
linguia	O
;	O
FS3	O
it	O
contains	O
a	O
green	O
tissue	O
cassette	O
labeled	O
"	O
FS3	O
,	O
"	O
which	O
holds	O
a	O
1	O
.	O
8	O
x	O
.	O

1	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
pink	O
-	O
tan	O
frozen	O
section	O
tissue	O
remnant	O
.	O

Labeled	O
E1	O
(	O
FS3	O
)	O
.	O

Also	O
present	O
within	O
the	O
container	O
is	O
a	O
.	O
previously	O
inked	O
and	O
sectioned	O
lingula	O
lobectomy	O
specimen	O
.	O
weighing	O
78	O
.	O
5	O
g	O
.	O
and	O
measuring	O
13	O
x	O
12	O
.	O
5	O
x	O
3	O
cm	O
.	O

A	O
.	O
staple	O
line	O
is	O
present	O
at	O
the	O
site	O
of	O
resection	O
.	O

The	O
staple	O
line	O
is	O
removed	O
and	O
its	O
underlying	O
parenchymal	O
resection	O
.	O
margin	O
is	O
inked	O
black	O
.	O

Sectioned	O
to	O
show	O
a	O
3	B
.	I
2	I
x	I
2	I
.	I
7	I
x	I
2	I
.	I
5	I
cm	I
tumor	O
mass	O
,	O
which	O
is	O
located	O
approximately	O
0	O
.	O
5	O
cm	O
.	O
from	O
the	O
nearest	O
inked	O
parenchymal	O
resection	O
margin	O
(	O
sampled	O
in	O
E3	O
)	O
and	O
is	O
located	O
1	O
.	O
2	O
from	O
the	O
bronchial	O
resection	O
.	O
margin	O
.	O

The	O
pleural	O
surface	O
overlying	O
the	O
tumor	O
shows	O
puckering	O
that	O
measures	O
0	O
.	O
5	O
cm	O
in	O
the	O
greatest	O
dimension	O
.	O

The	O
pleural	O
surface	O
in	O
this	O
area	O
is	O
inked	O
blue	O
.	O

The	O
uninvolved	O
area	O
of	O
lung	O
is	O
further	O
sectioned	O
to	O
show	O
brown	O
-	O
tan	O
,	O
.	O
spongy	O
,	O
unremarkable	O
parenchyma	O
.	O

Upon	O
further	O
inspection	O
,	O
a	O
0	O
.	O
2	O
cm	O
white	O
-	O
yellow	O
,	O
pearly	O
lesion	O
is	O
present	O
at	O
the	O
.	O
periphery	O
of	O
the	O
pleural	O
surface	O
(	O
sampled	O
in	O
E8	O
)	O
.	O

Labeled	O
E2	O
-	O
bronchial	O
and	O
vascular	O
resection	O
margin	O
;	O
E3	O
.	O
tumor	O
.	O

in	O
.	O
relation	O
to	O
the	O
nearest	O
inked	O
parenchymal	O
resection	O
margin	O
;	O
E4	O
-	O
tumor	O
in	O
relation	O
to	O
the	O
pleural	O
puckering	O
;	O
E5	O
-	O
.	O
additional	O
tumor	O
with	O
pieural	O
puckering	O
;	O
E6	O
-	O
additional	O
tumor	O
with	O
black	O
inked	O
parenchymal	O
resection	O
margin	O
;	O
E7	O
-	O
.	O
more	O
tumor	O
with	O
pleural	O
puckering	O
;	O
E8	O
-	O
0	O
.	O
4	O
cm	O
pearly	O
pleural	O
nodule	O
;	O
E9	O
-	O
grossly	O
uninvolved	O
lung	O
.	O

Jar	O
2	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
LUNG	O
CARCINOMA	O
.	O

The	O
provided	O
tumor	O
staging	O
also	O
includes	O
the	O
information	O
acquired	O
from	O
the	O
patients	O
prior	O
biopsy	O
specimen	O
.	O

NEOPLASM	O
.	O

A	O
neoplasm	O
is	O
present	O
.	O

HISTOPATHOLOGIC	O
TYPE	O
.	O

The	O
histologic	O
classification	O
of	O
the	O
tumor	O
is	O
adenocarcinoma	O
,	O
acinar	O
(	O
usual	O
)	O
type	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
G	O
)	O
.	O

The	O
grade	O
of	O
the	O
tumor	O
is	O
poorly	O
differentiated	O
(	O
G3	O
)	O
.	O

TUMOR	O
SIZE	O
.	O

The	O
maximum	O
dimension	O
of	O
the	O
tumor	O
is	O
3	B
.	I
2	I
cm	I
.	O

LYMPHATIC	O
INVASION	O
.	O

Lymphatic	O
invasion	O
by	O
tumor	O
is	O
absent	O
(	O
LO	O
)	O
.	O

VENOUS	O
INVASION	O
.	O

Venous	O
invasion	O
by	O
tumor	O
is	O
absent	O
(	O
V0	O
)	O
.	O

ARTERIAL	O
INVASION	O
.	O

Arterial	O
invasion	O
by	O
tumor	O
is	O
present	O
.	O

PLEURAL	O
INVOLVEMENT	O
.	O

Pleural	O
invoivement	O
is	O
present	O
;	O
tumor	O
invades	O
through	O
visceral	O
pleura	O
,	O
without	O
invoivement	O
of	O
parietal	O
pleura	O
(	O
PL2	O
)	O
.	O

SAMPLED	O
SPECIMEN	O
MARGINS	O
.	O

The	O
sampled	O
surgical	O
margins	O
are	O
uninvolved	O
by	O
tumor	O
.	O

NON	O
-	O
NEOPLASTIC	O
TISSUE	O
.	O

The	O
non	O
-	O
neoplastic	O
lung	O
tissue	O
shows	O
granulomatous	O
inflammation	O
.	O

PRIMARY	O
TUMOR	O
(	O
T	O
)	O
.	O

Tumor	O
>	O
3	O
cm	O
but	O
<	O
=	O
7	O
cm	O
or	O
tumor	O
with	O
any	O
of	O
the	O
following	O
features	O
(	O
T2	O
tumors	O
with	O
these	O
features	O
are	O
classified	O
as	O
.	O
T2a	O
if	O
<	O
=	O
5	O
cm	O
)	O
(	O
T2	O
)	O
.	O

Invades	O
visceral	O
pleura	O
(	O
PL1	O
or	O
PL2	O
)	O
.	O

Tumor	O
>	O
3	O
cm	O
but	O
<	O
=	O
5	O
cm	O
in	O
greatest	O
dimension	O
(	O
T2a	O
)	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
N	O
)	O
.	O

No	O
regional	O
lymph	O
node	O
metastasis	O
histologically	O
,	O
no	O
examination	O
for	O
ITC	O
(	O
pNo	O
)	O
.	O

DISTANT	O
METASTASIS	O
(	O
M	O
)	O
.	O

Separate	O
tumor	O
nodules	O
in	O
contralateral	O
lobe	O
;	O
tumor	O
with	O
pleural	O
nodules	O
or	O
malignant	O
pleural	O
or	O
pericardial	O
effusion	O
.	O

(	O
M1a	O
)	O
.	O

STAGE	O
GROUPING	O
.	O

The	O
overall	O
international	O
stage	O
is	O
T2a	O
/	O
NO	O
/	O
/	O
M1a	O
(	O
Stage	O
IV	O
)	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
and	O
may	O
change	O
after	O
integration	O
of	O
clinical	O
.	O
data	O
not	O
provided	O
with	O
this	O
specimen	O
.	O

Corrections	O
.	O

Corrected	O
:	O
Previous	O
Signout	O
Date	O
:	O
Comment	O
:	O
This	O
case	O
was	O
corrected	O
to	O
change	O
the	O
synoptic	O
report	O
.	O

Corrected	O
:	O
Previous	O
Signout	O
Date	O
:	O
Comment	O
:	O
This	O
case	O
wes	O
corrected	O
to	O
change	O
the	O
synoptic	O
report	O
.	O

Surgical	O
Pathology	O
report	O
is	O
available	O
.	O

Client	O
:	O
(	O
Age	O
:	O
)	O
Location	O
:	O
Gender	O
:	O
F	O
Accnt	O
:	O
Phy	O
Location	O
:	O
Clinical	O
History	O
.	O
woman	O
has	O
had	O
bowel	O
and	O
urinary	O
incontinence	O
and	O
leg	O
weakness	O
with	O
L5	O
-	O
S1	O
spine	O
.	O
degeneration	O
.	O
for	O
about	O
six	O
to	O
eight	O
months	O
.	O
the	O
patient	O
has	O
experienced	O
headache	O
and	O
expressive	O
.	O
aphasia	O
.	O

On	O
imaging	O
,	O
there	O
are	O
multifocal	O
lesions	O
,	O
some	O
interconnected	O
,	O
in	O
both	O
cerebral	O
hemispheres	O
,	O
more	O
.	O
numerous	O
on	O
the	O
.	O
right	O
side	O
.	O

The	O
masses	O
are	O
irregularly	O
enhancing	O
.	O

Operative	O
Diagnoses	O
.	O

Brain	O
tumor	O
.	O

Operation	O
/	O
Specimen	O
.	O

A	O
:	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

B	O
:	O
Right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

Pathologic	O
Diagnosis	O
.	O

A	O
,	O
B	O
.	O

Brain	O
,	O
right	O
frontal	O
,	O
craniotomy	O
:	O
1	O
.	O

Glioblastoma	O
,	O
WHO	O
grade	O
4	O
.	O

2	O
.	O

Negative	O
immunostain	O
for	O
mutant	O
IDH1	O
-	O
R132H	O
protein	O
.	O

3	O
.	O

Negative	O
for	O
codeletion	O
of	O
chromosomal	O
arms	O
1p	O
and	O
19q	O
.	O

4	O
.	O

KI	O
-	O
67	O
/	O
MIB	O
-	O
1	O
proliferation	O
index	O
:	O
up	O
to	O
23	O
%	O
.	O

Senior	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

Procedures	O
/	O
Addenda	O
.	O

PCR	O
for	O
EGFR	O
variant	O
III	O
mutation	O
.	O

Interpretation	O
.	O

POSITIVE	O
-	O
EGFRvIII	O
mutation	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

TEST	O
DESCRIPTION	O
:	O
Testing	O
performed	O
on	O
RNA	O
extracted	O
from	O
paraffin	O
tissue	O
block	O
.	O

(	O
A3	O
)	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

The	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
is	O
an	O
attractive	O
molecular	O
target	O
in	O
glioblastoma	O
because	O
it	O
.	O

is	O
amplified	O
,	O
.	O
overexpressed	O
,	O
and	O
/	O
or	O
mutated	O
in	O
up	O
to	O
40	O
%	O
to	O
50	O
%	O
of	O
patients	O
.	O

Epidermal	O
growth	O
factor	O
receptor	O
variant	O
.	O

III	O
.	O

(	O
EGFRvIII	O
)	O
is	O
an	O
oncogenic	O
,	O
constitutively	O
active	O
mutant	O
form	O
of	O
EGFR	O
that	O
is	O
commonly	O
expressed	O
in	O
.	O
glioblastoma	O
.	O

Cell	O
culture	O
and	O
in	O
vivo	O
models	O
of	O
glioblastoma	O
have	O
demonstrated	O
EGFRvIII	O
as	O
defining	O
prognostically	O
.	O
distinct	O
.	O

subgroups	O
of	O
glioblastomas	O
.	O

Additionally	O
,	O
the	O
presence	O
of	O
EGFRvIII	O
has	O
been	O
shown	O
to	O
sensitize	O
tumors	O
.	O
to	O
EGFR	O
.	O
tyrosine	O
kinase	O
inhibitors	O
when	O
the	O
tumor	O
suppressor	O
protein	O
PTEN	O
is	O
intact	O
.	O

RNA	O
is	O
extracted	O
from	O
.	O
formalin	O
fixed	O
,	O
.	O
paraffin	O
embedded	O
tissue	O
samples	O
and	O
reverse	O
transcribed	O
to	O
cDNA	O
.	O

The	O
cDNA	O
is	O
then	O
amplified	O
using	O
.	O
standard	O
PCR	O
.	O
technique	O
for	O
DNA	O
templates	O
.	O

PCR	O
products	O
are	O
detected	O
by	O
gel	O
electrophoresis	O
.	O

The	O
limit	O
of	O
detection	O
of	O
.	O
this	O
assay	O
.	O
has	O
been	O
determined	O
to	O
be	O
approximately	O
5	O
mutant	O
cells	O
in	O
100	O
normal	O
cells	O
.	O

FDA	O
Comment	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
stand	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
.	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
as	O
required	O
.	O
by	O
CLIA	O
'	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
the	O
context	O
of	O
established	O
.	O
procedures	O
.	O

and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

MGMT	O
Promoter	O
Methylation	O
.	O

Interpretation	O
.	O

NEGATIVE	O
:	O
No	O
evidence	O
of	O
methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
paraffin	O
tissue	O
block	O
.	O

(	O
A3	O
)	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Patients	O
with	O
glioma	O
containing	O
a	O
methylated	O
MGMT	O
promoter	O
have	O
been	O
shown	O
to	O
.	O
benefit	O
.	O
from	O
therapy	O
with	O
alkylating	O
agents	O
.	O

Assessment	O
of	O
MGMT	O
promoter	O
methylation	O
status	O
involves	O
bisulfite	O
.	O
treatment	O
of	O
.	O

DNA	O
followed	O
by	O
real	O
-	O
time	O
PCR	O
amplification	O
.	O
of	O
methylated	O
and	O
unmethylated	O
DNA	O
.	O
sequences	O
.	O

The	O
.	O
analytic	O
sensitivity	O
of	O
this	O
assay	O
was	O
determined	O
by	O
serial	O
dilution	O
of	O
methylated	O
positive	O
control	O
DNA	O
into	O
.	O
unmethylated	O
DNA	O
,	O
and	O
was	O
assessed	O
to	O
be	O
1	O
%	O
of	O
methylated	O
DNA	O
in	O
the	O
background	O
of	O
unmethylated	O
.	O

DNA	O
.	O

Factors	O
.	O
such	O
as	O
the	O
presence	O
of	O
>	O
50	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
sample	O
,	O
or	O
extensive	O
tissue	O
necrosis	O
,	O
may	O
.	O
preclude	O
the	O
.	O
detection	O
of	O
methylated	O
MGMT	O
promoter	O
sequences	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
stand	O
alone	O
diagnostic	O
.	O
test	O
.	O

This	O
test	O
.	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
as	O
required	O
.	O
by	O
CLIA	O
'	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
the	O
context	O
of	O
established	O
.	O
procedures	O
.	O

and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

Loss	O
of	O
Heterozygosity	O
1p	O
,	O
19q	O
Assay	O
(	O
LOH	O
)	O
.	O

Interpretation	O
.	O

POSITIVE	O
:	O
Allelic	O
loss	O
on	O
chromosome	O
arm	O
19q	O
is	O
detected	O
.	O

Allelic	O
loss	O
on	O
chromosome	O
arm	O
1p	O
is	O
not	O
detected	O
.	O

Informative	O
loci	O
are	O
:	O
D1S548	O
,	O
D1S1592	O
,	O
D19S412	O
,	O
D19S606	O
,	O
D19S1182	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
tumor	O
paraffin	O
block	O
.	O

(	O
A3	O
)	O
.	O

DNA	O
extracted	O
from	O
a	O
.	O
corresponding	O
blood	O
specimen	O
was	O
used	O
as	O
a	O
normal	O
reference	O
control	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Allelic	O
loss	O
is	O
assessed	O
by	O
PCR	O
assay	O
in	O
Normal	O
DNA	O
(	O
baseline	O
)	O
/	O
Tumor	O
DNA	O
.	O
pairs	O
using	O
3	O
.	O
markers	O
at	O
both	O
1p	O
and	O
19q	O
.	O

The	O
3	O
markers	O
on	O
1p	O
are	O
D1S548	O
,	O
D1S1592	O
,	O
and	O
D1S552	O
(	O
with	O
D1S468	O
,	O
.	O
D1S1612	O
,	O
and	O
.	O
D1S496	O
as	O
backup	O
markers	O
)	O
and	O
the	O
3	O
markers	O
on	O
19q	O
are	O
D19S219	O
,	O
D19S412	O
,	O
and	O
PLA2G4C	O
(	O
with	O
.	O
D19S606	O
and	O
.	O
D19S1182	O
as	O
backup	O
)	O
.	O

All	O
markers	O
are	O
microsatellites	O
(	O
2	O
or	O
4	O
nt	O
repeats	O
)	O
except	O
PLA2G4C	O
which	O
is	O
a	O
.	O
minisatellite	O
(	O
26	O
.	O
nt	O
repeat	O
)	O
polymorphism	O
.	O

The	O
markers	O
were	O
selected	O
based	O
on	O
heterozygosity	O
score	O
,	O
amplicon	O
size	O
,	O
and	O
.	O
ease	O
of	O
.	O
interpretation	O
.	O

The	O
backup	O
markers	O
are	O
used	O
if	O
the	O
first	O
line	O
markers	O
at	O
that	O
chromosome	O
arm	O
are	O
.	O
uninformative	O
or	O
.	O
otherwise	O
ambiguous	O
in	O
their	O
interpretation	O
.	O

LOH	O
at	O
all	O
informative	O
loci	O
on	O
each	O
chromosomal	O
arm	O
.	O
represents	O
the	O
.	O
typical	O
finding	O
in	O
oligodendrogliomas	O
with	O
1p	O
and	O
19q	O
deletion	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
stand	O
-	O
alone	O
diagnostic	O
.	O
test	O
.	O

This	O
test	O
.	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
as	O
required	O
.	O
by	O
CLIA	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
the	O
context	O
of	O
established	O
.	O
procedures	O
.	O

and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

TECHNICAL	O
SENSITIVITY	O
:	O
The	O
presence	O
of	O
>	O
15	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
sample	O
may	O
preclude	O
the	O
.	O
detection	O
of	O
.	O
allelic	O
loss	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

Intra	O
-	O
Operative	O
Consultation	O
.	O

A	O
.	O

Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
:	O
1	O
.	O

Sparsely	O
cellular	O
,	O
few	O
gemistocyte	O
astrocytes	O
.	O

No	O
lymphoma	O
or	O
inflammation	O
.	O

Touch	O
preparation	O
.	O
smears	O
.	O

performed	O
at	O
.	O
and	O
results	O
reported	O
to	O
the	O
Physician	O
of	O
Record	O
.	O

2	O
.	O

Diffuse	O
proliferation	O
of	O
gemistocyte	O
-	O
like	O
astrocytes	O
(	O
C	O
/	O
N	O
diffuse	O
astrocytic	O
neoplasm	O
,	O
high	O
grade	O
,	O
R	O
/	O
O	O
.	O
other	O
.	O
No	O
.	O
lymphoma	O
)	O
.	O

Frozen	O
section	O
performed	O
at	O
.	O
and	O
results	O
reported	O
to	O
the	O
Physician	O
of	O
.	O

Record	O
.	O

Senior	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

"	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
"	O
received	O
fresh	O
,	O
one	O
fragment	O
of	O
cerebral	O
tissue	O
,	O
2	B
.	I
3	I
x	I
2	I
.	I
3	I
x	I
1	I
.	I
3	I
cm	I
.	O

Semi	O
.	O
firm	O
,	O
pasty	O
,	O
.	O
poor	O
cortical	O
-	O
white	O
matter	O
interphase	O
,	O
creamy	O
-	O
white	O
.	O

Serially	O
sectioned	O
.	O

Half	O
of	O
specimen	O
submitted	O
,	O
A1	O
-	O
.	O

A4	O
,	O
frozen	O
.	O
tissue	O
A5	O
.	O

B	O
.	O

"	O
Right	O
frontal	O
tumor	O
,	O
"	O
excision	O
biopsy	O
:	O
CONTAINER	O
LABEL	O
:	O
right	O
frontal	O
tumor	O
.	O

FIXATIVE	O
:	O
Formalin	O
.	O

NO	O
.	O

PIECES	O
:	O
several	O
gray	O
tan	O
fragments	O
.	O

SIZE	O
/	O
VOL	O
:	O
2	B
.	I
2	I
x	I
1	I
.	I
8	I
X	I
0	I
.	I
8	I
cm	I
.	O
,	O
1	O
.	O
25	O
.	O
grams	O
.	O

CASSETTES	O
:	O
1	O
,	O
2	O
NS	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
323	O
.	O
9323	O
.	O
9	O
.	O

B	O
:	O
EGFRvIII	O
:	O
LOH	O
1p19q	O
:	O
MGMT	O
:	O
Histo	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
blopsy	O
.	O

Stain	O
/	O
cnt	O
Block	O
Ordered	O
Comment	O
.	O

H	O
&	O
E	O
x	O
1	O
1	O
.	O

TPS	O
H	O
&	O
E	O
x	O
1	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
2	O
.	O

x	O
13	O
.	O

Run	O
IDH1	O
,	O
please	O
.	O

EGFR	O
vill	O
-	O
curls	O
x	O
13	O
.	O

H	O
&	O
E	O
x	O
13	O
.	O

LOH	O
-	O
curls	O
x	O
13	O
.	O

LOH	O
-	O
curls	O
x	O
13	O
.	O

MGMT	O
-	O
curls	O
x	O
13	O
.	O

MIB1	O
-	O
DA	O
x	O
1	O
3	O
.	O

H	O
&	O
E	O
x	O
1	O
4	O
.	O

FS	O
H	O
&	O
E	O
x	O
1	O
5	O
.	O

H	O
&	O
E	O
x	O
1	O
5	O
.	O

Part	O
B	O
:	O
Right	O
frontal	O
tumor	O
,	O
excision	O
blopsy	O
.	O

Stain	O
/	O
cnt	O
Block	O
Ordered	O
Comment	O
.	O

H	O
&	O
E	O
x	O
1	O
1	O
.	O

H	O
&	O
E	O
x	O
12	O
.	O

THIS	O
IS	O
AN	O
ADDENDUM	O
REPORT	O
.	O

Surgical	O
Pathology	O
Consultation	O
/	O
Department	O
of	O
Pathology	O
.	O

Case	O
Type	O
:	O
CLINICAL	O
HISTORY	O
:	O
gentleman	O
with	O
rhinorrhea	O
in	O
.	O

MRI	O
revealed	O
tumor	O
,	O
which	O
pathology	O
revealed	O
oligodendroglioma	O
.	O

Had	O
left	O
-	O
sided	O
stroke	O
(	O
illegible	O
)	O
month	O
postop	O
.	O

Began	O
having	O
headaches	O
.	O
recently	O
and	O
had	O
MRI	O
done	O
revealing	O
a	O
right	O
frontal	O
lesion	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
the	O
following	O
specimens	O
in	O
the	O
Department	O
of	O
Pathology	O
,	O
labeled	O
.	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O

A	O
.	O

"	O
Tumor	O
"	O
.	O

B	O
.	O

"	O
Tumor	O
"	O
.	O

C	O
.	O

"	O
Tumor	O
"	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
without	O
fixative	O
and	O
consists	O
of	O
two	O
pieces	O
.	O
of	O
beige	O
to	O
gray	O
-	O
tan	O
soft	O
tissue	O
,	O
that	O
measure	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
and	O
0	O
.	O
5	O
.	O

x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
,	O
respectively	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
.	O
frozen	O
section	O
;	O
the	O
frozen	O
section	O
diagnosis	O
is	O
"	O
Infiltrating	O
glioma	O
,	O
.	O
oligodendroglioma	O
not	O
excluded	O
;	O
grade	O
deferred	O
to	O
permanents	O
,	O
per	O
.	O

The	O
frozen	O
tissue	O
is	O
resubmitted	O
in	O
FSA1	O
,	O
and	O
the	O
remaining	O
.	O
tissue	O
is	O
submitted	O
in	O
A2	O
,	O
for	O
permanent	O
processing	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
unfixed	O
and	O
consists	O
of	O
a	O
32	O
.	O
5	O
gm	O
portion	O
.	O
of	O
apparent	O
cerebral	O
cortex	O
and	O
underlying	O
subcortical	O
white	O
matter	O
,	O
.	O
measuring	O
3	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
2	O
.	O
8	O
cm	O
,	O
with	O
a	O
1	O
.	O
E	O
x	O
1	O
.	O
5	O
cm	O
ragged	O
,	O
hemorrhagic	O
.	O
component	O
.	O

Deep	O
surfaces	O
appear	O
cauterized	O
.	O

Sections	O
reveal	O
effacement	O
.	O
of	O
the	O
gray	O
-	O
white	O
junction	O
,	O
especially	O
adjacent	O
to	O
the	O
ragged	O
hemorrhagic	O
.	O
region	O
,	O
and	O
a	O
pale	O
tan	O
-	O
yellow	O
tan	O
discoloration	O
of	O
the	O
subcortical	O
.	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
B1	O
-	O
B6	O
,	O
for	O
permanent	O
.	O
processing	O
.	O

The	O
specimen	O
is	O
received	O
unfixed	O
and	O
consists	O
of	O
an	O
8	O
.	O
0	O
gm	O
portion	O
.	O
of	O
apparent	O
cerebral	O
cortex	O
and	O
underlying	O
subcortical	O
white	O
matter	O
,	O
.	O
measuring	O
4	O
.	O
2	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
.	O

Sections	O
reveal	O
a	O
better	O
-	O
defined	O
.	O
gray	O
-	O
white	O
junction	O
and	O
minimal	O
tan	O
discoloration	O
in	O
white	O
matter	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
C1	O
-	O
C4	O
,	O
for	O
permanent	O
processing	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
Tumor	O
"	O
,	O
biopsy	O
:	O
Oligodendroglioma	O
,	O
with	O
anaplastic	O
foci	O
.	O

(	O
see	O
comment	O
)	O
.	O

B	O
.	O

"	O
Tumor	O
"	O
,	O
excision	O
:	O
Oligodendroglioma	O
,	O
with	O
anaplastic	O
.	O
foci	O
(	O
see	O
comment	O
)	O
.	O

C	O
.	O

"	O
Tumor	O
"	O
,	O
excision	O
:	O
Oligodendroglioma	O
,	O
with	O
anaplastic	O
.	O
foci	O
(	O
see	O
comment	O
)	O
.	O

Comment	O
:	O
This	O
infiltrating	O
oligodendroglioma	O
appears	O
to	O
have	O
caused	O
a	O
.	O

"	O
vacuolar	O
"	O
degeneration	O
in	O
large	O
areas	O
of	O
involved	O
white	O
matter	O
.	O

(	O
GFAP	O
-	O
immunoperoxidase	O
)	O
,	O
and	O
has	O
diffusely	O
infiltrated	O
overlying	O
cortex	O
.	O

Perhaps	O
of	O
greater	O
concern	O
,	O
however	O
,	O
are	O
deeper	O
areas	O
with	O
increased	O
.	O
cellular	O
density	O
and	O
nuclear	O
atypia	O
,	O
in	O
which	O
Ki	O
-	O
-	O
67	O
-	O
immunostain	O
focally	O
.	O
labels	O
up	O
to	O
20	O
%	O
of	O
nuclei	O
,	O
apparently	O
representing	O
areas	O
of	O
anaplastic	O
.	O

"	O
transformation	O
"	O
.	O

"	O
I	O
,	O
or	O
my	O
qualified	O
designee	O
,	O
have	O
performed	O
the	O
gross	O
examination	O
and	O
.	O
description	O
and	O
I	O
have	O
personally	O
reviewed	O
the	O
gross	O
description	O
and	O
.	O
specimen	O
preparations	O
referenced	O
herein	O
,	O
and	O
have	O
personally	O
issued	O
this	O
.	O
report	O
.	O

"	O
.	O

Resident	O
/	O
Prosector	O
/	O
Pathologist	O
:	O
Note	O
:	O
Test	O
systems	O
have	O
been	O
developed	O
and	O
their	O
performance	O
.	O
characteristics	O
determined	O
by	O
.	O

Some	O
tests	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
is	O
not	O
.	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
and	O
should	O
not	O
be	O
.	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O

as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

ADDENDUM	O
:	O
FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
(	O
FISH	O
)	O
WAS	O
PERFORMED	O
ON	O
REPRESENTATIVE	O
.	O

PARAFFIN	O
-	O
EMBEDDED	O
TUMOR	O
TISSUE	O
(	O
VYSIS	O
)	O
.	O

IN	O
THIS	O
CASE	O
,	O
DELETIONS	O
OF	O
BOTH	O
.	O

1P	O
AND	O
19Q	O
WERE	O
IDENTIFIED	O
.	O

RECENT	O
CLINICAL	O
STUDIES	O
HAVE	O
SUGGESTED	O
THAT	O
.	O

COMBINED	O
LOSS	O
OF	O
CHROMOSOME	O
1P	O
AND	O
19Q	O
IN	O
OLIGODENDROGLIAL	O
BRAIN	O
TUMORS	O
.	O

MAY	O
BE	O
ASSOCIATED	O
WITH	O
PROLONGED	O
SURVIVAL	O
AND	O
ENHANCED	O
RESPONSE	O
TO	O
.	O

CHEMOTHERAPY	O
(	O
REFS	O
1	O
-	O
5	O
)	O
.	O

REFERENCES	O
.	O

DEPARTMENT	O
OF	O
PATHOLOGY	O
AND	O
LABORATORY	O
MEDICINE	O
.	O

Date	O
Coll	O
:	O
Accession	O
No	O
.	O

:	O
SPECIMEN	O
.	O

A	O
.	O

Brain	O
tumor	O
.	O

B	O
.	O

Brain	O
tumor	O
.	O

C	O
.	O

Brain	O
tumor	O
.	O

CLINICAL	O
NOTES	O
.	O

CLINICAL	O
HISTORY	O
:	O
Left	O
frontal	O
brain	O
tumor	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

FSA	O
)	O
Left	O
frontal	O
-	O
At	O
least	O
anaplastic	O
astrocytoma	O
(	O
WHO	O
grade	O
.	O
III	O
)	O
.	O

Final	O
grade	O
deferred	O
to	O
permanent	O
sections	O
.	O

FSB	O
)	O
Brain	O
tumor	O
-	O
Predominantly	O
q	O
.	O
clude	O
rare	O
.	O
microscopic	O
involvement	O
by	O
tumor	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
,	O
labeled	O
"	O
brain	O
tumor	O
"	O
.	O
are	O
irregularly	O
shaped	O
fragments	O
of	O
hemorrhagic	O
tissue	O
that	O
.	O
measure	O
1	B
.	I
5	I
X	I
1	I
.	I
2	I
X	I
0	I
.	I
6	I
cm	I
.	O
in	O
dimension	O
.	O

Half	O
of	O
the	O
spe	O
.	O

is	O
.	O
frozen	O
and	O
the	O
remainder	O
is	O
taken	O
for	O
permanent	O
section	O
.	O

B	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
,	O
labeled	O
"	O
br	O
.	O

umor	O
"	O
.	O

is	O
an	O
irregularly	O
shaped	O
fragment	O
of	O
tan	O
-	O
white	O
tissue	O
that	O
.	O
measures	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
.	O
in	O
dimension	O
.	O

The	O
tissue	O
is	O
entirely	O
.	O
frozen	O
.	O

C	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
brain	O
.	O

tumor	O
-	O
routine	O
"	O
and	O
consists	O
of	O
multiple	O
pieces	O
of	O
pink	O
to	O
.	O
soft	O
yellow	O
tissue	O
me	O
.	O

X	O
1	O
.	O
0	O
cm	O
.	O

The	O
tissue	O
is	O
.	O
entirely	O
submitted	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Microscopic	O
sections	O
of	O
the	O
left	O
frontal	O
brain	O
tumor	O
.	O
reveals	O
a	O
malignant	O
diffuse	O
glioma	O
.	O

The	O
tumor	O
does	O
have	O
.	O
diffuse	O
high	O
grade	O
astrocyti	O
.	O

S	O
suggested	O
by	O
the	O
.	O

patient	O
'	O
s	O
prior	O
core	O
biopsy	O
.	O

The	O
current	O
material	O
,	O
.	O
however	O
,	O
does	O
have	O
what	O
appe	O
.	O
godendroglial	O
.	O

differentiation	O
suggesting	O
the	O
lesion	O
is	O
actually	O
a	O
mixed	O
glioma	O
.	O

For	O
tha	O
.	O
con	O
.	O

up	O
.	O
to	O
the	O
.	O
reviewe	O
.	O

sen	O
.	O

d	O
.	O
categorized	O
it	O
as	O
an	O
anaplastic	O
oligoastrocytoma	O
WHO	O
grade	O
III	O
.	O

They	O
.	O
will	O
be	O
doing	O
a	O
FISH	O
study	O
for	O
the	O
1P	O
/	O
19Q	O
deletion	O
which	O
is	O
seen	O
in	O
.	O
oligodendrogliomas	O
.	O

That	O
result	O
will	O
be	O
reported	O
separately	O
.	O

DIAGNOSIS	O
.	O

A	O
,	O
B	O
,	O
C	O
.	O

Brain	O
,	O
left	O
frontal	O
,	O
resection	O
:	O
A	O
.	O

Client	O
:	O
Gender	O
:	O
M	O
Accnt	O
:	O
Phy	O
Location	O
:	O
Clinical	O
History	O
.	O

-	O
old	O
man	O
has	O
past	O
history	O
of	O
left	O
leg	O
amputation	O
for	O
cartilaginous	O
tumor	O
(	O
Ollier	O
'	O
s	O
disease	O
)	O
,	O
and	O
.	O
has	O
several	O
.	O
intra	O
axial	O
,	O
intracranial	O
tumors	O
consistent	O
with	O
low	O
histological	O
grade	O
gliomas	O
.	O

Patient	O
experiences	O
.	O
medically	O
.	O

intractable	O
complex	O
partial	O
epilepsy	O
.	O

Operative	O
Diagnoses	O
.	O

Medically	O
intractable	O
complex	O
partial	O
epilepsy	O
.	O

Operation	O
/	O
Specimen	O
.	O

A	O
:	O
Para	O
sagittal	O
,	O
biopsy	O
.	O

B	O
:	O
Inferior	O
parietal	O
,	O
biopsy	O
.	O

Pathologic	O
Diagnosis	O
.	O

A	O
.	O

Brain	O
,	O
parasagittal	O
,	O
excision	O
:	O
1	O
.	O

Low	O
histological	O
grade	O
glioma	O
,	O
consistent	O
with	O
diffuse	O
astrocytoma	O
(	O
WHO	O
grade	O
2	O
)	O
.	O

2	O
.	O

IDH1	O
-	O
R132H	O
mutation	O
:	O
Positive	O
.	O

3	O
.	O

MIB	O
-	O
1	O
proliferation	O
index	O
:	O
>	O
9	O
%	O
.	O

4	O
.	O

1p	O
,	O
19q	O
LOH	O
:	O
Negative	O
.	O

5	O
.	O

MGMT	O
:	O
Low	O
positive	O
.	O

B	O
.	O

Brain	O
,	O
inferior	O
parietal	O
,	O
excision	O
:	O
1	O
.	O

Neoplastic	O
glial	O
infiltrate	O
,	O
sparse	O
.	O

2	O
.	O

Architectural	O
features	O
:	O
Uncertain	O
.	O

See	O
Microscopy	O
Description	O
and	O
Comment	O
.	O

Comment	O
.	O

Part	O
A	O
.	O
This	O
specimen	O
is	O
portions	O
of	O
cerebrum	O
that	O
are	O
moderately	O
infiltrated	O
by	O
a	O
glial	O
neoplastic	O
proliferation	O
that	O
.	O
has	O
a	O
.	O
mixed	O
oligo	O
astrocytic	O
phenotype	O
,	O
with	O
uniform	O
round	O
/	O
ovoid	O
nuclei	O
frequently	O
surrounded	O
by	O
halos	O
.	O

However	O
,	O
the	O
.	O
neoplastic	O
cells	O
are	O
devoid	O
of	O
the	O
1p	O
,	O
19q	O
deletion	O
characteristic	O
of	O
oligodendrogliomas	O
.	O

Mitotic	O
figures	O
are	O
.	O
found	O
with	O
.	O
great	O
difficulty	O
,	O
and	O
there	O
is	O
not	O
microvascular	O
proliferation	O
or	O
tumor	O
necrosis	O
.	O

The	O
MIB	O
-	O
1	O
proliferation	O
.	O
index	O
is	O
greater	O
.	O
than	O
9	O
%	O
(	O
as	O
normal	O
native	O
cells	O
are	O
entered	O
in	O
the	O
total	O
nuclear	O
count	O
;	O
the	O
index	O
is	O
probably	O
no	O
more	O
than	O
.	O
15	O
%	O
)	O
.	O

The	O
findings	O
are	O
interpreted	O
as	O
those	O
of	O
a	O
low	O
histological	O
grade	O
glial	O
neoplasm	O
that	O
has	O
molecular	O
.	O
features	O
of	O
.	O
astrocytoma	O
.	O

The	O
elevated	O
cycling	O
activity	O
may	O
portend	O
a	O
heightened	O
aggressive	O
potential	O
.	O

Part	O
B	O
.	O
This	O
specimen	O
is	O
three	O
small	O
fragments	O
of	O
cerebral	O
cortex	O
in	O
which	O
,	O
because	O
of	O
the	O
small	O
size	O
and	O
.	O
orientation	O
of	O
the	O
.	O
fragments	O
,	O
it	O
is	O
difficult	O
to	O
evaluate	O
the	O
cortical	O
architectural	O
features	O
.	O

Furthermore	O
,	O
the	O
IDH1	O
stain	O
.	O
demonstrates	O
a	O
.	O
somewhat	O
sparse	O
sprinkling	O
of	O
the	O
cortex	O
by	O
neoplastic	O
glial	O
cells	O
,	O
which	O
interferes	O
even	O
more	O
with	O
.	O
evaluation	O
of	O
the	O
.	O
distribution	O
of	O
normal	O
cells	O
.	O

There	O
is	O
not	O
obvious	O
architectural	O
distortion	O
,	O
dysmorphic	O
neuronal	O
element	O
,	O
or	O
.	O
balloon	O
.	O

cells	O
.	O

The	O
findings	O
are	O
interpreted	O
as	O
a	O
glial	O
neoplasm	O
sparsely	O
infiltrating	O
the	O
cerebral	O
cortex	O
;	O
and	O
non	O
.	O
conclusive	O
of	O
cortical	O
.	O
dysplasia	O
.	O

The	O
features	O
in	O
both	O
specimens	O
may	O
be	O
correlated	O
with	O
clinical	O
,	O
imaging	O
,	O
electrophysiological	O
,	O
and	O
.	O
operative	O
findings	O
.	O
for	O
their	O
interpretation	O
and	O
patient	O
'	O
s	O
follow	O
up	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

Consultant	O
:	O
Senior	O
Staff	O
Pathologist	O
.	O

Procedures	O
/	O
Addenda	O
.	O

Loss	O
of	O
Heterozygosity	O
1p	O
,	O
19q	O
Assay	O
(	O
LOH	O
)	O
.	O

Interpretation	O
.	O

NEGATIVE	O
:	O
Allelic	O
loss	O
on	O
chromosome	O
arm	O
1p	O
and	O
chromosome	O
arm	O
19q	O
is	O
NOT	O
detected	O
.	O

Informative	O
loci	O
are	O
:	O
D1S1592	O
,	O
D1S552	O
,	O
D19S412	O
,	O
D19S606	O
,	O
D19S1182	O
and	O
PLA2G4C	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
tumor	O
paraffin	O
block	O
.	O

(	O
A1	O
)	O
.	O

DNA	O
extracted	O
from	O
a	O
.	O
corresponding	O
blood	O
specimen	O
was	O
used	O
as	O
a	O
normal	O
reference	O
control	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Allelic	O
loss	O
is	O
assessed	O
by	O
PCR	O
assay	O
in	O
Normal	O
DNA	O
(	O
baseline	O
)	O
/	O
Tumor	O
DNA	O
.	O
pairs	O
using	O
3	O
.	O
markers	O
at	O
both	O
1p	O
and	O
19q	O
.	O

The	O
3	O
markers	O
on	O
1p	O
are	O
D1S548	O
,	O
D1S1592	O
,	O
and	O
D1S552	O
(	O
with	O
D1S468	O
,	O
.	O
D1S1612	O
,	O
and	O
.	O
D1S496	O
as	O
backup	O
markers	O
)	O
and	O
the	O
3	O
markers	O
on	O
19q	O
are	O
D19S219	O
,	O
D19S412	O
,	O
and	O
PLA2G4C	O
(	O
with	O
.	O
D19S606	O
and	O
.	O
D19S1182	O
as	O
backup	O
)	O
.	O

All	O
markers	O
are	O
microsatellites	O
(	O
2	O
or	O
4	O
nt	O
repeats	O
)	O
except	O
PLA2G4C	O
which	O
is	O
.	O

a	O
.	O
minisatellite	O
(	O
26	O
.	O
nt	O
repeat	O
)	O
polymorphism	O
.	O

The	O
markers	O
were	O
selected	O
based	O
on	O
heterozygosity	O
score	O
,	O
amplicon	O
size	O
,	O
and	O
.	O
ease	O
of	O
.	O
interpretation	O
.	O

The	O
backup	O
markers	O
are	O
used	O
if	O
the	O
first	O
line	O
markers	O
at	O
that	O
chromosome	O
arm	O
are	O
.	O
uninformative	O
or	O
.	O
otherwise	O
ambiguous	O
in	O
their	O
interpretation	O
.	O

LOH	O
at	O
all	O
informative	O
loci	O
on	O
each	O
chromosomal	O
arm	O
.	O
represents	O
the	O
.	O
typical	O
finding	O
in	O
oligodendrogliomas	O
with	O
1p	O
and	O
19q	O
deletion	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
stand	O
-	O
alone	O
diagnostic	O
.	O
test	O
.	O

This	O
test	O
.	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
as	O
required	O
.	O
by	O
CLIA	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
the	O
context	O
of	O
established	O
.	O
procedures	O
.	O

and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

TECHNICAL	O
SENSITIVITY	O
:	O
The	O
presence	O
of	O
>	O
15	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
sample	O
may	O
preclude	O
the	O
.	O
detection	O
of	O
.	O
allelic	O
loss	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

MGMT	O
Promoter	O
Methylation	O
.	O

Interpretation	O
.	O

LOW	O
POSITIVE	O
:	O
Methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
tumor	O
paraffin	O
block	O
.	O

(	O
A1	O
)	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Patients	O
with	O
glioma	O
containing	O
a	O
methylated	O
MGMT	O
promoter	O
have	O
been	O
shown	O
to	O
.	O
benefit	O
.	O
from	O
therapy	O
with	O
alkylating	O
agents	O
.	O

Assessment	O
of	O
MGMT	O
promoter	O
methylation	O
status	O
involves	O
bisulfite	O
.	O
treatment	O
of	O
.	O

DNA	O
followed	O
by	O
real	O
-	O
time	O
PCR	O
amplification	O
.	O
of	O
methylated	O
and	O
unmethylated	O
DNA	O
.	O
sequences	O
.	O

The	O
.	O
analytic	O
sensitivity	O
of	O
this	O
assay	O
was	O
determined	O
by	O
serial	O
dilution	O
of	O
methylated	O
positive	O
control	O
DNA	O
into	O
.	O
unmethylated	O
DNA	O
,	O
and	O
was	O
assessed	O
to	O
be	O
1	O
%	O
of	O
methylated	O
DNA	O
in	O
the	O
background	O
of	O
unmethylated	O
.	O

DNA	O
.	O

Factors	O
.	O
such	O
as	O
the	O
presence	O
of	O
>	O
50	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
sample	O
,	O
or	O
extensive	O
tissue	O
necrosis	O
,	O
may	O
.	O
preclude	O
the	O
.	O
detection	O
of	O
methylated	O
MGMT	O
promoter	O
sequences	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
stand	O
alone	O
diagnostic	O
.	O
test	O
.	O

This	O
test	O
.	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O
as	O
required	O
.	O
by	O
CLIA	O
'	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
(	O
FDA	O
)	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
the	O
context	O
of	O
established	O
.	O
procedures	O
.	O

and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

Senior	O
Staff	O
Pathologist	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Para	O
sagittal	O
,	O
biopsy	O
:	O
CONTAINER	O
LABEL	O
:	O
para	O
sagittal	O
.	O

FIXATIVE	O
:	O
Formalin	O
.	O

NO	O
.	O

PIECES	O
:	O
5	O
.	O

SIZE	O
/	O
VOL	O
:	O
2	O
-	O
4	O
mm	O
.	O
tan	O
brain	O
tissue	O
CASSETTES	O
:	O
1	O
.	O

B	O
.	O

Inferior	O
parietal	O
,	O
biopsy	O
:	O
CONTAINER	O
LABEL	O
:	O
inferior	O
parietal	O
.	O

FIXATIVE	O
:	O
Formalin	O
.	O

NO	O
.	O

PIECES	O
:	O
2	O
.	O

SIZE	O
/	O
VOL	O
:	O
3	O
-	O
4	O
mm	O
.	O

CASSETTES	O
:	O
1	O
.	O

Microscopic	O
Description	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
Part	O
A	O
:	O
The	O
GFAP	O
demonstrates	O
a	O
rather	O
delicate	O
gliofibrillary	O
background	O
.	O

The	O
tumor	O
cells	O
are	O
heavily	O
.	O
and	O
.	O

uniformly	O
reactive	O
with	O
IDH1	O
.	O

With	O
the	O
MIB	O
-	O
1	O
there	O
is	O
a	O
proliferation	O
index	O
of	O
more	O
than	O
9	O
%	O
,	O
since	O
the	O
.	O
normal	O
native	O
.	O
nuclei	O
are	O
included	O
in	O
the	O
total	O
cell	O
count	O
.	O

Part	O
B	O
:	O
The	O
IDH1	O
evinces	O
a	O
sparse	O
sprinkling	O
of	O
positive	O
glial	O
neoplastic	O
nuclei	O
sprinkled	O
throughout	O
the	O
.	O
cerebral	O
.	O

cortex	O
.	O

The	O
GFAP	O
demonstrates	O
absence	O
of	O
reactive	O
astrocytes	O
.	O

The	O
CD163	O
depicts	O
slight	O
dendritic	O
.	O
microglial	O
.	O

unrest	O
,	O
probably	O
associated	O
with	O
previous	O
mechanical	O
manipulation	O
.	O

The	O
NeuN	O
and	O
NFP	O
highlight	O
a	O
thin	O
,	O
.	O
tangentionally	O
sectioned	O
cerebral	O
cortex	O
that	O
overall	O
has	O
reasonable	O
well	O
preserved	O
layering	O
,	O
without	O
overt	O
.	O
disorganization	O
or	O
dysmorphism	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
191	O
.	O
0	O
191	O
.	O
0	O
.	O

Billina	O
Fee	O
Code	O
(	O
s	O
)	O
:	O
A	O
:	O
B	O
:	O
LOH	O
1p19q	O
:	O
MGMT	O
:	O
Histo	O
Data	O
.	O

Part	O
A	O
:	O
Para	O
sagittal	O
,	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
Block	O
Ordered	O
Comment	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
1	O
.	O

IDH1	O
-	O
sld	O
x	O
1	O
1	O
.	O

LOH	O
-	O
curls	O
x	O
1	O
1	O
.	O

MGMT	O
-	O
curls	O
x	O
1	O
1	O
.	O

MIB1	O
-	O
DA	O
x	O
1	O
1	O
.	O

Part	O
B	O
:	O
Inferior	O
parietal	O
,	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
Block	O
Ordered	O
Comment	O
.	O

CD163	O
Vector	O
x	O
1	O
1	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
1	O
.	O

IDH1	O
-	O
sld	O
x	O
1	O
1	O
.	O

NeuN	O
x	O
1	O
1	O
.	O

NF2F11	O
x	O
1	O
1	O
.	O

Rct	O
3	O
H	O
&	O
E	O
x	O
1	O
1	O
.	O

Previous	O
.	O

05	O
-	O
44224M	O
RT	O
:	O
SUPERIOR	O
TURBINATE	O
&	O
ANTERIOR	O
NASAL	O
.	O
biopsies	O
:	O
SEPTUM	O
.	O

04	O
-	O
43867M	O
allograft	O
renal	O
biopsy	O
.	O

02	O
-	O
23164M	O
ALLOGRAFT	O
RENAL	O
BIOPSY	O
/	O
is	O
.	O

01	O
-	O
27641M	O
TX	O
KIDNEY	O
BX	O
/	O
sr	O
.	O

(	O
and	O
more	O
)	O
.	O

DIAGNOSIS	O
.	O

Right	O
kidney	O
,	O
radical	O
nephrectomy	O
:	O
Chromophobe	O
renal	O
cell	O
carcinoma	O
.	O
see	O
svnontic	O
report	O
.	O

Kidney	O
:	O
Nephrectomy	O
,	O
partial	O
or	O
radical	O
Synopsis	O
.	O

MACROSCOPIC	O
.	O

Specimen	O
Type	O
:	O
Right	O
radical	O
nephrectomy	O
.	O

Focality	O
:	O
Unifo	O
cal	O
mass	O
.	O

Tumor	O
Site	O
.	O

Greatest	O
dimansien	O
:	O
3	B
.	I
0	I
.	I
m	I
.	O

MICROSCOPIC	O
.	O

ic	O
Type	O
:	O
Histologic	O
Grade	O
:	O
G1	O
:	O
Nuclei	O
round	O
,	O
uniform	O
,	O
approximately	O
10	O
microns	O
;	O
nucleoli	O
.	O
inconspicuous	O
or	O
absent	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

Primary	O
Tumor	O
:	O
pT1a	O
:	O
Tumor	O
4	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
limited	O
to	O
the	O
kidney	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Lymph	O
Nodes	O
:	O
None	O
submitted	O
.	O

Distant	O
metastasis	O
:	O
pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Adrenal	O
gland	O
:	O
Not	O
present	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Comments	O
:	O
Colloidal	O
iron	O
stain	O
shows	O
focal	O
granular	O
cytoplasmic	O
staining	O
consistent	O
with	O
the	O
.	O
above	O
diagnosis	O
.	O

The	O
tumor	O
arises	O
in	O
an	O
end	O
stage	O
kidney	O
.	O

Clinical	O
:	O
Right	O
renal	O
mass	O
.	O

Gross	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
the	O
medical	O
record	O
number	O
and	O
"	O
right	O
kidney	O
"	O
,	O
and	O
consists	O
of	O
a	O
.	O
laporascopic	O
radical	O
nephrectomy	O
specimen	O
.	O

The	O
kidney	O
with	O
attached	O
perinephric	O
fat	O
weighs	O
.	O

VI	O
gianto	O
.	O

NUI	O
ILLINIOU	O
to	O
auru	O
ure	O
specifical	O
.	O

a	O
well	O
circumscribed	O
tan	O
and	O
brown	O
nodule	O
measuring	O
3	O
.	O
0	O
x	O
3	O
.	O
0	O
X	O
1	O
.	O
5	O
cm	O
.	O

The	O
nodule	O
abuts	O
the	O
.	O
renal	O
capsule	O
but	O
no	O
invasion	O
into	O
perinephric	O
fat	O
is	O
noted	O
.	O

Small	O
cysts	O
are	O
noted	O
within	O
the	O
.	O
cortex	O
.	O

The	O
remainder	O
of	O
the	O
kidney	O
is	O
grossly	O
unremarkable	O
.	O

The	O
renal	O
mass	O
is	O
sectioned	O
and	O
.	O

a	O
portion	O
is	O
taken	O
for	O
tissue	O
bank	O
.	O

No	O
adrenal	O
gland	O
is	O
present	O
.	O

The	O
specimen	O
is	O
represented	O
.	O
as	O
follows	O
:	O
A	O
=	O
vascular	O
margin	O
,	O
B	O
=	O
ureter	O
margin	O
,	O
C	O
-	O
F	O
=	O
tumor	O
in	O
tumor	O
relation	O
to	O
kidney	O
and	O
.	O
perinephric	O
fat	O
,	O
F	O
=	O
cystic	O
areas	O
and	O
cortex	O
and	O
samples	O
of	O
cortex	O
and	O
medulla	O
,	O
G	O
=	O
section	O
of	O
.	O
grossly	O
unremarkable	O
perinephric	O
fat	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
right	O
,	O
posterior	O
sectionectomy	O
:	O
Hepatocellular	O
carcinoma	O
,	O
S6	O
.	O

1	O
)	O
Post	O
-	O
chemoembolization	O
status	O
:	O
absent	O
.	O

2	O
)	O
Size	O
of	O
tumor	O
;	O
4x2	B
.	I
8x2	I
.	I
2cm	I
.	O

3	O
)	O
Gross	O
type	O
:	O
multinodular	O
confluent	O
type	O
.	O

4	O
)	O
Satellite	O
nodule	O
:	O
present	O
.	O

5	O
)	O
Histologic	O
type	O
:	O
trabecular	O
.	O

6	O
)	O
Cell	O
type	O
:	O
classic	O
cell	O
group	O
.	O

7	O
)	O
Edmondson	O
and	O
Steiner	O
'	O
s	O
histologic	O
grade	O
:	O
The	O
worst	O
differentiation	O
:	O
4	O
.	O

The	O
major	O
differentiation	O
:	O
3	O
.	O

8	O
)	O
Fatty	O
change	O
:	O
absent	O
.	O

9	O
)	O
Hemorrhage	O
/	O
peliosis	O
:	O
present	O
(	O
2	O
%	O
)	O
.	O

10	O
)	O
Tumor	O
necrosis	O
:	O
present	O
(	O
5	O
%	O
)	O
.	O

11	O
)	O
Vascular	O
invasion	O
(	O
microscopic	O
)	O
:	O
present	O
.	O

12	O
)	O
Capsule	O
formation	O
:	O
absent	O
.	O

13	O
)	O
Septal	O
formation	O
:	O
present	O
.	O

14	O
)	O
Involvement	O
of	O
a	O
major	O
branch	O
of	O
the	O
portal	O
vein	O
:	O
absent	O
.	O

15	O
)	O
Involvement	O
of	O
a	O
major	O
branch	O
of	O
the	O
hepatic	O
vein	O
:	O
absent	O
.	O

16	O
)	O
Bile	O
duct	O
invasion	O
:	O
present	O
.	O

17	O
)	O
Serosal	O
invasion	O
:	O
present	O
(	O
Glisson	O
'	O
s	O
capsule	O
)	O
(	O
Fibrous	O
adhesion	O
)	O
.	O

18	O
)	O
Surgical	O
margin	O
:	O
clear	O
(	O
safety	O
margin	O
:	O
3cm	O
)	O
.	O

19	O
)	O
Intrahepatic	O
metastasis	O
:	O
present	O
.	O

20	O
)	O
Multicentric	O
occurrence	O
:	O
absent	O
.	O

21	O
)	O
Pathologic	O
stage	O
:	O
AJCC	O
(	O
pT2	O
)	O
,	O
.	O

(	O
pT4	O
)	O
.	O

22	O
)	O
Related	O
biopsy	O
:	O
none	O
.	O

23	O
)	O
Additional	O
pathologic	O
findings	O
.	O

a	O
)	O
Chronic	O
hepatitis	O
,	O
HBV	O
-	O
associated	O
.	O
with	O
minimal	O
lobular	O
activity	O
.	O
mild	O
porto	O
-	O
periportal	O
activity	O
.	O
periportal	O
fibrosis	O
.	O

b	O
)	O
Cirrhosis	O
:	O
absent	O
.	O

c	O
)	O
Dysplasia	O
:	O
absent	O
.	O

d	O
)	O
Bile	O
duct	O
adenoma	O
,	O
0	B
.	I
15mm	I
in	O
size	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

KIDNEY	O
,	O
RIGHT	O
,	O
LAPAROSCOPIC	O
RADICAL	O
NEPHRECTOMY	O
-	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
CELL	O
)	O
TYPE	O
,	O
FUHRMAN	O
NUCLEAR	O
GRADE	O
II	O
/	O
IV	O
,	O
5	B
.	I
5	I
CM	I
IN	O
.	O

GREATEST	O
DIMENSION	O
.	O

B	O
.	O

DIRECT	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
IDENTIFIED	O
,	O
GROSSLY	O
AND	O
MICROSCOPICALLY	O
.	O

C	O
.	O

TUMOR	O
SHOWS	O
NO	O
EVIDENCE	O
OF	O
INVASION	O
OF	O
RENAL	O
SINUS	O
OR	O
PERINEPHRIC	O
ADIPOSE	O
TISSUE	O
(	O
See	O
.	O
comment	O
)	O
.	O

D	O
.	O

ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

E	O
.	O

URETERITIS	O
CYSTICA	O
is	O
PRESENT	O
.	O

F	O
.	O

ADRENAL	O
GLAND	O
IS	O
NOT	O
IDENTIFIED	O
.	O

G	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pTNM	O
=	O
pT3b	O
NX	O
MX	O
.	O

Diagnosis	O
/	O
Diagnoses	O
:	O
Resectate	O
of	O
the	O
colon	O
under	O
inclusion	O
of	O
a	O
moderately	O
differentiated	O
adenocarcinoma	O
of	O
.	O
the	O
colorectal	O
type	O
,	O
of	O
maximum	O
2	B
.	I
5	I
cm	I
in	O
size	O
,	O
with	O
infiltration	O
of	O
the	O
pericolic	O
fatty	O
.	O
tissue	O
.	O

Tumor	O
-	O
free	O
regional	O
lymph	O
nodes	O
.	O

Tumor	O
-	O
free	O
mesenteric	O
resection	O
margin	O
.	O

Tumor	O
-	O
free	O
large	O
intestinal	O
resection	O
margins	O
.	O

Tumor	O
stage	O
:	O
pT3	O
pNO	O
(	O
0	O
/	O
35	O
)	O
pMX	O
;	O
G2	O
,	O
L0	O
,	O
V0	O
,	O
locally	O
R0	O
.	O

CONFIDENTIAL	O
.	O

Demographics	O
(	O
for	O
.	O
verification	O
purposes	O
)	O
.	O

Sex	O
:	O
M	O
.	O

Collected	O
Date	O
/	O
Tir	O
.	O

Received	O
Date	O
/	O
Time	O
.	O

Specimen	O
Description	O
.	O

A	O
.	O

Gallbladder	O
at	O
.	O

B	O
.	O

Liver	O
segment	O
6	O
at	O
.	O

Clinical	O
Information	O
.	O

Cirrhosis	O
secondary	O
to	O
ETOH	O
with	O
likely	O
HCC	O
.	O

Diagnosis	O
.	O

A	O
.	O

Gallbladder	O
:	O
Cholelithiasis	O
.	O

B	O
.	O

Liver	O
segment	O
6	O
:	O
Chronic	O
hepatitis	O
,	O
mild	O
.	O

Cirrhosis	O
,	O
micronodular	O
.	O

Hepatocellular	O
carcinoma	O
,	O
moderately	O
differentiated	O
,	O
solid	O
variant	O
,	O
.	O

2	B
.	I
5	I
cms	I
in	O
the	O
greast	O
dimension	O
,	O
with	O
metastases	O
to	O
the	O
portal	O
veins	O
.	O
and	O
intrahepatic	O
metastases	O
.	O

Tumor	O
0	O
.	O
3	O
cm	O
away	O
from	O
the	O
resection	O
margin	O
.	O

Verified	O
:	O
Gross	O
Description	O
.	O

Received	O
are	O
specimen	O
containers	O
A	O
to	O
B	O
.	O

All	O
requisitions	O
and	O
specimen	O
containers	O
are	O
.	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

The	O
cassettes	O
and	O
AP	O
identifiers	O
are	O
.	O
labelled	O
with	O
the	O
Surgical	O
Number	O
.	O

A	O
.	O

Specimen	O
is	O
received	O
fresh	O
.	O

The	O
container	O
is	O
designated	O
"	O
A	O
.	O

Gallbladder	O
"	O
.	O

The	O
.	O
specimen	O
consists	O
of	O
a	O
congested	O
intact	O
gallbladder	O
measuring	O
11	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
.	O

The	O
.	O
serosal	O
surface	O
is	O
smooth	O
and	O
glistening	O
.	O

Opening	O
reveals	O
the	O
gallbladder	O
to	O
be	O
filled	O
.	O
with	O
green	O
bile	O
.	O

Also	O
found	O
in	O
the	O
gallbladder	O
are	O
five	O
black	O
irregular	O
calculi	O
ranging	O
.	O
from	O
0	O
.	O
4	O
cm	O
up	O
to	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
mucosal	O
surface	O
is	O
dark	O
green	O
,	O
rough	O
.	O
and	O
the	O
gallbladder	O
wall	O
averages	O
between	O
0	O
.	O
1	O
to	O
0	O
.	O
2	O
cm	O
in	O
thickness	O
.	O

Found	O
at	O
the	O
neck	O
.	O
and	O
near	O
the	O
cystic	O
duct	O
are	O
two	O
firm	O
palpable	O
nodules	O
within	O
the	O
adipose	O
tissue	O
,	O
the	O
.	O
first	O
measuring	O
1	O
.	O
0	O
cm	O
,	O
the	O
other	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sections	O
are	O
as	O
follows	O
:	O
A1	O
.	O

-	O
three	O
sections	O
of	O
gallbladder	O
.	O

A2	O
.	O

-	O
the	O
smaller	O
node	O
bisected	O
.	O

A3	O
.	O

-	O
the	O
larger	O
node	O
bisected	O
.	O

B	O
.	O

Specimen	O
is	O
received	O
fresh	O
.	O

The	O
container	O
is	O
designated	O
"	O
Liver	O
segment	O
6	O
"	O
.	O

The	O
.	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
liver	O
weighing	O
50	O
.	O
8	O
g	O
and	O
measuring	O
6	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
liver	O
capsule	O
is	O
nodular	O
and	O
the	O
surgical	O
resection	O
margin	O
has	O
been	O
inked	O
blue	O
.	O

Sectioning	O
reveals	O
a	O
green	O
circumscribed	O
mass	O
measuring	O
2	O
.	O
5	O
x	O
2	O
.	O
3	O
x	O
2	O
.	O
5	O
cm	O
.	O

Adjacent	O
.	O

to	O
.	O
the	O
green	O
circumscribed	O
mass	O
is	O
a	O
hemorrhagic	O
circumscribed	O
mass	O
measuring	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
.	O

1	O
.	O
0	O
cm	O
.	O

The	O
green	O
mass	O
comes	O
within	O
0	O
.	O
3	O
cm	O
of	O
the	O
blue	O
painted	O
surgical	O
resection	O
margin	O
.	O
and	O
the	O
hemorrhagic	O
mass	O
0	O
.	O
1	O
cm	O
to	O
the	O
blue	O
painted	O
surgical	O
resection	O
margin	O
.	O

The	O
green	O
.	O
mass	O
comes	O
with	O
less	O
than	O
0	O
.	O
1	O
cm	O
of	O
the	O
liver	O
capsule	O
and	O
the	O
hemorrhagic	O
mass	O
comes	O
.	O
within	O
0	O
.	O
7	O
cm	O
of	O
the	O
liver	O
capsule	O
.	O

Sections	O
are	O
as	O
follows	O
:	O
B1	O
.	O

-	O
section	O
of	O
the	O
green	O
mass	O
and	O
its	O
relationship	O
to	O
the	O
liver	O
capsule	O
.	O

B2	O
.	O

-	O
section	O
of	O
the	O
green	O
mass	O
and	O
its	O
relationship	O
to	O
the	O
blue	O
painted	O
surgical	O
.	O
resection	O
margin	O
.	O

B3	O
.	O

-	O
hemorrhagic	O
mass	O
with	O
a	O
portion	O
of	O
the	O
adjacent	O
green	O
mass	O
and	O
the	O
relationship	O
.	O
to	O
the	O
blue	O
.	O
painted	O
surgical	O
margin	O
.	O

B4	O
.	O

-	O
further	O
section	O
of	O
hemorrhagic	O
mass	O
and	O
relationship	O
to	O
blue	O
painted	O
surgical	O
.	O
resection	O
margin	O
.	O

Please	O
note	O
that	O
upon	O
sectioning	O
of	O
the	O
hemorrhagic	O
mass	O
,	O
it	O
is	O
found	O
to	O
have	O
a	O
.	O
cut	O
surface	O
.	O
which	O
is	O
granular	O
and	O
the	O
substance	O
easily	O
pulls	O
out	O
of	O
the	O
.	O
circumscribed	O
area	O
,	O
query	O
blood	O
.	O
vessel	O
.	O

B5	O
.	O

-	O
representative	O
section	O
of	O
liver	O
parenchyma	O
.	O

Encounter	O
Number	O
.	O

Patient	O
Location	O
.	O

Temporary	O
Copy	O
.	O
case	O
.	O

Patienal	O
.	O

Collectee	O
.	O

Clinical	O
History	O
.	O
none	O
given	O
.	O

Diagnosis	O
.	O

1	O
.	O

"	O
LEFT	O
FRONTAL	O
LESION	O
"	O
,	O
(	O
BIOPSY	O
)	O
:	O
-	O
HIGH	O
GRADE	O
GLIOMA	O
MOST	O
CONSISTENT	O
WITH	O
ANAPLASTIC	O
OLIGODENDROGLIOMA	O
.	O

2	O
.	O

"	O
LEFT	O
FRONTAL	O
LESION	O
"	O
,	O
(	O
RESECTION	O
)	O
:	O
-	O
HIGH	O
GRADE	O
GLIOMA	O
MOST	O
CONSISTENT	O
WITH	O
ANAPLASTIC	O
OLIGODENDROGLIOMA	O
(	O
WHO	O
GRADE	O
.	O
III	O
)	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
.	O
diagnostic	O
evaluation	O
on	O
the	O
above	O
specimens	O
.	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
:	O
For	O
questions	O
regarding	O
this	O
case	O
,	O
call	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

Frozen	O
section	O
diagnosis	O
per	O
.	O

1FA	O
:	O
"	O
High	O
grade	O
glioma	O
"	O
.	O

Gross	O
Description	O
.	O

Two	O
containers	O
are	O
received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
.	O
number	O
.	O

Specimen	O
one	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
left	O
frontal	O
lesion	O
"	O
.	O

The	O
specimen	O
is	O
a	O
1	O
.	O
8	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
4	O
cm	O
portion	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

Half	O
of	O
this	O
.	O
tissue	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

Submitted	O
in	O
total	O
in	O
cassette	O
1FA	O
,	O
and	O
.	O

1A	O
.	O

Specimen	O
two	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
left	O
frontal	O
lesion	O
"	O
,	O
is	O
a	O
46	O
.	O
60	O
g	O
.	O
portion	O
of	O
pink	O
-	O
tan	O
focally	O
hemorrhagic	O
brain	O
tissue	O
.	O

The	O
tissue	O
is	O
9	O
.	O
0	O
x	O
7	O
.	O
5	O
x	O
.	O

3	O
.	O
0	O
cm	O
in	O
aggregate	O
.	O

Sectioning	O
shows	O
a	O
grey	O
to	O
dusky	O
pink	O
glistening	O
cut	O
surface	O
.	O

No	O
discrete	O
nodules	O
are	O
identified	O
.	O

Representative	O
sections	O
submitted	O
in	O
cassette	O
.	O

2A	O
-	O
2D	O
.	O

Microscopic	O
Examination	O
.	O

Temporary	O
Copy	O
.	O

Race	O
20f	O
2	O
.	O

Dase	O
.	O

o	O
.	O
logation	O
.	O

Performed	O
.	O

Synoptic	O
Report	O
.	O

No	O
AJCC	O
/	O
UICC	O
TNM	O
Staging	O
System	O
.	O

Protocol	O
web	O
posting	O
date	O
:	O
Protocol	O
effective	O
date	O
:	O
Specimen	O
type	O
/	O
procedure	O
:	O
Open	O
biopsy	O
.	O

Resection	O
.	O

Specimen	O
handling	O
:	O
Frozen	O
section	O
.	O

Unfrozen	O
for	O
permanent	O
paraffin	O
sections	O
.	O
other	O
.	O

Specify	O
:	O
Received	O
in	O
formalin	O
for	O
permanent	O
sections	O
.	O

Specimen	O
size	O
:	O
Greatest	O
dimension	O
9	O
.	O
0	O
cm	O
.	O

Additional	O
dimension	O
:	O
7	O
.	O
5	O
x	O
3	O
.	O
0	O
cm	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
site	O
:	O
Brain	O
,	O
cerebrum	O
.	O

Left	O
frontal	O
.	O

Histologic	O
type	O
and	O
grade	O
:	O
oligodendroglial	O
tumors	O
.	O

Histologic	O
Grade	O
:	O
Anaplastic	O
oligodendrogliom	O
(	O
WHO	O
grade	O
III	O
)	O
.	O

Margins	O
:	O
Cannot	O
be	O
assessed	O
.	O

Ancillary	O
studies	O
:	O
None	O
performed	O
.	O

Comments	O
:	O
Specimen	O
will	O
be	O
sent	O
in	O
consultation	O
to	O
the	O
.	O

at	O
.	O
division	O
of	O
neuropathology	O
.	O

Addendum	O
Report	O
.	O

Temporary	O
Copy	O
.	O

Page	O
10	O
1	O
.	O

Colected	O
.	O
pocauer	O
.	O

Addendum	O
Discussion	O
.	O

Outside	O
consultation	O
diagnosis	O
from	O
.	O

is	O
as	O
.	O
follows	O
:	O
DIAGNOSIS	O
:	O
BRAIN	O
,	O
LEFT	O
FRONTAL	O
LESION	O
,	O
BIOPSY	O
(	O
PART	O
1	O
)	O
AND	O
RESECTION	O
(	O
PART	O
2	O
)	O
,	O
.	O

-	O
ANAPLASTIC	O
OLIGODENDROGLIOMA	O
,	O
WHO	O
GRADE	O
III	O
(	O
SEE	O
COMMENT	O
)	O
.	O

Comment	O
:	O
Evaluation	O
of	O
the	O
1p	O
and	O
19q	O
status	O
of	O
this	O
neoplasm	O
will	O
be	O
performed	O
through	O
.	O
laboratories	O
;	O
the	O
results	O
of	O
this	O
testing	O
will	O
be	O
issued	O
in	O
a	O
separate	O
report	O
.	O

ORIGINAL	O
DIAGNOSIS	O
REMAINS	O
UNCHANGED	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
.	O
diagnostic	O
evaluation	O
on	O
the	O
above	O
specimen	O
(	O
s	O
)	O
.	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
:	O
Addendum	O
Report	O
.	O

Temporary	O
Copy	O
.	O

Gase	O
.	O
rocation	O
.	O

Addendum	O
Discussion	O
.	O

1p	O
/	O
19q	O
FISH	O
.	O

Fluorescence	O
in	O
-	O
situ	O
hybridization	O
(	O
FISH	O
)	O
analysis	O
for	O
deletions	O
of	O
1p	O
and	O
/	O
or	O
19q	O
.	O
are	O
performed	O
on	O
sections	O
from	O
block	O
"	O
2A	O
"	O
.	O

Calculated	O
1p	O
/	O
1q	O
ratio	O
=	O
0	O
.	O
49	O
(	O
<	O
0	O
.	O
74	O
is	O
deleted	O
)	O
.	O

Calculated	O
19q	O
/	O
19p	O
ratio	O
=	O
.	O
055	O
(	O
<	O
0	O
.	O
88	O
is	O
deleted	O
)	O
.	O

The	O
results	O
are	O
interpreted	O
as	O
deleted	O
for	O
1p	O
and	O
19q	O
.	O

This	O
assay	O
was	O
read	O
by	O
Dr	O
.	O
A	O
result	O
of	O
a	O
deleted	O
1p	O
and	O
19q	O
suggests	O
a	O
favorable	O
prognosis	O
.	O

A	O
solitary	O
1p	O
.	O
deletion	O
suggests	O
an	O
intermediate	O
prognosis	O
.	O

A	O
19q	O
solitary	O
deletion	O
may	O
suggest	O
a	O
.	O
favorable	O
prognosis	O
in	O
a	O
smaller	O
subset	O
of	O
tumors	O
.	O

The	O
lack	O
of	O
either	O
1p	O
and	O
/	O
or	O
.	O

19q	O
deletion	O
(	O
s	O
)	O
is	O
considered	O
a	O
poor	O
prognostic	O
indicator	O
and	O
may	O
be	O
associated	O
.	O
with	O
decreased	O
disease	O
-	O
free	O
survival	O
and	O
overall	O
survival	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
.	O
diagnostic	O
evaluation	O
on	O
the	O
above	O
speciment	O
(	O
s	O
)	O
.	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
:	O

Diagnosis	O
:	O
Distal	O
partial	O
gastric	O
resection	O
with	O
tumor	O
-	O
free	O
oral	O
resection	O
margin	O
and	O
inclusion	O
of	O
an	O
.	O
ulcerated	O
poorly	O
differentiated	O
adenocarcinoma	O
or	O
gastric	O
carcinoma	O
of	O
diffuse	O
(	O
so	O
-	O
called	O
.	O
signet	O
ring	O
cell	O
carcinoma	O
)	O
,	O
located	O
in	O
the	O
prepyloric	O
antrum	O
in	O
the	O
region	O
of	O
the	O
greater	O
.	O
curvature	O
,	O
with	O
infiltration	O
of	O
all	O
parietal	O
layers	O
,	O
encroachment	O
on	O
the	O
transverse	O
colon	O
,	O
several	O
.	O
regional	O
lymph	O
node	O
metastases	O
,	O
omentum	O
metastases	O
and	O
peritoneal	O
spread	O
also	O
in	O
the	O
region	O
.	O
of	O
the	O
distal	O
resection	O
margin	O
and	O
in	O
the	O
region	O
of	O
one	O
of	O
the	O
resection	O
margins	O
of	O
the	O
.	O
transverse	O
colon	O
resection	O
material	O
.	O

pT4	O
L1	O
V0	O
R2	O
pN3	O
21	O
/	O
27	O
pM1	O
)	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

2	O
.	O

SEX	O
:	O
M	O
.	O

PROCEDURE	O
:	O
SPHS	O
.	O

A	O
.	O
year	O
-	O
old	O
with	O
esophageal	O
cancer	O
arising	O
in	O
Barrett	O
'	O
s	O
.	O

PROCEDURE	O
:	O
SPGD	O
.	O

1	O
.	O

"	O
Esophagogastrectomy	O
"	O
.	O

Received	O
in	O
format	O
in	O
in	O
a	O
large	O
container	O
is	O
a	O
.	O
esophagogastrectomy	O
specimen	O
comprised	O
of	O
8	O
.	O
5	O
cm	O
long	O
,	O
5	O
cm	O
circumference	O
.	O
distal	O
esophagus	O
with	O
5	O
cm	O
x	O
12	O
cm	O
circumference	O
proximal	O
stomach	O
with	O
.	O
attached	O
perigastric	O
adipose	O
ranging	O
up	O
to	O
5	O
cm	O
.	O

Adventitia	O
and	O
serosal	O
.	O
surface	O
is	O
grossly	O
unremarkable	O
.	O

No	O
perforations	O
.	O

Esophageal	O
mucosa	O
is	O
.	O
wrinkled	O
grey	O
at	O
most	O
proximal	O
3	O
cm	O
with	O
a	O
6	O
cm	O
length	O
of	O
saimon	O
colored	O
.	O

Barrett	O
'	O
s	O
mucosa	O
extending	O
to	O
the	O
gastroesophageal	O
junction	O
with	O
a	O
3	O
.	O
3	O
x	O
2	O
.	O
5	O
.	O

cm	O
ulcer	O
with	O
heaped	O
-	O
up	O
borders	O
at	O
the	O
gastroesophageal	O
junction	O
.	O

Ulcer	O
.	O
extends	O
through	O
the	O
esophageal	O
mucosa	O
to	O
a	O
maximum	O
depth	O
of	O
1	O
.	O
0	O
cm	O
(	O
grossly	O
.	O
abutting	O
but	O
not	O
penetrating	O
muscularis	O
propria	O
)	O
.	O

Gastric	O
mucosa	O
wrinkled	O
,	O
tan	O
.	O
with	O
normal	O
folds	O
.	O

No	O
ulcers	O
or	O
other	O
masses	O
.	O

Several	O
lymph	O
nodes	O
identified	O
.	O
in	O
perigastric	O
adipose	O
tissue	O
.	O

1A	O
.	O

Neoplasm	O
at	O
greatest	O
depth	O
and	O
with	O
respect	O
to	O
proximal	O
.	O

18	O
.	O

Lesion	O
with	O
respect	O
to	O
distal	O
.	O

1C	O
and	O
D	O
.	O

Proximal	O
and	O
distal	O
including	O
gastroesophageal	O
junction	O
.	O
respectively	O
.	O

each	O
)	O
.	O

1E	O
.	O

Barrett	O
'	O
s	O
mucosa	O
to	O
proximal	O
esophagus	O
.	O

1F	O
.	O

Barrett	O
'	O
s	O
mucosa	O
to	O
gastroesophageal	O
junction	O
.	O

1G	O
.	O

Multiple	O
tymph	O
nodes	O
.	O

1H	O
.	O

Two	O
lymph	O
nodes	O
,	O
one	O
inked	O
blue	O
.	O

Each	O
bisected	O
.	O

11	O
.	O

One	O
grossly	O
positive	O
lymph	O
node	O
.	O

Trisected	O
.	O

1J	O
.	O

One	O
grossly	O
positive	O
Lymph	O
node	O
.	O

Sectioned	O
.	O

2	O
.	O

Cervical	O
esophagus	O
margin	O
"	O
.	O

Received	O
in	O
formal	O
in	O
in	O
a	O
small	O
container	O
is	O
a	O
.	O

1	O
.	O
8	O
cm	O
long	O
,	O
1	O
cm	O
internal	O
diameter	O
segment	O
of	O
esophagus	O
with	O
intact	O
.	O
adventitial	O
lining	O
and	O
wrinkled	O
grey	O
mucosa	O
.	O

One	O
stapled	O
and	O
open	O
margin	O
.	O

Sampled	O
at	O
open	O
end	O
.	O

3	O
.	O

"	O
Esophageal	O
Lymph	O
pode	O
"	O
Recaived	O
in	O
formalin	O
in	O
a	O
smait	O
containen	O
is	O
.	O

1	O
.	O
2	O
.	O

cm	O
anthracotic	O
lymph	O
node	O
.	O

Bisected	O
.	O

PROCEDURE	O
:	O
SPMI	O
.	O

ESOPHAGEAL	O
,	O
CARDIAC	O
AND	O
GASTROESOPHAGEAL	O
JUNCTION	O
CARCINOMA	O
:	O
PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

3	O
.	O

SEX	O
:	O
M	O
.	O

Type	O
of	O
carcinoma	O
:	O
Adenocarcinoma	O
.	O

If	O
adenocarcinoma	O
,	O
it	O
is	O
arising	O
in	O
:	O
Barrett	O
'	O
s	O
mucosa	O
.	O

Depth	O
of	O
invasion	O
:	O
Muscularis	O
propria	O
.	O

Number	O
of	O
positive	O
lymph	O
nodes	O
:	O
3	O
/	O
15	O
.	O

Extranodal	O
metastasis	O
:	O
Unknown	O
.	O

Pattern	O
of	O
invasion	O
:	O
Expansile	O
.	O

Esophageal	O
and	O
gastric	O
resection	O
margins	O
involved	O
:	O
No	O
.	O

Deep	O
resection	O
margin	O
involved	O
:	O
No	O
.	O

TNM	O
classification	O
:	O
T2	O
N1	O
Mx	O
.	O

PROCEDURE	O
:	O
SPOX	O
.	O

1	O
.	O

Esophagus	O
and	O
proximal	O
stomach	O
,	O
resection	O
:	O
Invasive	O
adenocarcinoma	O
.	O
arising	O
in	O
Barrett	O
'	O
s	O
mucosa	O
,	O
extending	O
focally	O
into	O
superficial	O
muscularis	O
.	O
propria	O
.	O

Resection	O
margins	O
negative	O
.	O

Angiolymphatic	O
invasion	O
present	O
.	O

Metastatic	O
adenocarcinoma	O
present	O
in	O
3	O
of	O
15	O
lymph	O
nodes	O
.	O

Incidental	O
.	O
esophageal	O
leiomyoma	O
.	O

Please	O
see	O
template	O
for	O
details	O
.	O

2	O
.	O

Cervical	O
esophageal	O
margin	O
,	O
resection	O
:	O
Esophagus	O
,	O
negative	O
for	O
neoplasm	O
.	O

3	O
.	O

Esophageal	O
lymph	O
node	O
,	O
excision	O
:	O
1	O
lymph	O
node	O
,	O
negative	O
for	O
neoplasm	O
.	O

1	O
,	O
.	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
.	O
examined	O
and	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

END	O
OF	O
PREVIOUS	O
DIAGNOSIS	O
INOUIRY	O
.	O

DOS	O
:	O
Female	O
.	O

FIN	O
:	O
ADMITTED	O
:	O
PT	O
LOCATION	O
,	O
.	O

ADMITTING	O
PROVIDER	O
:	O
DISCHARGED	O
:	O
PT	O
TYPE	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

Clinical	O
Information	O
.	O

Endometrial	O
c	O
	O
ncer	O
.	O

Diagnosis	O
.	O

A	O
.	O

Left	O
saipirigo	O
-	O
oophorectomy	O
:	O
Ovary	O
:	O
Fibrothecoma	O
(	O
4	B
.	I
5	I
cm	I
)	O
.	O

Fallopian	O
tube	O
:	O
without	O
diagnostic	O
abnormality	O
.	O

B	O
.	O

Total	O
abdominal	O
hysterectomy	O
with	O
right	O
salpingo	O
-	O
oophorectomy	O
:	O
Uterus	O
and	O
cervix	O
(	O
71	O
grams	O
)	O
:	O
Uterine	O
serous	O
carcinoma	O
with	O
focal	O
clear	O
cell	O
features	O
,	O
FIGO	O
3	O
,	O
see	O
summary	O
.	O

Other	O
findings	O
:	O
Cervix	O
:	O
squamous	O
atrophy	O
.	O

Focal	O
necrotizing	O
vasculitis	O
.	O

Endometrium	O
(	O
background	O
)	O
:	O
Inactive	O
.	O

Myometrium	O
:	O
focal	O
necrotizing	O
vasculitis	O
,	O
see	O
comment	O
.	O

Serosa	O
:	O
small	O
peritoneal	O
inclusion	O
cyst	O
.	O

Right	O
ovary	O
and	O
fallopian	O
tube	O
:	O
without	O
diagnostic	O
abnormality	O
.	O

SUMMARY	O
FOR	O
ENDOMETRIAL	O
NEOPLASMS	O
:	O
Specimen	O
(	O
s	O
)	O
submitted	O
and	O
Procedure	O
(	O
s	O
)	O
:	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
fallopian	O
tubes	O
,	O
bilateral	O
ovaries	O
,	O
omentum	O
and	O
.	O
regional	O
lymph	O
nodes	O
;	O
total	O
abdominal	O
hysterectomy	O
with	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
,	O
omentectomy	O
,	O
.	O
regional	O
lymph	O
node	O
dissections	O
.	O

Specimen	O
int	O
	O
grity	O
:	O
intact	O
,	O
bivalved	O
.	O

Histologic	O
type	O
:	O
serous	O
with	O
focal	O
clear	O
cell	O
features	O
.	O

Histologic	O
grade	O
:	O
high	O
grade	O
,	O
FIGO	O
3	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
cm	I
.	O

Myometrial	O
invasion	O
:	O
present	O
,	O
outer	O
half	O
,	O
see	O
comment	O
.	O

Depth	O
of	O
irivasion	O
:	O
8	O
mm	O
.	O

Myometrial	O
thickness	O
:	O
14	O
mm	O
.	O

Involvement	O
of	O
cervix	O
:	O
not	O
appreciated	O
.	O

Lower	O
uterine	O
segment	O
involvement	O
:	O
not	O
appreciated	O
.	O

Lymphatic	O
vascular	O
space	O
involvement	O
:	O
not	O
appreciated	O
.	O

Extent	O
of	O
involvement	O
of	O
other	O
organs	O
:	O
none	O
.	O

Margins	O
:	O
free	O
of	O
tumor	O
.	O

Summary	O
,	O
cytology	O
:	O
negative	O
,	O
see	O
separate	O
report	O
(	O
s	O
)	O
.	O

Summary	O
,	O
lymph	O
node	O
dissections	O
:	O
DOS	O
.	O

SEX	O
:	O
Female	O
.	O

FIN	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

COLLECTED	O
DATE	O
/	O
TIME	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

All	O
regions	O
:	O
Total	O
positive	O
/	O
total	O
removed	O
:	O
(	O
0	O
/	O
36	O
)	O
.	O

Pelvic	O
lymph	O
nodes	O
:	O
Total	O
positive	O
/	O
total	O
removed	O
:	O
(	O
0	O
/	O
27	O
)	O
.	O

Para	O
-	O
aortic	O
lymph	O
nodes	O
:	O
Total	O
positive	O
/	O
total	O
removed	O
:	O
(	O
0	O
/	O
9	O
)	O
.	O

Additional	O
pathologic	O
findings	O
:	O
as	O
above	O
.	O

Summary	O
,	O
Anciliary	O
studies	O
requested	O
/	O
obtained	O
:	O
study	O
(	O
les	O
)	O
obtained	O
on	O
fresh	O
tissue	O
.	O

Summary	O
,	O
Clinical	O
history	O
:	O
see	O
electronic	O
medical	O
record	O
.	O

Distant	O
metastasis	O
(	O
es	O
)	O
:	O
unknown	O
.	O

AJCC	O
7th	O
edition	O
Pathologic	O
Staging	O
:	O
pT1b	O
pNO	O
pMX	O
FIGO	O
IB	O
grade	O
3	O
.	O

C	O
.	O

J	O
.	O

Regional	O
lymph	O
node	O
resections	O
:	O
No	O
evidence	O
of	O
tumor	O
in	O
a	O
total	O
of	O
thirty	O
six	O
lymph	O
nodes	O
(	O
0	O
/	O
36	O
)	O
,	O
as	O
follows	O
:	O
C	O
.	O

Left	O
external	O
illac	O
lymph	O
node	O
:	O
(	O
0	O
/	O
8	O
)	O
.	O

D	O
.	O

Left	O
obturator	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
3	O
)	O
.	O

E	O
.	O

Left	O
common	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
3	O
)	O
.	O

F	O
.	O

Left	O
perlaortic	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
5	O
)	O
.	O

G	O
.	O

Right	O
external	O
Illac	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
5	O
)	O
.	O

H	O
.	O

Right	O
obturator	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
4	O
)	O
.	O

I	O
.	O

Right	O
common	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
4	O
)	O
.	O

J	O
.	O

Right	O
periaortic	O
lymph	O
nodes	O
:	O
(	O
0	O
/	O
4	O
)	O
.	O

K	O
.	O

Omentectomy	O
:	O
No	O
evidence	O
of	O
tumor	O
.	O

Pathologist	O
/	O
Electronically	O
signed	O
:	O
Report	O
verified	O
at	O
:	O
Comment	O
.	O

Focal	O
areas	O
exhibit	O
a	O
tubal	O
pattern	O
with	O
cytoplasmic	O
clearing	O
consistent	O
with	O
focal	O
features	O
of	O
clear	O
cell	O
carcinoma	O
(	O
slide	O
.	O
B9	O
)	O
.	O

Depth	O
of	O
invasion	O
is	O
difficult	O
to	O
measure	O
because	O
the	O
tumor	O
focus	O
is	O
polypoid	O
.	O

At	O
it	O
'	O
s	O
closest	O
point	O
(	O
slide	O
B13	O
)	O
,	O
tumor	O
is	O
.	O
approximately	O
B	O
mm	O
from	O
serosa	O
.	O

In	O
an	O
adjacent	O
section	O
(	O
on	O
the	O
same	O
slide	O
)	O
,	O
the	O
myometrium	O
is	O
14	O
mm	O
thick	O
,	O
so	O
depth	O
of	O
.	O
invasion	O
is	O
calculated	O
as	O
8	O
mm	O
in	O
a	O
14	O
mm	O
thick	O
myometrium	O
.	O

Rarely	O
vasculitis	O
identified	O
in	O
the	O
gyn	O
tract	O
is	O
associated	O
with	O
systemic	O
disorders	O
or	O
symptoms	O
.	O

Surg	O
Path	O
Intraoperative	O
Frozen	O
Section	O
.	O

A	O
.	O

FS	O
:	O
Left	O
ovary	O
:	O
Fibroma	O
.	O

Reported	O
to	O
Dr	O
.	O
with	O
read	O
back	O
.	O

M	O
.	O
D	O
.	O

Specimen	O
.	O

A	O
.	O

Left	O
fallopian	O
tube	O
and	O
ovary	O
.	O

B	O
.	O

Uterus	O
,	O
right	O
tube	O
and	O
ovary	O
.	O

C	O
.	O

Left	O
external	O
iliac	O
lymph	O
node	O
.	O

7	O
.	O

DOS	O
:	O
-	O
male	O
.	O

FIN	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

COLLECTED	O
DATE	O
/	O
TIME	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

D	O
.	O

Left	O
obturator	O
lymph	O
nodes	O
.	O

E	O
.	O

Left	O
common	O
lymph	O
nodes	O
.	O

F	O
.	O

Left	O
periaortic	O
lymph	O
nodes	O
.	O

G	O
.	O

Right	O
external	O
iliac	O
lymph	O
nodes	O
.	O

H	O
.	O

Right	O
obturator	O
lymph	O
nodes	O
.	O

I	O
.	O

Right	O
common	O
lymph	O
nodes	O
.	O

J	O
.	O

Right	O
perialortic	O
lymph	O
nodes	O
.	O

K	O
.	O

Omentum	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Received	O
tresh	O
for	O
frozen	O
section	O
diagnosis	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
left	O
fallopian	O
tube	O
.	O
and	O
ovary	O
"	O
is	O
	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
2	O
cm	O
tan	O
-	O
gray	O
,	O
glistening	O
ovary	O
.	O

The	O
specimen	O
is	O
sectioned	O
to	O
reveal	O
striated	O
,	O
homogenous	O
cut	O
.	O
surfaces	O
.	O

A	O
pprition	O
is	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O

Attached	O
to	O
the	O
ovary	O
is	O
a	O
4	O
cm	O
in	O
length	O
by	O
0	O
.	O
5	O
cm	O
in	O
.	O
diameter	O
fimbriated	O
fallopian	O
tube	O
.	O

The	O
serosa	O
appears	O
tan	O
-	O
brown	O
,	O
and	O
smooth	O
.	O

The	O
specimen	O
is	O
sectioned	O
to	O
reveal	O
a	O
.	O
complete	O
pinpoint	O
lumen	O
.	O

A	O
portion	O
of	O
tube	O
is	O
submitted	O
fresh	O
for	O
research	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

Frozen	O
section	O
of	O
ovary	O
.	O

2	O
-	O
3	O
.	O

Ovary	O
.	O

4	O
.	O

Fallopian	O
tube	O
.	O

B	O
.	O

Received	O
fresh	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
uterus	O
,	O
right	O
tube	O
and	O
ovary	O
"	O
is	O
a	O
71	O
g	O
previously	O
.	O
opened	O
uterus	O
with	O
attached	O
right	O
adnexa	O
.	O

The	O
uterus	O
measures	O
7	O
.	O
5	O
cm	O
from	O
cervix	O
to	O
fundus	O
,	O
4	O
cm	O
from	O
comu	O
to	O
cornu	O
,	O
.	O
and	O
3	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
serosa	O
appears	O
pink	O
-	O
brown	O
,	O
smooth	O
,	O
and	O
unremarkable	O
.	O

The	O
cervix	O
appears	O
.	O
tan	O
-	O
gray	O
,	O
focally	O
hemorrhagic	O
,	O
glistening	O
,	O
measures	O
3	O
.	O
8	O
cm	O
in	O
diameter	O
,	O
with	O
a	O
0	O
.	O
3	O
cm	O
slitlike	O
os	O
.	O

A	O
portion	O
of	O
attached	O
.	O
vaginal	O
mucosa	O
is	O
present	O
on	O
the	O
posterior	O
surface	O
measuring	O
2	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
upper	O
endocervical	O
canal	O
is	O
.	O
remarkable	O
for	O
multiple	O
cystic	O
structures	O
filled	O
with	O
gelatinous	O
material	O
ranging	O
in	O
size	O
from	O
0	O
.	O
3	O
-	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

These	O
cysts	O
appear	O
to	O
have	O
a	O
smooth	O
inner	O
lining	O
.	O

The	O
endometrial	O
cavity	O
measures	O
3	O
cm	O
from	O
comu	O
to	O
.	O
cornu	O
,	O
3	O
.	O
5	O
cmifrom	O
cervix	O
to	O
fundus	O
,	O
0	O
.	O
3	O
cm	O
in	O
thickness	O
,	O
and	O
is	O
remarkable	O
for	O
a	O
friable	O
,	O
fungating	O
,	O
polypoid	O
mass	O
.	O
measuring	O
2	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
located	O
primarily	O
on	O
the	O
right	O
side	O
,	O
and	O
extending	O
into	O
the	O
lower	O
uterine	O
segment	O
.	O

Upon	O
.	O
sectioning	O
,	O
the	O
mass	O
is	O
located	O
0	O
.	O
8	O
cm	O
from	O
the	O
serosal	O
surface	O
and	O
0	O
.	O
4	O
cm	O
from	O
the	O
upper	O
endocervical	O
canal	O
on	O
the	O
.	O
anterior	O
aspect	O
,	O
and	O
is	O
located	O
7	O
cm	O
from	O
the	O
serosa	O
surface	O
,	O
and	O
a	O
0	O
.	O
3	O
cm	O
from	O
the	O
upper	O
endocervical	O
canal	O
on	O
the	O
.	O
posterior	O
aspect	O
.	O

The	O
attached	O
right	O
fimbriated	O
fallopian	O
tube	O
measures	O
5	O
cm	O
in	O
length	O
,	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
,	O
with	O
a	O
serosa	O
which	O
appears	O
.	O
purple	O
-	O
tan	O
,	O
and	O
smooth	O
.	O

The	O
tube	O
is	O
sectioned	O
to	O
reveal	O
a	O
complete	O
pinpoint	O
lumen	O
.	O

The	O
attached	O
yellow	O
-	O
tan	O
,	O
cerebriform	O
.	O
ovary	O
measures	O
2	O
x	O
1	O
x	O
0	O
.	O
8	O
cm	O
,	O
and	O
is	O
sectioned	O
to	O
reveal	O
tan	O
-	O
gray	O
,	O
smooth	O
cut	O
surfaces	O
.	O

Portions	O
of	O
tumor	O
are	O
submitted	O
.	O
fresh	O
for	O
.	O
study	O
.	O

The	O
anterior	O
is	O
inked	O
blue	O
,	O
the	O
posterior	O
and	O
right	O
adnexa	O
are	O
inked	O
black	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

Vaginal	O
mucosa	O
.	O

JVI	O
.	O

DOS	O
:	O
1	O
.	O
ale	O
.	O

FW	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

COLLECTED	O
DATE	O
/	O
TIME	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

2	O
.	O

Cervix	O
anterior	O
.	O

3	O
.	O

Upper	O
endocervical	O
canal	O
anterior	O
.	O

4	O
.	O

Cervix	O
posterior	O
.	O

5	O
.	O

Upper	O
endocervical	O
canal	O
posterior	O
.	O

6	O
.	O

Represented	O
sections	O
of	O
the	O
cystic	O
structures	O
within	O
upper	O
endocervical	O
canal	O
.	O

7	O
-	O
8	O
.	O

Full	O
-	O
thickness	O
section	O
bisected	O
of	O
mass	O
on	O
anterior	O
.	O

9	O
-	O
10	O
.	O

Full	O
-	O
thickness	O
section	O
bisected	O
of	O
mass	O
on	O
anterior	O
.	O

11	O
.	O

Endomyometrium	O
anterior	O
.	O

12	O
-	O
13	O
.	O

Full	O
thickness	O
sections	O
of	O
mass	O
on	O
posterior	O
.	O

14	O
.	O

Endomyometrium	O
posterior	O
.	O

15	O
.	O

Left	O
parametria	O
.	O

16	O
.	O

Right	O
parametria	O
.	O

17	O
.	O

Fallopian	O
tube	O
.	O

18	O
.	O

Ovary	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
left	O
external	O
illac	O
lymph	O
node	O
are	O
multiple	O
.	O
portions	O
of	O
fibroadipose	O
tissue	O
which	O
aggregate	O
to	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Upon	O
dissection	O
multiple	O
pink	O
-	O
tan	O
,	O
firm	O
.	O

Ivmph	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
1	O
-	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidate	O
nodes	O
bisected	O
,	O
one	O
inked	O
blue	O
.	O

2	O
.	O

2	O
candidate	O
nodes	O
bisected	O
,	O
one	O
inked	O
blue	O
.	O

3	O
.	O

3	O
candidate	O
nodes	O
.	O

4	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
left	O
obturator	O
lymph	O
node	O
"	O
is	O
a	O
portion	O
of	O
.	O
fibroadipose	O
tissue	O
measuring	O
5	O
.	O
5	O
x	O
3x1	O
cm	O
.	O

Upon	O
dissection	O
multiple	O
tan	O
-	O
brown	O
,	O
firm	O
candidate	O
nodes	O
are	O
identified	O
.	O
ranging	O
In	O
size	O
from	O
0	O
.	O
5	O
-	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidate	O
nodes	O
.	O

2	O
-	O
3	O
.	O

1	O
candidate	O
node	O
sectioned	O
.	O

E	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
left	O
common	O
lymph	O
nodes	O
"	O
are	O
multiple	O
.	O
portions	O
of	O
fibroadipose	O
tissue	O
which	O
aggregate	O
to	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

Upon	O
dissection	O
3	O
tan	O
-	O
brown	O
,	O
firm	O
,	O
.	O
candidate	O
lymbh	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
0	O
.	O
7	O
-	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidate	O
nodes	O
.	O

2	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

DOS	O
:	O
Female	O
.	O

FIN	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

COLLECTED	O
DATE	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

K	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
omentum	O
"	O
is	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
.	O
which	O
aggregate	O
to	O
14	O
x	O
12	O
x	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
sectioned	O
to	O
reveal	O
95	O
%	O
yellow	O
,	O
lobulated	O
,	O
glistening	O
adipose	O
tissue	O
,	O
.	O
and	O
5	O
%	O
brown	O
fibrous	O
tissue	O
.	O

No	O
masses	O
or	O
areas	O
of	O
interest	O
are	O
identified	O
grossly	O
.	O

Microscopic	O
Description	O
.	O

A	O
nicroscopiciexamination	O
has	O
been	O
performed	O
and	O
is	O
reflected	O
in	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

QC	O
.	O

}	O
.	O

DOS	O
:	O
SEX	O
:	O
Female	O
.	O

FIN	O
:	O
Surgical	O
Pathology	O
Report	O
-	O
Final	O
.	O

COLLECTED	O
DATE	O
/	O
TIME	O
.	O

RECEIVED	O
DATE	O
/	O
TIME	O
.	O

F	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
left	O
periaortic	O
lymph	O
nodes	O
"	O
are	O
multiple	O
.	O
portions	O
of	O
fibroadipose	O
tissue	O
which	O
aggregate	O
to	O
4	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Upon	O
dissection	O
multiple	O
pink	O
-	O
tan	O
,	O
firm	O
.	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
1	O
.	O
2	O
-	O
2	O
cm	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
-	O
4	O
.	O

1	O
candidate	O
node	O
each	O
,	O
bisected	O
.	O

5	O
.	O

2	O
candidate	O
nodes	O
bisected	O
,	O
one	O
inked	O
blue	O
.	O

G	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
right	O
external	O
illac	O
lymph	O
nodes	O
"	O
are	O
.	O
multiple	O
portions	O
of	O
fibroadipose	O
tissue	O
which	O
aggregate	O
to	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Upon	O
dissection	O
multiple	O
.	O
pink	O
-	O
tan	O
,	O
.	O
firm	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
1	O
-	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
.	O
are	O
.	O

submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

2	O
.	O

1	O
candidat	O
	O
node	O
bisected	O
.	O

3	O
.	O

2	O
candidat	O
	O
nodes	O
.	O

4	O
-	O
5	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

H	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
right	O
obturator	O
lymph	O
nodes	O
"	O
are	O
multiple	O
.	O
portions	O
of	O
fibroadipose	O
tissue	O
which	O
aggregate	O
4	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Upon	O
dissection	O
multiple	O
tan	O
-	O
brown	O
,	O
.	O
firm	O
.	O

candidate	O
nodes	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
0	O
.	O
5	O
-	O
3	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidat	O
	O
nodes	O
.	O

2	O
.	O

1	O
candidate	O
node	O
.	O

3	O
-	O
4	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

I	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
right	O
common	O
lymph	O
nodes	O
"	O
are	O
multiple	O
.	O
portions	O
of	O
fibroadipose	O
tissue	O
measuring	O
5	O
x	O
2	O
x	O
0	O
.	O
5	O
cm	O
.	O

Upon	O
dissection	O
multiple	O
tan	O
and	O
brown	O
,	O
firm	O
lymph	O
nodes	O
are	O
.	O
identified	O
range	O
in	O
size	O
from	O
0	O
.	O
5	O
-	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidate	O
node	O
.	O

2	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

3	O
.	O

1	O
candidat	O
	O
node	O
bisected	O
.	O

J	O
.	O

Received	O
in	O
formalin	O
properly	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
labeled	O
"	O
right	O
periaortic	O
lymph	O
nodes	O
"	O
is	O
a	O
portion	O
of	O
.	O
fibroadipose	O
tissue	O
measuring	O
3	O
.	O
5	O
x	O
2x	O
1	O
cm	O
.	O

Upon	O
dissection	O
multiple	O
tan	O
-	O
brown	O
,	O
firm	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
.	O
in	O
size	O
from	O
0	O
.	O
5	O
-	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
possible	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
1	O
.	O

2	O
candidate	O
nodes	O
.	O

2	O
.	O

2	O
candidate	O
nodes	O
.	O

3	O
.	O

1	O
candidate	O
node	O
bisected	O
.	O

Morphology	O
shows	O
both	O
astrocytic	O
and	O
oligodendroglial	O
differentiation	O
.	O

No	O
evident	O
mitotic	O
.	O
activity	O
.	O

Proliferation	O
index	O
2	O
%	O
.	O

Diagnosis	O
.	O

Oligoastrocytoma	O
WHO	O
grade	O
II	O
.	O

Clinical	O
diagnosis	O
:	O
Brain	O
tumor	O
.	O

Gross	O
description	O
:	O
The	O
material	O
presented	O
by	O
grayish	O
soft	O
-	O
elastic	O
pieces	O
of	O
right	O
frontal	O
and	O
.	O
temporal	O
lobes	O
.	O

Microscopic	O
description	O
:	O
Received	O
material	O
is	O
represented	O
mainly	O
by	O
brain	O
tissue	O
with	O
the	O
adjacent	O
.	O
small	O
areas	O
of	O
oligoastrocytoma	O
.	O

WHO	O
Grade	O
II	O
with	O
a	O
large	O
number	O
of	O
.	O
calcifications	O
.	O

Final	O
diagnosis	O
:	O
Oligoastrocytoma	O
:	O
Grade	O
II	O
.	O

Segment	O
of	O
the	O
stomach	O
with	O
the	O
.	O

Adenocarci	O
.	O
tumor	O
of	O
12	B
X	I
8	I
cm	I
,	O
with	O
fatty	O
tissue	O
.	O
noma	O
,	O
G3	O
,	O
.	O
infiltration	O
.	O

with	O
.	O

Greater	O
and	O
lesser	O
omentum	O
lymph	O
.	O
perigastric	O
.	O

nodes	O
are	O
soft	O
,	O
hyperemic	O
.	O
fat	O
.	O

Omentum	O
is	O
hyperemic	O
.	O
infiltration	O
.	O

Fifteen	O
.	O
dissected	O
.	O

lymph	O
.	O
nodes	O
.	O

demonstra	O
.	O

te	O
sinus	O
.	O
histiocytos	O
.	O

is	O
,	O
reactive	O
.	O
changes	O
of	O
.	O
the	O
.	O

follicles	O
.	O

Omentum	O
:	O
fibrosis	O
,	O
.	O
focal	O
.	O

lymphoid	O
.	O
infiltration	O
.	O

Surgical	O
.	O
margins	O
.	O

along	O
the	O
.	O
esophagus	O
.	O

are	O
free	O
of	O
.	O
metastase	O
.	O

S	O
.	O

Tumor	O
Features	O
:	O
Exophytic	O
(	O
polypoid	O
)	O
,	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Tumor	O
Extent	O
:	O
Perigastric	O
fat	O
,	O
Venous	O
.	O

Invasion	O
:	O
Absent	O
,	O
Margins	O
:	O
Absent	O
,	O
.	O

Specimen	O
type	O
:	O
Subtotal	O
gastrectomy	O
.	O

Treatment	O
Effect	O
:	O
Tumor	O
site	O
:	O
Stomach	O
.	O

Tumor	O
size	O
:	O
8	B
X	I
0	I
X	I
12	I
cm	I
.	O

Tumor	O
features	O
:	O
Exophytic	O
(	O
polypoid	O
)	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Subserosa	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
15	O
positive	O
for	O
.	O
metastasis	O
(	O
Greater	O
and	O
lesser	O
omentum	O
.	O
0	O
/	O
15	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
.	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
.	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

ADDENDUM	O
.	O

DIAGNOSIS	O
.	O

RIGHT	O
KIDNEY	O
AND	O
ADRENAL	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CHROMOPHOBE	O
TYPE	O
(	O
SEE	O
COMMENT	O
)	O
.	O

COMMENT	O
.	O

The	O
purpose	O
of	O
this	O
addendum	O
report	O
is	O
to	O
classify	O
this	O
renal	O
carcinoma	O
based	O
on	O
the	O
immunohistochemical	O
pattern	O
.	O

The	O
tumor	O
is	O
.	O
positive	O
for	O
cytokeratin	O
7	O
and	O
CD117	O
and	O
shows	O
weak	O
diffuse	O
cytoplasmic	O
positivity	O
for	O
CD10	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
RIGHT	O
KIDNEY	O
AND	O
ADRENAL	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
(	O
8	B
.	I
5	I
CM	I
IN	O
MAXIMUM	O
DIMENSION	O
)	O
,	O
FUHRMAN	O
GRADE	O
3	O
(	O
SEE	O
COMMENT	O
)	O
.	O

TUMOR	O
IS	O
CONFINED	O
TO	O
THE	O
KIDNEY	O
.	O

INVASION	O
OF	O
INTRAPARENCHYMAL	O
HILAR	O
VESSELS	O
IS	O
PRESENT	O
.	O

Extraparenchymal	O
hilar	O
vessels	O
are	O
free	O
of	O
tumor	O
.	O

Margins	O
of	O
resection	O
are	O
free	O
of	O
tumor	O
.	O

Chronic	O
interstitial	O
nephritis	O
and	O
glomerulosclerosis	O
in	O
kidney	O
adjacent	O
to	O
tumor	O
.	O

Unremarkable	O
adrenal	O
gland	O
.	O

COMMENT	O
.	O

Immunohistochemical	O
stains	O
are	O
pending	O
and	O
the	O
results	O
will	O
be	O
reported	O
in	O
a	O
supplemental	O
report	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
RIGHT	O
KIDNEY	O
AND	O
ADRENAL	O
-	O
A	O
radical	O
nephrectomy	O
specimen	O
(	O
19	O
.	O
0	O
X	O
12	O
.	O
0	O
X	O
7	O
.	O
0	O
cm	O
)	O
,	O
including	O
the	O
right	O
kidney	O
(	O
13	O
.	O
0	O
X	O
.	O
5	O
.	O
5	O
X	O
3	O
.	O
0	O
cm	O
)	O
,	O
segment	O
of	O
the	O
renal	O
artery	O
,	O
the	O
renal	O
vein	O
and	O
ureter	O
(	O
14	O
.	O
0	O
cm	O
in	O
length	O
and	O
averaging	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
)	O
in	O
the	O
.	O
adrenal	O
gland	O
(	O
6	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
5	O
cm	O
)	O
.	O

There	O
is	O
an	O
8	B
.	I
5	I
X	I
8	I
.	I
5	I
X	I
6	I
.	I
5	I
cm	I
well	O
circumscribed	O
tumor	O
arising	O
from	O
the	O
anterior	O
surface	O
of	O
the	O
kidney	O
,	O
involving	O
the	O
upper	O
.	O
and	O
.	O

middle	O
.	O
pole	O
.	O

The	O
.	O
tumor	O
pushes	O
into	O
the	O
perinephric	O
adipose	O
tissue	O
and	O
extends	O
to	O
within	O
0	O
.	O
2	O
cm	O
from	O
the	O
inked	O
Gerota	O
'	O
s	O
fascia	O
.	O
in	O
an	O
area	O
marked	O
by	O
Dr	O
.	O
as	O
abutting	O
the	O
colon	O
.	O

The	O
tumor	O
is	O
centrally	O
cystic	O
(	O
approximately	O
60	O
%	O
of	O
the	O
tumor	O
)	O
.	O

This	O
cyst	O
is	O
.	O
filled	O
with	O
brown	O
opaque	O
fluid	O
.	O

The	O
wall	O
of	O
the	O
tumor	O
consists	O
of	O
lobulated	O
brown	O
,	O
friable	O
tissue	O
which	O
is	O
surrounded	O
by	O
a	O
thickened	O
.	O
fibrous	O
capsule	O
.	O

The	O
tumor	O
pushes	O
into	O
but	O
does	O
not	O
appear	O
to	O
invade	O
the	O
renal	O
sinus	O
and	O
does	O
not	O
appear	O
to	O
invade	O
the	O
.	O
perinephric	O
adipose	O
tissue	O
or	O
the	O
renal	O
vein	O
.	O

The	O
adjacent	O
kidney	O
parenchyma	O
is	O
unremarkable	O
.	O

No	O
additional	O
masses	O
are	O
identified	O
.	O

The	O
pelvicalyceal	O
system	O
is	O
.	O
smooth	O
and	O
devoid	O
of	O
any	O
lesions	O
.	O

No	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
hilum	O
of	O
the	O
kidney	O
.	O

Cross	O
sections	O
of	O
the	O
right	O
adrenal	O
.	O
gland	O
show	O
unremarkable	O
cortex	O
and	O
medulla	O
.	O

Portions	O
of	O
the	O
tumor	O
have	O
been	O
submitted	O
for	O
possible	O
electron	O
microscopy	O
,	O
on	O
hold	O
.	O

The	O
tumor	O
and	O
normal	O
renal	O
.	O
parenchyma	O
are	O
submitted	O
for	O
research	O
purposes	O
.	O

INK	O
CODE	O
:	O
Blue	O
-	O
Gerota	O
'	O
s	O
fascia	O
/	O
area	O
marked	O
by	O
surgeon	O
as	O
adherent	O
to	O
colon	O
.	O

SECTION	O
CODE	O
:	O
A1	O
-	O
A3	O
,	O
closest	O
approach	O
mass	O
to	O
inked	O
Gerota	O
'	O
s	O
fascia	O
/	O
area	O
marked	O
by	O
surgeon	O
as	O
adherent	O
to	O
colon	O
,	O
.	O
frozen	O
section	O
;	O
A4	O
,	O
vascular	O
and	O
ureter	O
margins	O
;	O
A5	O
,	O
representative	O
of	O
adrenal	O
gland	O
;	O
A6	O
-	O
A13	O
,	O
representative	O
of	O
tumor	O
(	O
A6	O
-	O
A8	O
with	O
.	O
relationship	O
to	O
renal	O
sinus	O
;	O
A9	O
-	O
A10	O
,	O
with	O
relationship	O
to	O
nonneoplastic	O
kidney	O
;	O
A11	O
-	O
A12	O
,	O
with	O
relationship	O
to	O
perinephric	O
adipose	O
.	O
tissue	O
;	O
A13	O
,	O
additional	O
representative	O
section	O
)	O
;	O
A14	O
,	O
A15	O
,	O
no	O
-	O
neoplastic	O
kidney	O
.	O

FS	O
/	O
DX	O
:	O
MARGIN	O
FREE	O
OF	O
TUMOR	O
.	O

1	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Bleeding	O
secondary	O
to	O
jejunal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Proximal	O
jejunum	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SMALL	O
BOWEL	O
,	O
PROXIMAL	O
JEJUNUM	O
:	O
RESECTION	O
:	O
-	O
SMOOTH	O
MUSCLE	O
NEOPLASM	O
,	O
CONSISTENT	O
WITH	O
A	O
LOW	O
GRADE	O
LEIOMYOSARCOMA	O
,	O
.	O

OF	O
JEJUNUM	O
,	O
SEE	O
NOTE	O
.	O

-	O
THE	O
TUMOR	O
INVOLVES	O
TRANSMURAL	O
SMALL	O
BOWEL	O
WALL	O
WITH	O
EXTENSION	O
TO	O
THE	O
.	O

MUCOSAL	O
SURFACE	O
WITH	O
EROSION	O
AND	O
IS	O
PRESENT	O
<	O
1	O
MM	O
FOR	O
THE	O
SEROSAL	O
SURFACE	O
.	O

-	O
THE	O
TUMOR	O
MEASURES	O
2	B
.	I
7	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

-	O
THE	O
TUMOR	O
EXHIBITS	O
A	O
NODULAR	O
AND	O
INFILTRATING	O
GROWTH	O
PATTERN	O
.	O

-	O
NO	O
TUMOR	O
NECROSIS	O
IS	O
NOTED	O
.	O

-	O
THE	O
ESTIMATED	O
MITOTIC	O
ACTIVITY	O
IS	O
2	O
-	O
3	O
/	O
10	O
HPF	O
.	O

-	O
NO	O
VASCULAR	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

SURGICAL	O
MARGINS	O
OF	O
RESECTION	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
UNINVOLVED	O
SMALL	O
BOWEL	O
MUCOSA	O
IS	O
UNREMARKABLE	O
.	O

NOTE	O
:	O
IMMUNOSTAINS	O
REVEAL	O
THAT	O
THE	O
TUMOR	O
CELLS	O
ARE	O
POSITIVE	O
FOR	O
DESMIN	O
.	O

AND	O
SMA	O
;	O
THEY	O
ARE	O
NEGATIVE	O
FOR	O
S100	O
,	O
CD34	O
,	O
AND	O
CD117	O
.	O

THE	O
ESTIMATED	O
.	O

PROLIFERATIVE	O
INDEX	O
(	O
MIB	O
-	O
1	O
)	O
IS	O
UP	O
TO	O
10	O
%	O
.	O

THIS	O
CASE	O
HAS	O
BEEN	O
REVIEWED	O
WITH	O
.	O

IN	O
CONSULTATION	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
proximal	O
jejunum	O
"	O
and	O
consists	O
.	O
of	O
an	O
unoriented	O
portion	O
of	O
small	O
bowel	O
measuring	O
9	O
.	O
0	O
cm	O
in	O
length	O
and	O
7	O
.	O
6	O
.	O

cm	O
in	O
circumference	O
.	O

There	O
is	O
a	O
tan	O
-	O
white	O
firm	O
fungating	O
tumor	O
measuring	O
.	O

2	B
.	I
7	I
x	I
2	I
.	I
2	I
x	I
1	I
.	I
8	I
cm	I
located	O
3	O
.	O
7	O
cm	O
from	O
one	O
resection	O
and	O
2	O
.	O
5	O
cm	O
from	O
the	O
.	O
other	O
resection	O
end	O
.	O

The	O
tumor	O
penetrates	O
the	O
bowel	O
wall	O
and	O
is	O
present	O
on	O
.	O
the	O
serosal	O
surface	O
.	O

This	O
area	O
is	O
inked	O
black	O
.	O

TPS	O
is	O
taken	O
.	O

Gross	O
.	O
photographs	O
are	O
taken	O
.	O

The	O
entire	O
tumor	O
is	O
submitted	O
.	O

The	O
remaining	O
specimen	O
.	O

is	O
representatively	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
M1	O
-	O
one	O
shaved	O
margin	O
.	O

M2	O
opposite	O
shaved	O
margin	O
.	O

T	O
tumor	O
.	O

D	O
-	O
normal	O
duodenum	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Proximal	O
jejunum	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

D	O
.	O

1	O
.	O

1	O
.	O

M1	O
.	O

1	O
.	O

1	O
.	O

M2	O
.	O

1	O
.	O

5	O
.	O

5	O
.	O

Pathology	O
R	O
.	O
Report	O
Typ	O
.	O

Date	O
of	O
Ev	O
.	O

M	O
.	O

Authored	O
by	O
.	O

Hosp	O
/	O
Group	O
.	O

Record	O
Status	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LEFT	O
NECK	O
LEVELS	O
II	O
,	O
III	O
AND	O
IV	O
,	O
DISSECTION	O
.	O

A	O
.	O

METASTATIC	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
UP	O
TO	O
1	B
CM	I
,	O
IN	O
THREE	O
OF	O
.	O

THIRTY	O
-	O
SEVEN	O
LYMPH	O
NODES	O
(	O
3	O
/	O
37	O
)	O
.	O

B	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
IS	O
PRESENT	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
NECK	O
LEVELS	O
IIA	O
AND	O
IIB	O
,	O
DISSECTION	O
.	O

THIRTY	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
31	O
)	O
.	O

PART	O
3	O
:	O
LARYNX	O
AND	O
BASE	O
OF	O
TONGUE	O
,	O
TOTAL	O
LARYNGECTOMY	O
AND	O
BASE	O
OF	O
.	O

TONGUE	O
.	O

RESECTION	O
.	O

A	O
.	O

SUPRAGLOTTIC	O
INVASIVE	O
KERATINIZING	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
.	O

5	B
.	I
4	I
.	I

CM	B
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
INVOLVING	O
BASE	O
OF	O
TONGUE	O
,	O
HYOID	O
BONE	O
,	O
.	O

GLOTTIS	O
,	O
.	O

AND	O
PYRIFORM	O
SINUSES	O
.	O

B	O
.	O

THYROID	O
CARTILAGE	O
IS	O
FREE	O
OF	O
CARCINOMA	O
.	O

C	O
.	O

VASCULAR	O
INVASION	O
IS	O
ABSENT	O
.	O

D	O
.	O

PERINEURAL	O
INVASION	O
IS	O
PRESENT	O
.	O

E	O
.	O

ALL	O
MARGINS	O
ARE	O
FREE	O
OF	O
CARCINOMA	O
.	O

F	O
.	O

TWO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

G	O
.	O

STOMA	O
WITH	O
REACTIVE	O
CHANGES	O
.	O

H	O
.	O

BENIGN	O
THYROID	O
TISSUE	O
.	O

I	O
.	O

pT4a	O
N2b	O
.	O

By	O
Pathologist	O
:	O
My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
.	O
submitted	O
.	O

material	O
(	O
s	O
)	O
and	O
the	O
final	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
in	O
three	O
parts	O
.	O

Part	O
1	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
S	O
name	O
,	O
initials	O
XX	O
,	O
medical	O
record	O
.	O
number	O
.	O
and	O
"	O
left	O
neck	O
dissection	O
levels	O
2	O
,	O
3	O
,	O
4	O
"	O
.	O

It	O
consists	O
of	O
an	O
.	O
unoriented	O
.	O

selective	O
left	O
neck	O
dissection	O
(	O
12	O
.	O
8	O
X	O
4	O
.	O
9	O
x	O
1	O
.	O
1	O
cm	O
)	O
and	O
shows	O
yellow	O
.	O
fibroadipose	O
tissue	O
and	O
several	O
prominent	O
lymph	O
nodes	O
ranging	O
in	O
size	O
.	O
from	O
0	O
.	O
1	O
.	O
to	O
2	O
.	O
0cm	O
.	O

There	O
is	O
an	O
area	O
of	O
firm	O
,	O
tan	O
-	O
brown	O
skeletal	O
muscle	O
(	O
1	O
.	O
9	O
X	O
.	O
1	O
.	O
5	O
x	O
.	O
0	O
.	O
3	O
cm	O
)	O
.	O

In	O
level	O
2A	O
there	O
is	O
one	O
prominent	O
lymph	O
node	O
(	O
2	O
.	O
2	O
X	O
1	O
.	O
9	O
X	O
0	O
.	O
3	O
cm	O
)	O
.	O

Additional	O
.	O
lymph	O
node	O
candidates	O
-	O
0	O
.	O
2	O
-	O
0	O
.	O
9	O
cm	O
.	O

In	O
level	O
2B	O
there	O
are	O
two	O
prominent	O
lymph	O
nodes	O
(	O
1	O
.	O
9	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
1	O
cm	O
and	O
.	O
2	O
.	O
5	O
x	O
.	O
0	O
.	O
7	O
X	O
0	O
.	O
3	O
cm	O
)	O
,	O
both	O
bisected	O
.	O

Additional	O
lymph	O
node	O
candidates	O
-	O
0	O
.	O
1	O
-	O
-	O
.	O

1	O
.	O
6	O
cm	O
.	O

In	O
level	O
3	O
there	O
is	O
one	O
prominent	O
lymph	O
node	O
(	O
1	O
.	O
2	O
X	O
0	O
.	O
9	O
x	O
0	O
.	O
1	O
cm	O
)	O
,	O
.	O
bisected	O
.	O

Two	O
additional	O
lymph	O
node	O
candidates	O
-	O
0	O
.	O
4	O
-	O
0	O
.	O
7	O
cm	O
.	O

In	O
level	O
4	O
there	O
are	O
lymph	O
node	O
candidates	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
7	O
cm	O
.	O

Section	O
code	O
:	O
1A	O
-	O
Level	O
2A	O
,	O
one	O
lymph	O
node	O
.	O

1B	O
-	O
1C	O
-	O
Level	O
2A	O
,	O
nine	O
lymph	O
nodes	O
.	O

1D	O
-	O
Level	O
2B	O
,	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

1E	O
-	O
Level	O
2B	O
,	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

1F	O
-	O
1G	O
-	O
Level	O
2B	O
,	O
eight	O
lymph	O
nodes	O
.	O

1H	O
-	O
Level	O
3	O
,	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

1I	O
-	O
Level	O
3	O
,	O
two	O
lymph	O
nodes	O
.	O

1K	O
-	O
1L	O
-	O
Level	O
4	O
,	O
thirteen	O
lymph	O
nodes	O
.	O

1J	O
-	O
Representative	O
sections	O
of	O
muscle	O
.	O

Time	O
in	O
formalin	O
:	O
22	O
hours	O
.	O

Part	O
2	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
S	O
name	O
,	O
initials	O
XX	O
,	O
medical	O
record	O
.	O
number	O
.	O
and	O
"	O
right	O
neck	O
,	O
short	O
stitch	O
level	O
2A	O
,	O
long	O
stitch	O
level	O
2B	O
"	O
.	O

It	O
.	O
consists	O
of	O
.	O

an	O
oriented	O
selective	O
right	O
neck	O
dissection	O
(	O
12	O
.	O
1	O
X	O
3	O
.	O
2	O
1	O
.	O
5	O
cm	O
)	O
and	O
.	O
shows	O
.	O

yellow	O
fibroadipose	O
tissue	O
and	O
several	O
prominent	O
lymph	O
nodes	O
.	O

In	O
level	O
2A	O
there	O
are	O
two	O
prominent	O
lymph	O
nodes	O
(	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
and	O
.	O
2	O
.	O
0	O
x	O
.	O
1	O
.	O
3	O
x	O
0	O
.	O
5	O
cm	O
)	O
both	O
are	O
bisected	O
.	O

There	O
are	O
nineteen	O
smaller	O
lymph	O
nodes	O
.	O
ranging	O
in	O
size	O
from	O
0	O
.	O
1	O
-	O
0	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
.	O

In	O
level	O
2B	O
there	O
is	O
one	O
prominent	O
lymph	O
node	O
(	O
2	O
.	O
0	O
X	O
1	O
.	O
2	O
x	O
0	O
.	O
3	O
cm	O
)	O
,	O
.	O
bisected	O
.	O

There	O
are	O
nine	O
smaller	O
lymph	O
nodes	O
ranging	O
in	O
size	O
from	O
0	O
.	O
1	O
-	O
1	O
.	O
0	O
cm	O
in	O
.	O
greatest	O
.	O

dimension	O
.	O

Time	O
in	O
formalin	O
:	O
22	O
hours	O
.	O

Section	O
code	O
:	O
2A	O
-	O
Level	O
2B	O
,	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

2B	O
2D	O
-	O
-	O
Level	O
2C	O
-	O
Level	O
2A	O
,	O
2B	O
,	O
lymph	O
node	O
,	O
bisected	O
bisected	O
.	O
nine	O
lymph	O
nodes	O
.	O
one	O
.	O

2E	O
-	O
Level	O
2A	O
,	O
one	O
lymph	O
node	O
,	O
.	O

2F	O
-	O
-	O
2H	O
-	O
Level	O
2A	O
,	O
nineteen	O
lymph	O
nodes	O
.	O

Part	O
3	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
XX	O
,	O
medical	O
record	O
.	O
number	O
.	O
and	O
"	O
total	O
laryngectomy	O
and	O
base	O
of	O
tongue	O
resection	O
"	O
.	O

It	O
consists	O
of	O
.	O

a	O
total	O
.	O
laryngectomy	O
specimen	O
(	O
SI	O
-	O
7	O
.	O
8	O
cm	O
,	O
AP	O
-	O
7	O
.	O
4	O
cm	O
,	O
W	O
-	O
6	O
.	O
6	O
-	O
cm	O
)	O
that	O
includes	O
.	O
attached	O
.	O

base	O
of	O
tongue	O
(	O
5	O
.	O
8	O
X	O
4	O
.	O
7	O
X	O
2	O
.	O
6	O
cm	O
)	O
,	O
right	O
and	O
left	O
pharyngeal	O
tissue	O
,	O
.	O
posterior	O
cricoid	O
tissue	O
,	O
anterior	O
compartment	O
soft	O
tissue	O
and	O
.	O
tracheostomy	O
.	O

stoma	O
with	O
attached	O
skin	O
(	O
1	O
.	O
3	O
1	O
.	O
3	O
X	O
0	O
.	O
9	O
cm	O
)	O
.	O

There	O
is	O
a	O
light	O
tan	O
,	O
.	O
friable	O
,	O
.	O
ulcerated	O
,	O
circumferential	O
mostly	O
supraglottic	O
tumor	O
(	O
5	B
.	I
4	I
X	I
5	I
.	I
3	I
X	I
2	I
.	I
2	I
.	I
cm	I
)	O
.	O
extending	O
1	O
.	O
0	O
cm	O
into	O
the	O
left	O
glottic	O
region	O
.	O

It	O
involves	O
the	O
left	O
.	O
false	O
.	O

vocal	O
cord	O
and	O
abuts	O
the	O
right	O
true	O
vocal	O
cord	O
,	O
right	O
and	O
left	O
pyriform	O
.	O
sinus	O
,	O
.	O
anterior	O
commissure	O
,	O
hyoid	O
bone	O
and	O
base	O
of	O
tongue	O
.	O

The	O
tumor	O
is	O
.	O
located	O
0	O
.	O
9	O
.	O

cm	O
from	O
the	O
left	O
laryngeal	O
margin	O
and	O
0	O
.	O
2	O
cm	O
from	O
the	O
base	O
of	O
tongue	O
.	O
deep	O
.	O

margin	O
.	O

The	O
tumor	O
does	O
not	O
grossly	O
involve	O
the	O
thyroid	O
or	O
cricoid	O
.	O
cartilage	O
.	O

One	O
candidate	O
lymph	O
node	O
(	O
0	O
.	O
4	O
cm	O
)	O
is	O
dissected	O
from	O
the	O
anterior	O
.	O
compartment	O
.	O

soft	O
tissue	O
.	O

The	O
tracheal	O
stoma	O
is	O
uninvolved	O
by	O
tumor	O
.	O

INK	O
CODE	O
:	O
Red	O
deep	O
margin	O
.	O

Green	O
hyoid	O
bone	O
region	O
.	O

Blue	O
base	O
of	O
tongue	O
.	O

Black	O
anterior	O
surface	O
.	O

CASSETTE	O
CODE	O
:	O
3AFS	O
Deep	O
margin	O
,	O
designated	O
by	O
surgeon	O
,	O
shave	O
.	O

3BFS	O
Left	O
lateral	O
pharyngeal	O
margin	O
,	O
shave	O
.	O

3CFS	O
Right	O
lateral	O
pharyngeal	O
margin	O
,	O
shave	O
.	O

3D	O
Tracheal	O
margin	O
,	O
shave	O
.	O

3E	O
Hyoid	O
bone	O
with	O
tumor	O
.	O

3F	O
-	O
3G	O
Base	O
of	O
tongue	O
,	O
shave	O
margin	O
.	O

3H	O
Posterior	O
cricoid	O
region	O
,	O
shave	O
margin	O
.	O

3I	O
Anterior	O
compartment	O
,	O
shave	O
.	O

3J	O
Deep	O
base	O
of	O
tongue	O
,	O
additional	O
shave	O
margin	O
.	O

3K	O
Representative	O
section	O
of	O
right	O
pyriform	O
sinus	O
.	O

3L	O
.	O

Representative	O
section	O
of	O
left	O
pyriform	O
sinus	O
.	O

3M	O
Anterior	O
commissure	O
.	O

3N	O
Right	O
true	O
and	O
false	O
vocal	O
cords	O
.	O

30	O
Left	O
true	O
and	O
false	O
vocal	O
cords	O
.	O

3P	O
Thyroid	O
cartilage	O
and	O
adjacent	O
grossly	O
normal	O
tissue	O
.	O

3Q	O
Stoma	O
,	O
submitted	O
entirely	O
.	O

3R	O
Base	O
of	O
tongue	O
with	O
tumor	O
at	O
deepest	O
level	O
of	O
involvement	O
.	O

(	O
perpendicular	O
.	O
section	O
)	O
.	O

3S	O
One	O
lymph	O
node	O
,	O
level	O
VI	O
.	O

Time	O
in	O
formalin	O
:	O
22	O
hours	O
.	O

DICTATED	O
BY	O
:	O
INTRAOPERATIVE	O
CONSULTATION	O
:	O
3AFS	O
:	O
DEEP	O
MARGIN	O
(	O
SHAVE	O
)	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

3BFS	O
:	O
LEFT	O
LATERAL	O
PHARYNGEAL	O
MARGIN	O
(	O
SHAVE	O
)	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

3CFS	O
:	O
RIGHT	O
LATERAL	O
PHARYNGEAL	O
MARGIN	O
(	O
SHAVE	O
)	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

MICROSCOPIC	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
diagnosis	O
.	O

The	O
following	O
statement	O
applies	O
to	O
all	O
immunohistochemistry	O
,	O
Insitu	O
.	O

Hybridization	O
Assays	O
(	O
ISH	O
&	O
FISH	O
)	O
,	O
Molecular	O
Anatomic	O
Pathology	O
,	O
and	O
.	O

Immunofluorescent	O
Testing	O
:	O
The	O
testing	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O
the	O
.	O

Department	O
of	O
Pathology	O
,	O
as	O
required	O
by	O
.	O
the	O
CLIA	O
.	O

'	O
88	O
regulations	O
.	O

The	O
testing	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
the	O
.	O
specific	O
use	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
,	O
but	O
the	O
FDA	O
has	O
.	O
determined	O
such	O
approval	O
is	O
not	O
necessary	O
for	O
clinical	O
use	O
.	O

Tissue	O
.	O
fixation	O
.	O

ranges	O
from	O
a	O
minimum	O
of	O
2	O
to	O
a	O
maximum	O
of	O
84	O
hours	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
"	O
CLIA	O
"	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
complexity	O
.	O
clinical	O
.	O

testing	O
.	O

Pursuant	O
to	O
the	O
requirements	O
of	O
CLIA	O
,	O
ASR	O
'	O
s	O
used	O
in	O
this	O
.	O
laboratory	O
.	O

have	O
been	O
established	O
and	O
verified	O
for	O
accuracy	O
and	O
precision	O
.	O

Additional	O
.	O
information	O
about	O
this	O
type	O
of	O
test	O
is	O
available	O
upon	O
request	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
LARYNX	O
RESECTIONS	O
.	O

TYPE	O
OF	O
LARYNGECTOMY	O
:	O
Total	O
.	O

TUMOR	O
LATERALITY	O
:	O
Bilateral	O
.	O

ATTACHED	O
STRUCTURES	O
:	O
Pyriform	O
sinus	O
,	O
Base	O
of	O
tongue	O
,	O
Thyroid	O
,	O
Skin	O
.	O

TUMOR	O
LOCATION	O
/	O
SEGMENT	O
:	O
Supraglottic	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
5	B
.	I
4	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
OF	O
TUMOR	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Moderately	O
differentiated	O
.	O

STRUCTURES	O
INVOLVED	O
BY	O
TUMOR	O
:	O
Anterior	O
commissure	O
,	O
False	O
cord	O
,	O
.	O

Ventricle	O
,	O
.	O

Epiglottis	O
,	O
Vallecula	O
-	O
base	O
of	O
tongue	O
,	O
Pyriform	O
sinus	O
,	O
Other	O
:	O
hyoid	O
bone	O
.	O

LYMPH	O
NODES	O
:	O
Lymph	O
nodes	O
positive	O
,	O
Right	O
:	O
0	O
.	O

Total	O
number	O
of	O
right	O
sided	O
lymph	O
nodes	O
examined	O
:	O
31	O
.	O

Lymph	O
nodes	O
positive	O
,	O
Left	O
:	O
3	O
.	O

Total	O
number	O
of	O
left	O
sided	O
lymph	O
nodes	O
examined	O
:	O
37	O
.	O

Site	O
of	O
'	O
other	O
'	O
lymph	O
nodes	O
:	O
level	O
VI	O
.	O

Lymph	O
nodes	O
positive	O
,	O
'	O
other	O
'	O
:	O
0	O
.	O

Total	O
number	O
of	O
'	O
other	O
'	O
lymph	O
nodes	O
examined	O
:	O
2	O
.	O

EXTRACAPSULAR	O
SPREAD	O
OF	O
LYMPH	O
NODE	O
METASTASES	O
.	O

INTRA	O
-	O
PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

VASCULAR	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
Free	O
(	O
2	O
mm	O
or	O
more	O
)	O
.	O

I	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
Supraglottis	O
,	O
pT4a	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN2b	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

PATIENT	O
HISTORY	O
:	O
CHIEF	O
COMPLAINT	O
/	O
PRE	O
-	O
OP	O
/	O
POST	O
-	O
OF	O
DIAGNOSIS	O
:	O
Supraglottic	O
carcinoma	O
.	O

PROCEDURE	O
:	O
Total	O
laryngectomy	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Not	O
answered	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
Not	O
answered	O
.	O

PRIOR	O
MALIGNANCY	O
:	O
Not	O
answered	O
.	O

CHEMORADIATION	O
THERAPY	O
Not	O
answered	O
.	O

ORGAN	O
TRANSPLANT	O
:	O
Not	O
answered	O
.	O

IMMUNOSUPPRESSION	O
Not	O
answered	O
.	O

OTHER	O
DISEASES	O
:	O
Not	O
answered	O
.	O

CYTOGENETIC	O
TESTS	O
:	O
Not	O
answered	O
.	O

HISTO	O
TISSUE	O
SUMMARY	O
/	O
SLIDES	O
REVIEWED	O
:	O
Part	O
1	O
:	O
Left	O
Neck	O
Dissection	O
Levels	O
2	O
-	O
4	O
.	O

Stain	O
/	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

K	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

Part	O
2	O
:	O
Right	O
Neck	O
.	O

Stain	O
,	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

Part	O
3	O
:	O
Total	O
Laryngectomy	O
and	O
Base	O
of	O
Tongue	O
Resection	O
.	O

Stain	O
,	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

K	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

L	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

M	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

N	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

O	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

P	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

R	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

S	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

T	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

AFS	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

BFS	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

CFS	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

DDR	O
.	O

OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
PROCEDURE	O
:	O
-	O
year	O
-	O
old	O
male	O
with	O
distal	O
esophageal	O
mass	O
showing	O
high	O
grade	O
dysplasia	O
.	O
changes	O
suspicious	O
for	O
invasive	O
cancer	O
.	O

Combined	O
hiatal	O
hernia	O
.	O

1	O
.	O
5	O
cm	O
left	O
.	O
basilar	O
lung	O
nodule	O
,	O
common	O
bile	O
duct	O
dilatation	O
and	O
2	O
-	O
3	O
cm	O
left	O
renal	O
(	O
esion	O
.	O
suspicious	O
for	O
renal	O
cell	O
carcinoma	O
.	O

ERCP	O
in	O
.	O
showed	O
ampullary	O
.	O
adenoma	O
.	O

PROCEDURE	O
:	O
1	O
.	O

"	O
Left	O
thoracic	O
inlet	O
tracheoesophageal	O
groove	O
"	O
.	O

1	B
.	I
9	I
x	I
1	I
.	I
7	I
x	I
0	I
.	I
6	I
.	I

cm	B
.	O
lobulated	O
,	O
firm	O
,	O
white	O
nodule	O
.	O

Bisected	O
.	O

1A	O
.	O

Frozen	O
section	O
control	O
.	O

18	O
.	O

Remainder	O
.	O

2	O
.	O

"	O
Retroportal	O
lymph	O
node	O
"	O
.	O

Two	O
tan	O
-	O
brown	O
soft	O
tissue	O
fragments	O
,	O
measuring	O
.	O

1	O
.	O
3	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
and	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

Both	O
bisected	O
and	O
submitted	O
in	O
.	O
cassettes	O
2A	O
-	O
B	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

3	O
.	O

REPORT	O
DATE	O
:	O
PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

ADM	O
DATE	O
:	O
SIRTHDATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
3	O
.	O

"	O
Gallbladder	O
"	O
.	O

A	O
12	O
.	O
0	O
cm	O
gallbladder	O
,	O
4	O
.	O
5	O
cm	O
in	O
diameter	O
with	O
pink	O
-	O
purple	O
,	O
.	O
unremarkable	O
serosal	O
surface	O
.	O

The	O
gallbladder	O
is	O
filled	O
with	O
amber	O
bile	O
and	O
.	O
has	O
a	O
velvety	O
,	O
red	O
-	O
brown	O
,	O
unremarkable	O
mucosa	O
.	O

Representative	O
pieces	O
from	O
.	O
mucosa	O
and	O
cystic	O
duct	O
submitted	O
in	O
cassette	O
3	O
.	O

4	O
.	O

"	O
Esophagus	O
and	O
proximel	O
stomach	O
"	O
.	O

An	O
8	O
.	O
0	O
cm	O
esophagus	O
,	O
2	O
.	O
3	O
cm	O
in	O
diameter	O
.	O
with	O
attached	O
5	O
.	O
4	O
cm	O
proximal	O
stomach	O
,	O
closed	O
at	O
both	O
ends	O
with	O
staple	O
.	O
lines	O
.	O

The	O
esophageal	O
mucosa	O
is	O
flattened	O
,	O
pink	O
-	O
gray	O
with	O
a	O
3	O
.	O
5	O
x	O
1	O
.	O
6	O
cm	O
.	O
fungating	O
,	O
partially	O
ulcerated	O
,	O
tan	O
-	O
brown	O
lesion	O
,	O
3	O
.	O
3	O
cm	O
from	O
the	O
proximal	O
.	O
margin	O
of	O
resection	O
.	O

At	O
the	O
level	O
of	O
the	O
gastroesophageal	O
junction	O
,	O
there	O
is	O
.	O
another	O
2	O
.	O
2	O
x	O
1	O
.	O
6	O
cm	O
fungating	O
,	O
tan	O
-	O
brown	O
(	O
esion	O
,	O
2	O
.	O
5	O
cm	O
from	O
the	O
distal	O
.	O
margin	O
of	O
resection	O
.	O

Both	O
Lesions	O
are	O
raised	O
1	O
.	O
2	O
cm	O
from	O
the	O
mucosal	O
surface	O
.	O
of	O
the	O
specimen	O
.	O

Deep	O
radial	O
margin	O
inked	O
black	O
.	O

The	O
mucosal	O
lesions	O
extend	O
.	O
grossly	O
to	O
the	O
level	O
of	O
the	O
muscularis	O
,	O
but	O
do	O
not	O
penetrate	O
into	O
the	O
.	O
surrounding	O
fat	O
.	O

It	O
appears	O
that	O
the	O
lesions	O
may	O
be	O
connected	O
at	O
a	O
level	O
deep	O
.	O
to	O
the	O
mucosa	O
.	O

Distal	O
margin	O
of	O
resection	O
inked	O
blue	O
.	O

The	O
surrounding	O
.	O
fibroadipose	O
tissue	O
contains	O
multiple	O
lymph	O
nodes	O
,	O
the	O
largest	O
of	O
which	O
.	O
appears	O
grossly	O
involved	O
.	O

4A	O
-	O
B	O
.	O

Proximal	O
mucosal	O
lesion	O
with	O
deepest	O
extension	O
.	O

4C	O
-	O
D	O
.	O

Distal	O
mucosal	O
lesion	O
with	O
deepest	O
extension	O
.	O

4c	O
contains	O
interface	O
.	O
between	O
proximal	O
and	O
distal	O
lesions	O
.	O

4E	O
.	O

Distal	O
margin	O
of	O
resection	O
.	O

4F	O
.	O

Uninvolved	O
gastric	O
and	O
esopnageal	O
mucosa	O
.	O

4G	O
-	O
H	O
.	O

Largest	O
lymph	O
node	O
.	O

41	O
-	O
J	O
.	O

Two	O
bisected	O
Lymph	O
nodes	O
each	O
.	O

One	O
node	O
has	O
been	O
inked	O
blue	O
in	O
each	O
.	O
case	O
.	O

4K	O
-	O
L	O
.	O

Four	O
lymph	O
nodes	O
each	O
.	O

5	O
.	O

Cervical	O
esophageal	O
margin	O
"	O
.	O

A	O
1	O
.	O
3	O
cm	O
segment	O
of	O
esophagus	O
,	O
2	O
.	O
0	O
cm	O
in	O
.	O
diameter	O
,	O
closed	O
at	O
one	O
end	O
with	O
a	O
staple	O
line	O
.	O

Cross	O
section	O
submitted	O
in	O
.	O
one	O
cassette	O
.	O

FROZEN	O
SECTION	O
REPORT	O
:	O
1A	O
.	O

Lymph	O
node	O
with	O
metastatic	O
adenocarcinoma	O
.	O
have	O
reviewed	O
and	O
interpreted	O
the	O
frozen	O
section	O
.	O
material	O
at	O
the	O
time	O
it	O
was	O
requested	O
.	O

Permanent	O
sections	O
confirm	O
frozen	O
section	O
report	O
.	O

PROCEDURE	O
:	O
ESOPNAGEAL	O
,	O
CARDIAC	O
AND	O
GASTROESOPHAGEAL	O
JUNCTION	O
CARCINOMA	O
:	O
Type	O
of	O
carcinoma	O
:	O
Adenocarcinoma	O
.	O

If	O
adenocarcinoma	O
,	O
is	O
it	O
arising	O
in	O
:	O
G	O
-	O
E	O
junction	O
otherwise	O
not	O
specified	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATF	O
.	O

4	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

BIRTHDATE	O
:	O
ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
Depth	O
of	O
invasion	O
:	O
Muscularis	O
propria	O
.	O

Number	O
of	O
positive	O
lymph	O
nodes	O
,	O
the	O
total	O
number	O
sampled	O
is	O
irrelevant	O
:	O
6	O
.	O

Extranodal	O
metastasis	O
:	O
Unknown	O
.	O

Pattern	O
of	O
invasion	O
:	O
Infiltrative	O
.	O

Esophageal	O
and	O
gastric	O
resection	O
margins	O
involved	O
:	O
No	O
.	O

Deep	O
resection	O
margin	O
involved	O
:	O
No	O
.	O

TNM	O
classification	O
:	O
T1N1MX	O
.	O

PROCEDURE	O
:	O
1	O
.	O

Lymph	O
node	O
,	O
"	O
left	O
thoracic	O
intet	O
trachecesophageal	O
groove	O
,	O
excision	O
:	O
One	O
.	O
lymph	O
node	O
positive	O
for	O
metastatic	O
carcinoma	O
(	O
1	O
/	O
1	O
)	O
.	O

2	O
.	O

Lymph	O
node	O
,	O
"	O
retroportal	O
lymph	O
node	O
"	O
,	O
excision	O
:	O
Two	O
Lymph	O
nodes	O
negative	O
.	O
for	O
neoplasm	O
(	O
0	O
/	O
2	O
)	O
.	O

3	O
.	O

Gallbladder	O
,	O
resection	O
:	O
Chronic	O
cholecystitis	O
.	O

4	O
-	O
5	O
.	O

Esophagus	O
,	O
resection	O
:	O
Invasive	O
adenocarcinoma	O
,	O
poorly	O
differentiated	O
,	O
.	O

5	B
.	I
7	I
cm	I
,	O
abutting	O
the	O
muscularis	O
propria	O
.	O

Lymphatic	O
invesion	O
present	O
.	O

Margins	O
.	O
negative	O
.	O

Please	O
see	O
template	O
.	O

1	O
,	O
.	O

D	O
.	O
,	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
.	O
examined	O
and	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

Code	O
:	O

CHIEF	O
COMPLAINT	O
/	O
PRE	O
-	O
OPI	O
POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
1	O
.	O
2	O
-	O
cm	O
mass	O
posterior	O
12	O
o	O
'	O
clock	O
right	O
breast	O
.	O

Core	O
blopsy	O
Invasive	O
ductal	O
.	O
carcinoma	O
.	O

LMP	O
DATE	O
:	O
Not	O
provided	O
.	O

PROCEDURE	O
.	O

Right	O
segmental	O
mastectomy	O
/	O
sentinel	O
lymph	O
node	O
biopsies	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Not	O
provided	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
No	O
.	O

PRIOR	O
MALIGNANCY	O
No	O
.	O

CHEMORADIATION	O
THERAPY	O
:	O
No	O
.	O

OTHER	O
DISEASES	O
No	O
.	O

ADDENDA	O
:	O
Addendum	O
.	O

There	O
a	O
few	O
satellite	O
nodules	O
ranging	O
in	O
size	O
from	O
0	O
.	O
5	O
-	O
2	O
mm	O
,	O
which	O
measure	O
0	O
.	O
5	O
-	O
1	O
.	O
2	O
cm	O
from	O
the	O
main	O
dominant	O
nodule	O
.	O

These	O
.	O
satellite	O
nodules	O
are	O
the	O
nodules	O
that	O
are	O
seen	O
closest	O
to	O
the	O
margins	O
,	O
as	O
reported	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
BREAST	O
	O
RIGHT	O
/	O
SEGMENTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
(	O
see	O
comment	O
)	O
.	O

B	O
.	O

NOTTINGHAM	O
GRADE	O
3	O
(	O
TUBULE	O
FORMATION	O
3	O
,	O
NUCLEAR	O
PLEOMORPHISM	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
3	O
;	O
.	O
TOTAL	O
SCORE	O
9	O
/	O
9	O
)	O
.	O

C	O
.	O

THE	O
INVASIVE	O
TUMOR	O
MEASURES	O
1	B
.	I
1	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
(	O
ON	O
SLIDE	O
IK	O
)	O
.	O

D	O
.	O

NO	O
DUCTAL	O
CARCINOMA	O
IN	O
-	O
SITU	O
(	O
DCIS	O
)	O
IS	O
IDENTIFIED	O
.	O

E	O
.	O

NO	O
LYMPHOVASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

F	O
.	O

RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
INVASIVE	O
CARCINOMA	O
;	O
INVASIVE	O
CARCINOMA	O
MEASURES	O
.	O

LESS	O
THAN	O
1	O
MM	O
FROM	O
THE	O
ANTERIOR	O
AND	O
INFERIOR	O
MARGINS	O
,	O
1	O
MM	O
FROM	O
THE	O
MEDIAL	O
MARGIN	O
,	O
AND	O
.	O

1	O
.	O
5	O
MM	O
FROM	O
THE	O
POSTERIOR	O
MARGIN	O
.	O

G	O
.	O

SKIN	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

H	O
.	O

ATYPICAL	O
DUCTAL	O
HYPERPLASIA	O
.	O

I	O
.	O

CALCIFICATIONS	O
ASSOCIATED	O
WITH	O
INVASIVE	O
CARCINOMA	O
.	O

J	O
.	O

FIBROCYSTIC	O
CHANGES	O
WITH	O
DUCTAL	O
EPITHELIAL	O
HYPERPLASIA	O
ANO	O
COLUMNAR	O
CELL	O
ALTERATIONS	O
.	O

K	O
.	O

CHANGES	O
CONSISTENT	O
WITH	O
PRIOR	O
BIOPSY	O
SITE	O
.	O

THE	O
INVASIVE	O
TUMOR	O
CELLS	O
ARE	O
NEGATIVE	O
FOR	O
ESTROGEN	O
AND	O
PROGESTERONE	O
RECEPTORS	O
AND	O
.	O

ALSO	O
N	O
	O
GATIVE	O
FOR	O
HER	O
-	O
2	O
/	O
NEU	O
(	O
SCORE	O
0	O
)	O
.	O

AS	O
PER	O
PREVIOUS	O
REPORT	O
.	O

PART	O
2	O
:	O
AXILLA	O
,	O
RIGHT	O
,	O
CYST	O
EXCISION	O
-	O
.	O

EPIDERMAL	O
INCLUSION	O
CYST	O
.	O

PART	O
3	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLARY	O
,	O
SENTINEL	O
#	O
1	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
4	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLARY	O
,	O
SENTINEL	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
5	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
AXILLARY	O
,	O
SENTINEL	O
#	O
3	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

COMMENT	O
:	O
The	O
triple	O
negative	O
invasive	O
tumor	O
was	O
reported	O
to	O
be	O
positive	O
for	O
basal	O
markers	O
,	O
as	O
per	O
previous	O
report	O
(	O
I	O
.	O

Although	O
the	O
mass	O
grossly	O
measured	O
1	O
.	O
4	O
cm	O
by	O
gross	O
examination	O
,	O
the	O
tumor	O
is	O
best	O
estimated	O
to	O
be	O
1	B
.	I
1	I
cm	I
.	O
based	O
on	O
the	O
microscopic	O
measurement	O
from	O
slide	O
1K	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
.	O

PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Right	O
.	O

PROCEDURE	O
:	O
Segmental	O
.	O

Clock	O
position	O
:	O
12	O
oclock	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
11	B
mm	I
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALTY	O
OF	O
INVASIVE	O
FOCI	O
:	O
TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
,	O
Other	O
Type	O
(	O
s	O
)	O
:	O
Basal	O
-	O
like	O
phenotype	O
confirmed	O
by	O
IHC	O
.	O
on	O
biopsy	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
3	O
.	O

Mitotic	O
activity	O
score	O
.	O

3	O
.	O

Total	O
Nottingham	O
score	O
:	O
9	O
.	O

Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
3	O
.	O

ANGIOL	O
YMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
CALCIFICATION	O
:	O
Yes	O
,	O
malignant	O
zones	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Distance	O
of	O
invasive	O
tumor	O
to	O
closest	O
margin	O
:	O
0	O
.	O
5	O
mm	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
0	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
3	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
.	O

SENTINEL	O
NODE	O
METASTASIS	O
:	O
SKIN	O
INVOLVED	O
(	O
ULCERATION	O
)	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
ADH	O
,	O
FCD	O
,	O
Other	O
:	O
ductal	O
epithelial	O
hyperplasia	O
,	O
columnar	O
cell	O
alterations	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pTic	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
:	O
Not	O
applicable	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
negative	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
negative	O
.	O

HER2	O
/	O
NEU	O
:	O
0	O
.	O

[	O
D	O
:	O
4027496E	O
-	O
5E84	O
-	O
4502	O
-	O
BD86	O
-	O
980339AD9896	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

A	O
.	O

METASTATIC	O
TUMOUR	O
IS	O
PRESENT	O
IN	O
THREE	O
OUT	O
OF	O
TWELVE	O
LYMPH	O
NODES	O
(	O
3	O
/	O
12	O
)	O
EXAMINED	O
.	O

B	O
.	O

LARGEST	O
METATSTATIC	O
FOCUS	O
MEASURES	O
0	O
.	O
4CM	O
.	O

C	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
IS	O
NOT	O
IDENTIFIED	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
EXCISION	O
-	O
.	O

NO	O
EVIDENCE	O
OF	O
NEOPLASIA	O
IN	O
THIRTEEN	O
(	O
0	O
/	O
13	O
)	O
LYMPH	O
NODES	O
EXAMINED	O
.	O

PART	O
3	O
:	O
PROSTATE	O
AND	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
RADICAL	O
PROSTATECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
,	O
ACINAR	O
TYPE	O
,	O
GLEASON	O
SCORE	O
4	O
+	O
3	O
-	O
7	O
.	O

WITH	O
TERTIARY	O
GLEASON	O
PATTERN	O
5	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
BOTH	O
THE	O
RIGHT	O
AND	O
LEFT	O
LOBES	O
AND	O
HAS	O
A	O
GREATEST	O
NODULAR	O
.	O

DIAMETER	O
OF	O
1	B
.	I
9CM	I
(	O
slide	O
3U	O
)	O
.	O

c	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
25	O
-	O
30	O
%	O
OF	O
THE	O
EXAMINED	O
PROSTATE	O
VOLUME	O
.	O

D	O
.	O

THE	O
CARCINOMA	O
SHOWS	O
ESTABLISHED	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

E	O
.	O

THE	O
EXTRACAPSULAR	O
EXTENSION	O
IS	O
SEEN	O
IN	O
THE	O
MID	O
AND	O
BASE	O
OF	O
RIGHT	O
POSTERIOR	O
REGION	O
(	O
slides	O
.	O
3V	O
AND	O
3W	O
)	O
.	O

F	O
.	O

CARCINOMA	O
INVOLVES	O
BILATERAL	O
SEMINAL	O
VESICLES	O
.	O

G	O
.	O

CARCINOMA	O
FOCALLY	O
INVOLVES	O
THE	O
SURGICAL	O
RESECTION	O
MARGINS	O
IN	O
THE	O
REGION	O
OF	O
RIGHT	O
.	O

POSTERIOR	O
APEX	O
AND	O
BASE	O
(	O
slides	O
3U	O
,	O
3W	O
)	O
AND	O
THE	O
SOFT	O
TISSUE	O
MARGIN	O
AT	O
THE	O
BASE	O
OF	O
RIGHT	O
.	O

SEMINAL	O
VESICLE	O
AND	O
VASDEFERENS	O
(	O
slides	O
3A	O
,	O
3B	O
)	O
.	O

H	O
.	O

PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
(	O
slides	O
3V	O
,	O
3W	O
,	O
3X	O
)	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
(	O
slide	O
3A	O
,	O
3C	O
)	O
.	O

J	O
.	O

MULTIFOCAL	O
HIGH	O
-	O
GRADE	O
PROSTATIC	O
INTRAEPITHELIAL	O
NEOPLASIA	O
IS	O
IDENTIFIED	O
.	O

K	O
.	O

PATHOLOGIC	O
TNM	O
STAGE	O
:	O
PT3b	O
N1	O
MX	O
.	O

L	O
.	O

TNM	O
HISTOLOGIC	O
GRADE	O
=	O
G3	O
-	O
4	O
.	O

M	O
.	O

BENIGN	O
PROSTATIC	O
HYPERTROPHY	O
AND	O
CHRONIC	O
PROSTATITIS	O
ARE	O
NOTED	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
PROSTATE	O
TUMORS	O
.	O

CLINICAL	O
DATA	O
:	O
PSA	O
value	O
:	O
9	O
.	O
77	O
.	O

INVASIVE	O
CA	O
IDENTIFIED	O
?	O
:	O
TUMOR	O
HISTOLOGY	O
:	O
Adenocarcinoma	O
NOS	O
.	O

PRIMARY	O
GLEASON	O
GRADE	O
:	O
4	O
.	O

SECONDARY	O
GLEASON	O
GRADE	O
:	O
3	O
.	O

GLEASON	O
SUM	O
SCORE	O
:	O
7	O
.	O

GLEASON	O
4	O
/	O
5	O
PERCENTAGE	O
:	O
60	O
%	O
.	O

WEIGHT	O
OF	O
PROSTATE	O
:	O
40	O
.	O
82gm	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
1	B
.	I
9	I
cm	I
.	O

LOBE	O
LATERALITY	O
:	O
Right	O
and	O
Left	O
Lobes	O
.	O

PERCENT	O
OF	O
SPECIMEN	O
INVOLVED	O
BY	O
TUMOR	O
:	O
>	O
25	O
%	O
.	O

MULTIFOCAL	O
DISEASE	O
:	O
HIGH	O
GRADE	O
PIN	O
:	O
Yes	O
-	O
multifocal	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
Yes	O
-	O
Established	O
(	O
>	O
0	O
.	O
8mm	O
)	O
.	O

PERINEURAL	O
INVASION	O
:	O
ANGIOLYMPHATIC	O
INVASION	O
:	O
SEMINAL	O
VESICLE	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
Widespread	O
tumor	O
involvement	O
at	O
margin	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
25	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
3	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
SIZE	O
OF	O
NODAL	O
METASTASIS	O
:	O
4mm	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3b	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
-	O
4	O
,	O
Poorly	O
differentiated	O
/	O
undifferentiated	O
.	O

Gross	O
Description	O
:	O
Tumors	O
is	O
located	O
in	O
Brain	O
,	O
Frontal	O
Lobe	O
,	O
with	O
6x5x5cm	B
in	O
size	O
,	O
soft	O
and	O
brown	O
-	O
white	O
.	O
surface	O
,	O
moderately	O
-	O
margin	O
.	O

Microscopic	O
Description	O
:	O
Tumor	O
is	O
increased	O
cellularity	O
and	O
hemogenous	O
.	O

Nuclei	O
are	O
round	O
and	O
irregular	O
.	O
and	O
hyperchromatic	O
.	O

Mitotic	O
figures	O
are	O
present	O
.	O

Tumor	O
cells	O
have	O
moderate	O
,	O
eosinophilic	O
or	O
clear	O
.	O
cytoplasm	O
around	O
a	O
central	O
spherical	O
nucleus	O
.	O

Tumor	O
tissue	O
intervenes	O
in	O
thin	O
vascular	O
and	O
invades	O
into	O
.	O
begnin	O
brain	O
tissue	O
.	O

Tumor	O
is	O
necrotic	O
.	O

Vasculae	O
are	O
hyperplastic	O
.	O

Diagnosis	O
Details	O
:	O
Oligodendroglioma	O
,	O
grade	O
Il	O
.	O

Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
Brain	O
tumor	O
checklist	O
.	O

Diagnosis	O
:	O
Oligodendroglioma	O
of	O
the	O
brain	O
.	O

Tumor	O
location	O
:	O
Brain	O
,	O
Frontal	O
Lobe	O
.	O

Tumor	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
size	O
:	O
6x5x5cm	B
.	O

Diagnosis	O
details	O
:	O
None	O
.	O

Comments	O
:	O
None	O
.	O

UTD	O
:	O
CDB6A529	O
-	O
DE8B	O
-	O
48F6	O
-	O
A569	O
-	O
D07251D139C3	O
.	O

FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Left	O
breast	O
,	O
modified	O
radical	O
mastectomy	O
:	O
-	O
Invasive	O
lobular	O
carcinoma	O
,	O
SBR	O
grade	O
II	O
,	O
see	O
pathologic	O
parameters	O
and	O
.	O
comment	O
.	O

-	O
Lobular	O
carcinoma	O
in	O
situ	O
,	O
classic	O
type	O
.	O

-	O
Metastatic	O
carcinoma	O
in	O
thirteen	O
of	O
fifteen	O
lymph	O
nodes	O
(	O
13	O
/	O
15	O
)	O
;	O
biopsy	O
.	O
site	O
present	O
in	O
one	O
node	O
.	O

Breast	O
Pathologic	O
Parameters	O
.	O

1	O
.	O

Invasive	O
carcinoma	O
:	O
A	O
.	O

Microscopic	O
measurement	O
:	O
6	B
.	I
6cm	I
(	O
slices	O
5	O
-	O
11	O
)	O
;	O
20	O
%	O
cellularity	O
.	O

See	O
.	O
comment	O
.	O

B	O
.	O

Composite	O
histologic	O
(	O
modified	O
SBR	O
)	O
grade	O
:	O
II	O
.	O

-	O
Architecture	O
:	O
3	O
.	O

-	O
Nuclear	O
grade	O
:	O
2	O
.	O

-	O
Mitotic	O
rate	O
:	O
1	O
.	O

C	O
.	O

Associated	O
lobular	O
carcinoma	O
in	O
situ	O
(	O
LCIS	O
)	O
:	O
-	O
Within	O
main	O
mass	O
and	O
extending	O
away	O
.	O

2	O
.	O

Excisional	O
biopsy	O
margins	O
:	O
Widely	O
(	O
>	O
1cm	O
)	O
free	O
of	O
tumor	O
.	O

3	O
.	O

Blood	O
vessel	O
and	O
lymphatic	O
invasion	O
:	O
Absent	O
.	O

4	O
.	O

Nipple	O
and	O
skin	O
:	O
unremarkable	O
.	O

5	O
.	O

Axillary	O
lymph	O
nodes	O
:	O
Positive	O
(	O
13	O
/	O
15	O
)	O
.	O

-	O
Size	O
of	O
largest	O
metastatic	O
deposit	O
:	O
1cm	O
.	O

-	O
Extranodal	O
extension	O
:	O
present	O
,	O
largest	O
focus	O
2mm	O
(	O
multifocal	O
)	O
.	O

6	O
.	O

Special	O
studies	O
(	O
see	O
.	O

-	O
ER	O
:	O
Moderate	O
to	O
strong	O
expression	O
in	O
80	O
%	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
PR	O
:	O
No	O
expression	O
of	O
invasive	O
tumor	O
nuclei	O
.	O

-	O
HER2	O
antigen	O
(	O
FISH	O
)	O
:	O
Non	O
-	O
amplified	O
(	O
ratio	O
:	O
1	O
.	O
10	O
)	O
.	O

7	O
.	O

pTNM	O
(	O
AJCC	O
,	O
7th	O
edition	O
,	O
2010	O
)	O
:	O
pT3	O
,	O
N3	O
,	O
MX	O
.	O

Clinical	O
History	O
:	O
The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
female	O
with	O
breast	O
cancer	O
undergoing	O
left	O
breast	O
.	O
modified	O
radical	O
mastectomy	O
.	O

Comment	O
.	O

The	O
tumor	O
exhibits	O
20	O
%	O
cellularity	O
.	O

Although	O
extensive	O
hyalinization	O
is	O
present	O
.	O
in	O
the	O
tumor	O
bed	O
,	O
this	O
feature	O
was	O
also	O
seen	O
on	O
the	O
pre	O
-	O
treatment	O
biopsy	O
.	O

Hence	O
,	O
.	O
response	O
to	O
chemotherapy	O
is	O
difficult	O
to	O
assess	O
.	O

Of	O
note	O
,	O
no	O
significant	O
.	O
treatment	O
response	O
is	O
seen	O
in	O
the	O
lymph	O
nodes	O
.	O

Specimens	O
Received	O
:	O
A	O
:	O
Left	O
breast	O
modified	O
radical	O
mastectomy	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

The	O
specimen	O
is	O
received	O
in	O
a	O
single	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
,	O
medical	O
record	O
number	O
,	O
and	O
additionally	O
identified	O
as	O
,	O
'	O
left	O
breast	O
.	O
modified	O
radical	O
mastectomy	O
'	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
1	O
,	O
276	O
.	O
6	O
.	O

gm	O
modified	O
radical	O
mastectomy	O
specimen	O
.	O

The	O
specimen	O
is	O
received	O
oriented	O
with	O
.	O

a	O
suture	O
designating	O
left	O
axillary	O
tail	O
.	O

The	O
specimen	O
measures	O
26	O
.	O
5	O
cm	O
from	O
.	O
superior	O
to	O
inferior	O
,	O
27	O
.	O
5	O
cm	O
from	O
medial	O
to	O
lateral	O
,	O
and	O
5	O
cm	O
from	O
anterior	O
to	O
.	O
posterior	O
.	O

There	O
is	O
an	O
attached	O
9	O
.	O
5	O
X	O
9	O
x	O
2	O
.	O
5	O
cm	O
axillary	O
tail	O
.	O

On	O
the	O
.	O
anterior	O
surface	O
is	O
a	O
23	O
.	O
5	O
X	O
13	O
cm	O
tan	O
-	O
white	O
ellipse	O
of	O
skin	O
with	O
a	O
6	O
x	O
5	O
cm	O
.	O
areola	O
and	O
a	O
1	O
.	O
1	O
X	O
1	O
cm	O
flattened	O
nipple	O
.	O

The	O
nipple	O
-	O
areolar	O
complex	O
reveals	O
no	O
.	O
evidence	O
of	O
ulceration	O
or	O
retraction	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
superior	O
edge	O
-	O
blue	O
;	O
.	O
inferior	O
edge	O
-	O
green	O
;	O
.	O
posterior	O
-	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
into	O
21	O
slices	O
to	O
.	O
reveal	O
a	O
firm	O
,	O
bulging	O
,	O
scallop	O
tan	O
-	O
white	O
to	O
pink	O
8	O
.	O
5	O
X	O
6	O
.	O
5	O
X	O
4	O
.	O
2	O
cm	O
mass	O
in	O
.	O
slices	O
5	O
-	O
13	O
.	O

The	O
mass	O
is	O
0	O
.	O
7	O
cm	O
from	O
posterior	O
margin	O
(	O
black	O
)	O
and	O
0	O
.	O
5	O
cm	O
from	O
.	O
anterior	O
skin	O
.	O

A	O
biopsy	O
tract	O
filled	O
with	O
gel	O
is	O
present	O
in	O
places	O
6	O
-	O
7	O
,	O
with	O
.	O
clip	O
present	O
in	O
slice	O
7	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
consists	O
of	O
.	O
approximately	O
5	O
%	O
dense	O
gray	O
-	O
white	O
fibrous	O
breast	O
parenchyma	O
and	O
95	O
%	O
lobulated	O
.	O
yellow	O
adipose	O
tissue	O
.	O

No	O
additional	O
masses	O
or	O
nodules	O
are	O
grossly	O
identified	O
.	O

Sectioning	O
through	O
the	O
axillary	O
tail	O
reveals	O
multiple	O
tan	O
-	O
brown	O
,	O
rubbery	O
lymph	O
.	O
nodes	O
ranging	O
from	O
0	O
.	O
6	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
4	O
-	O
2	O
X	O
0	O
.	O
9	O
x	O
0	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Breast	O
specimens	O
are	O
fixed	O
for	O
at	O
least	O
6	O
hours	O
in	O
10	O
%	O
NBF	O
and	O
no	O
more	O
than	O
72	O
.	O
hours	O
.	O

Block	O
summary	O
:	O
A1	O
:	O
mass	O
closest	O
approach	O
to	O
posterior	O
margin	O
(	O
black	O
)	O
,	O
slice	O
13	O
.	O

A2	O
:	O
mass	O
,	O
slice	O
12	O
.	O

A3	O
:	O
mass	O
,	O
slice	O
11	O
.	O

A4	O
:	O
mass	O
,	O
slice	O
10	O
.	O

A5	O
:	O
mass	O
,	O
slice	O
9	O
.	O

A6	O
:	O
mass	O
closest	O
approach	O
to	O
skin	O
,	O
slice	O
8	O
.	O

A7	O
:	O
mass	O
biopsy	O
tract	O
,	O
slice	O
7	O
.	O

A8	O
:	O
mass	O
biopsy	O
tract	O
,	O
slice	O
6	O
.	O

A9	O
:	O
mass	O
,	O
slice	O
5	O
.	O

A10	O
:	O
medial	O
to	O
lesion	O
,	O
slice	O
4	O
.	O

A11	O
:	O
medial	O
to	O
lesion	O
,	O
slice	O
14	O
.	O

A12	O
:	O
medial	O
to	O
lesion	O
,	O
slice	O
15	O
.	O

A13	O
:	O
upper	O
-	O
inner	O
quadrant	O
,	O
slice	O
5	O
.	O

A14	O
:	O
upper	O
-	O
outer	O
quadrant	O
slice	O
12	O
.	O

A15	O
:	O
lower	O
-	O
outer	O
quadrant	O
slice	O
9	O
.	O

A16	O
:	O
lower	O
-	O
inner	O
quadrant	O
slice	O
4	O
.	O

A17	O
:	O
nipple	O
.	O

A18	O
:	O
skin	O
subjacent	O
to	O
nipple	O
.	O

A19	O
-	O
A23	O
:	O
one	O
lymph	O
node	O
candidate	O
bisected	O
in	O
each	O
cassette	O
.	O

A24	O
:	O
three	O
lymph	O
node	O
candidates	O
.	O

A25	O
:	O
one	O
lymph	O
node	O
candidate	O
.	O

A26	O
:	O
three	O
lymph	O
node	O
candidates	O
.	O

A27	O
-	O
A29	O
:	O
one	O
lymph	O
node	O
candidate	O
bisected	O
in	O
each	O
cassette	O
.	O

MD	O
.	O

PhD	O
.	O

From	O
:	O
Page	O
:	O
4	O
/	O
13	O
.	O

Specimen	O
Description	O
.	O

Accession	O
#	O
:	O
Med	O
.	O

Rec	O
#	O
:	O
Clinical	O
History	O
.	O

Thyroid	O
cancer	O
.	O

Final	O
Pathologic	O
Diagnosie	O
.	O

A	O
.	O

Lymph	O
node	O
,	O
anterior	O
right	O
neek	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
one	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

B	O
.	O

Soft	O
tissue	O
,	O
right	O
inferior	O
neck	O
:	O
Benign	O
lymph	O
node	O
with	O
extensive	O
brown	O
pigment	O
deposition	O
,	O
.	O
consistent	O
with	O
hemosiderin	O
(	O
0	O
/	O
1	O
)	O
;	O
no	O
parathyroid	O
tissue	O
is	O
identified	O
.	O

Right	O
thyroid	O
lobe	O
:	O
Papillary	O
thyroid	O
carcinoma	O
(	O
See	O
SYNOPTIC	O
REPORT	O
)	O
.	O

Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
seven	O
of	O
seven	O
lymph	O
.	O
nodes	O
(	O
7	O
/	O
7	O
)	O
.	O

D	O
.	O

Right	O
anterior	O
Level	O
III	O
lymph	O
nodes	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
two	O
of	O
two	O
lymph	O
nodes	O
.	O

(	O
2	O
/	O
2	O
)	O
.	O

Right	O
central	O
neck	O
tissue	O
:	O
One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

F	O
.	O

Right	O
Level	O
III	O
and	O
IV	O
lymph	O
nodes	O
.	O

Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
five	O
of	O
fifteen	O
lymph	O
.	O
nodes	O
(	O
5	O
/	O
15	O
)	O
.	O

G	O
.	O

Soft	O
tissue	O
,	O
right	O
inferior	O
neck	O
:	O
Portions	O
of	O
a	O
lymph	O
node	O
with	O
extensive	O
brown	O
pigment	O
.	O
deposition	O
,	O
consistent	O
with	O
hemosiderin	O
(	O
0	O
/	O
1	O
)	O
:	O
no	O
parathyroid	O
tissue	O
is	O
.	O
identified	O
.	O

H	O
.	O

Left	O
thyroid	O
lobe	O
:	O
Nodular	O
goiter	O
with	O
focal	O
chronic	O
inflammation	O
.	O

One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

I	O
.	O

Superior	O
central	O
lymph	O
nodes	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
one	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

Print	O
this	O
Page	O
.	O

Specimen	O
Description	O
.	O

Submitting	O
.	O

Clinical	O
History	O
.	O

Thyroid	O
cancer	O
.	O

Final	O
Pathologic	O
Diagnosis	O
.	O

A	O
.	O

Lymph	O
node	O
,	O
anterior	O
right	O
neck	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
one	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

B	O
.	O

Soft	O
tissue	O
,	O
right	O
inferior	O
neck	O
:	O
Benign	O
lymph	O
node	O
with	O
extensive	O
brown	O
pigment	O
deposition	O
,	O
.	O
consistent	O
with	O
hemosiderin	O
(	O
0	O
/	O
1	O
)	O
i	O
no	O
parathyroid	O
tissue	O
is	O
identified	O
.	O

C	O
.	O

Right	O
thyroid	O
lobe	O
:	O
Papillary	O
thyroid	O
carcinoma	O
(	O
See	O
SYNOPTIC	O
REPORT	O
)	O
.	O

Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
seven	O
of	O
seven	O
lymph	O
.	O
nodes	O
(	O
7	O
/	O
7	O
)	O
.	O

D	O
.	O

Right	O
anterior	O
Level	O
III	O
lymph	O
nodes	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
two	O
of	O
two	O
lymph	O
nodes	O
.	O

(	O
2	O
/	O
2	O
)	O
.	O

E	O
.	O

Right	O
central	O
neck	O
tissue	O
:	O
One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

F	O
.	O

Right	O
Level	O
III	O
and	O
IV	O
lymph	O
nodes	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
five	O
of	O
fifteen	O
lymph	O
.	O
nodes	O
(	O
5	O
/	O
15	O
)	O
.	O

G	O
.	O

Soft	O
tissue	O
,	O
right	O
inferior	O
neck	O
:	O
Portions	O
of	O
a	O
lymph	O
node	O
with	O
extensive	O
brown	O
pigment	O
.	O
deposition	O
,	O
consistent	O
with	O
hemosiderin	O
(	O
0	O
/	O
1	O
)	O
;	O
no	O
parathyroid	O
tissue	O
is	O
.	O
identified	O
.	O

H	O
.	O

Left	O
thyroid	O
lobe	O
:	O
Nodular	O
goiter	O
with	O
focal	O
chronic	O
inflammation	O
.	O

One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

I	O
.	O

Superior	O
central	O
lymph	O
nodes	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
in	O
one	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

Synoptic	O
Report	O
.	O

SYNOPTIC	O
REPORT	O
FOR	O
THYROID	O
CANCER	O
:	O
Specimen	O
type	O
:	O
Total	O
thyroidectomy	O
.	O

Tumor	O
location	O
:	O
Right	O
thyroid	O
.	O

Tumor	O
size	O
:	O
9	B
.	I
4	I
cm	I
.	O

Histologic	O
type	O
:	O
Papillary	O
thyroid	O
carcinoma	O
.	O

Tumor	O
grade	O
:	O
Grade	O
2	O
of	O
3	O
.	O

Lymphatic	O
/	O
vascular	O
invasion	O
:	O
positive	O
.	O

Capsular	O
invasion	O
:	O
Negative	O
.	O

Tumor	O
extent	O
:	O
Confined	O
to	O
the	O
thyroid	O
:	O
yes	O
.	O

Multifocal	O
:	O
negative	O
.	O

Invasion	O
of	O
thyroid	O
cartilage	O
or	O
hyoid	O
bone	O
:	O
Negative	O
.	O

Infiltration	O
of	O
adjacent	O
structures	O
:	O
Negative	O
.	O

Margins	O
.	O

For	O
partial	O
or	O
subtotal	O
resection	O
:	O
uninvolved	O
.	O

Lymph	O
nodes	O
:	O
Total	O
number	O
examined	O
:	O
31	O
.	O

Sites	O
/	O
laterality	O
:	O
Right	O
side	O
and	O
superior	O
central	O
.	O

Number	O
positive	O
:	O
16	O
.	O

Number	O
negative	O
:	O
15	O
.	O

Extranodal	O
extension	O
:	O
negative	O
.	O

Additional	O
pathologic	O
findings	O
:	O
nodular	O
goiter	O
.	O

Special	O
studies	O
:	O
none	O
.	O

pTNM	O
:	O
pT3	O
pN1b	O
pMx	O
.	O

Comments	O
:	O
The	O
findings	O
from	O
the	O
previous	O
FNA	O
have	O
been	O
noted	O
.	O

The	O
above	O
synoptic	O
report	O
complies	O
,	O
in	O
slightly	O
modified	O
form	O
,	O
with	O
the	O
.	O
guidelines	O
of	O
the	O
Coliege	O
of	O
American	O
Pathologists	O
Protocols	O
and	O
the	O
AJCC	O
.	O

Cancer	O
Staging	O
Manual	O
,	O
7th	O
edition	O
,	O
2010	O
,	O
for	O
the	O
reporting	O
of	O
cancer	O
.	O
specimens	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
.	O

AF1	O
.	O

Anterior	O
lymph	O
node	O
right	O
neck	O
:	O
(	O
FROZEN	O
SECTION	O
PERFORMED	O
)	O
.	O

One	O
lymph	O
node	O
with	O
metastatic	O
papillary	O
thyroid	O
carcinoma	O
.	O

BF1	O
.	O

Possible	O
right	O
inferior	O
parathyroid	O
:	O
(	O
FROZEN	O
SECTION	O
PERFORMED	O
)	O
.	O

Not	O
parathyroid	O
.	O

Examining	O
pathologist	O
.	O

SPECIMEN	O
(	O
S	O
)	O
RECEIVED	O
.	O

A	O
:	O
Lymph	O
node	O
,	O
excision	O
.	O

B	O
:	O
Parathyroid	O
gland	O
,	O
BX	O
.	O

C	O
:	O
Thyroid	O
resection	O
total	O
or	O
lobe	O
.	O

D	O
:	O
Lymph	O
node	O
,	O
dissection	O
.	O

E	O
:	O
Lymph	O
node	O
,	O
dissection	O
.	O

F	O
:	O
Lymph	O
node	O
,	O
dissection	O
.	O

G	O
:	O
Parathyroid	O
gland	O
,	O
BX	O
.	O

H	O
:	O
Thyroid	O
resection	O
total	O
or	O
lobe	O
.	O

I	O
:	O
Lymph	O
node	O
,	O
dissection	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimens	O
are	O
received	O
in	O
nine	O
properly	O
labeled	O
containers	O
with	O
the	O
.	O

patient	O
'	O
s	O
name	O
and	O
accession	O
number	O
,	O
two	O
of	O
which	O
are	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

A	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
anterior	O
lymph	O
node	O
right	O
neck	O
"	O
and	O
.	O
consists	O
of	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
2	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
soft	O
tissue	O
in	O
which	O
there	O
is	O
.	O

a	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
lymph	O
node	O
.	O

The	O
specimen	O
is	O
resubmitted	O
as	O
received	O
.	O
from	O
frozen	O
section	O
in	O
cassette	O
AF1	O
.	O

TE	O
1	O
.	O

B	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
possible	O
right	O
inferior	O
.	O

parathyroid	O
"	O
and	O
consists	O
of	O
a	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
piece	O
of	O
soft	O
tissue	O
.	O

The	O
.	O
specimen	O
is	O
resubmitted	O
as	O
received	O
from	O
frozen	O
section	O
in	O
cassette	O
BF1	O
.	O

TE	O
.	O

1	O
.	O

C	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
right	O
thyroid	O
lobe	O
"	O
and	O
consists	O
of	O
.	O

a	O
317	O
.	O
6	O
gram	O
hemithyroidectomy	O
that	O
is	O
13	O
.	O
4	O
cm	O
from	O
superior	O
to	O
inferior	O
,	O
.	O

9	O
.	O
4	O
cm	O
from	O
medial	O
to	O
lateral	O
and	O
6	O
.	O
5	O
cm	O
in	O
the	O
anteroposterior	O
dimension	O
.	O

The	O
outer	O
surface	O
of	O
the	O
hemithyroid	O
is	O
diffusely	O
nodular	O
and	O
numerous	O
.	O
grossly	O
positive	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
perithyroidal	O
soft	O
.	O
tissue	O
.	O

The	O
isthmic	O
resection	O
edge	O
is	O
inked	O
orange	O
and	O
the	O
outer	O
surface	O
of	O
.	O
the	O
specimen	O
is	O
inked	O
blue	O
.	O

The	O
cut	O
surface	O
of	O
the	O
mass	O
is	O
solid	O
tan	O
-	O
white	O
.	O
and	O
has	O
foci	O
of	O
both	O
hemorrhage	O
and	O
necrosis	O
.	O

The	O
greatest	O
dimension	O
of	O
the	O
.	O
mass	O
is	O
9	O
.	O
4	O
cm	O
.	O

The	O
mass	O
diffusely	O
approaches	O
the	O
inked	O
outer	O
surface	O
of	O
.	O
the	O
thyroid	O
.	O

In	O
the	O
perithyroidal	O
soft	O
tissue	O
,	O
seven	O
lymph	O
nodes	O
are	O
.	O
identified	O
,	O
six	O
of	O
which	O
are	O
grossly	O
positive	O
for	O
tumor	O
.	O

The	O
largest	O
.	O
grossly	O
positive	O
lymph	O
node	O
is	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

(	O
.	O

Summary	O
of	O
Cassettes	O
:	O
C1	O
-	O
2	O
,	O
isthmic	O
resection	O
edge	O
,	O
perpendicular	O
;	O
.	O

C3	O
-	O
6	O
,	O
representative	O
sections	O
of	O
mass	O
to	O
inked	O
outer	O
surface	O
;	O
C7	O
,	O
necrotic	O
.	O
and	O
hemorrhagic	O
portion	O
of	O
mass	O
to	O
inked	O
outer	O
surface	O
;	O
C8	O
,	O
one	O
lymph	O
node	O
;	O
.	O

C9	O
,	O
representative	O
section	O
of	O
the	O
largest	O
grossly	O
positive	O
lymph	O
node	O
;	O
C10	O
,	O
.	O
representative	O
sections	O
of	O
three	O
grossly	O
positive	O
lymph	O
nodes	O
;	O
C11	O
,	O
.	O
representative	O
sections	O
of	O
two	O
grossly	O
positive	O
lymph	O
nodes	O
.	O

D	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
right	O
anterior	O
level	O
3	O
lymph	O
nodes	O
"	O
.	O
and	O
consists	O
of	O
a	O
4	O
.	O
7	O
x	O
2	O
.	O
3	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
tan	O
-	O
yellow	O
soft	O
tissue	O
.	O
that	O
contains	O
two	O
lymph	O
nodes	O
that	O
are	O
2	O
.	O
9	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
and	O
2	O
.	O
5	O
x	O
1	O
.	O
3	O
x	O
1	O
.	O
0	O
.	O

cm	O
respectively	O
.	O

The	O
lymph	O
nodes	O
are	O
grossly	O
positive	O
for	O
tumor	O
involvement	O
.	O

(	O
confirmed	O
by	O
touch	O
preparation	O
)	O
;	O
one	O
representative	O
section	O
of	O
each	O
lymph	O
.	O
node	O
is	O
submitted	O
for	O
microscopic	O
examination	O
.	O

Summary	O
of	O
Cassettes	O
:	O
D1	O
,	O
representative	O
section	O
of	O
one	O
grossly	O
.	O
positive	O
lymph	O
node	O
;	O
D2	O
,	O
representative	O
section	O
of	O
second	O
grossly	O
positive	O
.	O
lymph	O
node	O
.	O

Note	O
:	O
Each	O
grossly	O
positive	O
lymph	O
node	O
is	O
submitted	O
in	O
its	O
plane	O
of	O
.	O
greatest	O
dimension	O
.	O

E	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
right	O
central	O
neck	O
tissue	O
"	O
and	O
.	O
consists	O
of	O
one	O
sheet	O
of	O
tan	O
-	O
yellow	O
soft	O
tissue	O
that	O
is	O
4	O
.	O
2	O
x	O
3	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

No	O
lymph	O
nodes	O
are	O
grossly	O
identified	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
for	O
.	O
microscopic	O
examination	O
.	O

TE	O
2	O
.	O

F	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
right	O
level	O
3	O
and	O
4	O
lymph	O
nodes	O
"	O
.	O
and	O
consists	O
of	O
an	O
unoriented	O
piece	O
of	O
soft	O
yellow	O
adipose	O
tissue	O
that	O
is	O
.	O

6	O
.	O
2	O
x	O
5	O
.	O
7	O
x	O
1	O
.	O
9	O
cm	O
.	O

Multiple	O
possible	O
lymph	O
nodes	O
are	O
identified	O
that	O
range	O
.	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

Only	O
adipose	O
tissue	O
remains	O
in	O
.	O
the	O
container	O
.	O

RS	O
4	O
.	O

Summary	O
of	O
Cassettes	O
:	O
F1	O
,	O
six	O
possible	O
lymph	O
nodes	O
;	O
F2	O
,	O
five	O
possible	O
.	O
lymph	O
nodes	O
;	O
F3	O
,	O
three	O
possible	O
lymph	O
nodes	O
;	O
F4	O
,	O
one	O
possible	O
lymph	O
node	O
,	O
.	O
bisected	O
.	O

G	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
possible	O
right	O
inferior	O
.	O

parathyroid	O
"	O
and	O
consists	O
of	O
a	O
less	O
than	O
0	O
.	O
05	O
gram	O
aggregate	O
of	O
red	O
-	O
brown	O
.	O
soft	O
tissue	O
that	O
is	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
its	O
.	O
entirety	O
for	O
microscopic	O
examination	O
in	O
cassette	O
G1	O
.	O

TE	O
1	O
.	O

H	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
left	O
thyroid	O
lobe	O
"	O
and	O
consists	O
.	O

of	O
.	O

an	O
11	O
.	O
0	O
gram	O
hemithyroidectomy	O
that	O
is	O
5	O
.	O
4	O
cm	O
from	O
superior	O
to	O
inferior	O
,	O
.	O

3	O
.	O
6	O
cm	O
from	O
medial	O
to	O
lateral	O
and	O
1	O
.	O
3	O
cm	O
in	O
the	O
anteroposterior	O
dimension	O
.	O

The	O
isthmic	O
resection	O
margin	O
is	O
inked	O
orange	O
and	O
the	O
outer	O
surface	O
of	O
the	O
.	O
thyroid	O
is	O
inked	O
blue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
.	O
homogeneous	O
beefy	O
red	O
parenchyma	O
with	O
no	O
focal	O
masses	O
or	O
lesions	O
.	O

RS	O
4	O
.	O

Summary	O
of	O
Cassettes	O
:	O
H1	O
,	O
isthmic	O
resection	O
edge	O
,	O
shaved	O
;	O
H2	O
-	O
4	O
,	O
.	O
representative	O
sections	O
of	O
left	O
thyroid	O
lobe	O
.	O

I	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
superior	O
central	O
lymph	O
nodes	O
"	O
and	O
.	O
consists	O
of	O
one	O
piece	O
of	O
tan	O
-	O
white	O
soft	O
tissue	O
that	O
is	O
2	O
.	O
4	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
8	O
cm	O
.	O

Two	O
firm	O
possible	O
lymph	O
nodes	O
are	O
identified	O
that	O
are	O
0	O
.	O
4	O
and	O
1	O
.	O
4	O
cm	O
in	O
.	O
greatest	O
dimension	O
respectively	O
.	O

TE	O
2	O
.	O

Summary	O
of	O
Cassettes	O
:	O
11	O
,	O
one	O
possible	O
lymph	O
node	O
;	O
12	O
,	O
one	O
possible	O
.	O
lymph	O
node	O
,	O
bisected	O
.	O

Lab	O
Use	O
Only	O
:	O
Gross	O
description	O
by	O
:	O
Top	O
of	O
Page	O
.	O

SOURCE	O
:	O
A	O
.	O

Right	O
ureteral	O
margin	O
(	O
FS	O
)	O
.	O

B	O
.	O

Left	O
ureteral	O
margin	O
(	O
FS	O
)	O
.	O

C	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
.	O

D	O
.	O

Bladder	O
,	O
resection	O
,	O
partial	O
or	O
total	O
.	O

E	O
.	O

Anterior	O
peri	O
-	O
vesicular	O
fat	O
.	O

F	O
.	O

Superior	O
common	O
iliac	O
artery	O
lymph	O
nodes	O
(	O
ES	O
)	O
.	O

G	O
.	O

Additional	O
left	O
pelvic	O
nodes	O
.	O

H	O
.	O

Left	O
common	O
iliac	O
lymph	O
nodes	O
.	O

I	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
.	O

J	O
.	O

Final	O
left	O
ureteral	O
margin	O
.	O

K	O
.	O

Final	O
right	O
ureteral	O
margin	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Right	O
ureteral	O
margin	O
,	O
excision	O
:	O
Sections	O
of	O
ureter	O
with	O
no	O
.	O
evidence	O
of	O
dysplasia	O
or	O
carcinoma	O
.	O

Left	O
ureteral	O
margin	O
,	O
excision	O
:	O
Sections	O
of	O
ureter	O
with	O
.	O
evidence	O
of	O
dysplasia	O
or	O
carcinoma	O
.	O

C	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Urothelial	O
carcinoma	O
,	O
.	O
metastatic	O
to	O
one	O
regional	O
lymph	O
node	O
,	O
with	O
extracapsular	O
extension	O
.	O

(	O
1	O
/	O
1	O
)	O
.	O

D	O
.	O

Bladder	O
,	O
prostate	O
and	O
seminal	O
vesicles	O
,	O
radical	O
.	O
cystoprostatectomy	O
:	O
Bladder	O
:	O
-	O
Invasive	O
urothelial	O
carcinoma	O
,	O
high	O
grade	O
(	O
WHO	O
grade	O
.	O
3	O
/	O
3	O
)	O
,	O
0	B
.	I
4	I
cm	I
in	O
diameter	O
.	O

-	O
Ureteral	O
and	O
urethral	O
margins	O
negative	O
for	O
tumor	O
.	O

-	O
Polypoid	O
cystitis	O
.	O

-	O
Non	O
specific	O
granulomatous	O
inflammation	O
.	O

See	O
comment	O
.	O

Prostate	O
:	O
-	O
Urothelial	O
carc	O
	O
noma	O
,	O
metastatic	O
.	O

-	O
Benign	O
nodular	O
hyperplasia	O
.	O

-	O
Chronic	O
inflammation	O
.	O

Seminal	O
vesicles	O
:	O
No	O
evidence	O
of	O
carcinoma	O
.	O

E	O
.	O

Anterior	O
perivesicular	O
fat	O
,	O
excision	O
:	O
Mature	O
fibroadipose	O
.	O
tissue	O
.	O

F	O
.	O

Superior	O
common	O
iliac	O
artery	O
lymph	O
nodes	O
,	O
excision	O
:	O
Orothelial	O
.	O
carcinoma	O
metastatic	O
to	O
two	O
of	O
two	O
regional	O
lymph	O
nodes	O
(	O
2	O
/	O
2	O
)	O
.	O

G	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Thirteen	O
regional	O
lymph	O
nodes	O
.	O
with	O
no	O
evidence	O
of	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
13	O
)	O
.	O

H	O
.	O

Left	O
common	O
iliac	O
lymph	O
nodes	O
,	O
excision	O
:	O
Urothelial	O
carcinoma	O
.	O
metastatic	O
to	O
three	O
of	O
five	O
regional	O
lymph	O
nodes	O
(	O
3	O
/	O
5	O
)	O
.	O

I	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Urothelial	O
carcinoma	O
.	O
metastatic	O
to	O
three	O
of	O
nine	O
regional	O
lymph	O
nodes	O
(	O
3	O
/	O
9	O
)	O
.	O

Final	O
left	O
ureteral	O
margin	O
,	O
excision	O
:	O
Ureter	O
with	O
no	O
evidence	O
of	O
.	O
dysplasia	O
or	O
carcinoma	O
.	O

K	O
.	O

Final	O
right	O
ureteral	O
margin	O
,	O
excision	O
:	O
Urothelial	O
dysplasia	O
,	O
.	O
high	O
grade	O
,	O
no	O
carcinoma	O
identified	O
.	O

CLINICAL	O
DATA	O
:	O
The	O
patient	O
is	O
a	O
+	O
year	O
-	O
old	O
man	O
with	O
invasive	O
high	O
grade	O
bladder	O
cancer	O
.	O
diagnosed	O
on	O
biopsy	O
.	O

He	O
undergoes	O
radical	O
prostatectomy	O
and	O
cystectomy	O
,	O
with	O
.	O
biopsies	O
for	O
frozen	O
section	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
eleven	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
medical	O
record	O
number	O
.	O

Part	O
A	O
is	O
received	O
fresh	O
and	O
is	O
additionally	O
labeled	O
"	O
#	O
2	O
right	O
ureteral	O
.	O
margin	O
.	O
"	O
It	O
consists	O
of	O
one	O
soft	O
,	O
pink	O
-	O
tan	O
,	O
irregular	O
,	O
unoriented	O
tissue	O
.	O
fragment	O
,	O
measuring	O
0	O
.	O
6	O
x	O
0	O
.	O

x	O
0	O
.	O
4	O
cm	O
,	O
that	O
is	O
inked	O
at	O
one	O
end	O
.	O

The	O
specimen	O
.	O

is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS1	O
,	O
with	O
the	O
frozen	O
.	O
section	O
remnant	O
submitted	O
in	O
cassette	O
A1	O
.	O

Part	O
B	O
is	O
received	O
fresh	O
and	O
is	O
additionally	O
labeled	O
"	O
#	O
3	O
left	O
ureteral	O
margin	O
.	O
'	O
.	O

It	O
consists	O
of	O
one	O
soft	O
,	O
pink	O
-	O
tan	O
,	O
irregular	O
,	O
unoriented	O
tissue	O
fragment	O
,	O
.	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
,	O
that	O
is	O
inked	O
at	O
one	O
end	O
.	O

The	O
specimen	O
is	O
.	O
entirely	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS2	O
,	O
with	O
the	O
frozen	O
section	O
.	O
remnant	O
submitted	O
in	O
cassette	O
B1	O
.	O

Part	O
C	O
is	O
received	O
in	O
formalin	O
and	O
is	O
additionally	O
labeled	O
"	O
#	O
1	O
.	O

Left	O
pelvic	O
.	O
lymph	O
nodes	O
.	O
'	O
It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
yellow	O
-	O
red	O
,	O
fibrofatty	O
soft	O
.	O
tissue	O
,	O
measuring	O
3	O
x	O
1	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
entirely	O
.	O
submitted	O
in	O
cassettes	O
C1	O
and	O
C2	O
.	O

Part	O
D	O
,	O
additionally	O
labeled	O
"	O
#	O
4	O
bladder	O
,	O
consists	O
of	O
a	O
radical	O
.	O
cystoprostatectomy	O
,	O
including	O
bladder	O
,	O
ureters	O
,	O
prostate	O
and	O
seminal	O
vesicles	O
.	O

The	O
bladder	O
measures	O
18	O
x	O
12	O
x	O
4	O
.	O
5	O
cm	O
,	O
the	O
wall	O
averages	O
2	O
.	O
5	O
cm	O
in	O
thickness	O
.	O

The	O
bladder	O
mucosa	O
is	O
pale	O
tan	O
and	O
shows	O
two	O
ulcerations	O
,	O
one	O
in	O
the	O
trigone	O
.	O
and	O
one	O
in	O
the	O
dome	O
measuring	O
,	O
respectively	O
,	O
1	O
.	O
5	O
and	O
1	O
cm	O
in	O
diameter	O
,	O
the	O
.	O
bladder	O
wall	O
underlying	O
these	O
areas	O
is	O
indurated	O
and	O
dusky	O
.	O

The	O
surrounding	O
.	O
uninvolved	O
mucosa	O
is	O
mostly	O
polypoid	O
.	O

Grossly	O
no	O
tumors	O
are	O
identified	O
in	O
the	O
.	O
mucosa	O
and	O
bladder	O
wall	O
.	O

The	O
ureters	O
are	O
patent	O
.	O

The	O
prostate	O
measures	O
4	O
.	O
5	O
x	O
4	O
.	O

x	O
2	O
.	O
5	O
cm	O
,	O
the	O
cut	O
surface	O
reveals	O
nodularity	O
of	O
both	O
lobes	O
,	O
no	O
tumor	O
is	O
.	O
identified	O
grossly	O
.	O

The	O
right	O
ureter	O
measures	O
8	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
in	O
.	O
diameter	O
.	O

The	O
left	O
ureter	O
measures	O
10	O
cmin	O
length	O
and	O
0	O
.	O
3	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
urethra	O
measures	O
4	O
.	O
5	O
cm	O
in	O
length	O
.	O

The	O
right	O
seminal	O
vesicle	O
measures	O
1	O
cm	O
x	O
.	O

0	O
.	O
5	O
cm	O
in	O
average	O
diameter	O
.	O

The	O
left	O
seminal	O
vesicle	O
measures	O
2	O
cm	O
x	O
0	O
.	O
5	O
cm	O
in	O
.	O
average	O
diameter	O
.	O

The	O
posterior	O
surface	O
of	O
the	O
specimen	O
is	O
inked	O
black	O
,	O
.	O
anterior	O
-	O
right	O
is	O
inked	O
green	O
,	O
and	O
anterior	O
-	O
left	O
is	O
inked	O
blue	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
Cassette	O
D1	O
:	O
Left	O
ureteral	O
margin	O
,	O
.	O
inked	O
yellow	O
.	O

Cassette	O
D2	O
:	O
Right	O
ureteral	O
margin	O
,	O
inked	O
yellow	O
.	O

Cassettes	O
D3	O
-	O
D4	O
:	O
Urethral	O
margin	O
from	O
base	O
of	O
prostate	O
.	O

Cassette	O
D5	O
-	O
9	O
:	O
Trigone	O
.	O

Cassette	O
D10	O
:	O
Left	O
prostate	O
.	O

Cassette	O
D11	O
:	O
Left	O
.	O
prostate	O
plus	O
seminal	O
vesicle	O
.	O

Cassette	O
D12	O
:	O
Right	O
prostate	O
.	O

Cassette	O
D13	O
:	O
Right	O
prostate	O
plus	O
seminal	O
vesicle	O
.	O

Cassettes	O
D14	O
-	O
D17	O
:	O
Potential	O
lymph	O
nodes	O
.	O

Cassettes	O
D18	O
-	O
21	O
:	O
Trigone	O
ulceration	O
.	O

Cassette	O
.	O

D22	O
-	O
24	O
.	O

Dome	O
ulceration	O
.	O

Cassettes	O
D26	O
-	O
28	O
:	O
Nodular	O
area	O
of	O
right	O
.	O
prostate	O
.	O

Note	O
:	O
urethra	O
is	O
included	O
in	O
D27	O
-	O
28	O
,	O
which	O
contain	O
a	O
bisected	O
.	O
piece	O
.	O

Part	O
E	O
is	O
additionally	O
labeled	O
"	O
#	O
5	O
anterior	O
peri	O
-	O
vesical	O
fat	O
.	O
"	O
It	O
consists	O
.	O

of	O
.	O
two	O
pieces	O
of	O
yellow	O
-	O
red	O
fibrofatty	O
tissue	O
,	O
measuring	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
in	O
.	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
cassette	O
E1	O
.	O

Part	O
F	O
is	O
received	O
fresh	O
and	O
is	O
additionally	O
labeled	O
"	O
#	O
8	O
superior	O
common	O
iliac	O
.	O
artery	O
lymph	O
nodes	O
.	O
'	O
It	O
consists	O
of	O
two	O
soft	O
,	O
pink	O
-	O
tan	O
,	O
irregular	O
,	O
unoriented	O
.	O
tissue	O
fragments	O
,	O
measuring	O
4	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
in	O
aggregate	O
.	O

A	O
representative	O
.	O
section	O
is	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS3	O
.	O
with	O
the	O
frozen	O
.	O
section	O
remnant	O
submitted	O
in	O
cassette	O
F1	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
.	O
serially	O
sectioned	O
and	O
submitted	O
in	O
cassette	O
F2	O
.	O

Part	O
G	O
,	O
additionally	O
labeled	O
"	O
6	O
-	O
additional	O
left	O
pelvic	O
lymph	O
nodes	O
,	O
"	O
consists	O
.	O
of	O
multiple	O
red	O
-	O
yellow	O
fragments	O
of	O
soft	O
,	O
fatty	O
tissue	O
,	O
measuring	O
-	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
.	O

x	O
0	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

The	O
largest	O
portion	O
measures	O
-	O
7	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

This	O
latter	O
specimen	O
is	O
cut	O
into	O
thirds	O
.	O

The	O
small	O
fragments	O
are	O
submitted	O
as	O
.	O
cassettes	O
G1	O
-	O
G3	O
,	O
and	O
the	O
largest	O
fragment	O
cut	O
into	O
thirds	O
is	O
submitted	O
as	O
.	O
cassettes	O
G4	O
-	O
G6	O
.	O

Part	O
H	O
is	O
additionally	O
labeled	O
"	O
7	O
-	O
left	O
common	O
iliac	O
lymph	O
nodes	O
.	O

"	O
.	O

It	O
.	O
consists	O
of	O
three	O
portions	O
of	O
red	O
-	O
yellow	O
,	O
fibrofatty	O
tissue	O
,	O
measuring	O
1	O
.	O
5	O
x	O
.	O

0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
in	O
cassette	O
H1	O
.	O

Part	O
I	O
,	O
additionally	O
labeled	O
"	O
9	O
-	O
right	O
pelvic	O
lymph	O
nodes	O
,	O
"	O
consists	O
of	O
.	O
multiple	O
fragments	O
of	O
red	O
-	O
yellow	O
,	O
fibrofatty	O
tissue	O
,	O
measuring	O
6	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
0	O
.	O
9	O
.	O

cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
in	O
cassettes	O
I1	O
-	O
I5	O
.	O

Part	O
J	O
,	O
additionally	O
labeled	O
"	O
10	O
-	O
final	O
left	O
ureteral	O
margin	O
,	O
"	O
consists	O
of	O
a	O
.	O
single	O
portion	O
of	O
red	O
-	O
yellow	O
,	O
tubular	O
tissue	O
,	O
measuring	O
4	O
.	O
0	O
x	O
0	O
.	O
8	O
cm	O
in	O
.	O
diameter	O
,	O
with	O
a	O
staple	O
.	O

The	O
staple	O
is	O
removed	O
,	O
and	O
a	O
cross	O
section	O
from	O
the	O
.	O
stapled	O
end	O
is	O
submitted	O
as	O
cassette	O
J1	O
.	O

A	O
cross	O
sections	O
from	O
the	O
unstapled	O
.	O
side	O
is	O
submitted	O
in	O
cassette	O
J2	O
.	O

Part	O
K	O
,	O
additionally	O
labeled	O
"	O
11	O
-	O
final	O
right	O
ureteral	O
margin	O
,	O
"	O
consists	O
of	O
.	O
two	O
pieces	O
of	O
red	O
-	O
yellow	O
,	O
fibrofatty	O
tissue	O
,	O
measuring	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
in	O
.	O
aggregate	O
,	O
with	O
an	O
attached	O
staple	O
.	O

The	O
staple	O
is	O
removed	O
,	O
and	O
the	O
adjacent	O
.	O
cross	O
section	O
is	O
submitted	O
in	O
cassette	O
K1	O
.	O

A	O
representative	O
cross	O
section	O
of	O
.	O
the	O
unstapled	O
portion	O
as	O
well	O
as	O
a	O
sample	O
of	O
white	O
-	O
yellow	O
soft	O
tissue	O
are	O
.	O
submitted	O
in	O
cassette	O
K2	O
.	O

COMMENTS	O
:	O
Bladder	O
Tumor	O
Synoptic	O
Comment	O
1	O
.	O

Tumor	O
type	O
:	O
Urothelial	O
carcinoma	O
,	O
papillary	O
.	O
with	O
squamoid	O
features	O
.	O

2	O
.	O

Tumor	O
grade	O
:	O
Grade	O
3	O
/	O
3	O
(	O
2003	O
WHO	O
.	O
classification	O
)	O
3	O
.	O

Tumor	O
size	O
:	O
0	B
.	I
4	I
cm	I
(	O
D8	O
)	O
.	O

4	O
.	O

Extent	O
of	O
tumor	O
in	O
.	O
bladder	O
:	O
0	B
.	I
4	I
cm	I
focus	O
of	O
invasive	O
tumor	O
in	O
outer	O
half	O
of	O
the	O
muscularis	O
.	O
propria	O
(	O
D8	O
)	O
5	O
.	O

Lymphatic	O
/	O
vascular	O
invasion	O
:	O
Not	O
present	O
.	O

6	O
.	O

Epithelial	O
.	O
abnormalities	O
in	O
bladder	O
:	O
Polypoid	O
cystitis	O
and	O
nonspecific	O
granulomatous	O
.	O
inflammation	O
(	O
post	O
transurethral	O
resection	O
of	O
bladder	O
tumor	O
)	O
see	O
note	O
below	O
.	O

7	O
.	O

Extension	O
of	O
tumor	O
into	O
organs	O
adjacent	O
to	O
bladder	O
:	O
Prostate	O
.	O

8	O
.	O

Surgical	O
margins	O
:	O
Urethral	O
margin	O
:	O
Negative	O
.	O

Right	O
ureter	O
margin	O
:	O
High	O
grade	O
.	O
urothelial	O
dysplasia	O
.	O

Left	O
ureter	O
margin	O
:	O
Negative	O
.	O

Perivesical	O
margin	O
:	O
Negative	O
.	O

9	O
.	O

Lymph	O
nodes	O
:	O
Nine	O
of	O
30	O
lymph	O
nodes	O
contain	O
metastatic	O
tumor	O
.	O

(	O
9	O
/	O
30	O
)	O
;	O
the	O
largest	O
metastatic	O
deposit	O
measures	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

(	O
C2	O
)	O
i	O
there	O
is	O
focal	O
extranodal	O
tumor	O
growth	O
(	O
C1	O
)	O
.	O

11	O
.	O

AJCC	O
/	O
UICC	O
stage	O
:	O
pT2bN2MX	O
.	O

The	O
bladder	O
mucosa	O
,	O
submucosa	O
and	O
muscularis	O
propria	O
of	O
the	O
dome	O
and	O
trigone	O
.	O
show	O
an	O
intense	O
nonspecific	O
granulomatous	O
inflammatory	O
reaction	O
with	O
foreign	O
.	O
body	O
giant	O
cells	O
and	O
focal	O
necrotizing	O
palisading	O
granulomas	O
(	O
C8	O
)	O
These	O
.	O
findings	O
are	O
consistent	O
with	O
the	O
patient	O
'	O
s	O
recent	O
history	O
of	O
transurethral	O
.	O
resection	O
of	O
his	O
bladder	O
tumor	O
,	O
at	O
these	O
sites	O
.	O

The	O
bladder	O
mucosa	O
is	O
.	O
otherwise	O
benign	O
with	O
polypoid	O
type	O
chronic	O
inflammation	O
and	O
focal	O
hyperplasia	O
,	O
.	O
with	O
no	O
residual	O
carcinoma	O
or	O
dysplasia	O
.	O

There	O
is	O
a	O
microscopic	O
focus	O
of	O
high	O
.	O
grade	O
urothelial	O
carcinoma	O
located	O
in	O
the	O
outer	O
half	O
of	O
the	O
muscularis	O
propria	O
.	O
of	O
the	O
trigone	O
.	O

A	O
0	O
.	O
3	O
cm	O
focus	O
of	O
high	O
grade	O
urothelial	O
carcinoma	O
is	O
present	O
.	O
in	O
the	O
periurethral	O
prostate	O
.	O

PATHOLOGX	O
.	O

MR	O
No	O
.	O

:	O
Hosp	O
.	O

No	O
.	O

:	O
Service	O
:	O
GYNECOLOGY	O
.	O

7	O
.	O

BLADDER	O
,	O
SITE	O
NOT	O
SPECIFIED	O
,	O
BIOPSY	O
.	O

-	O
SQUAMOUS	O
METAPLASIA	O
(	O
SEE	O
COMMENT	O
)	O
.	O

-	O
CYSTITIS	O
CYSTICA	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BIOPSY	O
.	O

-	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
the	O
.	O
above	O
diagnosis	O
is	O
based	O
upon	O
my	O
.	O
personal	O
examination	O
of	O
the	O
slides	O
.	O

(	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
.	O
the	O
diagnosis	O
)	O
,	O
and	O
that	O
I	O
have	O
.	O
revrewed	O
and	O
approved	O
this	O
report	O
.	O

M	O
.	O
D	O
.	O

M	O
.	O
D	O
.	O

SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
.	O

Part	O
1	O
:	O
BLADDER	O
.	O

Part	O
2	O
:	O
CERVIX	O
.	O

HISTORY	O
.	O

The	O
patient	O
is	O
-	O
a	O
year	O
old	O
woman	O
with	O
cervical	O
cancer	O
and	O
.	O
irregular	O
bleeding	O
.	O

Clinical	O
diagnosis	O
:	O
Cervical	O
cancer	O
.	O

Operative	O
procedure	O
:	O
EUA	O
,	O
cysto	O
.	O

GROSS	O
.	O

The	O
specimens	O
are	O
received	O
in	O
two	O
containers	O
of	O
formalin	O
,	O
each	O
.	O
labelled	O
with	O
the	O
.	O

The	O
first	O
container	O
is	O
labelled	O
.	O

"	O
bladder	O
biopsy	O
.	O

It	O
contains	O
seven	O
.	O
fragments	O
of	O
tan	O
-	O
gray	O
,	O
soft	O
,	O
.	O
mucosal	O
tissue	O
measuring	O
1	O
.	O
2	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
2	O
ca	O
.	O
in	O
aggregate	O
.	O

Inked	O
and	O
wrapped	O
.	O

The	O
second	O
container	O
is	O
labelled	O
"	O
cervical	O
biopsy	O
.	O

It	O
contains	O
.	O
two	O
fragments	O
of	O
pink	O
-	O
gray	O
,	O
soft	O
,	O
mucosal	O
tissue	O
measuring	O
1	O
.	O
5	O
x	O
.	O

0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O
in	O
aggregate	O
.	O

OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
PROCEDURE	O
:	O
A	O
.	O
year	O
-	O
old	O
male	O
presented	O
with	O
dysphagia	O
.	O

Distal	O
esophageal	O
adenocarcinoma	O
.	O

Transhiatal	O
esophagectomy	O
.	O

PROCEDURE	O
:	O
1	O
.	O

"	O
Thoracic	O
esophagus	O
A	O
5	O
.	O
0	O
cm	O
segment	O
of	O
esophagus	O
,	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

At	O
.	O
the	O
distal	O
end	O
of	O
the	O
specimen	O
,	O
there	O
is	O
a	O
3	O
.	O
0	O
cm	O
portion	O
of	O
proximal	O
stomach	O
,	O
.	O

5	O
.	O
5	O
cm	O
in	O
circumference	O
.	O

Esophagus	O
has	O
been	O
opened	O
to	O
reveal	O
a	O
3	O
.	O
4	O
x	O
3	O
.	O
2	O
cm	O
.	O
raised	O
,	O
exophytic	O
lesion	O
at	O
the	O
gastroesophageal	O
junction	O
,	O
which	O
occupies	O
3	O
.	O
2	O
.	O
of	O
a	O
total	O
5	O
.	O
4	O
cm	O
circumference	O
.	O

This	O
Lesion	O
protrudes	O
0	O
.	O
4	O
cm	O
from	O
the	O
.	O
surrounding	O
mucosa	O
.	O

There	O
are	O
two	O
tan	O
tongues	O
of	O
possible	O
Barrett	O
'	O
s	O
mucosa	O
,	O
.	O

1	O
.	O
6	O
x	O
0	O
.	O
7	O
cm	O
and	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

These	O
are	O
at	O
the	O
proximal	O
end	O
of	O
the	O
previously	O
.	O
described	O
Lesion	O
.	O

The	O
remaining	O
esophageal	O
mucosa	O
is	O
wrinkled	O
,	O
gray	O
without	O
.	O
grossly	O
visible	O
lesions	O
.	O

The	O
associated	O
gastric	O
mucosa	O
is	O
rugated	O
tan	O
,	O
without	O
.	O

Lesions	O
.	O

Radial	O
margins	O
inked	O
black	O
.	O

The	O
(	O
esion	O
is	O
3	O
.	O
0	O
cm	O
from	O
the	O
proximal	O
.	O
margin	O
of	O
the	O
specimen	O
and	O
2	O
.	O
5	O
cm	O
from	O
the	O
distal	O
margin	O
.	O

Serial	O
longitudinal	O
.	O
cuts	O
reveal	O
that	O
the	O
lesion	O
appears	O
to	O
extend	O
into	O
the	O
underlying	O
muscularis	O
.	O
propria	O
.	O

It	O
has	O
firm	O
gray	O
-	O
white	O
cut	O
surfaces	O
.	O

A	O
search	O
through	O
the	O
associated	O
.	O
fibroadipose	O
reveals	O
multiple	O
possible	O
lymph	O
nodes	O
.	O

1A	O
.	O
-	O
c	O
.	O

Full	O
longitudinal	O
sections	O
of	O
lesion	O
and	O
adjacent	O
possible	O
Barrett	O
'	O
s	O
.	O
mucosa	O
.	O

The	O
deepest	O
extension	O
is	O
inked	O
in	O
cassette	O
1A	O
.	O

1D	O
.	O
&	O
E	O
.	O

Grossly	O
uninvolved	O
esophageal	O
and	O
gastric	O
mucosa	O
,	O
respectively	O
.	O

1F	O
.	O
-	O
1	O
.	O

Possible	O
Lymph	O
nodes	O
.	O

1J	O
.	O

One	O
bisected	O
possible	O
lymph	O
node	O
.	O

2	O
.	O

Cervical	O
esophagus	O
A	O
3	O
.	O
8	O
cm	O
length	O
of	O
esophagus	O
,	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
and	O
.	O
closed	O
at	O
one	O
end	O
with	O
a	O
staple	O
line	O
.	O

The	O
associated	O
mucosa	O
has	O
no	O
grossly	O
.	O
visible	O
lesions	O
.	O

One	O
representative	O
cross	O
-	O
section	O
submitted	O
in	O
cassette	O
#	O
2	O
.	O

3	O
.	O

"	O
Mediastinal	O
Lymph	O
node	O
"	O
A	O
3	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
2	O
cm	O
fragment	O
of	O
lobular	O
,	O
yellow	O
.	O
fibroadipose	O
,	O
containing	O
multiple	O
possible	O
lymph	O
nodes	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATE	O
:	O
4	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

ADM	O
DATE	O
:	O
BIRTHDATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
3A	O
.	O
&	O
B	O
.	O

One	O
bisected	O
lymph	O
node	O
each	O
.	O

3c	O
.	O

Three	O
possible	O
lymph	O
nodes	O
.	O

4	O
.	O

"	O
Periesophageal	O
lymph	O
node	O
A	O
2	O
.	O
6	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
fragment	O
of	O
lobular	O
,	O
tan	O
.	O
fibroadipose	O
,	O
containing	O
multiple	O
possible	O
Lymph	O
nodes	O
.	O

4A	O
.	O

One	O
bisected	O
lymph	O
node	O
.	O

4B	O
.	O

Possible	O
lymph	O
nodes	O
.	O

5	O
.	O

"	O
Gastrohepatic	O
ligament	O
A	O
5	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
8	O
cm	O
fragment	O
of	O
lobular	O
,	O
yellow	O
.	O
fibroadipose	O
,	O
containing	O
two	O
possible	O
lymph	O
nodes	O
.	O

5A	O
.	O

Possible	O
lymph	O
nodes	O
.	O

58	O
.	O

Fibroadipose	O
.	O

PROCEDURE	O
:	O
ESOPHAGEAL	O
,	O
CARDIAC	O
AND	O
GASTROESOPHAGEAL	O
JUNCTION	O
CARCINOMA	O
:	O
Type	O
of	O
carcinoma	O
:	O
Adenocarcinoma	O
.	O

If	O
adenocarcinoma	O
,	O
is	O
it	O
arising	O
in	O
:	O
GE	O
junction	O
otherwise	O
not	O
specified	O
.	O

Depth	O
of	O
invasion	O
:	O
Muscularis	O
propria	O
.	O

Number	O
of	O
positive	O
Lymph	O
nodes	O
,	O
the	O
total	O
number	O
sampled	O
is	O
irrelevant	O
:	O
6	O
/	O
18	O
.	O

Extranodal	O
metastasis	O
:	O
Unknown	O
.	O

Pattern	O
of	O
invasion	O
:	O
Infiltrative	O
.	O

Esophageal	O
and	O
gastric	O
resection	O
margins	O
involved	O
:	O
No	O
.	O

Deep	O
resection	O
margin	O
involved	O
:	O
No	O
.	O

TNM	O
classification	O
:	O
T2	O
N1	O
MX	O
.	O

PROCEDURE	O
:	O
1	O
.	O
&	O
2	O
.	O

Thoracic	O
esophagus	O
,	O
resection	O
:	O
Invasive	O
adenocarcinoma	O
,	O
extending	O
into	O
.	O
muscularis	O
propria	O
.	O

Margins	O
negative	O
.	O

Three	O
of	O
ten	O
lymph	O
nodes	O
surrounding	O
.	O
gastroesophageal	O
junction	O
positive	O
for	O
metastatic	O
adenocarcinoma	O
.	O

See	O
.	O
template	O
.	O

3	O
.	O

Mediastinal	O
Lymph	O
nodes	O
,	O
biopsy	O
:	O
One	O
of	O
five	O
lymph	O
nodes	O
positive	O
for	O
.	O
metastatic	O
adenocarcinoma	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATE	O
.	O

5	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

BIRTHDATE	O
:	O
ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
4	O
.	O

Paraesophageal	O
lymph	O
nodes	O
,	O
biopsy	O
:	O
Two	O
of	O
three	O
lymph	O
nodes	O
positive	O
for	O
.	O
metastatic	O
adenocarcinoma	O
.	O

5	O
.	O

Gastrohepatic	O
Ligament	O
,	O
biopsy	O
:	O
Unremarkable	O
fibroadipose	O
tissue	O
,	O
No	O
tymph	O
.	O
nodes	O
.	O

I	O
.	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personal	O
ly	O
.	O
examined	O
and	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

Code	O
:	O

SPECIMEN	O
.	O

Bladder	O
TURT	O
.	O

CLINICAL	O
DETAILS	O
.	O

Previous	O
G3	O
pTa	O
bladder	O
tumour	O
.	O

Now	O
2	O
lesions	O
.	O

1	O
papillary	O
at	O
bladder	O
neck	O
and	O
1	O
at	O
the	O
dome	O
of	O
the	O
bladder	O
.	O

MACROSCOPY	O
.	O

Four	O
pieces	O
of	O
tissue	O
,	O
the	O
largest	O
6	O
mm	O
.	O

MICROSCOPY	O
.	O

Please	O
note	O
only	O
one	O
specimen	O
received	O
.	O

Grade	O
:	O
3	O
poorly	O
differentiated	O
.	O

Growth	O
pattern	O
:	O
Papillary	O
.	O

Type	O
:	O
Transitional	O
cell	O
carcinoma	O
.	O

Muscularis	O
propria	O
:	O
Present	O
.	O

Stromal	O
invasion	O
:	O
The	O
basal	O
part	O
of	O
the	O
tumour	O
is	O
fragmented	O
,	O
with	O
individual	O
cells	O
appearing	O
to	O
.	O
invade	O
the	O
superficial	O
part	O
of	O
the	O
lamina	O
propria	O
;	O
this	O
may	O
be	O
artefactual	O
but	O
.	O
early	O
stromal	O
invasion	O
cannot	O
be	O
excluded	O
.	O

Vascular	O
channel	O
invasion	O
:	O
Not	O
identified	O
.	O

Background	O
urothelium	O
:	O
Flat	O
urothelium	O
is	O
present	O
which	O
is	O
not	O
dysplastic	O
.	O

SUMMARY	O
.	O

Bladder	O
,	O
transitional	O
cell	O
carcinoma	O
G3	O
,	O
equivocal	O
stage	O
.	O

Pathologists	O
-	O
.	O

DR	O
.	O

Diagnosis	O
.	O

This	O
concerns	O
sections	O
of	O
a	O
moderately	O
differentiated	O
rectal	O
carcinoma	O
(	O
colic	O
.	O
adenocarcinoma	O
in	O
rectal	O
position	O
)	O
with	O
infiltration	O
of	O
the	O
muscularis	O
(	O
pT2	O
)	O
,	O
without	O
clear	O
.	O
vascular	O
infiltration	O
(	O
L0	O
V0	O
)	O
,	O
as	O
well	O
as	O
free	O
lymph	O
nodes	O
.	O

Tumor	O
classification	O
:	O
ICDO	O
-	O
DA	O
M	O
-	O
8140	O
/	O
3	O
.	O

G2	O
.	O

pT2	O
,	O
L0	O
,	O
V0	O
,	O
pNO	O
.	O

Surgery	O
Date	O
:	O
DIAGNOSIS	O
.	O

(	O
A	O
)	O
RIGHT	O
KIDNEY	O
AND	O
ADRENAL	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
90	O
%	O
CLEAR	O
CELLS	O
AND	O
10	O
%	O
EOSINOPHILIC	O
CELLS	O
)	O
,	O
.	O

FUHRMAN	O
'	O
S	O
NUCLEAR	O
GRADE	O
3	O
.	O

TUMOR	O
EXTENDS	O
INTO	O
THE	O
PERINEPHRIC	O
ADIPOSE	O
TISSUE	O
.	O

TUMOR	O
INVADES	O
THE	O
ADRENAL	O
GLAND	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

TUMOR	O
INVADES	O
THE	O
RENAL	O
VEIN	O
.	O

THE	O
TUMOR	O
MEASURES	O
13	B
.	I
5	I
CM	I
IN	O
MAXIMUM	O
DIMENSION	O
.	O

Vascular	O
,	O
ureteral	O
and	O
soft	O
tissue	O
margins	O
,	O
free	O
of	O
tumor	O
.	O

COMMENT	O
.	O

The	O
.	O
tumor	O
extends	O
into	O
the	O
perinephric	O
adipose	O
tissue	O
compressing	O
the	O
adrenal	O
gland	O
.	O

In	O
addition	O
,	O
the	O
tumor	O
focally	O
invades	O
the	O
adrenal	O
.	O
gland	O
by	O
direct	O
extension	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
.	O

RIGHT	O
.	O

KIDNEY	O
.	O

AND	O
ADRENAL	O
-	O
A	O
nephrectomy	O
specimen	O
(	O
25	O
.	O
5	O
x	O
16	O
.	O
5	O
x	O
9	O
.	O
0	O
cm	O
)	O
including	O
compressed	O
adrenal	O
gland	O
(	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
0	O
.	O
1	O
.	O
cm	O
)	O
and	O
ureter	O
(	O
8	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
)	O
.	O

A	O
13	B
.	I
5	I
x	I
9	I
.	I
0	I
x	I
0	I
.	I
5	I
cm	I
solid	O
and	O
cystic	O
,	O
yellow	O
-	O
red	O
,	O
heterogeneous	O
tumor	O
is	O
present	O
.	O

The	O
tumor	O
is	O
mainly	O
located	O
within	O
the	O
upper	O
lobe	O
,	O
.	O
extending	O
to	O
the	O
mid	O
third	O
and	O
lower	O
pole	O
of	O
the	O
kidney	O
.	O

The	O
tumor	O
has	O
myxoid	O
,	O
degenerative	O
-	O
looking	O
areas	O
,	O
as	O
well	O
as	O
hemorrhagic	O
and	O
.	O
necrotic	O
foci	O
.	O

The	O
tumor	O
involves	O
the	O
perinephric	O
fat	O
,	O
bulging	O
out	O
from	O
the	O
kidney	O
and	O
extending	O
up	O
to	O
the	O
adrenal	O
gland	O
,	O
which	O
is	O
.	O
grossly	O
compressed	O
by	O
the	O
tumor	O
.	O

The	O
tumor	O
involves	O
the	O
renal	O
sinus	O
but	O
does	O
not	O
extend	O
to	O
the	O
pelvicalyceal	O
system	O
.	O

A	O
tumoral	O
.	O
thrombus	O
.	O

is	O
.	O
present	O
intraluminally	O
within	O
the	O
renal	O
vein	O
,	O
1	O
.	O
0	O
cm	O
away	O
from	O
the	O
vein	O
margin	O
.	O

The	O
soft	O
tissue	O
margins	O
appear	O
to	O
be	O
free	O
of	O
.	O
tumor	O
.	O

Portions	O
of	O
the	O
tumor	O
are	O
submitted	O
for	O
possible	O
electron	O
microscopic	O
studies	O
and	O
for	O
tissue	O
bank	O
.	O

The	O
uninvolved	O
kidney	O
parenchyma	O
is	O
unremarkable	O
.	O

INK	O
CODE	O
:	O
Black	O
-	O
soft	O
tissue	O
margin	O
.	O

SECTION	O
CODE	O
:	O
A1	O
,	O
renal	O
vein	O
,	O
renal	O
artery	O
and	O
ureter	O
margins	O
;	O
A2	O
-	O
A7	O
,	O
tumor	O
in	O
relation	O
to	O
adrenal	O
gland	O
;	O
A8	O
-	O
A12	O
,	O
tumor	O
in	O
relation	O
.	O

to	O
.	O
perinephric	O
fat	O
(	O
A11	O
and	O
A12	O
include	O
tumor	O
within	O
the	O
perinephric	O
fat	O
)	O
;	O
A13	O
,	O
tumor	O
within	O
the	O
renal	O
sinus	O
;	O
A14	O
,	O
tumor	O
in	O
relation	O
to	O
the	O
.	O
pelvicalyceal	O
system	O
;	O
A15	O
,	O
A16	O
,	O
tumor	O
within	O
renal	O
vein	O
,	O
in	O
relation	O
to	O
pelvicalyceal	O
system	O
;	O
A17	O
,	O
tumor	O
with	O
renal	O
vein	O
;	O
A18	O
,	O
tumor	O
within	O
.	O
vein	O
with	O
adjacent	O
renal	O
parenchyma	O
;	O
A19	O
,	O
tumor	O
with	O
renal	O
parenchyma	O
;	O
A20	O
,	O
nontumoral	O
kidney	O
parenchyma	O
.	O

CLINICAL	O
HISTORY	O
.	O

Right	O
renal	O
mass	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
71000	O
,	O
T	O
-	O
B3000	O
,	O
M	O
-	O
83123	O
.	O

1	O
.	O

SPECIMEN	O
TAKEN	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

THYROID	O
(	O
TOTAL	O
THYROIDECTOMY	O
)	O
:	O
SPECIMEN	O
TYPE	O
:	O
Total	O
thyroidectomy	O
.	O

TUMOR	O
SITE	O
:	O
Left	O
lobe	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Papillary	O
carcinoma	O
.	O

TUMOR	O
SIZE	O
:	O
1	B
.	I
0	I
CM	I
greatest	O
dimension	O
.	O

FOCALITY	O
:	O
Unifocal	O
.	O

LYMPH	O
NODES	O
:	O
All	O
TWO	O
(	O
2	O
)	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
:	O
pT1	O
:	O
Tumor	O
size	O
<	O
2	O
cm	O
,	O
limited	O
to	O
thyroid	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastases	O
.	O

DISTANT	O
METASTASIS	O
:	O
pMx	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
:	O
Margins	O
are	O
uninvolved	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
nearest	O
margin	O
:	O
<	O
1	O
mm	O
(	O
anterior	O
and	O
posterior	O
)	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
None	O
identified	O
.	O

Gross	O
Description	O
.	O

Microscopic	O
Description	O
.	O

Stomach	O
and	O
lower	O
part	O
of	O
the	O
.	O

Adenocarcinoma	O
(	O
cardia	O
-	O
esophageal	O
.	O
esophagus	O
.	O
In	O
the	O
cardia	O
part	O
of	O
.	O
junction	O
)	O
;	O
G2	O
;	O
adjacent	O
fatty	O
tissue	O
.	O
the	O
stomach	O
-	O
-	O
plate	O
-	O
like	O
tumor	O
.	O
invasion	O
;	O
tumor	O
spreads	O
into	O
the	O
wall	O
.	O
of	O
8	B
X	I
6	I
cm	I
in	O
size	O
.	O

Tumor	O
.	O
adjacent	O
lymph	O
node	O
.	O

Fifteen	O
lymph	O
.	O
spreads	O
to	O
the	O
esophagus	O
,	O
.	O
nodes	O
are	O
examined	O
,	O
two	O
lymph	O
.	O
invade	O
into	O
the	O
fat	O
tissue	O
.	O

Cardia	O
-	O
nodes	O
demonstrate	O
metastases	O
.	O
esophagial	O
lymph	O
nodes	O
are	O
rosy	O
.	O

Omentum	O
and	O
surgical	O
margins	O
are	O
.	O
colored	O
,	O
dense	O
.	O

Omentum	O
is	O
.	O
tumor	O
free	O
.	O
hyperemic	O
.	O

Separately	O
taken	O
.	O
lymph	O
node	O
is	O
black	O
colored	O
,	O
.	O
soft	O
.	O

Diagnosis	O
Details	O
.	O

Comments	O
.	O

Tumor	O
Features	O
:	O
Ulcerated	O
,	O
.	O

Tumor	O
Extent	O
:	O
Perigastric	O
fat	O
,	O
.	O

Venous	O
Invasion	O
:	O
Absent	O
,	O
.	O

Margins	O
:	O
Absent	O
,	O
Treatment	O
.	O

Effect	O
:	O
Laterality	O
.	O

Procure	O
.	O
ment	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Total	O
gastrectomy	O
.	O

Tumor	O
site	O
:	O
Gastroesophageal	O
junction	O
.	O

Tumor	O
size	O
:	O
6x0x8cm	B
.	O

Tumor	O
features	O
:	O
Ulcerated	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Subserosa	O
.	O

Lymph	O
nodes	O
:	O
2	O
/	O
15	O
positive	O
for	O
metastasis	O
.	O

(	O
Greater	O
and	O
lesser	O
omentum	O
2	O
/	O
15	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
.	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

CLINICAL	O
HISTORY	O
:	O
Malignant	O
neoplasm	O
of	O
corpus	O
uteri	O
.	O

Laparoscopic	O
total	O
hysterectomy	O
,	O
BSO	O
,	O
and	O
.	O
lymph	O
node	O
sampling	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
(	O
AF1	O
-	O
3	O
)	O
"	O
received	O
is	O
a	O
280	O
.	O
gram	O
,	O
10	O
.	O
6	O
x	O
6	O
.	O
8	O
x	O
5	O
.	O
5	O
cm	O
partially	O
morcellated	O
uterus	O
.	O

The	O
specimen	O
is	O
.	O
unoriented	O
and	O
contains	O
one	O
portion	O
of	O
the	O
cervix	O
(	O
posterior	O
cervix	O
)	O
which	O
is	O
.	O
detached	O
from	O
the	O
specimen	O
.	O

The	O
endocervical	O
canal	O
(	O
2	O
.	O
5	O
x	O
1	O
cm	O
)	O
is	O
white	O
-	O
tan	O
.	O
and	O
has	O
an	O
herringbone	O
pattern	O
.	O

The	O
endometrial	O
canal	O
(	O
not	O
able	O
to	O
be	O
.	O
measured	O
)	O
has	O
a	O
friable	O
,	O
soft	O
endometrium	O
which	O
begins	O
roughly	O
2	O
.	O
5	O
cm	O
from	O
.	O
the	O
.	O

lower	O
uterine	O
segment	O
.	O

Sectioning	O
reveals	O
a	O
0	O
.	O
6	O
cm	O
endometrium	O
overlying	O
a	O
2	O
.	O

cm	O
myometrium	O
.	O

The	O
friable	O
endometrium	O
does	O
not	O
appear	O
to	O
invade	O
the	O
.	O
myometrium	O
.	O

There	O
are	O
multiple	O
(	O
greater	O
than	O
20	O
)	O
white	O
,	O
whorled	O
lesions	O
in	O
.	O
the	O
myometrium	O
,	O
the	O
largest	O
of	O
which	O
measures	O
2	O
x	O
2	O
x	O
1	O
.	O
9	O
cm	O
.	O

Sectioning	O
.	O

of	O
.	O
these	O
white	O
,	O
whorled	O
lesions	O
does	O
not	O
reveal	O
any	O
hemorrhage	O
or	O
necrosis	O
.	O

The	O
.	O
right	O
tube	O
(	O
partially	O
morcellated	O
)	O
and	O
measures	O
3	O
cm	O
in	O
length	O
x	O
0	O
.	O
6	O
cm	O
in	O
.	O
diameter	O
and	O
has	O
an	O
unattached	O
fimbriae	O
.	O

Sectioning	O
reveals	O
an	O
unremarkable	O
.	O
tube	O
.	O

The	O
right	O
ovary	O
(	O
2	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
1	O
cm	O
)	O
is	O
white	O
,	O
cerebriform	O
,	O
and	O
is	O
.	O
grossly	O
unremarkable	O
.	O

The	O
left	O
tube	O
is	O
also	O
interrupted	O
but	O
measures	O
2	O
.	O
5	O
cm	O
.	O
in	O
length	O
x	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
.	O

Sectioning	O
reveals	O
an	O
unremarkable	O
tube	O
and	O
.	O
fimbriae	O
.	O

The	O
left	O
ovary	O
(	O
2	O
.	O
6	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
cm	O
)	O
is	O
white	O
,	O
cerebriform	O
,	O
and	O
upon	O
.	O
sectioning	O
contains	O
several	O
corpora	O
albicantia	O
.	O

The	O
serosal	O
surface	O
is	O
,	O
in	O
.	O
areas	O
where	O
it	O
is	O
not	O
morcellated	O
,	O
smooth	O
,	O
tan	O
,	O
and	O
grossly	O
unremarkable	O
.	O

BLOCK	O
SUMMARY	O
:	O
A1	O
-	O
2	O
-	O
(	O
AF1	O
-	O
2	O
)	O
full	O
-	O
thickness	O
posterior	O
endomyometrium	O
.	O

A3	O
-	O
.	O
endomyometrium	O
(	O
AF3	O
)	O
.	O

A4	O
-	O
.	O
anterior	O
cervix	O
.	O

A5	O
-	O
.	O
posterior	O
cervix	O
.	O

A6	O
-	O
.	O
anterior	O
lower	O
uterine	O
segment	O
.	O

A7	O
-	O
.	O
posterior	O
lower	O
uterine	O
segment	O
.	O

A8	O
-	O
.	O
posterior	O
endomyometrium	O
.	O

A9	O
-	O
A10	O
-	O
anterior	O
endomyometrium	O
with	O
deepest	O
invasion	O
and	O
leiomyoma	O
.	O

A11	O
-	O
representative	O
section	O
of	O
endometrium	O
.	O

A12	O
-	O
right	O
tube	O
and	O
fimbriae	O
.	O

[	O
D	O
:	O
2078431C	O
-	O
7385	O
-	O
4BD3	O
-	O
B597	O
-	O
85E613D898F6	O
.	O

A13	O
-	O
right	O
ovary	O
.	O

A14	O
-	O
left	O
tube	O
and	O
fimbriae	O
.	O

A15	O
-	O
left	O
ovary	O
.	O

A16	O
-	O
A17	O
-	O
posterior	O
endomyometrium	O
bisected	O
.	O

A18	O
-	O
A19	O
-	O
anterior	O
endomyometrium	O
,	O
bisected	O
.	O

A20	O
-	O
leiomyoma	O
with	O
overlying	O
endometrium	O
.	O

B	O
.	O

"	O
Posterior	O
vaginal	O
cuff	O
"	O
,	O
received	O
is	O
a	O
3	O
.	O
5	O
x	O
2	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
.	O
fibrofatty	O
tissue	O
which	O
is	O
unoriented	O
.	O

The	O
entire	O
specimen	O
is	O
.	O

C	O
.	O

"	O
Left	O
pelvic	O
nodes	O
"	O
,	O
received	O
is	O
a	O
5	O
x	O
2	O
.	O
5	O
x	O
1	O
cm	O
aggregate	O
of	O
fibroadipose	O
.	O
tissue	O
,	O
which	O
is	O
dissected	O
for	O
lymph	O
nodes	O
and	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
C1	O
-	O
.	O
three	O
lymph	O
node	O
candidates	O
.	O

C2	O
-	O
.	O
two	O
lymph	O
node	O
candidates	O
,	O
one	O
blue	O
and	O
bisected	O
.	O

C3	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

C4	O
-	O
.	O
two	O
lymph	O
node	O
candidates	O
,	O
bisected	O
,	O
one	O
inked	O
blue	O
.	O

C5	O
-	O
6	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

C7	O
-	O
.	O
remaining	O
fibroadipose	O
tissue	O
.	O

D	O
.	O

"	O
Right	O
external	O
iliac	O
lymph	O
node	O
"	O
,	O
received	O
is	O
a	O
3	O
.	O
2	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
8	O
cm	O
.	O
aggregate	O
of	O
fibroadipose	O
tissue	O
which	O
is	O
dissected	O
for	O
lymph	O
nodes	O
and	O
.	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
D1	O
-	O
two	O
lymph	O
node	O
candidates	O
.	O

D2	O
-	O
two	O
lymph	O
node	O
candidates	O
,	O
one	O
bisected	O
,	O
inked	O
blue	O
.	O

D3	O
-	O
remaining	O
fibroadipose	O
tissue	O
.	O

E	O
.	O

"	O
Right	O
obturator	O
nodes	O
"	O
,	O
received	O
is	O
a	O
5	O
.	O
8	O
x	O
4	O
.	O
2	O
x	O
1	O
.	O
4	O
cm	O
aggregate	O
of	O
.	O
fibroadipose	O
tissue	O
which	O
is	O
dissected	O
for	O
lymph	O
nodes	O
and	O
submitted	O
as	O
.	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
E1	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

E2	O
-	O
.	O
two	O
lymph	O
node	O
candidates	O
.	O

E3	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

E4	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

E5	O
-	O
6	O
-	O
remaining	O
fibroadipose	O
tissue	O
.	O

F	O
.	O

"	O
Right	O
aortic	O
lymph	O
node	O
(	O
low	O
)	O
"	O
,	O
received	O
is	O
a	O
3	O
.	O
8	O
x	O
2	O
x	O
0	O
.	O
6	O
cm	O
aggregate	O
.	O
of	O
fibroadipose	O
tissue	O
which	O
is	O
dissected	O
for	O
lymph	O
nodes	O
and	O
submitted	O
as	O
.	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
F1	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

F2	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

F3	O
-	O
remaining	O
fibroadipose	O
tissue	O
.	O

G	O
.	O

"	O
Right	O
aortic	O
lymph	O
node	O
(	O
high	O
)	O
"	O
.	O
received	O
is	O
a	O
1	O
.	O
5	O
x	O
1	O
x	O
0	O
.	O
5	O
cm	O
aggregate	O
.	O
of	O
fibroadipose	O
tissue	O
which	O
is	O
submitted	O
in	O
its	O
entirety	O
in	O
block	O
G1	O
.	O

H	O
.	O

"	O
Left	O
aortic	O
lymph	O
node	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

at	O
.	O

3	O
:	O
00	O
pm	O
is	O
a	O
3	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
fibrofatty	O
tissue	O
which	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
and	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
H1	O
-	O
three	O
lymph	O
node	O
candidates	O
.	O

H2	O
-	O
remaining	O
fibroadipose	O
tissue	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O
-	O
"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
"	O
:	O
AF1	O
-	O
2	O
-	O
(	O
full	O
-	O
thickness	O
.	O
posterior	O
endomyometrium	O
)	O
-	O
.	O
polyp	O
with	O
atypical	O
.	O
hyperplasia	O
,	O
no	O
invasive	O
.	O
carcinoma	O
is	O
seen	O
on	O
two	O
.	O
sections	O
(	O
Dr	O
.	O
AF3	O
-	O
endometrioid	O
.	O
adenocarcinoma	O
FIGO	O
2	O
of	O
3	O
,	O
.	O

no	O
invasion	O
seen	O
(	O
Dr	O
.	O
MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

IMMUNOHISTOCHEMICAL	O
FINDINGS	O
:	O
The	O
immunoperoxidase	O
tests	O
reported	O
herein	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
.	O

Some	O
of	O
them	O
may	O
not	O
be	O
cleared	O
or	O
approved	O
by	O
.	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
.	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
.	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvements	O
Amendments	O
.	O
of	O
1988	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
testing	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
HYSTERO	O
-	O
SALPINGO	O
-	O
OOPHORECTOMY	O
DISSECTION	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT1b	O
pNO	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
TUBES	O
AND	O
OVARIES	O
(	O
AF1	O
-	O
AF3	O
)	O
"	O
:	O
UTERUS	O
:	O
280	O
GRAMS	O
.	O

ENDOMETRIUM	O
:	O
TUMOR	O
SITE	O
:	O
DIFFUSE	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
ENDOMETRIOID	O
ADENOCARCINOMA	O
,	O
WITH	O
FOCAL	O
PAPILLARY	O
.	O

SEROUS	O
DIFTERENTIATION	O
,	O
SEE	O
COMMENT	O
.	O

FIGO	O
GRADE	O
:	O
3	O
.	O

TUMOR	O
SIZE	O
:	O
2	B
.	I
1	I
CM	I
(	O
SINGLE	O
SLIDE	O
MAXIMUM	O
MEASUREMENT	O
)	O
.	O

MAXIMUM	O
DEPTH	O
OF	O
MYOMETRIAL	O
INVASION	O
:	O
0	O
.	O
2	O
CM	O
,	O
IN	O
A	O
2	O
.	O
0	O
CM	O
THICK	O
WALL	O
.	O

LYMPHATIC	O
/	O
VASCULAR	O
INVASION	O
:	O
POSSIBLY	O
PRESENT	O
,	O
SEE	O
COMMENT	O
.	O

ADJACENT	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIUM	O
:	O
ENDOMETRIAL	O
POLYP	O
WITH	O
GENERALLY	O
.	O

INACTIVE	O
ENDOMETRIUM	O
.	O

REMAINING	O
MYOMETRIUM	O
:	O
LEIOMYOMATA	O
.	O

CERVIX	O
:	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SEROSA	O
:	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SPECIMEN	O
MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

RIGHT	O
AND	O
LEFT	O
FALLOPIAN	O
TUBES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

RIGHT	O
OVARY	O
:	O
BENIGN	O
BRENNER	O
TUMOR	O
(	O
1	B
CM	I
)	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

LEFT	O
OVARY	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

B	O
.	O

"	O
POSTERIOR	O
VAGINAL	O
CUFF	O
"	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

C	O
.	O

"	O
LEFT	O
PELVIC	O
NODES	O
"	O
(	O
DISSECTION	O
)	O
:	O
ELEVEN	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
11	O
)	O
.	O

D	O
.	O

"	O
RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODES	O
"	O
(	O
DISSECTION	O
)	O
:	O
SIX	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
6	O
)	O
.	O

E	O
.	O

"	O
RIGHT	O
OBTURATOR	O
NODES	O
"	O
(	O
DISSECTION	O
)	O
:	O
TEN	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
10	O
)	O
.	O

F	O
.	O

"	O
RIGHT	O
AORTIC	O
LYMPH	O
NODE	O
(	O
LOW	O
)	O
(	O
DISSECTION	O
)	O
:	O
SEVEN	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
7	O
)	O
.	O

G	O
.	O

"	O
RIGHT	O
AORTIC	O
NODE	O
(	O
HIGH	O
)	O
"	O
:	O
BENIGN	O
NERVE	O
AND	O
GANGLION	O
.	O

NEGATIVE	O
FOR	O
CARCINOMA	O
OR	O
LYMPH	O
NODES	O
.	O

H	O
.	O

"	O
LEFT	O
AORTIC	O
LYMPH	O
NODE	O
"	O
(	O
DISSECTION	O
)	O
:	O
FOUR	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
4	O
)	O
,	O
SEE	O
COMMENT	O
.	O

COMMENT	O
:	O
The	O
adenocarcinoma	O
in	O
part	O
A	O
has	O
areas	O
of	O
definitive	O
endometrioid	O
.	O
differentiation	O
,	O
but	O
in	O
many	O
areas	O
is	O
very	O
poorly	O
differentiated	O
,	O
not	O
.	O
exhibiting	O
a	O
definite	O
endometrioid	O
pattern	O
.	O

Some	O
areas	O
are	O
consistent	O
with	O
.	O
papillary	O
serous	O
carcinoma	O
.	O

Immunoperoxidase	O
stain	O
for	O
p53	O
on	O
block	O
All	O
'	O
is	O
.	O
diffusely	O
and	O
strongly	O
positive	O
,	O
consistent	O
with	O
serous	O
tumor	O
.	O

Only	O
.	O
superficial	O
myometrial	O
invasion	O
.	O

is	O
seen	O
.	O

The	O
tumor	O
does	O
involve	O
the	O
lower	O
.	O
uterine	O
segment	O
,	O
but	O
not	O
the	O
cervix	O
.	O

All	O
of	O
the	O
grossly	O
visible	O
tumor	O
has	O
been	O
.	O
submitted	O
(	O
tumor	O
size	O
was	O
grossly	O
difficult	O
to	O
determine	O
)	O
There	O
are	O
foci	O
.	O

of	O
.	O
tumor	O
cells	O
within	O
vascular	O
lumens	O
,	O
but	O
not	O
directly	O
attached	O
to	O
the	O
vessel	O
.	O
wall	O
,	O
which	O
is	O
suggestive	O
of	O
,	O
but	O
not	O
definite	O
for	O
,	O
vascular	O
invasion	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Specimen	O
.	O

)	O
Status	O
:	O
Sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

M	O
.	O
D	O
.	O

PREOPERATIVE	O
DIAGNOSIS	O
.	O

BREAST	O
CANCER	O
,	O
BENIGN	O
MAMMARY	O
DYSPLASIA	O
.	O

OPERATION	O
PERFORMED	O
.	O

DOCTOR	O
(	O
S	O
)	O
:	O
PROCEDURE	O
:	O
MASTECTOMY	O
MODIFIED	O
RADICAL	O
/	O
TOTAL	O
MASTECTOMY	O
.	O

TISSUE	O
REMOVED	O
.	O

A	O
.	O

RIGHT	O
AXILLARY	O
LYMPH	O
NODE	O
LEVEL	O
2	O
.	O

B	O
.	O

RIGHT	O
AXILLARY	O
LYMPH	O
NODE	O
LEVEL	O
3	O
.	O

C	O
.	O

LEFT	O
MASTECTOMY	O
STITCH	O
AT	O
.	O

D	O
.	O

RIGHT	O
MODIFIED	O
RADICAL	O
MASTECTOMY	O
STITCH	O
AT	O
.	O

GROSS	O
DESCRIPTION	O
.	O

RECEIVED	O
IN	O
4	O
PARTS	O
.	O

PART	O
A	O
RECEIVED	O
LABELED	O
.	O

RIGHT	O
AXILLARY	O
LEVEL	O
2	O
LYMPH	O
.	O

NODES	O
IS	O
A	O
NODULAR	O
PORTION	O
OF	O
YELLOW	O
FATTY	O
TISSUE	O
MEASURING	O
3	O
.	O
7	O
X	O
2	O
.	O
2	O
X	O
.	O

0	O
.	O
7	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
.	O

FOUR	O
FIRM	O
OVOID	O
STRUCTURES	O
ARE	O
IDENTIFIED	O
.	O

MEASURING	O
FROM	O
0	O
.	O
4	O
TO	O
1	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
.	O

THE	O
LARGER	O
NODES	O
ARE	O
.	O

EACH	O
SECTIONED	O
AND	O
GROSSLY	O
POSITIVE	O
.	O

ONE	O
-	O
HALF	O
OF	O
EACH	O
OF	O
THESE	O
IS	O
.	O

SUBMITTED	O
ALONG	O
WITH	O
THE	O
UNSECTIONED	O
SMALLER	O
NODE	O
LABELED	O
A	O
.	O

THE	O
.	O

REMAINING	O
NODAL	O
TISSUE	O
IS	O
SUBMITTED	O
PER	O
CLINICAL	O
BREAST	O
CARE	O
PROJECT	O
.	O

RESEARCH	O
PROTOCOL	O
LABELED	O
P1	O
-	O
P3	O
.	O

PART	O
B	O
RECEIVED	O
LABELED	O
.	O

RIGHT	O
AXILLARY	O
LEVEL	O
3	O
LYMPH	O
.	O

NODE	O
IS	O
A	O
FIRM	O
0	O
.	O
8	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
NODULE	O
AND	O
AN	O
IRREGULAR	O
.	O

PORTION	O
OF	O
NODULAR	O
YELLOW	O
FATTY	O
TISSUE	O
MEASURING	O
6	O
X	O
1	O
.	O
5	O
X	O
0	O
.	O
7	O
CM	O
.	O

FIVE	O
.	O

FIRM	O
OVOID	O
STRUCTURES	O
ARE	O
IDENTIFIED	O
IN	O
THIS	O
PORTION	O
OF	O
FATTY	O
TISSUE	O
.	O

THREE	O
OF	O
THE	O
NODULES	O
ARE	O
SUBMITTED	O
UNSECTIONED	O
LABELED	O
B1	O
.	O

ONE	O
-	O
HALF	O
.	O

FROM	O
2	O
SEPARATE	O
GROSSLY	O
POSITIVE	O
NODES	O
ARE	O
SUBMITTED	O
IN	O
B2	O
WITH	O
THE	O
.	O

REMAINING	O
TISSUE	O
FROM	O
THESE	O
2	O
NODES	O
SUBMITTED	O
AS	O
P4	O
.	O

THE	O
LARGEST	O
NODE	O
.	O

MEASURING	O
1	O
.	O
4	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
IS	O
GROSSLY	O
FOCALLY	O
POSITIVE	O
.	O

THIS	O
.	O

IS	O
SUBMITTED	O
BISECTED	O
AS	O
B3	O
.	O

PART	O
C	O
RECEIVED	O
LABELED	O
.	O

LEFT	O
MASTECTOMY	O
STITCH	O
AT	O
12	O
.	O

O	O
'	O
CLOCK	O
IS	O
A	O
1310	O
GRAM	O
SIMPLE	O
MASTECTOMY	O
MEASURING	O
23	O
CM	O
FROM	O
MEDIAL	O
TO	O
.	O

LATERAL	O
,	O
23	O
.	O
5	O
CM	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
,	O
AND	O
UP	O
TO	O
5	O
.	O
5	O
CM	O
FROM	O
.	O

Specimen	O
.	O

Sp	O
type	O
:	O
GICAL	O
P	O
.	O

M	O
.	O
D	O
.	O

GROSS	O
DESCRIPTION	O
.	O

ANTERIOR	O
TO	O
DEEP	O
.	O

THE	O
NIPPLE	O
IS	O
UNREMARKABLE	O
WITHIN	O
A	O
14	O
x	O
5	O
CM	O
SKIN	O
.	O

ELLIPSE	O
.	O

A	O
SUTURE	O
DENOTES	O
12	O
O	O
'	O
CLOCK	O
.	O

THE	O
ANTERIOR	O
ASPECT	O
IS	O
MARKED	O
.	O

WITH	O
BLUE	O
INK	O
,	O
THE	O
DEEP	O
MARGIN	O
WITH	O
BLACK	O
.	O

SECTIONING	O
REVEALS	O
THE	O
.	O

CENTRAL	O
50	O
%	O
OF	O
THE	O
SPECIMEN	O
TO	O
CONSIST	O
OF	O
DENSE	O
TAN	O
FIBROUS	O
TISSUE	O
.	O

THIS	O
.	O

IS	O
SURROUNDED	O
BY	O
A	O
PERIMETER	O
OF	O
YELLOW	O
FATTY	O
TISSUE	O
.	O

NO	O
MASSES	O
ARE	O
.	O

IDENTIFIED	O
.	O

REPRESENTATIVE	O
SECTIONS	O
ARE	O
SUBMITTED	O
AS	O
.	O

FOLLOWS	O
:	O
C1	O
-	O
-	O
NIPPLE	O
,	O
C2	O
-	O
-	O
CENTRAL	O
DEEP	O
MARGIN	O
,	O
C3	O
AND	O
4	O
-	O
-	O
UPPER	O
OUTER	O
QUADRANT	O
,	O
C5	O
.	O

AND	O
6	O
-	O
-	O
UPPER	O
INNER	O
QUADRANT	O
,	O
C7	O
AND	O
8	O
-	O
-	O
LOWER	O
INNER	O
QUADRANT	O
,	O
C9	O
AND	O
.	O

10	O
-	O
-	O
LOWER	O
OUTER	O
QUADRANT	O
.	O

ADDITIONALLY	O
WITHIN	O
THE	O
CONTAINER	O
AND	O
.	O

INCLUDED	O
THE	O
WEIGHT	O
ARE	O
ADDITIONAL	O
MULTIPLE	O
IRREGULAR	O
FRAGMENTS	O
OF	O
.	O

YELLOW	O
-	O
RED	O
FATTY	O
TISSUE	O
IN	O
AGGREGATE	O
MEASURING	O
10	O
X	O
10	O
x	O
2	O
.	O
3	O
CM	O
.	O

SECTIONING	O
REVEALS	O
BLAND	O
YELLOW	O
FATTY	O
TISSUE	O
AND	O
REPRESENTATIVE	O
SECTIONS	O
.	O

ARE	O
SUBMITTED	O
LABELED	O
C11	O
THROUGH	O
13	O
.	O

NOTE	O
:	O
MIRROR	O
IMAGE	O
SECTIONS	O
OF	O
THE	O
NIPPLE	O
ARE	O
SUBMITTED	O
AS	O
P15	O
AND	O
.	O

MIRROR	O
IMAGE	O
SECTIONS	O
TO	O
C3	O
,	O
C5	O
,	O
C7	O
,	O
AND	O
C9	O
ARE	O
SUBMITTED	O
FROZEN	O
IN	O
OCT	O
.	O

PER	O
CLINICAL	O
BREAST	O
CARE	O
PROJECT	O
RESEARCH	O
PROTOCOL	O
.	O

PART	O
D	O
RECEIVED	O
LABELED	O
.	O

RIGHT	O
MODIFIED	O
RADICAL	O
.	O

MASTECTOMY	O
STITCH	O
AT	O
12	O
O	O
'	O
CLOCK	O
IS	O
A	O
1460	O
GRAM	O
RIGHT	O
MODIFIED	O
RADICAL	O
.	O

MASTECTOMY	O
.	O

THE	O
MASTECTOMY	O
PORTION	O
MEASURES	O
24	O
.	O
5	O
CM	O
FROM	O
MEDIAL	O
TO	O
.	O

LATERAL	O
,	O
26	O
CM	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
,	O
AND	O
UP	O
TO	O
6	O
.	O
5	O
CM	O
FROM	O
ANTERIOR	O
.	O

TO	O
POSTERIOR	O
.	O

THE	O
AXILLARY	O
PORTION	O
MEASURES	O
10	O
x	O
9	O
x	O
2	O
.	O
5	O
CM	O
.	O

THE	O
.	O

ANTERIOR	O
MARGIN	O
IS	O
MARKED	O
BLUE	O
.	O

THE	O
DEEP	O
IS	O
MARKED	O
BLACK	O
.	O

THE	O
NIPPLE	O
.	O

IS	O
UNREMARKABLE	O
AND	O
SITS	O
IN	O
THE	O
MORE	O
SUPERIOR	O
PORTION	O
OF	O
THE	O
SKIN	O
.	O

ELLIPSE	O
.	O

THE	O
SKIN	O
ELLIPSE	O
MEASURES	O
14	O
x	O
5	O
.	O
5	O
CM	O
.	O

THE	O
12	O
O	O
'	O
CLOCK	O
SUTURE	O
.	O

IS	O
JUST	O
TO	O
THE	O
MEDIAL	O
SIDE	O
OF	O
THE	O
AREOLA	O
.	O

THE	O
AXILLARY	O
TAIL	O
IS	O
REMOVED	O
.	O

AND	O
RED	O
INK	O
IS	O
PLACED	O
IN	O
THIS	O
AREA	O
TO	O
INDICATE	O
THAT	O
IT	O
IS	O
NOT	O
TRUE	O
.	O

MARGIN	O
.	O

UPON	O
A	O
QUICK	O
PALPATION	O
OF	O
THE	O
AXILLARY	O
TAIL	O
THREE	O
ARE	O
3	O
.	O

PROMINENT	O
STRUCTURES	O
.	O

THE	O
1ST	O
IS	O
A	O
0	O
.	O
8	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
LYMPH	O
.	O

NODE	O
WHICH	O
IS	O
GROSSLY	O
NEGATIVE	O
AND	O
IS	O
SUBMITTED	O
BISECTED	O
AS	O
D1	O
.	O

THE	O
2ND	O
.	O

IS	O
A	O
2	O
.	O
5	O
CM	O
GROSSLY	O
NEGATIVE	O
NODAL	O
STRUCTURE	O
SUBMITTED	O
BISECTED	O
AS	O
D2	O
.	O

THE	O
3RD	O
STRUCTURE	O
IS	O
A	O
3	O
.	O
8	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
GROSSLY	O
POSITIVE	O
.	O

LYMPH	O
NODE	O
OF	O
WHICH	O
ONE	O
FULL	O
CROSS	O
SECTION	O
IS	O
SUBMITTED	O
IN	O
D3	O
AND	O
4	O
.	O

A	O
.	O

COIL	O
CLIP	O
IS	O
IDENTIFIED	O
AND	O
THE	O
AREA	O
OF	O
THE	O
CLIP	O
IS	O
SUBMITTED	O
IN	O
D5	O
.	O

THIS	O
IS	O
THE	O
SAME	O
NODE	O
AS	O
D3	O
AND	O
4	O
.	O

PORTIONS	O
OF	O
THIS	O
LARGEST	O
NODE	O
ARE	O
.	O

ALSO	O
SUBMITTED	O
IN	O
P5	O
AND	O
6	O
.	O

SECTIONING	O
REVEALS	O
THE	O
CENTRAL	O
PORTION	O
OF	O
.	O

THE	O
BREAST	O
TO	O
CONSIST	O
OF	O
DENSE	O
TAN	O
FIBROUS	O
TISSUE	O
AND	O
THIS	O
EXTENDS	O
TO	O
AN	O
.	O

ILL	O
-	O
DEFINED	O
GRAY	O
-	O
TAN	O
MASS	O
AT	O
9	O
O	O
'	O
CLOCK	O
WHICH	O
MEASURES	O
5	O
.	O
5	O
CM	O
FROM	O
MEDIAL	O
.	O

TO	O
LATERAL	O
,	O
8	O
CM	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
BY	O
PALPATION	O
,	O
AND	O
4	O
.	O
5	O
CM	O
FROM	O
.	O

ANTERIOR	O
TO	O
POSTERIOR	O
.	O

GROSSLY	O
IT	O
IS	O
1	O
CM	O
FROM	O
BOTH	O
THE	O
ANTERIOR	O
AND	O
.	O

DEEP	O
MARGIN	O
.	O

SECTIONS	O
ARE	O
SUBMITTED	O
AS	O
FOLLOWS	O
:	O
D6	O
-	O
-	O
NIPPLE	O
,	O
D7	O
THROUGH	O
.	O

D9	O
-	O
-	O
SECTIONS	O
OF	O
DEEP	O
MARGIN	O
BENEATH	O
LESION	O
,	O
D10	O
THROUGH	O
D14	O
-	O
-	O
A	O
CONTINUOUS	O
.	O

SECTION	O
OF	O
THE	O
LESION	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
WHERE	O
THE	O
RED	O
ENDS	O
ARE	O
.	O

Specimen	O
.	O

eq	O
#	O
:	O
SP	O
type	O
:	O
SURGICAL	O
P	O
.	O

.	O
D	O
.	O

GROSS	O
DESCRIPTION	O
.	O

THE	O
AREA	O
WHERE	O
THE	O
ONE	O
STRIP	O
WAS	O
SEPARATED	O
FROM	O
THE	O
ADJACENT	O
SECTION	O
,	O
.	O

015	O
-	O
-	O
SECTION	O
OF	O
THE	O
FAR	O
LATERAL	O
PORTION	O
OF	O
THE	O
GROSS	O
LESION	O
,	O
D16	O
-	O
-	O
SECTION	O
.	O

FROM	O
THE	O
FAR	O
MEDIAL	O
PORTION	O
OF	O
THE	O
GROSS	O
LESION	O
,	O
D17	O
-	O
-	O
TISSUE	O
DEEP	O
TO	O
THE	O
.	O

5	O
CROSS	O
SECTIONS	O
,	O
018	O
-	O
-	O
TISSUE	O
ANTERIOR	O
TO	O
TE	O
5	O
CROSS	O
SECTIONS	O
,	O
.	O

D19	O
-	O
-	O
RANDOM	O
SECTION	O
OF	O
LESION	O
FROM	O
THE	O
MIDPORTION	O
,	O
D20	O
-	O
-	O
RANDOM	O
TUMOR	O
.	O

INFERIOR	O
-	O
EDG	O
D21	O
-	O
-	O
UPPER	O
INNER	O
QUADRANT	O
2	O
.	O

CM	O
.	O
EROM	O
GROSS	O
TUMOR	O
,	O
.	O

D22	O
-	O
-	O
UPPER	O
OUTER	O
QUADRANT	O
3	O
CM	O
FROM	O
GROSS	O
TUMOR	O
,	O
D23	O
-	O
-	O
LOWER	O
OUTER	O
.	O

QUADRANT	O
3	O
CM	O
FROM	O
GROSS	O
TUMOR	O
,	O
D24	O
-	O
-	O
LOWER	O
INNER	O
QUADRANT	O
5	O
CM	O
FROM	O
GROSS	O
.	O

TUMOR	O
.	O

FURTHER	O
EXAMINATION	O
OF	O
THE	O
AXILLARY	O
TAIL	O
:	O
EIGHTEEN	O
(	O
18	O
)	O
ADDITIONAL	O
.	O

NODAL	O
STRUCTURES	O
ARE	O
IDENTIFIED	O
.	O

THESE	O
ARE	O
SUBMITTED	O
AS	O
FOLLOWS	O
:	O
D25	O
-	O
6	O
.	O

NODES	O
NOT	O
SECTIONED	O
,	O
D26	O
-	O
-	O
ONE	O
-	O
HALF	O
OF	O
2	O
GROSSLY	O
POSITIVE	O
LYMPH	O
NODES	O
.	O

PLUS	O
1	O
GROSSLY	O
FAT	O
REPLACED	O
LYMPH	O
NODE	O
,	O
BISECTED	O
,	O
D27	O
-	O
-	O
4	O
NODES	O
,	O
EACH	O
.	O

BISECTED	O
,	O
D28	O
-	O
-	O
2	O
NODES	O
,	O
EACH	O
BISECTED	O
,	O
D29	O
-	O
-	O
3	O
NODES	O
,	O
EACH	O
BISECTED	O
.	O

SECTIONS	O
PER	O
CLINICAL	O
BREAST	O
CARE	O
RESEARCH	O
PROTOCOL	O
ARE	O
SUBMITTED	O
FROM	O
.	O

THE	O
LYMPH	O
NODE	O
WITH	O
THE	O
CLIP	O
LABELED	O
P5	O
AND	O
P6	O
;	O
TWO	O
OF	O
THE	O
GROSSLY	O
.	O

POSITIVE	O
LYMPH	O
NODES	O
IN	O
CASSETTE	O
D26	O
AS	O
P16	O
;	O
AND	O
SECTIONS	O
OF	O
THE	O
TUMOR	O
.	O

AS	O
P7	O
THROUGH	O
P14	O
WITH	O
MIRROR	O
IMAGE	O
SECTIONS	O
FROZEN	O
IN	O
OCT	O
OF	O
P7	O
,	O
P8	O
,	O
.	O

p9	O
,	O
AND	O
013	O
AS	O
WELL	O
AS	O
TISSUE	O
FROZEN	O
IN	O
OCT	O
AS	O
MIRROR	O
IMAGE	O
TO	O
THE	O
.	O

NIPPLE	O
(	O
D6	O
)	O
AND	O
OF	O
THE	O
RANDOM	O
QUADRANT	O
SECTIONS	O
(	O
D21	O
THROUGH	O
D24	O
)	O
.	O

COMMENT	O
:	O
THIS	O
SPECIMEN	O
EXCEEDS	O
THE	O
MAXIMUM	O
CAP	O
/	O
ASCO	O
.	O

GUIDELINE	O
OF	O
48	O
HOURS	O
FORMALIN	O
FIXATION	O
.	O

PATH	O
PROCEDURES	O
.	O

PROCEDURES	O
:	O
88305	O
/	O
2	O
,	O
88307	O
,	O
88309	O
,	O
A	O
BLK	O
,	O
B	O
BLK	O
/	O
3	O
,	O
C	O
BLK	O
/	O
13	O
,	O
D	O
BLK	O
/	O
29	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

PART	O
A	O
RIGHT	O
AXILLARY	O
LEVEL	O
2	O
LYMPH	O
NODE	O
SAMPLING	O
:	O
METASTATIC	O
.	O

CARCINOMA	O
CONSISTENT	O
WITH	O
LOBULAR	O
CARCINOMA	O
OF	O
PRIMARY	O
BREAST	O
ORIGIN	O
.	O

INVOLVING	O
4	O
OF	O
4	O
LYMPH	O
NODES	O
WITH	O
THE	O
TUMOR	O
REPLACING	O
80	O
-	O
90	O
%	O
OF	O
THE	O
.	O

CELLS	O
IN	O
EACH	O
NODE	O
AND	O
THE	O
LARGEST	O
FOCUS	O
OF	O
TUMOR	O
SPANNING	O
A	O
DISTANCE	O
OF	O
.	O

APPROXIMATELY	O
9	O
MM	O
.	O

PART	O
B	O
RIGHT	O
AXILLARY	O
LEVEL	O
3	O
LYMPH	O
NODE	O
SAMPLING	O
:	O
METASTATIC	O
6	O
/	O
16	O
LN	O
(	O
level	O
3	O
)	O
.	O

Specimen	O
:	O
eceived	O
:	O
)	O
Status	O
:	O
aq	O
#	O
.	O

Sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

M	O
.	O
D	O
.	O

FINAL	O
D1AGNOSIS	O
.	O

CARCINOMA	O
IDENTIFIED	O
IN	O
6	O
OF	O
6	O
LYMPH	O
NODES	O
.	O

PART	O
C	O
LEFT	O
MASTECTOMY	O
:	O
SKIN	O
AND	O
FATTY	O
BREAST	O
TISSUE	O
WITH	O
FOCAL	O
.	O

FIBROCYSTIC	O
CHANGES	O
PRESENT	O
.	O

NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
OR	O
ATYPIA	O
.	O

PART	O
-	O
D	O
RIGHT	O
MODIFIED	O
RADICAL	O
MASTECTOMY	O
:	O
MULTICENTRIC	O
IN	O
SITU	O
AND	O
.	O

INFILTRATING	O
LOBULAR	O
CARCINOMA	O
OF	O
THE	O
PLEOMORPHIC	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
.	O

2	O
-	O
3	O
OF	O
3	O
WITH	O
A	O
LOW	O
MITOTIC	O
INDEX	O
WITH	O
DOCUMENTED	O
MICROSCOPIC	O
EVIDENCE	O
.	O

OF	O
TUMOR	O
SPANNING	O
A	O
DISTANCE	O
OF	O
AT	O
LEAST	O
78	B
MM	I
IN	O
A	O
SUPERIOR	O
TO	O
INFERIOR	O
.	O

DIRECTION	O
.	O

THE	O
TUMOR	O
WAS	O
8	O
MM	O
FROM	O
THE	O
CLOSEST	O
DEEP	O
MARGIN	O
.	O

METASTATIC	O
.	O

CARCINOMA	O
IDENTIFIED	O
IN	O
8	O
OF	O
20	O
AXILLARY	O
LYMPH	O
NODES	O
WITH	O
THE	O
LARGEST	O
.	O

FOCUS	O
OF	O
TUMOR	O
SPANNING	O
A	O
DISTANCE	O
OF	O
20	O
MM	O
AND	O
FOCAL	O
MICROSCOPIC	O
.	O

PERINODAL	O
SOFT	O
TISSUE	O
INVASION	O
PRESENT	O
.	O

M	O
.	O
D	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
,	O
LEFT	O
AXILLA	O
,	O
DISSECTION	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
2	O
:	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
3	O
:	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
4	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
4	O
:	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
5	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
5	O
:	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
3	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
(	O
SEE	O
COMMENT	O
)	O
.	O

PART	O
6	O
:	O
PALPABLE	O
LYMPH	O
NODE	O
#	O
1	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
7	O
:	O
NON	O
-	O
SENTINEL	O
LYMPH	O
NODE	O
,	O
LEFT	O
AXILLA	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
8	O
:	O
PALPABLE	O
LYMPH	O
NODE	O
#	O
2	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
9	O
:	O
BREAST	O
.	O

LEFT	O
,	O
SEGMENTAL	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
2	B
.	I
0	I
CM	I
(	O
GROSS	O
)	O
,	O
NOTTINGHAM	O
GRADE	O
3	O
(	O
COMBINED	O
NOTTINGHAM	O
.	O
SCORE	O
:	O
9	O
/	O
9	O
;	O
TUBULE	O
FORMATION	O
3	O
/	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
3	O
/	O
3	O
,	O
NUCLEAR	O
PLEOMORPHISM	O
3	O
/	O
3	O
)	O
.	O

B	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
NUCLEAR	O
GRADE	O
3	O
,	O
SOLID	O
WITH	O
COMEDO	O
NECROSIS	O
AND	O
ASSOCIATED	O
.	O

MICROCALCIFICATIONS	O
,	O
ADMIXED	O
WITH	O
INVASIVE	O
TUMOR	O
AND	O
COMPRISES	O
10	O
%	O
OF	O
TUMOR	O
MASS	O
.	O

C	O
.	O

LYMPHOVASCULAR	O
INVASION	O
IS	O
NOT	O
IDENTIFIED	O
.	O

D	O
.	O

MARGINS	O
FREE	O
.	O

E	O
.	O

ATYPICAL	O
DUCTAL	O
EPITHELIAL	O
HYPERPLASIA	O
.	O

F	O
.	O

FIBROADENOMATOID	O
NODULE	O
.	O

G	O
.	O

DUCTAL	O
EPITHELIAL	O
HYPERPLASIA	O
.	O

H	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
see	O
comment	O
)	O
.	O

CASE	O
JINUPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERALITY	O
:	O
Left	O
.	O

PROCEDURE	O
:	O
Segmental	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Not	O
specified	O
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
2	B
.	I
0	I
cm	I
.	O

TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
NOTTINGHAM	O
SCORE	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitotic	O
activity	O
score	O
:	O
3	O
.	O

Total	O
Nottingham	O
score	O
:	O
9	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
3	O
.	O

DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
CALCIFICATION	O
:	O
Not	O
applicable	O
.	O

TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Yes	O
,	O
malignant	O
zones	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Solid	O
,	O
DCIS	O
admixed	O
with	O
invasive	O
carcinoma	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
LYMPH	O
NODES	O
POSITIVE	O
:	O
0	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
8	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
,	O
Keratin	O
stain	O
.	O

NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
ADH	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
PROGESTERONE	O
RECEPTORS	O
:	O
previously	O
performed	O
.	O

HER2	O
/	O
NEU	O
:	O
previously	O
performed	O
.	O
zero	O
or	O
1	O
+	O
.	O

printed	O
:	O
Clinical	O
Consultant	O
&	O
Location	O
.	O

Unit	O
No	O
.	O

SPECIMEN	O
.	O

Right	O
eye	O
(	O
enucleation	O
)	O
.	O

CLINICAL	O
DETAILS	O
.	O

Right	O
choroidal	O
melanoma	O
.	O

See	O
diagram	O
.	O

MACROSCOPIC	O
DESCRIPTION	O
.	O

An	O
intact	O
right	O
eye	O
.	O

Dimensions	O
:	O
Axial	O
24mm	O
,	O
Horizontal	O
24mm	O
,	O
Vertical	O
23mm	O
.	O

Cornea	O
:	O
Horizontal	O
12mm	O
,	O
Vertical	O
12mm	O
.	O

Optic	O
nerve	O
.	O

Length	O
9mm	O
,	O
Diameter	O
4mm	O
.	O

Pupil	O
:	O
normal	O
,	O
regular	O
.	O

On	O
description	O
,	O
on	O
infero	O
postero	O
is	O
a	O
dark	O
pigmented	O
nodule	O
.	O
?	O
?	O
?	O

6mm	O
x	O
4mm	O
height	O
(	O
3mm	O
from	O
optic	O
nerve	O
)	O
.	O

On	O
trans	O
-	O
illumination	O
,	O
-	O
there	O
is	O
a	O
dark	O
shadow	O
in	O
?	O

side	O
of	O
.	O
the	O
globe	O
-	O
22	O
x	O
21mm	O
and	O
developed	O
in	O
the	O
optic	O
nerve	O
.	O
insertion	O
.	O

Plane	O
of	O
section	O
:	O
vertial	O
.	O

Intraocular	O
description	O
:	O
On	O
sectioning	O
a	O
dome	O
shaped	O
pigmented	O
choroidal	O
mass	O
.	O
measuring	O
LBD	O
15mm	B
,	O
height	O
12mm	B
.	O

Tumour	O
size	O
.	O

LBD	O
15mm	B
,	O
Height	O
12mm	B
.	O

MICROSCOPY	O
.	O

Histologically	O
,	O
the	O
enucleated	O
eye	O
demonstrates	O
a	O
normal	O
.	O
anterior	O
segment	O
with	O
an	O
unremarkable	O
cornea	O
,	O
a	O
deep	O
.	O
anterior	O
chamber	O
and	O
open	O
angles	O
.	O

The	O
iris	O
leaves	O
are	O
.	O
unremarkable	O
.	O

The	O
ciliary	O
muscles	O
are	O
moderately	O
atrophic	O
.	O
orinted	O
:	O
HISTOPATHOLOGY	O
REPORT	O
.	O

Lab	O
No	O
.	O

Clinical	O
Consultant	O
&	O
Location	O
.	O

Unit	O
No	O
.	O

There	O
is	O
mild	O
hyalinisation	O
of	O
the	O
ciliary	O
processes	O
.	O

The	O
.	O
lens	O
shows	O
moderately	O
advanced	O
cataractous	O
changes	O
.	O

In	O
the	O
posterior	O
segment	O
,	O
at	O
the	O
level	O
of	O
the	O
equator	O
,	O
a	O
.	O
choroidal	O
melanoma	O
can	O
be	O
seen	O
.	O

This	O
is	O
dome	O
-	O
shaped	O
with	O
a	O
.	O
large	O
accompanying	O
exudative	O
retinal	O
detachment	O
.	O

The	O
retina	O
.	O
overlying	O
the	O
tumour	O
is	O
atrophic	O
with	O
degenerative	O
changes	O
,	O
.	O
and	O
focally	O
there	O
is	O
retinal	O
invasion	O
.	O

The	O
tumour	O
is	O
partially	O
pigmented	O
and	O
consists	O
of	O
a	O
mixture	O
.	O
of	O
cells	O
,	O
both	O
epithelioid	O
and	O
spindle	O
cells	O
,	O
with	O
a	O
slight	O
.	O
dominance	O
of	O
the	O
latter	O
.	O

The	O
epithelioid	O
cell	O
component	O
is	O
.	O
approx	O
.	O
40	O
%	O
.	O

The	O
melanoma	O
cells	O
are	O
immunoreactive	O
for	O
.	O

MelanA	O
,	O
SOX	O
-	O
10	O
and	O
HSP	O
-	O
27	O
(	O
score	O
2	O
)	O
.	O

The	O
number	O
of	O
mitoses	O
is	O
approx	O
.	O
5	O
/	O
40	O
high	O
power	O
fields	O
.	O

The	O
.	O
microvasculature	O
of	O
the	O
melanoma	O
is	O
prominent	O
,	O
but	O
closed	O
.	O
loops	O
are	O
not	O
present	O
in	O
the	O
tissue	O
planes	O
evaluated	O
.	O

Occasional	O
"	O
vascular	O
lakes	O
"	O
can	O
be	O
observed	O
;	O
in	O
these	O
tumour	O
.	O
cells	O
can	O
be	O
see	O
located	O
within	O
the	O
lumen	O
.	O

The	O
lymphocytic	O
.	O
infiltrate	O
within	O
tumour	O
is	O
minimal	O
.	O

Macrophages	O
are	O
.	O
scattered	O
throughout	O
the	O
tumour	O
in	O
moderate	O
density	O
.	O

There	O
is	O
a	O
large	O
extraocular	O
growth	O
,	O
which	O
has	O
arisen	O
at	O
two	O
.	O
sites	O
,	O
transclerally	O
.	O

These	O
are	O
3mm	O
and	O
1mm	O
in	O
diameter	O
,	O
.	O
respectively	O
.	O

The	O
larger	O
is	O
encapsulated	O
only	O
by	O
a	O
very	O
thin	O
.	O
layer	O
of	O
connective	O
tissue	O
.	O

The	O
optic	O
nerve	O
is	O
tumour	O
free	O
,	O
and	O
demonstrates	O
mild	O
.	O
atrophic	O
changes	O
.	O

The	O
examined	O
vortex	O
veins	O
are	O
free	O
of	O
.	O
tumour	O
.	O

DIAGNOSIS	O
.	O

Choroidal	O
melanoma	O
of	O
mixed	O
cell	O
type	O
with	O
extraocular	O
.	O
melanoma	O
growth	O
.	O

COMMENT	O
.	O

Molecular	O
genetic	O
examination	O
of	O
DNA	O
extracted	O
from	O
the	O
.	O
tumour	O
cells	O
will	O
be	O
performed	O
using	O
multiplex	O
-	O
ligation	O
.	O
dependent	O
probe	O
amplification	O
(	O
MLPA	O
)	O
,	O
looking	O
at	O
chromosomes	O
.	O

Provider	O
Group	O
:	O
Date	O
of	O
Service	O
:	O
Date	O
Received	O
:	O
A	O
copy	O
of	O
this	O
renant	O
will	O
be	O
faxed	O
to	O
:	O
FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Diagnosis	O
:	O
A	O
.	O

-	O
C	O
.	O
)	O
LEFT	O
BREAST	O
,	O
ADDITIONAL	O
ANTERIOR	O
MARGIN	O
,	O
AND	O
LEFT	O
AXILLARY	O
SENTINEL	O
.	O

LYMPH	O
NODE	O
.	O

SIMPLE	O
MASTECTOMY	O
(	O
INCLUDING	O
RE	O
-	O
EXCISION	O
OF	O
.	O
ANTERIOR	O
MARGIN	O
)	O
AND	O
SENTINEL	O
NODE	O
BIOPSY	O
:	O
-	O
Invasive	O
ductal	O
carcinoma	O
,	O
Nottingham	O
grade	O
3	O
.	O

[	O
D	O
:	O
302E69E0	O
-	O
39F0	O
-	O
4CDB	O
-	O
97F9	O
-	O
A6CDDB307233	O
.	O

-	O
Size	O
:	O
2	B
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

-	O
Location	O
:	O
11	O
:	O
00	O
.	O

-	O
No	O
in	O
situ	O
component	O
identified	O
.	O

-	O
Margins	O
:	O
-	O
Invasive	O
carcinoma	O
is	O
widely	O
free	O
of	O
all	O
margins	O
(	O
at	O
least	O
1	O
cm	O
away	O
)	O
.	O

-	O
Additional	O
anterior	O
margin	O
consists	O
of	O
benign	O
skin	O
and	O
subcutaneous	O
tissue	O
.	O

-	O
No	O
lymphovascular	O
invasion	O
identified	O
.	O

-	O
Two	O
sentinel	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
2	O
)	O
.	O

-	O
Uninvolved	O
breast	O
parenchyma	O
with	O
focal	O
fibroadenomatoid	O
changes	O
.	O

-	O
Benign	O
skin	O
and	O
nipple	O
with	O
small	O
intraductal	O
papilloma	O
.	O

COMMENT	O
:	O
Breast	O
carcinoma	O
biomarker	O
studies	O
will	O
be	O
repeated	O
on	O
a	O
representative	O
.	O
section	O
of	O
tumor	O
(	O
block	O
A7	O
)	O
due	O
to	O
the	O
focal	O
weak	O
to	O
strong	O
reactivity	O
for	O
ER	O
and	O
PR	O
in	O
.	O

<	O
1	O
%	O
tumor	O
cells	O
seen	O
previously	O
on	O
core	O
biopsy	O
.	O

The	O
results	O
will	O
follow	O
in	O
an	O
.	O
addendum	O
.	O

PATHOLOGIC	O
TUMOR	O
STAGING	O
SYNOPSIS	O
:	O
Type	O
and	O
grade	O
(	O
invasive	O
)	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
Nottingham	O
grade	O
3	O
.	O

Type	O
and	O
grade	O
(	O
in	O
situ	O
)	O
:	O
N	O
/	O
A	O
.	O

Primary	O
tumor	O
:	O
pT2	O
.	O

Regional	O
lymph	O
nodes	O
:	O
pNo	O
(	O
i	O
-	O
)	O
(	O
sn	O
)	O
.	O

Distant	O
metastasis	O
:	O
N	O
/	O
A	O
.	O

Stage	O
:	O
IIA	O
.	O

Lymphovascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Margin	O
status	O
:	O
R0	O
,	O
negative	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
.	O

Page	O
1	O
/	O
6	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Invasive	O
Breast	O
Cancer	O
Tumor	O
Staging	O
Information	O
.	O

AJCC	O
Cancer	O
Staging	O
Handbook	O
,	O
7th	O
Ed	O
.	O
,	O
and	O
CAP	O
Protocol	O
(	O
revised	O
June	O
2012	O
)	O
.	O

Previous	O
pathology	O
specimens	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
.	O

Page	O
2	O
/	O
6	O
.	O

SPECIMEN	O
IDENTIFICATION	O
.	O

Simple	O
mastectomy	O
with	O
re	O
-	O
excision	O
of	O
anterior	O
.	O

Procedure	O
/	O
specimen	O
type	O
:	O
margin	O
.	O

Left	O
breast	O
.	O

Laterality	O
:	O
Sentinel	O
lymph	O
node	O
biopsy	O
.	O

Lymph	O
node	O
sampling	O
:	O
INVASIVE	O
CARCINOMA	O
TUMOR	O
CHARACTERISTICS	O
.	O

Invasive	O
ductal	O
carcinoma	O
.	O

Histologic	O
type	O
:	O
11	O
:	O
00	O
.	O

Tumor	O
site	O
:	O
2	B
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

Tumor	O
size	O
:	O
Unifocal	O
.	O

Tumor	O
focality	O
:	O
3	O
of	O
3	O
(	O
Nottingham	O
score	O
9	O
of	O
9	O
)	O
.	O

Histologic	O
grade	O
(	O
Nottingham	O
Score	O
)	O
:	O
3	O
of	O
3	O
.	O

Tubule	O
formation	O
:	O
3	O
of	O
3	O
.	O

Nuclear	O
pleomorphism	O
:	O
3	O
of	O
3	O
.	O

Mitotic	O
rate	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
invasion	O
:	O
Benign	O
skin	O
and	O
nipple	O
.	O

Macroscopic	O
and	O
microscopic	O
extent	O
of	O
tumor	O
:	O
Not	O
identified	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
:	O
MARGINS	O
.	O

Widely	O
free	O
of	O
all	O
margins	O
(	O
at	O
least	O
1	O
cm	O
away	O
)	O
.	O

Invasive	O
carcinoma	O
:	O
LYMPH	O
NODES	O
.	O

2	O
(	O
sentinel	O
nodes	O
)	O
.	O

Total	O
lymph	O
nodes	O
examined	O
.	O

0	O
.	O

Number	O
of	O
lymph	O
nodes	O
involved	O
.	O

N	O
/	O
A	O
.	O

Size	O
of	O
largest	O
metastatic	O
deposit	O
:	O
N	O
/	O
A	O
.	O

Extranodal	O
extension	O
:	O
PATHOLOGIC	O
STAGING	O
:	O
pT2	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
pNo	O
(	O
i	O
-	O
)	O
(	O
sn	O
)	O
.	O

N	O
/	O
A	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
IIA	O
.	O

AJCC	O
Stage	O
:	O
ANCILLARY	O
STUDIES	O
:	O
Negative	O
(	O
less	O
than	O
1	O
%	O
positive	O
cells	O
,	O
weak	O
.	O
Estrogen	O
receptor	O
:	O
intensity	O
)	O
.	O

Negative	O
(	O
less	O
than	O
1	O
%	O
positive	O
cells	O
,	O
strong	O
.	O
Progesterone	O
receptor	O
:	O
intensity	O
)	O
.	O

Negative	O
(	O
score	O
0	O
)	O
.	O

HER2	O
:	O
High	O
(	O
70	O
%	O
positive	O
cells	O
)	O
.	O

Ki	O
-	O
67	O
:	O
This	O
report	O
continues	O
.	O

Printed	O
:	O
-	O
Page	O
3	O
.	O

Page	O
3	O
/	O
6	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Source	O
of	O
Specimen	O
:	O
A	O
.	O

Breast	O
;	O
left	O
.	O

B	O
.	O

Sentinel	O
lymph	O
node	O
;	O
left	O
axillary	O
.	O

C	O
.	O

Breast	O
;	O
left	O
additional	O
anterior	O
margin	O
.	O

Clinical	O
History	O
/	O
Operative	O
Dx	O
:	O
Malignant	O
neoplasm	O
of	O
breast	O
(	O
female	O
,	O
left	O
)	O
.	O

Intraoperative	O
Diagnosis	O
:	O
B	O
.	O

Left	O
axillary	O
sentinel	O
lymph	O
node	O
.	O

:	O
No	O
tumor	O
cells	O
identifier	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Part	O
A	O
is	O
designated	O
as	O
left	O
breast	O
-	O
stitch	O
=	O
lateral	O
.	O

Initially	O
received	O
in	O
the	O
fresh	O
state	O
for	O
possible	O
.	O

is	O
an	O
862	O
gram	O
left	O
simple	O
mastectomy	O
,	O
26	O
.	O
8	O
cm	O
medial	O
-	O
lateral	O
,	O
20	O
.	O
8	O
cm	O
.	O
inferior	O
-	O
superior	O
,	O
and	O
4	O
.	O
0	O
cm	O
posterior	O
-	O
anterior	O
.	O

The	O
overlying	O
ellipse	O
of	O
wrinkled	O
,	O
tan	O
-	O
brown	O
skin	O
is	O
26	O
.	O
3	O
x	O
.	O

13	O
.	O
0	O
cm	O
with	O
a	O
medial	O
-	O
inferior	O
orientated	O
,	O
darkened	O
brown	O
,	O
wrinkled	O
areola	O
,	O
4	O
.	O
8	O
cm	O
in	O
diameter	O
with	O
a	O
.	O
prominent	O
1	O
.	O
3	O
cm	O
nipple	O
.	O

A	O
double	O
suture	O
marks	O
the	O
lateral	O
apex	O
of	O
the	O
skin	O
.	O

A	O
palpable	O
mass	O
is	O
.	O
appreciated	O
in	O
the	O
upper	O
inner	O
quadrant	O
(	O
approximating	O
11	O
:	O
00	O
)	O
.	O

The	O
surgical	O
margins	O
are	O
now	O
.	O
differentially	O
inked	O
as	O
follows	O
:	O
Superior	O
superficial	O
:	O
Blue	O
,	O
.	O

Inferior	O
superficial	O
:	O
Orange	O
,	O
.	O

Posterior	O
:	O
Black	O
.	O

Included	O
within	O
the	O
container	O
are	O
two	O
unoriented	O
strips	O
of	O
wrinkled	O
,	O
tan	O
-	O
brown	O
skin	O
measuring	O
11	O
.	O
7	O
X	O
2	O
.	O
7	O
x	O
.	O

0	O
.	O
7	O
cm	O
and	O
10	O
.	O
3	O
X	O
2	O
.	O
4	O
X	O
1	O
.	O
3	O
cm	O
each	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
.	O

Page	O
4	O
/	O
6	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

The	O
breast	O
is	O
serially	O
sectioned	O
perpendicularly	O
through	O
the	O
medial	O
-	O
lateral	O
long	O
axis	O
to	O
reveal	O
a	O
.	O
well	O
-	O
demarcated	O
,	O
soft	O
to	O
rubbery	O
,	O
light	O
gray	O
,	O
lobulated	O
tumor	O
mass	O
measuring	O
upwards	O
of	O
2	B
.	I
6	I
x	I
2	I
.	I
5	I
x	I
2	I
.	I
3	I
.	I

cm	B
(	O
slabs	O
6	O
-	O
7	O
,	O
from	O
medial	O
)	O
.	O

This	O
tumor	O
is	O
placed	O
grossly	O
1	O
.	O
0	O
cm	O
from	O
the	O
superior	O
superficial	O
,	O
2	O
.	O
4	O
cm	O
from	O
.	O
the	O
deep	O
and	O
greater	O
than	O
5	O
.	O
0	O
cm	O
from	O
the	O
inferior	O
superficial	O
,	O
most	O
medial	O
and	O
most	O
lateral	O
surgical	O
.	O
margins	O
.	O

Along	O
the	O
medial	O
periphery	O
of	O
the	O
lesion	O
is	O
an	O
embedded	O
twisted	O
radiologic	O
marker	O
.	O

The	O
remaining	O
cut	O
sections	O
of	O
the	O
breast	O
demonstrates	O
admixed	O
yellow	O
-	O
tan	O
fibrofatty	O
tissue	O
without	O
.	O
additional	O
discrete	O
nodularity	O
.	O

No	O
lymph	O
node	O
tissue	O
is	O
appreciated	O
along	O
the	O
lateral	O
periphery	O
.	O

Sectioning	O
.	O
through	O
the	O
remaining	O
two	O
strips	O
of	O
skin	O
demonstrate	O
unremarkable	O
fibrofatty	O
cut	O
surfaces	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Cassette	O
summary	O
:	O
A1	O
)	O
nipple	O
,	O
.	O

A2	O
)	O
medial	O
and	O
lateral	O
extension	O
of	O
skin	O
,	O
.	O

A3	O
)	O
upper	O
inner	O
quadrant	O
,	O
slab	O
3	O
,	O
.	O

A4	O
)	O
upper	O
inner	O
quadrant	O
,	O
slab	O
5	O
,	O
adjacent	O
to	O
tumor	O
,	O
.	O

A5	O
)	O
upper	O
inner	O
quadrant	O
,	O
tumor	O
and	O
superior	O
superficial	O
surgical	O
margin	O
,	O
slab	O
6	O
,	O
.	O

A6	O
-	O
A7	O
)	O
upper	O
inner	O
quadrant	O
,	O
tumor	O
and	O
superior	O
superficial	O
surgical	O
margin	O
,	O
contiguous	O
sections	O
,	O
slab	O
6	O
,	O
.	O

A8	O
)	O
upper	O
inner	O
quadrant	O
,	O
deep	O
margin	O
adjacent	O
to	O
tumor	O
,	O
slabs	O
6	O
-	O
7	O
,	O
.	O

A9	O
)	O
upper	O
inner	O
quadrant	O
-	O
central	O
superior	O
,	O
adjacent	O
to	O
tumor	O
,	O
slab	O
8	O
,	O
.	O

A10	O
-	O
A11	O
)	O
lower	O
inner	O
quadrant	O
,	O
slabs	O
4	O
and	O
6	O
,	O
respectively	O
,	O
.	O

A12	O
-	O
A13	O
)	O
lower	O
outer	O
quadrant	O
,	O
slabs	O
9	O
and	O
11	O
,	O
respectively	O
,	O
.	O

A14	O
-	O
A15	O
)	O
upper	O
outer	O
quadrant	O
,	O
slabs	O
9	O
and	O
11	O
,	O
respectively	O
,	O
.	O

A16	O
-	O
A17	O
)	O
representation	O
of	O
separate	O
strips	O
of	O
skin	O
and	O
subcutaneous	O
fat	O
,	O
two	O
pieces	O
each	O
.	O

B	O
.	O

Part	O
B	O
is	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
.	O

(	O
frozen	O
section	O
)	O
.	O

Initially	O
received	O
in	O
the	O
fresh	O
state	O
for	O
.	O
frozen	O
section	O
/	O
touch	O
prep	O
analysis	O
is	O
a	O
6	O
.	O
0	O
X	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
pad	O
of	O
yellow	O
-	O
tan	O
fatty	O
soft	O
tissue	O
.	O

Initial	O
.	O
sectioning	O
reveals	O
a	O
single	O
fatty	O
pink	O
and	O
tan	O
lymph	O
node	O
candidate	O
,	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

Two	O
.	O
touch	O
preparation	O
slides	O
are	O
forwarded	O
for	O
microscopic	O
evaluation	O
.	O

Further	O
examination	O
of	O
the	O
fat	O
reveais	O
.	O
possible	O
additional	O
lymph	O
node	O
tissue	O
up	O
to	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
.	O
entirely	O
submitted	O
for	O
routine	O
histology	O
with	O
a	O
sentinel	O
node	O
protocol	O
performed	O
in	O
B1	O
and	O
B2	O
,	O
and	O
the	O
.	O

additional	O
/	O
residual	O
lymph	O
node	O
tissue	O
candidacy	O
is	O
submitted	O
in	O
B3	O
and	O
B4	O
for	O
routine	O
histology	O
.	O

C	O
.	O

Part	O
C	O
is	O
additional	O
anterior	O
margin	O
-	O
left	O
.	O

Initially	O
received	O
in	O
the	O
fresh	O
state	O
is	O
a	O
15	O
gram	O
elliptical	O
.	O
excision	O
of	O
wrinkled	O
tan	O
-	O
brown	O
skin	O
and	O
subcutaneous	O
fat	O
,	O
11	O
.	O
1	O
x	O
2	O
.	O
6	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
margins	O
are	O
submitted	O
.	O
unoriented	O
;	O
the	O
possible	O
outer	O
margin	O
is	O
now	O
marked	O
blue	O
and	O
the	O
remaining	O
surgical	O
margins	O
are	O
marked	O
.	O
black	O
.	O

Sectioning	O
demonstrates	O
glistening	O
,	O
admixed	O
yellow	O
-	O
tan	O
fibrofatty	O
tissue	O
without	O
discrete	O
nodularity	O
.	O
or	O
grossly	O
unusual	O
areas	O
of	O
change	O
suggestive	O
of	O
residual	O
or	O
invasive	O
tumor	O
component	O
.	O

Representative	O
.	O
section	O
are	O
submitted	O
for	O
microscopic	O
evaluation	O
in	O
C1	O
-	O
C5	O
(	O
six	O
pieces	O
.	O
Microscopic	O
Description	O
:	O
A	O
.	O
-	O
C	O
.	O
)	O
Microscopic	O
sections	O
have	O
been	O
examined	O
.	O

The	O
microscopic	O
findings	O
are	O
reflected	O
in	O
the	O
diagnosis	O
.	O
rendered	O
.	O

The	O
sentinel	O
nodes	O
(	O
part	O
B	O
)	O
were	O
evaluated	O
by	O
H	O
&	O
E	O
levels	O
and	O
.	O
cytokeratin	O
immunostain	O
.	O

Controls	O
are	O
appropriate	O
.	O

Printed	O
:	O
This	O
report	O
continues	O
.	O

Page	O
5	O
/	O
6	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Printed	O
:	O
END	O
OF	O
REPORT	O
(	O
FINAL	O
)	O
.	O

Page	O
6	O
/	O
6	O
.	O

FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Brain	O
,	O
left	O
occipital	O
,	O
biopsy	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

B	O
.	O

Brain	O
,	O
left	O
occipital	O
,	O
biopsy	O
:	O
Glioblastoma	O
multiforme	O
,	O
WHO	O
grade	O
IV	O
.	O

Intraoperative	O
Diagnosis	O
.	O

FS1	O
.	O

(	O
A	O
)	O
Brain	O
,	O
left	O
occipital	O
tumor	O
,	O
biopsy	O
:	O
WHO	O
glioblastoma	O
multiforme	O
,	O
grade	O
IV	O
.	O

Tissue	O
section	O
and	O
.	O
cytologic	O
preparation	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
in	O
two	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
.	O
number	O
.	O

Part	O
A	O
is	O
additionally	O
labeled	O
"	O
left	O
occipital	O
tumor	O
.	O
"	O
It	O
consists	O
of	O
a	O
single	O
irregular	O
,	O
unoriented	O
fragment	O
of	O
.	O
tan	O
-	O
red	O
,	O
gelatinous	O
,	O
soft	O
tissue	O
,	O
measuring	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

A	O
small	O
portion	O
of	O
the	O
specimen	O
is	O
used	O
for	O
.	O
cytological	O
preparation	O
as	O
TP1	O
.	O

One	O
-	O
half	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS1	O
,	O
.	O
with	O
the	O
frozen	O
section	O
remnant	O
submitted	O
in	O
cassette	O
A1	O
.	O

The	O
remaining	O
half	O
of	O
the	O
specimen	O
is	O
submitted	O
.	O
in	O
cassette	O
A2	O
.	O

Part	O
B	O
is	O
additionally	O
labeled	O
"	O
tumor	O
.	O
"	O
It	O
consists	O
of	O
a	O
portion	O
of	O
brain	O
tissue	O
and	O
tumor	O
,	O
measuring	O
8	B
.	I
5	I
x	I
.	I

7	B
.	I
0	I
x	I
3	I
.	I
2	I
cm	I
.	O

Extensive	O
areas	O
of	O
necrosis	O
are	O
identified	O
.	O

Representative	O
sections	O
of	O
the	O
tumor	O
and	O
the	O
.	O
brain	O
-	O
tumor	O
interface	O
are	O
submitted	O
in	O
cassettes	O
B1	O
through	O
B9	O
,	O
with	O
cassette	O
B10	O
containing	O
uninvolved	O
.	O
brain	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
woman	O
with	O
a	O
left	O
occipital	O
tumor	O
,	O
suspicious	O
for	O
glioblastoma	O
multiforme	O
.	O

Diagnosis	O
based	O
on	O
gross	O
and	O
microscopic	O
examinations	O
.	O

Final	O
diagnosis	O
made	O
by	O
attending	O
pathologist	O
.	O
following	O
review	O
of	O
all	O
pathology	O
slides	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
.	O

LEFT	O
PYRIFORM	O
SINUS	O
:	O
INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
.	O

PHARYNGEAL	O
PLEXUS	O
OF	O
VAGUS	O
NERVE	O
:	O
Segment	O
.	O
of	O
-	O
nerve	O
,	O
-	O
-	O
no	O
tumor	O
present	O
.	O

(	O
C	O
)	O
.	O

TOTAL	O
LARYNGOPHARYNGECTOMY	O
,	O
BILATERAL	O
NECK	O
DISSECTIONS	O
,	O
EXCISION	O
OF	O
LEFT	O
.	O

NECK	O
SKIN	O
,	O
LEFT	O
THYROIDECTOMY	O
:	O
INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
OF	O
THE	O
.	O

LEFT	O
PYRIFORM	O
SINUS	O
EXTENDING	O
INTO	O
THE	O
LEFT	O
ARYEPIGLOTTIC	O
FOLD	O
,	O
.	O

ESOPHAGUS	O
,	O
LEFT	O
PARAGLOTTIC	O
SPACE	O
,	O
LEFT	O
PARATRACHEAL	O
/	O
PARA	O
-	O
.	O

ESOPHAGEAL	O
SOFT	O
TISSUE	O
AND	O
LEFT	O
THYROID	O
.	O

VASCULAR	O
/	O
LYMPHATIC	O
INVASION	O
PRESENT	O
.	O

Surgical	O
margins	O
,	O
free	O
of	O
tumor	O
.	O

METASTATIC	O
SQUAMOUS	O
CARCINOMA	O
IN	O
11	O
OF	O
53	O
LEFT	O
CERVICAL	O
LYMPH	O
.	O

NODES	O
(	O
11	O
/	O
53	O
)	O
,	O
1	O
/	O
2	O
SUBMANDIBULAR	O
/	O
SUBMAXILLARY	O
,	O
LEVEL	O
2	O
;	O
.	O

5	O
/	O
7	O
SUBDIGASTRIC	O
,	O
LEVEL	O
3	O
;	O
3	O
/	O
8	O
MIDJUGULAR	O
,	O
LEVEL	O
4	O
;	O
1	O
/	O
7	O
.	O

LOWER	O
JUGULAR	O
,	O
LEVEL	O
5	O
;	O
0	O
/	O
8	O
UPPER	O
POSTERIOR	O
CERVICAL	O
,	O
LEVEL	O
.	O

6	O
;	O
.	O

0	O
/	O
7	O
MID	O
POSTERIOR	O
CERVICAL	O
,	O
LEVEL	O
7	O
;	O
0	O
/	O
5	O
LOWER	O
POSTERIOR	O
.	O

CERVICAL	O
,	O
LEVEL	O
8	O
;	O
1	O
/	O
9	O
SUPRACLAVICULAR	O
/	O
SCALENE	O
,	O
LEVEL	O
9	O
.	O

LYMPH	O
NODES	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

METASTATIC	O
SQUAMOUS	O
CARCINOMA	O
IN	O
5	O
OF	O
29	O
RIGHT	O
CERVICAL	O
LYMPH	O
.	O

NODES	O
(	O
5	O
/	O
29	O
)	O
(	O
0	O
/	O
5	O
SUBMANDIBULAR	O
/	O
SUBMAXILLARY	O
,	O
LEVEL	O
2	O
;	O
2	O
/	O
4	O
.	O

SUBDIGASTRIC	O
,	O
LEVEL	O
3	O
;	O
1	O
/	O
1	O
MIDJUGULAR	O
,	O
LEVEL	O
4	O
;	O
0	O
/	O
4	O
LOWER	O
.	O

JUGULAR	O
,	O
LEVEL	O
5	O
;	O
1	O
/	O
2	O
UPPER	O
POSTERIOR	O
CERVICAL	O
,	O
LEVEL	O
6	O
;	O
1	O
/	O
5	O
.	O

MID	O
POSTERIOR	O
CERVICAL	O
,	O
LEVEL	O
7	O
;	O
0	O
/	O
8	O
LOWER	O
POSTERIOR	O
CERVICAL	O
,	O
.	O

LEVEL	O
8	O
LYMPH	O
NODES	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

METASTATIC	O
SQUAMOUS	O
CARCINOMA	O
IN	O
1	O
OF	O
2	O
PERITHYROIDAL	O
LYMPH	O
.	O

NODES	O
,	O
LEVEL	O
10	O
(	O
1	O
/	O
2	O
)	O
.	O

Right	O
and	O
left	O
submandibular	O
glands	O
,	O
no	O
tumor	O
present	O
.	O

Segment	O
of	O
left	O
jugular	O
vein	O
,	O
no	O
tumor	O
present	O
.	O

Segment	O
of	O
left	O
vagus	O
,	O
no	O
tumor	O
present	O
.	O

One	O
parathyroid	O
gland	O
,	O
no	O
tumor	O
present	O
.	O
skin	O
with	O
marked	O
solar	O
elastosis	O
and	O
subcutaneous	O
tissue	O
of	O
.	O
the	O
anterior	O
neck	O
with	O
marked	O
acute	O
inflammation	O
.	O

(	O
D	O
)	O
NEW	O
ESOPHAGEAL	O
MARGIN	O
:	O
Portion	O
of	O
esophagus	O
,	O
no	O
tumor	O
present	O
.	O

COMMENT	O
.	O

The	O
tumor	O
in	O
the	O
left	O
pyriform	O
sinus	O
is	O
9	B
.	I
5	I
cm	I
in	O
greatest	O
.	O
dimension	O
.	O

The	O
largest	O
lymph	O
node	O
involved	O
by	O
metastatic	O
tumor	O
is	O
2	O
.	O
5	O
cm	O
in	O
.	O
largest	O
dimension	O
and	O
located	O
in	O
the	O
left	O
subdigastric	O
area	O
.	O

Approximately	O
.	O

50	O
%	O
of	O
it	O
is	O
replaced	O
by	O
metastatic	O
tumor	O
.	O

However	O
,	O
many	O
of	O
the	O
other	O
lymph	O
.	O
nodes	O
involved	O
by	O
metastatic	O
tumor	O
are	O
almost	O
completely	O
replaced	O
by	O
the	O
.	O
metastasis	O
.	O

there	O
is	O
extranodal	O
extension	O
measuring	O
at	O
Teast	O
3	O
.	O
0	O
mm	O
.	O

SPECIMEN	O
.	O

(	O
A	O
)	O
LEFT	O
PYRIFORM	O
SINUS	O
:	O
PHARYNGEAL	O
PLEXUS	O
OF	O
VAGUS	O
NERVE	O
:	O
TOTAL	O
LARYNGOPHARYNGECTOMY	O
,	O
BILATERAL	O
NECK	O
DISSECTIONS	O
,	O
EXCISION	O
OF	O
LEFT	O
.	O

NEW	O
ESOPHAGEAL	O
MARGIN	O
:	O
SNOMED	O
CODES	O
.	O

T	O
-	O
55300	O
,	O
M	O
-	O
80703	O
,	O
T	O
-	O
C4200	O
,	O
M	O
-	O
80703	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Malignant	O
lesion	O
.	O

Right	O
lower	O
gingiva	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Anterior	O
lip	O
mucosa	O
margin	O
;	O
excision	O
(	O
fs	O
)	O
.	O

2	O
:	O
Right	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
(	O
fs	O
)	O
.	O

3	O
:	O
Left	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
(	O
fs	O
)	O
.	O

4	O
:	O
Posterior	O
margin	O
floor	O
of	O
mouth	O
;	O
excision	O
(	O
fs	O
)	O
.	O

5	O
:	O
Right	O
genial	O
glossus	O
margin	O
;	O
excision	O
(	O
fs	O
)	O
.	O

6	O
:	O
Right	O
neck	O
,	O
level	O
2B	O
;	O
excision	O
.	O

7	O
:	O
Right	O
neck	O
,	O
level	O
1A	O
;	O
excision	O
.	O

8	O
:	O
Right	O
neck	O
,	O
level	O
1B	O
;	O
excision	O
.	O

9	O
:	O
Right	O
neck	O
,	O
level	O
2A	O
;	O
excision	O
.	O

10	O
:	O
Right	O
neck	O
,	O
level	O
3	O
;	O
excision	O
.	O

11	O
:	O
Left	O
lateral	O
margin	O
,	O
buccal	O
mucosa	O
#	O
2	O
;	O
excision	O
.	O

12	O
:	O
Left	O
neck	O
level	O
1B	O
;	O
excision	O
.	O

13	O
:	O
Right	O
anterior	O
mandible	O
;	O
composite	O
resection	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Anterior	O
lip	O
mucosa	O
margin	O
;	O
excision	O
(	O
fs	O
)	O
:	O
Benign	O
squamous	O
mucosa	O
,	O
with	O
ulceration	O
and	O
reactive	O
atypia	O
.	O

2	O
.	O

Right	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
(	O
fs	O
)	O
:	O
-	O
Squamous	O
mucosa	O
with	O
focal	O
mild	O
dysplasia	O
.	O

3	O
.	O

Left	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
(	O
fs	O
)	O
:	O
-	O
Squamous	O
cell	O
carcinoma	O
in	O
situ	O
present	O
on	O
frozen	O
section	O
slide	O
only	O
.	O

4	O
.	O

Posterior	O
margin	O
floor	O
of	O
mouth	O
;	O
excision	O
(	O
fs	O
)	O
:	O
-	O
Squamous	O
mucosa	O
with	O
mild	O
dysplasia	O
.	O

5	O
.	O

Right	O
genial	O
glossus	O
margin	O
;	O
excision	O
(	O
fs	O
)	O
:	O
-	O
Benign	O
skeletal	O
muscle	O
.	O

6	O
.	O

Right	O
neck	O
,	O
level	O
2B	O
;	O
excision	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
5	O
.	O

7	O
.	O

Right	O
neck	O
,	O
level	O
1A	O
;	O
excision	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
7	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
metastatic	O
disease	O
:	O
2	O
.	O

Size	O
of	O
the	O
largest	O
lymph	O
node	O
involved	O
by	O
tumor	O
:	O
0	O
.	O
5cm	O
.	O

Size	O
of	O
the	O
largest	O
metastatic	O
focus	O
:	O
0	O
.	O
2	O
cm	O
.	O

Extranodal	O
extension	O
is	O
identified	O
.	O

8	O
.	O

Right	O
neck	O
,	O
level	O
18	O
;	O
excision	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
13	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
metastatic	O
disease	O
:	O
2	O
.	O

Size	O
of	O
the	O
largest	O
lymph	O
node	O
involved	O
by	O
tumor	O
:	O
1	O
.	O
4cm	O
.	O

Size	O
of	O
the	O
largest	O
metastatic	O
focus	O
:	O
1	O
.	O
4	O
cm	O
.	O

Extranodal	O
extension	O
is	O
not	O
identified	O
.	O

Benign	O
salivary	O
gland	O
with	O
lymphocytic	O
sialadenitis	O
is	O
also	O
.	O
present	O
.	O

9	O
.	O

Right	O
neck	O
,	O
level	O
2A	O
;	O
excision	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
12	O
.	O

10	O
.	O

Right	O
neck	O
,	O
level	O
3	O
;	O
excision	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
13	O
.	O

11	O
.	O

Left	O
lateral	O
margin	O
,	O
buccal	O
mucosa	O
#	O
2	O
;	O
excision	O
:	O
-	O
Benign	O
squamous	O
mucosa	O
.	O

12	O
.	O

Left	O
neck	O
level	O
1B	O
;	O
excision	O
:	O
Lymph	O
Node	O
Diasection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
11	O
.	O

Benign	O
salivary	O
gland	O
also	O
present	O
.	O

13	O
.	O

Right	O
anterior	O
mandible	O
;	O
composite	O
resection	O
:	O
Tumor	O
Type	O
:	O
Invasive	O
squamous	O
cell	O
carcinoma	O
.	O

Keratinizing	O
.	O

Histologic	O
Grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
3	B
.	I
0	I
cm	I
.	O

Maximal	O
thickness	O
1	B
.	I

8cm	B
.	O

Tumor	O
Location	O
:	O
Lower	O
gingiva	O
.	O

Tumor	O
Invasion	O
:	O
Tumor	O
extends	O
through	O
bone	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Identified	O
.	O

Pattern	O
of	O
Invasion	O
:	O
Invasive	O
islands	O
.	O

Tumor	O
Multicentricity	O
:	O
Not	O
identifed	O
.	O

In	O
situ	O
carcinoma	O
:	O
Not	O
identifed	O
.	O

Non	O
-	O
Neoplastic	O
Mucosa	O
:	O
Exhibits	O
chronic	O
inflammation	O
.	O

Surgical	O
Margins	O
:	O
Invasive	O
carcinoma	O
is	O
present	O
at	O
the	O
following	O
margin	O
(	O
s	O
)	O
:	O
deep	O
.	O
margin	O
,	O
lateral	O
side	O
.	O

Bone	O
Invasion	O
:	O
Involves	O
medullary	O
space	O
.	O

Bone	O
Margins	O
:	O
Benign	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
.	O

AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
.	O

"	O
Anterior	O
lip	O
mucosal	O
margin	O
"	O
and	O
consists	O
of	O
a	O
tan	O
mucosa	O
tissue	O
measuring	O
.	O

0	O
.	O
6	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

2	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
.	O

"	O
Right	O
lateral	O
margin	O
,	O
buccal	O
mucosa	O
"	O
and	O
consists	O
of	O
a	O
tan	O
mucosa	O
tissue	O
.	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

3	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
.	O

"	O
Left	O
lateral	O
margin	O
,	O
buccal	O
mucosa	O
"	O
and	O
consists	O
of	O
a	O
tan	O
mucosa	O
tissue	O
.	O
measuring	O
0	O
.	O
8	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

4	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
.	O

"	O
Posterior	O
margin	O
,	O
floor	O
of	O
mouth	O
"	O
and	O
consists	O
of	O
a	O
tan	O
mucosa	O
tissue	O
.	O
measuring	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

5	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
labeled	O
.	O

"	O
Right	O
genial	O
glossus	O
margin	O
"	O
and	O
consists	O
of	O
a	O
red	O
soft	O
tissue	O
measuring	O
.	O

1	O
.	O
0	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

6	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Right	O
neck	O
-	O
level	O
2B	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
7	O
cm	O
portion	O
of	O
adipose	O
tissue	O
,	O
which	O
upon	O
.	O
sectioning	O
displays	O
5	O
possible	O
tan	O
-	O
red	O
firm	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
3	O
x	O
.	O

0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
to	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
(	O
5	O
)	O
.	O

7	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Right	O
neck	O
-	O
level	O
1A	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
3	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
3	O
cm	O
portion	O
of	O
adipose	O
tissue	O
,	O
which	O
upon	O
.	O
sectioning	O
displays	O
10	O
possible	O
tan	O
-	O
red	O
firm	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
.	O

0	O
.	O
1	O
x	O
0	O
.	O
1	O
cm	O
to	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
(	O
10	O
)	O
.	O

8	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Right	O
neck	O
-	O
level	O
1B	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
5	O
.	O
8	O
x	O
4	O
.	O
5	O
x	O
3	O
.	O
6	O
cm	O
portion	O
of	O
adipose	O
tissue	O
with	O
attached	O
3	O
.	O
7	O
.	O

x	O
2	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
submandibular	O
gland	O
.	O

The	O
specimen	O
is	O
dissected	O
to	O
19	O
possible	O
.	O
tan	O
-	O
red	O
lymph	O
nodes	O
and	O
one	O
grossly	O
positive	O
lymph	O
node	O
ranging	O
from	O
0	O
.	O
2	O
.	O

x	O
.	O

0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
to	O
1	O
.	O
6	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
8	O
cm	O
.	O

All	O
identified	O
lymph	O
nodes	O
and	O
.	O
additional	O
representative	O
sections	O
of	O
the	O
remaining	O
specimen	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
SMG	O
submandibular	O
gland	O
.	O

LN	O
-	O
lymph	O
nodes	O
.	O

GPLN	O
-	O
grossly	O
positive	O
lymph	O
node	O
,	O
representative	O
.	O

9	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Right	O
neck	O
-	O
level	O
2A	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
4	O
.	O
1	O
x	O
3	O
.	O
4	O
x	O
2	O
.	O
0	O
cm	O
portion	O
of	O
adipose	O
tissue	O
,	O
which	O
upon	O
.	O
sectioning	O
displays	O
11	O
possible	O
tan	O
-	O
red	O
firm	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
.	O

0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
to	O
1	O
.	O
2	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
(	O
9	O
)	O
.	O

BLN	O
-	O
bisected	O
lymph	O
nodes	O
(	O
2	O
)	O
.	O

10	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Right	O
neck	O
-	O
level	O
3	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
6	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
portion	O
of	O
adipose	O
tissue	O
,	O
which	O
upon	O
.	O
sectioning	O
displays	O
15	O
possible	O
tan	O
-	O
red	O
firm	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
.	O

0	O
.	O
1	O
x	O
0	O
.	O
1	O
cm	O
to	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
(	O
15	O
)	O
.	O

11	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Left	O
lateral	O
margin	O
-	O
buccal	O
.	O
mucosa	O
#	O
2	O
"	O
,	O
and	O
consists	O
of	O
a	O
gray	O
-	O
tan	O
irregular	O
portion	O
of	O
mucosal	O
lined	O
.	O
soft	O
tissue	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
inked	O
and	O
entirely	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
-	O
-	O
undesignated	O
.	O

12	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Left	O
neck	O
level	O
1B	O
"	O
and	O
.	O
consists	O
of	O
a	O
4	O
.	O
8	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
fragment	O
of	O
adipose	O
tissue	O
with	O
attached	O
.	O

3	O
.	O
4	O
x	O
3	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
grosaly	O
unremarkable	O
salivary	O
gland	O
.	O

Sectioning	O
the	O
.	O
adipose	O
tissue	O
reveals	O
a	O
tan	O
,	O
soft	O
,	O
ovoid	O
,	O
tan	O
-	O
pink	O
lymph	O
nodes	O
,	O
ranging	O
.	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
bisected	O
.	O
and	O
one	O
half	O
is	O
submitted	O
to	O
the	O
TPS	O
and	O
the	O
remaining	O
half	O
is	O
submitted	O
for	O
.	O
permanent	O
.	O

The	O
remaining	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
and	O
the	O
.	O
remaining	O
specimen	O
is	O
representatively	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
whole	O
lymph	O
nodes	O
.	O

BLN	O
-	O
-	O
bisected	O
lymph	O
nodes	O
.	O

RHN	O
-	O
-	O
remaining	O
half	O
of	O
lymph	O
node	O
submitted	O
to	O
TPS	O
.	O

SG	O
salivary	O
gland	O
.	O

13	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
right	O
anterior	O
composite	O
.	O
resection	O
of	O
mandible	O
,	O
suture	O
marks	O
anterior	O
"	O
and	O
consists	O
of	O
a	O
resected	O
.	O
portion	O
of	O
mandible	O
with	O
attached	O
soft	O
tissue	O
and	O
a	O
mucosal	O
surface	O
.	O
measuring	O
7	O
.	O
2	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
2	O
cm	O
in	O
overall	O
dimension	O
.	O

The	O
mandible	O
measures	O
.	O

7	O
.	O
2	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
9	O
cm	O
.	O

The	O
soft	O
tissue	O
measures	O
6	O
x	O
3	O
.	O
5	O
3	O
.	O
1	O
cm	O
with	O
a	O
mucosal	O
.	O
surface	O
measuring	O
5	O
.	O
2	O
cm	O
(	O
anterior	O
to	O
posterior	O
)	O
x	O
3	O
.	O
5	O
cm	O
(	O
lateral	O
/	O
buccal	O
to	O
.	O
medial	O
/	O
gingival	O
)	O
The	O
mucosa	O
is	O
purple	O
grey	O
with	O
a	O
central	O
ulcerated	O
lesion	O
.	O
measuring	O
3	O
x1	O
.	O
8	O
cm	O
,	O
grossly	O
located	O
from	O
the	O
mucosal	O
margins	O
as	O
follows	O
:	O
0	O
.	O
9	O
cm	O
-	O
anterior	O
,	O
0	O
.	O
6	O
em	O
-	O
lateral	O
/	O
buccal	O
,	O
1	O
.	O
5	O
cm	O
-	O
posterior	O
and	O
0	O
.	O
6	O
cm	O
-	O
medial	O
.	O

The	O
lesion	O
is	O
1	O
.	O
1	O
cm	O
from	O
the	O
anterior	O
bone	O
margin	O
and	O
1	O
.	O
6	O
cm	O
from	O
the	O
.	O
posterior	O
bone	O
margin	O
.	O

The	O
specimen	O
is	O
inked	O
anterior	O
-	O
purple	O
,	O
.	O

lateral	O
/	O
buccal	O
-	O
green	O
,	O
posterior	O
-	O
orange	O
,	O
medial	O
-	O
blue	O
,	O
deep	O
-	O
black	O
.	O

Upon	O
.	O
sectioning	O
the	O
lesion	O
has	O
underlying	O
invasive	O
component	O
,	O
grosaly	O
extending	O
.	O
to	O
a	O
depth	O
of	O
1	O
cm	O
,	O
0	O
.	O
2	O
cm	O
from	O
the	O
nearest	O
(	O
lateral	O
)	O
margin	O
.	O

The	O
lesion	O
.	O
grosaly	O
extends	O
into	O
the	O
underlying	O
bone	O
.	O

A	O
representative	O
section	O
of	O
the	O
.	O
lesion	O
to	O
the	O
bone	O
is	O
submitted	O
following	O
decalcification	O
.	O

Perpendicular	O
.	O
sections	O
of	O
the	O
anterior	O
and	O
posterior	O
margins	O
are	O
submitted	O
;	O
the	O
remaining	O
.	O
lesion	O
is	O
blocked	O
out	O
and	O
submitted	O
sequentially	O
from	O
anterior	O
to	O
posterior	O
.	O
in	O
its	O
entirety	O
.	O

The	O
bone	O
margins	O
are	O
shaved	O
.	O

Gross	O
photographs	O
are	O
taken	O
.	O

Tumor	O
sampled	O
for	O
TPS	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
ABM	O
-	O
anterior	O
bone	O
margin	O
,	O
shaved	O
.	O

PBM	O
-	O
-	O
posterior	O
bone	O
margin	O
shaved	O
.	O

LB	O
-	O
-	O
lesion	O
to	O
bone	O
.	O

AM	O
-	O
-	O
anterior	O
mucosal	O
and	O
soft	O
tissue	O
margin	O
(	O
perpendicular	O
)	O
.	O

PM	O
-	O
-	O
posterior	O
mucosal	O
and	O
soft	O
tissue	O
margin	O
(	O
perpendicular	O
)	O
.	O

L	O
-	O
-	O
lesion	O
(	O
submitted	O
sequentially	O
from	O
anterior	O
to	O
posterior	O
)	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Anterior	O
lip	O
mucosa	O
margin	O
;	O
excision	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
2	O
:	O
Right	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
3	O
:	O
Left	O
lateral	O
margin	O
buccal	O
mucosa	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
4	O
:	O
Posterior	O
margin	O
floor	O
of	O
mouth	O
;	O
excisior	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
5	O
:	O
Right	O
genial	O
glossus	O
margin	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
6	O
:	O
Right	O
neck	O
,	O
level	O
2B	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

LN	O
.	O

5	O
.	O

Part	O
7	O
:	O
Right	O
neck	O
,	O
level	O
1A	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

LN	O
.	O

10	O
.	O

Part	O
8	O
:	O
Right	O
neck	O
,	O
level	O
1B	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

GPLN	O
.	O

1	O
.	O

4	O
.	O

LN	O
.	O

19	O
.	O

1	O
.	O

SMG	O
.	O

1	O
.	O

Part	O
9	O
:	O
Right	O
neck	O
,	O
level	O
2A	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

BLN	O
.	O

4	O
.	O

2	O
.	O

LN	O
.	O

9	O
.	O

Part	O
10	O
:	O
Right	O
neck	O
,	O
level	O
3	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O

LN	O
.	O

15	O
.	O

Part	O
11	O
:	O
Left	O
lateral	O
margin	O
,	O
buccal	O
mucosa	O
#	O
2	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

U	O
.	O

1	O
.	O

Part	O
12	O
:	O
Left	O
neck	O
level	O
1B	O
;	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BLN	O
.	O

2	O
.	O

2	O
.	O

LN	O
.	O

12	O
.	O

1	O
.	O

RHN	O
.	O

1	O
.	O

1	O
.	O

SG	O
.	O

1	O
.	O

Part	O
13	O
:	O
Right	O
anterior	O
mandible	O
;	O
composite	O
resection	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

ABM	O
.	O

1	O
.	O

1	O
.	O

AM	O
.	O

1	O
.	O

12	O
.	O

L	O
.	O

12	O
.	O

1	O
.	O

PBM	O
.	O

1	O
.	O

1	O
.	O

PM	O
.	O

1	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
.	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O

1	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Ulcerated	O
squamous	O
mucosa	O
with	O
atypia	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
Same	O
.	O

2	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Squamous	O
mucosa	O
with	O
moderate	O
.	O
dysplasia	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
Same	O
.	O

3	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
In	O
situ	O
squamous	O
cell	O
carcinoma	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
Same	O
.	O

4	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Squamous	O
mucosa	O
with	O
mild	O
dysplasia	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
Same	O
.	O

5	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
Benign	O
skeletal	O
muscle	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
Same	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
TONSIL	O
,	O
RIGHT	O
,	O
TONSILLECTOMY	O
BASALOID	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
2	B
.	I
2CM	I
.	O

IN	O
GREATEST	O
EXTENT	O
(	O
SEE	O
COMMENT	O
)	O
.	O

COMMENT	O
:	O
These	O
findings	O
correspond	O
to	O
AJCC	O
stage	O
II	O
(	O
pT2	O
,	O
pNn	O
/	O
a	O
)	O
.	O

CLINICAL	O
DATA	O
.	O

Clinical	O
Features	O
/	O
Dx	O
:	O
unspecified	O
.	O

Operation	O
:	O
unspecified	O
.	O

Operative	O
Findings	O
:	O
unspecified	O
.	O

Operative	O
Diagnosis	O
:	O
unspecified	O
.	O

Tissue	O
Submitted	O
:	O
1	O
)	O
right	O
tonsil	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
SOURCE	O
:	O
Tonsil	O
,	O
Right	O
.	O

Received	O
fresh	O
is	O
a	O
single	O
fragment	O
of	O
red	O
-	O
pink	O
tissue	O
,	O
measuring	O
3	O
.	O
5	O
x2	O
.	O
7	O
X	O
1	O
.	O
5	O
cm	O
.	O

The	O
.	O
mucosal	O
surface	O
is	O
lobulated	O
,	O
jagged	O
,	O
and	O
irregular	O
.	O

The	O
cauterized	O
surface	O
is	O
inked	O
entirely	O
in	O
blue	O
and	O
is	O
sectioned	O
to	O
.	O
reveal	O
a	O
mass	O
of	O
white	O
,	O
irregular	O
tissue	O
,	O
measuring	O
2	O
.	O
2	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
5	O
cm	O
.	O

The	O
surrounding	O
tissue	O
is	O
pink	O
-	O
tan	O
and	O
normally	O
.	O
lobulated	O
.	O

A	O
small	O
portion	O
of	O
tumor	O
is	O
submitted	O
for	O
research	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
.	O
sections	O
:	O
1A	O
-	O
B	O
,	O
1	O
/	O
1	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

ADDENDUM	O
REPORT	O
.	O

The	O
following	O
report	O
contains	O
additional	O
information	O
that	O
supplements	O
the	O
previously	O
issued	O
report	O
.	O

ADDENDUM	O
FINDINGS	O
:	O
DIAGNOSIS	O
:	O
1	O
)	O
TONSIL	O
,	O
RIGHT	O
,	O
TONSILLECTOMY	O
:	O
BASALOID	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
2	B
.	I
2CM	I
IN	O
.	O

GREATEST	O
EXTENT	O
;	O
NEGATIVE	O
FOR	O
LYMPHOVASCULAR	O
INVASION	O
;	O
EDGES	O
OFTHE	O
SPECIMEN	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
SEE	O
COMMENT	O
)	O
.	O

COMMENT	O
:	O
These	O
findings	O
correspond	O
to	O
AJCC	O
stage	O
II	O
(	O
pT2	O
,	O
pNn	O
/	O
a	O
)	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

1	O
.	O

SEX	O
:	O
F	O
.	O

ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
PROCEDURE	O
:	O
SPHS	O
.	O
year	O
-	O
old	O
female	O
with	O
pheochromocytoma	O
.	O

Operative	O
Procedure	O
:	O
Left	O
posterior	O
.	O
approach	O
.	O

Retroperitoneal	O
adrenalectomy	O
.	O

Fresh	O
.	O

PROCEDURE	O
:	O
SPGD	O
.	O

1	O
.	O

"	O
Left	O
adrenal	O
gland	O
.	O

Received	O
is	O
a	O
60	O
gram	O
adrenal	O
specimen	O
(	O
8	O
.	O
0	O
x	O
4	O
.	O
5	O
.	O
x	O
.	O
4	O
.	O
0	O
cm	O
)	O
.	O

Previously	O
inked	O
blue	O
.	O

Cross	O
sectioning	O
reveals	O
a	O
4	O
.	O
5	O
x	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O
encapsulated	O
mass	O
within	O
the	O
adrenal	O
gland	O
.	O

The	O
mass	O
is	O
partially	O
solid	O
and	O
.	O
cystic	O
with	O
hemorrhagic	O
and	O
necrotic	O
areas	O
.	O

1A	O
.	O

Section	O
of	O
solid	O
area	O
of	O
mass	O
.	O

1B	O
.	O

Section	O
of	O
hemorrhagic	O
/	O
necrotic	O
area	O
.	O

1C	O
.	O

Section	O
of	O
hemorrhagic	O
area	O
.	O

1D	O
.	O

Section	O
of	O
solid	O
area	O
.	O

1E	O
.	O

Section	O
of	O
mass	O
and	O
normal	O
adrenal	O
gland	O
.	O

1F	O
.	O

Section	O
of	O
normal	O
adrenal	O
gland	O
.	O

(	O
1	O
each	O
)	O
.	O

PROCEDURE	O
:	O
SPDX	O
.	O

1	O
.	O

Left	O
adrenal	O
gland	O
,	O
excision	O
:	O
Pheochromocytoma	O
(	O
4	B
.	I
5	I
cm	I
)	O
.	O

Margins	O
negative	O
.	O

1	O
,	O
.	O
,	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
.	O
examined	O
and	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

Code	O
:	O
END	O
OF	O
PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

F	O
.	O

Pathologic	O
Interpretation	O
:	O
A	O
.	O

LEFT	O
BREAST	O
LUMPECTOMY	O
:	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
poorly	O
differentiated	O
,	O
Nottingham	O
grade	O
3	O
(	O
3	O
+	O
3	O
+	O
3	O
=	O
9	O
)	O
,	O
2	O
.	O
1	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Resection	O
margins	O
are	O
free	O
of	O
tumor	O
;	O
closest	O
is	O
inferior	O
,	O
0	O
.	O
1	O
cm	O
.	O

B	O
.	O

LEFT	O
AXILLARY	O
CONTENTS	O
:	O
METASTATIC	O
DUCTAL	O
CARCINOMA	O
to	O
two	O
out	O
of	O
twenty	O
-	O
six	O
lymph	O
nodes	O
(	O
2	O
/	O
26	O
)	O
with	O
extranodal	O
.	O
extension	O
.	O

C	O
.	O

ADDITIONAL	O
LEFT	O
AXILLARY	O
CONTENTS	O
LEVEL	O
2	O
-	O
3	O
:	O
No	O
malignancy	O
seen	O
in	O
five	O
lymph	O
nodes	O
(	O
0	O
/	O
5	O
)	O
.	O

Surgical	O
Pathology	O
Cancer	O
Case	O
Summary	O
.	O

Specimen	O
:	O
Partial	O
breast	O
.	O

Procedure	O
:	O
Excision	O
without	O
wire	O
-	O
guided	O
localization	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Axillary	O
dissection	O
(	O
partial	O
or	O
complete	O
dissection	O
)	O
.	O

Specimen	O
Integrity	O
:	O
Single	O
intact	O
specimen	O
(	O
margins	O
can	O
be	O
evaluated	O
)	O
.	O

Specimen	O
Laterality	O
:	O
Left	O
.	O

Tumor	O
Size	O
:	O
Size	O
of	O
Largest	O
Invasive	O
Carcinoma	O
:	O
Greatest	O
dimension	O
of	O
largest	O
focus	O
of	O
invasion	O
over	O
0	O
.	O
1	O
cm	O
:	O
2	B
.	I
1	I
cm	I
.	O

Additional	O
dimensions	O
:	O
1	B
.	I
7	I
x	I
1	I
.	I
7	I
cm	I
.	O

Tumor	O
Focality	O
:	O
Single	O
focus	O
of	O
invasive	O
carcinoma	O
.	O

Macroscopic	O
and	O
Microscopic	O
Extent	O
of	O
Tumor	O
:	O
Skin	O
:	O
Skin	O
is	O
not	O
present	O
.	O

Skeletal	O
Muscle	O
:	O
No	O
skeletal	O
muscle	O
present	O
.	O

Ductal	O
Carcinoma	O
in	O
Situ	O
(	O
DCIS	O
)	O
:	O
DCIS	O
is	O
present	O
.	O

Architectural	O
Patterns	O
:	O
Solid	O
.	O

Nuclear	O
Grade	O
:	O
Grade	O
III	O
(	O
high	O
)	O
.	O

Histologic	O
Type	O
of	O
Invasive	O
Carcinoma	O
:	O
Invasive	O
ductal	O
carcinoma	O
(	O
no	O
special	O
type	O
or	O
not	O
otherwise	O
specified	O
)	O
.	O

Histologic	O
Grade	O
:	O
Nottingham	O
Histologic	O
Score	O
:	O
Glandular	O
(	O
Acinar	O
)	O
/	O
Tubular	O
Differentiation	O
.	O

Score	O
3	O
:	O
<	O
10	O
%	O
of	O
tumor	O
area	O
forming	O
glandular	O
/	O
tubular	O
structures	O
.	O

Nuclear	O
Pleomorphism	O
.	O

Score	O
3	O
:	O
Vesicular	O
nuclei	O
,	O
often	O
with	O
prominent	O
nucleoli	O
,	O
exhibiting	O
marked	O
variation	O
in	O
size	O
and	O
.	O
shape	O
,	O
occasionally	O
with	O
very	O
large	O
and	O
bizarre	O
forms	O
.	O

Mitotic	O
Count	O
.	O

Score	O
3	O
.	O

Overall	O
Grade	O
.	O

Grade	O
3	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
1	O
mm	O
(	O
inferior	O
)	O
.	O

Margins	O
uninvolved	O
by	O
DCIS	O
.	O

Lymph	O
Nodes	O
:	O
Number	O
of	O
sentinel	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
(	O
sentinel	O
and	O
nonsentinel	O
)	O
:	O
31	O
.	O

Number	O
of	O
lymph	O
nodes	O
with	O
macrometastases	O
(	O
>	O
0	O
.	O
2	O
cm	O
)	O
:	O
2	O
.	O

Largest	O
metastatic	O
deposit	O
:	O
3	O
.	O
0cm	O
.	O

Extranodal	O
Extension	O
:	O
Present	O
.	O

Method	O
of	O
Evaluation	O
of	O
Sentinel	O
Lymph	O
Nodes	O
:	O
Hematoxylin	O
and	O
eosin	O
(	O
H	O
&	O
E	O
)	O
,	O
one	O
level	O
.	O

Pathologic	O
Staging	O
(	O
pTNM	O
)	O
:	O
Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
>	O
20	O
mm	O
but	O
50	O
mm	O
in	O
greatest	O
dimension	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pN1a	O
:	O
Metastases	O
in	O
1	O
to	O
3	O
axillary	O
lymph	O
nodes	O
,	O
at	O
least	O
1	O
metastasis	O
greater	O
than	O
2	O
.	O
0	O
mm	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Ancillary	O
Studies	O
:	O
Estrogen	O
Receptor	O
:	O
Performed	O
on	O
another	O
specimen	O
:	O
Results	O
:	O
Less	O
than	O
1	O
%	O
immunoreactive	O
cells	O
present	O
.	O

Progesterone	O
Receptor	O
:	O
Performed	O
on	O
another	O
specimen	O
:	O
Results	O
:	O
Less	O
than	O
1	O
%	O
immunoreactive	O
cells	O
present	O
.	O

HER2	O
/	O
neu	O
Immunoperoxidase	O
Studies	O
:	O
Performed	O
on	O
another	O
specimen	O
:	O
Results	O
:	O
Positive	O
(	O
Score	O
3	O
+	O
)	O
.	O

Clinical	O
History	O
:	O
None	O
Provided	O
.	O

Operation	O
Performed	O
.	O

Left	O
Breast	O
Lumpectomy	O
.	O

Pre	O
Operative	O
Diagnosis	O
:	O
Breast	O
Cancer	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
/	O
Processing	O
Information	O
:	O
Fee	O
.	O

Codes	O
:	O
A	O
:	O
LEFT	O
BREAST	O
LUMPECTOMY	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
.	O

Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
.	O

1	O
.	O

B	O
:	O
LEFT	O
AXILLARY	O
CONTENTS	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
.	O

Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
.	O

H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
.	O

C	O
:	O
ADDITIONAL	O
LEFT	O
AXILLARY	O
CONTENTS	O
LEVEL	O
2	O
-	O
3	O
H	O
&	O
E	O
,	O
Initial	O
x	O
1	O
,	O
H	O
&	O
E	O
,	O
Initial	O
x	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Received	O
in	O
formalin	O
is	O
a	O
yellow	O
tan	O
fibrotic	O
adipose	O
tissue	O
fragment	O
weighing	O
86	O
grams	O
and	O
measures	O
8	O
.	O
0	O
x	O
.	O

7	O
.	O
0	O
x	O
4	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
is	O
oriented	O
with	O
a	O
long	O
stitch	O
lateral	O
,	O
short	O
superior	O
and	O
double	O
stitch	O
.	O

Inked	O
as	O
.	O
follows	O
:	O
Superior	O
in	O
Blue	O
-	O
deep	O
black	O
,	O
anterior	O
yellow	O
,	O
inferior	O
green	O
,	O
lateral	O
orange	O
and	O
medial	O
red	O
.	O

Cross	O
.	O
sections	O
of	O
the	O
specimen	O
shows	O
a	O
firm	O
pale	O
tan	O
well	O
circumscribed	O
mass	O
measuring	O
2	O
.	O
1	O
x	O
1	O
.	O
7	O
x	O
1	O
.	O
7	O
cm	O
.	O

It	O
is	O
.	O
within	O
1	O
mm	O
from	O
inferior	O
resection	O
margin	O
,	O
all	O
additional	O
margins	O
are	O
uninvolved	O
by	O
tumor	O
.	O

The	O
mass	O
shows	O
.	O

a	O
metallic	O
clip	O
(	O
previous	O
biopsy	O
site	O
)	O
.	O

No	O
additional	O
lesions	O
are	O
grossly	O
present	O
.	O

Sections	O
submitted	O
as	O
.	O
follows	O
:	O
Cassette	O
#	O
1	O
-	O
4	O
.	O

Representative	O
section	O
of	O
the	O
mass	O
with	O
relations	O
to	O
the	O
inferior	O
margin	O
(	O
almost	O
in	O
toto	O
)	O
.	O

(	O
Cassette	O
#	O
1	O
)	O
-	O
largest	O
dimension	O
of	O
the	O
mass	O
,	O
(	O
Cassette	O
#	O
4	O
)	O
previous	O
biopsy	O
site	O
.	O

Cassette	O
#	O
5	O
.	O

Superior	O
margin	O
.	O

Cassette	O
#	O
6	O
.	O

Deep	O
margin	O
.	O

Cassette	O
#	O
7	O
.	O

Anterior	O
margin	O
.	O

Cassette	O
#	O
8	O
.	O

Lateral	O
margin	O
.	O

Cassette	O
#	O
9	O
.	O

Medial	O
resection	O
margin	O
.	O

B	O
.	O

Received	O
in	O
formalin	O
are	O
multiple	O
yellow	O
tan	O
fibrotic	O
adipose	O
tissue	O
fragments	O
measuring	O
15	O
.	O
0	O
x	O
13	O
.	O
0	O
x	O
4	O
.	O
0	O
.	O

cm	O
in	O
aggregate	O
.	O

Twenty	O
-	O
six	O
lymph	O
nodes	O
were	O
grossly	O
identified	O
measuring	O
up	O
to	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

The	O
two	O
largest	O
lymph	O
nodes	O
show	O
a	O
metastatic	O
tumor	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1	O
.	O

Representative	O
section	O
from	O
one	O
large	O
lymph	O
node	O
.	O

Cassette	O
#	O
2	O
.	O

Representative	O
section	O
from	O
the	O
second	O
largest	O
lymph	O
node	O
.	O

Cassettes	O
#	O
3	O
&	O
4	O
.	O

One	O
lymph	O
node	O
in	O
toto	O
per	O
cassette	O
.	O

Cassettes	O
#	O
5	O
-	O
10	O
.	O

Four	O
lymph	O
nodes	O
in	O
toto	O
per	O
cassette	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
is	O
a	O
yellow	O
tan	O
fibrotic	O
adipose	O
tissue	O
fragment	O
.	O

It	O
measures	O
10	O
.	O

0	O
x	O
6	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
in	O
.	O
aggregate	O
.	O

The	O
five	O
lymph	O
nodes	O
are	O
grossly	O
identified	O
measuring	O
up	O
to	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1	O
.	O

Two	O
lymph	O
nodes	O
in	O
toto	O
.	O

Cassette	O
#	O
2	O
.	O

Three	O
lymph	O
nodes	O
in	O
toto	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

A	O
.	O
,	O
B	O
.	O

RIGHT	O
TEMPORAL	O
LOBE	O
OF	O
BRAIN	O
,	O
TUMOR	O
,	O
BIOPSY	O
AND	O
REMOVAL	O
:	O
-	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
(	O
WHO	O
GRADE	O
IV	O
)	O
.	O

By	O
the	O
signature	O
on	O
this	O
report	O
,	O
the	O
individual	O
or	O
group	O
listed	O
as	O
making	O
the	O
Final	O
Interpretation	O
/	O
Diagnosis	O
certifies	O
that	O
they	O
have	O
.	O
reviewed	O
this	O
case	O
.	O

Intraoperative	O
Consultation	O
:	O
A	O
:	O
Microscopic	O
and	O
touch	O
imprint	O
diagnosis	O
:	O
Glioblastoma	O
multiforme	O
.	O

Clinical	O
History	O
:	O
R	O
brain	O
tumor	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
R	O
TEMPORAL	O
NEOPLASM	O
.	O

B	O
:	O
RIGHT	O
TEMPORAL	O
NEOPLASM	O
.	O

Gross	O
Description	O
:	O
A	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
evaluation	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
hospital	O
number	O
and	O
.	O

"	O
right	O
temporal	O
neoplasm	O
"	O
are	O
two	O
irregular	O
fragments	O
of	O
white	O
-	O
pink	O
soft	O
tissue	O
,	O
0	O
.	O
9	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
and	O
.	O

0	O
.	O
7	O
X	O
0	O
.	O
5	O
X	O
2	O
.	O
4	O
cm	O
.	O

A	O
touch	O
prep	O
is	O
performed	O
on	O
a	O
portion	O
of	O
this	O
tissue	O
.	O

A	O
portion	O
of	O
this	O
tissue	O
is	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
in	O
two	O
cassettes	O
.	O

B	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
number	O
,	O
and	O
"	O
right	O
temporal	O
neoplasm	O
"	O
,	O
are	O
two	O
.	O
irregular	O
fragments	O
of	O
opaque	O
white	O
to	O
pink	O
tan	O
,	O
soft	O
,	O
cerebriform	O
tissue	O
measuring	O
in	O
aggregate	O
2	O
.	O
3	O
X	O
.	O

1	O
,	O
9	O
X	O
0	O
.	O
4	O
cm	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
is	O
submitted	O
to	O
.	O

The	O
remaining	O
tissue	O
is	O
submitted	O
.	O
entirely	O
in	O
one	O
cassette	O
.	O

page	O
1	O
/	O
1	O
.	O
copy	O
No	O
.	O

Examination	O
:	O
Histopathological	O
examination	O
.	O

Patier	O
.	O

PESEL	O
:	O
Gender	O
:	O
F	O
.	O

Material	O
:	O
Partial	O
organ	O
resection	O
-	O
lesion	O
from	O
the	O
left	O
breast	O
-	O
lower	O
outer	O
quadrant	O
.	O

Expected	O
time	O
of	O
examination	O
:	O
Clinical	O
diagnosis	O
:	O
Cancer	O
of	O
the	O
right	O
breast	O
,	O
typical	O
quadrant	O
marking	O
.	O

Macroscopic	O
description	O
:	O
Part	O
of	O
the	O
breast	O
sized	O
8	O
.	O
8	O
x	O
8	O
.	O
3	O
x	O
2	O
.	O
4	O
cm	O
with	O
a	O
skin	O
flap	O
of	O
5	O
.	O
8	O
x	O
2	O
.	O
3	O
cm	O
,	O
marked	O
typically	O
,	O
with	O
an	O
X	O
-	O
ray	O
.	O
image	O
.	O

Tumour	O
cross	O
section	O
sized	O
1	B
.	I
7	I
x	I
1	I
.	I
5	I
x	I
2	I
.	I
3	I
cm	I
.	O

Margins	O
:	O
to	O
the	O
base	O
0	O
.	O
1	O
cm	O
;	O
do	O
the	O
skin	O
surface	O
0	O
.	O
6	O
cm	O
;	O
.	O
to	O
the	O
sternum	O
2	O
.	O
2	O
cm	O
,	O
to	O
the	O
axilla	O
3	O
.	O
6	O
cm	O
,	O
to	O
the	O
shoulder	O
2	O
.	O
3	O
cm	O
,	O
lower	O
4	O
.	O
3	O
cm	O
.	O

Microscopic	O
description	O
:	O
Carcinoma	O
ductale	O
invasivum	O
:	O
NHG3	O
(	O
3	O
+	O
3	O
+	O
3	O
:	O
18	O
mitoses	O
/	O
10	O
HPF	O
-	O
diam	O
.	O
0	O
.	O
55mm	O
)	O
,	O
pT2	O
.	O

Solitary	O
DCIS	O
focuses	O
.	O
found	O
beneath	O
the	O
tumour	O
(	O
solid	O
type	O
with	O
medium	O
atypia	O
,	O
no	O
necrosis	O
)	O
placed	O
0	O
.	O
5	O
cm	O
from	O
the	O
incision	O
line	O
.	O

Histopathological	O
diagnosis	O
:	O
Resectio	O
partalis	O
mammae	O
dextrae	O
:	O
Carcinoma	O
ductale	O
invasivum	O
et	O
ductale	O
in	O
situ	O
(	O
NHG3	O
,	O
pT2	O
)	O
.	O

Results	O
of	O
immunohistochemical	O
examination	O
:	O
Estrogen	O
receptors	O
in	O
neoplastic	O
cell	O
nuclei	O
not	O
found	O
.	O

Progesterone	O
receptors	O
in	O
neoplastic	O
cell	O
nuclei	O
not	O
found	O
.	O

HER2	O
protein	O
stained	O
with	O
HercepTest	O
	O
by	O
DAKO	O
.	O

Negative	O
reaction	O
in	O
invasive	O
cancerous	O
cells	O
(	O
Score	O
=	O
0	O
)	O
.	O

Urology	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
year	O
old	O
with	O
pT2	O
urothelial	O
cell	O
carcinoma	O
,	O
status	O
post	O
2	O
courses	O
of	O
BCG	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
anterior	O
vaginal	O
wall	O
,	O
bladder	O
,	O
perivesical	O
lymph	O
nodes	O
.	O

2	O
:	O
SP	O
:	O
Right	O
distal	O
pelvic	O
lymph	O
nodes	O
.	O

3	O
:	O
SP	O
:	O
Left	O
pelvic	O
lymph	O
node	O
.	O

4	O
:	O
SP	O
:	O
Left	O
distal	O
pelvic	O
lymph	O
nodes	O
.	O

5	O
:	O
SP	O
:	O
Right	O
distal	O
ureter	O
.	O

6	O
:	O
SP	O
:	O
Left	O
distal	O
ureter	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
anterior	O
vaginal	O
wall	O
,	O
bladder	O
,	O
perivesical	O
lymph	O
nodes	O
:	O
Tumor	O
Type	O
:	O
Invasive	O
urothelial	O
carcinoma	O
,	O
NOS	O
.	O

Histologic	O
Grade	O
:	O
High	O
grade	O
.	O

Pattern	O
of	O
growth	O
of	O
the	O
Non	O
-	O
Invasive	O
component	O
:	O
In	O
situ	O
component	O
not	O
identified	O
.	O

Pattern	O
of	O
growth	O
of	O
the	O
Invasive	O
component	O
:	O
Infiltrating	O
.	O

Tumor	O
Multicentricity	O
:	O
Not	O
identified	O
.	O

Bladder	O
Local	O
Invasion	O
:	O
Perivesical	O
soft	O
tissues	O
.	O

Extravesical	O
Tumor	O
Extension	O
:	O
Ureters	O
uninvolved	O
.	O

Vascular	O
Invasion	O
:	O
No	O
definite	O
vascular	O
invasion	O
present	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

See	O
also	O
parts	O
5	O
and	O
6	O
.	O

Non	O
-	O
Neoplastic	O
Mucosa	O
:	O
Exhibiting	O
chronic	O
cystitis	O
.	O

Exhibiting	O
foreign	O
body	O
reaction	O
.	O

Female	O
Genital	O
Organs	O
:	O
The	O
endometrium	O
shows	O
endometrial	O
polyp	O
.	O

The	O
myometrium	O
shows	O
mural	O
leiomyomas	O
.	O

The	O
left	O
fallopian	O
tube	O
shows	O
simple	O
serous	O
cysts	O
.	O

The	O
right	O
ovary	O
shows	O
hilus	O
cell	O
and	O
stromal	O
hyperplasia	O
.	O

The	O
left	O
ovary	O
shows	O
stromal	O
hyperplasia	O
.	O

Remaining	O
genital	O
organs	O
are	O
unremarkable	O
.	O

Perivesical	O
Lymph	O
Nodes	O
:	O
LN	O
Not	O
involved	O
0	O
/	O
1	O
.	O

The	O
Pathologic	O
Stage	O
is	O
(	O
AJCC	O
.	O

pT3	O
(	O
Invasion	O
of	O
perivesicle	O
soft	O
tissue	O
)	O
.	O

2	O
.	O

SP	O
:	O
Right	O
distal	O
pelvic	O
lymph	O
nodes	O
:	O
Lymph	O
Nodes	O
:	O
Not	O
involved	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
2	O
.	O

3	O
.	O

SP	O
:	O
Left	O
pelvic	O
lymph	O
node	O
:	O
Lymph	O
Nodes	O
:	O
Not	O
involved	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
8	O
.	O

4	O
.	O

SP	O
:	O
Left	O
distal	O
pelvic	O
lymph	O
nodes	O
:	O
Lymph	O
Nodes	O
:	O
Not	O
involved	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
8	O
.	O

5	O
.	O

Right	O
distal	O
ureter	O
;	O
excision	O
:	O
-	O
Ureter	O
with	O
focal	O
mild	O
atypia	O
.	O

6	O
.	O

Left	O
distal	O
ureter	O
;	O
excision	O
:	O
-	O
Benign	O
ureter	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
,	O
anterior	O
vaginal	O
wall	O
,	O
bladder	O
and	O
perivesical	O
.	O
lymph	O
nodes	O
"	O
.	O

It	O
consists	O
of	O
a	O
cystectomy	O
-	O
hysterectomy	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
specimen	O
measuring	O
11	O
cm	O
from	O
.	O
superior	O
to	O
inferior	O
,	O
12cm	O
laterally	O
and	O
5cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
bladder	O
measures	O
13	O
x	O
11cm	O
,	O
the	O
uterus	O
measures	O
5	O
x	O
.	O

4	O
.	O
6	O
x	O
2	O
.	O
8	O
cm	O
,	O
the	O
right	O
ovary	O
measures	O
2	O
.	O
2x	O
1	O
.	O
0	O
x	O
0	O
.	O
9	O
cm	O
,	O
the	O
right	O
fallopian	O
tube	O
measures	O
5	O
,	O
4	O
x	O
0	O
.	O
7	O
cm	O
,	O
the	O
left	O
ovary	O
measures	O
.	O

2	O
.	O
7	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
9	O
cm	O
,	O
and	O
the	O
left	O
fallopian	O
tube	O
measures	O
4	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
portion	O
of	O
vaginal	O
cuff	O
measures	O
5	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O

The	O
distal	O
.	O
urethral	O
margin	O
and	O
the	O
vaginal	O
cuff	O
margin	O
are	O
shaved	O
and	O
submitted	O
.	O

The	O
ureteric	O
stumps	O
are	O
buried	O
in	O
the	O
specimen	O
,	O
measure	O
.	O
approximately	O
2	O
cm	O
and	O
show	O
probe	O
-	O
patent	O
lumen	O
.	O

The	O
specimen	O
is	O
inked	O
black	O
for	O
posterior	O
,	O
blue	O
for	O
anterior	O
and	O
the	O
bladder	O
is	O
.	O
opened	O
anteriorly	O
to	O
reveal	O
a	O
friable	O
fungating	O
mass	O
measuring	O
3	O
.	O
3	O
x	O
2	O
.	O
4	O
cm	O
located	O
in	O
the	O
dome	O
focally	O
extending	O
to	O
trigone	O
.	O

The	O
.	O
distance	O
from	O
the	O
left	O
and	O
the	O
right	O
ureteric	O
orifices	O
are	O
5	O
.	O
2	O
cm	O
and	O
5	O
.	O
3	O
cm	O
respectively	O
.	O

On	O
sectioning	O
,	O
the	O
tumor	O
extends	O
to	O
a	O
depth	O
.	O
of	O
2	B
.	I
0	I
cm	I
,	O
and	O
appears	O
to	O
extend	O
into	O
the	O
perivesical	O
fat	O
grossly	O
reaching	O
to	O
the	O
subserosa	O
.	O

The	O
remaining	O
bladder	O
mucosa	O
shows	O
.	O
flat	O
.	O

mucosa	O
.	O
without	O
.	O

additional	O
lesion	O
.	O

Discrete	O
perivesical	O
lymph	O
nodes	O
are	O
not	O
identified	O
.	O

The	O
uterus	O
is	O
bivalved	O
to	O
reveal	O
multiple	O
.	O
fibroids	O
ranging	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
5	O
cm	O
and	O
endometrial	O
polyp	O
measuring	O
2x	O
1	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
ovaries	O
and	O
fallopian	O
tubes	O
are	O
.	O
unremarkable	O
.	O

Tissue	O
is	O
submitted	O
for	O
.	O

Gross	O
photograph	O
is	O
taken	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
UTHM	O
-	O
urethral	O
margin	O
.	O

RUM	O
-	O
right	O
ureter	O
margin	O
.	O

LUM	O
-	O
left	O
ureter	O
margin	O
.	O

L	O
-	O
lesion	O
.	O

RUO	O
-	O
right	O
ureteric	O
orifice	O
.	O

LUO	O
-	O
left	O
ureteric	O
orifice	O
.	O

LP	O
-	O
left	O
posterior	O
wall	O
.	O

LA	O
-	O
left	O
anterior	O
wall	O
.	O

RP	O
-	O
right	O
posterior	O
wall	O
.	O

RA	O
-	O
right	O
anterior	O
wall	O
.	O

TRI	O
-	O
trigone	O
.	O

EMM	O
-	O
endomyometrium	O
.	O

CX	O
-	O
cervix	O
.	O

V	O
-	O
vagina	O
,	O
full	O
thickness	O
to	O
include	O
bladder	O
mucosa	O
.	O

DVM	O
-	O
distal	O
vaginal	O
margin	O
.	O

RTO	O
-	O
right	O
tube	O
and	O
ovary	O
.	O

LTO	O
-	O
left	O
tube	O
and	O
ovary	O
.	O

LN	O
-	O
possible	O
lymph	O
node	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
Right	O
distal	O
pelvic	O
lymph	O
nodes	O
"	O
and	O
consists	O
of	O
2	O
pink	O
tan	O
firm	O
lymph	O
nodes	O
.	O
measuring	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
and	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
larger	O
lymph	O
node	O
is	O
inked	O
black	O
and	O
bisected	O
.	O

All	O
identified	O
.	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
Left	O
pelvic	O
lymph	O
nodes	O
"	O
.	O

It	O
consists	O
of	O
multiple	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
.	O

cm	O
up	O
to	O
3	O
x	O
1	O
.	O
8	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
serially	O
sectioned	O
at	O
3	O
mm	O
intervals	O
and	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

BLN	O
-	O
bisected	O
lymph	O
node	O
.	O

LN1	O
-	O
lymph	O
node	O
number	O
one	O
.	O

LN2	O
-	O
lymph	O
node	O
number	O
two	O
.	O

LN3	O
-	O
lymph	O
node	O
number	O
three	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Left	O
distal	O
pelvic	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
multiple	O
pink	O
tan	O
firm	O
lymph	O
nodes	O
.	O
ranging	O
from	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
up	O
to	O
3	O
.	O
5	O
x	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

BLN	O
-	O
bisected	O
lymph	O
node	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
Right	O
distal	O
ureter	O
unclipped	O
is	O
a	O
margin	O
.	O
"	O
It	O
consists	O
of	O
a	O
segment	O
of	O
ureter	O
.	O
measuring	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
attached	O
adipose	O
tissue	O
measures	O
up	O
to	O
1	O
.	O
5	O
cm	O
in	O
thickness	O
.	O

There	O
is	O
a	O
.	O
clip	O
.	O
on	O
one	O
end	O
of	O
the	O
specimen	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
the	O
clipped	O
to	O
the	O
non	O
-	O
clipped	O
end	O
and	O
submitted	O
.	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
MC	O
-	O
margin	O
with	O
clip	O
.	O

SS	O
-	O
serial	O
sections	O
from	O
clipped	O
to	O
non	O
-	O
clipped	O
end	O
.	O
margin	O
without	O
clip	O
.	O

6	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
Left	O
distal	O
ureter	O
unclipped	O
is	O
a	O
margin	O
.	O
"	O
It	O
consists	O
of	O
a	O
segment	O
of	O
ureter	O
.	O
measuring	O
3	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
attached	O
adipose	O
tissue	O
measures	O
up	O
to	O
1	O
.	O
5	O
cm	O
in	O
thickness	O
.	O

There	O
is	O
.	O

a	O
.	O
clip	O
on	O
one	O
end	O
of	O
the	O
specimen	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
the	O
clipped	O
to	O
the	O
non	O
-	O
clipped	O
end	O
and	O
submitted	O
.	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
MC	O
-	O
margin	O
with	O
clip	O
.	O

SS	O
-	O
serial	O
sections	O
from	O
clipped	O
to	O
non	O
-	O
clipped	O
end	O
.	O

MWC	O
-	O
margin	O
without	O
clip	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
anterior	O
vaginal	O
wall	O
,	O
bladder	O
,	O
perivesical	O
lymph	O
nodes	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

CX	O
.	O

2	O
.	O

1	O
.	O
dnm	O
.	O

1	O
.	O

2	O
.	O
emm	O
.	O

2	O
.	O

6	O
.	O

L	O
.	O

6	O
.	O

1	O
.	O

la	O
.	O

2	O
.	O

1	O
.	O

LN	O
.	O

1	O
.	O

1	O
.	O
lof	O
.	O

2	O
.	O

1	O
.	O

Ip	O
.	O

2	O
.	O

1	O
.	O
lum	O
.	O

1	O
.	O

1	O
.	O
luo	O
.	O

1	O
.	O

1	O
.	O

ra	O
.	O

2	O
.	O

1	O
.	O
rof	O
.	O

2	O
.	O

1	O
.	O

rp	O
.	O

1	O
.	O

1	O
.	O
rum	O
.	O

1	O
.	O

1	O
.	O
ruo	O
.	O

1	O
.	O

1	O
.	O
tri	O
.	O

1	O
.	O

1	O
.	O
uthm	O
.	O

1	O
.	O

V	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Right	O
distal	O
pelvic	O
lymph	O
nodes	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

In	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Left	O
pelvic	O
lymph	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

bIn	O
.	O

1	O
.	O

1	O
.	O

In	O
.	O

1	O
.	O

2	O
.	O

In1	O
.	O

2	O
.	O

2	O
.	O

In2	O
.	O

2	O
.	O

2	O
.	O

In3	O
.	O

2	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Left	O
distal	O
pelvic	O
lymph	O
nodes	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BLN	O
.	O

1	O
.	O

1	O
.	O

LN	O
.	O

1	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Right	O
distal	O
ureter	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

mc	O
.	O

1	O
.	O

1	O
.	O
mwc	O
.	O

1	O
.	O

1	O
.	O

SS	O
.	O

1	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Left	O
distal	O
ureter	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

MC	O
.	O

1	O
.	O

1	O
.	O

MWC	O
.	O

1	O
.	O

1	O
.	O

SS	O
.	O

1	O
.	O

:	O
xxx	O
.	O

Examination	O
result	O
.	O

Clinical	O
diagnosis	O
(	O
suspicion	O
)	O
:	O
Skin	O
melanoma	O
on	O
the	O
right	O
arm	O
.	O

Date	O
of	O
admission	O
:	O
(	O
urgency	O
:	O
Standard	O
)	O
.	O

Material	O
:	O
1	O
)	O
Material	O
:	O
skin	O
of	O
the	O
arm	O
,	O
Method	O
of	O
collection	O
:	O
Lesion	O
resection	O
.	O

Histopathological	O
diagnosis	O
:	O
Malignant	O
melanoma	O
of	O
the	O
skin	O
with	O
ulceration	O
.	O

12	O
mm	O
,	O
diameter	O
24	B
mm	I
.	O

pT4b	O
,	O
pN3	O
.	O

Macroscopic	O
description	O
:	O
A	O
flap	O
of	O
skin	O
with	O
subcutaneous	O
tissue	O
sized	O
:	O
1	O
8	O
x	O
8	O
x	O
2	O
cm	O
.	O

Tumour	O
sized	O
2	B
.	I
4	I
x	I
2	I
.	I
4	I
x	I
1	I
cm	I
on	O
the	O
skin	O
,	O
.	O
brown	O
-	O
coloured	O
,	O
ulcerous	O
,	O
placed	O
1	O
cm	O
from	O
the	O
base	O
and	O
2	O
cm	O
from	O
the	O
side	O
edge	O
.	O

Small	O
satellite	O
tumours	O
on	O
the	O
skin	O
from	O
0	O
.	O
1	O
to	O
0	O
,	O
6	O
cm	O
(	O
side	O
margin	O
0	O
.	O
6	O
cm	O
,	O
from	O
the	O
base	O
0	O
.	O
4	O
cm	O
)	O
.	O

Proliferation	O
sized	O
3	O
x	O
1	O
.	O
7	O
x	O
3	O
.	O
5	O
cm	O
in	O
the	O
subcutaneous	O
tissue	O
,	O
reaching	O
the	O
base	O
.	O

Microscopic	O
description	O
:	O
Malignant	O
melanoma	O
of	O
the	O
skin	O
.	O

Clinical	O
data	O
and	O
histology	O
suggestive	O
of	O
a	O
primary	O
lesion	O
-	O
nodular	O
type	O
.	O

Level	O
V	O
according	O
to	O
.	O
thickness	O
of	O
12	O
mm	O
acc	O
.	O

to	O
.	O
the	O
largest	O
tumour	O
size	O
is	O
24	B
mm	I
.	O

A	O
faint	O
.	O
lymphocitary	O
proliferation	O
at	O
the	O
foot	O
of	O
the	O
lesion	O
,	O
no	O
signs	O
of	O
regression	O
.	O

Ulceration	O
and	O
satellite	O
lesions	O
.	O

No	O
.	O
remnants	O
of	O
the	O
pre	O
-	O
existing	O
naevus	O
.	O

Minimum	O
margin	O
of	O
healthy	O
tissues	O
to	O
the	O
side	O
of	O
the	O
surgical	O
specimen	O
:	O
0	O
.	O
3	O
cm	O
Minimum	O
margin	O
of	O
healthy	O
tissues	O
.	O
from	O
the	O
base	O
of	O
the	O
surgical	O
specimen	O
:	O
0	O
cm	O
.	O

PRIMARY	O
SITE	O
:	O
Stomach	O
(	O
Cardia	O
)	O
.	O

"	O
Product	O
of	O
esophagogastrectomy	O
"	O
:	O
Moderately	O
differentiated	O
invasive	O
and	O
ulcerated	O
adenocarcinoma	O
of	O
Laur	O
	O
n	O
'	O
s	O
intestinal	O
type	O
.	O

Neoplasia	O
size	O
:	O
5	B
.	I
0	I
x	I
4	I
.	I
0	I
x	I
1	I
.	I
4cm	I
.	O

Location	O
:	O
cardia	O
.	O

Depth	O
of	O
infiltration	O
:	O
up	O
to	O
subserosa	O
.	O

Sanguineous	O
vascular	O
invasion	O
:	O
not	O
detected	O
.	O

Lymphatic	O
vascular	O
invasion	O
:	O
present	O
.	O

Perineural	O
invasion	O
:	O
not	O
detected	O
.	O

Adjacent	O
gastric	O
mucosa	O
:	O
moderate	O
chronic	O
inactive	O
gastritis	O
.	O

Esophageal	O
adjacent	O
mucosa	O
:	O
moderate	O
chronic	O
esophagitis	O
.	O

Surgical	O
margins	O
free	O
of	O
neoplastic	O
involvement	O
.	O

19	O
lymph	O
nodes	O
were	O
dissected	O
from	O
peri	O
-	O
gastric	O
fat	O
,	O
all	O
free	O
of	O
tumor	O
(	O
0	O
/	O
19	O
)	O
,	O
distributed	O
as	O
.	O
follows	O
:	O
-	O
Chain	O
1	O
-	O
right	O
paracardic	O
:	O
0	O
/	O
2	O
.	O

-	O
Chain	O
2	O
-	O
left	O
paracardic	O
:	O
0	O
/	O
3	O
.	O

Presence	O
of	O
neoplastic	O
infiltration	O
in	O
the	O
.	O
adipose	O
tissue	O
.	O

-	O
Chain	O
3	O
-	O
lesser	O
curvature	O
:	O
0	O
/	O
5	O
.	O

-	O
Chain	O
7	O
-	O
left	O
gastric	O
artery	O
:	O
0	O
/	O
2	O
.	O

-	O
Chain	O
9	O
-	O
celiac	O
trunk	O
:	O
0	O
/	O
3	O
.	O

-	O
Chain	O
110	O
-	O
inferior	O
paraesophageal	O
:	O
0	O
4	O
.	O

"	O
Greater	O
omentum	O
"	O
:	O
.	O

Free	O
of	O
neoplasia	O
.	O

"	O
Esophageal	O
margin	O
"	O
:	O
.	O

Free	O
of	O
neoplasia	O
.	O

Hospital	O
of	O
Origin	O
:	O
QC	O
Pathologist	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
A	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
No	O
neoplasm	O
identified	O
in	O
three	O
lymph	O
nodes	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
No	O
neoplasm	O
identified	O
in	O
three	O
lymph	O
nodes	O
.	O

Aterus	O
,	O
cervix	O
,	O
bilateralovaries	O
and	O
fallopian	O
tubes	O
,	O
.	O

C	O
.	O
hysterectomy	O
with	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
Invasive	O
squamous	O
cell	O
carcinoma	O
.	O

-	O
.	O

Grade	O
:	O
Moderate	O
to	O
poorly	O
differentiated	O
.	O

Location	O
:	O
Circumferential	O
involvement	O
of	O
the	O
cervix	O
with	O
.	O
extensive	O
involvement	O
of	O
the	O
lower	O
uterine	O
segment	O
and	O
.	O
extension	O
into	O
the	O
uterine	O
corpus	O
.	O

Size	O
:	O
Approximately	O
3	O
.	O
8	O
cm	O
by	O
gross	O
evaluation	O
.	O

Tumor	O
involves	O
the	O
deep	O
stroma	O
of	O
the	O
cervix	O
and	O
lower	O
.	O
uterine	O
segment	O
.	O

Depth	O
of	O
deepest	O
invasion	O
is	O
approximately	O
1	O
.	O
8	O
cm	O
.	O

Tumor	O
invades	O
into	O
the	O
adipose	O
connective	O
tissue	O
outside	O
of	O
.	O
the	O
uterus	O
.	O

Lymphovascular	O
space	O
invasion	O
not	O
identified	O
.	O

Surgical	O
margin	O
status	O
:	O
Carcinoma	O
in	O
situ	O
closely	O
approximates	O
the	O
anterior	O
and	O
.	O
posterior	O
cervical	O
margin	O
.	O

Invasive	O
squamous	O
cell	O
carcinoma	O
involves	O
the	O
deep	O
.	O
connective	O
tissue	O
cauterized	O
surface	O
.	O

No	O
tumor	O
identified	O
in	O
the	O
separately	O
submitted	O
left	O
and	O
.	O
right	O
paracervical	O
tissue	O
.	O

Lymph	O
nodes	O
:	O
No	O
tumor	O
identified	O
in	O
three	O
lymph	O
nodes	O
of	O
the	O
left	O
.	O
paracervical	O
soft	O
tissue	O
.	O

No	O
neoplasm	O
identified	O
in	O
two	O
lymph	O
nodes	O
of	O
the	O
right	O
.	O
paracervical	O
soft	O
tissue	O
.	O

PTNM	O
stage	O
(	O
AJCC	O
2010	O
)	O
:	O
pT2a1	O
NO	O
.	O

Endometrium	O
-	O
.	O

Atrophy	O
.	O

Myometrium	O
-	O
.	O

Multiple	O
leiomyomas	O
with	O
areas	O
of	O
hyalinization	O
and	O
.	O
calcification	O
;	O
adenomyosis	O
.	O

Bilateral	O
ovaries	O
-	O
.	O

No	O
neoplasm	O
identified	O
.	O

Bilateral	O
fallopian	O
tubes	O
-	O
.	O

No	O
neoplasm	O
identified	O
.	O

D	O
.	O

Specimen	O
submitted	O
as	O
"	O
right	O
uterine	O
artery	O
"	O
,	O
.	O
excision	O
:	O
Benign	O
adipose	O
tissue	O
and	O
arterial	O
vessel	O
with	O
no	O
neoplasm	O
.	O
identified	O
.	O

COMMENTS	O
:	O
Selected	O
slides	O
have	O
been	O
reviewed	O
by	O
D	O
.	O
who	O
.	O

agrees	O
with	O
the	O
diagnosis	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
of	O
cervix	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Left	O
pelvic	O
lymph	O
node	O
-	O
FS	O
.	O

B	O
.	O

Right	O
pelvic	O
lymph	O
node	O
-	O
FS	O
.	O

C	O
.	O

Uterus	O
,	O
cervix	O
and	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

D	O
.	O

Right	O
uterine	O
artery	O
.	O

CODES	O
:	O
PROCEDURAL	O
DEMOGRAPHICS	O
:	O
Accession	O
Date	O
/	O
Time	O
:	O
GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
in	O
a	O
single	O
container	O
labeled	O
.	O
and	O
.	O

#	O
1	O
left	O
pelvic	O
lymph	O
node	O
is	O
a	O
6	O
.	O
2	O
x	O
5	O
.	O
3	O
x	O
1	O
.	O
1	O
cm	O
.	O
aggregate	O
.	O
of	O
fibroadipose	O
tissue	O
bearing	O
multiple	O
irregular	O
tan	O
-	O
yellow	O
.	O
firm	O
tissues	O
consistent	O
with	O
probable	O
lymph	O
node	O
ranging	O
.	O
from	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O
to	O
3	O
.	O
5	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
sectioned	O
and	O
representative	O
sections	O
are	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
frozen	O
section	O
residue	O
is	O
.	O
submitted	O
in	O
block	O
1	O
.	O

Additional	O
representative	O
sections	O
.	O
are	O
submitted	O
,	O
to	O
include	O
the	O
lymph	O
nodes	O
in	O
their	O
entirety	O
.	O
as	O
labeled	O
:	O
block	O
2	O
-	O
-	O
four	O
whole	O
probable	O
lymph	O
nodes	O
;	O
.	O
blocks	O
3	O
-	O
8	O
one	O
lymph	O
node	O
hisected	O
in	O
each	O
;	O
blocks	O
9	O
and	O
.	O

10	O
-	O
-	O
one	O
lymph	O
node	O
serially	O
sectioned	O
.	O

The	O
blocks	O
are	O
.	O
labeled	O
.	O

B	O
.	O

Received	O
in	O
a	O
single	O
container	O
labeled	O
.	O
and	O
.	O

#	O
2	O
right	O
pelvic	O
lymph	O
node	O
is	O
a	O
6	O
.	O
3	O
x	O
5	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
.	O
aggregate	O
of	O
fibroadipose	O
tissue	O
bearing	O
multiple	O
irregular	O
.	O
tan	O
-	O
yellow	O
firm	O
tissues	O
consistent	O
with	O
probable	O
lymph	O
node	O
.	O
ranging	O
from	O
1	O
.	O
3	O
X	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
.	O
to	O
2	O
.	O
5	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
.	O
specimen	O
is	O
sectioned	O
and	O
representativ	O
	O
sections	O
are	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
frozen	O
section	O
residue	O
is	O
.	O
submitted	O
in	O
block	O
1	O
.	O

Additional	O
representative	O
sections	O
.	O
are	O
submitted	O
,	O
to	O
include	O
the	O
ly	O
.	O

h	O
nodes	O
in	O
their	O
entirety	O
.	O
as	O
labeled	O
:	O
block	O
2	O
-	O
-	O
three	O
whc	O
.	O
,	O
robable	O
lymph	O
nodes	O
;	O
.	O
block	O
3	O
-	O
-	O
two	O
whole	O
probable	O
lymph	O
nodes	O
;	O
blocks	O
4	O
-	O
7	O
one	O
.	O
lymph	O
node	O
bisected	O
in	O
each	O
.	O

The	O
blocks	O
are	O
labeled	O
.	O

C	O
.	O

Received	O
in	O
a	O
single	O
container	O
labeled	O
,	O
.	O

!	O
and	O
.	O

#	O
3	O
uterus	O
,	O
cervix	O
and	O
bilateral	O
tubes	O
and	O
ovaries	O
is	O
a	O
244	O
.	O
gram	O
previously	O
opened	O
hysterectomy	O
specimen	O
consisting	O
of	O
a	O
.	O

7	O
.	O
8	O
x	O
6	O
.	O
8	O
x	O
3	O
.	O
4	O
cm	O
.	O
uterine	O
body	O
and	O
an	O
attached	O
4	O
.	O
4	O
x	O
4	O
.	O
2	O
x	O
.	O

3	O
.	O
8	O
cm	O
.	O
cervix	O
.	O

There	O
is	O
a	O
rim	O
of	O
gray	O
-	O
white	O
mucosa	O
.	O
surrounding	O
the	O
ectocervix	O
.	O

The	O
serosa	O
is	O
smooth	O
and	O
tan	O
-	O
pink	O
.	O

The	O
ectocervix	O
is	O
.	O
smooth	O
,	O
focally	O
hemorrhagic	O
and	O
gray	O
-	O
white	O
with	O
a	O
0	O
.	O
7	O
cm	O
.	O
slit	O
like	O
os	O
.	O

The	O
endocervical	O
canal	O
is	O
tan	O
and	O
3	O
.	O
6	O
cm	O
.	O

in	O
.	O
length	O
.	O

The	O
cut	O
surface	O
of	O
the	O
cervix	O
consists	O
of	O
a	O
3	O
.	O
8	O
x	O
.	O

2	O
.	O
5	O
cm	O
.	O
gray	O
-	O
white	O
to	O
yellow	O
lesion	O
with	O
a	O
thickness	O
of	O
2	O
.	O
1	O
.	O

cm	O
.	O

The	O
lesion	O
appears	O
to	O
abut	O
the	O
inked	O
margin	O
.	O

The	O
.	O
lesion	O
involves	O
all	O
four	O
quadrants	O
.	O

The	O
lesion	O
possibly	O
.	O
extends	O
into	O
the	O
lower	O
uterine	O
segment	O
.	O

The	O
identifiable	O
endometrial	O
cavity	O
is	O
1	O
.	O
8	O
cm	O
.	O
from	O
cornu	O
to	O
.	O
cornu	O
and	O
2	O
.	O
4	O
cm	O
.	O
in	O
length	O
.	O

The	O
endometrium	O
is	O
tan	O
and	O
.	O
averages	O
0	O
.	O
1	O
cm	O
.	O
in	O
thickness	O
.	O

The	O
myometrium	O
is	O
.	O
trabeculated	O
,	O
tan	O
-	O
pink	O
and	O
averages	O
1	O
.	O
9	O
cm	O
.	O
in	O
thickness	O
.	O

There	O
are	O
four	O
intramural	O
whorled	O
gray	O
-	O
white	O
dense	O
nodules	O
.	O
ranging	O
from	O
0	O
.	O
5	O
cm	O
.	O
to	O
3	O
.	O
9	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

No	O
.	O
areas	O
of	O
hemorrhage	O
or	O
necrosis	O
are	O
identified	O
in	O
the	O
.	O
nodules	O
.	O

One	O
of	O
the	O
nodules	O
is	O
diffusely	O
hardened	O
and	O
.	O
yellow	O
.	O

There	O
are	O
four	O
irregular	O
tan	O
-	O
yellow	O
to	O
white	O
firm	O
tissues	O
in	O
.	O
the	O
left	O
paracervical	O
soft	O
tissue	O
ranging	O
from	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
3	O
cm	O
.	O
to	O
1	O
.	O
1	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
cm	O
.	O

No	O
obvious	O
lymph	O
nodes	O
or	O
.	O
lesions	O
are	O
identified	O
in	O
the	O
right	O
paracervical	O
soft	O
.	O
tissue	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
is	O
a	O
3	O
.	O
1	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
.	O
ovary	O
with	O
an	O
attached	O
3	O
.	O
3	O
x	O
0	O
.	O
4	O
cm	O
.	O
fimbriated	O
fallopian	O
.	O
tube	O
.	O

The	O
outer	O
surface	O
of	O
the	O
ovary	O
is	O
lobulated	O
and	O
tan	O
.	O

The	O
cut	O
surface	O
is	O
tan	O
with	O
gray	O
-	O
white	O
corpora	O
albicans	O
.	O

The	O
fallopian	O
tube	O
has	O
a	O
tan	O
-	O
pink	O
serosa	O
and	O
a	O
pin	O
point	O
.	O
lumen	O
.	O

There	O
is	O
also	O
a	O
2	O
.	O
5	O
x	O
1	O
.	O
3	O
x	O
0	O
,	O
8	O
cm	O
.	O
ovary	O
with	O
a	O
detached	O
.	O

1	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O
fimbriated	O
fallopian	O
tube	O
.	O

The	O
outer	O
surface	O
.	O
of	O
the	O
ovary	O
is	O
lobulated	O
and	O
tan	O
.	O

The	O
cut	O
surface	O
is	O
tan	O
.	O
with	O
gray	O
-	O
white	O
corpora	O
albicans	O
.	O

The	O
fallopian	O
tube	O
has	O
a	O
.	O
tan	O
-	O
pink	O
serosa	O
and	O
a	O
pin	O
point	O
lumen	O
.	O

The	O
specimen	O
is	O
inked	O
,	O
serially	O
sectioned	O
and	O
representative	O
.	O
sections	O
are	O
submitted	O
as	O
labeled	O
:	O
block	O
1	O
-	O
-	O
cervix	O
12	O
to	O
.	O

3	O
:	O
00	O
;	O
2	O
-	O
-	O
cervix	O
3	O
to	O
6	O
:	O
00	O
;	O
3	O
-	O
-	O
cervix	O
6	O
to	O
9	O
:	O
00	O
;	O
4	O
-	O
-	O
cervix	O
9	O
.	O
to	O
12	O
:	O
00	O
;	O
5	O
-	O
-	O
anterior	O
lower	O
uterine	O
segment	O
;	O
6	O
-	O
-	O
posterior	O
.	O
lower	O
uterine	O
segment	O
;	O
7	O
-	O
-	O
anterior	O
endomyometrium	O
with	O
.	O
serosa	O
;	O
8	O
-	O
-	O
posterior	O
endomyometrium	O
;	O
block	O
9	O
-	O
-	O
two	O
myometrial	O
.	O
nodules	O
;	O
block	O
10	O
-	O
-	O
largest	O
myometrial	O
nodule	O
;	O
blocks	O
11	O
-	O
12	O
.	O
hardened	O
myometrial	O
nodule	O
,	O
following	O
decalcification	O
;	O
block	O
.	O

13	O
-	O
-	O
three	O
whole	O
firm	O
tissues	O
from	O
left	O
paracervical	O
soft	O
.	O
tissue	O
;	O
14	O
-	O
-	O
one	O
firm	O
tissue	O
from	O
left	O
paracervical	O
soft	O
.	O
tissue	O
,	O
bisected	O
;	O
blocks	O
15	O
-	O
16	O
right	O
paracervical	O
soft	O
.	O
hed	O
fallopian	O
tube	O
;	O
block	O
.	O
tissue	O
;	O
18	O
-	O
-	O
ovary	O
block	O
and	O
17	O
-	O
-	O
ovary	O
detached	O
with	O
fallopian	O
tube	O
.	O

The	O
blocks	O
are	O
.	O
labeled	O
Also	O
received	O
in	O
the	O
same	O
container	O
for	O
is	O
a	O
green	O
and	O
yellow	O
.	O
cassette	O
labeled	O
.	O
and	O
.	O

D	O
.	O

Received	O
artery	O
is	O
a	O
3	O
.	O
5	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
.	O
aggregate	O
blocks	O
of	O
.	O
in	O
a	O
single	O
container	O
labeled	O
.	O
right	O
fibroadipose	O
uterine	O
tissue	O
which	O
is	O
submitted	O
in	O
toto	O
in	O
1	O
-	O
2	O
.	O
labeled	O
.	O

INTRA	O
-	O
PROCEDURE	O
CONSULTATION	O
:	O
FSA	O
:	O
ESB	O
:	O
No	O
No	O
tumor	O
tumor	O
identified	O
identified	O
(	O
0	O
/	O
3	O
)	O
.	O

(	O
0	O
/	O
3	O
)	O
.	O

Both	O
diagnoses	O
are	O
per	O
Dr	O
.	O
XR	O
Chest	O
Bedside	O
.	O

EXAMINATION	O
:	O
CHEST	O
-	O
BEDSIDE	O
.	O

CPT	O
:	O
RIS	O
Order	O
:	O
COMPLETED	O
:	O
FULL	O
RESULT	O
:	O
Indication	O
:	O
Short	O
of	O
breath	O
.	O

Comparison	O
:	O
I	O
.	O

Findings	O
:	O
AP	O
chest	O
was	O
performed	O
.	O

Heart	O
size	O
is	O
normal	O
.	O

No	O
adenopathy	O
ist	O
;	O
.	O
evident	O
.	O

Minimal	O
basilar	O
atelectasis	O
or	O
infiltrate	O
is	O
present	O
.	O

There	O
is	O
.	O

no	O
pneumothorax	O
present	O
.	O

There	O
is	O
no	O
pleural	O
fluid	O
present	O
.	O

The	O
osseous	O
.	O
structures	O
appear	O
intact	O
.	O

Mildly	O
dilated	O
loops	O
of	O
bowel	O
are	O
seen	O
beneath	O
.	O
the	O
diaphragm	O
.	O

IMPRESSION	O
:	O
Mild	O
basilar	O
atelectasis	O
or	O
infiltrate	O
.	O

Otherwise	O
,	O
no	O
significant	O
change	O
.	O
in	O
the	O
appearance	O
of	O
the	O
lungs	O
.	O

a	O
.	O

INES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Left	O
kidney	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Laparoscopic	O
left	O
nephrectomy	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
KIDNEY	O
,	O
LEFT	O
,	O
LAPAROSCOPIC	O
LEFT	O
NEPHRECTOMY	O
-	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
CELL	O
)	O
TYPE	O
.	O

B	O
.	O

FUHRMAN	O
NUCLEAR	O
GRADE	O
IS	O
3	O
.	O

C	O
.	O

THE	O
GREATEST	O
DIAMETER	O
OF	O
THE	O
NEOPLASM	O
IS	O
5	B
.	I
5	I
cm	I
.	O

D	O
.	O

THE	O
NEOPLASM	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

E	O
.	O

NO	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
IDENTIFIED	O
.	O

F	O
.	O

NO	O
EVIDENCE	O
OF	O
ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

G	O
.	O

ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
THE	O
NEOPLASM	O
.	O

H	O
.	O

THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

I	O
.	O

TNM	O
STAGE	O
:	O
pT1b	O
NX	O
MX	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
KIDNEY	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Other	O
:	O
Laparoscopic	O
nephrectomy	O
.	O

LATERALITY	O
:	O
Left	O
.	O

TUMOR	O
SITE	O
:	O
Lower	O
pole	O
.	O

FOCALITY	O
:	O
Unifocal	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
5	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
5	B
.	I
3	I
x	I
4	I
.	I
5	I
cm	I
.	O

MACROSCOPIC	O
EXTENT	O
OF	O
TUMOR	O
:	O
Tumor	O
limited	O
to	O
kidney	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Clear	O
cell	O
(	O
conventional	O
)	O
renal	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
G3	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
pT1b	O
.	O

pNX	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

pMX	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

ADRENAL	O
GLAND	O
:	O
Not	O
present	O
.	O

VENOUS	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
)	O
:	O
Absent	O
.	O

LYMPHATIC	O
(	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
L	O
)	O
:	O
Absent	O
.	O

Printed	O
.	O

Sex	O
:	O
M	O
.	O

Date	O
of	O
Service	O
:	O
CLINICAL	O
HISTORY	O
:	O
?	O

Mesothelioma	O
?	O

Mucinous	O
adenocarcinoma	O
?	O

Lymphoma	O
.	O

Normal	O
.	O

MACROSCOPIC	O
:	O
File	O
.	O

1	O
.	O

Left	O
chest	O
wall	O
:	O
Nodular	O
piece	O
of	O
solid	O
grey	O
-	O
white	O
tissue	O
.	O
measuring	O
25mm	O
x	O
20mm	O
x	O
10mm	O
.	O

Slightly	O
shiny	O
cut	O
surface	O
(	O
FS	O
,	O
A	O
-	O
D	O
,	O
.	O
Notes	O
.	O
Requirer	O
.	O
1r	O
)	O
.	O

2	O
.	O

Left	O
lingula	O
:	O
A	O
wedge	O
shaped	O
section	O
of	O
lung	O
tissue	O
measuring	O
60mm	O
.	O

Motified	O
.	O

x	O
20mm	O
x	O
10mm	O
.	O

A	O
staple	O
margin	O
is	O
seen	O
at	O
one	O
edge	O
.	O

The	O
pleural	O
.	O
surface	O
shows	O
a	O
diffuse	O
firm	O
area	O
of	O
white	O
thickening	O
measuring	O
60mm	O
x	O
.	O

Patrent	O
.	O

10mm	O
.	O

The	O
cut	O
surface	O
shows	O
the	O
lung	O
parenchyma	O
to	O
be	O
replaced	O
by	O
firm	O
.	O

Will	O
Ca	O
!	O
.	O
white	O
tissue	O
.	O

FROZEN	O
SECTION	O
REPORT	O
:	O
Make	O
.	O

Appointm	O
.	O

1	O
.	O

INVASIVE	O
MALIGNANCY	O
.	O

Provisional	O
diagnosis	O
mesothelioma	O
vs	O
.	O
adenocarcinoma	O
.	O

Await	O
paraffin	O
and	O
IPOX	O
for	O
definite	O
diagnosis	O
.	O

Prescripti	O
.	O

MICROSCOPIC	O
:	O
On	O
Corte	O
.	O

1	O
.	O

Paraffin	O
sections	O
confirm	O
an	O
infiltrating	O
malignant	O
epithelioid	O
.	O

Treatmer	O
.	O
neoplasm	O
-	O
with	O
luminal	O
formation	O
.	O

There	O
are	O
ragged	O
nests	O
and	O
.	O
infiltrating	O
glandular	O
type	O
structures	O
present	O
with	O
some	O
focal	O
areas	O
of	O
.	O

Check	O
"	O
.	O

Doctor	O
.	O
necrosis	O
lying	O
within	O
a	O
fibroblastic	O
stroma	O
.	O

Some	O
areas	O
show	O
a	O
.	O
sheet	O
-	O
like	O
-	O
growth	O
pattern	O
and	O
large	O
nested	O
areas	O
of	O
growth	O
also	O
seen	O
.	O

The	O
tumour	O
appears	O
predominantly	O
infiltrative	O
however	O
there	O
is	O
also	O
.	O

Normal	O
.	O
some	O
surface	O
atypical	O
proliferation	O
with	O
papillary	O
pattern	O
also	O
.	O

File	O
.	O
present	O
.	O

Notes	O
.	O

2	O
.	O

Sections	O
show	O
infiltrating	O
malignant	O
tumour	O
with	O
overall	O
similar	O
.	O

Require	O
.	O
appearance	O
to	O
that	O
described	O
in	O
specimen	O
1	O
.	O

The	O
tumour	O
involves	O
the	O
.	O
pleural	O
surface	O
and	O
has	O
breached	O
the	O
visceral	O
pleural	O
and	O
extends	O
into	O
.	O

Patrent	O
.	O

Notifiet	O
.	O
the	O
underlying	O
pulmonary	O
parenchyma	O
.	O

Growth	O
is	O
on	O
a	O
broad	O
front	O
.	O

Focal	O
surface	O
overlying	O
fibrin	O
exudation	O
seen	O
.	O

There	O
is	O
also	O
extension	O
.	O

Pauen	O
.	O
in	O
small	O
vascular	O
spaces	O
along	O
the	O
septae	O
.	O

Focally	O
there	O
is	O
a	O
visceral	O
.	O

Will	O
Ca	O
.	O
pleural	O
atypical	O
papillary	O
proliferation	O
of	O
mesothelial	O
cells	O
.	O

Special	O
.	O

Make	O
.	O
stains	O
of	O
infiltrating	O
tumour	O
show	O
mucin	O
stains	O
are	O
negative	O
without	O
.	O

Appointit	O
.	O
definite	O
intracytoplasmic	O
neutral	O
mucin	O
positivity	O
.	O

Immunoperoxidase	O
.	O
stains	O
show	O
infiltrating	O
tumour	O
CALRETININ	O
positive	O
,	O
TTF	O
-	O
1	O
negative	O
,	O
.	O

Cotlec	O
.	O

Prescript	O
.	O

CAM	O
5	O
.	O
2	O
positive	O
,	O
CK	O
7	O
positive	O
,	O
CK20	O
patchy	O
weak	O
to	O
moderate	O
.	O
positivity	O
,	O
EMA	O
positive	O
with	O
cytoplasmic	O
and	O
rim	O
positivity	O
,	O
AE	O
1	O
/	O
3	O
.	O

On	O
Corr	O
.	O
positive	O
,	O
PSA	O
negative	O
,	O
CD15	O
negative	O
,	O
CEA	O
negative	O
,	O
CK5	O
/	O
6	O
patchy	O
.	O

Trezime	O
.	O
moderate	O
positivity	O
.	O

Check	O
"	O
.	O

Docto	O
.	O

M	O
.	O

Printed	O
.	O

M	O
.	O

Sex	O
:	O
M	O
.	O

-	O
3	O
-	O
.	O

Normal	O
.	O

File	O
.	O

CONCLUSION	O
:	O
1	O
.	O

&	O
2	O
.	O

Left	O
chest	O
wall	O
-	O
and	O
left	O
lingula	O
:	O
MALIGNANT	O
MESOTHELIOMA	O
.	O

Required	O
.	O

(	O
nodular	O
and	O
diffuse	O
growth	O
pattern	O
)	O
.	O

Noilfied	O
.	O

Will	O
Cart	O
.	O

Make	O
.	O

Appointment	O
.	O

Prescription	O
.	O

On	O
Correct	O
.	O

Treatment	O
.	O

Check	O
with	O
.	O

Docior	O
.	O

M	O
.	O

Pathology	O
Examination	O
.	O

Birthdate	O
.	O

Pathology	O
.	O

#	O
.	O

Male	O
.	O

Report	O
to	O
:	O
Gross	O
Description	O
by	O
:	O
SPECIMEN	O
SUBMITTED	O
:	O
RT	O
&	O
LT	O
OBTURATOR	O
NODES	O
/	O
PROSTATE	O
.	O

Procedure	O
date	O
.	O

Tissue	O
received	O
.	O

Report	O
Date	O
.	O

Diagnosed	O
by	O
.	O

Previous	O
biopsies	O
:	O
PROSTATE	O
BX	O
'	O
S	O
.	O

SKIN	O
SCALP	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

(	O
Right	O
obturator	O
lymph	O
node	O
,	O
A	O
-	O
C	O
)	O
:	O
Lymph	O
node	O
with	O
no	O
malignancy	O
identified	O
.	O

B	O
.	O

(	O
Left	O
obturator	O
lymph	O
node	O
D	O
-	O
F	O
)	O
:	O
Lymph	O
node	O
with	O
no	O
malignancy	O
identified	O
,	O
see	O
note	O
.	O

C	O
.	O

(	O
Prostate	O
,	O
G	O
-	O
X	O
)	O
:	O
Adenocarcinoma	O
,	O
see	O
synoptic	O
report	O
.	O

Note	O
:	O
Although	O
multiple	O
lymph	O
node	O
profiles	O
present	O
on	O
the	O
slides	O
of	O
the	O
left	O
obturator	O
lymph	O
node	O
.	O
specimen	O
,	O
the	O
number	O
of	O
individual	O
nodes	O
represented	O
by	O
these	O
profiles	O
is	O
not	O
clear	O
.	O

Prostate	O
Gland	O
:	O
Radical	O
prostatectomy	O
Synopsis	O
.	O

MICROSCOPIC	O
.	O

Histologic	O
Type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
Grade	O
-	O
-	O
Gleason	O
Pattern	O
.	O

Primary	O
pattern	O
:	O
Grade	O
3	O
.	O

Secondary	O
pattern	O
:	O
Grade	O
3	O
.	O

Total	O
Gleason	O
Score	O
:	O
6	O
.	O

Tumor	O
quantitation	O
.	O

#	O
Positive	O
Stides	O
.	O

Total	O
Slides	O
.	O

Left	O
.	O

3	O
.	O

5	O
.	O

Left	O
apex	O
.	O

2	O
.	O

3	O
.	O

Right	O
.	O

3	O
.	O

5	O
.	O

Right	O
apex	O
.	O

3	O
.	O

3	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

Primary	O
Tumor	O
:	O
pT2c	O
:	O
Bilateral	O
disease	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Lymph	O
Nodes	O
.	O

Number	O
examined	O
:	O
see	O
Comments	O
.	O

Number	O
involved	O
:	O
see	O
Comments	O
.	O

Margins	O
.	O

Tumor	O
extends	O
to	O
the	O
inked	O
capsular	O
margin	O
of	O
the	O
left	O
lobe	O
(	O
slides	O
U	O
and	O
V	O
)	O
.	O

The	O
bladder	O
.	O
margin	O
and	O
inked	O
apical	O
margins	O
are	O
free	O
of	O
tumor	O
.	O

Extraprostatic	O
extension	O
:	O
Absent	O
.	O

Seminal	O
vesicle	O
invasion	O
(	O
invasion	O
of	O
muscular	O
wall	O
required	O
)	O
:	O
Absent	O
.	O

Perineural	O
invasion	O
:	O
Present	O
.	O

Comments	O
:	O
There	O
is	O
one	O
right	O
obturator	O
lymph	O
node	O
and	O
that	O
shows	O
no	O
evidence	O
of	O
malignancy	O
.	O

Sections	O
of	O
the	O
left	O
obturator	O
lymph	O
node	O
specimen	O
reveal	O
multiple	O
lymph	O
node	O
profiles	O
,	O
but	O
is	O
not	O
.	O
clear	O
how	O
many	O
nodes	O
are	O
represented	O
by	O
these	O
profiles	O
.	O

However	O
all	O
of	O
these	O
sections	O
are	O
free	O
of	O
.	O
tumor	O
.	O

Clinical	O
:	O
Carcinoma	O
of	O
prostate	O
on	O
needle	O
biopsy	O
.	O

Gross	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
in	O
three	O
parts	O
,	O
all	O
labeled	O
.	O
and	O
the	O
medical	O
.	O
record	O
number	O
.	O

Part	O
1	O
is	O
additionally	O
labeled	O
"	O
right	O
obturator	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
a	O
3	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
fatty	O
.	O
tissue	O
excision	O
weighing	O
4	O
grams	O
.	O

The	O
specimen	O
is	O
sectioned	O
to	O
reveal	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
possible	O
.	O
lymph	O
node	O
with	O
a	O
tan	O
white	O
granular	O
cut	O
surface	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
unremarkable	O
.	O
fatty	O
tissue	O
.	O

The	O
specimen	O
is	O
represented	O
as	O
follows	O
:	O
A	O
=	O
large	O
node	O
bisected	O
,	O
B	O
-	O
C	O
=	O
adjacent	O
soft	O
.	O
tissue	O
.	O

Part	O
2	O
is	O
additionally	O
labeled	O
"	O
left	O
obturator	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
a	O
4	O
.	O
3	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
fatty	O
.	O
tissue	O
excision	O
,	O
weighing	O
4	O
grams	O
.	O

The	O
specimen	O
is	O
represented	O
as	O
follows	O
:	O
D	O
=	O
one	O
large	O
possible	O
.	O
node	O
bisected	O
,	O
E	O
-	O
F	O
=	O
soft	O
tissue	O
.	O

Part	O
3	O
is	O
additionally	O
labeled	O
"	O
prostate	O
"	O
and	O
consists	O
of	O
a	O
59	O
gram	O
prostate	O
specimen	O
measuring	O
.	O

5	O
.	O
5	O
X	O
5	O
.	O
2	O
X	O
4	O
.	O
5	O
cm	O
with	O
a	O
right	O
seminal	O
vesicle	O
measuring	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
and	O
a	O
left	O
seminal	O
.	O
vesicle	O
measuring	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
has	O
been	O
oriented	O
by	O
the	O
surgeon	O
with	O
a	O
stitch	O
.	O
in	O
the	O
right	O
seminal	O
vesicle	O
.	O

The	O
right	O
vas	O
deferens	O
is	O
3	O
cm	O
in	O
length	O
with	O
an	O
average	O
diameter	O
of	O
.	O

0	O
.	O
4	O
cm	O
,	O
the	O
left	O
vas	O
deferens	O
is	O
2	O
.	O
2	O
cm	O
in	O
length	O
with	O
an	O
average	O
diameter	O
of	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
.	O

is	O
inked	O
with	O
the	O
right	O
side	O
in	O
black	O
and	O
the	O
left	O
side	O
in	O
blue	O
and	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
.	O
the	O
base	O
.	O

There	O
is	O
diffuse	O
nodularity	O
in	O
the	O
apex	O
measuring	O
2	O
cm	O
in	O
greatest	O
diameter	O
.	O

There	O
is	O
.	O
additionally	O
in	O
the	O
posterior	O
apex	O
a	O
firm	O
rubbery	O
nodule	O
measuring	O
approximately	O
0	O
.	O
8	O
cm	O
in	O
largest	O
.	O
dimension	O
.	O
in	O
the	O
right	O
mid	O
apex	O
there	O
is	O
a	O
firm	O
white	O
nodule	O
measuring	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

In	O
the	O
left	O
mid	O
prostate	O
there	O
is	O
a	O
palpable	O
nodule	O
measuring	O
approximately	O
0	O
.	O
2	O
cm	O
.	O

There	O
is	O
additionally	O
some	O
diffuse	O
nodularity	O
posteriorly	O
in	O
the	O
mid	O
base	O
to	O
base	O
region	O
.	O

The	O
.	O
specimen	O
is	O
represented	O
as	O
follows	O
:	O
G	O
=	O
right	O
seminal	O
vesicle	O
and	O
vas	O
deferens	O
,	O
H	O
=	O
left	O
seminal	O
.	O
vesicle	O
and	O
vas	O
deferens	O
,	O
I	O
=	O
shaved	O
left	O
base	O
prostate	O
,	O
J	O
=	O
shaved	O
right	O
base	O
of	O
prostate	O
,	O
K	O
-	O
M	O
=	O
.	O
left	O
apex	O
,	O
N	O
-	O
P	O
=	O
right	O
apex	O
,	O
Q	O
=	O
left	O
and	O
right	O
posterior	O
apex	O
,	O
R	O
=	O
right	O
posterior	O
mid	O
apex	O
,	O
S	O
=	O
left	O
.	O
posterior	O
mid	O
prostate	O
,	O
T	O
=	O
left	O
posterior	O
mid	O
base	O
,	O
U	O
=	O
right	O
posterior	O
mid	O
base	O
,	O
V	O
=	O
left	O
base	O
,	O
W	O
=	O
.	O
left	O
and	O
right	O
base	O
,	O
X	O
=	O
right	O
mid	O
prostate	O
.	O

By	O
his	O
/	O
her	O
signature	O
above	O
,	O
the	O
senior	O
physician	O
certifies	O
that	O
he	O
/	O
she	O
personally	O
conducted	O
a	O
gross	O
and	O
/	O
or	O
microscopic	O
examination	O
of	O
the	O
described	O
.	O

specimens	O
(	O
s	O
)	O
and	O
rendered	O
or	O
confirmed	O
the	O
diagnosis	O
(	O
es	O
)	O
related	O
thereto	O
.	O

Immunohistochemistry	O
test	O
(	O
s	O
)	O
,	O
if	O
applicable	O
,	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
were	O
determined	O
by	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
.	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
.	O
laboratory	O
testing	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
RIGHT	O
ADNEXA	O
,	O
RIGHT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
INVOLVING	O
RIGHT	O
OVARY	O
AND	O
.	O

RIGHT	O
FALLOPIAN	O
TUBE	O
.	O

B	O
.	O

FOCAL	O
LYMPHOVASCULAR	O
INVASION	O
IDENTIFIED	O
.	O

C	O
.	O

PELVIC	O
CYTOLOGY	O
.	O

IS	O
POSITIVE	O
MALIGNANT	O
CELLS	O
.	O

D	O
.	O

FIGO	O
TUMOR	O
STAGE	O
:	O
IV	O
.	O

PART	O
2	O
:	O
LEFT	O
ADNEXA	O
,	O
LEFT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
.	O

A	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
INVOLVING	O
LEFT	O
OVARY	O
.	O

B	O
.	O

LEFT	O
FALLOPIAN	O
TUBE	O
,	O
UNREMARKABLE	O
,	O
.	O

PART	O
3	O
:	O
UTERUS	O
,	O
WITHOUT	O
ADNEXA	O
(	O
162	O
GRAMS	O
)	O
AND	O
ANTERIOR	O
BLADDER	O
PERITONEUM	O
,	O
TOTAL	O
ABDOMINAL	O
.	O

HYSTERECTOMY	O
AND	O
EXCISION	O
-	O
.	O

A	O
.	O

METASTATIC	O
HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
INVOLVING	O
.	O

ANTERIOR	O
BLADDER	O
PERITONEUM	O
,	O
UTERINE	O
SEROSA	O
AND	O
ADJACENT	O
MYOMETRIUM	O
.	O

B	O
.	O

CERVIX	O
WITH	O
LYMPHOVASCULAR	O
INVASION	O
BY	O
METASTATIC	O
HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
.	O

SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

C	O
.	O

WEAKLY	O
PROLIFERATING	O
ENDOMETRIUM	O
.	O

D	O
.	O

ADENOMYOSIS	O
.	O

PART	O
4	O
:	O
SIGMOID	O
MESENTERY	O
NODULE	O
,	O
EXCISION	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

PART	O
5	O
:	O
RIGHT	O
PELVIC	O
PERITONEUM	O
,	O
EXCISION	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

PART	O
6	O
:	O
RIGHT	O
PERICOLIC	O
GUTTER	O
TUMOR	O
,	O
EXCISION	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

PART	O
7	O
:	O
APPENDIX	O
,	O
APPENDECTOMY	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
INVOLVING	O
APPENDICEAL	O
.	O

SEROSA	O
AND	O
PERIAPPENDICEAL	O
TISSUE	O
.	O

PART	O
8	O
:	O
PERIAORTIC	O
LYMPH	O
NODES	O
,	O
DISSECTION	O
-	O
.	O

TWO	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
.	O

CARCINOMA	O
(	O
2	O
/	O
2	O
)	O
.	O

PART	O
9	O
:	O
OMENTUM	O
,	O
OMENTECTOMY	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

PART	O
10	O
:	O
DIAPHRAGMATIC	O
NODULE	O
,	O
EXCISION	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

PART	O
11	O
:	O
MESENTERIC	O
NODULE	O
,	O
EXCISION	O
-	O
.	O

HIGH	O
GRADE	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
PAPILLARY	O
CARCINOMA	O
.	O

SYNOPTIC	O
-	O
PRIMARY	O
OVARIAN	O
TUMORS	O
INCLUDING	O
BORDERLINE	O
TUMORS	O
.	O

TUMOR	O
LOCATION	O
:	O
Bilateral	O
.	O

PROCEDURE	O
:	O
TAH	O
with	O
salpingo	O
-	O
oophorectomy	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
17	B
.	I
5	I
cm	I
.	O

TUMOR	O
TYPE	O
:	O
Papillary	O
serous	O
carcinoma	O
.	O

HISTOLOGIC	O
SILVERBERG	O
GRADE	O
:	O
Poorly	O
differentiated	O
(	O
8	O
-	O
9	O
pts	O
)	O
.	O

ARCHITECTURAL	O
PATTERN	O
:	O
Solid	O
(	O
3	O
)	O
.	O

CYTOLOGIC	O
ATYPIA	O
:	O
Marked	O
(	O
3	O
)	O
.	O

MITOTIC	O
COUNTS	O
/	O
10hpf	O
:	O
>	O
or	O
=	O
25	O
(	O
3	O
)	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
serous	O
tumors	O
)	O
:	O
High	O
grade	O
.	O

VASCULAR	O
INVASION	O
:	O
TUMOR	O
CAPSULE	O
:	O
Intact	O
.	O

SURFACE	O
IMPLANTS	O
:	O
Invasive	O
.	O

SURFACE	O
IMPLANT	O
SITE	O
:	O
Uterus	O
,	O
Fallopian	O
Tubes	O
,	O
Omentum	O
,	O
Peritoneal	O
metastasis	O
beyond	O
the	O
pelvis	O
.	O

SURFACE	O
IMPLANT	O
SIZE	O
:	O
>	O
2	O
cm	O
.	O

MALIGNANT	O
CELLS	O
IN	O
ASCITES	O
OR	O
.	O

PERITONEAL	O
WASHING	O
:	O
LYMPH	O
NODES	O
EXAMINED	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
:	O
2	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
Number	O
of	O
positive	O
lymph	O
nodes	O
,	O
Right	O
:	O
2	O
.	O

Number	O
of	O
positive	O
lymph	O
nodes	O
,	O
Left	O
:	O
0	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
T	O
STAGE	O
,	O
PATHOLOGIC	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
continued	O
.	O

pT3c	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pN1	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pM1	O
.	O

FIGO	O
STAGE	O
:	O
IV	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
with	O
right	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
right	O
,	O
nephrectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Kidney	O
,	O
right	O
,	O
nephrectomy	O
.	O

Tumor	O
Type	O
:	O
Renal	O
cell	O
carcinoma	O
-	O
Conventional	O
(	O
clear	O
cell	O
)	O
type	O
.	O

Fuhrman	O
Nuclear	O
Grade	O
:	O
Nuclear	O
grade	O
II	O
/	O
IV	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
4	B
.	I
5	I
cm	I
.	O

Local	O
Invasion	O
(	O
for	O
renal	O
cortical	O
types	O
)	O
:	O
Not	O
Identified	O
.	O

Renal	O
Vein	O
Invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Non	O
-	O
Neoplastic	O
Kidney	O
:	O
Unremarkable	O
.	O

Adrenal	O
Gland	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Not	O
identified	O
.	O

Staging	O
for	O
renal	O
cell	O
carcinoma	O
/	O
oncocytoma	O
:	O
pT1	O
Tumor	O
<	O
=	O
7	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
limited	O
to	O
the	O
kidney	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
diagnosis	O
,	O
labeled	O
,	O
"	O
Right	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
26	O
.	O
0	O
X	O
12	O
.	O
0	O
x	O
6	O
.	O
5	O
cm	O
.	O
nephrectomy	O
specimen	O
with	O
abundant	O
attached	O
perinephric	O
fat	O
.	O

The	O
specimen	O
is	O
bivalved	O
revealing	O
a	O
10	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
kidney	O
.	O
with	O
a	O
4	O
.	O
5	O
x	O
4	O
.	O
5x3	O
.	O
5	O
cm	O
circumscribed	O
yellow	O
mass	O
within	O
the	O
renal	O
cortex	O
mid	O
-	O
pole	O
and	O
extending	O
into	O
the	O
adjacent	O
perinephric	O
.	O
fat	O
.	O

Gross	O
hemorrhage	O
is	O
identified	O
.	O

The	O
mass	O
does	O
not	O
extend	O
into	O
the	O
pelvi	O
-	O
calyceal	O
system	O
.	O

The	O
renal	O
vein	O
is	O
grossly	O
.	O
uninvolved	O
by	O
tumor	O
.	O

The	O
adrenal	O
gland	O
is	O
not	O
present	O
within	O
the	O
specimen	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
.	O
for	O
.	O

lymph	O
.	O
node	O
.	O

identification	O
and	O
no	O
lymph	O
nodes	O
are	O
grossly	O
identified	O
.	O

The	O
remaining	O
renal	O
parenchyma	O
is	O
serially	O
sectioned	O
at	O
0	O
.	O
5	O
cm	O
intervals	O
.	O
and	O
does	O
not	O
reveal	O
any	O
other	O
grossly	O
obvious	O
lesions	O
.	O

TPS	O
and	O
photographs	O
are	O
taken	O
.	O

Summary	O
of	O
Sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

MARG	O
-	O
vascular	O
and	O
ureteral	O
margins	O
.	O

NL	O
-	O
representative	O
normal	O
.	O

MASS	O
-	O
multiple	O
sections	O
of	O
mass	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
right	O
,	O
nephrectomy	O
(	O
fs	O
)	O
(	O
pjm	O
/	O
Img	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

1	O
.	O
marg	O
.	O

1	O
.	O

6	O
.	O
mass	O
.	O

6	O
.	O

1	O
.	O

nl	O
.	O

1	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
.	O
tissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Diagnosis	O
:	O
PROSTATE	O
,	O
RADICAL	O
PROSTATECTOMY	O
:	O
-	O
Prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
3	O
+	O
4	O
=	O
.	O

7	O
.	O

-	O
Multifocal	O
,	O
largest	O
focus	O
1	B
.	I
7	I
cm	I
.	O

-	O
Involves	O
right	O
and	O
left	O
prostate	O
.	O

-	O
No	O
extraprostatic	O
extension	O
identified	O
.	O

-	O
Perineural	O
invasion	O
present	O
.	O

-	O
Surgical	O
margins	O
free	O
of	O
tumor	O
.	O

PATHOLOGIC	O
TUMOR	O
STAGING	O
SYNOPSIS	O
:	O
Type	O
and	O
grade	O
:	O
Prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
3	O
+	O
4	O
=	O
7	O
.	O

Primary	O
tumor	O
:	O
pT2c	O
.	O

Regional	O
lymph	O
node	O
:	O
pNX	O
.	O

Distant	O
metastasis	O
:	O
pMX	O
.	O

Pathologic	O
stage	O
:	O
IIB	O
.	O

Lymphovascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
invasion	O
:	O
Present	O
.	O

Margin	O
status	O
:	O
R0	O
,	O
negative	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Prostate	O
Tumor	O
Staging	O
Information	O
.	O

(	O
data	O
derived	O
from	O
current	O
specimen	O
,	O
staging	O
in	O
accordance	O
with	O
or	O
modified	O
from	O
AJCC	O
Cancer	O
Staging	O
.	O

Handbook	O
,	O
7th	O
Ed	O
,	O
and	O
CAP	O
protocol	O
,	O
.	O

Procedure	O
:	O
Radical	O
prostatectomy	O
.	O

Specimen	O
type	O
:	O
Prostatectomy	O
.	O

Prostate	O
size	O
/	O
weight	O
:	O
52	O
grams	O
,	O
4	O
.	O
5	O
X	O
4	O
.	O
0	O
X	O
3	O
.	O
5	O
cm	O
.	O

Tumor	O
Features	O
:	O
Tumor	O
site	O
:	O
Right	O
and	O
left	O
prostate	O
lobes	O
.	O

Tumor	O
size	O
:	O
Multifocal	O
,	O
largest	O
focus	O
1	B
.	I
7	I
cm	I
.	O

Tumor	O
quantification	O
:	O
5	O
%	O
of	O
prostate	O
gland	O
.	O

Histologic	O
type	O
:	O
Prostatic	O
adenocarcinoma	O
.	O

Histologic	O
grade	O
(	O
Gleason	O
pattern	O
)	O
:	O
Primary	O
pattern	O
:	O
3	O
.	O

Secondary	O
pattern	O
:	O
4	O
.	O

Tertiary	O
pattern	O
:	O
N	O
/	O
A	O
.	O

Total	O
Gleason	O
score	O
:	O
7	O
.	O

Lymphovascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
invasion	O
:	O
Present	O
.	O

Extraprostatic	O
extension	O
:	O
Not	O
identified	O
.	O

Seminal	O
vesicle	O
invasion	O
:	O
Not	O
identified	O
.	O

Treatment	O
effect	O
:	O
N	O
/	O
A	O
.	O

Lymph	O
Nodes	O
:	O
N	O
/	O
A	O
.	O

Margin	O
Evaluation	O
:	O
Distance	O
to	O
closest	O
margin	O
:	O
0	O
.	O
1	O
cm	O
from	O
left	O
lateral	O
margin	O
.	O

Other	O
margins	O
:	O
0	O
.	O
2	O
cm	O
from	O
right	O
lateral	O
and	O
posterior	O
margins	O
.	O

Pathologic	O
tumor	O
staging	O
descriptors	O
:	O
Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2c	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
pNX	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
pMX	O
.	O

Margin	O
status	O
(	O
R	O
)	O
:	O
R0	O
,	O
negative	O
.	O

Pathologic	O
stage	O
:	O
IIB	O
.	O

Additional	O
findings	O
:	O
High	O
-	O
grade	O
prostatic	O
intraepithelial	O
neoplasia	O
.	O

Comment	O
:	O
N	O
/	O
A	O
.	O

FINAL	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
.	O

Source	O
of	O
Specimen	O
:	O
Prostate	O
.	O

Clinical	O
History	O
/	O
Operative	O
Dx	O
:	O
Malignant	O
neoplasm	O
prostate	O
.	O

Gross	O
Description	O
:	O
The	O
specimen	O
is	O
labeled	O
prostate	O
and	O
is	O
received	O
in	O
formalin	O
.	O

It	O
consists	O
of	O
a	O
prostatectomy	O
specimen	O
.	O
weighing	O
52	O
grams	O
.	O

The	O
prostate	O
gland	O
measures	O
4	O
.	O
5	O
x	O
4	O
X	O
3	O
.	O
5	O
cm	O
and	O
weighs	O
52	O
grams	O
.	O

It	O
includes	O
a	O
2	O
.	O
3	O
.	O

X	O
1	O
.	O
2	O
X	O
1	O
cm	O
portion	O
of	O
right	O
seminal	O
vesicle	O
,	O
a	O
1	O
cm	O
segment	O
of	O
right	O
vas	O
deferens	O
,	O
a	O
1	O
.	O
2	O
cm	O
segment	O
of	O
.	O
left	O
vas	O
deferens	O
,	O
and	O
a	O
2	O
X	O
1	O
.	O
7	O
X	O
0	O
.	O
8	O
cm	O
left	O
seminal	O
vesicle	O
.	O

The	O
right	O
anterior	O
surface	O
of	O
the	O
prostate	O
is	O
.	O
inked	O
blue	O
,	O
the	O
left	O
anterior	O
surface	O
is	O
inked	O
green	O
,	O
and	O
the	O
posterior	O
surface	O
is	O
inked	O
black	O
.	O

The	O
prostatic	O
.	O
apex	O
,	O
bladder	O
neck	O
,	O
and	O
seminal	O
vesicles	O
/	O
vasa	O
are	O
trimmed	O
.	O

The	O
prostate	O
is	O
divided	O
into	O
right	O
and	O
left	O
.	O
halves	O
and	O
is	O
sectioned	O
from	O
apex	O
to	O
bladder	O
neck	O
.	O

In	O
the	O
apical	O
third	O
of	O
the	O
right	O
prostate	O
,	O
there	O
is	O
a	O
0	B
.	I
7	I
.	I

cm	B
circumscribed	O
area	O
of	O
firm	O
yellowish	O
discoloration	O
suggestive	O
of	O
neoplasm	O
.	O

There	O
is	O
very	O
patchy	O
,	O
small	O
,	O
.	O
yellowish	O
discoloration	O
of	O
the	O
corresponding	O
portion	O
of	O
the	O
left	O
apical	O
prostate	O
.	O

The	O
prostatic	O
gland	O
.	O
parenchyma	O
is	O
otherwise	O
tan	O
and	O
shows	O
bulging	O
yellow	O
nodularity	O
in	O
the	O
periurethral	O
region	O
bilaterally	O
.	O

Also	O
in	O
the	O
specimen	O
container	O
are	O
three	O
cylindrical	O
fragments	O
of	O
pale	O
tan	O
tissue	O
suggestive	O
of	O
portions	O
of	O
.	O
vasa	O
varying	O
from	O
1	O
.	O
1	O
-	O
1	O
.	O
8	O
cm	O
in	O
length	O
and	O
up	O
to	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
.	O

Section	O
summary	O
:	O
A1	O
)	O
right	O
prostatic	O
apex	O
,	O
A2	O
)	O
left	O
prostatic	O
apex	O
,	O
A3	O
)	O
right	O
bladder	O
neck	O
,	O
A4	O
)	O
.	O
left	O
bladder	O
neck	O
,	O
A5	O
)	O
surgical	O
margin	O
right	O
vas	O
deferens	O
,	O
right	O
seminal	O
vesicle	O
,	O
A6	O
)	O
surgical	O
margin	O
left	O
vas	O
.	O
deferens	O
,	O
left	O
seminal	O
vesicle	O
,	O
A7	O
-	O
A22	O
)	O
prostate	O
,	O
apex	O
-	O
bladder	O
neck	O
,	O
A23	O
)	O
sections	O
of	O
separate	O
tissue	O
.	O

Microscopic	O
Description	O
:	O
Microscopic	O
sections	O
have	O
been	O
examined	O
.	O

The	O
microscopic	O
findings	O
are	O
reflected	O
in	O
the	O
diagnosis	O
.	O
rendered	O
.	O

SPECIMEN	O
.	O

A	O
.	O

Pericardial	O
reflection	O
node	O
.	O

B	O
.	O

Right	O
upper	O
and	O
middle	O
lobe	O
.	O

C	O
.	O

Lymph	O
node	O
level	O
11	O
.	O

D	O
.	O

Lymph	O
node	O
4R	O
.	O

E	O
.	O

Lymph	O
node	O
2R	O
.	O

F	O
.	O

Lymph	O
node	O
level	O
9	O
.	O

CLINICAL	O
NOTES	O
.	O

Non	O
-	O
small	O
cell	O
lung	O
cancer	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

A	O
)	O
Lymph	O
node	O
,	O
pericardial	O
reflection	O
node	O
,	O
excision	O
-	O
Metastatic	O
.	O
non	O
small	O
cell	O
carcinoma	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
pericardial	O
.	O
reflection	O
node	O
"	O
are	O
irregularly	O
shaped	O
fragments	O
of	O
tan	O
tissue	O
.	O
that	O
.	O

measure	O
0	O
.	O
6	O
X	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
in	O
aggregate	O
dimension	O
.	O

The	O
tissue	O
is	O
.	O
entirely	O
frozen	O
.	O

B	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
and	O
inflated	O
with	O
.	O
formalin	O
labelled	O
"	O
bilobe	O
right	O
upper	O
and	O
middle	O
lobe	O
"	O
is	O
.	O

a	O
.	O

14	O
.	O
0	O
X	O
12	O
.	O
0	O
x	O
5	O
,	O
7	O
cm	O
portion	O
of	O
lung	O
which	O
is	O
grossly	O
consistent	O
.	O
with	O
the	O
upper	O
and	O
middle	O
lobe	O
of	O
the	O
right	O
lung	O
.	O

The	O
pleural	O
is	O
.	O
violaceous	O
smooth	O
glistening	O
with	O
black	O
stippling	O
present	O
showing	O
a	O
.	O

3	O
.	O
0	O
cm	O
umbilication	O
at	O
the	O
fissure	O
of	O
the	O
middle	O
and	O
upper	O
lobe	O
.	O

This	O
focus	O
is	O
inked	O
and	O
the	O
specimen	O
is	O
sectioned	O
to	O
show	O
a	O
large	O
.	O
white	O
-	O
gray	O
firm	O
mass	O
which	O
is	O
5	O
.	O
5	O
x	O
5	O
.	O
0	O
X	O
3	O
.	O

cm	O
.	O

The	O
tumor	O
is	O
.	O
contiguous	O
with	O
the	O
umbilication	O
and	O
is	O
also	O
present	O
at	O
the	O
base	O
of	O
.	O
the	O
middle	O
lobe	O
.	O

There	O
are	O
staples	O
present	O
at	O
this	O
area	O
.	O

This	O
.	O
area	O
.	O

is	O
inked	O
and	O
on	O
sectioning	O
shows	O
no	O
discrete	O
tumor	O
invading	O
the	O
.	O
stapled	O
tissue	O
.	O

The	O
remainder	O
of	O
the	O
parenchyma	O
is	O
red	O
-	O
brown	O
and	O
.	O
fleshy	O
,	O
Few	O
hilar	O
nodes	O
are	O
grossly	O
identified	O
.	O

The	O
tumor	O
comes	O
.	O
within	O
1	O
.	O
5	O
cm	O
of	O
the	O
bronchial	O
margin	O
.	O

Representative	O
sections	O
of	O
.	O

GROSS	O
DESCRIPTION	O
.	O
the	O
specimen	O
are	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
1	O
-	O
brochial	O
and	O
vascular	O
margins	O
;	O
2	O
-	O
5	O
-	O
.	O
representative	O
section	O
of	O
tumor	O
to	O
umbilication	O
and	O
normal	O
;	O
6	O
-	O
.	O
representative	O
section	O
of	O
tumor	O
to	O
base	O
at	O
stapled	O
aspect	O
of	O
middle	O
.	O
lobe	O
;	O
7	O
-	O
tumor	O
to	O
bronchus	O
;	O
8	O
-	O
representative	O
normal	O
;	O
9	O
-	O
10	O
.	O
possible	O
hilar	O
lymph	O
node	O
(	O
block	O
10	O
is	O
bisected	O
)	O
.	O

RS	O
-	O
10	O
.	O

C	O
.	O

Received	O
fresh	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
lymph	O
node	O
level	O
11	O
"	O
is	O
a	O
1	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
4	O
cm	O
black	O
red	O
.	O
irregular	O
soft	O
tissue	O
fragment	O
which	O
is	O
entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

D	O
.	O

Received	O
fresh	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

'	O
lymph	O
node	O
4R	O
"	O
are	O
two	O
red	O
black	O
pink	O
irregular	O
soft	O
.	O
tissue	O
fragments	O
which	O
are	O
0	O
.	O
6	O
cm	O
each	O
in	O
greatest	O
dimension	O
.	O

The	O
.	O
specimens	O
are	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

E	O
.	O

Received	O
fresh	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
lymph	O
node	O
2R	O
"	O
are	O
multiple	O
pink	O
yellow	O
black	O
irregular	O
.	O
soft	O
to	O
hard	O
tissue	O
fragments	O
which	O
have	O
an	O
aggregate	O
measurement	O
.	O

of	O
.	O

2	O
.	O
2	O
X	O
1	O
.	O
5	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
specimens	O
are	O
entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

F	O
.	O

Received	O
fresh	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
lymph	O
node	O
level	O
9	O
"	O
is	O
a	O
2	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
cm	O
pink	O
black	O
.	O
irregular	O
soft	O
tissue	O
fragment	O
which	O
is	O
entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
The	O
tumor	O
measures	O
5	B
.	I
5	I
cm	I
.	O
in	O
dimension	O
and	O
is	O
.	O
present	O
within	O
less	O
than	O
0	O
.	O
2	O
cm	O
.	O
of	O
the	O
bronchial	O
margin	O
of	O
.	O
excision	O
,	O
PT2	O
.	O

Margins	O
of	O
resection	O
:	O
Invasive	O
carcinoma	O
is	O
present	O
in	O
soft	O
tissue	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O
of	O
the	O
lung	O
within	O
0	O
.	O
2	O
cm	O
.	O
of	O
the	O
bronchial	O
margin	O
of	O
excision	O
.	O

Direct	O
extension	O
of	O
tumor	O
:	O
Tumor	O
shows	O
multifocal	O
areas	O
of	O
.	O
extension	O
up	O
to	O
and	O
focally	O
into	O
the	O
pleural	O
but	O
is	O
not	O
identified	O
.	O
on	O
the	O
pleural	O
surface	O
.	O

Vessel	O
invasion	O
:	O
Present	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
Tumor	O
shows	O
involvement	O
of	O
hilar	O
lymph	O
.	O
nodes	O
which	O
appears	O
to	O
be	O
direct	O
extension	O
,	O
although	O
metastases	O
can	O
.	O
not	O
be	O
excluded	O
.	O

Metastatic	O
carcinoma	O
is	O
identified	O
in	O
a	O
.	O
pericardial	O
reflection	O
node	O
,	O
pN2	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
pMx	O
.	O

14x1	O
,	O
3x5	O
,	O
5x1	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Lymph	O
node	O
,	O
pericardial	O
reflection	O
node	O
,	O
excision	O
-	O
One	O
lymph	O
.	O
node	O
positive	O
for	O
metastatic	O
carc	O
	O
noma	O
(	O
1	O
/	O
1	O
)	O
.	O

B	O
.	O

Lung	O
,	O
right	O
upper	O
and	O
middle	O
lobe	O
,	O
excision	O
-	O
Invasive	O
poorly	O
.	O
differentiated	O
adenocarcinoma	O
(	O
see	O
tumor	O
characteristics	O
in	O
.	O
the	O
lung	O
resection	O
template	O
in	O
the	O
microscopic	O
description	O
)	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
level	O
11	O
,	O
excision	O
-	O
One	O
lymph	O
node	O
negative	O
for	O
.	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

D	O
.	O

Lymph	O
node	O
,	O
level	O
4R	O
,	O
excision	O
-	O
Two	O
lymph	O
nodes	O
negative	O
for	O
.	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
2	O
)	O
.	O

E	O
.	O

Lymph	O
node	O
,	O
level	O
2R	O
,	O
excision	O
-	O
Fragments	O
of	O
lymph	O
node	O
.	O
negative	O
for	O
metastatic	O
carcinoma	O
.	O

F	O
.	O

Lymph	O
node	O
,	O
level	O
9	O
,	O
excision	O
-	O
One	O
lymph	O
node	O
negative	O
for	O
.	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
-	O
-	O
End	O
Of	O
Report	O
-	O
-	O
-	O
.	O

E	O
.	O

Received	O
fresh	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

"	O
level	O
5	O
"	O
is	O
a	O
1	O
.	O
5	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
7	O
cm	O
.	O
black	O
pink	O
tan	O
.	O
irregular	O
.	O

rubbery	O
tissue	O
fragment	O
.	O

The	O
specimen	O
is	O
bisected	O
to	O
show	O
a	O
white	O
.	O
firm	O
rubbery	O
nodule	O
which	O
is	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

F	O
.	O

Received	O
fresh	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
.	O
labeled	O
"	O
level	O
4	O
is	O
a	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
pink	O
-	O
red	O
.	O
irregular	O
.	O

soft	O
tissue	O
fragment	O
which	O
is	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

AS	O
-	O
1	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

A	O
.	O

The	O
following	O
template	O
applies	O
to	O
the	O
left	O
lower	O
lobe	O
.	O
wedge	O
resection	O
:	O
Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
1	B
.	I
7	I
cm	I
(	O
pT1	O
)	O
.	O

Margins	O
of	O
resection	O
Uninvolved	O
.	O

Venous	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

Arterial	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymphatic	O
(	O
small	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
See	O
specimen	O
E	O
below	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
Cannot	O
be	O
evaluated	O
by	O
this	O
specimen	O
.	O

(	O
pMX	O
)	O
.	O

Other	O
findings	O
:	O
None	O
.	O

B	O
.	O

The	O
following	O
template	O
applies	O
to	O
the	O
left	O
upper	O
lobe	O
.	O
wedge	O
resection	O
:	O
Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
1	B
.	I
8	I
cm	I
(	O
pT1	O
)	O
.	O

Margins	O
of	O
resection	O
:	O
Uninvolved	O
.	O

Direct	O
extension	O
of	O
tumor	O
:	O
Tumor	O
invades	O
the	O
visceral	O
pleura	O
.	O

Venous	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

Arterial	O
(	O
large	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymphatic	O
(	O
small	O
vessel	O
)	O
invasion	O
:	O
Not	O
identified	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
See	O
specimen	O
E	O
below	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
Cannot	O
be	O
evaluated	O
by	O
this	O
specimen	O
.	O

(	O
pMX	O
)	O
.	O

Other	O
findings	O
:	O
None	O
.	O

C	O
.	O

The	O
level	O
7	O
lymph	O
node	O
demonstrates	O
no	O
evidence	O
of	O
.	O
metastasis	O
in	O
one	O
node	O
.	O

D	O
.	O

The	O
level	O
6	O
lymph	O
node	O
demonstrates	O
two	O
lymph	O
nodes	O
.	O
with	O
.	O

no	O
evidence	O
of	O
metastatic	O
disease	O
.	O

E	O
.	O

The	O
level	O
5	O
lymph	O
node	O
demonstrates	O
metastatic	O
poorly	O
.	O
differentiated	O
carcinoma	O
involving	O
one	O
lymph	O
node	O
.	O

The	O
size	O
of	O
the	O
.	O
metastasis	O
is	O
1	O
.	O
5	O
cm	O
.	O

F	O
.	O

The	O
level	O
4	O
lymph	O
node	O
demonstrates	O
no	O
evidence	O
of	O
.	O
metastasis	O
in	O
one	O
lymph	O
node	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

14x2	O
,	O
4x2	O
,	O
3x4	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Lung	O
,	O
left	O
lower	O
lobe	O
,	O
wide	O
resection	O
:	O
-	O
Poorly	O
differentiated	O
adenocarcinoma	O
,	O
1	B
.	I
7	I
cm	I
,	O
surgical	O
.	O
margins	O
uninvolved	O
.	O

B	O
.	O

Lung	O
,	O
left	O
upper	O
lobe	O
,	O
wedge	O
resection	O
:	O
-	O
Poorly	O
differentiated	O
adenocarcinoma	O
,	O
1	B
.	I
8	I
cm	I
,	O
surgical	O
.	O
margins	O
uninvolved	O
.	O

C	O
.	O

Level	O
7	O
lymph	O
node	O
,	O
resection	O
:	O
-	O
No	O
evidence	O
of	O
metastasis	O
to	O
one	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

D	O
.	O

Level	O
6	O
lymph	O
node	O
,	O
resection	O
:	O
-	O
No	O
evidence	O
of	O
metastasis	O
to	O
two	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

E	O
.	O

Level	O
5	O
lymph	O
node	O
,	O
resection	O
:	O
-	O
Metastatic	O
adenocarcinoma	O
involving	O
one	O
lymph	O
node	O
,	O
size	O
of	O
.	O
metastasis	O
1	O
.	O
5	O
cm	O
.	O

F	O
.	O

Level	O
4	O
lymph	O
node	O
,	O
resection	O
:	O
-	O
No	O
evidence	O
of	O
metastasis	O
to	O
one	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

Gender	O
:	O
Male	O
.	O

Race	O
:	O
Unknown	O
.	O

Report	O
Date	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
;	O
dissection	O
:	O
-	O
Nine	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
9	O
)	O
.	O

B	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
;	O
dissection	O
:	O
-	O
Seven	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
7	O
)	O
.	O

(	O
See	O
comment	O
)	O
.	O

C	O
.	O

Bladder	O
,	O
prostate	O
,	O
seminal	O
vesicles	O
,	O
vas	O
deferens	O
;	O
cystoprostatectomy	O
:	O
-	O
Urothelial	O
carcinoma	O
,	O
high	O
grade	O
,	O
with	O
extensive	O
squamous	O
differentiation	O
.	O
and	O
.	O

keratin	O
production	O
,	O
invasive	O
into	O
muscularis	O
propria	O
.	O

No	O
lymphovascular	O
invasion	O
present	O
.	O

-	O
Margins	O
of	O
resection	O
(	O
soft	O
tissue	O
,	O
.	O
prostatic	O
urethra	O
,	O
right	O
and	O
left	O
ureter	O
)	O
,	O
.	O

no	O
tumor	O
present	O
.	O

-	O
Extensive	O
chronic	O
lymphoplasmacytic	O
inflammatory	O
response	O
and	O
follicular	O
.	O
hyperplasia	O
.	O
in	O
the	O
extravesical	O
adipose	O
tissue	O
.	O

-	O
See	O
pathologic	O
parameters	O
and	O
comment	O
.	O

-	O
Prostate	O
with	O
high	O
grade	O
prostatic	O
intraepithelial	O
neoplasia	O
(	O
PIN	O
)	O
.	O

-	O
Bilateral	O
seminal	O
vesicles	O
and	O
vasa	O
deferentia	O
,	O
no	O
tumor	O
present	O
.	O

D	O
.	O

Urethral	O
margin	O
;	O
resection	O
:	O
-	O
Segment	O
of	O
prostatic	O
urethra	O
,	O
no	O
tumor	O
present	O
.	O

Urothelial	O
Carcinoma	O
Pathologic	O
Parameters	O
.	O

1	O
.	O

Tumor	O
type	O
:	O
Urothelial	O
carcinoma	O
with	O
extensive	O
squamous	O
.	O
differentiation	O
.	O

2	O
.	O

Grade	O
of	O
tumor	O
:	O
High	O
grade	O
.	O

3	O
.	O

Depth	O
of	O
invasion	O
:	O
Muscularis	O
propria	O
,	O
outer	O
half	O
.	O

4	O
.	O

Tumor	O
distribution	O
:	O
Solitary	O
,	O
7	B
.	I
0	I
x	I
3	I
.	I
5	I
x	I
3	I
.	I
0	I
cm	I
.	O

Involving	O
right	O
wall	O
,	O
anterior	O
wall	O
,	O
posterior	O
wall	O
and	O
dome	O
.	O

5	O
.	O

Ureteral	O
margins	O
:	O
Negative6	O
.	O

Distal	O
urethral	O
margin	O
:	O
Negative	O
.	O

7	O
.	O

Soft	O
tissue	O
margin	O
:	O
Negative	O
.	O

8	O
.	O

Lymph	O
nodes	O
:	O
Sixteen	O
lymph	O
nodes	O
,	O
no	O
tumor	O
present	O
(	O
0	O
/	O
16	O
)	O
.	O

9	O
.	O

pTNM	O
:	O
pT2b	O
,	O
NO	O
,	O
MX	O
.	O

Effective	O
.	O

I	O
this	O
Checklist	O
utilizes	O
the	O
7th	O
edition	O
TNM	O
staging	O
.	O
system	O
for	O
Bladder	O
of	O
the	O
American	O
Joint	O
Committee	O
on	O
Cancer	O
(	O
AJCC	O
)	O
and	O
the	O
.	O

Comment	O
.	O

Part	O
B5	O
:	O
The	O
sections	O
show	O
a	O
lymph	O
node	O
with	O
fibrosis	O
and	O
plasmacytic	O
.	O
infiltrate	O
.	O

The	O
immunohistochemical	O
stain	O
Cam5	O
.	O
2	O
is	O
positive	O
in	O
rare	O
dendritic	O
.	O
cells	O
.	O

Part	O
C	O
:	O
The	O
majority	O
of	O
tumor	O
shows	O
extensive	O
squamous	O
differentiation	O
with	O
.	O
keratin	O
production	O
(	O
99	O
%	O
)	O
.	O

M	O
.	O
D	O
.	O

Interpretation	O
performed	O
by	O
the	O
Attending	O
Pathologist	O
and	O
reviewed	O
with	O
the	O
.	O

Resident	O
/	O
Fellow	O
,	O
M	O
.	O
D	O
.	O
,	O
Ph	O
.	O
D	O
.	O

M	O
.	O
D	O
.	O

Clinical	O
History	O
:	O
The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
male	O
with	O
bladder	O
cancer	O
who	O
undergoes	O
.	O
prostatectomy	O
and	O
ileal	O
conduit	O
.	O

Specimens	O
Received	O
:	O
A	O
:	O
Right	O
pelvic	O
lymphnodes	O
.	O

B	O
:	O
Left	O
pelvic	O
lymphnodes	O
.	O

C	O
:	O
Bladder	O
,	O
prostate	O
,	O
seminal	O
vesicles	O
,	O
vas	O
deferens	O
.	O

D	O
:	O
Urethral	O
margin	O
.	O

Gross	O
Description	O
:	O
The	O
specimen	O
is	O
received	O
in	O
four	O
containers	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
medical	O
record	O
number	O
.	O

A	O
.	O

The	O
first	O
container	O
is	O
additionally	O
designated	O
"	O
1	O
.	O
right	O
pelvic	O
lymph	O
.	O

nodes	O
"	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
5	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
aggregate	O
.	O
of	O
fibrofatty	O
tissue	O
which	O
is	O
dissected	O
to	O
reveal	O
multiple	O
tentative	O
lymph	O
nodes	O
.	O
range	O
in	O
size	O
from	O
0	O
.	O
5	O
to	O
2	O
.	O
5	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
as	O
.	O
follows	O
:	O
A1	O
-	O
A5	O
:	O
one	O
node	O
,	O
bisected	O
in	O
each	O
cassette	O
.	O

A6	O
:	O
four	O
lymph	O
nodes	O
.	O

B	O
.	O

The	O
second	O
container	O
is	O
additionally	O
designated	O
"	O
2	O
.	O
left	O
pelvic	O
lymph	O
.	O

nodes	O
"	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
6	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
aggregate	O
.	O
of	O
fibrofatty	O
tissue	O
which	O
is	O
dissected	O
to	O
reveal	O
multiple	O
tentative	O
lymph	O
nodes	O
.	O
range	O
in	O
size	O
from	O
0	O
.	O
5	O
to	O
3	O
.	O
0	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
as	O
.	O
follows	O
:	O
B1	O
-	O
B2	O
:	O
largest	O
node	O
,	O
bisected	O
.	O

B3	O
:	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

B4	O
:	O
one	O
lymph	O
node	O
,	O
bisected	O
.	O

B5	O
:	O
four	O
lymph	O
nodes	O
between	O
sponges	O
.	O

B6	O
:	O
adjacent	O
fibrous	O
tissue	O
.	O

C	O
.	O

The	O
third	O
container	O
is	O
additionally	O
designated	O
"	O
3	O
.	O
bladder	O
,	O
prostate	O
,	O
.	O
seminal	O
vesicles	O
,	O
vas	O
deferens	O
"	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
303	O
.	O
gram	O
,	O
14	O
.	O
5	O
x	O
9	O
.	O
5	O
x	O
3	O
.	O
0	O
cm	O
cystoprostatectomy	O
specimen	O
with	O
attached	O
mesenteric	O
.	O
fat	O
.	O

The	O
bladder	O
measures	O
9	O
.	O
0	O
x	O
8	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

The	O
right	O
ureteral	O
stump	O
.	O
measures	O
0	O
.	O
5	O
cm	O
and	O
the	O
left	O
0	O
.	O
3	O
cm	O
.	O

Both	O
demonstrate	O
patent	O
lumina	O
.	O

The	O
.	O
prostate	O
measures	O
4	O
.	O
5	O
x	O
4	O
.	O
3	O
x	O
4	O
.	O
0	O
cm	O
.	O

The	O
right	O
seminal	O
vesicle	O
measures	O
4	O
.	O
5	O
.	O

x	O
.	O

3	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O

The	O
right	O
vas	O
deferens	O
measures	O
8	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
left	O
seminal	O
.	O
vesicles	O
measures	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
left	O
vas	O
deferens	O
measures	O
4	O
.	O
5	O
x	O
1	O
.	O
0	O
.	O

cm	O
.	O

The	O
right	O
half	O
of	O
the	O
prostate	O
and	O
bladder	O
is	O
inked	O
blue	O
and	O
the	O
left	O
half	O
.	O

is	O
inked	O
black	O
.	O

The	O
prostate	O
is	O
opened	O
anteriorly	O
along	O
the	O
urethra	O
and	O
.	O
continues	O
superiorly	O
through	O
the	O
bladder	O
in	O
a	O
Y	O
-	O
shaped	O
incision	O
.	O

The	O
prostate	O
.	O

is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
to	O
reveal	O
a	O
firm	O
white	O
0	O
.	O
6	O
cm	O
nodule	O
.	O
grossly	O
abutting	O
the	O
black	O
inked	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
prostate	O
is	O
.	O
unremarkable	O
.	O

The	O
seminal	O
vesicles	O
are	O
markedly	O
dilated	O
and	O
filled	O
with	O
a	O
.	O
yellow	O
-	O
green	O
gelatinous	O
fluid	O
.	O

The	O
bladder	O
demonstrates	O
a	O
7	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
0	O
cm	O
.	O
fungating	O
friable	O
yellow	O
-	O
tar	O
mass	O
grossly	O
involving	O
the	O
right	O
wall	O
,	O
anterior	O
.	O
wall	O
,	O
posterior	O
wall	O
and	O
the	O
dome	O
of	O
the	O
bladder	O
.	O

Serially	O
sectioning	O
reveals	O
.	O
tumor	O
invasion	O
into	O
the	O
muscularis	O
propria	O
to	O
a	O
depth	O
of	O
3	B
.	I
0	I
cm	I
extending	O
to	O
.	O
within	O
0	O
.	O
5	O
cm	O
of	O
the	O
inked	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
bladder	O
mucosa	O
is	O
.	O
tan	O
-	O
brown	O
,	O
edematous	O
and	O
glistening	O
with	O
a	O
uniform	O
0	O
.	O
3	O
cm	O
wall	O
thickness	O
.	O

The	O
.	O
bilateral	O
ureteral	O
orifices	O
are	O
identified	O
and	O
probe	O
patent	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
C1	O
:	O
urethral	O
margin	O
.	O

C2	O
:	O
right	O
ureteral	O
margin	O
,	O
between	O
sponges	O
.	O

C3	O
:	O
left	O
ureteral	O
margin	O
,	O
between	O
sponges	O
.	O

C4	O
:	O
prostatic	O
apical	O
margin	O
.	O

C5	O
-	O
C11	O
:	O
representative	O
prostate	O
.	O

C12	O
:	O
seminal	O
vesicles	O
and	O
vasa	O
deferentia	O
.	O

C13	O
-	O
C18	O
:	O
mass	O
from	O
inferior	O
to	O
superior	O
.	O

C19	O
:	O
right	O
ureteral	O
orifice	O
.	O

C20	O
:	O
left	O
ureteral	O
orifice	O
.	O

C21	O
:	O
dome	O
.	O

C22	O
:	O
anterior	O
wall	O
.	O

C23	O
:	O
posterior	O
wall	O
.	O

C24	O
:	O
left	O
wall	O
.	O

C25	O
:	O
trigone	O
.	O

D	O
.	O

The	O
fourth	O
container	O
is	O
additionally	O
designated	O
"	O
4	O
.	O
urethral	O
margin	O
"	O
.	O

Received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
an	O
unremarkable	O
-	O
oriented	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
.	O

0	O
.	O
5	O
cm	O
portion	O
of	O
tissue	O
which	O
is	O
focally	O
cauterized	O
.	O

The	O
specimen	O
is	O
serially	O
.	O
sectioned	O
and	O
entirely	O
submitted	O
in	O
cassette	O
D1	O
.	O
,	O
M	O
.	O
D	O
.	O

Nature	O
of	O
material	O
:	O
Esophagus	O
.	O

ANATOMOPATHOLOGIC	O
RESULT	O
.	O

MACROSCOPY	O
.	O

Received	O
3	O
vials	O
,	O
identified	O
as	O
follows	O
:	O
Vial	O
1	O
(	O
Esophagus	O
)	O
:	O
Received	O
in	O
formalin	O
,	O
surgical	O
specimen	O
represented	O
by	O
the	O
esophagus	O
.	O
and	O
proximal	O
stomach	O
,	O
previously	O
opened	O
at	O
its	O
greatest	O
diameter	O
,	O
weighing	O
79	O
grams	O
.	O

The	O
.	O
esophagus	O
measures	O
11	O
.	O
5	O
X	O
2	O
.	O
2	O
X	O
1	O
.	O
5	O
cm	O
while	O
the	O
stomach	O
measures	O
7	O
.	O
5	O
cm	O
in	O
length	O
and	O
3	O
.	O
1	O
.	O

cm	O
in	O
diameter	O
,	O
lying	O
stapled	O
at	O
its	O
distal	O
end	O
.	O

The	O
outer	O
surface	O
of	O
the	O
esophagus	O
is	O
grayish	O
and	O
.	O
rough	O
without	O
drilling	O
or	O
infiltration	O
areas	O
.	O

Its	O
wall	O
is	O
whitish	O
and	O
shows	O
thickening	O
in	O
its	O
middle	O
.	O
third	O
,	O
where	O
is	O
observed	O
infiltrating	O
and	O
ulcerated	O
mucosal	O
lesion	O
with	O
2	O
.	O
1	O
cm	O
in	O
length	O
.	O

The	O
.	O
lesion	O
is	O
4	O
.	O
1	O
cm	O
distant	O
from	O
closer	O
surgical	O
margin	O
(	O
distal	O
)	O
.	O

The	O
stomach	O
segment	O
displays	O
.	O
brown	O
and	O
smooth	O
serous	O
.	O

To	O
the	O
cuts	O
,	O
the	O
mucosa	O
is	O
brown	O
and	O
wrinkled	O
,	O
without	O
macroscopic	O
.	O
lesions	O
.	O

The	O
dissection	O
of	O
the	O
fat	O
adjacent	O
to	O
the	O
viscera	O
shows	O
nodular	O
,	O
gray	O
and	O
fibroelastic	O
.	O
structures	O
,	O
with	O
higher	O
measures	O
ranging	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
9	O
cm	O
.	O

-	O
Vial	O
2	O
(	O
Lymph	O
node	O
)	O
:	O
nodular	O
,	O
gray	O
and	O
fibroelastic	O
structure	O
,	O
with	O
smooth	O
outer	O
surface	O
and	O
.	O
absence	O
of	O
macroscopic	O
lesion	O
to	O
the	O
cuts	O
,	O
measuring	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
3	O
cm	O
.	O

-	O
Vial	O
3	O
(	O
Liver	O
)	O
:	O
brown	O
tissue	O
fragment	O
,	O
hardened	O
and	O
rectangular	O
,	O
measuring	O
0	O
.	O
5	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
.	O

MICROSCOPY	O
.	O

Description	O
dispensable	O
.	O

DIAGNOSTIC	O
.	O

Product	O
of	O
esophagectomy	O
and	O
partial	O
gastrectomy	O
:	O
-	O
Well	O
-	O
differentiated	O
squamous	O
cell	O
carcinoma	O
,	O
focally	O
ulcerated	O
in	O
the	O
middle	O
third	O
of	O
the	O
.	O
esophagus	O
,	O
associated	O
with	O
extensive	O
in	O
-	O
situ	O
component	O
.	O

-	O
Predominance	O
of	O
areas	O
with	O
squamous	O
cell	O
carcinoma	O
in	O
situ	O
,	O
being	O
that	O
the	O
neoplasm	O
has	O
.	O
macroscopic	O
measure	O
2	B
.	I
2	I
X	I
2	I
.	I
1	I
cm	I
.	O

-	O
Macroscopic	O
shape	O
:	O
ulcerated	O
and	O
infiltrative	O
.	O

-	O
Degree	O
of	O
infiltration	O
:	O
submucosa	O
.	O

-	O
Discrete	O
desmoplastic	O
stromal	O
reaction	O
.	O

-	O
Absence	O
of	O
lymphoid	O
aggregates	O
in	O
the	O
peritumoral	O
stroma	O
.	O

-	O
Absence	O
of	O
vascular	O
infiltration	O
.	O

-	O
Absence	O
of	O
perineural	O
infiltration	O
.	O

-	O
Free	O
surgical	O
margins	O
.	O

-	O
Metastasis	O
in	O
1	O
of	O
10	O
evaluated	O
lymph	O
nodes	O
(	O
1	O
/	O
10	O
)	O
.	O

-	O
Gastric	O
mucosa	O
of	O
body	O
/	O
fundus	O
standard	O
with	O
moderate	O
chronic	O
inflammatory	O
process	O
,	O
focally	O
.	O
active	O
.	O

Positive	O
resence	O
for	O
Helicobacter	O
pylori	O
in	O
small	O
quantity	O
.	O

-	O
Pathological	O
staging	O
pT1b	O
pN1	O
.	O

Product	O
of	O
liver	O
biopsy	O
:	O
-	O
Steatohepatitis	O
stage	O
3	O
,	O
with	O
moderate	O
steatosis	O
(	O
40	O
%	O
of	O
the	O
fragment	O
)	O
.	O

PARTICIPANTS	O
OF	O
APPRAISAL	O
REPORT	O
.	O

-	O
ISSUER	O
.	O

-	O
REVIEWER	O
.	O

page	O
1	O
/	O
2	O
.	O
conv	O
No	O
.	O

Examination	O
:	O
Histopathological	O
examination	O
.	O

Cost	O
of	O
diagnostic	O
procedure	O
.	O

Gender	O
:	O
F	O
.	O

Material	O
:	O
1	O
.	O
lesion	O
excision	O
-	O
from	O
the	O
left	O
breast	O
outer	O
upper	O
quadrant	O
.	O

Unit	O
in	O
charge	O
:	O
Central	O
C	O
.	O
Expected	O
time	O
of	O
examination	O
:	O
5	O
working	O
days	O
.	O

Clinical	O
diagnosis	O
:	O
and	O
left	O
axillary	O
nodes	O
in	O
one	O
block	O
.	O

Results	O
of	O
immunohistochemicarexaminanon	O
:	O
Estrogen	O
receptors	O
found	O
in	O
over	O
75	O
%	O
of	O
neoplastic	O
cell	O
nuclei	O
.	O

Progesterone	O
receptors	O
found	O
in	O
over	O
75	O
%	O
of	O
neoplastic	O
cell	O
.	O
nuclei	O
.	O

HER2	O
protein	O
stained	O
with	O
HercepTest	O
	O
M	O
by	O
DAKO	O
.	O

Score	O
=	O
2	O
+	O
,	O
FISH	O
verification	O
recommended	O
.	O

Macroscopic	O
description	O
:	O
Partial	O
resection	O
of	O
breast	O
-	O
outer	O
upper	O
quadrant	O
.	O

Breast	O
segment	O
sized	O
8	O
.	O
4	O
x	O
7	O
.	O
4	O
x	O
2	O
.	O
6	O
cm	O
with	O
a	O
2	O
.	O
8	O
x	O
6	O
.	O
8	O
cm	O
skin	O
flap	O
and	O
axillary	O
tissue	O
sized	O
8	O
x	O
9	O
x	O
2	O
,	O
no	O
RTG	O
.	O

Tumour	O
cross	O
section	O
sized	O
3	B
.	I
0	I
x	I
1	I
.	I
8	I
x	I
2	I
.	I
9	I
cm	I
.	O

Margin	O
:	O
to	O
the	O
base	O
0	O
.	O
1	O
cm	O
,	O
to	O
the	O
front	O
skin	O
surface	O
0	O
.	O
2	O
cm	O
,	O
to	O
the	O
sternum	O
3	O
.	O
5	O
cm	O
,	O
to	O
the	O
axilla	O
2	O
.	O
2	O
cm	O
,	O
to	O
the	O
shoulder	O
1	O
.	O
3	O
cm	O
,	O
.	O
lower	O
0	O
.	O
8	O
cm	O
.	O

Microscopic	O
description	O
:	O
Carcinoma	O
ductale	O
invasivum	O
NHG3	O
(	O
3	O
+	O
2	O
+	O
3	O
/	O
19	O
mitoses	O
/	O
10	O
HPF	O
-	O
visual	O
area	O
of	O
0	O
.	O
55	O
mm	O
)	O
.	O

Largest	O
dimension	O
of	O
the	O
lesion	O
3	B
.	I
0	I
cm	I
.	O

Minimum	O
margin	O
at	O
the	O
base	O
side	O
<	O
0	O
.	O
05	O
cm	O
.	O

The	O
other	O
margins	O
as	O
in	O
macroscopic	O
description	O
.	O

Lymph	O
nodes	O
:	O
Metastases	O
carcinomatosae	O
in	O
lymphonodis	O
(	O
No	O
II	O
/	O
XIII	O
)	O
.	O

Infiltratio	O
carcinomatosa	O
capsulae	O
lymphonodorum	O
et	O
telae	O
adiposae	O
perinodalis	O
.	O

Histopathological	O
diagnosis	O
:	O
Carcinoma	O
ductale	O
invasivum	O
NHG3	O
,	O
pT2	O
,	O
pN1a	O
.	O

Invasive	O
ductal	O
carcinoma	O
of	O
the	O
left	O
breast	O
.	O

Compliance	O
validated	O
t	O
.	O

Examination	O
:	O
Intraoperative	O
examination	O
.	O
page	O
2	O
/	O
2	O
.	O

Fyamination	O
No	O
.	O
:	O
Results	O
of	O
immunohistochemical	O
.	O
examination	O
:	O
RESULT	O
OF	O
HER2	O
/	O
neu	O
GENE	O
AMPLIFICATION	O
with	O
the	O
FISH	O
method	O
by	O
Path	O
Vysion	O
HER2	O
DNA	O
Probe	O
Kit	O
.	O

HER	O
-	O
2	O
GENE	O
AMPLIFICATION	O
NOT	O
FOUND	O
.	O

M	O
.	O

(	O
178	O
.	O
0cm	O
86	O
.	O
2kg	O
BSA	O
:	O
2	O
.	O
06m	O
	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
RIGHT	O
FRONTAL	O
BRAIN	O
MASS	O
.	O

OLIGODENDROGLIOMA	O
,	O
GRADE	O
2	O
(	O
WHO	O
)	O
.	O

(	O
B	O
)	O
RIGHT	O
FRONTAL	O
BRAIN	O
MASS	O
-	O
.	O

OLIGODENDROGLIOMA	O
,	O
GRADE	O
2	O
(	O
WHO	O
)	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

COMMENT	O
.	O

A	O
1p	O
/	O
19q	O
analysis	O
will	O
be	O
performed	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
RIGHT	O
FRONTAL	O
BRAIN	O
MASS	O
FOR	O
RESEARCH	O
-	O
The	O
specimen	O
consists	O
of	O
a	O
piece	O
of	O
cerebral	O
cortex	O
and	O
underlying	O
white	O
.	O
matter	O
.	O

measuring	O
.	O

5	O
.	O
0	O
x	O
5	O
,	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

On	O
cut	O
surface	O
is	O
a	O
delineated	O
gray	O
-	O
white	O
junction	O
seen	O
in	O
the	O
majority	O
of	O
the	O
specimen	O
.	O

However	O
,	O
a	O
portion	O
shows	O
an	O
obscure	O
gray	O
-	O
white	O
junction	O
.	O

This	O
portion	O
is	O
submitted	O
for	O
frozen	O
section	O
and	O
smear	O
in	O
cassette	O
A1	O
.	O

An	O
additional	O
representative	O
section	O
is	O
submitted	O
in	O
cassettes	O
A2	O
-	O
A10	O
.	O

Specimens	O
are	O
also	O
sent	O
for	O
research	O
studies	O
.	O

FS	O
/	O
DX	O
:	O
LOW	O
-	O
INTERMEDIATE	O
GRADE	O
INFILTRATING	O
GLIOMA	O
.	O

(	O
B	O
)	O
RIGHT	O
FRONTAL	O
BRAIN	O
MASS	O
-	O
The	O
specimen	O
is	O
received	O
fresh	O
in	O
one	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
.	O
record	O
.	O

number	O
.	O
and	O
.	O

designation	O
as	O
right	O
frontal	O
brain	O
mass	O
.	O

The	O
specimen	O
consists	O
of	O
two	O
irregular	O
fragments	O
of	O
yellow	O
to	O
white	O
-	O
tan	O
.	O
tissue	O
.	O

One	O
.	O
fragment	O
measures	O
3	O
.	O
2	O
x	O
2	O
.	O
4	O
x	O
0	O
.	O
7	O
cm	O
and	O
the	O
other	O
fragment	O
measures	O
2	O
.	O
7	O
x	O
2	O
.	O
4	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
cut	O
surface	O
of	O
the	O
.	O
specimen	O
.	O

is	O
.	O
white	O
to	O
yellow	O
-	O
tan	O
and	O
homogeneous	O
,	O
no	O
focal	O
lesions	O
are	O
identified	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
for	O
histologic	O
.	O
examination	O
.	O

SECTION	O
CODE	O
:	O
B1	O
-	O
B3	O
,	O
larger	O
fragment	O
of	O
the	O
specimen	O
submitted	O
entirely	O
;	O
B4	O
-	O
B6	O
,	O
the	O
smaller	O
fragment	O
of	O
specimen	O
.	O
submitted	O
entirely	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
A2000	O
,	O
M	O
-	O
94503	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Released	O
by	O
:	O
Start	O
of	O
ADDEND	O
	O
M	O
.	O

Page	O
:	O
2	O
.	O

M	O
.	O

(	O
178	O
.	O
0cm	O
86	O
.	O
2kg	O
BSA	O
:	O
2	O
.	O
06m	O
	O
.	O

ADDENDUM	O
.	O

Real	O
time	O
PCR	O
was	O
performed	O
for	O
markers	O
on	O
chromosomes	O
1p	O
and	O
199	O
and	O
shows	O
loss	O
at	O
both	O
chromosomal	O
arms	O
.	O

Combined	O
.	O

1p	O
/	O
19q	O
loss	O
has	O
been	O
shown	O
to	O
correlate	O
with	O
the	O
oligodendroglial	O
lineage	O
and	O
may	O
predict	O
a	O
more	O
favorable	O
response	O
to	O
adjuvant	O
.	O
therapy	O
compared	O
with	O
tumors	O
showing	O
intact	O
1p	O
/	O
19q	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

Released	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
.	O

Date	O
Coll	O
:	O
SPECIMEN	O
.	O

A	O
.	O

Left	O
axillary	O
sentinel	O
node	O
.	O

B	O
.	O

Left	O
breast	O
mass	O
.	O

Long	O
stitch	O
anterior	O
,	O
short	O
stitch	O
superior	O
.	O

CLINICAL	O
NOTES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Left	O
breast	O
cancer	O
.	O

CLINICAL	O
HISTORY	O
:	O
year	O
-	O
old	O
white	O
female	O
with	O
breast	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Left	O
breast	O
cancer	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
axillary	O
sentinel	O
nodes	O
"	O
.	O
are	O
two	O
slightly	O
rubbery	O
tan	O
-	O
white	O
-	O
pink	O
tissues	O
in	O
keeping	O
.	O
with	O
lymph	O
nodes	O
measuring	O
0	O
.	O
and	O
1	O
.	O
0	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

The	O
specimens	O
are	O
bisected	O
and	O
entirely	O
submitted	O
independently	O
in	O
.	O
two	O
blocks	O
(	O
one	O
bisected	O
tissue	O
per	O
cassette	O
)	O
.	O

B	O
.	O

Received	O
fresh	O
within	O
a	O
TranSpec	O
container	O
labeled	O
.	O

'	O
left	O
breast	O
mass	O
"	O
is	O
a	O
7	O
.	O
3	O
cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
x	O
6	O
.	O
5	O
.	O

cm	O
.	O

(	O
superior	O
to	O
inferior	O
)	O
x	O
3	O
.	O
7	O
cm	O
.	O

(	O
anterior	O
to	O
posterior	O
)	O
,	O
soft	O
,	O
.	O
lobulated	O
tan	O
gold	O
-	O
white	O
portion	O
of	O
fibroadipose	O
tissue	O
with	O
two	O
.	O
sutures	O
as	O
stated	O
previously	O
.	O

The	O
margins	O
are	O
inked	O
as	O
follows	O
:	O
Anterior	O
-	O
blue	O
,	O
posterior	O
-	O
black	O
,	O
superior	O
-	O
green	O
,	O
and	O
inferior	O
.	O
orange	O
.	O

The	O
specimen	O
is	O
sectioned	O
from	O
medial	O
to	O
lateral	O
.	O

There	O
is	O
.	O

a	O
central	O
,	O
moderately	O
well	O
-	O
circumscribed	O
,	O
3	O
.	O
2	O
cm	O
.	O

(	O
medial	O
to	O
.	O
lateral	O
)	O
x	O
2	O
.	O
5	O
cm	O
.	O

(	O
superior	O
to	O
inferior	O
)	O
x	O
2	O
.	O
4	O
cm	O
.	O

(	O
anterior	O
to	O
.	O
posterior	O
)	O
,	O
firm	O
tan	O
white	O
tumor	O
mass	O
with	O
several	O
central	O
.	O
associated	O
cylindrical	O
tan	O
white	O
structures	O
in	O
keeping	O
with	O
cyte	O
of	O
.	O
prior	O
needle	O
core	O
biopsy	O
.	O

A	O
portion	O
of	O
tumor	O
and	O
a	O
portion	O
of	O
.	O
normal	O
parenchyma	O
are	O
submitted	O
for	O
tissue	O
procurement	O
as	O
requested	O
.	O

The	O
tumor	O
appears	O
to	O
focally	O
extend	O
to	O
within	O
0	O
.	O
3	O
cm	O
.	O
of	O
both	O
the	O
.	O
anterior	O
and	O
posterior	O
inked	O
margins	O
.	O

The	O
cut	O
surfaces	O
throughout	O
.	O
the	O
remainder	O
of	O
the	O
specimen	O
consist	O
predominantly	O
of	O
glistening	O
.	O
lobulated	O
golden	O
yellow	O
adipose	O
tissue	O
with	O
a	O
minimal	O
amount	O
of	O
.	O
interspersed	O
dense	O
tan	O
-	O
white	O
fibrous	O
tissue	O
.	O

No	O
additional	O
.	O
abnormality	O
is	O
noted	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O

a	O
.	O
sequential	O
manner	O
from	O
medial	O
to	O
lateral	O
in	O
10	O
blocks	O
as	O
labeled	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
-	O
Representative	O
perpendicular	O
sections	O
medial	O
.	O
margin	O
cap	O
;	O
2	O
-	O
9	O
sequential	O
sections	O
;	O
10	O
-	O
representative	O
.	O
perpendicular	O
sections	O
lateral	O
margin	O
cap	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

A	O
.	O

Microscopic	O
examination	O
involved	O
the	O
evaluation	O
of	O
the	O
.	O
four	O
H	O
&	O
E	O
stained	O
sections	O
of	O
each	O
of	O
the	O
tissue	O
blocks	O
.	O

Also	O
pan	O
cytokeratin	O
AE1	O
/	O
AE3	O
immunohistochemical	O
stains	O
were	O
.	O
evaluated	O
of	O
each	O
tissue	O
block	O
and	O
no	O
metastatic	O
tumor	O
was	O
.	O
identified	O
in	O
any	O
of	O
the	O
examined	O
sections	O
(	O
0	O
/	O
2	O
)	O
(	O
snpNO	O
)	O
.	O

B	O
.	O

Microscopic	O
examination	O
of	O
the	O
left	O
breast	O
lumpectomy	O
.	O
specimen	O
reveals	O
:	O
Invasive	O
Carcinoma	O
:	O
Present	O
.	O

Histologic	O
type	O
:	O
Infiltrating	O
ductal	O
.	O

Histologic	O
grade	O
:	O
Elston	O
'	O
s	O
SBR	O
grade	O
2	O
.	O

Overall	O
grade	O
:	O
2	O
.	O

Architectural	O
score	O
:	O
2	O
.	O

Nuclear	O
score	O
:	O
2	O
.	O

Mitotic	O
score	O
:	O
2	O
.	O

Greatest	O
dimension	O
(	O
pT	O
)	O
:	O
3	B
.	I
2	I
cm	I
.	O
in	O
greatest	O
dimension	O
(	O
pT2	O
)	O
.	O

Specimen	O
margins	O
:	O
The	O
resection	O
margins	O
are	O
negative	O
for	O
.	O
carcinoma	O
with	O
the	O
closest	O
resection	O
margins	O
being	O
superior	O
and	O
.	O
anterior	O
where	O
invasive	O
tumor	O
is	O
2	O
mm	O
.	O
from	O
the	O
resection	O
.	O
margin	O
.	O

Tumor	O
is	O
3	O
mm	O
from	O
the	O
posterior	O
resection	O
margin	O
.	O

Vessel	O
invasion	O
:	O
Not	O
identified	O
.	O

Calcification	O
:	O
Present	O
.	O

Ductal	O
carcinoma	O
in	O
situ	O
:	O
Present	O
.	O

Histologic	O
pattern	O
:	O
Solid	O
with	O
cancerization	O
of	O
lobules	O
.	O

Nuclear	O
grade	O
:	O
High	O
grade	O
.	O

Central	O
necrosis	O
:	O
Absent	O
.	O

%	O
DCIS	O
of	O
total	O
tumor	O
(	O
if	O
mixed	O
)	O
:	O
Less	O
than	O
10	O
%	O
.	O

Extensive	O
intraductal	O
component	O
(	O
present	O
/	O
absent	O
)	O
:	O
Absent	O
.	O

Specimen	O
margins	O
:	O
DCIS	O
is	O
2	O
mm	O
from	O
the	O
anterior	O
and	O
superior	O
.	O
margins	O
and	O
3	O
mm	O
from	O
the	O
posterior	O
margin	O
.	O

Calcification	O
:	O
not	O
identified	O
.	O

Description	O
of	O
non	O
-	O
tumorous	O
breast	O
:	O
Fibrosis	O
,	O
apocrine	O
metaplasia	O
.	O
and	O
microcysts	O
with	O
sclerosing	O
adenosis	O
.	O

Prognostic	O
markers	O
,	O
Umpon	O
been	O
reported	O
previously	O
on	O
the	O
core	O
.	O
biopsy	O
see	O
.	O

4x2	O
,	O
20x1	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Left	O
axillary	O
sentinel	O
lymph	O
nodes	O
,	O
biopsy	O
:	O
Two	O
lymph	O
nodes	O
negative	O
for	O
metastatic	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

B	O
.	O

Left	O
)	O
breast	O
,	O
lumpectomy	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
Elston	O
'	O
s	O
SBR	O
grade	O
2	O
,	O
tumor	O
size	O
.	O

3	B
.	I
2	I
cm	I
.	O

Associated	O
high	O
grade	O
solid	O
ductal	O
carcinoma	O
in	O
-	O
situ	O
.	O

Invasive	O
and	O
in	O
-	O
situ	O
carcinoma	O
are	O
2	O
mm	O
from	O
the	O
resection	O
.	O
margins	O
designated	O
superior	O
and	O
anterior	O
and	O
3	O
mm	O
from	O
the	O
.	O
resection	O
margin	O
designated	O
posterior	O
.	O

No	O
lymphovascular	O
space	O
invasion	O
identified	O
.	O

See	O
microscopic	O
description	O
.	O

(	O
Electronic	O
Signature	O
)	O
.	O

End	O
Of	O
Report	O
-	O
-	O
-	O
.	O

CLINICAL	O
HTCTORY	O
:	O
Per	O
.	O
serous	O
carcinoma	O
uterus	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Right	O
common	O
iliac	O
node	O
"	O
,	O
received	O
fresh	O
for	O
frozen	O
and	O
later	O
placed	O
in	O
.	O
formalin	O
at	O
.	O

on	O
.	O

is	O
a	O
3	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
lymph	O
node	O
.	O

Representative	O
sections	O
submitted	O
for	O
frozen	O
as	O
AF1	O
,	O
frozen	O
section	O
remnant	O
.	O
submitted	O
in	O
block	O
A1	O
.	O

Remaining	O
lymph	O
node	O
is	O
submitted	O
in	O
block	O
A2	O
.	O

B	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
.	O
formalin	O
at	O
.	O

on	O
.	O

is	O
a	O
390	O
gram	O
(	O
post	O
fixed	O
weight	O
)	O
,	O
14	O
.	O
5	O
x	O
2	O
x	O
7	O
.	O
5	O
.	O

cm	O
uterus	O
with	O
a	O
2	O
.	O
2	O
cm	O
in	O
diameter	O
cervix	O
with	O
a	O
1	O
cm	O
patent	O
os	O
.	O

The	O
serosa	O
.	O

is	O
pink	O
-	O
tan	O
with	O
eight	O
subserosal	O
nodules	O
,	O
ranging	O
from	O
0	O
.	O
3	O
to	O
3	O
.	O
6	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

A	O
1	O
.	O
1	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
3	O
cm	O
pedunculated	O
subserosal	O
nodule	O
is	O
.	O
present	O
.	O

The	O
serosa	O
is	O
inked	O
black	O
.	O

A	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
cyst	O
is	O
seen	O
in	O
the	O
.	O
anterior	O
endocervical	O
canal	O
,	O
1	O
.	O
3	O
cm	O
away	O
from	O
the	O
ectocervix	O
.	O

The	O
surrounding	O
.	O
tissue	O
of	O
the	O
cervix	O
is	O
inked	O
blue	O
.	O

A	O
10	O
.	O
2	O
x	O
8	O
.	O
5	O
cm	O
area	O
of	O
irregularity	O
is	O
noted	O
in	O
the	O
endometrial	O
cavity	O
,	O
.	O
centered	O
in	O
the	O
fundus	O
of	O
the	O
uterus	O
and	O
involving	O
right	O
and	O
left	O
cornu	O
.	O

The	O
.	O
majority	O
of	O
the	O
lesion	O
overlies	O
the	O
6	O
.	O
2	O
x	O
8	O
.	O
5	O
x	O
4	O
.	O
5	O
cm	O
submucosal	O
diffusely	O
.	O
calcified	O
white	O
whorled	O
like	O
nodule	O
.	O

The	O
lesion	O
extends	O
to	O
4	O
.	O
7	O
cm	O
away	O
from	O
.	O
the	O
anterior	O
ectocervix	O
.	O

On	O
cut	O
surface	O
the	O
endometrium	O
is	O
0	O
.	O
2	O
cm	O
in	O
.	O
thickness	O
and	O
the	O
myometrium	O
is	O
1	O
.	O
6	O
cm	O
in	O
thickness	O
.	O

The	O
lesion	O
grossly	O
.	O
extends	O
into	O
the	O
inner	O
third	O
of	O
the	O
myometrium	O
.	O

A	O
3	O
.	O
8	O
x	O
2	O
.	O
2	O
x	O
2	O
.	O
8	O
cm	O
.	O
endometrial	O
polyp	O
is	O
seen	O
adjacent	O
to	O
the	O
right	O
cornu	O
.	O

The	O
polyp	O
is	O
0	O
.	O
5	O
cm	O
.	O
away	O
from	O
the	O
primary	O
lesion	O
.	O

Further	O
sectioning	O
reveals	O
three	O
intramural	O
.	O
white	O
whorled	O
like	O
nodules	O
ranging	O
from	O
0	O
.	O
5	O
through	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

A	O
1	O
.	O
1	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
7	O
cm	O
calcified	O
submucosal	O
nodule	O
is	O
seen	O
in	O
the	O
.	O
posterior	O
segment	O
of	O
the	O
uterus	O
.	O

The	O
right	O
fallopian	O
tube	O
is	O
8	O
.	O
5	O
cm	O
in	O
length	O
x	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
,	O
sectioning	O
.	O
reveals	O
no	O
masses	O
or	O
lesions	O
.	O

The	O
right	O
ovary	O
is	O
3	O
.	O
5	O
x	O
2	O
.	O
4	O
x	O
1	O
.	O
3	O
cm	O
with	O
a	O
.	O

1	O
.	O
5	O
.	O

x	O
1	O
.	O
1	O
x	O
0	O
.	O
9	O
cm	O
simple	O
cyst	O
.	O

Sectioning	O
reveals	O
yellow	O
lobulated	O
cut	O
.	O
surface	O
with	O
a	O
simple	O
uniloculated	O
cyst	O
with	O
no	O
excrescences	O
.	O

The	O
left	O
.	O
fallopian	O
tube	O
is	O
8	O
.	O
3	O
cm	O
in	O
length	O
and	O
0	O
.	O
8	O
cm	O
in	O
diameter	O
,	O
sectioning	O
reveals	O
.	O

no	O
masses	O
or	O
lesions	O
.	O

The	O
left	O
ovary	O
is	O
3	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
cut	O
surface	O
is	O
.	O
yellow	O
-	O
tan	O
and	O
lobulated	O
with	O
no	O
grossly	O
evident	O
masses	O
or	O
lesions	O
.	O

BLOCK	O
SUMMARY	O
:	O
B1	O
-	O
.	O
pedunculated	O
nodule	O
on	O
the	O
serosa	O
.	O

B2	O
-	O
.	O
anterior	O
endocervical	O
canal	O
and	O
lower	O
uterine	O
segment	O
.	O

B3	O
-	O
.	O
representative	O
section	O
of	O
cyst	O
in	O
the	O
anterior	O
lower	O
uterine	O
segment	O
.	O

B4	O
-	O
.	O
posterior	O
lower	O
uterine	O
segment	O
and	O
endocervical	O
canal	O
.	O

B5	O
-	O
6	O
-	O
.	O
representative	O
full	O
thickness	O
sections	O
of	O
the	O
lesion	O
.	O

B7	O
-	O
10	O
-	O
representative	O
sections	O
of	O
the	O
lesion	O
.	O

B11	O
-	O
.	O
lesion	O
with	O
respect	O
to	O
anterior	O
lower	O
uterine	O
segment	O
.	O

B12	O
-	O
.	O
representative	O
full	O
thickness	O
of	O
normal	O
anterior	O
segment	O
of	O
the	O
uterus	O
.	O

B13	O
-	O
.	O
representative	O
full	O
thickness	O
section	O
of	O
posterior	O
segment	O
of	O
uterus	O
.	O

B14	O
-	O
.	O
representative	O
sections	O
of	O
right	O
fallopian	O
tube	O
and	O
ovary	O
with	O
cyst	O
.	O

B15	O
-	O
.	O
representative	O
sections	O
of	O
left	O
fallopian	O
tube	O
and	O
ovary	O
.	O

B16	O
-	O
.	O
representative	O
section	O
of	O
intramural	O
nodules	O
.	O

B17	O
-	O
.	O
representative	O
section	O
of	O
subserosal	O
nodule	O
.	O

B18	O
-	O
.	O
representative	O
section	O
of	O
endometrial	O
polyp	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Right	O
common	O
iliac	O
node	O
"	O
:	O
AF1	O
(	O
representative	O
)	O
-	O
metastatic	O
carcinoma	O
present	O
.	O

MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
HYSTERECTOMY	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
,	O
LYMPH	O
NODE	O
BIOPSY	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pT3a	O
pN1	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
RIGHT	O
COMMON	O
ILIAC	O
NODE	O
"	O
(	O
BIOPSY	O
)	O
:	O
METASTATIC	O
ADENOCARCINOMA	O
IN	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
/	O
)	O
.	O

SIZE	O
OF	O
METASTASIS	O
:	O
0	O
.	O
6	O
CM	O
AT	O
LEAST	O
.	O

FOCAL	O
EXTRACAPSULAR	O
EXTENSION	O
IS	O
PRESENT	O
.	O

B	O
.	O

"	O
UTERUS	O
,	O
CERVIX	O
,	O
BILATERAL	O
TUBES	O
AND	O
OVARIES	O
"	O
(	O
HYSTERECTOMY	O
AND	O
BILATERAL	O
.	O
SALPINGOOOPHORECTOMY	O
)	O
:	O
UTERUS	O
,	O
390	O
GRAMS	O
:	O
CARCINOMA	O
OF	O
THE	O
ENDOMETRIUM	O
:	O
TUMOR	O
SITE	O
:	O
DIFFUSE	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

FIGO	O
GRADE	O
:	O
NOT	O
APPLICABLE	O
.	O

TUMOR	O
SIZE	O
:	O
10	B
.	I
2	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

MAXIMUM	O
DEPTH	O
OF	O
MYOMETRIAL	O
INVASION	O
:	O
SEE	O
COMMENT	O
.	O

LYMPHATIC	O
/	O
VASCULAR	O
INVASION	O
:	O
PRESENT	O
,	O
EXTENSIVE	O
.	O

ADJACENT	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIUM	O
:	O
ENDOMETRIAL	O
POLYP	O
.	O

REMAINING	O
MYOMETRIUM	O
:	O
ADENOMYOSIS	O
.	O

MULTIPLE	O
BENIGN	O
LEIOMYOMAS	O
,	O
UP	O
TO	O
6	B
.	I
2	I
CM	I
.	O

CERVIX	O
:	O
CARCINOMA	O
INVOLVES	O
ENDOCERVICAL	O
MUCOSA	O
.	O

CERVICAL	O
STROMA	O
FREE	O
OF	O
CARCINOMA	O
.	O

SEROSA	O
:	O
FREE	O
OF	O
CARCINOMA	O
.	O

SPECIMEN	O
MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

RIGHT	O
OVARY	O
:	O
CARCINOMA	O
PRESENT	O
WITHIN	O
OVARIAN	O
STROMA	O
.	O

BENIGN	O
BRENNER	O
TUMOR	O
,	O
0	B
.	I
9	I
CM	I
.	O

LEFT	O
OVARY	O
:	O
NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

BENIGN	O
BRENNER	O
TUMOR	O
,	O
0	B
.	I
9	I
CM	I
.	O

FALLOPIAN	O
TUBES	O
,	O
RIGHT	O
AND	O
LEFT	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

COMMENT	O
:	O
The	O
maximum	O
depth	O
of	O
definitive	O
tumor	O
tissue	O
invasion	O
is	O
.	O
approximately	O
2	O
mm	O
in	O
a	O
1	O
.	O
6	O
cm	O
thick	O
myometrium	O
.	O

Carcinoma	O
is	O
extensively	O
.	O
present	O
within	O
the	O
outer	O
half	O
of	O
the	O
myometrium	O
,	O
but	O
at	O
this	O
depth	O
the	O
tumor	O
.	O
appears	O
to	O
be	O
confined	O
within	O
vascular	O
spaces	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

KIONEY	O
,	O
RIGHT	O
,	O
HAND	O
-	O
ASSISTED	O
LAPAROSCOPIC	O
RADICAL	O
NEPHRECTOMY	O
-	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
CLEAR	O
CELL	O
(	O
CONVENTIONAL	O
)	O
TYPE	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
FUHRMAN	O
.	O

GRADE	O
2	O
/	O
4	O
(	O
3	B
.	I
5	I
CM	I
.	O
)	O
.	O

B	O
.	O

THE	O
TUMOR	O
DOES	O
NOT	O
INVADE	O
THE	O
RENAL	O
CAPSULE	O
NOR	O
THE	O
RENAL	O
VEIN	O
.	O

C	O
.	O

ALL	O
SURGICAL	O
RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

D	O
.	O

FOCAL	O
CHRONIC	O
TUBULAR	O
INTERSTITIAL	O
DISEASE	O
IN	O
THE	O
RENAL	O
PARENCHYMA	O
.	O

E	O
.	O

RIGHT	O
ADRENAL	O
GLAND	O
WITH	O
NODULAR	O
HYPERPLASIA	O
,	O
WITH	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
.	O

F	O
.	O

TNM	O
STAGE	O
:	O
pT1A	O
,	O
NX	O
,	O
MX	O
.	O

Final	O
Diagnosis	O
.	O

RECEIVED	O
17	O
SLIDES	O
.	O

LABELED	O
"	O
RIGHT	O
KIDNEY	O
MASS	O
,	O
FINE	O
NEEDLE	O
ASPIRATION	O
"	O
:	O
A	O
.	O

EXTREMELY	O
SCANT	O
SPECIMEN	O
INSUFFICIENT	O
FOR	O
DEFINITIVE	O
DIAGNOSIS	O
.	O

(	O
see	O
comment	O
)	O
.	O

B	O
.	O

RARE	O
ATYPICAL	O
CLEAR	O
CELLS	O
NOTED	O
.	O

(	O
see	O
comment	O
)	O
.	O

C	O
.	O

Rare	O
glomeruli	O
and	O
tubular	O
cells	O
noted	O
.	O

Comment	O
:	O
Twelve	O
smears	O
,	O
3	O
Thinprep	O
slides	O
,	O
and	O
2	O
cell	O
block	O
slides	O
were	O
reviewed	O
.	O

The	O
aspirate	O
is	O
very	O
scant	O
and	O
predominantly	O
consists	O
of	O
blood	O
.	O

One	O
(	O
slide	O
1C2	O
)	O
of	O
the	O
cell	O
block	O
slides	O
show	O
rare	O
atypical	O
clear	O
cells	O
with	O
some	O
scattered	O
hemosiderin	O
pigment	O
.	O

However	O
,	O
.	O
the	O
paucity	O
of	O
the	O
atypical	O
cells	O
precludes	O
a	O
definitive	O
diagnosis	O
.	O

Rare	O
glomeruli	O
and	O
benign	O
tubular	O
cells	O
are	O
also	O
.	O
identified	O
.	O

Repeat	O
sampling	O
is	O
recommended	O
for	O
a	O
definitive	O
diagnosis	O
.	O

SLIDE	O
DISPOSITION	O
:	O
DIAGNOSIS	O
:	O
A	O
.	O

Liver	O
,	O
portion	O
of	O
segment	O
VIII	O
,	O
wedge	O
resection	O
:	O
Subcapsular	O
.	O
fibrosis	O
with	O
associated	O
acellular	O
debris	O
(	O
2	O
.	O
8	O
X	O
1	O
.	O
8	O
X	O
0	O
.	O
8	O
cm	O
)	O
.	O

Negative	O
for	O
tumor	O
.	O

B	O
.	O

Liver	O
,	O
additional	O
portion	O
of	O
segment	O
VIII	O
,	O
wedge	O
resection	O
:	O
Poorly	O
-	O
differentiated	O
cholangiocarcinoma	O
forming	O
a	O
1	B
.	I
4	I
X	I
1	I
.	I
2	I
x	I
1	I
.	I
1	I
.	I

cm	B
mass	O
.	O

The	O
surgical	O
resection	O
margin	O
is	O
negative	O
for	O
tumor	O
(	O
free	O
.	O
by	O
0	O
.	O
cm	O
)	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
the	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
the	O
.	O

specimen	O
(	O
s	O
)	O
Hematoxylin	O
and	O
Eosin	O
(	O
H	O
&	O
E	O
)	O
permanent	O
sections	O
are	O
.	O
reviewed	O
to	O
confirm	O
these	O
findings	O
.	O

Any	O
substantive	O
changes	O
.	O
identified	O
on	O
permanent	O
section	O
review	O
will	O
be	O
reflected	O
in	O
a	O
.	O
revised	O
report	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
liver	O
,	O
portion	O
of	O
segment	O
VIII	O
"	O
is	O
a	O
.	O

10	O
.	O
92	O
gram	O
,	O
3	O
.	O
8	O
X	O
2	O
.	O
9	O
x	O
2	O
.	O
2	O
cm	O
liver	O
wedge	O
specimen	O
.	O

A	O
2	O
.	O
8	O
x	O
1	O
.	O
8	O
.	O

X	O
.	O

0	O
.	O
8	O
cm	O
necrotic	O
mass	O
is	O
present	O
,	O
located	O
0	O
.	O
4	O
cm	O
from	O
the	O
closest	O
.	O
surgical	O
resection	O
margin	O
,	O
which	O
is	O
inked	O
black	O
and	O
submitted	O
.	O
perpendicularly	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Grossed	O
by	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
liver	O
,	O
additional	O
portion	O
of	O
segment	O
.	O

VIII	O
"	O
is	O
a	O
9	O
.	O
19	O
gram	O
,	O
3	O
.	O
7	O
x	O
2	O
.	O
3	O
x	O
1	O
.	O
9	O
cm	O
liver	O
wedge	O
specimen	O
.	O

A	O
.	O
single	O
1	O
.	O

4	O
x	O
1	O
.	O
2	O
x	O
1	O
.	O
1	O
cm	O
tan	O
-	O
white	O
mass	O
is	O
present	O
,	O
located	O
0	O
.	O
6	O
cm	O
.	O
from	O
the	O
closest	O
surgical	O
resection	O
margin	O
,	O
which	O
is	O
submitted	O
.	O
perpendicularly	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Grossed	O
by	O
.	O

BLOCK	O
SUMMARY	O
:	O
Part	O
A	O
:	O
Liver	O
-	O
portion	O
of	O
segment	O
.	O

8	O
.	O

1	O
Liver	O
segment	O
8	O
-	O
1	O
.	O

2	O
Liver	O
segment	O
8	O
-	O
2	O
.	O

3	O
Liver	O
segment	O
8	O
-	O
3	O
.	O

4	O
Liver	O
segment	O
8	O
-	O
4	O
.	O

5	O
Liver	O
segment	O
8	O
-	O
5	O
.	O

Part	O
B	O
:	O
Liver	O
-	O
additional	O
portion	O
segment	O
8	O
.	O

1	O
Liver	O
segment	O
8	O
normal	O
.	O

2	O
Add	O
liver	O
seg	O
8	O
mass	O
.	O

3	O
Add	O
liver	O
seg	O
8	O
capsule	O
.	O

PAGE	O
:	O
1	O
.	O

5	O
LOC	O
:	O
U	O
#	O
.	O

AGE	O
/	O
SX	O
:	O
RM	O
/	O
BED	O
:	O
REG	O
DR	O
:	O
TLOC	O
:	O
DIS	O
:	O
SPEC	O
#	O
:	O
Obtained	O
:	O
CLINICAL	O
HISTORY	O
:	O
LEFT	O
EXTERNAL	O
ILIAC	O
(	O
EVALUATE	O
FOR	O
SUCCEED	O
)	O
.	O

SPECIMEN	O
/	O
PROCEDURE	O
:	O
1	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
OBTURATOR	O
I	O
.	O

2	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
EXTERNAL	O
ILIAC	O
.	O

3	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
COMMON	O
ILIAC	O
.	O

4	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
EXTERNAL	O
ILIAC	O
.	O

5	O
.	O

LYMPH	O
NODE	O
-	O
RIGHT	O
OBTURATOR	O
.	O

6	O
.	O

CERVIX	O
-	O
BIOPSY	O
TUMOR	O
.	O

7	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
EXTERNAL	O
ILIAC	O
.	O

8	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
OBTURATOR	O
.	O

9	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
COMMON	O
ILIAC	O
.	O

10	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
PARA	O
-	O
AORTIC	O
.	O

11	O
.	O

LYMPH	O
NODE	O
-	O
LEFT	O
EXTERNAL	O
ILIAC	O
.	O

IMPRESSION	O
:	O
1	O
)	O
.	O

RIGHT	O
OBTURATOR	O
LYMPH	O
NODE	O
:	O
Six	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
6	O
)	O
.	O

2	O
)	O
.	O

RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
:	O
One	O
lymph	O
node	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
)	O
.	O

RIGHT	O
COMMON	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Seven	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
7	O
)	O
.	O

4	O
)	O
.	O

RIGHT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Three	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
3	O
)	O
.	O

5	O
)	O
.	O

RIGHT	O
OBTURATOR	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

6	O
)	O
.	O

CERVICAL	O
BIOPSY	O
TUMOR	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
large	O
cell	O
keratinizing	O
with	O
stromal	O
invasion	O
.	O

7	O
)	O
.	O

LEFT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Seven	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
7	O
)	O
.	O

8	O
)	O
.	O

LEFT	O
OBTURATOR	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Page	O
:	O
2	O
.	O

SPEC	O
#	O
:	O
IMPRESSION	O
(	O
continued	O
)	O
.	O

Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

9	O
)	O
.	O

LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODE	O
:	O
One	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

10	O
)	O
LEFT	O
PARAAORTIC	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Two	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
2	O
)	O
.	O

11	O
)	O
LEFT	O
EXTERNAL	O
ILIAC	O
LYMPH	O
NODE	O
:	O
Four	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
(	O
0	O
/	O
4	O
)	O
.	O

Dictated	O
.	O

Entered	O
:	O
COMMENT	O
:	O
Thirty	O
-	O
five	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Entered	O
:	O
SPECIAL	O
STAINS	O
/	O
PROCEDURES	O
.	O

Mucicarmine	O
stain	O
is	O
negative	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
obturator	O
"	O
is	O
a	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
9	O
cm	O
.	O
portion	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
dissected	O
for	O
possible	O
lymph	O
.	O
nodes	O
.	O

Six	O
possible	O
lymph	O
nodes	O
identified	O
ranging	O
from	O
0	O
.	O
3	O
cm	O
to	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
and	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
1A	O
:	O
Five	O
possible	O
lymph	O
nodes	O
.	O

Cassettes	O
1B	O
-	O
1C	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

2	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
external	O
iliac	O
"	O
is	O
a	O
pink	O
to	O
pale	O
.	O
tan	O
apparent	O
lymph	O
node	O
with	O
a	O
small	O
amount	O
of	O
adherent	O
yellow	O
gold	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
9	O
cm	O
.	O

The	O
adherent	O
adipose	O
tissue	O
is	O
dissected	O
free	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
common	O
iliac	O
"	O
is	O
a	O
.	O

2	O
.	O
2	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
aggregate	O
of	O
pink	O
to	O
pale	O
tan	O
to	O
yellow	O
gold	O
portions	O
of	O
.	O
fibroadipose	O
tissue	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

Received	O
are	O
seven	O
pink	O
to	O
.	O
pale	O
tan	O
tissue	O
fragments	O
ranging	O
from	O
0	O
.	O
6	O
cm	O
to	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

These	O
.	O
fragments	O
are	O
submitted	O
as	O
follows	O
:	O
SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
(	O
continued	O
)	O
.	O

CASSETTE	O
SUMMARY	O
.	O

Cassette	O
3A	O
:	O
Five	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
3B	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

4	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
external	O
iliac	O
"	O
are	O
three	O
portions	O
.	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
ranging	O
from	O
1	O
.	O
0	O
cm	O
to	O
2	O
.	O
2	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

The	O
specimen	O
is	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

Three	O
.	O
possible	O
lymph	O
nodes	O
identified	O
ranging	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
and	O
.	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
4A	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
4B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

5	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
right	O
obturator	O
"	O
is	O
a	O
3	O
.	O
2	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O
aggregate	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
dissected	O
for	O
possible	O
lymph	O
.	O
nodes	O
.	O

Two	O
possible	O
lymph	O
nodes	O
identified	O
ranging	O
from	O
0	O
.	O
8	O
cm	O
to	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
dimension	O
and	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
5A	O
:	O
One	O
lymph	O
node	O
entirely	O
submitted	O
.	O

Cassette	O
5B	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
cervical	O
biopsy	O
tumor	O
"	O
is	O
a	O
pale	O
pink	O
.	O
tan	O
hemorrhagic	O
tissue	O
fragment	O
,	O
1	B
.	I
1	I
x	I
0	I
.	I
7	I
x	I
0	I
.	I
4	I
cm	I
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
in	O
cassette	O
#	O
6	O
.	O

7	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
external	O
iliac	O
"	O
is	O
a	O
.	O

4	O
.	O
4	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
2	O
cm	O
aggregate	O
of	O
pink	O
to	O
pale	O
tan	O
to	O
yellow	O
gold	O
portions	O
of	O
.	O
fibroadipose	O
tissue	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

Five	O
possible	O
lymph	O
nodes	O
.	O
identified	O
ranging	O
from	O
0	O
.	O
5	O
cm	O
to	O
1	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
and	O
submitted	O
as	O
.	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
7A	O
:	O
Three	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
7B	O
:	O
One	O
lymph	O
node	O
trisected	O
.	O

Cassettes	O
7C	O
-	O
7D	O
:	O
One	O
lymph	O
node	O
serially	O
sectioned	O
,	O
entirely	O
submitted	O
.	O

8	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
obturator	O
"	O
is	O
a	O
portion	O
of	O
yellow	O
.	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
,	O
3	O
.	O
2	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
dissected	O
.	O
for	O
possible	O
lymph	O
nodes	O
.	O

Two	O
possible	O
lymph	O
nodes	O
identified	O
ranging	O
from	O
0	O
.	O
8	O
cm	O
to	O
.	O

3	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
and	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
8A	O
:	O
One	O
possible	O
lymph	O
node	O
.	O

?	O
age	O
:	O
4	O
.	O

SPEC	O
#	O
:	O
Continued	O
)	O
.	O

GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O

Cassettes	O
8B	O
:	O
One	O
lymph	O
node	O
trisected	O
.	O

9	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
common	O
iliac	O
"	O
is	O
a	O
.	O

2	O
.	O
0	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
4	O
cm	O
portion	O
of	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
dissected	O
.	O
for	O
possible	O
lymph	O
nodes	O
.	O

One	O
lymph	O
node	O
identified	O
,	O
1	O
.	O
0	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O

cm	O
.	O

The	O
.	O
specimen	O
is	O
bisected	O
and	O
entirely	O
submitted	O
in	O
cassette	O
#	O
9	O
.	O

10	O
)	O
.	O

Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
para	O
-	O
aortic	O
"	O
are	O
two	O
portions	O
of	O
.	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
ranging	O
from	O
1	O
.	O
0	O
cm	O
to	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

Two	O
possible	O
lymph	O
nodes	O
identified	O
.	O
ranging	O
from	O
0	O
.	O
5	O
cm	O
to	O
0	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
and	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
10	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

11	O
)	O
Received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
external	O
iliac	O
"	O
are	O
two	O
portions	O
of	O
.	O
yellow	O
gold	O
to	O
pink	O
tan	O
fibroadipose	O
tissue	O
ranging	O
from	O
1	O
.	O
7	O
cm	O
to	O
2	O
.	O
1	O
cm	O
in	O
greatest	O
.	O
dimension	O
dissected	O
for	O
possible	O
lymph	O
nodes	O
.	O

Two	O
possible	O
lymph	O
nodes	O
identified	O
.	O
ranging	O
from	O
0	O
.	O
7	O
cm	O
to	O
1	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
and	O
submitted	O
as	O
follows	O
:	O
CASSETTE	O
SUMMARY	O
.	O

Cassette	O
11A	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
11B	O
:	O
One	O
lymph	O
node	O
trisected	O
.	O

Dictated	O
y	O
.	O

Entered	O
:	O
COPIES	O
TO	O
:	O
CPT	O
Codes	O
:	O
MUCICARMINE	O
-	O
88313	O
/	O
3999050	O
,	O
CERVICAL	O
BIOPSY	O
(	O
1	O
)	O
/	O
88305	O
/	O
3997100	O
,	O
.	O

LYMPH	O
NODE	O
BIOPSY	O
(	O
M	O
)	O
/	O
88305	O
/	O
3998021	O
/	O
2	O
,	O
LYMPH	O
NODE	O
,	O
REGIONAL	O
RESECT	O
/	O
88307	O
/	O
3998030	O
/	O
8	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Partial	O
gastrectomy	O
.	O

Tumor	O
Site	O
:	O
Body	O
,	O
greater	O
curvature	O
.	O

Tumor	O
configuration	O
:	O
Exophytic	O
(	O
polypoid	O
)	O
.	O

Tumor	O
size	O
:	O
8	B
.	I
0	I
x	I
7	I
.	I
0	I
X	I
2	I
.	I
5	I
cm	I
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Extent	O
of	O
invasion	O
:	O
Serosa	O
(	O
visceral	O
peritoneum	O
)	O
.	O

Lymph	O
nodes	O
:	O
1	O
of	O
8	O
lymph	O
nodes	O
positive	O
for	O
metastasis	O
.	O

Margins	O
-	O
Proximal	O
margin	O
:	O
Not	O
specified	O
.	O

Distal	O
margin	O
:	O
Not	O
specified	O
.	O

Omental	O
(	O
radial	O
)	O
margin	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
.	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Partial	O
gastrectomy	O
.	O

Tumor	O
Site	O
:	O
Body	O
,	O
greater	O
curvature	O
.	O

Tumor	O
configuration	O
:	O
Exophytic	O
(	O
polypoid	O
)	O
.	O

Tumor	O
size	O
:	O
8	B
.	I
0x7	I
.	I
0x2	I
.	I
5cm	I
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Extent	O
of	O
invasion	O
:	O
Serosa	O
(	O
visceral	O
peritoneum	O
)	O
.	O

Lymph	O
nodes	O
:	O
1	O
of	O
8	O
lymph	O
nodes	O
positive	O
for	O
metastasis	O
.	O

Margins	O
-	O
Proximal	O
margin	O
:	O
Not	O
specified	O
.	O

Distal	O
margin	O
:	O
Not	O
specified	O
.	O

Omental	O
(	O
radial	O
)	O
margin	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
.	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

GA	O
-	O
38	O
-	O
A44F	O
-	O
01A	O
-	O
PR	O
.	O

Diagnosis	O
:	O
A	O
:	O
Lung	O
,	O
right	O
upper	O
lobe	O
,	O
wedge	O
resection	O
.	O

Tumor	O
histologic	O
type	O
(	O
WHO	O
)	O
:	O
invasive	O
lung	O
adenocarcinoma	O
,	O
.	O
acinar	O
predominant	O
(	O
mixed	O
acinar	O
and	O
micropapillary	O
subtypes	O
)	O
.	O

Tumor	O
histologic	O
grade	O
(	O
WHO	O
)	O
:	O
moderate	O
to	O
poorly	O
differentiated	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
2	I
cm	I
maximum	O
tumor	O
size	O
by	O
gross	O
examination	O
.	O

Focality	O
:	O
unifocal	O
.	O

Other	O
structures	O
involved	O
:	O
none	O
.	O

In	O
situ	O
carcinoma	O
:	O
not	O
identified	O
.	O

Extent	O
of	O
invasion	O
:	O
Venous	O
:	O
not	O
identified	O
.	O

Arterial	O
:	O
not	O
identified	O
.	O

Lymphatic	O
:	O
not	O
identified	O
.	O

Perineural	O
:	O
not	O
identified	O
.	O

Pleura	O
:	O
not	O
identified	O
.	O

Surgical	O
margins	O
:	O
negative	O
.	O

Lymph	O
nodes	O
:	O
no	O
tumor	O
seen	O
in	O
one	O
lymph	O
node	O
in	O
this	O
specimen	O
.	O

(	O
0	O
/	O
1	O
)	O
.	O

Size	O
of	O
largest	O
metastasis	O
:	O
not	O
applicable	O
.	O

Extracapsular	O
extension	O
of	O
tumor	O
in	O
lymph	O
nodes	O
:	O
not	O
applicable	O
.	O

Findings	O
in	O
nontumorous	O
lung	O
:	O
emphysematous	O
changes	O
,	O
multifocal	O
.	O
bronchiolar	O
metaplasia	O
and	O
focal	O
fibrous	O
remodeling	O
.	O

AJCC	O
PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT2a	O
pNO	O
.	O

NOTE	O
:	O
This	O
pathologic	O
stage	O
assessment	O
is	O
based	O
on	O
information	O
.	O
available	O
at	O
the	O
time	O
of	O
this	O
report	O
,	O
and	O
is	O
subject	O
to	O
change	O
.	O
pending	O
clinical	O
review	O
and	O
additional	O
information	O
.	O

B	O
:	O
Lymph	O
node	O
,	O
Station	O
4	O
,	O
removal	O
.	O

-	O
Benign	O
fibroadipose	O
soft	O
tissue	O
;	O
no	O
lymph	O
nodes	O
identified	O
;	O
no	O
.	O
tumor	O
seen	O
.	O

Comment	O
:	O
Molecular	O
studies	O
have	O
been	O
ordered	O
on	O
a	O
representative	O
section	O
.	O
of	O
the	O
tumor	O
to	O
be	O
reported	O
separately	O
by	O
.	O

Clinical	O
History	O
:	O
year	O
-	O
old	O
.	O
with	O
right	O
upper	O
lobe	O
mass	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
two	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
is	O
additionally	O
labeled	O
"	O
right	O
upper	O
lobe	O
wedge	O
.	O
'	O
"	O
It	O
.	O
holds	O
a	O
51	O
.	O
8	O
gram	O
,	O
11	O
.	O
0	O
X	O
4	O
.	O
0	O
X	O
2	O
.	O
8	O
cm	O
wedge	O
of	O
lung	O
.	O

There	O
is	O
.	O

an	O
11	O
.	O
0	O
cm	O
staple	O
line	O
along	O
one	O
edge	O
which	O
is	O
removed	O
and	O
the	O
.	O
exposed	O
parenchyma	O
is	O
inked	O
green	O
.	O

The	O
pleura	O
is	O
notable	O
for	O
an	O
.	O
area	O
of	O
tan	O
/	O
white	O
discoloration	O
,	O
roughly	O
2	O
.	O
1	O
X	O
1	O
.	O
6	O
cm	O
which	O
is	O
.	O
inked	O
blue	O
.	O

This	O
area	O
comes	O
to	O
within	O
0	O
.	O
5	O
cm	O
of	O
the	O
green	O
inked	O
.	O
stapled	O
parenchymal	O
margin	O
.	O

Within	O
the	O
wedge	O
there	O
is	O
a	O
3	O
.	O
2	O
X	O
.	O

2	O
.	O
4	O
x	O
1	O
.	O
5	O
cm	O
tan	O
,	O
firm	O
,	O
somewhat	O
circumscribed	O
mass	O
with	O
central	O
.	O
cavitations	O
.	O

The	O
mass	O
is	O
0	O
.	O

4	O
cm	O
from	O
the	O
green	O
inked	O
stapled	O
.	O
parenchymal	O
margin	O
,	O
abuts	O
the	O
pleura	O
,	O
but	O
does	O
not	O
appear	O
to	O
.	O
grossly	O
invade	O
through	O
it	O
,	O
and	O
is	O
surrounded	O
by	O
tan	O
firm	O
lung	O
.	O
tissue	O
.	O

A	O
portion	O
of	O
the	O
mass	O
and	O
normal	O
is	O
submitted	O
to	O
Tissue	O
.	O

Procurement	O
.	O

The	O
remainder	O
of	O
the	O
parenchyma	O
is	O
tan	O
/	O
brown	O
and	O
.	O
spongy	O
.	O

Block	O
summary	O
:	O
A1	O
,	O
A2	O
-	O
mass	O
with	O
respect	O
to	O
green	O
inked	O
parenchymal	O
margin	O
,	O
.	O
perpendicular	O
and	O
overlying	O
pleura	O
.	O

A3	O
-	O
additional	O
section	O
of	O
mass	O
with	O
respect	O
to	O
pleura	O
.	O

A4	O
-	O
mass	O
and	O
adjacent	O
lung	O
parenchyma	O
.	O

A5	O
-	O
lung	O
parenchyma	O
away	O
from	O
mass	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
Station	O
4	O
lymph	O
nodes	O
.	O

"	O
It	O
.	O
holds	O
a	O
2	O
.	O
6	O
X	O
1	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
fragment	O
of	O
yellow	O
firm	O
fibrofatty	O
.	O
tissue	O
.	O

No	O
lymph	O
nodes	O
are	O
palpated	O
within	O
the	O
tissue	O
which	O
is	O
.	O
bisected	O
and	O
submitted	O
in	O
blocks	O
B1	O
-	O
B2	O
,	O
.	O

LAB	O
RESULTS	O
.	O

SURG	O
PATH	O
REPORT	O
.	O

1st	O
Specimen	O
collected	O
on	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

1	O
.	O

RIGHT	O
PYRIFORM	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

2	O
.	O

INFERIOR	O
MARGIN	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

3	O
.	O

RIGHT	O
VALLECULAE	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

4	O
.	O

LEFT	O
PYRIFORM	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

5	O
.	O

LEFT	O
VALLECULAE	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
AND	O
UNDERLYING	O
.	O

LYMPHOID	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

6	O
.	O

TONGUE	O
BASE	O
(	O
RESECTION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

1	O
.	O

RIGHT	O
NECK	O
LEVEL	O
2	O
(	O
RESECTION	O
)	O
:	O
SIXTEEN	O
(	O
16	O
)	O
LYMPH	O
NODES	O
WITH	O
.	O

BENIGN	O
LYMPHOID	O
HYPERPLASIA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SEE	O
NOTE	O
.	O

NOTE	O
:	O
has	O
reviewed	O
a	O
representative	O
lymph	O
node	O
node	O
.	O
from	O
this	O
section	O
,	O
and	O
agrees	O
with	O
the	O
diagnosis	O
of	O
benign	O
lymphoid	O
.	O
hyperplasia	O
.	O

8	O
.	O

RIGHT	O
NECK	O
LEVEL	O
3	O
(	O
RESECTION	O
)	O
:	O
EIGHT	O
(	O
8	O
)	O
LYMPH	O
NODES	O
AND	O
.	O

ASSOCIATED	O
FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

9	O
.	O

RIGHT	O
NECK	O
LEVEL	O
4	O
(	O
RESECTION	O
)	O
:	O
FIVE	O
(	O
5	O
)	O
LYMPH	O
NODES	O
AND	O
.	O

ASSOCIATED	O
FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

10	O
,	O
LEFT	O
NECK	O
LEVEL	O
2	O
(	O
RESECTION	O
)	O
:	O
TEN	O
(	O
10	O
)	O
LYMPH	O
NODES	O
WITH	O
BENIGN	O
.	O

LYMPHOID	O
HYPERPLASIA	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SEE	O
NOTE	O
.	O

NOTE	O
:	O
has	O
reviewed	O
a	O
representative	O
lymph	O
node	O
node	O
.	O
from	O
this	O
section	O
,	O
and	O
agrees	O
with	O
the	O
diagnosis	O
of	O
benign	O
lymphoid	O
.	O
hyperplasia	O
.	O

11	O
.	O

LEFT	O
NECK	O
LEVEL	O
3	O
(	O
RESECTION	O
)	O
:	O
THIRTY	O
-	O
ONE	O
(	O
31	O
)	O
LYMPH	O
NODES	O
AND	O
.	O

ASSOCIATED	O
FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

12	O
.	O

LEFT	O
NECK	O
LEVEL	O
4	O
(	O
RESECTION	O
)	O
:	O
THIRTEEN	O
(	O
13	O
)	O
LYMPH	O
NODES	O
AND	O
.	O

ASSOCIATED	O
FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

13	O
.	O

LARYNX	O
(	O
TOTAL	O
LARYNGECTOMY	O
)	O
:	O
SPECIMEN	O
TYPE	O
:	O
Resection	O
(	O
laryngectomy	O
)	O
:	O
TUMOR	O
SITE	O
:	O
LARYNX	O
:	O
Supraglottis	O
.	O

TUMOR	O
:	O
Greatest	O
dimension	O
3	O
.	O
2	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
conventional	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
:	O
Poorly	O
differentiated	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
SUPRAGLOTTIS	O
:	O
pT4a	O
:	O
Tumor	O
invades	O
through	O
thyroid	O
cartilage	O
.	O

Unofficial	O
lab	O
results	O
-	O
do	O
not	O
file	O
in	O
patient	O
chart	O
.	O

Contact	O
medical	O
records	O
for	O
official	O
chart	O
copy	O
.	O

UNLESS	O
OTHERWISE	O
NOTED	O
ON	O
THE	O
DETATL	O
PAGE	O
ALL	O
LAB	O
RESULTE	O
PEREORMED	O
AT	O
:	O
REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
ALL	O
AERODIGESTIVE	O
SITES	O
EXCEPT	O
.	O

NASOPHARYNX	O
.	O

pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

IXTRA	O
-	O
CAPSULAR	O
EXTENSION	O
OF	O
NODAL	O
TUMOR	O
.	O

Absent	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
pMx	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
INVOLVED	O
BY	O
TUMOR	O
:	O
Right	O
lateral	O
and	O
right	O
superior	O
mucosal	O
margins	O
(	O
specimen	O
.	O
margin	O
)	O
.	O

Left	O
superior	O
mucosal	O
margin	O
(	O
specimen	O
margin	O
)	O
.	O

For	O
true	O
.	O
margin	O
status	O
please	O
see	O
Parts	O
1	O
-	O
6	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
:	O
Absent	O
.	O

PERINEURAL	O
INVASION	O
:	O
Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Carcinoma	O
in	O
situ	O
and	O
chronic	O
inflammation	O
.	O

Attached	O
fragment	O
of	O
benign	O
thyroid	O
tissue	O
.	O

NOTE	O
:	O
This	O
case	O
was	O
shown	O
at	O
the	O
daily	O
Quality	O
Assurance	O
Conference	O
.	O

Unofficial	O
lab	O
results	O
-	O
do	O
not	O
file	O
in	O
patient	O
chart	O
.	O

Contact	O
medical	O
records	O
for	O
official	O
chart	O
copy	O
.	O

UNLESS	O
OTHERWISE	O
NOTED	O
ON	O
THE	O
DETAIL	O
PAGE	O
,	O
ALL	O
LAB	O
RESULTS	O
PERFORMED	O
AT	O
:	O

OF	O
SURGICAL	O
PATHOLOGY	O
.	O

Address	O
:	O
:	O
Hosp	O
.	O

No	O
.	O

:	O
DIAGNOSIS	O
.	O

OVARY	O
,	O
RIGHT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
POORLY	O
DIFFERENTIATED	O
.	O

PAPILLARY	O
SEROUS	O
ADENOCAROINOMA	O
(	O
SEE	O
COMMENT	O
)	O
.	O

OVARY	O
,	O
RIGHT	O
,	O
"	O
TUMOR	O
,	O
11	O
EXCISION	O
-	O
POORIYDIFFERENTIATED	O
PAPTLLARY	O
.	O

SEROUS	O
ADENOCARCINOMA	O
.	O

OVARY	O
,	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

METASTATIC	O
PAPILLARY	O
SEROUS	O
.	O

CARCINOMA	O
IN	O
PARA	O
-	O
OVARIAN	O
ADHESIONS	O
.	O

-	O
SEROUS	O
CYSTADENOMA	O
.	O

FALLOPIAN	O
TUBE	O
,	O
LEFT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
-	O
METASTATIC	O
PAPILLARY	O
.	O

SEROUS	O
ADENOCARCINOMA	O
IN	O
PERITUBAL	O
TISSUE	O
.	O

APPENDIX	O
,	O
APPENDECTOMY	O
-	O
METASTATIC	O
PAPILLARY	O
SEROUS	O
.	O

ADENOCARCINOMA	O
INVOLVING	O
THE	O
SEROSAL	O
SURFACE	O
OF	O
APPENDIX	O
.	O

OMENTUM	O
,	O
OMENTECTOMY	O
-	O
METASTATIC	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
MILD	O
ACUTE	O
AND	O
CHRONIC	O
INFLAMMATION	O
.	O

UTERUS	O
,	O
ENDOMETRIUM	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
INACTIVE	O
ENDOMETRIUM	O
(	O
SEE	O
COMMENT	O
)	O
.	O

UTERUS	O
,	O
MYOMETRIUM	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
LEIOMYOMAS	O
,	O
HYALINIZED	O
,	O
LARGEST	O
.	O

MEASURING	O
1	B
.	I
9	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
.	O

-	O
ADENOMYOSIS	O
.	O

UTERUS	O
,	O
SEROSA	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
-	O
METASTATIC	O
.	O

PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
IN	O
SEROSAL	O
ADHESIONS	O
.	O

-	O
-	O
1	O
-	O
-	O
.	O

OF	O
SURGICAL	O
PATHOLOGY	O
.	O

SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
.	O

Part	O
1	O
:	O
RIGHT	O
OVARY	O
.	O

Part	O
2	O
:	O
RIGHT	O
OVARY	O
TUMOR	O
.	O

Part	O
3	O
:	O
LEFT	O
OVARY	O
.	O

Part	O
4	O
-	O
UTERUS	O
,	O
CERVIX	O
.	O

Part	O
5	O
:	O
MESO	O
-	O
APPENDIX	O
.	O

Part	O
6	O
:	O
OMENTUM	O
.	O

HISTORY	O
.	O

The	O
patient	O
is	O
a	O
.	O
with	O
an	O
ovarian	O
neoplasm	O
with	O
.	O
tumor	O
extending	O
CO	O
omencum	O
on	O
CT	O
BCAN	O
,	O
Increased	O
CA	O
125	O
.	O

Rule	O
.	O
out	O
ovarian	O
carcinoma	O
.	O

Operative	O
procedure	O
:	O
Examination	O
under	O
.	O
anesthesia	O
,	O
laparotomy	O
,	O
total	O
abdominal	O
hysterectomy	O
,	O
bilateral	O
.	O
aalpingo	O
-	O
oophorectomy	O
,	O
omentectomy	O
,	O
An	O
intraoperative	O
.	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
Right	O
ovary	O
,	O
ovary	O
measuring	O
10	O
x	O
7	O
x	O
6	O
cm	O
with	O
a	O
6	O
x	O
3	O
cm	O
area	O
.	O
on	O
the	O
external	O
surface	O
with	O
smooth	O
serosa	O
.	O

The	O
surface	O
ie	O
.	O
replaced	O
by	O
a	O
friable	O
papillary	O
tumor	O
.	O

The	O
majority	O
of	O
the	O
.	O
specimen	O
is	O
cystic	O
and	O
contains	O
brown	O
-	O
gray	O
liquid	O
with	O
numerous	O
.	O
papillary	O
lesions	O
in	O
the	O
wall	O
.	O

Tumor	O
removed	O
in	O
ER	O
for	O
.	O

"	O
.	O

GROSS	O
.	O

The	O
-	O
specimens	O
are	O
received	O
-	O
in	O
six	O
containers	O
of	O
formalin	O
;	O
each	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
e	O
name	O
.	O

The	O
first	O
container	O
is	O
labeled	O
.	O

"	O
uterus	O
,	O
cervix	O
"	O
and	O
contains	O
a	O
uterus	O
with	O
cervix	O
weighing	O
184	O
.	O
grams	O
and	O
measuring	O
11	O
x	O
7	O
.	O
2	O
x	O
5	O
.	O
!	O

cm	O
in	O
greatest	O
dimensions	O
.	O

Externally	O
,	O
the	O
uterine	O
Berosa	O
is	O
irregular	O
at	O
the	O
regione	O
of	O
the	O
.	O
peritoneal	O
reflection	O
.	O

The	O
reat	O
of	O
the	O
serosa	O
appears	O
.	O
hemorrhagic	O
.	O

The	O
uterus	O
is	O
distorted	O
by	O
multiple	O
myomas	O
giving	O
it	O
.	O

a	O
.	O
multinodular	O
architecture	O
.	O

The	O
OB	O
is	O
slit	O
-	O
measuring	O
1	O
.	O

1	O
.	O

cm	O
in	O
greatest	O
dimensions	O
.	O

The	O
cervical	O
canal	O
measures	O
4	O
em	O
in	O
.	O
length	O
.	O

No	O
nodularities	O
or	O
papillary	O
areas	O
are	O
recognized	O
.	O

The	O
.	O
endometrial	O
cavity	O
measures	O
3	O
.	O
7	O
x	O
1	O
.	O
3	O
em	O
in	O
greatest	O
dimensions	O
.	O

There	O
appears	O
to	O
be	O
a	O
polypoid	O
structure	O
been	O
on	O
the	O
posterior	O
.	O
superior	O
wall	O
of	O
the	O
endometrium	O
.	O

This	O
polypoid	O
structure	O
.	O
measures	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
myometrium	O
has	O
a	O
maximum	O
thicknese	O
.	O
that	O
measures	O
3	O
cm	O
.	O

It	O
is	O
distorted	O
by	O
multiple	O
myomas	O
ranging	O
in	O
.	O

-	O
2	O
-	O
-	O
.	O

UF	O
SURGICAL	O
PATHOLOGY	O
.	O

GROSS	O
(	O
continued	O
)	O
.	O
size	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
9	O
cm	O
.	O

These	O
myomas	O
do	O
not	O
appear	O
to	O
show	O
any	O
.	O
evidence	O
of	O
cystification	O
,	O
necrosis	O
,	O
or	O
hemorrhage	O
.	O

Some	O
of	O
these	O
.	O
are	O
hyalinized	O
and	O
calcified	O
.	O

Occasional	O
subserosal	O
myomas	O
are	O
.	O
also	O
recognized	O
.	O

Labeled	O
:	O
C1	O
,	O
anterior	O
cervix	O
;	O
C2	O
,	O
posterior	O
.	O
cervix	O
;	O
E1	O
,	O
polypoid	O
area	O
;	O
E2	O
,	O
anterior	O
endomyometrium	O
;	O
E3	O
.	O
posterior	O
endomyometrium	O
;	O
M1	O
and	O
M2	O
,	O
leiomyomas	O
.	O

Jar	O
2	O
.	O

The	O
second	O
container	O
is	O
labelled	O
"	O
right	O
ovary	O
.	O

11	O
It	O
contains	O
a	O
.	O
previously	O
sectioned	O
ovary	O
measuring	O
10	O
X	O
7	O
x	O
6	O
cm	O
and	O
weighing	O
99	O
.	O
grams	O
.	O

The	O
external	O
Burface	O
is	O
blue	O
-	O
tan	O
and	O
glistening	O
in	O
areas	O
,	O
.	O
but	O
a	O
large	O
area	O
of	O
the	O
surface	O
shows	O
a	O
papillary	O
friable	O
mass	O
.	O
measuring	O
-	O
5	O
.	O
5	O
x	O
4	O
cm	O
.	O

No	O
distinct	O
fallopian	O
tube	O
is	O
recognized	O
.	O

The	O
opened	O
surface	O
of	O
the	O
ovary	O
ehows	O
a	O
thickened	O
wall	O
in	O
multiple	O
.	O
areas	O
with	O
a	O
unilocular	O
cystic	O
structure	O
having	O
multiple	O
papillary	O
.	O
friable	O
excrescences	O
.	O

The	O
cut	O
surface	O
in	O
areas	O
showe	O
a	O
somewhat	O
.	O
cystic	O
underlying	O
friable	O
tissue	O
.	O

Sections	O
taken	O
and	O
labelled	O
as	O
.	O
follows	O
RO1	O
-	O
RO8	O
,	O
cyst	O
wall	O
;	O
RO7	O
and	O
RO8	O
,	O
papillary	O
areas	O
from	O
the	O
.	O
external	O
surface	O
.	O

Jar	O
2	O
.	O

The	O
third	O
container	O
ie	O
labelled	O
"	O
right	O
ovary	O
tumor	O
.	O

"	O
It	O
contains	O
.	O

a	O
large	O
fragment	O
measuring	O
3	B
x	I
3	I
.	I
5	I
x	I
1	I
.	I
2	I
cm	I
in	O
greatest	O
.	O
dimensions	O
.	O

This	O
fragment	O
is	O
extremely	O
friable	O
having	O
a	O
papillary	O
.	O
configuration	O
.	O

Labelled	O
RO9	O
and	O
RO10	O
.	O

Jar	O
1	O
.	O

The	O
fourth	O
container	O
is	O
labelled	O
"	O
left	O
ovary	O
.	O

"	O
It	O
contains	O
a	O
.	O
ovary	O
with	O
attached	O
fallopian	O
tube	O
.	O

The	O
ovary	O
measures	O
3	O
x	O
2	O
.	O

x	O
.	O

1	O
.	O
1	O
cm	O
.	O
in	O
greatest	O
dimensione	O
.	O

Externally	O
,	O
each	O
.	O
shows	O
.	O

multinodular	O
white	O
-	O
yellow	O
configuration	O
with	O
a	O
irregular	O
papillary	O
.	O
area	O
seen	O
on	O
one	O
external	O
aspect	O
.	O

The	O
fallopian	O
tube	O
attached	O
.	O
measures	O
5	O
cm	O
in	O
length	O
having	O
a	O
diameter	O
of	O
0	O
.	O
9	O
cm	O
and	O
appears	O
.	O
free	O
of	O
tumor	O
.	O

The	O
cut	O
surface	O
of	O
the	O
ovary	O
shows	O
a	O
large	O
cystic	O
.	O
cavity	O
filled	O
with	O
serous	O
fluid	O
,	O
unilocular	O
having	O
a	O
emooth	O
.	O
lining	O
.	O

Sectione	O
taken	O
and	O
labelled	O
:	O
L01	O
,	O
ayet	O
of	O
the	O
ovary	O
;	O
L02	O
,	O
.	O
fallopian	O
tube	O
;	O
L03	O
,	O
papillary	O
area	O
,	O
Jar	O
1	O
.	O

The	O
fifth	O
container	O
is	O
labelled	O
"	O
nesoappendix	O
.	O

It	O
containe	O
an	O
.	O
appendix	O
with	O
attached	O
yellow	O
periappendiceal	O
fat	O
and	O
separate	O
.	O
fragment	O
in	O
the	O
same	O
container	O
of	O
yellow	O
fibrofatty	O
tissue	O
.	O

The	O
.	O
appendix	O
measures	O
7	O
cm	O
in	O
length	O
having	O
a	O
diameter	O
of	O
0	O
.	O
5	O
cm	O
in	O
.	O
the	O
upper	O
third	O
and	O
0	O
.	O
6	O
cin	O
in	O
the	O
middle	O
third	O
and	O
0	O
.	O
9	O
cm	O
in	O
the	O
.	O

-	O
3	O
.	O

OF	O
SURGICAL	O
PATHOLOGY	O
.	O

GROSS	O
(	O
continued	O
)	O
.	O
lower	O
third	O
.	O

There	O
appears	O
to	O
be	O
a	O
hemorrhagic	O
nodular	O
area	O
been	O
.	O
in	O
the	O
lower	O
third	O
of	O
the	O
appendix	O
.	O

The	O
attached	O
fibrofatty	O
.	O
fragment	O
measures	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
.	O

It	O
appears	O
unremarkable	O
.	O

The	O
separately	O
submitted	O
fibrofatty	O
fragment	O
measures	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
.	O

x	O
.	O

0	O
-	O
9	O
-	O
cm	O
-	O
Taken	O
and	O
labelled	O
as	O
follows	O
:	O
Al	O
,	O
appendix	O
;	O
A2	O
,	O
f	O
	O
t	O
.	O

Jar	O
1	O
.	O

The	O
sixth	O
container	O
is	O
labelled	O
"	O
omentum	O
.	O

It	O
contains	O
a	O
large	O
.	O
fragment	O
of	O
hemorrhagic	O
yellow	O
lobular	O
cmental	O
tissue	O
measuring	O
13	O
.	O

x	O
9	O
x	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimensions	O
.	O

The	O
omentum	O
is	O
completely	O
.	O
covered	O
in	O
~	O
70	O
%	O
of	O
the	O
area	O
by	O
a	O
papillary	O
friable	O
tumor	O
,	O
.	O

Representative	O
section	O
taken	O
and	O
labelled	O
B	O
.	O

Jar	O
2	O
.	O

COMMENT	O
.	O

Poorly	O
differentiated	O
papillary	O
serous	O
adenocarcinoma	O
completely	O
.	O
replaces	O
the	O
right	O
ovary	O
and	O
is	O
present	O
on	O
the	O
eurface	O
of	O
the	O
.	O
right	O
ovary	O
.	O

The	O
right	O
fallopian	O
tube	O
is	O
not	O
identified	O
and	O
may	O
.	O
have	O
been	O
completelyreplaced	O
by	O
adenocarcinoia	O
.	O

Small	O
implante	O
of	O
.	O
papillary	O
serous	O
adenocarcinoma	O
are	O
present	O
in	O
peritubal	O
tissue	O
in	O
.	O
the	O
left	O
fallopian	O
tube	O
and	O
within	O
adhesions	O
in	O
the	O
left	O
ovary	O
.	O

Metastatic	O
papillary	O
serous	O
adenocarcinoma	O
also	O
involves	O
the	O
.	O
serosal	O
surface	O
of	O
the	O
appendix	O
and	O
the	O
omentum	O
.	O

The	O
endometrium	O
.	O

is	O
atrophic	O
.	O

The	O
polypoid	O
lesion	O
described	O
grossly	O
represents	O
a	O
.	O
hyalinized	O
submucosal	O
leiomyoma	O
.	O

Numerous	O
hyalinized	O
leiomyomas	O
.	O
and	O
adenomyosis	O
are	O
present	O
in	O
the	O
myometrium	O
:	O
The	O
serosal	O
.	O
surface	O
of	O
the	O
uterus	O
also	O
contains	O
metastatic	O
papillary	O
gerous	O
.	O
carcinoma	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
OVARIAN	O
NEOPLASMS	O
.	O

la	O
.	O

A	O
neoplasm	O
ie	O
PRESENT	O
.	O

2	O
.	O

The	O
HISTOLOGIC	O
DIAGNOSIS	O
is	O
:	O
Serous	O
adenocarcinoma	O
.	O

3	O
.	O

The	O
LOCATION	O
(	O
(	O
s	O
)	O
OF	O
THE	O
PRIMARY	O
TUMOR	O
(	O
s	O
)	O
is	O
/	O
are	O
:	O
Right	O
and	O
left	O
ovary	O
.	O

5	O
.	O

The	O
NUCLEAR	O
(	O
BRODERS	O
'	O
'	O
)	O
GRADE	O
of	O
the	O
tumor	O
is	O
:	O
G3	O
.	O
poorly	O
-	O
differentiated	O
.	O

6	O
.	O

Tumor	O
IS	O
identified	O
on	O
the	O
ovarian	O
surface	O
(	O
s	O
)	O
-	O
.	O

Tumor	O
DOES	O
invade	O
the	O
mesovarium	O
.	O

-	O
4	O
-	O
-	O
.	O
or	O
SURGICAL	O
PATHOLOGY	O
.	O

COMMENT	O
(	O
continued	O
)	O
.	O

8	O
.	O

Invasion	O
of	O
adjacent	O
fallopian	O
tube	O
CANNOT	O
BE	O
EVALUATED	O
.	O

9	O
.	O

Tumor	O
DOES	O
invade	O
the	O
pelvic	O
soft	O
tissue	O
.	O

10	O
.	O

Tumor	O
involvement	O
of	O
the	O
pelvic	O
peritoneum	O
is	O
PRESENT	O
.	O

Metastatic	O
involvement	O
of	O
the	O
EXTRAPELVIC	O
peritoneum	O
.	O

CANNOT	O
BE	O
EVALUATED	O
.	O

12	O
.	O

Metastatic	O
involvement	O
of	O
the	O
omentum	O
is	O
PRESENT	O
.	O

14	O
.	O

Metastatic	O
involvement	O
of	O
the	O
uterine	O
serosa	O
is	O
PRESENT	O
.	O

15	O
.	O

Metastatic	O
involvement	O
of	O
the	O
endometrium	O
is	O
ABSENT	O
.	O

16	O
.	O

Regional	O
lymph	O
node	O
metastabes	O
CANNOT	O
BE	O
EVALUATED	O
.	O

17	O
.	O

The	O
total	O
number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
is	O
0	O
.	O

19	O
.	O

DETAILED	O
STAGING	O
INFORMATION	O
:	O
Based	O
on	O
the	O
above	O
information	O
,	O
the	O
PRIMARY	O
TUMOR	O
is	O
.	O
classified	O
as	O
:	O
TNM	O
SCHEME	O
.	O

FIGO	O
SCHEME	O
.	O

DEFINITION	O
.	O

T3a	O
.	O

IIIC	O
.	O

Macroscopic	O
peritoneal	O
.	O
metastasis	O
beyond	O
true	O
pelvis	O
.	O
measuring	O
greater	O
than	O
2	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
OR	O
.	O

Regional	O
lymph	O
node	O
metastasis	O
.	O

OR	O
Metastasis	O
to	O
capsule	O
of	O
.	O
liver	O
.	O

THE	O
REGIONAL	O
LYMPH	O
NODES	O
are	O
classified	O
as	O
:	O
NX	O
(	O
Nodal	O
status	O
cannot	O
be	O
asseased	O
)	O
.	O

THE	O
STATUS	O
OF	O
DISTANT	O
TUMOR	O
SITES	O
is	O
classified	O
as	O
:	O
MX	O
(	O
Status	O
cannot	O
be	O
asseased	O
)	O
.	O

20	O
.	O

The	O
FINAL	O
AJCC	O
/	O
FIGO	O
STAGE	O
requires	O
clinical	O
correlation	O
.	O

{	O
End	O
of	O
Report	O
)	O
.	O

Final	O
Surgical	O
Pathology	O
Report	O
.	O

Procedure	O
.	O

Diagnosis	O
.	O

A	O
.	O

Uterus	O
,	O
cervix	O
,	O
resection	O
:	O
Invasive	O
squamous	O
cell	O
carcinoma	O
,	O
poorly	O
differentiated	O
,	O
6	B
.	I
5	I
cm	I
.	O

Squamous	O
cell	O
carcinoma	O
in	O
situ	O
focally	O
extends	O
to	O
the	O
cervical	O
cuff	O
.	O
margin	O
,	O
(	O
6	O
-	O
9	O
o	O
'	O
clock	O
)	O
.	O

Lymphovascular	O
space	O
invasion	O
by	O
carcinoma	O
identified	O
.	O

Uterus	O
,	O
endometrium	O
,	O
resection	O
:	O
No	O
pathologic	O
diagnosis	O
.	O

Uterus	O
,	O
myometrium	O
,	O
resection	O
:	O
No	O
pathologic	O
diagnosis	O
.	O

Ovaries	O
,	O
right	O
and	O
left	O
,	O
resection	O
:	O
No	O
pathologic	O
diagnosis	O
.	O

Fallopian	O
tubes	O
,	O
right	O
and	O
left	O
,	O
resection	O
:	O
No	O
pathologic	O
diagnosis	O
.	O

B	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
,	O
resection	O
:	O
Metastatic	O
carcinoma	O
in	O
1	O
of	O
6	O
lymph	O
nodes	O
(	O
1	O
/	O
6	O
)	O
.	O

C	O
.	O

Right	O
periaortic	O
lymph	O
nodes	O
,	O
resection	O
:	O
No	O
evidence	O
of	O
metastasis	O
in	O
4	O
lymph	O
nodes	O
(	O
0	O
/	O
4	O
)	O
.	O

D	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
,	O
resection	O
:	O
Metastatic	O
carcinoma	O
in	O
1	O
of	O
1	O
lymph	O
node	O
(	O
1	O
/	O
1	O
)	O
.	O

E	O
.	O

Left	O
periaortic	O
lymph	O
nodes	O
,	O
resection	O
:	O
No	O
evidence	O
of	O
metastasis	O
in	O
2	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

Microscopic	O
Description	O
:	O
Microscopic	O
examination	O
performed	O
.	O

A	O
.	O

Histologic	O
type	O
:	O
Invasive	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
cervix	O
.	O

Histologic	O
grade	O
Poorly	O
differentiated	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
TNM	O
(	O
FIGO	O
)	O
:	O
6	B
.	I
5	I
cm	I
,	O
pT1b2	O
.	O

FIGO	O
IB2	O
.	O

Margins	O
of	O
resection	O
:	O
Distance	O
of	O
tumor	O
to	O
closest	O
margin	O
:	O
Less	O
than	O
0	O
.	O
5	O
mm	O
from	O
inked	O
.	O
circumferential	O
margin	O
.	O

Presence	O
of	O
carcinoma	O
in	O
situ	O
at	O
distal	O
margin	O
:	O
Squamous	O
carcinoma	O
.	O
in	O
situ	O
is	O
present	O
in	O
the	O
cervical	O
cuff	O
margin	O
between	O
6	O
and	O
9	O
:	O
00	O
.	O

Vascular	O
invasion	O
:	O
Present	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
Metastatic	O
carcinoma	O
is	O
present	O
in	O
one	O
right	O
.	O
and	O
one	O
left	O
pelvic	O
lymph	O
node	O
,	O
.	O

N1	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
Cannot	O
be	O
evaluated	O
by	O
the	O
specimen	O
,	O
pMX	O
.	O

Other	O
findings	O
None	O
.	O

B	O
.	O

The	O
right	O
pelvic	O
lymph	O
nodes	O
demonstrate	O
metastatic	O
carcinoma	O
in	O
.	O

1	O
.	O
of	O
6	O
nodes	O
.	O

C	O
.	O

The	O
right	O
periaortic	O
lymph	O
nodes	O
demonstrate	O
no	O
evidence	O
of	O
.	O
metastasis	O
4	O
lymph	O
nodes	O
.	O

D	O
.	O

The	O
left	O
pelvic	O
lymph	O
nodes	O
demonstrate	O
metastatic	O
squamous	O
cell	O
.	O
carcinoma	O
in	O
1	O
of	O
11ymph	O
node	O
.	O

E	O
.	O

The	O
left	O
periaortic	O
lymph	O
nodes	O
demonstrate	O
no	O
evidence	O
of	O
.	O
metastasis	O
in	O
2	O
lymph	O
nodes	O
.	O

Specimen	O
.	O

A	O
.	O

Uterus	O
,	O
cervix	O
,	O
tubes	O
and	O
ovaries	O
,	O
right	O
parametrium	O
.	O

B	O
.	O

Right	O
lymph	O
nodes	O
,	O
pelvic	O
.	O

C	O
.	O

Right	O
periaortic	O
lymph	O
node	O
.	O

D	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
.	O

E	O
.	O

Left	O
periaortic	O
lymph	O
node	O
.	O

Clinical	O
Information	O
.	O

Cervical	O
carcinoma	O
.	O

Intraoperative	O
Consultation	O
.	O

AFS1	O
,	O
AFS2	O
,	O
AFS3	O
-	O
uterus	O
,	O
cervix	O
,	O
resection	O
:	O
Invasive	O
Squamous	O
Cell	O
.	O

Carcinoma	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

Received	O
fresh	O
labeled	O
"	O
uterus	O
,	O
cervix	O
,	O
tubes	O
and	O
ovaries	O
,	O
right	O
.	O

parametrium	O
"	O
is	O
a	O
249	O
g	O
,	O
8	O
.	O
5	O
x	O
5	O
.	O
3	O
x	O
4	O
.	O
7	O
cm	O
symmetrical	O
uterine	O
corpus	O
.	O
with	O
attached	O
,	O
markedly	O
expanded	O
,	O
6	O
.	O
5	O
cm	O
cervix	O
and	O
bilateral	O
adnexa	O
.	O

The	O
serosa	O
is	O
smooth	O
to	O
scaberous	O
tan	O
-	O
pink	O
-	O
red	O
.	O

A	O
scant	O
amount	O
of	O
soft	O
.	O
tan	O
-	O
pink	O
-	O
gold	O
parametrial	O
tissue	O
is	O
present	O
along	O
the	O
right	O
and	O
left	O
.	O
lateral	O
aspects	O
.	O

The	O
cervix	O
measures	O
5	O
.	O
5	O
cm	O
from	O
right	O
to	O
left	O
and	O
5	O
.	O
3	O
.	O

cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
anterior	O
surface	O
is	O
inked	O
blue	O
and	O
.	O
the	O
posterior	O
surface	O
is	O
inked	O
black	O
.	O

The	O
annular	O
5	O
.	O
3	O
cm	O
ectocervix	O
.	O
ranges	O
from	O
smooth	O
tan	O
-	O
white	O
to	O
glistening	O
white	O
-	O
pink	O
in	O
keeping	O
with	O
.	O
tumor	O
.	O

A	O
thin	O
rim	O
of	O
wrinkled	O
tan	O
-	O
white	O
vaginal	O
mucosa	O
circumferences	O
.	O
the	O
ectocervical	O
margin	O
.	O

The	O
specimen	O
is	O
opened	O
along	O
the	O
lateral	O
.	O
aspects	O
to	O
show	O
a	O
circumferential	O
soft	O
tan	O
-	O
white	O
cervical	O
tumor	O
.	O

A	O
.	O
portion	O
of	O
the	O
tumor	O
and	O
a	O
portion	O
of	O
normal	O
are	O
submitted	O
for	O
tissue	O
.	O
procurement	O
as	O
requested	O
.	O

A	O
frozen	O
section	O
is	O
performed	O
.	O

On	O
.	O
sectioning	O
,	O
the	O
tumor	O
has	O
a	O
maximal	O
thickness	O
of	O
3	B
cm	I
(	O
invasive	O
.	O
thickness	O
)	O
,	O
however	O
tumor	O
replaces	O
the	O
entire	O
6	O
.	O
5	O
cm	O
cervix	O
.	O

Carcinoma	O
.	O
extends	O
to	O
within	O
less	O
than	O
0	O
.	O
1	O
cm	O
of	O
the	O
inked	O
posterior	O
surface	O
.	O

The	O
.	O
triangular	O
4	O
.	O
5	O
x	O
3	O
.	O
2	O
cm	O
uterine	O
cavity	O
is	O
lined	O
by	O
flat	O
tan	O
-	O
pink	O
-	O
red	O
.	O
endometrium	O
averaging	O
0	O
.	O
2	O
cm	O
.	O

The	O
myometrium	O
is	O
smooth	O
tan	O
-	O
pink	O
and	O
.	O
measures	O
up	O
to	O
2	O
.	O
3	O
cm	O
.	O

A	O
single	O
,	O
0	B
.	I
8	I
cm	I
tan	O
-	O
white	O
intramural	O
leiomyoma	O
.	O

is	O
present	O
anteriorly	O
(	O
see	O
block	O
15	O
)	O
.	O

The	O
rubbery	O
tan	O
-	O
pink	O
right	O
and	O
.	O
left	O
ovaries	O
average	O
2	O
.	O
8	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
2	O
cm	O
.	O

The	O
stroma	O
of	O
both	O
ovaries	O
is	O
.	O
pale	O
tan	O
with	O
identifiable	O
corpora	O
albicantia	O
.	O

A	O
few	O
cystic	O
structures	O
.	O
measuring	O
up	O
to	O
0	O
.	O
7	O
cm	O
are	O
present	O
within	O
the	O
left	O
ovary	O
.	O

The	O
.	O
centrally	O
discontinuous	O
tan	O
-	O
pink	O
right	O
and	O
left	O
fallopian	O
tubes	O
average	O
.	O

6	O
.	O
5	O
cm	O
in	O
length	O
and	O
range	O
from	O
0	O
.	O
4	O
-	O
0	O
.	O
7	O
cm	O
in	O
diameter	O
.	O

RS	O
20	O
.	O

Summary	O
:	O
1	O
-	O
12	O
-	O
3	O
o	O
'	O
clock	O
cervical	O
cuff	O
,	O
2	O
-	O
3	O
-	O
6	O
o	O
'	O
clock	O
cervical	O
.	O
cuff	O
,	O
3	O
-	O
6	O
-	O
9	O
S	O
'	O
clock	O
cervical	O
cuff	O
,	O
4	O
-	O
9	O
-	O
12	O
cervical	O
cuff	O
,	O
5	O
and	O
.	O

6	O
-	O
12	O
o	O
'	O
clock	O
cervix	O
/	O
Lus	O
,	O
7	O
and	O
8	O
-	O
3	O
o	O
'	O
clock	O
cervix	O
/	O
Lus	O
,	O
9	O
and	O
10	O
.	O

o	O
'	O
clock	O
-	O
6	O
o	O
'	O
clock	O
cervix	O
/	O
Lus	O
,	O
11	O
and	O
12	O
-	O
9	O
o	O
'	O
clock	O
cervix	O
/	O
Lus	O
,	O
13	O
.	O
and	O
14	O
-	O
posterior	O
cervix	O
tumor	O
to	O
closest	O
inked	O
surface	O
,	O
15	O
-	O
anterior	O
.	O
endomyometrium	O
,	O
16	O
-	O
posterior	O
endomyometrium	O
,	O
17	O
-	O
right	O
adnexa	O
,	O
18	O
-	O
.	O
left	O
adnexa	O
,	O
19	O
-	O
right	O
parametrium	O
,	O
20	O
-	O
left	O
parametrium	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
lymph	O
nodes	O
,	O
pelvic	O
"	O
is	O
a	O
7	O
.	O
7	O
x	O
6	O
.	O
5	O
x	O
.	O

3	O
.	O
2	O
cm	O
aggregate	O
of	O
soft	O
tan	O
gold	O
adipose	O
tissue	O
.	O

Several	O
soft	O
to	O
.	O
slightly	O
rubbery	O
tan	O
-	O
pink	O
-	O
gold	O
tissues	O
in	O
keeping	O
with	O
lymph	O
nodes	O
.	O
measuring	O
up	O
to	O
3	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
are	O
recovered	O
.	O

The	O
.	O
lymphoid	O
tissues	O
are	O
entirely	O
submitted	O
in	O
9	O
blocks	O
.	O

Summary	O
:	O
1	O
-	O
2	O
lymph	O
nodes	O
,	O
2	O
through	O
5	O
-	O
1	O
bisected	O
lymph	O
node	O
per	O
.	O
cassette	O
,	O
6	O
through	O
9	O
-	O
largest	O
lymph	O
node	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
periaortic	O
lymph	O
node	O
"	O
is	O
a	O
2	O
.	O
7	O
x	O
1	O
.	O
7	O
.	O

x	O
0	O
.	O
4	O
cm	O
aggregate	O
of	O
soft	O
,	O
lobulated	O
tan	O
gold	O
adipose	O
tissue	O
which	O
.	O
appears	O
to	O
contain	O
3	O
soft	O
tan	O
-	O
pink	O
tissues	O
in	O
keeping	O
with	O
lymph	O
nodes	O
.	O
measuring	O
up	O
to	O
0	O
.	O
7	O
cm	O
.	O

The	O
lymphoid	O
tissues	O
are	O
submitted	O
in	O
toto	O
in	O
.	O
one	O
block	O
.	O

D	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
5	O
.	O
9	O
x	O
5	O
.	O
5	O
x	O
.	O

2	O
.	O
2	O
cm	O
aggregate	O
of	O
soft	O
,	O
lobulated	O
tan	O
gold	O
adipose	O
tissue	O
.	O

A	O
single	O
,	O
.	O
ovoid	O
,	O
2	O
.	O
1	O
cm	O
soft	O
to	O
slightly	O
rubbery	O
tan	O
-	O
pink	O
-	O
gold	O
tissue	O
in	O
keeping	O
.	O
with	O
lymph	O
node	O
is	O
recovered	O
.	O

The	O
lymphoid	O
tissue	O
is	O
bisected	O
and	O
.	O
entirely	O
submitted	O
in	O
2	O
blocks	O
.	O

E	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
periaortic	O
lymph	O
node	O
"	O
is	O
a	O
2	O
.	O
1	O
x	O
2	O
.	O
0	O
.	O

x	O
.	O

0	O
.	O
8	O
cm	O
aggregate	O
of	O
soft	O
tan	O
gold	O
adipose	O
tissue	O
.	O

No	O
definitive	O
.	O
lymphoid	O
tissues	O
are	O
recovered	O
.	O

AS1	O
.	O

i	O
.	O

D	O
.	O
te	O
Reviewe	O
.	O

/	O
.	O

LAB	O
RESULTS	O
.	O

RG	O
PATH	O
REPORT	O
.	O

LECTION	O
DATE	O
/	O
TIME	O
.	O

1st	O
Specimen	O
collected	O
en	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

1	O
)	O
.	O

LEFT	O
TONGUE	O
BASE	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
.	O

NEGATIVE	O
FOR	O
.	O

TUMOR	O
.	O

2	O
)	O
RIGHT	O
POSTERIOR	O
PHARYNGEAL	O
WALL	O
(	O
EXCISION	O
}	O
:	O
SQUAMOUS	O
MUCOSA	O
.	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O
3	O
)	O
NASOPHARYNGEAL	O
MARGIN	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
.	O

NEGATIVE	O
FOR	O
.	O

TUMOR	O
.	O

-	O
1	O
)	O
.	O

SOFT	O
PALATE	O
UVULA	O
(	O
EXCISION	O
)	O
:	O
ULCERATED	O
SQUAMOUS	O
MUCOSA	O
WITH	O
.	O

POCAL	O
HIGH	O
GRADE	O
DYSPLASIA	O
.	O

SEE	O
NOTE	O
.	O

NOTE	O
:	O
The	O
focal	O
high	O
grade	O
dysplasia	O
is	O
seen	O
only	O
on	O
the	O
frozen	O
.	O
section	O
.	O

5	O
)	O
2ND	O
NASOPHARYNGEAL	O
MARGIN	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
WITH	O
.	O

CHRONIC	O
INFLAMMATION	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

6	O
)	O
LEFT	O
EUSTACHIAN	O
TUBE	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
.	O

NEGATIVE	O
FOR	O
.	O

TUMOR	O
.	O

1	O
)	O
2ND	O
SOFT	O
PALATE	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

a	O
)	O
TUMOR	O
AT	O
NASOPHARYNX	O
(	O
EXCISION	O
)	O
:	O
INFILTRATING	O
POORLY	O
.	O

DIFFERENTIATED	O
KERATINIZING	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

ADDITIONAL	O
NASOPHARYNX	O
(	O
EXCISION	O
)	O
:	O
RESPIRATORY	O
MUCOSA	O
WITH	O
.	O

:	O
ONIC	O
INFLAMMATION	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

10	O
)	O
SOFT	O
TISSUE	O
RIGHT	O
LINGUAL	O
ARTERY	O
(	O
EXCISION	O
)	O
:	O
BENIGN	O
.	O

FIBROCONNECTIVE	O
TISSUE	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

:	O
1	O
)	O
.	O

ADDITIONAL	O
SOFT	O
PALATE	O
(	O
EXCISION	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
AND	O
MINOR	O
.	O

SALIVARY	O
GLAND	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

2	O
)	O
LYMPH	O
NODES	O
,	O
RIGHT	O
NECK	O
(	O
DISSECTION	O
)	O
:	O
TWO	O
OF	O
ELEVEN	O
(	O
2	O
/	O
11	O
)	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
FOR	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
ONE	O
NODE	O
SHOWS	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
.	O

:	O
3	O
)	O
LYMPH	O
NODES	O
,	O
RIGHT	O
NECK	O
LEVEL	O
IV	O
(	O
DISSECTION	O
)	O
:	O
ONE	O
OF	O
EIGHT	O
.	O

(	O
1	O
/	O
8	O
)	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

EXTRACAPSULAR	O
.	O

EXTENSION	O
IS	O
PRESENT	O
.	O

14	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
(	O
DISSECTION	O
)	O
:	O
THREE	O
(	O
3	O
)	O
LYMPH	O
NODE	O
AND	O
.	O

ASSOCIATED	O
FIBROADIPOSE	O
TISSUE	O
,	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

LYMPH	O
NODES	O
,	O
LEVELS	O
II	O
AND	O
III	O
(	O
DISSECTION	O
)	O
:	O
ONE	O
OF	O
SEVEN	O
(	O
1	O
/	O
7	O
)	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
FOR	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
WITH	O
EXTENSION	O
INTO	O
.	O

SOFT	O
TISSUE	O
FORMING	O
A	O
NODULE	O
OF	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

(	O
5	B
.	I
0	I
CM	I
)	O
.	O

:	O
6	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
LEVEL	O
IV	O
(	O
DISSECTION	O
)	O
:	O
TWO	O
OF	O
SEVENTEEN	O
.	O

(	O
2	O
/	O
17	O
)	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

:	O
7	O
)	O
LARYNX	O
(	O
LARYNGOPHARYNGECTOMY	O
)	O
:	O
SPECIMEN	O
:	O
caryngopharyngectomy	O
.	O

TUMOR	O
SITE	O
:	O
Posterior	O
pharyngeal	O
space	O
.	O

Unofficial	O
lab	O
results	O
-	O
do	O
not	O
file	O
in	O
patient	O
chart	O
.	O

Contact	O
medical	O
records	O
for	O
official	O
chart	O
copy	O
.	O

INLESS	O
.	O

NOTED	O
.	O
rus	O
.	O

ORMED	O
AT	O
:	O
;	O
TOLOGIC	O
TYPE	O
:	O
Squamous	O
cell	O
carcinoma	O
(	O
keratinizing	O
)	O
.	O

TUMOR	O
SIZE	O
:	O
a	O
cm	O
greatest	O
dimension	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
poorly	O
differentiated	O
.	O

LYMPH	O
NODES	O
:	O
Metastatic	O
carc	O
	O
noma	O
in	O
6	O
of	O
51	O
lymph	O
nodes	O
:	O
Ipsilateral	O
,	O
.	O

Contralateral	O
.	O

Specify	O
largest	O
positive	O
node	O
:	O
5	O
cm	O
.	O

EXTRANODAL	O
EXTENSION	O
:	O
Present	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
.	O

pT4	O
:	O
Tumor	O
invades	O
nasopharynx	O
(	O
see	O
part	O
8	O
)	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pN2c	O
:	O
Metastasis	O
in	O
bilateral	O
or	O
contralateral	O
lymph	O
nodes	O
,	O
none	O
.	O

!	O
arger	O
than	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

DISTANT	O
METASTASIS	O
:	O
oMx	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
.	O

Margins	O
are	O
uninvolved	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
nearest	O
margin	O
:	O
1	O
mm	O
.	O

Specify	O
margin	O
:	O
Soft	O
tissue	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
asent	O
.	O

PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

NOTE	O
:	O
This	O
case	O
was	O
reviewed	O
with	O
.	O
who	O
concurs	O
with	O
the	O
.	O
diagnosis	O
.	O

Reported	O
bv	O
:	O
Unofficial	O
lab	O
results	O
-	O
do	O
not	O
file	O
in	O
patient	O
chart	O
.	O

Contact	O
medical	O
records	O
for	O
official	O
chart	O
copy	O
.	O

UNLESS	O
OTHEROTSE	O
NOTED	O
ON	O
TUR	O
DETATI	O
pace	O
ALI	O
DEDFORMED	O
AT	O
:	O

Nature	O
of	O
material	O
:	O
Liver	O
.	O

Biopsy	O
number	O
:	O
ANATOMOPATHOLOGIC	O
RESULT	O
.	O

MACROSCOPY	O
.	O

Received	O
2	O
vials	O
,	O
identified	O
as	O
follows	O
:	O
-	O
Liver	O
:	O
liver	O
fragment	O
,	O
wedge	O
-	O
shaped	O
,	O
measuring	O
7	O
.	O
5	O
X	O
6	O
.	O
0	O
X	O
1	O
.	O
5	O
cm	O
and	O
weighing	O
61	O
.	O
0	O
.	O

g	O
.	O

Its	O
external	O
surface	O
shows	O
capsule	O
with	O
opaque	O
and	O
rough	O
appearance	O
due	O
to	O
the	O
.	O
presence	O
of	O
multiple	O
micro	O
undulations	O
.	O

It	O
shows	O
a	O
softened	O
and	O
whitish	O
lesion	O
of	O
.	O
circular	O
shape	O
with	O
a	O
larger	O
diameter	O
2	O
.	O
5	O
cm	O
,	O
1	O
.	O
0	O
cm	O
away	O
from	O
the	O
surgical	O
resection	O
.	O
margin	O
.	O

The	O
remaining	O
portions	O
of	O
hepatic	O
parenchyma	O
show	O
hardened	O
,	O
brownish	O
and	O
a	O
.	O
cirrhotic	O
pattern	O
.	O

-	O
Gallbladder	O
:	O
gallbladder	O
,	O
previously	O
opened	O
in	O
its	O
longer	O
axis	O
,	O
measuring	O
7	O
.	O
5	O
x	O
3	O
.	O
5	O
X	O
1	O
.	O
0	O
.	O

cm	O
.	O

It	O
is	O
accompanied	O
by	O
the	O
cystic	O
duct	O
stump	O
,	O
measuring	O
1	O
.	O
5	O
cm	O
long	O
and	O
0	O
.	O
6	O
cm	O
in	O
.	O
diameter	O
.	O

Its	O
outer	O
surface	O
is	O
smooth	O
and	O
greenish	O
-	O
brown	O
.	O

The	O
wall	O
is	O
gray	O
and	O
.	O
homogeneous	O
,	O
while	O
the	O
mucosa	O
shows	O
velvety	O
appearance	O
and	O
yellowish	O
coloring	O
,	O
.	O
with	O
polypoid	O
aspect	O
folds	O
.	O

It	O
was	O
not	O
observed	O
stones	O
.	O

MICROSCOPY	O
.	O

Description	O
associated	O
with	O
the	O
diagnosis	O
.	O

DIAGNOSTIC	O
.	O

Product	O
of	O
partial	O
hepatectomy	O
and	O
cholecystectomy	O
:	O
-	O
Hepatocellular	O
carcinoma	O
of	O
multinodular	O
pattern	O
with	O
well	O
differentiated	O
(	O
grade	O
II	O
of	O
.	O
Edmonson	O
-	O
Steiner	O
-	O
in	O
40	O
%	O
of	O
the	O
lesion	O
)	O
and	O
poorly	O
differentiated	O
(	O
grade	O
IV	O
of	O
.	O
Edmonson	O
-	O
Steiner	O
-	O
in	O
60	O
%	O
of	O
the	O
lesion	O
)	O
areas	O
.	O

The	O
lesion	O
shows	O
solid	O
,	O
trabecular	O
and	O
.	O
small	O
cells	O
morphologic	O
pattern	O
,	O
with	O
higher	O
measure	O
of	O
2	O
.	O
5	O
cm	O
and	O
focally	O
infiltrating	O
.	O
liver	O
capsule	O
.	O

-	O
Vascular	O
invasion	O
and	O
angiolymphatic	O
embolization	O
undetected	O
.	O

-	O
Adjacent	O
hepatic	O
parenchyma	O
with	O
micronodular	O
cirrhosis	O
,	O
associated	O
with	O
moderate	O
.	O
necroinflammatory	O
activity	O
.	O

C	O
virus	O
infection	O
,	O
according	O
to	O
clinical	O
data	O
.	O

-	O
Free	O
surgical	O
margins	O
.	O

-	O
Gallbladder	O
with	O
tiny	O
and	O
polypoid	O
projections	O
in	O
mucosa	O
,	O
associated	O
with	O
xanthomized	O
.	O
macrophage	O
accumulation	O
(	O
cholesterol	O
polyps	O
)	O
:	O
Morphological	O
features	O
are	O
compatible	O
.	O
with	O
cholesterolosis	O
.	O

No	O
signs	O
of	O
malignancy	O
,	O
in	O
the	O
gallbladder	O
.	O

-	O
Pathological	O
staging	O
(	O
TNM	O
-	O
7th	O
ed	O
.	O
)	O
:	O
pT1	O
pNx	O
.	O

PARTICIPANTS	O
OF	O
APPRAISAL	O
REPORT	O
.	O

-	O
ISSUER	O
.	O

-	O
REVIEWER	O
.	O

Surgica	O
)	O
Report	O
.	O

Specimen	O
.	O

Description	O
.	O

Hospitar	O
.	O

Hospital	O
ID	O
:	O
Age	O
/	O
Sax	O
.	O

Attending	O
Physiciar	O
.	O

Performing	O
Physici	O
.	O

Hospital	O
of	O
Origir	O
.	O

QC	O
Pathologist	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
A	O
.	O
gallbladder	O
,	O
chalecystectomy	O
:	O
Chronic	O
cholecystitie	O
.	O

B	O
.	O
peri	O
-	O
portal	O
lymph	O
node	O
,	O
excision	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

Frozen	O
section	O
diagnosis	O
confirmed	O
.	O

C	O
.	O
perigastric	O
lymph	O
node	O
,	O
excision	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

Frozen	O
.	O
section	O
diagnosis	O
confirmed	O
.	O

D	O
.	O
distel	O
margin	O
of	O
pancreas	O
,	O
blopay	O
:	O
Severe	O
chronic	O
pancreatitis	O
,	O
malignancy	O
not	O
Identified	O
.	O

Frozen	O
section	O
diagnosis	O
confirmed	O
.	O

E	O
.	O
pancreas	O
and	O
duodenum	O
,	O
Whipple	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
-	O
type	O
:	O
Adenocarcinoma	O
.	O

2	O
.	O

Histologio	O
grade	O
:	O
2	O
,	O
moderately	O
differentisted	O
.	O

3	O
.	O

Tumor	O
site	O
:	O
Pancress	O
with	O
extension	O
into	O
ampulla	O
.	O

4	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
8	I
x	I
2	I
.	I
2	I
x	I
1	I
.	I
7	I
CM	I
.	O

5	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
a	O
.	O

Tumor	O
invades	O
:	O
Ampulia	O
.	O

6	O
.	O

Treatment	O
effect	O
:	O
Not	O
ridentified	O
.	O

7	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

8	O
.	O

Perineural	O
invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
:	O
Uncinate	O
.	O
process	O
,	O
bile	O
duct	O
.	O
pancreatic	O
resection	O
,	O
posterior	O
and	O
.	O
superior	O
soft	O
tissue	O
.	O

a	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
	O
.	O
i	O
CM	O
.	O

b	O
.	O

Specify	O
margin	O
(	O
if	O
possible	O
)	O
:	O
Anterior	O
and	O
inferior	O
.	O
soft	O
tissue	O
margins	O
.	O

2	O
,	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
:	O
None	O
.	O

Lymph	O
Node	O
Status	O
:	O
}	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
received	O
:	O
19	O
.	O

2	O
.	O

Total	O
number	O
of	O
fymph	O
nodes	O
involved	O
:	O
Une	O
.	O

Othe	O
:	O
1	O
.	O

pTNM	O
stage	O
:	O
p	O
T3N1	O
.	O

es	O
.	O

2	O
.	O

Other	O
significant	O
findings	O
:	O
Chronic	O
pancrealitis	O
.	O

COMMENTS	O
:	O
CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Pancreatic	O
cancer	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Gallbladder	O
.	O

B	O
.	O

Periportal	O
lymph	O
node	O
frozen	O
section	O
.	O

C	O
.	O

Perigastric	O
frozen	O
section	O
.	O

D	O
.	O

Distal	O
margin	O
of	O
pancreas	O
.	O

E	O
.	O

Pancreas	O
/	O
duodenum	O
stitch	O
in	O
deep	O
margin	O
/	O
inked	O
pancreatic	O
.	O
transection	O
margin	O
.	O

CODES	O
:	O
88304	O
.	O

88305	O
.	O

88331	O
.	O

88305	O
.	O

88331	O
.	O

88305	O
.	O

88331	O
.	O

88309	O
.	O

PROCEDURAL	O
DEMOGRAPHICS	O
:	O
Accession	O
Date	O
/	O
Time	O
:	O
GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
in	O
formalin	O
labelec	O
.	O
and	O
'	O
#	O
1	O
.	O

gallbladder	O
'	O
is	O
a	O
6	O
.	O
7	O
x	O
3	O
.	O
2	O
x	O
1	O
.	O
9	O
cm	O
Intact	O
galibladder	O
with	O
.	O

a	O
0	O
.	O
2	O
em	O
eystic	O
duet	O
.	O

The	O
serosa	O
is	O
smooth	O
and	O
tan	O
-	O
green	O
.	O

The	O
mucosa	O
is	O
velvety	O
and	O
tan	O
-	O
green	O
.	O

The	O
lumen	O
contains	O
.	O
green	O
bile	O
.	O

The	O
bile	O
and	O
formalin	O
are	O
filtered	O
through	O
a	O
.	O
fine	O
mesh	O
structure	O
and	O
no	O
choleliths	O
are	O
identified	O
in	O
the	O
.	O
lumen	O
or	O
the	O
specimen	O
container	O
.	O

The	O
wall	O
thickness	O
averages	O
.	O

0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
sectioned	O
and	O
representative	O
.	O
sections	O
are	O
submitted	O
in	O
one	O
rassatto	O
.	O

B	O
.	O

Received	O
labeled	O
.	O

'	O
#	O
2	O
periportal	O
lymph	O
.	O

node	O
'	O
is	O
a	O
2	O
.	O
3	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
irregular	O
tan	O
firm	O
tissue	O
.	O
consistent	O
with	O
a	O
probable	O
lymph	O
node	O
.	O

The	O
cut	O
surface	O
.	O
consists	O
of	O
lobulated	O
tan	O
soft	O
t	O
	O
ssue	O
.	O

The	O
specimen	O
is	O
.	O
bisected	O
and	O
submitted	O
in	O
its	O
entirety	O
for	O
frozen	O
section	O
.	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
submitted	O
in	O
blocks	O
1	O
and	O
.	O

2	O
labeled	O
.	O

C	O
,	O
Received	O
labeled	O
.	O
and	O
'	O
#	O
3	O
perigastric	O
.	O
lymph	O
node	O
'	O
is	O
a	O
0	O
.	O
7	O
x	O
0	O
,	O
5	O
x	O
0	O
.	O
2	O
cm	O
irregular	O
tan	O
firm	O
.	O
tissue	O
consistent	O
with	O
a	O
probable	O
lymph	O
node	O
with	O
attached	O
.	O
adipose	O
tissue	O
which	O
is	O
submitted	O
in	O
toto	O
for	O
frozen	O
section	O
.	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
submitted	O
in	O
one	O
cassette	O
.	O
labeled	O
.	O

D	O
.	O

Received	O
lapereu	O
.	O
and	O
'	O
#	O
4	O
distal	O
margin	O
of	O
.	O
pancreas	O
is	O
a	O
2	O
.	O
1	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
3	O
cm	O
irregular	O
tan	O
-	O
yellow	O
.	O
lobulated	O
soft	O
tissue	O
,	O
which	O
is	O
submitted	O
in	O
toto	O
for	O
froz	O
	O
n	O
.	O
section	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
submitted	O
in	O
one	O
.	O

E	O
Received	O
in	O
formalin	O
labeled	O
.	O

pancreas	O
/	O
duodenum	O
stitch	O
in	O
deep	O
margin	O
,	O
Ink	O
marking	O
.	O
pancreatic	O
resection	O
margin	O
'	O
is	O
a	O
Whipple	O
specimen	O
.	O
consisting	O
of	O
a	O
8	O
.	O
9	O
cm	O
segment	O
of	O
stomach	O
with	O
a	O
minimal	O
.	O
amount	O
of	O
allached	O
mesentery	O
,	O
a	O
13	O
.	O
6	O
cm	O
segment	O
of	O
duodenum	O
,	O
.	O

a	O
4	O
.	O
8	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
portion	O
of	O
pancreas	O
and	O
a	O
1	O
.	O
2	O
cm	O
.	O
segment	O
of	O
common	O
bile	O
duct	O
.	O

There	O
is	O
a	O
very	O
minimal	O
amount	O
.	O
of	O
attached	O
fibroadipose	O
tissue	O
on	O
the	O
duodenum	O
and	O
.	O
pancreas	O
.	O

There	O
is	O
a	O
suture	O
designating	O
the	O
deep	O
margin	O
and	O
.	O

Ink	O
on	O
the	O
pancreatic	O
resection	O
margin	O
.	O

The	O
outer	O
surface	O
of	O
the	O
pancreas	O
is	O
shaggy	O
and	O
tan	O
.	O

The	O
cut	O
.	O
surface	O
of	O
the	O
pancreas	O
consists	O
of	O
a	O
2	O
.	O
8	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
7	O
cm	O
.	O
ill	O
-	O
defined	O
slightly	O
cystic	O
gray	O
-	O
white	O
mass	O
,	O
2	O
.	O
2	O
cm	O
and	O
2	O
.	O
0	O
.	O

cm	O
from	O
the	O
pancreatic	O
resection	O
margin	O
and	O
common	O
bile	O
duct	O
.	O
margin	O
,	O
respectively	O
.	O

The	O
lesion	O
abuts	O
the	O
uncinate	O
process	O
,	O
.	O
anterior	O
,	O
posterior	O
and	O
interior	O
pancreatic	O
soft	O
tissue	O
.	O
margins	O
and	O
is	O
2	O
.	O
2	O
cm	O
from	O
the	O
superior	O
pancreatic	O
soft	O
.	O
tissue	O
margin	O
.	O

The	O
lesion	O
appears	O
to	O
involve	O
the	O
ampulla	O
of	O
.	O

Vater	O
,	O
but	O
does	O
not	O
involve	O
the	O
duodenal	O
mucosa	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
surface	O
of	O
the	O
pancreas	O
consists	O
of	O
.	O
lobulated	O
tan	O
-	O
yellow	O
soft	O
lissue	O
,	O
No	O
additional	O
lesions	O
are	O
.	O
identified	O
.	O

The	O
gastric	O
serosa	O
is	O
smooth	O
and	O
tan	O
-	O
pink	O
.	O

The	O
mucosa	O
is	O
.	O
tan	O
-	O
pink	O
with	O
the	O
normal	O
folda	O
.	O

No	O
mucosal	O
messes	O
are	O
.	O
identified	O
.	O

The	O
inner	O
circumference	O
averages	O
8	O
.	O
8	O
cm	O
and	O
the	O
.	O
wall	O
thickness	O
averages	O
0	O
.	O
5	O
cm	O
.	O

The	O
duodenal	O
serosa	O
is	O
smooth	O
to	O
shaggy	O
and	O
tan	O
-	O
pink	O
.	O

The	O
.	O
mucosa	O
is	O
tan	O
-	O
pink	O
with	O
the	O
normal	O
folds	O
.	O

No	O
mucosal	O
masses	O
.	O
are	O
Identified	O
.	O

The	O
inner	O
circumference	O
ranges	O
from	O
5	O
.	O
2	O
cm	O
.	O
to	O
11	O
.	O
2	O
cm	O
and	O
the	O
wall	O
thickness	O
averages	O
0	O
.	O
2	O
cm	O
.	O

There	O
are	O
multiple	O
irregular	O
tan	O
-	O
firm	O
tissues	O
consistent	O
.	O
with	O
probable	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
to	O
.	O

1	O
.	O
8x	O
0	O
.	O
5	O
x	O
0	O
.	O
6	O
em	O
,	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
is	O
a	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
7	O
cm	O
.	O
tan	O
firm	O
tissue	O
consistent	O
with	O
probable	O
lymph	O
node	O
.	O

The	O
cut	O
.	O
surface	O
is	O
tan	O
-	O
yellow	O
.	O

The	O
specimen	O
is	O
inked	O
,	O
sectioned	O
and	O
representative	O
sections	O
.	O
are	O
submitted	O
as	O
labeled	O
:	O
block	O
1	O
,	O
gastric	O
and	O
duodenal	O
.	O
margins	O
(	O
en	O
face	O
)	O
;	O
block	O
2	O
,	O
pancreatic	O
resection	O
-	O
margin	O
(	O
en	O
.	O
face	O
)	O
;	O
block	O
3	O
,	O
common	O
bile	O
duct	O
(	O
en	O
face	O
)	O
;	O
block	O
4	O
,	O
ampulla	O
.	O
of	O
Vater	O
,	O
block	O
5	O
,	O
tesion	O
to	O
uncinate	O
process	O
.	O

(	O
perpendicular	O
)	O
;	O
block	O
6	O
,	O
lesion	O
to	O
anterior	O
pancreatic	O
soft	O
.	O
tissue	O
;	O
block	O
7	O
;	O
lesion	O
to	O
posterior	O
pancreatic	O
soft	O
tissue	O
;	O
.	O
block	O
8	O
,	O
lesion	O
to	O
inferior	O
pancreatic	O
soft	O
tissue	O
;	O
block	O
9	O
,	O
.	O
lesion	O
;	O
block	O
10	O
,	O
superior	O
pancreatic	O
soft	O
tissue	O
(	O
.	O
perpendicular	O
)	O
;	O
block	O
11	O
,	O
uninvolved	O
pancreatic	O
parenchyma	O
;	O
.	O
block	O
12	O
,	O
pylorus	O
;	O
blocks	O
13	O
and	O
14	O
,	O
five	O
whole	O
perigastric	O
.	O
probable	O
lymph	O
nodes	O
in	O
each	O
;	O
blocks	O
15	O
and	O
16	O
,	O
two	O
whole	O
.	O
peripancreatic	O
probable	O
lymph	O
nodes	O
in	O
each	O
;	O
block	O
17	O
;	O
one	O
.	O
peripancreatic	O
lymph	O
node	O
,	O
trisected	O
;	O
block	O
18	O
,	O
one	O
.	O
peripancreatic	O
lymph	O
node	O
,	O
serially	O
sectioned	O
;	O
blocke	O
19	O
and	O
.	O

20	O
,	O
peripancreatic	O
and	O
duodenal	O
adipose	O
tissue	O
,	O
entirely	O
.	O
submitted	O
:	O
block	O
21	O
;	O
additional	O
tissue	O
,	O
bisected	O
.	O

The	O
blocks	O
.	O
labeled	O
.	O

Also	O
received	O
in	O
the	O
same	O
.	O
container	O
IS	O
a	O
blue	O
,	O
yellow	O
and	O
green	O
cassette	O
labeled	O
.	O
for	O
:	O
'	O
.	O

INTRA	O
-	O
PROCEDURE	O
CONSULTATION	O
:	O
FROZEN	O
SECTION	O
DIAGNOSES	O
:	O
Part	O
B	O
:	O
Tumor	O
not	O
identified	O
.	O

Part	O
C	O
:	O
Tumor	O
not	O
identified	O
.	O

Both	O
of	O
those	O
diagnoses	O
are	O
.	O

Part	O
D	O
:	O
Negative	O
for	O
tumor	O
.	O

Intraoperative	O
Consultation	O
:	O
A	O
:	O
Microscopic	O
:	O
Glioma	O
.	O

Addendum	O
.	O

Addendum	O
Diagnosis	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
,	O
performed	O
at	O
.	O
,	O
demonstrates	O
loss	O
of	O
both	O
chromosomes	O
.	O

1p	O
and	O
19q	O
.	O

A	O
copy	O
of	O
this	O
report	O
is	O
on	O
file	O
in	O
the	O
Department	O
of	O
Pathology	O
.	O

Clinical	O
History	O
:	O
I	O
frontal	O
neoplasm	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
LEFT	O
FRONTAL	O
NEOPLASM	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
hospital	O
number	O
,	O
and	O
"	O
left	O
frontal	O
.	O

neoplasm	O
"	O
,	O
are	O
multiple	O
,	O
pink	O
-	O
tan	O
,	O
soft	O
tissue	O
fragments	O
,	O
1	O
X	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
for	O
frozen	O
section	O
and	O
touch	O
imprint	O
.	O

The	O
remainder	O
of	O
tissue	O
is	O
submitted	O
entirely	O
for	O
permanents	O
.	O

Summary	O
of	O
Cassettes	O
:	O
A	O
.	O

1FS	O
.	O

2	O
.	O
permanents	O
.	O

Accession	O
#	O
:	O
Med	O
:	O
Rec	O
.	O

:	O
Phone	O
Number	O
:	O
Gender	O
:	O
F	O
.	O

Client	O
:	O
:	O
CLINICAL	O
HISTORY	O
.	O
woman	O
experienced	O
recent	O
onset	O
seizure	O
,	O
and	O
on	O
imaging	O
.	O
has	O
a	O
.	O

1	O
.	O
5	O
cm	O
,	O
left	O
anterior	O
temporal	O
lobe	O
lesion	O
with	O
cystic	O
component	O
and	O
.	O
peripheral	O
enhancement	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Possible	O
brain	O
tumor	O
left	O
temporal	O
lobe	O
.	O

Operation	O
/	O
Specimen	O
:	O
A	O
:	O
Brain	O
tumor	O
,	O
biopsy	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
Brain	O
,	O
site	O
not	O
specified	O
,	O
excisional	O
biopsy	O
:	O
Anaplastic	O
.	O
oligodendroglioma	O
.	O

See	O
Microscopy	O
Description	O
and	O
Comment	O
.	O

COMMENT	O
.	O

The	O
sections	O
contain	O
portions	O
of	O
cerebrum	O
that	O
are	O
heavily	O
.	O

infiltrated	O
/	O
effaced	O
.	O
by	O
a	O
neoplastic	O
proliferation	O
of	O
glial	O
cells	O
that	O
have	O
astrocyte	O
-	O
like	O
.	O
phenotype	O
,	O
but	O
with	O
rather	O
uniform	O
round	O
nuclei	O
and	O
frequently	O
with	O
.	O
perinuclear	O
halos	O
.	O

There	O
is	O
brisk	O
mitotic	O
activity	O
,	O
with	O
a	O
high	O
MIB	O
-	O
1	O
.	O
proliferation	O
index	O
of	O
about	O
30	O
%	O
.	O

There	O
is	O
prominent	O
endothelial	O
.	O
hyperplasia	O
,	O
.	O
and	O
focal	O
microvascular	O
cellular	O
proliferation	O
.	O

There	O
is	O
no	O
tumor	O
.	O
necrosis	O
.	O

The	O
features	O
are	O
those	O
of	O
an	O
anaplastic	O
oligodendroglioma	O
.	O

Results	O
of	O
molecular	O
testing	O
are	O
reported	O
below	O
.	O

PROCEDURES	O
/	O
ADDENDA	O
.	O

PCR	O
for	O
EGFR	O
variant	O
III	O
mutation	O
.	O

Interpretation	O
.	O

NEGATIVE	O
-	O
No	O
evidence	O
of	O
EGFRVIII	O
mutation	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

TEST	O
DESCRIPTION	O
:	O
Testing	O
performed	O
on	O
RNA	O
extracted	O
from	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

The	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
is	O
an	O
attractive	O
molecular	O
.	O
target	O
.	O
in	O
glioblastoma	O
because	O
it	O
is	O
amplified	O
,	O
overexpressed	O
,	O
and	O
/	O
or	O
mutated	O
.	O
in	O
up	O
.	O
to	O
40	O
%	O
to	O
50	O
%	O
of	O
patients	O
.	O

Epidermal	O
growth	O
factor	O
receptor	O
variant	O
.	O

III	O
.	O

(	O
EGFRvIII	O
)	O
is	O
an	O
oncogenic	O
,	O
constitutively	O
active	O
mutant	O
form	O
of	O
EGFR	O
.	O
that	O
is	O
.	O
commonly	O
expressed	O
in	O
glioblastoma	O
.	O

Cell	O
culture	O
and	O
in	O
vivo	O
models	O
of	O
.	O
glioblastoma	O
have	O
demonstrated	O
EGFRVIII	O
as	O
defining	O
prognostically	O
.	O
distinct	O
.	O

subgroups	O
of	O
glioblastomas	O
.	O

Additionally	O
,	O
the	O
presence	O
of	O
EGFRVIII	O
has	O
.	O
been	O
.	O

shown	O
to	O
sensitize	O
tumors	O
to	O
EGFR	O
tyrosine	O
kinase	O
inhibitors	O
when	O
the	O
.	O
tumor	O
.	O

suppressor	O
protein	O
PTEN	O
is	O
intact	O
.	O

RNA	O
is	O
extracted	O
from	O
formalin	O
.	O
fixed	O
,	O
.	O
paraffin	O
embedded	O
tissue	O
samples	O
and	O
reverse	O
transcribed	O
to	O
cDNA	O
.	O

The	O
.	O

cDNA	O
is	O
.	O
then	O
amplified	O
using	O
standard	O
PCR	O
technique	O
for	O
DNA	O
templates	O
.	O

PCR	O
.	O
products	O
.	O

are	O
detected	O
by	O
gel	O
electrophoresis	O
.	O

The	O
limit	O
of	O
detection	O
of	O
this	O
.	O
assay	O
has	O
.	O
been	O
determined	O
to	O
be	O
approximately	O
5	O
mutant	O
cells	O
in	O
100	O
normal	O
.	O
cells	O
.	O

FDA	O
Comment	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
.	O
from	O
a	O
.	O
stand	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
.	O
performance	O
.	O

characteristies	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
'	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
.	O
for	O
.	O

specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
.	O
has	O
.	O

determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
.	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

MGMT	O
Promoter	O
Methylation	O
.	O

Interpretation	O
.	O

NEGATIVE	O
:	O
No	O
evidence	O
of	O
methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
tumor	O
paraffin	O
block	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Patients	O
with	O
glioma	O
containing	O
a	O
methylated	O
MGMT	O
.	O
promoter	O
.	O

have	O
been	O
shown	O
to	O
benefit	O
from	O
therapy	O
with	O
alkylating	O
agents	O
.	O

Assessment	O
of	O
.	O

MGMT	O
promoter	O
methylation	O
status	O
involves	O
bisulfite	O
treatment	O
of	O
DNA	O
.	O
followed	O
.	O
by	O
real	O
-	O
time	O
PCR	O
amplification	O
(	O
MethyLight	O
)	O
of	O
methylated	O
and	O
.	O
unmethylated	O
DNA	O
.	O
sequences	O
.	O

The	O
analytic	O
sensitivity	O
of	O
this	O
assay	O
was	O
determined	O
by	O
.	O
serial	O
.	O

dilution	O
of	O
methylated	O
positive	O
control	O
DNA	O
into	O
unmethylated	O
DNA	O
,	O
and	O
.	O
was	O
.	O

assessed	O
to	O
be	O
1	O
%	O
of	O
methylated	O
DNA	O
in	O
the	O
background	O
of	O
unmethylated	O
.	O

DNA	O
.	O

Factors	O
such	O
as	O
the	O
presence	O
of	O
>	O
50	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
.	O
sample	O
,	O
or	O
.	O
extensive	O
tissue	O
necrosis	O
,	O
may	O
preclude	O
the	O
detection	O
of	O
methylated	O
.	O

MGMT	O
.	O
promoter	O
sequences	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
.	O
from	O
a	O
.	O
stand	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
.	O
performance	O
.	O

characteristics	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
'	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
.	O
for	O
.	O

specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
.	O
has	O
.	O

determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
.	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

Loss	O
of	O
Heterozygosity	O
1p	O
,	O
19q	O
Assay	O
(	O
LOH	O
)	O
.	O

Interpretation	O
.	O

POSITIVE	O
:	O
Allelic	O
loss	O
on	O
chromosome	O
arm	O
1p	O
is	O
detected	O
.	O

Loss	O
of	O
one	O
allele	O
noted	O
in	O
one	O
marker	O
on	O
chromosome	O
arm	O
19q	O
.	O
suggestive	O
of	O
.	O
partial	O
deletion	O
(	O
D19S1182	O
)	O
.	O

Informative	O
loci	O
are	O
:	O
D1S1592	O
,	O
D1S1612	O
,	O
D1S552	O
,	O
D19S219	O
,	O
D19S606	O
and	O
.	O

D19S1182	O
.	O

Results	O
-	O
Comments	O
-	O
.	O

Testing	O
performed	O
on	O
DNA	O
extracted	O
from	O
tumor	O
paraffin	O
block	O
.	O

DNA	O
extracted	O
from	O
a	O
corresponding	O
blood	O
specimen	O
was	O
used	O
as	O
a	O
normal	O
.	O
reference	O
control	O
.	O

H	O
and	O
E	O
slide	O
was	O
examined	O
and	O
no	O
microdissection	O
was	O
needed	O
.	O

TEST	O
DESCRIPTION	O
:	O
Allelic	O
loss	O
is	O
assessed	O
by	O
PCR	O
assay	O
in	O
Normal	O
DNA	O
.	O

(	O
baseline	O
)	O
,	O
/	O
Tumor	O
DNA	O
pairs	O
using	O
3	O
markers	O
at	O
both	O
1p	O
and	O
19q	O
.	O

The	O
3	O
.	O
markers	O
.	O
on	O
1p	O
are	O
D1S548	O
,	O
D1S1592	O
,	O
and	O
D1S552	O
(	O
with	O
D1S468	O
,	O
D1S1612	O
,	O
and	O
.	O
D1S496	O
as	O
.	O
backup	O
markers	O
)	O
and	O
the	O
3	O
markers	O
on	O
19q	O
are	O
D19S219	O
,	O
D19S412	O
,	O
and	O
.	O

PLA2G4C	O
.	O

(	O
with	O
D19S606	O
and	O
D19S1182	O
as	O
backup	O
)	O
All	O
markers	O
are	O
microsatellites	O
.	O

(	O
2	O
or	O
4	O
.	O
nt	O
repeats	O
)	O
except	O
PLA2G4C	O
which	O
is	O
a	O
minisatellite	O
(	O
26	O
nt	O
repeat	O
)	O
.	O
polymorphism	O
.	O

The	O
markers	O
were	O
selected	O
based	O
on	O
heterozygosity	O
score	O
,	O
.	O
amplicon	O
size	O
,	O
and	O
ease	O
of	O
interpretation	O
.	O

The	O
backup	O
markers	O
are	O
used	O
.	O

if	O
the	O
.	O
first	O
line	O
markers	O
at	O
that	O
chromosome	O
arm	O
are	O
uninformative	O
or	O
.	O
otherwise	O
.	O

ambiguous	O
in	O
their	O
interpretation	O
.	O

LOH	O
at	O
all	O
informative	O
loci	O
on	O
each	O
.	O
chromosomal	O
arm	O
represents	O
the	O
typical	O
finding	O
in	O
oligodendrogliomas	O
.	O
with	O
1p	O
.	O
and	O
19q	O
deletion	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
.	O
from	O
a	O
.	O
stand	O
-	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
.	O
performance	O
.	O

characteristics	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
$	O
88	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
.	O
for	O
.	O

specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
.	O
has	O
.	O

determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
.	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
.	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

TECHNICAL	O
SENSITIVITY	O
:	O
The	O
presence	O
of	O
>	O
15	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
.	O
the	O
sample	O
.	O
may	O
preclude	O
the	O
detection	O
of	O
allelic	O
loss	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

A	O
.	O

Brain	O
tumor	O
,	O
biopsy	O
:	O
Glial	O
neoplasm	O
,	O
with	O
abnormal	O
vessels	O
and	O
.	O
mitoses	O
,	O
high	O
.	O
histological	O
grade	O
(	O
astrocytic	O
?	O
?	O

R	O
/	O
O	O
oligodendroglioma	O
?	O
?	O
?	O
.	O

Touch	O
.	O
preparation	O
smears	O
performed	O
at	O
.	O
and	O
results	O
.	O
reported	O
to	O
.	O
the	O
Physician	O
of	O
Record	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Brain	O
tumor	O
,	O
biopsy	O
.	O

CONTAINER	O
LABEL	O
:	O
tumor	O
frozen	O
and	O
permanent	O
.	O

FIXATIVE	O
:	O
Formalin	O
.	O

NO	O
.	O

PIECES	O
:	O
several	O
pale	O
gray	O
tan	O
fragments	O
.	O

SIZE	O
/	O
VOL	O
:	O
12	O
x	O
9	O
x	O
3	O
mm	O
.	O
in	O
aggregate	O
.	O

CASSETTES	O
:	O
1	O
-	O
FS	O
remnant	O
,	O
2	O
-	O
4	O
-	O
remainder	O
.	O

NS	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
The	O
GFAP	O
demonstrates	O
prominent	O
.	O
gliofibrillogenesis	O
by	O
.	O
the	O
neoplastic	O
cells	O
.	O

The	O
synaptophysin	O
and	O
NFP	O
demonstrate	O
overall	O
.	O
tumor	O
.	O

nodules	O
partially	O
surrounded	O
by	O
strands	O
of	O
cerebral	O
tissue	O
,	O
within	O
.	O
which	O
there	O
.	O
may	O
be	O
NeuN	O
-	O
positive	O
scattered	O
non	O
-	O
neoplastic	O
neurons	O
.	O

The	O
p53	O
.	O
protein	O
is	O
.	O
strongly	O
over	O
expressed	O
by	O
virtually	O
all	O
neoplastic	O
cells	O
.	O

With	O
the	O
.	O

MIB	O
-	O
1	O
.	O
there	O
is	O
a	O
proliferation	O
index	O
of	O
about	O
30	O
%	O
throughout	O
the	O
tumor	O
.	O

The	O
.	O

CD34	O
.	O
depicts	O
a	O
rich	O
microvasculature	O
with	O
hyperplasia	O
and	O
microvascular	O
.	O
cellular	O
.	O

proliferation	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
239	O
.	O
6	O
239	O
.	O
6	O
.	O

Histo	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
tumor	O
.	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

FS	O
H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

TPS	O
H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

CD34	O
-	O
DA	O
x	O
1	O
.	O

2	O
.	O

EGFR	O
vIII	O
-	O
curls	O
x	O
1	O
.	O

2	O
.	O

mGFAP	O
-	O
DA	O
X	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

2	O
.	O

LOH	O
-	O
curls	O
X	O
1	O
.	O

2	O
.	O

MGMT	O
-	O
curls	O
X	O
1	O
.	O

2	O
.	O

MIB1	O
-	O
DA	O
X	O
1	O
.	O

2	O
.	O

NeuN	O
X	O
1	O
.	O

2	O
.	O

NF2F11	O
X	O
1	O
.	O

2	O
.	O

P53D07	O
x	O
1	O
.	O

2	O
.	O

Synap	O
-	O
DA	O
x	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

3	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

4	O
.	O

Main	O
diagnosis	O
/	O
diagnoses	O
:	O
Peripheral	O
bronchopulmonary	O
,	O
histologically	O
mucinous	O
adenocarcinoma	O
with	O
very	O
.	O
predominant	O
bronchioloalveolar	O
differentiation	O
and	O
spread	O
and	O
a	O
small	O
component	O
showing	O
.	O
destructive	O
,	O
infiltrative	O
growth	O
and	O
localization	O
in	O
S10	O
.	O

TNM	O
classification	O
on	O
the	O
basis	O
of	O
this	O
material	O
pT2	O
pNO	O
pMX	O
R0	O
stage	O
IB	O
.	O

C34	O
.	O
3	O
M	O
8255	O
/	O
3	O
.	O

Comment	O
/	O
supplementary	O
remark	O
:	O
There	O
is	O
no	O
evidence	O
of	O
the	O
carcinoma	O
having	O
infiltrated	O
the	O
visceral	O
pleura	O
.	O

The	O
resection	O
.	O
margin	O
of	O
the	O
bronchus	O
and	O
vessels	O
and	O
all	O
the	O
removed	O
lymph	O
nodes	O
are	O
also	O
tumor	O
-	O
free	O
.	O

(	O
Age	O
:	O
Visit	O
#	O
:	O
Resulted	O
:	O
Gender	O
:	O
F	O
.	O

Facility	O
:	O
SPECIMEN	O
(	O
S	O
)	O
RECEIVED	O
.	O

1	O
.	O

BRN	O
:	O
RIGHT	O
FRONTAL	O
PARIETAL	O
TEMPORAL	O
LESION	O
.	O

DIAGNOSIS	O
.	O

Brain	O
,	O
right	O
frontal	O
parietal	O
temporal	O
region	O
:	O
Glioblastoma	O
(	O
WHO	O
grade	O
.	O

IK	O
.	O

CLINICAL	O
HISTORY	O
.	O

RIGHT	O
BRAIN	O
TUMOUR	O
.	O

GROSS	O
DESCRIPTION	O
.	O

The	O
specimen	O
container	O
,	O
labeled	O
with	O
the	O
patient	O
1	O
S	O
name	O
and	O
as	O
"	O
right	O
.	O
frontal	O
parietal	O
temporal	O
lesion	O
"	O
.	O
contains	O
a	O
piece	O
of	O
pinkish	O
white	O
.	O
tissue	O
,	O
received	O
in	O
10	O
%	O
buffered	O
formalin	O
.	O

In	O
aggregate	O
this	O
measures	O
0	O
.	O
6	O
.	O

x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
and	O
weighs	O
less	O
than	O
1	O
gm	O
.	O

1A	O
-	O
specimen	O
submitted	O
in	O
.	O
toto	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Sections	O
show	O
an	O
infiltrating	O
glial	O
tumour	O
of	O
predominantly	O
astrocytic	O
.	O
derivation	O
.	O

Numerous	O
mitotic	O
figures	O
are	O
present	O
.	O

There	O
is	O
abundant	O
.	O
microvascular	O
proliferation	O
.	O

Areas	O
of	O
necrosis	O
are	O
not	O
present	O
in	O
the	O
.	O
specimen	O
.	O

Diagnosis	O
/	O
Diagnoses	O
.	O

1	O
.	O

Mechanically	O
altered	O
liver	O
tissue	O
with	O
sections	O
of	O
a	O
regressively	O
changed	O
cyst	O
with	O
.	O
partially	O
dystrophic	O
wall	O
calcification	O
.	O

2	O
.	O

Subcapsular	O
liver	O
tissue	O
with	O
circumscribed	O
,	O
clearly	O
regeneratory	O
,	O
nodular	O
.	O
hyperplasia	O
and	O
moderate	O
steatosis	O
.	O

3	O
.	O

Resected	O
ileocolic	O
sample	O
with	O
a	O
moderately	O
differentiated	O
adenocarcinoma	O
of	O
the	O
.	O
colorectal	O
type	O
,	O
measuring	O
max	O
4	B
cm	I
,	O
with	O
infiltration	O
of	O
the	O
tunica	O
muscularis	O
.	O
propria	O
up	O
to	O
the	O
border	O
of	O
the	O
perimuscular	O
fatty	O
tissue	O
.	O

Tumor	O
-	O
free	O
local	O
lymph	O
.	O
nodes	O
.	O

Tumor	O
-	O
free	O
small	O
and	O
large	O
intestine	O
resection	O
margins	O
.	O

Tumor	O
-	O
free	O
.	O
mesenteric	O
resection	O
margin	O
.	O

Complete	O
,	O
scarred	O
obliteration	O
of	O
the	O
appendix	O
with	O
a	O
.	O
condition	O
following	O
previous	O
appendicitis	O
.	O

The	O
tumor	O
stage	O
is	O
:	O
pT2	O
,	O
pNO	O
(	O
0	O
/	O
23	O
)	O
,	O
pMX	O
;	O
G2	O
,	O
LO	O
,	O
V0	O
,	O
R	O
.	O

Document	O
Date	O
:	O
Modified	O
.	O

Date	O
Collected	O
:	O
Date	O
Received	O
:	O
PT	O
:	O
SUPPLEMENTAL	O
REPORT	O
.	O

SUPPLEMENTAL	O
DIAGNOSIS	O
:	O
The	O
diagnoses	O
are	O
unchanged	O
.	O

COMMENT	O
:	O
MGMT	O
GENE	O
AMPLIFICATION	O
.	O

DNA	O
was	O
isolated	O
from	O
a	O
paraffin	O
embedded	O
block	O
of	O
the	O
brain	O
tumor	O
biopsy	O
.	O

DNA	O
methylation	O
patterns	O
in	O
the	O
CpG	O
island	O
of	O
the	O
MGMT	O
gene	O
.	O

)	O
was	O
determined	O
by	O
chemical	O
.	O

(	O
bisulfite	O
)	O
modification	O
of	O
unmethylated	O
,	O
but	O
not	O
methylated	O
,	O
cytosines	O
to	O
.	O
uracil	O
and	O
subsequent	O
PCR	O
using	O
primers	O
specific	O
for	O
either	O
methylated	O
or	O
the	O
.	O
modified	O
unmethylated	O
DNA	O
.	O

The	O
.	O

PCR	O
products	O
were	O
analyzed	O
in	O
duplicate	O
parallel	O
runs	O
by	O
capillary	O
gel	O
.	O
electrophoresis	O
.	O

The	O
sensitivity	O
of	O
the	O
assay	O
based	O
on	O
DNA	O
dilution	O
studies	O
.	O

is	O
at	O
least	O
1	O
:	O
1000	O
.	O

The	O
analyzed	O
region	O
of	O
the	O
MGMT	O
promoter	O
is	O
UNMETHYLATED	O
.	O

INTERPRETATION	O
:	O
MGMT	O
(	O
06	O
methylguaine	O
DNA	O
methyltransferase	O
)	O
is	O
a	O
DNA	O
repair	O
gene	O
.	O

Methylation	O
.	O
of	O
the	O
promotor	O
leads	O
to	O
gene	O
silencing	O
and	O
loss	O
of	O
MGMT	O
expression	O
.	O

a	O
recent	O
.	O
study	O
that	O
tested	O
the	O
methylation	O
status	O
of	O
the	O
same	O
region	O
of	O
the	O
MGMT	O
.	O
promoter	O
in	O
glioblastomas	O
found	O
that	O
MGMT	O
promoter	O
methylation	O
was	O
an	O
.	O
independent	O
favorable	O
prognostic	O
factor	O
and	O
was	O
associated	O
with	O
a	O
survival	O
.	O
benefit	O
in	O
patients	O
treated	O
with	O
temozolamide	O
and	O
radiotherapy	O
.	O

e	O
.	O

This	O
test	O
was	O
not	O
requested	O
,	O
performed	O
or	O
reported	O
at	O
.	O

Hospital	O
Department	O
of	O
Pathology	O
.	O

The	O
test	O
was	O
requested	O
by	O
.	O

n	O
.	O

The	O
test	O
was	O
performed	O
and	O
.	O
results	O
reported	O
by	O
.	O

1	O
,	O
Department	O
of	O
Pathology	O
,	O
.	O

Results	O
are	O
included	O
with	O
this	O
Surgical	O
Pathology	O
report	O
so	O
that	O
all	O
available	O
.	O
information	O
on	O
this	O
tumor	O
may	O
be	O
accessed	O
at	O
one	O
site	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

RIGHT	O
TEMPORAL	O
BRAIN	O
LESION	O
,	O
RESECTION	O
,	O
FS1A	O
,	O
TP1A	O
:	O
-	O
GLIOBLASTOMA	O
,	O
WHO	O
GRADE	O
IV	O
.	O

-	O
SEE	O
COMMENT	O
.	O

2	O
.	O

RIGHT	O
TEMPORAL	O
BRAIN	O
LESION	O
,	O
RESECTION	O
:	O
-	O
GLIOBLASTOMA	O
,	O
WHO	O
GRADE	O
IV	O
.	O

-	O
SEE	O
COMMENT	O
.	O

3	O
.	O

DURA	O
,	O
RESECTION	O
:	O
-	O
SECTION	O
OF	O
DURA	O
WITH	O
UNDERLYING	O
GLIOBLASTOMA	O
,	O
WHO	O
GRADE	O
IV	O
.	O

-	O
SEE	O
COMMENT	O
.	O

Pa	O
.	O

COMMENT	O
.	O

This	O
malignant	O
neoplasm	O
stains	O
positively	O
for	O
GFAP	O
and	O
a	O
stain	O
for	O
CD34	O
.	O
highlights	O
the	O
highly	O
proliferative	O
blood	O
vessels	O
of	O
this	O
neoplasm	O
.	O

Tumor	O
.	O
necrosis	O
is	O
identified	O
,	O
fulfilling	O
the	O
criteria	O
for	O
glioblastoma	O
,	O
WHO	O
grade	O
.	O

IV	O
.	O

Immunohistochemistry	O
for	O
neurofilament	O
shows	O
neoplastic	O
cells	O
invading	O
.	O
neurofilament	O
positive	O
axons	O
,	O
FISH	O
analysis	O
for	O
EGFR	O
gene	O
status	O
will	O
be	O
.	O
performed	O
and	O
a	O
separate	O
report	O
will	O
be	O
issued	O
.	O

Tissue	O
will	O
be	O
sent	O
for	O
MGMT	O
.	O
analysis	O
and	O
a	O
separate	O
report	O
will	O
be	O
issued	O
.	O

SPECIMEN	O
:	O
1	O
.	O

Right	O
temporal	O
brain	O
lesion	O
.	O

2	O
.	O

Right	O
temporal	O
brain	O
lesion	O
.	O

3	O
.	O

Dura	O
.	O

CLINICAL	O
HISTORY	O
/	O
OPERATIVE	O
FINDINGS	O
:	O
None	O
provided	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Specimen	O
#	O
1	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
is	O
labeled	O
.	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
and	O
as	O
"	O
right	O
temporal	O
brain	O
.	O
lesion	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
red	O
and	O
white	O
brain	O
tissue	O
that	O
is	O
soft	O
in	O
.	O
consistency	O
which	O
measures	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
X	O
0	O
.	O
4	O
cm	O
.	O

A	O
representative	O
section	O
is	O
.	O
taken	O
for	O
frozen	O
section	O
diagnosis	O
and	O
the	O
cryoblock	O
is	O
transferred	O
to	O
.	O
cassette	O
"	O
FS1A	O
.	O
"	O
The	O
rest	O
of	O
the	O
specimen	O
is	O
submitted	O
in	O
cassette	O
"	O
1B	O
.	O
"	O
.	O

Dictated	O
by	O
Dr	O
.	O
Specimen	O
#	O
2	O
is	O
received	O
in	O
formalin	O
and	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O
medical	O
record	O
number	O
and	O
as	O
"	O
right	O
frontal	O
brain	O
lesion	O
.	O

The	O
specimen	O
.	O
consists	O
of	O
multiple	O
fragments	O
of	O
brown	O
and	O
white	O
brain	O
tissue	O
measuring	O
3	O
.	O
0	O
X	O
.	O

2	O
.	O

X	O
0	O
.	O
6	O
cm	O
in	O
aggregate	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
.	O

"	O
2A	O
"	O
and	O
"	O
2B	O
.	O

"	O
Dictated	O
by	O
.	O

Specimen	O
#	O
3	O
is	O
received	O
in	O
formalin	O
and	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
.	O
medical	O
record	O
number	O
and	O
as	O
"	O
dura	O
.	O

"	O
The	O
specimen	O
consists	O
of	O
one	O
piece	O
of	O
.	O
fibrous	O
soft	O
tissue	O
,	O
measuring	O
4	O
.	O
5	O
X	O
2	O
.	O
1	O
x	O
0	O
.	O
3	O
cm	O
.	O

Representative	O
sections	O
.	O
are	O
submitted	O
in	O
cassette	O
"	O
3A	O
.	O
'	O
Dictated	O
by	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
FS1A	O
,	O
TP1A	O
:	O
RIGHT	O
TEMPORAL	O
BRAIN	O
LESION	O
,	O
BIOPSY	O
(	O
FROZEN	O
SECTION	O
,	O
TOUCH	O
.	O
PREPARATION	O
)	O
:	O
GLIOBLASTOMA	O
.	O

Frozen	O
Section	O
results	O
were	O
communicated	O
to	O
the	O
surgical	O
team	O
and	O
.	O
were	O
repeated	O
back	O
by	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
Microscopic	O
examination	O
performed	O
.	O

SPECIAL	O
STAINS	O
:	O
GFAP	O
.	O

DONE	O
.	O

CD34	O
.	O

DONE	O
.	O

NF	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

2	O
(	O
Continued	O
.	O

FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
.	O

SPECIMEN	O
:	O
Brain	O
,	O
right	O
temporal	O
brain	O
lesion	O
.	O

CLINICAL	O
HISTORY	O
/	O
REFERRING	O
DIAGNOSIS	O
:	O
Glioblastoma	O
,	O
WHO	O
grade	O
IV	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Paraffin	O
block	O
,	O
labeled	O
2A	O
.	O

TEST	O
PERFORMED	O
/	O
PROBES	O
USED	O
:	O
EGFR	O
gene	O
locus	O
specific	O
probe	O
(	O
7p12	O
)	O
.	O

Chromosome	O
7	O
alpha	O
satellite	O
DNA	O
specific	O
probe	O
(	O
7p11	O
.	O
1	O
-	O
7q11	O
.	O
1	O
)	O
-	O
.	O

POSITIVE	O
for	O
EGFR	O
gene	O
amplification	O
.	O
nuc	O
ish	O
amp	O
(	O
EGFR	O
)	O
[	O
193	O
/	O
200	O
]	O
.	O

INTERPRETATION	O
:	O
Flourescence	O
in	O
situ	O
hybridization	O
was	O
performed	O
using	O
the	O
above	O
listed	O
DNA	O
.	O
probes	O
(	O
Abbott	O
Molecular	O
,	O
Inc	O
.	O
)	O
The	O
probes	O
were	O
simultaneously	O
hybridized	O
to	O
a	O
.	O
section	O
of	O
the	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
tissue	O
submitted	O
for	O
.	O
evaluation	O
.	O

Of	O
200	O
interphase	O
nuclei	O
analyzed	O
,	O
96	O
%	O
of	O
cells	O
were	O
POSITIVE	O
for	O
EGFR	O
gene	O
.	O
amplification	O
.	O

Positive	O
and	O
negative	O
controls	O
were	O
appropriate	O
.	O

Correlation	O
.	O
with	O
clinical	O
and	O
other	O
laboratory	O
parameters	O
is	O
suggested	O
.	O

COMMENT	O
.	O

The	O
results	O
of	O
this	O
test	O
should	O
not	O
be	O
used	O
alone	O
as	O
the	O
sole	O
basis	O
for	O
.	O
diagnosis	O
and	O
/	O
or	O
treatment	O
.	O

These	O
results	O
may	O
,	O
however	O
,	O
prove	O
useful	O
when	O
.	O
used	O
in	O
conjunction	O
with	O
other	O
diagnostic	O
procedures	O
and	O
clinical	O
evaluations	O
.	O

Use	O
of	O
these	O
results	O
,	O
in	O
this	O
manner	O
,	O
can	O
be	O
considered	O
to	O
fall	O
within	O
the	O
.	O
scope	O
of	O
practice	O
of	O
medicine	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O

It	O
has	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Foud	O
anda	O
brug	O
.	O

Sex	O
:	O
M	O
.	O

Case	O
type	O
:	O
Surgical	O
History	O
.	O

Case	O
imported	O
from	O
legacy	O
computer	O
system	O
.	O

The	O
format	O
of	O
this	O
report	O
does	O
not	O
match	O
the	O
original	O
case	O
.	O

For	O
cases	O
prior	O
to	O
.	O
the	O
section	O
"	O
SPECIMEN	O
"	O
may	O
have	O
been	O
added	O
.	O

SUPPLEMENTAL	O
REPORT	O
.	O

DIAGNOSIS	O
:	O
(	O
B	O
)	O
TOTAL	O
LARYNGECTOMY	O
:	O
SQUAMOUS	O
CARCINOMA	O
IN	O
THYROID	O
CARTILAGE	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
Report	O
released	O
by	O
:	O
DIAGNOSIS	O
.	O

(	O
A	O
)	O
LARYNX	O
BIOPSY	O
:	O
INVASIVE	O
POORLY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
.	O

(	O
B	O
)	O
.	O

TOTAL	O
LARYNGECTOMY	O
AND	O
BILATERAL	O
NECK	O
DISSECTION	O
:	O
INVASIVE	O
POORLY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
,	O
PRESENCE	O
OF	O
.	O

LYMPHATIC	O
AND	O
PERINEURAL	O
INVASION	O
INVOLVING	O
RIGHT	O
AND	O
LEFT	O
.	O

FALSE	O
VOCAL	O
CORD	O
,	O
RIGHT	O
AND	O
LEFT	O
TRUE	O
VOCAL	O
CORDS	O
,	O
VENTRICLES	O
,	O
.	O

PRESENCE	O
OF	O
SUBGLOTTIC	O
EXTENSION	O
ON	O
THE	O
LEFT	O
SIDE	O
MEASURING	O
.	O

7	O
.	O
0	O
'	O
MM	O
.	O

TUMOR	O
INVADING	O
PERICHONDRIUM	O
.	O

Margins	O
of	O
excision	O
free	O
of	O
tumor	O
.	O

Ten	O
right	O
lymph	O
nodes	O
,	O
no	O
tumor	O
.	O

TWO	O
left	O
lymph	O
nodes	O
,	O
no	O
tumor	O
.	O

(	O
C	O
)	O
LEFT	O
LYMPH	O
NODES	O
:	O
Three	O
lymph	O
nodes	O
,	O
no	O
tumor	O
.	O

(	O
D	O
)	O
RIGHT	O
EPIGLOTTIC	O
FOLD	O
MARGIN	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
Report	O
released	O
by	O
:	O
GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
LARYNX	O
-	O
Three	O
portions	O
of	O
tan	O
-	O
pink	O
-	O
purple	O
soft	O
tissue	O
ranging	O
from	O
0	O
.	O
4	O
to	O
.	O

0	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
for	O
frozen	O
section	O
examination	O
as	O
A	O
.	O

FS	O
/	O
DX	O
:	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

Sex	O
:	O
M	O
.	O

Case	O
type	O
:	O
Surgical	O
History	O
.	O

(	O
B	O
)	O
TOTAL	O
LARYNGECTOMY	O
AND	O
BILATERAL	O
NECK	O
DISSECTION	O
-	O
A	O
total	O
laryngectomy	O
.	O
and	O
attached	O
fibroadipose	O
tissue	O
with	O
overall	O
measurements	O
of	O
9	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
5	O
.	O
5	O
.	O

cm	O
.	O

An	O
ulcerated	O
friable	O
mass	O
involving	O
the	O
right	O
transglottic	O
and	O
the	O
.	O
midline	O
and	O
glottic	O
and	O
subglottic	O
lesion	O
on	O
the	O
left	O
measuring	O
4	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
.	O

1	O
.	O
0	O
cm	O
.	O

The	O
mucosal	O
margin	O
appears	O
grossly	O
uninvolved	O
.	O

Small	O
fragments	O
of	O
.	O
soft	O
tissue	O
(	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
)	O
on	O
the	O
right	O
and	O
on	O
the	O
left	O
were	O
identified	O
,	O
and	O
.	O
the	O
lymph	O
node	O
was	O
submitted	O
separately	O
on	O
the	O
right	O
and	O
left	O
neck	O
dissection	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
from	O
right	O
to	O
Teft	O
in	O
cassettes	O
B2	O
-	O
B14	O
for	O
.	O
the	O
laryngeal	O
cancer	O
;	O
B15	O
-	O
817	O
,	O
right	O
lymph	O
node	O
:	O
818	O
,	O
section	O
of	O
thyroid	O
;	O
.	O

B19	O
-	O
B21	O
,	O
Tymph	O
nodes	O
from	O
the	O
left	O
side	O
.	O

(	O
c	O
)	O
LEFT	O
LYMPH	O
NODES	O
-	O
Received	O
are	O
three	O
pink	O
-	O
tan	O
lymph	O
nodes	O
ranging	O
from	O
.	O

0	O
.	O
9	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
to	O
1	O
.	O
9	O
x	O
1	O
x	O
0	O
.	O
7	O
cm	O
.	O

Entirely	O
submitted	O
in	O
C1	O
through	O
C3	O
,	O
one	O
.	O
lymph	O
node	O
each	O
.	O

(	O
D	O
)	O
RIGHT	O
EPIGLOTTIS	O
FOLD	O
MARGIN	O
-	O
A	O
single	O
portion	O
of	O
tan	O
-	O
pink	O
soft	O
tissue	O
.	O

(	O
1	O
.	O
2	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
)	O
.	O

Submitted	O
in	O
toto	O
for	O
frozen	O
section	O
examination	O
as	O
.	O

D	O
.	O

FS	O
/	O
DX	O
:	O
MUCOSA	O
,	O
NO	O
TUMOR	O
PRESENT	O
.	O

SNOMED	O
CODES	O
.	O

M	O
-	O
80703	O
T	O
-	O
24100	O
.	O

CLINICAL	O
HISTORY	O
:	O
Pelvic	O
mass	O
,	O
abdominal	O
/	O
pelvic	O
swell	O
NOS	O
.	O

(	O
montal	O
mining	O
with	O
bilateral	O
.	O
adnexal	O
masses	O
,	O
Post	O
menopausal	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Omentum	O
(	O
AF1	O
)	O
"	O
.	O
received	O
fresh	O
for	O
frozen	O
section	O
.	O

A	O
320	O
.	O
0	O
gram	O
,	O
15	O
.	O
5	O
x	O
.	O

11	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
portion	O
of	O
tan	O
-	O
yellow	O
,	O
firm	O
fibroadipose	O
tissue	O
with	O
diffuse	O
.	O
adhesions	O
and	O
white	O
-	O
tan	O
adherent	O
exudate	O
is	O
received	O
.	O

The	O
specimen	O
is	O
.	O
serially	O
sectioned	O
to	O
exhibit	O
a	O
tan	O
-	O
yellow	O
,	O
firm	O
,	O
cut	O
surface	O
throughout	O
,	O
i	O
.	O
e	O
.	O
tumor	O
size	O
greater	O
than	O
2	B
cm	I
.	O

A	O
representative	O
section	O
has	O
been	O
previously	O
.	O
frozen	O
as	O
AF1	O
and	O
the	O
frozen	O
section	O
remnant	O
is	O
entirely	O
submitted	O
in	O
block	O
.	O

A1	O
.	O

An	O
additional	O
representative	O
section	O
is	O
submitted	O
in	O
block	O
A2	O
.	O

B	O
.	O

"	O
Right	O
tube	O
and	O
ovary	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

A	O
101	O
.	O
0	O
.	O
gram	O
,	O
8	O
.	O
0	O
x	O
5	O
.	O
8	O
x	O
3	O
.	O
7	O
cm	O
ovary	O
with	O
an	O
adherent	O
5	O
.	O
5	O
cm	O
long	O
fimbriated	O
.	O
fallopian	O
tube	O
.	O

The	O
surface	O
of	O
the	O
ovary	O
is	O
focally	O
disrupted	O
and	O
is	O
serially	O
.	O
sectioned	O
to	O
exhibit	O
a	O
4	O
.	O
5	O
x	O
3	O
.	O
8	O
x	O
2	O
.	O
8	O
cm	O
thin	O
walled	O
cyst	O
filled	O
with	O
a	O
.	O
yellow	O
-	O
tan	O
,	O
waxy	O
,	O
sebaceous	O
material	O
,	O
and	O
a	O
small	O
amount	O
of	O
white	O
-	O
tan	O
mucinous	O
.	O
material	O
.	O

A	O
2	O
.	O
2	O
x	O
1	O
.	O
4	O
x	O
1	O
.	O
2	O
cm	O
tan	O
,	O
friable	O
nodule	O
is	O
attached	O
to	O
the	O
cyst	O
.	O
wall	O
.	O

No	O
additional	O
masses	O
or	O
papillary	O
excrescenses	O
are	O
grossly	O
.	O
identified	O
.	O

The	O
remainder	O
of	O
the	O
parenchyma	O
is	O
replaced	O
by	O
a	O
white	O
-	O
tan	O
,	O
firm	O
.	O
tissue	O
and	O
multiple	O
thin	O
walled	O
cysts	O
up	O
to	O
2	O
.	O
0	O
cm	O
,	O
one	O
of	O
which	O
is	O
lined	O
by	O
.	O
papillary	O
excrescenses	O
.	O

BLOCK	O
SUMMARY	O
:	O
B1	O
-	O
mass	O
adjacent	O
to	O
sebaceous	O
-	O
filled	O
cyst	O
.	O

B2	O
-	O
cyst	O
with	O
papillary	O
excrescenses	O
.	O

B3	O
-	O
representative	O
section	O
of	O
adherent	O
fallopian	O
tube	O
.	O

B4	O
-	O
representative	O
section	O
of	O
friable	O
nodule	O
.	O

C	O
.	O

"	O
Anterior	O
cul	O
-	O
de	O
-	O
sac	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
.	O

a	O
3	O
.	O
8	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
multiple	O
fragments	O
of	O
tan	O
-	O
yellow	O
.	O
fibroadipose	O
tissue	O
,	O
representative	O
of	O
which	O
are	O
submitted	O
in	O
block	O
C1	O
.	O

D	O
.	O

"	O
Left	O
tube	O
and	O
ovary	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

A	O
50	O
.	O
0	O
gram	O
,	O
.	O

6	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
2	O
.	O
2	O
cm	O
ovary	O
with	O
an	O
attached	O
and	O
focally	O
embedded	O
fimbriated	O
.	O
fallopian	O
tube	O
is	O
received	O
.	O

The	O
surface	O
of	O
the	O
ovary	O
is	O
disrupted	O
and	O
rough	O
.	O
with	O
multiple	O
adhesions	O
.	O

The	O
ovary	O
is	O
serially	O
sectioned	O
to	O
exhibit	O
a	O
firm	O
,	O
.	O
white	O
-	O
tan	O
cut	O
surface	O
with	O
multiple	O
cysts	O
up	O
to	O
2	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
,	O
.	O
one	O
of	O
which	O
is	O
lined	O
by	O
papillary	O
excrescenses	O
.	O

No	O
normal	O
ovarian	O
tissue	O
is	O
.	O
grossly	O
identified	O
.	O

The	O
fallopian	O
tube	O
is	O
5	O
.	O
2	O
cm	O
long	O
with	O
an	O
average	O
.	O
diameter	O
of	O
0	O
.	O
4	O
cm	O
.	O

BLOCK	O
SUMMARY	O
:	O
D1	O
-	O
cyst	O
with	O
papillary	O
excrescenses	O
.	O

D2	O
-	O
representative	O
section	O
of	O
white	O
-	O
tan	O
solid	O
tissue	O
.	O

D3	O
-	O
representative	O
section	O
of	O
embedded	O
fallopian	O
tube	O
.	O

E	O
.	O

"	O
Uterus	O
and	O
cervix	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
.	O

56	O
.	O
0	O
gram	O
,	O
8	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
3	O
.	O
5	O
cm	O
uterus	O
with	O
attached	O
cervix	O
.	O

The	O
serosa	O
is	O
.	O
covered	O
with	O
multiple	O
adhesions	O
and	O
multiple	O
,	O
firm	O
,	O
white	O
-	O
tan	O
adherent	O
.	O
nodules	O
.	O

The	O
white	O
-	O
tan	O
,	O
smooth	O
and	O
glistening	O
ectocervix	O
has	O
a	O
0	O
,	O
7	O
cm	O
patent	O
.	O

os	O
which	O
opens	O
into	O
a	O
2	O
.	O
0	O
cm	O
long	O
tan	O
,	O
trabeculated	O
endocervical	O
canal	O
.	O

The	O
.	O

3	O
.	O
4	O
x	O
1	O
.	O
5	O
cm	O
endometrial	O
cavity	O
is	O
lined	O
by	O
a	O
tan	O
,	O
smooth	O
endometrium	O
.	O

The	O
.	O

0	O
.	O
1	O
cm	O
endometrium	O
overlies	O
a	O
1	O
.	O
3	O
cm	O
myometrium	O
remarkable	O
for	O
a	O
1	O
.	O
3	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
white	O
,	O
well	O
-	O
circumscribed	O
,	O
whorled	O
nodule	O
with	O
a	O
bulging	O
.	O
rage	O
2015	O
.	O
cut	O
.	O

surface	O
.	O

Representative	O
sections	O
of	O
cervix	O
are	O
submitted	O
in	O
Block	O
E1	O
-	O
2	O
.	O
and	O
representative	O
sections	O
of	O
endomyometrium	O
are	O
submitted	O
in	O
blocks	O
E3	O
-	O
4	O
.	O

F	O
.	O

"	O
Left	O
cul	O
-	O
de	O
-	O
sac	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
.	O

5	O
.	O
2	O
x	O
4	O
.	O
5	O
x	O
1	O
.	O
6	O
cm	O
fragment	O
of	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
which	O
is	O
focally	O
.	O
indurated	O
.	O

Sectioning	O
reveals	O
a	O
white	O
-	O
tan	O
,	O
firm	O
cut	O
surface	O
with	O
yellow	O
,	O
.	O
lobulated	O
adipose	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
Block	O
F1	O
.	O

G	O
.	O

"	O
Rectosigmoid	O
colon	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
.	O

a	O
.	O

16	O
.	O
0	O
cm	O
long	O
unoriented	O
segment	O
of	O
large	O
intestine	O
that	O
ranges	O
in	O
.	O
circumference	O
from	O
2	O
.	O
5	O
cm	O
up	O
to	O
5	O
.	O
5	O
cm	O
.	O

The	O
serosa	O
is	O
diffusely	O
covered	O
.	O
with	O
.	O

adhesions	O
and	O
multiple	O
focal	O
areas	O
of	O
induration	O
.	O

The	O
lumen	O
is	O
focally	O
.	O
stenotic	O
and	O
surrounded	O
by	O
indurated	O
,	O
yellow	O
,	O
lobulated	O
adipose	O
tissue	O
.	O

The	O
.	O
mucosa	O
is	O
pink	O
-	O
tan	O
and	O
grossly	O
unremarkable	O
.	O

Sectioning	O
exhibits	O
areas	O
of	O
.	O
white	O
-	O
tan	O
,	O
firm	O
tissue	O
deep	O
to	O
the	O
mucosa	O
,	O
which	O
corresponds	O
to	O
the	O
areas	O
of	O
.	O
induration	O
on	O
the	O
serosa	O
.	O

BLOCK	O
SUMMARY	O
:	O
G1	O
-	O
.	O
stapled	O
margin	O
.	O

G2	O
-	O
.	O
open	O
margin	O
.	O

G3	O
-	O
4	O
-	O
.	O
representative	O
sections	O
of	O
mucosa	O
in	O
relation	O
to	O
white	O
-	O
tan	O
,	O
firm	O
.	O
tissue	O
.	O

H	O
.	O

"	O
Posterior	O
wall	O
of	O
bladder	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
2	O
.	O
7	O
x	O
2	O
.	O
7	O
x	O
0	O
.	O
7	O
cm	O
aggregate	O
of	O
multiple	O
fragments	O
of	O
gray	O
-	O
tan	O
.	O
tissue	O
which	O
is	O
entirely	O
submitted	O
in	O
block	O
H1	O
.	O

I	O
.	O

"	O
Left	O
pelvic	O
side	O
wall	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
.	O

is	O
a	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
fragment	O
of	O
firm	O
,	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
which	O
.	O

is	O
sectioned	O
to	O
exhibit	O
a	O
white	O
-	O
tan	O
,	O
firm	O
cut	O
surface	O
with	O
a	O
minimal	O
amount	O
of	O
.	O
yellow	O
,	O
lobulated	O
adipose	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
.	O

Block	O
I1	O
.	O

J	O
.	O

"	O
Small	O
bowel	O
nodules	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
.	O

a	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
4	O
cm	O
aggregate	O
of	O
multiple	O
fragments	O
of	O
firm	O
,	O
gray	O
-	O
tan	O
tissue	O
.	O
which	O
is	O
entirely	O
submitted	O
in	O
block	O
J1	O
.	O

K	O
.	O

"	O
Omentum	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
5	O
.	O
0	O
x	O
3	O
.	O
5	O
.	O

x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
two	O
fragments	O
of	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
with	O
.	O
focal	O
adhesions	O
.	O

Sectioning	O
exhibits	O
a	O
white	O
-	O
tan	O
,	O
firm	O
cut	O
surface	O
with	O
a	O
.	O
small	O
amount	O
of	O
fibroadipose	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
.	O
block	O
K1	O
.	O

L	O
.	O

"	O
Supragastric	O
nodule	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
.	O

a	O
3	O
.	O
5	O
x	O
2	O
.	O
3	O
x	O
0	O
.	O
9	O
cm	O
fragment	O
of	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
.	O

Sectioning	O
.	O
exhibits	O
a	O
white	O
-	O
tan	O
,	O
firm	O
cut	O
surface	O
with	O
a	O
small	O
amount	O
of	O
fibroadipose	O
.	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
block	O
L1	O
.	O

M	O
.	O

"	O
Transverse	O
colon	O
nodule	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
.	O

is	O
a	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
fragment	O
of	O
tan	O
-	O
gray	O
tissue	O
,	O
which	O
is	O
sectioned	O
and	O
.	O
submitted	O
entirely	O
in	O
block	O
M1	O
.	O

N	O
.	O

"	O
Left	O
high	O
pericolic	O
gutter	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
3	O
.	O
3	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
1	O
cm	O
fragment	O
of	O
tan	O
-	O
gray	O
,	O
firm	O
fibroadipose	O
.	O
tissue	O
.	O

Sectioning	O
exhibits	O
a	O
white	O
-	O
tan	O
,	O
firm	O
cut	O
surface	O
with	O
a	O
small	O
amount	O
.	O
of	O
fibroadipose	O
tissue	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
in	O
block	O
N1	O
.	O

o	O
.	O

"	O
Colon	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
3	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
5	O
cm	O
fragment	O
of	O
tan	O
-	O
gray	O
tissue	O
with	O
a	O
3	O
.	O
0	O
cm	O
long	O
stapled	O
line	O
.	O

The	O
.	O
stapled	O
line	O
is	O
removed	O
and	O
the	O
remaining	O
soft	O
tissue	O
is	O
entirely	O
submitted	O
in	O
.	O
block	O
01	O
.	O

P	O
.	O

"	O
Proximal	O
donut	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
1	O
.	O
2	O
.	O

cm	O
annular	O
fragment	O
of	O
gray	O
-	O
tan	O
tissue	O
with	O
a	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
central	O
.	O
defect	O
which	O
is	O
bisected	O
and	O
entirely	O
submitted	O
in	O
block	O
P1	O
.	O

Q	O
.	O

"	O
Distal	O
donut	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
.	O

Received	O
is	O
a	O
1	O
.	O
2	O
.	O

x	O
.	O

1	O
.	O
2	O
x	O
1	O
.	O
0	O
cm	O
fragment	O
of	O
gray	O
-	O
tan	O
tissue	O
with	O
a	O
tan	O
,	O
glistening	O
mucosa	O
which	O
.	O

is	O
remarkable	O
for	O
a	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
defect	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
.	O
entirely	O
submitted	O
in	O
block	O
Q1	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Omentum	O
"	O
:	O
AF1	O
-	O
adenocarcinoma	O
.	O

MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

PATROLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
Hysterectomy	O
,	O
bilateral	O
salpingo	O
-	O
oohphorectomy	O
,	O
omentectomy	O
,	O
.	O
partial	O
colectomy	O
,	O
multiple	O
biopsies	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT3c	O
pNX	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
.	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
SUMMARY	O
DIAGNOSIS	O
:	O
SEROUS	O
ADENOCARCINOMA	O
OF	O
THE	O
RIGHT	O
AND	O
LEFT	O
OVARIES	O
,	O
.	O

INVOLVING	O
BILATERAL	O
FALLOPIAN	O
TUBES	O
,	O
UTERINE	O
SEROSA	O
,	O
OMENTUM	O
,	O
RECTOSIGMOID	O
.	O

COLON	O
,	O
AND	O
MULTIPLE	O
ADDITIONAL	O
PERITONEAL	O
SITES	O
AS	O
LISTED	O
BELOW	O
.	O

DETAILED	O
DIAGNOSES	O
BY	O
SITE	O
:	O
A	O
.	O

"	O
OMENTUM	O
"	O
(	O
OMENTECTOMY	O
)	O
:	O
METASTATIC	O
SEROUS	O
ADENOCARCINOMA	O
.	O

TUMOR	O
SIZE	O
:	O
GREATER	O
THAN	O
2	B
CM	I
.	O

B	O
.	O

"	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
"	O
(	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
MODERATELY	O
DIFFERENTIATED	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
OF	O
THE	O
OVARY	O
.	O

TUMOR	O
SIZE	O
:	O
8	B
CM	I
.	O

FIGO	O
GRADE	O
:	O
2	O
OF	O
3	O
.	O

SURFACE	O
INVOLVEMENT	O
:	O
PRESENT	O
.	O

REMAINDER	O
OF	O
OVARY	O
WITH	O
MATURE	O
CYSTIC	O
TERATOMA	O
(	O
4	O
.	O
5	O
CM	O
)	O
,	O
SEE	O
COMMENT	O
.	O

FALLOPIAN	O
TUBE	O
:	O
POSITIVE	O
FOR	O
SEROUS	O
CARCINOMA	O
.	O

COMMENT	O
:	O
Adjacent	O
to	O
the	O
tumor	O
in	O
the	O
ovary	O
is	O
a	O
mature	O
cystic	O
teratoma	O
.	O

(	O
dermoid	O
cyst	O
)	O
The	O
epithelium	O
in	O
the	O
dermoid	O
is	O
unremarkable	O
and	O
there	O
is	O
no	O
.	O
evidence	O
that	O
the	O
carcinoma	O
arose	O
from	O
the	O
dermoid	O
.	O

C	O
.	O

"	O
ANTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

D	O
.	O

"	O
LEFT	O
TUBE	O
AND	O
OVARY	O
"	O
(	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
MODERATELY	O
DIFFERENTIATED	O
PAPILLARY	O
SEROUS	O
ADENOCARCINOMA	O
OF	O
THE	O
OVARY	O
.	O

TUMOR	O
SIZE	O
:	O
6	B
.	I
5	I
CM	I
.	O

FIGO	O
GRADE	O
:	O
2	O
OF	O
3	O
.	O
rage	O
40	O
)	O
.	O

SURFACE	O
INVOLVEMENT	O
:	O
PRESENT	O
.	O

FALLOPIAN	O
TUBE	O
:	O
POSITIVE	O
FOR	O
SEROUS	O
CARCINOMA	O
.	O

E	O
.	O

"	O
UTERUS	O
AND	O
CERVIX	O
"	O
(	O
HYSTERECTOMY	O
)	O
:	O
UTERUS	O
WITH	O
SEROSAL	O
IMPLANTS	O
OF	O
SEROUS	O
ADENOCARCINOMA	O
.	O

ENDOMETRIUM	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

MYOMETRIUM	O
:	O
LEIOMYOMA	O
.	O

CERVIX	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

F	O
.	O

"	O
LEFT	O
CUL	O
-	O
DE	O
-	O
SAC	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

G	O
.	O

"	O
RECTOSIGMOID	O
COLON	O
"	O
(	O
RESECTION	O
)	O
:	O
SEGMENT	O
OF	O
COLON	O
WITH	O
EXTENSIVE	O
INVOLVEMENT	O
BY	O
SEROUS	O
ADENOCARCINOMA	O
.	O

H	O
.	O

"	O
POSTERIOR	O
WALL	O
OF	O
BLADDER	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

I	O
.	O

"	O
LEFT	O
PELVIC	O
SIDEWALL	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

J	O
.	O

"	O
SMALL	O
BOWEL	O
NODULES	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

K	O
.	O

"	O
OMENTUM	O
"	O
(	O
OMENTECTOMY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

L	O
.	O

"	O
SUPRAGASTRIC	O
NODULE	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

M	O
.	O

"	O
TRANSVERSE	O
COLON	O
NODULE	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

N	O
.	O

"	O
LEFT	O
HIGH	O
PERICOLIC	O
GUTTER	O
"	O
(	O
BIOPSY	O
)	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

o	O
.	O

"	O
COLON	O
"	O
(	O
EXCISION	O
)	O
:	O
COLON	O
WITH	O
ACUTE	O
SEROSITIS	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

P	O
.	O

"	O
PROXIMAL	O
DONUT	O
"	O
(	O
EXCISION	O
)	O
:	O
COLON	O
WITH	O
ACUTE	O
AND	O
ORGANIZING	O
SEROSITIS	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
,	O
.	O
rage	O
5	O
of	O
.	O

Q	O
.	O

"	O
DISTAL	O
DONUT	O
"	O
(	O
EXCISION	O
)	O
:	O
COLON	O
WITH	O
ACUTE	O
AND	O
ORGANIZING	O
SEROSITIS	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

SPECIMEN	O
INF	O
.	O

DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Right	O
oophorectomy	O
:	O
Serous	O
adenocarcinomal	O
.	O

Grade	O
;	O
III	O
.	O

Tumor	O
show	O
near	O
total	O
replacement	O
of	O
specimen	O
.	O

Size	O
:	O
10	B
.	I
6	I
cm	I
in	O
greatest	O
dimension	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

Right	O
fallopian	O
tube	O
-	O
Focal	O
mucosal	O
and	O
serosal	O
involvement	O
by	O
serous	O
adenocarcinoma	O
.	O

B	O
.	O

Omentum	O
,	O
excision	O
:	O
Metastatic	O
serous	O
adenocarcinoma	O
.	O

C	O
.	O

Ovary	O
,	O
left	O
oophorectomy	O
:	O
Serous	O
adenocarcinoma	O
.	O

Grade	O
:	O
III	O
.	O

Focal	O
calcified	O
fibrous	O
nodule	O
with	O
adjacent	O
necrotic	O
tissue	O
.	O

Tumor	O
shows	O
near	O
total	O
replacement	O
of	O
ovary	O
.	O

Size	O
:	O
9	B
.	I
1	I
cm	I
in	O
greatest	O
dimension	O
.	O

Lymphovascular	O
space	O
invasion	O
present	O
.	O

Left	O
fallopian	O
tube	O
"	O
not	O
identified	O
grossly	O
or	O
histologically	O
.	O

D	O
.	O

Peritoneum	O
,	O
left	O
gutter	O
,	O
biopsy	O
:	O
Metastatic	O
adenocarcinoma	O
.	O

E	O
.	O

Peritoneum	O
,	O
right	O
gutter	O
,	O
biopsy	O
:	O
Metastatic	O
adenocarcinoma	O
.	O

F	O
.	O

Diaphragm	O
,	O
biopsy	O
:	O
Melastatic	O
adenocarcinoma	O
.	O

G	O
.	O

Sigmoid	O
mesenteric	O
implant	O
,	O
biopsy	O
:	O
Metastatic	O
adenocarcinoma	O
.	O

H	O
.	O

Uterus	O
,	O
hysterectomy	O
:	O
Uterine	O
cervix	O
.	O

Microscopic	O
focus	O
of	O
high	O
grade	O
serous	O
carcinoma	O
.	O
at	O
transition	O
zone	O
.	O

Multiple	O
foci	O
of	O
metastatic	O
tumor	O
within	O
intravascular	O
space	O
and	O
submucosal	O
connective	O
tissue	O
.	O

Benign	O
endocervical	O
polyp	O
.	O

Endometrium	O
-	O
.	O

Endometrial	O
polyp	O
.	O

Background	O
atrophy	O
.	O

Myometrium	O
-	O
.	O

Foci	O
of	O
metastatic	O
adenocarcinoma	O
within	O
vessels	O
and	O
connective	O
tissue	O
.	O

Multiple	O
hyalinized	O
leiomyomas	O
.	O

Uterine	O
serosa	O
-	O
.	O

Foci	O
of	O
metastatic	O
adenocarcinoma	O
.	O

DIAGNOSIS	O
.	O

pTNM	O
stage	O
:	O
T3NXMX	O
.	O

COMMENTS	O
:	O
This	O
case	O
has	O
been	O
reviewed	O
by	O
Dr	O
.	O
vho	O
agrees	O
with	O
the	O
diagnosis	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologia	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Right	O
ovary	O
.	O

B	O
.	O

Omentum	O
.	O

C	O
.	O

Left	O
ovary	O
.	O

D	O
.	O

Left	O
gutter	O
.	O

E	O
.	O

Right	O
gutter	O
.	O

F	O
.	O

Biopsy	O
of	O
diaphragm	O
.	O

G	O
.	O

Sigmoid	O
mesenteric	O
implant	O
.	O

H	O
.	O

Uterus	O
.	O

SPECIMENDATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Part	O
A	O
received	O
in	O
formalin	O
labeled	O
.	O
and	O
#	O
1	O
is	O
a	O
10	O
.	O
6	O
x	O
10	O
.	O
1	O
x	O
4	O
.	O
4	O
cm	O
irregular	O
to	O
ovoid	O
,	O
shaggy	O
tan	O
pink	O
to	O
red	O
purple	O
membranous	O
.	O
tissue	O
,	O
with	O
an	O
attached	O
2	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
tubular	O
tissue	O
.	O

The	O
cut	O
surface	O
of	O
the	O
tissue	O
consists	O
of	O
a	O
10	O
.	O
8	O
cm	O
cyst	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
surface	O
consists	O
.	O
tan	O
pink	O
to	O
gray	O
white	O
consistent	O
with	O
probable	O
fallopian	O
tube	O
.	O

Also	O
.	O
in	O
the	O
same	O
container	O
is	O
a	O
4	O
.	O
6	O
x	O
3	O
.	O
1	O
x	O
1	O
.	O
5	O
cm	O
irregular	O
gray	O
white	O
soft	O
tissue	O
,	O
consistent	O
with	O
possible	O
ovary	O
.	O

The	O
outer	O
surface	O
is	O
lobulated	O
.	O
shaggy	O
and	O
gray	O
white	O
.	O

The	O
cut	O
surface	O
is	O
gray	O
white	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
for	O
frozen	O
section	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
submitted	O
in	O
block	O
1	O
.	O

Additional	O
representative	O
sections	O
are	O
submitted	O
as	O
labeled	O
:	O
membranous	O
tissue	O
block	O
8	O
tubular	O
tissue	O
attached	O
to	O
membranous	O
tissue	O
.	O
blocks	O
9	O
and	O
10	O
additional	O
tissue	O
.	O

The	O
blocks	O
are	O
labeled	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
are	O
three	O
orange	O
cassettes	O
labeled	O
A	O
C	O
.	O
and	O
D	O
and	O
a	O
green	O
and	O
yellow	O
cassette	O
labeled	O
.	O
for	O
genomic	O
research	O
study	O
.	O

B	O
.	O

Part	O
B	O
received	O
in	O
formalin	O
labeled	O
.	O
ind	O
#	O
2	O
omentum	O
is	O
a	O
15	O
.	O
8	O
x	O
12	O
,	O
1	O
x	O
3	O
.	O
2	O
cm	O
aggregate	O
of	O
fibroadipose	O
tissue	O
,	O
consistent	O
with	O
.	O
omentum	O
.	O

The	O
cut	O
surface	O
consists	O
of	O
predominantly	O
yellow	O
lobulated	O
adipose	O
tissue	O
,	O
with	O
a	O
minimal	O
amount	O
of	O
gray	O
white	O
fibrous	O
tissue	O
.	O

There	O
are	O
.	O
several	O
firm	O
gray	O
white	O
areas	O
on	O
the	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
one	O
cassette	O
labeled	O
.	O

C	O
.	O

Part	O
C	O
received	O
in	O
formalin	O
labeled	O
.	O
and	O
#	O
3	O
left	O
ovary	O
is	O
a	O
9	O
.	O
1	O
x	O
4	O
.	O
7	O
x	O
2	O
.	O
6	O
cm	O
irregular	O
,	O
shaggy	O
tan	O
red	O
soft	O
tissue	O
.	O

The	O
cut	O
surface	O
.	O
consists	O
of	O
focally	O
gritty	O
gray	O
white	O
to	O
tan	O
soft	O
tissue	O
.	O

There	O
is	O
a	O
1	O
.	O
1	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
hard	O
nodule	O
within	O
the	O
cut	O
surface	O
.	O

No	O
ovarian	O
stroma	O
is	O
identified	O
.	O

A	O
.	O
fallopian	O
tube	O
is	O
not	O
identified	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
six	O
cassettes	O
,	O
with	O
the	O
hard	O
nodule	O
.	O
submitted	O
in	O
cassette	O
6	O
,	O
following	O
decalcification	O
.	O

The	O
cassettes	O
are	O
labeled	O
.	O

D	O
.	O

Part	O
D	O
received	O
in	O
formalin	O
labeled	O
.	O
and	O
#	O
4	O
left	O
gutter	O
is	O
an	O
8	O
.	O
4	O
x	O
3	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
irregular	O
gray	O
white	O
to	O
tan	O
red	O
membranous	O
tissue	O
,	O
with	O
.	O
attached	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
one	O
cassette	O
labeled	O
.	O

E	O
.	O

Part	O
E	O
is	O
received	O
in	O
formalin	O
labeled	O
.	O

nd	O
#	O
5	O
right	O
gutter	O
is	O
a	O
7	O
.	O
4	O
x	O
5	O
.	O
2	O
x	O
1	O
.	O
1	O
cm	O
irregular	O
,	O
granular	O
gray	O
white	O
to	O
tan	O
red	O
membranous	O
.	O
tissue	O
,	O
with	O
attached	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
in	O
one	O
cassette	O
labeled	O
.	O

F	O
.	O

Part	O
F	O
received	O
in	O
formalin	O
labeled	O
.	O
ind	O
#	O
6	O
biopsy	O
diaphragm	O
is	O
a	O
2	O
.	O
7	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
aggregate	O
of	O
gray	O
white	O
to	O
red	O
soft	O
tissue	O
,	O
which	O
is	O
.	O
serially	O
sectioned	O
and	O
submitted	O
in	O
its	O
entirety	O
in	O
one	O
cassette	O
labeled	O
.	O

G	O
.	O

Part	O
G	O
received	O
in	O
formalin	O
labeled	O
.	O
ind	O
#	O
7	O
sigmoid	O
mesenteric	O
implant	O
is	O
a	O
1	O
.	O
3	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
4	O
cm	O
irregular	O
,	O
gritty	O
gray	O
white	O
soft	O
tissue	O
,	O
.	O
vith	O
attached	O
adipose	O
tissue	O
,	O
which	O
is	O
serially	O
sectioned	O
and	O
submitted	O
in	O
its	O
entirety	O
in	O
one	O
cassette	O
labeled	O
.	O

H	O
.	O

Part	O
H	O
received	O
in	O
formalin	O
labele	O
.	O
and	O
#	O
8	O
uterus	O
is	O
a	O
52	O
gram	O
previously	O
opened	O
hysterectomy	O
specimen	O
,	O
consisting	O
of	O
a	O
4	O
.	O
7	O
x	O
4	O
.	O
3	O
x	O
.	O

2	O
.	O
6	O
.	O

cm	O
.	O
uterine	O
body	O
and	O
a	O
2	O
.	O
4	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
cervix	O
.	O

The	O
specimen	O
can	O
not	O
be	O
oriented	O
.	O

The	O
serosa	O
is	O
shaggy	O
and	O
tan	O
pink	O
to	O
red	O
.	O

The	O
exocervix	O
is	O
.	O
smooth	O
and	O
gray	O
white	O
with	O
a	O
0	O
.	O
1	O
cm	O
circular	O
os	O
.	O

The	O
endocervical	O
canal	O
is	O
glistening	O
tan	O
and	O
1	O
.	O
6	O
cm	O
in	O
length	O
.	O

There	O
is	O
a	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
endocervical	O
.	O
polyp	O
.	O

The	O
identifiable	O
probable	O
endometrium	O
is	O
glistening	O
tan	O
and	O
averages	O
0	O
.	O
1	O
cm	O
in	O
thickness	O
.	O

There	O
is	O
a	O
1	O
.	O
2	O
cm	O
cystic	O
gray	O
white	O
possible	O
.	O
endometrial	O
polyp	O
.	O

The	O
myometrium	O
is	O
trabeculated	O
,	O
tan	O
pink	O
,	O
and	O
averages	O
1	O
.	O
3	O
cm	O
in	O
thickness	O
.	O

There	O
are	O
multiple	O
intramural	O
whorled	O
gray	O
white	O
.	O
dense	O
nodules	O
,	O
ranging	O
from	O
0	O
.	O
4	O
to	O
1	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

No	O
areas	O
of	O
hemormhage	O
or	O
necrosis	O
are	O
identified	O
in	O
the	O
nodules	O
.	O

The	O
largest	O
nodule	O
.	O
has	O
a	O
gritty	O
.	O
hard	O
gray	O
white	O
to	O
yellow	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
representative	O
sections	O
are	O
submitted	O
as	O
labeled	O
:	O
blocks	O
1	O
.	O
and	O
2	O
anterior	O
and	O
posterior	O
cervix	O
block	O
3	O
endocervical	O
polyp	O
,	O
entirely	O
submitted	O
blocks	O
4	O
and	O
5	O
endomyometrium	O
to	O
include	O
probable	O
endometrial	O
polyp	O
.	O
in	O
its	O
entirety	O
block	O
6	O
myometrial	O
nodules	O
block	O
7	O
largest	O
myometrial	O
nodule	O
,	O
following	O
decalcification	O
block	O
8	O
serosa	O
.	O

The	O
blocks	O
are	O
labeled	O
.	O

NTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
:	O
FSA	O
:	O
'	O
Adenocarcinoma	O
:	O
Favor	O
ovarian	O
primary	O
'	O
per	O
Dr	O
.	O
.	O
i	O
.	O

Main	O
diagnosis	O
/	O
diagnoses	O
:	O
Peripheral	O
bronchopulmonary	O
,	O
histologically	O
mixed	O
-	O
cell	O
adenocarcinoma	O
of	O
the	O
left	O
lower	O
.	O
lobe	O
of	O
the	O
lung	O
with	O
a	O
predominant	O
acinar	O
and	O
small	O
large	O
-	O
cell	O
solid	O
component	O
,	O
a	O
.	O
bronchioloalveolar	O
pattern	O
of	O
spread	O
in	O
the	O
tumor	O
periphery	O
and	O
main	O
localization	O
in	O
S6	O
.	O

TNM	O
classification	O
on	O
the	O
basis	O
of	O
this	O
material	O
pT2	O
pNO	O
pMX	O
R0	O
,	O
stage	O
IB	O
.	O

C34	O
.	O
3	O
;	O
M	O
8255	O
/	O
3	O
.	O

Comment	O
/	O
supplementary	O
remark	O
:	O
The	O
carcinoma	O
has	O
infiltrated	O
the	O
visceral	O
pleura	O
.	O

The	O
resection	O
margin	O
of	O
the	O
bronchus	O
and	O
.	O
vessels	O
and	O
all	O
the	O
lymph	O
nodes	O
removed	O
are	O
tumor	O
-	O
free	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Two	O
left	O
renal	O
masses	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Tumor	O
interpolar	O
region	O
left	O
kidney	O
.	O

2	O
:	O
SP	O
:	O
Lower	O
pole	O
tumor	O
,	O
left	O
kidney	O
.	O

3	O
:	O
SP	O
:	O
Cyst	O
wall	O
interpolar	O
region	O
left	O
kidney	O
.	O

4	O
:	O
SP	O
:	O
Left	O
perinephric	O
fat	O
-	O
lower	O
pole	O
.	O

5	O
:	O
SP	O
:	O
Supra	O
tumor	O
interpolar	O
region	O
.	O

6	O
:	O
SP	O
:	O
Left	O
renal	O
sinus	O
fat	O
.	O

7	O
:	O
SP	O
:	O
Left	O
lower	O
pole	O
fat	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

KIDNEY	O
,	O
INTERPOLAR	O
REGION	O
,	O
LEFT	O
,	O
PARTIAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
CLEAR	O
CELL	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
II	O
/	O
IV	O
.	O

-	O
THE	O
TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
2	B
.	I
0	I
CM	I
.	O

-	O
THE	O
TUMOR	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

-	O
ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

2	O
)	O
.	O

KIDNEY	O
,	O
LOWER	O
POLE	O
,	O
LEFT	O
,	O
PARTIAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
CLEAR	O
CELL	O
TYPE	O
,	O
CYSTIC	O
,	O
NUCLEAR	O
GRADE	O
II	O
/	O
IV	O
.	O

-	O
THE	O
TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
2	B
.	I
6	I
CM	I
.	O

-	O
THE	O
TUMOR	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

-	O
ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

3	O
)	O
.	O

KIDNEY	O
,	O
INTERPOLAR	O
REGION	O
CYST	O
WALL	O
,	O
LEFT	O
,	O
EXCISION	O
:	O
-	O
FRAGMENTS	O
OF	O
MULTILOCULAR	O
CYSTIC	O
RENAL	O
CELL	O
CARCINOMA	O
.	O

4	O
)	O
.	O

KIDNEY	O
,	O
LOWER	O
POLE	O
,	O
PERINEPHRIC	O
FAT	O
,	O
LEFT	O
,	O
EXCISION	O
:	O
-	O
BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

5	O
)	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
SUPRA	O
TUMOR	O
,	O
INTERPOLAR	O
REGION	O
,	O
EXCISION	O
:	O
-	O
BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

6	O
)	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
RENAL	O
SINUS	O
FAT	O
,	O
LEFT	O
,	O
EXCISION	O
:	O
-	O
BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

7	O
)	O
.	O

KIDNEY	O
,	O
LOWER	O
POLE	O
,	O
FAT	O
,	O
LEFT	O
,	O
EXCISION	O
:	O
-	O
BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
,	O
labeled	O
"	O
Tumor	O
interpolar	O
region	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
4	B
.	I
0	I
x	I
2	I
.	I
0	I
.	I

x	B
1	I
.	I
5	I
cm	I
partial	O
nephrectomy	O
specimen	O
.	O

The	O
cut	O
surface	O
reveals	O
a	O
2	O
.	O
0	O
-	O
x	O
1	O
.	O
5	O
X	O
1	O
.	O
4	O
cm	O
circumscribed	O
multilobulated	O
,	O
tan	O
-	O
yellow	O
to	O
.	O
gray	O
-	O
white	O
mess	O
adjacent	O
to	O
1	O
,	O
0	O
cm	O
segment	O
of	O
normal	O
kidney	O
parenchyma	O
.	O

The	O
outer	O
surface	O
Is	O
inked	O
bleck	O
.	O

A	O
.	O
specimen	O
.	O

is	O
.	O
submitted	O
for	O
frozen	O
section	O
.	O

A	O
specimen	O
is	O
also	O
submitted	O
for	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

T	O
-	O
multiple	O
sections	O
of	O
tumor	O
including	O
cepsule	O
and	O
normal	O
kidney	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
,	O
labeled	O
"	O
Lower	O
pole	O
tumor	O
,	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
.	O

cm	O
tan	O
-	O
pink	O
nodule	O
.	O

The	O
specimen	O
is	O
inked	O
and	O
soctioned	O
revealing	O
a	O
circumscribed	O
,	O
partly	O
cystic	O
mass	O
with	O
tan	O
-	O
pink	O
,	O
friable	O
.	O
cut	O
.	O

surface	O
and	O
minimal	O
rim	O
of	O
normal	O
kidney	O
.	O

Representative	O
sections	O
are	O
submitted	O
,	O
.	O

is	O
also	O
taken	O
for	O
this	O
.	O

Summary	O
of	O
Sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

T	O
-	O
multiple	O
sections	O
of	O
tumor	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
,	O
rabeled	O
Cyst	O
well	O
interpolar	O
region	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
two	O
soft	O
.	O
tissues	O
measuring	O
2	O
.	O
1	O
x	O
2	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
in	O
aggregate	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
Sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
In	O
formalin	O
,	O
labeled	O
"	O
Left	O
perinephric	O
fat	O
-	O
lower	O
pole	O
"	O
.	O

Il	O
consists	O
of	O
a	O
5	O
.	O
0	O
X	O
4	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
.	O
aggregate	O
of	O
tan	O
-	O
yellow	O
lobulated	O
fatty	O
tissue	O
.	O

No	O
masses	O
are	O
identified	O
or	O
palpated	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
PNF	O
-	O
perinephric	O
fat	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Supra	O
tumor	O
interpolar	O
region	O
"	O
.	O

It	O
consists	O
of	O
an	O
8	O
.	O
0	O
X	O
2	O
,	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O
tan	O
-	O
yellow	O
lobulated	O
fally	O
tissue	O
with	O
probable	O
palpable	O
lymph	O
nodes	O
.	O

All	O
lymph	O
nodes	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
PLN	O
-	O
possible	O
lymph	O
nodes	O
.	O

BLN	O
-	O
bisected	O
lymph	O
nodes	O
.	O

6	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
lebeled	O
"	O
Left	O
renal	O
sinus	O
fat	O
"	O
.	O

It	O
consists	O
of	O
a	O
6	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
aggregate	O
of	O
.	O
tan	O
-	O
yellow	O
lobulated	O
fally	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summery	O
of	O
Sections	O
:	O
RSF	O
-	O
renal	O
sinus	O
fat	O
.	O

7	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Left	O
lower	O
pole	O
fat	O
"	O
.	O

It	O
consists	O
of	O
a	O
7	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
aggregate	O
of	O
.	O
lobulated	O
fibrofatty	O
tissue	O
,	O
No	O
messes	O
are	O
grossly	O
palpated	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
LPF	O
-	O
lower	O
pole	O
fat	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Tumor	O
interpolar	O
reglon	O
left	O
kidney	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

5	O
.	O

t	O
.	O

5	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Lower	O
pole	O
tumor	O
,	O
left	O
kidney	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

5	O
.	O

5	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Cyst	O
wall	O
interpolar	O
region	O
left	O
kidney	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Left	O
perinephric	O
fat	O
-	O
lower	O
pole	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O
pnf	O
.	O

3	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Supra	O
tumor	O
interpolar	O
region	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O
bln	O
.	O

2	O
.	O

5	O
.	O
pln	O
.	O

5	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Left	O
renal	O
sinus	O
fat	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O
rsf	O
.	O

4	O
.	O

Part	O
7	O
:	O
SP	O
:	O
Left	O
lower	O
pole	O
fat	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O
lpf	O
.	O

4	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
RENAL	O
CORTICAL	O
NEOPLASM	O
.	O

INKED	O
MARGIN	O
FREE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

2	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
RENAL	O
CORTICAL	O
NEOPLASM	O
,	O
INKED	O
MARGIN	O
BENIGN	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

3	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
CYSTIC	O
RENAL	O
CORTICAL	O
LESION	O
SUSPICIOUS	O
FOR	O
RENAL	O
CORTICAL	O
.	O

CARCINOMA	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
,	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
.	O
1	O
A2	O
B1	O
C1	O
C2	O
C3	O
C4	O
C5	O
C6	O
C7	O
C8	O
C9	O
C10	O
C11	O
C12	O
C13	O
C14	O
.	O

C15	O
.	O

Right	O
lobe	O
liver	O
(	O
2890	O
.	O
0	O
grams	O
,	O
24	O
.	O
3	O
x	O
22	O
.	O
0	O
x	O
13	O
.	O
3	O
cm	O
)	O
,	O
a	O
.	O
pericholedochal	O
lymph	O
node	O
(	O
2	O
.	O
1	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
8	O
cm	O
)	O
,	O
and	O
gallbladder	O
.	O

(	O
9	O
.	O
2	O
x	O
4	O
.	O
4	O
x	O
2	O
.	O
1	O
cm	O
)	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
right	O
lobe	O
,	O
resection	O
:	O
Grade	O
3	O
(	O
of	O
4	O
)	O
hepatocellular	O
.	O
carcinoma	O
forming	O
a	O
22	B
.	I
0	I
x	I
15	I
.	I
3	I
x	I
12	I
.	I
8	I
cm	I
mass	O
in	O
the	O
right	O
lobe	O
of	O
.	O
noncirrhotic	O
liver	O
.	O

The	O
surgical	O
margins	O
are	O
free	O
of	O
tumor	O
by	O
a	O
.	O
minimum	O
of	O
1	O
.	O
1	O
cm	O
.	O

A	O
large	O
(	O
10	O
.	O
3	O
x	O
7	O
.	O
4	O
x	O
5	O
.	O
5	O
cm	O
)	O
subcapsular	O
.	O
hematoma	O
is	O
also	O
present	O
.	O

Lymph	O
node	O
,	O
pericholedochal	O
,	O
excision	O
:	O
A	O
single	O
pericholedochal	O
.	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
Mild	O
chronic	O
cholecystitis	O
with	O
.	O
cholesterolosis	O
and	O
a	O
single	O
benign	O
cystic	O
duct	O
lymph	O
node	O
are	O
.	O
identified	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
A2	O
B1	O
C1	O
C2	O
C3	O
C4	O
C5	O
C6	O
C7	O
CB	O
C9	O
C10	O
C11	O
C12	O
C13	O
C14	O
.	O

C15	O
.	O

Right	O
lobe	O
liver	O
(	O
2890	O
.	O
0	O
grams	O
,	O
24	O
.	O
3	O
x	O
22	O
.	O
0	O
x	O
13	O
.	O
3	O
cm	O
)	O
,	O
a	O
.	O
pericholedochal	O
lymph	O
node	O
(	O
2	O
.	O
1	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
8	O
cm	O
)	O
,	O
and	O
gallbladder	O
.	O

(	O
9	O
.	O
2	O
x	O
4	O
.	O
4	O
x	O
2	O
.	O
1	O
cm	O
)	O
.	O

DIAGNOSIS	O
:	O
Liver	O
,	O
right	O
lobe	O
,	O
resection	O
:	O
Grade	O
3	O
(	O
of	O
4	O
)	O
hepatocellular	O
.	O
carcinome	O
forming	O
a	O
22	B
.	I
0	I
x	I
15	I
.	I
3	I
x	I
12	I
.	I
8	I
cm	I
mass	O
in	O
the	O
right	O
lobe	O
of	O
.	O
noncirrhotic	O
liver	O
.	O

The	O
surgical	O
margins	O
are	O
free	O
of	O
tumor	O
by	O
a	O
.	O
minimum	O
of	O
1	O
.	O
1	O
cm	O
.	O

A	O
large	O
(	O
10	O
.	O
3	O
x	O
7	O
.	O
4	O
x	O
5	O
.	O
5	O
cm	O
)	O
subcapsular	O
.	O
hematome	O
is	O
also	O
present	O
.	O

Lymph	O
node	O
,	O
pericholedochal	O
,	O
excision	O
:	O
A	O
single	O
pericholedochal	O
.	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
Mild	O
chronic	O
cholecystitis	O
with	O
.	O
cholesterolosis	O
and	O
a	O
single	O
benign	O
cystic	O
duct	O
lymph	O
node	O
are	O
.	O
identified	O
.	O

Sex	O
:	O
F	O
.	O

Account	O
:	O
Date	O
Collected	O
:	O
Date	O
Received	O
:	O
Clinical	O
Data	O
:	O
Right	O
renal	O
mass	O
.	O

FINAL	O
PATHOLOGIO	O
DIAGNOSIS	O
.	O

1	O
.	O

Right	O
kidney	O
(	O
14	O
grams	O
)	O
,	O
partial	O
nephrectomy	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
.	O

2	O
.	O

Right	O
kidney	O
(	O
deep	O
margin	O
)	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
;	O
new	O
margin	O
free	O
of	O
tumor	O
.	O

SYNOPTIC	O
REPORT	O
.	O

Tumor	O
site	O
:	O
Right	O
kidney	O
.	O

Histologic	O
type	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
.	O

-	O
Sarcomatoid	O
features	O
:	O
Not	O
identified	O
.	O

Histologic	O
(	O
Fuhrman	O
)	O
grade	O
:	O
G2	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
6	I
cm	I
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Extent	O
of	O
tumor	O
:	O
Tumor	O
is	O
limited	O
to	O
kidney	O
.	O

Parenchymal	O
margin	O
:	O
Negative	O
for	O
malignancy	O
(	O
1	O
.	O
0	O
cm	O
from	O
tumor	O
)	O
.	O

Angiolymphatic	O
invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Pathology	O
Staging	O
:	O
pT1a	O
NX	O
.	O

Pathologist	O
,	O
Electronic	O
Signature	O
.	O

SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
:	O
GROSS	O
DESCRIPTION	O
.	O

1	O
.	O

Right	O
renal	O
mass	O
:	O
In	O
formalin	O
labeled	O
"	O
right	O
renal	O
mass	O
"	O
is	O
a	O
14	O
gram	O
,	O
4	O
x	O
3	O
.	O
3	O
x	O
3	O
.	O
3	O
cm	O
partial	O
nephrectomy	O
specimen	O
.	O

There	O
is	O
a	O
3	O
.	O
6	O
cm	O
lobulated	O
pale	O
tan	O
-	O
red	O
mass	O
present	O
.	O

The	O
mass	O
abuts	O
and	O
elevates	O
the	O
renal	O
capsule	O
;	O
however	O
,	O
no	O
.	O
invasion	O
into	O
or	O
through	O
the	O
capsule	O
is	O
noted	O
.	O

The	O
mass	O
is	O
grossly	O
present	O
,	O
however	O
,	O
at	O
the	O
deep	O
parenchymal	O
resection	O
.	O
margin	O
.	O

The	O
perinephric	O
fat	O
is	O
inked	O
black	O
,	O
with	O
the	O
parenchymal	O
margin	O
inked	O
blue	O
.	O

Representative	O
sections	O
submitted	O
.	O
in	O
four	O
cassettes	O
,	O
A	O
through	O
D	O
.	O

2	O
.	O

Deep	O
margin	O
:	O
in	O
formalin	O
labeled	O
"	O
deep	O
margin	O
"	O
is	O
a	O
3	O
.	O
3	O
x	O
1	O
.	O
3	O
x	O
1	O
.	O
2	O
cm	O
portion	O
of	O
renal	O
parenchyma	O
,	O
with	O
an	O
attached	O
.	O
portion	O
of	O
lobulated	O
pale	O
tan	O
-	O
red	O
tumor	O
and	O
an	O
additional	O
2	B
.	I
5	I
x	I
2	I
.	I
5	I
X	I
1	I
.	I
3	I
cm	I
aggregate	O
of	O
loose	O
tumor	O
fragments	O
.	O

The	O
.	O
tumor	O
is	O
grossly	O
1	O
cm	O
from	O
what	O
appears	O
to	O
be	O
the	O
true	O
deep	O
margin	O
,	O
which	O
is	O
inked	O
blue	O
.	O

Representative	O
sections	O
.	O
submitted	O
in	O
two	O
cassettes	O
,	O
A	O
and	O
B	O
.	O

CPT	O
CODE	O
(	O
S	O
)	O
:	O
ICD	O
-	O
9	O
CODE	O
(	O
S	O
)	O
:	O
FACILITY	O
:	O
SURGICAL	O
PATHOLOGY	O
REPORT	O
-	O
CONTINUED	O
.	O

Result	O
ID	O
:	O
88307	O
,	O
88305	O
.	O

J	O
Location	O
.	O

Receiv	O
.	O

Accessioned	O
:	O
Physician	O
(	O
s	O
)	O
:	O
Other	O
Related	O
Clinical	O
Data	O
:	O
DIAGNOSIS	O
:	O
OVARY	O
,	O
RIGHT	O
,	O
OOPHORECTOMY	O
.	O

-	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
ADENOCARCINOMA	O
.	O

-	O
SEE	O
SYNOPTIC	O
.	O

FALLOPIAN	O
TUBE	O
,	O
RIGHT	O
,	O
SALPINGECTOMY	O
.	O

-	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
ADENOCARCINOMA	O
BY	O
DIRECT	O
EXTENSION	O
.	O

OVARY	O
,	O
LEFT	O
,	O
OOPHORECTOMY	O
.	O

-	O
POORLY	O
DIFFERENTIATED	O
SEROUS	O
ADENOCARCINOMA	O
.	O

-	O
FOCAL	O
LYMPHVASCULAR	O
SPACE	O
INVASION	O
BY	O
ADENOCARCINOMA	O
IS	O
IDENTIFIED	O
.	O

FALLOPIAN	O
TUBE	O
,	O
LEFT	O
,	O
SALPINGECTOMY	O
.	O

-	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

SOFT	O
TISSUE	O
,	O
ANTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

SOFT	O
TISSUE	O
,	O
POSTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

SOFT	O
TISSUE	O
,	O
LEFT	O
PELVIC	O
SIDEWALL	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

SOFT	O
TISSUE	O
,	O
RIGHT	O
PELVIC	O
SIDEWALL	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

SOFT	O
TISSUE	O
,	O
RIGHT	O
GUTTER	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

SOFT	O
TISSUE	O
,	O
LEFT	O
GUTTER	O
,	O
BIOPSY	O
.	O

-	O
UNREMARKABLE	O
FIBROADIPOSE	O
TISSUE	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
PELVIC	O
,	O
DISSECTION	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
EIGHT	O
LYMPH	O
NODES	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
PELVIC	O
,	O
DISSECTION	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
SIX	O
LYMPH	O
NODES	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
COMMON	O
PERIAORTIC	O
,	O
DISSECTION	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
TWO	O
LYMPH	O
NODES	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
COMMON	O
PERIAORTIC	O
,	O
DISSECTION	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
TWO	O
LYMPH	O
NODES	O
.	O

OMENTUM	O
,	O
OMENTECTOMY	O
.	O

-	O
FOCAL	O
ENDOSALPINGIOSIS	O
.	O

-	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
IN	O
ONE	O
INCIDENTAL	O
LYMPH	O
NODE	O
.	O

By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
the	O
above	O
diagnosis	O
is	O
.	O
based	O
upon	O
my	O
personal	O
.	O
examination	O
of	O
the	O
slides	O
(	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
the	O
.	O
diagnosis	O
)	O
.	O

Peport	O
Electronically	O
Reviewed	O
and	O
Signed	O
Out	O
By	O
.	O

Intraoperative	O
Consultation	O
:	O
An	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
interpreted	O
as	O
:	O
"	O
Called	O
to	O
pick	O
up	O
'	O
right	O
tube	O
and	O
ovary	O
,	O
consisting	O
of	O
a	O
3	O
.	O
5	O
x	O
2	O
.	O
7	O
x	O
2	O
.	O
5	O
cm	O
.	O
ovary	O
with	O
smooth	O
serosal	O
surface	O
,	O
and	O
solid	O
cystic	O
areas	O
.	O

Solid	O
component	O
.	O
measures	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
,	O
and	O
2	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O

cm	O
(	O
two	O
nodules	O
)	O
with	O
papillary	O
.	O
cut	O
surface	O
.	O

Unremarkable	O
fallopian	O
tube	O
measures	O
6	O
x	O
0	O
.	O
8	O
cm	O
.	O

A	O
section	O
is	O
cut	O
.	O
for	O
frozen	O
section	O
(	O
FS1	O
)	O
Rest	O
for	O
permanents	O
,	O
by	O
.	O

A	O
second	O
intraoperative	O
non	O
-	O
microscopic	O
consultation	O
was	O
obtained	O
and	O
.	O
interpreted	O
as	O
:	O
Called	O
to	O
pick	O
up	O
'	O
left	O
tube	O
and	O
ovary	O
,	O
consisting	O
of	O
a	O
3	O
x	O
.	O

2	O
.	O

cm	O
pink	O
-	O
white	O
ovary	O
with	O
pink	O
smooth	O
surface	O
and	O
portion	O
of	O
unremarkable	O
.	O
fallopian	O
tube	O
.	O

Ovarian	O
cut	O
surface	O
is	O
tan	O
-	O
white	O
.	O

Tumor	O
and	O
fallopian	O
tube	O
for	O
.	O
tumor	O
bank	O
.	O

No	O
frozen	O
.	O

All	O
for	O
permanents	O
,	O
"	O
by	O
.	O

FS1	O
:	O
Right	O
ovary	O
.	O

-	O
Serous	O
papillary	O
carcinoma	O
.	O

MICTOSCODIC	O
Description	O
and	O
Comment	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
cited	O
diagnosis	O
.	O

History	O
:	O
The	O
patient	O
is	O
a	O
.	O
with	O
bilateral	O
adnexal	O
masses	O
;	O
her	O
CA125	O
is	O
.	O
greater	O
than	O
100	O
.	O

Operative	O
procedure	O
:	O
EUA	O
,	O
exploratory	O
laparotomy	O
,	O
bilateral	O
.	O
salpingo	O
-	O
oophorectomy	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
:	O
A	O
:	O
OVARY	O
AND	O
TUBE	O
,	O
RIGHT	O
.	O

B	O
:	O
OVARY	O
AND	O
TUBE	O
,	O
LEFT	O
.	O

C	O
:	O
ANTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
.	O

D	O
:	O
POSTERIOR	O
CUL	O
-	O
DE	O
-	O
SAC	O
.	O

E	O
:	O
LEFT	O
PELVIC	O
SIDEWALL	O
.	O

F	O
:	O
RIGHT	O
PELVIC	O
SIDEWALL	O
.	O

G	O
:	O
RIGHT	O
GUTTER	O
.	O

H	O
:	O
LEFT	O
GUTTER	O
.	O

I	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
PELVIC	O
.	O

J	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
PELVIC	O
.	O

K	O
:	O
LYMPH	O
NODE	O
,	O
RIGHT	O
COMMON	O
PERIAORTIC	O
.	O

L	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
COMMON	O
PERIAORTIC	O
.	O

M	O
:	O
OMENTUM	O
.	O

Gross	O
Description	O
.	O

The	O
specimens	O
are	O
received	O
in	O
thirteen	O
formalin	O
-	O
filled	O
containers	O
,	O
each	O
labeled	O
.	O

The	O
first	O
container	O
is	O
labeled	O
"	O
right	O
tube	O
and	O
ovary	O
.	O

"	O
.	O
contains	O
a	O
previously	O
-	O
opened	O
ovary	O
that	O
weighs	O
19	O
.	O
17	O
grams	O
,	O
along	O
with	O
the	O
.	O
attached	O
fallopian	O
tube	O
.	O

The	O
measurements	O
are	O
consistent	O
with	O
those	O
in	O
the	O
.	O
intraoperative	O
consultation	O
.	O

Also	O
in	O
the	O
container	O
is	O
a	O
frozen	O
section	O
cassette	O
.	O
labeled	O
"	O
FS1	O
,	O
N	O
with	O
tan	O
-	O
white	O
tissue	O
measuring	O
2	O
.	O
1	O
x	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
as	O
.	O

A1	O
.	O

Additional	O
sections	O
submitted	O
in	O
A2	O
to	O
A4	O
.	O

A5	O
-	O
fallopian	O
tube	O
.	O

The	O
second	O
container	O
is	O
labeled	O
"	O
left	O
tube	O
and	O
ovary	O
,	O
It	O
contains	O
a	O
15	O
.	O
07	O
gram	O
.	O
tubo	O
-	O
ovarian	O
complex	O
.	O

The	O
ovary	O
measures	O
2	O
.	O
5	O
x	O
2	O
x	O
1	O
.	O
6	O
cm	O
.	O

The	O
fallopian	O
tube	O
.	O

is	O
adhesed	O
to	O
the	O
ovary	O
,	O
and	O
measures	O
2	O
.	O
2	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
surface	O
of	O
the	O
ovary	O
is	O
.	O
irregular	O
.	O

Labeled	O
B1	O
to	O
B4	O
-	O
ovary	O
;	O
B5	O
-	O
ovary	O
and	O
fallopian	O
tube	O
.	O

The	O
third	O
container	O
is	O
labeled	O
"	O
anterior	O
cul	O
-	O
de	O
-	O
sac	O
.	O
)	O
It	O
contains	O
a	O
white	O
-	O
tan	O
.	O
fragment	O
of	O
fatty	O
tissue	O
measuring	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
x	O
1	O
cm	O
.	O

The	O
fourth	O
container	O
is	O
labeled	O
"	O
posterior	O
cul	O
-	O
de	O
-	O
sac	O
.	O

It	O
contains	O
a	O
soft	O
.	O
tissue	O
fragment	O
measuring	O
1	O
.	O
1	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
fifth	O
container	O
is	O
labeled	O
"	O
left	O
pelvic	O
sidewall	O
.	O

It	O
contains	O
a	O
1	O
x	O
0	O
.	O
3	O
x	O
.	O

0	O
.	O
3	O
cm	O
tan	O
tissue	O
.	O

The	O
sixth	O
container	O
is	O
labeled	O
"	O
right	O
pelvic	O
sidewall	O
.	O

It	O
contains	O
a	O
1	O
x	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
3	O
cm	O
yellow	O
-	O
tan	O
fatty	O
tissue	O
.	O

The	O
seventh	O
container	O
is	O
labeled	O
"	O
right	O
gutter	O
.	O

It	O
contains	O
a	O
1	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
cm	O
.	O
fatty	O
tissue	O
:	O
The	O
eighth	O
container	O
is	O
labeled	O
"	O
left	O
gutter	O
.	O

It	O
contains	O
two	O
yellow	O
-	O
tan	O
.	O
fragments	O
of	O
tissue	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
each	O
.	O

The	O
ninth	O
container	O
is	O
labeled	O
left	O
pelvic	O
lymph	O
nodes	O
.	O

It	O
contains	O
fatty	O
.	O
tissue	O
measuring	O
,	O
in	O
aggregate	O
,	O
6	O
x	O
5	O
x	O
2	O
cm	O
.	O

Labeled	O
I1	O
to	O
I5	O
-	O
one	O
.	O
putative	O
.	O

lymph	O
node	O
bisected	O
each	O
;	O
I6	O
-	O
multiple	O
single	O
lymph	O
nodes	O
.	O

The	O
tenth	O
container	O
is	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
.	O

It	O
contains	O
.	O
fibrofatty	O
tissue	O
measuring	O
-	O
7	O
x	O
5	O
x	O
1	O
cm	O
.	O

Labeled	O
J1	O
to	O
J5	O
-	O
single	O
putative	O
.	O
lymph	O
node	O
bisected	O
;	O
J6	O
-	O
individual	O
single	O
lymph	O
node	O
.	O

The	O
eleventh	O
container	O
is	O
labeled	O
"	O
right	O
common	O
peri	O
-	O
aortic	O
lymph	O
node	O
.	O

It	O
.	O
contains	O
a	O
single	O
3	O
x	O
2	O
x	O
1	O
cm	O
yellow	O
fatty	O
tissue	O
.	O

Entire	O
tissue	O
appears	O
to	O
be	O
.	O

a	O
putative	O
single	O
lymph	O
node	O
.	O

Serially	O
sectioned	O
.	O

The	O
twelfth	O
container	O
is	O
labeled	O
"	O
left	O
common	O
peri	O
-	O
aortic	O
lymph	O
node	O
.	O
'	O
It	O
.	O
contains	O
two	O
fatty	O
fragments	O
of	O
tissue	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
6	O
and	O
1	O
.	O
5	O
x	O
1	O
x	O
.	O

0	O
.	O
3	O
cm	O
.	O

Labeled	O
L1	O
-	O
smaller	O
fragment	O
bisected	O
;	O
L2	O
-	O
larger	O
fragment	O
in	O
.	O
multiple	O
sections	O
.	O

The	O
thirteenth	O
container	O
is	O
labeled	O
"	O
omentum	O
.	O
"	O
It	O
contains	O
a	O
100	O
-	O
gram	O
omentum	O
.	O
measuring	O
15	O
x	O
5	O
x	O
1	O
cm	O
.	O

There	O
are	O
no	O
papillary	O
projections	O
,	O
or	O
tumor	O
nodules	O
.	O
noted	O
on	O
the	O
omental	O
surface	O
.	O

Labeled	O
M1	O
to	O
M5	O
.	O

Jar	O
2	O
.	O

SYNOPTIC	O
REPORTING	O
FORM	O
FOR	O
MALIGNANT	O
OVARIAN	O
NEOPLASMS	O
.	O

HISTOPATHOLOGIC	O
TYPE	O
.	O

The	O
histologic	O
diagnosis	O
is	O
serous	O
adenocarcinoma	O
.	O

TUMOR	O
LOCATION	O
.	O

The	O
locations	O
of	O
the	O
primary	O
tumor	O
(	O
s	O
)	O
are	O
the	O
right	O
and	O
left	O
ovary	O
(	O
synchronous	O
.	O
primary	O
tumors	O
)	O
.	O

HISTOLOGIC	O
GRADE	O
.	O

The	O
histologic	O
grade	O
is	O
poorly	O
differentiated	O
(	O
G3	O
)	O
.	O

TUMOR	O
INVASION	O
.	O

Tumor	O
does	O
invade	O
the	O
adjacent	O
fallopian	O
tube	O
/	O
peritubal	O
soft	O
tissue	O
.	O

TUMOR	O
INVOLVEMENT	O
.	O

Tumor	O
involvement	O
of	O
the	O
pelvic	O
peritoneum	O
/	O
soft	O
tissue	O
is	O
absent	O
.	O

PRIMARY	O
TUMOR	O
(	O
T	O
)	O
.	O

Based	O
on	O
the	O
above	O
information	O
,	O
the	O
primary	O
tumor	O
is	O
classified	O
as	O
extension	O
.	O

and	O
/	O
or	O
implants	O
on	O
uterus	O
and	O
/	O
or	O
tubes	O
(	O
T2a	O
/	O
IIA	O
)	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
N	O
)	O
.	O

The	O
regional	O
lymph	O
nodes	O
are	O
classified	O
as	O
no	O
regional	O
lymph	O
node	O
metastasis	O
.	O

(	O
NO	O
)	O
.	O

The	O
total	O
number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
is	O
19	O
.	O

DISTANT	O
METASTASIS	O
(	O
M	O
)	O
.	O

The	O
status	O
of	O
distant	O
tumor	O
site	O
cannot	O
be	O
assessed	O
(	O
MX	O
)	O
.	O

STAGE	O
GROUPING	O
.	O

The	O
Final	O
AJCC	O
/	O
UICC	O
/	O
FIGO	O
stage	O
has	O
insufficient	O
data	O
to	O
assign	O
stage	O
(	O
Stage	O
X	O
)	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
and	O
may	O
.	O
change	O
after	O
integration	O
of	O
clinical	O
data	O
not	O
provided	O
with	O
this	O
specimen	O
.	O

The	O
performance	O
characteristics	O
of	O
some	O
immunohistochemical	O
stains	O
,	O
fluorescence	O
.	O

in	O
-	O
situ	O
hybridization	O
tests	O
and	O
immunophenotyping	O
by	O
flow	O
cytometry	O
cited	O
in	O
.	O
this	O
report	O
(	O
if	O
any	O
)	O
were	O
determined	O
by	O
the	O
.	O
as	O
part	O
of	O
an	O
ongoing	O
quality	O
assurance	O
and	O
111	O
.	O
compliance	O
with	O
federally	O
mandated	O
regulations	O
drawn	O
from	O
the	O
.	O

Some	O
of	O
these	O
tests	O
rely	O
on	O
the	O
.	O
use	O
of	O
"	O
analyte	O
specific	O
reagents	O
"	O
and	O
are	O
subject	O
to	O
specific	O
labeling	O
.	O
requirements	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
test	O
is	O
used	O
.	O
for	O
clinical	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
.	O
research	O
.	O

Nevertheless	O
,	O
federal	O
rules	O
concerning	O
the	O
medical	O
use	O
of	O
analyte	O
.	O
specific	O
reagents	O
require	O
that	O
the	O
following	O
disclaimer	O
be	O
attached	O
to	O
the	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
.	O
the	O
.	O

Surnical	O
Pathology	O
Report	O
.	O

CLINICAL	O
HISTORY	O
.	O
with	O
right	O
parieto	O
-	O
occipital	O
glioblastoma	O
in	O
.	O

Currently	O
,	O
recurrence	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Not	O
Given	O
.	O

Operation	O
/	O
Specimen	O
:	O
A	O
:	O
Brain	O
,	O
biopsy	O
.	O

B	O
:	O
Brain	O
,	O
resection	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
A	O
and	O
B	O
.	O

Brain	O
,	O
right	O
parieto	O
-	O
occipital	O
,	O
excision	O
:	O
Glioblastoma	O
.	O

See	O
comment	O
.	O

COMMENT	O
.	O

The	O
specimens	O
are	O
fragments	O
of	O
cerebrum	O
containing	O
a	O
neoplastic	O
proliferation	O
.	O
of	O
astrocytes	O
with	O
nuclear	O
anaplasia	O
,	O
mitotic	O
figures	O
,	O
microvascular	O
.	O
proliferation	O
and	O
necrosis	O
.	O

There	O
are	O
zones	O
of	O
pseudosarcoma	O
,	O
and	O
the	O
neurons	O
.	O
present	O
are	O
interpreted	O
as	O
entrapped	O
.	O

PROCEDURES	O
/	O
ADDENDA	O
.	O

Interpretation	O
.	O

MIB	O
-	O
1	O
PROLIFERATION	O
INDEX	O
19	O
%	O
.	O

Results	O
-	O
Comments	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
The	O
GFAP	O
depicts	O
sparse	O
glial	O
fibrillogenesis	O
by	O
the	O
.	O
tumor	O
cells	O
in	O
the	O
more	O
cellular	O
zones	O
,	O
a	O
little	O
more	O
abundant	O
in	O
the	O
looser	O
.	O
areas	O
.	O

With	O
the	O
MIB	O
-	O
1	O
,	O
there	O
is	O
a	O
proliferation	O
index	O
of	O
about	O
19	O
%	O
in	O
the	O
.	O
more	O
active	O
areas	O
.	O

[	O
NTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

Brain	O
,	O
biopsy	O
,	O
touch	O
prep	O
and	O
smears	O
:	O
Malignant	O
tumor	O
(	O
c	O
/	O
w	O
glioma	O
)	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
,	O
2	O
fragments	O
,	O
0	B
.	I
8	I
cm	I
.	O
across	O
in	O
aggregate	O
.	O

Semi	O
firm	O
,	O
.	O
tannish	O
-	O
grey	O
.	O

In	O
total	O
,	O
Ai	O
and	O
A2	O
.	O

B	O
.	O

Reeived	O
fresh	O
,	O
2	O
fragments	O
,	O
1	O
.	O
7	O
cm	O
.	O
across	O
,	O
in	O
aggregate	O
.	O

Semi	O
-	O
firm	O
,	O
.	O
tannish	O
-	O
white	O
.	O

In	O
total	O
,	O
B1	O
and	O
B2	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
191	O
.	O
3	O
.	O
191	O
3	O
.	O

Histo	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
.	O
biopsy	O
.	O

Block	O
.	O

Comment	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

MIB1	O
-	O
DA	O
X	O
1	O
.	O

1	O
.	O

Part	O
B	O
:	O
Brain	O
.	O
resection	O
.	O

Diagnosis	O
:	O
A	O
:	O
Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
regional	O
resection	O
.	O

-	O
No	O
evidence	O
of	O
metastatic	O
disease	O
in	O
ten	O
lymph	O
nodes	O
(	O
0	O
/	O
10	O
)	O
.	O

-	O
Follicular	O
lymphoid	O
hyperplasia	O
.	O

B	O
:	O
Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
regional	O
resection	O
.	O

-	O
No	O
evidence	O
of	O
metastatic	O
disease	O
in	O
twelve	O
lymph	O
nodes	O
(	O
0	O
/	O
12	O
)	O
.	O

-	O
Follicular	O
lymphoid	O
hyperplasia	O
.	O

C	O
:	O
Cervix	O
,	O
uterus	O
and	O
parametrium	O
,	O
radical	O
hysterectomy	O
.	O

Histologic	O
type	O
:	O
Invasive	O
non	O
-	O
keratinizing	O
squamous	O
cell	O
.	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
moderate	O
to	O
poorly	O
differentiated	O
.	O

Tumor	O
focality	O
/	O
site	O
(	O
quadrant	O
(	O
s	O
)	O
of	O
cervix	O
)	O
invasive	O
carcinoma	O
.	O

6	O
-	O
3	O
o	O
'	O
clock	O
clockwise	O
(	O
3	O
quadrants	O
)	O
.	O

CIN3	O
at	O
5	O
o	O
'	O
clock	O
.	O

Tumor	O
size	O
:	O
(	O
greatest	O
dimension	O
)	O
4	B
.	I
0	I
cm	I
.	O

Extent	O
of	O
invasion	O
:	O
Depth	O
:	O
1	B
.	I
6	I
cm	I
Wall	O
thickness	O
:	O
2	O
.	O
3	O
cm	O
.	O

Percent	O
70	O
%	O
.	O

(	O
See	O
sections	O
C6	O
and	O
C7	O
)	O
.	O

Horizontal	O
extent	O
:	O
2	O
.	O
7	O
cm	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
none	O
identified	O
.	O

Parametrial	O
soft	O
tissue	O
involvement	O
:	O
-	O
no	O
evidence	O
of	O
tumor	O
.	O
involvement	O
in	O
the	O
right	O
or	O
left	O
parametrium	O
.	O

-	O
3	O
benign	O
right	O
parametrial	O
lymph	O
nodes	O
and	O
1	O
benign	O
left	O
.	O
parametrial	O
lymph	O
node	O
(	O
0	O
/	O
4	O
)	O
.	O

Vaginal	O
cuff	O
involvement	O
negative	O
,	O
margins	O
clear	O
.	O

Surgical	O
margins	O
:	O
clear	O
.	O

Invasive	O
:	O
carcinoma	O
comes	O
within	O
0	O
.	O
5	O
cm	O
of	O
the	O
anterior	O
cervical	O
.	O
soft	O
tissue	O
margin	O
at	O
12	O
o	O
'	O
clock	O
in	O
section	O
C7	O
(	O
closest	O
margin	O
)	O
.	O

Intraepithelial	O
:	O
widely	O
free	O
.	O

Regional	O
lymph	O
nodes	O
(	O
see	O
other	O
specimens	O
)	O
:	O
Total	O
number	O
involved	O
:	O
0	O
.	O

Total	O
number	O
examined	O
:	O
26	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Endometrium	O
.	O

-	O
Proliferative	O
phase	O
.	O

Myometrium	O
.	O

-	O
Leiomyomata	O
,	O
no	O
significant	O
atypia	O
,	O
mitotic	O
activity	O
,	O
or	O
tumor	O
.	O
necrosis	O
identified	O
.	O

AJCC	O
Pathologic	O
Stage	O
:	O
pT1b1	O
pNO	O
pMx	O
.	O

Note	O
:	O
This	O
staging	O
information	O
is	O
based	O
on	O
the	O
pathologic	O
.	O
specimen	O
and	O
may	O
be	O
incomplete	O
.	O

A	O
comprehensive	O
review	O
of	O
all	O
.	O
available	O
clinical	O
information	O
is	O
recommended	O
to	O
determine	O
final	O
.	O
staging	O
.	O

Clinical	O
History	O
:	O
-	O
year	O
-	O
old	O
with	O
Stage	O
1B	O
cervical	O
cancer	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
three	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
is	O
additionally	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
node	O
.	O

It	O
consists	O
of	O
a	O
4	O
.	O
3	O
X	O
2	O
.	O
6	O
X	O
1	O
.	O
5	O
cm	O
portion	O
of	O
adipose	O
tissue	O
.	O
that	O
is	O
dissected	O
for	O
lymph	O
node	O
candidates	O
of	O
which	O
nine	O
are	O
.	O
identified	O
ranging	O
from	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
up	O
to	O
4	O
.	O
3	O
x	O
.	O

1	O
.	O
5	O
X	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Block	O
summary	O
:	O
:	O
A1	O
-	O
five	O
lymph	O
nodes	O
.	O

A2	O
-	O
two	O
lymph	O
nodes	O
.	O

A3	O
-	O
one	O
lymph	O
node	O
,	O
serially	O
sectioned	O
.	O

A4	O
-	O
A6	O
-	O
one	O
lymph	O
node	O
,	O
serially	O
sectioned	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
node	O
.	O

It	O
.	O
consists	O
of	O
a	O
6	O
.	O

1	O
X	O
2	O
.	O
1	O
X	O
1	O
.	O
4	O
cm	O
portion	O
of	O
adipose	O
tissue	O
that	O
.	O

is	O
dissected	O
for	O
lymph	O
node	O
candidates	O
of	O
which	O
eleven	O
are	O
.	O
identified	O
ranging	O
from	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
up	O
to	O
4	O
.	O

1	O
X	O
.	O

1	O
.	O
3	O
X	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

Block	O
summary	O
:	O
B1	O
-	O
four	O
lymph	O
nodes	O
.	O

B2	O
-	O
B7	O
-	O
-	O
each	O
contains	O
one	O
lymph	O
node	O
,	O
serially	O
sectioned	O
.	O

B8	O
-	O
B9	O
-	O
-	O
one	O
lymph	O
node	O
,	O
serially	O
sectioned	O
.	O

Container	O
C	O
is	O
additionally	O
labeled	O
"	O
uterus	O
,	O
cervix	O
,	O
.	O
parametrium	O
.	O
"	O
.	O

Specimen	O
fixation	O
:	O
formalin	O
.	O

Specimen	O
type	O
:	O
radical	O
hysterectomy	O
with	O
attached	O
bilateral	O
.	O
parametrium	O
.	O

Adnexa	O
:	O
absent	O
.	O

Weight	O
:	O
:	O
345	O
grams	O
.	O

Shape	O
:	O
distorted	O
pyriform	O
.	O

Dimensions	O
:	O
Height	O
:	O
10	O
.	O
5	O
cm	O
.	O

Anterior	O
to	O
posterior	O
width	O
:	O
5	O
.	O
2	O
cm	O
.	O

Breadth	O
at	O
fundus	O
:	O
7	O
.	O
1	O
cm	O
.	O

Serosa	O
:	O
pink	O
/	O
tan	O
,	O
smooth	O
and	O
glistening	O
with	O
two	O
homogeneous	O
.	O
white	O
whorled	O
rubbery	O
nodules	O
(	O
1	O
.	O
0	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
6	O
cm	O
and	O
7	O
.	O
1	O
X	O
4	O
.	O
7	O
.	O
X	O
4	O
.	O
6	O
cm	O
)	O
,	O
each	O
of	O
which	O
bulges	O
on	O
cut	O
section	O
;	O
Anterior	O
.	O

cervix	O
=	O
blue	O
,	O
posterior	O
cervix	O
=	O
black	O
.	O

Cervix	O
:	O
Ectocervix	O
:	O
4	O
.	O

1	O
cm	O
in	O
diameter	O
;	O
smooth	O
and	O
gray	O
,	O
of	O
which	O
.	O
approximately	O
75	O
%	O
of	O
the	O
anterior	O
ectocervix	O
is	O
eroded	O
by	O
tumor	O
;	O
.	O
the	O
posterior	O
ectocervix	O
has	O
a	O
focus	O
of	O
abutting	O
tumor	O
but	O
is	O
.	O
intact	O
,	O
smooth	O
and	O
glistening	O
.	O

Tumor	O
size	O
:	O
4	B
.	I
0	I
.	I
x	I
2	I
.	I
7	I
X	I
1	I
.	I
5	I
cm	I
(	O
protruding	O
into	O
the	O
canal	O
)	O
.	O

Tumor	O
site	O
:	O
Tumor	O
involves	O
from	O
6	O
o	O
'	O
clock	O
up	O
through	O
3	O
o	O
'	O
clock	O
.	O

(	O
clockwise	O
fashion	O
)	O
with	O
3	O
-	O
5	O
o	O
'	O
clock	O
uninvolved	O
by	O
mass	O
;	O
the	O
.	O
mass	O
is	O
soft	O
,	O
tan	O
/	O
yellow	O
,	O
well	O
circumscribed	O
and	O
partially	O
.	O
friable	O
but	O
is	O
without	O
hemorrhage	O
or	O
necrosis	O
;	O
the	O
mass	O
.	O
partially	O
erodes	O
the	O
anterior	O
ectocervix	O
and	O
grossly	O
abuts	O
the	O
.	O
posterior	O
ectocervix	O
,	O
extends	O
1	O
.	O
2	O
cm	O
into	O
the	O
stroma	O
,	O
0	O
.	O
3	O
cm	O
.	O
from	O
the	O
anterior	O
cervical	O
soft	O
tissue	O
margin	O
,	O
0	O
.	O
9	O
cm	O
from	O
the	O
.	O
posterior	O
cervical	O
soft	O
tissue	O
margin	O
,	O
1	O
.	O
4	O
cm	O
from	O
the	O
anterior	O
.	O
lower	O
uterine	O
segment	O
,	O
1	O
.	O
1	O
cm	O
from	O
the	O
posterior	O
lower	O
uterine	O
.	O
segment	O
,	O
and	O
0	O
.	O
8	O
cm	O
closest	O
to	O
the	O
vaginal	O
mucosal	O
margin	O
(	O
at	O
.	O
12	O
o	O
'	O
clock	O
)	O
.	O

Endocervix	O
:	O
involved	O
by	O
mass	O
except	O
from	O
3	O
-	O
5	O
o	O
'	O
clock	O
.	O

Other	O
features	O
:	O
none	O
.	O

Endometrium	O
:	O
Length	O
of	O
endometrial	O
cavity	O
:	O
3	O
.	O
9	O
cm	O
.	O

Width	O
:	O
3	O
.	O
8	O
cm	O
.	O

Endometrial	O
surface	O
:	O
red	O
/	O
brown	O
,	O
slightly	O
granular	O
(	O
less	O
than	O
0	O
.	O
1	O
.	O
cm	O
thick	O
)	O
.	O

Other	O
findings	O
:	O
none	O
.	O

Myometrium	O
:	O
Thickness	O
of	O
wall	O
:	O
2	O
.	O
5	O
cm	O
.	O

Other	O
findings	O
:	O
The	O
myometrium	O
is	O
tan	O
,	O
trabeculated	O
and	O
contains	O
.	O
approximately	O
10	O
homogenous	O
white	O
whorled	O
rubbery	O
nodules	O
up	O
to	O
.	O

3	O
.	O
5	O
X	O
3	O
.	O
5	O
X	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
,	O
all	O
of	O
which	O
.	O
bulge	O
on	O
cut	O
section	O
.	O

Vagina	O
:	O
The	O
vaginal	O
mucosa	O
measures	O
4	O
.	O
7	O
cm	O
in	O
diameter	O
X	O
1	O
.	O
3	O
cm	O
.	O
wide	O
x	O
0	O
.	O

1	O
cm	O
thick	O
and	O
is	O
tan	O
,	O
smooth	O
and	O
glistening	O
and	O
.	O
unremarkable	O
.	O

Urinary	O
bladder	O
:	O
n	O
/	O
a	O
.	O

Rectum	O
:	O
n	O
/	O
a	O
.	O

Digital	O
picture	O
:	O
not	O
taken	O
.	O

Tissue	O
give	O
to	O
tissue	O
procurement	O
:	O
Tumor	O
is	O
given	O
to	O
the	O
Tumor	O
.	O

Procurement	O
foundation	O
.	O

Block	O
summary	O
:	O
C1	O
-	O
vaginal	O
mucosal	O
margin	O
,	O
en	O
face	O
from	O
12	O
to	O
3	O
o	O
'	O
clock	O
.	O

C2	O
-	O
vaginal	O
mucosal	O
margin	O
,	O
en	O
face	O
,	O
from	O
3	O
to	O
6	O
o	O
'	O
'	O
clock	O
.	O

C3	O
-	O
vaginal	O
mucosal	O
margin	O
,	O
en	O
face	O
,	O
from	O
6	O
to	O
9	O
o	O
'	O
clock	O
.	O

C4	O
-	O
vaginal	O
mucosal	O
margin	O
,	O
en	O
face	O
,	O
from	O
9	O
to	O
12	O
o	O
'	O
clock	O
.	O

C5	O
-	O
perpendicular	O
of	O
mass	O
at	O
9	O
o	O
'	O
clock	O
with	O
vaginal	O
mucosa	O
.	O

C6	O
-	O
C8	O
-	O
cervix	O
,	O
12	O
o	O
'	O
clock	O
,	O
longitudinal	O
section	O
from	O
.	O
ectocervix	O
through	O
the	O
anterior	O
lower	O
uterine	O
segment	O
,	O
one	O
piece	O
.	O
trisected	O
(	O
C6	O
contains	O
mass	O
eroding	O
through	O
ectocervix	O
,	O
C7	O
has	O
.	O
vaginal	O
mucosa	O
and	O
cervical	O
soft	O
tissue	O
,	O
C8	O
is	O
anterior	O
lower	O
.	O
uterine	O
segment	O
with	O
intramural	O
nodule	O
)	O
.	O

C9	O
-	O
perpendicular	O
of	O
mass	O
at	O
3	O
o	O
'	O
clock	O
.	O

C10	O
-	O
perpendicular	O
of	O
cervix	O
at	O
5	O
o	O
'	O
clock	O
.	O

C11	O
-	O
C13	O
-	O
cervix	O
at	O
6	O
o	O
'	O
clock	O
,	O
one	O
full	O
length	O
longitudinal	O
.	O
section	O
from	O
ectocervix	O
towards	O
posterior	O
lower	O
uterine	O
segment	O
,	O
.	O
one	O
piece	O
,	O
trisected	O
(	O
C11	O
has	O
mass	O
with	O
ectocervix	O
and	O
vaginal	O
.	O
mucosa	O
,	O
C12	O
is	O
mass	O
within	O
endocervical	O
canal	O
,	O
C13	O
is	O
posterior	O
.	O
lower	O
uterine	O
segment	O
)	O
.	O

C14	O
-	O
perpendicular	O
cervix	O
at	O
approximately	O
8	O
o	O
'	O
clock	O
with	O
mass	O
.	O

C15	O
-	O
C16	O
-	O
anterior	O
corpus	O
,	O
full	O
thickness	O
,	O
bisected	O
,	O
with	O
.	O
subserosal	O
nodule	O
.	O

C17	O
-	O
C18	O
-	O
posterior	O
corpus	O
,	O
full	O
thickness	O
,	O
bisected	O
with	O
.	O
intramural	O
nodule	O
.	O

C19	O
-	O
C21	O
-	O
intramural	O
nodules	O
.	O

C22	O
-	O
C24	O
-	O
largest	O
subserosal	O
nodule	O
.	O

C25	O
-	O
C29	O
-	O
right	O
lateral	O
parametrial	O
soft	O
tissue	O
,	O
serially	O
.	O
sectioned	O
.	O

C30	O
-	O
C34	O
-	O
left	O
parametrial	O
soft	O
tissue	O
,	O
serially	O
sectioned	O
.	O

Research	O
Gross	O
Description	O
.	O
male	O
with	O
left	O
renal	O
mass	O
.	O

Research	O
Dx	O
.	O

CASE	O
SUMMARY	O
FOR	O
NEPHRECTOMY	O
FOR	O
RENAL	O
CELL	O
CARCINOMA	O
:	O
Procedure	O
:	O
Laparoscopic	O
partial	O
nephrectomy	O
.	O

Specimen	O
laterality	O
:	O
Left	O
.	O

Tumor	O
site	O
:	O
Inferolateral	O
cortex	O
.	O

Tumor	O
size	O
:	O
1	B
x	I
1	I
x	I
0	I
.	I
7	I
cm	I
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Macroscopic	O
extent	O
of	O
tumor	O
:	O
Tumor	O
limited	O
to	O
the	O
kidney	O
.	O

Histologic	O
type	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
,	O
type	O
I	O
.	O

Sarcomatoid	O
features	O
:	O
Not	O
identified	O
.	O

Tumor	O
necrosis	O
:	O
Not	O
identified	O
.	O

Histologic	O
grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
2	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
Tumor	O
limited	O
to	O
the	O
kidney	O
.	O

Margins	O
:	O
Negative	O
for	O
carcinoma	O
(	O
tumor	O
extends	O
to	O
within	O
0	O
.	O
5	O
mm	O
of	O
the	O
parenchymal	O
margin	O
.	O

Lymph	O
-	O
Vascular	O
invasion	O
:	O
Not	O
identified	O
.	O

Pathologic	O
staging	O
(	O
pTNM	O
)	O
:	O
Primary	O
tumor	O
:	O
pT1a	B
:	O
Tumor	O
4	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
limited	O
to	O
the	O
kidney	O
.	O

Regional	O
lymph	O
nodes	O
:	O
pNX	O
:	O
Unable	O
to	O
assess	O
.	O

Distant	O
metastasis	O
:	O
pM	O
:	O
Not	O
applicable	O
.	O

Pathologic	O
findings	O
in	O
nonneoplastic	O
kidney	O
:	O
No	O
significant	O
histologic	O
abnormalities	O
.	O

Other	O
tumors	O
and	O
/	O
or	O
tumor	O
-	O
like	O
lesions	O
:	O
None	O
identified	O
.	O

AJCC	O
Staging	O
(	O
7th	O
edition	O
)	O
pT1a	O
pNX	O
pM	O
:	O
Not	O
applicable	O
.	O

Research	O
QC	O
.	O

Tumor	O
T1	O
:	O
100	O
%	O
tumor	O
nuclei	O
.	O

0	O
%	O
necrosis	O
.	O

0	O
%	O
normal	O
.	O

Normal	O
N1	O
:	O
100	O
%	O
benign	O
kidney	O
.	O

Research	O
Specimen	O
.	O

Specimen	O
Process	O
Time	O
.	O

Blood	O
draw	O
time	O
:	O
Plasma	O
frozen	O
time	O
.	O

Serum	O
frozen	O
time	O
:	O
Buffy	O
coat	O
frozen	O
time	O
:	O
Tissue	O
:	O
Cold	O
ischemia	O
start	O
time	O
:	O
Formalin	O
fixation	O
start	O
time	O
.	O

Frozen	O
start	O
time	O
:	O
Total	O
cold	O
ischemia	O
time	O
:	O
Formalin	O
fixation	O
stop	O
time	O
:	O
Total	O
formalin	O
fixation	O
time	O
:	O
1	O
.	O

Specimen	O
Weight	O
.	O

Normal	O
.	O

1	O
-	O
112	O
mg	O
.	O

Tumor	O
.	O

1	O
-	O
135	O
mg	O
_	O
.	O

Specimen	O
Size	O
.	O

Plasma	O
x	O
3	O
.	O

Serum	O
x	O
1	O
.	O

Buffy	O
coat	O
X	O
1	O
.	O

Cryovials	O
X	O
2	O
.	O

Normal	O
X	O
1	O
.	O

Tumor	O
x	O
1	O
.	O

Metastatic	O
x	O
0	O
.	O

FFPE	O
X	O
2	O
.	O

Normal	O
x	O
1	O
.	O

Tumor	O
x	O
1	O
(	O
.	O
-	O
no	O
FS	O
)	O
.	O

Metastatic	O
x	O
0	O
.	O

Study	O
.	O

Patient	O
Consent	O
.	O

A	O
description	O
for	O
each	O
data	O
field	O
can	O
be	O
found	O
in	O
the	O
'	O
Data	O
description	O
worksheet	O
(	O
yellow	O
tab	O
)	O
.	O
tion	O
Details	O
.	O

Histology	O
and	O
staging	O
.	O

TUMOUR	O
.	O

FF	O
.	O

LUL	O
lung	O
mass	O
.	O

Adenocarcinoma	O
.	O

0	O
.	O

11	O
.	O

RESECT	O
.	O

LUL	O
.	O

3	O
.	O
20	O
.	O

03	O
.	O

III	O
.	O

T2	O
,	O
NOS	O
.	O

MO	O
.	O

DATE	O
OBTAINED	O
:	O
DATE	O
RECEIVED	O
:	O
SUBMITTING	O
MD	O
:	O
DIAGNOSIS	O
.	O

#	O
1	O
-	O
CHOLECYSTECTOMY	O
:	O
MILD	O
CHRONIC	O
CHOLECYSTITIS	O
.	O

#	O
2	O
-	O
LIVER	O
,	O
RIGHT	O
LOBE	O
,	O
RESECTION	O
:	O
HEPATOCELLULAR	O
CARCINOMA	O
.	O

Tumor	O
type	O
:	O
Hepatocellular	O
Carcinoma	O
.	O

Number	O
of	O
tumors	O
:	O
One	O
main	O
tumor	O
mass	O
,	O
with	O
multiple	O
surrounding	O
satellite	O
lesions	O
.	O

Tumor	O
size	O
:	O
9	B
cm	I
.	O

Location	O
(	O
R	O
or	O
L	O
lobe	O
)	O
:	O
Right	O
lobe	O
.	O

Tumor	O
Necrosis	O
:	O
Present	O
,	O
incomplete	O
.	O

Worst	O
Tumor	O
differentiation	O
:	O
Grade	O
2	O
.	O

Infiltrative	O
pattern	O
:	O
Absent	O
.	O

Vascular	O
Invasion	O
:	O
Present	O
.	O

Hepatic	O
capsule	O
:	O
No	O
extrahepatic	O
invasion	O
.	O

Local	O
extension	O
:	O
Absent	O
.	O

Margins	O
:	O
Negative	O
.	O

Multifocality	O
:	O
Satellite	O
lesions	O
present	O
,	O
multiple	O
,	O
up	O
to	O
1	O
.	O
5	O
cm	O
diameter	O
.	O

Other	O
findings	O
:	O
Adjacent	O
hepatic	O
parenchyma	O
with	O
areas	O
of	O
hemorrhage	O
,	O
hemosiderin	O
.	O
deposition	O
,	O
reactive	O
changes	O
,	O
and	O
mild	O
portal	O
chronic	O
inflammation	O
.	O

ypTNM	O
:	O
pT1	O
pNx	O
.	O

#	O
3	O
-	O
DIAPHRAGM	O
,	O
PARTIAL	O
RESECTION	O
:	O
SEGMENT	O
OF	O
SKELETAL	O
MUSCLE	O
CONSISTENT	O
WITH	O
DIAPHRAGM	O
.	O

WITH	O
SURFACE	O
FIBROUS	O
ADHESIONS	O
AND	O
FOCAL	O
GRANULATION	O
TISSUE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

#	O
4	O
-	O
SEGMENT	O
OF	O
OMENTUM	O
:	O
BENIGN	O
ADIPOSE	O
TISSUE	O
WITH	O
FOCAL	O
FIBROSIS	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

COMMENT	O
.	O

88309	O
,	O
88304	O
,	O
88305	O
,	O
88329B	O
,	O
88311	O
.	O

Clinical	O
Diagnosis	O
and	O
History	O
:	O
Liver	O
cancer	O
.	O

Tissue	O
(	O
s	O
)	O
Submitted	O
:	O
1	O
:	O
GALLBLADDER	O
.	O

2	O
:	O
RIGHT	O
LOBE	O
OF	O
LIVER	O
.	O

3	O
:	O
SECTION	O
OF	O
DIAPHRAGM	O
.	O

4	O
:	O
SEGMENT	O
OF	O
OMENTUM	O
.	O

Gross	O
Description	O
:	O
Specimen	O
#	O
1	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
gallbladder	O
,	O
and	O
consists	O
of	O
an	O
8	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
intact	O
gallbladder	O
with	O
attached	O
pink	O
.	O
cystic	O
duct	O
exhibiting	O
a	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
lumen	O
.	O

The	O
serosa	O
is	O
gray	O
-	O
pink	O
and	O
smooth	O
.	O

Opening	O
reveals	O
approximately	O
15	O
-	O
20	O
CC	O
of	O
.	O
amber	O
viscous	O
bile	O
.	O

The	O
wall	O
averages	O
0	O
.	O
1	O
cm	O
.	O

The	O
mucosa	O
is	O
tan	O
-	O
red	O
and	O
velvety	O
.	O

No	O
choleliths	O
are	O
identified	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
labeled	O
1A	O
.	O

Specimen	O
#	O
2	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
right	O
lobe	O
of	O
liver	O
(	O
tissue	O
removal	O
time	O
.	O
)	O
,	O
and	O
.	O
consists	O
of	O
a	O
1	O
,	O
289	O
-	O
gram	O
,	O
16	O
x	O
13	O
.	O
5	O
x	O
9	O
.	O
5	O
cm	O
right	O
lobe	O
of	O
liver	O
exhibiting	O
a	O
focally	O
retracted	O
and	O
nodular	O
capsule	O
associated	O
with	O
a	O
.	O
foci	O
of	O
adhesions	O
.	O

The	O
resection	O
margin	O
is	O
inked	O
blue	O
and	O
the	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
9	O
.	O
1	O
x	O
9	O
X	O
6	O
.	O
8	O
cm	O
lobulated	O
.	O
mass	O
exhibiting	O
a	O
variegated	O
yellow	O
-	O
tan	O
to	O
hemorrhagic	O
(	O
approximately	O
20	O
%	O
)	O
cut	O
surface	O
.	O

The	O
mass	O
comes	O
to	O
within	O
1	O
.	O
6	O
cm	O
of	O
the	O
.	O
blue	O
inked	O
resection	O
margin	O
.	O

The	O
above	O
is	O
related	O
to	O
the	O
surgeon	O
intraoperatively	O
.	O

The	O
remaining	O
parenchyma	O
appears	O
gross	O
.	O
unremarkable	O
,	O
exhibiting	O
a	O
homogeneous	O
mahogany	O
surface	O
.	O

Representative	O
normal	O
and	O
tumor	O
are	O
triaged	O
per	O
a	O
depth	O
and	O
.	O
protocol	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
2B	O
:	O
tumor	O
to	O
closest	O
blue	O
inked	O
resection	O
margin	O
.	O

2C	O
-	O
2E	O
:	O
representative	O
sections	O
of	O
tumor	O
with	O
blue	O
inked	O
capsular	O
adhesions	O
/	O
calcifications	O
and	O
hemorrhage	O
(	O
after	O
decalcification	O
)	O
.	O

2F	O
-	O
21	O
:	O
additional	O
representative	O
sections	O
of	O
variegated	O
cut	O
surface	O
.	O

2J	O
:	O
representative	O
sections	O
of	O
normal	O
liver	O
parenchyma	O
.	O

2K	O
-	O
2O	O
:	O
periphery	O
of	O
tumor	O
,	O
question	O
satellite	O
lesions	O
.	O

2P	O
-	O
2T	O
:	O
Question	O
vascular	O
invasion	O
of	O
tumor	O
.	O

Specimen	O
#	O
3	O
is	O
received	O
in	O
formalin	O
labeled	O
section	O
of	O
diaphragm	O
and	O
consists	O
of	O
a	O
1	O
.	O
5	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
tan	O
white	O
tissue	O
fragment	O
.	O
exhibiting	O
a	O
focally	O
granular	O
cut	O
surface	O
.	O

The	O
tissue	O
is	O
bisected	O
and	O
entirely	O
submitted	O
labeled	O
3A	O
.	O

Specimen	O
#	O
4	O
is	O
received	O
is	O
received	O
fresh	O
labeled	O
segment	O
of	O
omentum	O
and	O
consists	O
of	O
a	O
10	O
.	O
0	O
x	O
7	O
.	O
5	O
X	O
1	O
.	O
8	O
cm	O
lobulated	O
portion	O
of	O
.	O
omentum	O
exhibiting	O
focal	O
cautery	O
and	O
erythema	O
.	O

Sectioning	O
reveals	O
no	O
gross	O
nodules	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O
labeled	O
4A	O
-	O
4B	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

2A	O
/	O
.	O

SURGICAL	O
MARGIN	O
GROSSLY	O
NEGATIVE	O
1	O
.	O
6CM	O
FROM	O
THE	O
TUMOR	O
.	O

TO	O
.	O

Patient	O
:	O
:	O
Specimen	O
#	O
:	O
Race	O
:	O
WHITE	O
.	O

Physician	O
(	O
s	O
)	O
:	O
SPECIMEN	O
:	O
A	O
:	O
RIGHT	O
OUTER	O
BREAST	O
LUMPECTOMY	O
.	O

B	O
:	O
HIGHEST	O
RIGHT	O
AXILLARY	O
LYMPH	O
NODE	O
.	O

C	O
:	O
RIGHT	O
AXILLARY	O
LYMPH	O
NODE	O
DISSECTION	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

BREAST	O
,	O
RIGHT	O
OUTER	O
,	O
LUMPECTOMY	O
:	O
-	O
TUMOR	O
TYPE	O
:	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
,	O
PLEOMORPHIC	O
TYPE	O
(	O
SEE	O
.	O
COMMENT	O
)	O
.	O

NOTTINGHAM	O
GRADE	O
:	O
POORLY	O
DIFFERENTIATED	O
(	O
G3	O
)	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
8	O
/	O
9	O
(	O
Tubules	O
=	O
3	O
,	O
Nuclei	O
=	O
3	O
,	O
Mitoses	O
=	O
2	O
)	O
.	O

-	O
TUMOR	O
SIZE	O
(	O
GREATEST	O
DIMENSION	O
)	O
:	O
3	B
.	I
2	I
CM	I
(	O
MEASURED	O
GROSSLY	O
)	O
.	O

-	O
TUMOR	O
FOCALITY	O
:	O
SINGLE	O
FOCUS	O
OF	O
INVASIVE	O
CARCINOMA	O
.	O

-	O
TUMOR	O
SIDE	O
(	O
QUADRANT	O
)	O
:	O
RIGHT	O
OUTER	O
.	O

-	O
VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
PRESENT	O
.	O

-	O
MARGINS	O
:	O
POSITIVE	O
.	O

TUMOR	O
EXTENDS	O
TO	O
THE	O
ANTERIOR	O
AND	O
INFERIOR	O
INKED	O
TISSUE	O
EDGES	O
.	O

-	O
LOBULAR	O
CARCINOMA	O
IN	O
SITU	O
:	O
NOT	O
IDENTIFIED	O
.	O

-	O
LYMPH	O
NODES	O
:	O
TWENTY	O
-	O
THREE	O
(	O
23	O
)	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
.	O

CARCINOMA	O
(	O
SEE	O
PARTS	O
"	O
B	O
"	O
AND	O
"	O
C	O
"	O
)	O
.	O

-	O
ESTROGEN	O
RECEPTORS	O
:	O
POSITIVE	O
(	O
95	O
%	O
NUCLEI	O
STAINING	O
,	O
REFER	O
TO	O
.	O

-	O
PROGESTERONE	O
RECEPTORS	O
:	O
NEGATIVE	O
(	O
0	O
%	O
STAINING	O
.	O

REFER	O
TO	O
.	O

-	O
HER	O
2	O
NEU	O
by	O
IHC	O
:	O
NEGATIVE	O
,	O
1	O
+	O
(	O
REFER	O
TO	O
.	O

-	O
AJCC	O
PATHOLOGIC	O
STAGE	O
(	O
7TH	O
EDITION	O
)	O
:	O
pT2	O
N3a	O
.	O

B	O
.	O

AXILLARY	O
LYMPH	O
NODE	O
,	O
RIGHT	O
(	O
"	O
HIGHEST	O
"	O
)	O
BIOPSY	O
:	O
-	O
ONE	O
(	O
1	O
)	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
SEE	O
COMMENT	O
)	O
.	O

SIZE	O
OF	O
LARGEST	O
METASTATIC	O
DEPOSIT	O
:	O
0	O
.	O
9	O
CM	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
:	O
FOCALLY	O
PRESENT	O
.	O

C	O
.	O

AXILLARY	O
LYMPH	O
NODES	O
,	O
RIGHT	O
,	O
DISSECTION	O
:	O
-	O
TWENTY	O
-	O
TW	O
(	O
22	O
)	O
OF	O
TWENTY	O
-	O
THREE	O
(	O
23	O
)	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
.	O

METASTATIC	O
CARCINOMA	O
(	O
SEE	O
COMMENT	O
)	O
.	O

SIZE	O
OF	O
LARGEST	O
METASTATIC	O
DEPOSIT	O
:	O
2	O
.	O
1	O
CM	O
.	O

EXTRACAPSULAR	O
EXTENSION	O
:	O
PRESENT	O
.	O

Specimen	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
(	O
continued	O
)	O
:	O
Comment	O
:	O
The	O
lymph	O
node	O
metastases	O
seen	O
in	O
parts	O
"	O
B	O
"	O
and	O
"	O
C	O
"	O
.	O
demonstrate	O
multiple	O
foci	O
of	O
extracapsular	O
extension	O
and	O
in	O
most	O
cases	O
.	O
represent	O
near	O
complete	O
replacement	O
of	O
the	O
underlying	O
nodal	O
architecture	O
.	O

This	O
case	O
received	O
prospective	O
peer	O
review	O
.	O

CLINICAL	O
DIAGNOSIS	O
AND	O
HISTORY	O
:	O
female	O
with	O
medical	O
diagnosis	O
of	O
breast	O
cancer	O
(	O
invasive	O
.	O
mammary	O
adenocarcinoma	O
,	O
right	O
breast	O
breast	O
;	O
positive	O
right	O
axillary	O
node	O
)	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
None	O
provided	O
.	O

POST	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
None	O
provided	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
designated	O
,	O
"	O
Right	O
Outer	O
Breast	O
Lumpectomy	O
"	O
and	O
consists	O
of	O
an	O
.	O
irregular	O
portion	O
of	O
soft	O
tissue	O
oriented	O
with	O
a	O
single	O
suture	O
-	O
anterior	O
;	O
.	O
double	O
-	O
lateral	O
;	O
and	O
short	O
-	O
superior	O
.	O

The	O
specimen	O
measures	O
10	O
.	O
5	O
.	O

cm	O
.	O
superior	O
to	O
inferior	O
;	O
7	O
.	O
0	O
cm	O
medial	O
to	O
lateral	O
;	O
and	O
3	O
.	O
0	O
cm	O
anterior	O
to	O
.	O
posterior	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
superior	O
=	O
blue	O
;	O
inferior	O
=	O
.	O
green	O
;	O
medial	O
=	O
red	O
;	O
lateral	O
=	O
yellow	O
;	O
anterior	O
=	O
orange	O
;	O
and	O
posterior	O
=	O
.	O
black	O
.	O

Serial	O
sections	O
reveal	O
a	O
poorly	O
-	O
defined	O
,	O
firm	O
tan	O
-	O
white	O
mass	O
.	O
measuring	O
3	O
.	O
2	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O

The	O
mass	O
approaches	O
the	O
closest	O
margin	O
as	O
.	O
follows	O
:	O
0	O
.	O
2	O
cm	O
inferior	O
;	O
0	O
.	O
5	O
cm	O
deep	O
and	O
anterior	O
;	O
and	O
1	O
.	O
0	O
cm	O
medial	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
composed	O
of	O
lobulated	O
,	O
yellow	O
-	O
tan	O
adipose	O
.	O
tissue	O
admixed	O
with	O
a	O
minimal	O
amount	O
of	O
fibrous	O
tissue	O
and	O
is	O
otherwise	O
.	O
unremarkable	O
.	O

Representative	O
sections	O
are	O
sequentially	O
submitted	O
from	O
.	O
superior	O
to	O
inferior	O
as	O
follows	O
A1	O
-	O
superior	O
margin	O
;	O
A2	O
-	O
A4	O
-	O
adjacent	O
.	O
normal	O
;	O
A5	O
-	O
A7	O
-	O
mass	O
with	O
deep	O
and	O
anterior	O
margins	O
;	O
A8	O
-	O
-	O
mass	O
;	O
A9	O
-	O
A10	O
-	O
mass	O
.	O
with	O
deep	O
margin	O
;	O
All	O
-	O
A13	O
-	O
-	O
mass	O
with	O
deep	O
,	O
anterior	O
and	O
medial	O
margin	O
;	O
.	O

A14	O
-	O
A16	O
-	O
-	O
mass	O
with	O
lateral	O
,	O
inferior	O
and	O
anterior	O
margin	O
;	O
A17	O
-	O
A19	O
-	O
mass	O
.	O
with	O
deep	O
and	O
inferior	O
margins	O
.	O

Matched	O
sections	O
of	O
A4	O
and	O
A6	O
-	O
A8	O
-	O
are	O
submitted	O
in	O
OCT	O
and	O
Paraffin	O
per	O
.	O

Specimen	O
#	O
:	O
GROSS	O
DESCRIPTION	O
(	O
continued	O
)	O
:	O
CBCP	O
protocol	O
.	O

Time	O
in	O
formalin	O
:	O
28	O
hours	O
.	O

B	O
:	O
Received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
designated	O
,	O
"	O
Highest	O
Right	O
Axillary	O
Lymph	O
Node	O
"	O
and	O
consists	O
.	O
of	O
an	O
irregular	O
fragment	O
of	O
tan	O
-	O
yellow	O
adipose	O
tissue	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
.	O

x	O
0	O
.	O
5	O
cm	O
.	O

Blunt	O
dissection	O
reveals	O
an	O
ovoid	O
fragment	O
of	O
tan	O
,	O
soft	O
tissue	O
.	O
representing	O
possible	O
lymph	O
node	O
measuring	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sectioning	O
of	O
the	O
possible	O
lymph	O
node	O
reveals	O
a	O
tan	O
-	O
white	O
,	O
firm	O
cut	O
.	O
surface	O
.	O

C	O
:	O
Received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
ind	O
designated	O
,	O
"	O
Right	O
Axillary	O
Lymph	O
Node	O
Dissection	O
"	O
and	O
.	O
consists	O
of	O
an	O
irregular	O
fragment	O
of	O
tan	O
-	O
yellow	O
,	O
lobular	O
adipose	O
tissue	O
.	O
measuring	O
10	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

The	O
specimen	O
is	O
blunt	O
dissected	O
to	O
reveal	O
.	O

22	O
roughly	O
ovoid	O
fragments	O
of	O
tan	O
-	O
white	O
,	O
firm	O
tissue	O
representing	O
possible	O
.	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
4	O
to	O
4	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sectioning	O
.	O
of	O
the	O
possible	O
lymph	O
nodes	O
reveals	O
a	O
tan	O
-	O
white	O
,	O
firm	O
cut	O
surface	O
with	O
.	O
focal	O
areas	O
of	O
hemorrhage	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
:	O
C1	O
-	O
five	O
.	O
possible	O
lymph	O
nodes	O
;	O
C2	O
-	O
representative	O
sections	O
of	O
four	O
possible	O
lymph	O
.	O
nodes	O
;	O
C3	O
-	O
-	O
representative	O
sections	O
of	O
four	O
possible	O
lymph	O
node	O
;	O
C4	O
-	O
.	O
representative	O
sections	O
of	O
three	O
possible	O
lymph	O
nodes	O
;	O
C5	O
-	O
representative	O
.	O
sections	O
of	O
two	O
possible	O
lymph	O
nodes	O
;	O
C6	O
-	O
representative	O
sections	O
of	O
two	O
.	O
possible	O
lymph	O
nodes	O
;	O
C7	O
-	O
-	O
representative	O
section	O
of	O
one	O
possible	O
lymph	O
.	O
node	O
;	O
C8	O
-	O
-	O
one	O
whole	O
possible	O
lymph	O
node	O
,	O
bisected	O
.	O

Direct	O
diai	O
.	O

Summary	O
pathology	O
report	O
.	O

Left	O
orchidectomy	O
;	O
seminoma	O
;	O
diameter	O
9	O
.	O
0	O
cm	O
;	O
no	O
angio	O
-	O
invasion	O
;	O
no	O
invasion	O
of	O
tunica	O
.	O
albuginea	O
;	O
epididymis	O
,	O
rete	O
testis	O
and	O
spermatic	O
cord	O
not	O
present	O
in	O
the	O
available	O
slides	O
.	O

=	O
date	O
of	O
orchidectomy	O
)	O
:	O
pathologist	O
.	O

Report	O
Status	O
.	O

Type	O
Surgical	O
Pathology	O
.	O

Specimen	O
Type	O
:	O
Kidney	O
,	O
partial	O
or	O
total	O
resection	O
.	O

Procedure	O
Date	O
:	O
Resident	O
:	O
Pathologia	O
.	O

PATHOLOGIC	O
DIAGNOSIS	O
:	O
RIGHT	O
KIDNEY	O
,	O
/	O
NEPHRECTOMY	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CLEAR	O
CELL	O
TYPE	O
(	O
9	B
.	I
2	I
cm	I
)	O
,	O
Furman	O
grade	O
3	O
of	O
4	O
.	O

Tumor	O
does	O
not	O
invade	O
Gerota	O
'	O
s	O
fascia	O
.	O

Tumor	O
extends	O
into	O
the	O
wall	O
but	O
not	O
through	O
the	O
renal	O
vein	O
.	O

Vascular	O
and	O
ureteral	O
margins	O
negative	O
for	O
tumor	O
.	O

No	O
lymphovascular	O
invasion	O
is	O
identified	O
.	O

Two	O
(	O
2	O
)	O
lymph	O
nodes	O
;	O
no	O
tumor	O
present	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
,	O
BIOPSY	O
:	O
One	O
(	O
1	O
)	O
lymph	O
node	O
;	O
no	O
tumor	O
present	O
.	O

CLINICAL	O
DATA	O
:	O
History	O
:	O
with	O
pain	O
and	O
hematuria	O
.	O

R	O
kidney	O
mass	O
and	O
possible	O
lung	O
.	O
nodules	O
.	O

Operation	O
:	O
Nephrectomy	O
.	O

Clinical	O
Diagnosis	O
:	O
As	O
above	O
.	O

TISSUE	O
SUBMITTED	O
:	O
#	O
1	O
)	O
R	O
.	O
kidney	O
.	O

#	O
2	O
)	O
Regional	O
lymph	O
nodes	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
in	O
two	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
?	O
s	O
.	O
name	O
and	O
unit	O
number	O
.	O

Part	O
A	O
,	O
labeled	O
"	O
#	O
1	O
.	O

R	O
.	O
kidney	O
"	O
,	O
consists	O
of	O
a	O
right	O
radical	O
nephrectomy	O
.	O
specimen	O
(	O
976	O
.	O
5	O
grams	O
,	O
28	O
.	O
6	O
x	O
10	O
.	O
8	O
x	O
6	O
.	O
7	O
cm	O
)	O
,	O
to	O
include	O
right	O
kidney	O
(	O
16	O
.	O
3	O
x	O
.	O
8	O
.	O
x	O
5	O
.	O
5	O
cm	O
)	O
,	O
ureter	O
(	O
8	O
.	O
0	O
cm	O
in	O
length	O
x	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
)	O
,	O
renal	O
vein	O
at	O
.	O
hilum	O
(	O
0	O
.	O
5	O
cm	O
in	O
length	O
x	O
1	O
.	O
2	O
cm	O
in	O
diameter	O
)	O
,	O
renal	O
artery	O
(	O
3	O
.	O
5	O
cm	O
in	O
length	O
x	O
.	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
)	O
,	O
additional	O
clip	O
vascular	O
structure	O
(	O
11	O
cm	O
in	O
length	O
x	O
0	O
.	O
3	O
.	O
cm	O
in	O
diameter	O
-	O
consistent	O
with	O
a	O
vein	O
)	O
,	O
Gerota	O
'	O
s	O
fascia	O
(	O
12	O
.	O
5	O
x	O
7	O
.	O
0	O
x	O
0	O
.	O
1	O
cm	O
)	O
.	O
and	O
abundant	O
attached	O
perinephric	O
fat	O
.	O

There	O
is	O
a	O
golden	O
yellow	O
/	O
red	O
/	O
tan	O
,	O
.	O
partially	O
encapsulated	O
nodular	O
focally	O
hemorrhagic	O
centrally	O
necrotic	O
mass	O
(	O
9	O
.	O
2	O
.	O
x	O
7	O
.	O
7	O
x	O
5	O
.	O
7	O
cm	O
)	O
within	O
the	O
upper	O
pole	O
,	O
focally	O
impinging	O
upon	O
the	O
renal	O
capsule	O
.	O
and	O
closely	O
opposed	O
black	O
-	O
inked	O
Gerota	O
'	O
s	O
fascia	O
,	O
focally	O
appears	O
to	O
impinge	O
the	O
.	O
renal	O
vein	O
,	O
coming	O
to	O
within	O
1	O
.	O
2	O
cm	O
of	O
the	O
renal	O
vein	O
,	O
2	O
.	O
8	O
cm	O
from	O
the	O
renal	O
.	O
artery	O
margin	O
,	O
and	O
grossly	O
appears	O
to	O
abut	O
but	O
invade	O
the	O
renal	O
pelvis	O
coming	O
.	O
to	O
within	O
8	O
cm	O
of	O
he	O
ureteral	O
margin	O
.	O

Representative	O
sections	O
of	O
the	O
tumor	O
are	O
.	O
submitted	O
to	O
cytogenetics	O
and	O
electron	O
microscopy	O
for	O
future	O
studies	O
.	O

A	O
0	O
.	O
4	O
x	O
.	O

0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
white	O
firm	O
nodule	O
is	O
identified	O
within	O
a	O
medullary	O
pyramid	O
along	O
.	O
the	O
anterior	O
/	O
lateral	O
aspect	O
of	O
within	O
the	O
mid	O
pole	O
of	O
the	O
kidney	O
,	O
1	O
.	O
1	O
cm	O
.	O
lateral	O
and	O
inferior	O
to	O
the	O
aforementioned	O
mass	O
.	O

The	O
remaining	O
renal	O
.	O
parenchyma	O
displays	O
a	O
well	O
-	O
defined	O
cortico	O
-	O
medullary	O
junction	O
with	O
no	O
other	O
.	O
gross	O
lesions	O
.	O

Two	O
brown	O
/	O
pink	O
rubbery	O
nodules	O
(	O
1	O
.	O
3	O
cm	O
and	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
are	O
identified	O
within	O
the	O
perihilar	O
soft	O
tissue	O
.	O

Representative	O
.	O
cortex	O
is	O
submitted	O
for	O
future	O
electron	O
microscopy	O
,	O
immunofluorescence	O
studies	O
.	O
and	O
to	O
the	O
tissue	O
bank	O
for	O
special	O
studies	O
.	O

Tumor	O
is	O
also	O
submitted	O
to	O
the	O
.	O
tissue	O
bank	O
(	O
T1	O
,	O
T2	O
and	O
T3	O
)	O
.	O

Micro	O
A1	O
:	O
ureteral	O
,	O
arterial	O
and	O
venous	O
margins	O
,	O
en	O
face	O
,	O
4	O
frags	O
,	O
.	O

Micro	O
A2	O
:	O
"	O
T1	O
"	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A3	O
:	O
"	O
T2	O
"	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A4	O
:	O
"	O
T3	O
"	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A5	O
-	O
6	O
:	O
renal	O
mass	O
at	O
deepest	O
extension	O
,	O
in	O
relationship	O
to	O
Gerota	O
'	O
s	O
.	O
fascia	O
,	O
2	O
frags	O
,	O
.	O

Micro	O
A7	O
-	O
8	O
:	O
renal	O
mass	O
at	O
possible	O
invasion	O
into	O
vein	O
and	O
relationship	O
with	O
.	O
pelvis	O
,	O
2	O
frags	O
,	O
.	O

Micro	O
A9	O
:	O
random	O
tumor	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A10	O
-	O
11	O
:	O
additional	O
white	O
firm	O
nodule	O
in	O
relationship	O
to	O
mass	O
,	O
2	O
frags	O
,	O
.	O

Micro	O
A12	O
:	O
cortico	O
-	O
medullary	O
junction	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A13	O
:	O
bisected	O
nodules	O
(	O
?	O
lymph	O
node	O
)	O
2	O
frags	O
,	O
.	O

Micro	O
A14	O
:	O
bisected	O
perihilar	O
nodule	O
(	O
?	O
lymph	O
node	O
)	O
,	O
2	O
frags	O
,	O
.	O

Part	O
B	O
,	O
labeled	O
"	O
#	O
2	O
.	O
regional	O
nodes	O
"	O
,	O
consists	O
of	O
an	O
unoriented	O
portion	O
of	O
.	O

yellow	O
/	O
tan	O
fatty	O
soft	O
tissue	O
(	O
6	O
.	O
5	O
x	O
4	O
.	O
2	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O

Sectioning	O
reveals	O
a	O
large	O
.	O

gray	O
/	O
pink	O
/	O
yellow	O
matted	O
firm	O
probable	O
lymph	O
node	O
(	O
5	O
.	O
4	O
x	O
3	O
.	O
3	O
x	O
2	O
.	O
0	O
cm	O
)	O
.	O

The	O
.	O
tissue	O
is	O
bisected	O
and	O
one	O
-	O
half	O
of	O
the	O
entire	O
matted	O
lymph	O
node	O
is	O
submitted	O
.	O

Micro	O
B1	O
-	O
6	O
:	O
large	O
matted	O
lymph	O
node	O
(	O
one	O
-	O
half	O
of	O
specimen	O
)	O
6	O
frags	O
,	O
.	O

By	O
his	O
/	O
her	O
signature	O
below	O
,	O
the	O
senior	O
physician	O
certifies	O
that	O
he	O
/	O
she	O
.	O
personally	O
conducted	O
a	O
microscopic	O
examination	O
(	O
"	O
gross	O
only	O
"	O
exam	O
if	O
so	O
stated	O
)	O
.	O
of	O
the	O
described	O
specimen	O
(	O
s	O
)	O
and	O
rendered	O
or	O
confirmed	O
the	O
diagnosis	O
(	O
es	O
)	O
.	O
related	O
thereto	O
.	O

Resident	O
Review	O
by	O
.	O

Ginal	O
Diagnosis	O
by	O
.	O

Report	O
Status	O
:	O
Type	O
Cytogenetics	O
.	O

PATIEN	O
.	O

Cvtogeneticist	O
.	O

KARYOTYPE	O
:	O
T1	O
:	O
92	O
,	O
XXYY	O
,	O
der	O
(	O
1	O
)	O
x2	O
,	O
del	O
(	O
3	O
)	O
(	O
p12	O
)	O
x2	O
(	O
1	O
)	O
.	O

T3	O
:	O
46	O
,	O
XY	O
.	O

METAPHASES	O
COUNTED	O
:	O
16	O
.	O

ANALYZED	O
:	O
6	O
.	O

SCORED	O
:	O
10	O
.	O

BANDING	O
:	O
GTG	O
.	O

INTERPRETATION	O
:	O
Three	O
different	O
specimens	O
from	O
the	O
same	O
tumor	O
were	O
received	O
.	O

Specimen	O
#	O
1	O
:	O
only	O
1	O
metaphase	O
cell	O
was	O
obtained	O
,	O
and	O
contains	O
a	O
deletion	O
of	O
the	O
.	O
short	O
arm	O
of	O
chromosome	O
3	O
,	O
a	O
characteristic	O
finding	O
in	O
renal	O
cell	O
carcinoma	O
,	O
.	O
clear	O
cell	O
type	O
.	O

Specimen	O
#	O
2	O
:	O
No	O
metaphases	O
were	O
obtained	O
,	O
and	O
therefore	O
the	O
cytogenetic	O
.	O
analysis	O
could	O
not	O
be	O
performed	O
.	O

Specimen	O
#	O
3	O
:	O
No	O
cytogenetic	O
aberrations	O
were	O
identified	O
.	O

COMMENTS	O
.	O

Mosaicism	O
and	O
small	O
chromosome	O
anomalies	O
may	O
not	O
be	O
detectable	O
using	O
the	O
.	O
standard	O
methods	O
employed	O
.	O

Chromosome	O
analysis	O
was	O
performed	O
at	O
a	O
level	O
of	O
400	O
.	O
bands	O
or	O
greater	O
.	O

INDICATION	O
FOR	O
TEST	O
:	O
?	O

RCC	O
.	O

DIAGNOSIS	O
:	O
(	O
A	O
)	O
ANTERIOR	O
MANDIBLE	O
:	O
MODERATELY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
INVADING	O
ANTERIOR	O
.	O

MANDIBLE	O
,	O
RESECTION	O
MARGINS	O
FREE	O
OF	O
TUMOR	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
.	O

CHIN	O
INCLUDING	O
ANTERIOR	O
MANDIBLE	O
AND	O
OVERLYING	O
SKIN	O
AND	O
BASE	O
OF	O
TONGUE	O
,	O
.	O

RESECTION	O
:	O
INVASIVE	O
,	O
MODERATELY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
INVOLVING	O
.	O

SKIN	O
,	O
SUBCUTANEOUS	O
TISSUE	O
AND	O
FLOOR	O
OF	O
MOUTH	O
,	O
RESECTION	O
MARGINS	O
.	O

FREE	O
OF	O
TUMOR	O
.	O

Sections	O
of	O
bone	O
pending	O
decalcification	O
.	O

(	O
B	O
)	O
RIGHT	O
LINGUAL	O
NERVE	O
:	O
Peripheral	O
nerve	O
,	O
no	O
evidence	O
of	O
carcinoma	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
MIDDLE	O
JUGULAR	O
:	O
Lymph	O
nodes	O
,	O
no	O
evidence	O
of	O
metastatic	O
disease	O
.	O

COMMENT	O
.	O

Perineural	O
and	O
lymphovascular	O
invasion	O
are	O
not	O
seen	O
.	O

SPECIMEN	O
.	O

(	O
A	O
)	O
.	O

CHIN	O
INCLUDING	O
ANTERIOR	O
MANDIBLE	O
AND	O
OVERLYING	O
SKIN	O
AND	O
BASE	O
OF	O
TONGUE	O
,	O
.	O

RIGHT	O
LINGUAL	O
NERVE	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
MIDDLE	O
JUGULAR	O
:	O
SNOMED	O
CODES	O
.	O

T	O
-	O
11180	O
,	O
M	O
-	O
80703	O
.	O

HISTOPATHOLOGY	O
REPORT	O
.	O

ORIGINAL	O
REPORT	O
.	O

SPECINEN	O
:	O
A	O
.	O

Gallbladder	O
.	O

B	O
.	O

Node	O
of	O
.	O
importance	O
.	O

c	O
.	O

Whipple	O
'	O
s	O
specimen	O
.	O

CLINICAL	O
HISTORY	O
:	O
Pancreatic	O
cancer	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

GALLBLADDER	O
,	O
.	O

CHRONIC	O
CHOLECYSTITIS	O
.	O

B	O
.	O

NODE	O
OF	O
IMPORTANCE	O
,	O
BIOPSY	O
:	O
MESTASTASTATIC	O
PANCREATIC	O
ADENOCARCINOMA	O
.	O

C	O
.	O

DUODENUM	O
AND	O
HEAD	O
OF	O
PANCREAS	O
,	O
WHIPPLE	O
'	O
S	O
SURGERY	O
:	O
MODERATELY	O
DIFFERENTIATED	O
INFILTRATING	O
DUCTAL	O
ADENOCARCINOMA	O
.	O

MAXIMUM	O
DIAMETER	O
3	B
.	I
.	I

5	B
CM	I
,	O
WITH	O
FOCAL	O
EXTRAPANCRHATIC	O
CANCER	O
ADJACENT	O
.	O

TO	O
PYLORIC	O
LYMPH	O
NODES	O
,	O
ABUTTING	O
ON	O
PAINTED	O
RESECTION	O
MARGIN	O
,	O
.	O

PANCREATIC	O
INTRAEPITHELTAL	O
NEOPLASIA	O
(	O
PANIN	O
1B	O
/	O
2	O
)	O
LOCATED	O
AT	O
THE	O
NECK	O
.	O

RESECTION	O
MARGIN	O
IN	O
LARGER	O
PANCREATIC	O
DUCTS	O
.	O

2	O
OF	O
17	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
MISTASTATIC	O
.	O

ADENOCARCINOMA	O
.	O

INCIDENTAL	O
PANCREATIC	O
HAMARTOMA	O
/	O
EETEROTOPIA	O
IN	O
DUCIDENAL	O
WALL	O
.	O

HISTOPATHOUOGV	O
REPORT	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
7	O
.	O
0	O
x	O
3	O
.	O
!	O

x	O
1	O
.	O
5	O
em	O
gallbladder	O
with	O
a	O
grey	O
.	O
congested	O
serosa	O
.	O

The	O
thickness	O
of	O
the	O
wall	O
ranges	O
from	O
0	O
.	O
2	O
to	O
0	O
.	O
3	O
cm	O
.	O

The	O
.	O
mugosal	O
surface	O
is	O
green	O
and	O
velvety	O
,	O
No	O
stones	O
are	O
identified	O
.	O

The	O
cystio	O
.	O
duot	O
is	O
patent	O
,	O
Three	O
representative	O
sections	O
are	O
submitted	O
in	O
cassette	O
A	O
,	O
.	O

B	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
irregular	O
fragment	O
of	O
soft	O
tissue	O
measuring	O
.	O

1	O
.	O
1	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
3	O
cm	O
.	O

Bisected	O
and	O
submitted	O
in	O
toto	O
in	O
cassette	O
B	O
,	O
.	O

c	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
21	O
.	O
0	O
cm	O
of	O
duodenum	O
with	O
a	O
proximal	O
segment	O
of	O
.	O
pancreas	O
measuring	O
4	O
.	O
5	O
x	O
4	O
.	O
6	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
common	O
bile	O
duot	O
is	O
patent	O
and	O
its	O
.	O
resection	O
margin	O
is	O
taken	O
enface	O
.	O

There	O
is	O
a	O
3	O
.	O
!	O

x	O
1	O
.	O
2	O
x	O
2	O
.	O
6	O
am	O
firm	O
mass	O
.	O
oddupying	O
all	O
the	O
tissue	O
located	O
above	O
the	O
common	O
bile	O
duot	O
,	O
This	O
mass	O
is	O
.	O
located	O
at	O
0	O
.	O
2	O
am	O
from	O
the	O
surface	O
in	O
contaot	O
with	O
the	O
mesenteric	O
blood	O
.	O
vessels	O
and	O
0	O
,	O
4	O
cm	O
from	O
the	O
anterior	O
surface	O
of	O
the	O
pancreas	O
.	O

Located	O
at	O
the	O
.	O
mucosal	O
surface	O
at	O
3	O
.	O
8	O
om	O
and	O
7	O
.	O
4	O
em	O
from	O
the	O
proximal	O
resection	O
,	O
there	O
are	O
.	O
two	O
.	O

sections	O
are	O
submitted	O
as	O
follows	O
:	O
01	O
.	O
common	O
bile	O
duct	O
margin	O
enface	O
.	O

C2	O
.	O
pancreatic	O
distal	O
margin	O
enface	O
.	O

C3	O
,	O
.	O
proximal	O
resection	O
margin	O
(	O
stomach	O
)	O
.	O

C4	O
,	O
.	O
distal	O
resection	O
margin	O
(	O
duodenum	O
)	O
.	O

C5	O
-	O
7	O
,	O
.	O
uncinate	O
process	O
,	O
blood	O
vessels	O
'	O
and	O
distal	O
margins	O
(	O
black	O
,	O
blue	O
and	O
.	O
orange	O
colors	O
respectively	O
)	O
.	O
tumor	O
and	O
duodenal	O
mudosa	O
.	O

C11	O
.	O
preserved	O
pancreatid	O
tissue	O
and	O
preserved	O
duodenum	O
mucosa	O
.	O
yellow	O
nodular	O
lesions	O
at	O
the	O
duodenal	O
mucosa	O
.	O

C13	O
.	O
distal	O
stomach	O
lymph	O
nodes	O
.	O

014	O
-	O
15	O
,	O
.	O
common	O
bile	O
dudt	O
area	O
lymph	O
nodes	O
.	O

016	O
,	O
.	O
panoreatic	O
head	O
lymph	O
nodes	O
.	O

C17	O
.	O
duodenal	O
lymph	O
node	O
,	O
trisected	O
.	O
duodenal	O
Jymph	O
nodes	O
,	O
uncut	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
The	O
slides	O
from	O
specimen	O
C	O
show	O
a	O
malignant	O
neoplasm	O
composed	O
by	O
a	O
.	O
proliferation	O
of	O
large	O
epithelial	O
cella	O
with	O
hyperchromatic	O
,	O
irregular	O
nuclei	O
.	O
forming	O
primiti	O
.	O
ve	O
duotal	O
structures	O
surrounded	O
by	O
a	O
dense	O
,	O
collagenized	O
.	O

HISTOPATHOLOGY	O
REPORT	O
.	O

MICROSCOP	O
.	O
C	O
DESCRIPTION	O
:	O
stroma	O
.	O

The	O
uncinate	O
and	O
other	O
main	O
resection	O
margins	O
are	O
clear	O
of	O
malignant	O
.	O
dells	O
but	O
there	O
is	O
extranodal	O
invasive	O
carcinoma	O
around	O
the	O
pyloric	O
nodes	O
.	O
that	O
touches	O
the	O
painted	O
outer	O
surface	O
of	O
the	O
specimen	O
.	O

Two	O
of	O
the	O
pyloria	O
.	O
nodes	O
have	O
metastatic	O
cander	O
.	O

15	O
other	O
nod	O
	O
s	O
are	O
negative	O
.	O

The	O
resection	O
margin	O
at	O
the	O
neck	O
of	O
the	O
panoreas	O
is	O
clear	O
of	O
carc	O
	O
noma	O
,	O
but	O
.	O
there	O
are	O
some	O
atypical	O
changes	O
compatible	O
with	O
PAN	O
IN	O
1B	O
and	O
2	O
present	O
in	O
the	O
.	O
pancreatic	O
duot	O
at	O
this	O
margin	O
.	O

Anatomic	O
Site	O
:	O
Right	O
Ureter	O
(	O
FS	O
)	O
.	O

Left	O
Ureter	O
(	O
FS	O
)	O
.	O

Bladder	O
(	O
FS	O
on	O
urethra	O
)	O
.	O

Distal	O
right	O
ureter	O
(	O
FS	O
)	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
(	O
FS	O
)	O
.	O

Final	O
urethral	O
margin	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
.	O

Final	O
left	O
ureter	O
.	O

Clinical	O
Diagnosis	O
/	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O

-	O
year	O
-	O
old	O
woman	O
.	O

No	O
further	O
clinical	O
history	O
is	O
provided	O
.	O

A	O
recent	O
consult	O
.	O
indicates	O
a	O
transurethral	O
bladder	O
tumor	O
resection	O
showing	O
invasive	O
high	O
-	O
grade	O
.	O
urothelial	O
carcinoma	O
with	O
invasion	O
of	O
the	O
.	O
muscularis	O
propria	O
.	O

Gross	O
Description	O
:	O
The	O
specimen	O
is	O
received	O
in	O
eight	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
medical	O
record	O
number	O
.	O

Parts	O
A	O
through	O
E	O
are	O
.	O
received	O
fresh	O
.	O

Parts	O
F	O
-	O
H	O
are	O
received	O
in	O
formalin	O
.	O

Part	O
A	O
is	O
additionally	O
labeled	O
"	O
right	O
ureter	O
(	O
frozen	O
)	O
"	O
It	O
consists	O
of	O
a	O
.	O
single	O
segment	O
of	O
ureter	O
,	O
measuring	O
2	O
.	O
8	O
cm	O
in	O
length	O
.	O
and	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
diameter	O
.	O

The	O
specimen	O
is	O
oriented	O
by	O
a	O
black	O
stitch	O
.	O
and	O
verbally	O
by	O
the	O
surgeon	O
.	O

Gross	O
tumor	O
extends	O
.	O
from	O
the	O
distal	O
end	O
of	O
the	O
ureter	O
.	O

The	O
proximal	O
margin	O
is	O
submitted	O
en	O
face	O
.	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS1	O
,	O
with	O
the	O
.	O
frozen	O
section	O
remnant	O
submitted	O
in	O
cassette	O
A1	O
.	O

The	O
remaining	O
ureter	O
is	O
.	O
entirely	O
submitted	O
as	O
follows	O
:	O
Cassette	O
A2	O
:	O
Proximal	O
half	O
of	O
remaining	O
ureter	O
.	O

Cassette	O
A3	O
:	O
Distal	O
half	O
of	O
remaining	O
ureter	O
.	O

Part	O
B	O
is	O
additionally	O
labeled	O
"	O
left	O
ureter	O
(	O
frozen	O
)	O
"	O
It	O
consists	O
of	O
one	O
.	O
fragment	O
of	O
pink	O
-	O
red	O
ureter	O
,	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
.	O

0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O

as	O
.	O

FS2	O
,	O
with	O
the	O
frozen	O
section	O
remnant	O
submitted	O
in	O
.	O
cassette	O
B1	O
.	O

Part	O
C	O
is	O
additionally	O
labeled	O
"	O
bladder	O
.	O

It	O
consists	O
of	O
a	O
specimen	O
,	O
weighing	O
.	O

271	O
gm	O
and	O
measuring	O
22	O
x	O
13	O
x	O
3	O
.	O
5	O
cm	O
.	O

Present	O
.	O
within	O
the	O
specimen	O
is	O
a	O
bladder	O
,	O
with	O
a	O
stent	O
protruding	O
through	O
the	O
left	O
.	O
ureter	O
.	O

In	O
addition	O
,	O
there	O
is	O
included	O
the	O
left	O
.	O
fallopian	O
tube	O
and	O
ovary	O
.	O

There	O
is	O
a	O
small	O
portion	O
of	O
the	O
vaginal	O
cuff	O
.	O
posterior	O
to	O
the	O
urethra	O
.	O

The	O
small	O
stub	O
of	O
the	O
left	O
.	O
ureter	O
measures	O
0	O
.	O
3	O
cm	O
in	O
length	O
and	O
0	O
.	O
2	O
em	O
in	O
diameter	O
and	O
is	O
grossly	O
normal	O
.	O

The	O
remnant	O
fragment	O
of	O
right	O
ureter	O
measures	O
.	O

1	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
9	O
cm	O
in	O
diameter	O
,	O
and	O
there	O
is	O
gross	O
tumor	O
at	O
the	O
.	O
proximal	O
end	O
.	O

An	O
en	O
face	O
margin	O
of	O
the	O
urethra	O
is	O
.	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
FS3	O
,	O
with	O
the	O
frozen	O
section	O
remnant	O
.	O
submitted	O
in	O
cassette	O
C1	O
.	O

The	O
right	O
-	O
anterior	O
.	O
half	O
of	O
the	O
bladder	O
is	O
inked	O
green	O
,	O
the	O
left	O
-	O
anterior	O
half	O
is	O
inked	O
blue	O
,	O
and	O
.	O
the	O
posterior	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
.	O
then	O
opened	O
anteriorly	O
through	O
the	O
remaining	O
urethra	O
to	O
reveal	O
a	O
yellow	O
-	O
tan	O
,	O
.	O
friable	O
mass	O
,	O
measuring	O
3	O
x	O
2	O
x	O
1	O
.	O
8	O
cm	O
,	O
near	O
the	O
.	O
right	O
ureter	O
opening	O
and	O
posterior	O
bladder	O
wall	O
.	O

Within	O
the	O
posterior	O
aspect	O
,	O
.	O
there	O
is	O
an	O
area	O
of	O
potential	O
bladder	O
wall	O
.	O
involvement	O
by	O
the	O
tumor	O
,	O
with	O
possible	O
tumor	O
within	O
0	O
.	O
1	O
cm	O
of	O
the	O
posterior	O
.	O
surgical	O
resection	O
margin	O
.	O

No	O
other	O
focal	O
lesions	O
.	O
are	O
identified	O
.	O

The	O
left	O
fallopian	O
tube	O
measures	O
5	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
4	O
cm	O
.	O
in	O
average	O
diameter	O
.	O

The	O
fimbriae	O
are	O
lush	O
,	O
and	O
.	O
cross	O
sections	O
are	O
grossly	O
normal	O
.	O

The	O
left	O
ovary	O
measures	O
2	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
9	O
cm	O
.	O
and	O
has	O
a	O
grossly	O
normal	O
parenchyma	O
.	O

The	O
.	O
perivesicular	O
fat	O
is	O
extensively	O
searched	O
for	O
lymph	O
nodes	O
,	O
with	O
two	O
candidate	O
.	O
lymph	O
nodes	O
identified	O
.	O

Representative	O
sections	O
.	O
are	O
submitted	O
as	O
follows	O
:	O
Cassette	O
C1	O
:	O
Remnant	O
from	O
FS3	O
.	O

Cassette	O
C2	O
:	O
Right	O
and	O
left	O
ureter	O
margins	O
.	O

Cassette	O
C3	O
:	O
Left	O
fallopian	O
tube	O
and	O
ovary	O
.	O

Cassette	O
C4	O
:	O
Normal	O
bladder	O
.	O

Cassette	O
C5	O
:	O
Tumor	O
at	O
posterior	O
bladder	O
.	O

Cassette	O
C6	O
:	O
Tumor	O
at	O
posterior	O
bladder	O
.	O

Cassette	O
C7	O
:	O
Mass	O
at	O
right	O
ureter	O
.	O

Cassette	O
C8	O
:	O
Mass	O
at	O
candidate	O
remnant	O
urethra	O
.	O

Cassette	O
C9	O
:	O
Two	O
candidate	O
lymph	O
nodes	O
and	O
candidate	O
right	O
.	O
fallopian	O
tube	O
.	O

Part	O
D	O
is	O
additionally	O
labeled	O
"	O
distal	O
right	O
ureter	O
,	O
long	O
stitch	O
=	O
proximal	O
.	O
end	O
.	O
"	O
It	O
consists	O
of	O
a	O
single	O
red	O
-	O
tan	O
,	O
tubular	O
.	O
structure	O
,	O
measuring	O
4	O
.	O
3	O
cm	O
in	O
length	O
and	O
1	O
.	O
4	O
cm	O
in	O
greatest	O
diameter	O
.	O

The	O
.	O
lumen	O
measures	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

A	O
long	O
stitch	O
.	O
marks	O
the	O
proximal	O
margin	O
,	O
and	O
a	O
short	O
stitch	O
marks	O
the	O
distal	O
margin	O
.	O

An	O
en	O
.	O
face	O
cut	O
of	O
the	O
proximal	O
margin	O
is	O
submitted	O
for	O
.	O
frozen	O
section	O
diagnosis	O
as	O
FS4	O
,	O
with	O
the	O
frozen	O
section	O
remnant	O
submitted	O
in	O
.	O
cassette	O
D1	O
.	O

The	O
remaining	O
specimen	O
is	O
entirely	O
.	O
submitted	O
as	O
follows	O
:	O
Cassette	O
D2	O
:	O
Remaining	O
proximal	O
one	O
-	O
third	O
.	O

Cassette	O
D3	O
:	O
Remaining	O
mid	O
one	O
-	O
third	O
.	O

Cassette	O
D4	O
:	O
Remaining	O
distal	O
one	O
-	O
third	O
.	O

Part	O
E	O
,	O
additionally	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
,	O
consists	O
of	O
soft	O
,	O
.	O
red	O
-	O
yellow	O
,	O
fibro	O
-	O
fatty	O
tissue	O
measuring	O
8	O
x	O
5	O
.	O
5	O
x	O
1	O
.	O

cm	O
and	O
weighing	O
26	O
gm	O
.	O

Multiple	O
prominent	O
lymph	O
node	O
candidates	O
are	O
.	O
identified	O
.	O

Representative	O
sections	O
from	O
two	O
lymph	O
node	O
.	O
candidates	O
are	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
5	O
.	O

The	O
first	O
frozen	O
.	O
section	O
remnant	O
is	O
submitted	O
in	O
cassette	O
E1	O
,	O
with	O
the	O
.	O
remainder	O
of	O
the	O
lymph	O
node	O
candidate	O
submitted	O
in	O
cassette	O
E2	O
.	O

The	O
second	O
.	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
cassette	O
E3	O
,	O
.	O
with	O
the	O
remainder	O
of	O
the	O
lymph	O
node	O
candidates	O
submitted	O
in	O
cassettes	O
E4	O
-	O
E5	O
.	O

Following	O
fixation	O
,	O
the	O
remainder	O
of	O
the	O
lymph	O
.	O
node	O
candidates	O
are	O
submitted	O
as	O
follows	O
:	O
Cassette	O
E6	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

Cassette	O
E7	O
:	O
One	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

Cassette	O
E8	O
:	O
One	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

Cassette	O
E9	O
:	O
TWO	O
lymph	O
node	O
candidates	O
,	O
bisected	O
and	O
differentially	O
.	O
inked	O
.	O

Cassette	O
E10	O
:	O
Three	O
small	O
lymph	O
node	O
candidates	O
,	O
bisected	O
,	O
two	O
.	O
differentially	O
inked	O
.	O

Cassette	O
Ell	O
:	O
Multiple	O
small	O
lymph	O
node	O
candidates	O
,	O
submitted	O
whole	O
.	O

Part	O
F	O
,	O
additionally	O
labeled	O
"	O
4	O
-	O
final	O
urethral	O
margin	O
,	O
"	O
consists	O
of	O
one	O
.	O
firm	O
,	O
yellow	O
-	O
brown	O
,	O
irregular	O
,	O
unoriented	O
tissue	O
.	O
fragment	O
measuring	O
2	O
.	O
2	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
specimen	O
is	O
sectioned	O
and	O
entirely	O
.	O
submitted	O
in	O
cassette	O
F1	O
.	O

Part	O
G	O
,	O
additionally	O
labeled	O
"	O
7	O
-	O
left	O
pelvic	O
lymph	O
nodes	O
,	O
"	O
consists	O
of	O
.	O
multiple	O
soft	O
,	O
yellow	O
,	O
irregular	O
,	O
unoriented	O
,	O
.	O
fibroadipose	O
tissue	O
fragments	O
measuring	O
9	O
x	O
5	O
x	O
3	O
.	O
5	O
cm	O
in	O
aggregate	O
and	O
.	O
containing	O
multiple	O
lymph	O
node	O
candidates	O
ranging	O
from	O
.	O

0	O
.	O
3	O
to	O
3	O
.	O
1	O
cm	O
in	O
greatest	O
diameter	O
.	O

The	O
lymph	O
node	O
candidates	O
are	O
submitted	O
.	O
as	O
follows	O
:	O
Cassette	O
G1	O
:	O
Intact	O
lymph	O
node	O
candidates	O
.	O

Cassette	O
G2	O
:	O
Two	O
bisected	O
lymph	O
node	O
candidates	O
,	O
inked	O
in	O
.	O
different	O
colors	O
.	O

Cassettes	O
G3	O
-	O
G5	O
:	O
Single	O
lymph	O
node	O
candidate	O
,	O
trisected	O
.	O

Cassettes	O
G6	O
-	O
G9	O
:	O
Single	O
lymph	O
node	O
candidate	O
,	O
sectioned	O
into	O
four	O
sections	O
.	O

Part	O
H	O
,	O
additionally	O
labeled	O
"	O
8	O
-	O
final	O
left	O
ureter	O
,	O
"	O
consists	O
of	O
one	O
soft	O
,	O
.	O
tan	O
-	O
white	O
,	O
irregular	O
,	O
unoriented	O
,	O
fibrous	O
tissue	O
.	O
fragment	O
measuring	O
1	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
trisected	O
and	O
entirely	O
.	O
submitted	O
in	O
cassette	O
H1	O
.	O

The	O
immunoperoxidase	O
stain	O
(	O
s	O
)	O
reported	O
above	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

U	O
.	O

S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
.	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
be	O
.	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
.	O
of	O
1988	O
(	O
"	O
CLIA	O
"	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
complexity	O
clinical	O
testing	O
.	O

Diagnosis	O
Comments	O
:	O
Bladder	O
Tumor	O
Synoptic	O
Comment	O
.	O

1	O
.	O

Tumor	O
type	O
:	O
Urothelial	O
(	O
transitional	O
cell	O
)	O
.	O

2	O
.	O

Tumor	O
grade	O
:	O
High	O
grade	O
.	O

3	O
.	O

Tumor	O
size	O
:	O
3	B
cm	I
.	O

4	O
.	O

Extent	O
of	O
tumor	O
in	O
bladder	O
:	O
Invasion	O
into	O
outer	O
half	O
of	O
muscularis	O
.	O
propria	O
.	O

5	O
.	O

Lymphatic	O
/	O
vascular	O
invasion	O
:	O
None	O
identified	O
.	O

6	O
.	O

Epithelial	O
abnormalities	O
in	O
bladder	O
:	O
Carcinoma	O
in	O
situ	O
.	O

7	O
.	O

Extension	O
of	O
tumor	O
into	O
organs	O
adjacent	O
to	O
bladder	O
:	O
Ureter	O
,	O
right	O
.	O

8	O
.	O

Surgical	O
margins	O
:	O
Urethral	O
margin	O
:	O
Free	O
of	O
tumor	O
.	O

Right	O
ureter	O
margin	O
:	O
Final	O
margin	O
free	O
of	O
tumor	O
.	O

Left	O
ureter	O
margin	O
:	O
Final	O
margin	O
free	O
of	O
tumor	O
.	O

Perivesical	O
margin	O
:	O
Negative	O
,	O
closest	O
margin	O
is	O
0	O
.	O
2	O
cm	O
,	O
posterior	O
,	O
slide	O
.	O

C5	O
.	O

9	O
.	O

Lymph	O
nodes	O
:	O
No	O
tumor	O
(	O
0	O
/	O
24	O
)	O
.	O

10	O
.	O

Other	O
pathologic	O
findings	O
in	O
bladder	O
:	O
Olceration	O
and	O
chronic	O
.	O
inflammation	O
.	O

11	O
.	O

AJCC	O
/	O
UICC	O
stage	O
:	O
pT2bNOMX	O
.	O

12	O
.	O

Additional	O
margin	O
:	O
The	O
distal	O
end	O
of	O
Part	O
A	O
(	O
right	O
ureter	O
)	O
is	O
involved	O
by	O
.	O
high	O
grade	O
invasive	O
carcinoma	O
(	O
slide	O
A3	O
)	O
into	O
the	O
.	O
muscularis	O
propria	O
;	O
however	O
the	O
proximal	O
specimen	O
margin	O
(	O
slide	O
A1	O
)	O
.	O
demonstrates	O
chronic	O
inflammation	O
of	O
the	O
lamina	O
propria	O
with	O
.	O
atypia	O
of	O
the	O
urothelial	O
mucosa	O
with	O
we	O
regard	O
as	O
reactive	O
atypia	O
.	O

In	O
Part	O
D	O
.	O

(	O
labeled	O
final	O
proximal	O
margin	O
of	O
the	O
right	O
.	O
ureter	O
)	O
the	O
proximal	O
specimen	O
margin	O
(	O
slide	O
D1	O
)	O
is	O
negative	O
for	O
dysplasia	O
or	O
.	O
carcinoma	O
.	O

However	O
the	O
distal	O
end	O
of	O
this	O
specimen	O
.	O

(	O
slide	O
D4	O
)	O
reveals	O
nuclear	O
atypia	O
of	O
urothelial	O
carcinoma	O
in	O
situ	O
.	O

Because	O
of	O
.	O
the	O
intense	O
chronic	O
inflammation	O
,	O
distinguishing	O
.	O
reactive	O
vs	O
dysplastic	O
changes	O
are	O
difficult	O
.	O

Immunohistochemical	O
stain	O
for	O
.	O

p53	O
was	O
performed	O
on	O
slide	O
D3	O
where	O
the	O
inflamed	O
.	O
urothelium	O
have	O
atypical	O
,	O
round	O
,	O
slightly	O
enlarged	O
nuclei	O
and	O
prominent	O
.	O
nucleoli	O
.	O

The	O
stains	O
highlights	O
scattered	O
positivity	O
.	O

Thus	O
based	O
on	O
the	O
morphology	O
and	O
results	O
of	O
the	O
immunohistochemical	O
stain	O
,	O
the	O
.	O
atypical	O
changes	O
on	O
slide	O
D3	O
are	O
regarded	O
as	O
.	O
reactive	O
.	O

Dr	O
.	O
has	O
reviewed	O
select	O
portions	O
of	O
Parts	O
A	O
and	O
D	O
.	O
and	O
concurs	O
.	O

Level	O
section	O
on	O
C9	O
confirms	O
the	O
.	O
diagnosis	O
.	O

Interoperative	O
Diagnosis	O
:	O
FS1	O
(	O
A	O
)	O
Right	O
ureter	O
,	O
proximal	O
margin	O
,	O
biopsy	O
:	O
Chronic	O
ureteritis	O
with	O
.	O
atypia	O
,	O
favor	O
dysplasia	O
.	O

FS2	O
(	O
B	O
)	O
Left	O
urater	O
,	O
biopsy	O
:	O
No	O
tumor	O
seen	O
.	O

FS3	O
(	O
C	O
)	O
Distal	O
urethra	O
,	O
biopsy	O
:	O
No	O
tumor	O
seen	O
.	O

FS4	O
(	O
D	O
)	O
Right	O
ureter	O
,	O
proximal	O
margin	O
,	O
biopsy	O
:	O
No	O
tumor	O
seen	O
.	O

14	O
.	O

FS5	O
(	O
E	O
)	O
Right	O
pelvic	O
lymph	O
nodes	O
,	O
biopsy	O
:	O
Representative	O
section	O
of	O
two	O
.	O
lymph	O
node	O
candidates	O
,	O
no	O
tumor	O
seen	O
.	O

Final	O
Diagnosis	O
:	O
A	O
.	O

Right	O
ureter	O
,	O
distal	O
,	O
resection	O
:	O
1	O
.	O

Proximal	O
specimen	O
margin	O
with	O
chronic	O
ureteritis	O
and	O
atypia	O
;	O
see	O
comment	O
.	O

2	O
.	O

Distal	O
end	O
of	O
ureter	O
with	O
high	O
grade	O
invasive	O
urothelial	O
carcinoma	O
into	O
.	O
muscularis	O
propria	O
.	O

B	O
.	O

Left	O
ureter	O
,	O
distal	O
,	O
biopsy	O
:	O
No	O
dysplasia	O
or	O
carcinoma	O
.	O

C	O
.	O

Bladder	O
and	O
left	O
fallopian	O
tube	O
and	O
ovary	O
,	O
cystectomy	O
and	O
.	O
salpingo	O
-	O
oophorectomy	O
:	O
1	O
.	O

Bladder	O
with	O
invasive	O
high	O
grade	O
urothelial	O
carc	O
	O
noma	O
,	O
into	O
outer	O
one	O
-	O
half	O
.	O
of	O
muscularis	O
propria	O
;	O
see	O
comment	O
.	O

2	O
.	O

No	O
tumor	O
in	O
one	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
.	O

Left	O
fallopian	O
tube	O
and	O
ovary	O
with	O
no	O
significant	O
pathologic	O
abnormality	O
.	O

D	O
.	O

Right	O
ureter	O
,	O
final	O
proximal	O
margin	O
,	O
biopsy	O
:	O
Proximal	O
specimen	O
margin	O
with	O
.	O

no	O
dysplasia	O
or	O
carcinoma	O
.	O

E	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
dissection	O
:	O
No	O
tumor	O
in	O
seventeen	O
lymph	O
nodes	O
.	O

(	O
0	O
/	O
17	O
)	O
.	O

F	O
.	O

Urethra	O
,	O
"	O
final	O
margin	O
,	O
biopsy	O
:	O
No	O
dysplasia	O
or	O
carcinoma	O
.	O

G	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
dissection	O
:	O
No	O
tumor	O
in	O
six	O
lymph	O
nodes	O
(	O
0	O
/	O
6	O
)	O
.	O

H	O
.	O

Left	O
ureter	O
,	O
final	O
margin	O
,	O
biopsy	O
:	O
No	O
dysplasia	O
or	O
carcinoma	O
.	O

PRIMARY	O
SITE	O
:	O
Buccal	O
mucosa	O
.	O

1	O
-	O
"	O
Neck	O
lymph	O
nodes	O
-	O
Right	O
"	O
:	O
Eighteen	O
lymph	O
nodes	O
with	O
no	O
evidence	O
of	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
18	O
)	O
.	O

-	O
Salivary	O
gland	O
fragments	O
with	O
congestion	O
,	O
uninvolved	O
by	O
neoplasia	O
.	O

2	O
-	O
"	O
Neck	O
lymph	O
nodes	O
"	O
:	O
-	O
Two	O
of	O
seven	O
lymph	O
nodes	O
involved	O
by	O
metastatic	O
carcinoma	O
(	O
2	O
/	O
7	O
)	O
,	O
with	O
capsular	O
.	O
involvement	O
.	O

3	O
-	O
Anterior	O
margin	O
uninvolved	O
by	O
neoplasia	O
.	O

4	O
-	O
"	O
Retromolar	O
lesion	O
surgical	O
excision	O
specimen	O
"	O
:	O
-	O
Poorly	O
differentiated	O
squamous	O
cell	O
carcinoma	O
,	O
ulcerated	O
,	O
measured	O
4	B
.	I
1	I
cm	I
,	O
1	B
.	I
4	I
cm	I
.	O
deep	O
,	O
with	O
necrosis	O
sites	O
.	O

-	O
Lymphovascular	O
invasion	O
:	O
present	O
.	O

-	O
Perineural	O
invasion	O
:	O
present	O
.	O

-	O
Osseous	O
tissue	O
involved	O
by	O
carcinoma	O
.	O

-	O
Intense	O
peritumoral	O
desmoplasia	O
.	O

-	O
Scarce	O
peritumoral	O
lymphocitary	O
infiltrate	O
.	O

-	O
Deep	O
margin	O
involved	O
by	O
carcinoma	O
.	O

-	O
Other	O
surgical	O
margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Histopathology	O
Report	O
.	O

SEE	O
SUPPLEMENTARY	O
REPORT	O
BELOW	O
.	O

HISTORY	O
.	O

Frozen	O
section	O
.	O

Squamous	O
cell	O
carcinoma	O
.	O

Trunchus	O
intermedius	O
.	O

MACROSCOPIC	O
.	O

Six	O
specimens	O
received	O
:	O
1	O
:	O
The	O
specimen	O
is	O
unlabelled	O
and	O
consists	O
of	O
a	O
fragment	O
of	O
tissue	O
measuring	O
6	O
.	O

X	O
4	O
x	O
3	O
mm	O
.	O

[	O
BIT	O
,	O
1A	O
]	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
No	O
evidence	O
of	O
malignancy	O
.	O

Phoned	O
to	O
.	O

2	O
:	O
The	O
specimen	O
is	O
labelled	O
"	O
(	O
R	O
)	O
lung	O
'	O
and	O
consists	O
of	O
a	O
right	O
lung	O
measuring	O
.	O

220	O
mm	O
superior	O
to	O
inferior	O
,	O
160	O
mm	O
anterior	O
to	O
posterior	O
and	O
90	O
mm	O
medial	O
to	O
.	O
lateral	O
.	O

The	O
upper	O
and	O
lower	O
lobes	O
are	O
formed	O
well	O
.	O

The	O
right	O
middle	O
lobe	O
is	O
.	O
quite	O
rudimentary	O
and	O
the	O
horizontal	O
fissure	O
is	O
only	O
very	O
poorly	O
formed	O
.	O

The	O
.	O
pleural	O
surface	O
is	O
quite	O
ragged	O
particularly	O
over	O
the	O
right	O
lower	O
lobe	O
.	O

A	O
.	O
piece	O
of	O
redundant	O
pleura	O
is	O
present	O
at	O
the	O
inferolateral	O
aspect	O
of	O
this	O
lobe	O
.	O

Several	O
discrete	O
areas	O
of	O
firm	O
induration	O
can	O
be	O
palpated	O
over	O
the	O
medial	O
.	O
surface	O
of	O
the	O
right	O
lower	O
lobe	O
.	O

The	O
pleural	O
surface	O
of	O
the	O
right	O
upper	O
lobe	O
.	O

is	O
much	O
smoother	O
,	O
however	O
the	O
lung	O
itself	O
is	O
quite	O
firm	O
in	O
the	O
inferior	O
aspect	O
.	O
of	O
the	O
right	O
upper	O
lobe	O
and	O
a	O
firm	O
mass	O
can	O
be	O
palpated	O
in	O
the	O
right	O
lower	O
lobe	O
.	O
close	O
to	O
the	O
hilar	O
region	O
.	O

On	O
sectioning	O
of	O
the	O
lung	O
the	O
right	O
upper	O
lobe	O
is	O
.	O
largely	O
free	O
of	O
pathology	O
.	O

In	O
the	O
right	O
lower	O
lobe	O
numerous	O
perihilar	O
lymph	O
.	O
nodes	O
can	O
be	O
seen	O
and	O
a	O
firm	O
tumour	O
mass	O
measuring	O
43	B
x	I
25	I
x	I
20	I
mm	I
.	O

It	O
has	O
an	O
.	O
endobronchial	O
component	O
approaching	O
to	O
within	O
7	O
mm	O
of	O
the	O
bronchial	O
resection	O
.	O
margin	O
and	O
appearing	O
to	O
completely	O
obstruct	O
the	O
right	O
lower	O
lobe	O
bronchus	O
.	O

The	O
.	O
right	O
lower	O
lobe	O
is	O
nearly	O
completely	O
replaced	O
by	O
pneumonia	O
and	O
large	O
amounts	O
.	O
of	O
tenacious	O
pus	O
are	O
noted	O
throughout	O
this	O
lobe	O
of	O
lung	O
.	O

[	O
2A	O
-	O
B	O
,	O
bronchial	O
.	O
resection	O
margin	O
,	O
2A	O
is	O
the	O
upper	O
lobe	O
bronchus	O
,	O
2B	O
is	O
the	O
lower	O
lobe	O
bronchus	O
;	O
.	O
2C	O
-	O
H	O
,	O
peribronchial	O
lymph	O
nodes	O
;	O
21	O
,	O
endobronchial	O
tumour	O
;	O
2J	O
-	O
L	O
,	O
tumour	O
close	O
.	O
to	O
resection	O
margin	O
;	O
2M	O
,	O
lower	O
lobe	O
lung	O
including	O
pneumonia	O
;	O
2N	O
,	O
bullous	O
area	O
.	O
of	O
lung	O
from	O
the	O
upper	O
lobe	O
;	O
20	O
,	O
normal	O
lung	O
and	O
subpleural	O
lymph	O
node	O
from	O
the	O
.	O
upper	O
lobe	O
;	O
2P	O
,	O
area	O
of	O
attached	O
redundant	O
pleura	O
from	O
the	O
lower	O
lobe	O
]	O
.	O

3	O
:	O
The	O
specimen	O
is	O
labelled	O
'	O
No	O
.	O
3	O
lymph	O
node	O
'	O
and	O
consists	O
of	O
a	O
piece	O
of	O
.	O
nodal	O
tissue	O
measuring	O
15	O
x	O
19	O
X	O
10	O
mm	O
.	O

[	O
Bisected	O
and	O
BIT	O
,	O
3A	O
]	O
.	O

4	O
:	O
The	O
specimen	O
is	O
labelled	O
'	O
No	O
.	O
7	O
plus	O
8	O
lymph	O
node	O
'	O
and	O
consists	O
of	O
nodal	O
.	O
tissue	O
measuring	O
35	O
X	O
15	O
x	O
20	O
mm	O
.	O

[	O
Sectioned	O
and	O
BIT	O
,	O
4A	O
-	O
C	O
]	O
.	O

5	O
:	O
The	O
specimen	O
is	O
labelled	O
'	O
No	O
.	O
9	O
lymph	O
node	O
and	O
consists	O
of	O
a	O
piece	O
of	O
nodal	O
.	O

Histopathology	O
Report	O
.	O
tissue	O
measuring	O
20	O
X	O
15	O
x	O
10	O
mm	O
.	O

[	O
Bisected	O
and	O
BIT	O
,	O
5A	O
]	O
.	O

6	O
:	O
The	O
specimen	O
is	O
labelled	O
'	O
No	O
.	O
10	O
lymph	O
node	O
'	O
and	O
consists	O
of	O
a	O
piece	O
of	O
.	O
nodal	O
tissue	O
measuring	O
15	O
X	O
10	O
X	O
10	O
mm	O
.	O

[	O
Bisected	O
and	O
BIT	O
,	O
6A	O
]	O
.	O

MICROSCOPIC	O
.	O

1	O
:	O
Paraffin	O
sections	O
confirm	O
the	O
frozen	O
section	O
diagnosis	O
of	O
no	O
evidence	O
of	O
.	O
malignancy	O
.	O

The	O
biopsy	O
includes	O
bronchial	O
cartilage	O
and	O
seromucinous	O
glands	O
.	O
and	O
surrounding	O
fibroadipose	O
tissue	O
.	O

2	O
:	O
Sections	O
show	O
a	O
moderately	O
differentiated	O
squamous	O
cell	O
carcinoma	O
that	O
is	O
.	O
forming	O
a	O
polypoid	O
endobronchial	O
mass	O
and	O
is	O
invading	O
through	O
the	O
bronchial	O
.	O
wall	O
and	O
into	O
the	O
adjacent	O
lung	O
and	O
hilar	O
fibroadipose	O
tissue	O
.	O

Pleural	O
.	O
invasion	O
is	O
not	O
identified	O
.	O

There	O
is	O
no	O
blood	O
vessel	O
invasion	O
and	O
no	O
lymphatic	O
.	O
permeation	O
is	O
seen	O
.	O

Perineural	O
permeation	O
is	O
identified	O
and	O
this	O
extends	O
.	O
closely	O
to	O
(	O
0	O
.	O
3	O
mm	O
)	O
a	O
hilar	O
soft	O
tissue	O
margin	O
.	O

The	O
lesion	O
is	O
well	O
clear	O
of	O
.	O
the	O
bronchial	O
resection	O
margin	O
.	O

At	O
the	O
bronchial	O
resection	O
,	O
squamous	O
.	O
metaplasia	O
is	O
identified	O
.	O

There	O
is	O
involvement	O
of	O
peribronchial	O
lymph	O
nodes	O
.	O
within	O
the	O
region	O
of	O
the	O
tumour	O
.	O

Distal	O
to	O
the	O
tumour	O
,	O
there	O
is	O
evidence	O
of	O
.	O
obstructive	O
pneumonitis	O
with	O
mild	O
bronchiectasis	O
.	O

The	O
uninvolved	O
lung	O
shows	O
.	O
mild	O
respiratory	O
bronchiolitis	O
,	O
peribronchial	O
dust	O
deposition	O
and	O
emphysema	O
.	O

Elastic	O
pulmonary	O
arteries	O
show	O
mild	O
atheroma	O
.	O

The	O
attached	O
pleural	O
adhesion	O
.	O
appears	O
fibrotic	O
.	O

Within	O
the	O
peribronchial	O
lymph	O
nodes	O
,	O
there	O
are	O
silicotic	O
.	O
nodules	O
together	O
with	O
prominent	O
sinus	O
histiocytosis	O
.	O

Focally	O
the	O
histiocytes	O
.	O
are	O
forming	O
poorly	O
developed	O
granulomata	O
.	O

The	O
granulomata	O
may	O
be	O
in	O
response	O
.	O
to	O
the	O
tumour	O
however	O
,	O
a	O
rare	O
granuloma	O
contains	O
central	O
necrosis	O
and	O
special	O
.	O
stains	O
for	O
micro	O
-	O
organisms	O
will	O
be	O
undertaken	O
.	O

A	O
large	O
silicotic	O
nodule	O
is	O
.	O
present	O
in	O
the	O
subpleural	O
lymph	O
node	O
.	O

3	O
:	O
Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
reactive	O
changes	O
only	O
.	O

There	O
is	O
no	O
.	O
evidence	O
of	O
malignancy	O
.	O

4	O
:	O
Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
reactive	O
changes	O
only	O
.	O

There	O
is	O
no	O
.	O
evidence	O
of	O
malignancy	O
.	O

5	O
:	O
Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
reactive	O
changes	O
only	O
.	O

There	O
is	O
no	O
.	O
evidence	O
of	O
malignancy	O
.	O

6	O
:	O
Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
reactive	O
changes	O
only	O
.	O

There	O
is	O
no	O
.	O
evidence	O
of	O
malignancy	O
.	O

SUMMARY	O
.	O

1	O
-	O
6	O
:	O
Right	O
lung	O
and	O
lymph	O
nodes	O
:	O
A	O
:	O
Moderately	O
differentiated	O
squamous	O
cell	O
carcinoma	O
;	O
43	B
mm	I
in	O
maximal	O
.	O
dimension	O
.	O

Histopathology	O
Report	O
.	O

B	O
:	O
Perineural	O
permeation	O
identified	O
but	O
no	O
blood	O
vessel	O
or	O
lymphatic	O
invasion	O
.	O
present	O
.	O

C	O
:	O
No	O
pleural	O
invasion	O
identified	O
;	O
clear	O
of	O
bronchial	O
margin	O
but	O
close	O
to	O
.	O
hilar	O
soft	O
tissue	O
margin	O
(	O
0	O
.	O
3	O
mm	O
)	O
.	O

D	O
:	O
Peribronchial	O
lymph	O
node	O
metastases	O
.	O

E	O
:	O
T3N1	O
.	O

F	O
:	O
Non	O
-	O
neoplastic	O
lung	O
:	O
Emphysema	O
and	O
mild	O
respiratory	O
bronchiolitis	O
.	O

SUPPLEMENTARY	O
REPORT	O
.	O

1	O
:	O
No	O
microorganisms	O
are	O
identified	O
within	O
the	O
lymph	O
node	O
granulomata	O
with	O
.	O
special	O
stains	O
(	O
Grocott	O
and	O
Ziehl	O
-	O
Neelsen	O
)	O
.	O

SUPPLEMENTARY	O
REPORT	O
.	O

2	O
:	O
A	O
further	O
section	O
of	O
the	O
tumour	O
has	O
been	O
examined	O
[	O
2Q	O
]	O
.	O

The	O
tumour	O
appears	O
.	O
confined	O
to	O
the	O
bronchus	O
in	O
this	O
sectioned	O
and	O
there	O
is	O
no	O
involvement	O
of	O
the	O
.	O
hilar	O
margin	O
.	O

The	O
section	O
containing	O
the	O
close	O
nerve	O
is	O
said	O
to	O
be	O
in	O
the	O
.	O
region	O
of	O
the	O
frozen	O
section	O
.	O

c	O
.	O
c	O
.	O

Lung	O
Cancer	O
Registry	O
.	O

Diagnosis	O
:	O
A	O
:	O
Left	O
kidney	O
,	O
nephrectomy	O
.	O

-	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
,	O
eosinophilic	O
variant	O
,	O
tumor	O
size	O
3	B
.	I
5	I
cm	I
.	O
in	O
greatest	O
dimension	O
,	O
nuclear	O
grade	O
2	O
(	O
of	O
4	O
)	O
,	O
tumor	O
confined	O
to	O
kidney	O
,	O
surgical	O
.	O
margins	O
free	O
of	O
tumor	O
.	O

-	O
Renal	O
vein	O
,	O
artery	O
and	O
ureter	O
with	O
no	O
tumor	O
seen	O
.	O

-	O
Portion	O
of	O
adrenal	O
gland	O
with	O
no	O
tumor	O
seen	O
.	O

B	O
:	O
Left	O
adrenal	O
gland	O
,	O
mass	O
removal	O
.	O

-	O
Adrenal	O
myelolipoma	O
,	O
tumor	O
size	O
14	B
cm	I
in	O
greatest	O
dimension	O
.	O

Comment	O
:	O
None	O
.	O

Clinical	O
History	O
:	O
year	O
-	O
old	O
male	O
with	O
left	O
adrenal	O
mass	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
two	O
appropriately	O
labeled	O
containers	O
.	O

Container	O
A	O
:	O
Specimen	O
fixation	O
:	O
formalin	O
.	O

Type	O
of	O
specimen	O
:	O
nephrectomy	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
500	O
grams	O
,	O
14	O
.	O
5	O
x	O
10	O
.	O
0	O
x	O
4	O
.	O
8	O
cm	O
.	O

Presence	O
/	O
absence	O
of	O
adrenal	O
gland	O
:	O
questionably	O
present	O
,	O
an	O
area	O
of	O
yellow	O
/	O
orange	O
.	O
discoloration	O
is	O
present	O
in	O
the	O
perirenal	O
adipose	O
tissue	O
,	O
but	O
not	O
definitive	O
for	O
an	O
.	O
adrenal	O
gland	O
.	O

Tumor	O
description	O
:	O
circumscribed	O
,	O
yellow	O
/	O
tan	O
,	O
soft	O
,	O
and	O
partially	O
encapsulated	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
5	I
X	I
3	I
.	I
5	I
X	I
3	I
.	I
0	I
cm	I
.	O

Presence	O
/	O
absence	O
of	O
multicentricity	O
:	O
absent	O
,	O
one	O
focus	O
is	O
identified	O
.	O

Confinement	O
/	O
Non	O
-	O
confinement	O
to	O
kidney	O
:	O
the	O
tumor	O
grossly	O
appears	O
to	O
contain	O
.	O
questionable	O
areas	O
of	O
extracapsular	O
extension	O
into	O
the	O
surrounding	O
fat	O
.	O

Extent	O
of	O
invasion	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
questionably	O
involved	O
.	O

Renal	O
vein	O
:	O
tumor	O
does	O
not	O
grossly	O
involve	O
.	O

Ureter	O
:	O
tumor	O
does	O
not	O
grossly	O
involve	O
.	O

Surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
extends	O
to	O
within	O
0	O
.	O
8	O
cm	O
of	O
the	O
closest	O
black	O
inked	O
.	O
deep	O
soft	O
tissue	O
margin	O
.	O

Renal	O
vein	O
:	O
negative	O
.	O

Renal	O
artery	O
:	O
negative	O
.	O

Ureter	O
:	O
negative	O
.	O

Description	O
of	O
kidney	O
away	O
from	O
tumor	O
:	O
has	O
a	O
pink	O
/	O
tan	O
,	O
smooth	O
,	O
and	O
grossly	O
.	O
unremarkable	O
cut	O
surface	O
,	O
with	O
distinct	O
corticomedullary	O
junctions	O
;	O
the	O
cortex	O
contains	O
two	O
linear	O
.	O
incisional	O
defects	O
,	O
containing	O
suture	O
material	O
,	O
one	O
located	O
on	O
each	O
pole	O
.	O

Lymph	O
nodes	O
(	O
hilar	O
)	O
:	O
none	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
:	O
none	O
.	O

Block	O
Summary	O
:	O
A1	O
-	O
vascular	O
and	O
ureteral	O
margins	O
.	O

A2	O
-	O
tumor	O
at	O
closest	O
approach	O
to	O
black	O
ink	O
.	O

A3	O
,	O
A4	O
-	O
tumor	O
at	O
area	O
of	O
questionable	O
extracapsular	O
extension	O
.	O

A5	O
,	O
A6	O
-	O
additional	O
representative	O
tumor	O
.	O

A7	O
-	O
additional	O
representative	O
normal	O
kidney	O
.	O

A8	O
-	O
representative	O
section	O
of	O
area	O
with	O
adipose	O
tissue	O
containing	O
an	O
.	O

orange	O
/	O
yellow	O
discoloration	O
(	O
possible	O
portion	O
of	O
adrenal	O
gland	O
)	O
.	O

Container	O
B	O
is	O
additionally	O
labeled	O
"	O
left	O
adrenal	O
mass	O
.	O
"	O
It	O
holds	O
a	O
1010	O
gram	O
,	O
14	O
.	O
2	O
.	O

X	O
13	O
.	O
2	O
x	O
7	O
.	O
0	O
cm	O
ovoid	O
,	O
circumscribed	O
,	O
soft	O
tan	O
/	O
gray	O
mass	O
,	O
containing	O
areas	O
of	O
.	O
disrupted	O
surface	O
.	O

A	O
10	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
area	O
contains	O
an	O
orange	O
/	O
yellow	O
minimal	O
amount	O
of	O
.	O
adherent	O
portion	O
of	O
tissue	O
,	O
consistent	O
with	O
adrenal	O
gland	O
.	O

Sectioning	O
reveals	O
a	O
.	O
soft	O
,	O
yellow	O
/	O
tan	O
,	O
focally	O
hemorrhagic	O
and	O
focally	O
necrotic	O
cut	O
surface	O
.	O

This	O
mass	O
.	O
diffusely	O
abuts	O
the	O
blue	O
inked	O
surgical	O
margin	O
.	O

The	O
area	O
underlying	O
the	O
.	O

yellow	O
/	O
orange	O
surface	O
has	O
a	O
red	O
/	O
brown	O
,	O
hemorrhagic	O
cut	O
surface	O
,	O
with	O
a	O
small	O
,	O
.	O
approximately	O
0	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
rim	O
of	O
orange	O
yellow	O
tissue	O
,	O
consistent	O
with	O
adrenal	O
.	O
gland	O
.	O

B1	O
-	O
B5	O
-	O
representative	O
sections	O
.	O

B6	O
-	O
sections	O
of	O
area	O
containing	O
yellow	O
/	O
orange	O
possible	O
adrenal	O
gland	O
.	O

Light	O
Microscopy	O
:	O
Light	O
microscopic	O
examination	O
is	O
performed	O
by	O
Dr	O
.	O
Specimen	O
A	O
:	O
Histologic	O
tumor	O
type	O
/	O
subtype	O
:	O
renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
,	O
eosinophilic	O
variant	O
.	O

Histologic	O
grade	O
(	O
if	O
applicable	O
)	O
:	O
2	O
(	O
of	O
4	O
)	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
3	B
.	I
5	I
cm	I
.	O

Extent	O
of	O
tumor	O
invasion	O
:	O
Capsular	O
invasion	O
/	O
perirenal	O
adipose	O
tissue	O
:	O
negative	O
.	O

Renal	O
vein	O
:	O
negative	O
.	O

Ureter	O
:	O
negative	O
.	O

Blood	O
vascular	O
:	O
negative	O
.	O

Lymphovascular	O
:	O
negative	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
free	O
of	O
tumor	O
.	O

Renal	O
vein	O
:	O
free	O
of	O
tumor	O
.	O

Renal	O
artery	O
:	O
free	O
of	O
tumor	O
.	O

Ureter	O
:	O
free	O
of	O
tumor	O
.	O

Adrenal	O
gland	O
:	O
no	O
tumor	O
seen	O
.	O

Separately	O
submitted	O
specimen	O
B	O
shows	O
a	O
14	B
cm	I
.	O
myelolipoma	O
of	O
the	O
adrenal	O
gland	O
.	O

Lymph	O
nodes	O
:	O
not	O
identified	O
.	O

Other	O
significant	O
findings	O
:	O
none	O
.	O

Female	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Liver	O
,	O
segments	O
II	O
and	O
III	O
,	O
partial	O
hepatectomy	O
:	O
Hepatocellular	O
.	O
carcinoma	O
,	O
well	O
differentiated	O
(	O
grade	O
1	O
of	O
4	O
)	O
,	O
forming	O
a	O
dominant	O
,	O
.	O

14	B
.	I
5	I
x	I
10	I
.	I
5	I
x	I
10	I
.	I
0	I
cm	I
mass	O
with	O
multiple	O
satellite	O
masses	O
(	O
see	O
parts	O
.	O
C	O
,	O
E	O
,	O
F	O
)	O
.	O

The	O
tumor	O
is	O
confined	O
to	O
the	O
liver	O
.	O

The	O
resection	O
margin	O
.	O

is	O
negative	O
for	O
tumor	O
(	O
tumor	O
free	O
margin	O
,	O
0	O
.	O
5	O
cm	O
)	O
Macroscopic	O
.	O
large	O
vessel	O
(	O
venous	O
)	O
invasion	O
is	O
absent	O
.	O

Microscopic	O
(	O
small	O
.	O
vessel	O
)	O
invasion	O
is	O
absent	O
.	O

No	O
regional	O
lymph	O
nodes	O
are	O
identified	O
.	O

The	O
surrounding	O
non	O
-	O
neoplastic	O
hepatic	O
parenchyma	O
shows	O
no	O
.	O
significant	O
diagnostic	O
abnormality	O
(	O
see	O
comment	O
)	O
.	O

Pathologic	O
staging	O
based	O
on	O
available	O
surgical	O
pathology	O
material	O
.	O

(	O
AJCC	O
7th	O
edition	O
)	O
:	O
pT3a	O
.	O

Comment	O
:	O
The	O
sections	O
of	O
the	O
large	O
mass	O
present	O
in	O
segments	O
II	O
and	O
.	O

III	O
(	O
part	O
A	O
)	O
demonstrate	O
a	O
well	O
differentiated	O
neoplasm	O
with	O
bland	O
.	O
cytology	O
that	O
shows	O
loss	O
of	O
the	O
normal	O
reticulin	O
network	O
and	O
.	O
dispersion	O
of	O
the	O
neoplastic	O
cells	O
by	O
an	O
intercellular	O
material	O
.	O
suggestive	O
of	O
mucin	O
.	O

The	O
reticulin	O
network	O
is	O
preserved	O
in	O
the	O
.	O
surrounding	O
liver	O
parenchyma	O
.	O

A	O
glypican	O
3	O
stain	O
is	O
negative	O
in	O
the	O
.	O
neoplastic	O
cells	O
and	O
is	O
noncontributory	O
.	O

The	O
separately	O
submitted	O
.	O
wedge	O
resections	O
from	O
segment	O
VI	O
,	O
segment	O
VIII	O
,	O
and	O
segment	O
IVB	O
show	O
.	O
smaller	O
nodules	O
with	O
similar	O
histologic	O
features	O
.	O

No	O
defined	O
lesion	O
.	O

is	O
identified	O
in	O
the	O
liver	O
segment	O
VII	O
.	O

The	O
overall	O
features	O
including	O
loss	O
of	O
the	O
reticulin	O
network	O
and	O
the	O
.	O
multifocality	O
suggest	O
,	O
although	O
the	O
cytologic	O
features	O
are	O
bland	O
and	O
.	O
well	O
differentiated	O
,	O
that	O
this	O
represents	O
a	O
well	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
.	O

Case	O
seen	O
with	O
.	O

Additional	O
reticulin	O
stains	O
will	O
be	O
performed	O
on	O
parts	O
C	O
and	O
E	O
as	O
.	O
well	O
as	O
a	O
mucicarmine	O
stain	O
performed	O
on	O
part	O
A	O
.	O

These	O
stains	O
will	O
.	O

be	O
reported	O
in	O
an	O
addendum	O
,	O
when	O
available	O
.	O

B	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
Mild	O
chronic	O
cholecystitis	O
.	O

C	O
.	O

Liver	O
,	O
segment	O
VI	O
,	O
resection	O
:	O
Well	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
,	O
forming	O
a	O
1	B
.	I
2	I
x	I
1	I
.	I
:	I
x	I
0	I
.	I
8	I
cm	I
nodule	O
,	O
0	O
.	O
9	O
.	O

cm	O
from	O
the	O
surgical	O
resection	O
margin	O
.	O

D	O
.	O

Liver	O
,	O
segment	O
VII	O
,	O
resection	O
:	O
Hepatic	O
tissue	O
with	O
cautery	O
.	O
effect	O
.	O

No	O
definitive	O
lesion	O
is	O
identified	O
.	O

E	O
.	O

Liver	O
,	O
segment	O
VIII	O
,	O
resection	O
:	O
Well	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
,	O
forming	O
a	O
1	B
.	I
0	I
x	I
1	I
.	I
0	I
x	I
0	I
.	I
9	I
cm	I
nodule	O
,	O
0	O
.	O
1	O
.	O

cm	O
from	O
the	O
surgical	O
resection	O
margin	O
.	O

F	O
.	O

Liver	O
,	O
segment	O
IVB	O
,	O
resection	O
:	O
Well	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
,	O
forming	O
a	O
1	B
.	I
1	I
x	I
1	I
.	I
0	I
x	I
0	I
.	I
6	I
cm	I
nodule	O
,	O
.	O
abutting	O
the	O
inked	O
surgical	O
resection	O
margin	O
.	O

Interpreted	O
by	O
:	O
ADDENDUM	O
:	O
Reticulin	O
stains	O
are	O
performed	O
on	O
two	O
of	O
the	O
satellite	O
nodules	O
.	O

(	O
blocks	O
C1	O
and	O
E1	O
)	O
The	O
stains	O
show	O
convincing	O
loss	O
of	O
the	O
.	O
reticulin	O
framework	O
in	O
both	O
nodules	O
,	O
adding	O
further	O
support	O
for	O
the	O
.	O
diagnosis	O
of	O
hepatocellular	O
carcinoma	O
with	O
multiple	O
satellite	O
.	O
nodules	O
.	O

Given	O
the	O
mucinous	O
character	O
of	O
the	O
cut	O
tumor	O
surface	O
,	O
a	O
mucicarmine	O
.	O
stain	O
is	O
performed	O
on	O
a	O
representative	O
tumor	O
block	O
(	O
A2	O
)	O
.	O

There	O
is	O
.	O

a	O
.	O
faint	O
pink	O
blush	O
in	O
the	O
dilated	O
sinusoids	O
,	O
but	O
no	O
intracellular	O
.	O
mucin	O
is	O
identified	O
.	O

Some	O
hepatocellular	O
carcinomas	O
can	O
overexpress	O
.	O
mucin	O
-	O
related	O
proteins	O
(	O
particularly	O
MUC1	O
)	O
i	O
that	O
could	O
possibly	O
.	O
account	O
for	O
both	O
the	O
gross	O
and	O
histochemical	O
findings	O
.	O

Surg	O
Path	O
Fina	O
Report	O
.	O

Temporary	O
Copy	O
.	O

o	O
2	O
.	O
case	O
.	O

Clinical	O
History	O
.	O

Left	O
temporal	O
tumor	O
.	O

Diagnosis	O
.	O

'	O
LEFT	O
TEMPORAL	O
TUMOR	O
"	O
,	O
(	O
RESECTION	O
)	O
:	O
-	O
DIFFUSE	O
ASTROCYTOMA	O
,	O
WHO	O
GRADE	O
II	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
.	O
diagnostic	O
evaluation	O
on	O
the	O
above	O
specimens	O
.	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
:	O
For	O
questions	O
regarding	O
this	O
case	O
,	O
call	O
.	O

Resident	O
.	O

Gross	O
Description	O
.	O

A	O
single	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
.	O
record	O
number	O
and	O
"	O
#	O
1	O
left	O
temporal	O
tumor	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
three	O
,	O
.	O
unoriented	O
tan	O
-	O
white	O
to	O
gray	O
tissue	O
fragments	O
,	O
grossly	O
consistent	O
with	O
brain	O
tissue	O
.	O
measuring	O
3	B
.	I
0	I
x	I
2	I
.	I
5	I
x	I
1	I
.	I
0	I
cm	I
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
no	O
.	O
focal	O
lesions	O
.	O

Submitted	O
entirely	O
in	O
cassettes	O
1A	O
-	O
1B	O
.	O

Microscopic	O
Examination	O
.	O

Sections	O
show	O
foci	O
of	O
increased	O
cellularity	O
within	O
gray	O
and	O
white	O
matter	O
.	O

The	O
foci	O
.	O
have	O
infiltrative	O
borders	O
and	O
are	O
composed	O
of	O
cells	O
with	O
irregularly	O
shaped	O
nuclei	O
.	O
and	O
moderate	O
amounts	O
of	O
eosinophilic	O
cytoplasm	O
.	O

Frequent	O
pleomorphic	O
,	O
.	O
hyperchromatic	O
,	O
and	O
occasional	O
multinucleated	O
cells	O
are	O
present	O
.	O

No	O
significant	O
.	O
mitotic	O
figures	O
,	O
necrosis	O
or	O
vascular	O
proliferation	O
with	O
hyperplasia	O
is	O
identified	O
.	O

Immunohistochemical	O
stains	O
are	O
performed	O
with	O
appropriately	O
reactive	O
positive	O
and	O
.	O
negative	O
controls	O
and	O
show	O
the	O
neoplastic	O
cells	O
to	O
be	O
positive	O
for	O
GFAP	O
and	O
.	O
negative	O
for	O
synaptophysin	O
and	O
NeuN	O
.	O

Synoptic	O
Report	O
.	O

No	O
AJCC	O
/	O
UICC	O
TNM	O
Staging	O
System	O
.	O

Protocol	O
web	O
posting	O
date	O
:	O
Protocol	O
effective	O
date	O
:	O
Specimen	O
type	O
/	O
procedure	O
:	O
Resection	O
.	O

Specimen	O
handling	O
:	O
Unfrozen	O
for	O
routine	O
permanent	O
paraffin	O
sections	O
.	O

Specimen	O
size	O
:	O
Greatest	O
dimension	O
:	O
3	O
.	O
0	O
cm	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
site	O
:	O
Brain	O
/	O
cerebrum	O
:	O
Left	O
temporal	O
lobe	O
.	O
surg	O
Path	O
-	O
Fina	O
Repor	O
.	O
emporary	O
Gopy	O
.	O

Ratiene	O
.	O

Histologic	O
type	O
and	O
grade	O
:	O
Diffuse	O
astrocytoma	O
(	O
WHO	O
grade	O
II	O
)	O
.	O

Histologic	O
Grade	O
:	O
WHO	O
grade	O
II	O
.	O

Ancillary	O
studies	O
:	O
Immunohistochemistry	O
.	O

GFAP	O
-	O
positive	O
.	O

NeuN	O
-	O
negative	O
.	O

Synaptophysin	O
-	O
negative	O
.	O

Additional	O
pathologic	O
findings	O
:	O
None	O
.	O

Critais	O
.	O

Dragnoris	O
Discresanty	O
.	O

Pomari	O
Tumer	O
Site	O
Discreponicy	O
.	O

QUALIFIED	O
/	O
.	O

Weif	O
.	O

BTh	O
Reviewed	O
10	O
/	O
2	O
/	O
2013	O
.	O

CLINICAL	O
HISTORY	O
.	O
with	O
recent	O
onset	O
seizures	O
has	O
right	O
frontal	O
.	O
heterogeneously	O
.	O

intra	O
axial	O
tumor	O
,	O
with	O
hemorrhage	O
,	O
vasogenic	O
edema	O
,	O
and	O
mass	O
.	O
effect	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Not	O
Given	O
.	O

B	O
:	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

operation	O
/	O
Specimen	O
:	O
A	O
:	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
frontal	O
,	O
excision	O
Glioblastoma	O
.	O

MIB	O
-	O
1	O
.	O
proliferation	O
.	O

A	O
and	O
B	O
.	O

Brain	O
,	O
right	O
.	O
index	O
:	O
30	O
%	O
.	O

See	O
Comment	O
.	O

COMMENT	O
contain	O
portions	O
of	O
a	O
neoplastic	O
proliferation	O
a	O
high	O
proliferation	O
of	O
small	O
glial	O
.	O

The	O
cells	O
,	O
specimens	O
with	O
nuclear	O
anaplasia	O
,	O
cellular	O
proliferation	O
mitotic	O
figures	O
,	O
and	O
necrosis	O
,	O
very	O
and	O
zones	O
with	O
of	O
tumor	O
.	O
necrosis	O
index	O
,	O
microvascular	O
with	O
pseudopalisading	O
There	O
are	O
zones	O
of	O
hemorrhage	O
,	O
prominent	O
.	O
thrombosis	O
of	O
vessels	O
.	O

The	O
predominantly	O
phenotype	O
from	O
of	O
astrocytic	O
.	O
malignant	O
this	O
high	O
oligodendrogliomas	O
.	O

These	O
histological	O
small	O
cell	O
grade	O
glioblastomas	O
glioma	O
Determining	O
(	O
WHO	O
grade	O
are	O
the	O
difficult	O
LOH	O
IV	O
)	O
status	O
is	O
to	O
of	O
.	O
tell	O
this	O
patient	O
apart	O
may	O
better	O
characterize	O
the	O
neoplasm	O
.	O

PROCEDURES	O
/	O
ADDENDA	O
.	O

MGMT	O
Promoter	O
Methylation	O
.	O

Interpretation	O
.	O

POSITIVE	O
-	O
Methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

Results	O
-	O
Comments	O
.	O

Testing	O
was	O
done	O
on	O
block	O
.	O

TEST	O
DESCRIPTION	O
:	O
Bisulfite	O
treatment	O
of	O
DNA	O
followed	O
by	O
PCR	O
amplification	O
of	O
.	O
both	O
methylated	O
and	O
unmethylated	O
MGMT	O
promoter	O
sequences	O
,	O
with	O
products	O
.	O
detected	O
by	O
gel	O
electrophoresis	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
.	O
stand	O
-	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O

Laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
.	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
.	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

A	O
.	O

Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
,	O
touch	O
prep	O
and	O
smears	O
:	O
High	O
.	O
histological	O
grade	O
glioma	O
,	O
C	O
/	O
W	O
glioblastoma	O
.	O

Frozen	O
section	O
performed	O
.	O

at	O
.	O
and	O
results	O
reported	O
to	O
the	O
Physician	O
of	O
.	O

Record	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
,	O
several	O
fragments	O
,	O
1	O
.	O
2	O
cm	O
.	O

In	O
aggregate	O
.	O

Soft	O
,	O
tannish	O
-	O
brown	O
,	O
.	O
with	O
small	O
blood	O
clot	O
.	O

In	O
total	O
,	O
A1	O
and	O
A2	O
.	O

B	O
.	O

SPECIMEN	O
:	O
Right	O
frontal	O
tumor	O
.	O

FIXATIVE	O
:	O
Formalin	O
.	O

GENERAL	O
:	O
A	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O
,	O
1	O
.	O
36	O
gm	O
.	O
aggregate	O
of	O
several	O
irregularly	O
.	O
shaped	O
red	O
to	O
gray	O
-	O
tan	O
fragments	O
of	O
brain	O
tissue	O
.	O

SECTIONS	O
:	O
B1	O
,	O
B2	O
all	O
submitted	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
The	O
GFAP	O
demonstrates	O
focal	O
sparse	O
gliofibrillogenesis	O
.	O
by	O
the	O
neoplastic	O
cells	O
.	O

The	O
neoplastic	O
cells	O
do	O
not	O
over	O
express	O
the	O
p53	O
.	O
protein	O
.	O

With	O
the	O
MIB	O
-	O
1	O
there	O
is	O
a	O
proliferation	O
index	O
of	O
about	O
30	O
%	O
in	O
the	O
.	O
more	O
active	O
areas	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
191	O
.	O
1	O
191	O
.	O
9	O
.	O
nisto	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
,	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

FS	O
H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

Part	O
B	O
:	O
Brain	O
right	O
frontal	O
tumor	O
,	O
excision	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

Please	O
repeat	O
at	O
normal	O
.	O
and	O
lower	O
dilution	O
.	O

Thanks	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

MGMT	O
X	O
1	O
.	O

1	O
.	O

MIB1	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

P53D07	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

2	O
.	O

(	O
Age	O
:	O
Date	O
Received	O
:	O
Patient	O
!	O
ype	O
.	O

H3A	O
.	O

D	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
BIOPSY	O
.	O

-	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MODERATELY	O
IFFERENTIATED	O
.	O

(	O
SEE	O
DESCRIPTION	O
)	O
,	O
.	O

By	O
this	O
signature	O
,	O
l	O
/	O
attest	O
that	O
the	O
.	O
above	O
diaghosis	O
is	O
based	O
upon	O
my	O
.	O
personal	O
examination	O
of	O
the	O
slides	O
.	O

(	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
.	O
the	O
diagnosis	O
)	O
,	O
and	O
that	O
I	O
have	O
.	O
reviewed	O
and	O
approved	O
this	O
report	O
.	O

HISTORY	O
.	O

The	O
patient	O
is	O
a	O
year	O
oil	O
woman	O
who	O
underwent	O
cervical	O
biopsy	O
.	O

GROSS	O
.	O

Submitted	O
by	O
Dr	O
.	O
ior	O
review	O
is	O
one	O
slide	O
labeled	O
.	O
accompanied	O
by	O
a	O
correscandirg	O
pathology	O
report	O
.	O
material	O
orikinater	O
r	O
on	O
.	O

Diagnosis	O
:	O
Left	O
kidney	O
,	O
radical	O
nephrectomy	O
.	O

-	O
Renal	O
cell	O
carcinoma	O
,	O
clear	O
cell	O
type	O
,	O
tumor	O
size	O
10	B
cm	I
.	O
in	O
greatest	O
dimension	O
,	O
nuclear	O
grade	O
3	O
(	O
of	O
4	O
)	O
,	O
extending	O
.	O
through	O
capsule	O
of	O
kidney	O
into	O
perirenal	O
adipose	O
tissue	O
,	O
.	O
involving	O
lumen	O
of	O
renal	O
vein	O
with	O
tumor	O
present	O
at	O
margin	O
.	O
of	O
renal	O
vein	O
.	O

-	O
Adrenal	O
gland	O
with	O
no	O
tumor	O
seen	O
.	O

-	O
Two	O
perirenal	O
lymph	O
nodes	O
with	O
no	O
tumor	O
seen	O
(	O
0	O
/	O
2	O
)	O
.	O

Comment	O
:	O
None	O
.	O

Clinical	O
History	O
:	O
with	O
a	O
left	O
renal	O
mass	O
now	O
undergoes	O
left	O
nephrectomy	O
.	O

Gross	O
Description	O
:	O
Received	O
is	O
one	O
appropriately	O
labeled	O
container	O
.	O

Specimen	O
fixation	O
:	O
formalin	O
.	O

Type	O
of	O
specimen	O
:	O
radical	O
nephrectomy	O
.	O

Size	O
and	O
weight	O
of	O
specimen	O
:	O
17	O
X	O
9	O
X	O
8	O
.	O
5	O
cm	O
,	O
610	O
gm	O
.	O

Presence	O
/	O
absence	O
of	O
adrenal	O
gland	O
:	O
present	O
with	O
no	O
gross	O
.	O
abnormality	O
noted	O
.	O

Tumor	O
description	O
:	O
Predominantly	O
solid	O
yellow	O
and	O
tan	O
/	O
white	O
.	O
mass	O
with	O
a	O
gelatinous	O
appearance	O
and	O
irregular	O
borders	O
.	O

Tumor	O
size	O
:	O
approximately	O
10	B
X	I
6	I
X	I
5	I
.	I
8	I
cm	I
.	O

Presence	O
/	O
absence	O
of	O
tulticentricity	O
:	O
absent	O
.	O

Confinement	O
/	O
Non	O
-	O
confinement	O
to	O
kidney	O
:	O
appears	O
to	O
be	O
.	O
confined	O
within	O
the	O
renal	O
capsule	O
and	O
there	O
is	O
perirenal	O
.	O
fat	O
around	O
the	O
tumor	O
.	O

Extent	O
of	O
invasion	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
tumor	O
grossly	O
does	O
not	O
involve	O
.	O
the	O
perirenal	O
adipose	O
tissue	O
.	O

Renal	O
vein	O
:	O
tumor	O
is	O
present	O
in	O
lumen	O
of	O
renal	O
vein	O
and	O
is	O
.	O
present	O
at	O
margin	O
.	O

Ureter	O
:	O
not	O
involved	O
.	O

Other	O
organs	O
:	O
the	O
adrenal	O
gland	O
does	O
not	O
appear	O
to	O
be	O
.	O
involved	O
.	O

Surgical	O
margins	O
:	O
Perirenal	O
adipose	O
tissue	O
:	O
negative	O
.	O

Renal	O
vein	O
:	O
positive	O
.	O

Renal	O
artery	O
:	O
negative	O
.	O

Ureter	O
:	O
positive	O
.	O

Description	O
of	O
kidney	O
away	O
from	O
tumor	O
:	O
unremarkable	O
.	O

Lymph	O
nodes	O
(	O
hilar	O
)	O
:	O
there	O
is	O
one	O
large	O
hilar	O
possible	O
.	O
lymph	O
node	O
which	O
is	O
bisected	O
.	O

Tissue	O
submitted	O
for	O
special	O
investigations	O
:	O
A	O
portion	O
of	O
.	O
the	O
tumor	O
and	O
the	O
non	O
-	O
tumorous	O
kidney	O
are	O
given	O
to	O
tissue	O
.	O

Block	O
Summary	O
:	O
A1	O
-	O
A2	O
-	O
sections	O
of	O
the	O
hilum	O
.	O

A3	O
-	O
possible	O
hilar	O
lymph	O
node	O
bisected	O
.	O

A4	O
-	O
adrenal	O
gland	O
.	O

A5	O
-	O
A14	O
-	O
representative	O
sections	O
of	O
the	O
tumor	O
.	O

A15	O
-	O
non	O
-	O
tumorous	O
-	O
renal	O
parenchyma	O
.	O

Light	O
Microscopy	O
:	O
Light	O
microscopic	O
examination	O
is	O
performed	O
.	O

Histologic	O
tumor	O
type	O
/	O
subtype	O
:	O
renal	O
cell	O
carcinoma	O
,	O
clear	O
.	O
cell	O
type	O
.	O

Histologic	O
grade	O
(	O
if	O
applicable	O
)	O
:	O
3	O
(	O
of	O
4	O
)	O
.	O

Tumor	O
size	O
(	O
greatest	O
dimension	O
)	O
:	O
10	B
cm	I
.	O

Extent	O
of	O
tumor	O
invasion	O
:	O
Capsular	O
invasion	O
/	O
perirenal	O
adipose	O
tissue	O
:	O
capsular	O
.	O
penetration	O
identified	O
with	O
involvment	O
of	O
perirenal	O
.	O
adipose	O
tissue	O
.	O

Renal	O
vein	O
:	O
involved	O
with	O
tumor	O
.	O

Ureter	O
:	O
not	O
involved	O
.	O

Lymphovascular	O
:	O
not	O
involved	O
.	O

Adjacent	O
organs	O
:	O
not	O
involved	O
.	O

Histologic	O
assessment	O
of	O
surgical	O
margins	O
.	O

Perirenal	O
adipose	O
tissue	O
:	O
margins	O
negative	O
.	O

Renal	O
vein	O
:	O
involved	O
at	O
margin	O
.	O

Renal	O
artery	O
:	O
not	O
involved	O
.	O

Ureter	O
:	O
not	O
involved	O
.	O

Adrenal	O
gland	O
:	O
not	O
tumor	O
seen	O
.	O

Lymph	O
nodes	O
:	O
no	O
tumor	O
seen	O
in	O
2	O
perirenal	O
lymph	O
nodes	O
.	O

path	O
report	O
.	O

Microscopic	O
.	O

Sections	O
demonstrate	O
a	O
glial	O
neoplasm	O
that	O
diffusely	O
infiltrates	O
both	O
gray	O
and	O
white	O
matter	O
.	O

In	O
.	O
the	O
gray	O
matter	O
,	O
there	O
is	O
prominent	O
perineuronal	O
satellitosis	O
as	O
well	O
as	O
subpial	O
surface	O
spread	O
.	O

Tumor	O
cells	O
have	O
round	O
nuclei	O
with	O
few	O
apparent	O
cytoplasmic	O
processes	O
.	O

Many	O
demonstrate	O
.	O
perinuclear	O
halos	O
.	O

There	O
is	O
little	O
cytologic	O
atypia	O
.	O

No	O
mitotic	O
figures	O
are	O
seen	O
.	O

There	O
is	O
no	O
.	O
microvascular	O
proliferation	O
or	O
necrosis	O
.	O

Addendum	O
discussion	O
:	O
Numerous	O
MIB	O
-	O
1	O
reactive	O
cells	O
are	O
present	O
throughout	O
the	O
specimen	O
.	O

A	O
labeling	O
index	O
of	O
21	O
%	O
is	O
.	O
calculated	O
.	O

This	O
is	O
indicative	O
of	O
a	O
markedly	O
proliferative	O
glial	O
neoplasm	O
.	O

Despite	O
this	O
,	O
no	O
mitotic	O
.	O
figures	O
are	O
identified	O
on	O
the	O
.	O
stain	O
and	O
only	O
a	O
rare	O
mitotic	O
figure	O
was	O
indentified	O
on	O
the	O
.	O
immunohistochemistry	O
.	O

Consequently	O
,	O
the	O
tumor	O
must	O
be	O
classified	O
as	O
low	O
grade	O
/	O
grade	O
II	O
.	O

Nevertheless	O
,	O
the	O
very	O
high	O
MIB	O
-	O
1	O
labeling	O
index	O
suggests	O
more	O
aggressive	O
behavior	O
.	O

Close	O
.	O
clinical	O
follow	O
-	O
up	O
is	O
indicated	O
.	O

Final	O
Addendum	O
Diagnosis	O
:	O
Oligodendroglioma	O
,	O
low	O
grade	O
,	O
WHO	O
grade	O
II	O
.	O

ADDENDED	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
1	O
.	O

Left	O
temporal	O
lobe	O
brain	O
tumor	O
:	O
GLIOBLASTOMA	O
,	O
WHO	O
GRADE	O
iv	O
.	O

SEE	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

2	O
.	O

Left	O
temporal	O
lobe	O
brain	O
tumor	O
:	O
GLIOBLASTOMA	O
,	O
WHO	O
GRADE	O
iv	O
.	O

This	O
diagnostic	O
report	O
has	O
been	O
personally	O
interpreted	O
by	O
the	O
signatory	O
.	O
of	O
record	O
.	O

Addendum	O
.	O

IMMUNOHISTOCHEMICAL	O
STAINS	O
.	O

GFAP	O
:	O
POSITIVE	O
STAINING	O
OF	O
TUMOR	O
CELLS	O
.	O

KI67	O
:	O
AREAS	O
OF	O
THE	O
TUMOR	O
SHOW	O
ON	O
SLIDE	O
2A	O
POSITIVE	O
NUCLEAR	O
STAINING	O
OF	O
.	O

GREATER	O
THAN	O
30	O
%	O
OF	O
TUMOR	O
CELL	O
NUCLEI	O
.	O

P53	O
:	O
POSITIVE	O
STAINING	O
OF	O
ONLY	O
A	O
VERY	O
FEW	O
CELLS	O
WITHIN	O
THE	O
TUMOR	O
.	O

SPECIMEN	O
(	O
SLIDE	O
2A	O
)	O
.	O

Microscopic	O
Description	O
:	O
The	O
tumor	O
is	O
composed	O
of	O
pleomorphic	O
glial	O
cells	O
.	O

Mitotic	O
figures	O
are	O
.	O
identified	O
in	O
tumor	O
cells	O
.	O

The	O
features	O
of	O
Glioblastoma	O
including	O
.	O
areas	O
of	O
pseudopalisading	O
necrosis	O
are	O
best	O
seen	O
on	O
the	O
actual	O
frozen	O
.	O
tissue	O
sections	O
.	O

Frozen	O
Section	O
Diagnosis	O
:	O
1	O
.	O

Left	O
temporal	O
lobe	O
brain	O
tumor	O
:	O
Gliob	O
lastoma	O
.	O

Frozen	O
section	O
.	O
diagnosis	O
by	O
.	O

Clinical	O
History	O
and	O
Diagnosis	O
:	O
Left	O
temporal	O
lobe	O
brain	O
tumor	O
.	O

Source	O
of	O
Specimen	O
:	O
1	O
:	O
Left	O
temporal	O
lobe	O
brain	O
tumor	O
.	O

2	O
:	O
Left	O
temporal	O
lobe	O
brain	O
tumor	O
.	O

Gross	O
Description	O
:	O
1	O
.	O

Left	O
temporal	O
lobe	O
brain	O
tumor	O
:	O
Received	O
fresh	O
for	O
frozen	O
are	O
.	O
multiple	O
fragments	O
of	O
tan	O
-	O
red	O
soft	O
tissue	O
measuring	O
0	O
.	O
9	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
2	O
cm	O
.	O
in	O
aggregate	O
dimension	O
.	O

Touch	O
preps	O
are	O
prepared	O
and	O
approximate	O
ly	O
50	O
%	O
.	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
frozen	O
sectioning	O
one	O
cassette	O
.	O

The	O
.	O
remainder	O
is	O
submitted	O
for	O
permanents	O
in	O
one	O
additional	O
cassette	O
.	O

2	O
.	O

Left	O
temporal	O
lobe	O
brain	O
tumor	O
:	O
Received	O
in	O
formalin	O
in	O
a	O
specimen	O
.	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
#	O
2	O
left	O
temporal	O
lobe	O
.	O
brain	O
tumor	O
"	O
are	O
2	O
fragments	O
of	O
tan	O
-	O
white	O
soft	O
tissue	O
measuring	O
1	B
.	I
9	I
X	I
.	I

0	B
.	I
6	I
X	I
0	I
.	I
3	I
cm	I
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

Histology	O
Laboratory	O
.	O

H	O
&	O
E	O
.	O

Immunohistochemistry	O
Notes	O
.	O

1	O
.	O

Quantification	O
of	O
immunohistochemistry	O
assay	O
for	O
ER	O
and	O
PR	O
studies	O
.	O

is	O
by	O
the	O
method	O
of	O
Battiafora	O
et	O
.	O
al	O
.	O

Applied	O
Immunohistochemistry	O
,	O
.	O

2	O
.	O

Hercept	O
Test	O
(	O
DakoCytomation	O
)	O
Formalin	O
fixed	O
,	O
paraff	O
in	O
embedded	O
.	O

Interpretation	O
follows	O
the	O
manufacturer	O
'	O
S	O
recommendation	O
.	O

Documented	O
by	O
.	O

EGFR	O
pharmDx	O
Clone	O
2	O
-	O
18C9	O
Formalin	O
fixed	O
,	O
paraffin	O
embedded	O
.	O

Interpretation	O
follows	O
the	O
manufacturer	O
'	O
S	O
recommendation	O
.	O

Doucmented	O
by	O
.	O

3	O
.	O

Analyte	O
Specific	O
Reagent	O
(	O
ASCR	O
)	O
Disclaimer	O
.	O

The	O
use	O
of	O
one	O
or	O
more	O
.	O
reagents	O
in	O
the	O
above	O
tests	O
is	O
regulated	O
as	O
an	O
analyte	O
specific	O
reagent	O
.	O

(	O
ASR	O
)	O
.	O

These	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
.	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
.	O
necessary	O
.	O

Laterality	O
:	O
Malignant	O
melanoma	O
.	O

Path	O
Report	O
:	O
SKIN	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Surgical	O
resection	O
.	O

Tumor	O
site	O
:	O
Skin	O
.	O

Tumor	O
size	O
:	O
3	B
x	I
3	I
X	I
1	I
cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
,	O
Pigmented	O
.	O

Satellite	O
nodules	O
:	O
Not	O
specified	O
.	O

Histologic	O
type	O
:	O
Malignant	O
melanoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Lymph	O
nodes	O
:	O
1	O
/	O
10	O
positive	O
for	O
metastasis	O
(	O
Right	O
inguinal	O
lymph	O
node	O
1	O
/	O
10	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Breslow	O
depth	O
10mm	O
.	O

Comments	O
:	O
None	O
.	O

Document	O
Date	O
:	O
Modified	O
.	O

SUPPLEMENTAL	O
REPORT	O
.	O

SUPPLEMENTAL	O
DIAGNOSIS	O
:	O
Previous	O
diagnosis	O
remains	O
unchanged	O
.	O

See	O
.	O

Molecular	O
Diagnostics	O
.	O

Reprot	O
.	O
results	O
for	O
Block	O
1A	O
.	O

COMMENT	O
:	O
This	O
test	O
was	O
not	O
requested	O
,	O
performed	O
or	O
reported	O
at	O
.	O

The	O
test	O
was	O
requested	O
by	O
.	O

The	O
test	O
was	O
performed	O
and	O
.	O
reported	O
by	O
Center	O
for	O
.	O

Results	O
are	O
included	O
with	O
this	O
Surgical	O
Pathology	O
report	O
so	O
that	O
.	O
all	O
available	O
.	O
information	O
on	O
this	O
tumor	O
may	O
be	O
accessed	O
at	O
one	O
site	O
.	O

MGMT	O
GENE	O
AMPLIFICATION	O
.	O

DNA	O
was	O
isolated	O
from	O
a	O
paraffin	O
embedded	O
block	O
of	O
the	O
brain	O
tumor	O
.	O
biopsy	O
.	O

DNA	O
methylation	O
patterns	O
in	O
the	O
CpG	O
island	O
of	O
the	O
.	O

MGMT	O
gene	O
.	O
was	O
determined	O
.	O
by	O
chemical	O
.	O

(	O
bisulfite	O
)	O
modification	O
of	O
unmethylated	O
,	O
but	O
not	O
methylated	O
,	O
.	O
cytosines	O
to	O
.	O
uracil	O
and	O
subsequent	O
PCR	O
using	O
primers	O
specific	O
for	O
either	O
.	O
methylated	O
or	O
the	O
.	O
modified	O
unmethylated	O
DNA	O
.	O

The	O
.	O

PCR	O
products	O
were	O
analyzed	O
in	O
duplicate	O
parallel	O
runs	O
by	O
capillary	O
.	O
gel	O
.	O

electrophoresis	O
.	O

The	O
sensitivity	O
of	O
the	O
assay	O
based	O
on	O
DNA	O
.	O
dilution	O
studies	O
.	O

is	O
at	O
least	O
1	O
:	O
1000	O
.	O

The	O
analyzed	O
region	O
of	O
the	O
MGMT	O
promoter	O
is	O
UNMETHYLATED	O
.	O

INTERPRETATION	O
:	O
MGMT	O
(	O
06	O
methylguaine	O
DNA	O
nethyltransferase	O
)	O
is	O
a	O
DNA	O
repair	O
gene	O
.	O

Methylation	O
.	O
of	O
the	O
promotor	O
leads	O
to	O
gene	O
silencing	O
and	O
loss	O
of	O
MGMT	O
.	O
expression	O
.	O

a	O
recent	O
.	O
study	O
that	O
tested	O
the	O
methylation	O
status	O
of	O
the	O
same	O
region	O
of	O
the	O
.	O

MGMT	O
.	O
promoter	O
in	O
glioblastomas	O
found	O
that	O
MGMT	O
promoter	O
methylation	O
was	O
.	O

an	O
.	O
independent	O
favorable	O
prognostic	O
factor	O
and	O
was	O
associated	O
with	O
a	O
.	O
survival	O
.	O

benefit	O
in	O
patients	O
treated	O
with	O
temozolamide	O
and	O
radiotherapy	O
.	O
and	O
Benefit	O
from	O
.	O

Temozolomide	O
.	O
in	O
Glioblastomas	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

RIGHT	O
FRONTAL	O
BRAIN	O
LESION	O
,	O
RESECTION	O
,	O
FS1A	O
,	O
TP1A	O
:	O
-	O
GLIOBLASTOMA	O
WITH	O
OLIGODENDROGLIOMA	O
COMPONENT	O
,	O
WHO	O
GRADE	O
IV	O
.	O

-	O
SEE	O
COMMENT	O
.	O

2	O
.	O

RIGHT	O
FRONTAL	O
BRAIN	O
LESION	O
,	O
RESECTION	O
:	O
-	O
GLIOBLASTOMA	O
WITH	O
OLIGODENDROGLIOMA	O
COMPONENT	O
,	O
WHO	O
GRADE	O
IV	O
.	O

-	O
SEE	O
COMMENT	O
.	O

COMMENT	O
:	O
This	O
glioblastoma	O
has	O
an	O
element	O
of	O
oligodendroglioma	O
within	O
it	O
,	O
.	O
comprising	O
.	O

approximately	O
20	O
%	O
of	O
neoplastic	O
cells	O
.	O

Perhaps	O
more	O
.	O
morphologically	O
.	O

impressive	O
is	O
the	O
high	O
degree	O
of	O
angiogenesis	O
and	O
the	O
extensive	O
.	O
reactive	O
.	O

stromal	O
component	O
associated	O
with	O
it	O
.	O

In	O
the	O
majority	O
of	O
this	O
.	O
stromal	O
.	O

reaction	O
,	O
the	O
matrix	O
has	O
a	O
myxoid	O
appearance	O
whereas	O
in	O
others	O
of	O
.	O
the	O
stroma	O
.	O
has	O
a	O
more	O
highly	O
spindled	O
and	O
collagen	O
-	O
rich	O
.	O

These	O
stromal	O
.	O
elements	O
are	O
.	O
interpreted	O
as	O
a	O
reactive	O
process	O
associated	O
with	O
the	O
angiogenesis	O
.	O
because	O
of	O
.	O
the	O
geographic	O
association	O
of	O
these	O
two	O
processes	O
.	O

FISH	O
analysis	O
.	O
of	O
EGFR	O
and	O
.	O

1p	O
/	O
19q	O
have	O
been	O
ordered	O
and	O
the	O
results	O
will	O
be	O
issued	O
in	O
a	O
.	O
separate	O
.	O

report	O
.	O

Tissue	O
has	O
been	O
sent	O
for	O
MGMT	O
analysis	O
and	O
the	O
results	O
.	O
will	O
be	O
issued	O
.	O
in	O
a	O
separate	O
report	O
.	O

SPECIMEN	O
:	O
1	O
.	O

Right	O
frontal	O
brain	O
lesion	O
.	O

2	O
.	O

Right	O
frontal	O
brain	O
lesion	O
.	O

CLINICAL	O
HISTORY	O
/	O
OPERATIVE	O
FINDINGS	O
:	O
Right	O
craniotomy	O
.	O

Brain	O
tumor	O
.	O

GROSS	O
DESCRIPTION	O
.	O

Two	O
specimens	O
are	O
received	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
medical	O
.	O
record	O
number	O
.	O

Specimen	O
#	O
1	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
.	O

is	O
labeled	O
.	O
as	O
"	O
right	O
frontal	O
brain	O
lesion	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
multiple	O
.	O
fragments	O
.	O
of	O
pink	O
-	O
tan	O
,	O
soft	O
tissue	O
measuring	O
in	O
aggregate	O
,	O
0	O
.	O
8	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
.	O

cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
.	O
and	O
the	O
.	O
contents	O
of	O
the	O
cryoblock	O
are	O
transferred	O
to	O
cassette	O
"	O
FS1A	O
.	O

"	O
A	O
.	O
touch	O
prep	O
is	O
.	O
also	O
performed	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
in	O
.	O
cassette	O
.	O

"	O
1B	O
.	O
'	O
.	O

Specimen	O
#	O
2	O
is	O
received	O
in	O
formalin	O
and	O
is	O
labeled	O
as	O
"	O
right	O
.	O
frontal	O
brain	O
.	O
lesion	O
.	O

"	O
It	O
consists	O
of	O
multiple	O
fragments	O
of	O
brain	O
with	O
adherent	O
.	O
hemorrhage	O
.	O

measuring	O
4	O
.	O
0	O
X	O
3	O
.	O
8	O
X	O
2	O
.	O
3	O
cm	O
in	O
aggregate	O
.	O

The	O
entire	O
specimen	O
is	O
.	O
submitted	O
.	O
in	O
cassettes	O
"	O
2A	O
"	O
through	O
"	O
2G	O
.	O
"	O
Dictated	O
by	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
FS1A	O
,	O
TP1A	O
:	O
RIGHT	O
FRONTAL	O
BRAIN	O
LESION	O
,	O
BIOPSY	O
(	O
FROZEN	O
SECTION	O
,	O
.	O
TOUCH	O
.	O
PREPARATION	O
)	O
:	O
GLIOBLASTOMA	O
.	O

Frozen	O
Section	O
results	O
were	O
communicated	O
to	O
the	O
surgical	O
.	O
team	O
and	O
.	O
were	O
repeated	O
back	O
by	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
Microscopic	O
examination	O
performed	O
.	O

SPECIAL	O
STAINS	O
:	O
FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FISH	O
.	O

DONE	O
.	O

FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
.	O

SPECIMEN	O
:	O
Brain	O
,	O
right	O
frontal	O
lesion	O
.	O

CLINICAL	O
HISTORY	O
/	O
REFERRING	O
DIAGNOSIS	O
:	O
Glioblastoma	O
with	O
oligodendroglioma	O
component	O
,	O
WHO	O
grade	O
IV	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Paraffin	O
block	O
1B	O
.	O

TEST	O
PERFORMED	O
/	O
PROBES	O
USED	O
:	O
EGFR	O
gene	O
locus	O
specific	O
probe	O
(	O
7p12	O
)	O
.	O

Chromosome	O
7	O
alpha	O
satellite	O
DNA	O
specific	O
probe	O
(	O
7p11	O
.	O
1	O
-	O
7q11	O
.	O
1	O
)	O
.	O

Probe	O
for	O
chromosome	O
1p36	O
.	O

Probe	O
for	O
chromosome	O
1q25	O
.	O

Probe	O
for	O
chromosome	O
19p13	O
.	O

Probe	O
for	O
chromosome	O
19q13	O
.	O

NEGATIVE	O
for	O
EGFR	O
gene	O
amplification	O
.	O
nuc	O
ish	O
7cen	O
(	O
D7Z1x2	O
-	O
10	O
)	O
,	O
7p12	O
(	O
EGFRx2	O
-	O
10	O
)	O
[	O
200	O
/	O
200	O
]	O
.	O

NEGATIVE	O
for	O
chromosome	O
1p36	O
deletion	O
.	O
nuc	O
ish	O
(	O
TP73	O
x	O
2	O
)	O
,	O
(	O
ANGPTL	O
X	O
2	O
)	O
[	O
170	O
/	O
200	O
]	O
.	O

NEGATIVE	O
for	O
chromosome	O
19q13	O
deletion	O
.	O
nuc	O
ish	O
(	O
ZNF443	O
X	O
2	O
)	O
,	O
(	O
GLTSCR	O
x	O
2	O
)	O
[	O
166	O
/	O
200	O
]	O
.	O

INTERPRETATION	O
:	O
Flourescence	O
in	O
situ	O
hybridization	O
was	O
performed	O
using	O
the	O
above	O
.	O
listed	O
DNA	O
.	O
probes	O
.	O

The	O
probes	O
were	O
simultaneously	O
.	O
hybridized	O
to	O
a	O
.	O
section	O
of	O
the	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
tissue	O
submitted	O
.	O
for	O
.	O

evaluation	O
.	O

Submittion	O
Ph	O
,	O
.	O

Intracp	O
Patholeg	O
:	O
at	O
:	O
Performing	O
Phymiciani	O
.	O

HIETORY	O
:	O
YEAR	O
-	O
OLD	O
FEMALE	O
NITH	O
HISTORY	O
OF	O
PITUITARY	O
ADENCIA	O
EXCIEION	O
,	O
PAPATHYROID	O
ADENOMA	O
.	O

PRECPERATIVE	O
.	O

MASS	O
AT	O
HEAD	O
CF	O
FANCREAS	O
.	O

EPECIMEN	O
.	O

Me	O
CALE	O
-	O
BLADDER	O
,	O
LIVER	O
BIOPSY	O
PS	O
.	O

B	O
.	O

PANCREATIC	O
DUODENESTOMY	O
4FS	O
.	O

FINAL	O
DIADNCSIE	O
:	O
A	O
.	O

LIVER	O
,	O
CALLBLADDER	O
FOSSA	O
,	O
BIOPSY	O
:	O
Liver	O
parenciyma	O
with	O
aream	O
of	O
necromia	O
and	O
grant	O
cell	O
fore	O
:	O
gn	O
body	O
resction	O
.	O

No	O
viable	O
tumor	O
is	O
identified	O
.	O

a	O
.	O

PANCREATIC	O
DUODENECTOMY	O
:	O
Pancrestic	O
neuroendoerine	O
.	O
tumar	O
,	O
.	O

ISee	O
key	O
pathologic	O
findings	O
)	O
.	O

KEY	O
PATHOLOGICAL	O
FINDINGS	O
.	O

Epezimen	O
type	O
:	O
Whipple	O
procedure	O
.	O

Tumor	O
site	O
:	O
Read	O
of	O
pancreas	O
.	O
type	O
:	O
Pancreatic	O
tumor	O
.	O

Tumar	O
differantiatiane	O
.	O

Kell	O
differentiated	O
.	O

Tumor	O
Tacality	O
.	O

Twa	O
tumaz	O
poduies	O
.	O

Tumor	O
configusation	O
:	O
Nodulor	O
.	O

Tunor	O
mire	O
:	O
1	O
.	O
3	O
-	O
and	O
0	O
,	O
5	O
em	O
in	O
greatent	O
dimension	O
,	O
respectively	O
.	O

Other	O
organse	O
.	O

Duadenum	O
,	O
and	O
distal	O
portion	O
of	O
stonach	O
.	O

Extent	O
of	O
invanion	O
:	O
Pancream	O
and	O
up	O
to	O
of	O
duodemut	O
.	O

Le	O
invasion	O
:	O
Present	O
.	O

Perineural	O
invasion	O
:	O
Not	O
identifaed	O
.	O

Mitotic	O
autivity	O
:	O
2	O
/	O
50	O
.	O

Margina	O
:	O
Free	O
c	O
!	O

tumor	O
,	O
however	O
the	O
tumor	O
is	O
at	O
Ims	O
.	O

of	O
.	O
the	O
.	O

retraperitoneal	O
.	O
resection	O
margin	O
.	O

Lymph	O
noder	O
:	O
Mecastatic	O
pascrestic	O
.	O
tumor	O
to	O
five	O
of	O
nine	O
regional	O
lymph	O
aodes	O
involved	O
by	O
tumor	O
145	O
/	O
91	O
.	O

Distant	O
.	O

Liver	O
with	O
no	O
evidence	O
of	O
viable	O
tumor	O
,	O
Additional	O
.	O
pathologic	O
findinga	O
:	O
Focal	O
acute	O
pancreation	O
,	O
Pathclogic	O
.	O
stage	O
:	O
NA	O
.	O

I	O
.	O

M	O
.	O
D	O
.	O
the	O
attending	O
pathologist	O
,	O
perocnally	O
revieved	O
the	O
entire	O
.	O
pathlory	O
case	O
and	O
rendered	O
the	O
final	O
Electronically	O
Signed	O
out	O
by	O
.	O

OTHER	O
RELATED	O
CLINICAL	O
LATA	O
:	O
NA	O
.	O

INTRACPERATIVE	O
.	O

FROZEN	O
CECTION	O
DIAGNOEIE	O
.	O

FEA	O
.	O

CALLELADDER	O
,	O
LIVER	O
BIOPEY	O
.	O

FEAL	O
.	O

Benign	O
liver	O
tiasue	O
.	O

No	O
viable	O
tumor	O
seen	O
.	O

FEE	O
.	O

PANCREATIC	O
DOCDENECTOMY	O
.	O

FEBI	O
.	O

Parenchymal	O
renection	O
margin	O
im	O
negative	O
.	O

FEB2	O
.	O

Bile	O
duct	O
margin	O
5	O
segative	O
.	O

FEB3	O
:	O
Smaller	O
tumor	O
im	O
neuroeniogrine	O
tumor	O
.	O

7E34	O
.	O

Large	O
timor	O
im	O
neurcendocrine	O
tumor	O
.	O

CONDENT	O
:	O
This	O
frezen	O
aection	O
was	O
cumminicated	O
to	O
and	O
acknowledged	O
by	O
.	O

I	O
,	O
.	O

M	O
.	O
D	O
.	O
,	O
have	O
performed	O
the	O
intrapperative	O
.	O
conmultation	O
and	O
incued	O
the	O
above	O
diagnoses	O
.	O

GROCE	O
DESCRIPTION	O
:	O
A	O
.	O

Specimen	O
A	O
is	O
received	O
Exenh	O
labeled	O
:	O
allbladdex	O
fosms	O
,	O
liver	O
bicpay	O
.	O
"	O
The	O
.	O
specimen	O
consists	O
of	O
an	O
irregular	O
,	O
uncriented	O
fragment	O
CE	O
tan	O
cod	O
-	O
brown	O
rubbery	O
.	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
which	O
is	O
submitted	O
entirely	O
for	O
section	O
.	O

as	O
.	O

D	O
.	O

Specimen	O
a	O
is	O
received	O
freak	O
labeled	O
pancreatic	O
all	O
margins	O
on	O
.	O
rozen	O
aection	O
,	O
mingle	O
long	O
in	O
pancreatic	O
margin	O
,	O
double	O
long	O
in	O
.	O
mingle	O
abort	O
is	O
bile	O
duct	O
margim	O
-	O
The	O
apecimen	O
conniata	O
of	O
ducdenum	O
19	O
.	O
6	O
en	O
.	O
in	O
length	O
and	O
up	O
to	O
3	O
.	O
5	O
en	O
in	O
sircumferecce	O
at	O
the	O
stapled	O
distal	O
remection	O
.	O

margia	O
)	O
,	O
diatal	O
pertion	O
of	O
atomach	O
115	O
,	O
0	O
along	O
lesser	O
curvature	O
,	O
15	O
.	O
0	O
em	O
along	O
.	O
the	O
greater	O
curvature	O
,	O
and	O
13	O
.	O
0	O
em	O
in	O
circumfexence	O
et	O
the	O
ptapled	O
proximal	O
.	O
resectica	O
margin	O
)	O
,	O
pancreatic	O
head	O
17	O
.	O
0	O
x	O
6	O
.	O
0	O
2	O
.	O
5	O
=	O
m	O
)	O
There	O
is	O
11	O
.	O

of	O
.	O
adipose	O
tissue	O
et	O
graster	O
and	O
lemmer	O
cimextium	O
attached	O
to	O
the	O
grester	O
and	O
leaser	O
.	O
curvature	O
of	O
the	O
stcmach	O
reppectively	O
.	O

The	O
peroma	O
,	O
of	O
tha	O
atomach	O
in	O
tan	O
-	O
pick	O
,	O
.	O
glistening	O
,	O
mildly	O
connested	O
.	O

The	O
outer	O
surface	O
of	O
the	O
ducdemum	O
is	O
phaggy	O
.	O
with	O
amall	O
amount	O
of	O
attacked	O
fibroadipose	O
tissue	O
.	O

The	O
apecimea	O
ia	O
aziented	O
.	O
according	O
to	O
the	O
surgeon	O
'	O
a	O
depignation	O
and	O
inked	O
on	O
follows	O
:	O
Proximal	O
resection	O
margin	O
of	O
the	O
atomach	O
opened	O
and	O
inked	O
black	O
.	O

Distal	O
resection	O
margin	O
of	O
the	O
duodenum	O
opened	O
and	O
inked	O
blue	O
.	O

Euperior	O
aspect	O
of	O
the	O
papcrestic	O
head	O
inked	O
black	O
.	O

Anterion	O
aspect	O
of	O
the	O
pancrestic	O
heard	O
and	O
uncinate	O
proceda	O
inked	O
greeri	O
.	O

Uncinate	O
reascion	O
margin	O
inked	O
blue	O
.	O

Petroperitansal	O
resection	O
sargin	O
inked	O
crange	O
.	O

Tangential	O
section	O
of	O
the	O
pareschymal	O
resectica	O
margin	O
ct	O
the	O
pancreatic	O
hend	O
da	O
.	O
mubitter	O
for	O
Frozen	O
section	O
as	O
FEBT	O
.	O

Tangential	O
section	O
of	O
the	O
bide	O
duct	O
mary	O
:	O
for	O
fromen	O
section	O
as	O
PSB2	O
.	O

Representative	O
sectiona	O
DE	O
the	O
maller	O
and	O
.	O
larger	O
tumora	O
submitted	O
fcr	O
frozen	O
mection	O
as	O
PEB3	O
and	O
PER4	O
respectively	O
.	O

On	O
.	O
accioming	O
,	O
the	O
pancrestic	O
head	O
reveals	O
2	O
tumor	O
zodules	O
.	O

The	O
tamor	O
nodule	O
number	O
.	O

1	O
.	O
measures	O
up	O
to	O
1	O
,	O
3	O
em	O
in	O
greatent	O
dimensica	O
and	O
in	O
0	O
.	O
3	O
em	O
from	O
the	O
closest	O
anterior	O
.	O
margin	O
of	O
pancreatic	O
head	O
,	O
0	O
.	O
3	O
cm	O
from	O
the	O
dicdenal	O
wall	O
,	O
1	O
.	O
4	O
cm	O
frcm	O
the	O
common	O
.	O
bile	O
duct	O
,	O
0	O
.	O
8	O
cm	O
from	O
the	O
clonest	O
resection	O
maryin	O
,	O
and	O
4	O
.	O
0	O
em	O
.	O
from	O
the	O
parenchymel	O
resection	O
margin	O
of	O
the	O
pancreatic	O
head	O
.	O

The	O
cut	O
surface	O
of	O
.	O
the	O
nodule	O
mumber	O
in	O
tham	O
pink	O
wichcue	O
evidence	O
of	O
necrosia	O
.	O
axx	O
.	O

hemorrhage	O
.	O

The	O
tumor	O
nedule	O
number	O
2	O
measuren	O
up	O
to	O
a	O
.	O
s	O
em	O
in	O
dumension	O
.	O
and	O
in	O
0	O
.	O
2	O
em	O
from	O
the	O
clesent	O
anterice	O
ampect	O
of	O
pancreatic	O
headi	O
.	O

This	O
tumor	O
la	O
.	O

1	O
.	O
0	O
em	O
from	O
the	O
cloment	O
uncinate	O
procesa	O
resection	O
margin	O
,	O
1	O
.	O
5	O
em	O
from	O
the	O
vall	O
of	O
.	O
main	O
pancreatic	O
duet	O
,	O
2	O
.	O
5	O
em	O
from	O
the	O
wall	O
ef	O
common	O
biie	O
duat	O
;	O
and	O
1	O
.	O
7	O
from	O
the	O
.	O
duodenal	O
wall	O
.	O

The	O
remaining	O
parenchyms	O
of	O
the	O
head	O
DE	O
gancreas	O
in	O
tan	O
pale	O
-	O
yellow	O
.	O
to	O
tan	O
-	O
pink	O
,	O
lobulated	O
,	O
and	O
grosmly	O
unremarkable	O
.	O

The	O
main	O
pancrectic	O
duet	O
and	O
.	O
comman	O
bile	O
duet	O
ar	O
#	O
grocaly	O
usremarkable	O
.	O

The	O
ampalla	O
of	O
Vater	O
in	O
al	O
inbtly	O
.	O
promiment	O
and	O
grously	O
unsemarkable	O
.	O

The	O
the	O
stomach	O
is	O
tan	O
-	O
pink	O
,	O
.	O
plisteming	O
,	O
focally	O
erythematoum	O
,	O
and	O
exhibita	O
preservation	O
of	O
rugae	O
.	O

The	O
mucoma	O
of	O
.	O
the	O
duodestum	O
in	O
tan	O
-	O
pick	O
,	O
macth	O
,	O
glistening	O
,	O
and	O
ham	O
the	O
intestisal	O
folds	O
.	O

The	O
peripheral	O
margina	O
of	O
pancrestic	O
head	O
compoaed	O
=	O
E	O
tan	O
pale	O
-	O
yellew	O
,	O
soft	O
,	O
.	O
lebulated	O
adipoge	O
tinsue	O
,	O
which	O
ia	O
ranging	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O
5	O
em	O
in	O
th	O
	O
ckneas	O
.	O

A	O
.	O
single	O
possible	O
lymph	O
node	O
1a	O
identified	O
with	O
:	O
fibroadipose	O
tionue	O
of	O
the	O
superior	O
.	O
ampect	O
of	O
the	O
pancreatic	O
head	O
.	O

Five	O
grossly	O
recognizable	O
lymph	O
nodes	O
are	O
dentified	O
.	O
within	O
fibroadipone	O
ticaue	O
of	O
retroperitoneal	O
aspect	O
of	O
pancreatic	O
head	O
,	O
ranging	O
.	O
frem	O
0	O
.	O
1	O
to	O
1	O
.	O
2	O
cm	O
in	O
greatent	O
dimencion	O
.	O

The	O
biggest	O
Tymph	O
sode	O
in	O
groasly	O
.	O
positive	O
for	O
malignancy	O
.	O

No	O
lymph	O
nodes	O
are	O
identified	O
within	O
fibroadipcse	O
tiasue	O
.	O

af	O
anterior	O
aspect	O
of	O
pancreatic	O
head	O
.	O

No	O
lymph	O
noden	O
are	O
identified	O
within	O
adipone	O
.	O
tupaue	O
c	O
	O
pertion	O
of	O
greater	O
cmentum	O
.	O

No	O
lymph	O
nodes	O
are	O
identified	O
attached	O
to	O
the	O
.	O
lesner	O
curvature	O
c5	O
the	O
stomach	O
and	O
duodenum	O
.	O

Representative	O
dection	O
of	O
the	O
.	O
specimen	O
submitted	O
to	O
the	O
procurement	O
laboratory	O
.	O

The	O
digital	O
picture	O
c	O
	O
.	O
the	O
.	O

specimen	O
is	O
taken	O
.	O

Representative	O
secticas	O
of	O
the	O
specimen	O
aze	O
submitted	O
in	O
19	O
.	O
cassettes	O
,	O
ar	O
-	O
a19	O
,	O
as	O
ollows	O
:	O
21	O
-	O
93	O
:	O
Tangential	O
section	O
of	O
he	O
proximal	O
resection	O
sargin	O
of	O
.	O
the	O
stonach	O
.	O

84	O
:	O
Tangential	O
nection	O
of	O
the	O
distal	O
resection	O
margio	O
c	O
!	O

the	O
.	O
ducdenum	O
.	O

BS	O
:	O
Ampulla	O
of	O
Vater	O
.	O

Ares	O
of	O
junceios	O
between	O
main	O
pancreatic	O
duet	O
and	O
common	O
.	O
bile	O
duet	O
.	O

97	O
-	O
26	O
:	O
Tumor	O
number	O
with	O
clomeat	O
anterior	O
aspect	O
of	O
.	O
pancreatio	O
head	O
.	O

Tumor	O
number	O
1	O
with	O
clomest	O
duodenal	O
wall	O
.	O

810	O
,	O
.	O

Tumor	O
number	O
1	O
with	O
ciccest	O
common	O
bilm	O
duet	O
wall	O
.	O
all	O
.	O

Tangential	O
section	O
of	O
uncinate	O
process	O
resection	O
margin	O
.	O

012	O
-	O
813	O
:	O
Bemaining	O
tumor	O
number	O
2	O
with	O
closest	O
anterior	O
ampest	O
.	O
of	O
panscestic	O
hesd	O
.	O

204	O
,	O
.	O

Two	O
lymph	O
nodea	O
,	O
grester	O
periteneal	O
aspect	O
of	O
pancreatio	O
bead	O
.	O

315	O
:	O
One	O
lyeph	O
node	O
,	O
retropezitcneal	O
ampect	O
.	O

al6	O
:	O
Twa	O
lymph	O
nodes	O
,	O
retroperitoment	O
ampect	O
.	O

017	O
-	O
910	O
:	O
The	O
remaining	O
retexperitopeal	O
resection	O
margin	O
of	O
the	O
.	O
pancreatio	O
head	O
,	O
perpendiculas	O
sectiona	O
.	O

One	O
lymph	O
node	O
,	O
superior	O
mapect	O
OF	O
pancreation	O
head	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
DISTAL	O
PANCREAS	O
,	O
RESECTION	O
-	O
.	O

A	O
.	O

SEEIOMYOSARCOM	O
	O
;	O
INTERMEDIATE	O
GRADE	O
(	O
3	B
.	I
5	I
CM	I
)	O
,	O
INVOLVING	O
PANCREATIC	O
PARENCHYMA	O
(	O
see	O
.	O
comment	O
)	O
.	O

B	O
.	O

PANCREATIC	O
MARGIN	O
IS	O
FREE	O
OF	O
TUMOR	O
.	O

C	O
.	O

PANCREATIC	O
PARENCHYMA	O
WITH	O
FOCAL	O
CHRONIC	O
PANCREATITIS	O
AND	O
LOW	O
GRADE	O
PaniN	O
.	O

D	O
.	O

FOUR	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
4	O
)	O
.	O

E	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT1b	O
NO	O
Mx	O
.	O

PART	O
2	O
:	O
SPLEEN	O
,	O
SPLENECTOMY	O
-	O
.	O

A	O
.	O

SPLEEN	O
WITH	O
NO	O
SIGNIFICANT	O
ABNORMALITY	O
.	O

B	O
.	O

THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

PART	O
3	O
:	O
LYMPH	O
NODE	O
,	O
HEPATIC	O
ARTERY	O
,	O
EXCISION	O
-	O
.	O

TWO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

COMMENT	O
:	O
The	O
neoplasm	O
is	O
composed	O
of	O
pleomorphic	O
spindled	O
cells	O
arranged	O
in	O
fascicles	O
with	O
focal	O
necrosis	O
(	O
approximately	O
5	O
%	O
)	O
.	O
and	O
mitoses	O
of	O
21	O
per	O
50	O
high	O
power	O
fields	O
.	O

The	O
tumor	O
is	O
strongly	O
immunoreactive	O
for	O
actin	O
and	O
desmin	O
and	O
Ki67	O
.	O
decorates	O
approximately	O
20	O
%	O
of	O
the	O
tumor	O
nuclei	O
.	O

CD34	O
highlights	O
the	O
vasculature	O
.	O

S100	O
,	O
AE1	O
/	O
3	O
,	O
DOG1	O
,	O
CKit	O
and	O
.	O

HMB45	O
are	O
negative	O
.	O

These	O
results	O
together	O
with	O
the	O
morphology	O
support	O
an	O
intermediate	O
grade	O
leiomyosarcoma	O
.	O

The	O
.	O
tumor	O
may	O
represent	O
a	O
primary	O
intra	O
-	O
abdominal	O
/	O
retroperitoneal	O
leiomyosarcoma	O
and	O
has	O
been	O
staged	O
as	O
such	O
in	O
this	O
.	O
report	O
.	O

Alternatively	O
,	O
the	O
tumor	O
may	O
represent	O
a	O
metastasis	O
.	O

A	O
uterine	O
primary	O
may	O
be	O
considered	O
.	O

Clinical	O
and	O
.	O
radiographic	O
correlation	O
is	O
suggested	O
.	O
has	O
also	O
reviewed	O
part	O
2	O
in	O
this	O
case	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
SOFT	O
TISSUE	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Radical	O
resection	O
.	O

TUMOR	O
SITE	O
:	O
pancreas	O
.	O

TUMOR	O
DEPTH	O
:	O
Deep	O
:	O
Intra	O
-	O
abdominal	O
.	O

Deep	O
:	O
Retroperitoneal	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
3	B
.	I
1	I
cm	I
.	O

PRERESECTION	O
TREATMENT	O
:	O
No	O
therapy	O
.	O

HISTOLOGIC	O
TYPE	O
(	O
WHO	O
classification	O
of	O
soft	O
tissue	O
tumors	O
)	O
:	O
leiomyosarcoma	O
.	O

RESULTS	O
OF	O
ANCILLARY	O
STUDIES	O
:	O
see	O
comment	O
.	O

MITOTIC	O
RATE	O
:	O
6	O
/	O
10	O
high	O
-	O
power	O
fields	O
.	O

MACROSCOPIC	O
NECROSIS	O
:	O
Absent	O
.	O

MICROSCOPIC	O
NECROSIS	O
:	O
Present	O
:	O
Extent	O
:	O
5	O
%	O
.	O

GRADE	O
:	O
System	O
used	O
:	O
r	O
.	O

Grade	O
:	O
Grade	O
2	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
pT1b	O
.	O

pNO	O
.	O

Number	O
regional	O
lymph	O
nodes	O
examined	O
:	O
9	O
.	O

Number	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

pMX	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
sarcoma	O
.	O

MICROSCOPIC	O
VENOUS	O
/	O
LYMPHATIC	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
:	O
Absent	O
.	O

PERINEURAL	O
INVASION	O
:	O
Absent	O
.	O

Reason	O
for	O
the	O
Exam	O
:	O
PANCREATIC	O
MASS	O
.	O

EXAMINATION	O
PERFORMED	O
:	O
CT	O
ABDOMEN	O
WITH	O
AND	O
WITHOUT	O
CONTRAST	O
.	O

CLINICAL	O
INDICATION	O
:	O
Pancreatic	O
mass	O
with	O
pathology	O
consistent	O
with	O
spindle	O
cell	O
carcinoma	O
.	O

TECHNIQUE	O
:	O
Helical	O
2	O
.	O

.	O
5mm	O
images	O
were	O
obtained	O
from	O
the	O
lung	O
apices	O
through	O
the	O
.	O
pelvis	O
following	O
the	O
uneventful	O
IV	O
administration	O
of	O
125cc	O
of	O
Isovue	O
.	O

370	O
.	O

Post	O
-	O
contrast	O
images	O
were	O
obtained	O
during	O
arterial	O
and	O
venous	O
.	O
phases	O
per	O
pancreatic	O
mass	O
protocol	O
.	O

COMPARISON	O
:	O
None	O
.	O

FINDINGS	O
:	O
Lung	O
:	O
There	O
is	O
mild	O
emphysema	O
;	O
otherwise	O
lungs	O
are	O
clear	O
.	O

There	O
is	O
no	O
.	O
effusion	O
or	O
pneumothorax	O
.	O

Heart	O
size	O
is	O
normal	O
with	O
no	O
effusion	O
.	O

No	O
.	O
enlarged	O
thora	O
	O
ic	O
lymph	O
nodes	O
are	O
noted	O
.	O

Abdomen	O
:	O
There	O
is	O
a	O
3x3cm	O
hypo	O
-	O
attenuating	O
and	O
hypovascular	O
lesion	O
.	O
inproximal	O
body	O
of	O
pancreas	O
.	O

The	O
lesion	O
is	O
round	O
and	O
is	O
well	O
.	O
demarcated	O
with	O
has	O
lower	O
attenuation	O
than	O
the	O
rest	O
of	O
pancreas	O
on	O
.	O
all	O
phases	O
.	O

There	O
is	O
no	O
finding	O
of	O
invasion	O
to	O
adjacent	O
organs	O
or	O
.	O
vascular	O
structures	O
.	O

The	O
remainder	O
of	O
the	O
pancreas	O
is	O
normal	O
with	O
no	O
.	O
additional	O
focal	O
lesion	O
,	O
atrophy	O
or	O
ductal	O
dilatation	O
.	O

There	O
is	O
a	O
small	O
hypoattenuating	O
lesion	O
in	O
segment	O
8	O
of	O
liver	O
,	O
.	O
measuring	O
1	O
.	O
3cm	O
.	O

The	O
lesion	O
is	O
hypoattenuating	O
on	O
the	O
unenhanced	O
and	O
.	O
arterial	O
phases	O
;	O
on	O
the	O
portal	O
phase	O
,	O
there	O
is	O
the	O
suggestion	O
of	O
.	O
subtle	O
discontinuous	O
nodular	O
peripheral	O
enhancement	O
,	O
favoring	O
a	O
.	O
benign	O
etiology	O
(	O
such	O
as	O
sclerosed	O
hemangioma	O
)	O
The	O
liver	O
is	O
.	O
otherwise	O
normal	O
.	O

The	O
hepatic	O
vessels	O
are	O
patent	O
.	O

The	O
spleen	O
and	O
.	O
adrenal	O
glands	O
are	O
unremarkable	O
.	O

There	O
is	O
a	O
7mm	O
hypoattenuating	O
.	O
lesion	O
in	O
the	O
midpole	O
of	O
the	O
left	O
kidney	O
which	O
is	O
too	O
small	O
to	O
.	O
characterize	O
.	O

The	O
kidneys	O
are	O
otherwise	O
normal	O
.	O

There	O
is	O
no	O
.	O
intra	O
-	O
abdaminal	O
fluid	O
collection	O
or	O
enlarged	O
lymph	O
nodes	O
.	O

The	O
stomach	O
.	O
and	O
loops	O
of	O
small	O
and	O
large	O
bowel	O
are	O
normal	O
in	O
course	O
and	O
.	O
appearance	O
.	O

Pelvis	O
:	O
The	O
rectum	O
,	O
sigmoid	O
,	O
appendix	O
,	O
uterus	O
and	O
adnexa	O
and	O
bladder	O
.	O
are	O
unremarkable	O
.	O

There	O
is	O
no	O
intrapelvic	O
fluid	O
collection	O
or	O
.	O
enlarged	O
lymph	O
nodes	O
.	O

No	O
osseous	O
abnormalities	O
are	O
identified	O
.	O

IMPRESSION	O
:	O
CHEST	O
:	O
1	O
.	O

MILD	O
EMPHYSEMA	O
;	O
NO	O
FINIDNGS	O
OF	O
METASTASIS	O
.	O

ABDOMEN	O
:	O
1	O
.	O

3X3CM	O
WELL	O
-	O
DEFINED	O
HYPOVASCULAR	O
MASS	O
WITHIN	O
THE	O
PROXIMAL	O
BODY	O
OF	O
.	O

PANCREAS	O
CORRELATING	O
TO	O
PATIENT	O
'	O
S	O
KNOWN	O
SARCOMA	O
;	O
THERE	O
IS	O
NOFINIDNG	O
.	O

OF	O
INVASION	O
INTO	O
VASCULAR	O
STRUCTURES	O
OR	O
ADJACENT	O
ORGANS	O
.	O

2	O
.	O

SMALL	O
HYPOATTENUATING	O
LESION	O
IN	O
SEGMENT	O
8	O
OF	O
THE	O
LIVER	O
IS	O
FAVORED	O
.	O

TO	O
BE	O
DUE	O
TO	O
A	O
BENIGN	O
ETIOLOGY	O
WITH	O
DIFFERENTIAL	O
CONSIDERATIONS	O
.	O

INCLUDINGSCLEROSED	O
HEMANGIOMA	O
VERSUS	O
CYST	O
.	O

FOLLOW	O
-	O
UP	O
CT	O
CAN	O
ASSESS	O
.	O

STABILITY	O
.	O

PELVIS	O
:	O
1	O
.	O

UNREMARKABLE	O
PELVIC	O
CT	O
.	O

CLINICAL	O
HISTORY	O
:	O
-	O
year	O
-	O
old	O
female	O
status	O
post	O
laparoscopic	O
distal	O
pancreatectomy	O
and	O
.	O
splenectomy	O
for	O
pancreatic	O
leiomyosarcoma	O
on	O
.	O

COMPARISON	O
:	O
TECHNIQUE	O
:	O
2	O
5mm	O
axial	O
images	O
of	O
the	O
chest	O
,	O
abdomen	O
,	O
and	O
pelvis	O
were	O
obt	O
	O
ined	O
.	O
with	O
125	O
CC	O
of	O
Isovue	O
-	O
370	O
intravenous	O
contrast	O
and	O
Readi	O
-	O
Cat	O
oral	O
.	O
contrast	O
in	O
the	O
portal	O
venous	O
phase	O
.	O

Coronal	O
and	O
Bagittal	O
reformats	O
.	O
were	O
also	O
provided	O
.	O

.	O
FINDINGS	O
:	O
CHEST	O
:	O
"	O
The	O
visualized	O
thyroid	O
gland	O
and	O
great	O
vessels	O
are	O
unremarkable	O
.	O

A	O
.	O

3	O
.	O

nm	O
subpleural	O
right	O
lower	O
lobe	O
nodule	O
is	O
\	O
table	O
since	O
.	O
representing	O
a	O
benign	O
lesion	O
.	O

The	O
lungs	O
ar	O
	O
,	O
clear	O
without	O
suspicious	O
.	O
pulmonary	O
nodules	O
,	O
consolidation	O
,	O
or	O
pleural	O
effusion	O
.	O

There	O
are	O
no	O
.	O
enlarged	O
thoracic	O
lymph	O
nodes	O
.	O

The	O
heart	O
size	O
is	O
normal	O
with	O
no	O
.	O
pericardial	O
effusion	O
.	O

ABDOMEN	O
:	O
The	O
suspicious	O
hypodense	O
lesion	O
in	O
segment	O
has	O
enlarged	O
,	O
measuring	O
.	O

.	O
3cm	O
from	O
1	O
.	O
1cm	O
previously	O
.	O

Several	O
new	O
hypodense	O
lesions	O
including	O
.	O
segment	O
4A	O
1	O
.	O
3cm	O
focus	O
and	O
2	O
.	O
4x2	O
.	O
7cm	O
segment	O
6	O
lesion	O
are	O
new	O
and	O
.	O
concerning	O
for	O
metastases	O
.	O

The	O
nonenhancing	O
segment	O
4A	O
lesion	O
likely	O
.	O
representing	O
a	O
hepatic	O
cyst	O
isunchanged	O
.	O

The	O
spleen	O
,	O
distal	O
pancreas	O
,	O
.	O
and	O
gallbladder	O
are	O
surgically	O
absent	O
.	O

There	O
is	O
no	O
evidence	O
of	O
.	O
disease	O
recurrence	O
in	O
the	O
surgical	O
bed	O
.	O

The	O
adrenal	O
glands	O
and	O
right	O
.	O
kidney	O
are	O
unremarkable	O
.	O

A	O
lower	O
pole	O
posterior	O
left	O
renal	O
cyst	O
is	O
.	O
unchanged	O
.	O

The	O
small	O
and	O
large	O
bowel	O
are	O
normal	O
in	O
caliber	O
without	O
.	O
focal	O
wall	O
thickening	O
.	O

There	O
is	O
no	O
free	O
fluid	O
,	O
free	O
air	O
,	O
or	O
enlarged	O
.	O
lymph	O
nodes	O
in	O
the	O
abdomen	O
or	O
pelvis	O
.	O

Mild	O
atherosclerotic	O
calcifications	O
are	O
seen	O
in	O
a	O
normal	O
caliber	O
.	O
abdominal	O
aorta	O
.	O

A	O
5	O
cm	O
fat	O
containing	O
umbilical	O
hernia	O
is	O
unchanged	O
.	O

PELVIS	O
:	O
The	O
urinary	O
bladder	O
,	O
uterus	O
,	O
ovaries	O
,	O
and	O
rectum	O
are	O
unremarkable	O
.	O

Sigmoid	O
diverticulosis	O
is	O
seen	O
with	O
no	O
CT	O
evidence	O
of	O
diverticulitis	O
.	O

No	O
osteoblastic	O
or	O
lytic	O
lesions	O
are	O
identified	O
in	O
the	O
chest	O
,	O
.	O
abdomen	O
,	O
or	O
pelvis	O
.	O

IMPRESSION	O
:	O
CHEST	O
:	O
1	O
.	O

No	O
metastatic	O
disease	O
in	O
the	O
chest	O
.	O

ABDOMEN	O
:	O
1	O
.	O

Development	O
of	O
multiple	O
hypodense	O
lesions	O
compatible	O
with	O
.	O
metastatic	O
disease	O
in	O
segments	O
4A	O
,	O
6	O
,	O
and	O
7	O
with	O
the	O
largest	O
.	O
measuring	O
2	O
.	O
4x2	O
.	O
7cm	O
in	O
segment	O
6	O
.	O

2	O
.	O

No	O
evidence	O
of	O
local	O
disease	O
recurrence	O
or	O
enlarged	O
lymph	O
nodes	O
.	O

3	O
.	O

Unchanged	O
fat	O
containing	O
umbilical	O
hernia	O
.	O

PELVIS	O
:	O
1	O
.	O

No	O
acute	O
abnormalities	O
in	O
the	O
pelvis	O
.	O

2	O
.	O

Sigmoid	O
diverticulosis	O
.	O

CLINICAL	O
HISTORY	O
:	O
Date	O
of	O
Event	O
.	O

Liver	O
lesion	O
.	O

History	O
of	O
leiomyosarcoma	O
of	O
pancreas	O
.	O

SOURCE	O
-	O
OF	O
SPECIMEN	O
:	O
LIVER	O
,	O
US	O
-	O
GUIDED	O
FINE	O
NEEDLE	O
ASPIRATION	O
.	O

Addendum	O
.	O

The	O
liver	O
FNA	O
was	O
reviewed	O
at	O
.	O

(	O
outside	O
accession	O
number	O
.	O
and	O
interpreted	O
as	O
"	O
Positive	O
for	O
malignant	O
cells	O
,	O
Metastatic	O
high	O
.	O
grade	O
leiomyosarcoma	O
which	O
is	O
in	O
agreement	O
with	O
the	O
original	O
diagnosis	O
.	O
rendered	O
in	O
this	O
case	O
.	O

The	O
outside	O
pathology	O
report	O
is	O
archived	O
and	O
available	O
.	O
from	O
the	O
.	O
athology	O
Department	O
upon	O
request	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
LIVER	O
,	O
US	O
-	O
GUIDED	O
FINE	O
NEEDLE	O
ASPIRATION	O
:	O
SATISFACTORY	O
FOR	O
INTTERPRETATION	O
.	O

POSITIVE	O
FOR	O
MALIGNANT	O
CELLS	O
.	O

METASTATIC	O
LEIOMYOSARCOMA	O
(	O
SEE	O
COMMENT	O
)	O
.	O

LXP	O
/	O
LXP	O
.	O

COMMENT	O
:	O
The	O
FNA	O
contains	O
a	O
spindle	O
cell	O
neoplasm	O
with	O
myxoid	O
change	O
.	O

Immunostains	O
.	O
performed	O
on	O
scant	O
cell	O
block	O
material	O
show	O
that	O
the	O
tumor	O
cells	O
are	O
positive	O
.	O
for	O
desmin	O
and	O
cladesmon	O
which	O
supports	O
the	O
above	O
diagnosis	O
.	O

The	O
cell	O
block	O
.	O
contains	O
insufficient	O
tumor	O
material	O
to	O
evaluate	O
actin	O
and	O
8100	O
stains	O
.	O

SURG	O
PATH	O
#	O
:	O
SPECIMEN	O
CLASS	O
:	O
ALT	O
ID	O
#	O
:	O
SEX	O
:	O
F	O
.	O

DATE	O
RECEIVED	O
:	O
DATE	O
OF	O
PRINTING	O
:	O
Material	O
Received	O
:	O
A	O
:	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
blue	O
.	O

B	O
:	O
C	O
:	O
D	O
:	O
left	O
left	O
breast	O
axillary	O
total	O
sentinel	O
mastectomy	O
lymph	O
node	O
#	O
2	O
blue	O
Site	O
e50	O
.	O
9	O
.	O

8	O
o	O
'	O
clock	O
additional	O
medial	O
short	O
superior	O
,	O
long	O
anterior	O
,	O
clip	O
true	O
margin	O
.	O

E	O
:	O
8	O
o	O
'	O
clock	O
additional	O
inferior	O
short	O
anterior	O
,	O
long	O
lateral	O
clip	O
true	O
margin	O
.	O

F	O
:	O
8	O
o	O
'	O
clock	O
additional	O
anterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
.	O

G	O
:	O
8	O
o	O
'	O
clock	O
additional	O
posterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
.	O

H	O
:	O
additional	O
skin	O
left	O
breast	O
blue	O
at	O
3	O
:	O
00	O
.	O

History	O
:	O
year	O
old	O
female	O
with	O
a	O
clinical	O
history	O
of	O
breast	O
cancer	O
.	O

Final	O
Diagnosis	O
:	O
A	O
.	O

Lymph	O
node	O
,	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
blue	O
"	O
,	O
biopsy	O
:	O
Micrometastatic	O
mammary	O
carcinoma	O
(	O
0	B
.	I
23	I
mm	I
)	O
identified	O
on	O
permanent	O
and	O
pancytokeratin	O
immunostained	O
sections	O
.	O
only	O
.	O

See	O
comment	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
2	O
blue	O
"	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
(	O
0	O
/	O
1	O
)	O
.	O

Deeper	O
sections	O
and	O
a	O
pancytokeratin	O
immunostain	O
are	O
negative	O
in	O
support	O
of	O
the	O
above	O
diagnosis	O
.	O

C	O
.	O

Breast	O
,	O
"	O
left	O
breast	O
total	O
mastectomy	O
"	O
,	O
mastectomy	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
moderately	O
differentiated	O
,	O
nuclear	O
grade	O
2	O
,	O
two	O
foci	O
(	O
measuring	O
1	B
.	I
2	I
cm	I
and	O
1	B
.	I
8	I
cm	I
in	O
greatest	O
.	O
dimension	O
respectively	O
)	O
.	O

See	O
comment	O
.	O

D	O
.	O

Fibroadipose	O
tissue	O
,	O
"	O
8	O
o	O
'	O
clock	O
additional	O
medial	O
short	O
superior	O
,	O
long	O
anterior	O
,	O
clip	O
true	O
margin	O
"	O
,	O
reresection	O
:	O
No	O
diagnostic	O
abnormalities	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

E	O
.	O

Fibroadipose	O
tissue	O
,	O
"	O
8	O
o	O
'	O
clock	O
additional	O
inferior	O
short	O
anterior	O
,	O
long	O
lateral	O
clip	O
true	O
margin	O
"	O
,	O
reresection	O
:	O
No	O
diagnostic	O
abnormalities	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

F	O
.	O

Fibroadipose	O
tissue	O
,	O
"	O
8	O
o	O
'	O
clock	O
additional	O
anterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
"	O
,	O
reresection	O
:	O
No	O
diagnostic	O
abnormalities	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

G	O
.	O

Skeletal	O
muscle	O
and	O
adipose	O
tissue	O
,	O
"	O
8	O
o	O
'	O
clock	O
additional	O
posterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
"	O
,	O
reresection	O
:	O
Date	O
of	O
Printing	O
:	O
SURGICAL	O
PAIHOLOGY	O
REPORT	O
.	O

SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
No	O
diagnostic	O
abnormalities	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

H	O
.	O

Skin	O
,	O
"	O
additional	O
skin	O
left	O
breast	O
blue	O
at	O
3	O
:	O
00	O
"	O
,	O
reresection	O
:	O
No	O
diagnostic	O
abnormalities	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

Comment	O
:	O
INVASIVE	O
CARCINOMA	O
OF	O
THE	O
BREAST	O
.	O

Specimen	O
Type	O
:	O
mastectomy	O
.	O

Laterality	O
:	O
left	O
.	O

Tumor	O
Site	O
:	O
lower	O
inner	O
quadrant	O
at	O
8	O
:	O
00	O
and	O
mid	O
outer	O
quadrant	O
at	O
3	O
:	O
00	O
.	O

Histologic	O
Type	O
:	O
Invasive	O
ductal	O
carcinoma	O
.	O

Size	O
of	O
Invasive	O
Component	O
:	O
1	B
.	I
2	I
cm	I
in	O
greatest	O
dimension	O
(	O
8	O
:	O
00	O
)	O
and	O
1	B
.	I
8	I
cm	I
in	O
greatest	O
dimension	O
(	O
3	O
:	O
00	O
)	O
.	O

Tumor	O
Multicentricity	O
:	O
Present	O
(	O
2	O
foci	O
as	O
noted	O
above	O
)	O
.	O

Surgical	O
Margins	O
:	O
Final	O
margins	O
are	O
negative	O
for	O
carcinoma	O
.	O

In	O
the	O
mastectomy	O
,	O
the	O
8	O
:	O
00	O
focus	O
is	O
within	O
0	O
.	O
1	O
cm	O
of	O
the	O
inferior	O
,	O
.	O
medial	O
.	O
and	O
anterior	O
margins	O
and	O
within	O
0	O
.	O
2	O
cm	O
of	O
the	O
deep	O
margin	O
;	O
however	O
the	O
separately	O
submitted	O
additional	O
medial	O
,	O
inferior	O
,	O
.	O
anterior	O
and	O
posterior	O
margins	O
(	O
specimens	O
D	O
through	O
G	O
)	O
are	O
negative	O
for	O
carcinoma	O
.	O

Histologic	O
Grade	O
(	O
Nottingham	O
Histologic	O
Score	O
)	O
:	O
II	O
/	O
III	O
.	O

Tubule	O
Formation	O
:	O
3	O
.	O

Nuclear	O
Grade	O
:	O
2	O
.	O

Mitotic	O
Count	O
(	O
40x	O
objective	O
)	O
:	O
1	O
.	O

Total	O
Nottingham	O
Score	O
:	O
6	O
/	O
9	O
.	O

Ductal	O
Carcinoma	O
In	O
-	O
situ	O
(	O
DCIS	O
)	O
:	O
Present	O
,	O
focal	O
,	O
intermediate	O
nuclear	O
grade	O
,	O
without	O
necrosis	O
.	O

Lobular	O
Carcinoma	O
In	O
-	O
situ	O
(	O
LCIS	O
)	O
:	O
Absent	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Present	O
,	O
focal	O
.	O

Perineural	O
Invasion	O
:	O
not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
not	O
identified	O
.	O

Nipple	O
Involvement	O
:	O
not	O
identified	O
.	O

Skin	O
Involvement	O
:	O
not	O
identified	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Sentinel	O
lymph	O
node	O
(	O
s	O
)	O
only	O
.	O

Total	O
number	O
of	O
involved	O
nodes	O
/	O
total	O
nodes	O
found	O
:	O
1	O
micrometastasis	O
out	O
of	O
2	O
nodes	O
.	O

Size	O
of	O
largest	O
metastasis	O
:	O
0	O
.	O
23	O
mm	O
.	O

Extranodal	O
extension	O
:	O
not	O
identified	O
.	O

Fixation	O
to	O
one	O
another	O
:	O
Non	O
-	O
neoplastic	O
Breast	O
Tissue	O
:	O
not	O
identified	O
.	O

Treatment	O
Effect	O
(	O
Response	O
to	O
Presurgical	O
Neoadjuvant	O
Therapy	O
)	O
:	O
In	O
the	O
Breast	O
:	O
In	O
the	O
Lymph	O
Nodes	O
:	O
Prognostic	O
markers	O
:	O
See	O
.	O
for	O
addendum	O
.	O
on	O
prior	O
biopsy	O
.	O

Fixation	O
Time	O
between	O
6	O
-	O
48	O
hours	O
:	O
Yes	O
.	O

Pathologic	O
Staging	O
:	O
pT2N	O
(	O
sn	O
)	O
1miM	O
(	O
not	O
applicable	O
)	O
.	O

Primary	O
Tumor	O
(	O
Invasive	O
Carcinoma	O
)	O
(	O
pT	O
)	O
.	O

pT1	O
:	O
Tumor	O
<	O
20	O
mm	O
in	O
greatest	O
dimension	O
.	O

pT1c	O
:	O
Tumor	O
>	O
10	O
mm	O
but	O
<	O
20	O
mm	O
in	O
greatest	O
dimension	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
.	O

(	O
sn	O
)	O
:	O
Only	O
sentinel	O
node	O
(	O
s	O
)	O
evaluated	O
.	O

If	O
6	O
or	O
more	O
sentinel	O
nodes	O
and	O
/	O
or	O
nonsentinel	O
nodes	O
are	O
removed	O
,	O
this	O
modifier	O
.	O
should	O
not	O
be	O
used	O
.	O

pN1mi	O
:	O
Micrometastases	O
(	O
greater	O
than	O
0	O
.	O
2	O
mm	O
and	O
/	O
or	O
more	O
than	O
200	O
cells	O
,	O
but	O
none	O
greater	O
than	O
2	O
.	O
0	O
mm	O
)	O
.	O

Distant	O
Metastasis	O
(	O
M	O
)	O
.	O

Not	O
applicable	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
as	O
it	O
reflects	O
only	O
current	O
pathologic	O
data	O
and	O
does	O
not	O
.	O
incorporate	O
full	O
knowledge	O
of	O
the	O
patient	O
'	O
s	O
clinical	O
status	O
and	O
/	O
or	O
prior	O
pathology	O
.	O

The	O
final	O
diagnosis	O
has	O
been	O
communicated	O
via	O
electronic	O
mail	O
to	O
.	O

Attestation	O
:	O
By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
I	O
have	O
personally	O
formulated	O
the	O
final	O
interpretation	O
expressed	O
in	O
this	O
report	O
and	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
.	O
upon	O
my	O
examination	O
of	O
the	O
slides	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
this	O
report	O
.	O

Interpreted	O
by	O
:	O
Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
blue	O
"	O
is	O
an	O
irregular	O
portion	O
of	O
red	O
-	O
tan	O
.	O
fibroadipose	O
tissue	O
.	O

The	O
tissue	O
is	O
palpated	O
to	O
reveal	O
one	O
possible	O
lymph	O
node	O
measuring	O
2	O
.	O
8	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
.	O

is	O
.	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
cassettes	O
A1FS	O
and	O
A2FS	O
for	O
frozen	O
and	O
permanent	O
diagnosis	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
2	O
blue	O
"	O
is	O
an	O
irregular	O
portion	O
of	O
red	O
-	O
tan	O
.	O
fibroadipose	O
tissue	O
.	O

The	O
tissue	O
is	O
palpated	O
to	O
reveal	O
one	O
possible	O
lymph	O
node	O
measuring	O
2	O
.	O
5	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
possible	O
lymph	O
.	O
node	O
is	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
in	O
cassette	O
B1FS	O
for	O
frozen	O
and	O
permanent	O
diagnosis	O
.	O

C	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
breast	O
total	O
mastectomy	O
short	O
superior	O
/	O
long	O
lateral	O
"	O
is	O
a	O
650	O
gram	O
.	O
simple	O
mastectomy	O
specimen	O
measuring	O
20	O
.	O
5	O
x	O
18	O
x	O
3	O
.	O
5	O
cm	O
.	O

There	O
is	O
a	O
short	O
stitch	O
marking	O
superior	O
and	O
a	O
long	O
stitch	O
marking	O
.	O
lateral	O
.	O

The	O
breast	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
tan	O
-	O
pink	O
stellate	O
mass	O
that	O
is	O
22	O
.	O
5	O
cm	O
from	O
the	O
lateral	O
margin	O
,	O
.	O
abutting	O
the	O
medial	O
margin	O
,	O
8	O
.	O
4	O
cm	O
from	O
the	O
superior	O
margin	O
,	O
abutting	O
the	O
inferior	O
margin	O
,	O
0	O
.	O
2	O
cm	O
from	O
the	O
superficial	O
margin	O
,	O
and	O
.	O

0	O
.	O
2	O
cm	O
from	O
the	O
deep	O
margin	O
.	O

The	O
mass	O
is	O
located	O
in	O
the	O
lower	O
inner	O
quadrant	O
at	O
approximately	O
8	O
:	O
00	O
.	O

The	O
deep	O
resection	O
margin	O
.	O

is	O
inked	O
black	O
and	O
the	O
superficial	O
resection	O
margin	O
is	O
inked	O
blue	O
.	O

The	O
medial	O
margin	O
of	O
the	O
mass	O
is	O
inked	O
orange	O
and	O
the	O
inferior	O
.	O
margin	O
of	O
the	O
mass	O
is	O
inked	O
green	O
.	O

A	O
second	O
tan	O
-	O
white	O
stellate	O
mass	O
measuring	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
is	O
located	O
6	O
.	O
5	O
cm	O
from	O
the	O
.	O
lateral	O
margin	O
,	O
13	O
.	O
6	O
cm	O
from	O
the	O
medial	O
margin	O
,	O
13	O
.	O
6	O
cm	O
from	O
the	O
superficial	O
margin	O
,	O
8	O
.	O
3	O
cm	O
from	O
the	O
inferior	O
margin	O
,	O
.	O

2	O
.	O
4	O
cm	O
from	O
the	O
superficial	O
margin	O
/	O
skin	O
and	O
3	O
.	O
7	O
cm	O
from	O
the	O
deep	O
margin	O
.	O

The	O
mass	O
is	O
located	O
in	O
the	O
mid	O
outer	O
portion	O
of	O
the	O
.	O
specimen	O
at	O
approximately	O
3	O
:	O
00	O
.	O

The	O
remainder	O
of	O
the	O
breast	O
parenchyma	O
is	O
yellow	O
-	O
white	O
and	O
unremarkable	O
.	O

The	O
specimen	O
.	O
contains	O
a	O
tan	O
-	O
brown	O
skin	O
ellipse	O
measuring	O
7	O
.	O
2	O
x	O
4	O
.	O
5	O
cm	O
.	O

The	O
nipple	O
measures	O
1	O
.	O
4	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
cm	O
.	O

There	O
is	O
no	O
dimpling	O
or	O
skin	O
.	O
retraction	O
identified	O
.	O

The	O
breast	O
is	O
placed	O
in	O
formalin	O
at	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
C1	O
.	O

Lower	O
inner	O
quadrant	O
mass	O
to	O
medial	O
margin	O
.	O

C2	O
-	O
C4	O
.	O

Remainder	O
of	O
lower	O
inner	O
quadrant	O
mass	O
(	O
to	O
superficial	O
,	O
deep	O
and	O
inferior	O
margin	O
)	O
.	O

C5	O
-	O
C6	O
.	O

Second	O
mass	O
to	O
deep	O
margin	O
(	O
bisected	O
)	O
.	O

C7	O
-	O
C8	O
Second	O
mass	O
to	O
superficial	O
margin	O
/	O
skin	O
(	O
bisected	O
)	O
.	O

C9	O
-	O
C14	O
Remainder	O
of	O
second	O
mass	O
.	O

C15	O
.	O

Representative	O
section	O
from	O
upper	O
inner	O
quadrant	O
.	O

C16	O
.	O

Representative	O
section	O
from	O
lower	O
inner	O
quadrant	O
.	O

C17	O
.	O

Representative	O
section	O
from	O
lower	O
outer	O
quadrant	O
.	O

C18	O
.	O

Representative	O
section	O
from	O
upper	O
outer	O
quadrant	O
.	O

C19	O
.	O

Nipple	O
(	O
serially	O
sectioned	O
)	O
.	O

C20	O
.	O

Skin	O
.	O

D	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
8	O
:	O
00	O
additional	O
medial	O
,	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
"	O
is	O
a	O
2	O
.	O
6	O
.	O

x	O
.	O

1	O
.	O
9	O
x	O
1	O
.	O
0	O
cm	O
lumpectomy	O
specimen	O
,	O
with	O
a	O
short	O
suture	O
designating	O
superior	O
,	O
a	O
long	O
stitch	O
designating	O
anterior	O
,	O
and	O
clips	O
.	O
designating	O
the	O
true	O
(	O
medial	O
)	O
margin	O
.	O

The	O
specimen	O
is	O
received	O
as	O
follows	O
:	O
Anterior	O
orange	O
.	O

Posterior	O
-	O
black	O
.	O

True	O
(	O
medial	O
)	O
-	O
green	O
.	O

Lateral	O
blue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
superior	O
to	O
inferior	O
to	O
reveal	O
a	O
tan	O
-	O
yellow	O
,	O
glistening	O
cut	O
surface	O
.	O

No	O
discrete	O
lesions	O
are	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
from	O
superior	O
to	O
inferior	O
in	O
cassettes	O
D1	O
through	O
D4	O
.	O

The	O
breast	O
was	O
placed	O
.	O

in	O
.	O
formalin	O
at	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
E	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
8	O
:	O
00	O
additional	O
inferior	O
short	O
anterior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
"	O
is	O
.	O

a	O
3	O
.	O
0	O
x	O
2	O
.	O
3	O
x	O
1	O
.	O
1	O
cm	O
lumpectomy	O
specimen	O
,	O
with	O
short	O
suture	O
designating	O
anterior	O
,	O
long	O
suture	O
designating	O
lateral	O
,	O
and	O
clips	O
marking	O
.	O
the	O
true	O
margin	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
Anterior	O
-	O
orange	O
.	O

Posterior	O
-	O
black	O
.	O

Superior	O
blue	O
.	O

True	O
(	O
inferior	O
)	O
-	O
green	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
to	O
reveal	O
a	O
yellow	O
-	O
gold	O
,	O
glistening	O
cut	O
surface	O
.	O

No	O
discrete	O
lesions	O
are	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
from	O
medial	O
to	O
lateral	O
in	O
cassette	O
E1	O
through	O
E4	O
.	O

The	O
breast	O
is	O
placed	O
in	O
formalin	O
.	O

at	O
.	O

F	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
8	O
:	O
00	O
additional	O
anterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
true	O
margin	O
"	O
.	O

is	O
a	O
3	O
.	O
2	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
3	O
cm	O
lumpectomy	O
specimen	O
,	O
with	O
short	O
sutures	O
designating	O
superior	O
,	O
a	O
long	O
stitch	O
designating	O
lateral	O
,	O
and	O
clips	O
.	O
designating	O
the	O
true	O
(	O
inferior	O
)	O
margin	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
True	O
(	O
anterior	O
)	O
-	O
orange	O
.	O

Posterior	O
black	O
.	O

Medial	O
green	O
.	O

Lateral	O
blue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
superior	O
to	O
inferior	O
to	O
reveal	O
a	O
yellow	O
,	O
glistening	O
cut	O
surface	O
.	O

No	O
discrete	O
lesions	O
are	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
from	O
superior	O
to	O
inferior	O
in	O
cassettes	O
F1	O
through	O
F3	O
.	O

The	O
breast	O
is	O
.	O
placed	O
.	O

in	O
.	O
formalin	O
at	O
.	O

G	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
8	O
:	O
00	O
additional	O
posterior	O
short	O
superior	O
,	O
long	O
lateral	O
,	O
clip	O
at	O
true	O
.	O

margin	O
"	O
is	O
a	O
2	O
.	O
1	O
x	O
1	O
.	O
9	O
x	O
0	O
.	O
6	O
cm	O
lumpectomy	O
specimen	O
with	O
short	O
sutures	O
designating	O
superior	O
,	O
a	O
long	O
set	O
of	O
sutures	O
designating	O
.	O
lateral	O
,	O
and	O
clips	O
designating	O
the	O
true	O
margin	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
Anterior	O
-	O
orange	O
.	O

True	O
(	O
posterior	O
)	O
-	O
black	O
.	O

Medial	O
green	O
.	O

Lateral	O
blue	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
superior	O
to	O
inferior	O
to	O
reveal	O
a	O
tan	O
-	O
pink	O
to	O
tan	O
-	O
brown	O
cut	O
surface	O
.	O

No	O
discrete	O
lesions	O
are	O
.	O
grossly	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
entirely	O
from	O
superior	O
to	O
inferior	O
in	O
cassettes	O
G1	O
through	O
G3	O
.	O

The	O
specimen	O
.	O

is	O
.	O
placed	O
in	O
formalin	O
at	O
.	O

H	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
additional	O
skin	O
left	O
breast	O
blue	O
at	O
3	O
:	O
00	O
"	O
is	O
a	O
5	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
C	O
-	O
shaped	O
.	O
portion	O
of	O
tan	O
-	O
brown	O
skin	O
and	O
subcutaneous	O
tissue	O
with	O
an	O
attached	O
strip	O
of	O
brown	O
skin	O
measuring	O
13	O
.	O
9	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
skin	O
.	O
on	O
the	O
specimen	O
was	O
inked	O
blue	O
in	O
the	O
OR	O
and	O
designates	O
3	O
:	O
00	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
12	O
to	O
3	O
:	O
00	O
orange	O
.	O

3	O
to	O
6	O
:	O
00	O
purple	O
.	O

6	O
to	O
9	O
:	O
00	O
blue	O
.	O

9	O
to	O
12	O
:	O
00	O
-	O
green	O
.	O

Deep	O
-	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
12	O
to	O
6	O
:	O
00	O
,	O
and	O
no	O
discrete	O
lesions	O
are	O
identified	O
.	O

Also	O
received	O
within	O
the	O
container	O
are	O
.	O
two	O
irregular	O
portions	O
of	O
tan	O
-	O
brown	O
skin	O
and	O
subcutaneous	O
tissue	O
measuring	O
1	O
.	O
4	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
cm	O
and	O
8	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
5	O
cm	O
.	O

This	O
tissue	O
.	O

is	O
serially	O
sectioned	O
and	O
no	O
discrete	O
lesions	O
are	O
identified	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
H1	O
.	O

Representative	O
sections	O
from	O
the	O
12	O
to	O
3	O
:	O
00	O
margin	O
.	O

H2	O
-	O
H4	O
-	O
.	O

Representative	O
sections	O
from	O
the	O
3	O
to	O
6	O
:	O
00	O
margin	O
.	O

H5	O
.	O

Representative	O
sections	O
from	O
the	O
6	O
to	O
9	O
:	O
00	O
margin	O
.	O

H6	O
.	O

Representative	O
sections	O
from	O
the	O
9	O
to	O
12	O
:	O
00	O
margin	O
.	O

H7	O
-	O
H8	O
-	O
.	O

Representative	O
sections	O
from	O
the	O
additional	O
skin	O
and	O
underlying	O
soft	O
tissue	O
.	O

Intraoperative	O
Consultation	O
:	O
A1FS	O
,	O
A2FS	O
,	O
lymph	O
node	O
,	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
blue	O
"	O
:	O
Negative	O
for	O
carcinoma	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
B1FS	O
,	O
lymph	O
node	O
,	O
"	O
left	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
2	O
blue	O
"	O
:	O
Negative	O
for	O
carcinoma	O
.	O

If	O
immunohistochemical	O
stains	O
and	O
/	O
or	O
in	O
situ	O
hybridization	O
are	O
cited	O
in	O
this	O
report	O
,	O
the	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
.	O
in	O
compliance	O
with	O
CLIA	O
'	O
88	O
.	O
regulations	O
.	O

Some	O
of	O
these	O
tests	O
rely	O
on	O
the	O
use	O
of	O
"	O
analyte	O
specific	O
reagents	O
"	O
and	O
are	O
subject	O
to	O
specific	O
labeling	O
requirements	O
by	O
the	O
FDA	O
.	O

Known	O
.	O
positive	O
and	O
negative	O
control	O
tissues	O
demonstrate	O
appropriate	O
staining	O
.	O

This	O
testing	O
was	O
developed	O
by	O
the	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
FDA	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
.	O

is	O
not	O
necessary	O
.	O

Date	O
of	O
Printing	O
:	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
5	B
cm	I
right	O
renal	O
tumor	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
.	O

2	O
:	O
SP	O
:	O
Paracaval	O
lymph	O
nodes	O
.	O

3	O
:	O
SP	O
:	O
Gallbladder	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

KIDNEY	O
,	O
RIGHT	O
;	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
CELL	O
)	O
TYPE	O
.	O

NUCLEAR	O
GRADE	O
II	O
/	O
IV	O
.	O

THE	O
PATTERN	O
OF	O
GROWTH	O
IS	O
ACINAR	O
.	O

THE	O
.	O

TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
4	B
.	I
5	I
CM	I
.	O

THE	O
TUMOR	O
IS	O
CONFINED	O
.	O

WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

NO	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
.	O

IDENTIFIED	O
.	O

ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

THE	O
.	O

NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
SHOWS	O
BENIGN	O
CYSTS	O
.	O

2	O
)	O
.	O

LYMPH	O
NODES	O
,	O
PARACAVAL	O
;	O
EXCISION	O
:	O
-	O
THREE	O
LYMPH	O
NODES	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
3	O
)	O
.	O

3	O
)	O
.	O

GALLBLADDER	O
;	O
CHOLECYSTECTOMY	O
:	O
-	O
CHRONIC	O
CHOLECYSTITIS	O
AND	O
CHOLELITHIASIS	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Right	O
kidney	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
nephrectomy	O
specimen	O
.	O

The	O
entire	O
specimen	O
weighs	O
.	O

330	O
grams	O
and	O
measures	O
13	O
X	O
7	O
x	O
4	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
4	B
.	I
5	I
.	I

cm	B
circumscribed	O
yellow	O
somewhat	O
friable	O
tumor	O
towards	O
the	O
upper	O
.	O
pole	O
.	O

The	O
tumor	O
measures	O
4	B
.	I
5	I
cm	I
in	O
maximal	O
dimension	O
and	O
is	O
.	O
confined	O
within	O
the	O
kidney	O
.	O

Multiple	O
cysts	O
are	O
identified	O
in	O
the	O
.	O
kidney	O
with	O
the	O
largest	O
measuring	O
4	O
cm	O
towards	O
the	O
upper	O
pole	O
.	O

The	O
cysts	O
are	O
lined	O
by	O
smooth	O
glistening	O
lining	O
and	O
contains	O
.	O
clear	O
fluid	O
.	O

The	O
uninvolved	O
kidney	O
appears	O
unremarkable	O
with	O
.	O
prominent	O
cortical	O
medullary	O
junction	O
.	O

The	O
tumor	O
does	O
not	O
extend	O
.	O
into	O
the	O
renal	O
pelvic	O
.	O

There	O
is	O
no	O
evidence	O
of	O
invasion	O
of	O
renal	O
.	O
vein	O
grossly	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
T	O
-	O
tumor	O
.	O

TK	O
-	O
tumor	O
with	O
kidney	O
.	O

TC	O
-	O
tumor	O
with	O
capsule	O
.	O

C	O
-	O
representative	O
sections	O
of	O
cyst	O
.	O

K	O
-	O
uninvolved	O
kidney	O
.	O

GF	O
-	O
Gerota	O
'	O
s	O
fascia	O
.	O

UM	O
-	O
ureteric	O
margin	O
.	O

VM	O
-	O
vascular	O
margin	O
.	O

HF	O
-	O
hilar	O
fat	O
.	O

2	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Paracaval	O
.	O
lymph	O
nodes	O
"	O
.	O

It	O
consists	O
of	O
fatty	O
tissue	O
with	O
multiple	O
lymph	O
.	O
nodes	O
with	O
the	O
largest	O
measuring	O
2	O
cm	O
.	O

All	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
LNB	O
-	O
bisected	O
lymph	O
nodes	O
.	O

LN	O
-	O
multiple	O
lymph	O
nodes	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Gallbladder	O
"	O
.	O

It	O
consists	O
of	O
a	O
gallbladder	O
measuring	O
7	O
x	O
3	O
.	O
5	O
x	O
2	O
cm	O
.	O

The	O
.	O
specimen	O
has	O
previously	O
been	O
opened	O
to	O
reveal	O
multiple	O
black	O
.	O
irregular	O
gallstones	O
measuring	O
from	O
2	O
.	O
0	O
to	O
0	O
.	O
5	O
cm	O
.	O

The	O
.	O
gallbladder	O
wall	O
measures	O
0	O
.	O
3	O
cm	O
in	O
thickness	O
.	O

The	O
mucosa	O
is	O
.	O
green	O
and	O
granular	O
with	O
no	O
gross	O
lesions	O
.	O

Representative	O
sections	O
.	O
are	O
submitted	O
.	O

Summary	O
of	O
section	O
:	O
U	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
.	O

Sect	O
.	O

SiteBlocks	O
Pieces	O
All	O
.	O

C	O
.	O

2	O
.	O

M	O
.	O

GF	O
.	O

1	O
.	O

M	O
.	O

HF	O
.	O

2	O
.	O

M	O
.	O

K	O
.	O

1	O
.	O

M	O
.	O

2	O
.	O

M	O
.	O

TC	O
.	O

1	O
.	O

M	O
.	O

TK	O
.	O

M	O
.	O

UM	O
.	O

1	O
.	O

M	O
.	O

VM	O
.	O

M	O
.	O

2	O
.	O

LN	O
.	O

2	O
.	O

LNB	O
.	O

1	O
.	O

3	O
.	O

3	O
.	O

U	O
.	O

3	O
.	O

Facility	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Parathyroid	O
:	O
left	O
upper	O
parathyroid	O
qs	O
.	O

2	O
.	O
left	O
hemi	O
-	O
thyroid	O
stitch	O
upper	O
pole	O
.	O

Diagnosis	O
.	O

1	O
.	O

No	O
pathological	O
diagnosis	O
:	O
Parathyroid	O
(	O
left	O
upper	O
)	O
blopsy	O
.	O

2	O
.	O

Multifical	O
papillary	O
carcinoma	O
,	O
dominant	O
follicular	O
variant	O
,	O
1	B
.	I
5	I
cm	I
;	O
arising	O
in	O
follicular	O
nodular	O
disease	O
and	O
chronic	O
.	O
lymphocytic	O
thyroiditis	O
:	O
Thyroid	O
(	O
left	O
)	O
hemithyroidectorny	O
specimen	O
.	O

Comment	O
.	O

There	O
is	O
a	O
unifocal	O
1	B
.	I
5	I
cm	I
papillary	O
carcinoma	O
transformation	O
in	O
the	O
dominant	O
lesion	O
.	O

Synoptic	O
Data	O
.	O

Procedure	O
:	O
Left	O
hemithyroidectomy	O
.	O

Fresh	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Left	O
lobe	O
:	O
4	O
.	O
3	O
cm	O
.	O

3	O
.	O
3	O
cm	O
.	O

2	O
.	O
3	O
cm	O
.	O

Isthmus	O
+	O
/	O
-	O
pyramidal	O
lobe	O
:	O
3	O
.	O
0	O
cm	O
.	O

1	O
.	O
7	O
cm	O
.	O

1	O
.	O
2	O
cm	O
.	O

Specimen	O
Weight	O
:	O
23	O
.	O
5	O
g	O
.	O

Tumor	O
Focality	O
:	O
Multifocal	O
,	O
ipsilateral	O
.	O

DOMINANT	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
1	B
.	I
5cm	I
.	O

Histologic	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Papillary	O
carcinoma	O
,	O
oncocytic	O
or	O
oxyphilic	O
variant	O
.	O

Follicular	O
architecture	O
.	O
per	O
TSS	O
,	O
follicular	O
variant	O
>	O
99	O
%	O
.	O

Classical	O
cytomorphology	O
.	O

Oncocytic	O
or	O
oxyphilic	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
None	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

SECOND	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Left	O
lobe	O
.	O

Isthmus	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
0	B
.	I
7cm	I
.	O

Additional	O
dimensions	O
:	O
0	B
.	I
2	I
cm	I
.	O

Histologic	O
Type	O
:	O
Papiliary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Papillary	O
carcinoma	O
,	O
microcarcinoma	O
(	O
occult	O
,	O
small	O
or	O
microscopic	O
)	O
variant	O
.	O

Papillary	O
carcinoma	O
,	O
oncocytic	O
or	O
oxyphilic	O
variant	O
.	O

Follicular	O
architecture	O
.	O

Classical	O
cytomorphology	O
.	O

Oncocytic	O
or	O
oxyphilic	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
None	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

TNM	O
Descriptors	O
:	O
m	O
(	O
multiple	O
primary	O
tumors	O
)	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT1b	O
:	O
Tumor	O
more	O
than	O
1	O
cm	O
but	O
not	O
more	O
than	O
2	O
cm	O
in	O
greatest	O
dimension	O
,	O
limited	O
to	O
.	O
the	O
thyroid	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Regional	O
lymph	O
nodes	O
cannot	O
be	O
assigned	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Adenomatoid	O
nodule	O
(	O
s	O
)	O
or	O
Nodular	O
follicular	O
disease	O
.	O

Thyroiditis	O
,	O
other	O
:	O
chronic	O
lymphyoctic	O
thyroiditis	O
.	O

Ancillary	O
Studies	O
:	O
Type	O
:	O
IHC	O
.	O

Results	O
:	O
The	O
1	O
.	O
5	O
cm	O
focus	O
(	O
slide	O
no	O
2E	O
)	O
is	O
negative	O
for	O
Galectin	O
-	O
3	O
and	O
is	O
focally	O
.	O
positive	O
for	O
cytokeratin	O
19	O
.	O

Few	O
cells	O
are	O
positive	O
for	O
HBME	O
-	O
1	O
with	O
an	O
apical	O
and	O
.	O
membranous	O
pattern	O
.	O

Pathologic	O
Staging	O
is	O
based	O
on	O
AJCC	O
/	O
UICC	O
TNM	O
,	O
.	O

Edition	O
.	O

Gross	O
Description	O
.	O

1	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
Parathyroid	O
:	O
Left	O
upper	O
parathyroid	O
QS	O
"	O
consists	O
of	O
a	O
piece	O
of	O
.	O
reddish	O
tissue	O
that	O
weighs	O
0	O
.	O
007	O
g	O
and	O
measures	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
.	O

It	O
is	O
frozen	O
for	O
intraoperative	O
consultation	O
.	O

1A	O
.	O
frozen	O
section	O
block	O
resubmitted	O
.	O

2	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
left	O
hemi	O
-	O
thyroid	O
stitch	O
upper	O
pole	O
"	O
,	O
consists	O
of	O
a	O
left	O
.	O
hemithyroidectomy	O
specimen	O
that	O
weighs	O
23	O
.	O
5	O
g	O
.	O

The	O
lobe	O
measures	O
4	O
.	O
3	O
cm	O
SI	O
x	O
3	O
.	O
3	O
cm	O
ML	O
x	O
2	O
.	O
4	O
cm	O
AP	O
and	O
the	O
isthmus	O
.	O
measures	O
3	O
.	O
0	O
cm	O
SI	O
x	O
1	O
.	O
7	O
cm	O
ML	O
x	O
1	O
.	O
2	O
cm	O
AP	O
.	O

No	O
parathyroid	O
glands	O
and	O
no	O
lymph	O
nodes	O
are	O
identified	O
grossly	O
.	O

The	O
.	O
external	O
surface	O
is	O
painted	O
with	O
blue	O
dye	O
.	O

The	O
upper	O
to	O
lower	O
pole	O
of	O
the	O
lobe	O
contains	O
a	O
well	O
delineated	O
nodule	O
that	O
.	O
measures	O
4	O
.	O
1	O
cm	O
SI	O
x	O
3	O
.	O
1	O
cm	O
ML	O
x	O
2	O
.	O
3	O
cm	O
AP	O
.	O

The	O
remainder	O
of	O
the	O
thyroid	O
tissue	O
is	O
unremarkable	O
.	O

Sections	O
of	O
nodule	O
.	O
and	O
normal	O
tissue	O
are	O
stored	O
frozen	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
2A	O
-	O
J	O
.	O
lobe	O
,	O
superior	O
to	O
inferior	O
.	O

2K	O
-	O
M	O
isthmus	O
.	O

Quick	O
Section	O
utagnosis	O
.	O

QS	O
-	O
1A	O
:	O
Parathyroid	O
tissue	O
identified	O
:	O
Parathyroid	O
(	O
left	O
upper	O
)	O
biopsy	O
.	O

Dr	O
.	O
Microscopic	O
Description	O
.	O

The	O
1	O
.	O
5	O
cm	O
focus	O
(	O
slide	O
no	O
2E	O
)	O
is	O
negative	O
for	O
Galectin	O
-	O
3	O
and	O
is	O
focally	O
positive	O
for	O
cytokeratin	O
19	O
.	O

Few	O
cells	O
are	O
positive	O
.	O
for	O
HBME	O
-	O
1	O
with	O
an	O
apical	O
and	O
membranous	O
pattern	O
.	O

The	O
rest	O
of	O
dominant	O
lesion	O
is	O
negative	O
for	O
HBME	O
-	O
1	O
,	O
cytokeratin	O
19	O
.	O
and	O
Galectin	O
-	O
3	O
.	O

LARGE	O
INTESTINE	O
TISSUE	O
.	O

CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Excision	O
of	O
tumor	O
.	O

Specimen	O
size	O
:	O
Not	O
specified	O
.	O

Tumor	O
site	O
:	O
Rectus	O
abdominus	O
.	O

Tumor	O
size	O
:	O
5	B
X	I
5	I
X	I
1	I
cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
.	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Perirectal	O
tissues	O
.	O

Lymph	O
nodes	O
:	O
12	O
/	O
12	O
positive	O
for	O
.	O
metastasis	O
(	O
Pararectal	O
12	O
/	O
12	O
)	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
.	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Gynecology	O
.	O

F	O
.	O

DIAGNOSIS	O
:	O
UTERUS	O
,	O
CERVIX	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
MODERATELY	O
DIFFERENTIATED	O
NON	O
-	O
KERATINIZING	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
5	B
CM	I
IN	O
.	O

GREATEST	O
DIMENSION	O
.	O

.	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
INVADES	O
TO	O
A	O
DEPTH	O
OF	O
14	B
MM	I
(	O
TOTAL	O
WALL	O
THICKNESS	O
15	O
MM	O
)	O
.	O

SQUAMOUS	O
CELL	O
CARCINOMA	O
IS	O
PRESENT	O
LESS	O
THAN	O
1	O
MM	O
FROM	O
THE	O
INKED	O
MARGIN	O
IN	O
THE	O
.	O

ANTERIOR	O
LOWER	O
UTERINE	O
SEGMENT	O
.	O

-	O
EXTENSIVE	O
LYMPHATIC	O
AND	O
VASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

PARAMETRIA	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

-	O
FOCAL	O
ENDOSALPINGIOSIS	O
.	O

-	O
VESSELS	O
WITH	O
COMPLEX	O
ATHEROSCLEROSIS	O
.	O

LYMPH	O
NODES	O
,	O
PARAMETRIAL	O
SOFT	O
TISSUE	O
,	O
RADICAL	O
HISTERECTOMY	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
IN	O
THREE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

VAGINA	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
NO	O
CARCINOMA	O
OR	O
DYSPLASIA	O
IDENTIFIED	O
.	O

UTERUS	O
,	O
ENDOMETRIUM	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

-	O
IN	O
SITU	O
AND	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
EXTENSIVELY	O
INVOLVING	O
ENDOMETRIUM	O
.	O

-	O
ENDOMETRIAL	O
POLYPS	O
,	O
WITH	O
INVOLVEMENT	O
BY	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
IN	O
SITU	O
.	O

-	O
INACTIVE	O
ENDOMETRIUM	O
.	O

UTERUS	O
.	O

MYOMETRIUM	O
,	O
RADICAL	O
HYSTERECTOMY	O
.	O

-	O
LEIOMYOMATA	O
,	O
LARGEST	O
0	B
.	I
9	I
CM	I
.	O

-	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
BY	O
DIRECT	O
EXTENSION	O
.	O

OVARY	O
,	O
RIGHT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

FALLOPIAN	O
TUBE	O
,	O
RIGHT	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

OVARY	O
,	O
LEFT	O
.	O

SALPINGO	O
-	O
OOPHORECTOMY	O
.	O

-	O
NO	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
vith	O
right	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
&	O
adrenal	O
gland	O
.	O

2	O
:	O
SP	O
:	O
Right	O
paracaval	O
nodes	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

KIDNEY	O
AND	O
ADRENAL	O
GLAND	O
,	O
RIGHT	O
;	O
RADICAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CHROMOPHOBE	O
TYPE	O
.	O

-	O
THE	O
TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
18	B
CM	I
.	O

-	O
THE	O
TUMOR	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

-	O
NO	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
IDENTIFIED	O
.	O

-	O
ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

-	O
THE	O
ADRENAL	O
GLAND	O
IS	O
UNREMARKABLE	O
.	O

2	O
)	O
.	O

LYMPH	O
NODES	O
,	O
RIGHT	O
PARACAVAL	O
;	O
EXCISION	O
:	O
-	O
EIGHT	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
8	O
)	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

RECUT	O
.	O

RECUT	O
.	O

RECUT	O
.	O

1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Right	O
Kidney	O
and	O
Adrenal	O
Gland	O
"	O
.	O

It	O
consists	O
of	O
a	O
kidney	O
,	O
adrenal	O
gland	O
and	O
.	O
tumor	O
.	O

The	O
specimen	O
measures	O
19	O
cm	O
(	O
superior	O
-	O
inferior	O
)	O
x	O
14	O
.	O
5	O
cm	O
(	O
anterior	O
-	O
posterior	O
)	O
x	O
17	O
.	O
2	O
cm	O
(	O
lateral	O
)	O
.	O

The	O
specimen	O
weighs	O
.	O

1	O
,	O
800	O
grams	O
.	O

The	O
adrenal	O
gland	O
is	O
disrupted	O
and	O
measures	O
8	O
.	O
7	O
x	O
3	O
.	O
1	O
x	O
0	O
.	O
7	O
cm	O
.	O

The	O
ureter	O
measures	O
6	O
.	O
5	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

The	O
.	O
tumor	O
measures	O
18	B
x	I
15	I
X	I
13	I
.	I
5	I
cm	I
.	O

The	O
adrenal	O
gland	O
appears	O
to	O
be	O
uninvolved	O
by	O
tumor	O
.	O

On	O
the	O
cross	O
section	O
,	O
tumor	O
has	O
a	O
.	O
centrally	O
located	O
scar	O
and	O
appears	O
to	O
be	O
light	O
mahogany	O
in	O
color	O
.	O

There	O
are	O
some	O
areas	O
of	O
hemorrhagic	O
.	O

The	O
tumor	O
arises	O
from	O
.	O
the	O
superior	O
pole	O
of	O
the	O
kidney	O
and	O
appears	O
to	O
be	O
well	O
-	O
demarcated	O
.	O

The	O
kidney	O
measures	O
9	O
.	O
5	O
x	O
7	O
.	O
5	O
x	O
6	O
cm	O
.	O

Gross	O
photographs	O
.	O
and	O
.	O

are	O
taken	O
.	O

The	O
tumor	O
does	O
not	O
involve	O
the	O
kidney	O
pelvis	O
and	O
it	O
has	O
a	O
thin	O
,	O
fibrous	O
membrane	O
around	O
it	O
.	O

The	O
tumor	O
is	O
.	O
very	O
friable	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
MA	O
-	O
ureteral	O
vascular	O
margins	O
and	O
representative	O
sections	O
of	O
adrenal	O
gland	O
.	O

C	O
-	O
section	O
of	O
tumor	O
with	O
capsule	O
.	O

K	O
-	O
section	O
of	O
uninvolved	O
kidney	O
.	O

P	O
-	O
section	O
of	O
kidney	O
pelvic	O
.	O

T	O
-	O
sections	O
of	O
the	O
tumor	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Right	O
Paracaval	O
Nodes	O
"	O
.	O

It	O
consists	O
of	O
a	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
aggreate	O
of	O
.	O
fibrofatty	O
tissue	O
fragments	O
with	O
multiple	O
lymph	O
nodes	O
dissected	O
ranging	O
from	O
0	O
.	O
9	O
to	O
2	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
largest	O
two	O
.	O
lymph	O
nodes	O
are	O
bisected	O
and	O
each	O
is	O
submitted	O
in	O
a	O
separate	O
cassette	O
.	O

The	O
remainder	O
of	O
the	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
Sections	O
:	O
BLN1	O
-	O
first	O
bisected	O
lymph	O
node	O
.	O

BLN2	O
-	O
second	O
bisected	O
lymph	O
node	O
.	O

LN	O
-	O
remainder	O
of	O
the	O
lymph	O
nodes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
&	O
adrenal	O
gland	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

C	O
.	O

1	O
.	O

1	O
.	O

K	O
.	O

1	O
.	O

1	O
.	O

MA	O
.	O

4	O
.	O

1	O
.	O

P	O
.	O

1	O
.	O

7	O
.	O

T	O
.	O

7	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Right	O
paracaval	O
nodes	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BLN1	O
.	O

2	O
.	O

1	O
.	O

BLN2	O
.	O

2	O
.	O

2	O
.	O

LN	O
.	O

4	O
.	O

Report	O
Status	O
:	O
Amend	O
/	O
Adder	O
.	O

Type	O
:	O
Surgical	O
Pathology	O
.	O

Specimen	O
Type	O
:	O
Kidney	O
.	O
partial	O
or	O
total	O
resection	O
.	O

Procedure	O
Date	O
:	O
PATHOLOGIC	O
DIAGNOSIS	O
:	O
SPECIMEN	O
LABELED	O
LEFT	O
KIDNEY	O
'	O
(	O
475	O
gm	O
)	O
:	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
/	O
clear	O
cell	O
type	O
(	O
3	B
.	I
0	I
cm	I
)	O
.	O

Fuhrman	O
nuclear	O
grade	O
II	O
of	O
IV	O
.	O

Tumor	O
is	O
confined	O
to	O
the	O
kidney	O
and	O
does	O
not	O
involve	O
perihilar	O
or	O
.	O
perinephric	O
adipose	O
tissue	O
.	O

Artery	O
,	O
vein	O
and	O
ureter	O
resection	O
margins	O
are	O
negative	O
for	O
tumor	O
.	O

No	O
lymphovascular	O
invasion	O
is	O
identified	O
.	O

Simple	O
cyst	O
(	O
10	O
cm	O
)	O
.	O

Non	O
-	O
neoplastic	O
renal	O
parenchyma	O
will	O
be	O
evaluated	O
by	O
the	O
Renal	O
Pathology	O
.	O

Service	O
and	O
the	O
results	O
will	O
be	O
reported	O
in	O
an	O
addendum	O
.	O

B	O
.	O

SPECIMEN	O
LABELED	O
"	O
RETROPERITONEAL	O
LYMPH	O
NODES	O
"	O
:	O
Fibroadipose	O
tissue	O
with	O
no	O
tumor	O
present	O
.	O

No	O
lymphoid	O
tissue	O
identified	O
(	O
the	O
specimen	O
was	O
entirely	O
submitted	O
for	O
.	O
histologic	O
analysis	O
)	O
.	O

AJCC	O
Classification	O
(	O
6th	O
Edition	O
)	O
:	O
Tla	O
NX	O
MX	O
.	O

CLINICAL	O
DATA	O
:	O
History	O
:	O
70	O
yo	O
female	O
,	O
incidental	O
L	O
renal	O
mass	O
RCC	O
by	O
bx	O
.	O

PMH	O
:	O
COPD	O
,	O
breast	O
ca	O
.	O

Operation	O
:	O
L	O
radical	O
nephrectomy	O
.	O

Clinical	O
Diagnosis	O
:	O
Renal	O
cell	O
ca	O
L	O
kidney	O
.	O

TISSUE	O
SUBMITTED	O
:	O
A	O
/	O
1	O
.	O

L	O
kidney	O
.	O

B	O
/	O
2	O
.	O

Regional	O
retroperitoneal	O
lymph	O
nodes	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
in	O
two	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patients	O
.	O
name	O
and	O
unit	O
number	O
.	O

Part	O
A	O
,	O
"	O
1	O
.	O

L	O
kidney	O
"	O
,	O
consists	O
of	O
475g	O
nephrectomy	O
specimen	O
,	O
consisting	O
of	O
a	O
.	O
left	O
kidney	O
(	O
18	O
.	O
2	O
x	O
9	O
.	O
0	O
x	O
5	O
.	O
9	O
cm	O
)	O
including	O
a	O
thin	O
-	O
walled	O
cyst	O
(	O
10	O
x	O
9	O
.	O
5	O
x	O
5	O
.	O
9	O
.	O
cm	O
)	O
in	O
the	O
lower	O
pole	O
(	O
lined	O
by	O
smooth	O
walls	O
and	O
filled	O
with	O
a	O
thin	O
,	O
serous	O
.	O
fluid	O
)	O
.	O
the	O
ureter	O
(	O
6	O
.	O
0	O
cm	O
length	O
,	O
0	O
.	O
3	O
cm	O
diameter	O
)	O
the	O
renal	O
artery	O
(	O
1	O
.	O
2	O
cm	O
.	O
length	O
,	O
0	O
.	O
9	O
cm	O
diameter	O
)	O
,	O
and	O
the	O
renal	O
vein	O
(	O
0	O
.	O
5	O
cm	O
length	O
,	O
1	O
.	O
1	O
cm	O
diameter	O
)	O
.	O

The	O
specimen	O
has	O
been	O
previously	O
inked	O
and	O
bivalved	O
,	O
revealing	O
a	O
circumscribed	O
,	O
.	O

tan	O
/	O
yellow	O
,	O
focally	O
hemorrhagic	O
mass	O
(	O
3	O
.	O
0	O
x	O
2	O
.	O
6	O
x	O
2	O
.	O
5	O
cm	O
)	O
in	O
the	O
upper	O
/	O
mid	O
.	O
kidney	O
abutting	O
the	O
renal	O
pelvis	O
.	O

The	O
mass	O
is	O
1	O
.	O
2	O
cm	O
from	O
the	O
renal	O
vein	O
.	O
resection	O
margin	O
,	O
1	O
.	O
0	O
Cm	O
from	O
the	O
renal	O
artery	O
resection	O
margin	O
,	O
8	O
.	O
3	O
cm	O
from	O
.	O
the	O
ureteral	O
resection	O
margin	O
,	O
and	O
0	O
.	O
3	O
cm	O
from	O
the	O
closest	O
black	O
-	O
inked	O
deep	O
.	O
margin	O
.	O

(	O
hilar	O
fat	O
)	O
The	O
mass	O
does	O
not	O
appear	O
to	O
grossly	O
invade	O
the	O
renal	O
.	O
pelvis	O
.	O

The	O
remaining	O
renal	O
parenchyma	O
is	O
unremarkable	O
.	O

The	O
corticomedullary	O
.	O
junction	O
is	O
distinct	O
.	O

A	O
representative	O
section	O
of	O
tumor	O
has	O
been	O
submitted	O
to	O
.	O

Cytogenetics	O
,	O
the	O
Tissue	O
Bank	O
,	O
and	O
for	O
quick	O
-	O
fix	O
,	O
and	O
a	O
representative	O
section	O
.	O
of	O
normal	O
tissue	O
has	O
been	O
submitted	O
to	O
the	O
Tissue	O
Bank	O
(	O
cortex	O
and	O
medulla	O
)	O
.	O
for	O
EM	O
(	O
cortex	O
)	O
,	O
and	O
for	O
IF	O
(	O
cortex	O
)	O
.	O

Micro	O
A1	O
:	O
vascular	O
ureteral	O
margins	O
,	O
multi	O
frag	O
.	O

Micro	O
A2	O
:	O
quick	O
-	O
fixed	O
section	O
of	O
tumor	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A3	O
:	O
tumor	O
and	O
renal	O
vein	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A4	O
:	O
tumor	O
and	O
closest	O
deep	O
margin	O
(	O
inked	O
black	O
)	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A5	O
:	O
tumor	O
and	O
renal	O
pelvis	O
,	O
1	O
frag	O
,	O
.	O

Micro	O
A6	O
:	O
lower	O
pole	O
cyst	O
wall	O
,	O
cyst	O
w	O
/	O
respect	O
to	O
uninvolved	O
renal	O
.	O
parenchyma	O
,	O
3	O
frag	O
,	O
.	O

Part	O
B	O
,	O
"	O
2	O
.	O
retroperitoneal	O
lymph	O
nodes	O
"	O
,	O
consists	O
of	O
multiple	O
fragments	O
of	O
.	O
soft	O
tan	O
/	O
yellow	O
adipose	O
tissue	O
(	O
4	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
2	O
cm	O
in	O
aggregate	O
)	O
.	O

There	O
.	O
are	O
no	O
.	O
palpable	O
lymph	O
nodes	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
.	O

un	O
an	O
.	O

Micro	O
B1	O
-	O
B2	O
:	O
multi	O
frag	O
/	O
cass	O
,	O
.	O

By	O
his	O
/	O
her	O
signature	O
below	O
,	O
the	O
senior	O
physician	O
certifies	O
that	O
he	O
/	O
she	O
.	O
personally	O
conducted	O
a	O
microscopic	O
examination	O
(	O
"	O
gross	O
only	O
"	O
exam	O
if	O
so	O
stated	O
)	O
.	O
of	O
the	O
described	O
specimen	O
(	O
s	O
)	O
and	O
rendered	O
or	O
confirmed	O
the	O
diagnosis	O
(	O
es	O
)	O
.	O
related	O
thereto	O
.	O

ADDENDUM	O
.	O

RENAL	O
PATHOLOGY	O
EVALUATION	O
OF	O
KIDNEY	O
PARENCHYMA	O
:	O
LEFT	O
KIDNEY	O
,	O
NEPHRECTOMY	O
:	O
SIMPLE	O
CYSTS	O
(	O
approximately	O
5	O
up	O
to	O
10	O
cm	O
)	O
,	O
MOST	O
LIKELY	O
RESULTING	O
FROM	O
.	O

URINARY	O
OBSTRUCTION	O
AND	O
RETENTION	O
,	O
WITH	O
COMPRESSION	O
-	O
RELATED	O
CHANGES	O
OF	O
.	O

THE	O
ADJACENT	O
KIDNEY	O
PARENCHYMA	O
.	O

MILD	O
CHRONIC	O
CHANGES	O
OF	O
THE	O
KIDNEY	O
PARENCHYMA	O
,	O
INCLUDING	O
.	O

FOCAL	O
GLOBAL	O
AND	O
SEGMENTAL	O
GLOMERULOSCLEROSIS	O
,	O
MILD	O
(	O
98	O
OF	O
GLOMERULI	O
)	O
.	O
,	O
.	O

MOST	O
LIKELY	O
SECONDARY	O
TO	O
FUNCTIONAL	O
ADAPTATIONS	O
FROM	O
NEPHRON	O
LOSS	O
.	O

TUBULAR	O
ATROPHY	O
AND	O
INTERSTITIAL	O
FIBROSIS	O
,	O
MILD	O
(	O
10	O
-	O
15	O
%	O
OF	O
CORTEX	O
)	O
.	O

-	O
ARTERIAL	O
AND	O
ARTERIOLAR	O
SCLEROSIS	O
,	O
MODERATE	O
.	O

(	O
SEE	O
NOTE	O
)	O
.	O

PAPILLARY	O
ADENOMA	O
(	O
0	O
.	O
1	O
cm	O
)	O
.	O

NOTE	O
:	O
Mild	O
chronic	O
changes	O
are	O
present	O
in	O
the	O
kidney	O
parenchyma	O
,	O
not	O
including	O
the	O
.	O
loss	O
of	O
nephrons	O
from	O
cyst	O
and	O
tumor	O
-	O
related	O
compression	O
.	O

Because	O
these	O
.	O
changes	O
are	O
a	O
result	O
of	O
functional	O
adaptations	O
to	O
nephron	O
loss	O
from	O
any	O
.	O
glomerular	O
,	O
tubular	O
,	O
interstitial	O
,	O
vascular	O
,	O
or	O
mass	O
-	O
replacing	O
process	O
,	O
a	O
.	O
similar	O
degree	O
of	O
chronic	O
damage	O
would	O
be	O
expected	O
in	O
the	O
contralateral	O
kidney	O
.	O

Incidental	O
note	O
is	O
made	O
of	O
a	O
papillary	O
adenoma	O
.	O

The	O
kidney	O
parenchyma	O
has	O
been	O
reviewed	O
by	O
.	O

Renal	O
Pathology	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
Sections	O
of	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
tissue	O
(	O
block	O
A6	O
)	O
were	O
evaluated	O
.	O
using	O
HE	O
,	O
PAS	O
,	O
Jones	O
silver	O
methenamine	O
,	O
and	O
AFOG	O
(	O
trichrome	O
)	O
stains	O
.	O

The	O
sample	O
consists	O
of	O
cortex	O
and	O
medulla	O
.	O

There	O
are	O
157	O
glomeruli	O
present	O
.	O
away	O
from	O
the	O
cyst	O
wall	O
,	O
of	O
which	O
12	O
are	O
globally	O
sclerosed	O
and	O
2	O
are	O
.	O
segmentally	O
sclerosed	O
.	O

Extensive	O
glomerulosclerosis	O
is	O
present	O
adjacent	O
to	O
the	O
.	O
cyst	O
wall	O
;	O
the	O
parenchyma	O
in	O
this	O
area	O
also	O
shows	O
compression	O
-	O
related	O
changes	O
.	O
and	O
entrapped	O
tubules	O
,	O
vessels	O
with	O
smooth	O
muscle	O
hypertrophy	O
,	O
and	O
glomeruli	O
.	O

The	O
remaining	O
glomeruli	O
show	O
no	O
significant	O
expansion	O
of	O
the	O
mesangial	O
areas	O
.	O

There	O
are	O
no	O
discernible	O
craters	O
or	O
spikes	O
,	O
but	O
a	O
few	O
double	O
contours	O
of	O
the	O
.	O
glomerular	O
capillary	O
wall	O
basement	O
membranes	O
are	O
seen	O
.	O

Approximately	O
10	O
-	O
15	O
%	O
of	O
.	O
the	O
cortical	O
parenchyma	O
shows	O
tubular	O
atrophy	O
and	O
interstitial	O
fibrosis	O
.	O

Arteries	O
and	O
arterioles	O
exhibit	O
a	O
moderate	O
degree	O
of	O
sclerosis	O
.	O

GROSS	O
DESCRIPTION	O
.	O

Additional	O
sections	O
were	O
submitted	O
to	O
further	O
characterize	O
the	O
nature	O
.	O
cyst	O
wall	O
.	O

Micro	O
.	O

Non	O
-	O
neoplastic	O
kidney	O
and	O
cyst	O
wall	O
,	O
1	O
frag	O
each	O
,	O
.	O

[	O
Clinical	O
history	O
:	O
Breast	O
cancer	O
,	O
severe	O
COPD	O
,	O
creatinine	O
0	O
.	O
6	O
-	O
1	O
.	O
1	O
)	O
.	O
Report	O
Status	O
:	O
Final	O
.	O
Type	O
:	O
Cytogenetics	O
.	O
Cytogeneticist	O
.	O
KARYOTYPE	O
:	O
46	O
,	O
XX	O
,	O
+	O
X	O
,	O
der	O
(	O
3	O
)	O
t	O
(	O
3	O
;	O
8	O
)	O
(	O
p2	O
?	O
1	O
;	O
q2	O
?	O
3	O
)	O
-	O
8	O
(	O
10	O
]	O
.	O

METAPHASES	O
COUNTED	O
:	O
10	O
.	O

ANALYZED	O
:	O
7	O
.	O

SCORED	O
:	O
3	O
.	O

BANDING	O
:	O
GTG	O
.	O

INTERPRETATION	O
:	O
All	O
metaphases	O
contained	O
clonal	O
aberrations	O
including	O
loss	O
of	O
the	O
short	O
arm	O
of	O
.	O
chromosome	O
3	O
,	O
which	O
is	O
a	O
characteristic	O
finding	O
in	O
renal	O
cell	O
carcinoma	O
,	O
clear	O
.	O
cell	O
type	O
.	O

COMMENTS	O
:	O
Mosaicism	O
and	O
small	O
chromosome	O
anomalies	O
may	O
not	O
be	O
detectable	O
using	O
the	O
.	O
standard	O
methods	O
employed	O
.	O

Chromosome	O
analysis	O
was	O
performed	O
at	O
a	O
level	O
of	O
400	O
.	O
bands	O
or	O
greater	O
.	O

INDICATION	O
FOR	O
TEST	O
:	O
?	O

RCC	O
.	O

PAGE	O
10	O
.	O

SPEC	O
#	O
:	O
CLINICAL	O
HISTORY	O
-	O
-	O
.	O

PRE	O
-	O
OP	O
DX	O
:	O
Not	O
provided	O
.	O

PROCEDURE	O
:	O
Not	O
provided	O
.	O

RELEVANT	O
CLINICAL	O
HX	O
:	O
Not	O
provided	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Upper	O
lip	O
margin	O
clip	O
superior	O
(	O
skin	O
)	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
which	O
measures	O
1	O
.	O
4	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
1	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Specimen	O
.	O
submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

B	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Inferior	O
margin	O
clip	O
superior	O
(	O
skin	O
)	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Specimen	O
submitted	O
.	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

C	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Inferior	O
lateral	O
margin	O
clip	O
superior	O
(	O
skin	O
)	O
"	O
is	O
a	O
soft	O
.	O
tissue	O
fragment	O
which	O
measures	O
1	O
.	O
3	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

D	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Lower	O
lip	O
margin	O
clip	O
superior	O
(	O
skin	O
)	O
'	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
which	O
measures	O
1	O
.	O
3	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
.	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

E	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Mental	O
margin	O
clip	O
superior	O
(	O
skin	O
)	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
which	O
measures	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
X	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
is	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
.	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

F	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Upper	O
cheek	O
margin	O
(	O
skin	O
)	O
"	O
is	O
a	O
soft	O
tissue	O
fragment	O
which	O
.	O
measures	O
1	O
.	O
3	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
toto	O
for	O
frozen	O
.	O
section	O
in	O
one	O
cassette	O
.	O

G	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Nasolabial	O
margin	O
(	O
skin	O
)	O
clip	O
posterior	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
which	O
measures	O
1	O
.	O
5	O
x	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
.	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

H	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Right	O
lower	O
alveolar	O
ridge	O
"	O
is	O
a	O
soft	O
tissue	O
fragment	O
.	O
measuring	O
2	O
.	O
0	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Right	O
lower	O
gingival	O
labial	O
mucosa	O
margin	O
"	O
is	O
a	O
soft	O
.	O
tissue	O
fragment	O
which	O
measures	O
1	O
.	O
2	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

PAGE	O
11	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
(	O
Continued	O
)	O
.	O
for	O
frozen	O
section	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Lower	O
lip	O
margin	O
clip	O
at	O
oral	O
commissure	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
measuring	O
1	O
.	O
3	O
X	O
0	O
.	O

X	O
0	O
.	O
2	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
.	O
cassette	O
for	O
frozen	O
section	O
.	O

K	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Upper	O
lip	O
mucosal	O
margin	O
"	O
is	O
a	O
soft	O
tissue	O
fragment	O
which	O
.	O
measures	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Anterior	O
buccal	O
margin	O
clip	O
anterior	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

Clip	O
margin	O
is	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
toto	O
.	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

M	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Posterior	O
buccal	O
margin	O
clip	O
posterior	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
measuring	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Clip	O
margin	O
inked	O
in	O
blue	O
.	O

Submitted	O
in	O
toto	O
in	O
.	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

N	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Retromolar	O
trigone	O
"	O
is	O
a	O
soft	O
tissue	O
fragment	O
which	O
.	O
measures	O
1	O
.	O
1	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
3	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
section	O
.	O

o	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Retromandibular	O
mucosa	O
margin	O
"	O
is	O
a	O
soft	O
tissue	O
fragment	O
.	O
which	O
measures	O
1	O
.	O
0	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
frozen	O
.	O
section	O
.	O

P	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Posterior	O
buccal	O
fat	O
"	O
is	O
a	O
fibroadipose	O
tissue	O
which	O
.	O
measures	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

Representative	O
section	O
submitted	O
for	O
frozen	O
and	O
no	O
.	O
lesions	O
grossly	O
identified	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1FS	O
:	O
Frozen	O
section	O
.	O

Cassette	O
#	O
1	O
:	O
Remaining	O
tissue	O
submitted	O
in	O
toto	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Lower	O
right	O
mandible	O
periosteal	O
margin	O
"	O
is	O
a	O
soft	O
tissue	O
.	O
fragment	O
which	O
measures	O
0	O
.	O
9	O
X	O
0	O
.	O
1	O
x	O
0	O
.	O
1	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
for	O
.	O
frozen	O
section	O
.	O

R	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Buccal	O
resection	O
,	O
buccal	O
mucosa	O
and	O
cheek	O
skin	O
,	O
.	O
lower	O
lip	O
,	O
mental	O
skin	O
suture	O
superior	O
"	O
is	O
a	O
specimen	O
with	O
skin	O
mucosa	O
and	O
.	O
fibroadipose	O
tissue	O
which	O
measures	O
5	O
.	O
5	O
x	O
5	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

The	O
skin	O
measures	O
4	O
.	O
0	O
X	O
3	O
.	O
0	O
X	O
.	O

0	O
.	O
1	O
cm	O
.	O

A	O
surgical	O
scar	O
on	O
the	O
skin	O
surface	O
measures	O
2	O
.	O
0	O
cm	O
in	O
length	O
X	O
0	O
.	O
1	O
X	O
0	O
.	O
1	O
cm	O
.	O

The	O
mucosa	O
measures	O
5	O
.	O
0	O
X	O
3	O
.	O
0	O
X	O
0	O
.	O
1	O
cm	O
.	O

The	O
external	O
surface	O
of	O
the	O
mucosa	O
is	O
nodular	O
.	O
with	O
small	O
focal	O
ulceration	O
which	O
is	O
less	O
than	O
0	O
.	O
1	O
cm	O
.	O

Specimen	O
is	O
inked	O
as	O
follows	O
:	O
This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

PAGE	O
12	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
superior	O
,	O
blue	O
;	O
inferior	O
,	O
green	O
;	O
anterior	O
,	O
red	O
;	O
posterior	O
,	O
black	O
.	O

Sectioning	O
reveals	O
a	O
.	O
poorly	O
defined	O
nodular	O
tumor	O
which	O
is	O
tan	O
to	O
white	O
.	O

Tumor	O
appears	O
0	O
.	O
5	O
cm	O
from	O
the	O
.	O
anterior	O
margin	O
,	O
1	O
.	O
0	O
cm	O
from	O
posterior	O
margin	O
,	O
less	O
than	O
0	O
.	O
1	O
cm	O
from	O
the	O
inferior	O
.	O
margin	O
,	O
1	O
.	O
0	O
cm	O
from	O
the	O
superior	O
margin	O
.	O

The	O
tumor	O
extends	O
to	O
the	O
mucosal	O
margin	O
.	O

It	O
.	O

is	O
1	O
.	O
0	O
cm	O
from	O
skin	O
.	O

The	O
tumor	O
measures	O
2	B
.	I
5	I
x	I
2	I
.	I
5	I
X	I
3	I
.	I
0	I
cm	I
.	O

Sections	O
submitted	O
as	O
.	O
follows	O
:	O
Cassette	O
#	O
1	O
:	O
Anterior	O
margin	O
,	O
two	O
fragments	O
.	O

Cassette	O
#	O
2	O
:	O
Posterior	O
margin	O
,	O
two	O
fragments	O
.	O

Cassette	O
#	O
3	O
:	O
Inferior	O
margin	O
.	O

Cassette	O
#	O
4	O
:	O
Superior	O
margin	O
.	O

Cassette	O
#	O
5	O
:	O
Tumor	O
in	O
relation	O
to	O
mucosal	O
margin	O
and	O
ulcerated	O
area	O
and	O
also	O
shows	O
.	O
relationship	O
of	O
tumor	O
to	O
skin	O
.	O

Cassettes	O
#	O
6	O
&	O
7	O
:	O
Composite	O
section	O
of	O
tumor	O
with	O
surrounding	O
fat	O
.	O

Cassettes	O
#	O
8	O
&	O
9	O
:	O
Composite	O
section	O
of	O
tumor	O
.	O

Cassette	O
#	O
10	O
:	O
Representative	O
section	O
of	O
brown	O
area	O
extending	O
from	O
tumor	O
.	O

S	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Right	O
buccal	O
fat	O
pad	O
"	O
are	O
multiple	O
fragments	O
of	O
.	O
adipose	O
tissue	O
which	O
measures	O
4	O
.	O
0	O
X	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
in	O
aggregate	O
.	O

No	O
lesions	O
grossly	O
.	O
identified	O
.	O

No	O
lymph	O
nodes	O
.	O

Specimen	O
submitted	O
in	O
toto	O
in	O
cassettes	O
#	O
1	O
-	O
4	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Left	O
neck	O
dissection	O
level	O
1B	O
"	O
is	O
a	O
fibroadipose	O
.	O
tissue	O
which	O
measures	O
5	O
.	O
0	O
X	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
.	O

Salivary	O
gland	O
is	O
present	O
which	O
measures	O
4	O
.	O

6	O
.	O

x	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
cm	O
.	O

Largest	O
lymph	O
node	O
measures	O
2	O
.	O
3	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

Sections	O
submitted	O
as	O
.	O
follows	O
:	O
Cassette	O
#	O
1	O
:	O
Largest	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
2	O
:	O
Two	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
3	O
:	O
Representative	O
section	O
of	O
salivary	O
gland	O
.	O

U	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Left	O
neck	O
dissection	O
level	O
2A	O
"	O
is	O
a	O
fibroadipose	O
.	O
tissue	O
which	O
measures	O
6	O
.	O
0	O
X	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
.	O

Largest	O
lymph	O
node	O
measures	O
2	O
.	O
0	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
5	O
.	O

cm	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1	O
:	O
Four	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
2	O
:	O
Four	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
3	O
:	O
Four	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
4	O
:	O
Four	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
5	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
6	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
7	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

PAGE	O
13	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
Cassette	O
#	O
8	O
:	O
One	O
lymph	O
node	O
.	O

V	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Right	O
neck	O
dissection	O
level	O
2B	O
"	O
is	O
a	O
fibroadipose	O
.	O
tissue	O
which	O
measures	O
3	O
.	O
5	O
x	O
1	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
.	O

Largest	O
lymph	O
node	O
measures	O
0	O
.	O
6	O
x	O
0	O
.	O
5	O
X	O
0	O
.	O
3	O
.	O

cm	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1	O
:	O
One	O
lymph	O
node	O
.	O

Cassette	O
#	O
2	O
:	O
Remainder	O
of	O
fibroadipose	O
tissue	O
in	O
toto	O
.	O

W	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Right	O
neck	O
dissection	O
levels	O
1A	O
,	O
1B	O
,	O
2A	O
,	O
3	O
,	O
4	O
"	O
is	O
a	O
.	O
fibroadipose	O
tissue	O
which	O
measures	O
8	O
.	O
0	O
X	O
5	O
.	O
5	O
X	O
4	O
.	O
0	O
cm	O
.	O

Specimen	O
is	O
unoriented	O
.	O

Salivary	O
gland	O
is	O
identified	O
which	O
measures	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
cm	O
.	O

Largest	O
.	O
lymph	O
.	O

node	O
.	O
measures	O
1	O
.	O
7	O
X	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
Cassette	O
#	O
1	O
:	O
Largest	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
2	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
3	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
4	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
5	O
:	O
One	O
lymph	O
node	O
bisected	O
.	O

Cassette	O
#	O
6	O
:	O
Six	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
7	O
:	O
Six	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
8	O
:	O
Five	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
9	O
:	O
Six	O
possible	O
lymph	O
nodes	O
.	O

Cassette	O
#	O
10	O
:	O
One	O
lymph	O
node	O
bisected	O
and	O
representative	O
section	O
of	O
salivary	O
gland	O
.	O

x	O
.	O

Received	O
in	O
formalin	O
and	O
labeled	O
"	O
Left	O
forearm	O
subcutaneous	O
mass	O
"	O
are	O
small	O
fragments	O
.	O
of	O
pale	O
tan	O
/	O
white	O
tissue	O
which	O
measures	O
1	O
.	O
5	O
X	O
1	O
.	O
3	O
X	O
1	O
.	O
0	O
cm	O
in	O
aggregate	O
.	O

Submitted	O
in	O
.	O
toto	O
in	O
one	O
cassette	O
.	O

Y	O
.	O

Received	O
fresh	O
and	O
labeled	O
"	O
Right	O
thyroid	O
lobe	O
with	O
isthmus	O
"	O
is	O
a	O
right	O
thyroid	O
lobe	O
.	O
with	O
isthmus	O
.	O

Specimen	O
weighs	O
13	O
.	O
82	O
grams	O
and	O
measures	O
4	O
.	O
3	O
X	O
2	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O

Isthmus	O
.	O
measures	O
1	O
.	O
0	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
.	O

External	O
surface	O
is	O
smooth	O
and	O
has	O
no	O
lesions	O
.	O

It	O
is	O
.	O
inked	O
in	O
black	O
.	O

There	O
is	O
a	O
nodule	O
in	O
the	O
right	O
lobe	O
which	O
extends	O
from	O
the	O
superior	O
.	O
pole	O
through	O
the	O
mid	O
pole	O
which	O
is	O
well	O
circumscribed	O
and	O
measures	O
3	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O

It	O
is	O
yellow	O
and	O
colloid	O
in	O
appearance	O
.	O

There	O
is	O
a	O
small	O
nodule	O
in	O
the	O
isthmus	O
which	O
.	O
measures	O
1	O
.	O
0	O
X	O
0	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
.	O

It	O
is	O
yellow	O
and	O
well	O
circumscribed	O
.	O

Representative	O
.	O
section	O
of	O
large	O
nodule	O
submitted	O
for	O
frozen	O
section	O
.	O

Isthmus	O
margin	O
submitted	O
for	O
.	O
frozen	O
section	O
.	O

Remainder	O
of	O
specimen	O
is	O
placed	O
in	O
formalin	O
for	O
permanent	O
.	O

There	O
are	O
.	O
some	O
calcifications	O
in	O
the	O
nodule	O
.	O

Remainder	O
of	O
thyroid	O
gland	O
is	O
beefy	O
red	O
brown	O
and	O
.	O
unremarkable	O
.	O

Thyroid	O
submitted	O
in	O
toto	O
.	O

Sections	O
submitted	O
as	O
follows	O
:	O
This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

PAGE	O
14	O
.	O

SPEC	O
#	O
:	O
GROSS	O
DESCRIPTION	O
:	O
Cassette	O
#	O
1FS	O
Margin	O
at	O
isthmus	O
.	O

Cassette	O
#	O
2FS	O
:	O
Representative	O
section	O
of	O
nodule	O
.	O

Cassettes	O
#	O
1	O
-	O
3	O
:	O
-	O
Nodule	O
in	O
superior	O
pole	O
of	O
right	O
lobe	O
.	O

Cassettes	O
#	O
4	O
-	O
7	O
:	O
Nodule	O
in	O
middle	O
pole	O
right	O
lobe	O
.	O

Cassettes	O
#	O
8	O
&	O
9	O
:	O
Nodule	O
in	O
normal	O
thyroid	O
gland	O
tissue	O
and	O
inferior	O
pole	O
right	O
lobe	O
.	O

Cassettes	O
#	O
10	O
&	O
11	O
:	O
Isthmus	O
with	O
nodule	O
in	O
toto	O
.	O

Cassette	O
#	O
11	O
:	O
Two	O
lymph	O
nodes	O
submitted	O
with	O
isthmus	O
.	O

OPERATING	O
ROOM	O
CONSULT	O
.	O

A	O
)	O
Upper	O
lip	O
margin	O
,	O
clip	O
superior	O
,	O
Skin	O
.	O

Skin	O
.	O

no	O
malignancy	O
Seen	O
.	O

B	O
)	O
Inferior	O
margin	O
,	O
clip	O
superior	O
,	O
Skin	O
.	O

Same	O
as	O
A	O
.	O

C	O
)	O
Inferior	O
lateral	O
margin	O
,	O
Clip	O
Superior	O
,	O
Skin	O
.	O

Same	O
as	O
A	O
.	O

D	O
)	O
Lower	O
lip	O
margin	O
,	O
clip	O
superior	O
,	O
Skin	O
.	O

Same	O
as	O
A	O
.	O

E	O
)	O
Mental	O
Margin	O
,	O
clip	O
superior	O
,	O
Skin	O
.	O

Same	O
as	O
A	O
.	O

F	O
)	O
Upper	O
cheek	O
margin	O
,	O
Skin	O
.	O

Same	O
as	O
A	O
.	O

G	O
)	O
Naso	O
Labial	O
margin	O
,	O
Skin	O
,	O
Clip	O
Posterior	O
.	O

Same	O
as	O
A	O
.	O

H	O
)	O
Right	O
lower	O
alveolar	O
ridge	O
.	O

No	O
malignancy	O
seen	O
.	O

I	O
)	O
Right	O
lower	O
gingival	O
labial	O
mucosa	O
margin	O
.	O

Same	O
as	O
H	O
)	O
.	O

J	O
)	O
Lower	O
lip	O
margin	O
.	O

Clip	O
at	O
oral	O
commisure	O
.	O

Same	O
as	O
H	O
)	O
.	O

K	O
)	O
Upper	O
lip	O
mucosal	O
margin	O
.	O

Same	O
as	O
H	O
)	O
.	O

L	O
)	O
Anterior	O
buccal	O
margin	O
.	O

Clip	O
anterior	O
.	O

Same	O
as	O
H	O
)	O
.	O

M	O
)	O
Posterior	O
Buccal	O
Margin	O
.	O

Clip	O
Posterior	O
.	O

Same	O
as	O
H	O
)	O
.	O

N	O
)	O
Retromolar	O
trigone	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

PAGE	O
15	O
.	O

SPEC	O
#	O
:	O
OPERATING	O
ROOM	O
CONSULT	O
.	O

Same	O
as	O
H	O
)	O
.	O

O	O
)	O
Retromandibular	O
mucosal	O
margin	O
.	O

Same	O
as	O
H	O
)	O
.	O

P	O
)	O
Posterior	O
Buccal	O
Fat	O
.	O

Same	O
as	O
H	O
)	O
.	O

Q	O
)	O
Lower	O
right	O
mandible	O
periosteal	O
margin	O
.	O

Same	O
as	O
H	O
)	O
.	O

Y	O
)	O
Right	O
thyroid	O
lobe	O
with	O
ishmus	O
.	O

Representative	O
section	O
:	O
-	O
Follicular	O
lesion	O
.	O

-	O
Defer	O
final	O
diagnosis	O
for	O
complete	O
sampling	O
and	O
permanent	O
sections	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

REG	O
DR	O
:	O
Copies	O
to	O
:	O
Submit	O
Dr	O
:	O
This	O
is	O
a	O
corrected	O
report	O
.	O

Any	O
previous	O
versions	O
are	O
stored	O
internally	O
and	O
are	O
available	O
if	O
necessary	O
.	O

SPECIMEN	O
ID	O
:	O
A	O
.	O

SKIN	O
-	O
Upper	O
lip	O
margin	O
,	O
clip	O
superior	O
.	O

Skin	O
.	O
,	O
.	O

B	O
.	O

SKIN	O
-	O
Inferior	O
margin	O
clip	O
superior	O
,	O
Skin	O
.	O

C	O
.	O

SKIN	O
-	O
Inferior	O
lateral	O
margin	O
,	O
clip	O
superior	O
,	O
Skin	O
,	O
.	O

D	O
.	O

SKIN	O
-	O
Lower	O
lip	O
margin	O
,	O
clip	O
superior	O
,	O
skin	O
,	O
.	O

E	O
.	O

SKIN	O
-	O
mental	O
margin	O
clip	O
superior	O
,	O
skin	O
,	O
F	O
.	O

SKIN	O
-	O
upper	O
cheek	O
margin	O
,	O
skin	O
,	O
.	O

G	O
.	O

SKIN	O
-	O
Nasolabial	O
margin	O
,	O
skin	O
,	O
clip	O
posterior	O
,	O
.	O

H	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Right	O
lower	O
alveolar	O
ridge	O
.	O

I	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Right	O
lower	O
gingival	O
labial	O
mucosa	O
margin	O
.	O

J	O
.	O

LIP	O
,	O
NOS	O
-	O
lower	O
lip	O
margin	O
,	O
clip	O
at	O
oral	O
comminsure	O
.	O
,	O
.	O

K	O
.	O

LIP	O
,	O
NOS	O
-	O
upper	O
lip	O
mucosal	O
margin	O
,	O
.	O

L	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Anterior	O
Buccal	O
margin	O
clip	O
anterior	O
,	O
.	O

M	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Posterior	O
Buccal	O
Margin	O
Clip	O
Poterior	O
,	O
.	O

N	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Retromolar	O
trigone	O
,	O
.	O

o	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Retromandibular	O
mucosal	O
margin	O
,	O
.	O

P	O
.	O

ADIPOSE	O
TISSUE	O
-	O
posterior	O
buccal	O
fat	O
,	O
.	O

Q	O
.	O

SOFT	O
TISSUES	O
OF	O
HEAD	O
AND	O
NECK	O
-	O
Lower	O
right	O
mandible	O
periosteal	O
margin	O
,	O
.	O

R	O
.	O

SOFT	O
TISSUE	O
-	O
BUCCAL	O
RESECTION	O
,	O
BUCCAL	O
MUCOSA	O
AND	O
CHEEK	O
SKIN	O
,	O
LOWER	O
LIP	O
,	O
.	O

S	O
.	O

SOFT	O
TISSUE	O
-	O
RIGHT	O
BUCCAL	O
FAT	O
PAD	O
,	O
T	O
.	O

NECK	O
,	O
NOS	O
-	O
LEFT	O
NECK	O
DISSECTION	O
.	O

LEVEL	O
.	O

IB	O
,	O
.	O

U	O
.	O

NECK	O
,	O
NOS	O
-	O
LEFT	O
NECK	O
DISSECTION	O
LEVELS	O
2A	O
,	O
.	O

V	O
.	O

NECK	O
,	O
NOS	O
-	O
RIGHT	O
NECK	O
DISSECTION	O
LEVEL	O
2B	O
,	O
.	O

W	O
.	O

NECK	O
,	O
NOS	O
-	O
RIGHT	O
NECK	O
DISSECTION	O
LEVELS	O
1A	O
,	O
1B	O
,	O
2A	O
,	O
3	O
,	O
4	O
,	O
.	O

X	O
.	O

SOFT	O
TISSUE	O
-	O
LEFT	O
FOREARM	O
SUBCUTANEOUS	O
MASS	O
,	O
.	O

Y	O
.	O

THYROID	O
GLAND	O
-	O
Right	O
thyroid	O
lobe	O
with	O
ishmus	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
SPECIMEN	O
ID	O
:	O
(	O
Corrected	O
Result	O
)	O
.	O

Edit	O
Date	O
:	O
Edit	O
Reason	O
:	O
DIAGNOSIS	O
EDIT	O
/	O
CLARIFICATION	O
.	O

A	O
.	O

UPPER	O
LIP	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

B	O
.	O

INFERIOR	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

C	O
.	O

INFERIOR	O
LATERAL	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

D	O
.	O

LOWER	O
LIP	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

E	O
.	O

MENTAL	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

F	O
.	O

UPPER	O
CHEEK	O
MARGIN	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

(	O
Corrected	O
Result	O
)	O
.	O

G	O
.	O

NASOLABIAL	O
MARGIN	O
,	O
SKIN	O
,	O
CLIP	O
POSTERIOR	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

H	O
.	O

RIGHT	O
LOWER	O
ALVEOLAR	O
RIDGE	O
:	O
No	O
malignancy	O
seen	O
.	O

RIGHT	O
LOWER	O
GINGIVAL	O
LABIAL	O
MUCOSA	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

J	O
.	O

LOWER	O
LIP	O
MARGIN	O
,	O
CLIP	O
AT	O
ORAL	O
COMMISSURE	O
:	O
No	O
malignancy	O
seen	O
.	O

K	O
.	O

UPPER	O
LIP	O
MUCOSAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

L	O
.	O

ANTERIOR	O
BUCCAL	O
MARGIN	O
,	O
CLIP	O
ANTERIOR	O
:	O
No	O
malignancy	O
seen	O
.	O

M	O
.	O

POSTERIOR	O
BUCCAL	O
MARGIN	O
,	O
CLIP	O
POSTERIOR	O
:	O
No	O
malignancy	O
seen	O
.	O

N	O
.	O

RETROMOLAR	O
TRIGONE	O
:	O
No	O
malignancy	O
seen	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

(	O
Corrected	O
Result	O
)	O
.	O

o	O
.	O

RETROMANDIBULAR	O
MUCOSAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

P	O
.	O

POSTERIOR	O
BUCCAL	O
FAT	O
:	O
No	O
malignancy	O
seen	O
.	O

LOWER	O
RIGHT	O
MANDIBLE	O
PERIOSTEAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

R	O
.	O

BUCCAL	O
RESECTION	O
,	O
BUCCAL	O
MUCOSA	O
AND	O
CHEEK	O
SKIN	O
,	O
LOWER	O
LIP	O
:	O
This	O
case	O
was	O
reviewed	O
and	O
discussed	O
at	O
the	O
weekly	O
.	O

In	O
my	O
.	O
opinion	O
,	O
the	O
buccal	O
mucosa	O
carcinoma	O
is	O
best	O
characterized	O
as	O
a	O
low	O
to	O
intermediate	O
.	O
grade	O
mucoepidermoid	O
carcinoma	O
.	O

The	O
case	O
was	O
discussed	O
with	O
.	O

Tumor	O
size	O
2	B
.	I
0	I
cm	I
(	O
by	O
microscopic	O
estimate	O
)	O
.	O

No	O
perineural	O
or	O
lymphovascular	O
invasion	O
seen	O
.	O

Margins	O
negative	O
for	O
tumor	O
(	O
see	O
frozen	O
section	O
A	O
through	O
Q	O
above	O
)	O
.	O

S	O
.	O

RIGHT	O
BUCCAL	O
FAT	O
PAD	O
:	O
Benign	O
adipose	O
tissue	O
and	O
salivary	O
gland	O
tissue	O
.	O

No	O
evidence	O
of	O
malignancy	O
.	O

T	O
.	O

LEFT	O
NECK	O
DISSECTION	O
,	O
LEVEL	O
1B	O
:	O
This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

(	O
Corrected	O
Result	O
)	O
.	O

Lymph	O
nodes	O
(	O
2	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

Benign	O
salivary	O
gland	O
tissue	O
;	O
negative	O
for	O
tumor	O
.	O

U	O
.	O

LEFT	O
NECK	O
DISSECTION	O
LEVELS	O
2A	O
:	O
Lymph	O
nodes	O
(	O
17	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

V	O
.	O

RIGHT	O
NECK	O
DISSECTION	O
LEVEL	O
2B	O
:	O
Lymph	O
nodes	O
(	O
4	O
)	O
i	O
negative	O
for	O
tumor	O
.	O

W	O
.	O

RIGHT	O
NECK	O
DISSECTION	O
LEVELS	O
1A	O
,	O
1B	O
,	O
2A	O
,	O
3	O
,	O
4	O
:	O
Lymph	O
nodes	O
(	O
25	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

Salivary	O
gland	O
tissue	O
;	O
no	O
evidence	O
of	O
malignancy	O
,	O
.	O

X	O
.	O

LEFT	O
FOREARM	O
SUBCUTANEOUS	O
MASS	O
:	O
Angiolipoma	O
.	O

Y	O
.	O

RIGHT	O
THYROID	O
LOBE	O
WITH	O
ISTHMUS	O
:	O
Multiple	O
follicular	O
colloid	O
nodules	O
consistent	O
with	O
goiter	O
with	O
focal	O
chronic	O
.	O
inflammation	O
.	O

No	O
evidence	O
of	O
malignancy	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

(	O
Corrected	O
Result	O
)	O
.	O

A	O
.	O

UPPER	O
LIP	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

B	O
.	O

INFERIOR	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

C	O
.	O

INFERIOR	O
LATERAL	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

D	O
.	O

LOWER	O
LIP	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

E	O
.	O

MENTAL	O
MARGIN	O
,	O
CLIP	O
SUPERIOR	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

F	O
.	O

UPPER	O
CHEEK	O
MARGIN	O
,	O
SKIN	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

G	O
.	O

NASOLABIAL	O
MARGIN	O
,	O
SKIN	O
,	O
CLIP	O
POSTERIOR	O
:	O
Skin	O
,	O
no	O
malignancy	O
seen	O
.	O

H	O
.	O

RIGHT	O
LOWER	O
ALVEOLAR	O
RIDGE	O
:	O
This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

No	O
malignancy	O
seen	O
.	O

I	O
.	O

RIGHT	O
LOWER	O
GINGIVAL	O
LABIAL	O
MUCOSA	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

J	O
.	O

LOWER	O
LIP	O
MARGIN	O
,	O
CLIP	O
AT	O
ORAL	O
COMMISSURE	O
:	O
No	O
malignancy	O
seen	O
.	O

K	O
.	O

UPPER	O
LIP	O
MUCOSAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

L	O
.	O

ANTERIOR	O
BUCCAL	O
MARGIN	O
,	O
CLIP	O
ANTERIOR	O
:	O
No	O
malignancy	O
seen	O
.	O

M	O
.	O

POSTERIOR	O
BUCCAL	O
MARGIN	O
,	O
CLIP	O
POSTERIOR	O
:	O
No	O
malignancy	O
seen	O
.	O

N	O
.	O

RETROMOLAR	O
TRIGONE	O
:	O
No	O
malignancy	O
seen	O
.	O

o	O
.	O

RETROMANDIBULAR	O
MUCOSAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

P	O
.	O

POSTERIOR	O
BUCCAL	O
FAT	O
:	O
No	O
malignancy	O
seen	O
.	O

LOWER	O
RIGHT	O
MANDIBLE	O
PERIOSTEAL	O
MARGIN	O
:	O
No	O
malignancy	O
seen	O
.	O

R	O
.	O

BUCCAL	O
RESECTION	O
,	O
BUCCAL	O
MUCOSA	O
AND	O
CHEEK	O
SKIN	O
,	O
LOWER	O
LIP	O
:	O
Invasive	O
well	O
differentiated	O
squamous	O
cell	O
carcinoma	O
.	O

Tumor	O
size	O
2	B
.	I
0	I
cm	I
(	O
by	O
microscopic	O
estimate	O
)	O
.	O

No	O
perineural	O
or	O
lymphovascular	O
invasion	O
seen	O
.	O

Margins	O
negative	O
for	O
tumor	O
(	O
see	O
frozen	O
section	O
A	O
through	O
Q	O
above	O
)	O
.	O

S	O
.	O

RIGHT	O
BUCCAL	O
FAT	O
PAD	O
:	O
Benign	O
adipose	O
tissue	O
and	O
salivary	O
gland	O
tissue	O
.	O

No	O
evidence	O
of	O
malignancy	O
.	O

T	O
.	O

LEFT	O
NECK	O
DISSECTION	O
,	O
LEVEL	O
1B	O
:	O
Lymph	O
nodes	O
(	O
2	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

Benign	O
salivary	O
gland	O
tissue	O
;	O
negative	O
for	O
tumor	O
.	O

U	O
.	O

LEFT	O
NECK	O
DISSECTION	O
LEVELS	O
2A	O
:	O
Lymph	O
nodes	O
(	O
17	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

SPEC	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

V	O
.	O

RIGHT	O
NECK	O
DISSECTION	O
LEVEL	O
2B	O
:	O
Lymph	O
nodes	O
(	O
4	O
)	O
i	O
negative	O
for	O
tumor	O
.	O

W	O
.	O

RIGHT	O
NECK	O
DISSECTION	O
LEVELS	O
1A	O
,	O
1B	O
,	O
2A	O
,	O
3	O
,	O
4	O
:	O
Lymph	O
nodes	O
(	O
25	O
)	O
;	O
negative	O
for	O
tumor	O
.	O

Salivary	O
gland	O
tissue	O
;	O
no	O
evidence	O
of	O
malignancy	O
.	O

x	O
.	O

LEFT	O
FOREARM	O
SUBCUTANEOUS	O
MASS	O
:	O
Angiolipoma	O
.	O

Y	O
.	O

RIGHT	O
THYROID	O
LOBE	O
WITH	O
ISTHMUS	O
:	O
Multiple	O
follicular	O
colloid	O
nodules	O
consistent	O
with	O
goiter	O
with	O
focal	O
chronic	O
.	O
inflammation	O
.	O

No	O
evidence	O
of	O
malignancy	O
.	O

This	O
report	O
is	O
privileged	O
,	O
confidential	O
and	O
exempt	O
from	O
disclosure	O
under	O
applicable	O
law	O
.	O

If	O
you	O
receive	O
this	O
report	O
inadvertently	O
,	O
please	O
call	O
.	O
and	O
.	O

return	O
the	O
report	O
to	O
us	O
by	O
mail	O
.	O

I	O
Surgical	O
Pathology	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
A1	O
B1	O
B2	O
B3	O
B4	O
B5	O
B6	O
B7	O
B8	O
B9	O
B10	O
B11	O
C1	O
C2	O
C3	O
.	O

C4	O
C5	O
D1	O
D2	O
.	O

D3	O
D4	O
D5	O
D6	O
E1	O
E2	O
E3	O
E4	O
E5	O
.	O

Uterus	O
,	O
right	O
ovary	O
(	O
2	O
.	O
0	O
X	O
1	O
.	O
5	O
X	O
0	O
.	O
9	O
cm	O
)	O
with	O
5	O
.	O
9	O
cm	O
.	O
segment	O
of	O
.	O
right	O
fallopian	O
tube	O
,	O
and	O
left	O
ovary	O
(	O
1	O
.	O
9	O
X	O
1	O
.	O
8	O
X	O
0	O
.	O
9	O
cm	O
)	O
.	O
with	O
7	O
.	O
3	O
.	O

cm	O
segment	O
of	O
left	O
fallopian	O
tube	O
together	O
weighing	O
95	O
.	O
0	O
.	O
grams	O
,	O
.	O
separately	O
submitted	O
tissue	O
from	O
the	O
pelvic	O
peritoneum	O
.	O

(	O
biopsy	O
,	O
1	O
.	O
4	O
.	O
x	O
1	O
.	O
0	O
X	O
0	O
.	O
2	O
cm	O
)	O
,	O
right	O
and	O
left	O
pelvic	O
lymph	O
nodes	O
and	O
.	O
left	O
.	O

para	O
-	O
aortic	O
nodes	O
.	O

DIAGNOSIS	O
:	O
Uterus	O
,	O
bilateral	O
ovaries	O
,	O
and	O
fallopian	O
tubes	O
;	O
total	O
.	O
abdominal	O
.	O

hysterectomy	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
Invasive	O
FIGO	O
.	O
grade	O
I	O
(	O
of	O
III	O
)	O
endometrial	O
adenocarcinoma	O
,	O
endometrioid	O
.	O
type	O
.	O

forming	O
a	O
mass	O
(	O
8	B
.	I
5	I
X	I
2	I
.	I
6	I
x	I
1	I
.	I
1	I
cm	I
)	O
invading	O
0	O
.	O
7	O
cm	O
into	O
.	O
the	O
1	O
.	O
8	O
cm	O
.	O
myometrial	O
thickness	O
.	O

Tumor	O
locally	O
involves	O
the	O
lower	O
.	O
uterine	O
.	O

segment	O
.	O

The	O
cervix	O
is	O
uninvolved	O
.	O

Ovary	O
,	O
right	O
,	O
oophorectomy	O
:	O
Focus	O
of	O
endometriosis	O
.	O

Ovary	O
,	O
left	O
,	O
oophorectomy	O
:	O
Without	O
diagnostic	O
.	O
abnormality	O
.	O

Fallopian	O
tubes	O
,	O
right	O
and	O
left	O
,	O
salpingectomies	O
:	O
Without	O
.	O
diagnostic	O
abnormality	O
.	O

Soft	O
tissue	O
,	O
pelvic	O
peritoneum	O
,	O
biopsy	O
:	O
Inflamed	O
.	O
fibroconnective	O
.	O

tissue	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
(	O
11	O
.	O
external	O
.	O
iliac	O
,	O
4	O
common	O
iliac	O
,	O
1	O
internal	O
iliac	O
and	O
3	O
obturator	O
)	O
.	O
are	O
.	O

negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
lymphadenectomy	O
:	O
A	O
single	O
left	O
.	O
pelvic	O
.	O

obturator	O
(	O
of	O
9	O
)	O
is	O
positive	O
for	O
metastatic	O
.	O
adenocarcinoma	O
.	O

Multiple	O
.	O

(	O
1	O
external	O
iliac	O
,	O
4	O
common	O
iliac	O
,	O
1	O
internal	O
iliac	O
)	O
are	O
.	O
negative	O
.	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
left	O
para	O
-	O
aortic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
.	O

(	O
8	O
)	O
left	O
.	O
para	O
-	O
aortic	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

CLINICAL	O
HISTORY	O
:	O
Ovarian	O
carcinoma	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Right	O
tube	O
and	O
ovary	O
"	O
.	O

In	O
formalin	O
.	O

Received	O
is	O
an	O
ovoid	O
-	O
shaped	O
,	O
tan	O
.	O
hemorrhagic	O
soft	O
tissue	O
measuring	O
9	O
.	O
5	O
x	O
6	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O
in	O
greatest	O
dimensions	O
.	O

There	O
are	O
multiple	O
various	O
-	O
sized	O
cystic	O
structures	O
on	O
the	O
serosa	O
.	O

The	O
.	O
largest	O
measures	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

Part	O
of	O
the	O
serosa	O
is	O
smooth	O
and	O
.	O
glistening	O
.	O

Multiple	O
surgical	O
clips	O
are	O
present	O
.	O

There	O
is	O
a	O
small	O
amount	O
.	O

of	O
.	O
attached	O
soft	O
tissue	O
,	O
probably	O
the	O
adnexa	O
.	O

The	O
mucosal	O
surface	O
consists	O
of	O
.	O
multiple	O
various	O
-	O
sized	O
hemorrhagic	O
cystic	O
structures	O
.	O

Some	O
of	O
which	O
are	O
.	O
filled	O
serous	O
fluid	O
and	O
blood	O
clots	O
.	O

Blocks	O
are	O
submitted	O
as	O
follows	O
:	O
Blocks	O
A1	O
,	O
A2	O
-	O
Representative	O
sections	O
of	O
the	O
ovary	O
.	O

Block	O
A3	O
-	O
Representative	O
sections	O
of	O
the	O
presumed	O
adnexa	O
.	O

Block	O
A4	O
-	O
More	O
sections	O
of	O
the	O
ovary	O
.	O

B	O
.	O

"	O
Left	O
ovary	O
"	O
.	O

In	O
formalin	O
.	O

Received	O
is	O
a	O
pale	O
-	O
white	O
ovoid	O
soft	O
tissue	O
.	O
measuring	O
5	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
.	O
in	O
greatest	O
dimensions	O
.	O

There	O
are	O
multiple	O
.	O
various	O
-	O
sized	O
cystic	O
structures	O
on	O
the	O
serosal	O
surface	O
and	O
the	O
largest	O
one	O
.	O
measures	O
0	O
.	O
4	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O

Otherwise	O
,	O
the	O
surface	O
is	O
smooth	O
and	O
glistening	O
.	O

On	O
cross	O
-	O
sections	O
,	O
the	O
cysts	O
are	O
filled	O
with	O
serous	O
fluid	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
Blocks	O
B1	O
and	O
B2	O
.	O

C	O
.	O

"	O
Peritoneal	O
nodules	O
.	O

Fresh	O
.	O

Received	O
is	O
an	O
aggregate	O
of	O
yellow	O
,	O
firm	O
,	O
.	O
fatty	O
soft	O
tissue	O
measuring	O
12	O
.	O
5	O
x	O
8	O
.	O
5	O
x	O
3	O
.	O
0	O
cm	O
.	O

They	O
consists	O
of	O
multiple	O
.	O
various	O
-	O
sized	O
indurated	O
nodules	O
measuring	O
from	O
2	O
.	O
5	O
x	O
1	O
.	O
6	O
x	O
1	O
.	O
2	O
cm	O
.	O
to	O
0	O
.	O
4	O
x	O
.	O

0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
are	O
submitted	O
as	O
.	O

Blocks	O
C1	O
through	O
C4	O
.	O

D	O
.	O

"	O
Tumor	O
"	O
.	O

In	O
formalin	O
.	O

Received	O
is	O
a	O
plaque	O
-	O
like	O
,	O
tan	O
,	O
hemorrhagic	O
.	O
nodular	O
structure	O
which	O
weighs	O
1810	O
grams	O
and	O
measures	O
35	B
.	I
0	I
x	I
27	I
.	I
0	I
x	I
5	I
.	I
5	I
cm	I
.	O
in	O
greatest	O
dimensions	O
.	O

On	O
the	O
surface	O
,	O
there	O
are	O
numerous	O
small	O
blood	O
clots	O
.	O
and	O
tumor	O
nodules	O
in	O
various	O
sizes	O
,	O
The	O
latter	O
is	O
fused	O
in	O
a	O
conglomerate	O
.	O
plaque	O
structure	O
.	O

Serial	O
sections	O
reveal	O
mostly	O
solid	O
tumor	O
,	O
mixed	O
with	O
.	O
blood	O
clots	O
and	O
rather	O
homogenous	O
in	O
nature	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
as	O
Blocks	O
D1	O
through	O
D7	O
.	O

E	O
.	O

"	O
Appendix	O
"	O
.	O

In	O
formalin	O
.	O

Vermiform	O
appendix	O
and	O
attached	O
soft	O
tissue	O
.	O
measuring	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
0	O
.	O
1	O
cm	O
.	O

The	O
attached	O
soft	O
tissue	O
is	O
yellow	O
,	O
.	O
hemorrhagic	O
and	O
nodular	O
in	O
nature	O
.	O

Cross	O
-	O
sections	O
reveal	O
a	O
pale	O
white	O
.	O
infiltrates	O
consistent	O
with	O
tumor	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
.	O

Blocks	O
E1	O
and	O
E2	O
.	O

F	O
.	O

"	O
Spleen	O
"	O
.	O

In	O
formalin	O
.	O

Received	O
is	O
a	O
bean	O
-	O
shaped	O
,	O
gray	O
-	O
pink	O
spleen	O
.	O
measuring	O
12	O
.	O
0	O
x	O
6	O
.	O
2	O
x	O
3	O
.	O
5	O
cm	O
.	O

It	O
weighs	O
110	O
grams	O
,	O
The	O
capsule	O
is	O
rather	O
.	O
smooth	O
and	O
glistening	O
over	O
the	O
superior	O
surface	O
;	O
however	O
,	O
the	O
ventral	O
surface	O
.	O

is	O
centrally	O
covered	O
with	O
fatty	O
tissues	O
and	O
possibly	O
intermixed	O
with	O
nodule	O
.	O
structures	O
.	O

They	O
are	O
mostly	O
situated	O
in	O
the	O
hilum	O
area	O
.	O

Serial	O
sections	O
.	O
reveal	O
beefy	O
-	O
red	O
surfaces	O
;	O
no	O
infarcts	O
or	O
suspicious	O
tumor	O
infiltrates	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
:	O
Block	O
F1	O
-	O
Representative	O
section	O
of	O
the	O
spleen	O
,	O
.	O
including	O
the	O
nodules	O
.	O

Block	O
F2	O
-	O
More	O
sections	O
of	O
the	O
spleen	O
,	O
including	O
the	O
nodules	O
and	O
capsule	O
.	O

Block	O
F3	O
-	O
Additional	O
section	O
of	O
the	O
spleen	O
.	O

G	O
.	O

"	O
Omentum	O
"	O
.	O

In	O
formalin	O
.	O

Received	O
is	O
an	O
aggregate	O
of	O
yellow	O
,	O
fatty	O
soft	O
.	O
tissue	O
measuring	O
17	O
.	O
0	O
x	O
9	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
.	O
in	O
greatest	O
dimensions	O
.	O

The	O
serosal	O
.	O
surfaces	O
are	O
covered	O
by	O
numerous	O
various	O
-	O
sized	O
tumor	O
nodules	O
and	O
some	O
of	O
them	O
.	O
are	O
arranged	O
in	O
a	O
plaque	O
-	O
like	O
fashion	O
.	O

Most	O
of	O
them	O
are	O
less	O
than	O
0	O
.	O
8	O
cm	O
.	O

in	O
.	O
greatest	O
dimension	O
.	O

However	O
,	O
serial	O
sections	O
reveal	O
nodules	O
measure	O
up	O
to	O
.	O

2	O
.	O

x	O
1	O
.	O
0	O
x	O
0	O
.	O
8	O
cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
Blocks	O
G1	O
.	O
through	O
G5	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
"	O
:	O
INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
SEROUS	O
CYSTADENOCARCINOMA	O
WITH	O
VASCULAR	O
.	O

CHANNEL	O
INVASION	O
.	O

NO	O
TUBAL	O
TISSUE	O
DETECTED	O
.	O

B	O
.	O

"	O
LEFT	O
OVARY	O
"	O
:	O
OVARIAN	O
TISSUE	O
WITH	O
INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
SEROUS	O
.	O

CYSTADENOCARCINOMA	O
.	O

C	O
.	O

"	O
PERITONEAL	O
NODULES	O
"	O
:	O
OMENTAL	O
TISSUE	O
WITH	O
MULTIPLE	O
DEPOSITS	O
OF	O
SEROUS	O
CYSTADENOCARCINOMA	O
.	O

D	O
.	O

"	O
TUMOR	O
"	O
:	O
OMENTAL	O
TISSUE	O
WITH	O
MULTIPLE	O
DEPOSITS	O
OF	O
SEROUS	O
CYSTADENOCARCINOMA	O
.	O

E	O
.	O

"	O
APPENDIX	O
"	O
:	O
APPENDIX	O
WITH	O
FIBROUS	O
LUMINAL	O
OBLITERATION	O
.	O

MESOAPPENDIX	O
WITH	O
DEPOSITS	O
OF	O
SEROUS	O
CYSTADENOCARCINOMA	O
.	O

F	O
.	O

"	O
SPLEEN	O
"	O
:	O
SPLEEN	O
(	O
110	O
GRAMS	O
)	O
WITH	O
MULTIPLE	O
CAPSULAR	O
SURFACE	O
DEPOSITS	O
OF	O
SEROUS	O
.	O

CYSTOADENOCARCINOMA	O
.	O

G	O
.	O

"	O
OMENTUM	O
"	O
:	O
OMENTAL	O
TISSUE	O
WITH	O
DEPOSITS	O
OF	O
SEROUS	O
CYSTADENOCARCINOMA	O
.	O

ADDENDUM	O
1	O
:	O
Immunostaining	O
for	O
carcinoembryonic	O
antigen	O
(	O
CEAN	O
)	O
is	O
performed	O
on	O
sections	O
.	O
from	O
Block	O
A1	O
(	O
"	O
right	O
ovary	O
"	O
)	O
and	O
G1	O
(	O
"	O
omentum	O
"	O
)	O
.	O

The	O
immunostaining	O
is	O
done	O
.	O
using	O
DAKO	O
rabbit	O
anti	O
-	O
-	O
human	O
CEA	O
which	O
is	O
"	O
the	O
purified	O
immunoglobulin	O
.	O
fraction	O
of	O
rabbit	O
antiserum	O
(	O
DAKO	O
product	O
A115	O
)	O
The	O
histological	O
sections	O
of	O
.	O
ovary	O
contains	O
abundant	O
adenocarcinoma	O
for	O
evaluation	O
.	O

The	O
tumor	O
cells	O
stain	O
.	O
focally	O
for	O
carcinoembryonic	O
antigen	O
.	O

The	O
cells	O
that	O
stain	O
positively	O
are	O
.	O
scattered	O
throughout	O
the	O
tumor	O
,	O
and	O
I	O
estimate	O
that	O
the	O
positively	O
staining	O
.	O
cells	O
comprise	O
only	O
1	O
to	O
2	O
%	O
of	O
the	O
population	O
.	O

The	O
positively	O
staining	O
cells	O
.	O
exhibit	O
mildly	O
intense	O
staining	O
.	O

There	O
are	O
focal	O
areas	O
within	O
the	O
tumor	O
where	O
.	O
there	O
is	O
a	O
greater	O
percentage	O
of	O
cells	O
which	O
stain	O
positively	O
(	O
approximately	O
.	O
1	O
/	O
3	O
of	O
the	O
tumor	O
cells	O
are	O
positive	O
)	O
,	O
but	O
this	O
is	O
compensated	O
for	O
by	O
other	O
.	O
areas	O
in	O
which	O
none	O
of	O
the	O
tumor	O
cells	O
stain	O
positively	O
.	O

Overall	O
,	O
there	O
is	O
.	O
insignificant	O
expression	O
of	O
CEA	O
by	O
the	O
tumor	O
.	O

The	O
histological	O
sections	O
from	O
the	O
omentum	O
also	O
contain	O
abundant	O
tumor	O
.	O

There	O
.	O

is	O
no	O
significant	O
staining	O
of	O
the	O
tumor	O
cells	O
for	O
carcinoembryonic	O
antigen	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Pre	O
-	O
Op	O
Diagnosis	O
.	O

Right	O
lower	O
lobe	O
squamous	O
cell	O
cancer	O
.	O

Post	O
-	O
Op	O
Diagnosis	O
.	O

Same	O
as	O
above	O
.	O

Clinical	O
History	O
.	O

Nothing	O
indicated	O
.	O

Gross	O
Description	O
:	O
Four	O
parts	O
.	O

Received	O
in	O
formalin	O
labeled	O
"	O
.	O

1	O
-	O
level	O
9	O
lymph	O
.	O
node	O
right	O
lung	O
"	O
is	O
a	O
1	O
.	O
1	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
irregular	O
black	O
soft	O
tissue	O
.	O
consistent	O
with	O
probable	O
lymph	O
node	O
,	O
which	O
is	O
bisected	O
and	O
submitted	O
.	O
in	O
its	O
entirety	O
in	O
one	O
cassette	O
.	O

Received	O
in	O
formalin	O
labeled	O
.	O

2	O
-	O
level	O
10	O
lymph	O
.	O
node	O
right	O
lung	O
"	O
are	O
three	O
irregular	O
granular	O
black	O
soft	O
tissues	O
.	O
consistent	O
with	O
probable	O
lymph	O
node	O
ranging	O
from	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
.	O
to	O
1	O
.	O
1	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
3	O
cm	O
,	O
which	O
are	O
submitted	O
in	O
toto	O
in	O
one	O
cassette	O
.	O

Received	O
labeled	O
.	O

3	O
-	O
right	O
lower	O
lung	O
lobe	O
"	O
is	O
a	O
.	O

185	O
gram	O
,	O
19	O
.	O
4	O
x	O
10	O
.	O
5	O
x	O
3	O
.	O
2	O
cm	O
lower	O
lung	O
lobe	O
with	O
an	O
attached	O
0	O
.	O
8	O
.	O

cm	O
segment	O
of	O
bronchus	O
.	O

The	O
pleura	O
is	O
smooth	O
to	O
wrinkled	O
and	O
.	O
tan	O
-	O
pink	O
to	O
gray	O
-	O
purple	O
with	O
black	O
anthracotic	O
areas	O
.	O

There	O
is	O
a	O
3	O
.	O
1	O
.	O

cm	O
linear	O
staple	O
line	O
adjacent	O
to	O
the	O
hilum	O
.	O

No	O
additional	O
.	O
parenchymal	O
staple	O
lines	O
are	O
identified	O
.	O

There	O
is	O
a	O
1	O
.	O
4	O
x	O
1	O
.	O
1	O
cm	O
.	O
slightly	O
ill	O
-	O
defined	O
umbilicated	O
area	O
of	O
pleura	O
2	O
.	O
2	O
cm	O
from	O
the	O
.	O
hilum	O
.	O

The	O
cut	O
surface	O
of	O
this	O
area	O
consists	O
of	O
a	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
2	O
cm	O
.	O
well	O
circumscribed	O
tan	O
nodule	O
,	O
3	O
.	O
4	O
cm	O
from	O
the	O
bronchial	O
margin	O
and	O
.	O

3	O
.	O
8	O
cm	O
from	O
the	O
staple	O
line	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
surface	O
.	O
consists	O
of	O
spongy	O
tan	O
-	O
red	O
parenchyma	O
.	O

There	O
are	O
two	O
tan	O
-	O
white	O
.	O
nodules	O
measuring	O
0	O
.	O
1	O
cm	O
and	O
0	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
which	O
abut	O
.	O
the	O
pleura	O
near	O
the	O
periphery	O
of	O
the	O
specimen	O
.	O

The	O
nodules	O
are	O
3	O
.	O
6	O
.	O

cm	O
from	O
each	O
other	O
.	O

No	O
additional	O
parenchymal	O
lesions	O
are	O
.	O
identified	O
.	O

No	O
obvious	O
intraparenchymal	O
or	O
hilar	O
lymph	O
nodes	O
are	O
.	O
identified	O
.	O

The	O
specimen	O
is	O
inked	O
,	O
serially	O
sectioned	O
and	O
.	O
representative	O
sections	O
are	O
submitted	O
as	O
labeled	O
:	O
A	O
-	O
bronchial	O
and	O
.	O
vascular	O
margins	O
(	O
en	O
face	O
)	O
;	O
B	O
-	O
pleural	O
margin	O
(	O
perpendicular	O
)	O
i	O
C	O
-	O
F	O
.	O

-	O
lesion	O
,	O
entirely	O
submitted	O
;	O
G	O
-	O
larger	O
nodule	O
,	O
entirely	O
submitted	O
;	O
.	O

H	O
-	O
smaller	O
nodule	O
,	O
in	O
toto	O
.	O

Also	O
received	O
in	O
the	O
same	O
container	O
is	O
.	O

a	O
blue	O
,	O
yellow	O
and	O
green	O
cassette	O
labeled	O
.	O
genomic	O
.	O

research	O
study	O
.	O

Received	O
in	O
formalin	O
labeled	O
.	O

4	O
-	O
level	O
4	O
lymph	O
.	O
node	O
right	O
lung	O
"	O
is	O
a	O
2	O
.	O
8	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
irregular	O
fibroadipose	O
.	O
tissue	O
bearing	O
three	O
irregular	O
black	O
firm	O
tissues	O
consistent	O
with	O
.	O
probable	O
lymph	O
node	O
ranging	O
from	O
1	O
.	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
to	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
.	O

0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
sectioned	O
and	O
representative	O
sections	O
are	O
.	O
submitted	O
,	O
to	O
include	O
the	O
lymph	O
nodes	O
in	O
their	O
entirety	O
,	O
as	O
labeled	O
:	O
A	O
-	O
C	O
-	O
one	O
lymph	O
node	O
,	O
bisected	O
in	O
each	O
.	O

Microscopic	O
Description	O
:	O
See	O
diagnosis	O
.	O

Final	O
Diagnosis	O
.	O

Lymph	O
node	O
,	O
right	O
lung	O
,	O
level	O
9	O
,	O
excision	O
:	O
Reactive	O
hyperplasia	O
,	O
negative	O
for	O
malignancy	O
,	O
one	O
node	O
.	O

Lymph	O
node	O
,	O
right	O
lung	O
,	O
level	O
10	O
,	O
excision	O
:	O
Reactive	O
hyperplasia	O
,	O
negative	O
for	O
malignancy	O
,	O
three	O
nodes	O
.	O

Lung	O
,	O
right	O
lower	O
lobe	O
,	O
lobectomy	O
:	O
Tumor	O
characteristics	O
:	O
Specimen	O
integrity	O
:	O
Intact	O
,	O
margins	O
can	O
be	O
evaluated	O
.	O

Specimen	O
laterality	O
:	O
Right	O
side	O
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
non	O
-	O
keratinizing	O
.	O

Histologic	O
grade	O
:	O
2	O
(	O
moderately	O
differentiated	O
)	O
.	O

Tumor	O
site	O
:	O
Right	O
lower	O
lobe	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
8	I
x	I
1	I
.	I
5	I
x	I
1	I
.	I
2	I
cm	I
.	O

Visceral	O
pleural	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
extension	O
:	O
Not	O
identified	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
(	O
no	O
specific	O
history	O
provided	O
)	O
.	O

Surgical	O
margin	O
status	O
:	O
Tumor	O
distance	O
from	O
bronchial	O
margin	O
:	O
3	O
.	O
4	O
cm	O
.	O

Tumor	O
distance	O
from	O
stapled	O
margin	O
:	O
3	O
.	O
8	O
cm	O
.	O

Tumor	O
distance	O
from	O
pleural	O
surface	O
:	O
0	O
.	O
1	O
cm	O
.	O

Lymph	O
node	O
status	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
received	O
(	O
includes	O
all	O
four	O
parts	O
of	O
.	O
this	O
case	O
)	O
:	O
10	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
carcinoma	O
:	O
0	O
.	O

Other	O
significant	O
findings	O
:	O
Two	O
small	O
subpleural	O
fibrous	O
nodules	O
are	O
present	O
consistent	O
with	O
.	O
areas	O
of	O
scarring	O
.	O

pTN	O
stage	O
:	O
pTla	O
,	O
NO	O
PAS	O
9	O
SPC	O
-	O
NP	O
.	O

Comments	O
.	O

The	O
history	O
of	O
"	O
back	O
lower	O
lobe	O
squamous	O
cell	O
carcinoma	O
"	O
is	O
noted	O
.	O

There	O
is	O
however	O
no	O
prior	O
material	O
identified	O
in	O
our	O
files	O
for	O
.	O
review	O
and	O
comparison	O
.	O

The	O
two	O
small	O
subpleural	O
nodules	O
identified	O
grossly	O
,	O
separate	O
from	O
.	O
the	O
malignancy	O
,	O
are	O
both	O
areas	O
of	O
fibrosis	O
containing	O
some	O
.	O
histiocytes	O
and	O
reactive	O
alveolar	O
lining	O
cells	O
,	O
possibly	O
.	O
representing	O
areas	O
of	O
resold	O
pneumonia	O
.	O

At	O
the	O
request	O
of	O
the	O
undersigned	O
pathologist	O
,	O
these	O
slides	O
have	O
.	O
been	O
additionally	O
reviewed	O
by	O
Dr	O
.	O
who	O
concurs	O
with	O
the	O
.	O
diagnosis	O
.	O

PRIMARY	O
SITE	O
:	O
Cervix	O
.	O

"	O
Uterine	O
cervix	O
biopsy	O
"	O
:	O
Invasive	O
poorly	O
differentiated	O
squamous	O
cell	O
carcinoma	O
.	O

Amended	O
.	O

DATE	O
OBTAINED	O
:	O
DATE	O
RECEIVED	O
:	O
SUBMITTING	O
MD	O
:	O
MD	O
.	O

DIAGNOSIS	O
.	O

1	O
.	O

SUPERFICIAL	O
RIGHT	O
AXILLARY	O
BREAST	O
TISSUE	O
,	O
EXCISION	O
:	O
SMALL	O
FOCUS	O
OF	O
INVASIVE	O
LOBULAR	O
.	O

CARCINOMA	O
(	O
0	O
.	O
6MM	O
)	O
PRESENT	O
AT	O
THE	O
EDGE	O
OF	O
ONE	O
FRAGMENT	O
,	O
WITH	O
SURROUNDING	O
ADIPOSE	O
.	O

TISSUE	O
;	O
RARE	O
BENIGN	O
BREAST	O
ACINI	O
;	O
SEE	O
COMMENT	O
.	O

2	O
.	O

RIGHT	O
AXILLARY	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
:	O
ONE	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
MICROMETASTASIS	O
.	O

(	O
0	O
.	O
6	O
MM	O
)	O
;	O
SEE	O
COMMENT	O
.	O

3	O
.	O

RIGHT	O
AXILLARY	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
:	O
ONE	O
LYMPH	O
NODE	O
POSITIVE	O
FOR	O
MULTIPLE	O
FOCI	O
OF	O
.	O

MICROMETASTASIS	O
(	O
LARGEST	O
1	O
.	O
5MM	O
)	O
,	O
CONFIRMED	O
BY	O
CYTOKERATIN	O
STAIN	O
;	O
NO	O
EXTRANODAL	O
.	O

EXTENSION	O
.	O

4	O
.	O

RIGHT	O
BREAST	O
,	O
MASTECTOMY	O
:	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
.	O

SIZE	O
(	O
INVASIVE	O
)	O
:	O
3	B
.	I
5	I
cm	I
.	O

LATERALITY	O
:	O
Right	O
.	O

TUMOR	O
FOCALITY	O
:	O
Unifocal	O
.	O

LESIONAL	O
SITE	O
:	O
10	O
:	O
00	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Invasive	O
lobular	O
carcinoma	O
,	O
classical	O
and	O
pleomorphic	O
types	O
.	O

NUCLEAR	O
GRADE	O
:	O
II	O
and	O
III	O
of	O
III	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
N	O
/	O
A	O
.	O

(	O
invasive	O
lobular	O
carcinoma	O
)	O
.	O

IN	O
-	O
SITU	O
COMPONENT	O
:	O
LCIS	O
.	O

(	O
Classical	O
and	O
focal	O
pleomorphic	O
types	O
;	O
NG	O
II	O
,	O
focal	O
III	O
)	O
.	O

LYMPH	O
NODE	O
SAMPLING	O
:	O
Positive	O
(	O
2	O
/	O
15	O
)	O
,	O
largest	O
3mm	O
;	O
no	O
extranodal	O
involvement	O
;	O
see	O
specimens	O
#	O
2	O
,	O
#	O
3	O
&	O
#	O
6	O
.	O

AJCC	O
CATEGORIES	O
:	O
Stage	O
IIB	O
.	O

pTNM	O
:	O
pT2	O
.	O

pN1mi	O
.	O

cTNM	O
:	O
cT2	O
.	O

cN1	O
.	O

cM0	O
.	O

INTEGRITY	O
/	O
ORIENTATION	O
:	O
Intact	O
specimen	O
with	O
designated	O
margins	O
.	O

MARGINS	O
(	O
invasive	O
lobular	O
)	O
:	O
Focal	O
positive	O
superior	O
/	O
anterior	O
margin	O
(	O
see	O
final	O
margin	O
in	O
#	O
1	O
)	O
;	O
.	O

Other	O
margins	O
negative	O
(	O
>	O
3mm	O
)	O
.	O

LYMPHOVASCULAR	O
INVASION	O
:	O
Present	O
.	O

MICROCALCIFICATIONS	O
:	O
Not	O
identified	O
.	O

NIPPLE	O
/	O
SKIN	O
:	O
Negative	O
skin	O
and	O
nipple	O
.	O

SKELETAL	O
MUSCLE	O
:	O
Present	O
,	O
focal	O
,	O
negative	O
for	O
tumor	O
.	O

OTHER	O
:	O
Focal	O
sclerosing	O
adenosis	O
,	O
columnar	O
cell	O
changes	O
and	O
usual	O
mild	O
hyperplasia	O
.	O

5	O
.	O

LEFT	O
BREAST	O
,	O
PROPHYLACTIC	O
MASTECTOMY	O
:	O
BENIGN	O
BREAST	O
WITH	O
SMALL	O
PAPILLOMATOSIS	O
,	O
.	O

SCLEROSING	O
ADENOSIS	O
AND	O
MILD	O
USUAL	O
DUCTAL	O
HYPERPLASIA	O
;	O
NO	O
ATYPIA	O
;	O
NEGATIVE	O
SKIN	O
AND	O
.	O

NIPPLE	O
.	O

6	O
.	O

RIGHT	O
AXILLARY	O
CONTENTS	O
,	O
DISSECTION	O
:	O
THIRTEEN	O
NEGATIVE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
13	O
)	O
.	O

COMMENT	O
.	O

#	O
1	O
:	O
There	O
is	O
one	O
small	O
focus	O
of	O
invasive	O
carcinoma	O
at	O
the	O
edge	O
of	O
a	O
fragment	O
(	O
0	O
.	O
6mm	O
,	O
confirmed	O
by	O
negative	O
calponin	O
and	O
p63	O
.	O
immunostain	O
)	O
,	O
with	O
severe	O
cautery	O
artefact	O
,	O
which	O
was	O
not	O
seen	O
on	O
frozen	O
section	O
.	O

The	O
tumor	O
is	O
surrounded	O
by	O
fatty	O
tissue	O
,	O
and	O
.	O
thus	O
would	O
be	O
regarded	O
as	O
negative	O
final	O
margin	O
for	O
specimen	O
#	O
4	O
.	O

#	O
2	O
:	O
There	O
is	O
single	O
focus	O
of	O
micrometastasis	O
in	O
the	O
SLN	O
#	O
1	O
.	O

This	O
focus	O
is	O
only	O
present	O
in	O
slide	O
2B	O
CTD2	O
,	O
and	O
not	O
on	O
other	O
levels	O
,	O
.	O
frozen	O
smears	O
and	O
cytokeratin	O
immunostained	O
slides	O
.	O

88307x5	O
,	O
88305	O
,	O
88331	O
,	O
88332	O
,	O
88333x2	O
,	O
88342x3	O
.	O

Clinical	O
Diagnosis	O
and	O
History	O
:	O
Right	O
breast	O
cancer	O
10	O
o	O
'	O
clock	O
.	O

cT2	O
,	O
cNI	O
,	O
cMo	O
,	O
clinical	O
stage	O
2B	O
.	O

Tissue	O
(	O
s	O
)	O
Submitted	O
:	O
1	O
:	O
SUPERFICIAL	O
RIGHT	O
AXILLARY	O
BREAST	O
TISSUE	O
.	O

2	O
:	O
RIGHT	O
AXILLARY	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
1	O
.	O

3	O
:	O
RIGHT	O
AXILLARY	O
SENTINEL	O
LYMPH	O
NODE	O
#	O
2	O
.	O

4	O
:	O
RIGHT	O
BREAST	O
LONG	O
STITCH	O
LATERAL	O
SHORT	O
STITCH	O
SUPERIOR	O
.	O

5	O
:	O
LEFT	O
BREAST	O
LONG	O
STITCH	O
LATERAL	O
SHORT	O
STITCH	O
SUPERIOR	O
.	O

6	O
:	O
RIGHT	O
AXILLARY	O
CONTENTS	O
.	O

Gross	O
Description	O
:	O
Specimen	O
#	O
1	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
superficial	O
right	O
axillary	O
breast	O
.	O
tissue	O
,	O
and	O
consists	O
of	O
a	O
2	O
.	O
7	O
x	O
1	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
tan	O
-	O
yellow	O
lobulated	O
adipose	O
tissue	O
which	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O
analysis	O
labeled	O
1AFS	O
-	O
1BFS	O
.	O

Specimen	O
#	O
2	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
right	O
axillary	O
sentinal	O
lymph	O
node	O
.	O

#	O
1	O
,	O
and	O
consists	O
of	O
a	O
single	O
tan	O
-	O
pink	O
,	O
nodular	O
tissue	O
consistent	O
with	O
lymph	O
node	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
.	O
serially	O
sectioned	O
and	O
two	O
intraoperative	O
smears	O
are	O
performed	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
labeled	O
2A	O
-	O
2B	O
.	O

Specimen	O
#	O
3	O
is	O
received	O
fresh	O
on	O
a	O
blue	O
surgical	O
towel	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
right	O
.	O
axillary	O
sentinal	O
lymph	O
node	O
#	O
2	O
,	O
and	O
consists	O
of	O
a	O
single	O
tan	O
-	O
pink	O
,	O
nodular	O
tissue	O
consistent	O
with	O
lymph	O
node	O
measuring	O
1	O
.	O
0	O
x	O
0	O
,	O
5	O
x	O
.	O

0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
an	O
intraoperative	O
smear	O
is	O
prepared	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
labeled	O
.	O

3A	O
-	O
3B	O
.	O

Specimen	O
#	O
4	O
is	O
received	O
fresh	O
for	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
right	O
breast	O
,	O
long	O
stitch	O
lateral	O
,	O
short	O
stitch	O
superior	O
,	O
.	O
and	O
consists	O
of	O
a	O
520	O
gram	O
,	O
18	O
(	O
superior	O
to	O
inferior	O
)	O
by	O
17	O
(	O
medial	O
to	O
lateral	O
)	O
by	O
4	O
(	O
anterior	O
to	O
posterior	O
)	O
cm	O
right	O
mastectomy	O
.	O
specimen	O
.	O

A	O
short	O
suture	O
designating	O
superior	O
,	O
and	O
a	O
long	O
suture	O
designating	O
lateral	O
are	O
present	O
.	O

A	O
14	O
x	O
4	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
white	O
-	O
tan	O
,	O
.	O
unremarkable	O
ellipse	O
of	O
skin	O
is	O
identified	O
containing	O
a	O
1	O
.	O
3	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
3	O
cm	O
unremarkable	O
,	O
everted	O
nipple	O
.	O

The	O
areola	O
measures	O
3	O
.	O
5	O
x	O
.	O

2	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
differentially	O
inked	O
as	O
follows	O
:	O
superior	O
/	O
anterior	O
-	O
blue	O
,	O
inferior	O
/	O
anterior	O
-	O
green	O
,	O
posterior	O
/	O
deep	O
-	O
black	O
.	O
and	O
.	O

serially	O
.	O
sectioned	O
from	O
lateral	O
to	O
medial	O
to	O
reveal	O
a	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
firm	O
,	O
tan	O
-	O
pink	O
,	O
irregular	O
mass	O
at	O
the	O
10	O
o	O
'	O
clock	O
position	O
.	O

This	O
mass	O
is	O
focally	O
0	O
.	O
2	O
cm	O
from	O
the	O
posterior	O
,	O
0	O
.	O
2	O
cm	O
from	O
the	O
superior	O
/	O
anterior	O
,	O
and	O
greater	O
than	O
4	O
cm	O
from	O
the	O
inferior	O
margins	O
.	O

The	O
mass	O
is	O
present	O
in	O
multiple	O
sections	O
and	O
is	O
seen	O
to	O
extend	O
more	O
centrally	O
.	O

No	O
other	O
lesions	O
are	O
grossly	O
identified	O
.	O

The	O
.	O
surrounding	O
breast	O
parenchyma	O
consists	O
of	O
white	O
,	O
fibrous	O
tissue	O
(	O
60	O
%	O
)	O
and	O
tan	O
lobular	O
adipose	O
tissue	O
(	O
40	O
%	O
)	O
.	O

Time	O
in	O
formalin	O
:	O
14	O
:	O
20	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
4A	O
-	O
4B	O
:	O
Mass	O
closest	O
to	O
superior	O
/	O
anterior	O
and	O
deep	O
margins	O
,	O
contiguous	O
section	O
.	O

4C	O
:	O
Mass	O
to	O
deep	O
margin	O
.	O

4D	O
:	O
Mass	O
to	O
superior	O
/	O
anterior	O
margin	O
.	O

4E	O
:	O
Mass	O
to	O
deep	O
margin	O
.	O

4F	O
-	O
4G	O
:	O
Tumor	O
without	O
margin	O
.	O

4H	O
:	O
Mass	O
to	O
deep	O
.	O

41	O
:	O
Tumor	O
without	O
margin	O
.	O

4J	O
:	O
Inferior	O
margin	O
closest	O
to	O
tumor	O
.	O

4K	O
-	O
4L	O
:	O
Fibrous	O
tissue	O
immediately	O
medial	O
to	O
mass	O
.	O

4M	O
:	O
Fibrous	O
tissue	O
in	O
central	O
breast	O
.	O

4N	O
:	O
Fibrous	O
tissue	O
in	O
medial	O
most	O
breast	O
.	O

40	O
:	O
Nipple	O
and	O
skin	O
section	O
closest	O
to	O
mass	O
.	O

4P	O
:	O
Outer	O
upper	O
quadrant	O
.	O

4Q	O
:	O
Outer	O
lower	O
quadrant	O
.	O

4R	O
:	O
Inner	O
upper	O
quadrant	O
.	O

4S	O
:	O
Inner	O
lower	O
quadrant	O
.	O

Specimen	O
#	O
5	O
is	O
received	O
fresh	O
for	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
left	O
breast	O
,	O
long	O
stitch	O
lateral	O
,	O
short	O
stitch	O
superior	O
,	O
.	O
and	O
consists	O
of	O
a	O
550	O
-	O
gram	O
,	O
20	O
(	O
superior	O
to	O
inferior	O
)	O
by	O
15	O
.	O
9	O
(	O
medial	O
to	O
lateral	O
)	O
by	O
5	O
.	O
4	O
(	O
anterior	O
to	O
posterior	O
)	O
product	O
of	O
left	O
.	O
mastectomy	O
.	O

An	O
unremarkable	O
,	O
tan	O
ellipse	O
of	O
skin	O
is	O
identified	O
measuring	O
13	O
.	O
3	O
x	O
4	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
everted	O
nipple	O
measures	O
1	O
x	O
.	O

0	O
.	O
9	O
cm	O
and	O
resides	O
within	O
a	O
4	O
x	O
2	O
.	O
9	O
cm	O
areola	O
.	O

The	O
specimen	O
is	O
differentially	O
inked	O
as	O
follows	O
:	O
superior	O
/	O
anterior	O
-	O
blue	O
,	O
.	O

inferior	O
/	O
anterior	O
-	O
green	O
,	O
posterior	O
/	O
deep	O
-	O
black	O
and	O
serially	O
sectioned	O
from	O
medial	O
to	O
lateral	O
to	O
reveal	O
no	O
distinct	O
mass	O
but	O
areas	O
.	O
consistent	O
.	O

with	O
.	O
fibrocystic	O
changes	O
containing	O
blue	O
domed	O
cysts	O
averaging	O
0	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
surrounding	O
breast	O
.	O
parenchyma	O
consists	O
of	O
tan	O
-	O
yellow	O
lobulated	O
adipose	O
tissue	O
(	O
60	O
%	O
)	O
and	O
white	O
,	O
fibrous	O
areas	O
(	O
40	O
%	O
)	O
.	O

No	O
other	O
lesions	O
are	O
grossly	O
.	O
identified	O
.	O

Time	O
in	O
formalin	O
:	O
Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
5A	O
:	O
Nipple	O
.	O

5B	O
:	O
Outer	O
upper	O
quadrant	O
.	O

5C	O
:	O
Inner	O
upper	O
quadrant	O
.	O

5D	O
:	O
Inner	O
lower	O
quadrant	O
.	O

5E	O
:	O
Outer	O
lower	O
quadrant	O
.	O

5F	O
-	O
5L	O
:	O
Fibrous	O
areas	O
.	O

5M	O
:	O
Superior	O
margin	O
to	O
fibrous	O
area	O
.	O

5N	O
:	O
Deep	O
margin	O
to	O
fibrous	O
area	O
.	O

50	O
:	O
Inferior	O
margin	O
to	O
fibrous	O
area	O
.	O

Specimen	O
#	O
6	O
is	O
received	O
fresh	O
on	O
a	O
blue	O
surgical	O
towel	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
right	O
axillary	O
contents	O
,	O
and	O
consists	O
of	O
.	O
multiple	O
tan	O
-	O
pink	O
,	O
nodular	O
tissues	O
consistent	O
with	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
5	O
to	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
grossly	O
.	O
identifiable	O
lymph	O
nodes	O
are	O
submitted	O
as	O
follows	O
:	O
6A	O
-	O
B	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
,	O
each	O
cassette	O
.	O

6C	O
-	O
6D	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
.	O

6E	O
-	O
F	O
:	O
One	O
lymph	O
node	O
,	O
bisected	O
,	O
each	O
cassette	O
.	O

6G	O
-	O
H	O
:	O
Intact	O
lymph	O
nodes	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

1A	O
-	O
1B	O
/	O
FSDX	O
:	O
BENIGN	O
BREAST	O
TISSUE	O
AND	O
FAT	O
;	O
NO	O
MALIGNANCY	O
.	O

2A	O
/	O
GDX	O
/	O
SMDX	O
:	O
NEGATIVE	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

3A	O
/	O
GDX	O
/	O
SMDX	O
:	O
POSITIVE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
.	O

Amendments	O
.	O

Amended	O
:	O
Reason	O
:	O
Further	O
review	O
of	O
case	O
.	O

SLN	O
#	O
2	O
should	O
be	O
counted	O
as	O
multiple	O
micromet	O
.	O

Previous	O
Signout	O
Date	O
:	O

Laboratory	O
Services	O
.	O

PHN	O
:	O
ACB	O
:	O
Telephone	O
:	O
Encounter	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Specimen	O
Description	O
.	O

A	O
.	O

Gallbladder	O
.	O

B	O
.	O

Liver	O
.	O

C	O
.	O

Tumor	O
thrombus	O
-	O
left	O
hepatic	O
vein	O
.	O

Clinical	O
Information	O
.	O

Hepatocellular	O
carcinoma	O
.	O

Diagnosis	O
.	O

A	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
-	O
Normal	O
gallbladder	O
with	O
no	O
pathologic	O
abnormality	O
.	O

B	O
.	O

Liver	O
,	O
partial	O
hepatectomy	O
:	O
-	O
Moderately	O
differentiated	O
hepatocellular	O
carcinoma	O
.	O

-	O
Solitary	O
,	O
11	B
.	I
0	I
cm	I
in	O
greatest	O
dimension	O
,	O
0	O
.	O
8	O
cm	O
from	O
the	O
resection	O
.	O
margin	O
.	O

-	O
Background	O
liver	O
negative	O
for	O
cirrhosis	O
or	O
significant	O
steatosis	O
.	O

C	O
.	O

Tumor	O
thrombus	O
,	O
left	O
hepatic	O
vein	O
:	O
PHN	O
:	O
ACB	O
:	O
Surc	O
.	O

Received	O
Date	O
/	O
Time	O
:	O
-	O
-	O
Hepatocellular	O
carcinoma	O
with	O
necrosis	O
.	O

Verified	O
:	O
Synoptic	O
Report	O
.	O

B	O
:	O
Liver	O
,	O
Resection	O
,	O
Microscopic	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Hepatocellular	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
GII	O
:	O
Moderately	O
differentiated	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Solitary	O
tumor	O
with	O
vascular	O
invasion	O
or	O
multiple	O
tumors	O
none	O
more	O
than	O
5	O
cm	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
.	O

MARGINS	O
:	O
Parenchymal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
0	O
.	O
8	O
mm	O
.	O

Specify	O
margin	O
:	O
Parenchymal	O
resection	O
margin	O
.	O

Bile	O
duct	O
margin	O
cannot	O
be	O
assessed	O
.	O

VENOUS	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
)	O
:	O
Present	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
None	O
identified	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
specimens	O
A	O
to	O
C	O
.	O

All	O
requisitions	O
and	O
specimen	O
containers	O
are	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

The	O
cassettes	O
and	O
AP	O
identifiers	O
are	O
labelled	O
with	O
the	O
Surgical	O
Number	O
.	O

PHN	O
:	O
ACB	O
:	O
Surgicali	O
Pathology	O
Report	O
.	O

Received	O
Date	O
/	O
Time	O
:	O
A	O
.	O

The	O
specimen	O
Is	O
labelled	O
as	O
"	O
gallbladder	O
"	O
and	O
consists	O
of	O
a	O
cholecystectomy	O
specimen	O
,	O
measuring	O
6	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
gallbladder	O
contains	O
green	O
bile	O
and	O
no	O
stone	O
.	O

The	O
gallbladder	O
surface	O
attached	O
to	O
the	O
liver	O
was	O
sampled	O
and	O
.	O
submitted	O
in	O
A1	O
.	O

Representative	O
sections	O
of	O
the	O
rest	O
of	O
the	O
gallbladder	O
wall	O
are	O
submitted	O
in	O
A2	O
.	O

B	O
,	O
.	O
specimen	O
is	O
labelled	O
as	O
"	O
Liver	O
"	O
and	O
consists	O
of	O
a	O
partial	O
hepatectomy	O
specimen	O
weighing	O
723	O
grams	O
that	O
has	O
been	O
.	O
previously	O
.	O

inked	O
with	O
silver	O
nitrate	O
.	O

The	O
resection	O
margin	O
has	O
been	O
painted	O
black	O
.	O

The	O
specimen	O
measures	O
approximately	O
.	O

18	O
.	O
0	O
x	O
13	O
.	O
0	O
x	O
8	O
.	O
0	O
cm	O
.	O

Serial	O
sectioning	O
through	O
the	O
specimen	O
shows	O
that	O
95	O
%	O
of	O
the	O
specimen	O
is	O
occupied	O
by	O
a	O
relatively	O
.	O
circumscribed	O
,	O
soft	O
,	O
tan	O
mass	O
lesion	O
.	O

The	O
mass	O
lesion	O
measures	O
11	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
cut	O
surface	O
is	O
.	O
hemorrhagic	O
with	O
possible	O
necrosis	O
.	O

Grossly	O
,	O
the	O
mass	O
lesion	O
is	O
approximately	O
0	O
.	O
8	O
cm	O
to	O
the	O
liver	O
resection	O
margin	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
:	O
B1	O
.	O

Representative	O
section	O
of	O
tumor	O
with	O
closest	O
liver	O
resection	O
margin	O
,	O
which	O
is	O
painted	O
.	O
black	O
.	O

B2	O
-	O
B6	O
.	O

Multiple	O
representative	O
sections	O
of	O
the	O
mass	O
lesion	O
.	O

B7	O
,	O
88	O
.	O

Representative	O
sections	O
of	O
the	O
hemorrhagic	O
and	O
possible	O
necrotic	O
area	O
.	O

B9	O
,	O
810	O
.	O

Representative	O
sections	O
of	O
the	O
uninvolved	O
background	O
liver	O
parenchyma	O
.	O

C	O
.	O

The	O
specimen	O
consists	O
of	O
one	O
fragment	O
of	O
white	O
solid	O
mass	O
lesion	O
.	O

It	O
is	O
submitted	O
in	O
toto	O
in	O
cassette	O
C	O
.	O

Microscopic	O
Description	O
.	O

The	O
main	O
tumor	O
consists	O
of	O
nests	O
and	O
cords	O
of	O
malignant	O
hepatic	O
cells	O
with	O
enlarged	O
nuclei	O
and	O
prominent	O
nucleoli	O
.	O

Globular	O
eosinophilic	O
inclusions	O
are	O
seen	O
in	O
many	O
hepatocytes	O
.	O

There	O
are	O
foci	O
of	O
hemorrhage	O
and	O
necrosis	O
present	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

2	O
.	O

REPORT	O
DATE	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

ADM	O
DATE	O
:	O
BIRTHDATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
PROCEDURE	O
:	O
rear	O
-	O
old	O
male	O
with	O
long	O
history	O
of	O
reflux	O
.	O

Recent	O
onset	O
dysphagia	O
/	O
weight	O
.	O
loss	O
.	O

Evaluation	O
indicates	O
adenocarcinoma	O
.	O

No	O
chemo	O
or	O
x	O
-	O
ray	O
therapy	O
.	O

PROCEDURE	O
:	O
1	O
.	O

"	O
Esophagus	O
.	O

"	O
A	O
13	O
.	O
0	O
x	O
7	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
specimen	O
comprised	O
of	O
7	O
cm	O
of	O
distal	O
.	O
esophagus	O
and	O
6	O
cm	O
of	O
proximal	O
stomach	O
.	O

Received	O
opened	O
longitudinally	O
.	O

At	O
the	O
.	O

GE	O
junction	O
there	O
is	O
a	O
somewhat	O
nodular	O
thickening	O
of	O
the	O
mucosa	O
,	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
.	O

cm	O
.	O

Maximum	O
depth	O
of	O
lesion	O
1	O
.	O
3	O
cm	O
.	O

Remainder	O
of	O
the	O
GE	O
junction	O
shows	O
slight	O
.	O
irregularity	O
and	O
possible	O
ulceration	O
.	O

Distal	O
and	O
proximal	O
staple	O
lines	O
.	O
removed	O
.	O

Deep	O
inked	O
black	O
.	O

1A	O
-	O
B	O
.	O

Distal	O
stomach	O
resection	O
margin	O
.	O

1C	O
.	O

Proximal	O
uninvolved	O
esophagus	O
,	O
proximal	O
end	O
inked	O
black	O
.	O

1D	O
-	O
G	O
.	O

Sections	O
through	O
major	O
portion	O
of	O
Lesion	O
.	O

1H	O
-	O
J	O
.	O

Lymph	O
node	O
dissection	O
.	O

2	O
.	O

"	O
Cervical	O
esophageal	O
margin	O
.	O
"	O
A	O
3	O
.	O
2	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
length	O
of	O
esophagus	O
.	O
closed	O
at	O
one	O
end	O
with	O
staple	O
line	O
.	O

2A	O
.	O

Stapled	O
end	O
.	O

28	O
.	O

Non	O
-	O
stapled	O
end	O
.	O

PROCEDURE	O
:	O
ESOPHAGEAL	O
,	O
CARDIAC	O
AND	O
GASTROESOPHAGEAL	O
JUNCTION	O
CARCINOMA	O
:	O
Type	O
of	O
carcinoma	O
:	O
Adenocarcinoma	O
.	O

If	O
adenocarcinoma	O
,	O
is	O
it	O
arising	O
in	O
:	O
GE	O
junction	O
.	O

Depth	O
of	O
invasion	O
:	O
Omental	O
surface	O
.	O

Number	O
of	O
positive	O
lymph	O
nodes	O
,	O
the	O
total	O
number	O
sampled	O
is	O
irrelevant	O
:	O
0	O
.	O

Extranodal	O
metastasis	O
:	O
Unknown	O
.	O

Pattern	O
of	O
invasion	O
:	O
Infiltrative	O
.	O

Esophageal	O
and	O
gastric	O
resection	O
margins	O
involved	O
:	O
No	O
.	O

Deep	O
resection	O
margin	O
involved	O
:	O
Yes	O
.	O

PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

REPORT	O
DATE	O
:	O
3	O
.	O

PATIENT	O
NBR	O
:	O
SEX	O
:	O
M	O
.	O

BIRTHDATE	O
:	O
ADM	O
DATE	O
:	O
OPER	O
DATE	O
:	O
REQ	O
DOC	O
:	O
TNM	O
classification	O
:	O
T2NOMx	O
.	O

PROCEDURE	O
:	O
1	O
.	O

Esophagus	O
,	O
resection	O
:	O
Moderately	O
to	O
poorly	O
differentiated	O
adenocarcinoma	O
.	O
arising	O
from	O
the	O
gastroesophageal	O
junction	O
(	O
1	B
.	I
5	I
cm	I
)	O
.	O

Tumor	O
penetrates	O
.	O
muscularis	O
propria	O
and	O
reaches	O
the	O
omentum	O
surface	O
.	O

Distal	O
gastric	O
margin	O
.	O
negative	O
for	O
neoplasm	O
.	O

Four	O
lymph	O
nodes	O
negative	O
for	O
neoplasm	O
.	O

See	O
template	O
.	O

2	O
.	O

Cervical	O
esophageal	O
margin	O
,	O
resection	O
:	O
Negative	O
for	O
neoplasm	O
.	O

1	O
,	O
.	O

he	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
examined	O
and	O
.	O
interpreted	O
the	O
slides	O
from	O
this	O
case	O
.	O

Code	O
:	O
END	O
OF	O
PREVIOUS	O
DIAGNOSIS	O
INQUIRY	O
.	O

eck	O
.	O

Neck	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
FNA	O
left	O
lobe	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Total	O
thyroid	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Total	O
thyroid	O
:	O
Tumor	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Histologic	O
Grade	O
:	O
Well	O
differentiated	O
.	O

Mitotic	O
Activity	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Tumor	O
Location	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
1	B
.	I
2	I
cm	I
.	O

Tumor	O
Encapsulation	O
:	O
Completely	O
surrounded	O
.	O

Capsular	O
Invasion	O
:	O
Focal	O
invasion	O
.	O

Blood	O
Vessel	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroid	O
Extension	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Tumor	O
Multicentricity	O
:	O
Not	O
identified	O
.	O

Non	O
-	O
Neoplastic	O
Thyroid	O
:	O
Exhibits	O
nodular	O
hyperplasia	O
.	O

Exhibits	O
chronic	O
lymphocytic	O
thyrolditis	O
.	O

Parathyroid	O
Glands	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Four	O
benign	O
lymph	O
nodes	O
(	O
0	O
/	O
4	O
)	O
.	O

LATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
is	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
THAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
b	O
.	O

1	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
total	O
thyroid	O
"	O
and	O
consists	O
of	O
a	O
thyrold	O
weighing	O
18	O
.	O
0	O
g	O
.	O

The	O
right	O
lobe	O
measures	O
5	O
.	O
5	O
.	O

x	O
.	O

3	O
.	O
0	O
x	O
0	O
.	O
9	O
cm	O
,	O
the	O
left	O
lobe	O
measures	O
4	O
x	O
2x1	O
cm	O
and	O
the	O
isthmus	O
measures	O
2	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
external	O
surface	O
is	O
covered	O
by	O
a	O
.	O
thin	O
fibrous	O
capsule	O
.	O

The	O
posterior	O
surface	O
of	O
the	O
specimen	O
is	O
inked	O
black	O
,	O
and	O
the	O
anterior	O
is	O
inked	O
blue	O
.	O

Sectioning	O
of	O
the	O
left	O
.	O
lobe	O
reveals	O
a	O
1	O
.	O
2	O
CM	O
light	O
brown	O
nodule	O
with	O
central	O
cystic	O
degeneration	O
,	O
located	O
at	O
the	O
upper	O
pole	O
of	O
the	O
left	O
lobe	O
and	O
abutting	O
the	O
.	O
thyroid	O
capsule	O
.	O

Sections	O
through	O
the	O
right	O
lobe	O
reveal	O
red	O
tan	O
and	O
beefy	O
thyrold	O
parenchyma	O
with	O
a	O
vague	O
nodularity	O
(	O
gelatinous	O
.	O
fleshy	O
nodules	O
)	O
.	O

The	O
isthmus	O
is	O
red	O
tan	O
and	O
beefy	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
(	O
left	O
lobe	O
nodule	O
)	O
are	O
submitted	O
for	O
.	O

TPS	O
.	O

The	O
remaining	O
tissue	O
is	O
serially	O
sectioned	O
and	O
representatively	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
-	O
nodule	O
,	O
entirely	O
submitted	O
.	O

LL	O
left	O
lobe	O
.	O

RL	O
right	O
lobe	O
.	O

IS	O
isthmus	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Total	O
thyroid	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

IS	O
.	O

1	O
.	O

1	O
.	O

LL	O
.	O

1	O
.	O

2	O
.	O

N	O
.	O

2	O
.	O

2	O
.	O

RL	O
.	O

2	O
.	O

WUID	O
:	O
D38D2FD4	O
-	O
78EF	O
-	O
4F49	O
-	O
976E	O
-	O
529855A6D9A9	O
.	O

Copies	O
To	O
:	O
DIAGNOSIS	O
:	O
A	O
.	O

RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
,	O
EXCISION	O
:	O
No	O
tumor	O
identified	O
in	O
two	O
lymph	O
nodes	O
(	O
0	O
/	O
2	O
)	O
.	O

B	O
.	O

LEFT	O
COMMON	O
ILIAC	O
AND	O
PRECAVAL	O
LYMPH	O
NODE	O
,	O
EXCISION	O
:	O
No	O
tumor	O
identified	O
in	O
seven	O
lymph	O
nodes	O
(	O
0	O
/	O
7	O
)	O
.	O

C	O
.	O

LEFT	O
PELVIC	O
LYMPH	O
NODE	O
,	O
EXCISION	O
:	O
No	O
tumor	O
identified	O
in	O
seven	O
lymph	O
nodes	O
(	O
0	O
/	O
7	O
)	O
.	O

D	O
.	O

LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODE	O
,	O
EXCISION	O
:	O
No	O
tumor	O
identified	O
in	O
one	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

E	O
.	O

CERVIX	O
,	O
UTERUS	O
,	O
TUBES	O
AND	O
OVARIES	O
,	O
TOTAL	O
ABDOMINAL	O
HYSTERECTOMY	O
.	O

WITH	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
:	O
Endometrial	O
adenocarcinoma	O
,	O
high	O
-	O
grade	O
,	O
see	O
note	O
.	O

Grade	O
III	O
of	O
III	O
.	O

Tumor	O
size	O
:	O
Microscopic	O
foci	O
of	O
residual	O
endometrial	O
adenocarcinoma	O
.	O

No	O
myometrial	O
invasion	O
is	O
identified	O
.	O

Extensive	O
lymphovascular	O
space	O
invasion	O
is	O
identified	O
.	O

All	O
inked	O
surgical	O
margins	O
are	O
free	O
of	O
tumor	O
.	O

Parametrium	O
is	O
free	O
of	O
tumor	O
.	O

Pathologic	O
stage	O
:	O
pT1a	O
NO	O
Mx	O
FIGO	O
IA	O
.	O

Chronic	O
cervicitis	O
.	O

-	O
Adenomyosis	O
.	O

Leiomyomas	O
(	O
5	O
,	O
0	B
.	I
3	I
to	O
1	B
.	I
7	I
cm	I
with	O
foci	O
of	O
hyalinization	O
)	O
.	O

Bilateral	O
ovaries	O
and	O
fallopian	O
tube	O
without	O
malignancy	O
.	O

See	O
note	O
.	O

NOTE	O
:	O
The	O
adenocarcinoma	O
is	O
higb	O
-	O
grade	O
and	O
does	O
not	O
fit	O
the	O
typical	O
histologic	O
features	O
of	O
an	O
.	O
endometrioid	O
adenocarcinoma	O
or	O
a	O
serous	O
carcinoma	O
.	O

However	O
given	O
the	O
high	O
nuclear	O
grade	O
and	O
.	O
extensive	O
lymphovascular	O
space	O
invasion	O
a	O
component	O
of	O
high	O
-	O
grade	O
serous	O
adenocarcinoma	O
is	O
.	O
favored	O
.	O

Intradepartmental	O
consultation	O
obtained	O
.	O

HISTORY	O
:	O
Uterine	O
cancer	O
.	O

MICROSCOPIC	O
:	O
Patient	O
Case	O
(	O
s	O
)	O
:	O
Page	O
of	O
}	O
.	O

NOTIFIEDOR	O
RESULTS	O
.	O

NURSE	O
:	O
part	O
.	O

Sce	O
diagnosis	O
.	O

GROSS	O
:	O
A	O
.	O

RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
node	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
2	O
.	O
2	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
.	O
aggregate	O
of	O
soft	O
yellow	O
adipose	O
tissue	O
.	O

One	O
lymph	O
node	O
is	O
identified	O
,	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

Entirely	O
.	O
submitted	O
.	O

A1	O
.	O

Multiple	O
.	O

B	O
.	O

LEFT	O
COMMON	O
ILIAC	O
AND	O
PRECAVAL	O
LYMPH	O
NODES	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
left	O
common	O
iliac	O
and	O
precaval	O
lymph	O
nodes	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
.	O

a	O
3	O
.	O
1	O
x	O
2	O
.	O
6	O
x	O
0	O
.	O
5	O
cm	O
aggregate	O
of	O
soft	O
yellow	O
adipose	O
tissue	O
.	O

Two	O
definitive	O
lymph	O
nodes	O
are	O
identified	O
,	O
measuring	O
.	O

1	O
.	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
and	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
.	O

Entirely	O
submitted	O
.	O

B1	O
.	O

Two	O
lymph	O
nodes	O
-	O
2	O
.	O

B2	O
.	O

Additional	O
adipose	O
tissue	O
-	O
multiple	O
.	O

C	O
.	O

LEFT	O
PELVIC	O
LYMPH	O
NODE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
node	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
6	O
cm	O
.	O
aggregate	O
of	O
soft	O
yellow	O
adipose	O
tissue	O
.	O

Three	O
lymph	O
nodes	O
are	O
identified	O
,	O
ranging	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
1	O
cm	O
.	O

Entirely	O
.	O
submitted	O
.	O

CI	O
.	O

Three	O
lymph	O
nodes	O
-	O
3	O
.	O

C2	O
.	O

Additional	O
adipose	O
tissue	O
-	O
multiple	O
.	O

D	O
.	O

LEFT	O
COMMON	O
ILIAC	O
LYMPH	O
NODE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
left	O
common	O
iliac	O
lymph	O
node	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
2	O
.	O
5	O
x	O
1	O
.	O
1	O
x	O
.	O

0	O
,	O
4	O
cm	O
aggregate	O
of	O
soft	O
yellow	O
adipose	O
tissue	O
.	O

One	O
lymph	O
node	O
is	O
identified	O
,	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
.	O
lymph	O
node	O
and	O
adipose	O
tissue	O
are	O
entirely	O
submitted	O
.	O

D1	O
.	O

Multiple	O
.	O

E	O
.	O

CERVIX	O
UTERUS	O
TUBES	O
AND	O
OVARIES	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
"	O
cervix	O
uterus	O
tubes	O
and	O
ovaries	O
"	O
,	O
and	O
received	O
fresh	O
in	O
the	O
Operating	O
.	O

Room	O
for	O
intraoperative	O
consultation	O
and	O
subsequently	O
fixed	O
in	O
formalin	O
is	O
a	O
75	O
gram	O
specimen	O
consisting	O
of	O
a	O
.	O
previous	O
incised	O
uterus	O
with	O
attached	O
bilateral	O
fallopian	O
tubes	O
and	O
ovaries	O
.	O

The	O
uterus	O
measures	O
9	O
.	O
7	O
cm	O
from	O
fundus	O
.	O
to	O
ectocervical	O
margin	O
,	O
4	O
.	O
8	O
cm	O
from	O
comu	O
to	O
comu	O
and	O
a	O
maximum	O
of	O
3	O
.	O
8	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
.	O
ectocervix	O
measures	O
3	O
.	O
5	O
cm	O
and	O
has	O
a	O
diameter	O
of	O
2	O
.	O
8	O
cm	O
.	O

The	O
external	O
os	O
measures	O
0	O
.	O
7	O
cm	O
.	O

The	O
left	O
ovary	O
.	O
measures	O
1	O
.	O
8	O
x	O
1	O
.	O
1	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
left	O
,	O
fimbriated	O
fallopian	O
tube	O
is	O
4	O
.	O
0	O
cm	O
long	O
,	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
and	O
has	O
a	O
patent	O
.	O
lumen	O
up	O
to	O
0	O
.	O
1	O
cm	O
in	O
diameter	O
.	O

The	O
right	O
ovary	O
measures	O
2	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
right	O
,	O
fimbriated	O
fallopian	O
tube	O
.	O

is	O
4	O
.	O
5	O
cm	O
long	O
has	O
a	O
diameter	O
of	O
0	O
.	O
5	O
cm	O
and	O
a	O
patent	O
lumen	O
up	O
to	O
0	O
.	O
1	O
cm	O
in	O
diameter	O
.	O

The	O
endometrial	O
cavity	O
.	O
measures	O
3	O
.	O
9	O
cm	O
in	O
length	O
and	O
a	O
maximum	O
of	O
2	O
.	O
5	O
cm	O
in	O
width	O
.	O

The	O
myometrium	O
has	O
a	O
thickness	O
of	O
1	O
.	O
8	O
cm	O
.	O

The	O
endometrial	O
cavity	O
shows	O
to	O
focal	O
areas	O
of	O
thickening	O
,	O
one	O
on	O
the	O
anterior	O
surface	O
measuring	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
1	O
cm	O
.	O
and	O
one	O
on	O
the	O
posterior	O
surface	O
measuring	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
1	O
cm	O
.	O

Sectioning	O
of	O
these	O
lesions	O
reveals	O
them	O
to	O
be	O
.	O
confined	O
to	O
the	O
endometrial	O
cavity	O
with	O
no	O
obvious	O
invasion	O
.	O

Also	O
noted	O
are	O
approximately	O
5	O
.	O
0	O
leiomyomata	O
.	O
located	O
intramurally	O
,	O
submucosally	O
,	O
and	O
subserosally	O
.	O

Sectioning	O
of	O
all	O
nodules	O
reveais	O
a	O
firm	O
white	O
whorled	O
.	O
appearance	O
with	O
no	O
areas	O
of	O
hemorrhage	O
or	O
necrosis	O
.	O

They	O
range	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
exocervix	O
,	O
the	O
external	O
os	O
and	O
endocervical	O
canal	O
are	O
grossly	O
unremarkable	O
.	O

The	O
uninvolved	O
portion	O
of	O
.	O
endometrial	O
cavity	O
is	O
covered	O
by	O
tan	O
-	O
pink	O
hemorrhagic	O
mucosal	O
surface	O
without	O
additional	O
gross	O
lesions	O
.	O

The	O
serosa	O
.	O
shows	O
no	O
gross	O
abnormalities	O
.	O

The	O
bilateral	O
ovaries	O
and	O
fallopian	O
tube	O
are	O
grossly	O
unremarkable	O
.	O

Ink	O
key	O
:	O
Anterior	O
cervix	O
-	O
blue	O
.	O

Posterior	O
cervix	O
-	O
black	O
.	O

Slide	O
key	O
:	O
E1	O
.	O

Left	O
ovary	O
-	O
2	O
.	O

E2	O
.	O

Left	O
fallopian	O
tube	O
-	O
3	O
.	O

E3	O
.	O

Right	O
ovary	O
and	O
fallopian	O
tube	O
-	O
4	O
.	O

E4	O
.	O

Anterior	O
cervix	O
-	O
I	O
.	O

E5	O
.	O

Posterior	O
cervix	O
-	O
1	O
.	O

E6	O
.	O

Anterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

E7	O
.	O

Anterior	O
uterine	O
fundus	O
-	O
\	O
.	O

E8	O
,	O
E9	O
.	O

Anterior	O
uterine	O
corpus	O
with	O
polypoid	O
lesion	O
-	O
1	O
each	O
.	O

E10	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
-	O
!	O
.	O

E11	O
.	O

Posterior	O
uterine	O
fundus	O
-	O
1	O
.	O

E12	O
-	O
E14	O
.	O

Posterior	O
uterine	O
corpus	O
with	O
polypoid	O
lesion	O
-	O
I	O
each	O
.	O

E15	O
.	O

Leiomyomas	O
-	O
2	O
.	O

Gross	O
dictated	O
by	O
.	O
,	O
M	O
.	O
D	O
.	O

OPERATIVE	O
CALL	O
.	O

OPERATIVE	O
CONSULT	O
(	O
GROSS	O
)	O
:	O
E	O
.	O

CERVIX	O
,	O
UTERUS	O
,	O
TUBES	O
AND	O
OVARIES	O
,	O
GROSS	O
ONLY	O
:	O
Focal	O
endometrial	O
thickening	O
with	O
some	O
myometrial	O
invasion	O
(	O
demarcation	O
between	O
endometrium	O
and	O
.	O
myometrium	O
is	O
inapparent	O
)	O
.	O

Fibroids	O
and	O
right	O
hydrosalpinx	O
.	O

Cervix	O
and	O
bilateral	O
ovaries	O
show	O
no	O
apparent	O
focal	O
lesions	O
.	O

Tissue	O
procured	O
for	O
research	O
.	O

M	O
.	O
D	O
.	O
)	O
.	O

If	O
this	O
report	O
includes	O
immunohistochemical	O
test	O
results	O
.	O
please	O
note	O
the	O
following	O
:	O
Numerous	O
immunohistochemical	O
lests	O
were	O
develoned	O
and	O
their	O
performance	O
characteristics	O
determined	O
.	O

Those	O
immunohistochemical	O
tests	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
,	O
and	O
FDA	O
approval	O
is	O
not	O
required	O
.	O

I	O
have	O
personally	O
examined	O
the	O
specimen	O
.	O
interpreted	O
the	O
results	O
.	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

Gross	O
Description	O
:	O
Microscopic	O
Description	O
:	O
Diagnosis	O
Details	O
:	O
Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
LIVER	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Hepatectomy	O
.	O

Tumor	O
size	O
:	O
7	B
.	I
5	I
X	I
7	I
.	I
5	I
X	I
7	I
.	I
5	I
cm	I
.	O

Focality	O
:	O
Not	O
specified	O
.	O

Histologic	O
type	O
:	O
Hepatocellular	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
CD10	O
+	O
,	O
Hepar	O
+	O
,	O
AFP	O
+	O
.	O

Comments	O
:	O
None	O
.	O

REVISED	O
REPORT	O
(	O
Revised	O
information	O
underlined	O
)	O
ICD	O
-	O
0	O
-	O
3	O
-	O
.	O

TISSUE	O
DESCRIPTION	O
:	O
B1	O
B2	O
B3	O
B4	O
B5	O
B6	O
B7	O
C1	O
C23C4C5C67C8	O
C9	O
.	O

C10	O
C11	O
D1	O
.	O

D2	O
D3	O
D4	O
D5	O
D6	O
D7	O
D8	O
D9	O
D10	O
D11	O
D12	O
D13	O
E1	O
E2	O
E3	O
F1	O
G1	O
H1	O
.	O

Il	O
.	O

Uterus	O
,	O
right	O
ovary	O
(	O
2	O
.	O
0	O
X	O
1	O
.	O
9	O
X	O
1	O
.	O
3	O
cm	O
)	O
with	O
8	O
.	O
8	O
cm	O
.	O
segment	O
of	O
.	O
right	O
fallopian	O
tube	O
,	O
and	O
left	O
ovary	O
(	O
3	O
.	O
2	O
X	O
2	O
.	O
1	O
X	O
1	O
.	O
3	O
cm	O
)	O
.	O
with	O
8	O
.	O

5	O
.	O

cm	O
segment	O
of	O
left	O
fallopian	O
tube	O
together	O
weighing	O
200	O
.	O
0	O
.	O
grams	O
.	O

previously	O
submitted	O
tissue	O
from	O
the	O
abdomen	O
(	O
skin	O
and	O
.	O
subcutaneous	O
.	O
tissue	O
without	O
umbilicus	O
,	O
2305	O
.	O
0	O
grams	O
)	O
i	O
right	O
and	O
left	O
.	O
pelvic	O
lymph	O
.	O
nodes	O
;	O
right	O
and	O
left	O
para	O
-	O
aortic	O
lymph	O
nodes	O
above	O
and	O
.	O
below	O
the	O
.	O
inferior	O
mesenteric	O
artery	O
;	O
right	O
gonadal	O
vessels	O
(	O
10	O
.	O
2	O
cm	O
.	O
in	O
.	O
length	O
)	O
.	O

DIAGNOSIS	O
:	O
Uterus	O
,	O
hysterectomy	O
:	O
FIGO	O
grade	O
III	O
(	O
of	O
III	O
)	O
endometrial	O
.	O
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
forming	O
an	O
8	B
.	I
4	I
X	I
3	I
.	I
5	I
x	I
.	I

2	B
.	I
4	I
cm	I
.	O
polypoid	O
mass	O
filling	O
the	O
endometrial	O
cavity	O
.	O

The	O
tumor	O
.	O
infiltrates	O
.	O

0	O
.	O
4	O
cm	O
into	O
the	O
myometrium	O
(	O
total	O
myometrial	O
thickness	O
,	O
.	O
2	O
.	O
0	O
cm	O
)	O
.	O

Angiolymphatic	O
invasion	O
is	O
not	O
identified	O
.	O

Multiple	O
(	O
2	O
)	O
.	O
intramural	O
.	O

leiomyomata	O
(	O
2	B
.	I
3	I
cm	I
and	O
1	B
.	I
2	I
cm	I
in	O
greatest	O
dimension	O
)	O
are	O
.	O
identified	O
.	O

The	O
cervix	O
is	O
uninvolved	O
by	O
tumor	O
.	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
right	O
and	O
left	O
,	O
salpingo	O
-	O
.	O
oophorectomy	O
:	O
Without	O
diagnostic	O
abnormality	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
A	O
.	O
single	O
(	O
1	O
of	O
5	O
)	O
.	O
right	O
.	O

external	O
iliac	O
lymph	O
node	O
is	O
positive	O
for	O
a	O
microscopic	O
.	O
focus	O
of	O
.	O
metastatic	O
adenocarcinoma	O
.	O

Multiple	O
right	O
pelvic	O
lymph	O
.	O
nodes	O
(	O
2	O
internal	O
iliac	O
,	O
3	O
common	O
iliac	O
,	O
9	O
obturator	O
)	O
are	O
.	O
negative	O
.	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
left	O
pelvic	O
.	O
lymph	O
.	O

nodes	O
(	O
4	O
external	O
iliac	O
,	O
2	O
internal	O
iliac	O
,	O
5	O
common	O
iliac	O
,	O
.	O
7	O
.	O
obturator	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
right	O
and	O
left	O
para	O
-	O
aortic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
.	O
para	O
-	O
aortic	O
lymph	O
nodes	O
above	O
the	O
inferior	O
mesenteric	O
.	O
artery	O
(	O
5	O
.	O
right	O
,	O
5	O
left	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Multiple	O
para	O
-	O
.	O
aortic	O
lymph	O
.	O
nodes	O
(	O
3	O
additional	O
right	O
,	O
2	O
right	O
below	O
the	O
inferior	O
.	O
mesenteric	O
.	O
artery	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Gonadal	O
vessel	O
,	O
right	O
,	O
excision	O
:	O
The	O
right	O
gonadal	O
vessel	O
.	O

is	O
.	O
negative	O
for	O
tumor	O
.	O

Skin	O
and	O
subcutaneous	O
tissue	O
,	O
abdomen	O
,	O
excision	O
:	O
Skin	O
and	O
.	O
subcutaneous	O
tissue	O
without	O
umbilicus	O
(	O
2305	O
.	O
0	O
grams	O
)	O
.	O
identified	O
.	O

grossly	O
.	O

AMENDMENTS	O
:	O
(	O
Previous	O
Signout	O
Date	O
:	O
Revision	O
Description	O
:	O
On	O
deeper	O
permanent	O
sections	O
,	O
.	O

a	O
.	O
single	O
(	O
1	O
of	O
.	O
5	O
)	O
right	O
external	O
iliac	O
lymph	O
node	O
shows	O
a	O
microscopic	O
.	O
focus	O
of	O
.	O
metastatic	O
adenocarcinoma	O
.	O

Original	O
Diagnosis	O
.	O

Uterus	O
,	O
hysterectomy	O
:	O
FIGO	O
grade	O
III	O
(	O
of	O
III	O
)	O
endometrial	O
.	O
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
forming	O
an	O
8	B
.	I
4	I
X	I
3	I
.	I
5	I
x	I
.	I

2	B
.	I
4	I
cm	I
.	O
polypoid	O
mass	O
filling	O
the	O
endometrial	O
cavity	O
.	O

The	O
tumor	O
.	O
infiltrates	O
.	O

0	O
.	O
4	O
cm	O
into	O
the	O
myometrium	O
(	O
total	O
myometrial	O
thickness	O
,	O
.	O
2	O
.	O
0	O
cm	O
)	O
.	O

Angiolymphatic	O
invasion	O
is	O
not	O
identified	O
.	O

Multiple	O
(	O
2	O
)	O
.	O
intramural	O
.	O

leiomyomata	O
(	O
2	B
.	I
3	I
cm	I
and	O
1	B
.	I
2	I
cm	I
in	O
greatest	O
dimension	O
)	O
are	O
.	O
identified	O
.	O

The	O
cervix	O
is	O
uninvolved	O
by	O
tumor	O
.	O

Ovary	O
and	O
fallopian	O
tube	O
,	O
right	O
and	O
left	O
,	O
salpingo	O
-	O
.	O
oophorectomy	O
.	O

Without	O
diagnostic	O
abnormality	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
right	O
.	O
pelvic	O
lymph	O
.	O
nodes	O
(	O
5	O
external	O
iliac	O
,	O
2	O
internal	O
iliac	O
,	O
3	O
common	O
iliac	O
,	O
.	O
9	O
.	O
obturator	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
left	O
pelvic	O
.	O
lymph	O
.	O

nodes	O
(	O
4	O
external	O
iliac	O
,	O
2	O
internal	O
iliac	O
,	O
5	O
common	O
iliac	O
,	O
.	O
7	O
.	O
obturator	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
nodes	O
,	O
right	O
and	O
left	O
para	O
-	O
aortic	O
,	O
lymphadenectomy	O
:	O
Multiple	O
.	O
para	O
-	O
aortic	O
lymph	O
nodes	O
above	O
the	O
inferior	O
mesenteric	O
.	O
artery	O
(	O
5	O
.	O
right	O
,	O
5	O
left	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Multiple	O
para	O
-	O
.	O
aortic	O
lymph	O
.	O
nodes	O
(	O
3	O
additional	O
right	O
,	O
2	O
right	O
below	O
the	O
inferior	O
.	O
mesenteric	O
.	O
artery	O
)	O
are	O
negative	O
for	O
tumor	O
.	O

Gonadal	O
vessel	O
,	O
right	O
,	O
excision	O
:	O
The	O
right	O
gonadal	O
vessel	O
.	O

is	O
.	O
negative	O
for	O
tumor	O
.	O

Skin	O
and	O
subcutaneous	O
tissue	O
,	O
abdomen	O
,	O
excision	O
:	O
Skin	O
and	O
.	O
subcutaneous	O
tissue	O
without	O
umbilicus	O
(	O
2305	O
.	O
0	O
grams	O
)	O
.	O
identified	O
.	O

grossly	O
.	O

Laterality	O
:	O
Path	O
Report	O
:	O
CERVIX	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Hysterectomy	O
,	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
.	O

Tumor	O
site	O
:	O
Cervix	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
6x2	I
.	I
5x0	I
.	I
98	I
cm	I
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Lesion	O
less	O
than	O
4	O
.	O
0	O
cm	O
.	O

Lymph	O
nodes	O
:	O
1	O
/	O
6	O
positive	O
for	O
metastasis	O
(	O
Pelvic	O
1	O
/	O
6	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Present	O
.	O

Venous	O
invasion	O
:	O
Present	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Right	O
leg	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Right	O
leg	O
mass	O
sarcoma	O
?	O
?	O
?	O
.	O

2	O
:	O
Lateral	O
fascial	O
margin	O
right	O
leg	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Right	O
leg	O
mass	O
sarcoma	O
;	O
excision	O
:	O
-	O
High	O
grade	O
spindle	O
and	O
pleomorphic	O
sarcoma	O
consistent	O
with	O
malignant	O
.	O
fibrous	O
histiocytoma	O
/	O
undifferentiated	O
high	O
grade	O
pleomorphic	O
sarcoma	O
.	O

-	O
Tumor	O
measures	O
9	B
x	I
6	I
x	I
4	I
cm	I
.	O

-	O
Tumor	O
involves	O
dermis	O
,	O
subcutis	O
and	O
extends	O
to	O
fascia	O
.	O

Necrosis	O
is	O
present	O
about	O
15	O
%	O
.	O

-	O
Tumor	O
extends	O
focally	O
to	O
the	O
deep	O
margin	O
of	O
resection	O
and	O
is	O
located	O
.	O

0	O
.	O
1	O
cm	O
from	O
the	O
lateral	O
resection	O
margin	O
(	O
Please	O
see	O
part	O
2	O
)	O
.	O

Tumor	O
does	O
not	O
.	O
involve	O
attached	O
periosteum	O
and	O
portion	O
of	O
bone	O
,	O
All	O
other	O
margins	O
are	O
.	O
negative	O
.	O

Note	O
:	O
Immunostains	O
show	O
that	O
the	O
tumor	O
cells	O
are	O
negative	O
for	O
SMA	O
,	O
myogenin	O
,	O
.	O
desmin	O
,	O
S	O
-	O
100	O
and	O
HMB45	O
.	O

2	O
.	O

Lateral	O
fascial	O
margin	O
right	O
leg	O
:	O
-	O
Benign	O
fibro	O
-	O
adipose	O
tissue	O
.	O

Some	O
of	O
the	O
immunohistochemistry	O
and	O
ISH	O
tests	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
.	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
should	O
not	O
.	O

be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
.	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
labeled	O
"	O
right	O
leg	O
mass	O
?	O
?	O

sarcoma	O
"	O
,	O
long	O
stitch	O
lateral	O
,	O
.	O
short	O
stitch	O
superior	O
.	O

Received	O
fresh	O
is	O
an	O
ellipse	O
of	O
skin	O
measuring	O
11	O
x	O
7	O
.	O

x	O
3	O
.	O
5	O
cm	O
.	O

The	O
skin	O
surface	O
is	O
tan	O
to	O
white	O
to	O
alightly	O
hemorrhagic	O
.	O

Two	O
.	O
stitches	O
are	O
identified	O
,	O
designated	O
by	O
the	O
surgeon	O
as	O
above	O
.	O

The	O
specimen	O
is	O
.	O
yellow	O
inked	O
Black	O
-	O
deep	O
,	O
blue	O
-	O
lateral	O
,	O
homogeneous	O
tan	O
/	O
yellow	O
,	O
red	O
-	O
superior	O
,	O
.	O
as	O
follows	O
:	O
green	O
-	O
medial	O
,	O
.	O

-	O
inferior	O
.	O

Serial	O
sectioning	O
reveals	O
a	O
.	O
partially	O
cystic	O
and	O
hemorrhagic	O
mass	O
measuring	O
9	O
x	O
6	O
x	O
4	O
cm	O
.	O

It	O
appears	O
to	O
.	O

be	O
within	O
1	O
mm	O
from	O
the	O
deep	O
and	O
lateral	O
margin	O
.	O

TPS	O
is	O
submitted	O
and	O
photos	O
.	O
are	O
taken	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
Summary	O
of	O
sections	O
:	O
IM	O
-	O
-	O
inferior	O
margin	O
.	O

TD	O
-	O
tumor	O
to	O
deep	O
margin	O
.	O

TL	O
-	O
tumor	O
to	O
lateral	O
margin	O
.	O

TM	O
-	O
tumor	O
to	O
medial	O
margin	O
.	O

TS	O
-	O
tumor	O
in	O
relation	O
to	O
skin	O
.	O

TC	O
-	O
tumor	O
in	O
cystic	O
and	O
hemorrhagic	O
areas	O
.	O

TF	O
-	O
tumor	O
in	O
relation	O
to	O
fat	O
.	O

T	O
-	O
tumor	O
.	O

NS	O
-	O
normal	O
skin	O
.	O

SM	O
-	O
superior	O
margin	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
Lateral	O
fascial	O
margin	O
.	O
right	O
leg	O
.	O
"	O
It	O
consists	O
of	O
an	O
elongated	O
piece	O
of	O
brown	O
-	O
tan	O
soft	O
tissue	O
.	O
measuring	O
4	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
sectioned	O
and	O
submitted	O
.	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Right	O
leg	O
mass	O
sarcoma	O
?	O
?	O
?	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

im	O
.	O

1	O
.	O

1	O
.	O

ns	O
.	O

1	O
.	O

1	O
.	O

sm	O
.	O

1	O
.	O

4	O
.	O

4	O
.	O

1	O
.	O

tc	O
.	O

1	O
.	O

2	O
.	O

td	O
.	O

2	O
.	O

1	O
.	O

tf	O
.	O

1	O
.	O

2	O
.	O

tl	O
.	O

2	O
.	O

2	O
.	O

tm	O
.	O

2	O
.	O

2	O
.	O

ts	O
.	O

2	O
.	O

Part	O
2	O
:	O
Lateral	O
fascial	O
margin	O
right	O
leg	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

u	O
.	O

1	O
.	O

Report	O
for	O
.	O

TEST	O
:	O
Surgical	O
Pathology	O
.	O

Collected	O
Date	O
&	O
Time	O
:	O
Result	O
Name	O
.	O

Reference	O
Range	O
.	O

SURGICAL	O
P	O
.	O

Location	O
:	O
Discharge	O
Location	O
.	O

(	O
Age	O
:	O
Service	O
:	O
Surgery	O
.	O

Physician	O
(	O
s	O
)	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Total	O
thyroid	O
.	O

B	O
:	O
Tip	O
of	O
possible	O
left	O
inferior	O
parathyroid	O
.	O

C	O
:	O
Level	O
six	O
lymph	O
nodes	O
.	O

D	O
:	O
Left	O
level	O
two	O
lymph	O
nodes	O
.	O

E	O
:	O
Left	O
modified	O
radical	O
neck	O
dissection	O
.	O

Pathologic	O
Diagnosis	O
.	O

Total	O
thyroid	O
(	O
A	O
)	O
:	O
Multifocal	O
papillary	O
carcinoma	O
involving	O
the	O
left	O
.	O
thyroid	O
lobe	O
and	O
left	O
portion	O
of	O
thyroid	O
isthmus	O
(	O
largest	O
focus	O
.	O
2	B
.	I
2	I
cm	I
)	O
with	O
numerous	O
(	O
<	O
10	O
)	O
microscopic	O
foci	O
and	O
remaining	O
.	O
thyroid	O
lobe	O
all	O
measuring	O
<	O
1	O
mm	O
in	O
greatest	O
dimension	O
.	O

Tumor	O
confined	O
to	O
the	O
thyroid	O
,	O
negative	O
for	O
extrathyroidal	O
.	O
extension	O
.	O

Margins	O
of	O
surgical	O
resection	O
negative	O
for	O
tumor	O
.	O
involvement	O
.	O

Negative	O
for	O
lymphovascular	O
and	O
perineural	O
invasion	O
.	O

Background	O
of	O
lymphocytic	O
thyroiditis	O
.	O

Tip	O
of	O
possible	O
left	O
inferior	O
parathyroid	O
(	O
B	O
)	O
:	O
Normocellar	O
parathyroid	O
tissue	O
.	O

Level	O
6	O
lymph	O
nodes	O
(	O
C	O
)	O
:	O
Metastatic	O
papillary	O
carcinoma	O
involving	O
two	O
of	O
three	O
.	O
lymph	O
nodes	O
(	O
largest	O
metastatic	O
focus	O
2	O
.	O
0	O
cm	O
,	O
negative	O
for	O
.	O
extranodal	O
extension	O
)	O
.	O

Level	O
2	O
lymph	O
nodes	O
(	O
D	O
)	O
:	O
Metastatic	O
papillary	O
carcinoma	O
involving	O
one	O
of	O
four	O
.	O
lymph	O
nodes	O
(	O
0	O
.	O
5	O
cm	O
metastatic	O
focus	O
,	O
negative	O
for	O
extranodal	O
.	O
extension	O
)	O
.	O

Left	O
modified	O
radical	O
neck	O
dissection	O
(	O
E	O
)	O
:	O
Metastatic	O
papillary	O
thyroid	O
carcinoma	O
involving	O
two	O
.	O
of	O
23	O
lymph	O
nodes	O
(	O
2	O
.	O
5	O
cm	O
and	O
2	O
.	O
0	O
cm	O
metastatic	O
foci	O
with	O
.	O
extranodal	O
extension	O
present	O
in	O
both	O
nodes	O
)	O
.	O

SURGICAL	O
PATHOLOGY	O
CANCER	O
CASE	O
SUMMARY	O
CHECKLIST	O
:	O
THYROID	O
GLAND	O
.	O

RESECTION	O
:	O
Procedure	O
:	O
Total	O
thyroidectomy	O
.	O

Received	O
:	O
In	O
formalin	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Right	O
lobe	O
:	O
4	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
.	O

Left	O
lobe	O
:	O
4	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
8	O
cm	O
.	O

Isthmus	O
:	O
1	O
.	O
0	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

Left	O
neck	O
dissection	O
:	O
9	O
.	O
0	O
x	O
5	O
.	O
5	O
x	O
1	O
.	O
3	O
cm	O
.	O

Specimen	O
Weight	O
:	O
14	O
grams	O
.	O

Tumor	O
Focality	O
Multifocal	O
,	O
ipsilateral	O
.	O

Dominant	O
Tumor	O
:	O
Tumor	O
Laterality	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
2	B
.	I
2	I
cm	I
.	O

Histologic	O
.	O

Variant	O
:	O
Type	O
:	O
Papillary	O
follicular	O
and	O
per	O
TSS	O
,	O
Follicular	O
.	O
carcinoma	O
,	O
.	O
classical	O
.	O

Architecture	O
:	O
Classical	O
and	O
follicular	O
.	O

Cytomorphology	O
:	O
Classical	O
.	O

Histologic	O
Grade	O
:	O
Grade	O
1	O
,	O
well	O
-	O
differentiated	O
.	O
margins	O
,	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
Not	O
present	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

Second	O
Tumor	O
:	O
Tumor	O
Laterality	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
>	O
10	O
foci	O
of	O
microscopic	O
tumor	O
surrounding	O
.	O
larger	O
nodule	O
,	O
all	O
measuring	O
<	O
1	O
mm	O
in	O
greatest	O
dimension	O
.	O

Histologic	O
Type	O
:	O
Variant	O
:	O
Follicular	O
variant	O
,	O
papillary	O
carcinoma	O
.	O

Architecture	O
:	O
Follicular	O
.	O

Histologic	O
Grade	O
:	O
Well	O
-	O
differentiated	O
.	O

Grade	O
1	O
.	O

Margins	O
:	O
Uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
Not	O
present	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
present	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
present	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
present	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Lymphocytic	O
thyroiditis	O
,	O
.	O
benign	O
Hurthle	O
cell	O
nodules	O
and	O
numerous	O
microscopic	O
foci	O
of	O
.	O
tumor	O
(	O
>	O
10	O
)	O
present	O
in	O
the	O
left	O
thyroid	O
lobe	O
and	O
focally	O
in	O
the	O
.	O
left	O
side	O
of	O
the	O
thyroid	O
isthmus	O
(	O
all	O
measuring	O
<	O
1	O
mm	O
in	O
greatest	O
.	O
dimension	O
)	O
.	O

Ancillary	O
Studies	O
:	O
Not	O
performed	O
.	O

Clinical	O
History	O
:	O
Defer	O
to	O
clinical	O
correlation	O
as	O
to	O
.	O
whether	O
this	O
patient	O
has	O
a	O
history	O
of	O
radiation	O
exposure	O
or	O
.	O
family	O
history	O
of	O
thyroid	O
neoplasia	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT2	O
(	O
m	O
)	O
,	O
pN1b	O
(	O
number	O
of	O
lymph	O
nodes	O
.	O
examined	O
30	O
,	O
total	O
number	O
of	O
positive	O
lymph	O
nodes	O
5	O
)	O
,	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
.	O

is	O
transmitted	O
to	O
this	O
Institution	O
'	O
S	O
Cancer	O
Registry	O
as	O
required	O
.	O
for	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
.	O

is	O
based	O
solely	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
.	O
and	O
does	O
not	O
incorporate	O
other	O
relevant	O
data	O
.	O

Pathology	O
stage	O
is	O
.	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
the	O
clinical	O
.	O
stage	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
.	O

S	O
.	O
operative	O
report	O
.	O

Primary	O
Pathologist	O
:	O
Clinical	O
History	O
.	O

Papillary	O
thyroid	O
cancer	O
.	O

Intraoperative	O
Consultation	O
.	O

B	O
.	O

Tip	O
of	O
possible	O
left	O
inferior	O
parathyroid	O
:	O
Parathyroid	O
.	O
tissue	O
(	O
microscopic	O
evaluation	O
)	O
.	O

Gross	O
Description	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
total	O
thyroidectomy	O
"	O
.	O
and	O
consists	O
of	O
a	O
14	O
g	O
total	O
thyroid	O
resection	O
.	O

There	O
is	O
a	O
.	O
suture	O
designating	O
the	O
pole	O
of	O
the	O
left	O
lobe	O
of	O
the	O
thyroid	O
.	O

The	O
.	O
surface	O
is	O
shaggy	O
and	O
gray	O
-	O
purple	O
.	O

The	O
right	O
lobe	O
which	O
is	O
inked	O
.	O
blue	O
is	O
4	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
left	O
lobe	O
which	O
is	O
inked	O
black	O
.	O

is	O
4	O
.	O
0	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
8	O
cm	O
.	O

The	O
isthmus	O
which	O
is	O
inked	O
yellow	O
is	O
1	O
.	O
0	O
.	O

x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
.	O
multinodular	O
ill	O
-	O
defined	O
firm	O
tan	O
-	O
brown	O
lesion	O
that	O
encompasses	O
.	O
the	O
majority	O
of	O
the	O
left	O
lobe	O
of	O
the	O
thyroid	O
and	O
approximates	O
2	O
.	O
2	O
.	O

x	O
1	O
.	O
5	O
x	O
1	O
.	O
3	O
cm	O
.	O

There	O
are	O
additional	O
nonsuspicious	O
.	O
well	O
-	O
circumscribed	O
soft	O
tan	O
-	O
brown	O
nodules	O
identified	O
in	O
the	O
.	O
isthmus	O
and	O
the	O
right	O
lobe	O
that	O
measure	O
up	O
to	O
0	O
.	O
4	O
cm	O
.	O

The	O
.	O
majority	O
of	O
the	O
right	O
lobe	O
has	O
a	O
firm	O
red	O
-	O
brown	O
cut	O
surface	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
A1	O
-	O
A6	O
entire	O
left	O
lobe	O
.	O
lesion	O
;	O
A7	O
isthmus	O
and	O
right	O
lobe	O
with	O
nodules	O
;	O
A8	O
and	O
A9	O
right	O
.	O
lobe	O
with	O
remaining	O
nodules	O
.	O

This	O
specimen	O
is	O
reviewed	O
with	O
.	O

A	O
portion	O
of	O
the	O
lesion	O
is	O
submitted	O
for	O
.	O
studies	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
.	O

"	O
possible	O
tip	O
of	O
left	O
inferior	O
parathyroid	O
"	O
and	O
consists	O
of	O
two	O
.	O
irregular	O
tan	O
-	O
pink	O
soft	O
tissue	O
fragments	O
that	O
are	O
10	O
mg	O
and	O
.	O
average	O
0	O
.	O
2	O
cm	O
.	O

The	O
are	O
frozen	O
and	O
submitted	O
in	O
their	O
entirety	O
.	O
in	O
cassette	O
B1FS	O
.	O

C	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
level	O
6	O
lymph	O
.	O

nodes	O
"	O
and	O
consists	O
of	O
two	O
firm	O
tan	O
-	O
gray	O
grossly	O
positive	O
lymph	O
.	O
nodes	O
that	O
are	O
1	O
.	O
5	O
and	O
2	O
.	O
0	O
cm	O
.	O

Two	O
representative	O
sections	O
.	O
from	O
.	O

each	O
lymph	O
node	O
are	O
submitted	O
as	O
C1	O
one	O
lymph	O
node	O
,	O
and	O
C2	O
.	O
other	O
lymph	O
node	O
.	O

D	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
left	O
level	O
2	O
.	O
lymph	O
nodes	O
"	O
and	O
consists	O
of	O
four	O
firm	O
tan	O
-	O
gray	O
lymph	O
nodes	O
that	O
.	O
range	O
from	O
0	O
.	O
5	O
to	O
2	O
.	O
5	O
cm	O
.	O

Their	O
cut	O
surfaces	O
are	O
firm	O
tan	O
-	O
gray	O
.	O
and	O
grossly	O
positive	O
.	O

They	O
are	O
submitted	O
entirely	O
as	O
D1	O
one	O
.	O
bisected	O
lymph	O
node	O
,	O
D2	O
two	O
whole	O
lymph	O
nodes	O
;	O
D3	O
one	O
bisected	O
.	O
lymph	O
node	O
.	O

E	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
left	O
modified	O
.	O
radical	O
neck	O
dissection	O
"	O
and	O
consists	O
of	O
a	O
9	O
.	O
0	O
x	O
5	O
.	O
!	O

x	O
1	O
.	O
3	O
cm	O
.	O
irregular	O
indurated	O
tan	O
-	O
yellow	O
portion	O
of	O
fibroadipose	O
tissue	O
.	O

There	O
is	O
a	O
double	O
suture	O
designating	O
the	O
lowest	O
level	O
4	O
and	O
a	O
.	O
single	O
suture	O
designating	O
the	O
lateral	O
level	O
5	O
.	O

The	O
specimen	O
is	O
.	O
divided	O
into	O
a	O
superior	O
half	O
(	O
with	O
level	O
4	O
)	O
and	O
an	O
inferior	O
half	O
.	O

(	O
with	O
level	O
5	O
)	O
.	O

There	O
is	O
no	O
attached	O
salivary	O
gland	O
identified	O
.	O

Identified	O
within	O
the	O
inferior	O
half	O
of	O
the	O
specimen	O
is	O
a	O
.	O
prominent	O
vessel	O
that	O
is	O
1	O
.	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

There	O
is	O
no	O
gross	O
evidence	O
of	O
tumor	O
involvement	O
.	O

There	O
are	O
two	O
.	O
enlarged	O
,	O
grossly	O
positive	O
lymph	O
nodes	O
identified	O
within	O
level	O
4	O
.	O

There	O
are	O
a	O
few	O
additional	O
firm	O
tan	O
-	O
gray	O
lymph	O
nodes	O
identified	O
.	O
that	O
range	O
from	O
0	O
.	O
2	O
to	O
0	O
.	O
6	O
cm	O
.	O

Also	O
noted	O
separate	O
from	O
the	O
.	O
oriented	O
tissue	O
are	O
two	O
irregular	O
,	O
indurated	O
tan	O
-	O
yellow	O
portions	O
.	O
of	O
fibroadipose	O
tissue	O
that	O
measure	O
4	O
cm	O
in	O
aggregate	O
.	O

Within	O
.	O
the	O
tissue	O
there	O
are	O
several	O
firm	O
tan	O
-	O
gray	O
lymph	O
nodes	O
that	O
range	O
.	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O

cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
nine	O
cassettes	O
.	O

Cassette	O
summary	O
:	O
E1	O
section	O
from	O
one	O
grossly	O
positive	O
lymph	O
.	O
node	O
,	O
level	O
4	O
;	O
E2	O
section	O
from	O
one	O
grossly	O
positive	O
lymph	O
node	O
,	O
.	O
level	O
1	O
;	O
E3	O
three	O
whole	O
lymph	O
nodes	O
,	O
level	O
4	O
;	O
E4	O
cross	O
-	O
sections	O
.	O
of	O
vessel	O
,	O
level	O
5	O
;	O
E5	O
two	O
whole	O
lymph	O
nodes	O
,	O
level	O
5	O
;	O
E6	O
five	O
.	O
whole	O
lymph	O
nodes	O
,	O
level	O
5	O
;	O
E7	O
one	O
bisected	O
lymph	O
node	O
and	O
.	O
additional	O
tissue	O
;	O
E8	O
five	O
whole	O
lymph	O
node	O
in	O
additional	O
.	O
tissue	O
;	O
E9	O
five	O
whole	O
lymph	O
nodes	O
in	O
additional	O
tissue	O
.	O

Microscopic	O
Description	O
.	O

Microscopic	O
examination	O
has	O
been	O
performed	O
on	O
all	O
slides	O
.	O

The	O
.	O
pathologic	O
diagnosis	O
encompasses	O
the	O
essential	O
microscopic	O
.	O
findings	O
of	O
this	O
case	O
.	O

Interpretation	O
performed	O
at	O
.	O

V3	O
.	O
00	O
110614	O
.	O

Instructions	O
:	O
The	O
TCGA	O
Missing	O
Pathology	O
Report	O
Form	O
should	O
be	O
completed	O
for	O
cases	O
for	O
which	O
a	O
pathology	O
report	O
is	O
not	O
.	O
available	O
.	O

General	O
Pathology	O
Report	O
Information	O
.	O

#	O
.	O

Data	O
Element	O
.	O

Entry	O
Alternatives	O
.	O

Working	O
Instructions	O
.	O

Provide	O
the	O
tumor	O
type	O
of	O
the	O
case	O
.	O

1	O
.	O

Tumor	O
type	O
:	O
Indicate	O
to	O
which	O
BCR	O
location	O
the	O
case	O
was	O
originally	O
sent	O
.	O

BCR	O
specimen	O
originally	O
sent	O
.	O

NCH	O
.	O

2	O
.	O

to	O
:	O
IGC	O
.	O

Biospecimen	O
Core	O
Resource	O
(	O
BCR	O
)	O
.	O

3	O
.	O

Date	O
specimen	O
received	O
at	O
.	O

BCR	O
:	O
ICD	O
-	O
0	O
-	O
3	O
Histology	O
Code	O
:	O
Provide	O
the	O
histology	O
code	O
for	O
the	O
sample	O
from	O
the	O
Case	O
.	O

Quality	O
Control	O
Form	O
(	O
CQCF	O
)	O
and	O
the	O
overall	O
case	O
(	O
patient	O
.	O
For	O
Specimen	O
:	O
(	O
CQCF	O
)	O
.	O
diagnosis	O
,	O
if	O
different	O
)	O
.	O

4	O
.	O

For	O
Case	O
:	O
(	O
patient	O
.	O
diagnosis	O
,	O
if	O
available	O
.	O
elsewhere	O
)	O
.	O

ICD	O
-	O
0	O
-	O
3	O
Site	O
Code	O
:	O
Provide	O
the	O
site	O
code	O
for	O
the	O
sample	O
from	O
the	O
Case	O
Quality	O
.	O

Control	O
Form	O
(	O
CQCF	O
)	O
and	O
the	O
overall	O
case	O
(	O
patient	O
diagnosis	O
,	O
if	O
.	O
different	O
)	O
.	O

For	O
Specimen	O
:	O
(	O
CQCF	O
)	O
.	O

5	O
.	O

For	O
Case	O
:	O
(	O
patient	O
.	O
diagnosis	O
,	O
if	O
available	O
.	O
elsewhere	O
)	O
.	O

Gross	O
Description	O
:	O
There	O
is	O
a	O
fragment	O
of	O
skin	O
8x4	O
cm	O
in	O
its	O
size	O
with	O
pigmented	O
mass	O
2x1	O
,	O
5	O
cm	O
in	O
its	O
.	O
size	O
with	O
invasion	O
into	O
fatty	O
tissue	O
.	O

Microscopic	O
Description	O
:	O
Malignant	O
melanona	O
(	O
pigmented	O
)	O
,	O
in	O
cells	O
of	O
nevus	O
,	O
with	O
ulcerating	O
.	O

Clarks	O
is	O
IV	O
,	O
.	O

Breslow	O
is	O
15	O
mm	O
.	O

Diagnosis	O
Details	O
:	O
Tumor	O
Features	O
:	O
Ulcerated	O
,	O
Tumor	O
Extent	O
:	O
More	O
than	O
4	O
mm	O
with	O
or	O
without	O
.	O
ulceration	O
,	O
Venous	O
Invasion	O
:	O
Absent	O
,	O
Margins	O
:	O
Absent	O
,	O
Treatment	O
Effect	O
:	O
Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
SKIN	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Excision	O
of	O
skin	O
lesion	O
.	O

Tumor	O
site	O
:	O
Skin	O
,	O
trunk	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
5x0x2cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
,	O
Pigmented	O
.	O

Satellite	O
nodules	O
:	O
Not	O
specified	O
.	O

Histologic	O
type	O
:	O
Malignant	O
melanoma	O
.	O

Histologic	O
grade	O
:	O
Undifferentiated	O
.	O

Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
No	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Clark	O
'	O
s	O
level	O
IV	O
,	O
Breslow	O
is	O
15	O
mm	O
.	O

Comments	O
:	O
None	O
.	O

PATH	O
#	O
:	O
A	O
/	O
S	O
:	O
F	O
.	O

Rec	O
:	O
:	O
Col	O
:	O
DIAGNOSIS	O
:	O
OMENTUM	O
,	O
ANTERIOR	O
ABDOMINAL	O
WALL	O
,	O
PELVIC	O
TUMOR	O
,	O
.	O

LESSER	O
SAC	O
TUMOR	O
,	O
OMENTUM	O
,	O
FALCIFORM	O
LIGAMENT	O
,	O
MESOCOLIC	O
TUMOR	O
,	O
.	O

RIGHT	O
GUTTER	O
TUMOR	O
,	O
RIGHT	O
HEPATIC	O
FLEXURE	O
,	O
PERITONEAL	O
TUMOR	O
,	O
RIGHT	O
.	O

COLON	O
TUMOR	O
,	O
CUL	O
-	O
DE	O
-	O
SAC	O
TUMOR	O
,	O
RECTOSIGMOID	O
TUMOR	O
,	O
ANTERIOR	O
RECTAL	O
.	O

WALL	O
,	O
BLADDER	O
PERITONEUM	O
TUMOR	O
,	O
AND	O
SIGMOID	O
TUMOR	O
(	O
TUMOR	O
.	O
DEBULKING	O
)	O
:	O
-	O
Metastatic	O
high	O
grade	O
Mullerian	O
-	O
derived	O
papillary	O
serous	O
.	O
carcinoma	O
.	O

-	O
Specimens	O
include	O
fibroadipose	O
,	O
adipose	O
,	O
and	O
fibromuscular	O
.	O
tissue	O
infiltrated	O
by	O
carcinoma	O
.	O

-	O
Some	O
of	O
the	O
tissues	O
are	O
mesothelial	O
lined	O
.	O

Focal	O
skeletal	O
muscle	O
(	O
specimen	O
#	O
3	O
,	O
pelvic	O
tumor	O
)	O
and	O
.	O
bladder	O
muscularis	O
(	O
specimen	O
#	O
19	O
,	O
bladder	O
peritoneum	O
tumor	O
)	O
.	O
are	O
also	O
noted	O
.	O

6	O
.	O

LIVER	O
(	O
WEDGE	O
RESECTION	O
)	O
:	O
-	O
Liver	O
with	O
metastatic	O
papillary	O
serous	O
carcinoma	O
.	O

13	O
.	O

APPENDIX	O
(	O
APPENDECTOMY	O
)	O
:	O
-	O
Appendix	O
with	O
metastatic	O
papillary	O
serous	O
carcinoma	O
involving	O
.	O
serosa	O
and	O
mesoappendix	O
.	O

-	O
Mucosa	O
and	O
muscularis	O
propria	O
with	O
no	O
evidence	O
of	O
carcinoma	O
.	O

14	O
.	O

RIGHT	O
OVARY	O
AND	O
FALLOPIAN	O
TUBE	O
(	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
-	O
Papillary	O
serous	O
carcinoma	O
involving	O
:	O
-	O
Ovary	O
(	O
12	B
cm	I
)	O
with	O
extensive	O
parenchymal	O
and	O
surface	O
.	O
involvement	O
.	O

-	O
Paratubal	O
and	O
paraovarian	O
soft	O
tissues	O
.	O

-	O
Fallopian	O
tube	O
is	O
compressed	O
by	O
tumor	O
but	O
no	O
mucosal	O
.	O
involvement	O
is	O
identified	O
.	O

15	O
.	O

UTERUS	O
,	O
LEFT	O
FALLOPIAN	O
TUBE	O
(	O
?	O
)	O
AND	O
OVARY	O
(	O
SUPRACERVICAL	O
.	O
HYSTERECTOMY	O
,	O
LEFT	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
:	O
-	O
Papillary	O
serous	O
carcinoma	O
involving	O
:	O
-	O
Ovary	O
(	O
6	B
cm	I
)	O
with	O
extensive	O
parenchymal	O
and	O
surface	O
.	O
involvement	O
.	O

-	O
Paraovarian	O
soft	O
tissues	O
.	O

-	O
Uterine	O
serosa	O
.	O

-	O
Fallopian	O
tube	O
not	O
identified	O
.	O

-	O
Atrophic	O
endometrium	O
with	O
a	O
few	O
cystic	O
glands	O
.	O

-	O
Subserosal	O
calcified	O
leiomyoma	O
(	O
0	B
.	I
45	I
cm	I
)	O
.	O

-	O
Scant	O
endocervical	O
mucosa	O
at	O
inferior	O
cervical	O
resection	O
.	O
margin	O
.	O

21	O
.	O

RECTOSIGMOID	O
COLON	O
(	O
SEGMENTAL	O
RESECTION	O
)	O
:	O
-	O
Metastatic	O
papillary	O
serous	O
carcinoma	O
involving	O
colonic	O
.	O
serosa	O
and	O
pericolic	O
fat	O
.	O

-	O
Mucosa	O
and	O
muscularis	O
propria	O
with	O
no	O
evidence	O
of	O
carcinoma	O
.	O

-	O
No	O
tumor	O
seen	O
at	O
surgical	O
margins	O
.	O

-	O
Two	O
pericolic	O
lymph	O
nodes	O
with	O
no	O
evidence	O
of	O
metastatic	O
.	O
carcinoma	O
(	O
0	O
/	O
2	O
)	O
.	O

22	O
.	O

LEFT	O
ILIAC	O
LYMPH	O
NODE	O
(	O
EXCISION	O
)	O
:	O
-	O
One	O
lymph	O
node	O
with	O
no	O
evidence	O
of	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

23	O
.	O

"	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
'	O
(	O
EXCISION	O
)	O
:	O
-	O
Benign	O
adipose	O
tissue	O
;	O
no	O
lymph	O
node	O
present	O
.	O

NOTE	O
:	O
The	O
adenocarcinoma	O
is	O
similar	O
in	O
all	O
specimens	O
with	O
features	O
.	O
of	O
a	O
Mullerian	O
-	O
derived	O
papillary	O
serous	O
carcinoma	O
characterized	O
by	O
.	O
high	O
nuclear	O
grade	O
with	O
architectural	O
patterns	O
including	O
.	O
papillations	O
,	O
gland	O
formations	O
,	O
cysts	O
,	O
solid	O
nests	O
,	O
and	O
.	O
micropapillations	O
.	O

Some	O
of	O
the	O
tumor	O
cella	O
exhibit	O
cytoplasmic	O
.	O
vacuolization	O
.	O

Many	O
psammoma	O
bodies	O
,	O
foci	O
of	O
necrosis	O
and	O
acute	O
.	O
inflammation	O
,	O
a	O
desmoplastic	O
stromal	O
reaction	O
,	O
and	O
focal	O
.	O
lymphovascular	O
invasion	O
are	O
also	O
noted	O
.	O

Some	O
of	O
the	O
specimens	O
show	O
.	O

a	O
.	O
surface	O
exudate	O
with	O
fibrin	O
,	O
histiocytes	O
,	O
leukocytes	O
,	O
mesothelial	O
.	O
cells	O
,	O
and	O
tumor	O
cells	O
.	O

The	O
patient	O
'	O
s	O
prior	O
left	O
breast	O
carcinoma	O
.	O

is	O
reviewed	O
,	O
.	O
and	O
it	O
does	O
not	O
resemble	O
the	O
current	O
ovarian	O
and	O
abdominal	O
tumor	O
,	O
.	O
which	O
is	O
consistent	O
with	O
a	O
new	O
primary	O
.	O

HISTORY	O
:	O
Ascites	O
,	O
diverticulitis	O
,	O
left	O
breast	O
carcinoma	O
.	O

MICROSCOPIC	O
:	O
See	O
Diagnosis	O
.	O

GROSS	O
:	O
1	O
:	O
OMENTUM	O
.	O

Labeled	O
'	O
amentum	O
'	O
,	O
received	O
fresh	O
in	O
the	O
Operating	O
Room	O
with	O
tissue	O
.	O
taken	O
for	O
clonogenic	O
studies	O
and	O
the	O
remainder	O
fixed	O
in	O
formalin	O
,	O
.	O

is	O
an	O
18	O
x	O
7	O
x	O
4	O
.	O
5	O
cm	O
portion	O
of	O
yellow	O
lobulated	O
fatty	O
tissue	O
.	O

The	O
portion	O
of	O
tissue	O
is	O
almost	O
completely	O
replaced	O
by	O
a	O
white	O
-	O
tan	O
.	O
firm	O
and	O
focally	O
cystic	O
mass	O
.	O

Cut	O
sections	O
through	O
the	O
mass	O
reveal	O
.	O
white	O
-	O
tan	O
,	O
focally	O
hemorrhagic	O
and	O
focally	O
yellow	O
solid	O
areas	O
and	O
.	O
also	O
cysts	O
filled	O
with	O
clear	O
and	O
mucoid	O
material	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

A	O
.	O

Solid	O
and	O
cystic	O
area	O
-	O
1	O
.	O

B	O
.	O

Cystic	O
area	O
-	O
1	O
.	O

2	O
:	O
ANTERIOR	O
ABDOMINAL	O
WALL	O
.	O

Labeled	O
"	O
anterior	O
abdominal	O
wall	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
3	O
x	O
.	O

1	O
x	O
1	O
cm	O
portion	O
of	O
white	O
-	O
tan	O
,	O
focally	O
hemorrhagic	O
soft	O
tissue	O
.	O

c	O
.	O

Multiple	O
.	O

3	O
:	O
PELVIC	O
TUMOR	O
.	O

Labeled	O
'	O
pelvic	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
are	O
eight	O
fragments	O
.	O
of	O
white	O
-	O
tan	O
,	O
focally	O
hemorrhagic	O
soft	O
tissue	O
ranging	O
from	O
1	B
.	I
2	I
to	O
.	O

5	B
.	I
5	I
cm	I
and	O
aggregating	O
to	O
7	B
.	I
5	I
x	I
7	I
.	I
5	I
x	I
2	I
.	I
5	I
cm	I
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

D	O
.	O

3	O
.	O

4	O
:	O
LESSER	O
SAC	O
TUMOR	O
.	O

Labeled	O
"	O
lesser	O
sac	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	B
.	I
5	I
x	I
3	I
.	I
0	I
.	I

x	B
1	I
.	I
5	I
cm	I
aggregate	O
of	O
multiple	O
white	O
-	O
tan	O
,	O
firm	O
portions	O
of	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

E	O
.	O

4	O
.	O

5	O
:	O
OMENTUM	O
.	O

Labeled	O
'	O
omentum	O
and	O
received	O
in	O
formalin	O
are	O
two	O
22	O
x	O
7	O
x	O
4	O
cm	O
.	O
and	O
22	O
x	O
8	O
x	O
4	O
cm	O
portions	O
of	O
fibrofatty	O
and	O
focally	O
hemorrhagic	O
.	O
soft	O
tissue	O
.	O

Both	O
portions	O
of	O
tissue	O
are	O
almost	O
completely	O
.	O
replaced	O
by	O
white	O
-	O
tan	O
,	O
focally	O
hemorrhagic	O
mass	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

F	O
.	O

2	O
.	O

LIVER	O
TUMOR	O
.	O

Labeled	O
'	O
liver	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
2	B
.	I
5	I
x	I
2	I
.	I
5	I
x	I
1	I
.	I
0	I
.	I

cm	B
portion	O
of	O
tan	O
-	O
brown	O
and	O
cauterized	O
soft	O
tissue	O
.	O

Cut	O
sections	O
.	O
through	O
the	O
tissue	O
reveal	O
a	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
white	O
-	O
tan	O
firm	O
.	O
nodule	O
and	O
brown	O
-	O
tan	O
soft	O
tissue	O
at	O
the	O
periphery	O
of	O
the	O
nodule	O
.	O

Representative	O
section	O
.	O

G	O
.	O

1	O
.	O

FALCIFORM	O
LIGAMENT	O
.	O

Labeled	O
falciform	O
ligament	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	O
.	O
7	O
x	O
.	O

2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
portion	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

There	O
are	O
multiple	O
.	O
white	O
-	O
tan	O
firm	O
nodules	O
identified	O
within	O
the	O
soft	O
tissue	O
.	O

The	O
.	O
nodules	O
range	O
from	O
0	O
.	O
2	O
to	O
1	O
.	O
5	O
cm	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
.	O

H	O
.	O

2	O
.	O

8	O
:	O
MESOCOLIC	O
TUMOR	O
.	O

Labeled	O
'	O
mesocolic	O
tumor	O
and	O
received	O
in	O
formalin	O
are	O
five	O
.	O
portions	O
of	O
white	O
-	O
tan	O
cauterized	O
soft	O
tissue	O
.	O

Portions	O
of	O
tissue	O
.	O
range	O
from	O
0	B
.	I
5	I
to	O
1	B
.	I
2	I
cm	I
.	O

Entirely	O
submitted	O
.	O

I	O
.	O

6	O
.	O

9	O
:	O
RIGHT	O
GUTTER	O
TUMOR	O
.	O

Labeled	O
right	O
gutter	O
tumor	O
"	O
and	O
received	O
in	O
formalin	O
is	O
an	O
8	O
.	B
5	I
x	I
.	I

4	B
.	I
0	I
x	I
1	I
.	I
5	I
cm	I
portion	O
of	O
yellow	O
lobulated	O
fibrofatty	O
tissue	O
.	O

Almost	O
.	O
the	O
entire	O
specimen	O
is	O
replaced	O
by	O
multiple	O
white	O
-	O
tan	O
firm	O
nodules	O
.	O
ranging	O
from	O
0	B
.	I
2	I
to	O
0	B
.	I
5	I
cm	I
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

J	O
.	O

5	O
.	O

10	O
:	O
RIGHT	O
HEPATIC	O
FLEXURE	O
.	O

Labeled	O
"	O
right	O
hepatic	O
flexure	O
'	O
and	O
received	O
in	O
formalin	O
is	O
an	O
8	O
.	O
0	O
.	O

x	O
3	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
portion	O
of	O
yellow	O
fatty	O
tissue	O
with	O
a	O
3	O
.	O
5	O
.	O

x	O
3	O
.	O
0	O
cm	O
area	O
of	O
multiple	O
white	O
-	O
tan	O
firm	O
nodules	O
adhesed	O
to	O
the	O
.	O
fatty	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

K	O
.	O

3	O
.	O

11	O
:	O
PERITONEAL	O
TUMOR	O
.	O

Labeled	O
'	O
peritoneal	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	B
.	I
0	I
x	I
3	I
.	I
0	I
.	I

x	B
1	I
.	I
2	I
cm	I
irregular	O
portion	O
of	O
tan	O
,	O
hemorrhagic	O
soft	O
tissue	O
.	O

A	O
.	O
portion	O
of	O
tissue	O
is	O
entirely	O
replaced	O
by	O
white	O
-	O
tan	O
firm	O
nodular	O
.	O
mass	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

L	O
.	O

2	O
.	O

12	O
:	O
RIGHT	O
COLON	O
TUMOR	O
.	O

Labeled	O
right	O
colon	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
1	B
.	I
2	I
x	I
1	I
.	I
0	I
.	I

x	B
0	I
.	I
5	I
cm	I
portion	O
of	O
white	O
-	O
tan	O
firm	O
tissue	O
.	O

Entirely	O
submitted	O
.	O

M	O
.	O

2	O
.	O

13	O
:	O
APPENDIX	O
.	O

Labeled	O
appendix	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
6	O
.	O
5	O
cm	O
in	O
length	O
,	O
.	O

0	O
.	O
7	O
cm	O
in	O
average	O
diameter	O
appendix	O
with	O
a	O
1	O
.	O
3	O
cm	O
in	O
width	O
attached	O
.	O
periappendiceal	O
fat	O
.	O

Appendiceal	O
serosa	O
is	O
brown	O
-	O
tan	O
and	O
focally	O
.	O
hemorrhagic	O
with	O
multiple	O
white	O
-	O
tan	O
firm	O
nodules	O
.	O

Periappendiceal	O
.	O
fat	O
is	O
also	O
partially	O
replaced	O
by	O
white	O
-	O
tan	O
firm	O
nodules	O
.	O

Cut	O
.	O
section	O
through	O
the	O
appendix	O
reveals	O
a	O
0	O
.	O
2	O
cm	O
in	O
thickness	O
white	O
.	O
appendiceal	O
wall	O
and	O
up	O
to	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
lumen	O
.	O

The	O
appendix	O
.	O

is	O
filled	O
with	O
feculent	O
material	O
.	O

Tumor	O
does	O
not	O
grossly	O
invade	O
the	O
.	O
appendiceal	O
wall	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

N	O
.	O

5	O
.	O

14	O
:	O
RIGHT	O
OVARY	O
.	O

Labeled	O
'	O
right	O
ovary	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
12	O
x	O
10	O
x	O
6	O
cm	O
.	O
distorted	O
ovary	O
.	O

The	O
surface	O
is	O
variegated	O
with	O
focally	O
.	O
hemorrhagic	O
areas	O
and	O
multiple	O
fibrous	O
adhesions	O
.	O

Cut	O
section	O
.	O
through	O
the	O
ovary	O
reveals	O
yellow	O
-	O
tan	O
hemorrhagic	O
variegated	O
soft	O
.	O
and	O
focally	O
necrotic	O
mass	O
.	O

There	O
is	O
a	O
9	O
.	O
0	O
cm	O
in	O
length	O
,	O
1	O
.	O
0	O
cm	O
in	O
.	O
diameter	O
fallopian	O
tube	O
attached	O
to	O
the	O
ovary	O
.	O

A	O
fimbriated	O
end	O
is	O
.	O
not	O
identified	O
.	O

Cut	O
sections	O
through	O
the	O
fallopian	O
tube	O
reveal	O
a	O
.	O

0	O
.	O
2	O
cm	O
in	O
thickness	O
wall	O
and	O
up	O
to	O
0	O
.	O
4	O
cm	O
lumen	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

o	O
-	O
s	O
.	O

1	O
each	O
.	O

15	O
:	O
UTERUS	O
,	O
LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
"	O
uterus	O
,	O
left	O
tube	O
and	O
ovary	O
and	O
received	O
in	O
formalin	O
is	O
a	O
.	O
supracervical	O
hysterectomy	O
with	O
attached	O
adnexa	O
.	O

The	O
uterus	O
and	O
.	O
ovary	O
weigh	O
70	O
grams	O
.	O

The	O
uterus	O
measures	O
4	O
.	O
5	O
cm	O
superior	O
to	O
.	O
excisional	O
cervical	O
margin	O
,	O
5	O
.	O
0	O
cm	O
cornu	O
to	O
cornu	O
,	O
and	O
2	O
.	O
0	O
cm	O
.	O
anterior	O
to	O
posterior	O
.	O

The	O
uterine	O
serosa	O
is	O
pink	O
-	O
tan	O
with	O
.	O
multiple	O
serous	O
adhesions	O
which	O
contain	O
multiple	O
white	O
-	O
tan	O
and	O
firm	O
.	O
nodules	O
.	O

There	O
is	O
also	O
a	O
1	O
.	O
0	O
cm	O
in	O
diameter	O
white	O
-	O
tan	O
firm	O
serosal	O
.	O
nodule	O
.	O

The	O
uterus	O
is	O
incised	O
on	O
both	O
sides	O
.	O

Cut	O
section	O
reveals	O
a	O
.	O

3	O
.	O
5	O
cm	O
in	O
length	O
,	O
up	O
to	O
1	O
.	O
5	O
cm	O
in	O
width	O
uterine	O
cavity	O
.	O

The	O
.	O
endometrium	O
is	O
pink	O
-	O
tan	O
,	O
grossly	O
unremarkable	O
,	O
and	O
ranges	O
in	O
width	O
.	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O
2	O
cm	O
.	O

The	O
myometrium	O
is	O
pink	O
-	O
tan	O
,	O
grossly	O
.	O
unremarkable	O
,	O
and	O
measures	O
up	O
to	O
1	O
.	O
5	O
cm	O
in	O
thickness	O
.	O

The	O
attached	O
.	O
left	O
adnexa	O
measures	O
6	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
consisting	O
of	O
a	O
variegated	O
,	O
.	O
focally	O
hemorrhagic	O
mass	O
.	O

The	O
fallopian	O
tube	O
is	O
not	O
definitively	O
.	O
identified	O
.	O

There	O
is	O
a	O
smaller	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
white	O
-	O
tan	O
firm	O
.	O
mass	O
which	O
is	O
loosely	O
attached	O
to	O
the	O
already	O
described	O
mass	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

T	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

U	O
.	O

Anterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

V	O
.	O

Anterior	O
corpus	O
-	O
1	O
.	O

W	O
.	O

Posterior	O
corpus	O
.	O

x	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
and	O
serosal	O
adhesions	O
-	O
2	O
.	O

Y	O
-	O
AA	O
.	O

Ovarian	O
and	O
tubal	O
mass	O
-	O
1	O
each	O
.	O

BB	O
.	O

Smaller	O
firm	O
mass	O
-	O
2	O
.	O

ADDITIONAL	O
SECTION	O
.	O

MM	O
.	O

Possible	O
fallopian	O
tube	O
-	O
4	O
.	O

16	O
:	O
CUL	O
DE	O
SAC	O
TUMOR	O
.	O

Labeled	O
'	O
cul	O
de	O
sac	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
9	B
.	I
5	I
x	I
7	I
.	I
5	I
.	I

x	B
3	I
.	I
5	I
cm	I
aggregate	O
of	O
white	O
-	O
tan	O
firm	O
tumor	O
and	O
clotted	O
blood	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

cc	O
.	O

2	O
.	O

17	O
:	O
RECTAL	O
SIGMOID	O
TUMOR	O
.	O

Labeled	O
"	O
rectal	O
sigmoid	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	B
.	I
5	I
x	I
.	I

2	B
.	I
5	I
x	I
0	I
.	I
5	I
cm	I
irregular	O
portion	O
of	O
tan	O
,	O
focally	O
hemorrhagic	O
soft	O
.	O
tissue	O
.	O

There	O
is	O
a	O
1	O
x	O
1	O
cm	O
white	O
-	O
tan	O
firm	O
area	O
at	O
one	O
surface	O
of	O
.	O
the	O
tissue	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

DD	O
.	O

3	O
.	O

18	O
:	O
ANTERIOR	O
RECTAL	O
WALL	O
.	O

Labeled	O
'	O
anterior	O
rectal	O
wall	O
'	O
and	O
received	O
in	O
formalin	O
are	O
four	O
.	O
portions	O
of	O
white	O
-	O
tan	O
soft	O
tissue	O
ranging	O
from	O
0	O
.	O
7	O
to	O
1	O
.	O
5	O
cm	O
.	O

Entirely	O
submitted	O
.	O

EE	O
.	O

Multiple	O
.	O

19	O
:	O
BLADDER	O
PERITONEUM	O
AND	O
TUMOR	O
.	O

Labeled	O
bladder	O
peritoneum	O
and	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
are	O
.	O
five	O
portions	O
of	O
yellow	O
lobulated	O
fatty	O
tissue	O
almost	O
entirely	O
.	O
replaced	O
by	O
white	O
-	O
tan	O
and	O
firm	O
tumor	O
nodules	O
which	O
range	O
from	O
0	B
.	I
2	I
.	O
to	O
2	B
.	I
0	I
cm	I
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

FF	O
.	O

3	O
.	O

20	O
:	O
SIGMOID	O
TUMOR	O
.	O

Labeled	O
sigmoid	O
tumor	O
'	O
and	O
received	O
in	O
formalin	O
are	O
two	O
2	B
.	I
0	I
and	O
.	O

1	B
.	I
0	I
cm	I
portions	O
of	O
white	O
-	O
tan	O
soft	O
tissue	O
.	O

Entirely	O
submitted	O
.	O

GG	O
.	O

2	O
.	O

21	O
:	O
RECTAL	O
SIGMOID	O
COLON	O
.	O

Labeled	O
"	O
rectal	O
sigmoid	O
colon	O
and	O
received	O
in	O
formalin	O
is	O
a	O
4	O
.	O
5	O
cm	O
.	O
in	O
length	O
,	O
5	O
cm	O
in	O
opened	O
circumference	O
segment	O
of	O
colon	O
with	O
a	O
5	O
.	O
5	O
.	O

cm	O
in	O
width	O
portion	O
of	O
attached	O
pericolonic	O
fat	O
.	O

The	O
serosa	O
is	O
.	O
pink	O
-	O
tan	O
and	O
smooth	O
with	O
multiple	O
small	O
white	O
-	O
tan	O
nodules	O
attached	O
.	O
to	O
the	O
serosa	O
and	O
in	O
the	O
pericolonic	O
fat	O
.	O

The	O
wall	O
measures	O
0	O
.	O
3	O
cm	O
.	O
in	O
thickness	O
and	O
is	O
grosaly	O
unremarkable	O
.	O

The	O
mucosal	O
folds	O
are	O
.	O
grossly	O
unremarkable	O
and	O
no	O
lesions	O
are	O
identified	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

HH	O
.	O

Serosal	O
nodule	O
.	O

II	O
.	O

Margins	O
.	O

JJ	O
.	O

Pericolonic	O
fat	O
with	O
nodules	O
-	O
Multiple	O
.	O

22	O
:	O
LEFT	O
ILIAC	O
LYMPH	O
NODE	O
.	O

Labeled	O
'	O
left	O
iliac	O
lymph	O
node	O
'	O
and	O
received	O
in	O
formalin	O
is	O
a	O
0	O
.	O
9	O
x	O
.	O

0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
lymph	O
noae	O
.	O

Entirely	O
submitted	O
.	O

KK	O
.	O

2	O
.	O

23	O
:	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
.	O

Labeled	O
"	O
right	O
pelvic	O
lymph	O
node	O
'	O
and	O
received	O
in	O
formalin	O
are	O
two	O
.	O

1	O
.	O
0	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
9	O
cm	O
portions	O
of	O
fatty	O
lobulated	O
tissue	O
.	O

No	O
grossly	O
.	O
identifiable	O
lymph	O
node	O
is	O
present	O
.	O

Entirely	O
submitted	O
.	O

LL	O
.	O

Multiple	O
.	O

Gross	O
dictated	O
by	O
.	O

OPERATIVE	O
CONSULT	O
(	O
GROSS	O
)	O
:	O
1	O
.	O

OMENTUM	O
:	O
-	O
Three	O
pieces	O
,	O
each	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
were	O
taken	O
for	O
.	O
the	O
extreme	O
drua	O
resistance	O
testing	O
.	O

Special	O
Studies	O
:	O
None	O
.	O

See	O
Also	O
:	O
I	O
,	O
.	O
the	O
pathologist	O
of	O
record	O
,	O
have	O
.	O
personally	O
examined	O
the	O
specimen	O
,	O
interpreted	O
the	O
.	O
results	O
,	O
reviewed	O
this	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

SPECIMEN	O
TAKEN	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

LEFT	O
THYROID	O
(	O
TOTAL	O
THYROIDECTOMY	O
)	O
:	O
SPECIMEN	O
TYPE	O
:	O
Total	O
thyroidectomy	O
.	O

TUMOR	O
SITE	O
:	O
Isthmus	O
,	O
Left	O
lobe	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Papillary	O
carcinoma	O
,	O
conventional	O
type	O
.	O

FOCALITY	O
:	O
Multifocal	O
:	O
2	B
.	I
5	I
cm	I
-	O
left	O
lobe	O
;	O
1	B
.	I
2cm	I
-	O
isthmus	O
.	O

LYMPH	O
NODES	O
:	O
Metastatic	O
carcinoma	O
in	O
2	O
of	O
3	O
perithyroidal	O
lymph	O
nodes	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
:	O
pT2	O
:	O
Tumor	O
>	O
2	O
cm	O
,	O
limited	O
to	O
thyroid	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pN1a	O
:	O
Nodal	O
metastasis	O
to	O
regional	O
lymph	O
nodes	O
.	O

DISTANT	O
METASTASIS	O
:	O
pMx	O
:	O
Cannot	O
be	O
assessed	O
.	O

MARGINS	O
:	O
Margins	O
are	O
uninvolved	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
nearest	O
.	O
margin	O
:	O
<	O
1	O
mm	O
(	O
posterior	O
margin	O
)	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
Present	O
.	O

Accession	O
Date	O
:	O
Attending	O
Physician	O
:	O
Procedure	O
Physician	O
/	O
Conias	O
In	O
.	O

Specimen	O
Class	O
:	O
Bench	O
Designate	O
:	O
PATIENT	O
HISTORY	O
:	O
CHIEF	O
COMPLAINT	O
/	O
PRE	O
-	O
OP	O
/	O
POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Respiratory	O
distress	O
.	O

PROCEDURE	O
:	O
Tracheostomy	O
,	O
Total	O
laryngectomy	O
,	O
Bilateral	O
neck	O
dissection	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Not	O
answered	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
Not	O
answered	O
.	O

PRIOR	O
MALIGNANCY	O
:	O
Not	O
answered	O
.	O

CHEMORADIATION	O
:	O
Not	O
answered	O
.	O

ORGAN	O
TRANSPLANT	O
:	O
Not	O
answered	O
.	O

IMMUNOSUPPRESSION	O
:	O
Not	O
answered	O
.	O

OTHER	O
DISEASES	O
:	O
Not	O
answered	O
.	O

ADDENDA	O
:	O
Addendum	O
.	O

The	O
results	O
of	O
ancillary	O
studies	O
are	O
as	O
follows	O
:	O
P16	O
mmunohistochemistry	O
:	O
negative	O
.	O

HPV	O
in	O
-	O
situ	O
hybridization	O
:	O
negative	O
.	O

EGFR	O
immunohistochemistry	O
:	O
1	O
+	O
membranous	O
staining	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
submitted	O
material	O
(	O
s	O
)	O
and	O
the	O
above	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
LYMPH	O
NODES	O
,	O
RIGHT	O
NECK	O
DISSECTION	O
LEVELS	O
2	O
-	O
4	O
,	O
BIOPSY	O
-	O
.	O

A	O
.	O

SIXTEEN	O
LYMPH	O
NODES	O
,	O
NO	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
PRESENT	O
(	O
0	O
/	O
18	O
)	O
.	O

B	O
.	O

METASTATIC	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
INVOLVING	O
TWO	O
OF	O
SIXTEEN	O
LYMPH	O
NODES	O
(	O
2	O
/	O
16	O
)	O
.	O

C	O
.	O

NO	O
EXTRACAPSULAR	O
SPREAD	O
PRESENT	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
DISSECTION	O
LEVELS	O
2	O
-	O
4	O
,	O
BIOPSY	O
-	O
.	O

TWENTY	O
-	O
ONE	O
LYMPH	O
NODES	O
,	O
NO	O
TUMOR	O
PRESENT	O
(	O
d	O
/	O
21	O
)	O
.	O

PART	O
3	O
:	O
LEFT	O
UPPER	O
PHARYNX	O
,	O
BIOPSY	O
-	O
.	O

MILD	O
DYSPLASIA	O
,	O
NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
4	O
:	O
BASE	O
OF	O
TONGUE	O
,	O
LEFT	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
5	O
:	O
BASE	O
OF	O
TONGUE	O
,	O
RIGHT	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
6	O
:	O
UPPER	O
PHARYNX	O
,	O
RIGHT	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
7	O
:	O
UPPER	O
PHARYNX	O
,	O
RIGHT	O
,	O
BIOPSY	O
-	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
8	O
:	O
UPPER	O
PHARYNX	O
,	O
LEFT	O
,	O
BIOPSY	O
-	O
.	O

MILD	O
DYSPLASIA	O
,	O
NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
9	O
:	O
LARYNX	O
,	O
TOTAL	O
LARYNGECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
(	O
3	B
.	I
5	I
CM	I
)	O
,	O
SUPRAGLOTTIC	O
,	O
.	O

INVOLVING	O
THE	O
RIGHT	O
AND	O
LEFT	O
EPIGLOTTIS	O
,	O
FALSE	O
CORDS	O
,	O
AND	O
EXTENDING	O
INTO	O
THE	O
PRE	O
-	O
.	O

EPIGLOTTIC	O
AND	O
PARAGLOTTIC	O
SPACES	O
,	O
AND	O
ANTERIOR	O
SOFT	O
TISSUE	O
(	O
see	O
comment	O
)	O
.	O

B	O
.	O

NO	O
THYROID	O
CARTILAGE	O
INVOLVEMENT	O
.	O

C	O
.	O

NO	O
ANGIOLYMPHATIC	O
INVASION	O
OR	O
PERINEURAL	O
INVASION	O
PRESENT	O
.	O

D	O
.	O

MARGINS	O
FREE	O
OF	O
TUMOR	O
.	O

E	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT4N0	O
.	O

F	O
.	O

HYPERCELLULAR	O
BONE	O
MARROW	O
WITH	O
TRILINEAGE	O
HEMATOPOIESIS	O
,	O
AND	O
SLIGHTLY	O
LEFT	O
SHIFTED	O
.	O

MYELOID	O
MATURATION	O
.	O

COMMENT	O
:	O
Part	O
9	O
:	O
Ancillary	O
studies	O
are	O
being	O
performed	O
and	O
the	O
results	O
will	O
be	O
reported	O
in	O
an	O
addendum	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
submitted	O
material	O
(	O
s	O
)	O
and	O
the	O
final	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
in	O
nine	O
parls	O
,	O
each	O
labeled	O
with	O
the	O
patlent	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
initials	O
.	O

Part	O
1	O
is	O
received	O
labeled	O
"	O
right	O
neck	O
,	O
levels	O
2	O
-	O
4	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
,	O
un	O
-	O
oriented	O
plece	O
of	O
fibroadipose	O
tissue	O
measuring	O
6	O
.	O
0	O
x	O
.	O

4	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
.	O

Throughout	O
the	O
tissue	O
are	O
numerous	O
tan	O
-	O
lo	O
-	O
white	O
calored	O
lymph	O
nodes	O
,	O
ranging	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
2	O
.	O
0	O
cm	O
.	O

The	O
.	O
nodes	O
vary	O
from	O
soft	O
to	O
firm	O
in	O
consistency	O
.	O

Representative	O
sections	O
are	O
submilted	O
for	O
permahent	O
histology	O
as	O
follows	O
:	O
1A	O
.	O
one	O
large	O
node	O
.	O

IB	O
.	O

4	O
nodes	O
.	O

IC	O
.	O

6	O
nodes	O
.	O

ID	O
-	O
1E	O
.	O
fibroadipose	O
tissue	O
.	O

Part	O
2	O
is	O
received	O
labeled	O
"	O
left	O
neck	O
,	O
levels	O
2	O
-	O
4	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
,	O
un	O
-	O
oriented	O
piece	O
of	O
fibroadipose	O
tissue	O
measuring	O
6	O
.	O
5	O
X	O
4	O
.	O
7	O
.	O

x	O
3	O
.	O
0	O
cm	O
.	O

Throughout	O
the	O
tissue	O
,	O
17	O
tan	O
-	O
to	O
-	O
white	O
colored	O
lymph	O
nodes	O
are	O
identified	O
,	O
ranging	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
2	O
.	O
0	O
cm	O
.	O

The	O
nodes	O
.	O
vary	O
from	O
soft	O
to	O
firm	O
in	O
consistency	O
.	O

The	O
remainder	O
of	O
the	O
fibroadipose	O
tissue	O
appears	O
unremarkable	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
for	O
permanent	O
histology	O
as	O
follows	O
:	O
2A	O
-	O
2D	O
.	O
nodes	O
.	O

2E	O
-	O
2G	O
.	O
fibroadipose	O
tissue	O
.	O

Part	O
3	O
is	O
received	O
labeled	O
"	O
left	O
upper	O
pharynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
soft	O
,	O
tan	O
-	O
white	O
tissue	O
measuring	O
1	O
.	O
5	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

Following	O
an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
single	O
cassette	O
labeled	O
3A	O
.	O

Part	O
4	O
is	O
received	O
labeled	O
"	O
left	O
base	O
of	O
tongue	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
soft	O
,	O
tan	O
-	O
brown	O
,	O
partially	O
cauterized	O
tissue	O
measuring	O
.	O

2	O
.	O
0	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O

Following	O
an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
single	O
.	O
cassette	O
labeled	O
4A	O
.	O

Part	O
5	O
is	O
received	O
labeled	O
"	O
right	O
base	O
of	O
tongue	O
"	O
.	O

It	O
consists	O
of	O
two	O
small	O
pieces	O
of	O
soft	O
,	O
tan	O
-	O
white	O
tissue	O
collectively	O
measuring	O
0	O
.	O
6	O
.	O

X	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Following	O
an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
single	O
.	O
cassette	O
labeled	O
5A	O
.	O

Part	O
6	O
is	O
received	O
labeled	O
"	O
right	O
upper	O
pharynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
soft	O
,	O
tan	O
-	O
brown	O
,	O
partially	O
cauterized	O
tissue	O
.	O
measuring	O
1	O
.	O
5	O
X	O
0	O
.	O
3	O
X	O
0	O
,	O
2	O
cm	O
.	O

Following	O
an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
.	O
single	O
cassette	O
labeled	O
6A	O
.	O

Part	O
7	O
is	O
received	O
labeled	O
"	O
right	O
hypopharynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
piece	O
of	O
soft	O
,	O
tan	O
-	O
brown	O
,	O
partially	O
cauterized	O
tissue	O
measuring	O
.	O

1	O
.	O
2	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
.	O

Following	O
an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
single	O
.	O
cassette	O
labeled	O
7A	O
.	O

Part	O
8	O
is	O
received	O
labeled	O
"	O
left	O
hypopharynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
single	O
strip	O
of	O
soft	O
,	O
tan	O
tissue	O
measuring	O
3	O
.	O
0	O
x	O
0	O
.	O
2	O
X	O
0	O
.	O
1	O
cm	O
.	O

Following	O
.	O

an	O
intraoperative	O
frozen	O
section	O
,	O
the	O
entire	O
tissue	O
is	O
submitted	O
for	O
permanent	O
histology	O
in	O
a	O
single	O
cassette	O
labeled	O
8A	O
.	O

Part	O
9	O
is	O
received	O
labeled	O
"	O
larynx	O
"	O
.	O

It	O
consists	O
of	O
a	O
complete	O
larynx	O
with	O
attached	O
tongue	O
base	O
,	O
superior	O
trachea	O
and	O
surrounding	O
.	O
soft	O
tissue	O
having	O
an	O
overall	O
measurement	O
of	O
8	O
.	O
5	O
x	O
5	O
.	O
5	O
X	O
5	O
.	O
0	O
cm	O
.	O

The	O
mucosal	O
surface	O
of	O
the	O
epiglottis	O
shows	O
a	O
peripherally	O
.	O
fungating	O
,	O
centrally	O
ulcerating	O
mass	O
lesion	O
that	O
measures	O
3	O
.	O
5	O
x	O
2	O
.	O
8	O
cm	O
.	O

The	O
lesion	O
Is	O
centered	O
approximately	O
0	O
.	O
5	O
cm	O
to	O
the	O
left	O
of	O
.	O
the	O
midline	O
and	O
3	O
.	O
1	O
cm	O
from	O
the	O
tlp	O
of	O
the	O
epiglottis	O
.	O

The	O
mass	O
extends	O
inferlorly	O
,	O
apparently	O
involving	O
the	O
left	O
false	O
vocal	O
chord	O
,	O
.	O
obscuring	O
the	O
left	O
ventricle	O
and	O
abutting	O
the	O
superior	O
surface	O
of	O
the	O
left	O
true	O
chord	O
.	O

On	O
the	O
right	O
,	O
the	O
mass	O
appears	O
to	O
extend	O
to	O
the	O
.	O
superior	O
aspect	O
of	O
the	O
false	O
chord	O
,	O
compressing	O
the	O
right	O
ventricle	O
.	O

The	O
right	O
true	O
chord	O
is	O
edematous	O
and	O
expanded	O
.	O

Serial	O
.	O
sections	O
along	O
the	O
mid	O
-	O
sagiltal	O
plane	O
at	O
3	O
mm	O
intervals	O
show	O
the	O
mass	O
extending	O
Into	O
the	O
pre	O
-	O
epiglottic	O
space	O
(	O
predominantly	O
on	O
.	O
the	O
left	O
)	O
,	O
with	O
extension	O
between	O
the	O
hyoid	O
bone	O
and	O
superlor	O
aspect	O
of	O
the	O
thyrold	O
cartilage	O
.	O

Maximum	O
thickness	O
of	O
the	O
leslon	O
is	O
.	O
approximately	O
2	O
.	O
0	O
cm	O
.	O

The	O
lesion	O
appears	O
to	O
invade	O
into	O
the	O
base	O
of	O
the	O
tongue	O
,	O
but	O
remains	O
at	O
least	O
0	O
.	O
5	O
cm	O
from	O
the	O
tongue	O
base	O
.	O
margin	O
.	O

The	O
lesion	O
directly	O
abuts	O
the	O
epiglottic	O
cartilage	O
In	O
multiple	O
areas	O
but	O
does	O
not	O
appear	O
to	O
Invade	O
it	O
.	O

At	O
the	O
tip	O
of	O
the	O
.	O
epiglottis	O
is	O
an	O
irregularly	O
shaped	O
area	O
of	O
ulceratlon	O
that	O
measures	O
0	O
,	O
8	O
X	O
0	O
.	O
6	O
cm	O
,	O
and	O
1	O
-	O
2	O
mm	O
in	O
depth	O
.	O

The	O
mucosa	O
overlying	O
the	O
.	O
left	O
pre	O
-	O
epiglottic	O
reglon	O
shows	O
a	O
deep	O
,	O
well	O
-	O
demarcated	O
ulceration	O
that	O
measures	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
,	O
with	O
a	O
depth	O
of	O
3	O
mm	O
.	O

On	O
.	O
sectioning	O
,	O
this	O
ulceration	O
Is	O
contiguous	O
with	O
the	O
invading	O
mass	O
lesion	O
in	O
the	O
underlying	O
pre	O
-	O
epiglottic	O
space	O
.	O

The	O
tracheal	O
mucosa	O
.	O

is	O
glistening	O
,	O
tan	O
,	O
and	O
shows	O
multifocal	O
pinpoint	O
hemorrhage	O
.	O

The	O
soft	O
tissue	O
surrounding	O
the	O
remainder	O
of	O
the	O
speclmen	O
cohsists	O
.	O
of	O
normal	O
appearing	O
muscle	O
and	O
ad	O
	O
pose	O
which	O
has	O
been	O
partially	O
cauterized	O
.	O

The	O
entire	O
soft	O
tissue	O
margin	O
of	O
resection	O
is	O
inked	O
,	O
.	O
seven	O
digital	O
images	O
are	O
taken	O
,	O
and	O
representative	O
sections	O
are	O
submitted	O
for	O
histology	O
as	O
follows	O
:	O
9A	O
.	O
tracheal	O
margin	O
,	O
shave	O
.	O

9B	O
.	O
epiglottis	O
,	O
tumor	O
and	O
longue	O
base	O
section	O
.	O

gc	O
.	O
tumor	O
,	O
epiglottis	O
,	O
pre	O
-	O
epigiollic	O
space	O
and	O
ulceration	O
.	O

gb	O
.	O
tumor	O
and	O
hyold	O
bone	O
.	O

gE	O
.	O
tumor	O
and	O
left	O
false	O
/	O
true	O
chords	O
.	O

gF	O
.	O
tumor	O
and	O
right	O
false	O
/	O
true	O
chords	O
.	O

gG	O
.	O
soft	O
lissue	O
margin	O
(	O
random	O
)	O
.	O
normal	O
trachea	O
.	O

Sections	O
A	O
,	O
D	O
,	O
E	O
,	O
F	O
are	O
submitted	O
for	O
decalcification	O
.	O

This	O
specimen	O
was	O
reviewed	O
with	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
3FS	O
:	O
LEFT	O
UPPER	O
PHARYNX	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
.	O

MILD	O
-	O
TO	O
-	O
MODERATE	O
.	O
DYSPLASIA	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

4FS	O
:	O
LEFT	O
BASE	O
OF	O
TONGUE	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

5FS	O
:	O
RIGHT	O
BASE	O
OF	O
TONGUE	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
.	O

6FS	O
:	O
RIGHT	O
UPPER	O
PHARYNX	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
.	O

MILD	O
DYSPLASIA	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

7FS	O
:	O
RIGHT	O
HYPOPHARYNX	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

8FS	O
:	O
LEFT	O
HYPOPHARYNX	O
.	O

A	O
.	O

BENIGN	O
.	O

B	O
ID	O
-	O
TO	O
-	O
MODERATE	O
.	O

DYSPLASIA	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

MICROSCOPIC	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
diagnosis	O
.	O

The	O
following	O
statement	O
applies	O
to	O
all	O
immunohistochemistry	O
,	O
insitu	O
hybridization	O
(	O
ISH	O
&	O
FISH	O
)	O
,	O
molecular	O
anatomic	O
pathology	O
,	O
and	O
.	O
immunofluorescence	O
testing	O
:	O
The	O
testing	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

as	O
.	O
required	O
by	O
the	O
CLIA	O
.	O
egulations	O
.	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
.	O

Administration	O
,	O
but	O
the	O
FDA	O
has	O
determined	O
such	O
approval	O
is	O
not	O
necessary	O
for	O
clinical	O
use	O
.	O

Tissue	O
fixation	O
ranges	O
from	O
a	O
minlmum	O
ol	O
.	O
to	O
a	O
maximum	O
of	O
.	O

This	O
laboratory	O
is	O
certifled	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
.	O
complexity	O
clinical	O
testing	O
.	O

Pursuant	O
to	O
the	O
requirements	O
of	O
CLIA	O
,	O
ASR	O
'	O
s	O
used	O
In	O
tills	O
laboratory	O
have	O
been	O
established	O
and	O
verilled	O
for	O
.	O
accuracy	O
and	O
precision	O
.	O

Additional	O
information	O
about	O
this	O
type	O
of	O
test	O
Is	O
available	O
upon	O
request	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
LARYNX	O
RESECTIONS	O
.	O

TYPE	O
OF	O
LARYNGECTOMY	O
:	O
Total	O
.	O

TUMOR	O
LOCATION	O
:	O
Midline	O
.	O

ATTACHED	O
STRUCTURES	O
:	O
Base	O
of	O
tongue	O
.	O

TUMOR	O
LOCATION	O
/	O
SEGMENT	O
:	O
Supraglottic	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
3	B
.	I
5	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
OF	O
TUMOR	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Moderately	O
differentiated	O
.	O

STRUCTURES	O
INVOLVED	O
BY	O
TUMOR	O
:	O
False	O
cord	O
,	O
Epiglottis	O
,	O
Pre	O
-	O
epiglottic	O
space	O
,	O
Paraglottic	O
space	O
,	O
Extralaryngeal	O
.	O
soft	O
tissue	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
Number	O
of	O
lymph	O
nodes	O
positive	O
:	O
:	O
0	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
:	O
37	O
.	O

EXTRACAPSULAR	O
SPREAD	O
OF	O
LYMPH	O
NODE	O
METASTASES	O
.	O

INTRA	O
-	O
PERINEURAL	O
INVASION	O
:	O
Absent	O
.	O

VASCULAR	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
Free	O
(	O
2	O
mm	O
or	O
more	O
)	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
Supraglottis	O
,	O
pT4a	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTO	O
TISSUE	O
SUMMARY	O
/	O
SLIDES	O
REVIEWED	O
:	O
Part	O
1	O
:	O
Right	O
Neck	O
Levels	O
2	O
-	O
4	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

Part	O
2	O
:	O
Left	O
Nock	O
1	O
availe	O
2	O
-	O
4	O
.	O

Recelved	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

A	O
.	O

H	O
&	O
E	O
.	O

B	O
.	O

H	O
&	O
E	O
.	O

x	O
.	O

C	O
.	O

H	O
&	O
E	O
.	O

x	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

Part	O
3	O
:	O
1	O
eft	O
Unner	O
Phanunx	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
4	O
:	O
Left	O
Base	O
of	O
Tongue	O
.	O

Recelved	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
5	O
:	O
Right	O
Base	O
of	O
Tongue	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
6	O
:	O
Right	O
.	O

Unner	O
Pharynx	O
.	O

Stain	O
/	O
cht	O
.	O

BIOCK	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
7	O
:	O
Right	O
Unner	O
Pharynx	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
8	O
:	O
1	O
oft	O
Unner	O
Pharnnx	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Afs	O
.	O

Part	O
9	O
;	O
Larynx	O
.	O

Stain	O
/	O
cht	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
Recut	O
x	O
1	O
.	O

C	O
.	O

IHPV	O
x	O
1	O
.	O

C	O
.	O
cmet	O
x	O
1	O
.	O

C	O
.	O

IEGFR	O
x	O
1	O
.	O

C	O
.	O

IBNKNC	O
x	O
1	O
.	O

C	O
.	O

IBNKNC	O
X	O
1	O
.	O

C	O
.	O

IBNKNC	O
x	O
1	O
.	O

C	O
.	O

IBNKNC	O
x	O
1	O
.	O

C	O
.	O

IBNKNC	O
x	O
1	O
.	O

C	O
.	O

IBNKNC	O
x	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

C	O
.	O

IISH	O
x	O
t	O
.	O

C	O
.	O

IISH	O
x	O
1	O
.	O

C	O
.	O

P16	O
x	O
1	O
.	O

C	O
.	O

V	O
-	O
EGFR	O
x	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Decal	O
x	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Decal	O
x	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Decal	O
x	O
1	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

Decal	O
x	O
I	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

ICD	O
-	O
9	O
Diagnosis	O
Codes	O
:	O
{	O
None	O
Entered	O
}	O
.	O

CONSULTING	O
PATHOLOGIST	O
(	O
S	O
)	O
:	O
SPECIAL	O
PROCEDURES	O
:	O
In	O
Situ	O
Procedure	O
.	O

Interpretation	O
.	O

PROBE	O
:	O
LSI	O
EGFR	O
/	O
CEP7	O
Dual	O
-	O
Color	O
Probe	O
.	O

Cytogenetic	O
Location	O
:	O
7p12	O
/	O
7p11	O
.	O
1	O
-	O
q11	O
.	O
1	O
.	O

EGFR	O
FISH	O
STUDIES	O
PERFORMED	O
ON	O
THE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
ARE	O
NEGATIVE	O
.	O

Number	O
of	O
cells	O
analyzed	O
:	O
60	O
.	O

Ratio	O
EGFRICEP7	O
:	O
1	O
.	O
53	O
.	O

High	O
Polysomy	O
:	O
0	O
%	O
.	O

SNR	O
(	O
signal	O
to	O
nucleus	O
ratio	O
)	O
:	O
2	O
.	O
5	O
.	O

Low	O
Polysomy	O
:	O
16	O
(	O
26	O
.	O
7	O
%	O
)	O
.	O

Trisomy	O
:	O
4	O
(	O
6	O
.	O
7	O
%	O
)	O
.	O

Disomy	O
:	O
40	O
(	O
66	O
.	O
6	O
%	O
)	O
.	O

PROBE	O
:	O
c	O
-	O
MET	O
/	O
CEP7	O
.	O

Cytogenetic	O
Location	O
:	O
7q31	O
.	O
2	O
/	O
7p11	O
.	O
1	O
-	O
q11	O
.	O
1	O
.	O

C	O
-	O
MET	O
FISH	O
STUDIES	O
PERFORMED	O
ON	O
THE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
ARE	O
NEGATIVE	O
FOR	O
AMPLIFICATION	O
.	O

Number	O
of	O
cells	O
analyzed	O
:	O
60	O
.	O

Ratio	O
c	O
-	O
MET	O
/	O
CEP7	O
:	O
1	O
.	O
07	O
.	O

SNR	O
(	O
signal	O
to	O
nucleus	O
ratio	O
)	O
:	O
2	O
.	O
2	O
.	O

Hlgh	O
Polysomy	O
:	O
0	O
%	O
.	O

Low	O
Polysomy	O
:	O
0	O
%	O
.	O

Trisomy	O
:	O
21	O
(	O
35	O
.	O
0	O
%	O
)	O
.	O

Disomy	O
:	O
39	O
(	O
65	O
.	O
0	O
%	O
)	O
.	O

My	O
signature	O
is	O
attestation	O
that	O
/	O
have	O
personally	O
reviewed	O
the	O
submitted	O
material	O
(	O
s	O
)	O
and	O
the	O
above	O
dlagnosis	O
reflects	O
that	O
evaluation	O
.	O

EGFR	O
FISH	O
analysis	O
was	O
manually	O
performed	O
and	O
quantitatively	O
assessed	O
by	O
analysis	O
of	O
a	O
minlimum	O
of	O
60	O
cells	O
using	O
the	O
EGFR	O
.	O

SpectrumOrange	O
and	O
the	O
CEP7	O
SpectumGreen	O
probes	O
.	O

C	O
-	O
MET	O
FISH	O
analysis	O
was	O
manually	O
performed	O
and	O
quantitatively	O
assessed	O
by	O
analysis	O
of	O
a	O
minimum	O
of	O
60	O
cells	O
using	O
the	O
c	O
-	O
MET	O
.	O

SpectrumOrange	O
and	O
the	O
CEP7	O
SpectrumGreen	O
(	O
centromeric	O
)	O
probes	O
.	O

EGFR	O
FISH	O
positive	O
:	O
High	O
Polysomy	O
:	O
>	O
four	O
gene	O
copies	O
in	O
>	O
40	O
%	O
of	O
cells	O
.	O

Gene	O
Amplification	O
:	O
Ratio	O
gene	O
/	O
chromosome	O
more	O
than	O
two	O
or	O
>	O
15	O
gene	O
copies	O
in	O
>	O
10	O
%	O
of	O
cells	O
.	O

EGFR	O
FISH	O
negative	O
:	O
Disomy	O
:	O
two	O
gene	O
copies	O
in	O
more	O
than	O
90	O
%	O
of	O
the	O
cells	O
.	O

Trisomy	O
:	O
three	O
gene	O
copies	O
in	O
more	O
than	O
10	O
%	O
of	O
cells	O
.	O

Low	O
Polysomy	O
:	O
>	O
four	O
gene	O
copies	O
in	O
more	O
than	O
10	O
%	O
but	O
less	O
than	O
40	O
%	O
of	O
cells	O
.	O

c	O
-	O
MET	O
FISH	O
positive	O
:	O
Gene	O
Amplification	O
:	O
Ratio	O
gene	O
/	O
chromosome	O
more	O
than	O
two	O
or	O
>	O
15	O
gene	O
copies	O
in	O
>	O
10	O
%	O
of	O
cells	O
.	O

c	O
-	O
MET	O
FISH	O
negative	O
:	O
Ratio	O
gene	O
/	O
chromosome	O
less	O
than	O
two	O
or	O
<	O
15	O
gene	O
copies	O
in	O
VI	O
10	O
%	O
of	O
the	O
cells	O
.	O

References	O
:	O

PATIENT	O
HISTORY	O
:	O
CHIEF	O
FCOMPLAINT	O
/	O
PRE	O
-	O
OP	O
/	O
POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Sigmoid	O
colon	O
mass	O
.	O

PROCEDURE	O
:	O
Sigmoid	O
colon	O
resection	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Not	O
answered	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
Not	O
answered	O
.	O

PRIOR	O
MALIGNANCY	O
:	O
Not	O
answered	O
.	O

CHEMOTHERAPY	O
:	O
Not	O
answered	O
.	O

ORGAN	O
TRANSPLANT	O
:	O
Not	O
answered	O
.	O

IMMUNOSUPPRESSION	O
:	O
Not	O
answered	O
.	O

OTHER	O
DISEASES	O
:	O
Not	O
answered	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
SIGMOID	O
COLON	O
,	O
SEGMENTAL	O
COLECTOMY	O
-	O
.	O

A	O
.	O

ULCERATED	O
,	O
POLYPOID	O
,	O
INVASIVE	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
COLONIC	O
ADENOCARCINOMA	O
,	O
3	B
CM	I
,	O
.	O

PRESENT	O
IN	O
THE	O
SIGMOID	O
COLON	O
3	O
CM	O
FROM	O
THE	O
PROXIMAL	O
AND	O
5	O
.	O
5	O
CM	O
FROM	O
THE	O
DISTAL	O
RESECTION	O
.	O

MARGINS	O
.	O

B	O
.	O

CARCINOMA	O
INVADES	O
DEEPLY	O
INTO	O
,	O
BUT	O
NOT	O
THROUGH	O
THE	O
MUSCULARIS	O
PROPRIA	O
.	O

C	O
.	O

PRESUMED	O
ANGIOLYMPHATIC	O
INVASION	O
(	O
see	O
diagnosis	O
G	O
)	O
.	O

D	O
.	O

ONE	O
SMALL	O
TUBULAR	O
ADENOMA	O
.	O

E	O
.	O

ALL	O
SURGICAL	O
RESECTION	O
MARGINS	O
,	O
SUBSEROSAL	O
AND	O
SEROSAL	O
SURFACE	O
ARE	O
BENIGN	O
.	O

F	O
.	O

NON	O
-	O
NEOPLASTIC	O
COLONIC	O
MUCOSA	O
WITH	O
NO	O
SIGNIFICANT	O
HISTOPATHOLOGIC	O
ABNORMALITY	O
.	O

G	O
.	O

METASTATIC	O
COLONIC	O
ADENOCARCINOMA	O
IS	O
PRESENT	O
AND	O
LARGELY	O
REPLACES	O
TWO	O
OF	O
TWELVE	O
(	O
2	O
/	O
12	O
)	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
.	O

THE	O
LARGER	O
METASTATIC	O
FOCUS	O
MEASURES	O
0	O
.	O
4	O
CM	O
.	O

NO	O
EXTRACAPSULAR	O
.	O

EXTENSION	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

TNM	O
PATHOLOGIC	O
STAGE	O
:	O
T2	O
N1	O
MX	O
(	O
see	O
synoptic	O
)	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
COLON	O
,	O
RECTAL	O
,	O
APPENDIX	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Sigmoidectomy	O
.	O

SPECIMEN	O
LENGTH	O
:	O
11	O
.	O
5	O
cm	O
.	O

TUMOR	O
SITE	O
:	O
Sigmoid	O
colon	O
.	O

TUMOR	O
CONFIGURATION	O
:	O
Exophytic	O
(	O
polypoid	O
)	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
cm	I
.	O

Additional	O
dimensions	O
:	O
3	B
x	I
1	I
.	I
7	I
cm	I
.	O

INTACTNESS	O
OF	O
MESORECTUM	O
:	O
Not	O
applicable	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Low	O
-	O
grade	O
(	O
well	O
to	O
moderately	O
differentiated	O
)	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
pT2	O
.	O

pN1	O
.	O

Number	O
of	O
nodes	O
examined	O
:	O
12	O
.	O

Number	O
of	O
nodes	O
involved	O
:	O
2	O
.	O

pMX	O
.	O

Treatment	O
:	O
Untreated	O
.	O

MARGINS	O
:	O
Proximal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distal	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Circumferential	O
(	O
radial	O
)	O
margin	O
-	O
Not	O
applicable	O
.	O

Mesenteric	O
margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

If	O
all	O
margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
:	O
distance	O
of	O
invasive	O
carcinoma	O
from	O
.	O
closest	O
margin	O
:	O
30	O
mm	O
.	O

Margin	O
:	O
Proximal	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
Present	O
.	O

PERINEURAL	O
INVASION	O
:	O
Absent	O
.	O

TUMOR	O
BORDER	O
CONFIGURATION	O
:	O
Infiltrating	O
.	O

ADDITIONAL	O
TUMOR	O
CHARACTERISTICS	O
:	O
None	O
.	O

ADDITIONAL	O
PATH	O
FINDINGS	O
(	O
check	O
all	O
that	O
apply	O
)	O
:	O
Adenoma	O
(	O
s	O
)	O
.	O

Date	O
Collected	O
:	O
Date	O
Received	O
.	O

DIAGNOSIS	O
.	O

1	O
.	O

BRAIN	O
,	O
LEFT	O
FRONTAL	O
,	O
BIOPSY	O
,	O
FS1A	O
:	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
.	O

2	O
.	O

BRAIN	O
,	O
LEFT	O
FRONTAL	O
,	O
EXCISION	O
:	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
.	O

-	O
SEE	O
COMMENT	O
.	O

COMMENT	O
:	O
This	O
infiltrating	O
astrocytoma	O
discloses	O
focal	O
anaplasia	O
,	O
high	O
.	O
cellularity	O
,	O
.	O
necrosis	O
and	O
microvascular	O
proliferation	O
.	O

These	O
features	O
are	O
.	O
indicative	O
of	O
.	O
glioblastoma	O
multiforme	O
.	O

However	O
,	O
other	O
areas	O
in	O
this	O
tumor	O
appear	O
.	O

to	O
.	O
represent	O
lower	O
grade	O
infiltrating	O
astrocytoma	O
.	O

The	O
infiltrative	O
.	O
nature	O
of	O
.	O
this	O
tumor	O
is	O
confirmed	O
in	O
a	O
neurofilament	O
immunohistochemical	O
.	O
stain	O
.	O

A	O
MIB1	O
.	O
proliferation	O
rate	O
is	O
estimated	O
at	O
approximately	O
10	O
-	O
15	O
%	O
in	O
the	O
.	O
higher	O
grade	O
.	O
areas	O
of	O
the	O
tumor	O
.	O

SPECIMEN	O
:	O
1	O
.	O

Left	O
frontal	O
brain	O
lesion	O
.	O

2	O
.	O

Left	O
frontal	O
brain	O
lesion	O
.	O

CLINICAL	O
HISTORY	O
/	O
OPERATIVE	O
FINDINGS	O
:	O
Craniotomy	O
,	O
brain	O
tumor	O
.	O

Brain	O
tumor	O
.	O

Left	O
frontal	O
craniotomy	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Specimen	O
#	O
1	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
.	O
labeled	O
with	O
.	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
left	O
frontal	O
.	O
brain	O
.	O

lesion	O
.	O
"	O
The	O
specimen	O
consists	O
of	O
multiple	O
pieces	O
of	O
tan	O
-	O
red	O
.	O
tissue	O
measuring	O
.	O
in	O
aggregate	O
0	B
.	I
7	I
x	I
0	I
.	I
7	I
x	I
0	I
.	I
3	I
cm	I
.	O

A	O
representative	O
section	O
is	O
.	O
submitted	O
for	O
.	O
frozen	O
tissue	O
diagnosis	O
,	O
and	O
the	O
contents	O
of	O
the	O
cryoblock	O
are	O
.	O
resubmitted	O
in	O
.	O
cassette	O
"	O
FS1A	O
.	O
"	O
The	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
in	O
.	O
cassette	O
.	O

"	O
1B	O
.	O

"	O
Immunohistochemical	O
stains	O
MIB1	O
and	O
neurofilament	O
are	O
.	O
ordered	O
on	O
.	O
cassette	O
"	O
1B	O
.	O
"	O
.	O

Specimen	O
#	O
2	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
s	O
.	O
name	O
,	O
medical	O
.	O
record	O
number	O
and	O
as	O
"	O
left	O
frontal	O
brain	O
lesion	O
.	O

"	O
The	O
specimen	O
.	O
consists	O
of	O
.	O
numerous	O
fragments	O
of	O
tan	O
-	O
red	O
tissue	O
measuring	O
in	O
aggregate	O
2	O
.	O
5	O
x	O
.	O

2	O
.	O
5	O
x	O
0	O
.	O
4	O
.	O

cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
"	O
2A	O
"	O
and	O
.	O

"	O
2B	O
.	O

Approximately	O
75	O
%	O
of	O
the	O
tissue	O
have	O
been	O
submitted	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
FS1A	O
:	O
LEFT	O
FRONTAL	O
BRAIN	O
LESION	O
(	O
FROZEN	O
SECTION	O
)	O
:	O
ASTROCYTOMA	O
;	O
GRADING	O
.	O

DEFERRED	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
Microscopic	O
examination	O
performed	O
.	O

Page	O
1	O
(	O
Continued	O
.	O

SPECIAL	O
STAINS	O
:	O
:	O
KI	O
-	O
67	O
.	O

DONE	O
.	O

KI	O
-	O
67	O
.	O

DONE	O
.	O

NF	O
.	O

DONE	O
.	O

NF	O
.	O

DONE	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Thyroid	O
papillary	O
carcinoma	O
on	O
FNA	O
right	O
lobe	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Right	O
paratracheal	O
nodes	O
(	O
fs	O
)	O
.	O

2	O
:	O
Total	O
thyroid	O
.	O

3	O
:	O
Pretracheal	O
tissue	O
.	O

4	O
:	O
Right	O
mediastinal	O
tissue	O
.	O

5	O
:	O
Left	O
mediastinal	O
tissue	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Right	O
paratracheal	O
nodes	O
(	O
fs	O
)	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
5	O
.	O

2	O
.	O

Total	O
thyroid	O
:	O
Tumor	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
tall	O
cell	O
variant	O
.	O

Mitotic	O
Activity	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Tumor	O
Location	O
:	O
site	O
:	O
thyroid	O
,	O
NOS	O
C13	O
.	O
9	O
.	O

Right	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
1	B
.	I
5	I
cm	I
.	O

Tumor	O
Encapsulation	O
:	O
None	O
Identified	O
.	O

Blood	O
Vessel	O
Invasion	O
:	O
Focal	O
Invasion	O
.	O

Extrathyroid	O
Extension	O
:	O
Invades	O
:	O
perithyroidal	O
fibradipose	O
tissue	O
and	O
skeletal	O
muscle	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Tumor	O
Multicentricity	O
:	O
Not	O
identified	O
.	O

Adenoma	O
(	O
s	O
)	O
(	O
away	O
from	O
the	O
carcinoma	O
)	O
:	O
Not	O
Identified	O
.	O

Non	O
-	O
Neoplastic	O
Thyroid	O
:	O
Exhibits	O
nodular	O
hyperplasia	O
.	O

Exhibits	O
chronic	O
lymphocytic	O
thyroiditis	O
.	O

Parathyroid	O
Glands	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Three	O
fymph	O
nodes	O
negative	O
for	O
metastatic	O
carcinoma	O
are	O
identified	O
(	O
0	O
/	O
3	O
)	O
.	O

3	O
.	O

Pretracheal	O
tissue	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
lymph	O
nodes	O
.	O

Number	O
of	O
lymph	O
nodes	O
examined	O
:	O
6	O
.	O

4	O
.	O

Right	O
mediastinal	O
tissue	O
:	O
Lymph	O
Node	O
Dissection	O
:	O
Benign	O
fibroadipose	O
tissue	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
2	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labelled	O
"	O
total	O
thyroid	O
,	O
stitch	O
marks	O
right	O
thyroid	O
lobe	O
"	O
and	O
consists	O
of	O
a	O
thyroid	O
weighing	O
12	O
.	O
5	O
g	O
.	O

The	O
right	O
lobe	O
measures	O
3	O
.	O
5x2x1	O
.	O
5	O
Cm	O
,	O
the	O
left	O
lobe	O
measures	O
4x3x1	O
cm	O
and	O
the	O
isthmus	O
measures	O
1	O
.	O
2x1x0	O
.	O
6	O
Cm	O
.	O

The	O
external	O
.	O
surface	O
is	O
covered	O
by	O
a	O
thin	O
fibrous	O
capsule	O
.	O

The	O
posterior	O
surface	O
of	O
the	O
specimen	O
is	O
inked	O
black	O
,	O
and	O
the	O
anterior	O
is	O
inked	O
blue	O
.	O

Sectioning	O
reveals	O
overall	O
multinodular	O
thyroid	O
tissue	O
with	O
one	O
prominent	O
nodule	O
with	O
white	O
tan	O
cut	O
surface	O
on	O
the	O
right	O
lobe	O
.	O
measuring	O
1	O
.	O
5x1	O
.	O
2x1	O
.	O
0	O
cm	O
.	O

Sections	O
through	O
the	O
remaining	O
tissue	O
reveal	O
beefy	O
red	O
parenchyma	O
.	O

The	O
remaining	O
thyroid	O
.	O
parenchyma	O
is	O
red	O
tan	O
and	O
beefy	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
are	O
submitted	O
for	O
TPS	O
.	O

The	O
remaining	O
tissue	O
is	O
serially	O
.	O
sectioned	O
and	O
representatively	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
nodule	O
.	O

RL	O
right	O
lobe	O
.	O

LL	O
left	O
lobe	O
.	O

IS	O
isthmus	O
.	O

3	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
,	O
"	O
pretracheal	O
tissue	O
"	O
,	O
and	O
consists	O
of	O
multiple	O
pieces	O
of	O
red	O
and	O
tan	O
soft	O
tissue	O
.	O
measuring	O
0	O
.	O
9	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

Entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
-	O
undesignated	O
.	O

4	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
right	O
superior	O
mediastinal	O
tissue	O
"	O
,	O
and	O
consists	O
of	O
two	O
irregular	O
fragments	O
of	O
.	O
pink	O
-	O
tan	O
soft	O
tissue	O
measuring	O
0	O
.	O
4	O
and	O
1	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

Submitted	O
entirely	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

5	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
left	O
superior	O
mediastinal	O
tissue	O
"	O
,	O
and	O
consists	O
of	O
an	O
irregular	O
fragment	O
of	O
pink	O
-	O
tan	O
.	O
soft	O
tissue	O
measuring	O
0	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Right	O
paratracheal	O
nodes	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

FSC	O
.	O

1	O
.	O

Part	O
2	O
:	O
Total	O
thyroid	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

IS	O
.	O

1	O
.	O

2	O
.	O

LL	O
.	O

2	O
.	O

4	O
.	O

N	O
.	O

4	O
.	O

3	O
.	O

RL	O
.	O

3	O
.	O

Part	O
3	O
:	O
Pretracheal	O
tissue	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

U	O
.	O

4	O
.	O

Part	O
4	O
:	O
Right	O
mediastinal	O
tissue	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

U	O
.	O

2	O
.	O

Part	O
5	O
:	O
Left	O
mediastinal	O
tissue	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

U	O
.	O

1	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O

1	O
.	O

Frozen	O
section	O
diagnosis	O
:	O
Right	O
paratracheal	O
nodes	O
(	O
fs	O
)	O
:	O
Benign	O
.	O

Permanent	O
diagnosis	O
:	O
same	O
.	O

Final	O
Surgical	O
Pathology	O
Report	O
.	O

Procedure	O
:	O
Diagnosis	O
.	O

Uterus	O
and	O
bilateral	O
adnexa	O
,	O
resection	O
:	O
Cervix	O
:	O
CIN	O
-	O
1	O
,	O
CIN2	O
.	O

Endometrium	O
:	O
Polypoid	O
endometrioid	O
type	O
endometrial	O
adenocarcinoma	O
,	O
.	O

FIGO	O
grade	O
2	O
.	O

Secretory	O
type	O
endometrium	O
.	O

Myometrium	O
:	O
Probable	O
very	O
superficial	O
myometrial	O
invasion	O
.	O

Ovaries	O
,	O
left	O
and	O
right	O
:	O
No	O
pathological	O
diagnosis	O
.	O

Uterine	O
tubes	O
,	O
left	O
and	O
right	O
:	O
No	O
pathological	O
diagnosis	O
.	O

Parametrium	O
,	O
left	O
and	O
right	O
:	O
No	O
pathological	O
diagnosis	O
.	O

Microscopic	O
Description	O
:	O
Histologic	O
type	O
:	O
Endometrioid	O
type	O
endometrial	O
adenocarcinoma	O
.	O
forming	O
an	O
exophytic	O
polyp	O
with	O
adjacent	O
secretory	O
type	O
.	O
endometrium	O
.	O

Histologic	O
grade	O
:	O
FIGO	O
II	O
.	O

The	O
tumor	O
is	O
greater	O
than	O
5	O
%	O
but	O
less	O
.	O
than	O
50	O
%	O
solid	O
.	O

There	O
is	O
micro	O
-	O
focal	O
increased	O
nuclear	O
.	O
grade	O
(	O
e	O
.	O
g	O
.	O
block	O
A16	O
)	O
.	O

Myometrial	O
invasion	O
:	O
Focal	O
probable	O
very	O
superficial	O
myometrial	O
.	O
invasion	O
K	O
<	O
10	O
%	O
)	O
.	O

Vascular	O
invasion	O
:	O
Absent	O
.	O

Endometrial	O
hyperplasia	O
:	O
Absent	O
.	O

Lower	O
uterine	O
segment	O
:	O
Negative	O
for	O
malignancy	O
.	O

Uterine	O
cervix	O
:	O
Transformation	O
zone	O
CIN	O
1	O
and	O
CIN	O
2	O
are	O
present	O
.	O

CIN2	O
is	O
present	O
at	O
the	O
ectocervical	O
epithelial	O
edge	O
of	O
the	O
.	O
specimen	O
in	O
block	O
RR2	O
.	O

Parametrium	O
:	O
Negative	O
for	O
malignancy	O
.	O

pTNM	O
:	O
Tla	O
.	O

MSI	O
testing	O
:	O
Ordered	O
on	O
block	O
A16	O
.	O

Other	O
findings	O
:	O
None	O
.	O

Specimen	O
.	O

Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

Clinical	O
Information	O
.	O

Patient	O
with	O
grade	O
1	O
endometrial	O
adenocarcinoma	O
on	O
biopsy	O
.	O

ASCUS	O
Pap	O
,	O
for	O
TAH	O
BSO	O
.	O

Intraoperative	O
Consultation	O
.	O

A	O
.	O

Uterus	O
and	O
bilateral	O
adnexa	O
,	O
resection	O
:	O
Polypoid	O
endometrial	O
adenocarcinoma	O
.	O

Grade	O
deferred	O
to	O
permanent	O
sections	O
.	O

No	O
definite	O
myometrial	O
invasion	O
seen	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
unfixed	O
labeled	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
.	O
tubes	O
and	O
ovaries	O
and	O
consists	O
of	O
a	O
uterus	O
and	O
bilateral	O
attached	O
.	O
adnexa	O
weighing	O
142	O
.	O
8	O
g	O
.	O

The	O
uterus	O
measures	O
10	O
.	O
5	O
by	O
5	O
.	O
5	O
by	O
5	O
cm	O
.	O

The	O
.	O
ectocervix	O
is	O
white	O
and	O
measures	O
3	O
by	O
2	O
.	O
7	O
cm	O
.	O

The	O
external	O
os	O
measures	O
.	O

1	O
.	O
4	O
X	O
0	O
.	O
1	O
cm	O
.	O

The	O
left	O
ovary	O
is	O
white	O
and	O
yellow	O
with	O
some	O
purplish	O
.	O
cortical	O
cysts	O
.	O

The	O
specimen	O
measures	O
2	O
point	O
2	O
x	O
2	O
by	O
1	O
.	O
2	O
cm	O
.	O

There	O
is	O
.	O
adjacent	O
pink	O
uterine	O
tube	O
measuring	O
3	O
cm	O
in	O
length	O
and	O
0	O
.	O
7	O
cm	O
in	O
.	O
diameter	O
.	O

The	O
right	O
ovary	O
is	O
white	O
with	O
some	O
cortical	O
cysts	O
.	O

The	O
ovary	O
.	O
measures	O
3	O
.	O
2	O
by	O
2	O
.	O
3	O
x	O
1	O
.	O
5	O
cm	O
.	O

There	O
is	O
some	O
adjacent	O
red	O
soft	O
tissue	O
.	O
that	O
might	O
be	O
2	O
segments	O
measure	O
2	O
and	O
1	O
.	O
5	O
cm	O
in	O
length	O
and	O
are	O
up	O
to	O
1	O
.	O

cm	O
in	O
diameter	O
.	O

The	O
uterus	O
is	O
opened	O
with	O
a	O
single	O
incision	O
at	O
the	O
3	O
:	O
00	O
.	O
lateral	O
side	O
.	O

There	O
is	O
a	O
polypoid	O
tumor	O
and	O
uterine	O
cavity	O
measuring	O
.	O

2	B
.	I
2	I
by	I
2	I
.	I
2	I
by	I
2	I
.	I
4	I
cm	I
.	O

Portions	O
of	O
polyp	O
and	O
underlying	O
posterior	O
.	O
myometrium	O
are	O
taken	O
for	O
frozen	O
section	O
diagnosis	O
as	O
requested	O
(	O
3	O
.	O
blocks	O
)	O
.	O

Additional	O
sections	O
after	O
fixation	O
.	O

Block	O
summary	O
:	O
1	O
-	O
3	O
left	O
ovary	O
,	O
uterine	O
tube	O
and	O
parametrium	O
;	O
4	O
-	O
6	O
right	O
.	O
ovary	O
,	O
uterine	O
tube	O
and	O
parametrium	O
;	O
7	O
-	O
11	O
anterior	O
cervix	O
and	O
.	O
endomyometrium	O
;	O
12	O
-	O
17	O
posterior	O
cervix	O
and	O
endomyometrium	O
.	O

RR1	O
-	O
8	O
.	O
cervix	O
.	O

Case	O
ID	O
.	O

Subject	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Gastrectomy	O
.	O

Tumor	O
site	O
:	O
Stomach	O
.	O

Tumor	O
size	O
:	O
8	B
X	I
5	I
X	I
1	I
.	I
7	I
cm	I
.	O

Tumor	O
features	O
:	O
None	O
specified	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Adjacent	O
structures	O
(	O
specify	O
)	O
-	O
.	O

Esophagus	O
,	O
lesser	O
omentum	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
5	O
positive	O
for	O
metastasis	O
.	O

(	O
Regional	O
0	O
/	O
5	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
.	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Gross	O
Description	O
.	O

Microscopic	O
.	O

Diagnos	O
.	O

Comme	O
.	O

Subject	O
ID	O
.	O

Description	O
.	O

is	O
.	O
nts	O
.	O

Details	O
.	O

Stomach	O
segment	O
with	O
.	O

Adenocarcinoma	O
,	O
.	O
the	O
plate	O
-	O
like	O
tumor	O
of	O
.	O
with	O
subserosa	O
.	O

6	B
X	I
5	I
.	I
5	I
cm	I
in	O
size	O
,	O
with	O
.	O
infiltration	O
.	O

entire	O
wall	O
layers	O
.	O

Morphological	O
.	O
invasion	O
.	O

features	O
of	O
the	O
.	O

Greater	O
and	O
lesser	O
.	O
tumor	O
structure	O
.	O
curvature	O
lymph	O
nodes	O
.	O
may	O
suggest	O
its	O
.	O
are	O
hyperemic	O
.	O
neuroendocrinal	O
.	O

Omentum	O
is	O
without	O
.	O
origin	O
.	O

changes	O
.	O

Fifteen	O
dissected	O
.	O
lymph	O
nodes	O
.	O
demonstrate	O
.	O

reactive	O
changes	O
.	O

Omentum	O
is	O
.	O
without	O
changes	O
.	O

Lateralit	O
.	O

Procure	O
.	O

y	O
.	O
ment	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

NA	O
.	O

Specimen	O
type	O
:	O
Subtotal	O
gastrectomy	O
.	O

Tumor	O
site	O
:	O
Pylorus	O
.	O

Tumor	O
size	O
:	O
5	B
.	I
5	I
X	I
0	I
X	I
6	I
cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Tumor	O
extent	O
:	O
Subserosa	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
15	O
positive	O
for	O
.	O
metastasis	O
(	O
Greater	O
and	O
lesser	O
omentum	O
.	O
0	O
/	O
15	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
.	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
.	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

CLINICAL	O
HISTORY	O
.	O
experienced	O
epileptic	O
uncal	O
fits	O
(	O
foul	O
chemical	O
taste	O
.	O
and	O
anxiety	O
)	O
.	O
,	O
and	O
has	O
enhancing	O
tumor	O
in	O
right	O
temporal	O
lobe	O
extending	O
to	O
the	O
.	O
uncus	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Not	O
Given	O
.	O

Operation	O
/	O
Specimen	O
A	O
:	O
Brain	O
,	O
resection	O
.	O

B	O
:	O
Brain	O
,	O
right	O
temporal	O
,	O
resection	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
A	O
.	O

Brain	O
,	O
site	O
not	O
specified	O
,	O
excisional	O
biopsy	O
:	O
Glioblastoma	O
.	O

MIB	O
-	O
1	O
.	O
proliferation	O
index	O
:	O
22	O
%	O
.	O

B	O
.	O

Brain	O
,	O
right	O
temporal	O
,	O
resection	O
Anaplastic	O
astrocytoma	O
MIB	O
-	O
1	O
.	O
proliferation	O
index	O
:	O
5	O
%	O
.	O

See	O
comment	O
.	O

COMMENT	O
.	O

Part	O
A	O
is	O
portions	O
of	O
cerebral	O
cortex	O
infiltrated	O
by	O
a	O
glial	O
neoplastic	O
.	O
proliferation	O
with	O
frequent	O
getalstocytes	O
,	O
easily	O
found	O
mitot	O
	O
c	O
figures	O
;	O
is	O
.	O

MIB	O
-	O
1	O
proliferation	O
index	O
of	O
22	O
%	O
,	O
and	O
focal	O
microvascular	O
cellular	O
.	O
proliferation	O
with	O
focal	O
vascular	O
karyorrhexis	O
,	O
i	O
.	O
e	O
.	O
a	O
glioblastoma	O
.	O

Part	O
B	O
is	O
portions	O
of	O
cerebrum	O
with	O
focal	O
white	O
matter	O
areas	O
infiltrated	O
by	O
an	O
.	O
astrocytoma	O
with	O
mitotic	O
figures	O
,	O
but	O
absent	O
microvascular	O
proliferation	O
or	O
.	O
necrosis	O
,	O
i	O
.	O
e	O
.	O
an	O
anaplastic	O
astrocytoma	O
.	O

PROCEDURES	O
/	O
ADDENDA	O
.	O

MGMT	O
Promoter	O
Methvlation	O
.	O

Interpretation	O
.	O

NEGATIVE	O
-	O
No	O
evidence	O
of	O
methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

esults	O
-	O
Comments	O
.	O

Submitted	O
,	O
block	O
A1	O
.	O

TEST	O
DESCRIPTION	O
:	O
Bisulfite	O
treatment	O
of	O
DNA	O
followed	O
by	O
PCR	O
amplification	O
of	O
.	O
both	O
methylated	O
and	O
unmethylated	O
MGMT	O
promoter	O
sequences	O
,	O
with	O
products	O
.	O
detected	O
by	O
gel	O
electrophoresis	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
idata	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
.	O
stand	O
-	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
.	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
.	O
specific	O
uses	O
by	O
the	O
J	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

Brain	O
,	O
touch	O
prep	O
and	O
smears	O
:	O
Glioma	O
,	O
high	O
grade	O
.	O

Part	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
,	O
three	O
fragments	O
,	O
0	O
.	O
7	O
cm	O
.	O
in	O
aggregate	O
.	O

Semi	O
firm	O
,	O
tan	O
.	O

In	O
.	O
total	O
,	O
Al	O
and	O
A2	O
.	O

B	O
.	O

SPECIMEN	O
:	O
Right	O
temporal	O
brain	O
tumor	O
.	O

FIXATIVE	O
:	O
None	O
.	O

GENERAL	O
:	O
Two	O
,	O
1	B
.	I
4	I
x	I
0	I
.	I
6	I
X	I
0	I
.	I
5	I
cm	I
.	O
and	O
4	B
.	I
0	I
x	I
2	I
.	I
5	I
x	I
1	I
.	I
7	I
cm	I
.	O
,	O
fragments	O
of	O
red	O
.	O
to	O
gray	O
-	O
tan	O
brain	O
tissue	O
,	O
having	O
a	O
combined	O
weight	O
of	O
7	O
.	O
26	O
gm	O
.	O

SECTIONS	O
:	O
B1	O
-	O
small	O
fragment	O
,	O
entirely	O
submitted	O
,	O
B2	O
-	O
B7	O
-	O
larger	O
fragment	O
,	O
.	O
serially	O
section	O
	O
d	O
and	O
entirely	O
submitted	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

IMMUNOHISTOCHEMISTRY	O
The	O
GFAP	O
demonstrates	O
prominent	O
glial	O
fibrillogenesis	O
.	O
by	O
the	O
neoplastic	O
cells	O
.	O

In	O
part	O
A	O
,	O
about	O
10	O
%	O
of	O
the	O
cells	O
over	O
express	O
the	O
.	O

p53	O
protein	O
,	O
a	O
phenomenon	O
absent	O
in	O
part	O
B	O
.	O

The	O
CD34	O
depicts	O
microvascular	O
.	O
cellular	O
proliferation	O
in	O
specimen	O
A	O
.	O

With	O
the	O
MIB	O
-	O
1	O
there	O
are	O
proliferation	O
.	O
indices	O
of	O
22	O
%	O
and	O
58	O
in	O
specimens	O
A	O
and	O
B	O
,	O
respectively	O
.	O

These	O
immuno	O
profiles	O
support	O
the	O
diagnosis	O
of	O
high	O
histological	O
grade	O
.	O
astrocytoma	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
191	O
2	O
191	O
2	O
.	O

Histo	O
Data	O
.	O

Part	O
A	O
;	O
Brain	O
.	O
resection	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

CD34	O
-	O
DA	O
X	O
1	O
.	O

1	O
.	O

EGFR	O
x	O
1	O
.	O

1	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

MIB1	O
-	O
DA	O
X	O
1	O
.	O

1	O
.	O

P53D07	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

3	O
.	O

Part	O
B	O
:	O
Brain	O
right	O
temporal	O
,	O
resection	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

3	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

4	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

5	O
.	O

H	O
/	O
E	O
X	O
1	O
.	O

6	O
.	O

MIB1	O
-	O
DA	O
X	O
1	O
.	O

6	O
.	O

P53D07	O
X	O
1	O
.	O

6	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

I	O
.	O

Sex	O
:	O
Female	O
.	O

MRN	O
#	O
:	O
Ref	O
Phy	O
.	O

SPECIMEN	O
INFORMATION	O
.	O

Acct	O
/	O
Reg	O
#	O
.	O

DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Omentum	O
,	O
biopsy	O
:	O
Tumor	O
not	O
identified	O
.	O

B	O
.	O

Left	O
paraaortic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Two	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

Frozen	O
section	O
diagnosis	O
confirmed	O
.	O

C	O
.	O

Left	O
paraaortic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Three	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

D	O
.	O

Right	O
paraaortic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Three	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

E	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Ten	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

F	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
,	O
excision	O
:	O
Eight	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

G	O
.	O

Uterus	O
,	O
bilateral	O
adnexa	O
,	O
hysterectomy	O
with	O
bilateral	O
salpingoophorectomy	O
:	O
Cervix	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Endometrioid	O
adenocarcinoma	O
.	O

2	O
.	O

Histologic	O
grade	O
:	O
3	O
.	O

3	O
.	O

Tumor	O
site	O
:	O
Endometrium	O
.	O

4	O
.	O

Tumor	O
size	O
:	O
5	B
.	I
0	I
x	I
2	I
.	I
7	I
cm	I
.	O

5	O
.	O

Myometrial	O
invasion	O
:	O
Tumor	O
extends	O
0	O
.	O
7	O
cm	O
into	O
a	O
2	O
.	O
8	O
cm	O
thick	O
myometrium	O
.	O

6	O
.	O

Involvement	O
of	O
cervix	O
Not	O
seen	O
.	O

7	O
.	O

Extent	O
of	O
involvement	O
of	O
other	O
organs	O
:	O
Not	O
identified	O
.	O

8	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Focally	O
present	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

Margins	O
uninvolved	O
:	O
Cervix	O
,	O
serosa	O
,	O
parametria	O
.	O

2	O
.	O

Margins	O
involved	O
:	O
None	O
.	O

Lymph	O
Node	O
Status	O
:	O
Number	O
of	O
lymph	O
nodes	O
received	O
:	O
See	O
above	O
.	O

Other	O
:	O
1	O
.	O

Other	O
significant	O
findings	O
:	O
a	O
.	O

Myometrium	O
leiomyomata	O
.	O

b	O
.	O

Attached	O
ovary	O
with	O
focus	O
of	O
stromal	O
hyperthecosis	O
.	O

c	O
.	O

Separate	O
ovary	O
and	O
bilateral	O
fallopian	O
tubes	O
without	O
evidence	O
of	O
malignancy	O
.	O

2	O
.	O

PTNM	O
stage	O
:	O
pT1aNO	O
(	O
FIGO	O
IA	O
)	O
.	O

COMMENTS	O
:	O
Appropriately	O
controlled	O
immunochemical	O
stains	O
performed	O
on	O
blocks	O
G3	O
show	O
the	O
following	O
results	O
:	O
P53	O
-	O
Focally	O
positive	O
in	O
lesional	O
cells	O
.	O

WT	O
-	O
1	O
-	O
Negative	O
in	O
lesional	O
cells	O
.	O

Cytokeratin	O
7	O
-	O
Positive	O
in	O
lesional	O
cells	O
.	O

Cytokeratin	O
20	O
-	O
Negative	O
in	O
lesional	O
cells	O
.	O

CDX2	O
-	O
Negative	O
in	O
lesional	O
cells	O
.	O

Inhibin	O
-	O
Negative	O
in	O
lesional	O
cells	O
.	O

Additional	O
controlled	O
immunostains	O
were	O
performed	O
on	O
block	O
G16	O
with	O
the	O
following	O
results	O
:	O
Cytokeratin	O
7	O
-	O
Negative	O
in	O
cellular	O
proliferation	O
.	O

Cytokeratin	O
20	O
-	O
Negative	O
in	O
cellular	O
proliferation	O
.	O

CDX2	O
-	O
Negative	O
in	O
cellular	O
proliferation	O
.	O

P53	O
-	O
Negative	O
in	O
cellular	O
proliferation	O
.	O

WT	O
-	O
1	O
.	O

Negative	O
in	O
cellular	O
proliferation	O
.	O

Inhibin	O
-	O
Positive	O
in	O
cellular	O
proliferation	O
.	O

Findings	O
consistent	O
with	O
stromal	O
hyperthecosis	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Omentum	O
biopsy	O
.	O

B	O
.	O

Left	O
paraaortic	O
lymph	O
nodes	O
.	O

C	O
.	O

Left	O
paraaortic	O
lymph	O
nodes	O
.	O

D	O
.	O

Right	O
paraaortic	O
lymph	O
nodes	O
.	O

E	O
.	O

Left	O
pelvic	O
lymph	O
nodes	O
.	O

F	O
.	O

Right	O
pelvic	O
lymph	O
nodes	O
.	O

G	O
.	O

Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

The	O
first	O
container	O
A	O
is	O
labeled	O
.	O
omentum	O
biopsy	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
piece	O
of	O
yellow	O
tan	O
fibroadipose	O
tissue	O
measuring	O
1	O
.	O
5	O
.	O

x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
.	O

There	O
are	O
no	O
nodules	O
grossly	O
identified	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

B	O
.	O

The	O
second	O
container	O
B	O
is	O
labeled	O
.	O
left	O
paraaortic	O
lymph	O
nodes	O
#	O
2	O
.	O

The	O
specimen	O
consists	O
of	O
two	O
probable	O
lymph	O
nodes	O
measuring	O
.	O

1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
and	O
1	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
smaller	O
piece	O
has	O
been	O
inked	O
.	O

Each	O
of	O
the	O
lymph	O
nodes	O
have	O
been	O
bisected	O
.	O

The	O
lymph	O
nodes	O
are	O
.	O
entirely	O
submitted	O
in	O
cassette	O
.	O

C	O
.	O

The	O
third	O
container	O
C	O
is	O
labeled	O
.	O
left	O
parasortic	O
lymph	O
node	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
.	O

6	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

Sectioning	O
reveals	O
three	O
probable	O
lymph	O
nodes	O
measuring	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
8	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
.	O
as	O
follows	O
:	O
one	O
probable	O
node	O
bisected	O
-	O
1	O
;	O
one	O
probable	O
node	O
bisected	O
-	O
2	O
;	O
one	O
probable	O
node	O
-	O
3	O
.	O

D	O
.	O

The	O
fourth	O
container	O
D	O
is	O
labeled	O
.	O
right	O
parasortic	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
flibroadipose	O
tissue	O
measuring	O
5	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
.	O

1	O
.	O
5	O
cm	O
.	O

Sectioning	O
reveais	O
three	O
probable	O
lymph	O
nodes	O
measuring	O
from	O
0	O
.	O
7	O
to	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
fymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
.	O
cassettes	O
.	O

3	O
follows	O
:	O
two	O
probable	O
nodes	O
-	O
1	O
;	O
one	O
probable	O
node	O
sectioned	O
-	O
2	O
to	O
5	O
.	O

E	O
.	O

The	O
fifth	O
container	O
E	O
is	O
labeled	O
.	O
left	O
pelvic	O
lymph	O
nodes	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
11	O
.	O
0	O
x	O
.	O

7	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

Sectioning	O
reveais	O
eleven	O
probable	O
lymph	O
nodes	O
measuring	O
from	O
0	O
.	O
7	O
up	O
to	O
2	O
.	O
5	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
.	O
as	O
follows	O
:	O
one	O
probable	O
node	O
bisected	O
-	O
1	O
two	O
probable	O
nodes	O
-	O
2	O
;	O
one	O
probable	O
node	O
bisected	O
-	O
3	O
and	O
4	O
;	O
one	O
probable	O
lymph	O
node	O
.	O

orsecteu	O
-	O
3	O
anu	O
u	O
,	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
7	O
and	O
8	O
;	O
one	O
probable	O
tymph	O
node	O
bisected	O
-	O
9	O
;	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
10	O
;	O
one	O
.	O
probable	O
lymph	O
node	O
bisected	O
-	O
11	O
and	O
12	O
;	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
13	O
and	O
14	O
.	O

F	O
.	O

The	O
sixth	O
container	O
F	O
is	O
labeled	O
.	O
right	O
pelvic	O
lymph	O
nodes	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
10	O
.	O
0	O
.	O

x	O
7	O
.	O
5	O
x	O
4	O
.	O
0	O
cm	O
.	O

Sectioning	O
reveals	O
seven	O
prooable	O
nodes	O
measuring	O
from	O
0	O
.	O
9	O
up	O
to	O
4	O
.	O
2	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
,	O
with	O
the	O
.	O
exception	O
of	O
the	O
largest	O
lymph	O
node	O
,	O
in	O
cassettes	O
.	O
as	O
follows	O
:	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
1	O
;	O
one	O
probable	O
lymph	O
node	O
.	O

bisected	O
-	O
2	O
;	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
3	O
;	O
two	O
symph	O
nodes	O
-	O
4	O
;	O
one	O
probable	O
lymph	O
node	O
-	O
5	O
;	O
one	O
probable	O
lymph	O
node	O
sectioned	O
-	O
6	O
to	O
.	O

9	O
;	O
representative	O
sections	O
from	O
the	O
largest	O
lymph	O
node	O
-	O
10	O
to	O
13	O
.	O

G	O
.	O

The	O
seventh	O
container	O
G	O
is	O
labeled	O
.	O
uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
previously	O
bisected	O
.	O
uterus	O
with	O
attached	O
cervix	O
,	O
attached	O
left	O
adnexa	O
and	O
separately	O
submitted	O
right	O
adnexa	O
.	O

The	O
serosal	O
surface	O
of	O
the	O
uterus	O
is	O
gray	O
to	O
brown	O
tan	O
with	O
.	O
slight	O
hemorrhage	O
and	O
adhesions	O
.	O

The	O
serosa	O
has	O
been	O
inked	O
.	O

Sections	O
from	O
the	O
parametrium	O
have	O
been	O
taken	O
.	O

The	O
cervix	O
measures	O
4	O
.	O
5	O
cm	O
in	O
length	O
.	O
and	O
3	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
ectocervix	O
is	O
gray	O
to	O
brown	O
tan	O
with	O
hemorrhage	O
.	O

The	O
endocervical	O
canal	O
is	O
light	O
tan	O
and	O
reveais	O
normal	O
mucosal	O
folds	O
.	O

There	O
are	O
no	O
masses	O
identified	O
.	O

The	O
endometrial	O
cavity	O
measures	O
6	O
.	O
0	O
cm	O
in	O
length	O
and	O
4	O
.	O
0	O
cm	O
in	O
diameter	O
.	O

The	O
lining	O
is	O
gray	O
to	O
brown	O
tan	O
and	O
.	O
hemorrhagic	O
revealing	O
a	O
brown	O
tan	O
shaggy	O
polypoid	O
mass	O
measuring	O
5	O
.	O
0	O
x	O
2	O
.	O
7	O
cm	O
that	O
is	O
within	O
2	O
.	O
1	O
cm	O
of	O
the	O
lower	O
uterine	O
segment	O
.	O

On	O
sectioning	O
the	O
.	O
mass	O
extends	O
into	O
the	O
underlying	O
myometrium	O
approximately	O
0	O
.	O
7	O
cm	O
into	O
a	O
2	O
.	O
8	O
cm	O
myometrium	O
.	O

The	O
myometrium	O
is	O
gray	O
tan	O
trabecular	O
.	O

There	O
are	O
.	O
white	O
tan	O
whorled	O
intramural	O
masses	O
identified	O
measuring	O
up	O
to	O
0	O
.	O
9	O
cm	O
.	O

On	O
sectioning	O
there	O
is	O
no	O
evidence	O
of	O
hemormhage	O
or	O
necrosis	O
.	O

The	O
attached	O
.	O
ovary	O
measures	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
surface	O
is	O
gray	O
tan	O
cribriform	O
.	O

On	O
sectioning	O
the	O
cut	O
surface	O
is	O
yellow	O
to	O
gray	O
tan	O
displaying	O
corpus	O
albicans	O
.	O
measuring	O
up	O
to	O
0	O
.	O
5	O
cm	O
.	O

The	O
corresponding	O
fallopian	O
tube	O
measures	O
3	O
.	O
0	O
cm	O
in	O
length	O
and	O
0	O
.	O
3	O
cm	O
in	O
diameter	O
.	O

The	O
surface	O
is	O
gray	O
to	O
brown	O
tan	O
.	O

On	O
.	O
sectioning	O
the	O
fallopian	O
tube	O
appears	O
grossly	O
unmarkable	O
.	O

The	O
separately	O
submitted	O
ovary	O
measures	O
4	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
surface	O
is	O
gray	O
tan	O
.	O
cribriform	O
.	O

On	O
sectioning	O
the	O
cut	O
surface	O
is	O
yellow	O
to	O
gray	O
tan	O
.	O

There	O
are	O
corpus	O
albicans	O
measuring	O
up	O
to	O
0	O
.	O
5	O
cm	O
identified	O
.	O

The	O
corresponding	O
.	O
fallopian	O
tube	O
measures	O
8	O
.	O
0	O
cm	O
in	O
length	O
and	O
1	O
.	O
0	O
cm	O
in	O
diameter	O
.	O

The	O
surface	O
is	O
gray	O
to	O
brown	O
tan	O
.	O

On	O
sectioning	O
the	O
lumen	O
is	O
dilated	O
measuring	O
up	O
to	O
.	O

0	O
.	O
7	O
cm	O
containina	O
serosanquineous	O
fluid	O
.	O

No	O
other	O
lesions	O
are	O
identified	O
.	O

Received	O
with	O
the	O
specimen	O
are	O
three	O
cassettes	O
,	O
one	O
green	O
,	O
one	O
blue	O
,	O
one	O
.	O
yellow	O
,	O
labeled	O
.	O

The	O
.	O
yellow	O
one	O
is	O
adrlitional	O
heled	O
16	O
.	O
green	O
one	O
additionally	O
labeled	O
17	O
,	O
and	O
the	O
blue	O
one	O
additionally	O
labeled	O
18	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
.	O
as	O
follows	O
:	O
anterior	O
cervix	O
-	O
1	O
;	O
posterior	O
cervix	O
-	O
2	O
;	O
full	O
thickness	O
sections	O
from	O
the	O
.	O
mass	O
bisected	O
as	O
follows	O
:	O
one	O
cross	O
section	O
-	O
3	O
and	O
4	O
;	O
one	O
cross	O
secuon	O
-	O
5	O
and	O
6	O
;	O
one	O
cross	O
section	O
-	O
7	O
and	O
8	O
;	O
one	O
cross	O
section	O
-	O
9	O
and	O
10	O
;	O
polypoid	O
attached	O
.	O
portion	O
of	O
the	O
mass	O
-	O
11	O
;	O
lower	O
uterine	O
segment	O
-	O
12	O
;	O
left	O
parametrium	O
-	O
13	O
;	O
right	O
parametrium	O
-	O
14	O
;	O
sections	O
from	O
the	O
myometrial	O
masses	O
-	O
15	O
;	O
.	O

ovary	O
-	O
16	O
;	O
corresponding	O
tube	O
-	O
17	O
;	O
separately	O
submitted	O
ovary	O
-	O
18	O
corresponding	O
tube	O
-	O
19	O
.	O

SPECIMENS	O
:	O
1	O
.	O

LEVEL	O
9	O
LYMPH	O
NODES	O
.	O

2	O
.	O

LUNG	O
,	O
RIGHT	O
UPPER	O
LOBE	O
.	O

3	O
.	O

LEVEL	O
7	O
LYMPH	O
NODES	O
.	O

4	O
.	O

LEVEL	O
4	O
LYMPH	O
NODES	O
.	O

5	O
.	O

ADDITIONAL	O
RIGHT	O
UPPER	O
LOBE	O
MARGIN	O
.	O

6	O
.	O

RIB	O
.	O

SEE	O
ADDENDUM	O
.	O

Reason	O
For	O
Addendum	O
#	O
1	O
:	O
Molecular	O
Studies	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
9	O
:	O
BIOPSY	O
.	O

-	O
FRAGMENTS	O
OF	O
BENIGN	O
ANTHRACOTIC	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
.	O

CARCINOMA	O
.	O

2	O
.	O

LUNG	O
,	O
RIGHT	O
,	O
UPPER	O
LOBE	O
:	O
RESECTION	O
.	O

-	O
ADENOCARCINOMA	O
(	O
1	B
.	I
5	I
CM	I
)	O
,	O
PREDOMINANTLY	O
BRONCHIOLOALVEOLAR	O
.	O

(	O
LEPIDIC	O
)	O
,	O
WITH	O
A	O
0	O
.	O
9	O
CM	O
FOCUS	O
OF	O
INVASIVE	O
ADENOCARCINOMA	O
OF	O
ACINAR	O
.	O

AND	O
MICROPAPILLARY	O
PATTERNS	O
.	O

BRONCHOVASCULAR	O
MARGIN	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

-	O
FIBRONECROTIZING	O
GRANULOMAS	O
,	O
SPECIAL	O
STAINS	O
NEGATIVE	O
FOR	O
FUNGI	O
.	O

AND	O
.	O

ACID	O
FAST	O
ORGANISMS	O
(	O
SEE	O
COMMENT	O
)	O
.	O

-	O
PLEURAL	O
FIBROSIS	O
.	O

-	O
BENIGN	O
ANTHRACOTIC	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

3	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
7	O
:	O
BIOPSY	O
.	O

-	O
FRAGMENTS	O
OF	O
BENIGN	O
ANTHRACOTIC	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
.	O

CARCINOMA	O
.	O

4	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
4	O
:	O
EXCISION	O
.	O

-	O
BENIGN	O
ANTHRACOTIC	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

5	O
.	O

LUNG	O
,	O
RIGHT	O
,	O
UPPER	O
LOBE	O
,	O
ADDITIONAL	O
MARGIN	O
:	O
RESECTION	O
.	O

-	O
NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

-	O
CARCINOID	O
TUMORLET	O
IN	O
THREE	O
FOCI	O
(	O
SPANNING	O
3	O
MM	O
,	O
3	O
MM	O
AND	O
2	O
.	O
MM	O
)	O
.	O

6	O
.	O

RIB	O
:	O
RESECTION	O
.	O

SEGMENT	O
OF	O
RIB	O
WITH	O
NO	O
DIAGNOSTIC	O
ABNORMALITY	O
,	O
NEGATIVE	O
FOR	O
.	O

CARCINOMA	O
.	O

Specimens	O
:	O
1	O
:	O
LEVEL	O
9	O
LYMPH	O
NODES	O
.	O

2	O
:	O
LUNG	O
,	O
RIGHT	O
UPPER	O
LOBE	O
.	O

3	O
:	O
LEVEL	O
7	O
LYMPH	O
NODES	O
.	O

4	O
:	O
LEVEL	O
4	O
LYMPH	O
NODES	O
.	O

5	O
:	O
ADDITIONAL	O
RIGHT	O
UPPER	O
LOBE	O
MARGIN	O
.	O

6	O
:	O
RIB	O
.	O

LUNG	O
:	O
Resection	O
.	O

SPECIMEN	O
.	O

Procedure	O
:	O
Lobectomy	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Laterality	O
:	O
Right	O
.	O

Tumor	O
Site	O
:	O
Upper	O
lobe	O
.	O

Tumor	O
Focality	O
:	O
Unifocal	O
.	O

TUMOR	O
.	O

Histologic	O
Type	O
:	O
Adenocarcinoma	O
.	O

EXTENT	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
(	O
cm	O
)	O
.	O

1	B
.	I
5cm	I
.	O

Additional	O
Dimension	O
(	O
cm	O
)	O
:	O
1	B
.	I
5cm	I
X	I
1cm	I
.	O

Visceral	O
Pleura	O
Invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
Extension	O
:	O
Not	O
identified	O
.	O

MARGINS	O
.	O

Bronchial	O
Margin	O
.	O

Bronchial	O
Margin	O
Involvement	O
by	O
Invasive	O
Carcinoma	O
:	O
Uninvolved	O
by	O
.	O
invasive	O
carcinoma	O
.	O

Vascular	O
Margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Parenchymal	O
Margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

ACCESSORY	O
FINDINGS	O
.	O

Treatment	O
Effect	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

SPECIAL	O
STUDIES	O
.	O

Epidermal	O
Growth	O
Factor	O
Receptor	O
(	O
EGFR	O
)	O
Analysis	O
Results	O
(	O
specify	O
.	O
method	O
)	O
:	O
To	O
follow	O
.	O

KRAS	O
Mutational	O
Analysis	O
(	O
specify	O
results	O
)	O
:	O
Positive	O
for	O
a	O
p	O
.	O
G12C	O
(	O
c	O
.	O
34G	O
>	O
T	O
)	O
mutation	O
in	O
codon	O
12	O
of	O
the	O
KRAS	O
.	O
gene	O
(	O
see	O
below	O
)	O
.	O

STAGE	O
(	O
pTNM	O
)	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT1a	O
:	O
Tumor	O
2	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
surrounded	O
by	O
lung	O
.	O
or	O
visceral	O
pleura	O
,	O
without	O
bronchoscopic	O
evidence	O
of	O
invasion	O
more	O
.	O
proximal	O
than	O
the	O
lobar	O
bronchus	O
(	O
i	O
.	O
e	O
.	O
,	O
not	O
in	O
the	O
main	O
bronchus	O
)	O
;	O
.	O
or	O
Superficial	O
spreading	O
tumor	O
of	O
any	O
size	O
with	O
its	O
invasive	O
.	O
component	O
limited	O
to	O
the	O
bronchial	O
wall	O
,	O
which	O
may	O
extend	O
proximally	O
.	O
to	O
the	O
main	O
bronchus	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
.	O

pN0	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Distant	O
Metastases	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

ADDITIONAL	O
NON	O
-	O
TUMOR	O
.	O

Additional	O
Pathologic	O
Finding	O
(	O
s	O
)	O
:	O
Inflammation	O
(	O
specify	O
type	O
)	O
.	O

Necrotizing	O
granuloma	O
.	O
interstitial	O
fibrosis	O
.	O

Comment	O
(	O
s	O
)	O
:	O
The	O
adenocarcinoma	O
is	O
positive	O
for	O
TTF	O
-	O
1	O
.	O

The	O
carcinoid	O
tumorlets	O
.	O
stain	O
positively	O
with	O
.	O

Correlation	O
with	O
microbiology	O
.	O
results	O
suggested	O
.	O

Case	O
reviewed	O
in	O
department	O
consensus	O
.	O
conference	O
.	O

CLINICAL	O
HISTORY	O
AND	O
PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Lung	O
cancer	O
.	O

MACROSCOPIC	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
six	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
.	O

patient	O
'	O
s	O
name	O
.	O

1	O
.	O

Part	O
one	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
9	O
lymph	O
node	O
'	O
.	O

It	O
.	O
consists	O
of	O
two	O
irregular	O
fragments	O
of	O
tan	O
soft	O
tissue	O
measuring	O
0	O
.	O
8	O
.	O

X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
and	O
0	O
.	O
6	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
cm	O
.	O

Entirely	O
submitted	O
in	O
one	O
.	O
cassette	O
.	O

2	O
.	O

Part	O
two	O
is	O
received	O
fresh	O
,	O
labeled	O
'	O
right	O
upper	O
lobectomy	O
'	O
.	O

It	O
.	O
consists	O
of	O
a	O
portion	O
of	O
right	O
upper	O
lobe	O
of	O
lung	O
,	O
measuring	O
15	O
.	O
6	O
X	O
.	O

3	O
.	O
8	O
cm	O
.	O

The	O
staple	O
line	O
measures	O
15	O
.	O
5	O
cm	O
.	O

The	O
staple	O
line	O
is	O
shaved	O
.	O
and	O
the	O
pleura	O
around	O
the	O
staple	O
line	O
is	O
inked	O
in	O
green	O
.	O

The	O
pleural	O
.	O
surface	O
is	O
pink	O
tan	O
glistening	O
and	O
reveals	O
a	O
thickened	O
,	O
bossellated	O
.	O
area	O
with	O
fibrous	O
thickening	O
.	O

The	O
bronchial	O
margin	O
measures	O
1	O
.	O
5	O
cm	O
.	O
and	O
the	O
vascular	O
margin	O
1	O
.	O
2	O
cm	O
.	O

Beneath	O
the	O
thickened	O
pleura	O
there	O
.	O

is	O
a	O
firm	O
gray	O
area	O
,	O
measuring	O
1	O
.	O
5	O
X	O
1	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
,	O
located	O
4	O
.	O
5	O
cm	O
.	O
from	O
the	O
staple	O
line	O
margin	O
.	O

Also	O
noted	O
a	O
second	O
separate	O
firm	O
gray	O
.	O
white	O
area	O
,	O
measuring	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
which	O
upon	O
.	O
pressure	O
exudes	O
cheesy	O
material	O
.	O

This	O
mass	O
is	O
located	O
1	O
cm	O
from	O
the	O
.	O
staple	O
line	O
margin	O
,	O
also	O
multiple	O
anthracotic	O
lymph	O
nodes	O
,	O
ranging	O
.	O
from	O
0	O
.	O
2	O
cm	O
to	O
0	O
.	O
5	O
cm	O
identified	O
from	O
the	O
hilar	O
area	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

3	O
.	O

Part	O
three	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
7	O
lymph	O
node	O
'	O
.	O

It	O
consists	O
of	O
three	O
irregular	O
fragments	O
of	O
tan	O
soft	O
tissue	O
.	O
measuring	O
1	O
.	O
5	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
3	O
cm	O
,	O
1	O
.	O
5	O
x	O
1	O
X	O
0	O
.	O
2	O
cm	O
and	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
.	O

cm	O
.	O

Entirely	O
submitted	O
in	O
two	O
cassettes	O
.	O

4	O
.	O

Part	O
four	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
4	O
lymph	O
node	O
'	O
.	O

It	O
consists	O
of	O
a	O
0	O
.	O
7	O
X	O
0	O
.	O
4	O
x	O
0	O
.	O
1	O
cm	O
irregular	O
portion	O
of	O
tan	O
soft	O
.	O
tissue	O
.	O

Entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

5	O
.	O

Part	O
five	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
additional	O
right	O
upper	O
.	O
lobe	O
margin	O
'	O
.	O

It	O
consists	O
of	O
a	O
6	O
.	O
5	O
X	O
4	O
.	O
5	O
X	O
2	O
.	O
5	O
cm	O
triangular	O
-	O
shaped	O
.	O
wedge	O
of	O
lung	O
tissue	O
,	O
with	O
a	O
6	O
.	O
5	O
cm	O
long	O
stapled	O
line	O
along	O
one	O
.	O
edge	O
,	O
and	O
two	O
stapled	O
lines	O
along	O
an	O
adjacent	O
edge	O
measuring	O
3	O
cm	O
.	O
and	O
4	O
cm	O
respectively	O
.	O

The	O
specimen	O
is	O
photographed	O
.	O

The	O
6	O
.	O
5	O
cm	O
.	O
long	O
stapled	O
edge	O
is	O
inked	O
black	O
;	O
the	O
3	O
cm	O
long	O
stapled	O
edge	O
.	O

(	O
adjacent	O
to	O
the	O
6	O
.	O
5cm	O
long	O
one	O
)	O
is	O
inked	O
blue	O
;	O
and	O
the	O
4	O
cm	O
long	O
.	O
stapled	O
edge	O
is	O
inked	O
green	O
.	O

The	O
black	O
and	O
blue	O
inked	O
stapled	O
lines	O
.	O
are	O
at	O
acute	O
angles	O
.	O

The	O
staples	O
are	O
trimmed	O
off	O
and	O
the	O
specimen	O
.	O

is	O
serially	O
sectioned	O
,	O
revealing	O
no	O
focal	O
lesions	O
or	O
masses	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

6	O
.	O

Part	O
six	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
'	O
rib	O
'	O
.	O

It	O
consists	O
of	O
.	O

a	O
1	O
.	O
4	O
X	O
1	O
.	O
4	O
X	O
0	O
.	O
6	O
cm	O
segment	O
of	O
rib	O
with	O
red	O
marrow	O
.	O

Entire	O
.	O
specimen	O
is	O
submitted	O
in	O
one	O
cassette	O
,	O
after	O
decalcification	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1A	O
entirely	O
submitted	O
.	O

2A	O
vascular	O
margin	O
.	O

2B	O
bronchial	O
margin	O
.	O

2C	O
-	O
2J	O
firm	O
area	O
.	O

2K	O
staple	O
line	O
margin	O
.	O

2L	O
-	O
2M	O
second	O
mass	O
close	O
to	O
the	O
staple	O
line	O
margin	O
.	O

2N	O
anthracotic	O
lymph	O
nodes	O
.	O

3A	O
-	O
3B	O
entirely	O
submitted	O
.	O

4A	O
entirely	O
submitted	O
.	O

5A	O
-	O
5E	O
representative	O
sections	O
.	O

6A	O
rib	O
,	O
after	O
decalcification	O
.	O

SPECIAL	O
PROCEDURES	O
:	O
Decalcification	O
,	O
AFB	O
,	O
GMS	O
,	O
Chromogranin	O
,	O
TTF1	O
.	O

RESULTS	O
:	O
Positive	O
for	O
a	O
p	O
.	O
G12C	O
(	O
c	O
.	O
34G	O
>	O
T	O
)	O
mutation	O
in	O
codon	O
12	O
of	O
.	O
the	O
KRAS	O
gene	O
.	O

INTERPRETATION	O
:	O
Mutations	O
in	O
the	O
KRAS	O
gene	O
are	O
reported	O
to	O
.	O
correlate	O
with	O
poor	O
prognosis	O
and	O
resistance	O
to	O
tyrosine	O
kinase	O
.	O
inhibitor	O
therapies	O
in	O
patients	O
with	O
non	O
-	O
small	O
lung	O
cancer	O
.	O

COMMENT	O
:	O
KRAS	O
mutations	O
occur	O
in	O
15	O
-	O
30	O
%	O
of	O
non	O
-	O
small	O
-	O
cell	O
lung	O
cancer	O
(	O
NSCLC	O
)	O
.	O
patients	O
and	O
are	O
strongly	O
associated	O
with	O
adenocarcinoma	O
and	O
smoking	O
.	O
history	O
.	O

This	O
assay	O
analyzes	O
codons	O
12	O
and	O
13	O
in	O
exon	O
2	O
of	O
the	O
KRAS	O
gene	O
;	O
.	O
based	O
on	O
the	O
current	O
literature	O
,	O
approximately	O
98	O
%	O
of	O
mutations	O
are	O
.	O
expected	O
to	O
occur	O
in	O
these	O
codons	O
.	O

The	O
analytical	O
sensitivity	O
of	O
.	O
the	O
assay	O
is	O
approximately	O
10	O
%	O
;	O
thus	O
mutations	O
present	O
in	O
a	O
low	O
.	O
percentage	O
of	O
cells	O
may	O
not	O
be	O
detected	O
.	O

This	O
test	O
is	O
validated	O
for	O
use	O
in	O
identifying	O
KRAS	O
codon	O
12	O
and	O
.	O
codon	O
13	O
mutations	O
in	O
fresh	O
,	O
frozen	O
,	O
or	O
formalin	O
-	O
fixed	O
paraffin	O
.	O
embedded	O
tissue	O
.	O

In	O
particular	O
the	O
test	O
performance	O
has	O
been	O
.	O
established	O
in	O
samples	O
of	O
colorectal	O
cancer	O
and	O
non	O
-	O
small	O
cell	O
lung	O
.	O
carcinoma	O
which	O
harbor	O
these	O
mutations	O
,	O
although	O
several	O
other	O
.	O
tissues	O
are	O
also	O
known	O
to	O
harbor	O
KRAS	O
mutations	O
(	O
e	O
.	O
g	O
.	O
tumors	O
of	O
.	O
pancreas	O
,	O
bile	O
duct	O
,	O
ovary	O
,	O
appendix	O
,	O
etc	O
.	O
)	O
.	O

METHOD	O
/	O
LIMITATION	O
:	O
Tissue	O
sections	O
are	O
reviewed	O
by	O
a	O
pathologist	O
and	O
relevant	O
tumor	O
is	O
.	O
selected	O
for	O
analysis	O
.	O

DNA	O
is	O
isolated	O
from	O
the	O
sample	O
,	O
quantified	O
.	O
and	O
amplified	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
using	O
primers	O
to	O
.	O
exon	O
2	O
of	O
the	O
KRAS	O
gene	O
.	O

PCR	O
products	O
are	O
subjected	O
to	O
single	O
.	O
nucleotide	O
primer	O
extension	O
to	O
detect	O
mutations	O
at	O
codons	O
12	O
and	O
13	O
;	O
.	O
primer	O
extension	O
products	O
are	O
analyzed	O
using	O
capillary	O
gel	O
.	O
electrophoresis	O
and	O
fluorescence	O
detection	O
.	O

False	O
positive	O
or	O
.	O
negative	O
results	O
may	O
occur	O
for	O
reasons	O
that	O
include	O
genetic	O
variants	O
.	O
or	O
somatic	O
heterogeneity	O
of	O
the	O
tissue	O
sample	O
.	O

REFERENCES	O
:	O
This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

US	O
Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
test	O
is	O
used	O
for	O
.	O
clinical	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
.	O
for	O
research	O
.	O

The	O
laboratory	O
is	O
regulated	O
under	O
the	O
.	O
as	O
qualified	O
to	O
.	O
perform	O
high	O
complexity	O
clinical	O
testing	O
.	O

This	O
particular	O
test	O
is	O
.	O
not	O
considered	O
a	O
stand	O
alone	O
test	O
and	O
should	O
be	O
only	O
used	O
in	O
the	O
.	O
context	O
of	O
other	O
diagnostic	O
tests	O
or	O
clinical	O
work	O
-	O
up	O
related	O
to	O
.	O
treatment	O
decisions	O
.	O
and	O
its	O
logo	O
are	O
trademarks	O
of	O
.	O
and	O
used	O
by	O
.	O

a	O
wholly	O
-	O
owned	O
.	O
subsidiary	O
of	O
.	O
under	O
license	O
.	O
and	O
.	O

are	O
operated	O
independently	O
from	O
.	O

Final	O
Diagnosis	O
performed	O
by	O
.	O

ADDENDUM	O
#	O
1	O
:	O
EGFR	O
Mutation	O
Analysis	O
.	O

Genzyme	O
Specimen	O
#	O
.	O

Body	O
Site	O
:	O
Lung	O
.	O

Clinical	O
Data	O
:	O
Adenocarcinoma	O
.	O

RESULTS	O
:	O
No	O
mutation	O
detected	O
.	O

INTERPRETATION	O
:	O
No	O
mutations	O
were	O
identified	O
;	O
however	O
18	O
-	O
20	O
%	O
of	O
.	O
patients	O
with	O
non	O
-	O
small	O
-	O
cell	O
lung	O
cancer	O
and	O
without	O
identifiable	O
.	O
mutations	O
are	O
reported	O
to	O
be	O
responsive	O
to	O
EGFR	O
tyrosine	O
kinase	O
.	O
inhibitor	O
therapies	O
.	O

COMMENT	O
:	O
This	O
assay	O
analyzes	O
exons	O
18	O
-	O
21	O
of	O
the	O
EGFR	O
tyrosine	O
.	O
kinase	O
domain	O
;	O
based	O
on	O
the	O
current	O
literature	O
,	O
the	O
vast	O
majority	O
of	O
.	O
mutations	O
are	O
expected	O
to	O
occur	O
in	O
these	O
exons	O
.	O

The	O
analytical	O
.	O
sensitivity	O
of	O
the	O
assay	O
is	O
10	O
-	O
20	O
%	O
,	O
thus	O
mutations	O
present	O
in	O
a	O
low	O
.	O
percentage	O
of	O
cells	O
may	O
not	O
be	O
detected	O
.	O

Most	O
data	O
published	O
to	O
date	O
pertain	O
to	O
gefitinib	O
.	O

Similar	O
data	O
have	O
been	O
seen	O
in	O
studies	O
using	O
erlotinib	O
(	O
Tarceva	O
(	O
r	O
)	O
)	O
.	O

This	O
test	O
is	O
validated	O
for	O
non	O
-	O
small	O
cell	O
lung	O
carcinoma	O
.	O

The	O
.	O
clinical	O
significance	O
and	O
utility	O
of	O
this	O
test	O
in	O
other	O
tumor	O
types	O
.	O

is	O
unknown	O
.	O

METHOD	O
/	O
LIMITATION	O
:	O
Tissue	O
sections	O
are	O
reviewed	O
by	O
a	O
pathologist	O
and	O
relevant	O
tumor	O
is	O
.	O
selected	O
for	O
analysis	O
.	O

DNA	O
is	O
isolated	O
from	O
the	O
samples	O
,	O
quantified	O
.	O
and	O
amplified	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
using	O
primers	O
to	O
.	O
exons	O
18	O
-	O
21	O
of	O
the	O
EGFR	O
gene	O
.	O

PCR	O
products	O
are	O
analyzed	O
by	O
.	O

bi	O
-	O
directional	O
direct	O
DNA	O
sequencing	O
using	O
capillary	O
electrophoresis	O
.	O
and	O
fluorescence	O
detection	O
.	O

False	O
positive	O
or	O
negative	O
results	O
may	O
.	O
occur	O
for	O
reasons	O
that	O
include	O
genetic	O
variants	O
or	O
somatic	O
.	O
heterogeneity	O
of	O
the	O
tissue	O
sample	O
.	O

REFERENCES	O
:	O
DISCLAIMER	O
:	O
This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O

The	O
laboratory	O
is	O
regulated	O
under	O
.	O
the	O
.	O

as	O
.	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
testing	O
.	O

This	O
.	O
particular	O
test	O
is	O
not	O
considered	O
a	O
stand	O
alone	O
test	O
and	O
should	O
be	O
.	O
used	O
only	O
in	O
the	O
context	O
of	O
other	O
diagnostic	O
tests	O
or	O
clinical	O
.	O
work	O
-	O
up	O
related	O
to	O
treatment	O
decisions	O
.	O
and	O
its	O
logo	O
are	O
trademarks	O
of	O
.	O
and	O
used	O
by	O
.	O

a	O
wholly	O
-	O
owned	O
.	O
subsidiary	O
of	O
.	O
under	O
license	O
.	O
and	O
.	O

are	O
operated	O
independently	O
from	O
.	O

Addendum	O
performed	O
by	O
.	O

The	O
electronic	O
signature	O
attests	O
that	O
the	O
named	O
Attending	O
.	O

Pathologist	O
has	O
evaluated	O
the	O
specimen	O
referred	O
to	O
in	O
the	O
signed	O
.	O
section	O
of	O
the	O
report	O
and	O
formulated	O
the	O
diagnosis	O
therein	O
.	O

This	O
report	O
may	O
include	O
one	O
or	O
more	O
immunohistochemical	O
stain	O
.	O
results	O
that	O
use	O
analyte	O
specific	O
reagents	O
.	O

The	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
.	O
necessary	O
.	O

MEDICAL	O
CENTER	O
.	O

LABORATORY	O
.	O

PAGE	O
:	O
1	O
.	O

Specimen	O
Inquiry	O
.	O

ACCT	O
#	O
:	O
LOC	O
:	O
U	O
#	O
:	O
AGE	O
/	O
SX	O
:	O
SPEC	O
#	O
:	O
CLINICAL	O
HISTORY	O
:	O
RIGHT	O
RENAL	O
MASS	O
.	O

SPECIMEN	O
/	O
PROCEDURE	O
:	O
1	O
.	O

KIDNEY	O
-	O
RIGHT	O
.	O

IMPRESSION	O
.	O

RIGHT	O
KIDNEY	O
,	O
RIGHT	O
NEPHRECTOMY	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
,	O
type	O
II	O
,	O
Fuhrman	O
nuclear	O
grade	O
3	O
,	O
with	O
focal	O
.	O
renal	O
capsule	O
invasion	O
.	O

(	O
Please	O
see	O
tumor	O
checklist	O
)	O
.	O

Margins	O
of	O
resection	O
,	O
free	O
of	O
tumor	O
.	O

KIDNEY	O
:	O
NEPHRECTOMY	O
,	O
PARTIAL	O
OR	O
RADICAL	O
CASE	O
SUMMARY	O
.	O

PROCEDURE	O
.	O

Radical	O
nephrectomy	O
.	O

SPECIMEN	O
LATERALITY	O
.	O

Right	O
.	O

TUMOR	O
SITE	O
.	O

Middle	O
.	O

TUMOR	O
SIZE	O
(	O
largest	O
tumor	O
if	O
multiple	O
)	O
.	O

Greatest	O
dimension	O
:	O
5	B
.	I
3	I
cm	I
.	O

Additional	O
dimensions	O
:	O
5	B
.	I
2	I
x	I
4	I
.	I
8	I
am	I
.	O

TUMOR	O
FOCALITY	O
.	O

Unifocal	O
.	O

MACROSCOPIC	O
EXTENT	O
OF	O
TUMOR	O
.	O

Tumor	O
abutting	O
the	O
renal	O
capsule	O
with	O
possible	O
extension	O
into	O
perinephric	O
tissue	O
(	O
beyond	O
.	O
renal	O
capsule	O
)	O
.	O

HISTOLOGIC	O
TYPE	O
.	O

Papillary	O
renal	O
cell	O
carcinoma	O
.	O

SARCOMATOID	O
FEATURES	O
.	O

Not	O
identified	O
.	O

TUMOR	O
NECROSIS	O
(	O
any	O
amount	O
)	O
.	O

Present	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
FUHRMAN	O
NUCLEAR	O
GRADE	O
)	O
.	O

G3	O
:	O
Nuclei	O
very	O
irregular	O
,	O
approximately	O
20	O
m	O
;	O
nucleoli	O
large	O
and	O
prominent	O
.	O

(	O
Continued	O
)	O
Page	O
:	O
2	O
.	O

SPEC	O
#	O
:	O
IMPRESSION	O
:	O
(	O
continued	O
)	O
.	O

MICROSCOPIC	O
TUMOR	O
EXTENSION	O
.	O

Tumor	O
extension	O
into	O
perinephric	O
tissue	O
(	O
beyond	O
renal	O
capsule	O
)	O
.	O

MARGINS	O
.	O

Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

LYMPH	O
-	O
VASCULAR	O
(	O
excluding	O
renal	O
vein	O
and	O
its	O
muscle	O
containing	O
segmental	O
branches	O
and	O
inferior	O
vena	O
cava	O
(	O
.	O

INVASION	O
.	O

Absent	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
.	O

pT3a	O
:	O
Tumor	O
invades	O
perirenal	O
and	O
/	O
or	O
renal	O
sinus	O
fat	O
but	O
not	O
beyond	O
Gerota	O
'	O
s	O
fascia	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
.	O

No	O
nodes	O
submitted	O
or	O
found	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
.	O

Not	O
applicable	O
.	O

PATHOLOGIC	O
FINDINGS	O
IN	O
NONNEOPLASTIC	O
KIDNEY	O
.	O

Significant	O
Tubulointerstitial	O
pathologic	O
alterations	O
disease	O
(	O
specify	O
type	O
)	O
:	O
Chronic	O
interstitial	O
nephritis	O
.	O

Pathologic	O
TNM	O
(	O
AJCC	O
7th	O
edition	O
)	O
:	O
pT3a	O
.	O

NX	O
M	O
.	O

COMMENT	O
.	O

Case	O
reviewed	O
by	O
.	O

SPECIAL	O
Immunohistochemical	O
STAINS	O
/	O
PROCEDURES	O
stains	O
were	O
performed	O
with	O
appropriate	O
positive	O
and	O
negative	O
controls	O
.	O

Pancytokeratin	O
:	O
Positive	O
in	O
tumor	O
cells	O
with	O
likely	O
perinephric	O
tissue	O
invasion	O
.	O

CD31	O
:	O
No	O
difinite	O
evidence	O
of	O
intravascular	O
tumor	O
invasion	O
seen	O
.	O

GROSS	O
DESCRIPTION	O
:	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
(	O
9	O
.	O
5	O
"	O
right	O
x	O
7	O
.	O
8	O
x	O
.	O
kidney	O
"	O
1	O
.	O
Received	O
is	O
a	O
302	O
gram	O
perirenal	O
right	O
radical	O
fat	O
measuring	O
nephrectomy	O
in	O
thickness	O
specimen	O
including	O
from	O
1	O
.	O
0	O
to	O
kidney	O
2	O
.	O
0	O
cm	O
.	O
No	O
adrenal	O
by	O
0	O
.	O
3	O
6	O
.	O
8	O
.	O
cm	O
)	O
and	O
is	O
surrounding	O
identified	O
.	O

Extending	O
from	O
the	O
renal	O
pelvis	O
is	O
a	O
ureter	O
(	O
2	O
.	O
5	O
cm	O
and	O
in	O
renal	O
length	O
artery	O
(	O
1	O
.	O
gland	O
cm	O
in	O
in	O
diameter	O
diameter	O
)	O
,	O
by	O
renal	O
0	O
.	O
4	O
cm	O
vein	O
in	O
diameter	O
)	O
.	O

(	O
0	O
.	O
5	O
cm	O
in	O
There	O
length	O
is	O
by	O
a	O
0	O
.	O
3	O
5	O
.	O
3	O
cm	O
x	O
5	O
.	O
2	O
in	O
diameter	O
)	O
,	O
x	O
4	O
.	O
8	O
cm	O
pale	O
-	O
white	O
tumor	O
with	O
.	O

cm	O
.	O

SPEC	O
#	O
:	O
(	O
Continued	O
)	O
Page	O
:	O
3	O
.	O

GROSS	O
DESCRIPTION	O
:	O
(	O
continued	O
)	O
.	O
focal	O
areas	O
of	O
hemorrhage	O
,	O
located	O
in	O
the	O
mid	O
-	O
portion	O
of	O
the	O
kidney	O
.	O

The	O
tumor	O
abutts	O
the	O
.	O
perirenal	O
fat	O
without	O
penetrating	O
the	O
renal	O
capsule	O
.	O

The	O
tumor	O
also	O
does	O
not	O
involve	O
renal	O
.	O
sinus	O
fat	O
or	O
the	O
renal	O
pelvis	O
.	O

The	O
remainder	O
of	O
the	O
renal	O
cortex	O
is	O
tan	O
/	O
brown	O
with	O
a	O
.	O
well	O
-	O
defined	O
cortical	O
medullary	O
junction	O
.	O

The	O
pelvis	O
and	O
calyces	O
are	O
covered	O
by	O
smooth	O
.	O
glistening	O
mucosa	O
.	O

The	O
adipose	O
tissue	O
is	O
thinly	O
sectioned	O
and	O
no	O
lymphnodes	O
are	O
identified	O
.	O

A	O
portion	O
of	O
the	O
tumor	O
is	O
taken	O
for	O
TCGA	O
research	O
.	O

Devitalization	O
time	O
:	O
Freeze	O
time	O
:	O
Ink	O
code	O
:	O
black	O
-	O
outer	O
surface	O
of	O
specimen	O
.	O

CASSETTE	O
SUMMARY	O
:	O
CASSETTE	O
1A	O
:	O
renal	O
artery	O
,	O
vein	O
and	O
ureter	O
.	O

CASSETTE	O
1B	O
-	O
1E	O
:	O
tumor	O
abutting	O
perirenal	O
fat	O
.	O

CASSETTE	O
1G	O
,	O
1H	O
:	O
tumor	O
adjacent	O
to	O
renal	O
sinus	O
\	O
.	O

CASSETTE	O
1J	O
:	O
tumor	O
with	O
kidney	O
parenchyma	O
.	O

CASSETTE	O
1K	O
:	O
normal	O
kidney	O
.	O

CASSETTE	O
1L	O
,	O
1M	O
:	O
additional	O
sections	O
of	O
tumor	O
with	O
kidney	O
parenchyma	O
.	O

Entered	O
.	O

COPIES	O
TO	O
:	O
CPT	O
Codes	O
:	O
IHC	O
CD31	O
-	O
88342	O
,	O
KIDNEY	O
,	O
PART	O
/	O
TTL	O
RESECTION	O
TUMOR	O
/	O
88307	O
,	O
IHC	O
KERATIN	O
COCKTAIL	O
-	O
88342	O
,	O
.	O

NEG	O
MAB	O
CONTROL	O
/	O
2	O
.	O

ICD9	O
Codes	O
:	O
189	O
.	O
0	O
.	O

Resident	O
Physician	O
:	O
I	O
have	O
personally	O
reviewed	O
the	O
material	O
.	O

(	O
specimen	O
/	O
slide	O
and	O
approve	O
this	O
final	O
report	O
.	O

END	O
OF	O
REPORT	O
tt	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

Right	O
frontal	O
mass	O
:	O
Diffuse	O
astrocytoma	O
(	O
WHO	O
grade	O
2	O
)	O
.	O

Feature	O
S	O
suggest	O
anaplastic	O
change	O
.	O

See	O
.	O
note	O
.	O

B	O
.	O

Tumor	O
cyst	O
wall	O
:	O
Scattered	O
astrocytoma	O
cells	O
within	O
white	O
matte	O
.	O

C	O
.	O

Right	O
frontal	O
mass	O
:	O
Diffuse	O
astrocytoma	O
(	O
WHO	O
grade	O
2	O
)	O
.	O

See	O
note	O
.	O

D	O
.	O

Tumor	O
cyst	O
wall	O
:	O
Scattered	O
astrocytoma	O
cells	O
within	O
white	O
matte	O
.	O

E	O
.	O

Middle	O
-	O
right	O
frontal	O
mass	O
:	O
Scattered	O
astrocytoma	O
cells	O
within	O
white	O
matter	O
.	O

F	O
.	O

Deep	O
cyst	O
wall	O
:	O
Cortex	O
and	O
white	O
matter	O
with	O
cyst	O
wall	O
lined	O
by	O
moderately	O
cellular	O
,	O
viable	O
tumor	O
.	O

(	O
15	O
%	O
of	O
total	O
tissue	O
)	O
.	O

Adjacent	O
white	O
matter	O
with	O
only	O
scattered	O
glioma	O
cells	O
.	O

G	O
.	O

Anterior	O
cyst	O
wall	O
:	O
Cyst	O
wall	O
lined	O
by	O
moderately	O
cellular	O
,	O
viable	O
tumor	O
(	O
10	O
%	O
of	O
total	O
tissue	O
)	O
.	O

The	O
.	O
adjacent	O
white	O
matter	O
shows	O
no	O
definite	O
tumor	O
(	O
intraoperative	O
smear	O
G	O
reviewed	O
,	O
and	O
shows	O
no	O
.	O
tumor	O
)	O
.	O

H	O
.	O

Deep	O
to	O
cyst	O
wall	O
:	O
Fragments	O
of	O
white	O
matter	O
with	O
mild	O
hypercellularity	O
and	O
few	O
atypical	O
cells	O
.	O

No	O
.	O
cellular	O
tumor	O
.	O

Technical	O
Performing	O
Location	O
;	O
.	O

For	O
.	O
questions	O
regarding	O
this	O
case	O
:	O
I	O
.	O

Deep	O
to	O
cyst	O
wall	O
:	O
White	O
matter	O
with	O
cyst	O
wall	O
lined	O
by	O
moderately	O
cellular	O
,	O
viable	O
tumor	O
.	O

Comment	O
:	O
This	O
astrocytoma	O
diffusely	O
infiltrates	O
white	O
and	O
gray	O
matter	O
.	O

In	O
some	O
areas	O
,	O
especially	O
the	O
cyst	O
.	O
wall	O
,	O
the	O
cells	O
are	O
associated	O
with	O
prominent	O
microcystic	O
change	O
.	O

Tumor	O
cells	O
have	O
moderately	O
.	O
pleomorphic	O
astrocytic	O
nuclei	O
,	O
some	O
naked	O
and	O
others	O
with	O
gemistocytic	O
cytoplasm	O
;	O
other	O
areas	O
have	O
a	O
.	O
more	O
round	O
,	O
monotonous	O
pattern	O
suggestive	O
of	O
an	O
oligodendroglioma	O
component	O
.	O

Immunostain	O
for	O
p53	O
is	O
.	O
diffusely	O
positive	O
,	O
however	O
,	O
arguing	O
against	O
an	O
oligodendroglioma	O
.	O

Perineuronal	O
satellitosis	O
is	O
seen	O
.	O

No	O
.	O
evidence	O
of	O
an	O
underlying	O
grade	O
1	O
tumor	O
is	O
seen	O
(	O
i	O
.	O
e	O
.	O
no	O
EGBs	O
,	O
Rosethal	O
fibers	O
or	O
noninfiltrative	O
areas	O
)	O
.	O

No	O
mitoses	O
are	O
present	O
.	O

Though	O
the	O
cellularity	O
and	O
pleomorphism	O
are	O
in	O
some	O
areas	O
pronounced	O
,	O
no	O
.	O
mitoses	O
,	O
vascular	O
endothelial	O
proliferation	O
or	O
necrosis	O
are	O
present	O
.	O

Immunostain	O
for	O
MIB	O
-	O
1	O
(	O
slide	O
C3	O
)	O
.	O
shows	O
a	O
nuclear	O
labeling	O
rate	O
of	O
up	O
to	O
6	O
%	O
(	O
rates	O
of	O
greater	O
than	O
3	O
%	O
are	O
considered	O
likely	O
to	O
represent	O
.	O
anaplastic	O
change	O
by	O
Burger	O
et	O
al	O
.	O
,	O
Surgical	O
Pathology	O
of	O
the	O
Nervous	O
System	O
and	O
its	O
Coverings	O
,	O
4th	O
.	O
ed	O
.	O
)	O
.	O

Thus	O
the	O
tumor	O
is	O
WHO	O
grade	O
2	O
,	O
but	O
is	O
likely	O
to	O
represent	O
early	O
anaplastic	O
change	O
.	O

Molecular	O
testing	O
for	O
.	O

MGMT	O
,	O
1p19q	O
are	O
in	O
progress	O
.	O

BRAIN	O
:	O
Resection	O
.	O

MACROSCOPIC	O
.	O

Specimen	O
Type	O
.	O

X	O
Resection	O
.	O

Specimen	O
Size	O
.	O

Greatest	O
dimension	O
:	O
4	O
.	O
3	O
x	O
4	O
x	O
up	O
to	O
2	O
.	O
7	O
cm	O
.	O

Tumor	O
Site	O
.	O

X	O
.	O

Cerebrum	O
:	O
right	O
frontal	O
.	O

Tumor	O
Size	O
.	O

X	O
.	O

Cannot	O
be	O
determined	O
.	O

MICROSCOPIC	O
.	O

Histologic	O
Type	O
.	O

X	O
.	O

Astrocytoma	O
,	O
diffuse	O
.	O

Histologic	O
Grade	O
.	O

X	O
.	O

WHO	O
Grade	O
2	O
.	O

Margins	O
.	O

X	O
.	O

Cannot	O
be	O
assessed	O
.	O

Additional	O
Studies	O
.	O

X	O
Molecular	O
testing	O
(	O
specify	O
)	O
:	O
See	O
above	O
.	O

Frozen	O
Section	O
Diagnosis	O
:	O
A	O
.	O

Right	O
frontal	O
mass	O
.	O

-	O
Infiltrating	O
glioma	O
,	O
features	O
of	O
an	O
oligodendroglioma	O
.	O

(	O
16	O
minutes	O
)	O
(	O
.	O

B	O
.	O

Tumor	O
cyst	O
wall	O
I	O
.	O

-	O
Glioma	O
.	O

(	O
17	O
minutes	O
)	O
.	O

D	O
.	O

Foci	O
of	O
tumor	O
present	O
.	O

(	O
10	O
minutes	O
)	O
.	O

F	O
.	O

(	O
white	O
matter	O
,	O
SMF1	O
)	O
:	O
Glioma	O
present	O
.	O

(	O
cortex	O
,	O
SMF2	O
)	O
:	O
No	O
tumor	O
seen	O
.	O

(	O
10	O
minutes	O
)	O
.	O

G	O
.	O

Anterior	O
cyst	O
wall	O
.	O

-	O
Benign	O
.	O

I	O
.	O

Deep	O
cyst	O
wall	O
1	O
.	O

-	O
Tumor	O
present	O
.	O

Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
right	O
frontal	O
mass	O
,	O
"	O
is	O
an	O
.	O
aggregate	O
of	O
tan	O
-	O
white	O
tissue	O
,	O
fragments	O
ranging	O
from	O
0	O
.	O
3	O
cm	O
to	O
0	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
,	O
.	O
which	O
are	O
entirely	O
submitted	O
in	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
tumor	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
1	B
.	I
0	I
.	I

x	B
0	I
.	I
3	I
x	I
0	I
.	I
2	I
cm	I
fragment	O
of	O
tan	O
-	O
white	O
tissue	O
,	O
which	O
is	O
trisected	O
and	O
entirely	O
submitted	O
in	O
.	O

C	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
right	O
frontal	O
mass	O
,	O
"	O
is	O
a	O
22	O
.	O
gram	O
,	O
4	O
.	O
3	O
x	O
4	O
x	O
up	O
to	O
2	O
.	O
7	O
cm	O
piece	O
of	O
irregular	O
gray	O
-	O
tan	O
brain	O
tissue	O
.	O

The	O
specimen	O
is	O
step	O
.	O
sectioned	O
to	O
reveal	O
gray	O
-	O
tan	O
-	O
white	O
cut	O
surface	O
.	O

A	O
portion	O
of	O
the	O
tissue	O
is	O
taken	O
for	O
brain	O
bank	O
.	O

Representative	O
sections	O
(	O
about	O
30	O
%	O
of	O
the	O
total	O
specimen	O
)	O
are	O
submitted	O
in	O
cassette	O
1	O
.	O

D	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
tumor	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
1	B
.	I
1	I
x	I
.	I

0	B
.	I
7	I
x	I
0	I
.	I
2	I
cm	I
irregular	O
piece	O
of	O
gray	O
-	O
white	O
soft	O
tissue	O
which	O
is	O
trisected	O
and	O
entirely	O
submitted	O
in	O
.	O
cassette	O
.	O

E	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
middle	O
-	O
right	O
frontal	O
mass	O
,	O
"	O
.	O

is	O
a	O
1	O
.	O
1	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
1	O
cm	O
piece	O
of	O
irregular	O
gray	O
-	O
white	O
soft	O
tissue	O
which	O
is	O
entirely	O
submitted	O
in	O
.	O
cassette	O
.	O

F	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O

'	O
and	O
"	O
deep	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
2	O
.	O
3	O
.	O
gram	O
,	O
3	O
x	O
2	O
.	O
2	O
x	O
up	O
to	O
0	O
.	O
8	O
cm	O
piece	O
of	O
irregular	O
gray	O
-	O
white	O
soft	O
tissue	O
which	O
is	O
cross	O
sectioned	O
to	O
.	O
reveal	O
gray	O
-	O
tan	O
cortex	O
with	O
gray	O
-	O
white	O
white	O
matter	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
cassettes	O
.	O

G	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
anterior	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
0	O
.	O
6	O
.	O
gram	O
,	O
2	O
x	O
1	O
.	O
1	O
x	O
up	O
to	O
0	O
.	O
4	O
cm	O
piece	O
of	O
irregular	O
white	O
-	O
tan	O
soft	O
tissue	O
which	O
is	O
step	O
sectioned	O
and	O
.	O
entirely	O
submitted	O
in	O
cassettes	O
.	O

H	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
deep	O
to	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
0	O
.	O
2	O
.	O
gram	O
,	O
1	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
2	O
cm	O
aggregate	O
of	O
multiple	O
fragments	O
of	O
gray	O
-	O
white	O
soft	O
tissue	O
which	O
is	O
entirely	O
.	O
submitted	O
in	O
cassette	O
.	O

I	O
.	O

Received	O
fresh	O
,	O
labeled	O
with	O
patient	O
'	O
s	O
name	O
,	O
.	O
and	O
"	O
deep	O
to	O
cyst	O
wall	O
,	O
"	O
is	O
a	O
0	O
.	O
1	O
.	O
gram	O
,	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
1	O
cm	O
piece	O
of	O
irregular	O
gray	O
-	O
white	O
soft	O
tissue	O
which	O
is	O
sectioned	O
and	O
entirely	O
.	O
submitted	O
in	O
cassette	O
.	O

Microscopic	O
Description	O
:	O
20	O
H	O
&	O
E	O
;	O
p53	O
immunostain	O
,	O
MIB1	O
,	O
semiquant	O
.	O

I	O
have	O
reviewed	O
all	O
diagnostic	O
slides	O
and	O
have	O
edited	O
the	O
gross	O
and	O
/	O
or	O
microscopic	O
portion	O
of	O
this	O
report	O
.	O
as	O
part	O
of	O
my	O
pathologic	O
assessment	O
and	O
final	O
diagnosis	O
.	O

Amended	O
Molecular	O
Analysis	O
Report	O
.	O

Test	O
Performed	O
.	O

MGMT	O
Methylation	O
Assay	O
.	O

Specimen	O
Type	O
.	O

Paraffin	O
Block	O
.	O

Gene	O
Methylation	O
DETECTED	O
.	O

Methylation	O
of	O
the	O
MGMT	O
(	O
O	O
(	O
6	O
)	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
)	O
gene	O
was	O
detected	O
using	O
methylation	O
specific	O
PCR	O
technologies	O
.	O

Methylation	O
Score	O
:	O
5	O
.	O
67	O
.	O
unmethylated	O
<	O
2	O
.	O
00	O
.	O
methylated	O
>	O
=	O
2	O
.	O
00	O
.	O

Background	O
.	O

MGMT	O
(	O
O	O
(	O
6	O
)	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
)	O
is	O
a	O
DNA	O
repair	O
enzyme	O
that	O
is	O
involved	O
in	O
the	O
repair	O
of	O
damage	O
caused	O
by	O
a	O
variety	O
of	O
.	O

DNA	O
crosslinking	O
compounds	O
,	O
including	O
alkylating	O
agents	O
.	O

Increased	O
methylation	O
of	O
the	O
MGMT	O
gene	O
promoter	O
region	O
causes	O
diminished	O
or	O
.	O
silenced	O
expression	O
of	O
the	O
gene	O
,	O
making	O
cells	O
more	O
sensitive	O
to	O
DNA	O
damage	O
.	O

This	O
relationship	O
has	O
been	O
shown	O
for	O
glioblastomas	O
and	O
.	O
alkylating	O
agents	O
such	O
as	O
Temodar	O
(	O
R	O
)	O
(	O
temozolomide	O
)	O
.	O

Approximately	O
40	O
%	O
to	O
45	O
%	O
of	O
glioblastoma	O
multiforme	O
(	O
GBM	O
)	O
tumors	O
exhibit	O
MGMT	O
gene	O
methylation	O
.	O

Retrospective	O
studies	O
have	O
shown	O
that	O
.	O
detection	O
of	O
MGMT	O
promoter	O
methylation	O
in	O
tumor	O
samples	O
is	O
associated	O
with	O
an	O
increased	O
likelihood	O
of	O
a	O
favorable	O
response	O
to	O
temozolomide	O
.	O

Methodology	O
.	O

DNA	O
is	O
isolated	O
from	O
formalin	O
-	O
fixed	O
,	O
paraffin	O
-	O
embedded	O
(	O
FFPE	O
)	O
specimen	O
.	O

Molecular	O
analysis	O
of	O
the	O
MGMT	O
gene	O
is	O
performed	O
by	O
methylation	O
-	O
.	O
specific	O
PCR	O
and	O
detected	O
on	O
ABI7900	O
.	O

The	O
MGMT	O
and	O
beta	O
-	O
Actin	O
copy	O
numbers	O
will	O
be	O
used	O
to	O
calculate	O
the	O
ratio	O
of	O
MGMT	O
/	O
beta	O
-	O
Actin	O
.	O

x1000	O
.	O

Molecular	O
-	O
based	O
testing	O
is	O
highly	O
accurate	O
,	O
but	O
as	O
in	O
any	O
laboratory	O
test	O
,	O
rare	O
diagnostic	O
errors	O
may	O
occur	O
.	O

Results	O
of	O
this	O
test	O
are	O
for	O
Investigational	O
Purposes	O
Only	O
.	O

The	O
performance	O
characteristic	O
of	O
this	O
assay	O
have	O
been	O
determined	O
by	O
.	O

The	O
.	O
result	O
should	O
not	O
be	O
used	O
as	O
a	O
diagnostic	O
procedure	O
without	O
confirmation	O
of	O
the	O
diagnosis	O
by	O
another	O
medically	O
established	O
diagnostic	O
product	O
.	O
or	O
procedure	O
.	O

Comments	O
.	O

Block	O
ID	O
:	O
Reference	O
.	O

1	O
.	O

Vlassenbroeck	O
I	O
.	O

et	O
al	O
.	O

Validation	O
of	O
Real	O
-	O
Time	O
Methylation	O
-	O
Specific	O
PCR	O
to	O
Determine	O
0	O
(	O
6	O
)	O
-	O
Methylguanine	O
-	O
DNA	O
Methyltransferase	O
Gene	O
.	O

Promoter	O
Methylation	O
in	O
Glioma	O
.	O

J	O
.	O

Molecular	O
Diagnostics	O
10	O
;	O
4	O
:	O
332	O
-	O
337	O
.	O

2008	O
.	O

2	O
.	O

Hegi	O
M	O
.	O

et	O
al	O
.	O

MGMT	O
Gene	O
Silencing	O
and	O
Benefit	O
from	O
Temozolomide	O
in	O
Glioblastoma	O
.	O

New	O
England	O
J	O
Medicine	O
352	O
;	O
10	O
:	O
997	O
-	O
1003	O
.	O

2005	O
.	O

3	O
.	O

Brandes	O
A	O
.	O

et	O
al	O
.	O

MGMT	O
Promoter	O
Methylation	O
Status	O
Can	O
Predict	O
the	O
Incidence	O
and	O
Outcome	O
of	O
Pseudoprogression	O
After	O
Concomitant	O
.	O

Radiochemotherapy	O
in	O
Newly	O
Diagnosed	O
Glioblastoma	O
Patients	O
.	O

J	O
.	O

Clinical	O
Oncology	O
26	O
;	O
13	O
:	O
2192	O
-	O
2197	O
.	O

2008	O
.	O

4	O
.	O

Hau	O
P	O
.	O

et	O
al	O
.	O

MGMT	O
Methylation	O
Status	O
:	O
The	O
Advent	O
of	O
Stratified	O
Therapy	O
in	O
Glioblastoma	O
.	O

Disease	O
Markers	O
23	O
:	O
97	O
-	O
104	O
.	O

2007	O
.	O

Director	O
Review	O
:	O
DISCLAIMER	O
:	O
Testing	O
performed	O
at	O
.	O

Revision	O
Reason	O
:	O
AMENDED	O
REPORT	O
.	O

(	O
Previously	O
reported	O
.	O

This	O
amended	O
report	O
is	O
issued	O
to	O
correct	O
a	O
typographical	O
error	O
in	O
the	O
original	O
report	O
.	O

The	O
sentence	O
in	O
the	O
Result	O
.	O
section	O
has	O
been	O
changed	O
from	O
"	O
Methylation	O
of	O
the	O
MGMT	O
(	O
O	O
(	O
6	O
)	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
)	O
gene	O
was	O
.	O
not	O
detected	O
using	O
methylation	O
specific	O
PCR	O
technologies	O
.	O
"	O
to	O
"	O
Methylation	O
of	O
the	O
MGMT	O
(	O
O	O
(	O
6	O
)	O
-	O
methylguanine	O
-	O
DNA	O
.	O
methyltransferase	O
)	O
gene	O
was	O
detected	O
using	O
methylation	O
specific	O
PCR	O
technologies	O
.	O
"	O
There	O
are	O
no	O
other	O
changes	O
.	O

to	O
.	O
the	O
original	O
report	O
.	O

This	O
document	O
contains	O
private	O
and	O
confidential	O
health	O
information	O
protected	O
by	O
state	O
and	O
federal	O
law	O
.	O

If	O
you	O
received	O
this	O
document	O
in	O
error	O
,	O
.	O

Chromosome	O
studies	O
performed	O
by	O
FISH	O
on	O
paraffin	O
blocks	O
of	O
tumor	O
(	O
.	O

-	O
1	O
showed	O
the	O
following	O
:	O
Chromosome	O
1p	O
intact	O
.	O

Chromosome	O
19q	O
intact	O
.	O

Immunostain	O
for	O
IDH1	O
.	O

is	O
positive	O
.	O

Date	O
Coll	O
:	O
SPECIMEN	O
.	O

A	O
.	O

R4	O
lymph	O
node	O
.	O

B	O
.	O

Level	O
10	O
lymph	O
node	O
.	O

C	O
.	O

Right	O
lobe	O
stitch	O
marks	O
probably	O
.	O

D	O
.	O

R4	O
lymph	O
node	O
.	O

E	O
.	O

Level	O
7	O
lymph	O
node	O
.	O

CLINICAL	O
NOTES	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

A	O
)	O
R4	O
lymph	O
node	O
,	O
biopsy	O
:	O
Negative	O
for	O
carcinoma	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
unfixed	O
labeled	O
"	O
R4	O
lymph	O
.	O

node	O
"	O
and	O
consists	O
of	O
multiple	O
pieces	O
of	O
red	O
and	O
black	O
soft	O
.	O
tissue	O
measuring	O
1	O
.	O
8	O
X	O
1	O
.	O
7	O
X	O
0	O
.	O
3	O
cm	O
.	O
in	O
aggregate	O
.	O

The	O
entire	O
.	O

n	O
is	O
submitted	O
for	O
frozen	O
section	O
diagnosis	O
as	O
requested	O
.	O

B	O
.	O

Specimen	O
is	O
received	O
unfixed	O
labeled	O
"	O
level	O
10	O
lymph	O
.	O
node	O
.	O

"	O
Specimen	O
is	O
received	O
unfixed	O
and	O
consists	O
of	O
two	O
.	O
pieces	O
of	O
pink	O
and	O
red	O
soft	O
tissue	O
measuring	O
2	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
4	O
cm	O
in	O
.	O
aggregate	O
.	O

AS	O
-	O
1	O
.	O

C	O
.	O

The	O
specimen	O
is	O
received	O
unfixed	O
labeled	O
"	O
right	O
lobe	O
"	O
.	O
and	O
consist	O
of	O
175	O
gram	O
lung	O
lobe	O
with	O
a	O
stapled	O
margin	O
.	O

The	O
specimen	O
measures	O
12	O
X	O
8	O
.	O
5	O
X	O
6	O
cm	O
.	O

The	O
pleural	O
surface	O
has	O
a	O
.	O
clefted	O
appearance	O
and	O
there	O
is	O
a	O
central	O
firm	O
area	O
by	O
palpation	O
.	O

On	O
cut	O
section	O
there	O
is	O
a	O
central	O
firm	O
white	O
mass	O
,	O
the	O
white	O
area	O
.	O
measures	O
4	O
by	O
approximately	O
3	O
cm	O
.	O

In	O
cross	O
sectional	O
dimension	O
,	O
a	O
.	O
portion	O
of	O
this	O
area	O
may	O
be	O
peritumoral	O
change	O
.	O

A	O
portion	O
of	O
.	O

n	O
is	O
taken	O
for	O
research	O
purposes	O
.	O

Sections	O
after	O
fixation	O
.	O

Block	O
summary	O
:	O
1	O
-	O
bronchial	O
and	O
vascular	O
margin	O
of	O
resection	O
,	O
2	O
-	O
next	O
.	O
level	O
of	O
bronchus	O
and	O
vessels	O
,	O
3	O
-	O
4	O
tumor	O
,	O
5	O
,	O
pulmonary	O
margin	O
,	O
7	O
-	O
11	O
.	O
tumor	O
.	O

D	O
.	O

Specimen	O
is	O
received	O
unfixed	O
labeled	O
"	O
R4	O
lymph	O
node	O
"	O
.	O
and	O
consists	O
of	O
a	O
piece	O
of	O
black	O
and	O
red	O
soft	O
tissue	O
.	O
measuring	O
1	O
x	O
0	O
.	O
4	O
X	O
0	O
.	O
7	O
cm	O
.	O

AS	O
-	O
1	O
.	O

E	O
.	O

Specimen	O
is	O
received	O
unfixed	O
labeled	O
"	O
level	O
7	O
lymph	O
.	O

node	O
"	O
and	O
consists	O
of	O
multiple	O
pieces	O
of	O
red	O
and	O
black	O
soft	O
.	O
tissue	O
occupying	O
approximately	O
2	O
.	O
5	O
mL	O
in	O
volume	O
.	O

AS	O
-	O
2	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

A	O
.	O

Multiple	O
lymph	O
node	O
pieces	O
are	O
negative	O
for	O
malignancy	O
.	O

B	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
in	O
either	O
of	O
2	O
lymph	O
nodes	O
.	O

C	O
.	O

Tumor	O
type	O
:	O
Adenocarcinoma	O
.	O

Tumor	O
grade	O
:	O
2	O
.	O

Mitotic	O
Index	O
:	O
12	O
mitoses	O
/	O
10	O
HPFs	O
(	O
1	O
HPF	O
=	O
0	O
.	O
19	O
sq	O
mm	O
)	O
.	O

Tumor	O
size	O
:	O
4	B
cm	I
.	O

Bronchial	O
resection	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

Pulmonary	O
margin	O
of	O
resection	O
:	O
Negative	O
for	O
malignancy	O
.	O

Pleura	O
:	O
Negative	O
for	O
malignancy	O
.	O

Vascular	O
invasion	O
:	O
Absent	O
.	O

Attached	O
lymph	O
nodes	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

in	O
.	O
one	O
peribronchial	O
lymph	O
node	O
.	O

pTNM	O
Stage	O
:	O
T2a	O
.	O

Non	O
-	O
tumorous	O
lung	O
:	O
Unremarkable	O
.	O

D	O
.	O

A	O
single	O
lymph	O
node	O
is	O
negative	O
for	O
malignancy	O
.	O

E	O
.	O

Multiple	O
lymph	O
node	O
pieces	O
are	O
negative	O
for	O
malignancy	O
.	O

3x4	O
,	O
4	O
,	O
14	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Lymph	O
node	O
,	O
R4	O
,	O
biopsy	O
:	O
Negative	O
for	O
malignancy	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
level	O
X	O
,	O
biopsy	O
:	O
There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O
in	O
either	O
of	O
2	O
lymph	O
nodes	O
.	O

C	O
.	O

Lung	O
,	O
right	O
lobe	O
,	O
resection	O
:	O
Moderately	O
well	O
-	O
differentiated	O
.	O
adenocarcinoma	O
.	O

D	O
.	O

Lymph	O
node	O
,	O
R4	O
,	O
biopsy	O
:	O
A	O
single	O
lymph	O
node	O
is	O
negative	O
for	O
.	O
malignancy	O
.	O

E	O
.	O

Lymph	O
node	O
,	O
level	O
VII	O
,	O
biopsy	O
:	O
Negative	O
for	O
malignancy	O
.	O

End	O
Of	O
Report	O
-	O
-	O
-	O
.	O

Case	O
imported	O
from	O
legacy	O
computer	O
system	O
.	O

The	O
format	O
of	O
this	O
report	O
does	O
not	O
match	O
the	O
original	O
case	O
.	O

For	O
cases	O
prior	O
to	O
.	O
the	O
section	O
"	O
SPECIMEN	O
"	O
may	O
have	O
been	O
added	O
.	O

SUPPLEMENTAL	O
REPORT	O
.	O

DIAGNOSIS	O
:	O
COMPOSITE	O
RESECTION	O
ANTERIOR	O
MANDIBLE	O
:	O
POORLY	O
DIFFERENTIATED	O
SQUAMOUS	O
CARCINOMA	O
INVADING	O
BONE	O
.	O

Mandibular	O
margins	O
of	O
resection	O
free	O
of	O
tumor	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
DIAGNOSIS	O
.	O

(	O
A	O
)	O
LEFT	O
NECK	O
CONTENTS	O
,	O
LEVELS	O
I	O
,	O
II	O
,	O
III	O
:	O
Fourteen	O
lymph	O
nodes	O
free	O
of	O
tumor	O
(	O
0	O
/	O
14	O
)	O
.	O

Salivary	O
gland	O
with	O
fibrosis	O
and	O
inflammation	O
consistent	O
with	O
.	O
radiation	O
effect	O
.	O

(	O
B	O
)	O
RIGHT	O
NECK	O
CONTENTS	O
,	O
LEVELS	O
I	O
,	O
II	O
,	O
III	O
:	O
Eleven	O
lymph	O
nodes	O
free	O
of	O
tumor	O
(	O
0	O
/	O
11	O
)	O
.	O

Salivary	O
gland	O
free	O
of	O
tumor	O
.	O

ANTERIOR	O
LABIAL	O
MARGIN	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

COMPOSITE	O
RESECTION	O
ANTERIOR	O
MANDIBLE	O
,	O
FLOOR	O
OF	O
MASS	O
,	O
VENTRAL	O
TONGUE	O
:	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
.	O

Tumor	O
thickness	O
1	B
.	I
4	I
cm	I
.	O

LYMPHOVASCULAR	O
INVASION	O
PRESENT	O
.	O

Perineural	O
invasion	O
not	O
identified	O
.	O

Margins	O
of	O
resection	O
free	O
of	O
tumor	O
.	O

Sections	O
of	O
mandible	O
are	O
pending	O
for	O
decalcification	O
.	O

(	O
E	O
)	O
.	O

LEFT	O
GINGIVAL	O
LINGUAL	O
SULCUS	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

(	O
F	O
)	O
.	O

LEFT	O
LINGUAL	O
MARGIN	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

ANTERIOR	O
LINGUAL	O
MARGIN	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

RIGHT	O
LINGUAL	O
MARGIN	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

RIGHT	O
GINGIVAL	O
LINGUAL	O
SULCUS	O
:	O
Squamous	O
mucosa	O
,	O
no	O
tumor	O
present	O
.	O

TEETH	O
:	O
Multiple	O
teeth	O
,	O
gross	O
diagnosis	O
only	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
CONTENTS	O
LEFT	O
LEVEL	O
I	O
,	O
II	O
,	O
III	O
NECK	O
-	O
specimen	O
received	O
in	O
three	O
.	O
containers	O
.	O

LEVEL	O
1	O
-	O
A	O
portion	O
of	O
fibromuscular	O
tissue	O
,	O
5	O
.	O
0	O
X	O
4	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
.	O

A	O
.	O
portion	O
of	O
salivary	O
gland	O
,	O
2	O
.	O
5	O
X	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
,	O
is	O
present	O
.	O

No	O
tumor	O
is	O
.	O
identified	O
in	O
the	O
salivary	O
gland	O
tissue	O
.	O

Multiple	O
lymph	O
nodes	O
,	O
0	O
.	O
2	O
-	O
1	O
.	O
0	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
are	O
identified	O
,	O
grossly	O
negative	O
.	O

SECTION	O
CODE	O
:	O
A1	O
,	O
representative	O
section	O
from	O
salivary	O
gland	O
tissue	O
;	O
A2	O
,	O
.	O
one	O
bisected	O
lymph	O
node	O
;	O
A3	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
A4	O
,	O
three	O
lymph	O
nodes	O
;	O
.	O

A5	O
,	O
three	O
lymph	O
nodes	O
;	O
A6	O
,	O
one	O
bisected	O
lymph	O
node	O
.	O

LEVEL	O
2	O
:	O
A	O
portion	O
of	O
fibromuscular	O
tissue	O
,	O
3	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
1	O
.	O
2	O
cm	O
.	O

One	O
.	O
possible	O
lymph	O
node	O
,	O
0	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
,	O
is	O
identified	O
.	O

The	O
.	O
remainder	O
of	O
the	O
tissue	O
consists	O
predominantly	O
of	O
fibroadipose	O
tissue	O
and	O
.	O
vessels	O
.	O

Negative	O
for	O
tumor	O
.	O

SECTION	O
CODE	O
:	O
A7	O
,	O
one	O
possible	O
lymph	O
node	O
;	O
A8	O
and	O
A9	O
,	O
remainder	O
of	O
level	O
.	O

2	O
in	O
toto	O
.	O

CONTENTS	O
OF	O
LEFT	O
NECK	O
LEVEL	O
3	O
:	O
A	O
fragment	O
of	O
fibroadipose	O
tissue	O
,	O
6	O
.	O
0	O
X	O
.	O

1	O
.	O
0	O
X	O
0	O
.	O
5	O
cm	O
.	O

Six	O
lymph	O
nodes	O
,	O
0	O
.	O
3	O
-	O
1	O
.	O
5	O
cm	O
,	O
are	O
identified	O
.	O

No	O
tumor	O
is	O
.	O
identified	O
.	O

SECTION	O
CODE	O
:	O
A10	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
A11	O
,	O
one	O
bisected	O
lymph	O
.	O
node	O
;	O
A12	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
A13	O
,	O
multiple	O
lymph	O
nodes	O
.	O

(	O
B	O
)	O
CONTENTS	O
RIGHT	O
NECK	O
-	O
Specimen	O
received	O
in	O
three	O
containers	O
.	O

LEVEL	O
1	O
:	O
Fibroadipose	O
tissue	O
and	O
salivary	O
gland	O
tissue	O
in	O
toto	O
,	O
5	O
.	O
7	O
x	O
4	O
.	O
0	O
.	O

X	O
1	O
.	O
7	O
cm	O
.	O

The	O
salivary	O
gland	O
measure	O
2	O
.	O
7	O
x	O
1	O
.	O
8	O
x	O
1	O
.	O
5	O
cm	O
.	O

Grossly	O
negative	O
.	O
for	O
.	O

tumor	O
.	O

Five	O
lymph	O
nodes	O
,	O
0	O
.	O
9	O
cm	O
up	O
to	O
1	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
,	O
are	O
.	O
identified	O
;	O
all	O
grossly	O
negative	O
for	O
metastasis	O
.	O

SECTION	O
CODE	O
:	O
B1	O
,	O
representative	O
section	O
from	O
salivary	O
gland	O
;	O
B2	O
,	O
one	O
.	O
bisected	O
lymph	O
node	O
;	O
B3	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
B4	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
.	O

B5	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
B6	O
,	O
one	O
bisected	O
lymph	O
node	O
.	O

CONTENTS	O
RIGHT	O
NECK	O
LEVEL	O
2	O
:	O
A	O
fragment	O
of	O
fibroadipose	O
tissue	O
and	O
.	O
muscular	O
tissue	O
,	O
4	O
.	O
0	O
X	O
2	O
.	O
7	O
x	O
0	O
.	O
9	O
cm	O
.	O

Three	O
lymph	O
nodes	O
are	O
identified	O
at	O
this	O
.	O
level	O
measuring	O
from	O
1	O
.	O
2	O
up	O
to	O
2	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
lymph	O
nodes	O
.	O
are	O
grossly	O
negative	O
for	O
metastasis	O
.	O

SECTION	O
CODE	O
:	O
B7	O
and	O
B8	O
,	O
largest	O
lymph	O
node	O
,	O
bisected	O
;	O
B9	O
,	O
one	O
bisected	O
.	O
lymph	O
node	O
;	O
B10	O
,	O
one	O
bisected	O
lymph	O
node	O
.	O

CONTENTS	O
RIGHT	O
NECK	O
LEVEL	O
3	O
:	O
A	O
portion	O
of	O
fibroadipose	O
tissue	O
,	O
6	O
.	O
0	O
X	O
1	O
.	O
0	O
.	O

X	O
0	O
.	O
6	O
cm	O
.	O

Three	O
lymph	O
nodes	O
,	O
0	O
.	O
9	O
cm	O
-	O
1	O
.	O
5	O
cm	O
,	O
are	O
identified	O
.	O

All	O
lymph	O
nodes	O
.	O
are	O
grossly	O
negative	O
for	O
metastasis	O
.	O

SECTION	O
CODE	O
:	O
B11	O
,	O
one	O
bisected	O
lymph	O
node	O
;	O
B12	O
,	O
one	O
bisected	O
lymph	O
.	O
node	O
;	O
B13	O
,	O
one	O
bisected	O
lymph	O
node	O
.	O

(	O
c	O
)	O
ANTERIOR	O
LABIAL	O
MARGIN	O
-	O
A	O
slenuer	O
strip	O
(	O
4	O
.	O
7	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
cm	O
)	O
.	O
without	O
any	O
orientation	O
.	O

Entirely	O
frozen	O
for	O
intraoperative	O
consultation	O
in	O
.	O

c	O
.	O

FS	O
/	O
DX	O
:	O
BENIGN	O
SQUAMOUS	O
MUCOSA	O
AND	O
SOFT	O
TISSUE	O
,	O
NO	O
TUMOR	O
PRESENT	O
.	O

FS	O
/	O
DX	O
:	O
BENIGN	O
SQUAMOUS	O
MUCOSA	O
AND	O
SOFT	O
TISSUE	O
,	O
NO	O
TUMOR	O
PRESENT	O
.	O

(	O
D	O
)	O
COMPOSITE	O
RESECTION	O
ANTERIOR	O
MANDIBLE	O
,	O
FLOOR	O
OF	O
MOUTH	O
,	O
VENTRAL	O
TONGUE	O
-	O
A	O
.	O
composite	O
resection	O
specimen	O
(	O
6	O
.	O
0	O
X	O
6	O
.	O
0	O
x	O
6	O
.	O
0	O
cm	O
)	O
consisting	O
of	O
anterior	O
.	O
mandible	O
(	O
6	O
.	O
0	O
X	O
6	O
.	O
0	O
X	O
2	O
.	O
5	O
cm	O
)	O
,	O
floor	O
of	O
mouth	O
and	O
ventral	O
tongue	O
(	O
3	O
.	O
0	O
X	O
2	O
.	O
0	O
X	O
.	O
2	O
.	O
0	O
cm	O
)	O
.	O

There	O
is	O
an	O
ulcerating	O
,	O
tan	O
-	O
gray	O
,	O
firm	O
tumor	O
involving	O
the	O
medial	O
floor	O
.	O
of	O
mouth	O
obliterating	O
the	O
Tingual	O
frenulum	O
and	O
eroding	O
anteriorly	O
through	O
the	O
.	O
mandible	O
to	O
involve	O
the	O
alveoli	O
of	O
the	O
two	O
first	O
incisors	O
and	O
the	O
left	O
second	O
.	O
incisor	O
.	O

The	O
tumor	O
protrudes	O
into	O
the	O
vestibular	O
gingiva	O
and	O
is	O
located	O
.	O
within	O
0	O
.	O
5	O
cm	O
of	O
the	O
anterior	O
gingival	O
margin	O
and	O
1	O
.	O
5	O
cm	O
of	O
the	O
deep	O
soft	O
.	O
tissue	O
margin	O
.	O

All	O
resection	O
margins	O
appear	O
grossly	O
uninvolved	O
.	O

The	O
.	O
remaining	O
teeth	O
,	O
mandible	O
,	O
tongue	O
,	O
and	O
soft	O
tissues	O
of	O
the	O
floor	O
of	O
mouth	O
are	O
.	O
unremarkable	O
without	O
discrete	O
Tesions	O
.	O

SECTION	O
CODE	O
:	O
D1	O
-	O
D12	O
,	O
representative	O
of	O
tumor	O
.	O

The	O
involved	O
dental	O
.	O
alveoli	O
are	O
submitted	O
to	O
the	O
bone	O
lab	O
for	O
decalcification	O
and	O
sectioning	O
.	O

LEFT	O
GINGIVAL	O
LINGUAL	O
SULCUS	O
-	O
A	O
1	O
.	O
3	O
cm	O
slender	O
strip	O
of	O
mucosa	O
,	O
entirely	O
.	O
frozen	O
in	O
E	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

(	O
F	O
)	O
.	O

LEFT	O
LINGUAL	O
MARGIN	O
-	O
A	O
3	O
.	O
2	O
cm	O
Slender	O
strip	O
of	O
mucosa	O
,	O
entirely	O
frozen	O
.	O
in	O
F	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

ANTERIOR	O
LINGUAL	O
MARGIN	O
-	O
A	O
2	O
.	O
7	O
CM	O
slender	O
strip	O
of	O
mucosa	O
,	O
entirely	O
.	O
frozen	O
in	O
G	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

.	O
RIGHT	O
LINGUAL	O
MARGIN	O
-	O
A	O
2	O
.	O
1	O
CIII	O
STEnder	O
strip	O
of	O
mucosa	O
,	O
entirely	O
frozen	O
.	O
in	O
H	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

RIGHT	O
GINGIVAL	O
LINGUAL	O
SULCUS	O
-	O
A	O
1	O
.	O
3	O
cm	O
slender	O
strip	O
of	O
mucosa	O
,	O
.	O
entirely	O
frozen	O
in	O
I	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

TEETH	O
-	O
Multiple	O
teeth	O
and	O
fragments	O
of	O
teeth	O
including	O
incisors	O
,	O
.	O
premolars	O
,	O
canines	O
and	O
molars	O
some	O
of	O
which	O
have	O
amalgam	O
.	O

No	O
sections	O
taken	O
,	O
.	O
gross	O
documentation	O
only	O
.	O

SNOMED	O
CODES	O
.	O

M	O
-	O
80703	O
r	O
-	O
11180	O
.	O

Sex	O
:	O
Female	O
.	O

DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
Breast	O
,	O
right	O
,	O
axillary	O
contents	O
;	O
modified	O
radical	O
mastectomy	O
and	O
axillary	O
node	O
dissection	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Pleomorphic	O
lobular	O
carcinoma	O
,	O
confirmed	O
by	O
negative	O
e	O
-	O
cadherin	O
stain	O
.	O

2	O
.	O

Size	O
:	O
10	B
.	I
0	I
x	I
10	I
.	I
0	I
x	I
7	I
.	I
2	I
cm	I
.	O

3	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

4	O
.	O

Elston	O
modification	O
of	O
Bloom	O
-	O
Richardson	O
grade	O
:	O
a	O
.	O

Architectural	O
score	O
:	O
3	O
/	O
3	O
.	O

b	O
.	O

Nuclear	O
score	O
:	O
2	O
/	O
3	O
.	O

C	O
.	O

Mitotic	O
score	O
:	O
1	O
/	O
3	O
.	O

d	O
.	O

Total	O
score	O
:	O
6	O
/	O
9	O
=	O
Grade	O
:	O
II	O
.	O

5	O
.	O

In	O
situ	O
component	O
:	O
Not	O
identified	O
.	O

6	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Present	O
.	O

7	O
.	O

Skin	O
involvement	O
Not	O
identified	O
.	O

8	O
.	O

Microcalcifications	O
:	O
Present	O
and	O
associated	O
with	O
invasive	O
carcinoma	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

Deep	O
surgical	O
margin	O
free	O
of	O
tumor	O
by	O
2	O
.	O
5	O
cm	O
as	O
measured	O
grossly	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
received	O
:	O
12	O
.	O

2	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
carcinoma	O
:	O
3	O
.	O

Size	O
of	O
largest	O
metastasis	O
:	O
2	O
.	O
5	O
cm	O
.	O

4	O
.	O

Extracapsular	O
extension	O
of	O
tumor	O
:	O
Present	O
.	O

Other	O
:	O
1	O
.	O

pTNM	O
stage	O
:	O
pT3	O
N2	O
.	O

CLINICAL	O
INFORMATION	O
:	O
CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosie	O
:	O
Right	O
MET	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptams	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
Right	O
breast	O
and	O
axillary	O
contents	O
.	O

at	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
.	O
right	O
breast	O
and	O
axillary	O
contents	O
the	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
breast	O
tissue	O
and	O
overlying	O
.	O
skin	O
that	O
measures	O
18	O
.	O
0	O
by	O
8	O
.	O
0	O
cm	O
and	O
weighs	O
1	O
,	O
529	O
gm	O
.	O

The	O
skin	O
surface	O
measures	O
23	O
.	O
0	O
x	O
13	O
.	O
8	O
cm	O
is	O
light	O
tan	O
wrinkled	O
there	O
is	O
a	O
scar	O
within	O
the	O
outer	O
.	O
quadrant	O
measuring	O
3	O
.	O
0	O
cm	O
that	O
is	O
9	O
.	O
2	O
cm	O
in	O
the	O
nipple	O
there	O
is	O
slight	O
ecchymosis	O
noted	O
within	O
the	O
upper	O
outer	O
quadrant	O
.	O

No	O
other	O
lesions	O
are	O
identified	O
.	O

The	O
.	O
nipple	O
.	O

is	O
.	O
eccentrically	O
.	O

placed	O
appears	O
grossly	O
unremarkable	O
.	O

Sectioning	O
reveais	O
a	O
firm	O
gray	O
-	O
tan	O
lobular	O
mass	O
that	O
measures	O
10	O
.	O
0	O
x	O
10	O
.	O
0	O
x	O
7	O
.	O
2	O
cm	O
.	O
that	O
is	O
centrally	O
located	O
it	O
is	O
within	O
2	O
.	O
5	O
cm	O
of	O
the	O
deep	O
margin	O
of	O
resection	O
the	O
surrounding	O
breast	O
tissue	O
reveais	O
yellow	O
-	O
tan	O
fatty	O
fibroadipose	O
tissue	O
with	O
.	O
areas	O
.	O

of	O
.	O
gray	O
fibrous	O
tissue	O
.	O

Attached	O
to	O
the	O
specimen	O
is	O
a	O
portion	O
of	O
axillary	O
contents	O
measuring	O
10	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
there	O
are	O
twelve	O
possible	O
lymph	O
.	O
nodes	O
that	O
measure	O
from	O
0	O
.	O
3	O
to	O
2	O
.	O
7	O
cm	O
.	O

Received	O
with	O
the	O
specimen	O
is	O
a	O
separate	O
piece	O
of	O
skin	O
and	O
underlying	O
subcutaneous	O
tisaue	O
14	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
1	O
.	O
5	O
.	O

cm	O
.	O
sectioning	O
cut	O
surface	O
is	O
yellow	O
-	O
tan	O
fatty	O
fibroadipose	O
tissue	O
lesions	O
not	O
identified	O
grossly	O
.	O

Received	O
with	O
specimen	O
are	O
three	O
cassettes	O
labeled	O
.	O
with	O
.	O

a	O
.	O
yellow	O
.	O

one	O
.	O
additionally	O
.	O

labeled	O
-	O
16	O
green	O
one	O
additionally	O
labeled	O
-	O
17	O
and	O
the	O
blue	O
one	O
additionally	O
labeled	O
-	O
18	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
cassettes	O
labeled	O
.	O
las	O
follows	O
:	O
Nipple	O
-	O
block	O
1	O
;	O
Deep	O
margin	O
overlying	O
mass	O
-	O
block	O
2	O
;	O
Sections	O
from	O
the	O
mass	O
-	O
.	O
blocks	O
3	O
-	O
8	O
;	O
Random	O
sections	O
from	O
the	O
upper	O
inner	O
quadrant	O
-	O
block	O
9	O
;	O
Lower	O
inner	O
quadrant	O
-	O
block	O
10	O
;	O
Lower	O
outer	O
quadrant	O
-	O
block	O
11	O
;	O
Upper	O
outer	O
.	O
quadrant	O
-	O
block	O
12	O
;	O
Six	O
probable	O
nodes	O
-	O
block	O
13	O
;	O
Two	O
probable	O
nodes	O
each	O
bisected	O
-	O
block	O
14	O
;	O
One	O
probable	O
node	O
bisected	O
block	O
15	O
;	O
One	O
probable	O
.	O
node	O
.	O

trisected	O
-	O
block	O
16	O
-	O
18	O
;	O
One	O
probable	O
node	O
bisected	O
-	O
block	O
19	O
;	O
One	O
probable	O
lymph	O
node	O
sectioned	O
-	O
blocks	O
20	O
-	O
23	O
;	O
Sections	O
from	O
separately	O
.	O

PROCEDURE	O
DATE	O
:	O
REPORT	O
DATE	O
:	O
10	O
Consultation	O
.	O

FS	O
DIAGNOSIS	O
:	O
#	O
1	O
:	O
"	O
No	O
neoplasm	O
consistent	O
with	O
organizing	O
pneumonia	O
"	O
reported	O
to	O
.	O

Dr	O
.	O
positive	O
patient	O
ID	O
,	O
by	O
Dr	O
.	O
Campus	O
.	O

#	O
2	O
:	O
"	O
Adenocarcinoma	O
"	O
reported	O
to	O
Dr	O
.	O
positive	O
patient	O
.	O

ID	O
,	O
by	O
Dr	O
.	O
Pre	O
-	O
Op	O
Diagnosis	O
.	O

Right	O
lower	O
and	O
upper	O
lobe	O
mass	O
.	O

Post	O
-	O
Op	O
Diagnosis	O
.	O

Same	O
as	O
above	O
.	O

Clinical	O
History	O
.	O

Nothing	O
indicated	O
.	O

Gross	O
Description	O
:	O
Five	O
parts	O
.	O

Container	O
labeled	O
.	O

1	O
-	O
right	O
lower	O
lobe	O
wedge	O
#	O
1	O
"	O
.	O

is	O
a	O
previously	O
sectioned	O
wedge	O
shaped	O
portion	O
of	O
recognizable	O
.	O
pulmonary	O
parenchyma	O
with	O
a	O
closed	O
staple	O
line	O
as	O
the	O
margin	O
of	O
.	O
resection	O
.	O

The	O
specimen	O
as	O
received	O
weighs	O
4	O
.	O
3	O
grams	O
and	O
on	O
.	O
reconstruction	O
measures	O
approximately	O
4	O
.	O
5	O
x	O
1	O
.	O
6	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
.	O
pleura	O
is	O
wrinkled	O
gray	O
red	O
.	O

The	O
cut	O
surface	O
is	O
rubbery	O
to	O
spongy	O
.	O
and	O
pink	O
red	O
without	O
discrete	O
gross	O
mass	O
lesion	O
.	O

The	O
portion	O
.	O
submitted	O
for	O
frozen	O
section	O
is	O
reported	O
as	O
"	O
no	O
neoplasm	O
consistent	O
.	O
with	O
organizing	O
pneumonia	O
"	O
reported	O
to	O
.	O
positive	O
.	O

patient	O
ID	O
,	O
by	O
.	O

The	O
frozen	O
residue	O
is	O
submitted	O
labeled	O
.	O

A	O
.	O

The	O
remaining	O
tissue	O
is	O
sectioned	O
and	O
submitted	O
labeled	O
B	O
-	O
D	O
.	O

Container	O
labeled	O
.	O

2	O
-	O
right	O
lower	O
lobe	O
wedge	O
#	O
2	O
"	O
.	O

is	O
a	O
previously	O
sectioned	O
partially	O
fragmented	O
wedge	O
shaped	O
portion	O
.	O
of	O
recognizable	O
pulmonary	O
parenchyma	O
weighing	O
as	O
received	O
22	O
grams	O
.	O
and	O
on	O
reconstruction	O
measures	O
approximately	O
5	O
.	O
7	O
X	O
4	O
.	O
2	O
x	O
3	O
.	O
0	O
cm	O
.	O
the	O
closed	O
staple	O
line	O
is	O
the	O
margin	O
of	O
resection	O
.	O

The	O
pleura	O
is	O
.	O
wrinkled	O
gray	O
pink	O
with	O
an	O
eccentric	O
2	O
.	O
5	O
X	O
2	O
.	O
5	O
cm	O
plaque	O
like	O
area	O
.	O
of	O
tan	O
gray	O
discoloration	O
and	O
umbilication	O
noted	O
0	O
.	O
8	O
cm	O
from	O
the	O
.	O
nearest	O
staple	O
line	O
margin	O
.	O

This	O
is	O
sectioned	O
to	O
reveal	O
a	O
well	O
.	O
defined	O
lobulated	O
gritty	O
gray	O
tan	O
fibrotic	O
lesion	O
with	O
focally	O
.	O
anthracotic	O
gritty	O
gray	O
tan	O
fibrotic	O
cut	O
surface	O
measuring	O
2	O
.	O
7	O
x	O
2	O
.	O
5	O
.	O

x	O
2	O
.	O
0	O
cm	O
.	O

This	O
grossly	O
extends	O
to	O
but	O
not	O
through	O
the	O
pleura	O
.	O

The	O
.	O
remaining	O
parenchyma	O
is	O
spongy	O
and	O
pink	O
red	O
.	O

The	O
portion	O
submitted	O
.	O
for	O
frozen	O
section	O
is	O
reported	O
as	O
"	O
adenocarcinoma	O
"	O
reported	O
to	O
Dr	O
.	O
ositive	O
patient	O
ID	O
,	O
by	O
Dr	O
.	O
In	O
addition	O
,	O
there	O
.	O
are	O
three	O
tissue	O
cassettes	O
within	O
the	O
specimen	O
container	O
labeled	O
.	O

The	O
frozen	O
residue	O
is	O
submitted	O
labeled	O
A	O
.	O

The	O
.	O
remaining	O
lesion	O
and	O
surrounding	O
tissue	O
is	O
submitted	O
labeled	O
B	O
-	O
H	O
.	O

Representative	O
remaining	O
parenchyma	O
is	O
submitted	O
labeled	O
I	O
-	O
J	O
.	O

Container	O
labeled	O
.	O

3	O
-	O
right	O
upper	O
lobe	O
wedge	O
"	O
.	O
has	O
a	O
15	O
gram	O
wedge	O
shaped	O
portion	O
of	O
recognizable	O
pulmonary	O
.	O
parenchyma	O
with	O
a	O
closed	O
staple	O
line	O
as	O
the	O
margin	O
of	O
resection	O
.	O

The	O
specimen	O
is	O
6	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
1	O
cm	O
.	O

The	O
pleura	O
is	O
slightly	O
wrinkled	O
.	O
pink	O
red	O
with	O
marked	O
anthracotic	O
streaking	O
and	O
a	O
few	O
areas	O
of	O
.	O
apparent	O
plaque	O
like	O
thickening	O
up	O
to	O
0	O
.	O
8	O
cm	O
which	O
are	O
poorly	O
.	O
defined	O
.	O

On	O
sectioning	O
in	O
the	O
central	O
portion	O
of	O
the	O
specimen	O
there	O
.	O

is	O
an	O
intraparenchymal	O
1	O
.	O
0	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
7	O
cm	O
lobulated	O
gray	O
tan	O
.	O
fibrotic	O
nodular	O
lesion	O
noted	O
0	O
.	O
4	O
cm	O
from	O
the	O
nearest	O
staple	O
line	O
.	O
margin	O
.	O

This	O
has	O
a	O
gritty	O
gray	O
tan	O
fibrotic	O
cut	O
surface	O
.	O

The	O
.	O
remaining	O
parenchyma	O
is	O
spongy	O
congested	O
and	O
markedly	O
anthracotic	O
.	O
streaked	O
with	O
moderate	O
honeycombing	O
.	O

The	O
specimen	O
is	O
step	O
sectioned	O
.	O
and	O
entirely	O
submitted	O
in	O
10	O
cassettes	O
.	O

Container	O
labeled	O
.	O

4	O
-	O
level	O
4	O
lymph	O
node	O
"	O
are	O
.	O

1	O
.	O
6	O
X	O
1	O
.	O
0	O
x	O
0	O
.	O
3	O
cm	O
of	O
gray	O
brown	O
to	O
black	O
fleshy	O
tissue	O
fragments	O
.	O
which	O
are	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O

5	O
-	O
level	O
7	O
lymph	O
node	O
"	O
are	O
.	O

4	O
.	O
0	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
1	O
cm	O
partially	O
fragmented	O
lobulated	O
portion	O
of	O
fleshy	O
.	O
gray	O
black	O
tissue	O
with	O
a	O
slightly	O
mottled	O
fleshy	O
gray	O
black	O
cut	O
.	O
surface	O
.	O

This	O
is	O
received	O
along	O
with	O
1	O
.	O
2	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
4	O
cm	O
of	O
similar	O
.	O
irregular	O
tissue	O
fragments	O
.	O

The	O
largest	O
portion	O
is	O
sectioned	O
and	O
.	O
submitted	O
labeled	O
A	O
-	O
E	O
while	O
the	O
smaller	O
portion	O
is	O
entirely	O
.	O
submitted	O
labeled	O
F	O
.	O

Microscopic	O
Description	O
:	O
Sections	O
of	O
specimen	O
#	O
2	O
show	O
a	O
large	O
cell	O
malignant	O
neoplasm	O
that	O
in	O
.	O
areas	O
shows	O
prominent	O
gland	O
formation	O
.	O

These	O
glandular	O
area	O
blend	O
.	O
into	O
more	O
solid	O
nests	O
of	O
neoplastic	O
cells	O
.	O

These	O
are	O
supported	O
by	O
a	O
.	O
dense	O
fibrous	O
stroma	O
and	O
alternate	O
with	O
areas	O
of	O
necrosis	O
.	O

The	O
.	O
neoplasm	O
extends	O
into	O
the	O
pleural	O
but	O
not	O
onto	O
the	O
pleural	O
surface	O
.	O

Sections	O
of	O
the	O
neoplasm	O
within	O
the	O
right	O
upper	O
lobe	O
specimen	O
#	O
3	O
.	O
show	O
a	O
large	O
cell	O
malignant	O
neoplasm	O
with	O
a	O
distinctly	O
different	O
.	O
growth	O
pattern	O
.	O

In	O
this	O
neoplasm	O
the	O
cells	O
form	O
sheets	O
that	O
have	O
.	O
irregular	O
borders	O
.	O

The	O
cells	O
have	O
a	O
moderate	O
amount	O
of	O
eosinophilic	O
.	O
cytoplasm	O
and	O
enlarged	O
pleomorphic	O
nuclei	O
.	O

Sections	O
of	O
the	O
lymph	O
node	O
specimens	O
show	O
no	O
areas	O
of	O
metastatic	O
.	O
carcinoma	O
.	O

Immunohistochemical	O
stains	O
are	O
performed	O
on	O
the	O
neoplasm	O
in	O
the	O
.	O
right	O
lower	O
lobe	O
specimen	O
and	O
right	O
upper	O
lobe	O
specimen	O
.	O

The	O
right	O
.	O
lower	O
lobe	O
specimen	O
shows	O
the	O
neoplasm	O
to	O
be	O
positive	O
for	O
CK7	O
and	O
.	O
negative	O
for	O
CK20	O
.	O

Some	O
of	O
the	O
cells	O
are	O
strongly	O
positive	O
for	O
.	O

TTF1	O
.	O

These	O
are	O
in	O
the	O
more	O
glandular	O
areas	O
.	O

The	O
more	O
solid	O
areas	O
.	O
are	O
negative	O
for	O
this	O
marker	O
.	O

The	O
more	O
solid	O
areas	O
do	O
express	O
.	O
positivity	O
for	O
CDX	O
-	O
2	O
where	O
the	O
glandular	O
areas	O
tend	O
to	O
be	O
negative	O
.	O
for	O
this	O
marker	O
.	O

The	O
cells	O
are	O
negative	O
for	O
p63	O
.	O

This	O
staining	O
.	O
pattern	O
would	O
support	O
this	O
being	O
an	O
adenocarcinoma	O
of	O
pulmonary	O
.	O
origin	O
.	O

It	O
is	O
unclear	O
why	O
some	O
of	O
the	O
cells	O
mark	O
with	O
the	O
.	O
colorectal	O
marker	O
CDX	O
-	O
2	O
.	O

This	O
same	O
panel	O
performed	O
on	O
the	O
right	O
.	O
upper	O
lobe	O
specimen	O
show	O
the	O
neoplastic	O
cells	O
to	O
be	O
negative	O
for	O
.	O
both	O
CK7	O
and	O
CK20	O
.	O

The	O
cells	O
are	O
negative	O
for	O
CDX	O
-	O
2	O
and	O
TTF1	O
.	O

The	O
.	O
cells	O
are	O
strongly	O
positive	O
for	O
p63	O
.	O

This	O
staining	O
pattern	O
would	O
.	O
support	O
this	O
being	O
a	O
squamous	O
carcinoma	O
that	O
is	O
very	O
poorly	O
.	O
differentiated	O
.	O

The	O
immunohistochemical	O
control	O
slides	O
stain	O
.	O
appropriately	O
.	O

Final	O
Diagnosis	O
.	O

Right	O
lung	O
lower	O
lobe	O
wedge	O
biopsy	O
#	O
1	O
with	O
frozen	O
section	O
:	O
Negative	O
for	O
carcinoma	O
.	O

Alveolar	O
changes	O
focally	O
with	O
pneumocyte	O
hyperplasia	O
consistent	O
.	O
with	O
organizing	O
pneumonia	O
.	O
and	O
atelectasis	O
.	O

Frozen	O
section	O
diagnosis	O
is	O
confirmed	O
.	O

Lung	O
,	O
right	O
lower	O
lobe	O
wedge	O
biopsy	O
#	O
2	O
with	O
frozen	O
section	O
:	O
Tumor	O
characteristics	O
:	O
Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
7	I
x	I
2	I
.	I
5	I
x	I
2	I
.	I
0	I
cm	I
.	O

Tumor	O
focality	O
:	O
Single	O
focus	O
of	O
right	O
lower	O
lobe	O
.	O

Visceral	O
pleural	O
invasion	O
:	O
Yes	O
(	O
PL1	O
)	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

Tumor	O
extension	O
:	O
Not	O
identified	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
.	O

Surgical	O
margin	O
status	O
:	O
Tumor	O
distance	O
from	O
bronchial	O
margin	O
:	O
Not	O
applicable	O
.	O

Tumor	O
distance	O
from	O
stapled	O
margin	O
:	O
0	O
.	O
8	O
cm	O
.	O

Lymph	O
node	O
status	O
:	O
See	O
specimens	O
four	O
and	O
five	O
.	O

Lung	O
,	O
right	O
upper	O
lobe	O
,	O
wedge	O
biopsy	O
:	O
Histologic	O
type	O
:	O
Poorly	O
differentiated	O
squamous	O
carcinoma	O
(	O
see	O
.	O
above	O
comments	O
)	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
site	O
:	O
Right	O
upper	O
lobe	O
.	O

Tumor	O
focality	O
:	O
Right	O
upper	O
lobe	O
,	O
single	O
focus	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
0	I
x	I
0	I
.	I
9	I
x	I
0	I
.	I
7	I
cm	I
.	O

Visceral	O
pleural	O
invasion	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
No	O
.	O

Tumor	O
extension	O
:	O
No	O
.	O

Treatment	O
effect	O
:	O
Not	O
identified	O
.	O

Surgical	O
margin	O
status	O
:	O
Tumor	O
distance	O
from	O
bronchial	O
margin	O
:	O
Not	O
applicable	O
.	O

Tumor	O
distance	O
from	O
parenchymal	O
stapled	O
margin	O
:	O
0	O
.	O
4	O
cm	O
.	O

Tumor	O
distance	O
from	O
pleural	O
surface	O
:	O
0	O
.	O
8	O
cm	O
(	O
as	O
measured	O
on	O
.	O
histologic	O
sections	O
)	O
.	O

Lymph	O
node	O
status	O
:	O
See	O
specimens	O
four	O
and	O
five	O
.	O

Lymph	O
node	O
level	O
4	O
,	O
excisional	O
biopsy	O
:	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

Lymph	O
node	O
level	O
7	O
,	O
excisional	O
biopsy	O
:	O
Negative	O
for	O
tumor	O
(	O
0	O
/	O
1	O
)	O
.	O

Pathology	O
stage	O
:	O
Comments	O
.	O

The	O
tumor	O
morphology	O
present	O
in	O
specimen	O
three	O
shows	O
focal	O
areas	O
.	O
with	O
morphology	O
compatible	O
with	O
a	O
poorly	O
differentiated	O
.	O
adenocarcinoma	O
.	O

The	O
possibility	O
of	O
focal	O
squamous	O
differentiation	O
.	O
cannot	O
be	O
completely	O
excluded	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
79	O
y	O
/	O
o	O
male	O
with	O
left	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
Left	O
,	O
Total	O
nephrectomy	O
:	O
2	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
Left	O
suprahilar	O
and	O
hilarand	O
left	O
adrenal	O
,	O
resection	O
.	O

3	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
Para	O
-	O
arotic	O
,	O
excision	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Kidnoy	O
,	O
Left	O
,	O
Total	O
nephrectomy	O
:	O
Tumor	O
Type	O
:	O
Renal	O
coll	O
carcinoma	O
.	O

Papillary	O
type	O
.	O

Type	O
2	O
.	O

Fuhrman	O
Nuclear	O
Grade	O
:	O
Nuclear	O
grade	O
III	O
/	O
IV	O
.	O

Tumor	O
Size	O
.	O

Greatest	O
diameter	O
is	O
7	B
.	I
5	I
cm	I
,	O
.	O

Local	O
Invasion	O
(	O
for	O
renal	O
cortical	O
types	O
)	O
:	O
Extends	O
through	O
renal	O
capsule	O
but	O
confined	O
within	O
Gerota	O
'	O
s	O
fascia	O
.	O

Renal	O
Vein	O
Invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Non	O
-	O
Neoplastic	O
Kidney	O
:	O
Chronic	O
inflammation	O
.	O

Adrenal	O
Gland	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Not	O
identified	O
.	O

Staging	O
for	O
renal	O
cell	O
carcinoma	O
/	O
oncocytoma	O
:	O
pT3a	O
Tumor	O
invades	O
the	O
adrenal	O
gland	O
or	O
perinephric	O
tissues	O
but	O
not	O
beyond	O
Gerota	O
'	O
s	O
fascia	O
.	O

2	O
.	O

Lymph	O
nodes	O
,	O
left	O
suprahilar	O
and	O
hilar	O
and	O
left	O
adrenal	O
,	O
resection	O
:	O
-	O
Renal	O
cell	O
carcinoma	O
,	O
papillary	O
type	O
involving	O
perirenal	O
adipose	O
tissue	O
.	O

-	O
Unremarkable	O
adrenal	O
gland	O
.	O

3	O
SP	O
:	O
Lymph	O
nodes	O
,	O
Para	O
-	O
arotic	O
,	O
excisioni	O
.	O
lymph	O
Nodes	O
:	O
Number	O
of	O
nodes	O
examined	O
:	O
T1	O
.	O

Number	O
of	O
metastatic	O
nodes	O
:	O
6	O
.	O

The	O
largest	O
metastatic	O
node	O
is	O
3	O
.	O
5cm	O
.	O

Perinodal	O
(	O
extracapsular	O
)	O
extension	O
identified	O
.	O

TATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
is	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
ANDIOR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
THAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
left	O
kidney	O
"	O
and	O
consists	O
of	O
a	O
kidney	O
with	O
attached	O
ureter	O
,	O
renal	O
vessels	O
and	O
perinephric	O
.	O
fat	O
weighing	O
285	O
9	O
in	O
total	O
.	O

The	O
kidney	O
measures	O
10	O
.	O
0	O
x	O
6	O
.	O
5	O
x	O
4	O
.	O
5	O
cm	O
.	O

The	O
attached	O
ureter	O
measures	O
2	O
,	O
5	O
cm	O
in	O
length	O
and	O
0	O
.	O
5	O
cm	O
.	O
in	O
diameter	O
.	O

The	O
attached	O
renal	O
vein	O
measures	O
0	O
.	O
8	O
cm	O
in	O
length	O
and	O
0	O
.	O
7	O
cm	O
in	O
diameter	O
.	O

The	O
renal	O
vessels	O
and	O
ureter	O
margins	O
are	O
.	O
grossly	O
unremarkable	O
.	O

An	O
adrenal	O
gland	O
is	O
not	O
identified	O
grossly	O
.	O

The	O
kidney	O
is	O
inked	O
black	O
and	O
bivalved	O
to	O
reveal	O
an	O
ill	O
-	O
defined	O
.	O
bright	O
-	O
yellow	O
tumor	O
,	O
located	O
at	O
mid	O
portion	O
of	O
kidney	O
and	O
protruding	O
out	O
and	O
involving	O
the	O
perinephric	O
fat	O
,	O
measuring	O
7	B
.	I
5	I
x	I
5	I
.	I
5	I
x	I
5	I
.	I
0	I
.	I

cm	B
.	O

Sections	O
through	O
the	O
remainder	O
of	O
the	O
kidney	O
reveal	O
a	O
pink	O
brown	O
parenchyma	O
,	O
with	O
a	O
well	O
-	O
defined	O
cortico	O
-	O
medullary	O
junction	O
.	O

The	O
cortex	O
measures	O
1	O
.	O
0	O
cm	O
and	O
the	O
calyces	O
appear	O
normal	O
.	O

No	O
lymph	O
nodes	O
are	O
identified	O
in	O
the	O
perinephric	O
fat	O
.	O

Representative	O
sections	O
are	O
submitted	O
for	O
TPS	O
and	O
for	O
permanent	O
sections	O
.	O

Summary	O
of	O
sections	O
:	O
UVM	O
-	O
-	O
ureteral	O
and	O
vessel	O
margins	O
.	O

T	O
-	O
.	O
tumor	O
.	O

THF	O
tumor	O
with	O
hilar	O
fat	O
.	O

TSF	O
-	O
-	O
tumor	O
with	O
sinus	O
fat	O
.	O

TK	O
-	O
-	O
tumor	O
with	O
adjacent	O
kidney	O
.	O

RP	O
renal	O
pelvis	O
representative	O
sections	O
.	O

K	O
-	O
-	O
representative	O
sections	O
kidney	O
.	O

F	O
-	O
hilar	O
fat	O
.	O

2	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
"	O
Left	O
suprahilar	O
,	O
and	O
hilar	O
lymph	O
node	O
and	O
left	O
adrenal	O
"	O
.	O

It	O
consists	O
of	O
a	O
segment	O
of	O
.	O
yellow	O
-	O
tan	O
fatty	O
lobular	O
tissue	O
containing	O
the	O
adrenal	O
gland	O
and	O
adjacent	O
encapsulated	O
,	O
seemingly	O
intact	O
red	O
-	O
brown	O
mass	O
.	O

The	O
.	O
overall	O
dimensions	O
of	O
the	O
specimen	O
are	O
14	O
.	O
5x5	O
:	O
x	O
3	O
cm	O
.	O

The	O
adrenal	O
measures	O
4	O
.	O
5	O
x	O
1	O
.	O
2	O
x	O
1	O
.	O
0	O
cm	O
,	O
and	O
on	O
cut	O
section	O
shows	O
.	O
unremarkable	O
yellow	O
orange	O
appearance	O
.	O

The	O
red	O
-	O
brown	O
mass	O
measures	O
4	O
4x3	O
cm	O
,	O
is	O
located	O
directly	O
adjacent	O
to	O
the	O
adrenal	O
.	O
gland	O
,	O
but	O
does	O
not	O
show	O
any	O
definite	O
involvement	O
of	O
the	O
gland	O
.	O

The	O
outer	O
surface	O
of	O
the	O
mass	O
is	O
inked	O
black	O
.	O

On	O
cul	O
section	O
of	O
.	O
the	O
mass	O
,	O
it	O
shows	O
cystic	O
,	O
markedly	O
friable	O
dark	O
red	O
hemorrhagic	O
appearance	O
filled	O
with	O
hemorrhagic	O
material	O
No	O
lymph	O
nodes	O
are	O
.	O
grossly	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
A	O
sample	O
of	O
the	O
mass	O
is	O
given	O
to	O
TPS	O
.	O

The	O
specimen	O
has	O
been	O
.	O
photographed	O
.	O

Summary	O
of	O
sections	O
:	O
ADR	O
-	O
adrenal	O
.	O

M	O
-	O
Mass	O
.	O

ADRM	O
-	O
adrenal	O
and	O
mass	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
Para	O
-	O
aortic	O
lymph	O
nodes	O
.	O

It	O
consists	O
of	O
multiple	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
3	O
.	O

x	O
0	O
.	O
3	O
cm	O
up	O
to	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimensions	O
.	O

Cut	O
section	O
of	O
one	O
of	O
the	O
largest	O
lymph	O
nodes	O
shows	O
mottled	O
yellow	O
orange	O
lo	O
.	O
black	O
appearance	O
.	O

Representative	O
sections	O
of	O
this	O
and	O
one	O
of	O
the	O
lymph	O
node	O
are	O
submitted	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
.	O
quadrisected	O
to	O
show	O
predominantly	O
yellow	O
-	O
tan	O
fally	O
lobular	O
appearance	O
with	O
focal	O
firm	O
white	O
-	O
tan	O
areas	O
.	O

After	O
the	O
largest	O
lymph	O
.	O
node	O
is	O
quadrisected	O
,	O
each	O
of	O
the	O
sections	O
is	O
bisected	O
.	O

The	O
remainder	O
of	O
the	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
A	O
-	O
section	O
of	O
largest	O
lymph	O
node	O
,	O
bisected	O
.	O

B	O
-	O
section	O
of	O
largest	O
lymph	O
node	O
,	O
bisected	O
.	O

C	O
-	O
section	O
of	O
largest	O
lymph	O
node	O
,	O
bisected	O
.	O

D	O
-	O
section	O
of	O
largest	O
lymph	O
node	O
,	O
bisected	O
.	O

RS1	O
-	O
representative	O
sections	O
of	O
one	O
of	O
the	O
largest	O
lymph	O
nodes	O
.	O

RS2	O
-	O
representative	O
section	O
of	O
one	O
of	O
the	O
largest	O
lymph	O
nodes	O
,	O
bisected	O
.	O

LN	O
-	O
lymph	O
nodes	O
.	O

BLN1	O
-	O
bisected	O
lymph	O
node	O
1	O
.	O

BLN2	O
-	O
bisected	O
lymph	O
node	O
2	O
.	O

BLN3	O
-	O
bisected	O
lymph	O
node	O
3	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
Left	O
,	O
Total	O
nephrectomy	O
:	O
Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

1	O
.	O

1	O
.	O

k	O
.	O

1	O
.	O

1	O
.	O

1	O
.	O

5	O
.	O

5	O
.	O

1	O
.	O
thf	O
.	O

1	O
.	O

1	O
.	O

tk	O
.	O

1	O
.	O

1	O
.	O
itsf	O
.	O

1	O
.	O

1	O
.	O
uvm	O
.	O

1	O
.	O

Part	O
.	O

2	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
Left	O
suprahilar	O
and	O
hilar	O
and	O
left	O
adrenal	O
,	O
resection	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O
adr	O
.	O

3	O
.	O

1	O
.	O
adrm	O
.	O

5	O
.	O

m	O
.	O

5	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Lymph	O
nodes	O
,	O
Para	O
-	O
arotic	O
,	O
excision	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O

a	O
.	O

2	O
.	O

2	O
.	O

b	O
.	O

2	O
.	O

1	O
.	O

bIn	O
1	O
.	O

1	O
.	O

1	O
.	O

bln2	O
.	O

1	O
.	O

1	O
.	O

bln3	O
.	O

1	O
.	O

2	O
.	O

c	O
.	O

2	O
.	O

2	O
.	O

d	O
.	O

2	O
.	O

1	O
.	O

In	O
.	O

1	O
.	O

2	O
.	O

rs1	O
.	O

2	O
.	O

2	O
.	O

rs2	O
.	O

2	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
VENTRAL	O
TONGUE	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

2	O
)	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

3	O
)	O
TONGUE	O
,	O
DORSAL	O
ANTERIOR	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

4	O
)	O
TONGUE	O
,	O
DORSAL	O
POSTERIOR	O
MARGIN	O
,	O
EXCISION	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
.	O

5	O
)	O
TONGUE	O
,	O
LEFT	O
,	O
HEMIGLOSSECTOMY	O
:	O
MODERATELY	O
-	O
DIFFERENTIATED	O
SQUAMOUS	O
CELL	O
.	O

CARCINOMA	O
,	O
2	B
.	I
5	I
CM	I
IN	O
GREATEST	O
EXTENT	O
,	O
PERINEURAL	O
INVASION	O
PRESENT	O
,	O
.	O

EXTENDING	O
TO	O
WITHIN	O
0	O
.	O
3	O
CM	O
OF	O
MEDIAL	O
MARGIN	O
AND	O
0	O
.	O
4	O
CM	O
OF	O
DEEP	O
MARGIN	O
,	O
ALL	O
.	O

SURGICAL	O
MARGINS	O
NEGATIVE	O
FOR	O
TUMOR	O
;	O
SEE	O
COMMENT	O
AND	O
SUMMARY	O
FINDINGS	O
.	O

6	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
,	O
LEVEL	O
1B	O
,	O
EXCISION	O
:	O
8	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
.	O

MALIGNANCY	O
(	O
0	O
/	O
8	O
)	O
;	O
BENIGN	O
SALIVARY	O
TISSUE	O
.	O

7	O
)	O
LYMPH	O
NODES	O
,	O
LEFT	O
NECK	O
,	O
LEVEL	O
2	O
&	O
3	O
,	O
EXCISION	O
:	O
14	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
.	O

FOR	O
MALIGNANCY	O
(	O
0	O
/	O
14	O
)	O
.	O

COMMENT	O
:	O
These	O
findings	O
correspond	O
to	O
AJCC	O
.	O

Edition	O
pathologic	O
Stage	O
II	O
.	O

(	O
pT2	O
,	O
NO	O
,	O
M	O
n	O
/	O
a	O
)	O
.	O

Upper	O
Aerodigestive	O
Tract	O
-	O
including	O
Minor	O
Salivary	O
Glands	O
,	O
Lip	O
,	O
Oral	O
.	O
cavity	O
,	O
Nasal	O
Cavity	O
,	O
Paranasal	O
Sinuses	O
,	O
Oropharynx	O
,	O
Nasopharynx	O
,	O
and	O
.	O

Hypopharynx	O
Summary	O
of	O
Findings	O
:	O
Specimen	O
Type	O
:	O
hemiglossectomy	O
.	O

Tumor	O
Site	O
:	O
left	O
tongue	O
.	O

Tumor	O
Size	O
:	O
2	B
.	I
5	I
cm	I
in	O
greatest	O
dimension	O
.	O

Laterality	O
:	O
X	O
Left	O
.	O

X	O
.	O

Margin	O
uninvolved	O
by	O
invasive	O
carcinoma	O
extending	O
to	O
within	O
0	O
.	O
3	O
cm	O
of	O
.	O
medial	O
margin	O
,	O
0	O
.	O
4	O
cm	O
of	O
deep	O
margin	O
.	O

(	O
Specify	O
distance	O
to	O
closest	O
margins	O
)	O
.	O

Histologic	O
Type	O
:	O
squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
Grade	O
:	O
moderately	O
differentiated	O
.	O

Pathologic	O
Staging	O
(	O
pTMN	O
)	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNO	O
.	O

Number	O
examined	O
:	O
22	O
.	O

Numbered	O
involved	O
:	O
0	O
.	O

Perineural	O
invasion	O
:	O
(	O
Select	O
one	O
)	O
.	O

X	O
Yes	O
.	O

Bony	O
/	O
Cartilage	O
Invasion	O
:	O
(	O
Select	O
one	O
)	O
.	O

X	O
.	O

Not	O
evaluable	O
.	O

Lymph	O
-	O
Vascular	O
invasion	O
:	O
(	O
Select	O
one	O
)	O
.	O

X	O
.	O

HPV	O
testing	O
ordered	O
:	O
NO	O
(	O
performed	O
on	O
oral	O
cavity	O
and	O
oropharyngeal	O
.	O
squamous	O
cell	O
carcinomas	O
)	O
.	O

CLINICAL	O
DATA	O
.	O

Clinical	O
Features	O
:	O
Unspecified	O
.	O

Operator	O
:	O
Operation	O
:	O
Unspecified	O
.	O

Operative	O
Findings	O
:	O
Unspecified	O
.	O

Operative	O
Diagnosis	O
:	O
Unspecified	O
.	O

Tissue	O
Submitted	O
:	O
1	O
)	O
ventral	O
tongue	O
margin	O
;	O
2	O
)	O
floor	O
of	O
mouth	O
.	O
margin	O
;	O
3	O
)	O
dorsal	O
anterior	O
tongue	O
margin	O
;	O
.	O

4	O
)	O
dorsal	O
posterior	O
tongue	O
margin	O
;	O
5	O
)	O
left	O
.	O
glossectomy	O
;	O
6	O
)	O
left	O
neck	O
level	O
1B	O
;	O
7	O
)	O
left	O
.	O
neck	O
level	O
2	O
&	O
3	O
.	O

GROSS	O
DESCRIPTION	O
:	O
1	O
)	O
SOURCE	O
:	O
Ventral	O
Tongue	O
Margin	O
.	O

Received	O
fresh	O
for	O
intraoperative	O
consultation	O
in	O
a	O
container	O
identified	O
.	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
is	O
a	O
sample	O
labeled	O
.	O

"	O
ventral	O
tongue	O
margin	O
.	O
"	O
The	O
sample	O
consists	O
of	O
a	O
3	O
.	O
0	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
cm	O
thin	O
.	O
strip	O
of	O
skin	O
.	O

The	O
sample	O
is	O
bisected	O
(	O
inked	O
green	O
where	O
sample	O
is	O
.	O
bisected	O
)	O
and	O
submitted	O
in	O
entirety	O
for	O
frozen	O
section	O
analysis	O
.	O

The	O
tissue	O
.	O
block	O
was	O
fragmented	O
during	O
frozen	O
section	O
analysis	O
and	O
specimen	O
was	O
.	O
refrozen	O
.	O

The	O
remainder	O
of	O
the	O
sample	O
is	O
submitted	O
in	O
entirety	O
for	O
.	O
permanent	O
sections	O
.	O

Summary	O
of	O
sections	O
:	O
1AFSC	O
,	O
2	O
/	O
1	O
.	O

2	O
)	O
SOURCE	O
:	O
Floor	O
of	O
Mouth	O
Margin	O
.	O

Received	O
fresh	O
for	O
intraoperative	O
consultation	O
in	O
a	O
container	O
identified	O
.	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
is	O
a	O
sample	O
labeled	O
.	O

"	O
floor	O
of	O
mouth	O
margin	O
.	O
'	O
The	O
sample	O
consists	O
of	O
a	O
3	O
.	O
8	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
.	O
portion	O
of	O
skin	O
with	O
associated	O
soft	O
tissue	O
.	O

The	O
sample	O
is	O
bisected	O
(	O
area	O
.	O
where	O
sample	O
is	O
bisected	O
is	O
inked	O
green	O
)	O
.	O

The	O
sample	O
is	O
then	O
submitted	O
in	O
.	O
entirety	O
for	O
frozen	O
section	O
analysis	O
and	O
the	O
remainder	O
for	O
permanent	O
.	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
2AFSC	O
,	O
4	O
/	O
1	O
.	O

3	O
)	O
SOURCE	O
:	O
Dorsal	O
Anterior	O
Tongue	O
Margin	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
dorsal	O
.	O
anterior	O
tongue	O
margin	O
"	O
is	O
a	O
single	O
fragment	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O
measuring	O
4	O
.	O
0	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
and	O
containing	O
a	O
pink	O
-	O
tan	O
mucosal	O
surface	O
.	O
along	O
one	O
edge	O
of	O
the	O
specimen	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
the	O
cut	O
edges	O
.	O
of	O
each	O
resulting	O
fragment	O
are	O
inked	O
in	O
black	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
.	O
its	O
entirety	O
for	O
frozen	O
section	O
evaluation	O
in	O
a	O
single	O
cassette	O
.	O

Summary	O
of	O
sections	O
:	O
3AFSC	O
,	O
2	O
/	O
1	O
.	O

4	O
)	O
SOURCE	O
:	O
Dorsal	O
Posterior	O
Tongue	O
Margin	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
dorsal	O
.	O
posterior	O
tongue	O
margin	O
"	O
is	O
a	O
single	O
fragment	O
of	O
unoriented	O
,	O
pink	O
-	O
tan	O
soft	O
.	O
tissue	O
,	O
which	O
measures	O
4	O
.	O
5	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
and	O
contains	O
a	O
pink	O
-	O
tan	O
mucosal	O
.	O
surface	O
along	O
one	O
edge	O
of	O
the	O
specimen	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
the	O
.	O
cut	O
edges	O
of	O
the	O
resulting	O
fragments	O
are	O
inked	O
in	O
black	O
.	O

The	O
specimen	O
is	O
.	O
submitted	O
in	O
its	O
entirety	O
for	O
frozen	O
section	O
evaluation	O
in	O
a	O
single	O
.	O
cassette	O
.	O

Summary	O
of	O
sections	O
:	O
4AFSC	O
,	O
2	O
/	O
1	O
.	O

5	O
)	O
SOURCE	O
:	O
Left	O
Glossectomy	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
.	O
glossectomy	O
,	O
stitch	O
=	O
anterior	O
"	O
is	O
a	O
hemiglossectomy	O
specimen	O
measuring	O
7	O
.	O

cm	O
from	O
anterior	O
to	O
posterior	O
X	O
5	O
.	O
5	O
cm	O
from	O
medial	O
to	O
lateral	O
X	O
3	O
cm	O
from	O
.	O
superior	O
to	O
inferior	O
.	O

A	O
surgical	O
suture	O
is	O
attached	O
to	O
one	O
aspect	O
of	O
the	O
.	O
specimen	O
,	O
which	O
is	O
consistent	O
anatomically	O
with	O
the	O
anterior	O
aspect	O
.	O

The	O
.	O
overlying	O
mucosal	O
surface	O
of	O
the	O
specimen	O
is	O
pink	O
-	O
tan	O
,	O
smooth	O
,	O
shiny	O
,	O
and	O
.	O
remarkable	O
for	O
an	O
area	O
of	O
central	O
ulceration	O
measuring	O
1	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
.	O

This	O
.	O
area	O
of	O
ulceration	O
overlies	O
a	O
palpable	O
,	O
firm	O
mass	O
exhibiting	O
approximate	O
,	O
.	O
palpable	O
dimensions	O
of	O
2	O
.	O
5	O
cm	O
from	O
anterior	O
to	O
posterior	O
X	O
2	O
.	O
0	O
cm	O
from	O
.	O
medial	O
to	O
lateral	O
X	O
1	O
.	O
5	O
cm	O
from	O
superior	O
to	O
inferior	O
.	O

The	O
opposite	O
surface	O
.	O
of	O
the	O
specimen	O
is	O
red	O
-	O
brown	O
and	O
focally	O
cauterized	O
.	O

The	O
specimen	O
is	O
inked	O
.	O
in	O
the	O
following	O
manner	O
:	O
anterior	O
orange	O
,	O
medial	O
purple	O
,	O
posterior	O
yellow	O
,	O
.	O
lateral	O
blue	O
,	O
and	O
deep	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
from	O
.	O
anterior	O
to	O
posterior	O
to	O
reveal	O
a	O
heterogeneous	O
,	O
white	O
-	O
tan	O
mass	O
with	O
focal	O
.	O
areas	O
of	O
hemorrhage	O
present	O
immediately	O
inferior	O
to	O
the	O
mucosal	O
surface	O
and	O
.	O
exhibiting	O
maximal	O
dimensions	O
of	O
2	O
.	O
5	O
cm	O
transversely	O
X	O
1	O
.	O
3	O
cm	O
in	O
maximal	O
.	O
depth	O
X	O
1	O
.	O
5	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
mass	O
appears	O
to	O
extend	O
to	O
.	O
within	O
1	O
.	O
4	O
cm	O
of	O
the	O
medial	O
surgical	O
margin	O
,	O
1	O
cm	O
of	O
the	O
lateral	O
surgical	O
.	O
margin	O
,	O
1	O
cm	O
of	O
the	O
deep	O
surgical	O
margin	O
,	O
and	O
appears	O
widely	O
free	O
of	O
the	O
.	O
anterior	O
and	O
posterior	O
margins	O
.	O

Representative	O
sections	O
are	O
submitted	O
for	O
.	O
evaluation	O
.	O

Summary	O
of	O
sections	O
:	O
5A	O
-	O
5B	O
,	O
perpendicular	O
approach	O
to	O
medial	O
and	O
deep	O
.	O
margins	O
,	O
1	O
/	O
1	O
each	O
;	O
5C	O
,	O
perpendicular	O
approach	O
to	O
lateral	O
margin	O
,	O
1	O
/	O
1	O
;	O
5D	O
,	O
.	O
additional	O
approach	O
to	O
lateral	O
margin	O
,	O
1	O
/	O
1	O
;	O
5E	O
,	O
representative	O
tumor	O
,	O
1	O
/	O
1	O
;	O
.	O

5F	O
,	O
representative	O
perpendicular	O
approach	O
to	O
posterior	O
margin	O
,	O
1	O
/	O
1	O
;	O
5G	O
,	O
.	O
representative	O
approach	O
to	O
anterior	O
margin	O
,	O
1	O
/	O
1	O
.	O

6	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Level	O
1B	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
.	O
neck	O
level	O
1B	O
"	O
is	O
a	O
single	O
unoriented	O
fragment	O
of	O
pink	O
-	O
yellow	O
fibrofatty	O
.	O
tissue	O
,	O
which	O
measures	O
5	O
X	O
4	O
X	O
1	O
.	O
5	O
cm	O
.	O

A	O
thorough	O
lymph	O
node	O
search	O
is	O
.	O
performed	O
,	O
which	O
reveals	O
4	O
candidate	O
lymph	O
nodes	O
,	O
the	O
largest	O
of	O
which	O
.	O
measuring	O
1	O
cm	O
in	O
greatest	O
dimension	O
,	O
as	O
well	O
as	O
normal	O
-	O
appearing	O
salivary	O
.	O
tissue	O
measuring	O
4	O
X	O
2	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
.	O

The	O
salivary	O
tissue	O
is	O
serially	O
.	O
sectioned	O
to	O
reveal	O
a	O
homogenous	O
,	O
pink	O
-	O
tan	O
,	O
lobulated	O
cut	O
surface	O
with	O
no	O
.	O
masses	O
or	O
other	O
lesions	O
appreciated	O
.	O

Representative	O
sections	O
of	O
salivary	O
.	O
tissue	O
as	O
well	O
as	O
all	O
candidate	O
lymph	O
node	O
tissue	O
are	O
submitted	O
for	O
.	O
evaluation	O
.	O

Summary	O
of	O
sections	O
:	O
6A	O
,	O
representative	O
salivary	O
tissue	O
,	O
2	O
/	O
1	O
;	O
6B	O
,	O
4	O
.	O
candidate	O
lymph	O
nodes	O
,	O
4	O
/	O
1	O
;	O
6C	O
,	O
largest	O
candidate	O
lymph	O
node	O
bisected	O
,	O
2	O
/	O
1	O
.	O

7	O
)	O
SOURCE	O
:	O
Left	O
Neck	O
Level	O
2	O
&	O
3	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
left	O
.	O
neck	O
level	O
2	O
&	O
3	O
"	O
is	O
a	O
single	O
,	O
irregular	O
,	O
unoriented	O
fragment	O
of	O
pink	O
-	O
tan	O
.	O
soft	O
tissue	O
,	O
which	O
measures	O
8	O
X	O
5	O
X	O
1	O
.	O
0	O
cm	O
.	O

A	O
thorough	O
lymph	O
node	O
search	O
is	O
.	O
performed	O
,	O
which	O
reveals	O
12	O
candidate	O
lymph	O
nodes	O
,	O
the	O
largest	O
of	O
which	O
.	O
measuring	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
candidate	O
lymphoid	O
tissue	O
is	O
.	O
submitted	O
for	O
evaluation	O
.	O

Summary	O
of	O
sections	O
:	O
7A	O
-	O
7C	O
,	O
4	O
candidate	O
lymph	O
nodes	O
each	O
,	O
4	O
/	O
1	O
each	O
.	O

Slides	O
and	O
report	O
reviewed	O
by	O
Attending	O
Pathologist	O
.	O

SURGICAL	O
PATHOLOGY	O
INTRAOPERATIVE	O
CONSULTATION	O
.	O

1	O
)	O
SOURCE	O
:	O
Ventral	O
Tongue	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

2	O
)	O
SOURCE	O
:	O
Floor	O
of	O
Mouth	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

3	O
)	O
SOURCE	O
:	O
Dorsal	O
Anterior	O
Tongue	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

4	O
)	O
SOURCE	O
:	O
Dorsal	O
Posterior	O
Tongue	O
Margin	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
BENIGN	O
.	O

SNOMED	O
:	O
T	O
-	O
53000	O
,	O
T	O
-	O
53000	O
,	O
M	O
-	O
80103	O
,	O
.	O

8380	O
/	O
3	O
he	O
.	O

GYNS	O
Adm	O
:	O
Ord	O
#	O
=	O
.	O

ASAP	O
/	O
RESULTED	O
.	O

Collect	O
D	O
/	O
T	O
=	O
.	O

Modifiers	O
:	O
(	O
1	O
of	O
1	O
)	O
.	O

CoPath	O
Specimen	O
.	O

Source	O
:	O
A	O
:	O
Uterus	O
IT	O
\	O
Cervix	O
.	O

B	O
:	O
Left	O
Pelvic	O
lymph	O
node	O
.	O

C	O
:	O
Left	O
Peri	O
-	O
aortic	O
lymph	O
node	O
.	O

D	O
:	O
Right	O
Pelvic	O
lymph	O
node	O
.	O

E	O
:	O
Right	O
Peri	O
-	O
aortic	O
lymph	O
node	O
.	O

Final	O
Diagnosis	O
.	O

A	O
.	O

Uterus	O
and	O
cervix	O
(	O
hysterectomy	O
,	O
85	O
gm	O
)	O
.	O

-	O
Polypoid	O
adenocarcinoma	O
,	O
endometrioid	O
type	O
,	O
FIGO	O
grade	O
2	O
-	O
3	O
,	O
.	O

1	B
.	I
6	I
X	I
1	I
.	I
5	I
X	I
1	I
.	I
0	I
cm	I
.	O

-	O
Tumor	O
shows	O
superficial	O
myometrial	O
invasion	O
involving	O
78	O
of	O
.	O
myometrial	O
wall	O
thickness	O
(	O
0	O
.	O
1	O
cm	O
/	O
1	O
.	O
4	O
cm	O
)	O
.	O

-	O
Tumor	O
does	O
not	O
involve	O
lower	O
uterine	O
segment	O
or	O
cervix	O
.	O

-	O
Highly	O
suspicious	O
for	O
lymphovascular	O
invasion	O
.	O

-	O
Left	O
and	O
right	O
parametrial	O
margins	O
are	O
negative	O
for	O
.	O
malignancy	O
.	O

-	O
Background	O
complex	O
hyperplasia	O
with	O
atypia	O
identified	O
in	O
lower	O
.	O
uterine	O
segment	O
.	O

-	O
Unremarkable	O
ectocervix	O
and	O
endocervix	O
.	O

-	O
Follicular	O
cyst	O
of	O
right	O
ovary	O
.	O

-	O
Hemorrhagic	O
corpus	O
luteum	O
cyst	O
of	O
left	O
ovary	O
.	O

Unremarkable	O
right	O
and	O
left	O
fallopian	O
tubes	O
.	O

B	O
.	O

Left	O
pelvic	O
lymph	O
node	O
(	O
excision	O
)	O
:	O
-	O
Four	O
lymph	O
nodes	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
4	O
)	O
.	O

C	O
.	O

Left	O
periaortic	O
lymph	O
node	O
(	O
excision	O
)	O
:	O
-	O
Three	O
lymph	O
nodes	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
3	O
)	O
.	O

D	O
.	O

Right	O
pelvic	O
lymph	O
node	O
(	O
excision	O
)	O
:	O
-	O
Fibroadipose	O
tissue	O
,	O
no	O
lymph	O
nodes	O
identified	O
.	O

E	O
.	O

Right	O
periaortic	O
lymph	O
node	O
(	O
excision	O
)	O
:	O
Two	O
lymph	O
nodes	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
2	O
)	O
.	O

RESULTS	O
FOR	O
SELECTED	O
GRID	O
CELL	O
,	O
SUMMARY	O
.	O

Printed	O
.	O

Nam	O
.	O

Loc	O
.	O

CYNS	O
Adm	O
:	O
Clinical	O
History	O
.	O
year	O
-	O
old	O
female	O
with	O
endometrial	O
cancer	O
.	O

Pre	O
Operative	O
Diagnosis	O
.	O

Endometrial	O
cancer	O
.	O

Operation	O
Performed	O
.	O

LSC	O
hysterectomy	O
;	O
BSO	O
+	O
BPPALND	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
5	O
parts	O
.	O

Part	O
A	O
is	O
labeled	O
"	O
uterus	O
and	O
cervix	O
"	O
and	O
consists	O
of	O
a	O
uterus	O
.	O
and	O
cervix	O
with	O
attached	O
adnexa	O
,	O
previously	O
opened	O
,	O
laterally	O
on	O
.	O
the	O
right	O
side	O
.	O

The	O
specimen	O
weighs	O
85	O
grams	O
and	O
measures	O
.	O

10	O
.	O
5	O
X	O
7	O
.	O
5	O
X	O
4	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

The	O
left	O
fallopian	O
tube	O
.	O
measures	O
3	O
.	O
4	O
cm	O
in	O
length	O
by	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
left	O
ovary	O
.	O
measures	O
2	O
.	O
6	O
X	O
2	O
.	O
4	O
X	O
1	O
.	O
5	O
cm	O
and	O
is	O
tan	O
-	O
white	O
with	O
multiple	O
,	O
<	O
.	O

0	O
.	O
5	O
cm	O
serous	O
cysts	O
.	O

The	O
right	O
fallopian	O
tube	O
measures	O
3	O
.	O
2	O
cm	O
.	O
in	O
length	O
by	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
right	O
ovary	O
measures	O
3	O
.	O

0	O
X	O
.	O

2	O
.	O
2	O
X	O
1	O
.	O
8	O
cm	O
and	O
is	O
tan	O
-	O
white	O
with	O
multiple	O
subcentimeter	O
cystic	O
.	O
lesions	O
.	O

The	O
uterus	O
measures	O
5	O
.	O
5	O
cm	O
in	O
width	O
,	O
7	O
.	O
3	O
cm	O
in	O
length	O
,	O
.	O
and	O
3	O
.	O
5	O
cm	O
anterior	O
to	O
posterior	O
.	O

The	O
cervix	O
measures	O
2	O
.	O
6	O
cm	O
in	O
.	O
diameter	O
.	O

The	O
endometrial	O
cavity	O
contains	O
a	O
1	O
.	O
6	O
X	O
1	O
.	O
5	O
X	O
1	O
.	O
0	O
cm	O
,	O
.	O
soft	O
,	O
partially	O
necrotic	O
lesion	O
in	O
the	O
anterior	O
half	O
.	O

The	O
.	O
endometrial	O
cavity	O
measures	O
2	O
.	O
0	O
X	O
5	O
.	O
0	O
X	O
0	O
.	O
6	O
cm	O
.	O

The	O
myometrium	O
.	O
measures	O
1	O
.	O
3	O
cm	O
in	O
thickness	O
and	O
the	O
endometrium	O
measures	O
0	O
.	O
2	O
cm	O
.	O
in	O
thickness	O
.	O

The	O
tumor	O
is	O
located	O
1	O
.	O
2	O
cm	O
from	O
the	O
anterior	O
.	O
margin	O
and	O
1	O
.	O
2	O
cm	O
from	O
the	O
posterior	O
margin	O
.	O

The	O
specimen	O
is	O
.	O
inked	O
as	O
follows	O
:	O
anterior	O
=	O
red	O
,	O
posterior	O
=	O
black	O
right	O
.	O

parametrium	O
=	O
orange	O
,	O
left	O
parametrium	O
=	O
green	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
follows	O
.	O

Cassette	O
Summary	O
:	O
A1	O
and	O
A2	O
right	O
ovary	O
and	O
fallopian	O
tube	O
,	O
representative	O
,	O
.	O

A3	O
left	O
ovary	O
and	O
fallopian	O
tube	O
,	O
representative	O
,	O
.	O

A4	O
.	O
left	O
parametrial	O
margin	O
,	O
.	O

A5	O
right	O
parametrial	O
margin	O
,	O
.	O

A6	O
.	O
anterior	O
cervix	O
,	O
.	O

A7	O
posterior	O
cervix	O
,	O
.	O

A8	O
anterior	O
lower	O
uterine	O
segment	O
,	O
.	O

A9	O
.	O
posterior	O
lower	O
uterine	O
segment	O
.	O

RESULTS	O
FOR	O
SELECTED	O
GRID	O
CELL	O
,	O
SUMMARY	O
.	O

Printed	O
.	O

LOC	O
:	O
A11	O
thru	O
A13	O
tumor	O
and	O
anterior	O
endomyometrium	O
,	O
.	O

A14	O
posterior	O
endomyometrium	O
and	O
margin	O
.	O

Part	O
B	O
is	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
.	O
multiple	O
fragments	O
of	O
fibroadipose	O
tissue	O
,	O
measuring	O
1	O
.	O
2	O
X	O
1	O
.	O
0	O
X	O
.	O

0	O
.	O
3	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
cassettes	O
B1	O
and	O
B2	O
.	O

Part	O
C	O
is	O
labeled	O
"	O
left	O
periaortic	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
.	O
multiple	O
fragments	O
of	O
fibroadipose	O
tissue	O
,	O
measuring	O
1	O
.	O
1	O
X	O
1	O
.	O
1	O
X	O
.	O

0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
cassette	O
C	O
.	O

Part	O
D	O
is	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
.	O
multiple	O
fragments	O
of	O
fibroadipose	O
tissue	O
,	O
measuring	O
1	O
.	O

1	O
X	O
1	O
.	O
0	O
x	O
.	O

0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
cassette	O
D	O
.	O

Part	O
E	O
is	O
labeled	O
"	O
right	O
periaortic	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
.	O
multiple	O
fragments	O
of	O
fibroadipose	O
tissue	O
,	O
measuring	O
1	O
.	O
0	O
X	O
1	O
.	O
0	O
X	O
.	O

0	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
cassette	O
E	O
.	O

Microscopic	O
Description	O
.	O

A	O
microscopic	O
examination	O
was	O
performed	O
.	O

1	O
.	O

Admit	O
Date	O
.	O

Discharge	O
Date	O
.	O

Chief	O
Complaint	O
:	O
vaginal	O
cuff	O
abscess	O
/	O
dehissance	O
.	O

LMP	O
:	O
HPI	O
:	O
y	O
/	O
o	O
G0	O
s	O
/	O
p	O
laparoscopic	O
hysterectomy	O
,	O
BSO	O
,	O
.	O
for	O
.	O

Stage	O
IB	O
,	O
G	O
2	O
-	O
3	O
Endometrial	O
adenoca	O
.	O

Patient	O
reports	O
occasional	O
vaginal	O
.	O
spotting	O
.	O

Her	O
pain	O
is	O
well	O
controlled	O
on	O
PO	O
pain	O
medications	O
.	O

She	O
denies	O
.	O

N	O
/	O
V	O
/	O
CP	O
/	O
SOB	O
/	O
F	O
/	O
C	O
.	O

On	O
post	O
-	O
op	O
-	O
exam	O
in	O
clinic	O
today	O
patient	O
noted	O
to	O
have	O
.	O
opening	O
at	O
vaginal	O
cuff	O
draining	O
copious	O
amounts	O
of	O
purulent	O
material	O
.	O

Of	O
note	O
,	O
the	O
patient	O
has	O
a	O
h	O
/	O
o	O
DM	O
and	O
reports	O
that	O
she	O
has	O
not	O
been	O
.	O
checking	O
her	O
BS	O
at	O
home	O
.	O

Past	O
Medical	O
History	O
:	O
DM	O
,	O
CHTN	O
,	O
Hypercholesterolemia	O
.	O

Past	O
Surgical	O
History	O
:	O
TLH	O
,	O
BSO	O
,	O
BPPALND	O
.	O

Past	O
OB	O
/	O
GYN	O
History	O
.	O

1	O
)	O
G	O
:	O
0	O
P	O
:	O
0	O
.	O

2	O
)	O
OB	O
History	O
:	O
n	O
/	O
a	O
.	O

3	O
)	O
Pap	O
/	O
STD	O
History	O
:	O
no	O
h	O
/	O
o	O
abnormal	O
Pap	O
or	O
STI	O
.	O

4	O
)	O
Menstrual	O
:	O
as	O
above	O
.	O

5	O
)	O
Last	O
Pap	O
:	O
as	O
per	O
HPI	O
.	O

6	O
)	O
Last	O
Mammo	O
:	O
in	O
.	O
benign	O
.	O

7	O
)	O
BCM	O
:	O
none	O
.	O

Social	O
History	O
:	O
Family	O
History	O
:	O
no	O
cancer	O
.	O

Medications	O
:	O
Allergies	O
:	O
NKDA	O
.	O

ROS	O
:	O
1	O
)	O
HEENT	O
:	O
negative	O
.	O

2	O
)	O
Cardiac	O
:	O
negative	O
.	O

3	O
)	O
Respiratory	O
:	O
negative	O
.	O

4	O
)	O
GI	O
,	O
Liver	O
:	O
negative	O
.	O

5	O
)	O
GU	O
:	O
see	O
HPI	O
/	O
GYN	O
Hx	O
.	O

Loc	O
/	O
SvC	O
=	O
/	O
GYIS	O
.	O

Admit	O
Date	O
:	O
Discharge	O
Date	O
:	O
6	O
)	O
Neuro	O
:	O
negative	O
.	O

7	O
)	O
Skin	O
:	O
negative	O
.	O

8	O
)	O
Bleeding	O
Tendencies	O
:	O
negative	O
.	O

9	O
)	O
Other	O
:	O
negative	O
.	O

Physical	O
Examination	O
:	O
1	O
)	O
HEENT	O
:	O
WNL	O
.	O

2	O
)	O
Breast	O
:	O
ND	O
.	O

3	O
)	O
Chest	O
/	O
Lungs	O
:	O
RRR	O
.	O

CTA	O
bilaterally	O
.	O

4	O
)	O
Abdomen	O
:	O
soft	O
.	O

NT	O
.	O

ND	O
.	O

no	O
masses	O
.	O

+	O
BS	O
.	O

Steri	O
-	O
strips	O
c	O
/	O
d	O
/	O
i	O
.	O

5	O
)	O
Extremities	O
:	O
no	O
edema	O
.	O

6	O
)	O
Neuro	O
:	O
nonfocal	O
.	O

7	O
)	O
Skin	O
:	O
WNL	O
.	O

8	O
)	O
LN	O
:	O
no	O
LAD	O
.	O

9	O
)	O
Pelvic	O
:	O
10	O
)	O
Vulva	O
:	O
WNL	O
.	O

11	O
)	O
Vagina	O
:	O
cuff	O
open	O
.	O
copious	O
amounts	O
of	O
purulent	O
discharge	O
.	O

Cultures	O
.	O
sent	O
.	O

Labs	O
:	O
ordered	O
.	O

Imaging	O
:	O
CT	O
Abd	O
/	O
Pelvis	O
ordered	O
.	O

Assessment	O
and	O
Plan	O
:	O
y	O
/	O
o	O
GO	O
.	O

s	O
/	O
p	O
TLH	O
,	O
BSO	O
,	O
PPALND	O
for	O
Stage	O
Ib	O
endometrial	O
adenoCA	O
,	O
.	O
admitted	O
to	O
gyn	O
service	O
for	O
cuff	O
abscess	O
/	O
dehissence	O
.	O

-	O
UA	O
,	O
UCx	O
,	O
cultures	O
of	O
vaginal	O
cuff	O
sent	O
from	O
clinic	O
today	O
.	O

-	O
Will	O
order	O
CT	O
abdomen	O
/	O
pelvis	O
with	O
PO	O
and	O
IV	O
contrast	O
.	O

-	O
CBC	O
with	O
dif	O
.	O

-	O
blood	O
cultures	O
x2	O
;	O
will	O
start	O
on	O
IV	O
Levaquin	O
/	O
Flagyl	O
once	O
blood	O
.	O
cultrues	O
drawn	O
.	O

-	O
DM	O
:	O
will	O
start	O
on	O
diabetic	O
diet	O
with	O
qAC	O
accucheck	O
.	O

-	O
HTN	O
:	O
will	O
re	O
-	O
start	O
home	O
meds	O
of	O
Atenolol	O
and	O
Benazepril	O
.	O

-	O
DVT	O
PPx	O
:	O
patient	O
to	O
complete	O
2week	O
outpatient	O
course	O
of	O
prophylactic	O
.	O

Admit	O
Date	O
=	O
.	O

LOC	O
/	O
Svc	O
=	O
/	O
GYNS	O
.	O

Discharge	O
Date	O
=	O
.	O

Lovenox	O
during	O
this	O
admission	O
.	O

1	O
R1	O
/	O
.	O

R4	O
.	O

DW	O
Onc	O
Fellow	O
.	O

PLEASE	O
SEE	O
ATTENDING	O
ADDENDUM	O
.	O

DISCUSSED	O
WITH	O
DOCTOR	O
:	O
(	O
MD	O
)	O
.	O

Text	O
Status	O
=	O
FINAL	O
.	O

Elec	O
Signed	O
By	O
=	O
(	O
Electronic	O
Signature	O
)	O
.	O

(	O
MD	O
)	O
.	O

Gross	O
Description	O
:	O
Microscopic	O
Description	O
:	O
Diagnosis	O
Details	O
:	O
Tumor	O
location	O
:	O
Subglottis	O
.	O

Comments	O
:	O
Formatted	O
Path	O
Reports	O
:	O
LARYNX	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Laryngectomy	O
.	O

Tumor	O
site	O
:	O
Larynx	O
.	O

Tumor	O
size	O
:	O
3	B
x	I
4x2	I
.	I
5cm	I
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Well	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
2	O
/	O
6	O
positive	O
for	O
metastasis	O
(	O
Regional	O
2	O
/	O
6	O
)	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
Tumor	O
location	O
:	O
Subglottis	O
.	O

Specimen	O
#	O
:	O
(	O
Age	O
:	O
F	O
Race	O
:	O
Physician	O
(	O
s	O
)	O
:	O
AMENDED	O
.	O

SPECIMEN	O
:	O
LEFT	O
BREAST	O
MASTECTOMY	O
AND	O
AXILLARY	O
CONTENTS	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

BREAST	O
,	O
LEFT	O
RADICAL	O
MASTECTOMY	O
:	O
-	O
RESIDUAL	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
BY	O
.	O

COMBINED	O
HISTOLOGIC	O
CRITERIA	O
,	O
PRESENT	O
IN	O
THE	O
AREA	O
OF	O
BIOPSY	O
CAVITY	O
.	O

AND	O
LOWER	O
OUTER	O
QUADRANT	O
.	O

ESTIMATED	O
TUMOR	O
SIZE	O
BASED	O
ON	O
PREVIOUS	O
NEEDLE	O
LOCALIZATION	O
.	O

BIOPSIES	O
AT	O
LEAST	O
3	B
.	I
0	I
CM	I
.	O

-	O
SEPERATE	O
TUMOR	O
MASS	O
IN	O
THE	O
UPPER	O
OUTER	O
QUADRANT	O
:	O
INFILTRATING	O
DUCTAL	O
CARCINOMA	O
,	O
POORLY	O
DIFFERENTIATED	O
.	O

TUMOR	O
SIZE	O
:	O
2	B
.	I
0	I
CM	I
(	O
GROSS	O
)	O
.	O

MARGIN	O
:	O
TUMOR	O
WITHIN	O
1MM	O
OF	O
SUPERIOR	O
SUPERFICIAL	O
MARGIN	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
,	O
INTERMEDIATE	O
-	O
GRADE	O
,	O
PREDOMINANTLY	O
SOLID	O
.	O

AND	O
CRIBRIFORM	O
TYPES	O
.	O

DEEP	O
MARGIN	O
:	O
TUMOR	O
(	O
DCIS	O
)	O
EXTENDS	O
WITHIN	O
1	O
.	O
0	O
MM	O
OF	O
DEEP	O
SURGICAL	O
.	O

MARGIN	O
IN	O
ONE	O
SECTION	O
(	O
SLIDE	O
A12	O
)	O
.	O

-	O
METASTASIS	O
TO	O
6	O
/	O
10	O
AXILLARY	O
LYMPH	O
NODES	O
WITH	O
EXTRA	O
CAPSULAR	O
.	O

EXTENSION	O
.	O

-	O
SKIN	O
AND	O
NIPPLE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

-	O
FIBROCYSTIC	O
CHANGES	O
.	O

BIOPSY	O
SITE	O
CHANGES	O
.	O

-	O
AJCC	O
STAGE	O
:	O
T2N2MX	O
.	O

COMMENT	O
:	O
The	O
amendment	O
is	O
made	O
to	O
report	O
that	O
there	O
is	O
a	O
seperate	O
tumor	O
.	O
mass	O
in	O
the	O
upper	O
outer	O
quadrant	O
and	O
also	O
the	O
deep	O
margin	O
status	O
.	O

The	O
amendment	O
is	O
made	O
in	O
the	O
absence	O
of	O
the	O
primary	O
pathologist	O
.	O

Specimen	O
#	O
:	O
FINAL	O
DIAGNOSIS	O
(	O
continued	O
)	O
:	O
CLINICAL	O
DIAGNOSIS	O
AND	O
HISTORY	O
:	O
Left	O
breast	O
carcinoma	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
is	O
a	O
167	O
gm	O
modified	O
radical	O
mastectomy	O
specimen	O
with	O
the	O
.	O
following	O
measurements	O
:	O
breast	O
12	O
.	O
6	O
x	O
11	O
.	O
6	O
x	O
1	O
.	O
6	O
cm	O
,	O
overlying	O
ellipse	O
of	O
.	O
nipple	O
-	O
bearing	O
skin	O
7	O
.	O
2	O
x	O
5	O
.	O
5	O
cm	O
,	O
attached	O
axillary	O
contents	O
12	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
.	O

0	O
.	O
9	O
cm	O
.	O

Ink	O
code	O
:	O
blue	O
=	O
superior	O
superficial	O
,	O
green	O
=	O
inferior	O
.	O
superficial	O
,	O
black	O
=	O
posterior	O
.	O

The	O
skin	O
is	O
notable	O
for	O
a	O
2	O
.	O
0	O
cm	O
well	O
.	O
healed	O
scar	O
near	O
the	O
lateral	O
edge	O
of	O
the	O
ellipse	O
.	O

Examination	O
of	O
the	O
.	O
axilla	O
reveals	O
multiple	O
firm	O
lymph	O
nodes	O
.	O

A	O
seperate	O
mass	O
is	O
present	O
in	O
.	O
the	O
upper	O
outer	O
quadrant	O
measuring	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
breast	O
is	O
then	O
serially	O
sectioned	O
revealing	O
extensive	O
white	O
fibrous	O
.	O
tissue	O
with	O
a	O
1	O
.	O
2	O
cm	O
multiloculated	O
biopsy	O
cavity	O
with	O
associated	O
.	O
hemorrhage	O
and	O
fat	O
necrosis	O
in	O
the	O
lower	O
outer	O
quadrant	O
.	O

Sections	O
of	O
the	O
tumor	O
mass	O
and	O
skin	O
and	O
breast	O
samples	O
for	O
.	O
protocol	O
with	O
matching	O
paraffin	O
sections	O
are	O
follows	O
:	O
cassette	O
A1	O
grossly	O
.	O
normal	O
skin	O
(	O
medial	O
tip	O
)	O
.	O
cassettes	O
A2	O
and	O
A3	O
2	O
.	O
0	O
cm	O
tumor	O
mass	O
from	O
upper	O
.	O
outer	O
quadrant	O
,	O
cassette	O
A4	O
1	O
.	O
7	O
cm	O
lymph	O
node	O
,	O
high	O
axilla	O
(	O
grossly	O
.	O
positive	O
)	O
,	O
cassette	O
A5	O
1	O
.	O
8	O
cm	O
grossly	O
normal	O
lymph	O
node	O
,	O
high	O
axilla	O
,	O
.	O
cassette	O
A6	O
biopsy	O
cavity	O
site	O
,	O
lower	O
outer	O
quadrant	O
,	O
cassette	O
A7	O
grossly	O
.	O
normal	O
fibrous	O
tissue	O
,	O
lower	O
outer	O
quadrant	O
(	O
approximately	O
2	O
.	O
0	O
cm	O
from	O
.	O
biopsy	O
cavity	O
)	O
cassette	O
A8	O
grossly	O
normal	O
fibrous	O
tissue	O
,	O
upper	O
outer	O
.	O
quadrant	O
,	O
cassette	O
A9	O
grossly	O
normal	O
fibrous	O
tissue	O
upper	O
inner	O
quadrant	O
,	O
.	O
cassette	O
A10	O
grossly	O
normal	O
fibrous	O
tissue	O
lower	O
inner	O
quadrant	O
,	O
cassette	O
.	O

A11	O
representative	O
sections	O
of	O
nipple	O
and	O
scar	O
from	O
skin	O
,	O
cassette	O
A12	O
.	O
biopsy	O
cavity	O
deep	O
margin	O
lateral	O
,	O
cassette	O
A13	O
biopsy	O
cavity	O
superior	O
.	O
medial	O
,	O
A14	O
biopsy	O
cavity	O
inferior	O
medial	O
,	O
A15	O
four	O
additional	O
lymph	O
nodes	O
.	O
from	O
axillary	O
tail	O
,	O
A16	O
two	O
additional	O
lymph	O
nodes	O
from	O
axillary	O
tail	O
,	O
.	O
cassette	O
A17	O
one	O
lymph	O
node	O
bisected	O
from	O
axillary	O
tail	O
.	O

Final	O
Diagnosis	O
:	O
A	O
.	O

C	O
-	O
D	O
.	O

Brain	O
,	O
left	O
frontal	O
mass	O
#	O
1	O
,	O
#	O
2	O
and	O
CUSA	O
,	O
biopsy	O
:	O
WHO	O
grade	O
III	O
(	O
of	O
IV	O
)	O
fibrillary	O
and	O
gemistocytic	O
.	O
astrocytoma	O
(	O
anaplastic	O
astrocytoma	O
)	O
.	O

B	O
.	O

Brain	O
,	O
left	O
temporal	O
cortex	O
,	O
biopsy	O
:	O
WHO	O
grade	O
III	O
(	O
of	O
IV	O
)	O
fibrillary	O
and	O
gemistocytic	O
astrocytoma	O
(	O
anaplastic	O
.	O
astrocytoma	O
)	O
.	O

Scen	O
in	O
consultation	O
with	O
.	O

Interpreted	O
by	O
:	O
Preliminary	O
Frozen	O
Section	O
Consultation	O
:	O
A	O
.	O

Brain	O
,	O
left	O
frontal	O
mass	O
#	O
1	O
,	O
smears	O
:	O
Glioma	O
.	O

Hold	O
over	O
to	O
classify	O
and	O
grade	O
.	O

Intraoperative	O
cytologic	O
smears	O
interpretation	O
performed	O
by	O
:	O
continued	O
next	O
page	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
with	O
left	O
upper	O
lobe	O
lung	O
nodule	O
squamous	O
cell	O
carcinoma	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Part	O
of	O
6th	O
rib	O
.	O

2	O
:	O
SP	O
:	O
Level	O
9	O
lymph	O
node	O
.	O

3	O
:	O
SP	O
:	O
Level	O
11	O
intralobar	O
lymph	O
node	O
.	O

4	O
:	O
SP	O
:	O
Level	O
5	O
lymph	O
node	O
.	O

5	O
:	O
SP	O
:	O
Level	O
12	O
lymph	O
node	O
.	O

6	O
:	O
SP	O
:	O
Left	O
upper	O
lobe	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

RIB	O
,	O
PART	O
OF	O
6TH	O
;	O
EXCISION	O
:	O
-	O
BENIGN	O
BONE	O
AND	O
BONE	O
MARROW	O
.	O

2	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
IX	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
XI	O
INTRALOBAR	O
;	O
BIOPSY	O
:	O
-	O
THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

4	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
V	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

5	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEVEL	O
XII	O
;	O
BIOPSY	O
:	O
-	O
THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

6	O
)	O
.	O

LUNG	O
,	O
LEFT	O
UPPER	O
LOBE	O
;	O
LOBECTOMY	O
:	O
-	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
OF	O
LEFT	O
UPPER	O
.	O

LOBE	O
.	O

-	O
THE	O
TUMOR	O
GREATEST	O
DIAMETER	O
IS	O
1	B
.	I
9	I
CM	I
.	O

-	O
LYMIPHOVASCULAR	O
INVASION	O
IS	O
PRESENT	O
.	O

-	O
NO	O
PERINEURAL	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

-	O
THE	O
BRONCHIAL	O
MARGIN	O
IS	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
PLEURA	O
IS	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
A	O
SEPARATE	O
FOCUS	O
OF	O
BRONCHIOLOALVEOLAR	O
CARCINOMA	O
IS	O
IDENTIFIED	O
IN	O
.	O

SECTION	O
AWAY	O
FROM	O
THE	O
MAIN	O
TUMOR	O
,	O
MEASURING	O
0	B
.	I
5	I
CM	I
IN	O
GREATEST	O
DIAMETER	O
.	O

-	O
MUL	O
/	O
TIPLE	O
FOCI	O
OF	O
ATYPICAL	O
ADENOMATOUS	O
HYPERPLASIA	O
ARE	O
SEEN	O
.	O

-	O
THE	O
NON	O
-	O
NEOPIASTIC	O
LUNG	O
SHOWS	O
THE	O
FOLLOWING	O
ABNORMALITIES	O
:	O
EMIPHYSEMATOUS	O
.	O

CHANGES	O
,	O
FOCAL	O
ORGANIZING	O
PNEUMONIA	O
AND	O
CARCINOID	O
TUMORLETS	O
.	O

-	O
THE	O
LYMPH	O
NODE	O
STATUS	O
IS	O
AS	O
FOLLOWS	O
(	O
EXPRESSED	O
AS	O
THE	O
NUMBER	O
OF	O
METASTATIC	O
.	O
NODES	O
IN	O
RELATION	O
TO	O
THE	O
TOTAL	O
NUMBER	O
OF	O
NODES	O
EXAMINED	O
)	O
:	O
PERIBRONCHIAL	O
:	O
0	O
/	O
4	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

1	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Part	O
of	O
sixth	O
rib	O
and	O
.	O
consists	O
of	O
a	O
segment	O
of	O
rib	O
bone	O
measuring	O
1	O
.	O
1	O
x	O
0	O
.	O
9	O
x	O
0	O
.	O
5	O
cm	O
.	O

One	O
end	O
.	O

is	O
.	O
inked	O
in	O
black	O
,	O
and	O
the	O
other	O
is	O
inked	O
in	O
green	O
.	O

The	O
specimen	O
is	O
bisected	O
.	O
and	O
reveals	O
homogeneous	O
red	O
-	O
tan	O
bony	O
cut	O
surface	O
with	O
no	O
discrete	O
.	O
abnormalities	O
grossly	O
noted	O
.	O

The	O
cortical	O
surface	O
appears	O
intact	O
.	O

The	O
.	O
specimen	O
is	O
bisected	O
and	O
submitted	O
entirely	O
,	O
pending	O
decal	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Level	O
9	O
lymph	O
node	O
"	O
and	O
.	O
consists	O
of	O
an	O
anthracotic	O
lymphoid	O
fragment	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
,	O
.	O
which	O
is	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Level	O
11	O
intralobar	O
.	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
three	O
anthracotic	O
lymphoid	O
fragments	O
ranging	O
.	O
from	O
0	O
.	O
2	O
to	O
0	O
.	O
8	O
cm	O
,	O
which	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Level	O
5	O
lymph	O
node	O
"	O
and	O
.	O
consists	O
of	O
a	O
0	O
.	O
8	O
cm	O
anthracotic	O
lymphoid	O
fragment	O
,	O
which	O
is	O
entirely	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Level	O
12	O
lymph	O
node	O
"	O
and	O
.	O
consists	O
of	O
three	O
anthracotic	O
lymphoid	O
fragments	O
ranging	O
from	O
0	O
.	O
4	O
to	O
0	O
.	O
9	O
cm	O
.	O
which	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

6	O
.	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
,	O
"	O
left	O
upper	O
lobe	O
"	O
.	O
consists	O
of	O
a	O
17	O
x	O
10	O
x	O
2	O
.	O
5	O
Cm	O
lung	O
lobe	O
with	O
attached	O
bronchus	O
and	O
blood	O
.	O
vessels	O
straddled	O
by	O
multiple	O
staple	O
lines	O
,	O
which	O
weighs	O
230	O
grams	O
following	O
.	O
fixation	O
.	O

The	O
specimen	O
is	O
received	O
with	O
an	O
incision	O
.	O

The	O
attached	O
bronchus	O
.	O
measures	O
0	O
.	O
6	O
cm	O
in	O
length	O
.	O

The	O
pleural	O
surface	O
is	O
smooth	O
and	O
glistening	O
.	O

The	O
pleural	O
surface	O
is	O
inked	O
black	O
.	O

Serial	O
sectioning	O
reveals	O
a	O
1	B
.	I
5	I
x	I
1	I
.	I
5	I
.	I

x	B
.	I

1	B
.	I
2	I
cm	I
white	O
,	O
tan	O
,	O
stellate	O
tumor	O
.	O

The	O
tumor	O
has	O
irregular	O
borders	O
.	O

The	O
.	O
tumor	O
is	O
situated	O
in	O
the	O
peripheral	O
lung	O
parenchyma	O
,	O
located	O
5	O
cm	O
from	O
the	O
.	O
bronchial	O
margin	O
and	O
1	O
.	O
5	O
cm	O
from	O
the	O
closest	O
staple	O
line	O
.	O

The	O
tumor	O
is	O
.	O
subpleural	O
with	O
a	O
puckered	O
overlying	O
pleural	O
surface	O
.	O

The	O
tumor	O
grossly	O
.	O
does	O
not	O
involve	O
the	O
bronchus	O
.	O

The	O
bronchial	O
mucosa	O
is	O
smooth	O
and	O
.	O
glistening	O
.	O

Peribronchial	O
anthracotic	O
lymph	O
nodes	O
are	O
identified	O
and	O
are	O
.	O
submitted	O
.	O

The	O
uninvolved	O
lung	O
parenchyma	O
shows	O
congestion	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

TPS	O
is	O
submitted	O
and	O
photographs	O
are	O
taken	O
.	O

Summary	O
of	O
sections	O
:	O
BM	O
-	O
-	O
bronchial	O
margin	O
.	O

VM	O
-	O
-	O
vascular	O
margin	O
.	O

SM	O
-	O
-	O
staple	O
margin	O
.	O

T	O
-	O
-	O
tumor	O
.	O

RA	O
-	O
random	O
lung	O
parenchyma	O
at	O
least	O
3	O
cm	O
away	O
from	O
main	O
tumor	O
.	O

RC	O
-	O
random	O
lung	O
parenchyma	O
close	O
to	O
tumor	O
(	O
within	O
3	O
cm	O
of	O
main	O
tumor	O
)	O
.	O

LN	O
-	O
-	O
lymph	O
nodes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Part	O
of	O
6th	O
rib	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

u	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Level	O
9	O
lymph	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

u	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Level	O
11	O
intralobar	O
lymph	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

1	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Level	O
5	O
lymph	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

u	O
.	O

1	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Level	O
12	O
lymph	O
node	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

u	O
.	O

11	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Left	O
upper	O
lobe	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BM	O
.	O

1	O
.	O

LN	O
.	O

3	O
.	O

RA	O
.	O

3	O
.	O

3	O
.	O

RC	O
.	O

3	O
.	O

1	O
.	O

SM	O
.	O

1	O
.	O

4	O
.	O

4	O
.	O

1	O
.	O

VM	O
.	O

1	O
.	O

PATIENT	O
INFORMATION	O
.	O
sex	O
:	O
F	O
.	O

SPECIMEN	O
INFORMATION	O
.	O

Collectno	O
:	O
CONFOENTAL	O
.	O

CUINICALSINFORALATION	O
.	O

CLINICAL	O
INFORMATION	O
:	O
IMAGES	O
.	O

le	O
.	O
sestable	O
any	O
n	O
you	O
spedito	O
mpsil	O
.	O

The	O
freaco	O
"	O
nat	O
el	O
703	O
see	O
o	O
reviges	O
ew	O
"	O
them	O
rater	O
.	O

DIAGNOSIS	O
.	O

CERVIX	O
(	O
BIOPSY	O
)	O
:	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
NON	O
-	O
KERATINIZING	O
TYPE	O
,	O
MODERATELY	O
TO	O
.	O

POORLY	O
DIFFERENTIATED	O
(	O
GRADE	O
2	O
-	O
3	O
/	O
3	O
)	O
.	O

SEE	O
COMMENTS	O
.	O

COMMENTS	O
:	O
The	O
Invasive	O
equamous	O
colt	O
carcinoma	O
involves	O
all	O
fragments	O
submitted	O
.	O

One	O
tragment	O
showa	O
ulceratod	O
.	O
surface	O
mucoso	O
.	O
overlying	O
Infitrating	O
tumor	O
;	O
adjacent	O
intact	O
herign	O
squamous	O
spithellum	O
shows	O
mild	O
reactive	O
changu	O
'	O
s	O
.	O

The	O
.	O

Invasive	O
squamous	O
carcinoma	O
extends	O
to	O
peripneral	O
and	O
dcop	O
mergins	O
In	O
ell	O
fragmente	O
.	O

There	O
is	O
no	O
evidence	O
of	O
unequivocal	O
.	O
capiliary	O
-	O
lymphatio	O
space	O
Involvement	O
.	O

The	O
tumor	O
size	O
approximates	O
an	O
area	O
1	B
.	I
2	I
x	I
0	I
.	I
3cm	I
(	O
latered	O
extent	O
by	O
depth	O
)	O
.	O

There	O
is	O
no	O
provious	O
atnormal	O
pap	O
smear	O
available	O
in	O
our	O
flics	O
for	O
review	O
with	O
the	O
current	O
specimen	O
.	O

If	O
this	O
is	O
in	O
errer	O
,	O
contact	O
.	O
the	O
leboratory	O
to	O
request	O
a	O
reviaw	O
.	O

This	O
case	O
was	O
reviened	O
38	O
part	O
of	O
ou	O
.	O

These	O
findinge	O
are	O
discursed	O
with	O
.	O

The	O
report	O
is	O
FAXED	O
.	O

Plesse	O
don	O
'	O
t	O
.	O
husifate	O
to	O
contsct	O
me	O
at	O
.	O

ou	O
any	O
questions	O
regarding	O
the	O
pathologic	O
findings	O
.	O

SPECIMEN	O
DATA	O
.	O

SPECIMENS	O
:	O
Cervical	O
blopsy	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Tho	O
specimen	O
container	O
is	O
lebs	O
ed	O
with	O
the	O
patient	O
'	O
s	O
name	O
end	O
"	O
cervix	O
"	O
.	O

Roceived	O
in	O
formalin	O
are	O
mu	O
'	O
tiple	O
gray	O
-	O
white	O
.	O
irreguiar	O
.	O

fragments	O
c	O
/	O
soft	O
rissue	O
colledively	O
measuring	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
4	O
an	O
.	O

PATIENT	O
INFORMATION	O
.	O

SPECIMEN	O
INFORMATION	O
.	O

SPECIMEN	O
DATA	O
:	O
MICROSCOPIC	O
DESCRIPTION	O
:	O
Completo	O
misrescopic	O
sxamination	O
is	O
performed	O
.	O

OC	O
ID	O
.	O

Gross	O
Description	O
:	O
Breast	O
with	O
the	O
tumor	O
measuring	O
2	B
.	I
7	I
x	I
2	I
.	I
5	I
cm	I
.	O

Fatty	O
lymph	O
nodes	O
are	O
soft	O
and	O
hyperemic	O
.	O

Microscopic	O
Description	O
:	O
Infiltrating	O
duct	O
carcinoma	O
;	O
G2	O
.	O

Ten	O
examined	O
lymph	O
nodes	O
demonstrate	O
focal	O
fibrosis	O
and	O
lipomatosis	O
.	O

Diagnosis	O
Details	O
:	O
Tumor	O
Features	O
:	O
Unknown	O
,	O
Tumor	O
Extent	O
:	O
T2	O
tumor	O
size	O
more	O
than	O
2cm	O
not	O
more	O
than	O
5	O
cm	O
,	O
Venous	O
Invasion	O
:	O
Absent	O
,	O
.	O

Margins	O
:	O
Absent	O
,	O
Treatment	O
Effect	O
:	O
Comments	O
:	O
BREAST	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Radical	O
mastectomy	O
.	O

Specimen	O
size	O
:	O
Not	O
specified	O
.	O

Tumor	O
site	O
:	O
Central	O
breast	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
x	I
0x	I
2	I
.	I
7	I
cm	I
.	O

Grossly	O
evident	O
lesion	O
:	O
Yes	O
.	O

Histologic	O
type	O
:	O
Infiltrating	O
ductal	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
10	O
positive	O
for	O
metastasis	O
(	O
Axillary	O
0	O
/	O
10	O
)	O
.	O

Extracapsular	O
invasion	O
of	O
the	O
lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Nottingham	O
Histologic	O
Score	O
.	O

Tubule	O
formation	O
:	O
Not	O
specified	O
.	O

Nuclear	O
pleomorphism	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
25x	O
)	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
40x	O
)	O
:	O
Not	O
specified	O
.	O

Total	O
Nottingham	O
Score	O
:	O
Score	O
cannot	O
be	O
determined	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Laterality	O
:	O
Left	O
,	O
upper	O
inner	O
quadrant	O
(	O
central	O
)	O
.	O

HISTORY	O
.	O

Tissue	O
taken	O
at	O
lobectomy	O
.	O

MACROSCOPIC	O
.	O

Two	O
specimens	O
received	O
.	O

1	O
:	O
The	O
specimen	O
is	O
labelled	O
"	O
right	O
upper	O
lobe	O
"	O
and	O
consists	O
of	O
a	O
right	O
upper	O
lobectomy	O
which	O
measures	O
.	O

140	O
X	O
120	O
x	O
50	O
mm	O
in	O
maximum	O
dimension	O
.	O

On	O
palpation	O
there	O
is	O
a	O
firm	O
to	O
hard	O
mass	O
located	O
in	O
the	O
.	O
apical	O
segment	O
,	O
predominantly	O
on	O
the	O
posteromedial	O
aspect	O
.	O

The	O
mass	O
measures	O
approximately	O
60	O
X	O
65	O
.	O

X	O
40	O
mm	O
in	O
maximum	O
dimension	O
.	O

There	O
is	O
puckering	O
of	O
the	O
overlying	O
pleural	O
surface	O
at	O
the	O
apex	O
.	O

The	O
.	O
pleural	O
surface	O
on	O
the	O
medial	O
aspect	O
of	O
the	O
specimen	O
has	O
a	O
fibrinous	O
-	O
type	O
exudate	O
.	O

On	O
sectioning	O
there	O
.	O

is	O
a	O
solid	O
lobulated	O
tumour	O
which	O
has	O
a	O
yellow	O
greyish	O
-	O
white	O
cut	O
surface	O
.	O

It	O
,	O
in	O
places	O
,	O
has	O
a	O
villous	O
-	O
.	O
like	O
architecture	O
.	O

There	O
is	O
haemorrhage	O
scattered	O
throughout	O
the	O
tumour	O
.	O

The	O
tumour	O
appears	O
to	O
abut	O
.	O
the	O
pleural	O
surface	O
.	O

The	O
tumour	O
appears	O
to	O
lie	O
at	O
least	O
20	O
mm	O
from	O
the	O
bronchial	O
resection	O
margin	O
.	O

There	O
is	O
a	O
soft	O
tissue	O
resection	O
margin	O
which	O
has	O
a	O
row	O
of	O
staples	O
and	O
measures	O
85	O
mm	O
in	O
length	O
.	O

The	O
.	O
tumour	O
is	O
well	O
clear	O
of	O
this	O
.	O

The	O
surrounding	O
adjacent	O
uninvolved	O
lung	O
parenchyma	O
has	O
a	O
collapsed	O
.	O
appearance	O
.	O

[	O
1A	O
,	O
bronchial	O
resection	O
margin	O
;	O
1B	O
-	O
F	O
,	O
tumour	O
;	O
1G	O
,	O
adjacent	O
uninvolved	O
lung	O
.	O
parenchyma	O
;	O
1H	O
,	O
hilar	O
lymph	O
nodes	O
]	O
.	O

2	O
:	O
The	O
specimen	O
is	O
labelled	O
"	O
hilar	O
lymph	O
node	O
"	O
and	O
consists	O
of	O
four	O
irregular	O
greyish	O
-	O
black	O
pieces	O
of	O
.	O
tissue	O
which	O
measure	O
in	O
aggregate	O
30	O
x	O
20	O
X	O
10	O
mm	O
.	O

[	O
BIT	O
,	O
2A	O
]	O
.	O

MICROSCOPIC	O
.	O

1	O
:	O
Sections	O
show	O
a	O
well	O
differentiated	O
adenocarcinoma	O
.	O

The	O
tumour	O
has	O
a	O
prominent	O
.	O
bronchioloalveolar	O
component	O
with	O
a	O
marked	O
papillary	O
pattern	O
.	O

The	O
cells	O
are	O
tall	O
and	O
columnar	O
with	O
.	O
variable	O
cytoplasm	O
ranging	O
from	O
non	O
-	O
mucinous	O
to	O
clear	O
to	O
mucinous	O
.	O

The	O
lesion	O
is	O
subpleural	O
but	O
.	O
definite	O
pleural	O
invasion	O
is	O
not	O
identified	O
.	O

There	O
is	O
no	O
blood	O
vessel	O
invasion	O
and	O
no	O
lymphatic	O
.	O
permeation	O
is	O
seen	O
.	O

No	O
perineural	O
permeation	O
is	O
identified	O
.	O

The	O
lesion	O
is	O
well	O
clear	O
of	O
the	O
bronchial	O
.	O
resection	O
margin	O
.	O

Tumour	O
appears	O
to	O
be	O
present	O
at	O
a	O
diathermied	O
margin	O
,	O
possibly	O
related	O
to	O
pleura	O
in	O
.	O
block	O
1F	O
.	O

It	O
is	O
difficult	O
to	O
know	O
whether	O
this	O
represents	O
a	O
true	O
margin	O
.	O

No	O
lymph	O
node	O
metastases	O
are	O
.	O
present	O
.	O

The	O
adjacent	O
lung	O
shows	O
evidence	O
of	O
emphysema	O
.	O

Within	O
the	O
random	O
section	O
of	O
lung	O
,	O
there	O
.	O

is	O
.	O

a	O
localised	O
area	O
of	O
necrosis	O
with	O
surrounding	O
fibrosis	O
.	O

Special	O
stains	O
for	O
microorganisms	O
will	O
be	O
.	O
performed	O
.	O

2	O
:	O
Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
reactive	O
changes	O
only	O
.	O

There	O
is	O
no	O
evidence	O
of	O
malignancy	O
.	O

SUMMARY	O
.	O

Right	O
upper	O
lobe	O
lung	O
and	O
hilar	O
lymph	O
nodes	O
:	O
1	O
:	O
Well	O
differentiated	O
adenocarcinoma	O
;	O
65	B
mm	I
in	O
maximal	O
dimension	O
.	O

2	O
:	O
No	O
blood	O
vessel	O
,	O
lymphatic	O
or	O
perineural	O
invasion	O
present	O
.	O

3	O
:	O
No	O
pleural	O
invasion	O
identified	O
;	O
clear	O
of	O
bronchial	O
margin	O
but	O
extends	O
to	O
an	O
area	O
of	O
diathermy	O
(	O
see	O
.	O
report	O
)	O
.	O

4	O
:	O
No	O
lymph	O
node	O
metastases	O
.	O

5	O
:	O
T2N0MX	O
.	O

6	O
:	O
Emphysema	O
and	O
necrotic	O
lesion	O
;	O
special	O
stains	O
for	O
microorganisms	O
being	O
performed	O
.	O

SUPPLEMENTARY	O
REPORT	O
.	O

No	O
micro	O
-	O
organisms	O
are	O
identified	O
within	O
the	O
lung	O
granuloma	O
with	O
special	O
stains	O
.	O

T	O
-	O
28000	O
M	O
-	O
81403	O
P1	O
-	O
03000	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
RIGHT	O
EYE	O
,	O
FNA	O
SAMPLE	O
FOR	O
SEND	O
OUT	O
TESTING	O
ONLY	O
.	O

(	O
B	O
)	O
RIGHT	O
GLOBE	O
:	O
CHOROIDAL	O
MELANOMA	O
,	O
MIXED	O
EPITHELIOID	O
AND	O
SPINDLED	O
,	O
18	B
MM	I
BASE	O
.	O

EXTRAOCULAR	O
EXTENSION	O
PRESENT	O
.	O

TUMOR	O
INVADES	O
SCLERA	O
AND	O
CANAL	O
OF	O
SCHLEMM	O
,	O
EXTENDING	O
TO	O
SUBCONJUNCTIVAL	O
SURFACE	O
.	O

Optic	O
nerve	O
negative	O
for	O
tumor	O
.	O

Vortex	O
veins	O
negative	O
for	O
tumor	O
.	O

(	O
See	O
comment	O
)	O
.	O

COMMENT	O
.	O

The	O
tumor	O
in	O
the	O
extraocular	O
space	O
near	O
the	O
conjunctiva	O
is	O
entirely	O
covered	O
by	O
conjunctiva	O
/	O
soft	O
tissue	O
(	O
margins	O
negative	O
)	O
.	O
are	O
1	O
per	O
10	O
high	O
-	O
power	O
fields	O
.	O

The	O
specimen	O
for	O
part	O
A	O
was	O
sent	O
to	O
.	O
for	O
further	O
diagnostic	O
testing	O
by	O
.	O
which	O
will	O
be	O
reported	O
separately	O
W	O
.	O
the	O
scan	O
documents	O
of	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
RIGHT	O
EYE	O
,	O
FOR	O
SEND	O
OUT	O
ESTING	O
-	O
pale	O
-	O
gray	O
semitransparent	O
tissue	O
(	O
0	O
.	O
4	O
X	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
cm	O
)	O
within	O
pink	O
-	O
red	O
fluid	O
(	O
0	O
.	O
5	O
.	O
X	O
0	O
.	O
5	O
cm	O
)	O
in	O
a	O
sealed	O
container	O
.	O

The	O
specimen	O
is	O
forwarded	O
for	O
send	O
out	O
testing	O
.	O

(	O
B	O
)	O
RIGHT	O
GLOBE	O
-	O
An	O
enucleation	O
specimen	O
consisting	O
of	O
an	O
intact	O
left	O
lobe	O
(	O
21	O
.	O
0	O
X	O
20	O
.	O
0	O
x	O
21	O
.	O
0	O
mm	O
)	O
with	O
an	O
attached	O
13	O
.	O
optic	O
nerve	O
.	O

The	O
cornea	O
is	O
11	O
.	O
0	O
x	O
10	O
,	O
0	O
mm	O
with	O
a	O
round	O
central	O
2	O
.	O
0	O
mm	O
pupil	O
.	O

The	O
iris	O
is	O
pale	O
gray	O
-	O
yellow	O
with	O
possible	O
rim	O
C	O
.	O
hyperpigmentation	O
over	O
approximately	O
one	O
-	O
third	O
peripherally	O
.	O

1	O
.	O
0	O
mm	O
from	O
the	O
limbus	O
and	O
adjacent	O
to	O
the	O
area	O
of	O
possible	O
.	O
pigmentation	O
,	O
a	O
black	O
2	B
.	I
0	I
mm	I
probable	O
tumor	O
nodule	O
is	O
present	O
on	O
the	O
external	O
surface	O
of	O
the	O
sclera	O
with	O
loosely	O
adherent	O
.	O
conjunctiva	O
covering	O
the	O
entire	O
surface	O
coming	O
to	O
less	O
than	O
1	O
.	O
0	O
mm	O
from	O
the	O
resection	O
edge	O
.	O

An	O
irregular	O
intraocular	O
multinodular	O
mass	O
with	O
a	O
base	O
approximately	O
18	O
.	O
0	O
mm	O
in	O
greatest	O
dimension	O
extends	O
from	O
t	O
.	O
and	O
comes	O
to	O
5	O
.	O
0	O
mm	O
from	O
the	O
optic	O
nerve	O
within	O
the	O
choroidal	O
space	O
.	O

The	O
mass	O
is	O
located	O
between	O
2	O
.	O
0	O
and	O
6	O
o	O
'	O
clock	O
.	O

Tum	O
.	O
harvested	O
fresh	O
per	O
protocol	O
.	O

The	O
tumor	O
has	O
a	O
maximum	O
height	O
post	O
harvest	O
4	B
.	I
0	I
mm	I
and	O
the	O
tumor	O
surface	O
is	O
binodular	O
.	O

A	O
.	O
suggested	O
from	O
the	O
external	O
surface	O
,	O
the	O
region	O
of	O
extraocular	O
extension	O
noted	O
on	O
the	O
sclera	O
covered	O
by	O
cornea	O
is	O
visible	O
ad	O
.	O
to	O
the	O
tumor	O
.	O

The	O
tumor	O
flattens	O
and	O
becomes	O
thickened	O
again	O
in	O
kind	O
of	O
a	O
rolling	O
/	O
binodular	O
pattern	O
.	O

An	O
artificial	O
lens	O
is	O
in	O
p	O
.	O

SECTION	O
CODE	O
:	O
B1	O
,	O
regions	O
of	O
vortex	O
veins	O
;	O
B2	O
,	O
optic	O
-	O
nerve	O
margin	O
;	O
B3	O
,	O
B4	O
,	O
calottes	O
with	O
tumor	O
(	O
B3	O
with	O
extraoct	O
.	O
extension	O
and	O
in	O
extraocular	O
tissue	O
harvest	O
)	O
;	O
B5	O
,	O
pupil	O
-	O
optic	O
section	O
with	O
tumor	O
.	O

BIOMARKER	O
TESTING	O
.	O

Primary	O
tumor	O
B5	O
.	O

CLINICAL	O
HISTORY	O
.	O

Right	O
eye	O
uveal	O
melanoma	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
AA000	O
,	O
M	O
-	O
87203	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
no	O
.	O

Page	O
:	O
2	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
.	O

Ne	O
.	O

/	O
DI	O
.	O

Reviewed	O
10713	O
.	O

PHN	O
:	O
ACB	O
:	O
Telephone	O
:	O
Encounter	O
:	O
Collected	O
Date	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Specimen	O
Description	O
.	O

A	O
.	O

Liver	O
biopsy	O
at	O
.	O

B	O
.	O

Gallbladder	O
at	O
.	O

C	O
.	O

Portal	O
lymph	O
nodes	O
at	O
.	O

D	O
.	O

Whipple	O
'	O
s	O
specimen	O
at	O
.	O

Clinical	O
Information	O
.	O

Hx	O
:	O
Suspicion	O
of	O
pancreatic	O
adenocarcinoma	O
.	O

Infectious	O
patient	O
:	O
No	O
.	O

Immunocompromised	O
:	O
No	O
.	O

History	O
of	O
neoplasm	O
:	O
No	O
.	O

Diagnosis	O
.	O

A	O
:	O
Liver	O
Biopsy	O
:	O
Benign	O
bile	O
duct	O
hamartoma	O
.	O

Negative	O
for	O
malignancy	O
.	O

B	O
:	O
Gallbladder	O
,	O
Cholecystectomy	O
:	O
Chronic	O
cholecystitis	O
,	O
negative	O
for	O
atypia	O
.	O

Congested	O
cystic	O
duct	O
lymph	O
node	O
,	O
negative	O
for	O
malignancy	O
.	O

C	O
:	O
Portal	O
Lymph	O
Nodes	O
:	O
Reactive	O
changes	O
,	O
negative	O
for	O
malignancy	O
.	O

Chart	O
Request	O
ID	O
.	O

Pathology	O
:	O
Provider	O
-	O
Permanent	O
.	O

Print	O
Date	O
/	O
Time	O
:	O
PHN	O
:	O
ACB	O
:	O
Collected	O
Date	O
:	O
D	O
:	O
Head	O
of	O
Pancreas	O
(	O
Whipple	O
'	O
s	O
Resection	O
)	O
:	O
Invasive	O
duct	O
carcinoma	O
of	O
the	O
pancreas	O
,	O
with	O
focal	O
extension	O
to	O
.	O
uncinate	O
process	O
margin	O
.	O

Ulceration	O
of	O
the	O
distal	O
common	O
bile	O
duct	O
and	O
ampulla	O
,	O
with	O
.	O
carcinoma	O
invading	O
through	O
duodenal	O
muscularis	O
propria	O
at	O
the	O
.	O
level	O
of	O
the	O
ampulla	O
.	O

Metastatic	O
pancreatic	O
carcinoma	O
in	O
three	O
of	O
24	O
peripancreatic	O
lymph	O
.	O
nodes	O
.	O

Synoptic	O
Report	O
.	O

D	O
:	O
Pancreas	O
(	O
Exocrine	O
)	O
,	O
Microscopic	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Ductal	O
adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

MICROSCOPIC	O
TUMOR	O
EXTENSION	O
:	O
Tumor	O
invades	O
ampulla	O
of	O
Vater	O
or	O
sphincter	O
of	O
Oddi	O
.	O

Tumor	O
invades	O
peripancreatic	O
soft	O
tissues	O
.	O

MARGINS	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Uncinate	O
process	O
(	O
retroperitoneal	O
)	O
margin	O
(	O
nonperitonealized	O
surface	O
of	O
the	O
uncinate	O
process	O
)	O
.	O

TREATMENT	O
EFFECT	O
(	O
applicable	O
to	O
carcinomas	O
treated	O
with	O
neoadjuvant	O
therapy	O
)	O
:	O
Not	O
known	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Not	O
identified	O
.	O

PERINEURAL	O
INVASION	O
:	O
Not	O
identified	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
Chart	O
Request	O
ID	O
:	O
Print	O
Date	O
/	O
Time	O
:	O
Pathology	O
:	O
Provider	O
-	O
Permanent	O
.	O

PHN	O
:	O
ACB	O
:	O
Inquil	O
,	O
.	O

Collected	O
Date	O
:	O
pT3	O
:	O
Tumor	O
extends	O
beyond	O
the	O
pancreas	O
but	O
without	O
involvement	O
of	O
the	O
celiac	O
axis	O
or	O
the	O
superior	O
mesenteric	O
.	O
artery	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pN1	O
:	O
Regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
24	O
.	O

Number	O
involved	O
:	O
3	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
specimens	O
A	O
to	O
D	O
.	O

All	O
requisitions	O
and	O
specimen	O
containers	O
are	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O

The	O
cassettes	O
and	O
AP	O
identifiers	O
are	O
labelled	O
with	O
the	O
Surgical	O
Number	O
.	O

A	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
liver	O
biopsy	O
which	O
measures	O
1	O
.	O
0	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
.	O

All	O
tissue	O
is	O
submitted	O
for	O
QS	O
in	O
one	O
.	O
block	O
.	O

B	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
unopened	O
gallbladder	O
measuring	O
9	O
.	O
5	O
cm	O
in	O
length	O
and	O
up	O
to	O
2	O
.	O
5	O
cm	O
in	O
transverse	O
.	O
diameter	O
.	O

The	O
outer	O
surface	O
is	O
unremarkable	O
.	O

Sectioning	O
reveals	O
pale	O
green	O
mucoid	O
contents	O
containing	O
small	O
flecks	O
of	O
.	O
yellow	O
calculous	O
debris	O
measuring	O
up	O
to	O
0	O
.	O
2	O
cm	O
in	O
size	O
.	O

The	O
mucosa	O
is	O
smooth	O
and	O
velvety	O
.	O

A	O
cystic	O
duct	O
lymph	O
node	O
,	O
.	O

1	O
.	O
2	O
.	O

cm	O
.	O

in	O
.	O
greatest	O
dimension	O
,	O
is	O
present	O
at	O
the	O
neck	O
of	O
the	O
gallbladder	O
.	O

Representative	O
sections	O
of	O
the	O
neck	O
,	O
body	O
and	O
.	O
fundus	O
are	O
submitted	O
in	O
B1	O
.	O

The	O
cystic	O
duct	O
lymph	O
node	O
is	O
submitted	O
in	O
B2	O
.	O

C	O
.	O

The	O
specimen	O
consists	O
of	O
three	O
fragments	O
of	O
tissue	O
measuring	O
3	O
.	O
7	O
cm	O
,	O
3	O
.	O
0	O
cm	O
,	O
and	O
0	O
.	O
9	O
cm	O
in	O
greatest	O
dimension	O
.	O
respectively	O
.	O

The	O
largest	O
fragment	O
appears	O
to	O
consist	O
of	O
adipose	O
tissue	O
only	O
and	O
no	O
lymph	O
node	O
is	O
recognizable	O
.	O

Two	O
.	O
representative	O
sections	O
are	O
submitted	O
in	O
C1	O
.	O

The	O
second	O
largest	O
fragment	O
consists	O
entirely	O
of	O
a	O
firm	O
yellow	O
lymph	O
node	O
-	O
.	O
like	O
sample	O
.	O

Two	O
sections	O
are	O
submitted	O
in	O
C2	O
and	O
C3	O
.	O

The	O
smallest	O
fragment	O
is	O
submitted	O
in	O
C4	O
in	O
its	O
entirety	O
.	O

D	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
pancreaticoduodenectomy	O
specimen	O
in	O
which	O
the	O
distal	O
stomach	O
to	O
distal	O
duodenal	O
.	O
resection	O
margin	O
distance	O
is	O
23	O
.	O
0	O
cm	O
.	O

The	O
attached	O
head	O
of	O
pancreas	O
measures	O
approximately	O
8	O
.	O
0	O
X	O
5	O
.	O
0	O
x	O
6	O
.	O
0	O
cm	O
.	O

A	O
.	O
region	O
of	O
the	O
ampulla	O
is	O
distorted	O
by	O
what	O
appears	O
to	O
be	O
a	O
zone	O
of	O
ulceration	O
into	O
an	O
underlying	O
mass	O
in	O
the	O
head	O
of	O
the	O
.	O
pancreas	O
.	O

The	O
distal	O
common	O
bile	O
duct	O
opens	O
at	O
this	O
area	O
and	O
appears	O
to	O
be	O
up	O
to	O
1	O
.	O
3	O
cm	O
in	O
diameter	O
.	O

The	O
duodenal	O
wall	O
.	O
around	O
this	O
area	O
appears	O
congested	O
and	O
indurated	O
.	O

Sectioning	O
of	O
the	O
head	O
of	O
the	O
pancreas	O
shows	O
a	O
hard	O
tumor	O
mass	O
.	O
surrounding	O
the	O
common	O
bile	O
duct	O
and	O
measuring	O
4	B
.	I
5	I
X	I
3	I
,	I
5	I
X	I
approximately	I
4	I
.	I
0	I
cm	I
.	O

The	O
carcinoma	O
lies	O
close	O
to	O
the	O
.	O
uncinate	O
process	O
but	O
also	O
appears	O
to	O
encroach	O
on	O
the	O
posterior	O
surgical	O
margin	O
adjacent	O
to	O
the	O
duodenum	O
;	O
this	O
latter	O
area	O
.	O

is	O
painted	O
orange	O
.	O

The	O
uncinate	O
process	O
margin	O
is	O
painted	O
blue	O
.	O

Sections	O
are	O
taken	O
as	O
follows	O
:	O
Pathology	O
:	O
Provider	O
,	O
-	O
Permanent	O
.	O

PHN	O
:	O
ACB	O
:	O
Surqical	O
Pathology	O
Report	O
.	O

Collected	O
Date	O
:	O
D1	O
-	O
proximal	O
bile	O
duct	O
margin	O
.	O

D2	O
-	O
pancreatic	O
neck	O
resection	O
margin	O
.	O

D3	O
-	O
distal	O
duodenal	O
margin	O
,	O
en	O
face	O
.	O

D4	O
and	O
D5	O
-	O
ampulla	O
edge	O
(	O
D5	O
with	O
posterior	O
margin	O
)	O
.	O

D6	O
and	O
D7	O
-	O
indurated	O
posterior	O
margin	O
.	O

D8	O
through	O
D12	O
-	O
tumor	O
with	O
uncinate	O
margin	O
.	O

D13	O
-	O
tumor	O
in	O
relation	O
to	O
overlying	O
duodenum	O
.	O

D14	O
-	O
tumor	O
in	O
relation	O
to	O
overlying	O
proximal	O
duodenal	O
mucosa	O
.	O

D15	O
-	O
proximal	O
,	O
gastric	O
resection	O
margin	O
.	O

D16	O
and	O
D17	O
-	O
six	O
possible	O
lymph	O
nodes	O
from	O
distal	O
lesser	O
curve	O
.	O

D18	O
-	O
three	O
possible	O
lymph	O
nodes	O
in	O
pancreaticoduodenal	O
chain	O
.	O

D19	O
through	O
D21	O
-	O
11	O
possible	O
lymph	O
nodes	O
at	O
the	O
inferior	O
aspect	O
of	O
the	O
head	O
of	O
pancreas	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

A	O
,	O
Liver	O
Biopsy	O
:	O
Bile	O
duct	O
hamartoma	O
.	O

Negative	O
for	O
malignancy	O
.	O

Microscopic	O
Description	O
.	O

A	O
:	O
Sections	O
after	O
routine	O
processing	O
confirm	O
the	O
frozen	O
section	O
diagnosis	O
.	O

A	O
small	O
cluster	O
of	O
bile	O
ducts	O
form	O
a	O
localized	O
.	O
nodule	O
with	O
no	O
cytologic	O
atypia	O
.	O

B	O
:	O
Sections	O
show	O
mild	O
chronic	O
cholecystitis	O
,	O
but	O
no	O
cytologic	O
atypia	O
.	O

The	O
cystic	O
duct	O
lymph	O
node	O
is	O
congested	O
,	O
but	O
no	O
sign	O
.	O
of	O
malignancy	O
is	O
present	O
.	O

C	O
:	O
Fragments	O
of	O
adipose	O
tissue	O
include	O
small	O
nerve	O
trunks	O
.	O

The	O
large	O
lymph	O
node	O
-	O
like	O
fragment	O
is	O
comprised	O
of	O
lymph	O
.	O
nodes	O
showing	O
focal	O
lipogranulomatosis	O
.	O

No	O
sign	O
of	O
metastatic	O
disease	O
is	O
present	O
.	O

D	O
:	O
The	O
head	O
of	O
pancreas	O
is	O
largely	O
replaced	O
by	O
an	O
invasive	O
moderately	O
differentiated	O
pancreatic	O
duct	O
carcinoma	O
.	O

The	O
.	O
tumor	O
shows	O
varying	O
growth	O
patterns	O
ranging	O
from	O
well	O
defined	O
glandular	O
spaces	O
through	O
to	O
irregular	O
tongues	O
and	O
islands	O
.	O
of	O
carcinoma	O
with	O
prominent	O
nuclear	O
pleomorphism	O
.	O

Many	O
areas	O
show	O
clear	O
cytoplasm	O
consistent	O
with	O
mucinous	O
.	O
differentiation	O
.	O

The	O
carcinoma	O
invades	O
to	O
the	O
zone	O
of	O
the	O
ampulla	O
where	O
the	O
surface	O
of	O
the	O
bile	O
duct	O
is	O
large	O
eroded	O
and	O
.	O

Chart	O
Request	O
IC	O
.	O

Print	O
Date	O
/	O
Time	O
:	O
Pathology	O
:	O
Provider	O
-	O
Permanent	O
.	O

PHN	O
:	O
ACB	O
:	O
gical	O
Pathology	O
Renort	O
.	O

Inquiry	O
Numbe	O
.	O

Collected	O
Date	O
:	O
replaced	O
by	O
granulation	O
tissue	O
.	O

The	O
carcinoma	O
elements	O
extend	O
through	O
the	O
muscularis	O
propria	O
of	O
the	O
duodenum	O
at	O
the	O
.	O
level	O
of	O
the	O
ampulla	O
.	O

Carcinoma	O
focally	O
extends	O
to	O
the	O
uncinate	O
process	O
margin	O
,	O
but	O
does	O
not	O
directly	O
involve	O
the	O
posterior	O
.	O
soft	O
tissue	O
margin	O
.	O

Carcinoma	O
focally	O
extends	O
beyond	O
the	O
confines	O
of	O
the	O
pancreas	O
into	O
peripancreatic	O
adipose	O
tissue	O
.	O

Adjacent	O
pancreatic	O
parenchyma	O
shows	O
prominent	O
inflammation	O
and	O
fibrosis	O
.	O

The	O
en	O
face	O
section	O
of	O
the	O
neck	O
of	O
the	O
.	O
pancreas	O
is	O
negative	O
as	O
is	O
the	O
proximal	O
bile	O
duct	O
margin	O
.	O

Eight	O
lymph	O
nodes	O
are	O
incorporated	O
in	O
the	O
sections	O
of	O
pancreas	O
,	O
.	O
one	O
of	O
which	O
shows	O
metastatic	O
pancreatic	O
adenocarcinoma	O
.	O

There	O
are	O
16	O
lymph	O
nodes	O
dissected	O
from	O
the	O
peripancreatic	O
.	O
fatty	O
tissue	O
with	O
metastatic	O
duct	O
carcinoma	O
in	O
two	O
,	O
one	O
of	O
which	O
is	O
in	O
the	O
pancreatico	O
-	O
duodena	O
zone	O
and	O
one	O
in	O
a	O
lymph	O
.	O
node	O
along	O
inferior	O
margin	O
.	O

Pathology	O
:	O
Provider	O
-	O
Permanent	O
.	O

Ord	O
#	O
=	O
.	O

RESULTED	O
.	O

Collect	O
D	O
/	O
T	O
=	O
.	O

SURGICAL	O
PATHOL	O
.	O

Modifiers	O
:	O
(	O
1	O
of	O
1	O
)	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

Right	O
testicle	O
.	O

Clinical	O
History	O
.	O

Not	O
stated	O
.	O

Gross	O
Description	O
.	O

Right	O
testicle	O
:	O
Received	O
fresh	O
is	O
a	O
testicle	O
weighing	O
75	O
grams	O
and	O
.	O
measuring	O
overall	O
15	O
x	O
5	O
x	O
3	O
cm	O
.	O

The	O
testis	O
measures	O
6	O
.	O
5	O
x	O
5	O
x	O
3	O
cm	O
.	O

The	O
spermatic	O
cord	O
measures	O
11	O
x	O
2	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
entire	O
specimen	O
is	O
.	O
inked	O
black	O
.	O

The	O
tumor	O
measures	O
3	B
x	I
2	I
x	I
2	I
cm	I
and	O
is	O
firm	O
tan	O
with	O
.	O
brown	O
area	O
.	O

The	O
remaining	O
parenchyma	O
is	O
unremarkable	O
.	O

The	O
tumor	O
abuts	O
.	O
the	O
tunica	O
albuginea	O
,	O
however	O
,	O
the	O
tunica	O
albuginea	O
is	O
not	O
adherent	O
.	O
to	O
the	O
tumor	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
follows	O
:	O
1	O
spermatic	O
cord	O
margin	O
.	O

2	O
cord	O
adjacent	O
to	O
margin	O
(	O
green	O
)	O
and	O
mid	O
cord	O
section	O
.	O

3	O
epididymis	O
.	O

4	O
-	O
6	O
tumor	O
.	O

7	O
normal	O
.	O

Date	O
of	O
Dictation	O
:	O
Gross	O
Description	O
By	O
:	O
Microscopic	O
Description	O
.	O

Performed	O
.	O

Final	O
Pathologic	O
Diagnosis	O
.	O

Specimen	O
Type	O
Right	O
testicle	O
.	O

-	O
Laterality	O
:	O
Right	O
.	O

-	O
Focality	O
:	O
Multifocal	O
.	O

RESULTS	O
FOR	O
SELECTED	O
GRID	O
CELL	O
,	O
SUMMARY	O
.	O

-	O
-	O
Tumor	O
Size	O
:	O
3	O
x	O
2	O
x	O
2	O
LIII	O
.	O

-	O
Histologic	O
Type	O
:	O
Embryonal	O
carcinoma	O
,	O
pure	O
.	O

(	O
see	O
comment	O
)	O
.	O

Intratubular	O
germ	O
cell	O
neoplasia	O
is	O
present	O
(	O
slide	O
4	O
)	O
.	O

-	O
-	O
Tumor	O
is	O
limited	O
to	O
the	O
testis	O
.	O

Tumor	O
does	O
not	O
involve	O
rete	O
testis	O
,	O
.	O
epididymis	O
,	O
perihilar	O
fat	O
,	O
spermatic	O
cord	O
,	O
tunica	O
vaginalis	O
or	O
.	O
scrotal	O
wall	O
.	O

-	O
Lymphovascular	O
Invasion	O
:	O
Present	O
(	O
slide	O
5	O
)	O
.	O

-	O
Margin	O
:	O
Spermatic	O
cord	O
is	O
negative	O
for	O
tumor	O
.	O

-	O
Remaining	O
testicular	O
tissue	O
shows	O
tubular	O
atrophy	O
,	O
and	O
the	O
.	O
epididymis	O
normal	O
and	O
uninvolved	O
by	O
tumor	O
.	O

Comment	O
:	O
Immunohistochemical	O
stain	O
was	O
performed	O
on	O
slide	O
6	O
for	O
.	O
pancytokeratin	O
(	O
AE1	O
/	O
AE3	O
)	O
,	O
CD30	O
and	O
PLAP	O
are	O
positive	O
on	O
the	O
critical	O
.	O
cells	O
;	O
the	O
PLAP	O
stain	O
shows	O
membrane	O
staining	O
.	O

Immunohistochemical	O
.	O
stain	O
for	O
hCG	O
is	O
negative	O
for	O
syncytiotrophoblastic	O
elements	O
.	O

Pathologic	O
Tumor	O
Stage	O
:	O
pT2NXMX	O
(	O
Stage	O
IS	O
)	O
.	O

Attending	O
Pathologist	O
:	O
Note	O
:	O
Immunohistochemistry	O
testing	O
was	O
developed	O
and	O
its	O
.	O
performance	O
characteristics	O
determined	O
by	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
.	O

U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

This	O
test	O
is	O
used	O
for	O
.	O
clinical	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigation	O
or	O
.	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
.	O

Improvement	O
Amendments	O
of	O
1988	O
(	O
CLIA	O
-	O
88	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
.	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

F	O
/	O
Il	O
a	O
/	O
D	O
i	O
a	O
g	O
/	O
/	O
O	O
S	O
i	O
S	O
R	O
0	O
p	O
0	O
l	O
'	O
I	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
Final	O
Pathologic	O
Diagnosis	O
.	O

A	O
)	O
PALATE	O
AND	O
RETROMOLAR	O
TRIGONE	O
(	O
RADICAL	O
TONSILLECTOMY	O
PARTIAL	O
.	O
PALATECTOMY	O
AND	O
RETROMOLAR	O
TRIGONE	O
EXCISION	O
)	O
:	O
Invasive	O
keratinizing	O
squamous	O
cell	O
carcinoma	O
,	O
moderately	O
.	O
differentiated	O
.	O

(	O
See	O
synoptic	O
report	O
)	O
.	O

Unremarkable	O
tonsillar	O
tissue	O
,	O
negative	O
for	O
malignancy	O
.	O

B	O
)	O
LATERAL	O
BUCCAL	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Fibroadipose	O
tissue	O
with	O
smooth	O
muscle	O
,	O
negative	O
for	O
malignancy	O
.	O

C	O
)	O
DEEP	O
PTERYGOID	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Fibroadipose	O
tissue	O
with	O
smooth	O
muscle	O
,	O
negative	O
for	O
malignancy	O
.	O

D	O
)	O
DEEP	O
RETROMOLAR	O
TRIGONE	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Fibroadipose	O
tissue	O
with	O
submucosal	O
glands	O
,	O
negative	O
for	O
malignancy	O
.	O

E	O
)	O
INFERIOR	O
BUCCAL	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Squamous	O
mucosa	O
with	O
cautery	O
artifact	O
,	O
negative	O
for	O
malignancy	O
.	O

F	O
)	O
PALATE	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Fibroadipose	O
tissue	O
,	O
negative	O
for	O
malignancy	O
.	O

G	O
)	O
MEDIAL	O
PHARYNGEAL	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Squamous	O
mucosa	O
and	O
underlying	O
submucosal	O
glands	O
and	O
smooth	O
.	O
muscle	O
with	O
mild	O
chronic	O
inflammation	O
,	O
negative	O
for	O
malignancy	O
.	O

H	O
)	O
PHARYNGEAL	O
FAT	O
MARGIN	O
(	O
BIOPSY	O
)	O
:	O
Salivary	O
gland	O
tissue	O
,	O
negative	O
for	O
malignancy	O
.	O

I	O
)	O
LEVEL	O
2	O
(	O
LYMPH	O
NODE	O
DISSECTION	O
)	O
:	O
Printed	O
:	O
Page	O
:	O
1	O
of	O
7	O
.	O

F	O
i	O
Il	O
a	O
/	O
P	O
a	O
t	O
h	O
0	O
/	O
o	O
y	O
y	O
D	O
i	O
a	O
y	O
II	O
0	O
S	O
i	O
S	O
R	O
e	O
p	O
0	O
l	O
'	O
t	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
Two	O
benign	O
lymph	O
nodes	O
,	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
2	O
)	O
.	O

J	O
)	O
LEVEL	O
3	O
(	O
LYMPH	O
NODE	O
DISSECTION	O
)	O
:	O
One	O
benign	O
lymph	O
node	O
,	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
1	O
)	O
.	O

K	O
)	O
MEDIAL	O
LEVEL	O
5	O
(	O
LYMPH	O
NODE	O
DISSECTION	O
)	O
:	O
Nine	O
benign	O
lymph	O
nodes	O
,	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
9	O
)	O
.	O

L	O
)	O
LEVEL	O
5	O
(	O
LYMPH	O
NODE	O
DISSECTION	O
)	O
:	O
Two	O
of	O
two	O
lymph	O
nodes	O
positive	O
for	O
metastatic	O
squamous	O
cell	O
.	O
carcinoma	O
(	O
2	O
/	O
2	O
)	O
with	O
extracapsular	O
extension	O
.	O

I	O
attest	O
I	O
have	O
personally	O
reviewed	O
the	O
specimen	O
/	O
slides	O
and	O
agree	O
with	O
the	O
above	O
findings	O
.	O

Resident	O
:	O
Synoptic	O
Report	O
.	O

A	O
:	O
Lip	O
and	O
Oral	O
Cavity	O
.	O

SPECIMEN	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Other	O
(	O
specify	O
)	O
:	O
Tonsil	O
,	O
palate	O
,	O
retromolar	O
trigone	O
.	O

Fresh	O
.	O

PROCEDURE	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Resection	O
.	O

Palatectomy	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
.	O

SPECIMEN	O
SIZE	O
:	O
Greatest	O
dimensions	O
:	O
4	O
.	O
8	O
cm	O
.	O

Printed	O
:	O
Page	O
:	O
2	O
of	O
7	O
.	O

F	O
i	O
Il	O
a	O
/	O
P	O
a	O
I	O
h	O
0	O
/	O
y	O
Repor	O
t	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
SPECIMEN	O
LATERALITY	O
:	O
Right	O
.	O

TUMOR	O
SITE	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Other	O
(	O
specify	O
)	O
:	O
right	O
retromolar	O
trigone	O
.	O

TUMOR	O
FOCALITY	O
:	O
Single	O
focus	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimensions	O
:	O
3	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
1	B
X	I
0	I
.	I
3	I
cm	I
.	O

TUMOR	O
THICKNESS	O
(	O
pT1	O
AND	O
pT2	O
Tumors	O
)	O
:	O
Tumor	O
thickness	O
:	O
4	B
mm	I
.	O

TUMOR	O
DESCRIPTION	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Gross	O
subtype	O
.	O

Ulcerated	O
.	O

HISTOLOGIC	O
TYPE	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
conventional	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

MARGINS	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Distance	O
from	O
closest	O
margin	O
:	O
0	O
.	O
2cm	O
.	O

This	O
measurement	O
takes	O
into	O
account	O
the	O
additional	O
margins	O
(	O
Specimen	O
B	O
.	O
and	O
Specimen	O
C	O
)	O
.	O

While	O
some	O
of	O
the	O
margins	O
on	O
Specimen	O
A	O
appear	O
positive	O
,	O
additional	O
margins	O
were	O
taken	O
in	O
.	O

Specimen	O
B	O
through	O
Specimen	O
H	O
.	O
Specify	O
margin	O
(	O
s	O
)	O
,	O
per	O
orientation	O
,	O
if	O
possible	O
:	O
Lateral	O
and	O
deep	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Not	O
identified	O
.	O

PERINEURAL	O
INVASION	O
:	O
Not	O
identified	O
.	O

LYMPH	O
NODES	O
,	O
EXTRANODAL	O
EXTENSION	O
:	O
Present	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
.	O

pT2	O
:	O
Tumor	O
more	O
than	O
2	O
cm	O
but	O
not	O
more	O
than	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
.	O

pN2b	O
:	O
Metastasis	O
in	O
multiple	O
ipsilateral	O
lymph	O
nodes	O
,	O
none	O
more	O
than	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specify	O
:	O
Number	O
examined	O
:	O
15	O
.	O

Number	O
involved	O
:	O
2	O
.	O

DISTANT	O
METASTASIS	O
.	O

Not	O
Applicable	O
.	O

Printed	O
:	O
Page	O
:	O
3	O
of	O
7	O
.	O

Final	O
P	O
a	O
t	O
h	O
0	O
/	O
0	O
y	O
y	O
D	O
i	O
a	O
y	O
/	O
/	O
0	O
S	O
i	O
S	O
Repor	O
I	O
.	O
Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
(	O
Select	O
all	O
that	O
apply	O
)	O
:	O
Keratinizing	O
dysplasia	O
.	O

Moderate	O
.	O

Intraoperative	O
Diagnosis	O
.	O

FS	O
B1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
C1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
D1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
E1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
F1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
G1	O
:	O
Margin	O
negative	O
for	O
tumor	O
,	O
.	O

FS	O
H1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

Clinical	O
History	O
.	O
male	O
.	O

Pre	O
/	O
Post	O
-	O
operative	O
Diagnosis	O
.	O

SCCA	O
right	O
retromolar	O
trigone	O
mass	O
.	O

Gross	O
Anatomic	O
Description	O
.	O

Specimens	O
received	O
in	O
twelve	O
containers	O
.	O

Specimen	O
A	O
:	O
Designated	O
"	O
radical	O
tonsillectomy	O
,	O
partial	O
palatectomy	O
,	O
retromolar	O
trigone	O
excision	O
"	O
is	O
received	O
in	O
formalin	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
MRN	O
and	O
"	O
radical	O
tonsillectomy	O
,	O
partial	O
palatectomy	O
,	O
retromolar	O
trigone	O
excision	O
"	O
.	O

Specimen	O
.	O
consists	O
of	O
a	O
single	O
irregular	O
portion	O
of	O
soft	O
tissue	O
with	O
a	O
mucosal	O
surface	O
which	O
measures	O
4	O
.	O
8	O
X	O
2	O
.	O
9	O
x	O
0	O
.	O
6	O
cm	O
in	O
aggregate	O
.	O

The	O
.	O
specimen	O
is	O
oriented	O
.	O

The	O
mucosal	O
surface	O
is	O
tan	O
/	O
pink	O
with	O
a	O
roughly	O
central	O
portion	O
of	O
ulceration	O
measuring	O
3	O
.	O
5	O
X	O
1	O
x	O
0	O
.	O
3	O
.	O

cm	O
.	O

The	O
specimen	O
came	O
with	O
the	O
deep	O
margin	O
previously	O
inked	O
blue	O
.	O

Cut	O
surface	O
reveals	O
firm	O
and	O
somewhat	O
fibrotic	O
area	O
.	O
underlying	O
the	O
ulceration	O
which	O
grossly	O
abuts	O
the	O
deep	O
inked	O
margins	O
.	O

Inking	O
code	O
:	O
Black	O
-	O
lateral	O
;	O
green	O
-	O
medial	O
;	O
Red	O
-	O
superior	O
;	O
Orange	O
-	O
inferior	O
;	O
blue	O
-	O
deep	O
.	O

Section	O
.	O
code	O
:	O
A1	O
-	O
medial	O
margin	O
,	O
perpendicularly	O
sectioned	O
;	O
A2	O
-	O
lateral	O
margin	O
perpendicular	O
sections	O
;	O
A3	O
-	O
A8	O
-	O
sections	O
of	O
.	O
specimen	O
submitted	O
from	O
medial	O
to	O
lateral	O
,	O
entire	O
specimen	O
.	O

Printed	O
:	O
Page	O
:	O
4	O
of	O
7	O
.	O

F	O
i	O
Il	O
a	O
/	O
P	O
a	O
t	O
II	O
o	O
/	O
0	O
y	O
ID	O
i	O
a	O
y	O
II	O
o	O
S	O
i	O
S	O
R	O
e	O
[	O
/	O
0	O
l	O
'	O
t	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
Specimen	O
B	O
:	O
Designated	O
"	O
lateral	O
buccal	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
diagnosis	O
.	O

on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
lateral	O
buccal	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
tan	O
tissue	O
.	O
measuring	O
0	O
.	O
2	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
3	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
B1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
C	O
:	O
Designated	O
"	O
deep	O
pterygoid	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
.	O
diagnosis	O
on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
deep	O
pterygoid	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
red	O
.	O
tissue	O
measuring	O
0	O
.	O
7	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
2	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
B1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
.	O

D	O
:	O
Designated	O
"	O
deep	O
retromolar	O
trigone	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
.	O
diagnosis	O
on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
deep	O
retromolar	O
trigone	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
.	O
of	O
tan	O
tissue	O
measuring	O
0	O
.	O
6	O
X	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
D1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
E	O
:	O
Designated	O
"	O
inferior	O
buccal	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
diagnosis	O
.	O

on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
inferior	O
buccal	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
tan	O
tissue	O
.	O
measuring	O
0	O
.	O
4	O
X	O
0	O
.	O
2	O
X	O
0	O
.	O
1	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
E1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
F	O
:	O
Designated	O
"	O
palate	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
diagnosis	O
on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
palate	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
tan	O
tissue	O
measuring	O
1	O
.	O
3	O
x	O
.	O

0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
F1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
.	O

G	O
:	O
Designated	O
.	O

"	O
medial	O
pharyngeal	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
.	O
diagnosis	O
on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
medial	O
pharyngeal	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
.	O
tan	O
tissue	O
measuring	O
0	O
.	O
7	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
3	O
cm	O
,	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
G1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
H	O
:	O
Designated	O
"	O
pharyngeal	O
fat	O
margin	O
"	O
is	O
received	O
fresh	O
for	O
intraoperative	O
consultation	O
and	O
frozen	O
section	O
.	O
diagnosis	O
on	O
.	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
pharyngeal	O
fat	O
margin	O
"	O
.	O

Specimen	O
consists	O
of	O
one	O
piece	O
of	O
pink	O
/	O
.	O
tan	O
tissue	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
7	O
X	O
0	O
.	O
4	O
cm	O
,	O
trisected	O
and	O
entirely	O
frozen	O
.	O

Section	O
code	O
:	O
H1	O
-	O
frozen	O
section	O
control	O
,	O
entire	O
specimen	O
.	O

Specimen	O
I	O
:	O
Designated	O
"	O
level	O
2	O
"	O
is	O
received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
level	O
2	O
"	O
.	O

Specimen	O
consists	O
.	O

of	O
.	O

a	O
.	O
single	O
portion	O
of	O
soft	O
tan	O
/	O
yellow	O
bosselated	O
fibroadipose	O
tissue	O
measuring	O
3	O
.	O
8	O
X	O
2	O
.	O
9	O
X	O
0	O
.	O
6	O
cm	O
.	O

Two	O
lymph	O
nodes	O
are	O
.	O
grossly	O
.	O

appreciated	O
ranging	O
from	O
0	O
.	O
4	O
cm	O
to	O
1	O
.	O
0	O
cm	O
in	O
diameter	O
.	O

Section	O
code	O
:	O
I1	O
-	O
12	O
-	O
one	O
lymph	O
node	O
each	O
bisected	O
.	O

Printed	O
.	O

Page	O
:	O
5	O
of	O
7	O
.	O

F	O
i	O
Il	O
a	O
/	O
P	O
a	O
I	O
II	O
0	O
/	O
0	O
D	O
i	O
a	O
y	O
Il	O
o	O
S	O
i	O
S	O
Report	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
Specimen	O
J	O
:	O
Designated	O
"	O
level	O
3	O
"	O
is	O
received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
level	O
3	O
"	O
.	O

Specimen	O
consists	O
of	O
.	O

a	O
single	O
portion	O
of	O
soft	O
tan	O
/	O
yellow	O
bosselated	O
fibroadipose	O
tissue	O
measuring	O
3	O
.	O
1	O
X	O
2	O
.	O
1	O
X	O
0	O
.	O
7	O
cm	O
.	O

One	O
lymph	O
node	O
is	O
identified	O
.	O
measuring	O
0	O
.	O
8	O
cm	O
in	O
diameter	O
.	O

Section	O
code	O
:	O
J1	O
-	O
one	O
lymph	O
node	O
each	O
bisected	O
.	O

Specimen	O
K	O
:	O
Designated	O
"	O
medial	O
level	O
5	O
"	O
is	O
received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
medial	O
level	O
5	O
"	O
.	O

Specimen	O
consists	O
of	O
a	O
single	O
portion	O
of	O
soft	O
tan	O
/	O
yellow	O
bosselated	O
fibroadipose	O
tissue	O
measuring	O
2	O
.	O
5	O
X	O
1	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
.	O

No	O
.	O
lymph	O
nodes	O
are	O
grossly	O
appreciated	O
.	O

Section	O
code	O
:	O
K1	O
-	O
K2	O
-	O
entire	O
specimen	O
.	O

Specimen	O
L	O
:	O
Designated	O
"	O
level	O
5	O
"	O
is	O
received	O
fresh	O
for	O
Tumor	O
Bank	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
level	O
5	O
"	O
.	O

Specimen	O
.	O
consists	O
of	O
a	O
single	O
portion	O
of	O
soft	O
tan	O
/	O
yellow	O
bosselated	O
fibroadipose	O
tissue	O
measuring	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
6	O
cm	O
.	O

A	O
portion	O
of	O
one	O
.	O
lymph	O
node	O
is	O
given	O
for	O
Tumor	O
Bank	O
.	O

Two	O
lymph	O
nodes	O
are	O
grossly	O
identified	O
ranging	O
from	O
0	O
.	O
6	O
cm	O
to	O
0	O
.	O
8	O
cm	O
.	O

Section	O
code	O
:	O
L1	O
-	O
one	O
lymph	O
node	O
bisected	O
minus	O
portion	O
given	O
to	O
Tumor	O
Bank	O
;	O
L2	O
-	O
one	O
lymph	O
node	O
bisected	O
.	O

Printed	O
:	O
Page	O
:	O
6	O
of	O
7	O
.	O

/	O
.	O

/	O
/	O
t	O
l	O
'	O
a	O
0	O
[	O
/	O
e	O
l	O
'	O
a	O
.	O

S	O
.	O

R	O
e	O
Il	O
o	O
l	O
'	O
I	O
.	O

Senior	O
Pathologist	O
:	O
Collected	O
Date	O
/	O
Time	O
:	O
Received	O
Date	O
/	O
Time	O
:	O
Verified	O
Date	O
/	O
Time	O
:	O
Intraoperative	O
Diagnosis	O
.	O

FS	O
B1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
C1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
D1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
E1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
F1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
G1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

FS	O
H1	O
:	O
Margin	O
negative	O
for	O
tumor	O
.	O

Printed	O
:	O
Page	O
:	O
7	O
of	O
7	O
.	O

SPECIMEN	O
.	O

A	O
.	O

Level	O
5	O
lymph	O
node	O
.	O

B	O
.	O

Left	O
upper	O
lobe	O
.	O

C	O
.	O

Level	O
7	O
.	O

CLINICAL	O
NOTES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Lung	O
cancer	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

A	O
)	O
Lymph	O
node	O
,	O
level	O
5	O
,	O
excision	O
-	O
Non	O
small	O
cell	O
carcinoma	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
level	O
5	O
.	O
lymph	O
node	O
"	O
is	O
an	O
irregularly	O
shaped	O
fragment	O
of	O
tissue	O
.	O
that	O
measures	O
2	O
.	O
5	O
X	O
2	O
.	O
2	O
x	O
1	O
.	O
5	O
cm	O
in	O
dimension	O
.	O

A	O
representative	O
.	O
section	O
of	O
the	O
tissue	O
submitted	O
for	O
frozen	O
section	O
.	O

The	O
remaining	O
.	O
tissue	O
is	O
entirely	O
submitted	O
for	O
permanent	O
section	O
in	O
a	O
single	O
.	O
cassette	O
.	O

B	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
labeled	O
.	O

'	O
left	O
upper	O
lobe	O
"	O
is	O
a	O
14	O
.	O
5	O
X	O
5	O
.	O
5	O
x	O
4	O
.	O
0	O
cm	O
lung	O
specimen	O
.	O
which	O
is	O
partially	O
covered	O
with	O
pink	O
-	O
red	O
smooth	O
glistening	O
pleura	O
.	O
with	O
black	O
stippling	O
present	O
.	O

The	O
specimen	O
shows	O
a	O
umbilication	O
in	O
.	O
the	O
pleura	O
which	O
is	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
and	O
comes	O
within	O
.	O

3	O
.	O
0	O
cm	O
of	O
the	O
stapled	O
margin	O
.	O

The	O
pleura	O
is	O
inked	O
blue	O
and	O
black	O
.	O
and	O
the	O
specimen	O
is	O
sectioned	O
to	O
show	O
a	O
3	B
.	I
5	I
X	I
2	I
.	I
5	I
X	I
2	I
.	I
5	I
.	I

cm	B
.	O
white	O
-	O
tan	O
-	O
gray	O
firm	O
focus	O
grossly	O
consistent	O
with	O
tumor	O
.	O

This	O
.	O

is	O
.	O
contiguous	O
with	O
the	O
umbilication	O
grossly	O
identified	O
on	O
the	O
pleura	O
.	O
and	O
comes	O
within	O
0	O
.	O
7	O
cm	O
of	O
the	O
stapled	O
margin	O
(	O
inked	O
blue	O
)	O
.	O

Remainder	O
of	O
the	O
cut	O
surface	O
is	O
pink	O
-	O
tan	O
and	O
spongy	O
showing	O
no	O
.	O
other	O
.	O

discrete	O
gross	O
lesions	O
identified	O
.	O

Representative	O
sections	O
of	O
the	O
.	O
specimen	O
are	O
submitted	O
as	O
follows	O
:	O
BLOCK	O
SUMMARY	O
:	O
1	O
-	O
representative	O
normal	O
;	O
2	O
-	O
3	O
-	O
representative	O
.	O
section	O
tumor	O
to	O
stapled	O
margin	O
;	O
4	O
-	O
6	O
-	O
representative	O
section	O
of	O
.	O

GROSS	O
DESCRIPTION	O
.	O
tumor	O
to	O
pleura	O
and	O
normal	O
.	O

C	O
.	O

Received	O
fresh	O
,	O
subsequently	O
fixed	O
in	O
formalin	O
,	O
.	O
labeled	O
.	O

"	O
level	O
7	O
"	O
are	O
two	O
black	O
-	O
red	O
irregular	O
soft	O
tissue	O
.	O
fragments	O
.	O

measuring	O
0	O
.	O
8	O
em	O
and	O
0	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
.	O

Specimens	O
are	O
.	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

CLINICAL	O
HISTORY	O
.	O
with	O
headache	O
and	O
left	O
-	O
sided	O
weakness	O
has	O
right	O
.	O
parietal	O
mass	O
,	O
necrotic	O
,	O
with	O
peripheral	O
enhancement	O
and	O
edema	O
with	O
mass	O
.	O
effect	O
.	O

OPERATIVE	O
DIAGNOSES	O
.	O

Not	O
Given	O
.	O

Operation	O
/	O
Specimen	O
:	O
A	O
:	O
Brain	O
,	O
Right	O
parietal	O
biopsy	O
.	O

B	O
:	O
Brain	O
,	O
right	O
parietal	O
biopsy	O
.	O

PATHOLOGICAL	O
DIAGNOSIS	O
:	O
A	O
and	O
B	O
.	O

Brain	O
,	O
right	O
parietal	O
,	O
excisional	O
biopsy	O
and	O
excision	O
:	O
1	O
.	O

Malignant	O
glioma	O
.	O

2	O
.	O

MIB	O
-	O
1	O
proliferation	O
index	O
:	O
6	O
%	O
to	O
30	O
%	O
.	O

See	O
Comment	O
.	O

COMMENT	O
.	O

The	O
specimen	O
is	O
a	O
portion	O
of	O
cerebrum	O
extensively	O
effaced	O
by	O
a	O
small	O
cell	O
.	O
glial	O
neoplastic	O
proliferation	O
with	O
nuclear	O
anaplasia	O
,	O
brisk	O
mitotic	O
activity	O
,	O
.	O
microvascular	O
proliferation	O
,	O
and	O
zones	O
of	O
tumor	O
necrosis	O
.	O

In	O
part	O
B	O
there	O
is	O
.	O
extensive	O
necrosis	O
.	O

The	O
neoplasm	O
is	O
a	O
high	O
histological	O
grade	O
glioma	O
,	O
consistent	O
with	O
a	O
small	O
cell	O
.	O
glioblastoma	O
.	O

There	O
is	O
a	O
possibility	O
of	O
an	O
oligodendroglial	O
component	O
.	O

Additional	O
testing	O
may	O
further	O
characterize	O
the	O
neoplasm	O
.	O

PROCEDURES	O
/	O
ADDENDA	O
.	O

MGMT	O
Promoter	O
Methulation	O
.	O

Interpretation	O
.	O

POSITIVE	O
:	O
Methylated	O
MGMT	O
promoter	O
is	O
detected	O
.	O

esults	O
-	O
Comments	O
.	O

Testing	O
was	O
done	O
on	O
tissue	O
block	O
.	O

TEST	O
DESCRIPTION	O
:	O
Patients	O
with	O
glioma	O
containing	O
a	O
methylated	O
MGMT	O
promoter	O
.	O
have	O
been	O
shown	O
to	O
benefit	O
from	O
therapy	O
with	O
alkylating	O
agents	O
.	O

Assessment	O
of	O
.	O

MGMT	O
promoter	O
methylation	O
status	O
involves	O
bisulfite	O
treatment	O
of	O
DNA	O
followed	O
.	O
by	O
real	O
-	O
time	O
PCR	O
amplification	O
(	O
MethyLight	O
)	O
of	O
methylated	O
and	O
unmethylated	O
DNA	O
.	O
sequences	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
.	O
stand	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
.	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
.	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

Interpretation	O
.	O

NEGATIVE	O
:	O
Allelic	O
loss	O
on	O
chromosome	O
arm	O
1p	O
is	O
NOT	O
detected	O
.	O

There	O
is	O
loss	O
of	O
heterozygosity	O
in	O
only	O
one	O
of	O
the	O
markers	O
(	O
PLA2G4C	O
)	O
on	O
.	O
chromosome	O
arm	O
19q	O
suggestive	O
of	O
partial	O
deletion	O
.	O

Informative	O
loci	O
are	O
:	O
D1S1592	O
,	O
D1S468	O
,	O
D1S496	O
.	O

D19S412	O
,	O
PLA2G4C	O
,	O
D19S606	O
,	O
D19S1182	O
.	O

Results	O
-	O
Comments	O
.	O

TEST	O
DESCRIPTION	O
:	O
Allelic	O
loss	O
is	O
assessed	O
by	O
PCR	O
assay	O
in	O
Normal	O
DNA	O
.	O

(	O
baseline	O
)	O
/	O
Tumor	O
DNA	O
pairs	O
using	O
3	O
markers	O
at	O
both	O
1p	O
and	O
19q	O
.	O

The	O
3	O
markers	O
.	O
on	O
1p	O
are	O
D1S548	O
,	O
D1S1592	O
,	O
and	O
D1S552	O
(	O
with	O
D1S468	O
,	O
D1S1612	O
,	O
and	O
D1S496	O
as	O
.	O
backup	O
markers	O
)	O
and	O
the	O
3	O
markers	O
on	O
19q	O
are	O
D19S219	O
,	O
D19S412	O
,	O
and	O
PLA2G4C	O
.	O

(	O
with	O
D19S606	O
and	O
D19S1182	O
as	O
backup	O
)	O
All	O
markers	O
are	O
nicrosatellites	O
(	O
2	O
or	O
4	O
.	O
nt	O
repeats	O
)	O
except	O
PLA2G4C	O
which	O
is	O
a	O
minisatellite	O
(	O
26	O
nt	O
repeat	O
)	O
.	O
polymorphism	O
.	O

The	O
markers	O
were	O
selected	O
based	O
on	O
heterozygosity	O
score	O
,	O
.	O
amplicon	O
size	O
,	O
and	O
ease	O
of	O
interpretation	O
.	O

The	O
backup	O
markers	O
are	O
used	O
if	O
the	O
.	O
first	O
line	O
markers	O
at	O
that	O
chromosome	O
arm	O
are	O
uninformative	O
or	O
otherwise	O
.	O
ambiguous	O
in	O
their	O
interpretation	O
.	O

LOH	O
at	O
all	O
informative	O
loci	O
on	O
each	O
.	O
chromosomal	O
arm	O
represents	O
the	O
typical	O
finding	O
in	O
oligodendrogliomas	O
with	O
1p	O
.	O
and	O
19q	O
deletion	O
.	O

FDA	O
COMMENT	O
:	O
The	O
above	O
data	O
are	O
not	O
to	O
be	O
construed	O
as	O
the	O
results	O
from	O
a	O
.	O
stand	O
-	O
alone	O
diagnostic	O
test	O
.	O

This	O
test	O
was	O
developed	O
and	O
its	O
performance	O
.	O
characteristics	O
determined	O
by	O
the	O
.	O
laboratory	O
as	O
.	O
required	O
by	O
CLIA	O
,	O
.	O
regulations	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
.	O
specific	O
uses	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
results	O
are	O
.	O
provided	O
for	O
informational	O
purposes	O
only	O
,	O
and	O
should	O
be	O
interpreted	O
only	O
in	O
.	O
the	O
context	O
of	O
established	O
procedures	O
and	O
/	O
or	O
diagnostic	O
criteria	O
.	O

TECHNICAL	O
SENSITIVITY	O
:	O
The	O
presence	O
of	O
>	O
15	O
%	O
non	O
-	O
neoplastic	O
cells	O
in	O
the	O
sample	O
.	O
may	O
preclude	O
the	O
detection	O
of	O
allelic	O
loss	O
.	O

INTRA	O
-	O
OPERATIVE	O
CONSULTATION	O
.	O

A	O
.	O

Brain	O
,	O
Right	O
parietal	O
biopsy	O
,	O
touch	O
prep	O
and	O
smears	O
:	O
High	O
histological	O
grade	O
.	O
glioma	O
,	O
astrocytic	O
.	O

Touch	O
preparation	O
smears	O
performed	O
at	O
.	O
and	O
results	O
reported	O
to	O
the	O
Physician	O
of	O
Record	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

"	O
Right	O
parietal	O
,	O
"	O
received	O
fresh	O
,	O
one	O
fragment	O
,	O
0	O
.	O
9	O
cm	O
.	O

Across	O
.	O

Semi	O
firm	O
,	O
.	O
glistening	O
,	O
grey	O
.	O

In	O
total	O
,	O
A1	O
.	O

B	O
.	O

"	O
Right	O
parietal	O
,	O
several	O
fragments	O
,	O
soft	O
,	O
focally	O
hemorrhagic	O
,	O
2	O
.	O
0	O
cm	O
.	O
across	O
.	O
in	O
aggregate	O
.	O

In	O
total	O
,	O
B1	O
and	O
B2	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

IMMUNOHISTOCHEMISTRY	O
The	O
GFAP	O
demonstrates	O
focal	O
sparse	O
gliofibrillarity	O
,	O
.	O
and	O
focal	O
areas	O
with	O
prominent	O
gemistocytes	O
,	O
some	O
probably	O
reactive	O
,	O
.	O
neoplastic	O
,	O
and	O
some	O
minigemystocyte	O
-	O
like	O
.	O

About	O
10	O
%	O
of	O
neoplastic	O
cells	O
over	O
.	O
express	O
the	O
p53	O
protein	O
.	O

With	O
the	O
MIB	O
-	O
1	O
the	O
proliferation	O
index	O
ranges	O
.	O
between	O
6	O
%	O
and	O
30	O
%	O
in	O
the	O
more	O
active	O
areas	O
.	O

ICD	O
-	O
9	O
(	O
s	O
)	O
:	O
239	O
,	O
6	O
239	O
.	O
6	O
.	O

Histo	O
Data	O
.	O

Part	O
A	O
:	O
Brain	O
.	O

Right	O
parietal	O
biopsy	O
.	O

Stain	O
/	O
cht	O
.	O

Block	O
.	O

Comment	O
.	O

mGFAP	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

MGMT	O
x	O
1	O
.	O

1	O
.	O

Please	O
,	O
run	O
LOH	O
,	O
1p	O
,	O
19q	O
.	O

Thanks	O
.	O

MIB1	O
-	O
DA	O
X	O
1	O
.	O

1	O
.	O

NeuN	O
X	O
1	O
.	O

1	O
.	O

P53D07	O
X	O
1	O
.	O

1	O
.	O

Synap	O
-	O
DA	O
x	O
1	O
.	O

1	O
.	O

TPS	O
H	O
/	O
E	O
X	O
1	O
.	O

1	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

Part	O
B	O
:	O
Brain	O
.	O
right	O
narietal	O
biopsy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

Comment	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

1	O
.	O

mGFAP	O
-	O
DA	O
X	O
1	O
.	O

2	O
.	O

H	O
/	O
E	O
x	O
1	O
.	O

2	O
.	O

MIB1	O
-	O
DA	O
x	O
1	O
.	O

2	O
.	O

SPECIMENS	O
:	O
A	O
.	O

LOW	O
ANTERIOR	O
RESECTION	O
OF	O
RECTAL	O
CANCER	O
.	O

B	O
.	O

FINAL	O
DISTAL	O
RECTAL	O
MARGIN	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

LOW	O
ANTERIOR	O
RESECTION	O
OF	O
RECTAL	O
CANCER	O
.	O

B	O
.	O

FINAL	O
DISTAL	O
RECTAL	O
MARGIN	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
:	O
A	O
-	O
An	O
ulcerative	O
tumor	O
mass	O
,	O
9	O
.	O
5	O
cm	O
,	O
involving	O
the	O
colon	O
circumferentially	O
.	O

3	O
cm	O
from	O
the	O
distal	O
.	O
margin	O
of	O
resection	O
called	O
by	O
Dr	O
.	O
to	O
Dr	O
.	O
at	O
1	O
:	O
00	O
p	O
.	O
m	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

LOW	O
ANTERIOR	O
RESECTION	O
OF	O
RECTAL	O
CANCER	O
.	O

Received	O
fresh	O
is	O
a	O
30	O
-	O
cm	O
closed	O
segment	O
of	O
colon	O
.	O

The	O
serosa	O
is	O
smooth	O
.	O

There	O
is	O
a	O
suture	O
marking	O
.	O
the	O
distal	O
margin	O
;	O
this	O
region	O
is	O
inked	O
black	O
.	O

Specimen	O
is	O
opened	O
;	O
approximately	O
3	O
cm	O
from	O
the	O
distal	O
.	O
margin	O
is	O
a	O
9	O
X	O
7	O
.	O
5	O
X	O
0	O
.	O
4	O
-	O
cm	O
ulcerated	O
,	O
indurated	O
,	O
circumferential	O
mass	O
with	O
serpentine	O
borders	O
which	O
.	O
invades	O
the	O
mesocolonic	O
fat	O
.	O

A	O
gross	O
diagnosis	O
was	O
conveyed	O
to	O
O	O
.	O

R	O
.	O

The	O
remainder	O
of	O
the	O
mucosa	O
.	O
has	O
numerous	O
diverticuli	O
and	O
3	O
polyps	O
,	O
0	O
.	O
2	O
-	O
0	O
.	O
4	O
cm	O
.	O

Tissue	O
is	O
procured	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
as	O
follows	O
:	O
A1	O
:	O
proximal	O
margin	O
.	O

A2	O
:	O
distal	O
margin	O
.	O

A3	O
-	O
A8	O
:	O
mass	O
and	O
relationship	O
to	O
margins	O
and	O
normal	O
mucosa	O
.	O

A9	O
:	O
diverticulum	O
.	O

A10	O
:	O
possible	O
polyps	O
.	O

A11	O
:	O
normal	O
mucosa	O
.	O

A12	O
:	O
proximal	O
,	O
6	O
lymph	O
nodes	O
.	O

A13	O
:	O
proximal	O
,	O
5	O
lymph	O
nodes	O
.	O

A14	O
-	O
A16	O
:	O
proximal	O
,	O
2	O
lymph	O
nodes	O
each	O
.	O

A17	O
:	O
proximal	O
,	O
1	O
lymph	O
node	O
.	O

A18	O
-	O
A19	O
:	O
proximal	O
,	O
1	O
lymph	O
node	O
.	O

A20	O
-	O
A24	O
:	O
distal	O
,	O
6	O
lymph	O
nodes	O
each	O
.	O

A25	O
-	O
A26	O
:	O
distal	O
,	O
2	O
lymph	O
nodes	O
each	O
.	O

A27	O
-	O
A28	O
:	O
distal	O
,	O
1	O
lymph	O
nodes	O
each	O
.	O

A29	O
:	O
obstructed	O
mesenteric	O
blood	O
vessel	O
.	O
fat	O
placed	O
in	O
O	O
-	O
Fix	O
for	O
overnight	O
fixation	O
.	O

A30	O
:	O
proximal	O
,	O
6	O
lymph	O
nodes	O
.	O

A31	O
:	O
proximal	O
,	O
5	O
lymph	O
nodes	O
.	O

A32	O
-	O
A33	O
:	O
proximal	O
,	O
2	O
lymph	O
nodes	O
each	O
.	O

A34	O
-	O
A39	O
:	O
distal	O
,	O
6	O
lymph	O
nodes	O
each	O
.	O

B	O
.	O

FINAL	O
DISTAL	O
RECTAL	O
MARGIN	O
.	O

Received	O
in	O
formalin	O
is	O
a	O
piece	O
of	O
pink	O
-	O
tan	O
mucosa	O
with	O
surgical	O
staples	O
measuring	O
2	O
.	O
3	O
X	O
1	O
.	O
7	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
staples	O
are	O
removed	O
,	O
specimen	O
is	O
bisected	O
,	O
submitted	O
entirely	O
in	O
cassette	O
B1	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

RECTOSIGMOID	O
COLON	O
,	O
LOW	O
ANTERIOR	O
SEGMENTAL	O
RESECTION	O
:	O
-	O
INVASIVE	O
MODERATELY	O
DIFFERENTIATED	O
COLONIC	O
ADENOCARCINOMA	O
,	O
.	O

9	B
X	I
7	I
.	I
5	I
X	I
0	I
.	I
4	I
CM	I
,	O
INVADING	O
INTO	O
PERIRECTAL	O
ADIPOSE	O
TISSUE	O
.	O

-	O
MARGINS	O
OF	O
RESECTION	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

-	O
27	O
OF	O
72	O
LYMPH	O
NODES	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
(	O
27	O
/	O
72	O
)	O
.	O

-	O
SEE	O
SYNOPTIC	O
REPORT	O
.	O

B	O
.	O

DISTAL	O
RECTAL	O
MARGIN	O
,	O
EXCISION	O
:	O
-	O
COLON	O
TISSUE	O
WITH	O
NO	O
EVIDENCE	O
OF	O
CARCINOMA	O
.	O

SYNOPTIC	O
REPORT	O
-	O
COLON	O
&	O
RECTUM	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
A	O
:	O
LOW	O
ANTERIOR	O
RESECTION	O
OF	O
RECTAL	O
CANCER	O
.	O

Specimen	O
Type	O
:	O
Rectal	O
/	O
rectosigmoid	O
colon	O
(	O
low	O
anterior	O
resection	O
)	O
.	O

Tumor	O
Site	O
:	O
Rectum	O
.	O

Tumor	O
Configuration	O
:	O
Infiltrative	O
.	O

Ulcerating	O
.	O

Tumor	O
size	O
:	O
9cm	B
Additional	O
dimensions	O
7	B
.	I
5cm	I
X	I
0	I
.	I
4cm	I
.	O

WHO	O
Classification	O
.	O

Adenocarcinoma	O
8140	O
/	O
3	O
.	O

Histologic	O
Grade	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

Extent	O
of	O
Invasion	O
:	O
Adjacent	O
structures	O
.	O

Specific	O
Structures	O
:	O
Perirectal	O
adipose	O
tissue	O
.	O

Margins	O
:	O
Margin	O
(	O
s	O
)	O
uninvolved	O
by	O
invasive	O
carcinoma	O
(	O
Proximal	O
,	O
Distal	O
,	O
Radial	O
)	O
.	O

Distance	O
of	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
0	O
.	O
4cm	O
.	O

Venous	O
/	O
Lymphatic	O
Invasion	O
:	O
Present	O
.	O

Perineural	O
Invasion	O
:	O
Present	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Diverticulosis	O
.	O

Extent	O
of	O
Resection	O
:	O
R0	O
:	O
Complete	O
resection	O
with	O
grossly	O
and	O
microscopically	O
negative	O
margins	O
.	O

Lymph	O
Nodes	O
:	O
Positive	O
27	O
/	O
72	O
.	O

Extranodal	O
extension	O
:	O
Present	O
.	O

Implants	O
:	O
Present	O
.	O

Implants	O
:	O
in	O
pericolic	O
adipose	O
tissue	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT	O
3	O
N	O
2	O
M	O
X	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Rectal	O
cancer	O
.	O

Clinical	O
History	O
/	O
Diagnosis	O
:	O
Left	O
Renal	O
Mass	O
.	O

Source	O
of	O
Specimen	O
(	O
s	O
)	O
:	O
Left	O
kidney	O
.	O

Gross	O
Description	O
:	O
Received	O
in	O
one	O
part	O
.	O

Source	O
of	O
Tissue	O
:	O
1	O
.	O

Labeled	O
#	O
1	O
,	O
"	O
left	O
kidney	O
"	O
.	O

Gross	O
Description	O
:	O
Received	O
fresh	O
in	O
a	O
container	O
labeled	O
left	O
kidney	O
"	O
.	O

It	O
consists	O
of	O
a	O
.	O
left	O
radical	O
nephrectomy	O
.	O
specimen	O
weighing	O
638	O
grams	O
and	O
consists	O
of	O
a	O
left	O
kidney	O
measuring	O
11	O
.	O
0	O
x	O
.	O

7	O
.	O
5	O
X	O
7	O
.	O
0	O
cm	O
with	O
some	O
attached	O
perinephric	O
fat	O
measuring	O
from	O
1	O
.	O
4	O
up	O
to	O
.	O

4	O
.	O
0	O
cm	O
from	O
point	O
of	O
attachment	O
.	O

Superior	O
-	O
medially	O
there	O
is	O
some	O
residual	O
.	O
adrenal	O
gland	O
measuring	O
only	O
1	O
.	O
5	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
7	O
cm	O
and	O
is	O
unremarkable	O
.	O

The	O
.	O
renal	O
pelvis	O
is	O
a	O
7	O
.	O
0	O
cm	O
segment	O
of	O
ureter	O
measuring	O
0	O
.	O
6	O
cm	O
in	O
diameter	O
.	O
with	O
a	O
pin	O
point	O
lumen	O
.	O

The	O
ureter	O
is	O
opened	O
and	O
is	O
free	O
of	O
lesions	O
or	O
.	O
masses	O
.	O

At	O
the	O
hilum	O
the	O
vessels	O
are	O
unremarkable	O
.	O

Dissection	O
through	O
.	O
the	O
fat	O
discloses	O
no	O
lesions	O
,	O
masses	O
or	O
nodal	O
tissue	O
.	O

The	O
kidney	O
is	O
.	O
bivalved	O
disclosing	O
a	O
central	O
tumor	O
measuring	O
5	B
.	I
5	I
X	I
3	I
.	I
9	I
X	I
4	I
.	I
0	I
cm	I
.	O

The	O
.	O
tumor	O
is	O
pushing	O
on	O
the	O
renal	O
pelvis	O
however	O
no	O
lesion	O
is	O
noted	O
.	O

The	O
.	O
tumor	O
also	O
pushes	O
on	O
the	O
capsule	O
however	O
no	O
gross	O
invasion	O
is	O
identified	O
.	O
in	O
the	O
capsule	O
or	O
fat	O
.	O

The	O
tumor	O
is	O
firm	O
to	O
soft	O
,	O
predominantly	O
.	O
orangish	O
-	O
yellow	O
with	O
some	O
more	O
white	O
fibrotic	O
areas	O
and	O
an	O
appreciable	O
.	O
amount	O
of	O
hemorrhage	O
.	O

The	O
adjacent	O
parenchyma	O
is	O
brownish	O
-	O
red	O
with	O
no	O
.	O
additional	O
lesions	O
or	O
masses	O
and	O
well	O
-	O
defined	O
cortical	O
-	O
medullary	O
.	O
junctions	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
1A	O
-	O
J	O
.	O

Designation	O
of	O
Sections	O
:	O
1A	O
-	O
vessels	O
and	O
ureter	O
margin	O
,	O
1B	O
-	O
1C	O
-	O
tumor	O
in	O
.	O
relationship	O
to	O
capsule	O
and	O
fat	O
,	O
1D	O
-	O
tumor	O
in	O
relationship	O
to	O
renal	O
.	O
pelvis	O
,	O
1E	O
-	O
tumor	O
in	O
relationship	O
-	O
to	O
adjacent	O
parenchyma	O
,	O
1F	O
-	O
tumor	O
,	O
1G	O
-	O
.	O
additional	O
overlying	O
fat	O
,	O
1H	O
-	O
uninvolved	O
kidney	O
,	O
1I	O
-	O
adrenal	O
gland	O
,	O
1J	O
-	O
.	O
perinephric	O
fat	O
at	O
hilum	O
.	O

Final	O
Diagnosis	O
:	O
1	O
.	O

Left	O
kidney	O
,	O
radical	O
nephrectomy	O
:	O
-	O
Clear	O
cell	O
renal	O
cell	O
carcinoma	O
(	O
5	B
.	I
5	I
cm	I
)	O
.	O

Fuhrman	O
nuclear	O
grade	O
III	O
.	O

Tumor	O
invades	O
into	O
perinephric	O
fat	O
.	O

See	O
note	O
.	O

-	O
Vascular	O
invasion	O
is	O
not	O
identified	O
.	O

-	O
Renal	O
vein	O
,	O
ureteral	O
and	O
perinephric	O
fat	O
(	O
circumferential	O
)	O
margins	O
are	O
.	O
free	O
of	O
tumor	O
.	O

-	O
Benign	O
adrenal	O
gland	O
.	O

Note	O
:	O
Tumor	O
cells	O
are	O
positive	O
for	O
CD10	O
,	O
Pancytokeratin	O
and	O
Vimentin	O
and	O
.	O
are	O
negative	O
for	O
CD117	O
supporting	O
the	O
diagnosis	O
.	O

pT3	O
Nx	O
Mx	O
.	O

Colect	O
date	O
:	O
PRIMARY	O
SITE	O
:	O
Floor	O
of	O
mouth	O
.	O

1	O
-	O
"	O
Lymph	O
Nodes	O
-	O
Level	O
1	O
,	O
2	O
and	O
3	O
-	O
Right	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
:	O
(	O
0	O
/	O
22	O
)	O
.	O

-	O
Submandibular	O
gland	O
uninvolved	O
by	O
carcinoma	O
.	O

2	O
-	O
"	O
Lymph	O
Nodes	O
-	O
Level	O
1	O
,	O
2	O
and	O
3	O
-	O
Left	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
:	O
(	O
0	O
/	O
26	O
)	O
.	O

-	O
Submandibular	O
gland	O
uninvolved	O
by	O
carcinoma	O
.	O

3	O
-	O
"	O
Shared	O
of	O
right	O
miloioide	O
muscle	O
"	O
.	O

-	O
Absence	O
of	O
neoplasia	O
.	O

4	O
-	O
"	O
Pelvi	O
-	O
mandibulectomy	O
central	O
arch	O
"	O
:	O
-	O
Squamous	O
cell	O
carcinoma	O
basaloid	O
type	O
.	O

-	O
Tumor	O
size	O
:	O
4	B
,	I
5x3	I
,	I
6x2	I
,	I
3	I
cm	I
.	O

-	O
Tumor	O
involves	O
floor	O
of	O
mouth	O
,	O
gingiva	O
,	O
tongue	O
and	O
jaw	O
.	O

-	O
Intense	O
stromal	O
desmoplasia	O
.	O

-	O
Perineural	O
invasion	O
:	O
not	O
identified	O
.	O

-	O
Lymph	O
-	O
vascular	O
invasion	O
:	O
present	O
.	O

-	O
Foci	O
of	O
carcinoma	O
in	O
situ	O
.	O

-	O
Margins	O
uninvolved	O
by	O
invasive	O
tumor	O
.	O

5	O
-	O
"	O
Ment	O
of	O
subcutaneous	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
.	O

CLINICAL	O
DIAGNOSIS	O
:	O
Pancreatic	O
cancer	O
.	O

Specimen	O
:	O
pancreas	O
.	O

GROSS	O
:	O
Specimen	O
status	O
:	O
Fresh	O
.	O

Operation	O
:	O
Pylorus	O
preserving	O
pancreaticoduodenectomy	O
and	O
cholecystectomy	O
.	O

Organs	O
:	O
Small	O
intestine	O
(	O
17	O
.	O
0	O
cm	O
in	O
length	O
and	O
3	O
.	O
5	O
cm	O
in	O
greatest	O
circumference	O
)	O
.	O

Pancreas	O
,	O
partial	O
(	O
5	O
.	O
5	O
x	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
)	O
.	O

Gallbladder	O
(	O
10	O
.	O
0	O
cm	O
in	O
length	O
,	O
3	O
,	O
5	O
cm	O
in	O
diameter	O
,	O
and	O
0	O
.	O
3	O
cm	O
in	O
thickness	O
)	O
.	O

Lesions	O
:	O
An	O
ill	O
-	O
defined	O
pale	O
tan	O
solid	O
and	O
firm	O
mass	O
(	O
2	O
.	O
0	O
X	O
1	O
.	O
8	O
X	O
1	O
.	O
5	O
cm	O
)	O
in	O
pancreatic	O
head	O
.	O

Cut	O
surface	O
:	O
Yellowish	O
tan	O
,	O
firm	O
and	O
granular	O
.	O

Extent	O
:	O
Extension	O
to	O
peripancreatic	O
soft	O
tissue	O
.	O

Resection	O
margins	O
of	O
bile	O
duct	O
,	O
small	O
intestine	O
and	O
pancreas	O
:	O
Free	O
of	O
tumor	O
.	O

Frozen	O
diagnosis	O
.	O

FS1	O
,	O
Bile	O
duct	O
margin	O
:	O
No	O
tumor	O
present	O
.	O

FS2	O
-	O
3	O
,	O
Pancreatic	O
resection	O
margin	O
:	O
Tumor	O
present	O
.	O

FS4	O
,	O
More	O
resected	O
pancreatic	O
resection	O
margin	O
:	O
No	O
tumor	O
present	O
.	O

Gross	O
photo	O
:	O
Present	O
.	O

MICROSCOPIC	O
:	O
Tumor	O
type	O
:	O
Ductal	O
adenocarcinoma	O
.	O

Tumor	O
location	O
:	O
Pancreatic	O
head	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
0	I
X	I
1	I
.	I
8	I
X	I
1	I
.	I
5	I
cm	I
.	O

Extent	O
:	O
Peripancreatic	O
soft	O
tissue	O
,	O
and	O
muscle	O
and	O
submucosa	O
of	O
small	O
intestine	O
.	O

Lymphovascular	O
invasion	O
:	O
Present	O
.	O

Perineural	O
invasion	O
:	O
Present	O
.	O

Surgical	O
margins	O
:	O
All	O
surgical	O
margins	O
are	O
free	O
from	O
tumor	O
.	O

Lymph	O
node	O
metastasis	O
:	O
Absent	O
(	O
0	O
/	O
19	O
)	O
.	O

DIAGNOSIS	O
:	O
Pancreas	O
,	O
head	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Ductal	O
adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
infiltrating	O
.	O

Small	O
intestine	O
,	O
duodenum	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Direct	O
tumor	O
extension	O
from	O
pancreas	O
.	O

Bile	O
duct	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
No	O
tumor	O
present	O
.	O

Gallbladder	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Chronic	O
cholecystitis	O
.	O

Lymph	O
node	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Lymph	O
node	O
,	O
7	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
1	O
)	O
.	O

Lymph	O
node	O
,	O
8	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
5	O
)	O
.	O

Lymph	O
node	O
,	O
12	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
4	O
)	O
.	O

Lymph	O
node	O
,	O
13	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
3	O
)	O
.	O

Lymph	O
node	O
,	O
peripancreatic	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
6	O
)	O
.	O

Suggestion	O
:	O

Diagnosis	O
(	O
diagnoses	O
)	O
:	O
Resected	O
colon	O
sample	O
with	O
a	O
centrally	O
ulcerated	O
,	O
moderately	O
differentiated	O
.	O
adenocarcinoma	O
of	O
the	O
colorectal	O
type	O
,	O
measuring	O
a	O
max	O
of	O
4	B
.	I
8	I
cm	I
in	O
diameter	O
,	O
with	O
broad	O
.	O
infiltration	O
of	O
the	O
pericolic	O
fatty	O
tissue	O
and	O
two	O
local	O
lymph	O
node	O
metastases	O
immediately	O
.	O
next	O
to	O
the	O
tumor	O
.	O

Tumor	O
-	O
free	O
colon	O
resection	O
margins	O
.	O

Tumor	O
-	O
free	O
mesenteric	O
resection	O
.	O
margin	O
.	O

Otherwise	O
,	O
individual	O
tubular	O
adenomas	O
of	O
the	O
colon	O
mucous	O
membrane	O
with	O
.	O
predominant	O
moderate	O
dysplasia	O
(	O
synonym	O
:	O
mild	O
intraepithelial	O
neoplasia	O
)	O
.	O

The	O
tumor	O
stage	O
is	O
:	O
pT2	O
,	O
pNO	O
(	O
0	O
/	O
27	O
)	O
pMX	O
;	O
G2	O
,	O
L0	O
,	O
V0	O
,	O
R0	O
.	O

Final	O
Pathologic	O
Diagnosis	O
:	O
A	O
.	O

Lung	O
,	O
right	O
,	O
resection	O
:	O
Poorly	O
differentiated	O
squamous	O
cell	O
carcinoma	O
.	O

All	O
margins	O
negative	O
for	O
neoplasm	O
.	O

Carcinoma	O
involving	O
3	O
out	O
11	O
of	O
lymph	O
nodes	O
(	O
3	O
/	O
11	O
)	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
level	O
7	O
subcarinal	O
,	O
excision	O
:	O
One	O
lymph	O
node	O
negative	O
for	O
neoplasm	O
(	O
0	O
/	O
1	O
)	O
.	O

C	O
.	O

Lymph	O
nodes	O
,	O
upper	O
paratracheal	O
,	O
excision	O
:	O
Three	O
lymph	O
nodes	O
negative	O
for	O
neoplasm	O
(	O
0	O
/	O
3	O
)	O
.	O

D	O
.	O

Lymph	O
nodes	O
,	O
lower	O
paratracheal	O
,	O
excision	O
:	O
Thirteen	O
lymph	O
nodes	O
negative	O
for	O
neoplasm	O
(	O
0	O
/	O
13	O
)	O
.	O

E	O
.	O

Lymph	O
nodes	O
,	O
level	O
10	O
,	O
excision	O
:	O
Three	O
lymph	O
nodes	O
negative	O
for	O
neoplasm	O
(	O
0	O
/	O
3	O
)	O
.	O

F	O
.	O

Bronchial	O
margin	O
,	O
excision	O
:	O
Negative	O
for	O
malignancy	O
.	O

Frozen	O
section	O
diagnosis	O
confirmed	O
.	O

Lung	O
resection	O
:	O
Specimen	O
:	O
Lung	O
.	O

Procedure	O
:	O
Pneumonectomy	O
.	O

Specimen	O
laterality	O
:	O
Right	O
.	O

Tumor	O
site	O
:	O
Upper	O
lobe	O
.	O

Specimen	O
integrity	O
:	O
Intact	O
.	O

Tumor	O
size	O
:	O
6	B
cm	I
(	O
greatest	O
dimension	O
)	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Tumor	O
histologic	O
type	O
:	O
Squamous	O
carcinoma	O
.	O

Tumor	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Visceral	O
pleura	O
invasion	O
:	O
None	O
.	O

Tumor	O
extension	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Bronchial	O
margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Vascular	O
margin	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Parietal	O
pleural	O
margin	O
:	O
Not	O
applicable	O
.	O

Chest	O
wall	O
margin	O
:	O
Not	O
applicable	O
.	O

Other	O
attached	O
tissue	O
margin	O
:	O
Not	O
applicable	O
.	O

If	O
all	O
margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
:	O
Distanceof	O
invasive	O
carcinoma	O
from	O
closest	O
margin	O
:	O
9	O
mm	O
.	O

Specify	O
margin	O
:	O
Parenchymal	O
.	O

Treatment	O
effect	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
vascular	O
invasion	O
:	O
present	O
.	O

Pathologic	O
Staging	O
(	O
pTNM	O
)	O
:	O
TNM	O
Descriptors	O
:	O
None	O
known	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2b	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
pN1	O
.	O

Number	O
examined	O
:	O
31	O
.	O

Number	O
involved	O
:	O
3	O
.	O

If	O
lymph	O
node	O
(	O
s	O
)	O
involved	O
,	O
specify	O
involved	O
nodal	O
station	O
(	O
s	O
)	O
:	O
ipsilateral	O
peribronchial	O
.	O

Distant	O
metastasis	O
(	O
pM	O
)	O
:	O
pMX	O
.	O

Notes	O
:	O
Totally	O
,	O
seven	O
lymph	O
nodes	O
are	O
fibrotic	O
or	O
with	O
central	O
necrosis	O
,	O
but	O
there	O
is	O
.	O

no	O
carcinoma	O
.	O

These	O
lymph	O
nodes	O
are	O
located	O
in	O
the	O
peribronchial	O
,	O
level	O
7	O
and	O
.	O
lower	O
paratracheal	O
regions	O
.	O

The	O
examination	O
of	O
this	O
case	O
material	O
and	O
the	O
preparation	O
of	O
this	O
report	O
were	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
:	O
FSF	O
:	O
Bronchial	O
margin	O
:	O
Negative	O
for	O
malignancy	O
.	O

Gross	O
Description	O
:	O
The	O
specimens	O
are	O
received	O
in	O
six	O
formalin	O
filled	O
containers	O
,	O
all	O
labeled	O
with	O
.	O
the	O
patient	O
'	O
s	O
name	O
.	O

Part	O
A	O
is	O
additionally	O
labeled	O
"	O
right	O
lung	O
(	O
for	O
precision	O
)	O
.	O

"	O
The	O
specimen	O
.	O
consists	O
of	O
a	O
right	O
lung	O
with	O
dimensions	O
of	O
21	O
X	O
12	O
X	O
6	O
.	O
5	O
cm	O
.	O

The	O
lung	O
has	O
a	O
.	O
weight	O
of	O
400	O
grams	O
.	O

There	O
are	O
multiple	O
stapled	O
vascular	O
structures	O
present	O
at	O
.	O
the	O
hilum	O
.	O

Additionally	O
,	O
there	O
are	O
staple	O
lines	O
within	O
the	O
parenchyma	O
that	O
have	O
.	O

a	O
total	O
length	O
of	O
13	O
cm	O
.	O

The	O
surgical	O
staple	O
lines	O
are	O
removed	O
and	O
the	O
.	O
parenchymal	O
margins	O
are	O
inked	O
blue	O
.	O

The	O
pleural	O
surface	O
of	O
the	O
specimen	O
is	O
.	O
gray	O
-	O
purple	O
to	O
tan	O
-	O
white	O
and	O
generally	O
smooth	O
.	O

The	O
pleural	O
surface	O
has	O
been	O
.	O
inked	O
black	O
overlying	O
the	O
area	O
of	O
the	O
mass	O
and	O
a	O
portion	O
of	O
the	O
tissue	O
sent	O
for	O
.	O
precision	O
diagnostic	O
studies	O
.	O

The	O
specimen	O
is	O
remarkable	O
for	O
a	O
firm	O
tan	O
-	O
white	O
.	O
fungating	O
mass	O
within	O
the	O
bronchus	O
of	O
the	O
right	O
upper	O
lobe	O
.	O

Serial	O
sectioning	O
.	O
reveals	O
that	O
the	O
mass	O
has	O
overall	O
dimensions	O
of	O
6	B
X	I
5	I
x	I
4	I
cm	I
.	O

The	O
cut	O
surfaces	O
.	O
of	O
the	O
mass	O
are	O
firm	O
,	O
tan	O
-	O
white	O
and	O
heterogeneous	O
with	O
areas	O
of	O
necrosis	O
and	O
.	O
hemorrhage	O
.	O

The	O
mass	O
appears	O
to	O
fill	O
the	O
majority	O
of	O
the	O
right	O
upper	O
bronchus	O
.	O
and	O
erode	O
through	O
the	O
wall	O
.	O

It	O
comes	O
to	O
within	O
0	O
.	O
1	O
cm	O
of	O
the	O
pleural	O
surface	O
.	O

The	O
mass	O
comes	O
to	O
within	O
0	O
.	O
5	O
cm	O
of	O
the	O
inked	O
parenchymal	O
margin	O
.	O

The	O
remaining	O
.	O
uninvolved	O
lung	O
is	O
pink	O
-	O
tan	O
to	O
red	O
-	O
brown	O
and	O
spongy	O
.	O

The	O
bronchial	O
spaces	O
are	O
.	O
filled	O
with	O
gray	O
-	O
green	O
mucoid	O
material	O
.	O

Multiple	O
lymph	O
nodes	O
are	O
present	O
.	O
adjacent	O
to	O
the	O
hilar	O
structures	O
.	O

These	O
range	O
in	O
greatest	O
dimension	O
from	O
0	O
.	O
5	O
to	O
.	O

1	O
.	O
3	O
cm	O
.	O

Cassettes	O
are	O
submitted	O
as	O
follows	O
:	O
A1	O
.	O
vascular	O
margin	O
;	O
.	O

A2	O
-	O
3	O
.	O
mass	O
in	O
right	O
upper	O
bronchus	O
;	O
.	O

A4	O
.	O
mass	O
to	O
nearest	O
parenchymal	O
margin	O
;	O
.	O

A5	O
-	O
6	O
remaining	O
parenchymal	O
margin	O
taken	O
en	O
face	O
;	O
.	O

A7	O
.	O
mass	O
to	O
pleura	O
;	O
.	O

A8	O
-	O
11	O
additional	O
representative	O
sections	O
of	O
mass	O
;	O
.	O

A12	O
uninvolved	O
lung	O
;	O
.	O

A13	O
-	O
15	O
multiple	O
lymph	O
nodes	O
submitted	O
in	O
toto	O
;	O
.	O

A16	O
.	O
one	O
lymph	O
node	O
bisected	O
.	O

Part	O
B	O
is	O
additionally	O
labeled	O
"	O
level	O
7	O
subcarinal	O
lymph	O
node	O
.	O
"	O
The	O
specimen	O
.	O
consists	O
of	O
a	O
gray	O
-	O
tan	O
irregular	O
tissue	O
with	O
dimensions	O
of	O
3	O
.	O
8	O
X	O
3	O
X	O
1	O
cm	O
.	O

This	O
.	O
may	O
represent	O
a	O
single	O
lymph	O
node	O
or	O
multiple	O
matted	O
lymph	O
nodes	O
.	O

Sectioning	O
.	O
reveals	O
multiple	O
tan	O
-	O
white	O
areas	O
of	O
discoloration	O
within	O
the	O
tissue	O
,	O
as	O
well	O
as	O
.	O
focal	O
calcification	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
and	O
submitted	O
entirely	O
.	O
in	O
cassettes	O
B1	O
-	O
B5	O
following	O
decalcification	O
.	O

Part	O
C	O
is	O
additionally	O
labeled	O
"	O
upper	O
paratracheal	O
lymph	O
node	O
.	O
'	O
The	O
specimen	O
.	O
consists	O
of	O
a	O
portion	O
of	O
yellow	O
-	O
tan	O
fibrofatty	O
tissue	O
with	O
dimensions	O
of	O
3	O
.	O
3	O
X	O
.	O

2	O
.	O
3	O
X	O
0	O
.	O
6	O
cm	O
.	O

Multiple	O
probable	O
lymph	O
nodes	O
are	O
identified	O
with	O
greatest	O
.	O
dimensions	O
ranging	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
6	O
cm	O
.	O

These	O
nodes	O
are	O
submitted	O
in	O
toto	O
in	O
.	O
cassette	O
C1	O
.	O

Part	O
D	O
is	O
additionally	O
labeled	O
"	O
lower	O
paratracheal	O
lymph	O
node	O
.	O
"	O
The	O
specimen	O
.	O
consists	O
of	O
a	O
portion	O
of	O
yellow	O
-	O
tan	O
lobulated	O
fibrofatty	O
tissue	O
with	O
dimensions	O
.	O
of	O
4	O
.	O
2	O
X	O
3	O
.	O
1	O
X	O
1	O
.	O
5	O
cm	O
.	O

Palpation	O
and	O
sectioning	O
reveals	O
multiple	O
probable	O
lymph	O
.	O
nodes	O
with	O
greatest	O
dimensions	O
ranging	O
from	O
0	O
.	O
4	O
to	O
3	O
cm	O
.	O

Sectioning	O
of	O
the	O
.	O
largest	O
of	O
these	O
nodes	O
reveals	O
abundant	O
calcification	O
.	O

Cassettes	O
are	O
submitted	O
as	O
follows	O
:	O
D1	O
-	O
2	O
.	O
multiple	O
whole	O
probable	O
lymph	O
nodes	O
;	O
.	O

D3	O
-	O
5	O
.	O
one	O
lymph	O
node	O
submitted	O
entirely	O
,	O
pending	O
decalcification	O
.	O

Part	O
E	O
is	O
additionally	O
labeled	O
"	O
level	O
10	O
lymph	O
node	O
.	O
'	O
The	O
specimen	O
consists	O
of	O
.	O
two	O
portions	O
of	O
gray	O
-	O
tan	O
fibrofatty	O
tissue	O
with	O
dimensions	O
of	O
1	O
.	O
6	O
X	O
0	O
.	O
7	O
X	O
0	O
.	O
3	O
cm	O
.	O
and	O
1	O
.	O
5	O
X	O
1	O
.	O
2	O
X	O
0	O
.	O
5	O
cm	O
.	O

The	O
smaller	O
tissue	O
is	O
submitted	O
in	O
toto	O
in	O
cassette	O
E1	O
.	O

The	O
larger	O
tissue	O
is	O
bisected	O
and	O
submitted	O
entirely	O
in	O
cassette	O
E2	O
.	O

Part	O
F	O
is	O
additionally	O
labeled	O
"	O
bronchial	O
margin	O
.	O
"	O
The	O
specimen	O
is	O
received	O
.	O
fresh	O
for	O
frozen	O
section	O
intraoperative	O
consultation	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
.	O
pink	O
-	O
red	O
ring	O
of	O
bronchus	O
that	O
has	O
dimensions	O
of	O
3	O
.	O
2	O
X	O
2	O
.	O
8	O
X	O
0	O
.	O
7	O
cm	O
.	O

This	O
.	O
tissue	O
is	O
submitted	O
for	O
frozen	O
section	O
F	O
.	O

The	O
residual	O
tissue	O
from	O
frozen	O
.	O
section	O
F	O
is	O
bisected	O
and	O
resubmitted	O
in	O
cassettes	O
F1	O
and	O
F2	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
KIDNEY	O
,	O
LEFT	O
,	O
RADICAL	O
LAPARASCOPIC	O
NEPHRECTOMY	O
-	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
(	O
CLEAR	O
CELL	O
)	O
TYPE	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
MEASURES	O
8	B
.	I
8	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
AND	O
HAS	O
A	O
FUHRMAN	O
GRADE	O
OF	O
2	O
OUT	O
OF	O
4	O
.	O

C	O
.	O

THE	O
TUMOR	O
IS	O
CONFINED	O
TO	O
THE	O
KIDNEY	O
AND	O
DOES	O
NOT	O
EXTEND	O
INTO	O
THE	O
PERINEPHRIC	O
FAT	O
.	O

D	O
.	O

ALL	O
SURGICAL	O
RESECTION	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

E	O
.	O

NO	O
EVIDENCE	O
OF	O
ANGIOLYMPHATIO	O
INVASION	O
.	O

F	O
.	O

PATHOLOGIC	O
STAGE	O
T2NxMx	O
.	O

G	O
.	O

UNINVOLVED	O
RENAL	O
PARENCHYMA	O
UNREMARKABLE	O
.	O

Sex	O
:	O
Female	O
.	O

SPECIMENINFORMATION	O
.	O

Acct	O
/	O
Reg	O
#	O
:	O
DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
Left	O
partial	O
nephrectomy	O
with	O
tumor	O
:	O
Carcinoma	O
.	O

Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Conventional	O
-	O
clear	O
cell	O
.	O

2	O
.	O

Tumor	O
site	O
:	O
Left	O
kidney	O
.	O

3	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

4	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
x	I
2x	I
1	I
.	I
5	I
cm	I
.	O

5	O
.	O

Macroscopic	O
extent	O
of	O
tumor	O
:	O
Limited	O
to	O
kidney	O
.	O

6	O
.	O

Microscopic	O
extent	O
of	O
tumor	O
:	O
Limited	O
to	O
kidney	O
.	O

7	O
.	O

Nuclear	O
grade	O
:	O
Fuhrman	O
grade	O
2	O
/	O
4	O
.	O

8	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

9	O
.	O

Sarcomatoid	O
features	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margin	O
Status	O
:	O
Margins	O
uninvolved	O
,	O
tumor	O
present	O
approximately	O
0	O
.	O
1	O
cm	O
from	O
posterior	O
(	O
stitch	O
)	O
margin	O
,	O
tumor	O
abuts	O
capsule	O
.	O

Lymph	O
Node	O
Status	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
received	O
:	O
None	O
.	O

Other	O
:	O
1	O
.	O

Other	O
significant	O
findings	O
:	O
None	O
.	O

2	O
.	O

pTN	O
stage	O
:	O
pT1a	O
NX	O
.	O

EINICAEINEORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Stitch	O
on	O
posterior	O
margin	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
Left	O
renal	O
tumor	O
/	O
mass	O
.	O

SPECIMENT	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
a	O
single	O
formalin	O
filled	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
.	O
and	O
"	O
left	O
renal	O
tumor	O
/	O
mass	O
"	O
and	O
consists	O
of	O
.	O

a	O
3	O
.	O
5	O
x	O
2	O
.	O
4	O
x	O
2	O
.	O
2	O
cm	O
partial	O
nephrectomy	O
specimen	O
.	O

Red	O
-	O
pink	O
,	O
shaggy	O
renal	O
parenchyma	O
is	O
present	O
on	O
one	O
aspect	O
and	O
it	O
bears	O
a	O
stitch	O
.	O

The	O
opposite	O
.	O
aspect	O
is	O
smooth	O
and	O
encapsulated	O
.	O

The	O
sutured	O
parenchymal	O
aspect	O
is	O
inked	O
blue	O
and	O
the	O
encapsulated	O
aspect	O
is	O
inked	O
blue	O
.	O

The	O
specimen	O
is	O
.	O
sectioned	O
to	O
reveal	O
a	O
2	O
.	O
5x	O
2	O
.	O
0x	O
1	O
.	O
5	O
cm	O
,	O
well	O
circumscribed	O
,	O
yellow	O
-	O
tan	O
,	O
hemorrhagic	O
and	O
variegated	O
mass	O
that	O
approaches	O
to	O
within	O
0	O
.	O
1	O
cm	O
of	O
.	O
the	O
.	O

sutured	O
parenchymal	O
aspect	O
and	O
abuts	O
the	O
encapsulated	O
aspect	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
cassettes	O
1	O
-	O
6	O
labeled	O
.	O

Additionally	O
,	O
a	O
yellow	O
and	O
green	O
cassette	O
are	O
submitted	O
for	O
genomics	O
research	O
,	O
each	O
labeled	O
.	O

LABORATORY	O
MEDICINE	O
PROGRAM	O
.	O

Facility	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Adrenal	O
:	O
right	O
adrenal	O
gland	O
.	O

Diagnosis	O
.	O

Pheochromocytoma	O
:	O
Adrenal	O
(	O
right	O
)	O
adrenalectomy	O
specimen	O
.	O

Comment	O
.	O

This	O
is	O
an	O
unusual	O
pheochromocytoma	O
.	O

The	O
architecture	O
and	O
cytology	O
mimic	O
a	O
cortical	O
lesion	O
,	O
but	O
the	O
.	O
immunohistochemistry	O
identifies	O
the	O
correct	O
diagnosis	O
.	O

Clinical	O
History	O
.	O

None	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
right	O
adrenal	O
gland	O
"	O
contains	O
an	O
adrenal	O
gland	O
with	O
a	O
.	O
mass	O
.	O

The	O
specimen	O
weighs	O
39	O
.	O
0	O
grams	O
and	O
measures	O
9	O
.	O
0	O
X	O
4	O
.	O
7	O
X	O
2	O
.	O
5	O
cm	O
.	O

The	O
external	O
surface	O
is	O
painted	O
with	O
silver	O
that	O
.	O
nitrate	O
.	O

After	O
removal	O
of	O
adherent	O
fat	O
,	O
the	O
adrenal	O
weighs	O
33	O
.	O
5	O
grams	O
.	O

On	O
section	O
there	O
is	O
a	O
well	O
-	O
delineated	O
mass	O
.	O
measures	O
3	O
.	O
4	O
x	O
3	O
.	O
2	O
x	O
3	O
.	O
0	O
cm	O
and	O
has	O
a	O
solid	O
bright	O
yellow	O
to	O
yellow	O
-	O
orange	O
homogenous	O
cut	O
surface	O
.	O

The	O
remainder	O
of	O
.	O
the	O
adrenal	O
is	O
unremarkable	O
.	O

The	O
specimen	O
is	O
submitted	O
in	O
toto	O
as	O
follows	O
:	O
1A	O
-	O
M	O
.	O
mass	O
from	O
one	O
end	O
to	O
the	O
other	O
.	O

1N	O
-	O
X	O
remainder	O
of	O
the	O
adrenal	O
gland	O
.	O

Microscopic	O
Description	O
.	O

DOMINANT	O
LESION	O
:	O
adrenal	O
tumor	O
.	O

SIZE	O
:	O
9	B
.	I
0	I
cm	I
maximum	O
dimension	O
.	O

WEIGHT	O
:	O
33	O
.	O
5	O
g	O
.	O

ARCHITECTURE	O
:	O
solid	O
nesting	O
and	O
trabecular	O
architecture	O
.	O

CYTOLOGY	O
:	O
round	O
cells	O
with	O
well	O
-	O
defined	O
cell	O
borders	O
,	O
abundant	O
clear	O
to	O
basophilic	O
cytoplasm	O
and	O
no	O
nuclear	O
.	O
pleomorphism	O
.	O

DEGENERATION	O
:	O
none	O
identified	O
.	O

ENCAPSULATION	O
:	O
incomplete	O
capsule	O
.	O

CAPSULAR	O
INVASION	O
:	O
no	O
frank	O
invasion	O
identified	O
.	O

EXTRA	O
-	O
ADRENAL	O
INVASION	O
:	O
not	O
identified	O
.	O

RESECTION	O
MARGINS	O
:	O
not	O
involved	O
.	O

LYMPHOVASCULAR	O
INVOLVEMENT	O
:	O
not	O
identified	O
.	O

OTHER	O
ADRENAL	O
PATHOLOGY	O
:	O
none	O
;	O
no	O
cortical	O
atrophy	O
or	O
hyperplasia	O
and	O
no	O
medullary	O
hyperplasia	O
.	O

LYMPH	O
NODES	O
:	O
none	O
identified	O
.	O

IMMUNOHISTOCHEMISTRY	O
:	O
positive	O
for	O
chromogranin	O
and	O
tyrosine	O
hydroxylase	O
;	O
sustentacular	O
cells	O
stain	O
for	O
S100	O
.	O
protein	O
.	O

Result	O
Data	O
.	O

Site	O
:	O
Jongue	O
NOS	O
C02	O
.	O
9	O
.	O

Component	O
.	O

Lab	O
.	O

Clinical	O
History	O
.	O

Tongue	O
cancer	O
.	O

Gross	O
Examination	O
.	O

A	O
.	O

"	O
Right	O
lateral	O
tongue	O
lesion	O
"	O
,	O
received	O
unfixed	O
for	O
frozen	O
section	O
and	O
.	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
0	O
.	O
9	O
X	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
tan	O
-	O
gray	O
.	O
fragment	O
of	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
section	O
as	O
AF1	O
.	O

The	O
.	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
A1	O
.	O

B	O
.	O

"	O
Anterior	O
gingival	O
margin	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
2	O
.	O
1	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
tan	O
-	O
gray	O
,	O
focally	O
hemorrhagic	O
.	O
fragment	O
of	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
section	O
BF1	O
.	O

The	O
frozen	O
.	O
section	O
remnant	O
is	O
submitted	O
in	O
B1	O
.	O

C	O
.	O

"	O
Deep	O
tongue	O
margin	O
"	O
,	O
received	O
unfixed	O
for	O
frozen	O
section	O
and	O
placed	O
in	O
.	O
formalin	O
on	O
.	O

is	O
a	O
2	O
.	O
5	O
X	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
red	O
-	O
brown	O
fragment	O
of	O
.	O
soft	O
tissue	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
for	O
frozen	O
section	O
as	O
CF1	O
.	O

The	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
C1	O
.	O

D	O
.	O

"	O
Anterior	O
tongue	O
attachment	O
"	O
,	O
received	O
unfixed	O
for	O
frozen	O
section	O
and	O
.	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
tan	O
-	O
red	O
.	O
fragment	O
of	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
section	O
as	O
DF1	O
.	O

The	O
.	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
D1	O
.	O

E	O
.	O

"	O
Right	O
floor	O
of	O
mouth	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
2	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
tan	O
,	O
elongated	O
,	O
focally	O
hemorrhagic	O
.	O
fragment	O
of	O
mucosal	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
as	O
EF1	O
.	O

The	O
frozen	O
.	O
section	O
remnant	O
is	O
submitted	O
in	O
E1	O
.	O

F	O
.	O

"	O
Right	O
posterior	O
tongue	O
margin	O
"	O
,	O
received	O
unfixed	O
for	O
frozen	O
section	O
and	O
.	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
3	O
.	O
2	O
X	O
0	O
.	O

-	O
x	O
0	O
.	O
2	O
cm	O
tan	O
-	O
red	O
,	O
.	O
focally	O
hemorrhagic	O
fragment	O
of	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
.	O
section	O
as	O
FF1	O
.	O

The	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
F1	O
.	O

G	O
.	O

"	O
Left	O
floor	O
of	O
mouth	O
"	O
,	O
received	O
unfixed	O
for	O
frozen	O
section	O
and	O
placed	O
in	O
.	O
formalin	O
on	O
.	O

is	O
a	O
1	O
.	O
8	O
X	O
0	O
.	O

x	O
0	O
.	O
2	O
cm	O
tan	O
-	O
red	O
fragment	O
of	O
.	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
section	O
as	O
GF1	O
.	O

The	O
frozen	O
section	O
.	O
remnant	O
is	O
submitted	O
in	O
G1	O
.	O

H	O
.	O

"	O
Left	O
posterior	O
tongue	O
margin	O
"	O
,	O
received	O
fresh	O
for	O
frozen	O
section	O
and	O
.	O
placed	O
in	O
formalin	O
at	O
.	O

is	O
a	O
2	O
.	O
2	O
x	O
0	O
.	O
2	O
X	O
0	O
.	O
2	O
cm	O
tan	O
,	O
.	O
elongated	O
strip	O
of	O
soft	O
tissue	O
submitted	O
entirely	O
for	O
frozen	O
section	O
as	O
HF1	O
.	O

The	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
H1	O
.	O

I	O
.	O

"	O
Right	O
hemiglossectomy	O
,	O
stitch	O
at	O
tip	O
of	O
tongue	O
"	O
,	O
received	O
unfixed	O
and	O
.	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
right	O
hemiglossectomy	O
specimen	O
,	O
.	O

6	O
.	O
5	O
X	O
4	O
.	O
5	O
X	O
3	O
.	O
2	O
cm	O
in	O
dimension	O
.	O

The	O
surgeon	O
has	O
marked	O
the	O
tip	O
of	O
the	O
tongue	O
.	O
with	O
a	O
black	O
suture	O
.	O

The	O
right	O
half	O
of	O
the	O
deep	O
aspect	O
is	O
marked	O
with	O
black	O
.	O
ink	O
,	O
and	O
the	O
left	O
half	O
of	O
the	O
deep	O
aspect	O
is	O
marked	O
with	O
blue	O
ink	O
.	O

The	O
.	O
peripheral	O
mucosal	O
and	O
tongue	O
resection	O
margins	O
are	O
shaved	O
and	O
submitted	O
in	O
.	O

a	O
.	O
clockwise	O
fashion	O
.	O

Sectioning	O
through	O
the	O
tongue	O
reveals	O
a	O
tan	O
-	O
gray	O
,	O
well	O
-	O
circumscribed	O
tumor	O
.	O
mass	O
which	O
focally	O
ulcerates	O
the	O
mucosal	O
surface	O
of	O
the	O
tongue	O
.	O

The	O
tumor	O
.	O
mass	O
is	O
1	B
.	I
9	I
X	I
1	I
.	I
5	I
x	I
1	I
.	I
5	I
cm	I
in	O
dimension	O
and	O
extends	O
into	O
the	O
attached	O
floor	O
of	O
.	O
mouth	O
.	O

The	O
central	O
aspect	O
displays	O
a	O
central	O
hemorrhagic	O
area	O
.	O

The	O
tumor	O
.	O
comes	O
to	O
0	O
.	O
1	O
cm	O
from	O
the	O
deep	O
resection	O
margin	O
of	O
the	O
specimen	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
as	O
follows	O
.	O

BLOCK	O
SUMMARY	O
.	O

Il	O
12	O
-	O
3	O
:	O
00	O
specimen	O
margin	O
,	O
en	O
face	O
.	O

I2	O
3	O
-	O
6	O
:	O
00	O
specimen	O
margin	O
,	O
en	O
face	O
.	O

I3	O
6	O
-	O
9	O
:	O
00	O
specimen	O
margin	O
,	O
en	O
face	O
.	O

I4	O
9	O
-	O
12	O
:	O
00	O
specimen	O
margin	O
,	O
en	O
face	O
.	O

I5	O
-	O
I6	O
tumor	O
mass	O
with	O
relationship	O
to	O
deep	O
resection	O
margin	O
.	O

I7	O
-	O
8	O
tumor	O
mass	O
with	O
relationship	O
to	O
ulcerated	O
tongue	O
mucosa	O
.	O

J	O
.	O

"	O
Bilateral	O
level	O
1A	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
4	O
.	O
5	O
x	O
2	O
.	O
1	O
x	O
1	O
.	O
5	O
cm	O
fragment	O
of	O
adipose	O
tissue	O
.	O

All	O
lymph	O
node	O
.	O
candidates	O
are	O
submitted	O
in	O
J1	O
.	O

BLOCK	O
SUMMARY	O
:	O
J1	O
-	O
three	O
intact	O
lymph	O
node	O
candidates	O
.	O

K	O
.	O

"	O
Right	O
level	O
1B	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
4	O
.	O
8	O
x	O
3	O
.	O
5	O
X	O
2	O
.	O
5	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

Sectioning	O
.	O
reveals	O
a	O
central	O
tan	O
,	O
firm	O
and	O
lobulated	O
salivary	O
gland	O
.	O

The	O
surrounding	O
.	O
adipose	O
tissue	O
is	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Sections	O
are	O
submitted	O
as	O
.	O
follows	O
.	O

BLOCK	O
SUMMARY	O
:	O
K1	O
-	O
2	O
-	O
eight	O
intact	O
lymph	O
node	O
candidates	O
.	O

K3	O
-	O
.	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

K4	O
-	O
5	O
-	O
representative	O
salivary	O
gland	O
.	O

L	O
.	O

"	O
Right	O
level	O
4	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
2	O
.	O
4	O
x	O
1	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

All	O
lymph	O
node	O
candidates	O
are	O
submitted	O
as	O
.	O
follows	O
.	O

BLOCK	O
SUMMARY	O
:	O
L1	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

L2	O
-	O
two	O
intact	O
lymph	O
node	O
candidates	O
.	O

M	O
.	O

"	O
Right	O
level	O
2A	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
tan	O
-	O
gray	O
firm	O
portion	O
of	O
tissue	O
measuring	O
4	O
.	O
8	O
x	O
3	O
.	O
5	O
X	O
1	O
.	O
5	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
large	O
,	O
gray	O
-	O
white	O
indurated	O
nodule	O
which	O
is	O
3	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

Sectioning	O
of	O
the	O
nodule	O
reveals	O
tumor	O
involvement	O
.	O

All	O
.	O
lymph	O
node	O
candidates	O
and	O
a	O
representative	O
section	O
of	O
the	O
nodule	O
are	O
submitted	O
.	O
in	O
blocks	O
M1	O
-	O
3	O
.	O

BLOCK	O
SUMMARY	O
:	O
M1	O
-	O
three	O
intact	O
lymph	O
node	O
candidates	O
.	O

M2	O
-	O
representative	O
section	O
of	O
large	O
nodular	O
mass	O
.	O

M3	O
-	O
one	O
lymph	O
node	O
,	O
trisected	O
.	O

N	O
.	O

"	O
Right	O
level	O
3	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
6	O
.	O
5	O
X	O
4	O
.	O

1	O
x	O
1	O
.	O
2	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
.	O

BLOCK	O
SUMMARY	O
:	O
N1	O
-	O
three	O
intact	O
lymph	O
node	O
candidates	O
.	O

N2	O
-	O
six	O
intact	O
lymph	O
node	O
candidates	O
.	O

O	O
.	O

"	O
Right	O
level	O
2B	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
2	O
.	O
2	O
X	O
1	O
.	O
3	O
X	O
0	O
.	O
8	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

The	O
specimen	O
.	O

is	O
entirely	O
submitted	O
in	O
01	O
-	O
2	O
.	O

P	O
.	O

"	O
Left	O
level	O
1B	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
yellow	O
lobulated	O
firm	O
portion	O
of	O
fatty	O
tissue	O
measuring	O
5	O
.	O
7	O
x	O
3	O
.	O
7	O
x	O
2	O
.	O
5	O
.	O

cm	O
.	O

Sectioning	O
reveals	O
a	O
tan	O
lobulated	O
salivary	O
gland	O
.	O

No	O
nodules	O
or	O
masses	O
.	O
are	O
noted	O
within	O
the	O
salivary	O
gland	O
.	O

The	O
remaining	O
adipose	O
tissue	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Sections	O
are	O
submitted	O
as	O
follows	O
.	O

BLOCK	O
SUMMARY	O
:	O
P1	O
-	O
salivary	O
gland	O
.	O

P2	O
-	O
one	O
lymph	O
node	O
candidate	O
,	O
bisected	O
.	O

P3	O
-	O
three	O
lymph	O
node	O
candidates	O
,	O
intact	O
.	O

P4	O
-	O
5	O
-	O
one	O
lymph	O
node	O
,	O
serially	O
sectioned	O
.	O

Q	O
.	O

"	O
Left	O
level	O
4	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
4	O
X	O
.	O

1	O
X	O
1	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
in	O
Q1	O
-	O
3	O
.	O

R	O
.	O

"	O
Right	O
level	O
2A	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
3	O
.	O
2	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
firm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

Sectioning	O
.	O
reveals	O
two	O
tan	O
firm	O
lymph	O
node	O
candidates	O
,	O
The	O
largest	O
is	O
2	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Both	O
are	O
bisected	O
and	O
entirely	O
submitted	O
in	O
R1	O
-	O
2	O
.	O

S	O
.	O

"	O
Left	O
level	O
3	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
5	O
.	O
2	O
x	O
3	O
x	O
1	O
cm	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
.	O

The	O
specimen	O
is	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

All	O
lymph	O
node	O
candidates	O
are	O
submitted	O
in	O
S1	O
-	O
2	O
.	O

T	O
.	O

"	O
Left	O
level	O
2B	O
"	O
,	O
received	O
unfixed	O
and	O
placed	O
in	O
formalin	O
on	O
.	O

is	O
a	O
fragment	O
of	O
yellow	O
adipose	O
tissue	O
2	O
.	O
8	O
X	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
.	O

is	O
.	O
entirely	O
submitted	O
in	O
T1	O
.	O

Intraoperative	O
Consultation	O
.	O

A	O
.	O

"	O
Right	O
lateral	O
tongue	O
lesion	O
"	O
JF1	O
(	O
total	O
)	O
-	O
reactive	O
lingual	O
tonsillar	O
.	O
tissue	O
.	O

No	O
carcinoma	O
or	O
dysplasia	O
seen	O
(	O
Dr	O
.	O
B	O
.	O

"	O
Anterior	O
gingival	O
margin	O
"	O
:	O
BF1	O
(	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
or	O
high	O
grade	O
.	O
dysplasia	O
(	O
Dr	O
.	O
C	O
.	O

"	O
Deep	O
tissue	O
margin	O
"	O
:	O
CF1	O
(	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
(	O
Dr	O
.	O
D	O
.	O

"	O
Anterior	O
tongue	O
attachment	O
"	O
:	O
DF1	O
(	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
.	O

(	O
Dr	O
.	O
E	O
.	O

"	O
Right	O
floor	O
of	O
mouth	O
"	O
:	O
EF1	O
(	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
(	O
Dr	O
.	O
F	O
.	O

"	O
Right	O
posterior	O
tongue	O
margin	O
"	O
:	O
FF1	O
(	O
total	O
)	O
1	O
-	O
negative	O
for	O
carcinoma	O
.	O

(	O
Dr	O
.	O
G	O
.	O
"	O
Left	O
floor	O
of	O
mouth	O
"	O
:	O
GF1	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
(	O
Dr	O
.	O
H	O
.	O

"	O
Left	O
posterior	O
tongue	O
margin	O
"	O
:	O
HF1	O
(	O
total	O
)	O
-	O
negative	O
for	O
carcinoma	O
.	O

(	O
Dr	O
.	O
Microscopic	O
Examination	O
.	O

Microscopic	O
examination	O
is	O
performed	O
.	O

Immunohistochemical	O
Findings	O
.	O

An	O
immunohistochemical	O
stain	O
for	O
p16	O
was	O
performed	O
on	O
block	O
I5	O
,	O
and	O
is	O
.	O
negative	O
.	O

The	O
immunoperoxidase	O
tests	O
reported	O
herein	O
were	O
developed	O
and	O
their	O
.	O
performance	O
characteristics	O
were	O
determined	O
by	O
the	O
.	O

Some	O
of	O
them	O
may	O
not	O
be	O
cleared	O
or	O
approved	O
by	O
.	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
.	O
purposes	O
.	O

They	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
complexity	O
clinical	O
.	O
testing	O
.	O

Pathologic	O
Stage	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pT2	O
pN2c	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

Diagnosis	O
.	O

A	O
.	O

"	O
RIGHT	O
LATERAL	O
TONGUE	O
LESION	O
"	O
(	O
BIOPSY	O
)	O
:	O
LINGUAL	O
TONSILLAR	O
TISSUE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

B	O
.	O

"	O
ANTERIOR	O
GINGIVAL	O
MARGIN	O
"	O
(	O
BIOPSY	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
WITH	O
NO	O
EVIDENCE	O
OF	O
MALIGNANCY	O
.	O

C	O
.	O

"	O
DEEP	O
TONGUE	O
MARGIN	O
"	O
(	O
BIOPSY	O
)	O
:	O
SKELETAL	O
MUSCLE	O
AND	O
FIBROADIPOSE	O
TISSUE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

D	O
.	O

"	O
ANTERIOR	O
TONGUE	O
ATTACHMENT	O
"	O
(	O
BIOPSY	O
)	O
:	O
FIBROADIPOSE	O
AND	O
VASCULAR	O
TISSUE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

E	O
.	O

"	O
RIGHT	O
FLOOR	O
OF	O
MOUTH	O
"	O
(	O
BIOPSY	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
,	O
SALIVARY	O
TISSUE	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

F	O
.	O

"	O
RIGHT	O
POSTERIOR	O
TONGUE	O
MARGIN	O
"	O
(	O
BIOPSY	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

G	O
.	O

"	O
LEFT	O
FLOOR	O
OF	O
MOUTH	O
"	O
(	O
BIOPSY	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

H	O
.	O

"	O
LEFT	O
POSTERIOR	O
TONGUE	O
MARGIN	O
"	O
(	O
BIOPSY	O
)	O
:	O
SQUAMOUS	O
MUCOSA	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

I	O
.	O

"	O
RIGHT	O
HEMIGLOSSECTOMY	O
"	O
(	O
HEMIGLOSSECTOMY	O
)	O
:	O
CARCINOMA	O
OF	O
ORAL	O
CAVITY	O
:	O
Specimen	O
:	O
-	O
Procedure	O
:	O
RIGHT	O
HEMIGLOSSECTOMY	O
.	O

-	O
Specimen	O
size	O
:	O
6	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
3	O
.	O
2	O
CM	O
.	O

-	O
Specimen	O
integrity	O
:	O
SINGLE	O
,	O
INTACT	O
.	O

Tumor	O
features	O
.	O

-	O
Histologic	O
type	O
:	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
KERATINIZING	O
TYPE	O
.	O

-	O
Grade	O
:	O
GRADE	O
2	O
(	O
MODERATELY	O
DIFFERENTIATED	O
)	O
.	O

Tumor	O
extent	O
:	O
-	O
Tumor	O
size	O
:	O
1	B
.	I
9	I
x	I
1	I
.	I
5	I
CM	I
.	O

-	O
Invasion	O
depth	O
:	O
1	O
.	O
9	O
MILLIMETERS	O
.	O

-	O
Tumor	O
thickness	O
:	O
0	B
.	I
8	I
MILLIMETERS	I
.	O

-	O
Primary	O
location	O
:	O
RIGHT	O
TONGUE	O
.	O

-	O
Focality	O
:	O
UNIFOCAL	O
.	O

-	O
Contiguous	O
invasion	O
:	O
LESS	O
THAN	O
4	O
CM	O
(	O
pT2	O
)	O
.	O

Accessory	O
:	O
-	O
Lymphvascular	O
invasion	O
:	O
POSITIVE	O
.	O

-	O
Perineural	O
invasion	O
:	O
POSITIVE	O
.	O

HPV	O
status	O
:	O
p16	O
NEGATIVE	O
.	O

Margins	O
:	O
SPECIMEN	O
MARGINS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

J	O
.	O

"	O
BILATERAL	O
LEVEL	O
1A	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
FIVE	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
5	O
)	O
.	O

K	O
.	O

"	O
RIGHT	O
LEVEL	O
1B	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
FIVE	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
5	O
)	O
.	O

SALIVARY	O
GLAND	O
WITH	O
CHRONIC	O
SIALADENITIS	O
.	O

L	O
.	O

"	O
RIGHT	O
LEVEL	O
4	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
THREE	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
3	O
)	O
.	O

M	O
.	O

"	O
RIGHT	O
LEVEL	O
2A	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
ONE	O
OF	O
SEVEN	O
LYMPH	O
NODES	O
:	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

(	O
1	O
/	O
7	O
)	O
.	O

3	O
CM	O
,	O
EXTRACAPSULAR	O
EXTENSION	O
IS	O
PRESENT	O
.	O

N	O
.	O

"	O
RIGHT	O
LEVEL	O
3	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
ONE	O
OF	O
EIGHT	O
LYMPH	O
NODES	O
:	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

(	O
1	O
/	O
8	O
)	O
.	O

0	O
.	O
7	O
CM	O
,	O
EQUIVOCAL	O
FOR	O
EXTRACAPSULAR	O
EXTENSION	O
.	O

O	O
.	O

"	O
RIGHT	O
LEVEL	O
2B	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
FOUR	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
4	O
)	O
.	O

P	O
.	O

"	O
LEFT	O
LEVEL	O
1B	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
TWO	O
OF	O
THREE	O
LYMPH	O
NODES	O
:	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

(	O
2	O
/	O
3	O
)	O
.	O

0	O
.	O
8	O
AND	O
0	O
.	O
9	O
CM	O
,	O
EXTRACAPSULAR	O
EXTENSION	O
IS	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
.	O

Q	O
.	O

"	O
LEFT	O
LEVEL	O
4	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
TWO	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
2	O
)	O
.	O

R	O
.	O

"	O
RIGHT	O
LEVEL	O
2A	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
TWO	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
2	O
)	O
.	O

S	O
.	O

"	O
LEFT	O
LEVEL	O
3	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
TWO	O
OF	O
FIVE	O
LYMPH	O
NODES	O
:	O
POSITIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

(	O
2	O
/	O
5	O
)	O
.	O

0	O
.	O
9	O
AND	O
1	O
.	O
2	O
CM	O
,	O
EXTRACAPSULAR	O
EXTENSION	O
IS	O
PRESENT	O
IN	O
ONE	O
LYMPH	O
NODE	O
.	O

T	O
.	O

"	O
LEFT	O
LEVEL	O
2B	O
"	O
(	O
LYMPH	O
NODE	O
BIOPSY	O
)	O
:	O
FOUR	O
LYMPH	O
NODES	O
:	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

(	O
0	O
/	O
4	O
)	O
.	O

Comment	O
:	O
I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Dr	O
.	O
M	O
.	O
D	O
.	O

Testing	O
Performed	O
By	O
.	O

Lab	O
-	O
Abbreviation	O
.	O

Director	O
.	O

Valid	O
Date	O
Range	O
.	O

Lab	O
and	O
Collection	O
.	O

Surgical	O
Pathology	O
on	O
.	O

Abnormality	O
.	O

Priority	O
.	O

Source	O
.	O

Routine	O
.	O

Authorizing	O
Provider	O
Information	O
.	O

MD	O
.	O

Surgical	O
Pathology	O
(	O
Order	O
.	O

Authorizing	O
:	O
MD	O
.	O

Pathology	O
and	O
Cytology	O
.	O

Department	O
.	O

General	O
.	O

Released	O
By	O
:	O
Release	O
Date	O
/	O
Time	O
.	O

Start	O
Date	O
/	O
Time	O
.	O

End	O
Date	O
/	O
Time	O
.	O

Frequency	O
.	O

Duration	O
.	O

Priority	O
.	O

Once	O
.	O

1	O
occurrence	O
.	O

Routine	O
.	O

Encounter	O
.	O

View	O
Encounter	O
.	O

Reprint	O
Requisition	O
.	O

Surgical	O
Pathology	O
(	O
Order	O
#	O
.	O

on	O
.	O

Original	O
Order	O
.	O

Lab	O
.	O

i	O
.	O

Office	O
.	O

Pager	O
/	O
beeper	O
E	O
-	O
mail	O
.	O

Authorizing	O
Provider	O
.	O

MD	O
.	O

There	O
are	O
no	O
order	O
-	O
level	O
documents	O
.	O

No	O
order	O
transmittal	O
information	O
available	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
TOTAL	O
LARYNGECTOMY	O
,	O
BILATERAL	O
NECK	O
DISSECTIONS	O
,	O
LEVEL	O
II	O
,	O
III	O
AND	O
IV	O
AND	O
RIGHT	O
.	O

HEMITHYROIDECTOMY	O
:	O
INVASIVE	O
SQUAMOUS	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
2	B
.	I
2	I
CM	I
INVOLVING	O
RIGHT	O
.	O

TRANSGLOTIO	O
REGION	O
(	O
SEE	O
COMMENT	O
)	O
.	O

Tumor	O
Features	O
:	O
Gross	O
:	O
Exophytic	O
.	O

Size	O
:	O
2	B
.	I
2	I
cm	I
in	O
largest	O
dimension	O
.	O

Invasion	O
:	O
Present	O
,	O
depth	O
1	O
.	O
6	O
cm	O
.	O

Tumor	O
Border	O
:	O
Infiltrative	O
with	O
thick	O
cords	O
>	O
4	O
cells	O
.	O

Perineural	O
Invasion	O
:	O
Absent	O
.	O

Vascular	O
Invasion	O
:	O
Absent	O
.	O

Bone	O
/	O
Cartilage	O
Invasion	O
:	O
Pending	O
Decalcification	O
(	O
see	O
addendum	O
)	O
.	O

Lymphocyte	O
Infiltration	O
:	O
Mild	O
.	O

Right	O
neck	O
dissection	O
.	O

No	O
tumor	O
present	O
in	O
16	O
Lymph	O
Nodes	O
.	O

Level	O
II	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
6	O
.	O

Level	O
III	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
7	O
.	O

Level	O
IV	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
3	O
.	O

Left	O
neck	O
dissection	O
.	O

No	O
tumor	O
present	O
in	O
27	O
Lymph	O
Nodes	O
.	O

Level	O
II	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
10	O
.	O

Level	O
III	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
7	O
.	O

Level	O
IV	O
:	O
Positive	O
Nodes	O
=	O
0	O
.	O

Total	O
Nodes	O
=	O
10	O
.	O

Thyroid	O
,	O
no	O
tumor	O
present	O
.	O

(	O
B	O
)	O
POSTERIOR	O
CRICOID	O
:	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
tumor	O
.	O

(	O
C	O
)	O
RIGHT	O
LATERAL	O
PHARYNX	O
:	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
tumor	O
.	O

(	O
D	O
)	O
LEFT	O
LATERAL	O
PHARYNX	O
:	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
tumor	O
.	O

COMMENT	O
.	O

(	O
A	O
)	O
.	O

The	O
balance	O
of	O
right	O
transglotic	O
region	O
with	O
subjacent	O
cartilage	O
and	O
bone	O
is	O
pending	O
decalcification	O
(	O
A5	O
-	O
A9	O
)	O
.	O

The	O
.	O
results	O
will	O
be	O
reported	O
in	O
a	O
separate	O
addendum	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
TOTAL	O
LARYNGECTOMY	O
,	O
BILATERAL	O
NECK	O
DISSECTIONS	O
,	O
LEVEL	O
II	O
,	O
III	O
AND	O
IV	O
AND	O
RIGHT	O
.	O

HEMITHYROIDECTOMY	O
-	O
A	O
total	O
laryngectomy	O
specimen	O
(	O
7	O
.	O
8	O
X	O
4	O
.	O
0	O
X	O
4	O
.	O
0	O
cm	O
)	O
with	O
attached	O
soft	O
tissue	O
and	O
muscle	O
(	O
8	O
.	O
0	O
X	O
6	O
.	O
0	O
.	O

X	O
1	O
.	O
2	O
cm	O
and	O
right	O
thyroid	O
(	O
3	O
.	O
0	O
X	O
3	O
.	O
0	O
X	O
2	O
.	O
1	O
cm	O
)	O
.	O

There	O
is	O
a	O
polypoid	O
mass	O
in	O
the	O
right	O
transglottic	O
region	O
measuring	O
2	O
.	O
2	O
X	O
1	O
.	O
9	O
cm	O
.	O
and	O
1	O
.	O
6	O
cm	O
in	O
depth	O
.	O

The	O
tumor	O
has	O
homogeneous	O
yellow	O
-	O
tan	O
cut	O
surface	O
with	O
no	O
grossly	O
hemorrhage	O
or	O
necrosis	O
.	O

The	O
mass	O
.	O
abuts	O
the	O
thyroid	O
cartilage	O
and	O
it	O
is	O
3	O
.	O
0	O
cm	O
to	O
the	O
tracheal	O
cartilage	O
resection	O
margin	O
.	O

The	O
left	O
transglottic	O
mucosa	O
is	O
grossly	O
.	O
uninvolved	O
by	O
the	O
mass	O
.	O

Sectioning	O
of	O
the	O
right	O
thyroid	O
reveals	O
spongy	O
,	O
brownish	O
mucosa	O
with	O
no	O
lesion	O
grossly	O
seen	O
.	O

Multiple	O
lymph	O
nodes	O
identified	O
in	O
the	O
neck	O
resection	O
soft	O
tissue	O
and	O
are	O
entirely	O
submitted	O
.	O

Normal	O
and	O
tumor	O
are	O
submitted	O
for	O
Tumor	O
Bank	O
.	O

SECTION	O
CODE	O
:	O
A1	O
,	O
tracheal	O
margin	O
;	O
A2	O
,	O
A3	O
,	O
random	O
section	O
of	O
right	O
thyroid	O
;	O
A4	O
,	O
left	O
transglottic	O
region	O
;	O
A5	O
-	O
A9	O
,	O
.	O
right	O
transglottic	O
mass	O
submitted	O
from	O
right	O
to	O
left	O
(	O
A5	O
-	O
A8	O
,	O
submitted	O
after	O
decalcification	O
)	O
;	O
A10	O
-	O
A11	O
,	O
left	O
level	O
II	O
,	O
one	O
possible	O
.	O
node	O
bisected	O
in	O
each	O
section	O
;	O
A12	O
-	O
A13	O
,	O
left	O
level	O
II	O
possible	O
lymph	O
nodes	O
,	O
four	O
per	O
each	O
section	O
;	O
A14	O
,	O
left	O
level	O
III	O
,	O
four	O
.	O
possible	O
nodes	O
;	O
A15	O
,	O
left	O
level	O
III	O
,	O
five	O
possible	O
lymph	O
nodes	O
.	O

A16	O
-	O
A18	O
,	O
left	O
level	O
4	O
,	O
five	O
possible	O
nodes	O
per	O
section	O
,	O
ATy	O
,	O
4	O
,	O
four	O
possible	O
nodes	O
;	O
A20	O
,	O
right	O
level	O
2	O
,	O
one	O
.	O
possible	O
node	O
bisected	O
;	O
A21	O
,	O
right	O
level	O
2	O
,	O
three	O
possible	O
nodes	O
;	O
A22	O
,	O
right	O
level	O
2	O
,	O
four	O
possible	O
nodes	O
;	O
A23	O
-	O
A25	O
,	O
right	O
level	O
.	O

3	O
,	O
five	O
possible	O
nodes	O
in	O
each	O
section	O
;	O
A26	O
,	O
right	O
level	O
4	O
,	O
one	O
possible	O
node	O
;	O
A27	O
,	O
right	O
level	O
4	O
,	O
one	O
possible	O
node	O
,	O
bisected	O
;	O
.	O

A28	O
,	O
right	O
level	O
4	O
,	O
one	O
possible	O
node	O
bisected	O
;	O
A29	O
,	O
muscle	O
.	O

(	O
B	O
)	O
.	O

POSTERIOR	O
CRICOID	O
-	O
Received	O
is	O
a	O
nink	O
soft	O
tissue	O
(	O
2	O
X	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
)	O
,	O
entirely	O
submitted	O
for	O
frozen	O
in	O
B	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

(	O
C	O
)	O
RIGHT	O
LATERAL	O
PHARYNX	O
-	O
Received	O
is	O
a	O
pink	O
soft	O
tissue	O
(	O
2	O
.	O
4	O
X	O
0	O
.	O
9	O
X	O
0	O
.	O
5	O
)	O
,	O
entirely	O
submitted	O
for	O
frozen	O
in	O
C	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

(	O
D	O
)	O
LEFT	O
LATERAL	O
PHARYNX	O
-	O
Received	O
is	O
a	O
pink	O
soft	O
tissue	O
(	O
2	O
X	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
)	O
,	O
entirely	O
submitted	O
for	O
frozen	O
in	O
D	O
.	O

FS	O
/	O
DX	O
:	O
NO	O
TUMOR	O
PRESENT	O
.	O

CLINICAL	O
HISTORY	O
.	O

Squamous	O
cell	O
carcinoma	O
,	O
larynx	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
C4200	O
,	O
T	O
-	O
24100	O
,	O
M	O
-	O
80706	O
,	O
M	O
-	O
80703	O
,	O
M	O
-	O
43000	O
,	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

ADDENDUM	O
.	O

This	O
modified	O
report	O
is	O
being	O
issued	O
to	O
provide	O
additional	O
information	O
/	O
results	O
.	O

Addendum	O
completed	O
by	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
TOTAL	O
LARYNGECTOMY	O
,	O
BILATERAL	O
NECK	O
DISSECTION	O
,	O
LEVELS	O
II	O
,	O
III	O
,	O
IV	O
AND	O
RIGHT	O
HEMITHYROIDECTOMY	O
:	O
INVASIVE	O
SQUAMOUS	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
,	O
ABUTTING	O
CARTILAGE	O
AND	O
BONE	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O

Caterality	O
:	O
Path	O
Report	O
:	O
SKIN	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Excision	O
of	O
tumor	O
.	O

Tumor	O
site	O
:	O
Skin	O
.	O

Tumor	O
size	O
:	O
5	B
.	I
5x4	I
.	I
5x1	I
.	I
3	I
cm	I
.	O

Tumor	O
features	O
:	O
Raised	O
,	O
Pigmented	O
.	O

Satellite	O
nodules	O
:	O
Not	O
specified	O
.	O

Histologic	O
type	O
:	O
Nodular	O
melanoma	O
.	O

Histologic	O
grade	O
:	O
Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
Clark	O
level	O
4	O
.	O

Gross	O
Description	O
:	O
Microscopic	O
Description	O
:	O
Diagnosis	O
Details	O
:	O

Service	O
Date	O
:	O
(	O
Age	O
:	O
)	O
.	O

Male	O
.	O

Soc	O
.	O

Sec	O
.	O

#	O
:	O
Client	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Brain	O
,	O
left	O
parietal	O
lobe	O
,	O
biopsy	O
:	O
Oligodendroglioma	O
,	O
WHO	O
grade	O
II	O
;	O
see	O
comment	O
.	O

B	O
.	O

Brain	O
,	O
left	O
parietal	O
,	O
excision	O
:	O
Oligodendroglioma	O
,	O
WHO	O
grade	O
II	O
;	O
see	O
comment	O
.	O

C	O
.	O

Brain	O
,	O
Cavitron	O
ultrasonic	O
surgical	O
aspiration	O
:	O
Oligodendroglioma	O
,	O
WHO	O
grade	O
II	O
;	O
.	O
see	O
comment	O
.	O

COMMENT	O
:	O
This	O
oligodendroglioma	O
shows	O
typical	O
features	O
,	O
with	O
a	O
moderately	O
cellular	O
proliferation	O
of	O
neoplastic	O
.	O
oligodendroglia	O
showing	O
uniform	O
round	O
nuclei	O
.	O

The	O
mitotic	O
activity	O
is	O
low	O
,	O
with	O
up	O
to	O
1	O
mitotic	O
figure	O
/	O
10	O
.	O

HPFs	O
.	O

No	O
necrosis	O
or	O
microvascular	O
proliferation	O
is	O
seen	O
,	O
.	O

A	O
macrophage	O
infiltrate	O
is	O
intermixed	O
with	O
the	O
tumor	O
,	O
and	O
multiple	O
vessels	O
are	O
cuffed	O
by	O
macrophages	O
.	O

Immunohistochemistry	O
for	O
IDH1	O
and	O
MIB	O
-	O
1	O
will	O
be	O
performed	O
on	O
block	O
A2	O
and	O
the	O
results	O
will	O
be	O
.	O
reported	O
in	O
an	O
addendum	O
.	O

In	O
addition	O
,	O
fluorescence	O
in	O
-	O
situ	O
hybridization	O
for	O
1p19q	O
will	O
be	O
performed	O
on	O
.	O
block	O
A2	O
at	O
the	O
.	O
and	O
the	O
results	O
will	O
be	O
reported	O
separately	O
.	O
has	O
reviewed	O
select	O
slides	O
of	O
the	O
case	O
and	O
agrees	O
with	O
the	O
diagnosis	O
.	O

Intraoperative	O
Diagnosis	O
.	O

FS1	O
(	O
A	O
)	O
Brain	O
,	O
biopsy	O
:	O
Infiltrating	O
glioma	O
,	O
favor	O
oligodendroglioma	O
,	O
at	O
least	O
WHO	O
grade	O
II	O
.	O

Tissue	O
.	O
section	O
and	O
cytologic	O
preparation	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
in	O
three	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
.	O
number	O
.	O

Part	O
A	O
,	O
additionally	O
labeled	O
"	O
L	O
tumor	O
-	O
FS	O
+	O
perm	O
,	O
"	O
consists	O
of	O
multiple	O
,	O
irregular	O
,	O
friable	O
,	O
tan	O
to	O
pink	O
.	O
glistening	O
tissue	O
fragments	O
(	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
)	O
.	O

A	O
representative	O
section	O
is	O
frozen	O
for	O
frozen	O
section	O
.	O
diagnosis	O
1	O
and	O
a	O
touch	O
prep	O
is	O
created	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
cassettes	O
as	O
follows	O
:	O
A1	O
:	O
Frozen	O
section	O
1	O
remnant	O
.	O

A2	O
:	O
Remaining	O
tissue	O
.	O

Part	O
B	O
,	O
additionally	O
labeled	O
"	O
tumor	O
,	O
"	O
consists	O
of	O
one	O
pink	O
,	O
irregular	O
,	O
unoriented	O
soft	O
tissue	O
fragment	O
(	O
1	B
x	I
.	I
1	I
x	I
0	I
.	I
3	I
cm	I
)	O
.	O

The	O
specimen	O
is	O
submitted	O
intact	O
in	O
cassette	O
B1	O
.	O

Part	O
C	O
,	O
additionally	O
labeled	O
"	O
CUSA	O
contents	O
,	O
"	O
consists	O
of	O
multiple	O
soft	O
,	O
pink	O
,	O
irregular	O
,	O
unoriented	O
soft	O
.	O
tissue	O
fragments	O
(	O
5	O
x	O
5	O
x	O
2	O
cm	O
in	O
aggregate	O
)	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
.	O

C1	O
-	O
C8	O
.	O

All	O
of	O
the	O
remaining	O
tissue	O
is	O
submitted	O
in	O
cassettes	O
C9	O
-	O
C16	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
-	O
year	O
-	O
old	O
man	O
who	O
presented	O
with	O
seizures	O
,	O
and	O
a	O
left	O
parietal	O
mass	O
with	O
a	O
small	O
.	O
area	O
of	O
focal	O
ring	O
enhancement	O
,	O
on	O
Decadron	O
and	O
Keppra	O
.	O

Per	O
.	O

MRI	O
shows	O
an	O
ill	O
-	O
defined	O
,	O
cortically	O
.	O
based	O
T2	O
/	O
FLAIR	O
hyperintense	O
mass	O
involving	O
the	O
left	O
postcentral	O
gyrus	O
and	O
left	O
Inferior	O
parietal	O
lobule	O
.	O

Diagnosis	O
based	O
on	O
gross	O
and	O
microscopic	O
examinations	O
.	O

Final	O
diagnosis	O
made	O
by	O
attending	O
pathologist	O
following	O
review	O
of	O
all	O
.	O
pathology	O
slides	O
.	O

The	O
attending	O
pathologist	O
has	O
reviewed	O
all	O
dictations	O
and	O
preliminary	O
interpretations	O
performed	O
by	O
any	O
resident	O
.	O
involved	O
in	O
the	O
case	O
and	O
performed	O
all	O
necessary	O
edits	O
before	O
signing	O
the	O
final	O
report	O
.	O

Pathology	O
Resident	O
.	O

/	O
Pathologist	O
.	O

Addendum	O
.	O

Date	O
Complete	O
:	O
Addendum	O
Comment	O
.	O

Immunohistochemical	O
studies	O
performed	O
and	O
evaluated	O
at	O
.	O
show	O
that	O
the	O
neoplastic	O
cells	O
are	O
.	O
positive	O
with	O
the	O
antibodies	O
against	O
IDH	O
-	O
1	O
(	O
R132H	O
mutant	O
)	O
protein	O
(	O
on	O
A2	O
)	O
.	O

MIB1	O
labeling	O
on	O
A2	O
is	O
estimated	O
at	O
approximately	O
4	O
%	O
.	O

The	O
immunoperoxidase	O
stain	O
(	O
s	O
)	O
reported	O
above	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O

S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
are	O
used	O
for	O
clinical	O
purposes	O
.	O

They	O
.	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
1988	O
(	O
"	O
CLIA	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
compiexity	O
clinical	O
testing	O
.	O

PATIENT	O
HISTORY	O
:	O
PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Left	O
renal	O
mass	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Left	O
nephrectomy	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
KIDNEY	O
,	O
LEFT	O
,	O
NEPHRECTOMY	O
.	O

A	O
.	O

RENAL	O
CELL	O
CARCINOMA	O
,	O
CONVENTIONAL	O
CLEAR	O
CELL	O
TYPE	O
,	O
WITH	O
FOCAL	O
SARCOMATOID	O
FEATURES	O
.	O

B	O
.	O

FUHRMAN	O
'	O
S	O
NUCLEAR	O
GRADE	O
IS	O
IV	O
OF	O
IV	O
.	O

C	O
.	O

THE	O
GREATEST	O
DIAMETER	O
OF	O
THE	O
NEOPLASM	O
is	O
9	B
.	I
5	I
CM	I
.	O

D	O
.	O

THE	O
NEOPLASM	O
EXTENDS	O
THROUGH	O
THE	O
RENAL	O
CAPSULE	O
,	O
BUT	O
IS	O
CONFINED	O
WITHIN	O
GEROTA	O
'	O
S	O
FASCIA	O
.	O

E	O
.	O

THE	O
NEOPLASM	O
EXTENDS	O
INTO	O
RENAL	O
PELVIS	O
ADIPOSE	O
TISSUE	O
.	O

F	O
.	O

INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
PRESENT	O
.	O

G	O
.	O

ALL	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
THE	O
NEOPLASM	O
.	O

H	O
.	O

THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
REVEALS	O
ARTERIOLOSCLEROSIS	O
,	O
FOCAL	O
GLOBAL	O
AND	O
SEGMENTAL	O
.	O

GLOMERULOSCLEROSIS	O
,	O
AND	O
FOCAL	O
CYSTIC	O
CHANGE	O
.	O

I	O
.	O

THE	O
ADRENAL	O
GLAND	O
IS	O
FREE	O
OF	O
TUMOR	O
,	O
WITH	O
MILD	O
CORTICAL	O
HYPERPLASIA	O
.	O

J	O
.	O

TNM	O
STAGE	O
:	O
pT3b	O
NO	O
MX	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODES	O
,	O
HILAR	O
,	O
EXCISION	O
-	O
.	O

NO	O
TUMOR	O
SEEN	O
IN	O
FOUR	O
LYMPH	O
NODES	O
(	O
0	O
/	O
4	O
)	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
KIDNEY	O
TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Radical	O
nephrectomy	O
.	O

LATERALITY	O
;	O
.	O

Left	O
.	O

TUMOR	O
SITE	O
:	O
Middle	O
.	O

Lower	O
pole	O
.	O

FOCALITY	O
:	O
Unifocal	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
9	B
.	I
5	I
cm	I
.	O

Additional	O
dimensions	O
:	O
6	B
x	I
6	I
cm	I
.	O

MACROSCOPIC	O
EXTENT	O
OF	O
TUMOR	O
:	O
Tumor	O
extension	O
into	O
perinephric	O
tissues	O
.	O

Tumor	O
extension	O
into	O
major	O
veins	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Clear	O
cell	O
(	O
conventional	O
)	O
renal	O
carcinoma	O
.	O

Sarcomatoid	O
carcinoma	O
arising	O
in	O
renal	O
cell	O
carcinoma	O
.	O

Subtype	O
and	O
%	O
of	O
sarcomatoid	O
element	O
:	O
5	O
%	O
.	O

HISTOLOGIC	O
GRADE	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
G4	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
:	O
pT3b	O
.	O

pNO	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
4	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

pMX	O
.	O

MARGINS	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

ADRENAL	O
GLAND	O
:	O
Uninvolved	O
by	O
tumor	O
.	O

VENOUS	O
(	O
LARGE	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
)	O
:	O
Present	O
.	O

LYMPHATIC	O
(	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
L	O
)	O
:	O
Absent	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Glomerular	O
disease	O
(	O
type	O
)	O
:	O
FOCAL	O
GLOBAL	O
AND	O
SEGMENTAL	O
.	O

GLOMERULOSCLEROSIS	O
.	O

Other	O
:	O
ARTERIOLOSCLEROSIS	O
.	O

CLINICAL	O
DIAGNOSIS	O
:	O
Pancreatic	O
head	O
cancer	O
.	O

Specimen	O
:	O
CBD	O
,	O
Pancreatic	O
head	O
(	O
LN	O
)	O
.	O

GROSS	O
:	O
Specimen	O
status	O
:	O
Fresh	O
.	O

Operation	O
:	O
Pylorus	O
preserving	O
pancreaticoduodenectomy	O
.	O

Cholecystectomy	O
.	O

Organs	O
:	O
Small	O
intestine	O
(	O
25	O
.	O
5	O
cm	O
in	O
length	O
and	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
)	O
,	O
.	O
pancreas	O
,	O
partial	O
(	O
7	O
.	O
5	O
x	O
5	O
.	O
4	O
x	O
3	O
.	O
5	O
cm	O
)	O
,	O
.	O
and	O
common	O
bile	O
duct	O
(	O
5	O
.	O
5	O
cm	O
in	O
length	O
and	O
1	O
.	O
0	O
cm	O
in	O
diameter	O
)	O
in	O
contintuity	O
.	O

Gallbladder	O
(	O
8	O
.	O
5	O
cm	O
in	O
length	O
,	O
3	O
.	O
4	O
cm	O
in	O
diameter	O
)	O
.	O

[	O
Pancreas	O
]	O
.	O

Lesion	O
:	O
An	O
ill	O
-	O
defined	O
ovoid	O
mass	O
in	O
pancreatic	O
head	O
to	O
ampullary	O
area	O
.	O

Size	O
:	O
2	B
.	I
5	I
x	I
1	I
.	I
8	I
x	I
1	I
.	I
5	I
cm	I
.	O

Cut	O
surface	O
:	O
Pale	O
tan	O
and	O
firm	O
mass	O
.	O

Extent	O
:	O
Extend	O
to	O
duodenal	O
wall	O
.	O

Resection	O
margins	O
:	O
Distal	O
pancreatic	O
resection	O
margin	O
:	O
Free	O
of	O
tumor	O
(	O
safety	O
margin	O
:	O
2	O
.	O
3	O
cm	O
)	O
.	O

Radial	O
pancreatic	O
margin	O
:	O
Very	O
close	O
to	O
tumor	O
(	O
safety	O
margin	O
:	O
0	O
.	O
1	O
cm	O
)	O
.	O

Common	O
bile	O
duct	O
resection	O
margin	O
:	O
Free	O
of	O
tumor	O
.	O

Remaining	O
pancreas	O
:	O
Fibrotic	O
change	O
.	O

[	O
Common	O
bile	O
duct	O
]	O
.	O

Eroded	O
and	O
no	O
mass	O
-	O
like	O
lesion	O
.	O

[	O
Duodenum	O
]	O
.	O

Unremarkable	O
.	O

[	O
Gallbladder	O
]	O
.	O

Mucosa	O
:	O
Dark	O
red	O
to	O
mahogany	O
and	O
velvety	O
.	O

Serosa	O
:	O
Pale	O
pink	O
and	O
smooth	O
.	O

Wall	O
:	O
0	O
.	O
6	O
cm	O
in	O
thickness	O
.	O

Frozen	O
section	O
diagnosis	O
.	O

FS1	O
-	O
2	O
,	O
proximal	O
bile	O
duct	O
resection	O
margin	O
:	O
No	O
tumor	O
present	O
.	O

FS3	O
,	O
distal	O
pancreatic	O
resection	O
margin	O
:	O
No	O
tumor	O
present	O
.	O

Gross	O
photo	O
:	O
Present	O
.	O

Blocks	O
.	O

T1	O
-	O
8	O
,	O
pancreatic	O
mass	O
X	O
8	O
.	O

BD	O
,	O
common	O
bile	O
duct	O
x	O
1	O
.	O

LN1	O
-	O
2	O
,	O
periduodenal	O
lymph	O
nodes	O
x	O
2	O
.	O

LN3	O
,	O
No	O
.	O
12	O
lymph	O
nodes	O
x	O
1	O
.	O

LN4	O
,	O
No	O
.	O
13	O
lymph	O
nodes	O
X	O
1	O
.	O

FS1	O
-	O
3	O
,	O
frozen	O
permanent	O
x	O
3	O
.	O

P	O
and	O
D	O
,	O
duodenal	O
resection	O
margin	O
x	O
2	O
.	O

GB	O
,	O
gallbladder	O
x	O
1	O
.	O

Microscopic	O
:	O
Tumor	O
type	O
:	O
Ductal	O
adenocarcinoma	O
.	O

Tumor	O
location	O
:	O
Pancreas	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

In	O
situ	O
carcinoma	O
:	O
Not	O
identified	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
5	I
x	I
1	I
.	I
8	I
x	I
1	I
.	I
5	I
cm	I
.	O

Direct	O
extension	O
:	O
Tumor	O
extends	O
beyond	O
the	O
pancreas	O
to	O
duodenum	O
and	O
peripancreatic	O
tissue	O
.	O

Lymphovascular	O
invasion	O
:	O
Present	O
.	O

Perineurial	O
invasion	O
:	O
Present	O
.	O

Surgical	O
margins	O
:	O
Radial	O
margin	O
:	O
Close	O
to	O
tumor	O
(	O
safety	O
margin	O
:	O
0	O
.	O
1	O
cm	O
)	O
.	O

Distal	O
pancreatic	O
resection	O
margin	O
:	O
Free	O
of	O
tumor	O
.	O

Proximal	O
bile	O
duct	O
resection	O
margin	O
:	O
Free	O
of	O
tumor	O
.	O

DIAGNOSIS	O
:	O
Pancreas	O
,	O
head	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Ductal	O
adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
infiltrating	O
.	O

Common	O
bile	O
duct	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
No	O
tumor	O
present	O
.	O

Small	O
intestine	O
,	O
duodenum	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Direct	O
tumor	O
extension	O
.	O

Gallbladder	O
,	O
cholecystectomy	O
:	O
Chronic	O
cholecystitis	O
.	O

Lymph	O
node	O
,	O
regional	O
,	O
pylorus	O
preserving	O
pancreaticoduodenectomy	O
:	O
Peripancreatic	O
:	O
Direct	O
tumor	O
extension	O
(	O
2	O
/	O
4	O
)	O
.	O

Periduodenal	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
9	O
)	O
.	O

Lymph	O
node	O
,	O
regional	O
,	O
biopsy	O
:	O
No	O
.	O
12	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
3	O
)	O
.	O

No	O
.	O
13	O
:	O
No	O
tumor	O
present	O
(	O
0	O
/	O
3	O
)	O
.	O

di	O
.	O

Source	O
of	O
Specimen	O
(	O
s	O
)	O
:	O
A	O
:	O
RENAL	O
TUMOR	O
.	O

B	O
:	O
PARA	O
AORTIC	O
LYMPH	O
NODE	O
LEFT	O
.	O

Other	O
Related	O
Clinical	O
Data	O
:	O
Clinical	O
History	O
/	O
Diagnosis	O
:	O
LT	O
RENAL	O
TUMOR	O
.	O

Specimen	O
(	O
s	O
)	O
:	O
1	O
.	O

RENAL	O
TUMOR	O
.	O

2	O
.	O

PARA	O
AORTIC	O
LYMPH	O
NODE	O
LEFT	O
.	O

Sunquest	O
Archived	O
Tests	O
:	O
NATURE	O
OF	O
SPECIMEN	O
:	O
RESECTION	O
,	O
FROZEN	O
SECTION	O
.	O

Gross	O
Description	O
:	O
GROSS	O
DESCRIPTION	O
:	O
Received	O
in	O
two	O
parts	O
.	O

SOURCE	O
OF	O
TISSUE	O
:	O
1	O
.	O

Labeled	O
#	O
1	O
,	O
"	O
renal	O
tumor	O
"	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
1FS	O
-	O
CLEAR	O
CELL	O
CARCINOMA	O
,	O
PER	O
DR	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
for	O
frozen	O
section	O
evaluation	O
is	O
a	O
.	O

1	O
,	O
426	O
.	O
gram	O
nephrectomy	O
having	O
an	O
abundant	O
amount	O
of	O
attached	O
perinephric	O
fat	O
.	O

The	O
.	O
kidney	O
itself	O
is	O
9	O
.	O
5	O
x	O
7	O
.	O
5	O
x	O
5	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
having	O
a	O
4	O
.	O
5	O
X	O
.	O

0	O
.	O
2	O
.	O

cm	O
portion	O
of	O
attached	O
ureter	O
,	O
having	O
a	O
lumen	O
,	O
0	O
.	O
2	O
cm	O
in	O
greatest	O
.	O
dimension	O
,	O
.	O
which	O
is	O
probe	O
patent	O
to	O
the	O
renal	O
pelvis	O
.	O

The	O
kidney	O
is	O
bivalved	O
to	O
.	O
reveal	O
.	O

red	O
-	O
purple	O
firm	O
renal	O
parenchyma	O
having	O
a	O
well	O
defined	O
corticomedullary	O
.	O
junction	O
.	O

In	O
the	O
mid	O
portion	O
there	O
is	O
a	O
5	B
.	I
5	I
x	I
3	I
.	I
5	I
x	I
3	I
.	I
0	I
cm	I
mass	O
having	O
.	O
golden	O
yellow	O
-	O
tan	O
to	O
red	O
-	O
purple	O
,	O
soft	O
,	O
variegated	O
and	O
nodular	O
cut	O
.	O
surfaces	O
.	O

Representative	O
section	O
of	O
this	O
mass	O
are	O
submitted	O
for	O
frozen	O
section	O
.	O
evaluation	O
and	O
the	O
frozen	O
section	O
residue	O
is	O
submitted	O
in	O
one	O
block	O
.	O

On	O
sectioning	O
through	O
the	O
perinephric	O
fat	O
there	O
is	O
a	O
4	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O
adrenal	O
gland	O
having	O
golden	O
yellow	O
-	O
tan	O
cut	O
surfaces	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
twelve	O
blocks	O
.	O

DESIGNATION	O
OF	O
SECTIONS	O
:	O
1FS	O
-	O
frozen	O
section	O
renal	O
mass	O
,	O
1A	O
-	O
ureter	O
and	O
.	O
vascular	O
margins	O
,	O
1B	O
-	O
1G	O
-	O
renal	O
mass	O
,	O
1H	O
-	O
1I	O
-	O
inked	O
circumferential	O
.	O
margin	O
,	O
.	O

1J	O
-	O
1K	O
-	O
random	O
kidney	O
sections	O
,	O
1L	O
-	O
adrenal	O
gland	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
FS	O
,	O
A	O
-	O
L	O
-	O
multiple	O
.	O

SOURCE	O
OF	O
TISSUE	O
:	O
2	O
.	O

Labeled	O
#	O
2	O
,	O
"	O
para	O
-	O
aortic	O
lymph	O
node	O
left	O
"	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
fresh	O
are	O
5	O
.	O
5	O
x	O
4	O
.	O
0	O
X	O
2	O
.	O
0	O
cm	O
of	O
yellow	O
-	O
tan	O
.	O
fibroadipose	O
tissue	O
.	O

It	O
contains	O
several	O
palpable	O
lymph	O
nodes	O
,	O
0	O
.	O
6	O
to	O
2	O
.	O
0	O
.	O

cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
eight	O
.	O
blocks	O
.	O

DESIGNATION	O
OF	O
SECTIONS	O
:	O
2A	O
-	O
2H	O
(	O
A	O
-	O
B	O
-	O
one	O
lymph	O
node	O
,	O
C	O
-	O
one	O
lymph	O
node	O
,	O
.	O
D	O
.	O
-	O
one	O
lymph	O
node	O
,	O
E	O
-	O
G	O
-	O
one	O
lymph	O
node	O
,	O
H	O
-	O
two	O
single	O
lymph	O
nodes	O
)	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
A	O
-	O
H	O
-	O
multiple	O
.	O

Final	O
Diagnosis	O
:	O
DIAGNOSIS	O
:	O
1	O
.	O

LEFT	O
KIDNEY	O
,	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
ADENOCARCINOMA	O
,	O
CLEAR	O
CELL	O
TYPE	O
,	O
INTERMEDIATE	O
.	O

GRADE	O
,	O
5	B
.	I
5CM	I
,	O
.	O

CONFINED	O
TO	O
THE	O
KIDNEY	O
.	O

-	O
NEGATIVE	O
ADRENAL	O
GLAND	O
.	O

TUMOR	O
DOES	O
NOT	O
INVOLVE	O
RENAL	O
VEIN	O
,	O
CAPSULE	O
OR	O
PERIRENAL	O
FAT	O
.	O

-	O
URETER	O
AND	O
VEIN	O
MARGINS	O
NEGATIVE	O
.	O

2	O
.	O

LYMPH	O
NODE	O
,	O
PARA	O
-	O
AORTIC	O
,	O
LEFT	O
,	O
EXCISION	O
:	O
-	O
SIX	O
NEGATIVE	O
LYMPH	O
NODES	O
(	O
0	O
/	O
6	O
)	O
.	O

REVISED	O
REPORT	O
(	O
Revised	O
information	O
underlined	O
)	O
.	O

Addendum	O
/	O
Procedure	O
included	O
.	O

DIAGNOSIS	O
:	O
D	O
.	O

Liver	O
,	O
left	O
lobe	O
,	O
resection	O
:	O
Poorly	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
forming	O
a	O
lobulated	O
mass	O
,	O
9	B
.	I
6	I
x	I
9	I
.	I
5	I
.	I

x	B
9	I
.	I
3	I
cm	I
.	O

There	O
is	O
extensive	O
lymphovascular	O
invasion	O
including	O
a	O
.	O
tumor	O
thrombus	O
.	O

The	O
margins	O
are	O
negative	O
for	O
tumor	O
by	O
<	O
0	O
.	O
1	O
cm	O
.	O

Multiple	O
(	O
1	O
caval	O
and	O
1	O
hilar	O
)	O
regional	O
lymph	O
nodes	O
are	O
negative	O
for	O
.	O
tumor	O
.	O

A	O
.	O

Lymph	O
nodes	O
,	O
celiac	O
artery	O
,	O
excision	O
:	O
Multiple	O
(	O
3	O
)	O
celiac	O
.	O
artery	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
hepatic	O
artery	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
hepatic	O
.	O
artery	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
pericholedochal	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
.	O
pericholedochal	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Photographed	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
the	O
.	O
specimen	O
(	O
s	O
)	O
.	O

ADDENDUM	O
:	O
In	O
situ	O
hybridization	O
for	O
albumin	O
is	O
positive	O
.	O

AMENDMENTS	O
:	O
(	O
Previous	O
Signout	O
Date	O
.	O

Revision	O
Description	O
:	O
Removed	O
"	O
favor	O
bile	O
duct	O
primary	O
"	O
from	O
the	O
.	O
original	O
diagnosis	O
.	O

Previous	O
Diagnosis	O
.	O

D	O
.	O

Liver	O
,	O
left	O
lobe	O
,	O
resection	O
:	O
Poorly	O
differentiated	O
.	O
hepatocellular	O
carcinoma	O
favor	O
bile	O
duct	O
primary	O
,	O
forming	O
.	O

a	O
lobulated	O
mass	O
,	O
9	B
.	I
6	I
x	I
9	I
.	I
5	I
x	I
9	I
.	I
3	I
cm	I
.	O

There	O
is	O
extensive	O
.	O
lymphovascular	O
invasion	O
including	O
a	O
tumor	O
thrombus	O
.	O

The	O
margins	O
are	O
.	O
negative	O
for	O
tumor	O
by	O
<	O
0	O
.	O
1	O
cm	O
.	O

Multiple	O
(	O
1	O
caval	O
and	O
1	O
hilar	O
)	O
.	O
regional	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

A	O
.	O

Lymph	O
nodes	O
,	O
celiac	O
artery	O
,	O
excision	O
:	O
Multiple	O
(	O
3	O
)	O
celiac	O
.	O
artery	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
hepatic	O
artery	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
hepatic	O
.	O
artery	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Lymph	O
node	O
,	O
pericholedochal	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
.	O
pericholedochal	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Photographed	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
the	O
.	O
specimen	O
(	O
s	O
)	O
.	O
igning	O
Pathologist	O
.	O

AMENDMENTS	O
:	O
(	O
Previous	O
Signout	O
Date	O
:	O
Revision	O
Description	O
:	O
Special	O
stains	O
support	O
hepatocellular	O
.	O
carcinoma	O
for	O
part	O
D	O
.	O

Diagnosis	O
changed	O
to	O
reflect	O
this	O
.	O

Original	O
Diagnosis	O
.	O

D	O
.	O

Liver	O
,	O
left	O
lobe	O
,	O
resection	O
:	O
Poorly	O
differentiated	O
.	O
adenocarcinoma	O
,	O
favor	O
bile	O
duct	O
primary	O
,	O
forming	O
a	O
lobulated	O
mass	O
,	O
.	O

9	B
.	I
6	I
x	I
9	I
.	I
5	I
x	I
9	I
.	I
3	I
cm	I
.	O

There	O
is	O
extensive	O
lymphovascular	O
invasion	O
.	O
including	O
a	O
tumor	O
thrombus	O
.	O

The	O
margins	O
are	O
negative	O
for	O
tumor	O
by	O
<	O
.	O

0	O
.	O
1	O
cm	O
.	O

Multiple	O
(	O
1	O
caval	O
and	O
1	O
hilar	O
)	O
regional	O
lymph	O
nodes	O
are	O
.	O
negative	O
for	O
tumor	O
.	O

A	O
.	O

Lymph	O
nodes	O
,	O
celiac	O
artery	O
,	O
excision	O
:	O
Multiple	O
(	O
3	O
)	O
celiac	O
.	O
artery	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Lymph	O
node	O
,	O
hepatic	O
artery	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
hepatic	O
.	O
artery	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
pericholedochal	O
,	O
excision	O
:	O
A	O
single	O
(	O
1	O
)	O
.	O
pericholedochal	O
lymph	O
node	O
is	O
negative	O
for	O
tumor	O
.	O

Photographed	O
.	O

This	O
final	O
pathology	O
report	O
is	O
based	O
on	O
the	O
gross	O
/	O
macroscopic	O
.	O
examination	O
and	O
frozen	O
section	O
histologic	O
evaluation	O
of	O
the	O
.	O
specimen	O
(	O
s	O
)	O
.	O

Path	O
No	O
.	O
:	O
Date	O
Obtained	O
:	O
(	O
Age	O
:	O
)	O
.	O

Date	O
Received	O
:	O
F	O
.	O

See	O
Addendum	O
/	O
Procedure	O
.	O

SPECIMEN	O
:	O
A	O
:	O
Subnipple	O
tissue	O
,	O
right	O
breast	O
,	O
excision	O
.	O

B	O
:	O
Lymph	O
node	O
,	O
right	O
axilla	O
sentinel	O
node	O
,	O
biopsy	O
.	O

C	O
:	O
Lymph	O
node	O
,	O
right	O
axilla	O
sentinel	O
node	O
#	O
2	O
,	O
biopsy	O
.	O

D	O
:	O
Breast	O
,	O
right	O
,	O
total	O
mastectomy	O
.	O

E	O
:	O
Skin	O
,	O
right	O
breast	O
,	O
excision	O
.	O

DIAGNOSIS	O
(	O
ES	O
)	O
:	O
A	O
.	O

Subnipple	O
tissue	O
,	O
right	O
breast	O
,	O
excision	O
:	O
Nipple	O
ducts	O
with	O
atypical	O
micropapillary	O
hyperplasia	O
.	O

No	O
carcinoma	O
seen	O
.	O

B	O
.	O

Lymph	O
node	O
,	O
right	O
axilla	O
sentinel	O
node	O
,	O
biopsy	O
:	O
Lymph	O
node	O
,	O
bisected	O
and	O
serially	O
sectioned	O
,	O
negative	O
for	O
carcinoma	O
.	O

IHC	O
for	O
cytokeratin	O
is	O
negative	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
right	O
axilla	O
sentinel	O
node	O
#	O
2	O
,	O
biopsy	O
:	O
Lymph	O
node	O
,	O
quadrasected	O
and	O
serially	O
sectioned	O
,	O
single	O
focus	O
of	O
carcinoma	O
seen	O
by	O
light	O
microscopy	O
.	O
and	O
IHC	O
for	O
cytokeratin	O
(	O
focus	O
of	O
<	O
10	O
cells	O
,	O
ITC	O
)	O
.	O

D	O
.	O

Breast	O
,	O
right	O
,	O
total	O
mastectomy	O
:	O
Infiltrating	O
ductal	O
carcinoma	O
,	O
well	O
differentiated	O
(	O
1	O
+	O
2	O
+	O
1	O
=	O
4	O
/	O
9	O
)	O
,	O
spanning	O
2	B
,	I
0	I
cm	I
,	O
arising	O
in	O
a	O
background	O
.	O
of	O
ductal	O
carcinoma	O
in	O
situ	O
,	O
intermediate	O
to	O
high	O
grade	O
.	O

Infiltrating	O
ductal	O
carcinoma	O
,	O
separate	O
focus	O
,	O
moderately	O
differentiated	O
(	O
3	O
+	O
3	O
+	O
1	O
=	O
719	O
)	O
,	O
spanning	O
0	B
.	I
6	I
cm	I
.	O

Extensive	O
ductal	O
carcinoma	O
in	O
situ	O
,	O
solid	O
,	O
cribriform	O
and	O
micropapillary	O
type	O
,	O
with	O
necrosis	O
and	O
.	O
microcalcification	O
,	O
seen	O
on	O
15	O
of	O
26	O
slides	O
and	O
extending	O
to	O
within	O
0	O
.	O
1	O
cm	O
of	O
deep	O
margin	O
.	O

The	O
.	O
micropapillary	O
DCIS	O
is	O
seen	O
in	O
the	O
nipple	O
duct	O
sections	O
.	O

Lobular	O
carcinoma	O
in	O
situ	O
,	O
monomorphic	O
type	O
.	O

Intraductal	O
papillomas	O
and	O
sclerosing	O
adenosis	O
with	O
microcalcification	O
.	O

Fibroadenoma	O
.	O

E	O
.	O

Skin	O
,	O
right	O
breast	O
,	O
excision	O
:	O
Fragments	O
of	O
skin	O
.	O

CLINICAL	O
INFORMATION	O
:	O
Right	O
breast	O
cancer	O
,	O
.	O

GROSS	O
DESCRIPTION	O
;	O
.	O

The	O
specimen	O
is	O
received	O
in	O
five	O
parts	O
.	O

Part	O
A	O
is	O
received	O
fresh	O
from	O
the	O
operating	O
room	O
for	O
frozen	O
section	O
diagnosis	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
"	O
Rt	O
subnipple	O
tissue	O
R	O
/	O
O	O
cancer	O
"	O
.	O

It	O
consists	O
of	O
one	O
piece	O
of	O
red	O
soft	O
tissue	O
measuring	O
1	B
.	I
1	I
x	I
0	I
,	I
9	I
X	I
0	I
.	I
3	I
cm	I
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
one	O
cassette	O
labeled	O
AFS	O
.	O

Part	O
B	O
is	O
received	O
fresh	O
from	O
the	O
operating	O
room	O
for	O
frozen	O
section	O
diagnosis	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
"	O
Right	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
1	O
"	O
.	O

It	O
consists	O
of	O
one	O
piece	O
of	O
fatty	O
tissue	O
measuring	O
3	O
.	O
2	O
x	O
1	O
.	O
4	O
x	O
0	O
.	O
8	O
cm	O
.	O

One	O
lymph	O
node	O
is	O
palpated	O
measuring	O
1	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
node	O
is	O
bisected	O
.	O

The	O
specimen	O
is	O
.	O
entirely	O
submitted	O
in	O
four	O
cassettes	O
labeled	O
BFS1	O
-	O
BFS2	O
,	O
B1	O
and	O
B2	O
.	O

Please	O
note	O
:	O
Three	O
levels	O
and	O
cytokeratin	O
stains	O
.	O
are	O
ordered	O
for	O
the	O
lymph	O
node	O
only	O
.	O

Legend	O
:	O
BFS1	O
-	O
BFS2	O
=	O
frozen	O
section	O
-	O
lymph	O
node	O
,	O
B1	O
-	O
B2	O
=	O
remaining	O
tissue	O
.	O

Part	O
C	O
is	O
received	O
fresh	O
from	O
the	O
operating	O
room	O
for	O
frozen	O
section	O
diagnosis	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O
name	O
and	O
"	O
Right	O
axillary	O
sentinel	O
lymph	O
node	O
#	O
2	O
"	O
.	O

It	O
consists	O
of	O
one	O
piece	O
of	O
fatty	O
tissue	O
measuring	O
2	O
.	O
8	O
x	O
1	O
.	O
9	O
x	O
1	O
.	O
1	O
cm	O
.	O

One	O
.	O
lymph	O
node	O
is	O
palpated	O
measuring	O
2	O
.	O
7	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
node	O
is	O
quadrisected	O
.	O

The	O
specimen	O
.	O

is	O
entirely	O
submitted	O
in	O
five	O
cassettes	O
labeled	O
CFS1	O
-	O
CFS4	O
and	O
C1	O
.	O

Please	O
note	O
:	O
Three	O
levels	O
and	O
cytokeratin	O
stains	O
are	O
.	O
ordered	O
for	O
the	O
lymph	O
node	O
only	O
.	O

Legend	O
:	O
CFS1	O
-	O
CFS4	O
=	O
frozen	O
section	O
-	O
lymph	O
node	O
,	O
C1	O
=	O
remaining	O
tissue	O
.	O

Part	O
D	O
is	O
received	O
unfixed	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
Right	O
breast	O
mastectomy	O
,	O
stitch	O
short	O
.	O
anterior	O
subnipple	O
tissue	O
,	O
stitch	O
long	O
=	O
lateral	O
"	O
.	O

It	O
consists	O
of	O
a	O
right	O
total	O
skin	O
sparing	O
mastectomy	O
specimen	O
measuring	O
.	O

22	O
.	O
0	O
.	O

x	O
.	O

14	O
.	O
0	O
.	O

X	O
.	O

3	O
.	O
5	O
cm	O
.	O

A	O
short	O
suture	O
is	O
noted	O
indicating	O
the	O
subareolar	O
and	O
a	O
long	O
suture	O
is	O
noted	O
indicating	O
the	O
superior	O
.	O

(	O
as	O
per	O
Dr	O
.	O
the	O
long	O
suture	O
was	O
mistakenly	O
labeled	O
"	O
lateral	O
"	O
)	O
.	O

An	O
underlying	O
mass	O
is	O
palpable	O
located	O
1	O
.	O
0	O
cm	O
.	O
from	O
.	O

the	O
.	O
subareolar	O
.	O

The	O
subareolar	O
is	O
inked	O
blue	O
,	O
the	O
superficial	O
margin	O
is	O
inked	O
yellow	O
and	O
the	O
deep	O
margin	O
is	O
inked	O
.	O
black	O
.	O

The	O
axillary	O
tissue	O
measures	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

No	O
lymph	O
nodes	O
are	O
palpable	O
within	O
it	O
.	O

The	O
.	O
specimen	O
is	O
serially	O
sectioned	O
at	O
closely	O
spaced	O
intervals	O
,	O
revealing	O
an	O
area	O
of	O
white	O
,	O
cystic	O
parenchyma	O
measuring	O
.	O

6	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
located	O
in	O
the	O
center	O
,	O
0	O
.	O
5	O
cm	O
from	O
the	O
deep	O
margin	O
and	O
0	O
.	O
2	O
cm	O
from	O
the	O
superficial	O
margin	O
.	O

Within	O
.	O
the	O
cystic	O
parenchyma	O
is	O
a	O
firm	O
,	O
poorly	O
circumscribed	O
,	O
white	O
-	O
tan	O
mass	O
measuring	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
5	O
cm	O
which	O
comes	O
to	O
.	O
within	O
0	O
.	O
6	O
cm	O
from	O
the	O
deep	O
margin	O
and	O
1	O
.	O
3	O
cm	O
from	O
the	O
superficial	O
margin	O
.	O

At	O
least	O
four	O
scattered	O
yellow	O
-	O
white	O
nodules	O
.	O
measuring	O
from	O
0	O
.	O
5	O
cm	O
to	O
0	O
.	O
8	O
cm	O
in	O
diameter	O
are	O
also	O
seen	O
within	O
the	O
cystic	O
parenchyma	O
located	O
0	O
.	O
3	O
cm	O
from	O
the	O
.	O
deep	O
.	O

margin	O
and	O
1	O
.	O
5	O
cm	O
from	O
the	O
superficial	O
margin	O
and	O
at	O
least	O
1	O
.	O
0	O
cm	O
from	O
the	O
mass	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
.	O
composed	O
of	O
a	O
moderate	O
amount	O
of	O
breast	O
tissue	O
(	O
60	O
%	O
)	O
and	O
a	O
moderate	O
amount	O
of	O
yellow	O
fatty	O
tissue	O
(	O
40	O
%	O
)	O
.	O

Also	O
.	O
received	O
in	O
the	O
container	O
is	O
one	O
irregular	O
piece	O
of	O
soft	O
,	O
fibrofatty	O
,	O
yellow	O
-	O
red	O
tissue	O
measuring	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

On	O
cut	O
.	O
surface	O
,	O
no	O
discrete	O
lesions	O
or	O
lymph	O
nodes	O
are	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
26	O
cassettes	O
.	O
labeled	O
D1	O
-	O
D26	O
.	O

Please	O
note	O
:	O
The	O
specimen	O
was	O
placed	O
in	O
formalin	O
at	O
.	O

LEGEND	O
:	O
D1	O
-	O
D2	O
=	O
Submucosal	O
area	O
.	O

D3	O
-	O
D4	O
=	O
Mass	O
with	O
adjacent	O
deep	O
margin	O
.	O

D5	O
-	O
D7	O
=	O
Remaining	O
portion	O
of	O
mass	O
.	O

D8	O
=	O
Superficial	O
margin	O
closest	O
to	O
mass	O
.	O

D9	O
-	O
D10	O
=	O
Nodule	O
closest	O
to	O
mass	O
with	O
adjacent	O
surrounding	O
tissue	O
and	O
deep	O
margin	O
.	O

D11	O
=	O
Remaining	O
portion	O
of	O
nodule	O
with	O
adjacent	O
surrounding	O
tissue	O
.	O

D12	O
-	O
D15	O
=	O
Surrounding	O
nodules	O
in	O
cystic	O
parenchyma	O
.	O

D16	O
-	O
D17	O
=	O
Cystic	O
parenchyma	O
.	O

D18	O
-	O
D19	O
=	O
Upper	O
inner	O
quadrant	O
.	O

D20	O
-	O
D21	O
=	O
Lower	O
inner	O
quadrant	O
.	O

D22	O
-	O
D23	O
=	O
Lower	O
outer	O
quadrant	O
.	O

D24	O
-	O
D25	O
=	O
Upper	O
outer	O
quadrant	O
.	O

D26	O
=	O
Fibrofatty	O
tissue	O
also	O
received	O
in	O
the	O
container	O
.	O

Part	O
E	O
Is	O
received	O
unfixed	O
in	O
a	O
container	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
"	O
Skin	O
from	O
mastectomy	O
R	O
breast	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
strip	O
of	O
rubbery	O
,	O
tan	O
-	O
brown	O
skin	O
measuring	O
11	O
.	O
6	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
one	O
cassette	O
labeled	O
E1	O
.	O

Please	O
note	O
:	O
The	O
specimen	O
was	O
placed	O
in	O
formalin	O
at	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
AFS	O
:	O
Benign	O
breast	O
tissue	O
and	O
large	O
ducts	O
.	O

No	O
carcinoma	O
seen	O
.	O

BFS1	O
,	O
BFS2	O
:	O
No	O
carcinoma	O
seen	O
.	O

CFS1	O
,	O
CFS2	O
:	O
No	O
carcinoma	O
seen	O
.	O

CFS3	O
,	O
CFS4	O
:	O
No	O
carcinoma	O
seen	O
.	O

Performed	O
by	O
:	O
Resident	O
:	O
Interpreted	O
by	O
:	O
Attending	O
:	O
MICROSCOPIC	O
DESCRIPTION	O
:	O
TYPE	O
OF	O
SPECIMEN	O
:	O
Right	O
total	O
mastectomy	O
with	O
sentinel	O
node	O
dissection	O
.	O

II	O
.	O

LOCATION	O
OF	O
THE	O
TUMOR	O
:	O
Central	O
.	O

III	O
.	O

TYPE	O
OF	O
NEOPLASM	O
:	O
Carcinoma	O
,	O
Invasive	O
,	O
Ductal	O
-	O
NOS	O
(	O
Nodule	O
1	O
)	O
.	O

Well	O
Differentiated	O
,	O
Total	O
score	O
4	O
.	O

(	O
Tubule	O
Score	O
1	O
,	O
Nuclear	O
Grade	O
Score	O
2	O
,	O
Mitotic	O
Score	O
1	O
)	O
.	O

TUMOR	O
SIZE	O
:	O
The	O
tumor	O
'	O
s	O
greatest	O
dimension	O
2	B
.	I
0	I
cm	I
.	O

Carcinoma	O
,	O
Invasive	O
,	O
Ductal	O
-	O
NOS	O
(	O
Nodule	O
2	O
)	O
.	O

Moderately	O
Differentiated	O
,	O
Total	O
score	O
7	O
.	O

(	O
Tubule	O
Score	O
3	O
,	O
Nuclear	O
Grade	O
Score	O
3	O
,	O
Mitotic	O
Score	O
1	O
)	O
.	O

TUMOR	O
SIZE	O
:	O
The	O
tumor	O
'	O
s	O
greatest	O
dimension	O
0	B
.	I
6	I
cm	I
.	O

Ductal	O
carcinoma	O
in	O
situ	O
,	O
nuclear	O
grade	O
3	O
,	O
widespread	O
30	O
%	O
.	O

QUANTITATION	O
:	O
Ductal	O
carcinoma	O
in	O
situ	O
is	O
present	O
in	O
15	O
of	O
26	O
slides	O
of	O
breast	O
.	O

Intraductal	O
solid	O
subtype	O
,	O
cribriform	O
,	O
comedo	O
,	O
micropapillary	O
/	O
.	O

VI	O
.	O

VASCULAR	O
SPACE	O
INVASION	O
:	O
Present	O
in	O
lymphatics	O
.	O

VII	O
.	O

CALCIFICATION	O
:	O
Present	O
in	O
both	O
malignant	O
and	O
benign	O
areas	O
.	O

VIII	O
.	O

NIPPLE	O
:	O
Ducts	O
involved	O
by	O
DCIS	O
.	O

IX	O
.	O

SKIN	O
:	O
Present	O
,	O
uninvolved	O
by	O
cancer	O
.	O

X	O
.	O

ADJACENT	O
BREAST	O
TISSUE	O
:	O
Cystic	O
disease	O
,	O
proliferative	O
with	O
atypia	O
.	O

MARGINS	O
:	O
Tumor	O
distance	O
from	O
closest	O
margin	O
DCIS	O
-	O
<	O
0	O
.	O
1	O
cm	O
fromm	O
deep	O
margin	O
.	O

XII	O
.	O

AXILLARY	O
LYMPH	O
NODES	O
:	O
Sentinel	O
-	O
2	O
.	O

XIII	O
.	O

POSITIVE	O
LYMPH	O
NODES	O
:	O
Sentinel	O
-	O
ITC	O
only	O
.	O

XV	O
.	O

PATHOLOGIC	O
STAGING	O
(	O
pTNM	O
)	O
AJCC	O
7th	O
Edition	O
:	O
Reflects	O
staging	O
only	O
.	O
of	O
the	O
current	O
specimen	O
.	O

Ultimate	O
.	O
staging	O
responsibility	O
rests	O
with	O
the	O
primary	O
physician	O
.	O

pT1c	O
:	O
Tumor	O
more	O
than	O
1	O
.	O
0	O
cm	O
but	O
not	O
more	O
than	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

pNO	O
(	O
ITC	O
,	O
i	O
+	O
)	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
on	O
H	O
&	O
E	O
histologically	O
,	O
(	O
ie	O
.	O

Individual	O
tumor	O
cells	O
seen	O
,	O
.	O
none	O
greater	O
than	O
0	B
.	I
2	I
mm	I
,	O
positive	O
IHC	O
.	O

COMMENT	O
(	O
S	O
)	O
:	O
Case	O
shown	O
at	O
.	O

This	O
report	O
has	O
been	O
reviewed	O
electronically	O
and	O
signed	O
on	O
.	O

Interpreted	O
by	O
:	O
Attending	O
:	O
The	O
diagnosis	O
was	O
rendered	O
by	O
the	O
attending	O
pathologist	O
.	O

Receptor	O
Expression	O
Analysis	O
.	O

INTERPRETATION	O
.	O

Test	O
Performed	O
on	O
formalin	O
fixed	O
paraffin	O
embedded	O
section	O
of	O
:	O
mastectomy	O
.	O

The	O
results	O
are	O
for	O
invasive	O
carc	O
	O
noma	O
#	O
1	O
.	O

Specimen	O
part	O
:	O
D	O
.	O

Slide	O
#	O
.	O

D3	O
.	O

Fixation	O
:	O
adequate	O
.	O

This	O
tumor	O
is	O
considered	O
positive	O
for	O
estrogen	O
receptor	O
expression	O
(	O
21	O
%	O
of	O
the	O
cells	O
are	O
positive	O
)	O
.	O

The	O
.	O
specimen	O
was	O
adequate	O
for	O
evaluation	O
for	O
ER	O
as	O
per	O
ASCO	O
/	O
CAP	O
guidelines	O
2010	O
.	O

Approximately	O
75	O
%	O
of	O
the	O
.	O
carcinoma	O
cell	O
nuclei	O
stain	O
with	O
an	O
immunohistochemical	O
stain	O
utilizing	O
an	O
anti	O
-	O
estrogen	O
receptor	O
antibody	O
.	O

)	O
with	O
an	O
average	O
intermediate	O
intensity	O
.	O

This	O
tumor	O
is	O
considered	O
positive	O
for	O
progesterone	O
receptor	O
expression	O
(	O
>	O
1	O
%	O
of	O
the	O
cells	O
are	O
positive	O
)	O
.	O

The	O
.	O
specimen	O
was	O
adequate	O
for	O
evaluation	O
for	O
PR	O
as	O
per	O
ASCO	O
/	O
CAP	O
guidelines	O
2010	O
,	O
Approximately	O
80	O
%	O
of	O
the	O
.	O
carcinoma	O
cell	O
nuclei	O
stain	O
with	O
an	O
immunohistochemical	O
stain	O
utilizing	O
an	O
anti	O
-	O
progesterone	O
receptor	O
antibody	O
.	O

)	O
with	O
an	O
average	O
strong	O
intensity	O
.	O

Equivocal	O
/	O
indeterminate	O
for	O
HER2	O
expression	O
.	O

Her	O
-	O
2	O
/	O
neu	O
over	O
-	O
expression	O
has	O
been	O
evaluated	O
,	O
on	O
a	O
formalin	O
fixed	O
.	O
paraffin	O
embedded	O
section	O
,	O
using	O
the	O
.	O

(	O
proprietary	O
kit	O
)	O
.	O

Using	O
the	O
ASCO	O
/	O
CAP	O
scoring	O
criteria	O
,	O
the	O
.	O
score	O
is	O
:	O
2	O
.	O

Invasive	O
carcinoma	O
#	O
2	O
:	O
This	O
tumor	O
is	O
considered	O
positive	O
for	O
estrogen	O
receptor	O
expression	O
(	O
>	O
1	O
%	O
of	O
the	O
cells	O
are	O
positive	O
)	O
.	O

The	O
.	O
specimen	O
was	O
adequate	O
for	O
evaluation	O
for	O
ER	O
as	O
per	O
ASCO	O
/	O
CAP	O
guidelines	O
2010	O
,	O
Approximately	O
100	O
%	O
of	O
the	O
.	O
carcinoma	O
cell	O
nuclei	O
stain	O
with	O
an	O
immunohistochemical	O
stain	O
utilizing	O
an	O
anti	O
-	O
estrogen	O
receptor	O
antibody	O
.	O

SP1	O
)	O
with	O
an	O
average	O
strong	O
intensity	O
.	O

This	O
tumor	O
is	O
considered	O
positive	O
for	O
progesterone	O
receptor	O
expression	O
@	O
1	O
%	O
of	O
the	O
cells	O
are	O
positive	O
)	O
.	O

The	O
.	O
specimen	O
was	O
adequate	O
for	O
evaluation	O
for	O
PR	O
as	O
per	O
ASCO	O
/	O
CAP	O
guidelines	O
2010	O
.	O

Approximately	O
100	O
%	O
of	O
the	O
.	O
carcinoma	O
cell	O
nuclei	O
stain	O
with	O
an	O
immunohistochemical	O
stain	O
utilizing	O
an	O
anti	O
-	O
progesterone	O
receptor	O
antibody	O
.	O

1E2	O
)	O
with	O
an	O
average	O
strong	O
intensity	O
.	O

Positive	O
for	O
HER2	O
overexpression	O
.	O

Her	O
-	O
2	O
/	O
neu	O
over	O
-	O
expression	O
has	O
been	O
evaluated	O
,	O
on	O
formalin	O
fixed	O
paraffin	O
.	O
embedded	O
sections	O
,	O
using	O
the	O
.	O

(	O
proprietary	O
kit	O
)	O
.	O

Using	O
the	O
ASCO	O
/	O
CAP	O
scoring	O
criteria	O
,	O
the	O
.	O
score	O
:	O
3	O
.	O

This	O
procedure	O
/	O
addenda	O
has	O
been	O
electronically	O
reviewed	O
and	O
signed	O
on	O
.	O

Interpreted	O
by	O
:	O
Attending	O
:	O
Note	O
:	O
Immunochemistry	O
testing	O
performed	O
at	O
.	O
was	O
developed	O
and	O
ils	O
performance	O
characteristics	O
determined	O
by	O
the	O
.	O

These	O
tests	O
were	O
interpreted	O
in	O
conjunction	O
with	O
externel	O
positive	O
and	O
internal	O
negative	O
controis	O
,	O
unless	O
otherwise	O
noted	O
,	O
It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
.	O

FDA	O
.	O

This	O
test	O
is	O
used	O
for	O
clinical	O
purposes	O
only	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
research	O
.	O

END	O
OF	O
REPORTI	O
.	O

Breast	O
,	O
right	O
,	O
total	O
mastectomy	O
:	O
Infiltrating	O
ductal	O
carcinoma	O
,	O
Nottingham	O
grade	O
II	O
(	O
of	O
III	O
)	O
,	O
[	O
tubules	O
3	O
/	O
3	O
,	O
nuclei	O
2	O
/	O
3	O
,	O
mitoses	O
1	O
/	O
3	O
;	O
.	O
Nottingham	O
score	O
6	O
/	O
9	O
]	O
,	O
forming	O
a	O
2	B
.	I
1	I
x	I
1	I
.	I
4	I
x	I
1	I
.	I
1	I
cm	I
mass	O
located	O
in	O
the	O
central	O
breast	O
(	O
AJCC	O
pT2	O
)	O
.	O

Ductal	O
carcinoma	O
.	O

in	O
.	O
situ	O
,	O
.	O
intermediate	O
nuclear	O
grade	O
,	O
comprising	O
approximately	O
5	O
-	O
25	O
%	O
of	O
tumor	O
volume	O
.	O

Angiolymphatic	O
invasion	O
is	O
present	O
.	O

The	O
non	O
-	O
.	O
neoplastic	O
breast	O
parenchyma	O
shows	O
proliferative	O
fibrocystic	O
changes	O
.	O

Calcifications	O
present	O
in	O
malignant	O
ducts	O
.	O

Biopsy	O
site	O
.	O
changes	O
present	O
.	O

The	O
tumor	O
does	O
not	O
involve	O
the	O
nipple	O
,	O
overlying	O
skin	O
,	O
or	O
underlying	O
chest	O
wall	O
.	O

All	O
surgical	O
resection	O
margins	O
,	O
.	O
including	O
deep	O
margin	O
,	O
are	O
negative	O
for	O
tumor	O
(	O
minimum	O
tumor	O
free	O
margin	O
,	O
2	O
.	O
1	O
cm	O
,	O
deep	O
margin	O
)	O
.	O

Lymph	O
nodes	O
,	O
right	O
axillary	O
sentinel	O
Nos	O
.	O

1A	O
,	O
1B	O
,	O
1C	O
and	O
2	O
,	O
sentinel	O
biopsy	O
:	O
Three	O
(	O
of	O
4	O
)	O
right	O
axillary	O
sentinel	O
lymph	O
nodes	O
are	O
.	O
positive	O
for	O
metastatic	O
carcinoma	O
(	O
>	O
2	O
.	O
0	O
mm	O
)	O
[	O
AJCC	O
pN1	O
(	O
5n	O
)	O
]	O
.	O

Extranodal	O
extension	O
is	O
not	O
present	O
.	O

Blue	O
dye	O
is	O
identified	O
in	O
.	O
lymph	O
nodes	O
Nos	O
.	O

1A	O
and	O
1B	O
.	O

Lymph	O
node	O
No	O
.	O
1C	O
does	O
not	O
contain	O
blue	O
dye	O
.	O

Lymph	O
nodes	O
,	O
right	O
axillary	O
,	O
dissection	O
:	O
Multiple	O
(	O
18	O
)	O
right	O
axillary	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Breast	O
,	O
left	O
,	O
total	O
mastectomy	O
:	O
Ductal	O
carcinoma	O
in	O
situ	O
,	O
micropapillary	O
and	O
cribriform	O
types	O
,	O
low	O
nuclear	O
grade	O
without	O
.	O
intraluminal	O
necrosis	O
,	O
involving	O
an	O
area	O
over	O
5	B
.	I
7	I
x	I
2	I
.	I
3	I
x	I
1	I
.	I
4	I
cm	I
[	O
AJCC	O
pTis	O
]	O
.	O

The	O
non	O
-	O
neoplastic	O
breast	O
parenchyma	O
shows	O
.	O
nonproliferative	O
fibrocystic	O
changes	O
.	O

Calcifications	O
are	O
present	O
in	O
malignant	O
ducts	O
.	O

Biopsy	O
site	O
changes	O
are	O
present	O
.	O

Nipple	O
and	O
.	O
skin	O
are	O
without	O
diagnostic	O
abnormality	O
.	O

All	O
surgical	O
resection	O
margins	O
are	O
negative	O
for	O
tumor	O
(	O
minimum	O
tumor	O
free	O
margin	O
,	O
1	O
.	O
5	O
.	O
cm	O
,	O
deep	O
margin	O
)	O
.	O

Sex	O
:	O
M	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
(	O
1	B
.	I
5	I
CM	I
)	O
INVOLVING	O
THE	O
LEFT	O
LOBE	O
AND	O
EXTENDING	O
INTO	O
THE	O
.	O

PERITHYROID	O
SOFT	O
TISSUE	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

Two	O
follicular	O
adenomas	O
(	O
0	B
.	I
8	I
cm	I
)	O
,	O
left	O
lobe	O
.	O

Adenomatoid	O
colloid	O
nodule	O
,	O
right	O
lobe	O
.	O

Margins	O
of	O
resection	O
,	O
free	O
.	O

(	O
B	O
)	O
LEFT	O
CRICOTHYROID	O
TISSUE	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
IN	O
FIBROUS	O
TISSUE	O
.	O

(	O
C	O
)	O
THYROID	O
ARYTENOID	O
:	O
Skeletal	O
muscle	O
and	O
adipose	O
tissue	O
.	O

No	O
tumor	O
present	O
.	O

(	O
D	O
)	O
THYROID	O
CARTILAGE	O
:	O
Pending	O
section	O
for	O
decalcification	O
.	O

Supplemental	O
report	O
will	O
follow	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
TOTAL	O
THYROIDECTOMY	O
-	O
-	O
A	O
product	O
of	O
total	O
thyroidectomy	O
with	O
marked	O
adhesion	O
and	O
fibrosis	O
with	O
overall	O
measurements	O
.	O
of	O
8	O
.	O
0x4	O
.	O
5x2	O
.	O
5	O
cm	O
.	O

The	O
right	O
lobe	O
is	O
nodular	O
,	O
elongated	O
and	O
measures	O
6	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
4	O
cm	O
,	O
and	O
the	O
left	O
lobe	O
is	O
irregular	O
,	O
fibrotic	O
.	O
with	O
marked	O
adhesion	O
and	O
measures	O
4	O
.	O
5	O
X	O
3	O
.	O
0	O
X	O
2	O
.	O
5	O
cm	O
.	O

Multiple	O
nodules	O
are	O
identified	O
ranging	O
in	O
size	O
from	O
0	O
.	O
4	O
to	O
1	O
.	O
7	O
cm	O
are	O
.	O
noted	O
throughout	O
the	O
gland	O
.	O

The	O
left	O
lobe	O
shows	O
a	O
fibrotic	O
and	O
firm	O
nodule	O
extending	O
from	O
the	O
superior	O
-	O
to	O
-	O
inferior	O
aspect	O
of	O
the	O
.	O
lobe	O
and	O
involves	O
the	O
soft	O
tissue	O
and	O
muscle	O
surrounding	O
the	O
lobe	O
and	O
abutting	O
the	O
posterior	O
aspect	O
of	O
the	O
margin	O
.	O

The	O
.	O
specimen	O
is	O
submitted	O
entirely	O
as	O
follows	O
.	O

The	O
right	O
lobe	O
was	O
sequentially	O
sectioned	O
from	O
superior	O
to	O
inferior	O
under	O
A1	O
-	O
A7	O
,	O
and	O
.	O
the	O
left	O
lobe	O
sequentially	O
sectioned	O
from	O
superior	O
to	O
inferior	O
under	O
A8	O
to	O
A24	O
.	O

(	O
B	O
)	O
LEFT	O
CRICOTHYROID	O
TISSUE	O
-	O
Two	O
soft	O
tissue	O
fragments	O
measuring	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
each	O
,	O
entirely	O
submitted	O
for	O
frozen	O
.	O
in	O
B	O
.	O

FS	O
/	O
DX	O
:	O
THYROID	O
NEOPLASM	O
IN	O
FIBROUS	O
TISSUE	O
.	O

(	O
C	O
)	O
THYROID	O
ARYTENOID	O
-	O
A	O
small	O
soft	O
tissue	O
fragment	O
1	O
.	O
5	O
x	O
0	O
.	O
3	O
X	O
0	O
.	O
4	O
cm	O
.	O

Submitted	O
entirely	O
under	O
C	O
.	O

(	O
D	O
)	O
THYROID	O
CARTILAGE	O
-	O
A	O
fragment	O
of	O
cartilage	O
and	O
bone	O
submitted	O
for	O
decal	O
under	O
D	O
.	O

Sex	O
:	O
M	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

ADDENDUM	O
.	O

Addendum	O
completed	O
by	O
.	O

DIAGNOSIS	O
.	O

(	O
D	O
)	O
THYROID	O
CARTILAGE	O
:	O
PAPILLARY	O
CARCINOMA	O
OF	O
THYROID	O
INVOLVING	O
CARTILAGE	O
.	O

Released	O
by	O
:	O

-	O
Confidential	O
Document	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
of	O
.	O
regarding	O
.	O

patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Document	O
Date	O
:	O
Acc	O
#	O
:	O
(	O
Age	O
:	O
)	O
.	O

F	O
.	O

Client	O
:	O
Submitting	O
.	O

Phys	O
:	O
Final	O
Surgical	O
Pathology	O
Report	O
.	O

ADDENDUM	O
PRESENT	O
.	O

Addendum	O
Diagnosis	O
.	O

THE	O
DIAGNOSIS	O
REMAINS	O
THE	O
SAME	O
.	O

Addendum	O
Comment	O
.	O

The	O
following	O
special	O
stains	O
and	O
/	O
or	O
immunohistochemical	O
stains	O
were	O
performed	O
:	O
STAIN	O
.	O

Pancytokeratin	O
.	O

The	O
neoplasm	O
is	O
predomimantly	O
lymphocytic	O
,	O
but	O
has	O
expected	O
numbers	O
of	O
weakly	O
staining	O
epithelial	O
cells	O
.	O

Confidential	O
Document	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
of	O
.	O
regarding	O
.	O

patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Final	O
Pathologic	O
Diagnosis	O
.	O

A	O
.	O

INFERIOR	O
MEDIASTINAL	O
MASS	O
,	O
VIDEO	O
-	O
ASSISTED	O
THORACIC	O
SURGERY	O
,	O
A1FS	O
:	O
-	O
THYMOMA	O
,	O
TYPE	O
B1	O
,	O
LYMPHOCYTE	O
RICH	O
(	O
5	B
.	I
0	I
X	I
3	I
.	I
0	I
X	I
2	I
.	I
0	I
CM	I
)	O
,	O
WITH	O
DEGENERATIVE	O
CYSTIC	O
CHANGES	O
AND	O
.	O

FIBROSIS	O
.	O

-	O
THYMOMA	O
FOCALLY	O
EXTENDS	O
INTO	O
CAPSULE	O
,	O
AND	O
ABUTS	O
THE	O
INKED	O
SURFACE	O
.	O

-	O
SEE	O
SYNOPTIC	O
REPORT	O
.	O

Assisted	O
by	O
:	O
Flow	O
Cytometry	O
/	O
Sigried	O
Out	O
.	O

Addendum	O
/	O
Signed	O
Out	O
.	O

Synoptic	O
Worksheet	O
.	O

A	O
.	O

Inferior	O
mediastinal	O
mass	O
,	O
FS	O
:	O
Specimen	O
:	O
Not	O
specified	O
.	O

Procedure	O
:	O
Other	O
:	O
Right	O
Video	O
-	O
assisted	O
thoracic	O
surgery	O
(	O
VATS	O
)	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Weight	O
:	O
27	O
.	O
6	O
(	O
g	O
)	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
5	B
.	I
0	I
cm	I
.	O

Additional	O
Dimension	O
:	O
3	B
.	I
0	I
cm	I
.	O

Additional	O
Dimension	O
:	O
2	B
.	I
0	I
cm	I
.	O

Histologic	O
Type	O
:	O
Type	O
B1	O
thymoma	O
.	O

Tumor	O
Extension	O
:	O
Not	O
identified	O
.	O

Margins	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
tumor	O
.	O

Margin	O
(	O
s	O
)	O
:	O
peripheral	O
.	O

Treatment	O
Effect	O
:	O
Not	O
applicable	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
Cannot	O
be	O
assessed	O
.	O

Number	O
examined	O
:	O
0	O
.	O

Number	O
involved	O
:	O
0	O
.	O

Pathologic	O
Staging	O
for	O
Thymomas	O
(	O
Modified	O
Masaoka	O
)	O
:	O
Stage	O
lla	O
:	O
Microscopic	O
transcapsular	O
invasion	O
.	O

Implants	O
/	O
Distant	O
Metastasis	O
:	O
Cannot	O
be	O
assessed	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Fibrosis	O
.	O

Cystic	O
changes	O
in	O
tumor	O
.	O

Confidential	O
Document	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
of	O
.	O
regarding	O
.	O

patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Clinical	O
History	O
.	O

Mediastinal	O
mass	O
.	O

Right	O
VATS	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Inferior	O
mediastinal	O
mass	O
,	O
FS	O
.	O

Gross	O
Description	O
.	O

Specimen	O
A	O
is	O
received	O
fresh	O
along	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
medical	O
record	O
number	O
and	O
as	O
"	O
inferior	O
mediastinal	O
mass	O
,	O
FS	O
.	O
"	O
The	O
.	O
specimen	O
consists	O
of	O
two	O
fragments	O
of	O
soft	O
tissue	O
mass	O
,	O
the	O
larger	O
one	O
measures	O
6	O
.	O

0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
and	O
weighs	O
25	O
gm	O
.	O

The	O
.	O
specimen	O
is	O
already	O
incised	O
when	O
received	O
.	O

The	O
smaller	O
fragment	O
measures	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
and	O
weighs	O
2	O
.	O
6	O
grams	O
.	O

An	O
.	O
ill	O
-	O
defined	O
encapsulated	O
mass	O
lesion	O
is	O
identified	O
in	O
the	O
larger	O
fragment	O
and	O
measures	O
5	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
.	O

The	O
cutting	O
surface	O
of	O
.	O
this	O
lesion	O
showing	O
yellowish	O
and	O
flesh	O
color	O
.	O

A	O
representative	O
section	O
from	O
this	O
ill	O
-	O
defined	O
mass	O
lesion	O
is	O
submitted	O
for	O
.	O
intraoperative	O
consultation	O
as	O
"	O
A1FS	O
.	O
"	O
Another	O
ill	O
-	O
defined	O
mass	O
lesion	O
is	O
identified	O
in	O
the	O
small	O
fragment	O
which	O
measures	O
0	B
.	I
5	I
x	I
.	I

0	B
.	I
5	I
x	I
0	I
.	I
2	I
cm	I
,	O
the	O
cutting	O
surface	O
of	O
this	O
small	O
ill	O
-	O
defined	O
mass	O
lesion	O
is	O
fish	O
-	O
flesh	O
.	O

The	O
outside	O
surface	O
of	O
the	O
entire	O
specimen	O
is	O
.	O
inked	O
blue	O
.	O

Sections	O
submitted	O
are	O
indicated	O
below	O
.	O

Dictated	O
by	O
.	O

/	O
.	O

CASSETTE	O
SUMMARY	O
:	O
A1FS	O
:	O
A	O
representative	O
section	O
of	O
the	O
mass	O
lesion	O
from	O
the	O
larger	O
fragment	O
(	O
intraoperative	O
consultation	O
)	O
.	O

A2	O
-	O
A7	O
:	O
Representative	O
sections	O
of	O
the	O
mass	O
lesion	O
from	O
the	O
larger	O
fragment	O
.	O

A8	O
:	O
Representative	O
sections	O
of	O
the	O
small	O
fragment	O
with	O
the	O
small	O
mass	O
lesion	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

A1FS	O
:	O
INFERIOR	O
MEDIASTINAL	O
MASS	O
(	O
FROZEN	O
SECTION	O
)	O
:	O
CORTICAL	O
THYMOMA	O
VERSUS	O
LYMPHOMA	O
.	O

Frozen	O
section	O
results	O
were	O
communicated	O
to	O
the	O
surgical	O
team	O
and	O
were	O
repeated	O
back	O
by	O
.	O

In	O
at	O
.	O
out	O
at	O
.	O

Microscopic	O
Description	O
.	O

Microscopic	O
examination	O
performed	O
.	O

Flow	O
Cytometry	O
.	O

Interpretation	O
.	O

Flow	O
cytometric	O
immunophenotyping	O
of	O
the	O
submitted	O
mediastinal	O
mass	O
is	O
performed	O
using	O
antibodies	O
to	O
the	O
listed	O
analytes	O
.	O

sample	O
)	O
.	O

The	O
remainder	O
of	O
the	O
sample	O
is	O
comprised	O
of	O
apparent	O
debris	O
and	O
/	O
or	O
nonviable	O
cells	O
.	O

Phenotypic	O
analysis	O
reveals	O
a	O
distinct	O
population	O
of	O
cells	O
with	O
low	O
light	O
scatter	O
properties	O
comprising	O
approximately	O
98	O
%	O
of	O
the	O
.	O
total	O
sample	O
which	O
express	O
CD2	O
,	O
variable	O
CD3	O
,	O
partial	O
CD4	O
,	O
CD5	O
,	O
CD7	O
,	O
partial	O
CD8	O
,	O
CD38	O
,	O
and	O
CD45	O
.	O

Confidential	O
Document	O
.	O

This	O
information	O
is	O
subject	O
to	O
all	O
Federal	O
and	O
State	O
laws	O
regarding	O
confidentiality	O
and	O
privacy	O
and	O
to	O
the	O
policies	O
and	O
procedures	O
of	O
.	O
regarding	O
.	O

patient	O
information	O
.	O

Any	O
unauthorized	O
use	O
,	O
disclosure	O
,	O
or	O
reproduction	O
of	O
this	O
information	O
is	O
strictly	O
prohibited	O
.	O

Anat	O
Path	O
Reports	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
demonstrate	O
the	O
presence	O
of	O
an	O
immature	O
T	O
-	O
lymphocyte	O
population	O
consistent	O
with	O
thymocytes	O
.	O

Clinical	O
and	O
laboratory	O
correlation	O
recommended	O
.	O

REFERENCES	O
:	O
Blood	O
.	O

2008	O
Apr	O
15	O
;	O
111	O
(	O
8	O
)	O
:	O
3941	O
-	O
67	O
.	O

Cytometry	O
B	O
Clin	O
Cytom	O
.	O

2007	O
;	O
72	O
Suppl	O
1	O
:	O
S14	O
-	O
22	O
.	O

Cytometry	O
B	O
Clin	O
Cytom	O
.	O

2007	O
;	O
72	O
Suppl	O
1	O
:	O
S5	O
-	O
13	O
.	O

Assisted	O
by	O
:	O
Clinical	O
History	O
.	O

Mediastinal	O
mass	O
.	O

Specimen	O
-	O
Gross	O
Description	O
.	O

Soft	O
tan	O
tissue	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
4	O
cm	O
with	O
10	O
mL	O
of	O
clear	O
pink	O
fluid	O
identified	O
as	O
"	O
mediastinal	O
mass	O
"	O
is	O
received	O
.	O

Analytes	O
Tested	O
.	O

CD2	O
,	O
CD3	O
,	O
CD4	O
,	O
CD5	O
,	O
CD7	O
,	O
CD8	O
,	O
CD10	O
,	O
CD11b	O
,	O
CD11c	O
,	O
CD13	O
,	O
CD14	O
,	O
CD15	O
,	O
CD16	O
,	O
CD19	O
,	O
CD20	O
,	O
CD22	O
,	O
CD23	O
,	O
CD25	O
,	O
CD33	O
,	O
.	O

CD34	O
,	O
CD36	O
,	O
CD38	O
,	O
CD45	O
,	O
CD56	O
,	O
CD103	O
,	O
CD117	O
,	O
FMC7	O
,	O
HLA	O
-	O
DR	O
,	O
Kappa	O
,	O
Lambda	O
.	O

This	O
test	O
was	O
performed	O
at	O
.	O

The	O
results	O
of	O
this	O
test	O
should	O
not	O
be	O
used	O
alone	O
as	O
the	O
sole	O
basis	O
for	O
diagnosis	O
and	O
/	O
or	O
treatment	O
.	O

These	O
results	O
may	O
,	O
however	O
,	O
prove	O
useful	O
when	O
used	O
in	O
conjunction	O
.	O
with	O
.	O

other	O
diagnostic	O
procedures	O
and	O
clinical	O
evaluations	O
.	O

Use	O
of	O
these	O
results	O
,	O
in	O
this	O
manner	O
,	O
can	O
be	O
considered	O
to	O
fall	O
within	O
the	O
scope	O
of	O
the	O
practice	O
of	O
medicine	O
This	O
.	O
test	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
.	O

It	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
United	O
States	O
Food	O
and	O
.	O

Drug	O
Administration	O
.	O

Visit	O
#	O
:	O
Service	O
Date	O
.	O

Male	O
.	O

Soc	O
.	O

Sec	O
.	O

#	O
:	O
Client	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Perinephric	O
fat	O
,	O
excision	O
:	O
Fibroadipose	O
tissue	O
,	O
no	O
tumor	O
seen	O
.	O

B	O
.	O

Superior	O
margin	O
,	O
excision	O
:	O
Fibroadipose	O
tissue	O
,	O
no	O
tumor	O
seen	O
.	O

C	O
.	O

Base	O
margin	O
,	O
excision	O
:	O
No	O
tumor	O
seen	O
.	O

D	O
.	O

Right	O
renal	O
mass	O
,	O
excision	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
(	O
chromophil	O
)	O
,	O
3	O
.	O
5cm	O
.	O
diameter	O
,	O
Fuhrman	O
nuclear	O
grade	O
2	O
,	O
excised	O
.	O

E	O
.	O

Perinephric	O
fat	O
,	O
excision	O
:	O
No	O
tumor	O
identified	O
.	O
renal	O
cell	O
(	O
Chromosited	O
826013	O
.	O

COMMENT	O
:	O
Kidney	O
Tumor	O
Synoptic	O
Comment	O
.	O

-	O
Histologic	O
type	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
papillary	O
(	O
chromophil	O
)	O
type	O
.	O

-	O
Grade	O
:	O
2	O
.	O

-	O
Maximum	O
tumor	O
diameter	O
:	O
3	B
.	I
5	I
cm	I
.	O

-	O
Capsule	O
/	O
perirenal	O
fat	O
:	O
Tumor	O
does	O
not	O
penetrate	O
the	O
capsule	O
which	O
surrounds	O
the	O
tumor	O
completely	O
;	O
only	O
part	O
of	O
this	O
capsule	O
is	O
.	O
surrounded	O
by	O
fat	O
or	O
renal	O
tissue	O
.	O

-	O
Hilar	O
lymph	O
nodes	O
(	O
number	O
positive	O
/	O
number	O
of	O
nodes	O
)	O
:	O
None	O
submitted	O
or	O
found	O
.	O

-	O
Resection	O
margins	O
:	O
"	O
Superior	O
margin	O
"	O
and	O
"	O
Base	O
margin	O
"	O
are	O
negative	O
for	O
tumor	O
.	O

-	O
Stage	O
:	O
pTlaNxMx	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Perinephric	O
fat	O
.	O

B	O
:	O
Superior	O
margin	O
(	O
FS	O
)	O
.	O

C	O
:	O
Base	O
margin	O
(	O
FS	O
)	O
.	O

D	O
:	O
Right	O
renal	O
mass	O
.	O

E	O
:	O
Perinephric	O
fat	O
.	O

Intraoperative	O
Diagnosis	O
.	O

FS1	O
(	O
B1	O
)	O
"	O
Soft	O
tissue	O
,	O
"	O
superior	O
margin	O
,	O
biopsy	O
:	O
Fibroadipose	O
tissue	O
,	O
no	O
tumor	O
.	O

FS2	O
(	O
C1	O
)	O
"	O
Kidney	O
,	O
"	O
Base	O
margin	O
,	O
biopsy	O
:	O
Renal	O
parenchyma	O
,	O
no	O
tumor	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O
year	O
-	O
old	O
man	O
with	O
a	O
right	O
renal	O
mass	O
,	O
who	O
undergoes	O
resection	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
five	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
medical	O
record	O
number	O
.	O

Parts	O
A	O
-	O
D	O
are	O
received	O
fresh	O
.	O

Part	O
E	O
is	O
received	O
in	O
formalin	O
.	O

Part	O
A	O
,	O
additionally	O
labeled	O
"	O
1	O
-	O
perinephric	O
fat	O
,	O
"	O
consists	O
of	O
fatty	O
tissue	O
measuring	O
1	O
.	O
9	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
as	O
a	O
.	O
pile	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
cassette	O
A1	O
.	O

Part	O
B	O
,	O
additionally	O
labeled	O
"	O
2	O
-	O
superior	O
margin	O
,	O
"	O
consists	O
of	O
fibrofatty	O
tissue	O
with	O
no	O
visible	O
soft	O
tissue	O
.	O
measuring	O
2	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
entire	O
specimen	O
is	O
frozen	O
for	O
frozen	O
section	O
1	O
,	O
with	O
the	O
remnant	O
.	O
submitted	O
in	O
cassette	O
B1	O
.	O

Part	O
C	O
,	O
additionally	O
labeled	O
"	O
3	O
-	O
base	O
margin	O
(	O
FS	O
)	O
,	O
"	O
consists	O
of	O
a	O
single	O
segment	O
of	O
normal	O
-	O
appearing	O
kidney	O
.	O
measuring	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
;	O
it	O
corresponds	O
to	O
a	O
puncture	O
of	O
the	O
renal	O
mass	O
capsule	O
(	O
specimen	O
D	O
)	O
.	O

The	O
.	O
deep	O
margin	O
is	O
inked	O
blue	O
by	O
the	O
surgeon	O
;	O
it	O
is	O
re	O
-	O
inked	O
black	O
and	O
then	O
entirely	O
submitted	O
for	O
frozen	O
.	O
sections	O
2	O
and	O
3	O
and	O
the	O
tissue	O
blocks	O
are	O
subsequently	O
entirely	O
submitted	O
in	O
cassettes	O
C1	O
-	O
C2	O
.	O

Part	O
D	O
,	O
additionally	O
labeled	O
"	O
right	O
renal	O
mass	O
,	O
"	O
consists	O
of	O
a	O
3	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
nodule	O
that	O
is	O
inked	O
on	O
50	O
%	O
.	O
of	O
the	O
surface	O
.	O

There	O
is	O
attached	O
fat	O
,	O
measuring	O
4	O
.	O
0	O
x	O
3	O
.	O
5	O
x	O
2	O
.	O
0	O
cm	O
as	O
a	O
pile	O
.	O

The	O
nodule	O
is	O
incised	O
to	O
reveal	O
.	O

a	O
brown	O
-	O
tan	O
,	O
soft	O
mass	O
that	O
appears	O
to	O
be	O
necrotic	O
.	O

Attached	O
to	O
the	O
nodule	O
is	O
a	O
rim	O
of	O
brown	O
tissue	O
.	O
measuring	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
7	O
cm	O
.	O

Representative	O
sections	O
of	O
the	O
nodule	O
and	O
the	O
attached	O
brown	O
tissue	O
are	O
.	O
submitted	O
in	O
cassettes	O
D1	O
-	O
D4	O
.	O

The	O
fatty	O
tissue	O
is	O
thoroughly	O
evaluated	O
for	O
candidate	O
lymph	O
nodes	O
and	O
.	O
candidate	O
lymph	O
nodes	O
are	O
submitted	O
in	O
cassette	O
D5	O
.	O

Representative	O
sections	O
of	O
the	O
fat	O
are	O
submitted	O
in	O
.	O
cassette	O
D6	O
.	O

Part	O
E	O
,	O
additionally	O
labeled	O
"	O
5	O
-	O
perinephric	O
fat	O
,	O
"	O
consists	O
of	O
multiple	O
yellow	O
,	O
glistening	O
,	O
irregular	O
,	O
unoriented	O
.	O
adipose	O
tissue	O
fragments	O
measuring	O
14	O
.	O
0	O
x	O
8	O
.	O
0	O
x	O
2	O
.	O
5	O
cm	O
in	O
aggregate	O
.	O

Upon	O
sectioning	O
,	O
the	O
specimen	O
.	O
consists	O
of	O
grossly	O
normal	O
-	O
appearing	O
adipose	O
tissue	O
without	O
areas	O
of	O
thickening	O
.	O

Representative	O
sections	O
.	O
are	O
submitted	O
in	O
cassettes	O
E1	O
-	O
E3	O
.	O

Diagnosis	O
based	O
on	O
gross	O
and	O
microscopic	O
examinations	O
.	O

Final	O
diagnosis	O
made	O
by	O
attending	O
pathologist	O
.	O
following	O
review	O
of	O
all	O
pathology	O
slides	O
.	O

Pathology	O
Resident	O
.	O
athologist	O
.	O

PRIMARY	O
SITE	O
:	O
Stomach	O
(	O
Body	O
)	O
.	O

"	O
1	O
-	O
Stomach	O
+	O
D2	O
lymphadenectomy	O
+	O
right	O
extended	O
colectomy	O
:	O
-	O
Invasive	O
ulcerated	O
moderately	O
differentiated	O
adenocarcinoma	O
,	O
Lauren	O
'	O
s	O
intestinal	O
type	O
.	O

-	O
Size	O
of	O
neoplasia	O
:	O
5	O
.	O
0x4	O
.	O
5x4	O
.	O
0	O
cm	O
.	O

-	O
Invasion	O
level	O
:	O
serosa	O
and	O
adjacent	O
fat	O
tissue	O
,	O
with	O
involvement	O
of	O
omentum	O
and	O
colon	O
.	O
to	O
submucosa	O
,	O
with	O
ulceration	O
of	O
mucosa	O
.	O

-	O
Blood	O
vessel	O
invasion	O
:	O
present	O
.	O

-	O
Lymphatic	O
invasion	O
:	O
present	O
.	O

-	O
Perineural	O
invasion	O
:	O
present	O
.	O

-	O
Adjacent	O
mucosa	O
:	O
inactive	O
discrete	O
chronic	O
gastritis	O
.	O

-	O
Surgical	O
margins	O
(	O
stomach	O
and	O
colon	O
)	O
:	O
uninvolved	O
by	O
neopalsia	O
.	O

-	O
Five	O
out	O
of	O
33	O
examined	O
perigastric	O
lymph	O
nodes	O
involved	O
by	O
neoplasia	O
(	O
5	O
/	O
33	O
)	O
,	O
with	O
.	O
capsular	O
invasion	O
,	O
without	O
conglomerate	O
formation	O
.	O

2	O
-	O
Perisplenic	O
omentum	O
:	O
-	O
Lymph	O
node	O
uninvolved	O
by	O
neoplasia	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
-	O
Transverse	O
mesocolon	O
lymph	O
node	O
:	O
-	O
Uninvolved	O
by	O
neoplasia	O
(	O
0	O
/	O
3	O
)	O
.	O

4	O
-	O
Esophageal	O
margin	O
:	O
-	O
Uninvolved	O
by	O
neoplasia	O
.	O

5	O
-	O
Lymph	O
nodes	O
following	O
standardization	O
:	O
-	O
-	O
Five	O
lymph	O
nodes	O
uninvolved	O
by	O
neoplasia	O
(	O
0	O
/	O
5	O
)	O
,	O
distributed	O
as	O
follows	O
:	O
-	O
Chain	O
8	O
-	O
-	O
anterior	O
hepatic	O
artery	O
(	O
8a	O
)	O
:	O
0	O
/	O
1	O
.	O

-	O
-	O
Chain	O
11	O
-	O
proximal	O
splenic	O
artery	O
(	O
11p	O
)	O
:	O
0	O
/	O
3	O
.	O

-	O
Chain	O
12	O
-	O
hepatoduodenal	O
ligament	O
(	O
12a	O
)	O
:	O
0	O
/	O
1	O
.	O
"	O
.	O

THIS	O
IS	O
A	O
CONFIDENTIAL	O
AND	O
PRIVILEGED	O
COMMUNICATION	O
.	O

PLEASE	O
DISPOSE	O
OF	O
PAPER	O
COPIES	O
APPROPRIATELY	O
.	O

Test	O
Name	O
:	O
RIGHT	O
RIB	O
8	O
{	O
PLEURA	O
,	O
RIGHT	O
{	O
DIAPHRAGMATIC	O
PLEURA	O
,	O
.	O

RIGHT	O
{	O
RIGHT	O
LOWER	O
LOBE	O
NODULE	O
1	O
{	O
RT	O
.	O

MIDDLE	O
LOBE	O
NODULE	O
.	O

Test	O
Date	O
:	O
{	O
LEVEL	O
4	O
LYMPH	O
NODE	O
,	O
RIGHT	O
{	O
LEVEL	O
9	O
LYMPH	O
NODE	O
,	O
RIGHT	O
{	O
LEVEL	O
7	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
{	O
THORACOSCOPY	O
,	O
PORT	O
SITE	O
1	O
,	O
RIGHT	O
.	O

(	O
THORACOSCOPY	O
,	O
PORT	O
SITE	O
2	O
,	O
RIGHT	O
.	O

SPECIMEN	O
NUMBER	O
:	O
SPECIMENS	O
:	O
1	O
.	O

RIGHT	O
RIB	O
8	O
.	O

2	O
.	O

PLEURA	O
,	O
RIGHT	O
.	O

3	O
.	O

DIAPHRAGMATIC	O
PLEURA	O
,	O
RIGHT	O
.	O

4	O
.	O

RIGHT	O
LOWER	O
LOBE	O
NODULE	O
1	O
.	O

5	O
.	O

RT	O
.	O

MIDDLE	O
LOBE	O
NODULE	O
.	O

6	O
.	O

LEVEL	O
4	O
LYMPH	O
NODE	O
,	O
RIGHT	O
.	O

7	O
.	O

LEVEL	O
9	O
LYMPH	O
NODE	O
,	O
RIGHT	O
.	O

8	O
.	O

LEVEL	O
7	O
LYMPH	O
NODE	O
,	O
RIGHT	O
.	O

9	O
.	O

THORACOSCOPY	O
,	O
PORT	O
SITE	O
1	O
,	O
RIGHT	O
.	O

10	O
.	O

THORACOSCOPY	O
,	O
PORT	O
SITE	O
2	O
,	O
RIGHT	O
.	O

11	O
.	O

AZYGOUS	O
VEIN	O
,	O
RIGHT	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

RIB	O
#	O
8	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
BONE	O
AND	O
BONE	O
MARROW	O
WITH	O
TRILINEAGE	O
MATURATION	O
.	O

2	O
.	O

PLEURA	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
MALIGNANT	O
MESOTHELIOMA	O
,	O
EPITHELIOD	O
TYPE	O
,	O
INFILTRATING	O
ADIPOSE	O
.	O

TISSUE	O
.	O

-	O
FOCAL	O
FOREIGN	O
BODY	O
GIANT	O
CELL	O
REACTION	O
AND	O
BIREFRINGENT	O
MATERIAL	O
.	O

SUGGESTIVE	O
OF	O
TALC	O
PLEURODESIS	O
.	O

3	O
.	O

DIAPHRAGMATIC	O
PLEURA	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
MALIGNANT	O
MESOTHELIOMA	O
,	O
EPITHELIOD	O
TYPE	O
,	O
INFILTRATING	O
ADIPOSE	O
.	O

TISSUE	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

4	O
.	O

LUNG	O
,	O
RIGHT	O
LOWER	O
LOBE	O
,	O
NODULE	O
#	O
1	O
:	O
WEDGE	O
RESECTION	O
.	O

-	O
MALIGNANT	O
MESOTHELIOMA	O
,	O
EPITHELIOD	O
TYPE	O
,	O
INVOLVING	O
LUNG	O
.	O

PARENCHYMA	O
.	O

-	O
PARENCHYMAL	O
MARGIN	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

SEE	O
NOTE	O
.	O

NOTE	O
:	O
Immunostains	O
on	O
part	O
4	O
(	O
right	O
lower	O
lobe	O
nodule	O
)	O
demonstrate	O
that	O
.	O
the	O
tumor	O
cells	O
are	O
positive	O
for	O
CK5	O
/	O
6	O
,	O
D2	O
-	O
40	O
,	O
WT	O
-	O
1	O
(	O
weak	O
,	O
focal	O
)	O
.	O
and	O
negative	O
for	O
TTF	O
-	O
1	O
.	O

The	O
stain	O
for	O
Calretinin	O
is	O
.	O
non	O
-	O
contributory	O
.	O

This	O
immunoprofile	O
supports	O
the	O
diagnosis	O
of	O
.	O
malignant	O
mesothelioma	O
.	O

5	O
.	O

LUNG	O
,	O
RIGHT	O
MIDDLE	O
LOBE	O
,	O
NODULE	O
:	O
WEDGE	O
RESECTION	O
.	O

-	O
MALIGNANT	O
MESOTHELIOMA	O
,	O
EPITHELIOD	O
TYPE	O
,	O
INVOLVING	O
LUNG	O
.	O

PARENCHYMA	O
.	O

-	O
PARENCHYMAL	O
MARGIN	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

6	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
4	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
FIVE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MESOTHELIOMA	O
(	O
0	O
/	O
5	O
)	O
.	O

7	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
9	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
MESOTHELIOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

8	O
.	O

LYMPH	O
NODE	O
,	O
LEVEL	O
7	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
THREE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MESOTHELIOMA	O
(	O
0	O
/	O
3	O
)	O
.	O

9	O
.	O

THORACOSCOPY	O
PORT	O
SITE	O
#	O
1	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
SKIN	O
WITH	O
MILD	O
DERMAL	O
FIBROSIS	O
.	O

10	O
.	O

THORACOSCOPY	O
PORT	O
SITE	O
#	O
2	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
SKIN	O
WITH	O
MILD	O
DERMAL	O
FIBROSIS	O
AND	O
LYMPHOHISTIOCYTIC	O
.	O

INFILTRATE	O
.	O

11	O
.	O

AZYGOUS	O
VEIN	O
,	O
RIGHT	O
:	O
EXCISION	O
.	O

-	O
VEIN	O
WITH	O
NO	O
SIGNIFICANT	O
ALTERATIONS	O
.	O

CLINICAL	O
HISTORY	O
AND	O
PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Mesothelioma	O
.	O

MACROSCOPIC	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
eleven	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
.	O

patient	O
'	O
s	O
name	O
.	O

1	O
.	O

Part	O
one	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
'	O
right	O
rib	O
#	O
8	O
'	O
.	O

It	O
.	O
consists	O
of	O
three	O
fragments	O
of	O
bone	O
ranging	O
from	O
4	O
to	O
8	O
.	O
2	O
cm	O
in	O
.	O
length	O
.	O

The	O
outer	O
surface	O
is	O
smooth	O
and	O
shows	O
scant	O
attached	O
.	O
fibromuscular	O
tissue	O
.	O

Sectioning	O
reveals	O
an	O
unremarkable	O
marrow	O
.	O

Representative	O
section	O
is	O
submitted	O
in	O
one	O
cassette	O
following	O
.	O
decalcification	O
.	O

2	O
.	O

Part	O
two	O
is	O
labeled	O
'	O
pleura	O
,	O
right	O
'	O
.	O

It	O
consists	O
of	O
three	O
.	O
irregular	O
fragments	O
of	O
pleural	O
tissue	O
measuring	O
31	O
X	O
19	O
X	O
1	O
cm	O
.	O

The	O
.	O
parietal	O
pleural	O
surface	O
shows	O
focal	O
adipose	O
tissue	O
.	O

The	O
wall	O
.	O
thickness	O
ranges	O
from	O
0	O
.	O
1	O
to	O
0	O
.	O
6	O
cm	O
.	O

Multiple	O
small	O
firm	O
nodules	O
.	O
are	O
noted	O
studded	O
on	O
the	O
pleural	O
surface	O
.	O

These	O
nodules	O
range	O
from	O
.	O

0	O
.	O
2	O
to	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
in	O
five	O
cassettes	O
.	O

3	O
.	O

Part	O
three	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
diaphragmatic	O
pleura	O
,	O
.	O

right	O
'	O
.	O

It	O
consists	O
of	O
pleural	O
tissue	O
fragments	O
ranging	O
14	O
x	O
10	O
X	O
.	O

1	O
.	O
5	O
cm	O
.	O

Focally	O
yellow	O
lobulated	O
adipose	O
tissue	O
is	O
attached	O
.	O

The	O
.	O
remainder	O
of	O
the	O
pleura	O
is	O
gray	O
-	O
purple	O
and	O
shows	O
multiple	O
thickened	O
.	O
nodular	O
areas	O
ranging	O
from	O
0	O
.	O
5	O
to	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

Cut	O
.	O
surface	O
of	O
these	O
nodules	O
is	O
white	O
,	O
firm	O
.	O

Representative	O
sections	O
of	O
.	O
these	O
nodules	O
are	O
submitted	O
in	O
four	O
cassettes	O
.	O

4	O
.	O

Part	O
four	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
right	O
lower	O
lobe	O
nodule	O
.	O

#	O
1	O
'	O
.	O

It	O
consists	O
of	O
a	O
wedge	O
of	O
lung	O
measuring	O
6	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
8	O
cm	O
.	O

The	O
staple	O
line	O
is	O
inked	O
.	O

The	O
pleural	O
surface	O
is	O
gray	O
-	O
purple	O
and	O
.	O
shows	O
a	O
well	O
-	O
defined	O
firm	O
tan	O
lesion	O
measuring	O
1	O
.	O
5	O
x	O
1	O
x	O
0	O
.	O
4	O
cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

5	O
.	O

Part	O
five	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
right	O
middle	O
lobe	O
.	O

nodule	O
'	O
.	O

It	O
consists	O
of	O
a	O
wedge	O
of	O
lung	O
measuring	O
4	O
.	O
2	O
x	O
1	O
.	O
8	O
x	O
0	O
.	O
5	O
.	O

cm	O
.	O

The	O
staple	O
line	O
is	O
inked	O
black	O
.	O

The	O
pleural	O
surface	O
is	O
.	O
gray	O
-	O
purple	O
and	O
shows	O
a	O
well	O
-	O
circumscribed	O
pleural	O
based	O
lesion	O
.	O
measuring	O
1	O
.	O
2	O
x	O
0	O
.	O
7	O
cm	O
.	O

Cut	O
surface	O
of	O
the	O
lesion	O
is	O
tan	O
and	O
.	O
extends	O
into	O
the	O
lung	O
parenchyma	O
.	O

The	O
lesion	O
is	O
0	O
.	O
7	O
cm	O
from	O
the	O
.	O
staple	O
margin	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

6	O
.	O

Part	O
six	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
4	O
lymph	O
node	O
,	O
.	O

right	O
'	O
.	O

It	O
consists	O
of	O
a	O
portion	O
of	O
fibrofatty	O
tissue	O
measuring	O
3	O
.	O
5	O
.	O

x	O
2	O
x	O
1	O
.	O
5	O
cm	O
.	O

Four	O
possible	O
gray	O
-	O
black	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
8	O
.	O
to	O
1	O
.	O
2	O
cm	O
are	O
noted	O
.	O

Entirely	O
submitted	O
in	O
two	O
cassettes	O
.	O

7	O
.	O

Part	O
seven	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
9	O
lymph	O
node	O
,	O
.	O

right	O
'	O
.	O

It	O
consists	O
of	O
a	O
single	O
fragment	O
of	O
tan	O
-	O
brown	O
firm	O
tissue	O
.	O
measuring	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
.	O

Totally	O
submitted	O
in	O
one	O
cassette	O
.	O

8	O
.	O

Part	O
eight	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
level	O
7	O
lymph	O
node	O
,	O
.	O

right	O
'	O
.	O

It	O
consists	O
of	O
two	O
fragments	O
of	O
tissue	O
composed	O
of	O
group	O
of	O
.	O
gray	O
-	O
black	O
lymph	O
nodes	O
measuring	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
and	O
3	O
x	O
1	O
x	O
0	O
.	O
4	O
.	O

cm	O
.	O

The	O
entire	O
specimen	O
is	O
submitted	O
in	O
two	O
cassettes	O
.	O

9	O
.	O

Part	O
nine	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
"	O
thoracoscopy	O
port	O
site	O
.	O

#	O
1	O
,	O
right	O
'	O
.	O

It	O
consists	O
of	O
an	O
ellipse	O
of	O
skin	O
measuring	O
2	O
.	O
2	O
x	O
0	O
.	O
5	O
.	O

cm	O
,	O
excised	O
to	O
a	O
depth	O
of	O
0	O
.	O
5	O
cm	O
.	O

The	O
skin	O
'	O
s	O
surface	O
is	O
tan	O
-	O
white	O
.	O
and	O
shows	O
a	O
linear	O
scar	O
measuring	O
1	O
.	O
3	O
cm	O
in	O
length	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
one	O
cassette	O
.	O

10	O
.	O

Part	O
ten	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
thoracoscopy	O
port	O
site	O
.	O

#	O
2	O
,	O
right	O
'	O
It	O
consists	O
of	O
an	O
ellipse	O
of	O
skin	O
measuring	O
2	O
.	O
5	O
x	O
0	O
.	O
5	O
.	O

cm	O
,	O
excised	O
to	O
a	O
depth	O
of	O
1	O
.	O
5	O
cm	O
.	O

The	O
skin	O
'	O
s	O
surface	O
is	O
tan	O
-	O
pink	O
.	O
and	O
shows	O
a	O
linear	O
scar	O
measuring	O
1	O
.	O
5	O
cm	O
in	O
length	O
.	O

The	O
underlying	O
.	O
soft	O
tissue	O
appears	O
unremarkable	O
.	O

Representative	O
section	O
is	O
.	O
submitted	O
in	O
one	O
cassette	O
.	O

11	O
.	O

Part	O
eleven	O
is	O
received	O
in	O
saline	O
,	O
labeled	O
'	O
right	O
azygous	O
vein	O
'	O
.	O

It	O
consists	O
of	O
a	O
segment	O
of	O
vein	O
measuring	O
1	O
.	O
7	O
cm	O
in	O
length	O
and	O
0	O
.	O
6	O
.	O

cm	O
in	O
diameter	O
.	O

The	O
outer	O
surface	O
is	O
tan	O
-	O
pink	O
and	O
unremarkable	O
.	O

Representative	O
section	O
is	O
submitted	O
in	O
one	O
cassette	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
:	O
1A	O
representative	O
.	O

2A	O
-	O
2E	O
representative	O
.	O

3A	O
-	O
3D	O
representative	O
.	O

4A	O
-	O
4B	O
entire	O
firm	O
lesion	O
.	O

4C	O
unremarkable	O
lung	O
.	O

4D	O
stapled	O
margin	O
.	O

5A	O
-	O
5B	O
entire	O
lesion	O
.	O

5C	O
uninvolved	O
lung	O
.	O

5D	O
stapled	O
margin	O
.	O

6A	O
two	O
lymph	O
nodes	O
.	O

6B	O
two	O
lymph	O
nodes	O
.	O

7A	O
in	O
toto	O
.	O

8A	O
-	O
8B	O
in	O
toto	O
.	O

9A	O
representative	O
.	O

10A	O
representative	O
.	O

11A	O
representative	O
.	O

SPECIAL	O
PROCEDURES	O
:	O
Decalcification	O
.	O

Final	O
Diagnosis	O
performed	O
by	O
.	O

The	O
electronic	O
signature	O
attests	O
that	O
the	O
named	O
Attending	O
.	O

Pathologist	O
has	O
evaluated	O
the	O
specimen	O
referred	O
to	O
in	O
the	O
signed	O
.	O
section	O
of	O
the	O
report	O
and	O
formulated	O
the	O
diagnosis	O
therein	O
.	O

This	O
report	O
may	O
include	O
one	O
or	O
more	O
immunohistochemical	O
stain	O
.	O
results	O
that	O
use	O
analyte	O
specific	O
reagents	O
.	O

The	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
.	O
determined	O
by	O
.	O

They	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
or	O
approval	O
is	O
not	O
.	O
necessary	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
with	O
left	O
thigh	O
sarcoma	O
,	O
status	O
post	O
excisional	O
biopay	O
here	O
.	O
for	O
re	O
-	O
excision	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Posterior	O
left	O
thigh	O
sarcoma	O
.	O

2	O
:	O
SP	O
:	O
Posterior	O
and	O
lateral	O
nodule	O
left	O
thigh	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SOFT	O
TISSUE	O
,	O
LEFT	O
POSTERIOR	O
THIGH	O
;	O
RESECTION	O
:	O
-	O
HIGH	O
GRADE	O
MALIGNANT	O
FIBROUS	O
HISTIOCYTOMA	O
,	O
STORIFORM	O
AND	O
PLEOMORPHIC	O
TYPE	O
,	O
.	O

INVOVLING	O
SUBCUTANEOUS	O
FIBROADIPOSE	O
TISSUE	O
AND	O
EXTENDING	O
TO	O
DERMIS	O
.	O

TUMOR	O
DIMENSIONS	O
:	O
6	B
x	I
4	I
.	I
5	I
x	I
3	I
CM	I
.	O

-	O
GROSSLY	O
THE	O
TUMOR	O
APPEARS	O
TO	O
HAVE	O
\	O
R	O
\	O
30	O
%	O
NECROSIS	O
.	O

-	O
PREVIOUS	O
PROCEDURE	O
RELATED	O
CHANGES	O
.	O

-	O
SURGICAL	O
MARGINS	O
ARE	O
NEGATIVE	O
.	O

2	O
.	O

SOFT	O
TISSUE	O
,	O
LEFT	O
POSTERIOR	O
AND	O
LATERAL	O
THIGH	O
;	O
EXICSION	O
:	O
-	O
LOBULATED	O
ADIPOSE	O
TISSUE	O
CONSISTENT	O
WITH	O
LIPOMA	O
.	O

-	O
TUMOR	O
DIMENSIONS	O
:	O
6	B
x	I
4	I
x	I
2	I
CM	I
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
posterior	O
left	O
thigh	O
sarcoma	O
,	O
1	O
.	O
stitch	O
proximal	O
/	O
lateral	O
,	O
2	O
stitches	O
distal	O
/	O
medial	O
and	O
consists	O
of	O
an	O
.	O
oriented	O
piece	O
of	O
skin	O
and	O
soft	O
tissue	O
measuring	O
15	O
.	O
6	O
x	O
10	O
x	O
4	O
cm	O
in	O
overall	O
.	O
dimensions	O
.	O

There	O
is	O
an	O
overlying	O
tan	O
-	O
beige	O
skin	O
ellipse	O
measuring15	O
.	O
3	O
x	O
2	O
.	O
9	O
.	O

cm	O
with	O
a	O
centrally	O
located	O
sutured	O
scar	O
area	O
measuring	O
4	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
.	O

is	O
inked	O
as	O
follows	O
:	O
Proximal	O
yellow	O
,	O
distal	O
blue	O
,	O
lateral	O
orange	O
,	O
medial	O
.	O
red	O
,	O
anterior	O
green	O
and	O
deep	O
black	O
.	O

The	O
specimen	O
is	O
bisected	O
along	O
its	O
.	O
longitudinal	O
axis	O
to	O
reveal	O
a	O
well	O
circumscribed	O
,	O
unencapsulated	O
tan	O
-	O
grey	O
.	O
hemorrhagic	O
mass	O
measuring	O
6	O
x	O
4	O
.	O
5	O
x	O
3	O
cm	O
.	O

Grossly	O
the	O
tumor	O
appears	O
\	O
RI	O
30	O
%	O
.	O
necrotic	O
.	O

The	O
masa	O
is	O
located	O
the	O
following	O
distances	O
from	O
the	O
respective	O
.	O
margins	O
:	O
0	O
.	O
3	O
cm	O
from	O
anteior	O
/	O
skin	O
,	O
0	O
.	O
5	O
cm	O
from	O
deep	O
,	O
6	O
cm	O
from	O
proximal	O
,	O
7	O
.	O

cm	O
from	O
distal	O
,	O
1	O
.	O
5	O
cm	O
from	O
medial	O
and	O
3	O
cm	O
from	O
lateral	O
.	O

Photographs	O
are	O
.	O
taken	O
and	O
a	O
portion	O
of	O
the	O
tumor	O
is	O
submitted	O
for	O
TPS	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
PM	O
proximal	O
margin	O
.	O

DM	O
distal	O
margin	O
.	O

LM	O
lateral	O
margin	O
.	O

MMT	O
medial	O
margin	O
with	O
tumor	O
.	O

DMT	O
deep	O
margin	O
with	O
tumor	O
.	O

SKT	O
skin	O
with	O
tumor	O
.	O

T	O
tumor	O
.	O

2	O
.	O
)	O
The	O
specimen	O
is	O
in	O
formalin	O
,	O
labeled	O
"	O
posterior	O
and	O
lateral	O
nodule	O
left	O
.	O

thigh	O
"	O
and	O
consists	O
of	O
an	O
unoriented	O
piece	O
of	O
fatty	O
tissue	O
measuring	O
6	O
x	O
4	O
x	O
.	O

2	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
inked	O
black	O
and	O
serially	O
sectioned	O
to	O
reveal	O
.	O

a	O
homogenous	O
yellow	O
fatty	O
cut	O
surface	O
with	O
no	O
gross	O
lesions	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
U	O
-	O
undesignated	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Posterior	O
left	O
thigh	O
sarcoma	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

AMT	O
.	O

1	O
.	O

1	O
.	O

DM	O
.	O

1	O
.	O

1	O
.	O

DMT	O
.	O

1	O
.	O

1	O
.	O

LM	O
.	O

1	O
.	O

1	O
.	O

PM	O
.	O

1	O
.	O

1	O
.	O

SKT	O
.	O

1	O
.	O

4	O
.	O

T	O
.	O

4	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Posterior	O
and	O
lateral	O
nodule	O
left	O
thigh	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

4	O
.	O

U	O
.	O

4	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Papillary	O
carcinoma	O
of	O
right	O
tracheal	O
right	O
FNA	O
and	O
(	O
+	O
)	O
for	O
papillary	O
.	O

Right	O
thyroid	O
nodule	O
.	O

Rule	O
out	O
malignancy	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Right	O
thyroid	O
and	O
isthmus	O
,	O
right	O
hemithyroidectomy	O
.	O

2	O
:	O
Left	O
thyroid	O
and	O
isthmus	O
,	O
left	O
hemithyroidectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Right	O
thyroid	O
and	O
isthmus	O
,	O
right	O
hemithyroidectomy	O
:	O
Part	O
#	O
1	O
.	O

Tumor	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
classical	O
type	O
.	O

Histologic	O
Grade	O
:	O
Well	O
differentiated	O
.	O

Mitotic	O
Activity	O
:	O
Not	O
identified	O
.	O

Tumor	O
Necrosis	O
:	O
Not	O
identified	O
.	O

Other	O
Tumor	O
Features	O
:	O
Psammoma	O
bodies	O
.	O

Tumor	O
Location	O
:	O
Right	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
3	B
.	I
0	I
cm	I
.	O

Tumor	O
Encapsulation	O
:	O
PartIally	O
surrounded	O
.	O

Blood	O
Vessel	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroid	O
Extension	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Tumor	O
Multicentricity	O
:	O
Not	O
identified	O
.	O

Adenoma	O
(	O
s	O
)	O
(	O
away	O
from	O
the	O
carcinoma	O
)	O
:	O
Not	O
Identified	O
.	O

Non	O
-	O
Neoplastic	O
Thyroid	O
:	O
exhibits	O
chronic	O
inflammation	O
.	O

Parathyrold	O
Glands	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
One	O
benign	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

2	O
.	O

Left	O
thyroid	O
and	O
isthmus	O
,	O
left	O
hemithyroidectomy	O
:	O
-	O
Nodular	O
hyperplasia	O
.	O

-	O
No	O
parathyroid	O
gland	O
identified	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

Gross	O
Description	O
:	O
1	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
right	O
thyroid	O
and	O
isthmus	O
"	O
.	O

It	O
consists	O
of	O
a	O
thyroid	O
lobe	O
measuring	O
5	O
x	O
3	O
x	O
1	O
.	O
5	O
cm	O
.	O

(	O
right	O
lobe	O
)	O
with	O
isthmus	O
(	O
1	O
.	O
2	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
)	O
and	O
weighing	O
16	O
.	O
5	O
g	O
.	O

The	O
specimen	O
is	O
oriented	O
by	O
a	O
long	O
stitch	O
designating	O
the	O
upper	O
.	O
pole	O
and	O
a	O
short	O
stitch	O
designating	O
the	O
isthmus	O
.	O

The	O
specimen	O
is	O
inked	O
as	O
follows	O
:	O
anterior	O
-	O
blue	O
and	O
posterior	O
-	O
black	O
.	O

The	O
specimen	O
.	O

is	O
serially	O
sectioned	O
revealing	O
a	O
well	O
-	O
circumscribed	O
,	O
well	O
encapsulated	O
nodule	O
with	O
focal	O
areas	O
of	O
necrosis	O
situated	O
in	O
the	O
right	O
lobe	O
.	O
extending	O
from	O
the	O
upper	O
to	O
the	O
mid	O
-	O
portion	O
of	O
the	O
lobe	O
.	O

The	O
nodule	O
measures	O
3	O
.	O
0	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
.	O
submitted	O
.	O

A	O
representative	O
portion	O
of	O
the	O
nodule	O
has	O
been	O
submitted	O
for	O
TPS	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
-	O
nodule	O
.	O

RL	O
-	O
right	O
lobe	O
.	O

I	O
isthmus	O
.	O

2	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
left	O
thyroid	O
and	O
isthmus	O
"	O
.	O

It	O
consists	O
of	O
a	O
thyroid	O
lobe	O
measuring	O
4	O
x	O
2	O
x	O
0	O
.	O
8	O
cm	O
.	O

(	O
left	O
lobe	O
)	O
with	O
isthmus	O
(	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
)	O
and	O
welghing	O
5	O
g	O
.	O

The	O
specimen	O
is	O
oriented	O
by	O
a	O
long	O
stitch	O
designating	O
the	O
upper	O
pole	O
.	O
and	O
a	O
short	O
stitch	O
designating	O
the	O
isthmus	O
.	O

The	O
specimen	O
Is	O
inked	O
as	O
follows	O
:	O
anterior	O
-	O
blue	O
and	O
posterior	O
-	O
black	O
.	O

The	O
specimen	O
is	O
.	O
serially	O
sectioned	O
revealing	O
a	O
tan	O
/	O
red	O
unremarkable	O
cut	O
-	O
surface	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LL	O
left	O
lobe	O
.	O

/	O
-	O
isthmus	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Right	O
thyroid	O
and	O
isthmus	O
,	O
right	O
hemithyroidectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

1	O
.	O

10	O
.	O

N	O
.	O

10	O
.	O

2	O
.	O

RL	O
.	O

2	O
.	O

Part	O
2	O
:	O
Left	O
thyrold	O
and	O
isthmus	O
,	O
left	O
hemithyroldectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

1	O
.	O

4	O
.	O

LL	O
.	O

4	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

1	O
.	O

THYROID	O
(	O
THYROIDECTOMY	O
)	O
.	O

SPECIMEN	O
TYPE	O
:	O
Total	O
thyroidectomy	O
.	O

TUMOR	O
SITE	O
:	O
Left	O
lobe	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Papillary	O
carcinoma	O
with	O
focal	O
tall	O
cell	O
features	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
0	I
cm	I
.	O

FOCALITY	O
:	O
Unifocal	O
.	O

LYMPH	O
NODES	O
:	O
Metastatic	O
carcinoma	O
in	O
2	O
of	O
12	O
nodes	O
(	O
includes	O
all	O
parts	O
)	O
.	O

EXTENT	O
OF	O
INVASION	O
.	O

PRIMARY	O
TUMOR	O
:	O
pT3	O
:	O
Minimal	O
extrathyroidal	O
.	O
extension	O
into	O
left	O
inferior	O
pole	O
parathyroid	O
gland	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
pN1b	O
:	O
Nodal	O
metastasis	O
to	O
cervical	O
nodes	O
.	O

MARGINS	O
:	O
Involved	O
by	O
invasive	O
carcinoma	O
(	O
posterior	O
surgical	O
margin	O
)	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
INVASION	O
:	O
Present	O
.	O

2	O
.	O

LEFT	O
LEVEL	O
III	O
,	O
IV	O
,	O
AND	O
V	O
(	O
MODIFIED	O
RADICAL	O
NECK	O
DISSECTION	O
)	O
:	O
METASTATIC	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
PRESENT	O
IN	O
ONE	O
OF	O
six	O
(	O
1	O
.	O
OF	O
6	O
)	O
LYMPH	O
NODES	O
(	O
0	O
.	O
9	O
CM	O
)	O
.	O

EXTRANODAL	O
EXTENSION	O
IS	O
PRESENT	O
.	O

NOTE	O
:	O
The	O
carcinoma	O
involves	O
an	O
adjacent	O
parathyroid	O
gland	O
(	O
left	O
inferior	O
pole	O
)	O
.	O

PART	O
#	O
1	O
:	O
TOTAL	O
THYROID	O
AND	O
CENTRAL	O
WEDGE	O
DISSECTION	O
.	O

Dictated	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
xxxx	O
and	O
is	O
designated	O
.	O

'	O
total	O
thyroid	O
and	O
central	O
neck	O
dissection	O
'	O
.	O

The	O
specimen	O
has	O
been	O
previously	O
oriented	O
.	O
with	O
a	O
stitch	O
marking	O
the	O
left	O
tumor	O
.	O

The	O
total	O
thyroid	O
weighs	O
18	O
.	O
7	O
gm	O
and	O
measures	O
7	O
.	O
0	O
x	O
.	O

5	O
.	O
5	O
x	O
2	O
.	O
9	O
cm	O
The	O
left	O
lobe	O
measures	O
4	O
.	O
0	O
x	O
3	O
.	O
0	O
x	O
2	O
.	O
9	O
cm	O
and	O
the	O
right	O
lobe	O
measures	O
4	O
.	O
0	O
x	O
.	O

3	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
anterior	O
aspect	O
of	O
the	O
specimen	O
is	O
inked	O
orange	O
,	O
while	O
the	O
posterior	O
.	O
aspect	O
of	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
reveal	O
a	O
lesion	O
in	O
the	O
left	O
.	O
lobe	O
measuring	O
3	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
that	O
is	O
harvested	O
by	O
the	O
tissue	O
bank	O
.	O

This	O
mass	O
has	O
a	O
.	O
homogeneous	O
,	O
yellow	O
,	O
firm	O
,	O
gelatinous	O
cut	O
surface	O
and	O
measures	O
.	O
cut	O
off	O
.	O

There	O
.	O

is	O
an	O
attached	O
portion	O
of	O
yellow	O
,	O
fibrofatty	O
tissue	O
along	O
the	O
left	O
inferior	O
thyroid	O
pole	O
.	O
which	O
measures	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
.	O

An	O
attempt	O
is	O
made	O
to	O
search	O
for	O
lymph	O
nodes	O
.	O

Three	O
possible	O
lymph	O
nodes	O
are	O
identified	O
.	O

SUMMARY	O
OF	O
SECTIONS	O
.	O

1	O
A	O
1	O
.	O

(	O
RIGHT	O
SUPERIOR	O
LOBE	O
)	O
.	O

1	O
B	O
1	O
.	O

(	O
RIGHT	O
MIDDLE	O
LOBE	O
)	O
.	O

1	O
C	O
1	O
.	O

(	O
RIGHT	O
INFERIOR	O
LOBE	O
)	O
.	O

1	O
D	O
-	O
1	O
.	O

(	O
LEFT	O
SUPERIOR	O
LOBE	O
)	O
.	O

1	O
E	O
1	O
.	O

(	O
LEFT	O
MIDDLE	O
LOBE	O
)	O
.	O

1	O
F	O
-	O
1	O
.	O

(	O
LEFT	O
INFERIOR	O
LOBE	O
)	O
.	O

1	O
G	O
1	O
.	O

(	O
ISTHMUS	O
)	O
.	O

2	O
-	O
H	O
,	O
I	O
-	O
1	O
EACH	O
(	O
TUMOR	O
)	O
.	O

1	O
J	O
-	O
1	O
.	O

(	O
TUMOR	O
IN	O
RELATION	O
TO	O
NORMAL	O
)	O
.	O

1	O
-	O
K	O
-	O
MULTIPLE	O
(	O
LN	O
CANDIDATES	O
)	O
.	O

1	O
-	O
L	O
-	O
MULTIPLE	O
(	O
REMAINDER	O
OF	O
SOFT	O
TISSUE	O
)	O
.	O

12	O
-	O
TOTAL	O
-	O
M	O
.	O

Neuropathology	O
.	O

Commentary	O
:	O
Histology	O
and	O
morphology	O
corresponds	O
to	O
astrocytoma	O
WHO	O
grade	O
II	O
.	O

Diagnosis	O
:	O
Astrocvtoma	O
WHO	O
grade	O
II	O
.	O

Sex	O
:	O
Female	O
.	O

MRN	O
#	O
:	O
Ref	O
Phy	O
.	O

SPECIMEN	O
INFORMATION	O
.	O

Acct	O
/	O
Reg	O
#	O
:	O
DIAGNOSIS	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

Right	O
ovary	O
and	O
fallopian	O
tube	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O
Ovary	O
and	O
fallopian	O
tube	O
without	O
significant	O
pathologic	O
abnormality	O
.	O

B	O
.	O

Left	O
ovary	O
and	O
fallopian	O
tube	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O
Ovarian	O
tissue	O
without	O
significant	O
pathologic	O
abnormality	O
.	O

Fallopian	O
tube	O
tissue	O
not	O
identified	O
.	O

C	O
.	O

Uterus	O
,	O
hysterectomy	O
:	O
Tumor	O
Characteristics	O
:	O
1	O
.	O

Histologic	O
type	O
:	O
Papillary	O
serous	O
carcinoma	O
.	O

2	O
.	O

Histologic	O
grade	O
:	O
High	O
grade	O
.	O

3	O
.	O

Tumor	O
site	O
:	O
Endometrium	O
.	O

4	O
.	O

Tumor	O
size	O
:	O
3	B
.	I
2x27cm	I
.	O

5	O
.	O

Myometrial	O
invasion	O
:	O
Tumor	O
extends	O
0	O
.	O
6	O
cm	O
into	O
a	O
1	O
.	O
4	O
cm	O
thick	O
myometrium	O
,	O
as	O
measured	O
microscopically	O
(	O
less	O
than	O
one	O
-	O
half	O
)	O
.	O

6	O
.	O
involvement	O
of	O
cervix	O
:	O
Tumor	O
focally	O
present	O
within	O
endocervical	O
mucosa	O
,	O
as	O
well	O
as	O
within	O
stromal	O
tissue	O
.	O

7	O
.	O

Extent	O
of	O
involvement	O
of	O
other	O
organs	O
:	O
Not	O
identified	O
.	O

8	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
Not	O
identified	O
.	O

Surgical	O
Margin	O
Status	O
:	O
1	O
.	O

Margins	O
uninvolved	O
:	O
Cervix	O
,	O
serosa	O
,	O
bilateral	O
parametria	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O

See	O
below	O
.	O

Other	O
:	O
1	O
.	O

pTNM	O
stage	O
:	O
pT2	O
,	O
NO	O
(	O
FIGO	O
:	O
ii	O
)	O
.	O

D	O
.	O

Right	O
external	O
iliac	O
lymph	O
nodes	O
,	O
excision	O
:	O
Three	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

E	O
.	O

Right	O
obturator	O
lymph	O
nodes	O
,	O
excision	O
.	O

Eight	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

F	O
.	O

Right	O
lower	O
periaortic	O
and	O
common	O
lymph	O
nodes	O
,	O
excision	O
:	O
Six	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

G	O
.	O

Left	O
external	O
iffac	O
tymph	O
nodes	O
,	O
excrsion	O
:	O
Two	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

H	O
.	O

Left	O
obturator	O
lymph	O
nodes	O
,	O
excision	O
.	O

Seven	O
lymph	O
nodes	O
,	O
negative	O
for	O
metastatic	O
disease	O
.	O

I	O
Left	O
lower	O
periaortic	O
and	O
common	O
!	O
ymph	O
nodes	O
,	O
excision	O
:	O
Seven	O
lymph	O
nodes	O
.	O
negative	O
for	O
metastatic	O
diseas	O
-	O
.	O

J	O
.	O

Omentum	O
.	O

Negative	O
for	O
malignancy	O
.	O

CLINICAL	O
INFORMATION	O
.	O

CLINICAL	O
HISTORY	O
:	O
Preoperative	O
Diagnosis	O
:	O
Serous	O
carcinoma	O
of	O
the	O
endometrium	O
.	O

Postoperative	O
Diagnosis	O
:	O
Symptoms	O
/	O
Radiologic	O
Findings	O
:	O
SPECIMENS	O
:	O
A	O
.	O

Right	O
ovary	O
and	O
hibe	O
.	O

B	O
.	O

Left	O
ovary	O
and	O
tube	O
.	O

C	O
.	O

Uterus	O
and	O
cervix	O
.	O

D	O
.	O

Right	O
external	O
illac	O
.	O

E	O
.	O

Right	O
obturator	O
.	O

F	O
.	O

Right	O
lower	O
periaortic	O
and	O
common	O
.	O

G	O
.	O

Left	O
external	O
iliad	O
.	O

H	O
.	O

Left	O
obturator	O
.	O

1	O
.	O

Left	O
lower	O
periaortic	O
and	O
common	O
.	O

J	O
.	O

Omentum	O
.	O

SPECIMEN	O
DATA	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
.	O
jht	O
ovary	O
and	O
tube	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
ovary	O
with	O
attached	O
fallopian	O
tube	O
.	O

The	O
ovary	O
.	O
measures	O
2	O
.	O
2	O
x	O
0	O
,	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
surface	O
IS	O
yellow	O
to	O
gray	O
-	O
tan	O
.	O

On	O
sectioning	O
,	O
the	O
cut	O
surface	O
is	O
yellow	O
-	O
gray	O
and	O
reveals	O
corpus	O
albicans	O
measuring	O
up	O
.	O
to	O
0	O
.	O
5	O
cm	O
identified	O
.	O

There	O
are	O
no	O
lesions	O
grossly	O
identified	O
.	O

The	O
attached	O
fallopian	O
tube	O
measures	O
3	O
.	O
6	O
cm	O
in	O
length	O
and	O
0	O
.	O
2	O
cm	O
in	O
diameter	O
,	O
and	O
the	O
.	O
surface	O
is	O
gray	O
-	O
tan	O
.	O

On	O
sectioning	O
,	O
there	O
is	O
no	O
material	O
or	O
lesions	O
Identified	O
within	O
the	O
tumen	O
.	O

The	O
fallopian	O
tube	O
appears	O
grossly	O
unremarkable	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
labeled	O
.	O

3S	O
follows	O
:	O
ovary	O
in	O
total	O
-	O
-	O
1	O
-	O
2	O
;	O
representative	O
fattopian	O
tube	O
-	O
3	O
.	O

B	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
.	O
left	O
ovary	O
and	O
tube	O
.	O

The	O
specimen	O
consists	O
of	O
an	O
ovary	O
measuring	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
surface	O
is	O
.	O
gray	O
-	O
tan	O
.	O

On	O
sectioning	O
there	O
Is	O
corpus	O
albicans	O
identified	O
measuring	O
up	O
to	O
0	O
.	O
5	O
cm	O
.	O

There	O
are	O
no	O
lesions	O
grossly	O
identified	O
.	O

The	O
fallopian	O
tube	O
segment	O
is	O
.	O
not	O
grossly	O
identified	O
.	O

The	O
ovary	O
is	O
entirely	O
submitted	O
in	O
two	O
cassettes	O
labeled	O
.	O

81	O
-	O
2	O
.	O

C	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
.	O
terus	O
and	O
cervix	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
previously	O
bisected	O
uterus	O
with	O
attached	O
cervix	O
.	O

The	O
.	O
uterus	O
.	O

measures	O
.	O

4	O
.	O
5	O
.	O

x	O
.	O

4	O
.	O
5	O
.	O

x	O
.	O

3	O
.	O
2	O
.	O

cm	O
.	O
and	O
.	O

weighs	O
46	O
gm	O
.	O

The	O
serosal	O
surface	O
of	O
the	O
uterus	O
is	O
gray	O
to	O
brown	O
-	O
tan	O
.	O

Sections	O
from	O
the	O
parametrium	O
have	O
been	O
.	O
taken	O
.	O

The	O
cervix	O
measures	O
3	O
.	O
5	O
cm	O
in	O
length	O
and	O
2	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
exocervix	O
is	O
gray	O
-	O
tan	O
to	O
brown	O
-	O
tan	O
with	O
hemorrhage	O
.	O

The	O
endocervical	O
canal	O
is	O
.	O
light	O
tan	O
and	O
reveais	O
normal	O
mucosa	O
)	O
folds	O
.	O

There	O
are	O
no	O
lesions	O
identified	O
grossly	O
.	O

The	O
endometrial	O
cavity	O
measures	O
3	O
,	O
5	O
cm	O
in	O
length	O
and	O
3	O
.	O
5	O
cm	O
in	O
.	O
diameter	O
and	O
reveals	O
a	O
gray	O
-	O
tan	O
,	O
lobular	O
mass	O
measuring	O
3	O
.	O
2	O
x	O
2	O
.	O
7	O
cm	O
that	O
is	O
within	O
0	O
.	O
4	O
cm	O
of	O
the	O
lower	O
uterine	O
segment	O
.	O

On	O
sectioning	O
,	O
the	O
mass	O
.	O
extends	O
into	O
the	O
underlying	O
myometrium	O
approximately	O
0	O
.	O
7	O
cm	O
into	O
a	O
1	O
.	O
4	O
cm	O
thick	O
myometrium	O
.	O

The	O
myometrium	O
is	O
gray	O
-	O
tan	O
and	O
trabecufar	O
and	O
there	O
.	O
are	O
no	O
lesions	O
grossly	O
identified	O
Received	O
with	O
the	O
specimen	O
are	O
three	O
cassettes	O
,	O
one	O
green	O
.	O
one	O
yellow	O
and	O
one	O
blue	O
,	O
labeled	O
.	O
with	O
the	O
.	O
yellow	O
additionally	O
tabeled	O
-	O
16	O
,	O
the	O
green	O
additionally	O
labeled	O
-	O
17	O
,	O
and	O
the	O
blue	O
additionally	O
labeled	O
-	O
18	O
.	O

Representative	O
sections	O
are	O
suonated	O
in	O
.	O
cassettes	O
labeled	O
.	O
as	O
follows	O
:	O
anterior	O
cervix	O
-	O
1	O
;	O
posterior	O
cervix	O
-	O
2	O
;	O
full	O
thickness	O
sections	O
from	O
the	O
lesion	O
-	O
3	O
-	O
7	O
;	O
lower	O
uterine	O
segment	O
.	O

-	O
8	O
;	O
left	O
parametrium	O
-	O
9	O
;	O
rignt	O
parametrium	O
-	O
10	O
.	O

D	O
.	O

The	O
specimen	O
is	O
received	O
labelec	O
.	O

it	O
external	O
iliac	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
7	O
.	O
5	O
x	O
4	O
.	O
0	O
x	O
.	O

1	O
.	O
0	O
.	O

cm	O
.	O

Sectioning	O
.	O
reveals	O
.	O

three	O
.	O
probapie	O
.	O

lymph	O
nodes	O
that	O
measure	O
from	O
0	O
.	O
6	O
to	O
2	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O
in	O
casseltes	O
.	O

&	O
as	O
follows	O
:	O
one	O
probable	O
node	O
-	O
1	O
;	O
one	O
probable	O
bisected	O
-	O
2	O
-	O
3	O
;	O
one	O
probable	O
node	O
bisected	O
-	O
4	O
-	O
5	O
.	O

E	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
1	O
.	O
right	O
obturator	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
4	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
1	O
.	O
0	O
.	O

em	O
tectioning	O
reveais	O
eight	O
probable	O
lympn	O
nodes	O
that	O
measure	O
from	O
0	O
.	O
5	O
to	O
1	O
.	O
8	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
39067E	O
,	O
.	O

$	O
follows	O
:	O
one	O
probable	O
node	O
bisected	O
-	O
1	O
;	O
three	O
probable	O
nodes	O
-	O
2	O
;	O
one	O
probable	O
node	O
bisected	O
-	O
3	O
;	O
two	O
probable	O
nodes	O
-	O
4	O
;	O
one	O
probable	O
.	O
node	O
bisected	O
-	O
5	O
;	O
one	O
probable	O
lymph	O
node	O
bisected	O
-	O
6	O
.	O

F	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
.	O
ight	O
lower	O
periaortic	O
and	O
common	O
.	O

The	O
specimen	O
consists	O
of	O
portion	O
of	O
fibroadipose	O
tissue	O
,	O
3	O
.	O
5	O
x	O
2	O
.	O
0	O
.	O

x	O
0	O
.	O
6	O
cm	O
.	O

Sectioning	O
reveals	O
six	O
probable	O
lymph	O
nodes	O
that	O
measure	O
from	O
0	O
,	O
3	O
to	O
1	O
.	O
6	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
labeled	O
.	O
est	O
,	O
as	O
follows	O
:	O
three	O
probable	O
nodes	O
-	O
1	O
:	O
one	O
probable	O
lymph	O
node	O
,	O
bisected	O
-	O
2	O
;	O
one	O
probable	O
lymph	O
node	O
,	O
bisected	O
-	O
3	O
;	O
one	O
probable	O
lymph	O
.	O
usected	O
-	O
4	O
.	O

G	O
.	O

The	O
specimen	O
is	O
received	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
left	O
external	O
iliac	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
.	O
measuring	O
5	O
.	O
2	O
:	O
3	O
,	O
5x0	O
.	O
9	O
cm	O
.	O

Sectionina	O
ravaale	O
tun	O
tymph	O
nodes	O
that	O
measure	O
1	O
.	O
5	O
and	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
.	O
entirely	O
submitted	O
in	O
cassettes	O
labele	O
.	O
bllows	O
:	O
one	O
probable	O
node	O
bisected	O
-	O
1	O
;	O
one	O
probable	O
node	O
trisected	O
-	O
2	O
-	O
4	O
.	O

H	O
.	O

The	O
specimen	O
is	O
received	O
labelec	O
.	O

t	O
obturator	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
5	O
.	O
2	O
:	O
4	O
.	O
5	O
1	O
5	O
cm	O
.	O

Sectioning	O
reveals	O
seven	O
probable	O
lymph	O
nodes	O
that	O
measure	O
from	O
0	O
.	O
7	O
to	O
1	O
.	O
8	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
in	O
cassett	O
.	O

4	O
as	O
.	O
follows	O
:	O
one	O
probable	O
node	O
,	O
bisected	O
-	O
1	O
;	O
three	O
probable	O
nodes	O
-	O
2	O
;	O
one	O
probable	O
node	O
,	O
bisected	O
-	O
3	O
;	O
one	O
probable	O
fymph	O
,	O
bisecteu	O
-	O
4	O
.	O
one	O
probable	O
.	O
lymph	O
node	O
,	O
bisected	O
-	O
5	O
-	O
6	O
.	O

L	O
.	O

The	O
specimen	O
is	O
received	O
labelec	O
.	O

ft	O
lower	O
perlaortic	O
and	O
common	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
portion	O
of	O
fibroadipose	O
tissue	O
measuring	O
.	O

3	O
.	O
5	O
x	O
3	O
.	O
0	O
x	O
0	O
.	O
5	O
cm	O
.	O

Sectioning	O
reveais	O
seven	O
possible	O
lymph	O
nodes	O
that	O
measure	O
from	O
0	O
,	O
5	O
to	O
1	O
.	O
5	O
cm	O
.	O

The	O
lymph	O
nodes	O
are	O
entireiy	O
submitted	O
in	O
.	O
laheled	O
:	O
is	O
follows	O
:	O
two	O
probable	O
nodes	O
bisected	O
-	O
1	O
:	O
one	O
probable	O
Ivmph	O
node	O
.	O
bisected	O
-	O
3	O
two	O
probable	O
nodes	O
-	O
3	O
:	O
two	O
.	O
probable	O
nodes	O
-	O
4	O
.	O

J	O
The	O
apecimen	O
is	O
received	O
tabeled	O
.	O
intum	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
piece	O
of	O
yellow	O
-	O
tan	O
lobular	O
fibreadipose	O
omentum	O
tissue	O
that	O
.	O
measures	O
520x12	O
.	O
0x	O
1	O
.	O
5	O
cm	O
,	O
On	O
sectioning	O
.	O
there	O
are	O
no	O
nodules	O
arossiv	O
identified	O
Representative	O
sactions	O
are	O
submitted	O
in	O
four	O
cassettes	O
labeled	O
.	O

SPECIMEN	O
.	O

Right	O
kidney	O
.	O

CLINICAL	O
NOTES	O
.	O

Renal	O
mass	O
.	O

GROSS	O
DESCRIPTION	O
.	O

Received	O
fresh	O
for	O
tissue	O
procurement	O
labeled	O
"	O
right	O
.	O

kidney	O
"	O
is	O
a	O
1	O
,	O
005	O
gram	O
,	O
20	O
x	O
11	O
X	O
8	O
.	O
5	O
cm	O
right	O
kidney	O
.	O
with	O
.	O

attached	O
,	O
probe	O
-	O
patent	O
,	O
7	O
cm	O
ureter	O
averaging	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

An	O
abundant	O
amount	O
of	O
perirenal	O
adipose	O
tissue	O
is	O
present	O
which	O
is	O
.	O
received	O
predominantly	O
torn	O
from	O
the	O
kidney	O
proper	O
.	O

Multiple	O
.	O
stapled	O
vessels	O
are	O
at	O
the	O
hilum	O
.	O

No	O
adrenal	O
gland	O
appears	O
to	O
be	O
.	O
present	O
.	O

The	O
capsule	O
is	O
smooth	O
to	O
slightly	O
scabrous	O
delicate	O
.	O
tan	O
-	O
pink	O
and	O
strips	O
with	O
relative	O
ease	O
from	O
the	O
underlying	O
cortical	O
.	O
surface	O
.	O

On	O
sectioning	O
,	O
there	O
is	O
a	O
moderately	O
well	O
circumscribed	O
,	O
.	O
calcified	O
necrosed	O
11	B
.	I
8	I
x	I
10	I
.	I
5	I
x	I
8	I
.	I
5	I
cm	I
golden	O
brown	O
tumor	O
mass	O
.	O
which	O
occupies	O
the	O
inferior	O
pole	O
.	O

The	O
tumor	O
appears	O
to	O
extend	O
up	O
.	O

to	O
,	O
but	O
not	O
through	O
the	O
delicate	O
capsular	O
surface	O
.	O

The	O
.	O
aforementioned	O
calcified	O
region	O
of	O
the	O
specimen	O
appears	O
to	O
be	O
.	O
predominantly	O
central	O
.	O

The	O
renal	O
pelvis	O
is	O
flat	O
,	O
glistening	O
.	O
tan	O
-	O
white	O
.	O

The	O
uninvolved	O
renal	O
parenchyma	O
is	O
uniform	O
red	O
-	O
brown	O
.	O
with	O
a	O
moderately	O
well	O
defined	O
corticomedullary	O
junction	O
and	O
a	O
.	O
maximal	O
cortical	O
thickness	O
of	O
1	O
.	O
2	O
cm	O
.	O

No	O
additional	O
mass	O
lesions	O
.	O

or	O
.	O
abnormalities	O
are	O
identified	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
.	O
in	O
nine	O
blocks	O
as	O
labeled	O
.	O

RS	O
-	O
9	O
.	O

BLOCK	O
SUMMARY	O
1	O
-	O
Vascular	O
and	O
ureteral	O
margins	O
;	O
2	O
-	O
5	O
-	O
tumor	O
full	O
.	O
thickness	O
to	O
inked	O
capsular	O
surface	O
;	O
6	O
-	O
tumor	O
to	O
normal	O
.	O
parenchyma	O
;	O
.	O

7	O
-	O
renal	O
pelvis	O
;	O
8	O
,	O
9	O
-	O
random	O
normal	O
parenchyma	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Sections	O
show	O
a	O
mass	O
lesion	O
composed	O
of	O
nests	O
or	O
broad	O
of	O
.	O
large	O
polygonal	O
cells	O
with	O
abundant	O
cytoplasm	O
,	O
perinuclear	O
.	O
halos	O
,	O
and	O
distinct	O
cell	O
borders	O
.	O

Nuclei	O
are	O
bland	O
,	O
and	O
.	O
calcifications	O
are	O
easily	O
identifiable	O
.	O

Cytoplasm	O
stains	O
.	O
positively	O
.	O

colloidal	O
iron	O
.	O

Findings	O
are	O
consistent	O
with	O
renal	O
cell	O
.	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

Histologic	O
type	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

Histologic	O
grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
2	O
.	O

Primary	O
tumor	O
(	O
pT	O
)	O
:	O
pT2	O
(	O
size	O
11	B
.	I
8	I
cm	I
;	O
confined	O
to	O
kidney	O
)	O
.	O

Margins	O
of	O
resection	O
:	O
Negative	O
.	O

Regional	O
lymph	O
nodes	O
(	O
pN	O
)	O
:	O
None	O
submitted	O
.	O

Adrenal	O
gland	O
:	O
Not	O
submitted	O
.	O

Vascular	O
invasion	O
:	O
Negative	O
.	O

Non	O
-	O
neoplastic	O
kidney	O
Unremarkable	O
.	O

4	O
,	O
18	O
.	O

DIAGNOSIS	O
.	O

Kidney	O
,	O
right	O
,	O
nephrectomy	O
:	O
Renal	O
cell	O
carcinoma	O
,	O
chromophobe	O
type	O
.	O

Size	O
:	O
11	B
.	I
1	I
8	I
cm	I
in	O
greatest	O
dimension	O
(	O
inferior	O
pole	O
)	O
.	O

Margins	O
:	O
negative	O
.	O

Vascular	O
invasion	O
:	O
not	O
identified	O
.	O

Examination	O
:	O
Histopathological	O
examination	O
.	O

Material	O
:	O
Multiple	O
organ	O
resection	O
-	O
segment	O
of	O
the	O
large	O
intestine	O
.	O

Clinical	O
diagnosis	O
:	O
Sigmoid	O
colon	O
carcinoma	O
-	O
sigmoidektomia	O
.	O

Macroscopic	O
description	O
:	O
13	O
.	O
3	O
cm	O
length	O
of	O
the	O
large	O
intestine	O
with	O
a	O
segment	O
of	O
the	O
mesenterium	O
sized	O
15	O
x	O
10	O
x	O
2	O
.	O
5cm	O
.	O

Cauliflower	O
-	O
shaped	O
tumour	O
sized	O
5	B
.	I
9	I
x	I
4	I
.	I
9	I
x	I
1	I
.	I
3	I
cm	I
in	O
the	O
mucosa	O
.	O

The	O
lesion	O
surrounding	O
95	O
%	O
of	O
.	O
the	O
intestine	O
circumference	O
,	O
located	O
3	O
.	O
6cm	O
from	O
one	O
of	O
the	O
incision	O
lines	O
,	O
and	O
6	O
.	O
2	O
cm	O
from	O
the	O
.	O
opposite	O
one	O
.	O

Microscopic	O
description	O
:	O
Adenocarcinoma	O
tubulopapillare	O
(	O
G2	O
)	O
.	O

Infiltratio	O
carcinomatosa	O
telae	O
adiposae	O
pericolicae	O
.	O

Intestine	O
ends	O
free	O
of	O
neoplastic	O
lesions	O
.	O

Metastases	O
carcinomatosae	O
in	O
lymphonodo	O
(	O
No	O
I	O
/	O
VIII	O
)	O
.	O

Histopathological	O
diagnosis	O
:	O
Adenocarcinoma	O
tubulopapillare	O
coli	O
.	O

Metastases	O
carcinomatosae	O
in	O
lymphonodo	O
(	O
No	O
1	O
/	O
VIII	O
)	O
.	O

(	O
G2	O
,	O
Dukes	O
C	O
,	O
Astler	O
-	O
Coller	O
C2	O
,	O
pT3	O
,	O
pN1	O
)	O
.	O

/	O
F	O
.	O

Acct	O
#	O
:	O
M	O
.	O
D	O
.	O

Specimen	O
:	O
Sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

A	O
.	O
D	O
.	O

PREOPERATIVE	O
DIAGNOSIS	O
.	O

CANCER	O
OF	O
THE	O
RIGHT	O
BREAST	O
AND	O
AXILLARY	O
NODES	O
.	O

A	O
.	O

OPERATION	O
PERFORMED	O
.	O

DOCTOR	O
(	O
S	O
)	O
:	O
PROCEDURE	O
:	O
MASTECTOMY	O
MODIFIED	O
RADICAL	O
.	O

TISSUE	O
REMOVED	O
.	O

A	O
.	O

RIGHT	O
BREAST	O
.	O

B	O
.	O

RIGHT	O
AXILLARY	O
CONTENTS	O
.	O

GROSS	O
DESCRIPTION	O
.	O

RECEIVED	O
IN	O
2	O
PARTS	O
.	O

PART	O
A	O
RECEIVED	O
LABELED	O
.	O

RIGHT	O
BREAST	O
DOUBLE	O
BLACK	O
.	O

STITCH	O
12	O
O	O
'	O
CLOCK	O
AT	O
NIPPLE	O
IS	O
A	O
1	O
,	O
416	O
GRAM	O
MASTECTOMY	O
MEASURING	O
28	O
.	O
5	O
CM	O
.	O

FROM	O
MEDIAL	O
TO	O
LATERAL	O
,	O
26	O
.	O
5	O
CM	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
,	O
AND	O
UP	O
TO	O
6	O
.	O

CM	O
FROM	O
ANTERIOR	O
TO	O
POSTERIOR	O
.	O

A	O
SUTURE	O
DENOTES	O
12	O
O	O
'	O
CLOCK	O
.	O

THE	O
NIPPLE	O
.	O

IS	O
FLAT	O
WITH	O
THE	O
SURROUNDING	O
AREOLA	O
MEASURING	O
6	O
CM	O
IN	O
DIAMETER	O
.	O

IN	O
THE	O
.	O

UPPER	O
OUTER	O
QUADRANT	O
6	O
CM	O
FROM	O
THE	O
NIPPLE	O
THERE	O
IS	O
A	O
0	O
.	O
3	O
CM	O
ULCERATION	O
.	O

AT	O
THE	O
MOST	O
LATERAL	O
ELLIPTICAL	O
TIP	O
OF	O
THE	O
SKIN	O
IS	O
A	O
2ND	O
SMALL	O
ULCERATION	O
.	O

0	O
.	O
5	O
CM	O
IN	O
GREATEST	O
DIMENSION	O
.	O

THIS	O
IS	O
16	O
CM	O
FROM	O
THE	O
NIPPLE	O
.	O

THE	O
SKIN	O
.	O

ELLIPSE	O
MEASURES	O
25	O
.	O
6	O
x	O
11	O
.	O
5	O
CM	O
.	O

THERE	O
IS	O
A	O
PALPABLE	O
MASS	O
AT	O
12	O
.	O

O	O
'	O
CLOCK	O
.	O

"	O
MRM	O
"	O
IS	O
WRITTEN	O
ON	O
THE	O
SPECIMEN	O
AT	O
12	O
O	O
'	O
CLOCK	O
.	O

THE	O
ANTERIOR	O
.	O

MARGIN	O
IS	O
MARKED	O
BLUE	O
AND	O
THE	O
DEEP	O
IS	O
MARKED	O
BLACK	O
.	O

SECTIONING	O
REVEALS	O
.	O

THE	O
MAJORITY	O
OF	O
THE	O
BREAST	O
TO	O
CONSIST	O
OF	O
BLAND	O
YELLOW	O
FATTY	O
TISSUE	O
WITH	O
.	O

FINE	O
FIBROUS	O
BANDS	O
.	O

THERE	O
ARE	O
BROADER	O
AREAS	O
OF	O
FIBROSIS	O
IN	O
THE	O
MORE	O
.	O

CENTRAL	O
ASPECT	O
OF	O
THE	O
SPECIMEN	O
.	O

IN	O
THE	O
12	O
-	O
1	O
O	O
'	O
CLOCK	O
AREA	O
THERE	O
IS	O
A	O
.	O

FIRM	O
GRAY	O
-	O
TAN	O
MASS	O
WHICH	O
IS	O
GREATER	O
THAN	O
1	O
CM	O
FROM	O
THE	O
DEEP	O
MARGIN	O
.	O

MEASURING	O
5	O
.	O
8	O
CM	O
FROM	O
SUPERIOR	O
TO	O
INFERIOR	O
,	O
2	O
.	O
5	O
CM	O
FROM	O
ANTERIOR	O
TO	O
.	O

POSTERIOR	O
,	O
AND	O
4	O
CM	O
FROM	O
MEDIAL	O
TO	O
LATERAL	O
.	O

CENTRALLY	O
THERE	O
IS	O
AN	O
.	O

IRREGULAR	O
AREA	O
OF	O
RED	O
-	O
BROWN	O
DISCOLORATION	O
.	O

THIS	O
IS	O
ALSO	O
GREATER	O
THAN	O
.	O

1	O
.	O

CM	O
FROM	O
THE	O
OVERLYING	O
SKIN	O
.	O

A	O
COIL	O
CLIP	O
IS	O
IDENTIFIED	O
WITHIN	O
THE	O
.	O

LESION	O
.	O

SECTIONS	O
ARE	O
SUBMITTED	O
AS	O
FOLLOWS	O
:	O
A1	O
-	O
-	O
NIPPLE	O
,	O
A2	O
-	O
-	O
KKIN	O
.	O

ULCERATIONS	O
AND	O
12	O
O	O
'	O
CLOCK	O
SKIN	O
MARGIN	O
,	O
A3	O
-	O
-	O
DEEP	O
MARGIN	O
TO	O
CENTRAL	O
.	O

LESION	O
,	O
A4	O
-	O
-	O
ANTERIOR	O
MARGIN	O
TO	O
CENTRAL	O
LESION	O
,	O
A5	O
THROUGH	O
A7	O
-	O
-	O
A	O
SUPERIOR	O
.	O

TO	O
INFERIOR	O
CROSS	O
SECTION	O
THROUGH	O
THE	O
LESION	O
AT	O
LEVEL	O
OF	O
CLIP	O
,	O
A8	O
-	O
-	O
THE	O
.	O

MOST	O
MEDIAL	O
ASPECT	O
OF	O
LESION	O
,	O
A9	O
-	O
-	O
MOST	O
LATERAL	O
ASPECT	O
OF	O
LESION	O
,	O
A10	O
AND	O
.	O

Specimen	O
:	O
Raceived	O
:	O
sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

M	O
.	O
D	O
.	O

GROSS	O
DESCRIPTION	O
.	O

11	O
-	O
-	O
ADDITIONAL	O
SECTIONS	O
OF	O
MASS	O
,	O
A12	O
-	O
-	O
UPPER	O
INNER	O
QUADRANT	O
4	O
CM	O
FROM	O
.	O

LESION	O
,	O
A13	O
-	O
-	O
UPPER	O
OUTER	O
QUADRANT	O
5	O
CM	O
FROM	O
LESION	O
,	O
A14	O
-	O
-	O
LOWER	O
OUTER	O
.	O

QUADRANT	O
5	O
CM	O
FROM	O
LESION	O
,	O
A15	O
-	O
-	O
LOWER	O
INNER	O
QUADRANT	O
4	O
CM	O
FROM	O
LESION	O
,	O
.	O

A16	O
-	O
-	O
TISSUE	O
DEEP	O
TO	O
NIPPLE	O
AT	O
MEDIAL	O
EDGE	O
OF	O
LESION	O
.	O

NOTE	O
:	O
TISSUEIS	O
-	O
SUBMITTED	O
-	O
-	O
PER	O
-	O
CLINICAL	O
-	O
BREAST	O
-	O
CARE	O
-	O
PROJECT	O
-	O
RESEARCH	O
-	O
.	O

PROTOCOL	O
OF	O
THE	O
TUMOR	O
LABELED	O
P1	O
-	O
p10	O
AND	O
MIRROR	O
IMAGE	O
SECTIONS	O
OF	O
THE	O
.	O

NIPPLE	O
(	O
A1	O
)	O
AND	O
THE	O
RANDOM	O
QUADRANT	O
SECTIONS	O
(	O
A12	O
-	O
A15	O
)	O
ARE	O
SUBMITTED	O
.	O

FROZEN	O
IN	O
CCI	O
.	O

PART	O
B	O
RECEIVED	O
LABELED	O
.	O

AXILLARY	O
CONTENTS	O
ARE	O
4	O
.	O

FRAGMENTS	O
OF	O
YELLOW	O
-	O
PINK	O
FATTY	O
TISSUE	O
TOGETHER	O
MEASURING	O
10	O
X	O
7	O
.	O
5	O
x	O
1	O
.	O
5	O
.	O

CM	O
.	O

THE	O
SPECIMEN	O
IS	O
THEN	O
EXAMINED	O
FOR	O
LYMPH	O
NODES	O
.	O

ALONG	O
ONE	O
EDGE	O
.	O

OF	O
.	O

THIS	O
SPECIMEN	O
THERE	O
ARE	O
STRANDS	O
OF	O
RED	O
MUSCLE	O
FIBERS	O
.	O

EXAMINATION	O
.	O

REVEALS	O
8	O
NODAL	O
STRUCTURES	O
.	O

THESE	O
ARE	O
SUBMITTED	O
AS	O
FOLLOWS	O
.	O

FOUR	O
(	O
4	O
)	O
.	O

OF	O
THESE	O
MEASURE	O
LESS	O
THAN	O
0	O
.	O
5	O
CM	O
AND	O
ARE	O
SUBMITTED	O
AS	O
B1	O
.	O

ONE	O
OF	O
THE	O
.	O

LARGER	O
NODES	O
IS	O
GROSSLY	O
POSITIVE	O
,	O
ONE	O
-	O
HALF	O
IS	O
SUBMITTED	O
IN	O
B2	O
,	O
THE	O
.	O

MIRROR	O
IMAGE	O
AS	O
Pll	O
PER	O
THE	O
CLINICAL	O
BREAST	O
CARE	O
PROJECT	O
RESEARCH	O
.	O

PROTOCOL	O
.	O

THE	O
REMAINING	O
3	O
LARGE	O
NODES	O
ARE	O
EACH	O
SUBMITTED	O
BISECTED	O
AND	O
.	O

SEPARATELY	O
LABELED	O
B3	O
THROUGH	O
B5	O
.	O

B6	O
IS	O
REPRESENTATIVE	O
MUSCLE	O
.	O

A	O
.	O

BIOPSY	O
CLIP	O
IS	O
NOT	O
GROSSLY	O
IDENTIFIED	O
.	O

COMMENT	O
:	O
THIS	O
CASE	O
IS	O
IN	O
COMPLIANCE	O
WITH	O
CAP	O
/	O
ASCO	O
GUIDELINES	O
OF	O
6	O
-	O
48	O
.	O

HOURS	O
FORMALIN	O
FIXATION	O
TIME	O
.	O

PATH	O
PROCEDURES	O
.	O

PROCEDURES	O
:	O
88309	O
,	O
A	O
BLK	O
/	O
16	O
,	O
B	O
BLK	O
/	O
6	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

PART	O
A	O
RIGHT	O
BREAST	O
,	O
SIMPLE	O
MASTECTOMY	O
:	O
INTRALOBULAR	O
AND	O
INFILTRATING	O
LOBULAR	O
CARCINOMA	O
WITH	O
SIGNET	O
-	O
RING	O
.	O

CELL	O
DIFFERENTIATION	O
,	O
GRADE	O
II	O
SHOWING	O
NUCLEAR	O
GRADE	O
2	O
/	O
3	O
AND	O
LOW	O
.	O

MITOTIC	O
INDEX	O
.	O

LCIS	O
OF	O
THE	O
CLASSIC	O
TYPE	O
SHOWS	O
NUCLEAR	O
GRADE	O
1	O
.	O

COMPRISING	O
APPROXIMATELY	O
5	O
%	O
OF	O
THE	O
TUMOR	O
.	O

2	O
.	O

THE	O
INVASIVE	O
COMPONENT	O
HAS	O
A	O
MAXIMUM	O
GROSS	O
DIMENSION	O
OF	O
5	B
.	I
8	I
CM	I
.	O

WITHIN	O
THE	O
CENTRAL	O
PORTION	O
OF	O
THE	O
BREAST	O
WHICH	O
EXTENDS	O
INTO	O
THE	O
.	O

Specimen	O
:	O
Req	O
#	O
:	O
Sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

1	O
.	O
D	O
.	O

ADDENDUM	O
.	O

METASTATIC	O
CARCINOMA	O
IS	O
IDENTIFIED	O
IN	O
ONE	O
OF	O
FOUR	O
ADDITIONAL	O
AXILLARY	O
.	O

LYMPH	O
NODES	O
INCLUDING	O
EXTENSION	O
OF	O
TUMOR	O
INTO	O
THE	O
EXTRANODAL	O
SOFT	O
.	O

TISSUE	O
(	O
1	O
/	O
4	O
)	O
.	O

A	O
SEPARATE	O
AREA	O
HAVING	O
BIOPSY	O
CHANGES	O
IS	O
ALSO	O
PRESENT	O
.	O

Addendum	O
Signed	O
.	O

(	O
signature	O
on	O
file	O
)	O
.	O

M	O
.	O
D	O
.	O

M	O
.	O
D	O
.	O

Speciment	O
.	O
tus	O
:	O
Req	O
#	O
:	O
Sp	O
type	O
:	O
SURGICAL	O
P	O
.	O

.	O
D	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

RETICULAR	O
DERMIS	O
UNDERLYING	O
THE	O
NIPPLE	O
SKIN	O
.	O

3	O
.	O

THE	O
NIPPLE	O
SKIN	O
,	O
SKIN	O
AND	O
BREAST	O
MARGINS	O
OF	O
RESECTION	O
,	O
AND	O
.	O

RANDOM	O
SECTIONS	O
FROM	O
THE	O
REMAINING	O
QUADRANTS	O
ARE	O
FREE	O
OF	O
TUMOR	O
WITH	O
.	O

THE	O
CLOSEST	O
LOCATED	O
4	O
MM	O
FROM	O
THE	O
NEAREST	O
INKED	O
DEEP	O
MARGIN	O
(	O
A3	O
)	O
-	O
.	O

4	O
.	O

LYMPHOVASCULAR	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

5	O
.	O

FIBROCYSTIC	O
CHANGES	O
INCLUDING	O
SCLEROSING	O
ADENOSIS	O
,	O
MICROCYST	O
.	O

FORMATION	O
AND	O
PATCHY	O
DENSE	O
STROMA	O
.	O

6	O
.	O

CALCIFICATIONS	O
ARE	O
SEEN	O
WITHIN	O
THE	O
TUMOR	O
AS	O
WELL	O
AS	O
BENIGN	O
PORTIONS	O
.	O

OF	O
THE	O
BREAST	O
.	O

7	O
.	O

SCLEROTIC	O
INTRADUCTAL	O
PAPILLOMA	O
.	O

8	O
.	O

BIOPSY	O
CHANGES	O
.	O

ARE	O
IDENTIFIED	O
.	O

9	O
.	O

SMALL	O
SKIN	O
ULCERATIONS	O
(	O
2	O
)	O
-	O
.	O

PART	O
B	O
RIGHT	O
AXILLA	O
,	O
LYMPH	O
NODE	O
DISSECTION	O
:	O
METASTATIC	O
BREAST	O
.	O

CARCINOMA	O
IS	O
IDENTIFIED	O
IN	O
4	O
OF	O
6	O
AXILLARY	O
LYMPH	O
NODES	O
EXAMINED	O
(	O
4	O
/	O
6	O
)	O
.	O

EXTENSION	O
OF	O
TUMOR	O
INTO	O
THE	O
PERINODAL	O
SOFT	O
TISSUE	O
INVOLVES	O
THE	O
.	O

LARGEST	O
AREA	O
OF	O
METASTATIC	O
TUMOR	O
WHICH	O
MEASURES	O
1	B
.	I
1	I
CM	I
IN	O
GREATEST	O
.	O

MICROSCOPIC	O
DIMENSION	O
.	O

A	O
REPRESEN	O
'	O
TATIVE	O
SECTION	O
OF	O
SKELETAL	O
MUSCLE	O
IS	O
.	O

NEGATIVE	O
FOR	O
TUMOR	O
.	O

BIOPSY	O
CHANGES	O
ARE	O
NOT	O
IDENTIFIED	O
GROSSLY	O
OR	O
.	O

MICROSCOPICALLY	O
IN	O
THE	O
NODAL	O
DISSECTION	O
.	O

ADDENDUM	O
.	O

Addendum	O
#	O
1	O
.	O

Entered	O
:	O
THE	O
LATERAL	O
UPPER	O
OUTER	O
QUADRANT	O
IS	O
RE	O
-	O
EXAMINED	O
AND	O
A	O
WING	O
CLIP	O
IS	O
.	O

IDENTIFIED	O
IN	O
AN	O
AREA	O
OF	O
FATTY	O
TISSUE	O
,	O
WITH	O
THE	O
TISSUE	O
ANTERIOR	O
HAVING	O
A	O
.	O

YELLOW	O
-	O
WHITE	O
INDURATION	O
CONSISTENT	O
WITH	O
A	O
PREVIOUS	O
BIOPSY	O
AREA	O
.	O

THE	O
AREA	O
.	O

OF	O
THE	O
CLIP	O
PROPER	O
IS	O
SUBMITTED	O
IN	O
A17	O
AND	O
18	O
.	O

THE	O
TISSUE	O
ANTERIOR	O
TO	O
.	O

THIS	O
AREA	O
IS	O
SUBMITTED	O
IN	O
A19	O
AND	O
20	O
.	O

LATERAL	O
TO	O
THIS	O
,	O
THERE	O
IS	O
A	O
.	O

GROSSLY	O
POSITIVE	O
NODAL	O
STRUCTURE	O
0	O
.	O
6	O
CM	O
IN	O
DIAMETER	O
.	O

THIS	O
IS	O
SECTIONED	O
.	O

AND	O
SUBMITTED	O
IN	O
A21	O
.	O

AN	O
ADDITIONAL	O
POSSIBLE	O
NODE	O
IS	O
SUBMITTED	O
IN	O
A22	O
.	O

AND	O
23	O
.	O

AN	O
ADDITIONAL	O
POSSIBLE	O
0	O
.	O
4	O
CM	O
NODE	O
IS	O
SUBMITTED	O
IN	O
A24	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
BREAST	O
,	O
RIGHT	O
,	O
SEGMENTAL	O
MASTECTOMY	O
,	O
NEEDLE	O
LOCALIZATION	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
NOTTINGHAM	O
GRADE	O
3	O
(	O
TUBULE	O
FORMATION	O
3	O
,	O
NUCLEAR	O
.	O
POLYMORPHISM	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
3	O
,	O
TOTAL	O
SCORE	O
9	O
/	O
9	O
)	O
.	O

B	O
.	O

INVASIVE	O
TUMOR	O
MEASURES	O
2	B
.	I
1	I
CM	I
IN	O
GREATEST	O
DIMENSION	O
(	O
GROSS	O
MEASUREMENT	O
)	O
.	O

C	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
,	O
SOLID	O
PATTERN	O
,	O
NUCLEAR	O
GRADE	O
3	O
,	O
ADMIXED	O
WITH	O
INVASIVE	O
.	O

CARCINOMA	O
,	O
CONSTITUTING	O
ABOUT	O
FIVE	O
PERCENT	O
(	O
5	O
%	O
)	O
OF	O
TOTAL	O
TUMOR	O
VOLUME	O
.	O

D	O
.	O

RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
;	O
INVASIVE	O
CARCINOMA	O
IS	O
1	O
.	O
5	O
MM	O
TO	O
THE	O
.	O

CLOSEST	O
ANTERIOR	O
MARGIN	O
.	O

E	O
.	O

NO	O
DEFINITIVE	O
LYMPHOVASCULAR	O
INVASION	O
NOTED	O
.	O

F	O
.	O

FOCI	O
OF	O
MICROCALCIFICATIONS	O
ASSOCIATED	O
WITH	O
INVASIVE	O
CARCINOMA	O
.	O

G	O
.	O

FIBROCYSTIC	O
CHANGE	O
.	O

H	O
.	O

THE	O
INVASIVE	O
CARCINOMA	O
IS	O
ER	O
POSITIVE	O
,	O
PR	O
POSITIVE	O
,	O
HER2	O
/	O
NEU	O
WEAKLY	O
POSITIVE	O
AND	O
NO	O
.	O

AMPLIFICATION	O
BY	O
FISH	O
ANALYSIS	O
.	O

PART	O
2	O
:	O
AXILLA	O
#	O
1	O
SENTINEL	O
LYMPH	O
NODE	O
,	O
RIGHT	O
,	O
BIOPSY	O
-	O
.	O

ONE	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
CARCINOMA	O
.	O

SYNOPTIC	O
-	O
PRIMARI	O
INVASIVE	O
,	O
.	O

LATERALITY	O
:	O
Right	O
.	O

PROCEDURE	O
:	O
Segmental	O
.	O

Not	O
specified	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
2	B
.	I
1	I
cm	I
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
adenocarcinoma	O
,	O
NOS	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
:	O
3	O
.	O

Mitotic	O
activity	O
score	O
:	O
3	O
.	O

Total	O
Nottingham	O
score	O
:	O
9	O
.	O

Nottingham	O
grade	O
(	O
1	O
,	O
2	O
,	O
3	O
)	O
:	O
3	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
Not	O
applicable	O
.	O

CALCIFICATION	O
:	O
Yes	O
,	O
malignant	O
zones	O
.	O

TUMOR	O
TYPE	O
,	O
IN	O
SITU	O
:	O
Solid	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
Distance	O
of	O
invasive	O
tumor	O
to	O
closest	O
margin	O
:	O
1	O
.	O
5	O
mm	O
.	O

SURG	O
MARGINS	O
INVOLVED	O
BY	O
IN	O
SITU	O
COMPONENT	O
:	O
LYMPH	O
NODES	O
EXAMINED	O
:	O
1	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPH	O
NODE	O
EXAMINATION	O
:	O
H	O
/	O
E	O
stain	O
.	O

SENTINEL	O
NODE	O
METASTASIS	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
FCD	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT2	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
positive	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
positive	O
.	O

HER2	O
/	O
NEU	O
:	O
2	O
+	O
.	O

PATIENT	O
HISTORY	O
:	O
PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Colon	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
,	O
.	O

PROCEDURE	O
:	O
Sigmoid	O
colon	O
,	O
resection	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
BLADDER	O
WALL	O
,	O
EXCISION	O
-	O
.	O

1	O
:	O
POSITIVE	O
FOR	O
ADENOCARCINOMA	O
,	O
EXTENDING	O
TO	O
CAUTERIZED	O
SPECIMEN	O
EDGES	O
.	O

PARTS	O
2	O
A	O
.	O

AND	O
MODERATELY	O
4	O
:	O
SIGMOID	O
COLON	O
,	O
DIFFERENTIATED	O
SIGMOIDECTOMY	O
ADENOCARCINOMA	O
-	O
(	O
4	B
.	I
5	I
CM	I
)	O
INVOLVING	O
COLONIC	O
WALL	O
.	O

TRANSMURALLY	O
(	O
see	O
comment	O
)	O
.	O

B	O
.	O

AND	O
DISTAL	O
SURGICAL	O
MARGINS	O
FREE	O
OF	O
CARCINOMA	O
.	O

BOTH	O
ANGIOLYMPHATIC	O
AND	O
PERINEURAL	O
INVASION	O
IDENTIFIED	O
.	O

C	O
.	O

PROXIMAL	O
CARCINOMA	O
IS	O
PRESENT	O
ON	O
SEROSAL	O
SURFACE	O
AND	O
AT	O
CAUTERIZED	O
RADIAL	O
EDGE	O
OF	O
SPECIMEN	O
.	O

D	O
.	O

E	O
.	O

METASTATIC	O
ADENOCARCINOMA	O
IN	O
FIVE	O
OF	O
NINETEEN	O
LYMPH	O
NODES	O
(	O
5	O
/	O
19	O
)	O
.	O

PART	O
3	O
:	O
POSITIVE	O
LEFT	O
PELVIC	O
FOR	O
SIDEWALL	O
,	O
ADENOCARCINOMA	O
,	O
BIOPSY	O
-	O
EXTENDING	O
TO	O
CAUTERIZED	O
SPECIMEN	O
EDGES	O
.	O

PART	O
5	O
:	O
OMENTUM	O
,	O
EXCISION	O
-	O
.	O

POSITIVE	O
FOR	O
ADENOCARCINOMA	O
.	O

COMMENT	O
:	O
The	O
carcinoma	O
extensively	O
involves	O
the	O
colonic	O
wall	O
,	O
from	O
the	O
mucosa	O
to	O
the	O
pericolic	O
adipose	O
tissue	O
,	O
but	O
no	O
definite	O
.	O
precursor	O
lesion	O
is	O
seen	O
in	O
the	O
colonic	O
mucosa	O
.	O

There	O
is	O
extensive	O
,	O
plaque	O
-	O
like	O
extramural	O
/	O
subserosal	O
involvement	O
as	O
.	O
well	O
,	O
with	O
areas	O
of	O
serosal	O
penetration	O
and	O
at	O
least	O
one	O
focus	O
where	O
cauterized	O
carcinoma	O
is	O
present	O
at	O
what	O
appears	O
to	O
.	O

be	O
the	O
radial	O
and	O
/	O
or	O
mesocolic	O
specimen	O
edge	O
.	O

This	O
corresponds	O
to	O
the	O
operative	O
report	O
describing	O
dense	O
tumor	O
.	O
infiltrating	O
the	O
pelvic	O
sidewall	O
over	O
the	O
iliac	O
vessels	O
,	O
through	O
which	O
the	O
surgeon	O
cut	O
.	O

In	O
addition	O
,	O
immunohistochemical	O
.	O
stains	O
reveal	O
the	O
carcinoma	O
to	O
be	O
strongly	O
positive	O
for	O
cytokeratin	O
7	O
with	O
only	O
focal	O
positivity	O
for	O
cytokeratin	O
20	O
.	O

CDX	O
-	O
2	O
.	O

is	O
.	O
completely	O
negative	O
,	O
as	O
are	O
TTF	O
-	O
1	O
and	O
PSA	O
.	O

CEA	O
and	O
cytokeratin	O
19	O
are	O
positive	O
.	O

Positive	O
immunostains	O
for	O
the	O
DNA	O
.	O
mismatch	O
repair	O
proteins	O
MLH	O
-	O
1	O
,	O
PMS	O
-	O
2	O
,	O
MSH	O
-	O
2	O
and	O
MSH	O
-	O
6	O
reveal	O
preserved	O
nuclear	O
expression	O
.	O

In	O
summary	O
,	O
the	O
overall	O
.	O
morphological	O
findings	O
and	O
immunohistochemical	O
profile	O
are	O
not	O
typical	O
of	O
a	O
primary	O
colorectal	O
adenocarcinoma	O
.	O

A	O
.	O
possible	O
primary	O
site	O
compatible	O
with	O
the	O
immunomorphological	O
findings	O
is	O
the	O
pancreaticobiliary	O
system	O
.	O

Alternatively	O
,	O
.	O

if	O
another	O
potential	O
primary	O
site	O
cannot	O
be	O
found	O
clinically	O
,	O
this	O
could	O
be	O
a	O
primary	O
peritoneal	O
adenocarcinoma	O
with	O
.	O
extension	O
into	O
the	O
colonic	O
wall	O
.	O

Finally	O
,	O
the	O
lymph	O
node	O
total	O
includes	O
one	O
lymph	O
node	O
confirmed	O
to	O
be	O
negative	O
for	O
.	O
carcinoma	O
by	O
a	O
negative	O
cytokeratin	O
AE1	O
/	O
AE3	O
immunostain	O
.	O

SURG	O
PATH	O
#	O
:	O
SPECIMEN	O
CLASS	O
:	O
ALT	O
ID	O
#	O
:	O
SEX	O
:	O
M	O
.	O

DATE	O
RECEIVED	O
:	O
DATE	O
OF	O
PRINTING	O
:	O
Material	O
Received	O
:	O
A	O
:	O
Prostate	O
.	O

Historv	O
:	O
-	O
year	O
-	O
old	O
male	O
with	O
prostate	O
cancer	O
.	O

Final	O
Diagnosis	O
:	O
A	O
.	O

Prostate	O
,	O
prostatectomy	O
:	O
Prostatic	O
adenocarcinoma	O
,	O
moderately	O
differentiated	O
,	O
Gleason	O
grade	O
3	O
+	O
3	O
(	O
score	O
6	O
)	O
,	O
involving	O
the	O
right	O
lobe	O
with	O
.	O
perineural	O
invasion	O
.	O

See	O
comment	O
.	O

Comment	O
:	O
Prostate	O
.	O

Procedure	O
:	O
Prostatectomy	O
.	O

Histologic	O
Type	O
:	O
Prostatic	O
adenocarcinoma	O
.	O

Histologic	O
Grade	O
:	O
Moderately	O
differentiated	O
.	O

Gleason	O
Pattern	O
.	O

Primary	O
Pattern	O
:	O
3	O
.	O

Secondary	O
Pattern	O
:	O
3	O
.	O

Total	O
Gleason	O
Score	O
(	O
Primary	O
+	O
Secondary	O
)	O
:	O
6	O
.	O

Proportion	O
(	O
percent	O
)	O
of	O
prostate	O
involved	O
by	O
tumor	O
:	O
5	O
%	O
.	O

Tumor	O
Multicentricity	O
:	O
Present	O
.	O

Extraprostatic	O
Extension	O
:	O
Absent	O
,	O
however	O
very	O
close	O
in	O
two	O
foci	O
.	O

Seminal	O
Vesicle	O
Invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Free	O
of	O
tumor	O
(	O
within	O
1	O
mm	O
of	O
inked	O
margin	O
)	O
.	O

Perineural	O
Invasion	O
:	O
Present	O
.	O

Vascular	O
Invasion	O
:	O
Absent	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Stromal	O
hyperplasia	O
.	O

Lymph	O
Nodes	O
:	O
N	O
/	O
A	O
.	O

Pathologic	O
Staging	O
:	O
pT2aNxMx	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
.	O

pT2a	O
:	O
Unilateral	O
,	O
involving	O
one	O
-	O
half	O
of	O
1	O
side	O
(	O
"	O
lobe	O
"	O
)	O
or	O
less	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
.	O

pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
.	O

Date	O
of	O
Printing	O
:	O
SURG	O
PATH	O
#	O
:	O
ALT	O
ID	O
#	O
:	O
pMX	O
:	O
Distant	O
metastasis	O
cannot	O
be	O
assessed	O
.	O

The	O
pathologic	O
stage	O
assigned	O
here	O
should	O
be	O
regarded	O
as	O
provisional	O
,	O
as	O
it	O
reflects	O
only	O
current	O
pathologic	O
data	O
and	O
does	O
not	O
.	O
incorporate	O
full	O
knowledge	O
of	O
the	O
patient	O
'	O
s	O
clinical	O
status	O
and	O
/	O
or	O
prior	O
pathology	O
.	O

Attestation	O
:	O
By	O
this	O
signature	O
,	O
I	O
attest	O
that	O
I	O
have	O
personally	O
formulated	O
the	O
final	O
interpretation	O
expressed	O
in	O
this	O
report	O
and	O
that	O
the	O
above	O
diagnosis	O
is	O
based	O
.	O
upon	O
my	O
examination	O
of	O
the	O
slides	O
and	O
/	O
or	O
other	O
material	O
indicated	O
in	O
this	O
report	O
.	O

Interpreted	O
by	O
:	O
Gross	O
Description	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
prostate	O
"	O
is	O
a	O
radical	O
prostatectomy	O
specimen	O
measuring	O
from	O
4	O
.	O
2	O
cm	O
from	O
right	O
to	O
left	O
3	O
.	O
8	O
cm	O
from	O
.	O
apex	O
to	O
base	O
and	O
3	O
.	O
0	O
cm	O
from	O
anterior	O
to	O
posterior	O
.	O

The	O
right	O
seminal	O
vesicle	O
measures	O
2	O
.	O
2	O
cm	O
in	O
length	O
and	O
1	O
.	O
5	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
right	O
vas	O
deferens	O
measures	O
1	O
.	O
4	O
cm	O
in	O
length	O
and	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
left	O
seminal	O
vesicle	O
measures	O
2	O
.	O
3	O
cm	O
in	O
length	O
and	O
.	O

1	O
.	O
3	O
cm	O
in	O
diameter	O
.	O

The	O
left	O
vas	O
deferens	O
measures	O
1	O
.	O
7	O
cm	O
in	O
length	O
X	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
external	O
surface	O
is	O
of	O
the	O
prostate	O
.	O

is	O
.	O
tan	O
-	O
white	O
.	O

and	O
.	O
smooth	O
.	O

The	O
right	O
side	O
of	O
the	O
prostate	O
is	O
inked	O
black	O
and	O
the	O
left	O
side	O
is	O
inked	O
blue	O
.	O

The	O
prostate	O
is	O
serially	O
.	O
sectioned	O
.	O

to	O
.	O
reveal	O
.	O

a	O
tan	O
-	O
yellow	O
band	O
in	O
the	O
posterior	O
aspect	O
of	O
the	O
prostate	O
that	O
measures	O
2	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
cm	O
that	O
comes	O
within	O
0	O
.	O
1	O
.	O

cm	O
of	O
the	O
closest	O
margin	O
.	O

The	O
remainder	O
of	O
the	O
cut	O
-	O
surfaces	O
is	O
tan	O
-	O
pink	O
,	O
smooth	O
and	O
glistening	O
.	O

The	O
specimen	O
is	O
submitted	O
as	O
.	O
follows	O
:	O
A1	O
.	O

Right	O
bladder	O
neck	O
margin	O
(	O
radially	O
sectioned	O
)	O
.	O

A2	O
.	O

Left	O
bladder	O
neck	O
margin	O
(	O
radially	O
sectioned	O
)	O
.	O

A3	O
.	O

Right	O
distal	O
urethral	O
margin	O
(	O
radially	O
sectioned	O
)	O
.	O

A4	O
.	O

Left	O
distal	O
urethral	O
margins	O
(	O
radially	O
sectioned	O
)	O
.	O

A5	O
.	O

Right	O
and	O
left	O
seminal	O
vesicles	O
and	O
vas	O
deferens	O
margin	O
.	O

A6	O
.	O

Section	O
from	O
the	O
right	O
mid	O
-	O
anterior	O
prostate	O
.	O

A7	O
.	O

Section	O
from	O
the	O
left	O
mid	O
-	O
anterior	O
prostate	O
.	O

A8	O
-	O
A17	O
Entire	O
posterior	O
right	O
lobe	O
,	O
from	O
apex	O
to	O
base	O
.	O

A18	O
-	O
A28	O
Entire	O
posterior	O
left	O
lobe	O
,	O
from	O
apex	O
to	O
base	O
.	O

Date	O
of	O
Printing	O
:	O

FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

A	O
.	O

Left	O
ovary	O
,	O
fallopian	O
tube	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O
1	O
.	O

Ovary	O
with	O
papillary	O
serous	O
carcinoma	O
,	O
high	O
grade	O
;	O
see	O
comment	O
.	O

2	O
.	O

Fallopian	O
tube	O
with	O
no	O
significant	O
pathologic	O
abnormality	O
.	O

B	O
.	O

Right	O
ovary	O
,	O
fallopian	O
tube	O
,	O
salpingo	O
-	O
oophorectomy	O
:	O
1	O
.	O

Ovary	O
with	O
serous	O
cystadenoma	O
.	O

2	O
.	O

Fallopian	O
tube	O
with	O
papillary	O
serous	O
carcinoma	O
obstructing	O
lumen	O
and	O
.	O
hydrosalpinx	O
.	O

C	O
.	O

Omentum	O
,	O
partial	O
omentectomy	O
:	O
Metastatic	O
high	O
grade	O
papillary	O
serous	O
carcinoma	O
.	O

D	O
.	O

Uerus	O
,	O
cervix	O
,	O
abdominal	O
hysterectomy	O
:	O
-	O
Cervix	O
:	O
High	O
grade	O
serous	O
papillary	O
carcinoma	O
of	O
superior	O
cervix	O
.	O

-	O
Endometrium	O
:	O
1	O
.	O

High	O
grade	O
serous	O
papillary	O
carcinoma	O
involving	O
polyp	O
.	O

2	O
.	O

Mildly	O
proliferative	O
glands	O
.	O

-	O
Myometrium	O
:	O
1	O
.	O

Adenomyosis	O
.	O

2	O
.	O

Leiomyoma	O
.	O

-	O
Serosa	O
:	O
No	O
significant	O
pathologic	O
abnormality	O
.	O

E	O
.	O

Colon	O
,	O
biopsy	O
:	O
1	O
.	O

Metastatic	O
high	O
grade	O
papillary	O
serous	O
adenocarcinoma	O
,	O
infiltrating	O
peri	O
-	O
colic	O
fat	O
.	O
and	O
portion	O
of	O
intestinal	O
wall	O
.	O

2	O
.	O

Colonic	O
mucosa	O
with	O
no	O
significant	O
pathologic	O
abnormality	O
.	O

F	O
.	O

Appendix	O
,	O
appendectomy	O
:	O
Appendix	O
with	O
focal	O
intraluminal	O
calcification	O
.	O

No	O
tumor	O
.	O
seen	O
.	O

COMMENT	O
:	O
Ovarian	O
Tumor	O
Synoptic	O
Comment	O
.	O

Type	O
of	O
tumor	O
:	O
Papillary	O
serous	O
carcinoma	O
.	O

Grade	O
of	O
tumor	O
:	O
high	O
grade	O
,	O
delineated	O
as	O
follows	O
:	O
papillary	O
architecture	O
2	O
points	O
,	O
nuclear	O
pleomorphism	O
.	O

2	O
points	O
,	O
mitoses	O
3	O
points	O
for	O
a	O
sum	O
of	O
8	O
points	O
=	O
high	O
grade	O
.	O

Site	O
of	O
tumor	O
:	O
Left	O
ovary	O
,	O
(	O
also	O
right	O
fallopian	O
tube	O
,	O
endometrial	O
polyp	O
,	O
superior	O
cervix	O
,	O
perirectal	O
soft	O
.	O
tissue	O
,	O
omentum	O
)	O
.	O

Location	O
of	O
tumor	O
:	O
intracystic	O
and	O
surface	O
of	O
ovary	O
.	O

Condition	O
of	O
capsule	O
:	O
not	O
encapsulated	O
.	O

Cut	O
surface	O
:	O
solid	O
and	O
cystic	O
.	O

Necrosis	O
:	O
moderate	O
.	O

Lymphatic	O
/	O
vascular	O
invasion	O
:	O
not	O
identified	O
.	O

Sites	O
of	O
metastasis	O
in	O
pelvis	O
:	O
Left	O
fallopian	O
tube	O
,	O
cervix	O
,	O
endometrial	O
polyp	O
(	O
see	O
comments	O
below	O
)	O
;	O
.	O
diameter	O
of	O
largest	O
pelvic	O
metastasis	O
=	O
1	O
.	O
7	O
cm	O
,	O
right	O
fallopian	O
tube	O
.	O

Pelvic	O
lymph	O
nodes	O
:	O
None	O
sampled	O
.	O

Sites	O
of	O
metastasis	O
in	O
abdomen	O
:	O
omentum	O
and	O
peri	O
-	O
rectal	O
soft	O
tissue	O
;	O
maximum	O
diameter	O
of	O
largest	O
.	O
abdominal	O
metastasis	O
=	O
14	O
cm	O
,	O
omentum	O
.	O

Para	O
-	O
aortic	O
lymph	O
nodes	O
:	O
None	O
sampled	O
.	O

Peritoneal	O
cytology	O
:	O
positive	O
,	O
metastatic	O
papillary	O
adenocarcinoma	O
;	O
.	O

)	O
ther	O
abnormalities	O
:	O
endometrial	O
polyp	O
,	O
adenomyosis	O
.	O

FIGO	O
stage	O
:	O
IIIC	O
.	O

TNM	O
stage	O
:	O
pT3c	O
Nx	O
MO	O
.	O

Additional	O
comments	O
:	O
We	O
favor	O
this	O
to	O
be	O
a	O
primary	O
serous	O
carcinoma	O
of	O
the	O
left	O
ovary	O
with	O
peritoneal	O
.	O
spread	O
to	O
the	O
right	O
adnexa	O
,	O
and	O
intracavitary	O
spread	O
to	O
the	O
endometrial	O
polyp	O
and	O
superior	O
cervix	O
.	O

The	O
.	O
possibility	O
of	O
a	O
primary	O
uterine	O
carcinoma	O
with	O
spread	O
to	O
the	O
ovary	O
seems	O
unlikely	O
given	O
the	O
extensive	O
.	O
involvement	O
of	O
the	O
left	O
ovary	O
with	O
tumor	O
.	O

Multiple	O
synchronous	O
primary	O
serous	O
carcinomas	O
cannot	O
be	O
.	O
excluded	O
yet	O
also	O
seems	O
less	O
likely	O
.	O
has	O
reviewed	O
the	O
slides	O
and	O
concurs	O
.	O

Speciment	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Left	O
Ovary	O
.	O

B	O
:	O
Right	O
Ovary	O
.	O

C	O
:	O
Omentum	O
.	O

E	O
:	O
Colon	O
tissue	O
fragments	O
.	O

F	O
:	O
Appendix	O
,	O
incidental	O
.	O

G	O
:	O
Ovary	O
Blocks	O
-	O
.	O

Intraoperative	O
Diaghosis	O
.	O

FS1	O
(	O
A	O
)	O
Left	O
ovarv	O
.	O
salpingo	O
-	O
oophorectomy	O
:	O
Papillary	O
serous	O
carcinoma	O
.	O

FS2	O
(	O
B	O
)	O
(	O
Gross	O
evaluation	O
only	O
)	O
Hydrosalpinx	O
.	O

Specimen	O
not	O
frozen	O
,	O
but	O
left	O
intact	O
for	O
sampling	O
of	O
.	O
nodular	O
near	O
cystic	O
area	O
.	O

FS3	O
(	O
C	O
)	O
(	O
Gross	O
evaluation	O
only	O
)	O
Omentum	O
:	O
Grossly	O
involved	O
by	O
tumor	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O
with	O
a	O
history	O
of	O
severe	O
glandular	O
atypia	O
on	O
prior	O
endocervical	O
.	O
curettage	O
.	O

who	O
undergoes	O
total	O
abdominal	O
hysterectomy	O
and	O
bilateral	O
.	O
salpingo	O
-	O
oophorectomy	O
,	O
omentectomy	O
,	O
biopsy	O
of	O
colonic	O
implant	O
and	O
appendectomy	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
in	O
seven	O
parts	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
unit	O
number	O
.	O

Part	O
A	O
,	O
labeled	O
"	O
left	O
ovary	O
"	O
,	O
consists	O
of	O
a	O
grossly	O
distorted	O
ovary	O
weighing	O
243	O
grams	O
and	O
measuring	O
10	O
X	O
.	O

7	O
.	O

x	O
9	O
cm	O
.	O

There	O
are	O
multiple	O
papillated	O
masses	O
on	O
the	O
surface	O
.	O

A	O
portion	O
of	O
fallopian	O
tube	O
is	O
identified	O
which	O
.	O
measures	O
6	O
cm	O
in	O
length	O
and	O
1	O
cm	O
in	O
greatest	O
diameter	O
.	O

Serial	O
sectioning	O
reveals	O
that	O
the	O
nearly	O
the	O
.	O
entire	O
.	O

ovarian	O
mass	O
consists	O
of	O
tan	O
-	O
pink	O
,	O
soft	O
,	O
friable	O
,	O
papillary	O
structure	O
.	O

Cassette	O
A1	O
contains	O
a	O
frozen	O
section	O
.	O
remnant	O
.	O

Representative	O
sections	O
of	O
the	O
mass	O
are	O
submitted	O
in	O
cassettes	O
A2	O
-	O
A6	O
.	O

Part	O
B	O
,	O
labeled	O
"	O
right	O
ovary	O
"	O
,	O
consists	O
of	O
an	O
ovary	O
with	O
a	O
portion	O
of	O
fallopian	O
tube	O
weighing	O
83	O
.	O

5	O
grams	O
.	O
and	O
.	O

measuring	O
7	O
x	O
6	O
x	O
4	O
.	O
8	O
cm	O
.	O

The	O
fallopian	O
tube	O
measures	O
7	O
cm	O
in	O
length	O
and	O
2	O
cm	O
in	O
greatest	O
diameter	O
at	O
.	O
the	O
.	O

portion	O
of	O
hydrosalpinx	O
.	O

A	O
large	O
cyst	O
is	O
associated	O
with	O
the	O
ovary	O
measuring	O
6	O
.	O
5	O
cm	O
in	O
greatest	O
diameter	O
.	O
and	O
containing	O
clear	O
serous	O
fluid	O
.	O

The	O
external	O
surfaces	O
are	O
inked	O
in	O
black	O
.	O

The	O
internal	O
surface	O
of	O
the	O
cyst	O
.	O
cavity	O
is	O
smooth	O
.	O

A	O
1	O
.	O
3	O
cm	O
nodular	O
area	O
beneath	O
the	O
cyst	O
wall	O
is	O
visible	O
in	O
the	O
region	O
of	O
the	O
adherence	O
of	O
.	O
the	O
.	O

fimbriae	O
to	O
the	O
ovary	O
.	O

Sections	O
through	O
this	O
region	O
reveals	O
a	O
mass	O
which	O
is	O
contiguous	O
with	O
the	O
internal	O
.	O
surface	O
of	O
the	O
fallopian	O
tube	O
obstructing	O
the	O
distal	O
orifice	O
.	O

This	O
mass	O
measures	O
1	O
.	O
7	O
cm	O
in	O
greatest	O
.	O
diameter	O
.	O

A	O
section	O
of	O
this	O
area	O
is	O
submitted	O
in	O
cassette	O
B1	O
.	O

Two	O
irregularly	O
-	O
shaped	O
white	O
fibrous	O
-	O
appearing	O
areas	O
.	O
are	O
.	O

also	O
beneath	O
the	O
internal	O
cyst	O
wall	O
;	O
each	O
measuring	O
<	O
1	O
.	O
5	O
cm	O
in	O
greatest	O
diameter	O
.	O

Representative	O
sections	O
.	O

f	O
this	O
fibrous	O
area	O
as	O
well	O
as	O
a	O
section	O
of	O
normal	O
-	O
appearing	O
fallopian	O
tube	O
are	O
submitted	O
in	O
cassette	O
B2	O
,	O
.	O
art	O
C	O
,	O
labeled	O
"	O
omentum	O
"	O
,	O
consists	O
of	O
a	O
section	O
of	O
yellow	O
,	O
fatty	O
omental	O
tissue	O
measuring	O
30	O
X	O
15	O
X	O
4	O
cm	O
.	O

The	O
central	O
portion	O
if	O
firm	O
and	O
indurated	O
,	O
with	O
a	O
tan	O
-	O
white	O
mass	O
,	O
which	O
in	O
some	O
regions	O
has	O
a	O
papillated	O
.	O
border	O
.	O

This	O
central	O
area	O
of	O
caking	O
measures	O
14	O
cm	O
in	O
greatest	O
diameter	O
.	O

Representative	O
sections	O
are	O
.	O
submitted	O
in	O
cassettes	O
C1	O
-	O
C3	O
.	O

Part	O
D	O
,	O
labeled	O
"	O
uterus	O
"	O
,	O
consists	O
of	O
a	O
113	O
gram	O
,	O
pink	O
-	O
tan	O
uterus	O
which	O
measures	O
9	O
.	O
5	O
cm	O
superior	O
to	O
.	O
inferior	O
,	O
6	O
cm	O
laterally	O
,	O
and	O
4	O
.	O
5	O
cm	O
in	O
anterior	O
posterior	O
dimension	O
.	O

The	O
cervical	O
os	O
measures	O
1	O
cm	O
and	O
is	O
.	O
fish	O
mouth	O
.	O

The	O
cut	O
surfaces	O
are	O
inked	O
in	O
black	O
.	O

The	O
endometrial	O
surface	O
is	O
smooth	O
,	O
yellow	O
-	O
tan	O
and	O
focally	O
.	O
hemorrhagic	O
.	O

Two	O
polyps	O
emanate	O
from	O
the	O
anterior	O
left	O
endometrium	O
;	O
one	O
measuring	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
diameter	O
.	O

Small	O
cystic	O
spaces	O
are	O
present	O
within	O
the	O
myometrium	O
which	O
measures	O
2	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

The	O
spaces	O
measure0	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Representative	O
sections	O
are	O
submitted	O
as	O
.	O
follows	O
:	O
Cassette	O
D1	O
:	O
Anterior	O
cervix	O
,	O
.	O

Cassette	O
D2	O
:	O
Posterior	O
cervix	O
.	O

Cassette	O
D3	O
:	O
Anterior	O
endometrium	O
with	O
cystic	O
space	O
and	O
superior	O
polyp	O
.	O

Cassette	O
D4	O
:	O
Anterior	O
endomyometrium	O
.	O

Cassette	O
D5	O
:	O
Anterior	O
lower	O
uterine	O
segment	O
with	O
polyp	O
.	O

Cassette	O
D6	O
:	O
Posterior	O
endometrium	O
.	O

Cassette	O
D7	O
:	O
Section	O
of	O
lower	O
posterior	O
endomyometrium	O
.	O

Cassette	O
D8	O
:	O
Section	O
of	O
superior	O
endomyometrium	O
with	O
serosa	O
.	O

Cassette	O
D9	O
:	O
Section	O
of	O
superior	O
posterior	O
subserosal	O
nodule	O
.	O

Cassettes	O
D10	O
-	O
14	O
:	O
Serial	O
ascending	O
sections	O
of	O
anterior	O
superior	O
cervix	O
through	O
lower	O
uterine	O
segment	O
.	O

Cassettes	O
D15	O
-	O
18	O
:	O
Serial	O
ascending	O
sections	O
of	O
left	O
anterior	O
endometrium	O
with	O
base	O
of	O
polyp	O
.	O

Cassette	O
D19	O
:	O
Anterior	O
endometrial	O
polyp	O
.	O

Part	O
E	O
,	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
tissue	O
from	O
colon	O
"	O
,	O
consists	O
of	O
multiple	O
irregularly	O
-	O
shaped	O
,	O
yellow	O
-	O
tan	O
.	O
masses	O
of	O
fatty	O
,	O
firm	O
tissue	O
measuring	O
5	O
X	O
3	O
X	O
1	O
.	O
2	O
cm	O
in	O
aggregate	O
.	O

One	O
specimen	O
appears	O
to	O
contain	O
.	O
cystic	O
.	O

structures	O
associated	O
with	O
the	O
firm	O
,	O
white	O
nodule	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassette	O
E1	O
.	O

Part	O
F	O
,	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
appendix	O
"	O
,	O
consists	O
of	O
a	O
segment	O
of	O
appendix	O
measuring	O
2	O
in	O
length	O
.	O
and	O
0	O
.	O
7	O
cm	O
in	O
diameter	O
,	O
with	O
an	O
adjacent	O
2	O
cm	O
fatty	O
mesentery	O
.	O

The	O
external	O
surfaces	O
are	O
inked	O
black	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
cassette	O
F1	O
.	O

Part	O
G	O
,	O
is	O
received	O
as	O
11	O
,	O
tan	O
research	O
cassettes	O
,	O
each	O
containing	O
tissue	O
for	O
the	O
.	O

The	O
tan	O
cassettes	O
are	O
labeled	O
in	O
sequential	O
order	O
as	O
.	O

These	O
tan	O
cassettes	O
are	O
.	O
subsequently	O
submitted	O
as	O
cassettes	O
G1	O
-	O
G11	O
.	O

Diagnosis	O
based	O
on	O
gross	O
and	O
microscopic	O
examinations	O
.	O

Final	O
diagnosis	O
made	O
by	O
attending	O
.	O
pathologist	O
following	O
review	O
of	O
all	O
nathology	O
clidon	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
:	O
Fallopian	O
tube	O
with	O
focal	O
tubal	O
intraepithelial	O
carcinoma	O
(	O
See	O
synoptic	O
report	O
)	O
.	O

Ovary	O
with	O
corpora	O
albicantia	O
and	O
multifocal	O
reactive	O
lymphoid	O
aggregates	O
.	O

B	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
,	O
SALPINGO	O
-	O
OOPHORECTOMY	O
:	O
Metastatic	O
adenocarcinoma	O
with	O
lymphatic	O
space	O
invasion	O
,	O
high	O
grade	O
serous	O
.	O
type	O
,	O
from	O
endometrial	O
primary	O
.	O

Mullerian	O
inclusion	O
cysts	O
.	O

Fallopian	O
tube	O
with	O
tubal	O
intraepithelial	O
carcinoma	O
involving	O
fimbriated	O
end	O
.	O

C	O
.	O

UTERUS	O
WITH	O
CERVIX	O
,	O
TOTAL	O
HYSTERECTOMY	O
:	O
Cervix	O
:	O
Endocervical	O
and	O
ectocervical	O
stroma	O
diffusely	O
involved	O
by	O
high	O
grade	O
.	O
serous	O
adenocarcinoma	O
.	O

Lymphatic	O
space	O
invasion	O
present	O
.	O

Endometrium	O
:	O
Uterine	O
papillary	O
serous	O
carcinoma	O
(	O
UPSC	O
)	O
with	O
diffuse	O
involvement	O
of	O
.	O
endometrium	O
with	O
peripheral	O
endometrial	O
intraepithelial	O
carcinoma	O
.	O

Background	O
atrophic	O
changes	O
.	O

Myometrium	O
:	O
Diffusely	O
superficial	O
and	O
deep	O
myoinvasion	O
by	O
high	O
grade	O
serous	O
.	O
adenocarcinoma	O
(	O
full	O
thickness	O
involvement	O
to	O
serosa	O
)	O
.	O

Lymphatic	O
space	O
invasion	O
present	O
,	O
extensive	O
.	O

Monckeberg	O
'	O
s	O
vascular	O
medial	O
calcifications	O
.	O

Serosa	O
:	O
Involved	O
by	O
high	O
grade	O
serous	O
adenocarcinoma	O
(	O
full	O
thickness	O
involvement	O
.	O
to	O
serosa	O
)	O
.	O

Anterior	O
inked	O
margin	O
positive	O
.	O

D	O
.	O

OMENTUM	O
#	O
1	O
,	O
OMENTECTOMY	O
:	O
Metastatic	O
uterine	O
papillary	O
serous	O
carcinoma	O
.	O

Reactive	O
mesothelial	O
hyperplasia	O
.	O

E	O
.	O

OMENTUM	O
#	O
2	O
,	O
OMENTECTOMY	O
:	O
Metastatic	O
uterine	O
papillary	O
serous	O
carcinoma	O
.	O

Reactive	O
mesothelial	O
hyperplasia	O
.	O

SYNOPTIC	O
REPORT	O
:	O
Applies	O
To	O
:	O
Patient	O
Case	O
(	O
s	O
)	O
:	O
Copy	O
For	O
:	O
Page	O
1	O
or	O
4	O
.	O

A	O
:	O
LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

B	O
:	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

C	O
:	O
UTERUS	O
AND	O
CERVIX	O
.	O

D	O
:	O
OMENTUM	O
1	O
.	O

E	O
:	O
OMENTUM	O
2	O
.	O

Macroscopic	O
.	O

Uterus	O
.	O

Speclmen	O
Type	O
:	O
Right	O
ovary	O
.	O

Left	O
ovary	O
.	O

Right	O
fallopian	O
tube	O
.	O

Left	O
fallopian	O
tube	O
.	O

Omentum	O
.	O

None	O
.	O

Other	O
Organs	O
Present	O
:	O
Total	O
abdominal	O
hysterectomy	O
and	O
bilateral	O
salpingo	O
-	O
.	O

Procedure	O
:	O
oophorectomy	O
.	O

Intact	O
hysterectomy	O
specimen	O
.	O

Specimen	O
Integrity	O
:	O
No	O
lymph	O
nodes	O
present	O
.	O

Lymph	O
Node	O
Sampling	O
:	O
Microscopic	O
.	O

Serous	O
adenocarcinoma	O
.	O

Histologic	O
Type	O
:	O
G3	O
:	O
Poorly	O
differentiated	O
.	O

Histologic	O
Grade	O
:	O
Corpus	O
.	O

Tumor	O
Site	O
:	O
Fundus	O
.	O

Lower	O
uterine	O
segment	O
.	O

Isthmus	O
.	O

Greatest	O
dimension	O
:	O
5	O
.	O
2cm	O
.	O

Tumor	O
Size	O
:	O
Dimensions	O
:	O
5	O
.	O
2	O
x	O
5	O
X	O
3cm	O
.	O

Tumor	O
extends	O
through	O
the	O
entire	O
uterine	O
wall	O
to	O
serosal	O
.	O

Myometrial	O
Invasion	O
:	O
surface	O
.	O

Invasion	O
of	O
cervical	O
stromal	O
connective	O
tissue	O
.	O

Involvement	O
of	O
Cervix	O
:	O
Extent	O
of	O
Involvement	O
.	O

Left	O
ovary	O
.	O
of	O
Other	O
Organs	O
:	O
Tumor	O
involves	O
serosal	O
aspect	O
.	O

Margins	O
:	O
Present	O
.	O

Lymphovascular	O
Invasion	O
:	O
Pathologic	O
Staging	O
(	O
p	O
TNM	O
[	O
FIGO	O
]	O
)	O
AJCC	O
7th	O
Edition	O
2010	O
.	O

pT3a	O
[	O
IIIA	O
]	O
:	O
Tumor	O
involves	O
serosa	O
and	O
/	O
or	O
adnexa	O
(	O
direct	O
.	O
Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
extension	O
or	O
metastasis	O
)	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Number	O
of	O
pelvic	O
lymph	O
.	O

0	O
.	O
nodes	O
examined	O
:	O
Number	O
of	O
pelvic	O
lymph	O
.	O

0	O
.	O
nodes	O
involved	O
:	O
Number	O
of	O
para	O
-	O
aortic	O
.	O

0	O
.	O
lymph	O
nodes	O
examined	O
:	O
Number	O
of	O
para	O
-	O
aortic	O
.	O

0	O
.	O
lymph	O
nodes	O
involved	O
:	O
Number	O
of	O
common	O
iliac	O
.	O

0	O
.	O
lymph	O
nodes	O
examined	O
:	O
Number	O
of	O
common	O
iliac	O
.	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
pM1	O
[	O
IVB	O
]	O
Distant	O
metastasis	O
.	O

Site	O
(	O
s	O
)	O
:	O
Omentum	O
.	O

HISTORY	O
:	O
Pre	O
-	O
op	O
diagnosis	O
:	O
CA	O
endometrial	O
.	O

MICROSCOPIC	O
FINDINGS	O
:	O
See	O
diagnosis	O
.	O

GROSS	O
:	O
A	O
.	O

LT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
designated	O
"	O
It	O
tube	O
and	O
ovary	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
an	O
intact	O
.	O
adnexa	O
.	O

The	O
tortuous	O
fallopian	O
tube	O
measures	O
4	O
.	O
0	O
cm	O
in	O
length	O
and	O
ranges	O
from	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
to	O
.	O

0	O
.	O
9	O
cm	O
in	O
diameter	O
.	O

It	O
has	O
a	O
fimbriated	O
end	O
.	O

The	O
overlying	O
mesosalpinx	O
is	O
smooth	O
and	O
red	O
-	O
purple	O
.	O

Cut	O
.	O
surface	O
demonstrates	O
a	O
patent	O
lumen	O
lined	O
with	O
delicate	O
pink	O
-	O
tan	O
mucosa	O
.	O

The	O
ovary	O
measures	O
1	O
.	O
4	O
x	O
0	O
.	O
8	O
.	O

x	O
0	O
.	O
5	O
cm	O
and	O
has	O
a	O
smooth	O
pink	O
-	O
yellow	O
capsular	O
surface	O
.	O

Cut	O
surface	O
demonstrates	O
a	O
single	O
corpus	O
.	O
albicans	O
measuring	O
0	O
.	O
9	O
cm	O
in	O
greatest	O
dimension	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

A1	O
.	O

Proximal	O
and	O
mid	O
fallopian	O
tube	O
cross	O
sections	O
and	O
entire	O
fimbriated	O
tip	O
-	O
multiple	O
.	O

A2	O
.	O

Half	O
of	O
bisected	O
ovary	O
-	O
1	O
.	O

A3	O
.	O

Additional	O
tissue	O
-	O
multiple	O
.	O

B	O
.	O

RT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
designated	O
"	O
It	O
tube	O
and	O
ovary	O
"	O
.	O
and	O
received	O
in	O
formalin	O
is	O
an	O
intact	O
.	O
adnexa	O
.	O

The	O
tortuous	O
fimbriated	O
fallopian	O
tube	O
measures	O
5	O
.	O
5	O
cm	O
in	O
length	O
and	O
ranges	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
5	O
cm	O
.	O
in	O
diameter	O
.	O

The	O
overlying	O
mesosalpinx	O
is	O
smooth	O
pink	O
-	O
tan	O
and	O
unremarkable	O
.	O

The	O
cut	O
surface	O
.	O
demonstrates	O
a	O
patent	O
pinpoint	O
lumen	O
lined	O
with	O
delicate	O
tan	O
papilliferous	O
mucosa	O
.	O

The	O
attached	O
ovary	O
.	O
measures	O
1	O
.	O
8	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
capsular	O
surface	O
is	O
pink	O
and	O
yellow	O
.	O

The	O
cut	O
surface	O
demonstrates	O
.	O
unremarkable	O
ovarian	O
parenchyma	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Slide	O
key	O
:	O
B1	O
.	O

Proximal	O
and	O
mid	O
fallopian	O
tube	O
cross	O
sections	O
and	O
entire	O
fimbriated	O
tip	O
-	O
multiple	O
.	O

B2	O
.	O

Entire	O
bisected	O
ovary	O
-	O
2	O
.	O

B3	O
.	O

Entirely	O
submitted	O
additional	O
tissue	O
-	O
multiple	O
.	O

C	O
.	O

UTERUS	O
WITH	O
CERVIX	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
designated	O
"	O
uterus	O
and	O
cervix	O
"	O
,	O
and	O
received	O
fresh	O
for	O
intraoperative	O
.	O
consultation	O
is	O
a	O
uterus	O
and	O
attached	O
cervix	O
.	O

The	O
uterus	O
measures	O
7	O
.	O
3	O
cm	O
in	O
length	O
,	O
5	O
.	O
1	O
cm	O
cornu	O
to	O
.	O
cornu	O
,	O
and	O
5	O
.	O
0	O
cm	O
anterior	O
to	O
posterior	O
.	O

The	O
cervix	O
measures	O
2	O
.	O
6	O
cm	O
in	O
length	O
and	O
3	O
.	O
6	O
cm	O
in	O
maximum	O
.	O
transverse	O
dimensions	O
.	O

The	O
ectocervix	O
is	O
pink	O
to	O
red	O
and	O
granular	O
.	O

Entirely	O
filling	O
the	O
endometrial	O
cavity	O
.	O

is	O
a	O
large	O
exophytic	O
mass	O
measuring	O
5	O
.	O
2	O
x	O
5	O
.	O
0	O
x	O
3	O
.	O
0	O
cm	O
.	O

The	O
mass	O
grossly	O
extends	O
into	O
the	O
cervix	O
and	O
is	O
.	O
located	O
approximately	O
1	O
.	O
0	O
cm	O
from	O
the	O
os	O
on	O
the	O
anterior	O
side	O
and	O
1	O
.	O
5	O
cm	O
from	O
the	O
os	O
on	O
the	O
posterior	O
.	O
side	O
.	O

The	O
serosa	O
overlying	O
the	O
uterine	O
corpus	O
is	O
smooth	O
pink	O
-	O
red	O
unremarkable	O
.	O

Approximately	O
50	O
%	O
of	O
.	O
the	O
mass	O
has	O
a	O
friable	O
red	O
-	O
brown	O
necrotic	O
cut	O
surface	O
.	O

The	O
muscular	O
uterine	O
wall	O
ranges	O
from	O
0	O
.	O
6	O
to	O
1	O
.	O
8	O
.	O

cm	O
.	O

The	O
point	O
of	O
attachment	O
of	O
the	O
mass	O
is	O
on	O
the	O
right	O
wall	O
.	O

The	O
mass	O
invades	O
to	O
the	O
serosal	O
edge	O
on	O
.	O
the	O
right	O
side	O
.	O

The	O
small	O
amount	O
of	O
uninvolved	O
myometrium	O
is	O
rubbery	O
and	O
pink	O
-	O
tan	O
.	O

The	O
uninvolved	O
.	O
endometrium	O
is	O
smooth	O
and	O
pink	O
-	O
tan	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Ink	O
key	O
:	O
Black	O
-	O
Anterior	O
.	O

Blue	O
-	O
Posterior	O
.	O

Red	O
-	O
Cervical	O
end	O
of	O
lower	O
uterine	O
segment	O
.	O

Slide	O
key	O
:	O
C1	O
.	O

Anterior	O
cervix	O
-	O
1	O
.	O

C2	O
.	O

Anterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

C3	O
.	O

Posterior	O
cervix	O
-	O
1	O
.	O

C4	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

C5	O
-	O
C8	O
.	O

Anterior	O
myometrium	O
with	O
mass	O
and	O
serosa	O
-	O
1	O
each	O
.	O

C9	O
,	O
C10	O
.	O

Uninvolved	O
endomyometrium	O
with	O
serosa	O
to	O
mass	O
-	O
1	O
each	O
.	O

C11	O
,	O
C12	O
.	O

Posterior	O
myometrium	O
with	O
serosa	O
and	O
mass	O
-	O
1	O
each	O
.	O

D	O
.	O

OMENTUM	O
#	O
1	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
designated	O
"	O
omentum	O
#	O
1	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
fragment	O
of	O
.	O
finely	O
lobulated	O
yellow	O
adipose	O
tissue	O
consistent	O
with	O
omentum	O
measuring	O
7	O
.	O
6	O
x	O
6	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

Masses	O
.	O
are	O
not	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

D1	O
.	O

Multiple	O
.	O

E	O
.	O

OMENTUM	O
#	O
2	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
designated	O
"	O
omentum	O
#	O
2	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
fragment	O
of	O
.	O
finely	O
lobulated	O
yellow	O
adipose	O
tissue	O
consistent	O
with	O
omentum	O
measuring	O
7	O
.	O
2	O
x	O
4	O
.	O
5	O
x	O
1	O
.	O
1	O
cm	O
.	O

Masses	O
.	O
are	O
not	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

E1	O
.	O

Multiple	O
.	O

Gross	O
dictated	O
b	O
'	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
C	O
.	O

UTERUS	O
AND	O
CERVIX	O
,	O
GROSS	O
EXAMINATION	O
:	O
Bulky	O
necrotic	O
endometrial	O
tumor	O
with	O
gross	O
extrusion	O
/	O
involvement	O
of	O
cervix	O
.	O

NOTE	O
:	O
Portion	O
of	O
tumor	O
given	O
for	O
research	O
purposes	O
(	O
TCGA	O
)	O
.	O

A	O
AND	O
B	O
.	O

LEFT	O
AND	O
RIGHT	O
ADNEXA	O
,	O
GROSS	O
EXAMINATION	O
:	O
No	O
gross	O
tumor	O
seen	O
.	O

1	O
have	O
personally	O
examined	O
the	O
specimen	O
.	O
interpreted	O
the	O
results	O
,	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

If	O
this	O
report	O
includes	O
immunohistochemic	O
.	O
their	O
.	O

performance	O
charactenstics	O
determined	O
b	O
)	O
.	O
immunohistochemical	O
tests	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
,	O
and	O
FDA	O
approval	O
is	O
not	O
required	O
.	O

PATH	O
#	O
:	O
Hospital	O
No	O
.	O

:	O
A	O
/	O
S	O
:	O
Date	O
of	O
Birth	O
:	O
Soc	O
.	O

Sec	O
.	O

No	O
:	O
Attending	O
MD	O
:	O
Copies	O
To	O
:	O
DIAGNOSIS	O
:	O
1	O
-	O
4	O
.	O

PELVIC	O
NODULE	O
,	O
PELVIC	O
PERITONEUM	O
,	O
UMBILICAL	O
HERNIA	O
,	O
BLADDER	O
.	O

PERITONEUM	O
,	O
BIOPSIES	O
:	O
-	O
Positive	O
for	O
high	O
-	O
grade	O
papillary	O
serous	O
carcinoma	O
.	O

5	O
-	O
9	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
RIGHT	O
AND	O
LEFT	O
OVARIES	O
AND	O
FALLOPIAN	O
TUBES	O
,	O
.	O

HYSTERECTOMY	O
WITH	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
:	O
-	O
Papillary	O
serous	O
carcinoma	O
,	O
high	O
-	O
grade	O
.	O

-	O
Tumor	O
involves	O
both	O
right	O
and	O
left	O
ovaries	O
,	O
replacing	O
most	O
of	O
.	O
the	O
ovarian	O
parenchyma	O
.	O

-	O
Tumor	O
also	O
involves	O
the	O
right	O
and	O
left	O
fallopian	O
tubes	O
mucosa	O
.	O
with	O
transmural	O
invasion	O
.	O

-	O
Benign	O
endometrial	O
polyp	O
in	O
a	O
background	O
of	O
secretory	O
.	O
endometrium	O
.	O

-	O
The	O
myometrium	O
is	O
unremarkable	O
.	O

-	O
The	O
uterine	O
serosa	O
is	O
unremarkable	O
.	O

-	O
Cervix	O
shows	O
metastatic	O
deposits	O
of	O
papillary	O
serous	O
carcinoma	O
.	O
in	O
the	O
lymphatic	O
spaces	O
and	O
submucosal	O
stroma	O
.	O

10	O
.	O

APPENDIX	O
,	O
RESECTION	O
:	O
-	O
Metastatic	O
high	O
-	O
grade	O
papillary	O
serous	O
carcinoma	O
involving	O
.	O
periappendiceal	O
soft	O
tissue	O
.	O

11	O
-	O
17	O
.	O

SIGMOID	O
IMPLANT	O
,	O
TUMOR	O
NODULE	O
,	O
URETERAL	O
SACRAL	O
NODULE	O
,	O
.	O

OMENTUM	O
,	O
LESSER	O
SAC	O
,	O
COLON	O
NODULE	O
,	O
BLADDER	O
NODULE	O
,	O
BIOPSIES	O
:	O
-	O
Positive	O
for	O
high	O
-	O
grade	O
papillary	O
serous	O
carcinoma	O
.	O

HISTORY	O
:	O
Ovarian	O
carcinoma	O
.	O

MICROSCOPIC	O
:	O
See	O
Diagnosis	O
.	O

GROSS	O
:	O
1	O
.	O

PELVIC	O
NODULE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
are	O
two	O
firm	O
.	O
pink	O
-	O
white	O
portions	O
of	O
tissue	O
measuring	O
2	O
.	O
8	O
and	O
3	O
.	O
0	O
cm	O
in	O
greatest	O
.	O
dimensions	O
.	O

The	O
cut	O
surfaces	O
display	O
homogeneous	O
,	O
friable	O
,	O
.	O
tan	O
-	O
white	O
tumor	O
with	O
hemorrhage	O
.	O

Representative	O
section	O
.	O

A	O
:	O
1	O
.	O

2	O
.	O

PELVIC	O
PERITONEUM	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
soft	O
.	O
yellow	O
-	O
tan	O
5	O
.	O
2	O
x	O
3	O
.	O
1	O
x	O
0	O
.	O
4	O
cm	O
irregular	O
portion	O
of	O
membranous	O
.	O
tissue	O
.	O

The	O
specimen	O
is	O
studded	O
with	O
firm	O
,	O
white	O
tumor	O
nodules	O
.	O

Representative	O
section	O
.	O

B	O
:	O
1	O
.	O

3	O
.	O

UMBILICAL	O
HERNIA	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
portion	O
of	O
.	O
saccular	O
fibroadipose	O
and	O
fibromembranous	O
tissue	O
,	O
4	O
.	O
9	O
x	O
3	O
.	O
2	O
x	O
0	O
.	O
9	O
cm	O
.	O
in	O
greatest	O
dimensions	O
.	O

On	O
sectioning	O
a	O
cystic	O
area	O
containing	O
.	O
hemorrhage	O
is	O
identified	O
.	O

Representative	O
section	O
.	O

C	O
:	O
1	O
.	O

4	O
.	O

BLADDER	O
PERITONEUM	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
are	O
two	O
firm	O
.	O
pink	O
-	O
white	O
portions	O
of	O
tissue	O
measuring	O
1	O
.	O
3	O
and	O
2	O
.	O
2	O
cm	O
in	O
greatest	O
.	O
dimensions	O
.	O

Representative	O
sections	O
.	O

5	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
fallopian	O
.	O
tube	O
measuring	O
3	O
.	O
6	O
cm	O
in	O
length	O
,	O
and	O
0	O
.	O
7	O
cm	O
in	O
average	O
diameter	O
.	O

The	O
tube	O
is	O
diffusely	O
indurated	O
.	O

The	O
fimbriated	O
end	O
is	O
indurated	O
.	O
with	O
firm	O
,	O
white	O
tumor	O
.	O

On	O
sectioning	O
the	O
lumen	O
measures	O
0	O
.	O
3	O
cm	O
in	O
.	O
diameter	O
.	O

Attached	O
to	O
the	O
fallopian	O
tube	O
is	O
a	O
3	B
.	I
9	I
x	I
3	I
.	I
6	I
x	I
2	I
.	I
8	I
cm	I
.	O
solid	O
and	O
cystic	O
ovary	O
which	O
on	O
sectioning	O
is	O
completely	O
replaced	O
.	O
by	O
firm	O
,	O
white	O
tumor	O
.	O

Representative	O
sections	O
.	O

E	O
:	O
fallopian	O
tube	O
-	O
2	O
.	O

F	O
-	O
H	O
:	O
ovary	O
-	O
1	O
each	O
.	O

6	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
the	O
fresh	O
state	O
in	O
the	O
.	O

Operating	O
Room	O
for	O
frozen	O
section	O
diagnosis	O
and	O
subsequently	O
fixed	O
.	O
in	O
formalin	O
is	O
a	O
fallopian	O
tube	O
measuring	O
4	O
.	O
3	O
cm	O
in	O
length	O
,	O
and	O
.	O

1	O
.	O
2	O
cm	O
.	O
in	O
average	O
diameter	O
.	O

The	O
tube	O
is	O
diffusely	O
indurated	O
and	O
.	O
distended	O
by	O
firm	O
white	O
tumor	O
.	O

The	O
fimbriated	O
end	O
is	O
identified	O
.	O
grossly	O
.	O

On	O
sectioning	O
the	O
lumen	O
measures	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

Attached	O
to	O
the	O
segment	O
of	O
fallopian	O
tube	O
is	O
a	O
4	B
.	I
3	I
x	I
3	I
.	I
4	I
x	I
3	I
.	I
2	I
cm	I
.	O
cystic	O
and	O
solid	O
ovary	O
which	O
on	O
sectioning	O
is	O
completely	O
replaced	O
.	O
by	O
firm	O
,	O
white	O
tumor	O
.	O

Representative	O
sections	O
.	O

I	O
:	O
frozen	O
-	O
section	O
control	O
#	O
1	O
-	O
2	O
.	O

J	O
:	O
fallopian	O
tube	O
-	O
2	O
.	O

K	O
-	O
M	O
:	O
ovary	O
-	O
1	O
each	O
.	O

7	O
.	O

UTERUS	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
the	O
fresh	O
state	O
in	O
the	O
.	O

Operating	O
Room	O
for	O
intra	O
-	O
operative	O
gross	O
consultation	O
and	O
.	O
subsequently	O
fixed	O
in	O
formalin	O
is	O
a	O
uterus	O
without	O
attached	O
adnexa	O
.	O
which	O
weighs	O
270	O
grams	O
.	O

The	O
uterine	O
corpus	O
is	O
enlarged	O
,	O
measuring	O
.	O

6	O
.	O
3	O
cm	O
superior	O
to	O
inferior	O
,	O
8	O
.	O
4	O
cm	O
cornu	O
to	O
cornu	O
,	O
and	O
7	O
.	O
1	O
cm	O
.	O
anterior	O
to	O
posterior	O
.	O

The	O
serosa	O
is	O
tan	O
red	O
with	O
focal	O
.	O
hemorrhage	O
.	O

The	O
cervix	O
has	O
a	O
length	O
of	O
4	O
.	O
3	O
cm	O
and	O
a	O
diameter	O
of	O
.	O

4	O
.	O
1	O
cm	O
.	O

There	O
is	O
a	O
1	O
.	O
5	O
cm	O
slit	O
-	O
like	O
patent	O
os	O
.	O

The	O
ectocervical	O
.	O
mucosa	O
is	O
tan	O
-	O
pink	O
and	O
smooth	O
without	O
obvious	O
lesions	O
.	O

The	O
.	O
transformation	O
zone	O
is	O
distinct	O
.	O

The	O
endocervical	O
canal	O
is	O
3	O
.	O
1	O
cm	O
.	O
in	O
length	O
and	O
is	O
tan	O
and	O
rugose	O
.	O

The	O
endometrial	O
cavity	O
is	O
5	O
.	O
2	O
cm	O
.	O
in	O
length	O
,	O
3	O
.	O
7	O
cm	O
in	O
width	O
,	O
and	O
is	O
lined	O
by	O
a	O
soft	O
tan	O
,	O
smooth	O
.	O
endometrium	O
with	O
a	O
thickness	O
of	O
0	O
.	O
2	O
cm	O
.	O

The	O
endometrium	O
contains	O
.	O
two	O
tan	O
-	O
brown	O
soft	O
polyps	O
measuring	O
1	O
.	O
0	O
and	O
2	O
.	O
4	O
cm	O
in	O
greatest	O
.	O
dimensions	O
.	O

The	O
myometrium	O
is	O
2	O
.	O
3	O
cm	O
in	O
maximum	O
thickness	O
.	O

The	O
.	O
myometrium	O
is	O
grossly	O
unremarkable	O
.	O

Representative	O
sections	O
.	O

N	O
:	O
anterior	O
uterine	O
corpus	O
-	O
1	O
.	O

O	O
:	O
anterior	O
uterine	O
corpus	O
polyp	O
-	O
2	O
.	O

P	O
:	O
anterior	O
cervix	O
-	O
1	O
.	O

Q	O
:	O
posterior	O
uterine	O
corpus	O
-	O
1	O
.	O

R	O
:	O
posterior	O
uterine	O
corpus	O
polyp	O
-	O
1	O
.	O

S	O
:	O
posterior	O
cervix	O
-	O
1	O
.	O

8	O
.	O

LEFT	O
OVARY	O
TUMOR	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
firm	O
white	O
.	O

2	B
.	I
3	I
x	I
1	I
.	I
8	I
x	I
1	I
.	I
4	I
cm	I
irregular	O
portion	O
of	O
tissue	O
.	O

Representative	O
.	O
section	O
.	O

T	O
:	O
1	O
.	O

9	O
.	O

RIGHT	O
OVARY	O
TUMOR	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
firm	O
white	O
.	O

2	B
.	I
8	I
x	I
1	I
.	I
7	I
x	I
1	I
.	I
6	I
cm	I
irregular	O
portion	O
of	O
tissue	O
.	O

Representative	O
.	O
section	O
.	O

U	O
:	O
1	O
.	O

10	O
.	O

APPENDIX	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
vermiform	O
.	O
appendix	O
,	O
5	O
.	O
7	O
cm	O
long	O
and	O
0	O
.	O
8	O
cm	O
in	O
maximum	O
diameter	O
,	O
with	O
attached	O
.	O
fat	O
up	O
to	O
0	O
.	O
9	O
cm	O
in	O
width	O
and	O
1	O
.	O
1	O
cm	O
in	O
thickness	O
.	O

The	O
external	O
.	O
surface	O
is	O
tan	O
-	O
pink	O
and	O
bosselated	O
with	O
firm	O
white	O
tumor	O
nodules	O
.	O

No	O
exudate	O
is	O
seen	O
.	O

The	O
wall	O
varies	O
in	O
thickness	O
up	O
to	O
0	O
.	O
2	O
cm	O
and	O
.	O

is	O
firm	O
and	O
tan	O
-	O
white	O
.	O

There	O
is	O
no	O
gross	O
perforation	O
.	O

The	O
lumen	O
.	O
measures	O
up	O
to	O
0	O
.	O
3	O
cm	O
and	O
contains	O
a	O
small	O
amount	O
of	O
hemorrhagic	O
.	O
material	O
.	O

No	O
fecalith	O
is	O
identified	O
.	O

Representative	O
sections	O
.	O

V	O
:	O
3	O
.	O

11	O
.	O

SIGMOID	O
IMPLANT	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
are	O
five	O
firm	O
.	O
white	O
portions	O
of	O
tissue	O
measuring	O
from	O
0	O
.	O
6	O
to	O
0	O
.	O
9	O
cm	O
in	O
greatest	O
.	O
dimension	O
.	O

Representative	O
sections	O
.	O

W	O
:	O
3	O
.	O

12	O
.	O

TUMOR	O
NODULE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
are	O
six	O
soft	O
.	O
white	O
portions	O
of	O
tissue	O
measuring	O
from	O
0	B
.	I
5	I
to	O
1	B
.	I
0	I
cm	I
in	O
greatest	O
.	O
dimension	O
.	O

Representative	O
sections	O
.	O

X	O
:	O
3	O
.	O

13	O
.	O

URETERAL	O
SACRAL	O
NODULE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
firm	O
.	O
pink	O
-	O
white	O
2	O
.	O
8	O
x	O
1	O
.	O
6	O
x	O
1	O
.	O
4	O
cm	O
irregular	O
portion	O
of	O
tissue	O
.	O

Representative	O
section	O
.	O

Y	O
:	O
1	O
.	O

14	O
.	O

OMENTUM	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
22	B
.	I
5	I
x	I
5	I
.	I
8	I
.	I

x	B
3	I
.	I
4	I
cm	I
aggregate	O
of	O
indurated	O
adipose	O
tissue	O
with	O
diffuse	O
,	O
firm	O
,	O
.	O
white	O
tumor	O
nodularity	O
.	O

Representative	O
section	O
.	O

Z	O
:	O
1	O
.	O

15	O
.	O

LESSER	O
SAC	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
firm	O
.	O
yellow	O
-	O
white	O
2	B
.	I
3	I
x	I
1	I
.	I

x	B
0	I
.	I
8	I
cm	I
irregular	O
portion	O
of	O
tissue	O
.	O

Representative	O
section	O
.	O

A2	O
:	O
1	O
.	O

16	O
.	O

COLON	O
NODULE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
are	O
six	O
firm	O
.	O
pink	O
-	O
white	O
portions	O
of	O
tissue	O
measuring	O
from	O
0	O
.	O
6	O
to	O
1	O
.	O
2	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

Representative	O
sections	O
.	O

B2	O
:	O
2	O
.	O

17	O
.	O

BLADDER	O
NODULE	O
.	O

Labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
labeled	O
as	O
designated	O
on	O
the	O
.	O
specimen	O
requisition	O
form	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
firm	O
.	O
pink	O
-	O
white	O
1	O
.	O
3	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
2	O
cm	O
irregular	O
portion	O
of	O
tissue	O
.	O

Entirely	O
submitted	O
.	O

C2	O
:	O
1	O
.	O

OPERATIVE	O
CONSULT	O
(	O
FROZEN	O
)	O
:	O
#	O
6	O
.	O

MALIGNANT	O
TUMOR	O
,	O
FAVOR	O
PAPILLARY	O
SEROUS	O
CARCINOMA	O
.	O
nafarrad	O
to	O
noxmanents	O
.	O

OPERATIVE	O
CONSULT	O
(	O
GROSS	O
)	O
:	O
#	O
7	O
.	O

UTERUS	O
WITH	O
ENDOMETRIAL	O
POLYPS	O
:	O

Final	O
Pathology	O
Template	O
.	O

Final	O
Pathology	O
Report	O
Information	O
.	O

1	O
.	O
1	O
.	O

Tissue	O
Specimen	O
ID	O
Code	O
:	O
1	O
.	O
2	O
.	O

Date	O
of	O
Excision	O
:	O
1	O
.	O
3	O
.	O

Tumor	O
Location	O
(	O
anatomic	O
site	O
)	O
:	O
Stomach	O
,	O
Antrum	O
.	O

1	O
.	O
4	O
.	O

Tumor	O
Size	O
:	O
3	B
,	I
0x	I
4	I
,	I
0	I
(	I
cm	I
)	I
.	O

1	O
.	O
5	O
.	O

Lymph	O
Node	O
Status	O
:	O
1	O
.	O
5	O
.	O
1	O
.	O

Number	O
Nodes	O
Examined	O
:	O
5	O
.	O

1	O
.	O
5	O
.	O
2	O
.	O

Number	O
Nodes	O
Positive	O
:	O
3	O
.	O

1	O
.	O
5	O
.	O
3	O
.	O

Lymph	O
Node	O
Locations	O
(	O
Involved	O
Nodes	O
)	O
:	O
2	O
greater	O
curvature	O
,	O
.	O

3	O
.	O
lesser	O
curvature	O
.	O

1	O
.	O
6	O
.	O

Metastasis	O
:	O
1	O
.	O
6	O
.	O
1	O
.	O

Metastasis	O
Present	O
:	O
Unknown	O
.	O

1	O
.	O
6	O
.	O
2	O
.	O

Number	O
of	O
Mets	O
:	O
1	O
.	O
6	O
.	O
3	O
.	O

Site	O
(	O
s	O
)	O
Of	O
Metastasis	O
:	O
1	O
.	O
7	O
.	O

ICD	O
-	O
9	O
Code	O
for	O
Specimen	O
Diagnosis	O
:	O
C	O
16	O
.	O
3	O
.	O

1	O
.	O
8	O
.	O

Final	O
Pathology	O
Details	O
:	O
(	O
Please	O
suppy	O
de	O
-	O
identified	O
copy	O
of	O
original	O
language	O
final	O
pathology	O
report	O
in	O
.	O
addition	O
to	O
information	O
below	O
)	O
.	O

1	O
.	O
8	O
.	O
1	O
Macroscopic	O
Description	O
:	O
Surgical	O
specimen	O
of	O
stomach	O
,	O
.	O
measuring	O
12	O
cm	O
in	O
combination	O
with	O
greater	O
omentum	O
.	O

At	O
.	O

5	O
.	O
0	O
cm	O
from	O
the	O
distal	O
resection	O
margin	O
,	O
ulcerative	O
.	O
formation	O
.	O
with	O
regular	O
borders	O
3	O
.	O
0	O
x	O
4	O
.	O
0cm	O
in	O
.	O
dimension	O
,	O
infiltrating	O
the	O
1	O
/	O
2	O
gastric	O
wall	O
.	O

Greater	O
.	O
omentum	O
is	O
intact	O
.	O

5	O
lymph	O
nodes	O
(	O
2	O
-	O
greater	O
.	O
curvatures	O
,	O
3	O
-	O
lessen	O
curvature	O
)	O
.	O

1	O
.	O
8	O
.	O
2	O
.	O

Microscopic	O
.	O

Description	O
:	O
Moderately	O
differentiated	O
.	O
adenocarcinoma	O
of	O
stomach	O
,	O
mucinous	O
type	O
,	O
ulcerated	O
,	O
.	O
with	O
areas	O
hyalinosis	O
and	O
lymphoid	O
.	O

Tumor	O
invades	O
all	O
.	O
wall	O
of	O
the	O
stomach	O
.	O

Margins	O
resection	O
is	O
intact	O
.	O

Greater	O
omentum	O
is	O
intact	O
.	O

Lymph	O
nodes	O
status	O
positive	O
:	O
greater	O
curvature	O
(	O
2	O
from	O
2	O
)	O
and	O
lesser	O
curvature	O
.	O

(	O
1	O
.	O
form	O
3	O
)	O
.	O

1	O
.	O
8	O
.	O
3	O
.	O

Comment	O
(	O
if	O
applicable	O
)	O
:	O
1	O
.	O
8	O
.	O
4	O
.	O

Clinical	O
Diagnosis	O
:	O
Gastric	O
cancer	O
of	O
antrum	O
.	O

1	O
.	O
8	O
.	O
5	O
.	O

Stage	O
:	O
T3	O
N2	O
M0	O
,	O
st	O
.	O

IIIA	O
.	O

PROPRIETARY	O
AND	O
CONFIDENTIAL	O
.	O

SPECIMEN	O
.	O

A	O
.	O

Left	O
sentinel	O
lymph	O
node	O
#	O
1	O
.	O

B	O
.	O

Left	O
breast	O
stitch	O
12	O
o	O
'	O
clock	O
.	O

C	O
.	O

Left	O
breast	O
,	O
Tail	O
of	O
Spence	O
.	O

D	O
.	O

Left	O
breast	O
,	O
Nodule	O
inferior	O
skin	O
flap	O
-	O
stitch	O
6	O
o	O
'	O
clock	O
.	O

E	O
.	O

Right	O
breast	O
double	O
long	O
12	O
o	O
'	O
clock	O
single	O
long	O
hard	O
mass	O
10	O
.	O

b	O
'	O
clock	O
.	O

F	O
.	O

Palpable	O
area	O
right	O
axilla	O
.	O

G	O
.	O

Sentinel	O
node	O
#	O
2	O
,	O
right	O
breast	O
.	O

REPORT	O
REVISED	O
ON	O
.	O

AT	O
.	O

CLINICAL	O
NOTES	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Bilateral	O
breast	O
carcinoma	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

A	O
)	O
Lymph	O
node	O
,	O
sentinel	O
node	O
left	O
,	O
excision	O
:	O
One	O
lymph	O
node	O
.	O
negative	O
for	O
metastatic	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

FFS1	O
,	O
FFS2	O
:	O
Palpable	O
area	O
,	O
right	O
axilla	O
,	O
biopsy	O
-	O
Benign	O
lymph	O
.	O
node	O
.	O

present	O
.	O

GFS	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
right	O
axilla	O
,	O
biopsy	O
-	O
One	O
lymph	O
node	O
with	O
.	O

no	O
evidence	O
of	O
metastasis	O
.	O

GROSS	O
DESCRIPTION	O
.	O

A	O
.	O

Received	O
fresh	O
for	O
frozen	O
section	O
labeled	O
"	O
left	O
.	O
sentinel	O
lymph	O
node	O
#	O
1	O
"	O
is	O
an	O
irregularly	O
shaped	O
fragment	O
.	O
of	O
blue	O
stained	O
tissue	O
that	O
measures	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
4	O
cm	O
.	O

in	O
.	O
dimension	O
.	O

Tissue	O
is	O
entirely	O
frozen	O
.	O

B	O
.	O

Received	O
fresh	O
,	O
labeled	O
"	O
left	O
breast	O
stitch	O
12	O
.	O

o	O
'	O
clock	O
"	O
.	O

is	O
a	O
26	O
.	O
0	O
cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
x	O
24	O
.	O
5	O
cm	O
.	O

(	O
superior	O
to	O
.	O
inferior	O
)	O
x	O
4	O
.	O
5	O
cm	O
.	O

(	O
anterior	O
to	O
posterior	O
)	O
diffusely	O
cauterized	O
and	O
.	O
focally	O
blue	O
stained	O
soft	O
,	O
lobulated	O
tan	O
gold	O
-	O
white	O
portion	O
of	O
.	O
fibroadipose	O
tissue	O
in	O
keeping	O
with	O
breast	O
designated	O
as	O
left	O
per	O
.	O
requisition	O
slip	O
and	O
container	O
and	O
oriented	O
by	O
a	O
single	O
suture	O
as	O
.	O
stated	O
previously	O
.	O

A	O
5	O
.	O
5	O
cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
X	O
2	O
.	O
3	O
cm	O
.	O

(	O
superior	O
.	O
GROSS	O
DESCRIPTION	O
.	O
to	O
inferior	O
)	O
portion	O
of	O
dusky	O
tan	O
white	O
skin	O
with	O
a	O
central	O
,	O
.	O
everted	O
,	O
1	O
.	O
3	O
X	O
1	O
.	O
3	O
x	O
0	O
.	O
5	O
cm	O
.	O
nipple	O
is	O
present	O
along	O
the	O
anterior	O
.	O
aspect	O
.	O

The	O
deep	O
margin	O
is	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
.	O
sectioned	O
.	O

There	O
is	O
a	O
roughly	O
spherical	O
,	O
2	O
.	O
4	O
cm	O
.	O
clot	O
-	O
filled	O
.	O

biopsy	O
.	O
cavity	O
within	O
the	O
lower	O
inner	O
quadrant	O
.	O

The	O
cavity	O
is	O
present	O
.	O
within	O
1	O
.	O
2	O
cm	O
.	O
of	O
the	O
anterior	O
surface	O
(	O
inked	O
blue	O
see	O
block	O
2	O
)	O
and	O
.	O

2	O
.	O
8	O
cm	O
.	O
of	O
the	O
inked	O
deep	O
margin	O
(	O
see	O
block	O
1	O
)	O
.	O

Several	O
.	O
cylindrical	O
.	O

tan	O
white	O
firm	O
structures	O
are	O
evident	O
within	O
the	O
cavity	O
.	O

The	O
.	O
periphery	O
of	O
the	O
cavity	O
is	O
fibrotic	O
with	O
diffuse	O
chalky	O
yellow	O
fat	O
.	O
necrosis	O
.	O

Lateral	O
to	O
the	O
cavity	O
is	O
an	O
ill	O
-	O
defined	O
focus	O
of	O
firm	O
,	O
.	O
tan	O
white	O
fibrous	O
tissue	O
with	O
dilated	O
ductal	O
structures	O
(	O
see	O
blocks	O
.	O
6	O
and	O
7	O
)	O
Within	O
the	O
center	O
of	O
the	O
focus	O
,	O
there	O
appears	O
to	O
be	O
a	O
.	O
stellate	O
1	O
.	O
0	O
x	O
1	O
.	O
0	O
X	O
1	O
.	O
0	O
cm	O
.	O
rubbery	O
tan	O
white	O
lesion	O
which	O
is	O
0	O
.	O
5	O
.	O

cm	O
.	O
from	O
the	O
inked	O
deep	O
margin	O
(	O
see	O
blocks	O
7	O
and	O
8	O
)	O
-	O
.	O

The	O
remaining	O
.	O
cut	O
.	O

surfaces	O
throughout	O
the	O
specimen	O
consists	O
predominately	O
of	O
.	O
glistening	O
lobulated	O
golden	O
yellow	O
adipose	O
tissue	O
with	O
a	O
moderate	O
.	O
amount	O
of	O
interspersed	O
focally	O
blue	O
stained	O
dense	O
tan	O
white	O
fibrous	O
.	O
tissue	O
.	O

No	O
additional	O
mass	O
lesions	O
are	O
identified	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
fourteen	O
blocks	O
as	O
labeled	O
.	O

RS	O
-	O
14	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
-	O
Biopsy	O
cavity	O
to	O
inked	O
deep	O
margin	O
;	O
2	O
-	O
biopsy	O
.	O
cavity	O
to	O
anterior	O
surface	O
;	O
3	O
-	O
5	O
-	O
biopsy	O
cavity	O
to	O
adjacent	O
.	O
parenchyma	O
;	O
6	O
-	O
firm	O
area	O
lateral	O
to	O
biopsy	O
cavity	O
;	O
7	O
-	O
8	O
-	O
apparent	O
.	O
lesion	O
lateral	O
to	O
biopsy	O
cavity	O
to	O
inked	O
deep	O
margin	O
;	O
9	O
-	O
random	O
.	O
upper	O
outer	O
quadrant	O
;	O
10	O
-	O
upper	O
inner	O
quadrant	O
;	O
11	O
-	O
lower	O
inner	O
.	O
quadrant	O
;	O
12	O
-	O
lower	O
outer	O
quadrant	O
;	O
13	O
-	O
junction	O
of	O
the	O
four	O
.	O
quadrant	O
;	O
14	O
-	O
nipple	O
.	O

C	O
.	O

Received	O
fresh	O
,	O
labeled	O
"	O
tail	O
of	O
Spence	O
"	O
,	O
is	O
a	O
5	O
X	O
4	O
X	O
.	O

1	O
.	O
6	O
.	O

cm	O
.	O
portion	O
of	O
soft	O
,	O
lobulated	O
golden	O
-	O
yellow	O
adipose	O
.	O
tissue	O
.	O

Three	O
soft	O
tan	O
-	O
pink	O
-	O
gold	O
tissues	O
,	O
in	O
keeping	O
with	O
lymph	O
.	O
nodes	O
,	O
measuring	O
up	O
to	O
1	O
.	O
5	O
cm	O
.	O
in	O
greatest	O
dimension	O
,	O
are	O
.	O
recovered	O
.	O

The	O
lymphoid	O
tissues	O
are	O
entirely	O
submitted	O
in	O
three	O
blocks	O
,	O
as	O
.	O

GROSS	O
DESCRIPTION	O
.	O
labeled	O
.	O

RS	O
-	O
3	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
-	O
One	O
whole	O
presumptive	O
node	O
;	O
2	O
,	O
3	O
-	O
one	O
bisected	O
.	O
presumptive	O
node	O
per	O
cassette	O
.	O

D	O
.	O

Received	O
fresh	O
,	O
labeled	O
"	O
nodule	O
inferior	O
skin	O
flap	O
-	O
.	O
stitch	O
6	O
o	O
'	O
clock	O
"	O
,	O
is	O
a	O
3	O
.	O
8	O
cm	O
.	O

(	O
9	O
to	O
3	O
o	O
'	O
clock	O
)	O
x	O
0	O
.	O
9	O
cm	O
.	O

(	O
12	O
to	O
6	O
o	O
'	O
clock	O
)	O
wrinkled	O
tan	O
-	O
white	O
skin	O
ellipse	O
,	O
with	O
a	O
suture	O
.	O
along	O
one	O
aspect	O
,	O
as	O
stated	O
previously	O
.	O

The	O
12	O
'	O
clock	O
half	O
is	O
.	O
inked	O
blue	O
and	O
the	O
6	O
o	O
'	O
clock	O
half	O
is	O
inked	O
black	O
.	O

There	O
is	O
a	O
.	O
stellate	O
,	O
rubbery	O
,	O
0	O
.	O
6	O
X	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
cm	O
.	O
tan	O
-	O
white	O
nodular	O
lesion	O
.	O
within	O
the	O
9	O
o	O
'	O
clock	O
half	O
of	O
the	O
specimen	O
,	O
which	O
appears	O
to	O
extend	O
.	O
to	O
within	O
less	O
than	O
0	O
.	O

cm	O
.	O
of	O
the	O
inked	O
12	O
o	O
'	O
clock	O
surface	O
.	O

The	O
.	O
specimen	O
is	O
entirely	O
submitted	O
in	O
a	O
sequential	O
manner	O
from	O
3	O
to	O
9	O
.	O

"	O
clock	O
in	O
four	O
blocks	O
(	O
nodule	O
block	O
3	O
)	O
.	O

E	O
.	O

Received	O
fresh	O
,	O
labeled	O
"	O
right	O
breast	O
double	O
long	O
12	O
.	O

o	O
'	O
clock	O
,	O
single	O
long	O
hard	O
mass	O
10	O
o	O
'	O
clock	O
"	O
is	O
27	O
.	O
0	O
.	O

cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
x	O
23	O
.	O
5	O
cm	O
.	O

(	O
superior	O
to	O
inferior	O
)	O
X	O
4	O
.	O
5	O
.	O

cm	O
.	O

(	O
anterior	O
to	O
posterior	O
)	O
diffusely	O
cauterized	O
and	O
focally	O
blue	O
.	O
stained	O
soft	O
,	O
lobulated	O
tan	O
gold	O
-	O
white	O
portion	O
of	O
fibroadipose	O
.	O
tissue	O
in	O
keeping	O
with	O
breast	O
designated	O
as	O
right	O
per	O
requisition	O
.	O
slip	O
and	O
container	O
and	O
oriented	O
by	O
double	O
suture	O
as	O
stated	O
.	O
previously	O
.	O

A	O
4	O
.	O

4	O
cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
X	O
2	O
.	O
5	O
cm	O
.	O

(	O
superior	O
to	O
.	O
inferior	O
)	O
dusky	O
tan	O
white	O
skin	O
ellipse	O
with	O
a	O
central	O
,	O
everted	O
,	O
1	O
.	O
0	O
.	O

x	O
1	O
.	O

0	O
X	O
0	O
.	O
6	O
cm	O
.	O
nipple	O
is	O
present	O
along	O
the	O
anterior	O
aspect	O
.	O

A	O
.	O
second	O
single	O
suture	O
is	O
present	O
at	O
approximately	O
9	O
-	O
10	O
o	O
'	O
clock	O
.	O

The	O
.	O
intact	O
deep	O
margin	O
is	O
inked	O
black	O
and	O
the	O
specimen	O
is	O
sectioned	O
.	O

There	O
is	O
a	O
moderately	O
well	O
circumscribed	O
,	O
5	O
.	O
0	O
cm	O
.	O

(	O
superior	O
to	O
.	O
inferior	O
)	O
X	O
3	O
.	O
4	O
cm	O
.	O

(	O
medial	O
to	O
lateral	O
)	O
x	O
3	O
.	O
0	O
cm	O
.	O

(	O
anterior	O
to	O
.	O
posterior	O
)	O
auti	O
-	O
loculated	O
slightly	O
firm	O
cystic	O
structure	O
subjacent	O
.	O
to	O
the	O
aforementioned	O
single	O
suture	O
at	O
the	O
junction	O
of	O
the	O
upper	O
.	O
and	O
.	O

lower	O
outer	O
quadrants	O
.	O

The	O
cyst	O
focally	O
extends	O
to	O
within	O
0	O
.	O
3	O
cm	O
.	O
of	O
the	O
inked	O
deep	O
margin	O
(	O
see	O
blocks	O
1	O
and	O
2	O
)	O
and	O
is	O
1	O
.	O
5	O
cm	O
.	O
from	O
.	O

GROSS	O
DESCRIPTION	O
.	O
the	O
anterior	O
surface	O
(	O
subsequently	O
inked	O
blue	O
)	O
.	O

A	O
portion	O
of	O
the	O
.	O
cystic	O
focus	O
and	O
a	O
portion	O
of	O
normal	O
parenchyma	O
are	O
submitted	O
for	O
.	O
tissue	O
procurement	O
as	O
requested	O
.	O

The	O
cut	O
surfaces	O
throughout	O
the	O
.	O
remainder	O
of	O
the	O
specimen	O
consists	O
predominately	O
of	O
glistening	O
.	O
lobulated	O
golden	O
yellow	O
adipose	O
tissue	O
with	O
a	O
moderate	O
amount	O
of	O
.	O
interspersed	O
diffusely	O
cystic	O
tan	O
white	O
fibrous	O
tissue	O
.	O

No	O
mass	O
.	O
lesion	O
or	O
additional	O
abnormalities	O
are	O
identified	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
in	O
16	O
blocks	O
as	O
labeled	O
.	O

RS	O
-	O
16	O
.	O

BLOCK	O
SUMMARY	O
:	O
1	O
-	O
2	O
-	O
Cystic	O
structure	O
to	O
inked	O
deep	O
margin	O
;	O
3	O
-	O
4	O
-	O
.	O
cystic	O
structure	O
to	O
inked	O
anterior	O
margin	O
;	O
5	O
-	O
10	O
-	O
representative	O
.	O
cystic	O
structure	O
to	O
surrounding	O
parenchyma	O
including	O
firm	O
area	O
.	O
sequentially	O
from	O
lateral	O
to	O
medial	O
;	O
11	O
-	O
random	O
upper	O
outer	O
.	O
quadrant	O
;	O
12	O
-	O
upper	O
inner	O
quadrant	O
;	O
13	O
-	O
lower	O
inner	O
quadrant	O
;	O
14	O
.	O
lower	O
outer	O
quadrant	O
;	O
15	O
-	O
junction	O
of	O
the	O
four	O
quadrants	O
;	O
16	O
-	O
.	O
nipple	O
.	O

F	O
.	O

Container	O
F	O
is	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O
medical	O
.	O

record	O
number	O
and	O
"	O
palpable	O
area	O
right	O
axilla	O
"	O
.	O

The	O
.	O
specimen	O
consists	O
of	O
a	O
single	O
fragment	O
of	O
fatty	O
tissue	O
measuring	O
2	O
.	O

X	O
.	O

1	O
.	O
5	O
.	O

x	O
1	O
cm	O
.	O

AS	O
-	O
1	O
.	O

Blocks	O
FS1	O
and	O
FS2	O
.	O

G	O
.	O

Container	O
G	O
is	O
labeled	O
.	O

"	O
sentinel	O
node	O
#	O
2	O
right	O
axilla	O
"	O
.	O

The	O
specimen	O
consists	O
of	O
.	O

a	O
.	O
single	O
lymph	O
node	O
measuring	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
X	O
0	O
.	O
5	O
cm	O
.	O

ASF	O
,	O
GFF	O
,	O
bisected	O
.	O

This	O
case	O
is	O
being	O
handled	O
by	O
Dr	O
.	O
MICROSCOPIC	O
DESCRIPTION	O
.	O

B	O
.	O

Left	O
Breast	O
.	O

Invasive	O
carcinoma	O
:	O
Histologic	O
type	O
:	O
Ductal	O
.	O

Histologic	O
grade	O
:	O
II	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Overall	O
grade	O
:	O
6	O
/	O
9	O
.	O

Architectural	O
score	O
:	O
2	O
.	O

Nuclear	O
score	O
:	O
2	O
.	O

Mitotic	O
score	O
:	O
2	O
.	O

Greatest	O
dimension	O
(	O
pT	O
)	O
:	O
No	O
less	O
than	O
1	O
.	O
5	O
cm	O
(	O
adjacent	O
to	O
.	O
biopsy	O
.	O
cavity	O
)	O
.	O

Specimen	O
margins	O
:	O
Negative	O
.	O

Vessel	O
invasion	O
:	O
No	O
definitive	O
invasion	O
identified	O
.	O

Calcification	O
:	O
Present	O
.	O

Nipple	O
(	O
Paget	O
'	O
s	O
)	O
:	O
Negative	O
.	O

Invasion	O
of	O
skin	O
or	O
chest	O
wall	O
:	O
Negative	O
.	O

Ductal	O
carcinoma	O
in	O
situ	O
:	O
Histologic	O
pattern	O
:	O
Cribriform	O
and	O
solid	O
.	O

Nuclear	O
grade	O
:	O
3	O
.	O

Central	O
necrosis	O
:	O
Present	O
.	O

%	O
DCIS	O
of	O
total	O
tumor	O
(	O
if	O
mixed	O
)	O
:	O
20	O
%	O
.	O

Specimen	O
margins	O
:	O
DCIS	O
is	O
3	O
mm	O
from	O
deep	O
margin	O
(	O
two	O
small	O
.	O
foci	O
)	O
.	O

Calcification	O
:	O
Present	O
.	O

Description	O
of	O
non	O
-	O
tumorous	O
breast	O
:	O
Small	O
papillomas	O
;	O
fibrocystic	O
.	O
changes	O
with	O
microcalcifications	O
.	O

Comments	O
:	O
Previous	O
core	O
biopsy	O
.	O
reviewed	O
.	O

Carcinoma	O
.	O

is	O
lateral	O
to	O
prior	O
biopsy	O
site	O
.	O

Prognostic	O
markers	O
:	O
See	O
core	O
biopsy	O
report	O
,	O
.	O

D	O
.	O

"	O
Left	O
breast	O
,	O
Nodule	O
inferior	O
skin	O
flap	O
"	O
.	O

Invasive	O
Carcinoma	O
.	O

Histologic	O
type	O
:	O
Ductal	O
.	O

Histologic	O
grade	O
:	O
II	O
.	O

Overall	O
grade	O
:	O
6	O
/	O
9	O
.	O

Architectural	O
score	O
:	O
2	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Nuclear	O
score	O
:	O
3	O
.	O

Mitotic	O
score	O
.	O

1	O
.	O

Greatest	O
dimension	O
(	O
pT	O
)	O
:	O
7	O
mm	O
.	O

Specimen	O
margins	O
:	O
1	O
.	O
5	O
mm	O
from	O
resection	O
margin	O
(	O
several	O
areas	O
)	O
.	O

Vessel	O
invasion	O
:	O
Negative	O
.	O

Calcification	O
Present	O
.	O

Comments	O
:	O
Skin	O
not	O
directly	O
involved	O
by	O
carcinoma	O
.	O

Focal	O
duct	O
.	O
present	O
containing	O
necrotic	O
debris	O
and	O
calcification	O
,	O
without	O
.	O
definitive	O
ductal	O
carcinoma	O
in	O
-	O
situ	O
identified	O
.	O

Breast	O
Prognostic	O
Marker	O
Report	O
(	O
Part	O
D	O
)	O
.	O

Estrogen	O
receptor	O
.	O

80	O
%	O
.	O

Progesterone	O
receptor	O
:	O
.	O

0	O
%	O
.	O

Her2	O
/	O
neu	O
by	O
IHC	O
:	O
0	O
-	O
1	O
+	O
.	O

Interpretation	O
.	O

Estrogen	O
receptor	O
:	O
Positive	O
.	O

Progesterone	O
receptor	O
.	O

Negative	O
.	O

Her2	O
/	O
neu	O
by	O
IHC	O
:	O
Negative	O
.	O

Part	O
E	O
.	O
Right	O
breast	O
.	O

Ductal	O
carcinoma	O
in	O
situ	O
:	O
Outer	O
breast	O
.	O

Histologic	O
pattern	O
:	O
Solid	O
,	O
papillary	O
and	O
micropapillary	O
.	O

Nuclear	O
grade	O
:	O
2	O
.	O

Central	O
necrosis	O
:	O
Absent	O
.	O

Tumor	O
size	O
(	O
if	O
pure	O
in	O
situ	O
)	O
:	O
5	B
cm	I
.	O

Specimen	O
margins	O
:	O
DCIS	O
is	O
focally	O
2	O
mm	O
from	O
deep	O
margin	O
and	O
3	O
.	O

mm	O
.	O
from	O
anterior	O
margin	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

Calcification	O
Present	O
.	O

Comments	O
:	O
Fibrocystic	O
changes	O
are	O
intermixed	O
within	O
this	O
.	O
complex	O
.	O

mass	O
lesion	O
,	O
the	O
majority	O
of	O
which	O
is	O
composed	O
of	O
ducts	O
involved	O
.	O
by	O
carcinoma	O
in	O
-	O
situ	O
.	O

Invasive	O
carcinoma	O
is	O
not	O
identified	O
.	O

(	O
p63	O
performed	O
to	O
evaluate	O
)	O
Portions	O
of	O
case	O
also	O
reviewed	O
.	O
by	O
Dr	O
.	O
Nipple	O
:	O
large	O
ducts	O
of	O
nipple	O
involved	O
by	O
ductal	O
carcinoma	O
.	O

in	O
-	O
situ	O
.	O

Breast	O
Prognostic	O
Marker	O
Report	O
(	O
Part	O
E	O
)	O
.	O

Estrogen	O
receptor	O
:	O
100	O
%	O
.	O

Progesterone	O
receptor	O
:	O
.	O
.	O

0	O
%	O
.	O

Interpretation	O
.	O

Estrogen	O
receptor	O
:	O
Positive	O
.	O

Progesterone	O
receptor	O
.	O

Negative	O
.	O

Prognostic	O
markers	O
were	O
done	O
by	O
mmunohistochemical	O
stain	O
on	O
.	O
paraffin	O
sections	O
from	O
10	O
%	O
neutral	O
buffered	O
formalin	O
fixed	O
tissue	O
.	O
using	O
.	O

antibodies	O
on	O
a	O
Benchmark	O
automated	O
.	O
stainer	O
.	O

The	O
Her2	O
/	O
neu	O
antibody	O
is	O
clone	O
4B5	O
and	O
has	O
been	O
approved	O
by	O
the	O
FDA	O
.	O
as	O
an	O
aid	O
in	O
the	O
assessment	O
of	O
breast	O
cancer	O
patients	O
for	O
whom	O
.	O

Herceptin	O
treatment	O
is	O
considered	O
.	O

This	O
laboratory	O
meets	O
the	O
test	O
validation	O
and	O
quality	O
assurance	O
.	O
requirements	O
of	O
the	O
ASCO	O
/	O
CAP	O
guidelines	O
for	O
Her2	O
testing	O
for	O
.	O
carcinoma	O
of	O
the	O
breast	O
(	O
Arch	O
Pathol	O
Lab	O
Med	O
2007	O
;	O
131	O
:	O
18	O
-	O
43	O
)	O
-	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
.	O

[	O
A	O
few	O
of	O
the	O
antibodies	O
used	O
in	O
our	O
laboratory	O
may	O
be	O
classified	O
.	O
as	O
.	O
analyte	O
specific	O
reagents	O
.	O
These	O
antibodies	O
are	O
monitored	O
and	O
.	O
controlled	O
in	O
our	O
laboratory	O
and	O
their	O
performance	O
for	O
in	O
vitro	O
.	O
diagnosis	O
is	O
well	O
described	O
in	O
the	O
medical	O
literature	O
.	O
They	O
have	O
.	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
FDA	O
.	O
]	O
.	O

4x6	O
,	O
3	O
,	O
14x3	O
,	O
15	O
,	O
20x2	O
,	O
25x5	O
.	O

REPORT	O
REVISED	O
ON	O
.	O

AT	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Left	O
breast	O
,	O
sentinel	O
lymph	O
node	O
#	O
1	O
,	O
biopsy	O
:	O
One	O
negative	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

B	O
.	O

Breast	O
,	O
left	O
,	O
mastectomy	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
grade	O
II	O
,	O
size	O
no	O
less	O
than	O
1	O
.	O
5	O
.	O

cm	O
.	O
,	O
with	O
associated	O
ductal	O
carcinoma	O
in	O
-	O
situ	O
,	O
grade	O
3	O
,	O
with	O
.	O
necrosis	O
.	O

C	O
.	O

Lymph	O
node	O
,	O
Tail	O
of	O
Spence	O
,	O
left	O
breast	O
,	O
regional	O
resection	O
:	O
Three	O
negative	O
lymph	O
nodes	O
(	O
0	O
/	O
3	O
)	O
.	O

D	O
.	O

Breast	O
,	O
left	O
,	O
inferior	O
skin	O
flap	O
nodule	O
,	O
excisional	O
biopsy	O
:	O
Invasive	O
ductal	O
carcinoma	O
,	O
grade	O
II	O
,	O
7	O
mm	O
.	O
,	O
close	O
to	O
.	O
excisional	O
margin	O
.	O

E	O
.	O

Breast	O
,	O
right	O
,	O
mastectomy	O
:	O
Ductal	O
carcinoma	O
in	O
-	O
situ	O
,	O
grade	O
2	O
,	O
involving	O
5	O
cm	O
area	O
and	O
.	O
large	O
ducts	O
of	O
nipple	O
.	O

No	O
invasive	O
carcinoma	O
identified	O
.	O

F	O
.	O

Lymph	O
node	O
,	O
right	O
axilla	O
,	O
biopsy	O
:	O
One	O
negative	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

G	O
.	O

Sentinel	O
lymph	O
node	O
#	O
2	O
,	O
right	O
axilla	O
,	O
biopsy	O
:	O
One	O
negative	O
lymph	O
node	O
(	O
0	O
/	O
1	O
)	O
.	O

REPORT	O
REVISED	O
ON	O
.	O

AT	O
.	O

DIAGNOSIS	O
.	O

MD	O
(	O
Electronic	O
Signature	O
)	O
.	O

REVISED	O
REPORT	O
-	O
.	O

Clarification	O
of	O
specimen	O
identification	O
.	O

SEE	O
REPORT	O
.	O

PROCEDURE	O
DATE	O
:	O
SPECIMEN	O
DESCRIPTION	O
:	O
A	O
.	O

INFERIOR	O
PULMONARY	O
LIGAMENI	O
LYMPH	O
NODE	O
.	O

B	O
.	O

RIGHT	O
LOWER	O
LOBE	O
OF	O
LUNG	O
,	O
.	O

C	O
.	O

TRACHEAL	O
LYMPH	O
NODE	O
N2	O
.	O

D	O
.	O

SUBCARINAL	O
LYMPH	O
NODE	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Right	O
lower	O
lobe	O
lung	O
nodule	O
.	O

POST	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Same	O
,	O
pending	O
pathology	O
.	O

CLINICAL	O
INFORMATION	O
.	O

Right	O
lower	O
lobe	O
nodule	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
BPC	O
DIAGNOSIS	O
:	O
"	O
Non	O
-	O
small	O
cell	O
carcinoma	O
;	O
lesion	O
inked	O
black	O
"	O
by	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
is	O
a	O
brown	O
-	O
black	O
encapsulated	O
lymph	O
node	O
,	O
measuring	O
1	O
.	O
0	O
X	O
0	O
.	O
8	O
X	O
.	O

0	O
.	O
3	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
hyperpigmented	O
cut	O
surface	O
.	O

The	O
specimen	O
is	O
.	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

B	O
.	O

Received	O
in	O
formalin	O
is	O
a	O
previously	O
sectioned	O
lobe	O
of	O
lung	O
,	O
weighing	O
144	O
.	O
grams	O
and	O
measuring	O
20	O
.	O
2	O
X	O
19	O
.	O
2	O
X	O
4	O
.	O
8	O
cm	O
.	O

The	O
pleura	O
is	O
tan	O
-	O
pink	O
with	O
a	O
.	O
minimal	O
amount	O
of	O
scattered	O
anthracotic	O
pigmentation	O
.	O

There	O
is	O
a	O
staple	O
line	O
,	O
.	O
measuring	O
7	O
.	O
7	O
cm	O
,	O
present	O
along	O
the	O
medial	O
aspect	O
of	O
the	O
lobe	O
.	O

The	O
staple	O
.	O
line	O
is	O
located	O
adjacent	O
to	O
the	O
bronchial	O
margin	O
.	O

The	O
bronchial	O
margin	O
is	O
.	O
unremarkable	O
.	O

The	O
bronchi	O
are	O
dissected	O
.	O

There	O
is	O
a	O
minimal	O
amount	O
of	O
mucus	O
.	O
located	O
within	O
the	O
lumen	O
.	O

The	O
hilar	O
vessels	O
are	O
patent	O
with	O
a	O
minimal	O
amount	O
.	O
of	O
fatty	O
streaks	O
.	O

There	O
is	O
a	O
previously	O
sectioned	O
indurated	O
nod	O
	O
le	O
.	O
measuring	O
.	O

1	B
.	I
5	I
X	I
1	I
.	I
5	I
X	I
0	I
.	I
8	I
cm	I
,	O
located	O
2	O
.	O
6	O
cm	O
from	O
the	O
hilar	O
margin	O
.	O

The	O
outer	O
surface	O
.	O

is	O
inked	O
black	O
.	O

Sectioning	O
through	O
the	O
lesion	O
reveals	O
an	O
ill	O
-	O
defined	O
.	O
yellow	O
-	O
white	O
cut	O
surface	O
.	O

The	O
lesion	O
does	O
not	O
disrupt	O
the	O
overlying	O
pleura	O
.	O

The	O
surrounding	O
pulmonary	O
parenchyma	O
is	O
pink	O
-	O
red	O
and	O
fleshy	O
.	O

No	O
other	O
lesions	O
.	O
are	O
identified	O
.	O

Three	O
gray	O
-	O
black	O
hyperpigmented	O
lymph	O
nodes	O
are	O
found	O
.	O
surrounding	O
the	O
hilum	O
,	O
measuring	O
up	O
to	O
0	O
.	O
4	O
cm	O
in	O
greatest	O
dimension	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
seven	O
cassettes	O
as	O
follows	O
:	O
cassette	O
.	O

1	O
-	O
bronchial	O
and	O
vascular	O
margins	O
;	O
cassette	O
2	O
-	O
staple	O
line	O
margin	O
;	O
cassettes	O
.	O

3	O
and	O
4	O
-	O
entire	O
lesion	O
:	O
cassette	O
5	O
-	O
three	O
intact	O
possible	O
lymph	O
nodes	O
;	O
.	O
cassettes	O
6	O
and	O
7	O
-	O
random	O
lung	O
parenchyma	O
.	O

Requeste	O
.	O

Date	O
of	O
Service	O
.	O

Performing	O
Facility	O
.	O

Result	O
Provider	O
.	O

Report	O
Name	O
.	O

Surgical	O
Report	O
.	O

DXSTIC	O
.	O

BPC	O
.	O

Received	O
is	O
a	O
tan	O
-	O
pink	O
to	O
white	O
fleshy	O
portion	O
of	O
soft	O
tissue	O
,	O
measuring	O
.	O

1	O
.	O
2	O
X	O
0	O
.	O
9	O
X	O
0	O
.	O
3	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
one	O
cassette	O
.	O

C	O
.	O

Received	O
in	O
formalin	O
is	O
a	O
portion	O
of	O
tan	O
-	O
yellow	O
fibrofatty	O
tissue	O
.	O
measuring	O
3	O
.	O
8	O
X	O
2	O
.	O
2	O
x	O
:	O
0	O
.	O
3	O
cm	O
.	O

Sectioning	O
reveals	O
an	O
indurated	O
hyperpigmented	O
.	O
nodule	O
resembling	O
a	O
.	O
lymph	O
node	O
,	O
measuring	O
0	O
.	O
9	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
.	O
specimen	O
is	O
entirely	O
submitted	O
in	O
two	O
cassettes	O
as	O
follows	O
:	O
cassette	O
1	O
-	O
-	O
.	O
bisected	O
lymph	O
node	O
;	O
cassette	O
2	O
-	O
remaining	O
soft	O
tissue	O
.	O

D	O
.	O

Received	O
is	O
a	O
portion	O
of	O
tan	O
-	O
yellow	O
fibrofatty	O
tissue	O
,	O
measuring	O
2	O
.	O
3	O
X	O
2	O
.	O
0	O
.	O

X	O
0	O
.	O
6	O
cm	O
.	O

Sectioning	O
reveals	O
a	O
hyperpigmented	O
nodule	O
resembling	O
a	O
lymph	O
node	O
,	O
.	O
measuring	O
0	O
.	O
8	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
specimen	O
is	O
entirely	O
submitted	O
in	O
.	O
two	O
cassettes	O
as	O
follows	O
:	O
cassette	O
1	O
-	O
bisected	O
lymph	O
node	O
;	O
cassette	O
2	O
-	O
.	O
remaining	O
soft	O
tissue	O
.	O

MICROSCOPIC	O
DESCRIPTION	O
:	O
A	O
.	O

One	O
slide	O
is	O
examined	O
.	O

Sections	O
of	O
the	O
lymph	O
node	O
show	O
sinus	O
.	O
histiocytosis	O
with	O
anthracosis	O
.	O

No	O
metastatic	O
tumor	O
is	O
present	O
.	O

B	O
.	O

Sections	O
on	O
slides	O
B3	O
and	O
B4	O
show	O
a	O
subcapsular	O
tumor	O
with	O
the	O
morphology	O
.	O
of	O
well	O
differentiated	O
invasive	O
adenocarcinoma	O
of	O
bronchoalveolar	O
pattern	O
.	O

The	O
tumor	O
occurs	O
in	O
linear	O
arrays	O
of	O
tumor	O
lining	O
the	O
alveolar	O
spaces	O
.	O

There	O
.	O

is	O
a	O
small	O
central	O
scar	O
.	O

No	O
vascular	O
invasion	O
is	O
present	O
.	O

There	O
is	O
no	O
.	O
penetration	O
of	O
the	O
visceral	O
pleura	O
.	O

The	O
rest	O
of	O
the	O
lung	O
shows	O
changes	O
of	O
.	O
mild	O
chronic	O
obstructive	O
pulmonary	O
disease	O
.	O

The	O
bronchial	O
resection	O
margin	O
is	O
.	O
free	O
of	O
tumor	O
.	O

Sections	O
of	O
intrapulmonary	O
lymph	O
nodes	O
on	O
slide	O
B6	O
show	O
sinus	O
.	O
histiocytosis	O
with	O
anthracosis	O
.	O

No	O
metastatic	O
tumor	O
is	O
present	O
.	O

BPC	O
.	O

One	O
slide	O
is	O
examined	O
.	O

Sections	O
show	O
similar	O
tumor	O
as	O
described	O
above	O
.	O

C	O
.	O

Two	O
slides	O
are	O
examined	O
.	O

Sections	O
.	O
of	O
the	O
lymph	O
node	O
show	O
sinus	O
.	O
histiocytosis	O
with	O
anthracosis	O
.	O

No	O
metastatic	O
tumor	O
is	O
present	O
.	O

D	O
.	O

Two	O
slides	O
are	O
examined	O
.	O

Sections	O
of	O
the	O
lymph	O
nodes	O
show	O
sinus	O
.	O
histiocytosis	O
with	O
anthracosis	O
.	O

No	O
metastatic	O
tumor	O
is	O
present	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

LYMPH	O
NODE	O
,	O
INFERIOR	O
PULMONARY	O
LIGAMENT	O
:	O
1	O
.	O

NO	O
METASTATIC	O
TUMOR	O
.	O

2	O
.	O

SINUS	O
HISTIOCYTOSIS	O
WITH	O
FOCAL	O
ANTHRACOSIS	O
.	O

RIGHT	O
LUNG	O
,	O
LOWER	O
LOBE	O
,	O
RESECTION	O
:	O
1	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
ADENOCARCINOMA	O
,	O
BRONCHOALVEOLAR	O
TYPE	O
.	O

2	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
WELL	O
DIFFERENTIATED	O
.	O

3	O
.	O

EXTENT	O
OF	O
INVASION	O
:	O
pT1	O
(	O
MAXIMAL	O
DIAMETER	O
OF	O
TUMOR	O
IS	O
1	B
.	I
5	I
CM	I
)	O
.	O

4	O
.	O

MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

5	O
.	O

BLOOD	O
/	O
LYMPHATIC	O
VESSEL	O
INVASION	O
:	O
ABSENT	O
.	O

6	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
:	O
NOT	O
INVOLVED	O
(	O
SEE	O
A	O
,	O
C	O
,	O
AND	O
D	O
)	O
.	O

Requeste	O
.	O

Date	O
of	O
Service	O
.	O

Performing	O
Facility	O
.	O

Result	O
Provider	O
.	O

Report	O
Name	O
.	O

Surgical	O
Report	O
.	O

DXSTIC	O
.	O

DISTANT	O
METASTASIS	O
:	O
NOT	O
KNOWN	O
.	O

LYMPH	O
NODE	O
,	O
TRACHEAL	O
,	O
N2	O
:	O
1	O
.	O

NO	O
METASTATIC	O
TUMOR	O
IN	O
ONE	O
LYMPH	O
NODE	O
.	O

2	O
.	O

SINUS	O
HISTIOCYTOSIS	O
WITH	O
ANTHRACOSIS	O
.	O

D	O
.	O

LYMPH	O
NODE	O
,	O
SUBCARINAL	O
,	O
EXCISION	O
:	O
1	O
.	O

NO	O
METASTATIC	O
TUMOR	O
IN	O
ONE	O
LYMPH	O
NODE	O
.	O

2	O
.	O

SINUS	O
HISTIOCYTOSIS	O
WITH	O
ANTHRACOSIS	O
.	O

A	O
-	O
MALIGNANT	O
.	O

Report	O
Type	O
.	O

Date	O
of	O
Event	O
.	O

F	O
.	O

Authored	O
by	O
.	O

Hosp	O
/	O
Group	O
.	O

Record	O
Status	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
RIGHT	O
HEMIGLOSSECTOMY	O
.	O

A	O
.	O

INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
(	O
4	B
.	I
2	I
CM	I
)	O
,	O
MODERATELY	O
.	O

DIFFERENTIATED	O
,	O
KERATINIZING	O
,	O
INVOLVING	O
INTRINSIC	O
TONGUE	O
MUSCLES	O
.	O

B	O
.	O

VASCULAR	O
AND	O
PERINEURAL	O
INVASION	O
IS	O
PRESENT	O
.	O

C	O
.	O

ANTERIOR	O
,	O
POSTERIOR	O
,	O
AND	O
DEEP	O
TONGUE	O
MARGINS	O
ARE	O
FREE	O
OF	O
.	O

CARCINOMA	O
.	O

CARCINOMA	O
EXTENDS	O
TO	O
ANTERIOR	O
AND	O
POSTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGINS	O
.	O

(	O
see	O
parts	O
2	O
-	O
6	O
for	O
final	O
true	O
margins	O
)	O
.	O

D	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
pT3	O
N2b	O
.	O

PART	O
2	O
:	O
ANTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
,	O
RE	O
-	O
RESECTION	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

PART	O
3	O
:	O
POSTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
,	O
RE	O
-	O
RESECTION	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

PART	O
4	O
:	O
MEDIAL	O
POSTERIOR	O
FLOOR	O
OF	O
MOUTH	O
/	O
TONGUE	O
,	O
BIOPSY	O
.	O

INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
BASED	O
ON	O
ORIGINAL	O
FROZEN	O
SECTION	O
.	O

SLIDES	O
.	O

PART	O
5	O
:	O
NEW	O
POSTERIOR	O
MARGIN	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

PART	O
6	O
:	O
DEEP	O
MUSCLE	O
MARGIN	O
.	O

NO	O
TUMOR	O
SEEN	O
.	O

PART	O
7	O
:	O
RIGHT	O
NECK	O
DISSECTION	O
,	O
LEVELS	O
1	O
THROUGH	O
4	O
.	O

A	O
.	O

METASTATIC	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
,	O
UP	O
TO	O
3	B
.	I
5	I
CM	I
,	O
IN	O
FIVE	O
(	O
5	O
)	O
OF	O
.	O

TWENTY	O
-	O
FOUR	O
(	O
24	O
)	O
LYMPH	O
NODES	O
(	O
5	O
/	O
24	O
)	O
,	O
INVOLVING	O
LEVELS	O
1A	O
AND	O
2	O
.	O

B	O
.	O

EXTRANODAL	O
EXTENSION	O
IS	O
PRESENT	O
.	O

C	O
.	O

VASCULAR	O
INVASION	O
IS	O
PRESENT	O
.	O

By	O
Pathologist	O
:	O
My	O
signature	O
is	O
attestation	O
that	O
I	O
have	O
personally	O
reviewed	O
the	O
submitted	O
.	O

material	O
(	O
s	O
)	O
and	O
the	O
final	O
diagnosis	O
reflects	O
that	O
evaluation	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimen	O
is	O
received	O
in	O
seven	O
parts	O
.	O

Part	O
1	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
S	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
right	O
hemi	O
-	O
glossectomy	O
.	O
"	O
It	O
consists	O
of	O
a	O
wedge	O
of	O
tan	O
connective	O
tissue	O
,	O
.	O

5	O
.	O
8	O
x	O
3	O
.	O
2	O
X	O
1	O
.	O
6	O
cm	O
,	O
partially	O
covered	O
with	O
an	O
ulcerated	O
gray	O
-	O
white	O
mucosa	O
.	O

Upon	O
cross	O
-	O
sectioning	O
,	O
a	O
4	O
.	O
2	O
X	O
1	O
.	O
6	O
X	O
0	O
.	O
9	O
cm	O
,	O
white	O
,	O
firm	O
lesion	O
is	O
identified	O
.	O

Digital	O
image	O
photographs	O
are	O
taken	O
.	O

Normal	O
tissue	O
and	O
tissue	O
from	O
tumor	O
were	O
.	O
banked	O
for	O
.	O

Head	O
and	O
Neck	O
Tissue	O
Bank	O
.	O

Ink	O
Code	O
:	O
Blue	O
anterior	O
margin	O
.	O

Green	O
posterior	O
margin	O
.	O

Black	O
all	O
other	O
margins	O
.	O

Red	O
banked	O
area	O
.	O

Cassette	O
Code	O
:	O
1AFS	O
anterior	O
and	O
posterior	O
margin	O
,	O
shave	O
.	O

1BFS	O
anterior	O
tongue	O
margin	O
,	O
shave	O
.	O

1CFS	O
posterior	O
tongue	O
margin	O
margin	O
,	O
shave	O
.	O

1DFS	O
anterior	O
floor	O
of	O
mouth	O
margin	O
,	O
shave	O
.	O

1EFS	O
posterior	O
floor	O
of	O
mouth	O
margin	O
,	O
shave	O
.	O

1F	O
-	O
11	O
representative	O
sections	O
of	O
the	O
tumor	O
.	O

Part	O
2	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
S	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
resection	O
anterior	O
floor	O
of	O
mouth	O
.	O
'	O
It	O
consists	O
of	O
a	O
2	O
.	O
4	O
X	O
1	O
.	O
0	O
X	O
0	O
.	O
8	O
cm	O
,	O
tan	O
.	O
connective	O
tissue	O
and	O
gray	O
-	O
white	O
mucosa	O
.	O

A	O
suture	O
marks	O
medial	O
margin	O
(	O
inked	O
.	O
black	O
)	O
and	O
the	O
true	O
margin	O
was	O
identified	O
by	O
the	O
surgeon	O
(	O
inked	O
blue	O
)	O
.	O

After	O
.	O
frozen	O
section	O
analysis	O
the	O
specimen	O
is	O
submitted	O
in	O
cassette	O
2AFS	O
.	O

Part	O
3	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
resection	O
posterior	O
floor	O
of	O
mouth	O
.	O
"	O
It	O
consists	O
of	O
1	O
.	O
0	O
X	O
0	O
.	O
5	O
x	O
0	O
.	O
6	O
cm	O
of	O
.	O
tan	O
connective	O
tissue	O
and	O
gray	O
-	O
white	O
mucosa	O
.	O

A	O
suture	O
marks	O
posterior	O
margin	O
.	O

(	O
inked	O
black	O
)	O
and	O
the	O
true	O
margin	O
was	O
identified	O
by	O
the	O
surgeon	O
(	O
inked	O
blue	O
)	O
.	O

After	O
frozen	O
section	O
analysis	O
,	O
the	O
specimen	O
is	O
submitted	O
in	O
cassette	O
3AFS	O
.	O

Part	O
4	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
medial	O
posterior	O
floor	O
of	O
mouth	O
/	O
tongue	O
.	O
"	O
It	O
consists	O
of	O
0	O
.	O
9	O
x	O
0	O
.	O
7	O
X	O
0	O
.	O
6	O
cm	O
.	O
of	O
tan	O
,	O
connective	O
tissue	O
and	O
mucosa	O
.	O

A	O
suture	O
marks	O
posterior	O
margin	O
(	O
inked	O
.	O
black	O
)	O
and	O
the	O
true	O
margin	O
was	O
identified	O
by	O
the	O
surgeon	O
(	O
inked	O
blue	O
)	O
.	O

After	O
.	O
frozen	O
section	O
analysis	O
,	O
the	O
specimen	O
is	O
submitted	O
in	O
cassette	O
4AFS	O
.	O

Part	O
5	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
new	O
posterior	O
margin	O
.	O
"	O
It	O
consists	O
of	O
2	O
.	O
2	O
X	O
1	O
.	O
3	O
X	O
0	O
.	O
8	O
cm	O
of	O
tan	O
,	O
connective	O
.	O
tissue	O
and	O
mucosa	O
.	O

A	O
suture	O
marks	O
posterior	O
margin	O
(	O
inked	O
black	O
)	O
and	O
the	O
true	O
.	O
margin	O
was	O
identified	O
by	O
the	O
surgeon	O
(	O
inked	O
blue	O
)	O
.	O

After	O
frozen	O
section	O
.	O
analysis	O
the	O
specimen	O
is	O
submitted	O
in	O
cassette	O
5AFS	O
.	O

Part	O
6	O
is	O
received	O
fixed	O
labeled	O
with	O
the	O
patient	O
'	O
name	O
,	O
initials	O
XXX	O
and	O
.	O

"	O
deep	O
muscle	O
margin	O
.	O
"	O
It	O
consists	O
of	O
1	O
.	O
1	O
X	O
0	O
.	O
8	O
X	O
0	O
.	O
5	O
cm	O
of	O
tan	O
,	O
brown	O
,	O
.	O
connective	O
tissue	O
specimen	O
.	O

After	O
frozen	O
section	O
analysis	O
,	O
the	O
specimen	O
is	O
.	O
submitted	O
in	O
cassette	O
6AFS	O
.	O

Part	O
7	O
is	O
received	O
fixed	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
initials	O
,	O
XXX	O
and	O
.	O

"	O
right	O
neck	O
dissection	O
,	O
levels	O
1	O
-	O
4	O
"	O
.	O

It	O
consists	O
of	O
a	O
tan	O
-	O
yellow	O
,	O
elongated	O
.	O
fibroadipose	O
tissue	O
measuring	O
15	O
.	O
0	O
X	O
7	O
.	O
2	O
X	O
2	O
.	O
3	O
cm	O
with	O
attached	O
submandibular	O
.	O
gland	O
measuring	O
4	O
.	O
0	O
X	O
3	O
.	O
0	O
x	O
1	O
.	O
7	O
cm	O
.	O

The	O
specimen	O
is	O
divided	O
into	O
levels	O
1A	O
,	O
.	O

1B	O
,	O
level	O
2	O
,	O
level	O
3	O
and	O
level	O
4	O
.	O

Three	O
possible	O
lymph	O
nodes	O
are	O
identified	O
.	O
ranging	O
in	O
greatest	O
dimension	O
from	O
0	O
.	O
8	O
to	O
1	O
.	O
3	O
cm	O
in	O
level	O
1A	O
.	O

One	O
lymph	O
node	O
.	O

is	O
identified	O
measuring	O
in	O
greatest	O
dimension	O
1	O
.	O
6	O
cm	O
in	O
level	O
1B	O
.	O

Four	O
.	O
possible	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
in	O
greatest	O
dimension	O
from	O
0	O
.	O
2	O
to	O
.	O

3	O
.	O
5	O
cm	O
in	O
level	O
2	O
.	O

The	O
largest	O
lymph	O
node	O
is	O
serially	O
cross	O
sectioned	O
.	O
revealing	O
a	O
cystic	O
and	O
necrotic	O
cut	O
surfaces	O
.	O

Eight	O
possible	O
lymph	O
nodes	O
are	O
.	O
identified	O
ranging	O
in	O
greatest	O
dimension	O
from	O
0	O
.	O
7	O
to	O
2	O
.	O
5	O
cm	O
in	O
level	O
3	O
.	O

Four	O
.	O
possible	O
lymph	O
nodes	O
are	O
identified	O
ranging	O
in	O
greatest	O
dimension	O
from	O
0	O
.	O
4	O
to	O
.	O

1	O
.	O
6	O
cm	O
in	O
level	O
4	O
.	O

The	O
submandibular	O
gland	O
is	O
serially	O
cross	O
sectioned	O
revealing	O
a	O
lobular	O
.	O
tan	O
-	O
yellow	O
unremarkable	O
parenchyma	O
.	O

Cassette	O
code	O
:	O
7A	O
one	O
lymph	O
node	O
,	O
bisected	O
,	O
level	O
1A	O
.	O

7B	O
two	O
lymph	O
nodes	O
,	O
level	O
1A	O
.	O

7C	O
one	O
lymph	O
node	O
,	O
level	O
1B	O
.	O

7D	O
representative	O
of	O
submandibular	O
gland	O
.	O

7E	O
7F	O
representative	O
of	O
largest	O
lymph	O
node	O
,	O
level	O
2	O
.	O

7G	O
three	O
possible	O
lymph	O
nodes	O
,	O
level	O
2	O
.	O

7H	O
two	O
possible	O
lymph	O
nodes	O
,	O
level	O
3	O
.	O

7I	O
7J	O
three	O
possible	O
lymph	O
nodes	O
in	O
each	O
,	O
level	O
3	O
.	O

7K	O
four	O
possible	O
lymph	O
nodes	O
,	O
level	O
4	O
.	O

7L	O
three	O
possible	O
lymph	O
nodes	O
,	O
level	O
4	O
.	O

7M	O
one	O
possible	O
lymph	O
node	O
(	O
received	O
as	O
a	O
separate	O
fragment	O
from	O
the	O
main	O
.	O
specimen	O
)	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
PART	O
1AFS	O
:	O
ANTERIOR	O
AND	O
POSTERIOR	O
MARGINS	O
,	O
SHAVE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
1BFS	O
:	O
ANTERIOR	O
TONGUE	O
MARGIN	O
,	O
SHAVE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
1CFS	O
:	O
POSTERIOR	O
TONGUE	O
MARGIN	O
,	O
SHAVE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
1DFS	O
:	O
ANTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
,	O
SHAVE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

MALIGNANT	O
.	O

C	O
.	O

MICROSCOPIC	O
FOCUS	O
OF	O
INVASIVE	O
CLEAR	O
CELL	O
CARCINOMA	O
AND	O
SKELETAL	O
MUSCLE	O
.	O

PART	O
1EFS	O
:	O
POSTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
,	O
SHAVE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

MALIGNANT	O
.	O

C	O
.	O

MICROSCOPIC	O
FOCUS	O
OF	O
INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

D	O
.	O

SUBMUCOSAL	O
SOFT	O
TISSUE	O
.	O

PART	O
2AFS	O
:	O
ANTERIOR	O
FLOOR	O
OF	O
MOUTH	O
MARGIN	O
(	O
frozen	O
section	O
)	O
-	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
,	O
NO	O
MUCOSA	O
.	O

PART	O
3AFS	O
:	O
POSTERIOR	O
FLOOR	O
OF	O
MOUTH	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
4AFS	O
:	O
MEDIAL	O
POST	O
	O
RIOR	O
FLOOR	O
OF	O
MOUTH	O
/	O
TONGUE	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

MALIGNANT	O
.	O

C	O
.	O

INVASIVE	O
SQUAMOUS	O
CELL	O
CARCINOMA	O
.	O

PART	O
5AFS	O
:	O
NEW	O
POSTERIOR	O
MARGIN	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

PART	O
6AFS	O
:	O
DEEP	O
MUSCLE	O
MARGIN	O
(	O
frozen	O
section	O
)	O
.	O

A	O
.	O

SUFFICIENT	O
FOR	O
ANCILLARY	O
STUDIES	O
.	O

B	O
.	O

BENIGN	O
.	O

C	O
.	O

NO	O
TUMOR	O
PRESENT	O
.	O

MICROSCOPIC	O
:	O
Microscopic	O
examination	O
substantiates	O
the	O
above	O
diagnosis	O
.	O
caa	O
.	O

The	O
following	O
statement	O
applies	O
to	O
all	O
immunohistochemistry	O
,	O
Insitu	O
.	O

Hybridization	O
Assays	O
(	O
ISH	O
&	O
FISH	O
)	O
,	O
Molecular	O
Anatomic	O
Pathology	O
,	O
and	O
.	O

Immunofluorescent	O
Testing	O
:	O
The	O
testing	O
was	O
developed	O
and	O
its	O
performance	O
characteristics	O
determined	O
by	O
.	O
the	O
.	O

Department	O
of	O
Pathology	O
,	O
as	O
required	O
by	O
the	O
CLIA	O
.	O
regulations	O
.	O

The	O
testing	O
has	O
not	O
been	O
cleared	O
or	O
approved	O
for	O
the	O
.	O
specific	O
use	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
,	O
but	O
the	O
FDA	O
has	O
.	O
determined	O
such	O
approval	O
is	O
not	O
necessary	O
for	O
clinical	O
use	O
.	O

Tissue	O
fixation	O
.	O
ranges	O
from	O
a	O
minimum	O
of	O
2	O
to	O
a	O
maximum	O
of	O
84	O
hours	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
Improvement	O
.	O

Amendments	O
of	O
.	O

(	O
"	O
CLIA	O
"	O
)	O
as	O
qualified	O
to	O
perform	O
high	O
-	O
complexity	O
clinical	O
.	O
testing	O
.	O

Pursuant	O
to	O
the	O
requirements	O
of	O
CLIA	O
,	O
ASR	O
'	O
s	O
used	O
in	O
this	O
laboratory	O
.	O
have	O
been	O
established	O
and	O
verified	O
for	O
accuracy	O
and	O
precision	O
.	O

Additional	O
.	O
information	O
about	O
this	O
type	O
of	O
test	O
is	O
available	O
upon	O
request	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
UPPER	O
AERODIGESTIVE	O
TRACT	O
AND	O
SALIVARY	O
GLAND	O
.	O

TUMORS	O
.	O

SPECIMEN	O
TYPE	O
:	O
Resection	O
:	O
Right	O
hemiglossectomy	O
.	O

TUMOR	O
SITE	O
:	O
Oral	O
Cavity	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
4	B
.	I
2	I
cm	I
.	O

HISTOLOGIC	O
TYPE	O
:	O
Squamous	O
cell	O
carcinoma	O
,	O
conventional	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT3	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pN2b	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
24	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
5	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
pMX	O
.	O

MARGINS	O
:	O
Cannot	O
be	O
assessed	O
.	O

VENOUS	O
/	O
LYMPHATIC	O
(	O
LARGE	O
/	O
SMALL	O
VESSEL	O
)	O
INVASION	O
(	O
V	O
/	O
L	O
)	O
:	O
Present	O
.	O

PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

PATIENT	O
HISTORY	O
:	O
CHIEF	O
COMPLAINT	O
/	O
PRE	O
-	O
OP	O
/	O
POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
T3	O
M2	O
of	O
right	O
oral	O
/	O
tongue	O
.	O

PROCEDURE	O
:	O
Hemi	O
-	O
glossectomy	O
and	O
neck	O
dissection	O
.	O

SPECIFIC	O
CLINICAL	O
QUESTION	O
:	O
Margins	O
and	O
nodes	O
.	O

OUTSIDE	O
TISSUE	O
DIAGNOSIS	O
:	O
Yes	O
,	O
squamous	O
cell	O
carcinoma	O
.	O

PRIOR	O
MALIGNANCY	O
:	O
No	O
.	O
.	O

CHEMORADIATION	O
THERAPY	O
:	O
No	O
.	O

ORGAN	O
TRANSPLANT	O
:	O
No	O
.	O

IMMUNOSUPPRESSION	O
:	O
No	O
.	O

OTHER	O
DISEASES	O
:	O
No	O
.	O

HISTO	O
TISSUE	O
SUMMARY	O
/	O
SLIDES	O
REVIEWED	O
:	O
Part	O
1	O
:	O
Right	O
Hemi	O
Glossectomy	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

I	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

AFS	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

BFS	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

CFS	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

DFS	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

EFS	O
.	O

Part	O
2	O
:	O
Anterior	O
floor	O
of	O
mouth	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

AFS	O
.	O

Part	O
3	O
:	O
Posterior	O
floor	O
of	O
mouth	O
.	O

Stain	O
/	O
cnt	O
Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

AFS	O
.	O

Part	O
4	O
:	O
Medial	O
posterior	O
floor	O
of	O
mouth	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

AFS	O
.	O

Part	O
5	O
:	O
New	O
posterior	O
margin	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

AFS	O
.	O

Part	O
6	O
:	O
Deep	O
muscle	O
margin	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

AFS	O
.	O

Part	O
7	O
:	O
Right	O
Neck	O
Dissection	O
.	O

Stain	O
/	O
cnt	O
.	O

Block	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

A	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

B	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

C	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

D	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

E	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

F	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

G	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

H	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

I	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

J	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

K	O
.	O

H	O
&	O
E	O
x	O
1	O
.	O

L	O
.	O

H	O
&	O
E	O
X	O
1	O
.	O

M	O
.	O

TC1	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
8P	O
:	O
Uterus	O
,	O
cervix	O
,	O
bilateral	O
tubes	O
and	O
ovaries	O
.	O

2	O
:	O
SP	O
:	O
Portion	O
of	O
omentum	O
.	O

3	O
:	O
SP	O
:	O
Right	O
common	O
iliac	O
lymph	O
node	O
.	O

4	O
:	O
SP	O
:	O
Right	O
para	O
-	O
aortic	O
lymph	O
node	O
.	O

5	O
:	O
SP	O
:	O
Left	O
para	O
-	O
aortic	O
lymph	O
node	O
.	O

6	O
:	O
SP	O
:	O
Right	O
external	O
iliac	O
lymph	O
node	O
.	O

7	O
:	O
SP	O
:	O
Right	O
obturator	O
lymph	O
node	O
.	O

8	O
:	O
SP	O
:	O
Right	O
internal	O
iliac	O
lymph	O
node	O
.	O

9	O
:	O
SP	O
:	O
Left	O
external	O
iliac	O
lymph	O
node	O
.	O

10	O
:	O
SP	O
:	O
Left	O
hypogastric	O
lymph	O
node	O
.	O

11	O
:	O
SP	O
:	O
Left	O
obturator	O
lymph	O
node	O
.	O

AMENDED	O
DIAGNOSIS	O
:	O
1	O
)	O
.	O

UTERUS	O
,	O
CERVIX	O
,	O
FALLOPIAN	O
TUBES	O
AND	O
OVARIES	O
;	O
TOTAL	O
HYSTERECTOMY	O
.	O

AND	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORRCTOWY	O
:	O
-	O
ADENOCARCINOMA	O
OF	O
ENDOMETRIUM	O
,	O
ENDOMETRIOID	O
TYPE	O
,	O
NOS	O
,	O
FIGO	O
GRADE	O
II	O
.	O

(	O
6	O
-	O
50	O
%	O
SOLID	O
GROWTH	O
)	O
NUCLEAR	O
GRADK	O
2	O
.	O

-	O
THE	O
TUHOR	O
INVADES	O
TO	O
LESS	O
THAN	O
OR	O
EQUAL	O
TO	O
HALF	O
or	O
MYOKETRIUM	O
.	O

THE	O
NAXIMAL	O
THICKNESS	O
OF	O
MYONETRIAL	O
INVASION	O
IS	O
1	O
.	O
3	O
CN	O
.	O

-	O
THE	O
THICKNESS	O
or	O
THK	O
MYONETRIUM	O
IN	O
THE	O
AREA	O
OF	O
MAXIMAL	O
TUMOR	O
INVASION	O
.	O

IS	O
2	O
.	O
8	O
CM	O
.	O

-	O
NO	O
ENDOCERVICAL	O
INVASION	O
18	O
IDENTIFIED	O
.	O

-	O
NO	O
VASCULAR	O
INVASION	O
IB	O
IDENTIFIED	O
.	O

-	O
CERVIX	O
:	O
BENIGN	O
SQUAMOUS	O
MUCOSA	O
.	O

-	O
THE	O
ENDOMETRIUM	O
SHOWS	O
THE	O
FOLLOWING	O
ABNORMALITY	O
(	O
IES	O
)	O
:	O
ATROPHY	O
.	O

-	O
THE	O
MYOMETRIUM	O
SHOWS	O
THE	O
FOLLOWING	O
ABNORMALITY	O
(	O
IES	O
)	O
:	O
ADENOMYOSIS	O
AND	O
.	O

LEIOMYOMA	O
(	O
s	O
)	O
.	O

-	O
ALL	O
ADNEXAE	O
ARE	O
UNREMARKABLE	O
.	O

OMENTUM	O
;	O
EXCISION	O
:	O
-	O
BENIGN	O
FIBROADIPOSE	O
TISSUE	O
.	O

3	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
COMMON	O
ILIAC	O
;	O
EXICISION	O
:	O
ONE	O
BENION	O
LYMPK	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

4	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
PARA	O
-	O
AORTIC	O
-	O
AORTIC	O
;	O
EXCISION	O
:	O
-	O
FIVE	O
BENIGN	O
LYMPA	O
NODES	O
(	O
0	O
/	O
5	O
)	O
.	O

5	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
PARA	O
-	O
AORTIC	O
-	O
AORTIC	O
,	O
EXCISION	O
:	O
-	O
TWO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

6	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
EXTERNAL	O
ILIAC	O
:	O
EXCISION	O
:	O
-	O
THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

7	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
OBTURATOR	O
;	O
EXCISION	O
:	O
-	O
TWO	O
BENIGN	O
LYMPH	O
NODES	O
.	O

8	O
)	O
.	O

LYMPH	O
NODE	O
,	O
RIGHT	O
EXTERNAL	O
ILIAC	O
,	O
EXCISION	O
:	O
-	O
TNO	O
BENIGN	O
LYMPH	O
.	O

NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

9	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
EXTERNAL	O
ILIAC	O
;	O
EXCISION	O
:	O
-	O
THREE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
3	O
)	O
.	O

10	O
)	O
.	O

LYMPH	O
NODE	O
,	O
LEFT	O
HYPOGASTRIC	O
;	O
EXCISION	O
:	O
-	O
THO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

-	O
ONE	O
LYHPH	O
NODE	O
HAS	O
FOCAL	O
ENDOSALPINGIOSIS	O
.	O

11	O
)	O
.	O

LYNPH	O
NODE	O
,	O
LEFT	O
OBTURATOR	O
;	O
EXCISION	O
:	O
-	O
FOUR	O
BENION	O
LYMPH	O
NODES	O
(	O
0	O
/	O
4	O
)	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
.	O

OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

CLINICAL	O
HISTORY	O
:	O
Malignant	O
neoplasm	O
corpus	O
uteri	O
.	O

Per	O
E	O
-	O
browser	O
:	O
adenocarcinoma	O
diagnosed	O
at	O
.	O
outside	O
hospital	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
tubes	O
and	O
ovaries	O
(	O
AF1	O
)	O
"	O
Unfixed	O
for	O
frozen	O
section	O
and	O
.	O
transferred	O
to	O
formalin	O
at	O
.	O

is	O
a	O
85	O
gram	O
,	O
6	O
x	O
6	O
x	O
2	O
.	O
2	O
cm	O
.	O
uterus	O
with	O
bilateral	O
adnexa	O
.	O

The	O
uterine	O
serosa	O
is	O
tan	O
and	O
unremarkable	O
.	O

Sectioning	O
demonstrates	O
a	O
2	O
.	O
2	O
x	O
2	O
.	O

x	O
.	O

1	O
.	O
1	O
cm	O
tan	O
-	O
pink	O
,	O
friable	O
mass	O
at	O
the	O
fundus	O
extending	O
into	O
the	O
posterior	O
.	O
endometrium	O
.	O

The	O
mass	O
does	O
not	O
grossly	O
invade	O
the	O
myometrium	O
(	O
1	O
.	O
8	O
cm	O
thick	O
)	O
,	O
.	O

is	O
1	O
.	O
5	O
cm	O
from	O
the	O
closest	O
superior	O
endocervix	O
,	O
and	O
is	O
4	O
.	O
2	O
cm	O
from	O
the	O
.	O
cervical	O
os	O
.	O

The	O
endometrium	O
is	O
otherwise	O
tan	O
and	O
less	O
than	O
0	O
.	O
1	O
cm	O
thick	O
.	O

The	O
.	O
myometrium	O
is	O
unremarkable	O
.	O

The	O
anterior	O
endocervix	O
is	O
remarkable	O
for	O
a	O
1	O
.	O
1	O
cm	O
.	O
nabothian	O
cyst	O
.	O

The	O
ectocervical	O
and	O
endocervical	O
mucosa	O
are	O
otherwise	O
.	O
unremarkable	O
.	O

Representative	O
full	O
-	O
thickness	O
section	O
of	O
the	O
endometrial	O
mass	O
at	O
.	O
the	O
fundus	O
is	O
frozen	O
as	O
AF1	O
.	O

The	O
frozen	O
section	O
control	O
is	O
transferred	O
to	O
A1	O
.	O

BLOCK	O
SUMMARY	O
:	O
A2	O
-	O
8	O
.	O
mass	O
entirely	O
submitted	O
(	O
full	O
-	O
thickness	O
sections	O
)	O
from	O
fundus	O
to	O
.	O
posterior	O
endometrium	O
.	O

A9	O
.	O
adjacent	O
uninvolved	O
posterior	O
endomyometrium	O
.	O

A10	O
.	O
anterior	O
endomyometrium	O
.	O

All	O
.	O
posterior	O
cervix	O
.	O

A12	O
.	O
anterior	O
cervix	O
.	O

The	O
right	O
fallopian	O
tube	O
(	O
4	O
.	O
5	O
x	O
0	O
.	O
cm	O
)	O
has	O
a	O
tan	O
,	O
unremarkable	O
serosal	O
.	O
surface	O
and	O
an	O
unremarkable	O
cut	O
surface	O
.	O

The	O
right	O
ovary	O
(	O
2	O
.	O
5	O
x	O
2	O
x	O
0	O
.	O
8	O
cm	O
)	O
.	O
has	O
a	O
yellow	O
,	O
smooth	O
,	O
glistening	O
surface	O
.	O

The	O
cut	O
surface	O
is	O
unremarkable	O
.	O

Representative	O
right	O
fallopian	O
tube	O
and	O
ovary	O
are	O
submitted	O
in	O
block	O
A13	O
.	O

The	O
left	O
fallopian	O
tube	O
(	O
4	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
)	O
has	O
a	O
tan	O
,	O
smooth	O
,	O
glistening	O
surface	O
.	O

There	O
are	O
two	O
paratubal	O
cysts	O
up	O
to	O
0	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
cut	O
.	O
surface	O
is	O
unremarkable	O
.	O

The	O
left	O
ovary	O
(	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
6	O
cm	O
)	O
has	O
a	O
yellow	O
,	O
.	O
unremarkable	O
external	O
surface	O
and	O
an	O
unremarkable	O
cut	O
surface	O
.	O

Representative	O
.	O
left	O
fallopian	O
tube	O
and	O
ovary	O
submitted	O
in	O
block	O
A14	O
.	O

B	O
.	O

"	O
Toot	O
pelvic	O
lymph	O
node	O
"	O
.	O

Unfixed	O
and	O
transferred	O
to	O
formalin	O
at	O
.	O

on	O
.	O

is	O
a	O
2	O
.	O
5	O
x	O
2	O
x	O
0	O
.	O
6	O
cm	O
fragment	O
of	O
yellow	O
fibroadipose	O
tissue	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Two	O
apparent	O
lymph	O
nodes	O
up	O
to	O
1	O
cm	O
in	O
greatest	O
.	O
dimension	O
are	O
identified	O
and	O
submitted	O
in	O
block	O
B1	O
.	O

The	O
remaining	O
fibroadipose	O
.	O
tissue	O
is	O
submitted	O
in	O
block	O
B2	O
.	O

C	O
.	O

"	O
T	O
.	O
poft	O
pelvic	O
lymph	O
node	O
"	O
.	O

Unfixed	O
and	O
transferred	O
to	O
formalin	O
at	O
.	O

on	O
.	O

is	O
a	O
3	O
.	O
4	O
x	O
2	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
aggregate	O
of	O
yellow	O
fibroadipose	O
tissue	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Three	O
apparent	O
lymph	O
nodes	O
up	O
to	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
.	O
dimension	O
are	O
identified	O
and	O
submitted	O
in	O
block	O
C1	O
.	O

The	O
remaining	O
fibroadipose	O
.	O
tissue	O
is	O
submitted	O
in	O
block	O
C2	O
.	O

D	O
.	O

"	O
Right	O
pelvic	O
lymph	O
node	O
"	O
.	O

Unfixed	O
and	O
transferred	O
to	O
formalin	O
at	O
.	O

on	O
.	O

is	O
a	O
4	O
.	O
5	O
x	O
4	O
x	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
.	O
dissected	O
for	O
lymph	O
nodes	O
.	O

Apparent	O
lymph	O
nodes	O
up	O
to	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
.	O
dimension	O
are	O
identified	O
.	O

BLOCK	O
SUMMARY	O
:	O
D1	O
.	O
one	O
apparent	O
lymph	O
node	O
,	O
bisected	O
.	O

D2	O
.	O
five	O
apparent	O
lymph	O
nodes	O
.	O

D3	O
.	O
remaining	O
fibroadipose	O
tissue	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Uterus	O
,	O
cervix	O
,	O
tubes	O
and	O
ovaries	O
"	O
(	O
AF1	O
,	O
tumor	O
with	O
full	O
thickness	O
.	O
myometrium	O
)	O
:	O
Extensive	O
EIN	O
.	O

No	O
invasive	O
carcinoma	O
seen	O
(	O
Dr	O
.	O
MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
is	O
performed	O
.	O

PATHOLOGIC	O
STAGE	O
:	O
PROCEDURE	O
:	O
HYSTERECTOMY	O
,	O
BILATERAL	O
SALPINGO	O
-	O
OOPHORECTOMY	O
,	O
LYMPHADENECTOMY	O
.	O

PATHOLOGIC	O
STAGE	O
(	O
AJCC	O
6th	O
Edition	O
)	O
:	O
pT1a	O
pNO	O
pMX	O
.	O

NOTE	O
:	O
Information	O
on	O
pathology	O
stage	O
and	O
the	O
operative	O
procedure	O
is	O
.	O
transmitted	O
to	O
this	O
Institution	O
'	O
s	O
Cancer	O
Registry	O
as	O
required	O
for	O
.	O
accreditation	O
by	O
the	O
Commission	O
on	O
Cancer	O
.	O

Pathology	O
stage	O
is	O
based	O
solely	O
.	O
upon	O
the	O
current	O
tissue	O
specimen	O
being	O
evaluated	O
,	O
and	O
does	O
not	O
incorporate	O
.	O
information	O
on	O
any	O
specimens	O
submitted	O
separately	O
to	O
our	O
Cytology	O
section	O
,	O
.	O
past	O
pathology	O
information	O
,	O
imaging	O
studies	O
,	O
or	O
clinical	O
or	O
operative	O
.	O
findings	O
.	O

Pathology	O
stage	O
is	O
only	O
a	O
component	O
to	O
be	O
considered	O
in	O
determining	O
.	O
the	O
clinical	O
stage	O
,	O
and	O
should	O
not	O
be	O
confused	O
with	O
nor	O
substituted	O
for	O
it	O
.	O

The	O
exact	O
operative	O
procedure	O
is	O
available	O
in	O
the	O
surgeon	O
'	O
s	O
operative	O
report	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
UTERUS	O
,	O
CERVIX	O
,	O
TUBES	O
AND	O
OVARIES	O
"	O
(	O
HYSTERECTOMY	O
,	O
BILATERAL	O
.	O
SALPINGO	O
-	O
OOPHORECTOMY	O
)	O
:	O
UTERUS	O
:	O
85	O
GRAMS	O
.	O

ENDOMETRIUM	O
:	O
TUMOR	O
SITE	O
:	O
FUNDUS	O
,	O
POSTERIOR	O
ENDOMETRIUM	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
SEROUS	O
ADENOCARCINOMA	O
.	O

FIGO	O
GRADE	O
:	O
3	O
.	O

TUMOR	O
SIZE	O
:	O
2	B
.	I
2	I
x	I
2	I
x	I
1	I
.	I
1	I
CM	I
.	O

MAXIMUM	O
DEPTH	O
OF	O
MYOMETRIAL	O
INVASION	O
:	O
MINIMAL	O
INVASION	O
(	O
1	O
MM	O
)	O
IN	O
A	O
1	O
.	O
8	O
.	O

CM	O
THICK	O
WALL	O
.	O

LYMPHATIC	O
/	O
VASCULAR	O
INVASION	O
:	O
NEGATIVE	O
.	O

ADJACENT	O
NON	O
-	O
NEOPLASTIC	O
ENDOMETRIUM	O
:	O
ATROPHIC	O
.	O

REMAINING	O
MYOMETRIUM	O
:	O
ADENOMYOSIS	O
.	O

CERVIX	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

SEROSA	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

SPECIMEN	O
MARGINS	O
:	O
NOT	O
INVOLVED	O
.	O

RIGHT	O
AND	O
LEFT	O
OVARIES	O
AND	O
FALLOPIAN	O
TUBES	O
:	O
NO	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

B	O
.	O

"	O
LEFT	O
PELVIC	O
LYMPH	O
NODE	O
"	O
(	O
BIOPSY	O
)	O
:	O
THREE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
3	O
)	O
.	O

C	O
.	O

"	O
LEFT	O
PELVIC	O
LYMPH	O
NODE	O
"	O
(	O
BIOPSY	O
)	O
:	O
FOUR	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
4	O
)	O
.	O

D	O
.	O

"	O
RIGHT	O
PELVIC	O
LYMPH	O
NODE	O
"	O
(	O
BIOPSY	O
)	O
:	O
FIVE	O
LYMPH	O
NODES	O
,	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
(	O
0	O
/	O
5	O
)	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
y	O
/	O
o	O
female	O
with	O
biopsy	O
proven	O
left	O
ILC	O
at	O
.	O

Scheduled	O
for	O
left	O
total	O
.	O
mastectomy	O
and	O
SLN	O
/	O
possible	O
ALND	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
1	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
2	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
2	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

4	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
4	O
,	O
level	O
1	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

5	O
:	O
SP	O
:	O
Left	O
breast	O
(	O
sr	O
)	O
.	O

6	O
:	O
SP	O
:	O
Non	O
-	O
sentinel	O
node	O
level	O
1	O
,	O
left	O
axilla	O
.	O

7	O
:	O
SP	O
:	O
Left	O
axillary	O
contents	O
level	O
1	O
.	O

8	O
:	O
SP	O
:	O
Left	O
axillary	O
contents	O
level	O
2	O
ana	O
tag	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
1	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
METASTATIC	O
MAMMARY	O
CARCINOMA	O
INVOLVING	O
ONE	O
OF	O
ONE	O
LYMPH	O
NODE	O
(	O
1	O
/	O
1	O
)	O
.	O

-	O
NO	O
EXTRANODAL	O
TUMOR	O
EXTENSION	O
IS	O
PRESENT	O
.	O

2	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
2	O
LEVEL	O
II	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

3	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
3	O
LEVEL	O
II	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

4	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
4	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

5	O
)	O
.	O

BREAST	O
,	O
LEFT	O
;	O
MASTECTOMY	O
:	O
-	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
,	O
CLASSICAL	O
TYPE	O
,	O
DIFFUSELY	O
INVOLVING	O
THE	O
.	O

SUBMITTED	O
TISSUE	O
SECTIONS	O
.	O

THE	O
LARGEST	O
DIMENSION	O
OF	O
THE	O
INVASIVE	O
CARCINOMA	O
.	O

CANNOT	O
BE	O
ACCURATELY	O
DETERMINED	O
BECAUSE	O
OF	O
ITS	O
DIFFUSE	O
NATURE	O
,	O
BUT	O
BASED	O
ON	O
.	O

GROSS	O
EXAMINATION	O
IT	O
IS	O
ESTIMATED	O
THAT	O
THR	O
INVASIVE	O
CARCINOMA	O
SPANS	O
AN	O
AREA	O
.	O

OF	O
ABOUT	O
4	B
.	I
5	I
CM	I
.	O

-	O
THE	O
BASE	O
OF	O
THE	O
NIPPLE	O
IS	O
ALSO	O
INVOLVED	O
BY	O
INVASIVE	O
LOBULAR	O
CARCINOMA	O
.	O

-	O
LOBULAR	O
CARCINOMA	O
IN	O
SITU	O
(	O
LCIS	O
)	O
.	O

-	O
MICROCALCIICATIONS	O
ARE	O
PRESENT	O
IN	O
BENIGN	O
(	O
ENTRAPPED	O
)	O
BREAST	O
PARENCHYMA	O
.	O

-	O
LYMPHOVASCULAR	O
INVASION	O
IS	O
PRESENT	O
.	O

-	O
NO	O
INVOLVEMENT	O
OF	O
THE	O
SURGICAL	O
MARGINS	O
BY	O
CARCINOMA	O
IS	O
IDENTIFIED	O
.	O

SKIN	O
WITH	O
SCAR	O
.	O
,	O
THE	O
REMAINING	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
SHOWS	O
BIOPSY	O
SITE	O
CHANGES	O
AND	O
.	O

FOCAL	O
DUCTAL	O
HYPERPLASIA	O
WITH	O
FOCAL	O
ATYPIA	O
.	O

ONE	O
AXILLARY	O
LYMPH	O
NODE	O
IS	O
POSITIVE	O
FOR	O
METASTATIC	O
MAMMARY	O
CARCINOMA	O
.	O

(	O
1	O
/	O
1	O
)	O
-	O
NO	O
EXTRANODAL	O
TUMOR	O
EXTENSION	O
IS	O
PRESENT	O
.	O

-	O
RESULTS	O
OF	O
IMMUNOHISTOCHEMICAL	O
STAINS	O
ARE	O
AS	O
FOLLOWS	O
:	O
ER	O
:	O
95	O
%	O
NUCLEAR	O
STAINING	O
WITH	O
STRONG	O
INTENSITY	O
.	O

PR	O
:	O
70	O
%	O
NUCLEAR	O
STAINING	O
WITH	O
MODERATE	O
TO	O
STRONG	O
INTENSITY	O
.	O

HER	O
-	O
2	O
/	O
NEU	O
(	O
HERCEPTEST	O
)	O
:	O
NEGATIVE	O
(	O
STAINING	O
INTENSITY	O
OF	O
0	O
)	O
.	O

6	O
)	O
.	O

LYMPH	O
NODE	O
,	O
NON	O
-	O
SENTINEL	O
LEVEL	O
I	O
LEFT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

7	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
AXILLARY	O
CONTENTS	O
LEVEL	O
I	O
;	O
DISSECTION	O
:	O
-	O
TWENTY	O
-	O
TWO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
22	O
)	O
.	O

8	O
)	O
.	O

LYMPH	O
NODES	O
,	O
LEFT	O
AXILLARY	O
CONTENTS	O
LEVEL	O
II	O
;	O
DISSECTION	O
:	O
SIXTEEN	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
16	O
)	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
.	O

AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Commen	O
t	O
.	O

RECUT	O
.	O

ER	O
-	O
C	O
.	O

PR	O
-	O
C	O
.	O

HER2	O
-	O
C	O
.	O

NEG	O
CONT	O
.	O

IMM	O
RECUT	O
.	O

NEG	O
-	O
HER2	O
.	O

RECUT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Sentinel	O
node	O
#	O
1	O
level	O
.	O

1	O
axilla	O
"	O
and	O
consists	O
of	O
one	O
lymph	O
node	O
measuring	O
1	O
.	O
5	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
.	O

Bisected	O
and	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Sentinel	O
node	O
#	O
2	O
level	O
2	O
.	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
one	O
lymph	O
node	O
measuring	O
0	O
.	O
8	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O
,	O
M	O
.	O
D	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Sentinel	O
node	O
#	O
3	O
level	O
2	O
.	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
one	O
lymph	O
node	O
measuring	O
1	O
.	O
0	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
.	O

Entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O
,	O
M	O
.	O
D	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
labeled	O
"	O
Sentinel	O
node	O
#	O
4	O
level	O
.	O

1	O
.	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
lymph	O
node	O
measuring	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
.	O

Entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

M	O
.	O
D	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
,	O
"	O
Left	O
breast	O
,	O
stitch	O
marked	O
.	O
axillary	O
tail	O
"	O
and	O
consists	O
of	O
a	O
breast	O
with	O
attached	O
axillary	O
tail	O
.	O

The	O
.	O
breast	O
measures	O
35	O
.	O
5	O
x	O
24	O
.	O
0	O
x	O
3	O
.	O
8	O
cm	O
with	O
overlying	O
skin	O
ellipse	O
measuring	O
.	O

13	O
.	O
5	O
x	O
7	O
.	O
5	O
cm	O
.	O

Situated	O
centrally	O
on	O
the	O
skin	O
surface	O
is	O
an	O
unremarkable	O
.	O
nipple	O
measuring	O
1	O
.	O
2	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
and	O
areola	O
measuring	O
3	O
.	O
9	O
x	O
3	O
.	O
9	O
cm	O
.	O

The	O
.	O
skin	O
shows	O
a	O
linear	O
scar	O
measuring	O
8	O
.	O
0	O
cm	O
,	O
situated	O
vertically	O
near	O
the	O
.	O
nipple	O
.	O

A	O
suture	O
demarcates	O
the	O
axillary	O
tail	O
which	O
measures	O
4	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
.	O

3	O
.	O
5	O
cm	O
.	O

Sectioning	O
the	O
breast	O
reveals	O
a	O
biopsy	O
cavity	O
,	O
measuring	O
4	O
.	O
2	O
x	O
3	O
.	O
5	O
.	O

x	O
4	O
.	O
0	O
cm	O
with	O
a	O
fibrotic	O
area	O
superior	O
to	O
the	O
cavity	O
.	O

One	O
ill	O
-	O
defined	O
tan	O
.	O
mass	O
is	O
present	O
,	O
measuring	O
4	O
.	O
5	O
x	O
4	O
.	O
5	O
x	O
2	O
.	O
7	O
cm	O
,	O
located	O
lateral	O
to	O
the	O
nipple	O
.	O
in	O
UOQ	O
and	O
3	O
.	O
5	O
cm	O
from	O
the	O
deep	O
surgical	O
margin	O
.	O

The	O
remaining	O
breast	O
.	O
tissue	O
shows	O
unremarkable	O
intermingling	O
of	O
fatty	O
and	O
fibrotic	O
areas	O
.	O

The	O
.	O
axillary	O
tissue	O
is	O
dissected	O
to	O
reveal	O
one	O
lymph	O
node	O
,	O
measuring	O
1	O
.	O
1	O
x	O
0	O
.	O
5	O
x	O
.	O

0	O
.	O
5	O
cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

A	O
portion	O
of	O
tumor	O
is	O
.	O
submitted	O
to	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
-	O
nipple	O
.	O

NB	O
-	O
nipple	O
base	O
.	O

s	O
-	O
skin	O
scar	O
.	O

D	O
-	O
deep	O
margin	O
.	O

T	O
-	O
tumor	O
.	O

UIQ	O
-	O
upper	O
inner	O
quadrant	O
.	O

LIQ	O
-	O
lower	O
inner	O
quadrant	O
.	O

UOQ	O
-	O
upper	O
outer	O
quadrant	O
.	O

LOQ	O
-	O
lower	O
outer	O
quadrant	O
.	O

LNS	O
-	O
lymph	O
node	O
.	O

M	O
.	O
D	O
.	O

6	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
is	O
labeled	O
"	O
Non	O
-	O
sentinel	O
node	O
.	O
level	O
1	O
left	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
tan	O
soft	O
lymph	O
node	O
measuring	O
1	O
.	O
0	O
x	O
.	O

1	O
.	O
0	O
x	O
0	O
.	O
7	O
cm	O
.	O

Entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
node	O
(	O
bisected	O
)	O
.	O
,	O
M	O
.	O
D	O
.	O

7	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
and	O
is	O
labeled	O
"	O
Left	O
axillary	O
.	O
contents	O
level	O
1	O
"	O
and	O
consists	O
of	O
multiple	O
lymph	O
nodes	O
and	O
fat	O
measuring	O
8	O
.	O
0	O
.	O

x	O
7	O
.	O
0	O
x	O
1	O
.	O
1	O
cm	O
in	O
aggregate	O
.	O

The	O
lymph	O
nodes	O
measure	O
from	O
0	O
.	O
2	O
cm	O
to	O
3	O
.	O
0	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
BLN1	O
-	O
bisected	O
lymph	O
node	O
.	O

BLN2	O
-	O
bisected	O
lymph	O
node	O
.	O

LN	O
-	O
lymph	O
nodes	O
.	O

M	O
.	O
D	O
.	O

8	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
"	O
Left	O
axillary	O
contents	O
.	O
level	O
2	O
and	O
tag	O
"	O
and	O
consists	O
of	O
multiple	O
lymph	O
nodes	O
and	O
attached	O
fat	O
.	O
measuring	O
5	O
.	O
0	O
x	O
4	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
.	O

The	O
lymph	O
nodes	O
measure	O
from	O
0	O
.	O
3	O
cm	O
to	O
0	O
.	O
5	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

The	O
lymph	O
nodes	O
are	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
1	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
2	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
2	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
4	O
,	O
level	O
1	O
,	O
left	O
axilla	O
(	O
fs	O
)	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O
fsc	O
.	O

1	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Left	O
breast	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PC	O
'	O
s	O
.	O

1	O
.	O

dm	O
.	O

1	O
.	O

2	O
.	O
lig	O
.	O

2	O
.	O

1	O
.	O

Ins	O
.	O

1	O
.	O

2	O
.	O
loq	O
.	O

2	O
.	O

1	O
.	O

n	O
.	O

1	O
.	O

1	O
.	O

nb	O
.	O

1	O
.	O

1	O
.	O

sk	O
.	O

1	O
.	O

5	O
.	O

t	O
.	O

5	O
.	O

2	O
.	O
uiq	O
.	O

2	O
.	O

2	O
.	O
uoq	O
.	O

2	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Non	O
-	O
sentinel	O
node	O
level	O
1	O
,	O
left	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

In	O
.	O

1	O
.	O

Part	O
7	O
:	O
SP	O
:	O
Left	O
axillary	O
contents	O
level	O
1	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

2	O
.	O
blnl	O
.	O

2	O
.	O

2	O
.	O

bln2	O
.	O

2	O
.	O

6	O
.	O

In	O
.	O

6	O
.	O

Part	O
8	O
:	O
SP	O
:	O
Left	O
axillary	O
contents	O
level	O
2	O
and	O
tag	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

3	O
.	O

In	O
.	O

3	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
.	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

METASTATIC	O
CARCINOMA	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

2	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

3	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

4	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

NO	O
CARCINOMA	O
IDENTIFIED	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

Diagnosis	O
/	O
diagnoses	O
:	O
1	O
.	O
:	O
Tumor	O
-	O
free	O
lymph	O
nodes	O
.	O

2	O
.	O
:	O
Total	O
gastrectomy	O
preparation	O
with	O
the	O
inclusion	O
of	O
a	O
moderately	O
differentiated	O
.	O
mucigenous	O
adenocarcinoma	O
(	O
intestinal	O
type	O
)	O
in	O
the	O
prepyloric	O
antrum	O
of	O
the	O
stomach	O
,	O
with	O
a	O
.	O
maximum	O
diameter	O
of	O
3	B
cm	I
,	O
with	O
infiltration	O
of	O
the	O
perigastric	O
fatty	O
tissue	O
and	O
a	O
further	O
.	O
moderately	O
differentiated	O
adenocarcinoma	O
(	O
intestinal	O
type	O
)	O
,	O
likewise	O
in	O
the	O
antrum	O
,	O
measuring	O
.	O

1	B
.	I
5	I
cm	I
in	O
diameter	O
,	O
with	O
circumscribed	O
infiltration	O
of	O
the	O
tunica	O
submucosa	O
.	O

Six	O
regional	O
.	O
lymph	O
node	O
metastases	O
in	O
the	O
region	O
of	O
the	O
greater	O
curvature	O
.	O

Tumor	O
-	O
free	O
esophageal	O
.	O
resection	O
margin	O
covered	O
with	O
characteristic	O
squamous	O
epithelium	O
and	O
tumor	O
-	O
free	O
duodenal	O
.	O
resection	O
margin	O
.	O

Tumor	O
-	O
free	O
omentum	O
.	O

Tumor	O
stage	O
:	O
pT2b	O
(	O
2	O
)	O
pN1	O
(	O
6	O
/	O
42	O
)	O
pMX	O
;	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
old	O
with	O
sigmoid	O
colon	O
cancer	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Colon	O
,	O
terminal	O
ileum	O
,	O
appendix	O
;	O
total	O
colectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Colon	O
,	O
terminal	O
ileum	O
,	O
appendix	O
;	O
total	O
colectomy	O
:	O
Tumor	O
Type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
Grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
Location	O
:	O
Sigmoid	O
colon	O
.	O

Tumor	O
Size	O
:	O
Length	O
is	O
3	B
cm	I
.	O

Width	O
is	O
4	B
em	I
.	O

Maximal	O
thickness	O
is	O
0	B
.	I
3	I
cm	I
.	O

Tumor	O
Budding	O
:	O
Focal	O
.	O

Increased	O
Tumor	O
Infiltrating	O
Lymphocytes	O
:	O
Absent	O
.	O

Precursor	O
Lesions	O
:	O
Tubular	O
adenoma	O
.	O

Deepest	O
Tumor	O
Invasion	O
:	O
Subserosal	O
adipose	O
tissue	O
and	O
/	O
or	O
mesenteric	O
fat	O
.	O

Gross	O
Tumor	O
Perforation	O
:	O
Not	O
identified	O
.	O

Lymphovascular	O
Invasion	O
:	O
Identified	O
.	O

Large	O
Venous	O
Invasion	O
:	O
Not	O
Identified	O
.	O

Perineural	O
Invasion	O
:	O
Identified	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Polyps	O
/	O
Mucosa	O
Dysplasia	O
(	O
away	O
from	O
the	O
carcinoma	O
)	O
:	O
Tubular	O
adenoma	O
;	O
number	O
:	O
3	O
.	O

Non	O
-	O
Neoplastic	O
Bowel	O
:	O
Extensive	O
melanosis	O
coli	O
.	O

Appendix	O
:	O
Unremarkable	O
.	O

Lymph	O
Nodes	O
:	O
Number	O
with	O
metastasis	O
:	O
3	O
.	O

Total	O
number	O
examined	O
:	O
108	O
.	O

Tumor	O
staging	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
pT3	O
(	O
Tumor	O
invades	O
through	O
the	O
muscularis	O
propria	O
into	O
.	O
pericolorectal	O
tissues	O
)	O
.	O

Lymph	O
Node	O
Stage	O
(	O
AJCC	O
7th	O
Edition	O
)	O
:	O
N1b	O
(	O
Metastasis	O
in	O
2	O
-	O
3	O
regional	O
lymph	O
nodes	O
)	O
.	O

NOTE	O
:	O
THE	O
IMMUNOHISTOCHEMICAL	O
STAINING	O
FOR	O
THE	O
TESTED	O
DNA	O
MISMATCH	O
REPAIR	O
.	O

PROTEINS	O
(	O
MLH1	O
,	O
MSH2	O
,	O
MSH6	O
,	O
PMS2	O
)	O
IS	O
RETAINED	O
IN	O
THE	O
TUMOR	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

RECUT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
total	O
colectomy	O
"	O
and	O
consists	O
.	O
of	O
a	O
segment	O
of	O
terminal	O
ileum	O
,	O
cecum	O
with	O
attached	O
appendix	O
,	O
ascending	O
,	O
.	O
transverse	O
,	O
descending	O
and	O
sigmoid	O
colon	O
.	O

The	O
terminal	O
ileum	O
measures	O
12	O
cm	O
.	O
in	O
length	O
and	O
3	O
.	O
5	O
cm	O
in	O
circumference	O
at	O
the	O
proximal	O
resected	O
margin	O
.	O

The	O
.	O
remaining	O
colon	O
measures	O
95	O
.	O
5	O
in	O
length	O
with	O
a	O
circumference	O
of	O
nine	O
cm	O
at	O
.	O
the	O
distal	O
resected	O
margin	O
.	O

The	O
attached	O
appendix	O
measures	O
8	O
cm	O
in	O
length	O
.	O
and	O
averages	O
0	O
.	O
5	O
cm	O
in	O
diameter	O
The	O
appendiceal	O
and	O
intestinal	O
serosa	O
is	O
.	O
pink	O
tan	O
and	O
smooth	O
.	O

Focally	O
hemorrhagic	O
lobulated	O
yellow	O
tan	O
adipose	O
.	O
tissue	O
spans	O
the	O
length	O
of	O
the	O
specimen	O
measuring	O
up	O
to	O
2	O
.	O
5	O
cm	O
in	O
thickness	O
.	O

The	O
specimen	O
is	O
opened	O
to	O
reveal	O
a	O
mass	O
lesion	O
measuring	O
3	O
cm	O
in	O
length	O
and	O
.	O

4	O
.	O

cm	O
in	O
width	O
.	O

The	O
mass	O
is	O
located	O
in	O
the	O
sigmoid	O
colon	O
,	O
85	O
cm	O
from	O
the	O
.	O
proximal	O
margin	O
and	O
7	O
cm	O
from	O
the	O
distal	O
margin	O
.	O

Sectioning	O
shows	O
that	O
the	O
.	O
tumor	O
invades	O
the	O
muscularis	O
propria	O
and	O
possibly	O
the	O
serosa	O
.	O

The	O
depth	O
of	O
.	O
invasion	O
is	O
0	O
.	O
3	O
cm	O
grossly	O
.	O

The	O
remaining	O
mucosa	O
shows	O
two	O
sessile	O
polyp	O
,	O
.	O
measuring	O
0	O
.	O
5	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
and	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
x	O
0	O
.	O
2	O
cm	O
.	O

The	O
attached	O
adipose	O
.	O
tissue	O
is	O
submitted	O
for	O
lymph	O
node	O
dissection	O
and	O
all	O
identified	O
lymph	O
nodes	O
.	O
are	O
submitted	O
.	O

The	O
colon	O
is	O
extensively	O
sampled	O
with	O
representative	O
sections	O
.	O
submitted	O
for	O
permanent	O
sections	O
and	O
for	O
TPS	O
.	O

Summary	O
of	O
sections	O
:	O
PM	O
-	O
proximal	O
margin	O
shave	O
.	O

DM	O
-	O
distal	O
margin	O
shave	O
.	O

T	O
tumor	O
.	O

P	O
polyps	O
.	O

A	O
-	O
appendix	O
representative	O
sections	O
.	O

RS	O
-	O
representative	O
sections	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Colon	O
,	O
terminal	O
ileum	O
,	O
appendix	O
;	O
total	O
colectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCa	O
.	O

1	O
.	O

A	O
.	O

1	O
.	O

1	O
.	O

DM	O
.	O

1	O
.	O

23	O
.	O

LN	O
.	O

85	O
.	O

1	O
.	O

P	O
.	O

1	O
.	O

1	O
.	O

PM	O
.	O

1	O
.	O

10	O
.	O

RS	O
.	O

10	O
.	O

5	O
.	O

5	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
LEFT	O
PELVIC	O
LYMPH	O
NODES	O
:	O
METASTATIC	O
ADENOCARCINOMA	O
IN	O
TWO	O
OF	O
ELEVEN	O
LYMPH	O
NODES	O
WITH	O
EXTRANODAL	O
EXTENSION	O
.	O

(	O
2	O
/	O
11	O
)	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

(	O
B	O
)	O
RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
:	O
METASTATIC	O
ADENOCARCINOMA	O
IN	O
ONE	O
OF	O
EIGHT	O
LYMPH	O
NODES	O
(	O
1	O
/	O
8	O
)	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

(	O
C	O
)	O
"	O
LEFT	O
PERIVESICLE	O
"	O
LYMPH	O
NODES	O
:	O
Adipose	O
tissue	O
no	O
lymph	O
nodes	O
or	O
tumor	O
present	O
.	O

(	O
D	O
)	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
:	O
Supplemental	O
report	O
to	O
follow	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

COMMENT	O
.	O

The	O
foci	O
of	O
metastatic	O
carcinoma	O
measure	O
4	B
.	I
0	I
mm	I
and	O
8	B
.	I
0	I
mm	I
in	O
part	O
A	O
and	O
4	B
.	I
0	I
mm	I
in	O
part	O
B	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
LEFT	O
PELVIC	O
LYMPH	O
NODES	O
-	O
Received	O
are	O
multiple	O
fragments	O
of	O
fatty	O
tissue	O
measuring	O
in	O
aggregate	O
(	O
9	O
x	O
5	O
x	O
2	O
cm	O
)	O
.	O

Dissection	O
.	O
reveals	O
multiple	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
4	O
up	O
to	O
2	O
.	O
8	O
cm	O
in	O
their	O
greatest	O
dimension	O
.	O

Possible	O
lymph	O
nodes	O
.	O
are	O
entirely	O
submitted	O
in	O
cassettes	O
.	O

SECTION	O
CODE	O
:	O
A1	O
,	O
three	O
possible	O
lymph	O
nodes	O
;	O
A2	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
A3	O
,	O
one	O
sectioned	O
possible	O
.	O
lymph	O
node	O
;	O
A4	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
A5	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
A6	O
,	O
A7	O
,	O
one	O
sectioned	O
possible	O
.	O
lymph	O
node	O
;	O
A8	O
,	O
A9	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
A10	O
,	O
A11	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
A12	O
-	O
A14	O
,	O
one	O
sectioned	O
.	O
possible	O
lymph	O
node	O
.	O

(	O
B	O
)	O
RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
-	O
Multiple	O
fragments	O
of	O
fatty	O
tissue	O
measuring	O
in	O
aggregate	O
8	O
.	O
5	O
x	O
4	O
.	O
5	O
X	O
2	O
cm	O
.	O

Dissection	O
.	O
reveals	O
multiple	O
possible	O
lymph	O
nodes	O
ranging	O
from	O
0	O
.	O
5	O
up	O
to	O
3	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

Possible	O
lymph	O
nodes	O
are	O
entirely	O
.	O
submitted	O
in	O
cassettes	O
.	O

SECTION	O
CODE	O
:	O
B1	O
,	O
two	O
possible	O
lymph	O
nodes	O
;	O
B2	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
B3	O
,	O
one	O
sectioned	O
possible	O
.	O
lymph	O
node	O
;	O
B4	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
B5	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
;	O
B6	O
,	O
one	O
sectioned	O
possible	O
lymph	O
.	O
node	O
;	O
B7	O
-	O
B10	O
,	O
one	O
sectioned	O
possible	O
lymph	O
node	O
.	O

(	O
C	O
)	O
LEFT	O
PERIVESICLE	O
LYMPH	O
NODES	O
-	O
Multiple	O
fragments	O
of	O
fatty	O
tissue	O
measuring	O
in	O
aggregate	O
2	O
.	O
5	O
x	O
2	O
.	O
4	O
x	O
0	O
.	O
5	O
cm	O
.	O

Entirely	O
.	O
submitted	O
in	O
cassette	O
C	O
.	O

(	O
D	O
)	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
-	O
Supplemental	O
report	O
to	O
follow	O
.	O

CLINICAL	O
HISTORY	O
.	O

Prostatic	O
cancer	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
C4600	O
,	O
M	O
-	O
y1976	O
.	O

Page	O
:	O
2	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
Start	O
of	O
ADDENDUM	O
.	O

Page	O
:	O
3	O
.	O

ADDENDUM	O
.	O

This	O
modified	O
report	O
is	O
being	O
issued	O
to	O
provide	O
additional	O
information	O
/	O
results	O
.	O

Addendum	O
completed	O
by	O
.	O

DIAGNOSIS	O
.	O

(	O
D	O
)	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
:	O
PROSTATIC	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
9	O
(	O
4	O
+	O
5	O
)	O
.	O

(	O
SEE	O
COMMENT	O
)	O
.	O

TUMOR	O
EXTENDING	O
IN	O
MULTIPLE	O
AREAS	O
INTO	O
EXTRAPROSTATIC	O
TISSUE	O
.	O

TUMOR	O
INVADING	O
LEFT	O
SEMINAL	O
VESICLE	O
AND	O
LEFT	O
PERIVESICULAR	O
SOFT	O
TISSUE	O
.	O

FOCAL	O
EXTENSION	O
OF	O
TUMOR	O
TO	O
THE	O
MARGIN	O
OF	O
RESECTION	O
CANNOT	O
BE	O
EXCLUDED	O
.	O

Right	O
seminal	O
vesicle	O
and	O
segments	O
of	O
vasa	O
deferentia	O
,	O
no	O
tumor	O
present	O
.	O

SEE	O
PREVIOUS	O
REPORT	O
FOR	O
DIAGNOSIS	O
OF	O
THE	O
PELVIC	O
LYMPH	O
NODES	O
.	O

COMMENT	O
.	O

The	O
prostate	O
gland	O
contains	O
a	O
single	O
focus	O
of	O
prostatic	O
adenocarcinoma	O
.	O

The	O
tumor	O
is	O
located	O
in	O
the	O
right	O
.	O
anterior	O
,	O
mid	O
anterior	O
,	O
left	O
anterior	O
,	O
left	O
anterolateral	O
,	O
left	O
lateral	O
,	O
left	O
posterolateral	O
,	O
left	O
posterior	O
,	O
mid	O
.	O
posterior	O
,	O
right	O
posterior	O
,	O
right	O
posterolateral	O
and	O
right	O
lateral	O
peripheral	O
zone	O
.	O

It	O
is	O
estimated	O
that	O
the	O
tumor	O
.	O
occupies	O
approximately	O
70	O
%	O
of	O
the	O
prostatic	O
volume	O
.	O

The	O
tumor	O
focus	O
measures	O
4	B
.	I
5	I
X	I
3	I
.	I
0	I
cm	I
in	O
the	O
largest	O
.	O
cross	O
-	O
sectional	O
dimension	O
and	O
it	O
is	O
present	O
in	O
three	O
cross	O
sections	O
and	O
extensively	O
in	O
the	O
apex	O
and	O
base	O
.	O
regions	O
.	O

The	O
tumor	O
exhibits	O
extraprostatic	O
extension	O
in	O
the	O
left	O
lateral	O
and	O
left	O
posterolateral	O
aspect	O
of	O
the	O
.	O
prostate	O
,	O
left	O
superior	O
neurovascular	O
bundle	O
region	O
and	O
posterior	O
surface	O
of	O
the	O
prostate	O
at	O
the	O
base	O
level	O
.	O

At	O
the	O
sites	O
of	O
extraprostatic	O
extension	O
,	O
the	O
margin	O
of	O
resection	O
is	O
free	O
of	O
tumor	O
.	O

The	O
tumor	O
extends	O
in	O
the	O
.	O
right	O
posterolateral	O
aspect	O
of	O
the	O
prostate	O
to	O
less	O
than	O
0	O
.	O
1	O
mm	O
from	O
the	O
inked	O
surface	O
.	O

Focal	O
marginal	O
.	O
involvement	O
cannot	O
be	O
excluded	O
.	O

The	O
tumor	O
extensively	O
involves	O
the	O
left	O
seminal	O
vesicle	O
including	O
intra	O
and	O
extraprostatic	O
portions	O
.	O

Please	O
refer	O
to	O
the	O
previous	O
report	O
for	O
the	O
diagnosis	O
of	O
the	O
pelvic	O
lymph	O
nodes	O
.	O

GROSS	O
DESCRIPTION	O
.	O

Page	O
:	O
4	O
.	O

(	O
D	O
)	O
PROSTATE	O
AND	O
SEMINAL	O
VESICLES	O
-	O
A	O
specimen	O
consisting	O
of	O
a	O
prostate	O
,	O
attached	O
right	O
and	O
left	O
.	O
seminal	O
vesicles	O
and	O
attached	O
segments	O
of	O
right	O
and	O
left	O
vasa	O
deferentia	O
.	O

The	O
prostate	O
gland	O
(	O
5	O
.	O
8	O
X	O
3	O
.	O
3	O
X	O
3	O
.	O
4	O
cm	O
,	O
51	O
grams	O
,	O
post	O
-	O
fixation	O
)	O
has	O
the	O
usual	O
shape	O
.	O

The	O
soft	O
tissue	O
.	O
present	O
along	O
the	O
left	O
posterolateral	O
aspect	O
of	O
the	O
prostate	O
appears	O
more	O
abundant	O
than	O
along	O
the	O
right	O
side	O
.	O

Nodules	O
are	O
palpated	O
on	O
the	O
left	O
and	O
right	O
sides	O
of	O
the	O
prostate	O
.	O

Serial	O
cross	O
sections	O
after	O
fixation	O
.	O
demonstrate	O
areas	O
consistent	O
with	O
tumor	O
in	O
the	O
right	O
posterolateral	O
and	O
left	O
posterolateral	O
peripheral	O
zone	O
of	O
.	O
the	O
three	O
cross	O
sections	O
of	O
the	O
prostate	O
.	O

The	O
seminal	O
vesicles	O
and	O
segments	O
of	O
vasa	O
deferentia	O
are	O
grossly	O
free	O
of	O
tumor	O
.	O

SECTION	O
CODE	O
:	O
D1	O
-	O
D3	O
,	O
right	O
seminal	O
vesicle	O
and	O
segment	O
of	O
right	O
vas	O
deferens	O
from	O
the	O
base	O
.	O
towards	O
the	O
tip	O
;	O
D4	O
-	O
D6	O
,	O
left	O
seminal	O
vesicle	O
and	O
segment	O
of	O
left	O
vas	O
deferens	O
from	O
the	O
base	O
towards	O
the	O
tip	O
;	O
.	O

D7	O
,	O
D8	O
,	O
prostatic	O
base	O
,	O
right	O
border	O
;	O
D9	O
-	O
D12	O
,	O
prostatic	O
base	O
,	O
right	O
posterior	O
border	O
;	O
D13	O
-	O
D22	O
,	O
prostatic	O
base	O
,	O
.	O
central	O
portion	O
;	O
D23	O
,	O
D24	O
,	O
prostatic	O
base	O
,	O
left	O
border	O
;	O
D5	O
-	O
D28	O
,	O
prostatic	O
base	O
,	O
left	O
posterior	O
border	O
;	O
D29	O
-	O
D31	O
,	O
.	O
apex	O
anterior	O
;	O
D32	O
,	O
D33	O
,	O
apex	O
left	O
;	O
D34	O
,	O
D35	O
,	O
apex	O
posterior	O
;	O
D36	O
,	O
D37	O
,	O
apex	O
right	O
;	O
D38	O
-	O
D49	O
,	O
sections	O
of	O
.	O
the	O
three	O
cross	O
sections	O
of	O
the	O
prostate	O
according	O
to	O
specimen	O
radiograph	O
.	O

The	O
anterior	O
aspect	O
of	O
the	O
prostate	O
is	O
inked	O
in	O
green	O
,	O
left	O
surface	O
in	O
red	O
,	O
right	O
surface	O
in	O
yellow	O
and	O
.	O
posterior	O
surface	O
in	O
black	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
92000	O
,	O
M	O
-	O
Y1973	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O

PROCEDURE	O
.	O

Bilateral	O
simple	O
breast	O
mastectomy	O
with	O
sentinel	O
node	O
biopsy	O
left	O
.	O
breast	O
.	O

A	O
.	O

Right	O
breast	O
.	O

B	O
.	O

Left	O
breast	O
with	O
attached	O
sentinel	O
nodes	O
.	O

HISTORY	O
.	O

Left	O
breast	O
cancer	O
.	O

GROSS	O
.	O

A	O
.	O

Received	O
in	O
formalin	O
in	O
a	O
container	O
labeled	O
"	O
right	O
breast	O
"	O
is	O
a	O
.	O
mastectomy	O
(	O
22	O
x	O
18	O
x	O
5	O
cm	O
)	O
.	O

Orientation	O
of	O
the	O
specimen	O
is	O
not	O
.	O
provided	O
.	O

The	O
skin	O
ellipse	O
(	O
20	O
x	O
15	O
cm	O
)	O
has	O
a	O
central	O
unremarkable	O
.	O
nipple	O
and	O
areola	O
.	O

The	O
posterior	O
margin	O
is	O
composed	O
of	O
thin	O
fascia	O
.	O
without	O
attached	O
skeletal	O
muscle	O
.	O

The	O
margins	O
are	O
marked	O
with	O
black	O
.	O
ink	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
.	O

The	O
parenchyma	O
has	O
discrete	O
and	O
.	O
ill	O
-	O
defined	O
areas	O
of	O
soft	O
white	O
fibrous	O
tissue	O
.	O

A	O
suspicious	O
lesion	O
.	O

is	O
not	O
palpated	O
.	O

1	O
.	O

Nipple	O
and	O
areola	O
.	O

1NS	O
.	O

2	O
.	O

Subareolar	O
parenchyma	O
.	O

2SS	O
.	O

3	O
-	O
6	O
.	O

Representative	O
sections	O
from	O
four	O
quadrants	O
.	O

B	O
.	O

Received	O
fresh	O
in	O
a	O
container	O
labeled	O
"	O
left	O
breast	O
"	O
is	O
a	O
.	O
mastectomy	O
(	O
23	O
x	O
17	O
x	O
5	O
cm	O
)	O
with	O
a	O
7	O
cm	O
axillary	O
tail	O
.	O

The	O
skin	O
.	O
ellipse	O
(	O
20	O
x	O
12	O
cm	O
)	O
has	O
a	O
central	O
unremarkable	O
nipple	O
and	O
areola	O
.	O

The	O
parenchyma	O
is	O
serially	O
sectioned	O
.	O

The	O
medial	O
hemisphere	O
has	O
a	O
.	O

2	O
.	O
6	O
cm	O
in	O
greatest	O
dimension	O
hard	O
gray	O
-	O
white	O
sclerotic	O
neoplasm	O
with	O
.	O

an	O
ill	O
-	O
defined	O
radially	O
infiltrating	O
border	O
measuring	O
approximately	O
.	O

1	O
cm	O
from	O
the	O
posterior	O
margin	O
,	O
2	O
.	O
2	O
cm	O
from	O
the	O
skin	O
surface	O
and	O
1	O
.	O

cm	O
from	O
the	O
nearest	O
(	O
inferomedial	O
)	O
radial	O
margin	O
.	O

A	O
representative	O
.	O
portion	O
of	O
the	O
tumor	O
along	O
with	O
normal	O
parenchyma	O
away	O
from	O
the	O
.	O
neoplasm	O
is	O
submitted	O
for	O
TCGA	O
/	O
.	O

The	O
remaining	O
.	O
parenchyma	O
has	O
scattered	O
areas	O
of	O
ill	O
-	O
defined	O
fibrous	O
tissue	O
without	O
.	O

a	O
palpable	O
mass	O
.	O

The	O
axillary	O
tail	O
has	O
numerous	O
fatty	O
lymph	O
nodes	O
.	O

up	O
to	O
2	O
.	O
5	O
cm	O
in	O
greatest	O
dimension	O
.	O

1	O
.	O

Small	O
lymph	O
node	O
.	O

2	O
-	O
7	O
.	O

Bisected	O
lymph	O
nodes	O
(	O
1	O
lymph	O
node	O
per	O
cassette	O
)	O
.	O

8	O
-	O
10	O
.	O

Large	O
lymph	O
node	O
.	O

11	O
.	O

Nipple	O
and	O
areola	O
.	O

12	O
.	O

Skin	O
and	O
posterior	O
margin	O
nearest	O
neoplasm	O
.	O

13	O
.	O

Inferomedial	O
quadrant	O
nearest	O
neoplasm	O
.	O

14	O
-	O
16	O
.	O

Neoplasm	O
.	O

17	O
.	O

Superolateral	O
quadrant	O
.	O

18	O
.	O

Inferolateral	O
quadrant	O
.	O

MICROSCOPIC	O
.	O

A	O
-	O
B	O
.	O

Performed	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

Right	O
simple	O
mastectomy	O
:	O
Nonproliferative	O
breast	O
parenchyma	O
with	O
acellular	O
dense	O
.	O
stromal	O
fibrosis	O
and	O
rare	O
microcalcification	O
.	O

Nipple	O
,	O
free	O
of	O
lesion	O
.	O

CPT	O
88307	O
.	O

B	O
.	O

Left	O
mastectomy	O
with	O
attached	O
sentinel	O
nodes	O
:	O
Invasive	O
lobular	O
carcinoma	O
,	O
Nottingham	O
grade	O
1	O
(	O
previously	O
.	O
diagnosed	O
,	O
.	O

Nipple	O
and	O
skin	O
of	O
posterior	O
margin	O
(	O
nearest	O
neoplasm	O
)	O
,	O
free	O
.	O
of	O
lesion	O
.	O

Eight	O
of	O
eight	O
sentinel	O
lymph	O
nodes	O
,	O
free	O
of	O
metastatic	O
.	O
carcinoma	O
.	O

CPT	O
88309	O
.	O

BREAST	O
CARCINOMA	O
SUMMARY	O
:	O
SPECIMEN	O
:	O
Left	O
breast	O
.	O

PROCEDURE	O
:	O
Left	O
breast	O
with	O
attached	O
sentinel	O
lymph	O
nodes	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
Intact	O
.	O

SPECIMEN	O
LATERALITY	O
:	O
Left	O
.	O

SPECIMEN	O
SIZE	O
:	O
23	O
x	O
17	O
x	O
5	O
cm	O
.	O

LYMPH	O
NODE	O
SAMPLING	O
:	O
SENTINEL	O
LYMPH	O
NODES	O
:	O
8	O
of	O
8	O
,	O
negative	O
for	O
metastatic	O
.	O
carcinoma	O
.	O

TUMOR	O
SIZE	O
:	O
2	B
.	I
6	I
cm	I
.	O

TUMOR	O
FOCALITY	O
:	O
Single	O
focus	O
.	O

SKIN	O
INVOLVEMENT	O
:	O
Negative	O
for	O
cancer	O
.	O

NIPPLE	O
INVOLVEMENT	O
:	O
Negative	O
for	O
cancer	O
.	O

SKELETAL	O
MUSCLE	O
INVOLVEMENT	O
:	O
N	O
/	O
A	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
:	O
Not	O
present	O
.	O

LOBULAR	O
CARCINOMA	O
IN	O
SITU	O
(	O
LCIS	O
)	O
:	O
N	O
/	O
A	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Lobular	O
carcinoma	O
.	O

GRADING	O
(	O
NOTTINGHAM	O
)	O
:	O
Tubular	O
Formation	O
Score	O
:	O
3	O
.	O

Nuclear	O
Pleomorphism	O
Score	O
:	O
1	O
.	O

Mitotic	O
Rate	O
Score	O
:	O
1	O
.	O

COMBINED	O
GRADE	O
(	O
NOTTINGHAM	O
)	O
:	O
1	O
.	O

LYMPHOVASCULAR	O
INVASION	O
:	O
Not	O
seen	O
.	O

MARGIN	O
OF	O
EXCISION	O
:	O
Negative	O
for	O
carcinoma	O
.	O

LYMPH	O
NODES	O
:	O
See	O
above	O
.	O

MICROCALCIFICATION	O
:	O
Not	O
seen	O
.	O

OTHER	O
FINDINGS	O
:	O
N	O
/	O
A	O
.	O

HORMONE	O
RECEPTORS	O
:	O
ER	O
positive	O
.	O

PR	O
positive	O
.	O

HER2	O
:	O
Negative	O
(	O
1	O
+	O
)	O
.	O

PATHOLOGIC	O
.	O

(	O
AJCC	O
Seventh	O
Edition	O
)	O
:	O
pT2	O
pNO	O
.	O

(	O
Electronic	O
Signature	O
)	O
.	O

Completed	O
Action	O
List	O
:	O
on	O
.	O

Type	O
:	O
Sura	O
Path	O
Final	O
Report	O
.	O

Title	O
:	O
Contributor	O
system	O
:	O
SP	O
1st	O
Addendum	O
Report	O
.	O

SP	O
1ST	O
ADDENDUM	O
REPORT	O
.	O

ADDENDUM	O
REPORT	O
.	O

E	O
-	O
cadherin	O
immunostain	O
is	O
performed	O
on	O
block	O
B15	O
to	O
confirm	O
the	O
.	O
lobular	O
nature	O
of	O
the	O
infiltrating	O
mammary	O
carcinoma	O
.	O

The	O
stain	O
is	O
.	O
negative	O
,	O
supporting	O
the	O
diagnosis	O
of	O
invasive	O
LOBULAR	O
carcinoma	O
.	O

Positive	O
and	O
negative	O
tissue	O
controls	O
perform	O
as	O
expected	O
.	O

88342	O
.	O

(	O
Electronic	O
Signature	O
)	O
.	O

Completed	O
Action	O
List	O
:	O
Type	O
:	O
SP	O
1st	O
Addend	O
.	O

Title	O
:	O
SP	O
1ST	O
ADDENDUM	O
REPORT	O
.	O

Contributor	O
system	O
:	O

Gender	O
:	O
F	O
.	O

Result	O
Detail	O
.	O

Pathology	O
Result	O
:	O
Specimen	O
Collected	O
Date	O
:	O
Specimen	O
Received	O
Date	O
:	O
Medical	O
Record	O
Number	O
:	O
Facility	O
:	O
Date	O
Received	O
:	O
FINAL	O
DIAGNOSIS	O
.	O

A	O
.	O

"	O
TUMOR	O
MARGINS	O
"	O
,	O
BIOPSY	O
:	O
-	O
BLOOD	O
CONTAINING	O
FRAGMENTS	O
OF	O
CEREBRAL	O
CORTEX	O
DEMONSTRATE	O
FOCAL	O
GLIOMATOUS	O
.	O

INFILTRATION	O
.	O

B	O
.	O

"	O
LEFT	O
INTRACRANIAL	O
TUMOR	O
"	O
,	O
REMOVAL	O
:	O
-	O
OLIGODENDROGLIOMA	O
(	O
WHO	O
GRADE	O
II	O
)	O
.	O

Out	O
By	O
.	O

Intraoperative	O
Consultation	O
:	O
Microscopic	O
diagnosis	O
:	O
FSA1	O
:	O
Blood	O
cautery	O
with	O
low	O
grade	O
glioma	O
.	O

Dr	O
.	O
Clinical	O
History	O
:	O
left	O
intracranial	O
tumor	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
TUMOR	O
MARGINS	O
.	O

B	O
:	O
LEFT	O
INTRACRANIAL	O
TISSUE	O
.	O

Gross	O
Description	O
:	O
A	O
:	O
Received	O
fresh	O
for	O
intraoperative	O
consultation	O
,	O
labeled	O
with	O
the	O
.	O

patient	O
'	O
s	O
.	O
name	O
,	O
hospital	O
number	O
and	O
"	O
margins	O
"	O
,	O
is	O
a	O
segment	O
of	O
tan	O
and	O
red	O
soft	O
.	O
tissue	O
.	O

measuring	O
3	O
.	O
0	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
2	O
cm	O
.	O

The	O
specimen	O
is	O
bisected	O
and	O
representative	O
.	O
portion	O
is	O
submitted	O
for	O
frozen	O
evaluation	O
and	O
then	O
in	O
one	O
cassette	O
.	O

The	O
.	O
remainder	O
is	O
entirely	O
submitted	O
for	O
permanent	O
evaluation	O
in	O
one	O
additional	O
.	O
cassette	O
.	O

B	O
:	O
Received	O
fresh	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
number	O
,	O
are	O
multiple	O
.	O
light	O
tan	O
to	O
pink	O
-	O
tan	O
irregular	O
soft	O
tissue	O
fragments	O
measuring	O
2	O
.	O
8	O
x	O
2	O
.	O
0	O
x	O
0	O
.	O
6	O
.	O
of	O
2	O
.	O

cm	O
in	O
aggregate	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
cassette	O
.	O

2	O
of	O
2	O
.	O

PRIMARY	O
SITE	O
:	O
Larynx	O
.	O

I	O
-	O
)	O
"	O
Biopsy	O
of	O
the	O
left	O
vocal	O
fold	O
"	O
:	O
-	O
Invasive	O
moderately	O
differentiated	O
squamous	O
cells	O
carcinoma	O
.	O

II	O
-	O
)	O
"	O
Right	O
neck	O
dissection	O
specimen	O
level	O
IV	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
(	O
0	O
/	O
5	O
)	O
.	O

III	O
)	O
"	O
Right	O
neck	O
dissection	O
specimen	O
level	O
III	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
(	O
0	O
/	O
18	O
)	O
.	O

IV	O
-	O
)	O
"	O
Right	O
neck	O
dissection	O
specimen	O
level	O
II	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
(	O
0	O
/	O
8	O
)	O
.	O

V	O
-	O
)	O
"	O
Left	O
neck	O
dissection	O
specimen	O
level	O
II	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
(	O
0	O
/	O
17	O
)	O
.	O

VI	O
-	O
)	O
"	O
Left	O
neck	O
dissection	O
specimen	O
level	O
III	O
"	O
:	O
-	O
Metastatic	O
squamous	O
cell	O
carcinoma	O
in	O
one	O
lymph	O
node	O
(	O
1	O
/	O
7	O
)	O
,	O
without	O
capsular	O
.	O
involvement	O
.	O

VII	O
)	O
"	O
Left	O
neck	O
dissection	O
specimen	O
level	O
IV	O
"	O
:	O
-	O
Absence	O
of	O
neoplasia	O
(	O
0	O
/	O
11	O
)	O
.	O

VIII	O
)	O
Product	O
of	O
thyroid	O
and	O
larynx	O
ressection	O
.	O

-	O
Moderately	O
differentiated	O
squamous	O
cell	O
carcinoma	O
,	O
measuring	O
5	B
.	I
0	I
x	I
3	I
.	I
0	I
cm	I
on	O
the	O
.	O
greatest	O
dimensions	O
,	O
affecting	O
the	O
following	O
structures	O
:	O
Glottic	O
,	O
supraglottic	O
and	O
infraglottic	O
regions	O
on	O
the	O
left	O
.	O

Infraglottic	O
on	O
the	O
right	O
.	O

Piriform	O
sinus	O
on	O
the	O
left	O
.	O

Cricoid	O
,	O
arytenoid	O
and	O
thyroid	O
cartilages	O
.	O

Thyroid	O
isthmus	O
.	O

Soft	O
tissues	O
adjacent	O
to	O
the	O
larynx	O
.	O

Trachea	O
.	O

-	O
Angiolymphatic	O
and	O
perineural	O
invasion	O
not	O
observed	O
.	O

-	O
Left	O
soft	O
tissue	O
margins	O
involved	O
by	O
neoplasia	O
.	O

-	O
Other	O
surgical	O
margins	O
uninvolved	O
by	O
neoplasia	O
.	O

-	O
Right	O
thyroid	O
lobe	O
with	O
no	O
particularities	O
.	O

-	O
Small	O
follicular	O
adenoma	O
on	O
the	O
left	O
thyroid	O
lobe	O
.	O

SUMMARY	O
OF	O
HISTOLOGICAL	O
FINDINGS	O
:	O
-	O
Grade	O
2	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
larynx	O
,	O
transglottic	O
on	O
the	O
left	O
and	O
infraglottic	O
.	O
on	O
the	O
right	O
with	O
involvement	O
of	O
the	O
adjacent	O
soft	O
tissues	O
,	O
thyroid	O
and	O
hypopharynx	O
on	O
.	O
the	O
left	O
.	O

-	O
Right	O
lymph	O
nodes	O
:	O
0	O
/	O
31	O
.	O

-	O
Left	O
lymph	O
nodes	O
:	O
1	O
/	O
35	O
without	O
capsular	O
involvement	O
.	O

Papillary	O
Renal	O
Cell	O
Carcinoma	O
,	O
Type	O
I	O
,	O
moderately	O
differentiated	O
.	O

The	O
tumor	O
presents	O
as	O
a	O
multi	O
-	O
focal	O
.	O
one	O
.	O

Stage	O
:	O
pT1a	O
(	O
multifocal	O
)	O
,	O
RO	O
.	O

Grade	O
:	O
GII	O
.	O

ICD	O
-	O
0	O
-	O
Code	O
:	O
8260	O
/	O
3	O
.	O

Service	O
Date	O
:	O
Male	O
.	O

Soc	O
.	O

Sec	O
.	O

#	O
:	O
Client	O
:	O
FINAL	O
PATHOLOGIC	O
DIAGNOSIS	O
.	O

Prostate	O
and	O
seminal	O
vesicles	O
,	O
prostatectomy	O
:	O
1	O
.	O

Prostatic	O
adenocarcinoma	O
,	O
Gleason	O
score	O
3	O
+	O
3	O
=	O
6	O
;	O
see	O
comment	O
.	O

2	O
.	O

Seminal	O
vesicles	O
with	O
no	O
tumor	O
.	O

COMMENT	O
:	O
Synoptic	O
Comment	O
for	O
Prostate	O
Tumors	O
.	O

-	O
Type	O
of	O
tumor	O
:	O
Small	O
acinar	O
adenocarcinoma	O
.	O

-	O
Location	O
of	O
tumor	O
:	O
Left	O
posterior	O
midgland	O
,	O
slides	O
A5	O
,	O
A9	O
-	O
A10	O
;	O
left	O
anterior	O
midgland	O
,	O
slides	O
A5	O
,	O
.	O

A7	O
-	O
A8	O
;	O
right	O
posterior	O
apex	O
,	O
slide	O
A2	O
;	O
right	O
posterior	O
midgland	O
,	O
slide	O
A4	O
,	O
A6	O
,	O
A11	O
-	O
A12	O
;	O
right	O
anterior	O
.	O
midgland	O
,	O
silde	O
A4	O
,	O
A6	O
,	O
A13	O
.	O

-	O
Estimated	O
volume	O
of	O
tumor	O
:	O
4	O
.	O
2	O
cm	O
cubed	O
(	O
based	O
on	O
tumor	O
area	O
on	O
slides	O
0	O
.	O
5	O
cm	O
thick	O
slices	O
)	O
.	O

-	O
Gleason	O
score	O
:	O
3	O
+	O
3	O
.	O

-	O
Estimated	O
volume	O
>	O
Gleason	O
pattern	O
3	O
:	O
o	O
.	O

-	O
Involvement	O
of	O
capsule	O
:	O
Positive	O
(	O
A6	O
,	O
A11	O
,	O
A12	O
)	O
.	O

-	O
Extraprostatic	O
extension	O
:	O
None	O
.	O

-	O
Margin	O
status	O
for	O
tumor	O
:	O
Negative	O
.	O

-	O
Margin	O
status	O
for	O
benign	O
glands	O
:	O
Benign	O
glands	O
present	O
at	O
inked	O
excision	O
margins	O
(	O
A1	O
)	O
.	O

-	O
Involvement	O
of	O
seminal	O
vesicle	O
:	O
None	O
.	O

-	O
Perineural	O
infiltration	O
:	O
Positive	O
(	O
A11	O
)	O
.	O

-	O
Prostatic	O
intraepithelial	O
neoplasia	O
(	O
PIN	O
)	O
:	O
None	O
.	O

-	O
Lymph	O
node	O
status	O
:	O
None	O
present	O
.	O

-	O
AJCC	O
/	O
UICC	O
stage	O
:	O
pT2cNXMX	O
.	O

Specimen	O
(	O
s	O
)	O
Received	O
.	O

A	O
:	O
Prostate	O
and	O
seminal	O
vesicle	O
(	O
fresh	O
)	O
.	O

Clinical	O
History	O
.	O

The	O
patient	O
is	O
a	O
.	O
man	O
with	O
prostate	O
cancer	O
,	O
who	O
undergoes	O
robot	O
-	O
assisted	O
laparoscopic	O
.	O
radical	O
prostatectomy	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
in	O
one	O
part	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
unit	O
number	O
and	O
"	O
prostate	O
.	O

+	O
seminal	O
vesicles	O
fresh	O
,	O
"	O
and	O
consists	O
of	O
a	O
36	O
gm	O
prostate	O
gland	O
with	O
attached	O
seminal	O
vesicle	O
/	O
vas	O
.	O
deferens	O
bundles	O
.	O

The	O
gland	O
measures	O
3	O
.	O
5	O
cm	O
from	O
medial	O
-	O
lateral	O
,	O
3	O
cm	O
from	O
apex	O
-	O
base	O
,	O
and	O
3	O
cm	O
.	O
from	O
anterior	O
-	O
posterior	O
.	O

The	O
exterior	O
of	O
the	O
gland	O
is	O
smooth	O
with	O
a	O
staple	O
line	O
along	O
the	O
anterior	O
.	O
midline	O
,	O
with	O
a	O
red	O
-	O
tan	O
exterior	O
.	O

The	O
seminal	O
vesicle	O
/	O
vas	O
deferens	O
bundles	O
are	O
soft	O
and	O
red	O
-	O
tan	O
.	O

The	O
.	O
left	O
measures	O
3	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
1	O
cm	O
and	O
the	O
right	O
measures	O
2	O
.	O
5	O
x	O
2	O
x	O
1	O
cm	O
.	O

The	O
right	O
vas	O
deferens	O
measures	O
.	O

2	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
and	O
the	O
left	O
measures	O
4	O
x	O
0	O
.	O
5	O
cm	O
.	O

A	O
firm	O
mass	O
is	O
palpated	O
along	O
the	O
right	O
posterior	O
.	O
lateral	O
.	O

The	O
right	O
anterior	O
surface	O
of	O
the	O
gland	O
is	O
inked	O
in	O
green	O
,	O
the	O
left	O
anterior	O
surface	O
is	O
inked	O
in	O
.	O
blue	O
,	O
and	O
the	O
posterior	O
surface	O
is	O
inked	O
in	O
black	O
.	O

The	O
apical	O
and	O
bladder	O
margins	O
are	O
removed	O
,	O
and	O
the	O
.	O
remainder	O
of	O
the	O
gland	O
is	O
serially	O
sectioned	O
from	O
apex	O
to	O
base	O
into	O
six	O
slices	O
of	O
4	O
mm	O
average	O
thickness	O
.	O

The	O
seminal	O
vesicle	O
/	O
vas	O
deferens	O
bundles	O
are	O
attached	O
to	O
serial	O
slice	O
6	O
.	O

The	O
serial	O
slices	O
reveal	O
a	O
0	O
.	O
5	O
.	O

cm	O
area	O
of	O
firm	O
yellow	O
tissue	O
on	O
the	O
right	O
lateral	O
of	O
slice	O
2	O
.	O

No	O
other	O
lesions	O
are	O
grossly	O
identified	O
.	O

Following	O
further	O
dissection	O
and	O
submission	O
of	O
tissue	O
for	O
possible	O
research	O
evaluation	O
,	O
representative	O
.	O
sections	O
from	O
slices	O
1	O
-	O
3	O
are	O
taken	O
for	O
research	O
purposes	O
.	O

The	O
entire	O
gland	O
is	O
submitted	O
as	O
follows	O
:	O
Apical	O
margins	O
.	O

Cassette	O
A1	O
:	O
Left	O
.	O

Cassette	O
A2	O
:	O
Right	O
.	O

Serial	O
slice	O
1	O
.	O

Cassette	O
A3	O
:	O
Left	O
.	O

Cassette	O
A4	O
:	O
Right	O
.	O

Serial	O
slice	O
2	O
.	O

Cassette	O
A5	O
:	O
Left	O
.	O

Cassette	O
A6	O
:	O
Right	O
.	O

Left	O
anterior	O
quadrant	O
.	O

Cassette	O
A7	O
:	O
Slice	O
3	O
.	O

Cassette	O
A8	O
:	O
Slice	O
5	O
.	O

Left	O
posterior	O
quadrant	O
.	O

Cassette	O
A9	O
:	O
Slice	O
3	O
.	O

Cassette	O
A10	O
:	O
Slice	O
5	O
.	O

Right	O
posterior	O
quadrant	O
.	O

Cassette	O
A11	O
:	O
Slice	O
3	O
.	O

Cassette	O
A12	O
:	O
Slice	O
5	O
.	O

Right	O
anterior	O
quadrant	O
.	O

Cassette	O
A13	O
:	O
Slice	O
3	O
.	O

Cassette	O
A14	O
:	O
Slice	O
5	O
.	O

Bladder	O
margins	O
.	O

Cassette	O
A15	O
:	O
Left	O
.	O

Cassette	O
A16	O
:	O
Right	O
.	O

Prostatic	O
/	O
Seminal	O
vesicle	O
junction	O
.	O

Cassette	O
A17	O
:	O
Left	O
.	O

Cassette	O
A18	O
:	O
Right	O
.	O

Serial	O
slices	O
4	O
and	O
6	O
are	O
submitted	O
as	O
whole	O
-	O
mount	O
for	O
research	O
purposes	O
.	O

Diagnosis	O
based	O
on	O
gross	O
and	O
microscopic	O
examinations	O
.	O

Final	O
diagnosis	O
made	O
by	O
attending	O
pathologist	O
.	O
following	O
review	O
of	O
all	O
pathology	O
slides	O
.	O

PROCEDURE	O
DATE	O
:	O
RECEIVED	O
DATE	O
:	O
REPORT	O
DATE	O
:	O
10	O
Consultation	O
.	O

FS	O
DIAGNOSES	O
1	O
AND	O
2	O
:	O
"	O
Negative	O
for	O
neoplasm	O
(	O
reported	O
to	O
Dr	O
.	O
positive	O
patient	O
ID	O
)	O
"	O
by	O
Dr	O
.	O
campus	O
.	O

Pre	O
-	O
Op	O
Diagnosis	O
.	O

Lung	O
cancer	O
.	O

Post	O
-	O
Op	O
Diagnosis	O
.	O

Same	O
as	O
above	O
.	O

Clinical	O
History	O
.	O

Nothing	O
indicated	O
.	O

Gross	O
Description	O
:	O
Six	O
parts	O
.	O

Container	O
labeled	O
.	O

R	O
lymph	O
node	O
"	O
has	O
1	O
.	O
5	O
x	O
.	O

1	O
.	O
5	O
x	O
0	O
.	O
4	O
cm	O
of	O
gray	O
-	O
tan	O
to	O
yellow	O
fleshy	O
and	O
fibrofatty	O
tissue	O
.	O
fragments	O
which	O
are	O
submitted	O
for	O
frozen	O
section	O
and	O
reported	O
as	O
.	O

"	O
negative	O
for	O
neoplasm	O
(	O
reported	O
to	O
.	O
positive	O
patient	O
.	O
ID	O
)	O
"	O
by	O
Dr	O
.	O
The	O
frozen	O
residue	O
is	O
submitted	O
in	O
a	O
single	O
.	O
cassette	O
.	O

Container	O
labeled	O
.	O

1	O
.	O

L	O
lymph	O
node	O
"	O
has	O
a	O
0	O
.	O
6	O
.	O

x	O
0	O
.	O
4	O
x	O
0	O
.	O
2	O
cm	O
irregular	O
fragment	O
of	O
soft	O
gray	O
-	O
tan	O
to	O
pink	O
tissue	O
.	O
which	O
is	O
submitted	O
for	O
frozen	O
section	O
and	O
reported	O
as	O
"	O
negative	O
for	O
.	O
neoplasm	O
(	O
reported	O
to	O
.	O
positive	O
patient	O
ID	O
)	O
"	O
by	O
Dr	O
.	O
The	O
frozen	O
residue	O
is	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O

-	O
station	O
11	O
lymph	O
node	O
"	O
.	O
has	O
a	O
2	O
.	O
2	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
cm	O
lobulated	O
fleshy	O
red	O
-	O
brown	O
to	O
black	O
nodule	O
.	O
with	O
a	O
mottled	O
fleshy	O
gray	O
-	O
black	O
cut	O
surface	O
.	O

The	O
sectioned	O
specimen	O
.	O

is	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O
station	O
12	O
lymph	O
node	O
"	O
.	O
has	O
a	O
1	O
.	O
0	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
fleshy	O
tan	O
-	O
pink	O
to	O
brown	O
-	O
black	O
nodule	O
with	O
.	O

a	O
mottled	O
fleshy	O
brown	O
-	O
black	O
cut	O
surface	O
.	O

The	O
bisected	O
nodule	O
is	O
.	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Container	O
labeled	O
.	O
right	O
lower	O
lobe	O
"	O
has	O
a	O
.	O
previously	O
partially	O
sectioned	O
recognizable	O
portion	O
of	O
pulmonary	O
.	O
parenchyma	O
grossly	O
consistent	O
with	O
right	O
lower	O
lobe	O
of	O
lung	O
.	O

The	O
.	O
specimen	O
as	O
received	O
weighs	O
313	O
grams	O
and	O
measures	O
15	O
.	O
2	O
x	O
10	O
.	O
5	O
x	O
5	O
.	O
5	O
.	O

cm	O
.	O

The	O
margin	O
of	O
resection	O
is	O
a	O
stapled	O
bifurcated	O
tertiary	O
.	O
bronchus	O
.	O

The	O
pleura	O
is	O
smooth	O
and	O
pink	O
-	O
red	O
with	O
moderate	O
.	O
anthracotic	O
streaking	O
.	O

On	O
the	O
lower	O
medial	O
aspect	O
the	O
specimen	O
is	O
.	O
sectioned	O
to	O
reveal	O
a	O
previously	O
partially	O
sectioned	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
x	O
1	O
.	O
6	O
.	O

cm	O
subpleural	O
nodular	O
lesion	O
with	O
a	O
gritty	O
gray	O
-	O
tan	O
fibrotic	O
cut	O
.	O
surface	O
.	O

This	O
grossly	O
extends	O
to	O
but	O
not	O
through	O
the	O
pleural	O
on	O
the	O
.	O
medial	O
aspect	O
and	O
is	O
seen	O
at	O
its	O
nearest	O
point	O
1	O
.	O
1	O
cm	O
from	O
the	O
basal	O
.	O
pleura	O
.	O

The	O
lesion	O
is	O
seen	O
at	O
its	O
nearest	O
point	O
2	O
.	O
8	O
cm	O
from	O
the	O
.	O
bronchial	O
margin	O
.	O

An	O
apparent	O
bronchial	O
connection	O
is	O
identified	O
.	O

Noted	O
on	O
the	O
lower	O
outer	O
aspect	O
is	O
a	O
subpleural	O
0	O
.	O
8	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
.	O
subpleural	O
nodular	O
lesion	O
which	O
has	O
a	O
fibrotic	O
cut	O
surface	O
and	O
areas	O
.	O
of	O
calcification	O
.	O

The	O
remaining	O
parenchyma	O
is	O
spongy	O
,	O
slightly	O
.	O
edematous	O
,	O
and	O
tan	O
-	O
pink	O
without	O
additional	O
lesions	O
.	O

Also	O
received	O
in	O
.	O
the	O
same	O
container	O
are	O
three	O
tissue	O
cassettes	O
each	O
labeled	O
.	O

Representative	O
sections	O
are	O
submitted	O
labeled	O
.	O
as	O
follows	O
:	O
A	O
-	O
shaved	O
bronchial	O
margin	O
;	O
B	O
-	O
E	O
-	O
remaining	O
lesion	O
and	O
.	O
surrounding	O
tissue	O
;	O
F	O
-	O
lateral	O
partially	O
calcified	O
nodule	O
;	O
G	O
-	O
.	O
random	O
uninvolved	O
parenchyma	O
.	O

Container	O
labeled	O
.	O
station	O
7	O
lymph	O
node	O
"	O
has	O
.	O
two	O
irregular	O
fragments	O
of	O
soft	O
gray	O
-	O
pink	O
tissue	O
,	O
0	O
.	O
8	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
cm	O
.	O
each	O
.	O

Specimen	O
entirely	O
submitted	O
in	O
a	O
single	O
cassette	O
.	O

Microscopic	O
Description	O
:	O
See	O
diagnosis	O
.	O

Final	O
Diagnosis	O
.	O

4	O
R	O
lymph	O
node	O
,	O
biopsy	O
with	O
frozen	O
section	O
:	O
Lymph	O
node	O
with	O
anthracotic	O
pigment	O
,	O
negative	O
for	O
neoplasm	O
,	O
.	O
permanent	O
sections	O
confirm	O
the	O
.	O
frozen	O
section	O
diagnosis	O
.	O

4	O
L	O
lymph	O
node	O
,	O
biopsy	O
with	O
frozen	O
section	O
:	O
Negative	O
for	O
neoplasm	O
,	O
permanent	O
sections	O
confirm	O
the	O
frozen	O
.	O
section	O
diagnosis	O
.	O

Station	O
11	O
lymph	O
node	O
,	O
biopsy	O
:	O
Negative	O
for	O
neoplasm	O
,	O
extensive	O
anthracotic	O
pigment	O
and	O
reactive	O
.	O
changes	O
.	O

Station	O
12	O
lymph	O
node	O
,	O
biopsy	O
:	O
Negative	O
for	O
neoplasm	O
.	O

Lung	O
,	O
right	O
lower	O
lobe	O
,	O
lobectomy	O
:	O
Tumor	O
characteristics	O
:	O
Histologic	O
type	O
:	O
Adenocarcinoma	O
,	O
moderately	O
differentiated	O
.	O

Tumor	O
location	O
:	O
Subpleural	O
right	O
lower	O
lung	O
lobe	O
.	O

Tumor	O
size	O
:	O
2	B
.	I
0	I
x	I
2	I
.	I
0	I
x	I
1	I
.	I
6	I
cm	I
.	O

Tumor	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Pleural	O
invasion	O
:	O
Yes	O
(	O
tumor	O
appears	O
to	O
focally	O
involve	O
overlying	O
.	O
pleura	O
in	O
slide	O
5D	O
)	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
No	O
.	O

Surgical	O
margin	O
status	O
:	O
Tumor	O
distance	O
from	O
bronchial	O
margin	O
:	O
2	O
.	O
8	O
cm	O
.	O

Tumor	O
distance	O
from	O
stapled	O
margin	O
:	O
Not	O
applicable	O
.	O

Tumor	O
distance	O
from	O
pleural	O
surface	O
:	O
Less	O
than	O
0	O
.	O
5	O
cm	O
,	O
focally	O
.	O
involving	O
pleura	O
.	O
microscopically	O
.	O

Lymph	O
node	O
status	O
:	O
See	O
specimens	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
and	O
6	O
.	O

Station	O
7	O
lymph	O
node	O
:	O
Negative	O
for	O
tumor	O
.	O

Stage	O
:	O
T2N0	O
.	O

Comments	O
.	O

This	O
test	O
has	O
been	O
finalized	O
at	O
the	O
.	O

Campus	O
.	O

Original	O
report	O
signed	O
out	O
by	O
Dr	O
.	O
REVISION	O
:	O
This	O
revision	O
is	O
made	O
to	O
add	O
the	O
staging	O
to	O
the	O
Diagnosis	O
Section	O
.	O

There	O
is	O
no	O
change	O
in	O
the	O
original	O
diagnosis	O
.	O

printed	O
.	O

Clinical	O
Consultant	O
&	O
Location	O
.	O

Forenan	O
.	O

Unit	O
No	O
.	O

SPECIMEN	O
.	O

Enucleated	O
left	O
eye	O
.	O

CLINICAL	O
DETAILS	O
.	O

Suspected	O
choroidal	O
melanoma	O
.	O

MACROSCOPIC	O
DESCRIPTION	O
.	O

A	O
left	O
eye	O
.	O

Dimensions	O
:	O
Axial	O
24mm	O
,	O
Horizontal	O
23mm	O
,	O
Vertical	O
23mm	O
.	O

Cornea	O
:	O
Horizontal	O
12mm	O
,	O
Vertical	O
12mm	O
.	O

Description	O
:	O
clear	O
.	O

Optic	O
nerve	O
.	O

Length	O
12mm	O
,	O
Diameter	O
4mm	O
.	O

Anterior	O
chamber	O
:	O
normal	O
depth	O
.	O

On	O
rans	O
-	O
illumination	O
,	O
a	O
shadow	O
located	O
superiorly	O
measuring	O
.	O

19	O
x	O
18mm	O
.	O

Plane	O
of	O
section	O
:	O
vertical	O
.	O

Intraocular	O
description	O
:	O
On	O
opening	O
he	O
eye	O
a	O
large	O
pigmented	O
choroidal	O
melanoma	O
.	O
measuring	O
16mm	B
LBD	O
x	O
12mm	B
in	O
height	O
.	O

Tumour	O
size	O
.	O

BD	O
16mm	B
,	O
Height	O
12mm	B
.	O

MICROSCOPY	O
.	O

Histologically	O
,	O
the	O
enucleated	O
eye	O
demonstrates	O
a	O
normal	O
.	O
anterior	O
segment	O
with	O
an	O
unremarkable	O
cornea	O
,	O
a	O
deep	O
.	O
anterior	O
chamber	O
and	O
open	O
angles	O
.	O

The	O
iris	O
leaves	O
are	O
.	O
unremarkable	O
.	O

The	O
ciliary	O
muscles	O
are	O
moderately	O
atrophic	O
.	O
and	O
there	O
is	O
moderate	O
hyalinisation	O
of	O
the	O
ciliary	O
.	O
processes	O
.	O

The	O
lens	O
shows	O
advanced	O
cataractous	O
changes	O
.	O

In	O
the	O
posterior	O
third	O
of	O
the	O
posterior	O
segment	O
,	O
a	O
choroidal	O
.	O
printed	O
:	O
HISTOPATHOLOGY	O
REPORT	O
.	O

Lab	O
No	O
.	O

Clinical	O
Consultant	O
&	O
Location	O
.	O

Unit	O
No	O
.	O
melanoma	O
can	O
be	O
seen	O
.	O

This	O
is	O
dome	O
-	O
shaped	O
with	O
a	O
large	O
.	O
accompanying	O
exudative	O
retinal	O
detachment	O
.	O

The	O
retina	O
.	O
overlying	O
the	O
tumour	O
is	O
atrophic	O
with	O
degenerative	O
changes	O
.	O

The	O
tumour	O
is	O
pigmented	O
and	O
consists	O
of	O
a	O
mixture	O
of	O
cells	O
,	O
.	O
both	O
epithelioid	O
and	O
spindle	O
cells	O
,	O
with	O
a	O
dominance	O
of	O
the	O
.	O
latter	O
.	O

The	O
epithelioid	O
cell	O
component	O
represents	O
15	O
%	O
of	O
the	O
.	O
tumour	O
cell	O
population	O
.	O

The	O
melanoma	O
cells	O
are	O
immunoreactive	O
.	O
for	O
MelanA	O
and	O
HSP	O
-	O
27	O
(	O
score	O
2	O
)	O
.	O

The	O
number	O
of	O
mitoses	O
is	O
high	O
approx	O
.	O
12	O
/	O
40	O
high	O
power	O
.	O
fields	O
.	O

The	O
microvasculature	O
of	O
the	O
melanoma	O
is	O
prominent	O
,	O
and	O
.	O
closed	O
loops	O
are	O
focally	O
present	O
.	O

Occasional	O
"	O
vascular	O
.	O

lakes	O
"	O
can	O
be	O
observed	O
;	O
in	O
these	O
tumour	O
cells	O
can	O
be	O
see	O
.	O
located	O
within	O
the	O
lumen	O
.	O

The	O
lymphocytic	O
infiltrate	O
within	O
tumour	O
is	O
minimal	O
.	O

Macrophages	O
are	O
scattered	O
throughout	O
the	O
tumour	O
in	O
a	O
.	O
moderately	O
density	O
There	O
is	O
no	O
evidence	O
of	O
scleral	O
invasion	O
.	O
or	O
of	O
extraocular	O
growth	O
.	O

The	O
optic	O
nerve	O
is	O
tumour	O
free	O
,	O
.	O
and	O
demonstrates	O
mild	O
atrophic	O
changes	O
.	O

The	O
examined	O
vortex	O
.	O
veins	O
are	O
free	O
of	O
tumour	O
.	O

DIAGNOSI9	O
.	O

Choroid	O
melanoma	O
of	O
mixed	O
cell	O
type	O
.	O

COMMENT	O
.	O

SPECIMEN	O
.	O

2	O
=	O
Eye	O
.	O

TUMOUR	O
PRESENT	O
.	O

TUMOUR	O
TYPE	O
.	O

1	O
=	O
Melanoma	O
.	O

CELL	O
TYPE	O
.	O

3	O
=	O
Mixed	O
.	O

CT	O
LOOPS	O
.	O

2	O
=	O
Closed	O
loops	O
.	O

NECROSIS	O
.	O
printed	O
:	O
HISTOPATHOLOGY	O
REPORT	O
.	O

Lab	O
No	O
.	O

Clinical	O
Consultant	O
&	O
Location	O
.	O

Unit	O
No	O
.	O

PIGMENTATION	O
.	O

LYMPHOCYTIC	O
INFILTRATION	O
.	O

MITOTIC	O
FREQUENCY	O
.	O

12	O
/	O
40	O
HPF	O
.	O

DIFFUSE	O
MELANOMA	O
.	O

SPREAD	O
.	O

1	O
=	O
No	O
.	O

CLEARANCE	O
.	O

2	O
=	O
Adequate	O
.	O

HSP	O
-	O
27	O
POSITIVITY	O
.	O

2	O
=	O
21	O
-	O
70	O
%	O
.	O

LARGE	O
DIAMETER	O
.	O

16	B
mm	I
.	O

THICKNESS	O
.	O

12	B
mm	I
.	O

COMMENTS	O
:	O
Molecular	O
genetic	O
examination	O
of	O
DNA	O
extracted	O
from	O
the	O
.	O
tumour	O
cells	O
will	O
be	O
performed	O
using	O
multiplex	O
-	O
ligation	O
.	O
dependent	O
probe	O
amplification	O
(	O
MLPA	O
)	O
,	O
looking	O
at	O
chromosomes	O
.	O

1	O
,	O
3	O
,	O
6	O
and	O
8	O
.	O

A	O
supplementary	O
report	O
will	O
follow	O
as	O
soon	O
as	O
.	O
these	O
investigations	O
are	O
complete	O
.	O

SUPPLEMENTARY	O
REPORT	O
.	O

In	O
the	O
meantime	O
,	O
molecular	O
genetic	O
analysis	O
of	O
tumour	O
DNA	O
.	O
extracted	O
from	O
the	O
fresh	O
uveal	O
melanoma	O
tissue	O
was	O
performed	O
.	O
using	O
the	O
technique	O
termed	O
multiplex	O
ligation	O
-	O
dependent	O
.	O
probe	O
amplification	O
(	O
MLPA	O
)	O
These	O
investigations	O
were	O
.	O
performed	O
in	O
the	O
.	O

The	O
kit	O
P027	O
from	O
.	O
which	O
examines	O
for	O
gains	O
or	O
.	O
losses	O
in	O
31	O
loci	O
on	O
chromosomes	O
1	O
,	O
3	O
,	O
6	O
and	O
8	O
,	O
was	O
used	O
.	O

The	O
DNA	O
concentration	O
was	O
measured	O
using	O
.	O
and	O
the	O
.	O
quality	O
assessed	O
using	O
multiplex	O
-	O
PCR	O
prior	O
to	O
the	O
MLPA	O
.	O
reaction	O
.	O

The	O
DNA	O
concentration	O
was	O
high	O
and	O
of	O
good	O
quality	O
on	O
.	O
assessment	O
.	O

The	O
MLPA	O
reaction	O
was	O
run	O
at	O
least	O
twice	O
on	O
.	O
differing	O
occasions	O
,	O
resulting	O
in	O
similar	O
results	O
.	O

The	O
results	O
of	O
the	O
sequence	O
analysis	O
of	O
the	O
MLPA	O
products	O
is	O
.	O
printed	O
on	O
a	O
separate	O
report	O
.	O
printed	O
:	O
HISTOPATHOLOGY	O
REPORT	O
.	O

Lab	O
No	O
.	O

Clinical	O
Consultant	O
&	O
Location	O
.	O

Unit	O
No	O
.	O

In	O
summary	O
,	O
sequence	O
analysis	O
demonstrated	O
:	O
normal	O
.	O
chromosome	O
1	O
,	O
monosomy	O
3	O
,	O
normal	O
chromosome	O
6	O
and	O
gains	O
in	O
.	O
chromosome	O
8	O
.	O

These	O
molecular	O
data	O
require	O
correlation	O
with	O
the	O
clinical	O
.	O
and	O
morphological	O
data	O
for	O
metastatic	O
risk	O
assessment	O
.	O

From	O
.	O

To	O
.	O

P	O
.	O
8	O
/	O
33	O
.	O

RIGHT	O
AXILLA	O
,	O
SENTINEL	O
#	O
1	O
,	O
SENTINEL	O
NODG	O
BIOPSY	O
-	O
.	O

AVILLARY	O
LYMPH	O
NODE	O
.	O

NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

FART	O
2	O
:	O
LYMPH	O
NODE	O
.	O

LEFT	O
AXILLA	O
,	O
SENTINEL	O
#	O
1	O
,	O
SENTINEL	O
NODE	O
BIOPSY	O
-	O
.	O

ONE	O
AXILLARY	O
LYMPH	O
NODE	O
,	O
NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
3	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
AXILLA	O
,	O
SENTINEL	O
#	O
2	O
,	O
SENTINEL	O
NODE	O
BIOPSY	O
-	O
.	O

ONE	O
AXILLARY	O
LYMPH	O
NODE	O
.	O

NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
(	O
0	O
/	O
1	O
)	O
.	O

PART	O
4	O
:	O
BREAST	O
,	O
LEET	O
,	O
SIMPLE	O
MASTECTOMY	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINOMA	O
NO	O
SPECIAL	O
TYPE	O
.	O

B	O
.	O

NOTTINGHAM	O
GRADE	O
3	O
(	O
TUBULETORMATION	O
:	O
3	O
,	O
NUCLEAR	O
PLEOMORPHI8M	O
:	O
3	O
,	O
MITOTIC	O
ACTIVITY	O
:	O
2	O
;	O
TOTAL	O
.	O
SCORE	O
-	O
a	O
/	O
9	O
)	O
.	O

c	O
.	O

THE	O
INVASIVE	O
TUMOR	O
MEASURES	O
APPROXIMATELY	O
2	B
.	I
0	I
CM	I
IN	O
LARGEST	O
DIMENSION	O
(	O
FIVE	O
CONTIGUOUS	O
.	O
SECTIONS	O
)	O
.	O

D	O
.	O

THE	O
INVASIVE	O
CARCINOMA	O
18	O
LOCATED	O
AT	O
THE	O
JUNCTION	O
OF	O
UPPER	O
INNER	O
AND	O
LOWER	O
INNFR	O
.	O

QUADRANTS	O
.	O

E	O
.	O

LYMPHOVASCULAR	O
SPACE	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

F	O
.	O

RESECTION	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

G	O
.	O

THE	O
NIPPLE	O
18	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

H	O
.	O

THE	O
SKIN	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

I	O
.	O

CALCIFICATIONS	O
ARE	O
ASSOCIATED	O
WITH	O
INVASIVE	O
CARCINOMA	O
AND	O
BENIGN	O
BREAST	O
PARENCHYMA	O
.	O

J	O
.	O

ATYPICAL	O
DUCTAL	O
HYPERPLASIA	O
.	O

K	O
INTRADUCTAL	O
PAPILLOMA	O
.	O

L	O
.	O

THE	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
SMOWS	O
DUCTAL	O
EFITHELIAL	O
HYPERPLASIA	O
,	O
ADENOSIS	O
AND	O
FIBROCYSTIC	O
.	O

CHANGES	O
.	O

M	O
.	O

PREVIOUS	O
BIOPSY	O
SITE	O
CHANGES	O
.	O

N	O
.	O

THE	O
INVASIVE	O
TUMOR	O
CELLS	O
ARE	O
POSITIVE	O
FOR	O
ESTROGEN	O
AND	O
PROGESTERONE	O
RECEPTORS	O
AND	O
.	O

NEGATIVE	O
FOR	O
HER	O
-	O
2	O
,	O
AS	O
PER	O
PREVIOUS	O
PATHOLOGY	O
REPORT	O
"	O
.	O

PART	O
5	O
;	O
BREAST	O
,	O
RIGHL	O
SIMPLI	O
MASTECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
DUCTAL	O
CARCINONA	O
NO	O
SPECIAL	O
TYPE	O
.	O

B	O
.	O

NOT	O
TINGRAM	O
GRADE	O
2	O
(	O
TUBULE	O
FORMATION	O
:	O
2	O
.	O
NUCLEAR	O
PLEOMORPHISM	O
:	O
2	O
.	O
MITOTIC	O
ACTIVITY	O
:	O
2	O
;	O
TOTAL	O
.	O
SCORE	O
-	O
8	O
/	O
9	O
)	O
.	O

C	O
.	O

THE	O
INVASIVE	O
TUMOR	O
MFASUBEE	O
.	O

D	O
.	O

E	O
.	O

THE	O
DCIS	O
CONSTITUTES	O
-	O
10	O
%	O
OF	O
THE	O
TOTAL	O
TUMOR	O
MASS	O
AND	O
IS	O
PRESENT	O
ADMIXED	O
WITH	O
THE	O
INVASIVE	O
.	O

DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
.	O

CRIBRIFORM	O
AND	O
SOLID	O
TYPES	O
WITH	O
MINIMAL	O
NECROSIS	O
.	O

COMPONENT	O
.	O

F	O
.	O

LYMPHOVASCULAR	O
SPACE	O
INVASI	O
	O
N	O
IS	O
IDENTIFIED	O
.	O

G	O
.	O

RESECTION	O
MARGINA	O
ARE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
.	O

H	O
.	O

THE	O
INVASIVE	O
CARCINOMA	O
IS	O
LOCATED	O
AT	O
THE	O
UPPER	O
OUTER	O
QUADRANT	O
.	O

I	O
.	O

THE	O
NIPPLE	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

J	O
.	O

THE	O
SKIN	O
IS	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

K	O
.	O

ATYPICAL	O
.	O

DUCTAL	O
HYPERPLASIA	O
.	O

L	O
.	O

THE	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
SHOWS	O
FIBROCYSTIC	O
CHANGES	O
WITH	O
ASSOCIATED	O
.	O

MICROCALCIFICATIONS	O
.	O

M	O
.	O

PREVIOUS	O
BIOPSY	O
SITE	O
CHANGES	O
.	O

N	O
.	O

THE	O
INVASIVE	O
TUMOR	O
CELLS	O
ARE	O
POSITIVE	O
FOR	O
ESTROGEN	O
AND	O
PROGESTERONE	O
RECEPTORS	O
AND	O
.	O

NEGATIVE	O
FOR	O
HER	O
-	O
2	O
,	O
AS	O
PER	O
PREVIOUS	O
PATHOLOGY	O
REPORT	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
-	O
PRIMARY	O
INVASIVE	O
CARCINOMA	O
OF	O
BREAST	O
.	O

LATERAI	O
.	O
ITY	O
:	O
I	O
on	O
.	O

PROCEDURE	O
.	O

Simple	O
mastectoniy	O
.	O

Upper	O
inner	O
quadrant	O
.	O

Lower	O
inner	O
quadrent	O
.	O

SIZE	O
OF	O
TUMOR	O
:	O
Maximum	O
dimension	O
invasive	O
component	O
:	O
2	B
.	I
0	I
cm	I
.	O

MULTICENTRICITY	O
/	O
MULTIFOCALITY	O
OF	O
INVASIVE	O
FOCI	O
:	O
TUMOR	O
TYPE	O
(	O
invasive	O
component	O
)	O
:	O
Ductal	O
sdenocarcinonia	O
,	O
NOS	O
.	O

NOTTINGHAM	O
SCORE	O
:	O
Nuclear	O
grade	O
:	O
3	O
.	O

Tubule	O
formation	O
3	O
.	O

Mitolic	O
activity	O
score	O
.	O

2	O
.	O

Total	O
Nottingham	O
scure	O
:	O
8	O
.	O

Nultingham	O
grade	O
(	O
1	O
.	O
2	O
.	O
3	O
)	O
.	O

3	O
.	O

ANGIOLYMPHATIC	O
INVASION	O
:	O
DERMAL	O
LYMPHATIC	O
INVASION	O
:	O
CALCIFICATION	O
:	O
Ycs	O
.	O
benign	O
zonas	O
.	O

Yes	O
.	O
malignant	O
zones	O
.	O

SURGICAL	O
MARGINS	O
INVOLVED	O
BY	O
INVASIVE	O
COMPONENT	O
:	O
LYMPM	O
NODES	O
POSITIVE	O
:	O
o	O
.	O

I	O
.	O

YMPH	O
NODES	O
EXAMINED	O
:	O
2	O
.	O

METHOD	O
(	O
S	O
)	O
OF	O
LYMPN	O
NODE	O
EXAMINATION	O
:	O
HIVE	O
stoin	O
.	O

SKIN	O
INVOLVED	O
(	O
ULCERATION	O
)	O
:	O
NON	O
-	O
NEOPLASTIC	O
BREAST	O
TISSUE	O
:	O
ADH	O
,	O
Papilloma	O
,	O
rco	O
.	O

1	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pTic	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

ESTROGEN	O
RECEPTORS	O
:	O
positive	O
.	O

PROGESTERONE	O
RECEPTORS	O
:	O
positive	O
.	O

HER2	O
/	O
NEU	O
:	O
zoro	O
or	O
1	O
+	O
.	O

&	O
History	O
:	O
ith	O
right	O
renal	O
tumor	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Right	O
kidney	O
.	O

2	O
:	O
SP	O
:	O
Paracaval	O
lymph	O
nodes	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

KIDNEY	O
,	O
RIGHT	O
;	O
RADICAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CLEAR	O
CELL	O
TYPE	O
,	O
NUCLEAR	O
GRADE	O
.	O

II	O
/	O
IV	O
.	O

-	O
THE	O
PATTERN	O
OF	O
GROWTH	O
IS	O
ACINAR	O
.	O

-	O
THE	O
TUMOR	O
'	O
S	O
GREATEST	O
DIAMETER	O
IS	O
7	B
.	I
5	I
CM	I
.	O

-	O
THE	O
TUMOR	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

-	O
NO	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
IDENTIFIED	O
.	O

-	O
ALI	O
,	O
SURGICAL	O
MARGINS	O
ARE	O
FREE	O
OF	O
TUMOR	O
.	O

-	O
THE	O
NON	O
-	O
NEOPLASTIC	O
KIDNEY	O
IS	O
UNREMARKABLE	O
.	O

-	O
THE	O
ADRENAL	O
GLAND	O
IS	O
NOT	O
IDENTIFIED	O
.	O

2	O
)	O
.	O

LYMPH	O
NODES	O
,	O
PARACAVAL	O
;	O
DISSECTION	O
:	O
-	O
SIX	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
6	O
)	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
Right	O
Kidney	O
"	O
.	O

It	O
.	O
consists	O
of	O
a	O
kidney	O
and	O
perirenal	O
fat	O
measuring	O
15	O
x	O
10	O
x	O
7	O
em	O
.	O
and	O
weighing	O
400	O
grams	O
overall	O
.	O

A	O
portion	O
of	O
unremarkable	O
ureter	O
.	O
measures	O
8	O
x	O
0	O
.	O

x	O
0	O
.	O
3	O
cm	O
.	O

A	O
portion	O
of	O
unremarkable	O
renal	O
vein	O
.	O
measures	O
1	O
em	O
in	O
length	O
and	O
1	O
cm	O
in	O
diameter	O
.	O

Adrenal	O
gland	O
is	O
.	O
not	O
identified	O
.	O

The	O
specimen	O
is	O
bivalved	O
showing	O
partly	O
yellow	O
.	O
and	O
partly	O
light	O
tan	O
to	O
brown	O
,	O
focally	O
hemorrhagic	O
and	O
necrotic	O
.	O
tumor	O
measuring	O
7	B
.	I
5	I
x	I
5	I
.	I
5	I
x	I
4	I
cm	I
.	O

The	O
tumor	O
is	O
cortical	O
in	O
.	O
location	O
and	O
has	O
irregular	O
borders	O
with	O
lobulated	O
appearance	O
.	O

The	O
Gerota	O
'	O
s	O
fascia	O
around	O
the	O
tumor	O
is	O
inked	O
black	O
.	O

The	O
tumor	O
.	O
protrudes	O
the	O
renal	O
capsule	O
.	O

It	O
is	O
confined	O
within	O
the	O
Gerota	O
'	O
s	O
.	O
fascia	O
.	O

The	O
distance	O
from	O
the	O
tumor	O
to	O
the	O
nearest	O
Gerota	O
'	O
s	O
.	O
fascia	O
is	O
0	O
.	O
2	O
cm	O
and	O
to	O
the	O
renal	O
pelvis	O
0	O
.	O
3	O
cm	O
.	O

The	O
renal	O
vein	O
.	O
in	O
uninvolved	O
.	O

The	O
specimen	O
is	O
photographed	O
.	O

Representative	O
.	O
sections	O
are	O
submitted	O
.	O

Fresh	O
tissue	O
is	O
saved	O
for	O
TPS	O
and	O
EM	O
.	O

Summary	O
of	O
Sections	O
:	O
UM	O
-	O
ureteral	O
margin	O
.	O

RVM	O
-	O
renal	O
vein	O
margin	O
.	O

TRC	O
-	O
tumor	O
renal	O
capsule	O
.	O

TP	O
-	O
tumor	O
renal	O
pelvis	O
.	O

TG	O
.	O

-	O
tumor	O
Gerota	O
'	O
s	O
fascia	O
.	O

TN	O
.	O

-	O
tumor	O
normal	O
kidney	O
.	O

N	O
.	O

-	O
normal	O
kidney	O
.	O

-	O
additional	O
tumor	O
.	O

2	O
)	O
The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Paracaval	O
.	O

Lymph	O
Nodes	O
"	O
It	O
consists	O
of	O
two	O
pieces	O
of	O
fibroadipose	O
tissue	O
.	O
measuring	O
1	O
.	O
5	O
x	O
1	O
x	O
1	O
cm	O
and	O
3	O
x	O
2	O
x	O
1	O
cm	O
.	O

Few	O
lymph	O
nodes	O
are	O
.	O
identified	O
that	O
range	O
in	O
size	O
from	O
0	O
.	O
3	O
to	O
0	O
.	O
4	O
em	O
in	O
largest	O
.	O
dimension	O
.	O

Lymph	O
nodes	O
are	O
submitted	O
in	O
toto	O
.	O

Summary	O
of	O
Sections	O
.	O

LNS	O
-	O
lymph	O
nodes	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
.	O

Sect	O
.	O

SiteBlocks	O
Pieces	O
All	O
.	O

N	O
.	O

1	O
.	O

2	O
.	O

RVM	O
.	O

1	O
.	O

1	O
.	O

6	O
.	O

6	O
.	O

TG	O
.	O

2	O
.	O

2	O
.	O

TN	O
.	O

1	O
.	O

TP	O
.	O

1	O
.	O

2	O
.	O

TRC	O
.	O

2	O
.	O

2	O
.	O

UM	O
.	O

1	O
.	O

2	O
.	O

LNS	O
.	O

1	O
.	O

M	O
.	O

N	O
.	O

SP	O
FINAL	O
REPORT	O
Source	O
:	O
HISTORY	O
:	O
History	O
of	O
left	O
neck	O
mass	O
,	O
which	O
on	O
CT	O
showed	O
a	O
mass	O
at	O
the	O
left	O
base	O
of	O
.	O
tongue	O
with	O
left	O
neck	O
adenopathy	O
.	O

Stain	O
for	O
p	O
-	O
16	O
,	O
EGFR	O
and	O
HPV	O
.	O

GROSS	O
:	O
1	O
.	O

"	O
Left	O
base	O
of	O
tongue	O
'	O
Received	O
in	O
formalin	O
in	O
a	O
small	O
container	O
is	O
a	O
0	O
.	O
6	O
x	O
.	O

0	O
.	O
7	O
cm	O
irregular	O
portions	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

MICROSCOPIC	O
DIAGNOSIS	O
:	O
1	O
.	O

Left	O
base	O
of	O
tongue	O
,	O
biopsy	O
:	O
Invasive	O
,	O
poorly	O
-	O
differentiated	O
,	O
.	O
nonkeratinizing	O
squamous	O
cell	O
carcinoma	O
.	O

See	O
COMMENT	O
.	O

COMMENT	O
.	O

The	O
tumor	O
is	O
diffusely	O
and	O
strongly	O
positive	O
for	O
P16	O
and	O
EGFR	O
.	O

In	O
situ	O
.	O
hybridization	O
for	O
high	O
-	O
risk	O
HPV	O
is	O
positive	O
.	O
and	O
.	O

I	O
.	O
the	O
signing	O
staff	O
pathologist	O
,	O
have	O
personally	O
.	O
examined	O
and	O
interpreted	O
_	O
the	O
slides	O
from	O
this	O
case	O
,	O
.	O

This	O
test	O
was	O
develoned	O
and	O
its	O
nerformance	O
charateriszie	O
determined	O
by	O
the	O
.	O

It	O
has	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

FOOD	O
and	O
Drug	O
(	O
The	O
FDA	O
has	O
.	O
determined	O
that	O
such	O
clearance	O
is	O
not	O
necessary	O
.	O

This	O
test	O
is	O
used	O
for	O
.	O
clinical	O
purposes	O
.	O

It	O
should	O
not	O
be	O
regarded	O
as	O
investigational	O
or	O
for	O
.	O
research	O
This	O
laboratory	O
is	O
certified	O
under	O
the	O
Clinical	O
Laboratory	O
.	O

Improvement	O
Amendments	O
of	O
.	O

(	O
CLIA	O
'	O
]	O
as	O
qualified	O
to	O
perform	O
high	O
.	O
complexity	O
testing	O
)	O
-	O
.	O

M	O
.	O

Glose	O
.	O

LABORATORY	O
MEDICINE	O
PROGKAM	O
.	O

M	O
.	O

Facility	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Adrenal	O
:	O
resection	O
adrenal	O
mass	O
left	O
.	O

2	O
.	O

Fat	O
.	O

Diagnosis	O
.	O

1	O
.	O

Adrenal	O
cortical	O
carcinoma	O
:	O
Adrenal	O
.	O

No	O
pathological	O
diagnosis	O
:	O
Lymph	O
node	O
,	O
periadrenal	O
.	O

-	O
(	O
left	O
)	O
adrenalectomy	O
specimen	O
.	O

2	O
.	O

No	O
pathological	O
diagnosis	O
:	O
Adipose	O
tissue	O
,	O
(	O
site	O
not	O
listed	O
)	O
excisional	O
biopsy	O
.	O

Comment	O
.	O

The	O
morphological	O
and	O
immunohistochemical	O
features	O
are	O
consistent	O
with	O
an	O
adrenocortical	O
carcinoma	O
.	O

Synoptic	O
Data	O
.	O

Neoadjuvant	O
Therapy	O
:	O
Clinical	O
History	O
:	O
Other	O
:	O
left	O
side	O
pain	O
.	O

Tumor	O
Site	O
:	O
Adrenal	O
structure	O
.	O

Adrenal	O
Gland	O
Received	O
:	O
Fresh	O
.	O

Procedure	O
:	O
Adrenalectomy	O
,	O
total	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Greatest	O
dimension	O
:	O
7	O
.	O
0	O
cm	O
.	O

Additional	O
dimension	O
:	O
6	O
.	O
0	O
cm	O
.	O

Additional	O
dimension	O
:	O
5	O
.	O
0	O
cm	O
.	O

Specimen	O
Laterality	O
:	O
Left	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
5	O
.	O
0	O
cm	O
.	O

Additional	O
dimension	O
:	O
4	O
.	O
4	O
cm	O
.	O

Additional	O
dimension	O
:	O
4	O
.	O
0	O
cm	O
.	O

Tumor	O
gland	O
weight	O
:	O
47	O
.	O
3	O
g	O
.	O

Histologic	O
Type	O
:	O
Adrenal	O
cortical	O
carcinoma	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
tumor	O
.	O

Treatment	O
Effect	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Present	O
,	O
small	O
vessel	O
(	O
capillary	O
lymphatic	O
)	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Ancillary	O
Studies	O
:	O
Types	O
:	O
IHC	O
.	O

Results	O
:	O
The	O
tumor	O
is	O
strongly	O
positive	O
for	O
calretinin	O
,	O
synaptophysin	O
and	O
Melan	O
A	O
.	O

(	O
A103	O
)	O
.	O

There	O
is	O
variable	O
positivity	O
for	O
LMWK	O
(	O
CAM	O
5	O
.	O
2	O
)	O
,	O
inhibin	O
,	O
CD10	O
.	O

(	O
cytoplasmic	O
)	O
and	O
p53	O
.	O

Stains	O
for	O
EMA	O
,	O
S100	O
,	O
and	O
chromogranin	O
are	O
negative	O
.	O

MIB	O
-	O
1	O
LI	O
is	O
20	O
%	O
.	O

TNM	O
Descriptors	O
:	O
Not	O
applicable	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT1	O
:	O
Tumor	O
5	O
cm	O
or	O
less	O
in	O
greatest	O
dimension	O
,	O
no	O
extra	O
-	O
adrenal	O
invasion	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
of	O
Nodes	O
examined	O
:	O
1	O
.	O

Number	O
of	O
Nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Tumor	O
necrosis	O
.	O

Degenerative	O
changes	O
,	O
Hemorrhage	O
.	O

Pathologic	O
Staging	O
is	O
based	O
on	O
AJCC	O
/	O
UICC	O
TNM	O
,	O
7th	O
Edition	O
.	O

Clinical	O
History	O
.	O

Left	O
adrenal	O
adenoma	O
.	O

Gross	O
Description	O
.	O

1	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
resection	O
adrenal	O
gland	O
mass	O
left	O
"	O
contains	O
an	O
adrenal	O
gland	O
.	O
with	O
surrounding	O
fibroadipose	O
tissue	O
.	O

The	O
specimen	O
measures	O
7	O
.	O
0	O
x	O
6	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
and	O
weighs	O
70	O
.	O
2	O
g	O
.	O

The	O
surface	O
is	O
.	O
painted	O
with	O
silver	O
nitrate	O
and	O
the	O
fat	O
is	O
removed	O
.	O

The	O
adrenal	O
gland	O
measures	O
5	O
.	O
2	O
x	O
4	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
and	O
weighs	O
47	O
.	O
3g	O
.	O

On	O
.	O
section	O
,	O
there	O
is	O
a	O
well	O
-	O
circumscribed	O
multilobulated	O
mass	O
that	O
measures	O
4	O
.	O
4	O
x	O
4	O
.	O
0	O
x	O
5	O
.	O
0	O
cm	O
.	O

The	O
cut	O
surface	O
of	O
the	O
tumor	O
.	O
has	O
a	O
variegated	O
light	O
brown	O
to	O
tan	O
color	O
,	O
solid	O
and	O
firm	O
.	O

The	O
rest	O
of	O
the	O
adrenal	O
tissue	O
is	O
unremarkable	O
grossly	O
.	O

The	O
tumor	O
.	O
and	O
normal	O
tissue	O
are	O
stored	O
frozen	O
.	O

The	O
adrenal	O
tissue	O
is	O
submitted	O
as	O
follows	O
:	O
1A	O
-	O
AG	O
adrenal	O
gland	O
serially	O
sectioned	O
and	O
submitted	O
in	O
toto	O
.	O

2	O
.	O

The	O
.	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
fat	O
"	O
contains	O
a	O
single	O
piece	O
of	O
a	O
grossly	O
unremarkable	O
.	O
fibroadipose	O
tissue	O
that	O
measures	O
5	O
.	O
5	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
7	O
cm	O
.	O

2A	O
.	O
representative	O
sections	O
.	O

;	O
ription	O
.	O

Fuhrman	O
Nuclear	O
Grade	O
:	O
IV	O
.	O

Necrosis	O
:	O
Present	O
,	O
predominantly	O
single	O
cell	O
necrosis	O
.	O

Mitotic	O
activity	O
:	O
>	O
5	O
mitoses	O
/	O
50	O
high	O
power	O
fields	O
.	O

Atypical	O
mitosis	O
:	O
Present	O
.	O

Growth	O
pattern	O
:	O
Solid	O
and	O
diffuse	O
.	O

Cell	O
type	O
:	O
Eosinophilic	O
,	O
>	O
%	O
90	O
.	O

Lymphovascular	O
invasion	O
:	O
Present	O
,	O
sinusoidal	O
type	O
.	O

Capsule	O
invasion	O
:	O
Present	O
,	O
focal	O
.	O

Immunohistochemistry	O
:	O
The	O
tumor	O
is	O
strongly	O
positive	O
for	O
calretinin	O
,	O
synaptophysin	O
and	O
Melan	O
A	O
(	O
A103	O
)	O
.	O

There	O
is	O
variable	O
.	O
positivity	O
for	O
LMWK	O
(	O
CAM	O
5	O
.	O
2	O
)	O
,	O
inhibin	O
,	O
CD10	O
(	O
cytoplasmic	O
)	O
and	O
p53	O
.	O

Stains	O
for	O
EMA	O
,	O
S100	O
,	O
and	O
chromogranin	O
are	O
.	O
negative	O
.	O

MIB	O
-	O
1	O
LI	O
is	O
20	O
%	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
.	O

LEFT	O
THYROID	O
LOBE	O
AND	O
ISTHMUS	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
,	O
CONVENTIONAL	O
TYPE	O
.	O

Location	O
:	O
Left	O
lobe	O
.	O

Multi	O
-	O
focal	O
:	O
No	O
.	O

Size	O
=	O
2	B
.	I
5	I
cm	I
.	O

Extrathyroidal	O
extension	O
:	O
Present	O
,	O
extending	O
into	O
fibroadipose	O
tissue	O
.	O

Lymphovascular	O
invasion	O
:	O
Present	O
.	O

Resection	O
Margins	O
:	O
Negative	O
.	O

Background	O
Thyroid	O
:	O
Multinodular	O
adenomatous	O
goiter	O
.	O

Lymph	O
nodes	O
:	O
No	O
lymph	O
nodes	O
present	O
.	O

(	O
B	O
)	O
COMPLETION	O
,	O
RIGHT	O
THYROID	O
LOBE	O
:	O
Multinodular	O
adenomatous	O
goiter	O
,	O
no	O
tumor	O
present	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
.	O

LEFT	O
THYROID	O
LOBE	O
AND	O
ISTHMUS	O
-	O
A	O
thyroid	O
lobectomy	O
of	O
left	O
lobe	O
(	O
3	O
.	O
5	O
x	O
2	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
)	O
is	O
nearly	O
entirely	O
replaced	O
by	O
.	O

a	O
soft	O
pink	O
papillary	O
tumor	O
with	O
hyalinized	O
fibrosis	O
surrounding	O
the	O
nodule	O
(	O
2	O
.	O
5	O
x	O
1	O
.	O
5	O
x	O
0	O
.	O
9	O
cm	O
)	O
shows	O
an	O
irregular	O
border	O
.	O
outside	O
of	O
the	O
area	O
of	O
fibrosis	O
,	O
but	O
is	O
confined	O
to	O
the	O
thyroid	O
.	O

A	O
portion	O
of	O
skeletal	O
muscle	O
is	O
also	O
present	O
with	O
the	O
specimen	O
.	O

SECTION	O
CODE	O
:	O
A1	O
,	O
representative	O
section	O
for	O
frozen	O
assessment	O
with	O
touch	O
prep	O
;	O
A2	O
-	O
A8	O
,	O
serial	O
sections	O
of	O
the	O
left	O
.	O
lobe	O
and	O
full	O
examination	O
of	O
the	O
interface	O
of	O
nodule	O
with	O
surrounding	O
soft	O
tissue	O
.	O

FS	O
/	O
DX	O
:	O
PAPILLARY	O
THYROID	O
CARCINOMA	O
.	O

(	O
B	O
)	O
.	O

COMPLETION	O
,	O
RIGHT	O
THYROID	O
LOBE	O
-	O
A	O
right	O
thyroid	O
lobe	O
measuring	O
4	O
.	O
4	O
x	O
3	O
.	O
0	O
x	O
1	O
.	O
0	O
cm	O
.	O

Serial	O
sectioning	O
revealed	O
.	O
beefy	O
red	O
spongy	O
parenchyma	O
with	O
no	O
grossly	O
identifiable	O
lesion	O
.	O

Representative	O
sections	O
from	O
superior	O
to	O
inferior	O
submitted	O
.	O
in	O
B1	O
-	O
B4	O
.	O

CLINICAL	O
HISTORY	O
.	O

Nodule	O
,	O
left	O
thyroid	O
.	O

SNOMED	O
CODES	O
.	O

T	O
-	O
B6000	O
,	O
M	O
-	O
Y3420	O
,	O
T	O
-	O
B6000	O
,	O
M	O
-	O
80503	O
,	O
M	O
-	O
Y3420	O
,	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Case	O
type	O
:	O
Surgical	O
Case	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O

8340	O
/	O
3	O
.	O

F	O
.	O

Facility	O
:	O
Specimen	O
(	O
s	O
)	O
Received	O
.	O

1	O
.	O

Thyroid	O
:	O
right	O
subtotal	O
hemithyroid	O
stitch	O
upper	O
pole	O
.	O

Diagnosis	O
.	O

Multifocal	O
papillary	O
carcinoma	O
,	O
dominant	O
follicular	O
variant	O
,	O
2	B
.	I
2	I
cm	I
:	O
Thyroid	O
.	O

No	O
pathological	O
diagnosis	O
:	O
Lymph	O
node	O
,	O
isthmic	O
.	O

-	O
Right	O
hemithyroidectomy	O
specimen	O
.	O

Synoptic	O
Data	O
.	O

Procedure	O
:	O
Right	O
hemithyroidectomy	O
.	O

Fresh	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Right	O
lobe	O
:	O
3	O
.	O
9	O
cm	O
.	O

2	O
.	O
3	O
cm	O
.	O

1	O
.	O
6	O
cm	O
.	O

Isthmus	O
+	O
/	O
-	O
pyramidal	O
lobe	O
:	O
1	O
.	O
7	O
cm	O
.	O

1	O
.	O
6	O
cm	O
.	O

0	O
.	O
7	O
cm	O
.	O

Specimen	O
Weight	O
:	O
8	O
.	O
7	O
g	O
.	O

Tumor	O
Focality	O
:	O
Multifocal	O
,	O
ipsilateral	O
.	O

DOMINANT	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Right	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
2	B
.	I
2cm	I
.	O

Additional	O
dimension	O
:	O
2	B
.	I
1	I
cm	I
.	O

Additional	O
dimension	O
:	O
1	B
.	I
5	I
cm	I
.	O

Histologic	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
pn	O
TSS	O
,	O
follocular	O
varient	O
=	O
100	O
%	O
.	O

Papillary	O
carcinoma	O
,	O
macrofollicular	O
variant	O
.	O

Follicular	O
architecture	O
.	O

Macrofollicular	O
architecture	O
.	O

Classical	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Margins	O
:	O
Tumor	O
Capsule	O
:	O
Partially	O
encapsulated	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Present	O
,	O
extent	O
minimal	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

SECOND	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Right	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
0	O
.	O
1cm	O
.	O

Histologic	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
.	O

Papillary	O
carcinoma	O
,	O
microcarcinoma	O
(	O
occult	O
,	O
small	O
or	O
microscopic	O
)	O
.	O
variant	O
.	O

Follicular	O
architecture	O
.	O

Classical	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
None	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

TNM	O
Descriptors	O
:	O
m	O
(	O
multiple	O
primary	O
tumors	O
)	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
more	O
than	O
2	O
cm	O
,	O
but	O
not	O
more	O
than	O
4	O
cm	O
,	O
limited	O
to	O
.	O
thyroid	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNO	O
:	O
No	O
regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
1	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
None	O
Identified	O
.	O

Pathologic	O
Staging	O
is	O
based	O
on	O
AJCC	O
/	O
UICC	O
TNM	O
,	O
7th	O
Edition	O
.	O

Comment	O
.	O

The	O
dominant	O
nodule	O
exhibits	O
multifocal	O
transformation	O
to	O
papillary	O
carcinoma	O
and	O
the	O
extent	O
of	O
.	O
malignancy	O
warrants	O
classification	O
of	O
the	O
entire	O
nodule	O
as	O
papillary	O
carcinoma	O
.	O

There	O
is	O
also	O
a	O
0	O
.	O
1cm	O
.	O
follicular	O
variant	O
papillary	O
microcarcinoma	O
in	O
the	O
right	O
lobe	O
.	O

The	O
overall	O
morphological	O
features	O
are	O
those	O
.	O
of	O
a	O
low	O
risk	O
papillary	O
carcinoma	O
.	O

Gross	O
Description	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
right	O
subtotal	O
thyroid	O
stitch	O
upper	O
pole	O
"	O
,	O
consists	O
of	O
.	O

a	O
right	O
hemithyroidectomy	O
specimen	O
that	O
weighs	O
8	O
.	O
7	O
g	O
.	O

The	O
lobe	O
measures	O
3	O
.	O
9	O
cm	O
SI	O
x2	O
.	O
3	O
cm	O
ML	O
x	O
1	O
.	O
6	O
.	O

cm	O
AP	O
and	O
the	O
isthmus	O
measures	O
1	O
.	O
7	O
SI	O
x	O
1	O
.	O
6cm	O
ML	O
x	O
0	O
.	O
7cm	O
AP	O
.	O

No	O
parathyroid	O
gland	O
or	O
lymph	O
nodes	O
.	O
are	O
identified	O
grossly	O
.	O

The	O
mid	O
superior	O
lobe	O
contains	O
one	O
well	O
delineated	O
nodule	O
that	O
measures	O
2	O
.	O
1	O
cm	O
SI	O
.	O

X	O
2	O
.	O
2cm	O
ML	O
x	O
1	O
.	O
5	O
cm	O
AP	O
.	O

The	O
cut	O
surface	O
of	O
the	O
nodule	O
has	O
a	O
variegated	O
red	O
-	O
tan	O
color	O
,	O
and	O
has	O
a	O
soft	O
and	O
.	O
flabby	O
consistency	O
.	O

Sections	O
of	O
nodule	O
and	O
normal	O
tissue	O
are	O
stored	O
frozen	O
.	O

The	O
remainder	O
of	O
the	O
.	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
1A	O
-	O
F	O
.	O
lobe	O
,	O
superior	O
to	O
inferior	O
.	O

1G	O
.	O
isthmus	O
.	O

Clinical	O
diagnosis	O
:	O
Brain	O
tumor	O
.	O

Gross	O
description	O
:	O
The	O
material	O
presented	O
by	O
soft	O
gray	O
-	O
whitish	O
pieces	O
from	O
right	O
temporal	O
lobe	O
.	O

Microscopic	O
description	O
:	O
Received	O
material	O
is	O
represented	O
by	O
brain	O
tissue	O
consistent	O
with	O
anaplastic	O
.	O
oligodendroglioma	O
,	O
Ki	O
67	O
up	O
to	O
15	O
%	O
.	O

Final	O
diagnosis	O
:	O
Anaplastic	O
oligodendroglioma	O
:	O
Grade	O
III	O
.	O

Confidential	O
.	O

DIAGNOSIS	O
:	O
Lung	O
,	O
left	O
upper	O
lobe	O
,	O
lobectomy	O
Grade	O
4	O
(	O
of	O
4	O
)	O
squamous	O
cell	O
carcinoma	O
forming	O
a	O
2	B
.	I
0	I
x	I
2	I
.	I
0	I
x	I
.	I

1	B
.	I
5	I
cm	I
mass	O
located	O
1	O
.	O
8	O
cm	O
away	O
from	O
the	O
bronchial	O
margin	O
,	O
which	O
is	O
negative	O
for	O
tumor	O
.	O
histologically	O
,	O
as	O
are	O
multiple	O
(	O
10	O
)	O
intrapulmonary	O
peribronchial	O
lymph	O
nodes	O
and	O
the	O
visceral	O
.	O
pleura	O
.	O

Soft	O
tissue	O
,	O
left	O
hilar	O
region	O
,	O
excision	O
:	O
Grade	O
4	O
(	O
of	O
4	O
)	O
non	O
-	O
small	O
cell	O
carcinoma	O
with	O
.	O
squamous	O
features	O
.	O

Lung	O
,	O
left	O
lower	O
lobe	O
,	O
excision	O
:	O
Intraparenchymal	O
lymph	O
node	O
,	O
negative	O
for	O
neoplasm	O
,	O
but	O
non	O
-	O
.	O
necrotizing	O
granulomatous	O
inflammation	O
is	O
present	O
.	O

The	O
findings	O
of	O
special	O
.	O
stains	O
.	O

for	O
.	O
microorganisms	O
(	O
AR	O
,	O
GMS	O
)	O
will	O
be	O
reported	O
separately	O
in	O
an	O
addendum	O
.	O

Lymph	O
nodes	O
,	O
superior	O
mediastinal	O
,	O
aortic	O
,	O
inferior	O
mediastinal	O
,	O
left	O
lower	O
lobe	O
bronchus	O
,	O
.	O
excision	O
:	O
Multiple	O
superior	O
mediastinal	O
(	O
9	O
tracheobronchial	O
)	O
,	O
aortic	O
(	O
4	O
aortopulmonary	O
,	O
3	O
.	O
anterior	O
mediastinal	O
)	O
,	O
inferior	O
mediastinal	O
(	O
5	O
subcarinal	O
,	O
4	O
inferior	O
pulmonary	O
ligament	O
)	O
.	O
and	O
.	O

(	O
2	O
)	O
left	O
lower	O
lobe	O
bronchus	O
lymph	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Gastrectomy	O
.	O

Tumor	O
Site	O
:	O
Cardia	O
.	O

Tumor	O
configuration	O
:	O
Ulcerating	O
.	O

Tumor	O
size	O
:	O
8	B
X	I
5	I
X	I
1	I
.	I

cm	B
.	O

Histologic	O
type	O
:	O
Signet	O
ring	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Extent	O
of	O
invasion	O
:	O
Not	O
specified	O
.	O

Lymph	O
.	O
nodes	O
:	O
2	O
of	O
8	O
positive	O
for	O
metastasis	O
.	O

Margins	O
-	O
Proximal	O
margin	O
:	O
Not	O
specified	O
.	O

Distal	O
margin	O
:	O
Not	O
specified	O
.	O

Omental	O
(	O
radial	O
)	O
margin	O
:	O
Not	O
.	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
.	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

MODIFIED	O
REPORT	O
-	O
REVIEW	O
ADDENDUM	O
SECTION	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
STOMACH	O
,	O
"	O
POLYP	O
"	O
AT	O
HIATAL	O
HERNIA	O
,	O
BIOPSY	O
:	O
Oxyntic	O
/	O
fundic	O
mucosa	O
with	O
chronic	O
inactive	O
gastritis	O
and	O
muscularis	O
mucosae	O
hyperplasia	O
.	O

No	O
tumor	O
,	O
intestinal	O
metaplasia	O
or	O
Helicobacter	O
pylori	O
identified	O
.	O

Deeper	O
levels	O
are	O
examined	O
.	O

(	O
B	O
)	O
ESOPHAGUS	O
,	O
DISTAL	O
,	O
TUMOR	O
,	O
BIOPSY	O
:	O
ULCERATED	O
INVASIVE	O
POORLY	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
UNDERLYING	O
SQUAMOUS	O
MUCOSA	O
.	O

WITH	O
REACTIVE	O
EPITHELIAL	O
CHANGES	O
.	O

COMMENT	O
.	O

Immunohistochemistry	O
performed	O
and	O
reviewed	O
at	O
.	O
shows	O
the	O
neoplastic	O
cells	O
are	O
negative	O
for	O
chromogranin	O
and	O
.	O
synaptophysin	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
.	O

POLYP	O
.	O

AT	O
HIATAL	O
HERNIA	O
-	O
Multiple	O
light	O
gray	O
and	O
pink	O
fragments	O
of	O
soft	O
tissue	O
(	O
0	O
.	O
7	O
X	O
0	O
.	O
3	O
x	O
0	O
.	O
3	O
cm	O
in	O
aggregate	O
)	O
.	O

Entirely	O
.	O
submitted	O
in	O
A1	O
.	O

(	O
B	O
)	O
.	O

DISTAL	O
ESOPHAGEAL	O
TUMOR	O
-	O
Multiple	O
light	O
gray	O
and	O
pink	O
fragments	O
of	O
soft	O
tissue	O
(	O
1	B
.	I
0	I
x	I
0	I
.	I
4	I
X	I
0	I
.	I
3	I
cm	I
in	O
aggregate	O
)	O
.	O

Entirely	O
submitted	O
in	O
B1	O
.	O

BIOMARKER	O
TESTING	O
.	O

PRIMARY	O
TUMOR	O
:	O
Block	O
B1	O
.	O

NORMAL	O
:	O
Block	O
A1	O
.	O

CLINICAL	O
HISTORY	O
.	O

Esophageal	O
cancer	O
.	O

SNOMED	O
CODES	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

.	O
These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
Start	O
of	O
ADDENDUM	O
.	O

Page	O
:	O
2	O
.	O

ADDENDUM	O
.	O

This	O
modified	O
report	O
is	O
being	O
issued	O
to	O
report	O
special	O
studies	O
/	O
IHC	O
/	O
Molecular	O
studies	O
.	O

Addendum	O
completed	O
by	O
.	O

COMMENT	O
.	O

An	O
immunohistochemical	O
stain	O
for	O
Her2	O
-	O
neu	O
.	O
was	O
performed	O
in	O
our	O
lab	O
on	O
a	O
representative	O
.	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
section	O
of	O
distal	O
esophageal	O
adenocarcinoma	O
,	O
Block	O
:	O
B1	O
.	O

Staining	O
.	O

Score	O
.	O

Interpretation	O
.	O

No	O
membranous	O
staining	O
of	O
the	O
invasive	O
tumor	O
cells	O
.	O

0	O
.	O

Negative	O
.	O

FOOTNOTE	O
:	O
For	O
Her	O
2	O
:	O
Positive	O
cases	O
are	O
defined	O
as	O
those	O
with	O
strong	O
complete	O
,	O
basolateral	O
,	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
>	O
/	O
=	O
10	O
%	O
of	O
invasive	O
tumor	O
cells	O
in	O
.	O
resection	O
.	O

specimen	O
or	O
strong	O
complete	O
,	O
basolateral	O
,	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
any	O
invasive	O
tumor	O
cells	O
in	O
biopsy	O
specimen	O
(	O
Score	O
3	O
+	O
)	O
.	O

Negative	O
cases	O
are	O
defined	O
.	O

as	O
.	O
those	O
.	O

with	O
.	O

no	O
staining	O
(	O
Score	O
0	O
)	O
or	O
faint	O
or	O
barely	O
perceptible	O
membranous	O
staining	O
(	O
Score	O
1	O
+	O
)	O
of	O
the	O
invasive	O
tumor	O
cells	O
.	O

Equivocal	O
cases	O
are	O
defined	O
as	O
.	O
those	O
with	O
weak	O
to	O
moderate	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
>	O
/	O
=	O
10	O
%	O
of	O
invasive	O
tumor	O
cells	O
in	O
resection	O
specimen	O
or	O
weak	O
to	O
moderate	O
.	O
complete	O
,	O
basolateral	O
or	O
lateral	O
membranous	O
reactivity	O
in	O
any	O
invasive	O
tumor	O
cells	O
in	O
biopsy	O
specimen	O
(	O
Score	O
2	O
+	O
)	O
.	O

Reference	O
.	O

Hofmann	O
M	O
,	O
Stoss	O
O	O
,	O
Shi	O
D	O
et	O
al	O
.	O

Assessment	O
of	O
a	O
HER2	O
scoring	O
system	O
for	O
gastric	O
cancer	O
:	O
results	O
from	O
a	O
validation	O
Study	O
.	O

Histopathology	O
.	O

2008	O
;	O
52	O
(	O
7	O
)	O
:	O
797	O
-	O
805	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
.	O

AP	O
Surgical	O
Pathology	O
:	O
Additional	O
Info	O
.	O

CLINICAL	O
HISTORY	O
.	O

Brain	O
tumor	O
.	O

GROSS	O
EXAMINATION	O
:	O
A	O
.	O

"	O
Brain	O
tissue	O
(	O
AF1	O
)	O
"	O
,	O
received	O
fresh	O
for	O
frozen	O
section	O
is	O
a	O
2	B
.	I
5	I
x	I
1	I
.	I
5	I
x	I
.	I

1	B
.	I
2	I
cm	I
fragment	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

The	O
representative	O
section	O
has	O
been	O
.	O
frozen	O
as	O
AF1	O
and	O
the	O
frozen	O
section	O
remnant	O
is	O
submitted	O
in	O
block	O
A1	O
.	O

Additional	O
representative	O
sections	O
are	O
submitted	O
in	O
blocks	O
A2	O
,	O
with	O
the	O
.	O
remainder	O
retained	O
in	O
formalin	O
.	O

B	O
.	O

"	O
Brain	O
tissue	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
3	B
.	I
7	I
x	I
3	I
X	I
2	I
cm	I
.	O
aggregate	O
of	O
pink	O
-	O
tan	O
soft	O
tissue	O
.	O

Sectioning	O
demonstrates	O
a	O
white	O
-	O
pink	O
cut	O
.	O
surface	O
with	O
focal	O
areas	O
of	O
hemorrhage	O
.	O

Representative	O
cross	O
sections	O
are	O
.	O
submitted	O
in	O
blocks	O
B1	O
-	O
3	O
,	O
with	O
the	O
remainder	O
retained	O
in	O
formalin	O
.	O

C	O
.	O

"	O
Brain	O
tissue	O
"	O
,	O
received	O
fresh	O
and	O
placed	O
in	O
formalin	O
is	O
a	O
1	B
x	I
0	I
.	I
7	I
x	I
0	I
.	I
6	I
cm	I
.	O
aggregate	O
of	O
pink	O
-	O
tan	O
tissue	O
.	O

Representative	O
section	O
is	O
submitted	O
in	O
block	O
.	O

C1	O
,	O
with	O
the	O
remainder	O
retained	O
in	O
formalin	O
.	O

INTRA	O
OPERATIVE	O
CONSULTATION	O
:	O
A	O
.	O

"	O
Brain	O
tissue	O
"	O
AF1	O
-	O
glioma	O
,	O
high	O
grade	O
.	O

MICROSCOPIC	O
EXAMINATION	O
:	O
Microscopic	O
examination	O
shows	O
brain	O
infiltrated	O
by	O
a	O
malignant	O
astrocytic	O
.	O
neoplasm	O
characterized	O
by	O
cytologic	O
pleomorphism	O
,	O
mitotic	O
figures	O
,	O
.	O
microvascular	O
changes	O
and	O
pseudopalisading	O
necrosis	O
.	O

On	O
block	O
B3	O
,	O
.	O
subarachnoid	O
infiltration	O
is	O
evident	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
BRAIN	O
TISSUE	O
"	O
(	O
CRANIOTOMY	O
)	O
:	O
GLIOBLASTOMA	O
(	O
WHO	O
GRADE	O
IV	O
)	O
.	O

B	O
.	O

"	O
BRAIN	O
TISSUE	O
"	O
(	O
CRANIOTOMY	O
)	O
:	O
GLIOBLASTOMA	O
(	O
WHO	O
GRADE	O
IV	O
)	O
.	O

C	O
.	O

"	O
BRAIN	O
TISSUE	O
"	O
(	O
CRANIOTOMY	O
)	O
:	O
GLIOBLASTOMA	O
(	O
WHO	O
GRADE	O
IV	O
)	O
.	O

SUBARACHNOID	O
INFILTRATION	O
EVIDENT	O
.	O

COMMENT	O
:	O
NEUROPATHOLOGIST	O
OF	O
.	O

AND	O
THE	O
ORIGINAL	O
NEUROPATHOLOGIST	O
OF	O
THE	O
FIRST	O
BIOPSY	O
,	O
HAS	O
REVIEWED	O
.	O

THE	O
SLIDES	O
AND	O
CONCURS	O
WITH	O
THE	O
DIAGNOSES	O
RENDERED	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

ADDENDUM	O
1	O
:	O
Please	O
see	O
Image	O
Cytometry	O
Report	O
.	O
for	O
results	O
of	O
supplementary	O
.	O

1	O
of	O
3	O
.	O
tests	O
.	O

FISH	O
INTERPRETATION	O
SUMMARY	O
:	O
CHROMOSOME	O
7	O
CENTROMERE	O
-	O
POLYSOMY	O
(	O
76	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
POLYSOMY	O
)	O
.	O

EGFR	O
-	O
AMPLIFICATION	O
(	O
96	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
AMPLIFICATION	O
)	O
.	O

CHROMOSOME	O
10	O
CENTROMERE	O
-	O
CENTROMERE	O
LOSS	O
(	O
36	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
LOSS	O
)	O
.	O

PTEN	O
-	O
ALLELIC	O
LOSS	O
(	O
60	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
LOSS	O
)	O
.	O

1p36	O
-	O
INACT	O
(	O
NO	O
LOSS	O
)	O
.	O

1p32	O
-	O
INTACT	O
(	O
NO	O
LOSS	O
)	O
.	O

19q13	O
-	O
POLYSOMY	O
(	O
68	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
A	O
RATIO	O
FOR	O
19q13	O
/	O
19p13	O
OF	O
LESS	O
.	O
THAN	O
1	O
.	O
0	O
)	O
.	O

9p21	O
-	O
LOSS	O
(	O
58	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
LOSS	O
)	O
.	O

CHROMOSOME	O
9	O
CENTROMERE	O
-	O
POLYSOMY	O
(	O
56	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
POLYSOMY	O
)	O
.	O

FOR	O
THE	O
ASTROCYTIC	O
MARKERS	O
,	O
4	O
OF	O
4	O
MARKERS	O
ARE	O
ABNORMAL	O
AND	O
9p21	O
EXHIBITS	O
.	O

LOSS	O
.	O

FOR	O
THE	O
OLIGODENDROGLIAL	O
MARKERS	O
,	O
ALL	O
LOCI	O
ARE	O
INTACT	O
.	O

COMMENT	O
:	O
A	O
MULTIVARIATE	O
SURVIVAL	O
ANALYSIS	O
OF	O
.	O

PATIENTS	O
WITH	O
GLIOBLASTOMAS	O
.	O

REVEALS	O
THAT	O
THE	O
HAZARD	O
OF	O
SHORT	O
SURVIVAL	O
AMONG	O
PATIENTS	O
WITH	O
0	O
-	O
2	O
ABNORMAL	O
.	O

MARKERS	O
(	O
OUT	O
OF	O
4	O
)	O
WAS	O
SIGNIFICANTLY	O
LOWER	O
THAN	O
THAT	O
FOUND	O
WITH	O
PATIENTS	O
WITH	O
.	O

4	O
ABNORMAL	O
MARKERS	O
EVEN	O
AFTER	O
ADJUSTMENT	O
FOR	O
AGE	O
EFFECT	O
.	O

BOTH	O
FISH	O
AND	O
IMMUNOHISTOCHEMISTRY	O
FOR	O
PTEN	O
REVEAL	O
SIMILAR	O
FINDINGS	O
INDICATIVE	O
.	O

OF	O
LOSS	O
OF	O
PTEN	O
STATUS	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

ADDENDUM	O
2	O
:	O
IMMUNOHISTOCHEMICAL	O
LABELING	O
INDEX	O
OF	O
TUMOR	O
CELLS	O
:	O
TISSUE	O
TYPE	O
:	O
BRAIN	O
TISSUE	O
CONTAINING	O
GLIOBLASTOMA	O
(	O
WHO	O
GRADE	O
IV	O
;	O
.	O

VEGF	O
IMMUNOHISTOCHEMISTRY	O
:	O
NEGATIVE	O
(	O
2	O
X	O
5	O
%	O
=	O
score	O
10	O
)	O
.	O

PDGFR	O
-	O
A	O
IMMUNOHISTOCHEMISTRY	O
:	O
FOCAL	O
(	O
30	O
%	O
)	O
FOR	O
CYTOPLASMIC	O
AND	O
/	O
OR	O
MEMBRANE	O
.	O

REACTIVITY	O
.	O

PDGFR	O
-	O
B	O
IMMUNOHISTOCHEMISTRY	O
:	O
FOCAL	O
(	O
30	O
%	O
)	O
OR	O
NEGATIVE	O
FOR	O
CYTOPLASMIC	O
AND	O
/	O
OR	O
.	O

MEMBRANE	O
REACTIVITY	O
.	O

LEUCOCYTE	O
COMMON	O
ANTIGEN	O
(	O
LCA	O
)	O
:	O
25	O
%	O
OF	O
POSITIVE	O
CELLS	O
.	O

PROLIFERATION	O
INDEX	O
INTERPRETATION	O
:	O
HIGH	O
PROLIFERATION	O
INDEX	O
(	O
20	O
%	O
OF	O
TUMOR	O
.	O
CELLS	O
EXHIBIT	O
STAINING	O
)	O
.	O

MGMT	O
-	O
NEGATIVE	O
(	O
10	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

EGFR	O
wt	O
-	O
POSITIVE	O
(	O
3	O
+	O
IN	O
90	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

2	O
of	O
3	O
.	O

EGFR	O
VIII	O
-	O
NEGATIVE	O
(	O
0	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

PTEN	O
-	O
LOSS	O
(	O
2	O
+	O
IN	O
60	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

S6	O
-	O
POSITIVE	O
(	O
2	O
+	O
IN	O
30	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

AKT	O
-	O
NEGATIVE	O
(	O
2	O
+	O
IN	O
10	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

MAPK	O
-	O
POSITIVE	O
(	O
3	O
+	O
IN	O
20	O
%	O
OF	O
TUMOR	O
CELLS	O
)	O
.	O

Please	O
see	O
.	O
for	O
results	O
of	O
supplementary	O
.	O
tests	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

ADDENDUM	O
3	O
:	O
HAM	O
56	O
staining	O
reveals	O
a	O
focally	O
dense	O
macrophage	O
population	O
consisting	O
of	O
.	O
approximately	O
25	O
%	O
of	O
cells	O
in	O
regions	O
about	O
areas	O
of	O
necrosis	O
.	O

Remaining	O
.	O
areas	O
are	O
largely	O
negative	O
for	O
macrophages	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

ADDENDUM	O
5	O
:	O
Please	O
see	O
Image	O
Cytometry	O
Report	O
.	O
for	O
results	O
of	O
supplementary	O
.	O
tests	O
.	O

FISH	O
INTERPRETATION	O
SUMMARY	O
:	O
CKIT	O
-	O
POLYSOMY	O
(	O
89	O
%	O
OF	O
TUMOR	O
CELLS	O
EXHIBIT	O
POLYSOMY	O
)	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

CI	O
ADDENDUM	O
1	O
:	O
Please	O
see	O
Image	O
Cytometry	O
Report	O
.	O
for	O
results	O
of	O
supplementary	O
.	O
tests	O
.	O

I	O
certify	O
that	O
I	O
personally	O
conducted	O
the	O
diagnostic	O
evaluation	O
of	O
the	O
above	O
.	O
specimen	O
(	O
s	O
)	O
and	O
have	O
rendered	O
the	O
above	O
diagnosis	O
(	O
es	O
)	O
.	O

3	O
of	O
3	O
.	O

Path	O
Report	O
:	O
ESOPHAGUS	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Excision	O
of	O
tumor	O
.	O

Tumor	O
site	O
:	O
Esophagus	O
.	O

Tumor	O
size	O
:	O
3	B
X	I
3	I
x	I
1	I
.	I
2	I
cm	I
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Adventitia	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
4	O
positive	O
for	O
metastasis	O
(	O
Regional	O
0	O
/	O
4	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Diagnosis	O
.	O

1	O
.	O

Predominantly	O
poorly	O
differentiated	O
adenocarcinoma	O
of	O
the	O
prostate	O
in	O
the	O
peripheral	O
zone	O
on	O
.	O
both	O
sides	O
with	O
perineural	O
infiltration	O
and	O
invasion	O
of	O
the	O
lymph	O
vessels	O
.	O

Maximum	O
tumor	O
.	O
diameter	O
2	B
cm	I
.	O

Right	O
lateral	O
infiltration	O
of	O
the	O
periprostatic	O
fatty	O
connective	O
tissue	O
.	O

Focal	O
.	O
infiltration	O
of	O
the	O
right	O
seminal	O
vesicle	O
.	O

In	O
the	O
apex	O
region	O
on	O
both	O
sides	O
widespread	O
contact	O
with	O
.	O
the	O
color	O
-	O
labeled	O
preparation	O
margin	O
(	O
contact	O
area	O
measuring	O
max	O
.	O
8	O
mm	O
)	O
.	O

2	O
.	O

Fatty	O
tissue	O
with	O
4	O
tumor	O
-	O
free	O
lymph	O
nodes	O
.	O

3	O
.	O

Fatty	O
tissue	O
with	O
3	O
tumor	O
-	O
free	O
lymph	O
nodes	O
.	O

Summary	O
tumor	O
classification	O
:	O
pT3b	O
,	O
L1	O
,	O
V0	O
,	O
R1	O
;	O
pN0	O
(	O
0	O
/	O
7	O
)	O
;	O
Gleason	O
4	O
+	O
3	O
=	O
7	O
(	O
Gleason	O
4	O
:	O
approx	O
.	O
70	O
%	O
)	O
.	O

Subject	O
.	O

LARGE	O
INTESTINE	O
TISSUE	O
.	O

CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Resection	O
of	O
.	O
rectum	O
.	O

Specimen	O
size	O
:	O
Not	O
specified	O
.	O

Tumor	O
site	O
:	O
Rectum	O
.	O

Tumor	O
size	O
:	O
15	B
X	I
7	I
.	I
5	I
X	I
10	I
cm	I
.	O

Tumor	O
features	O
:	O
None	O
specified	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
.	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Pericolonic	O
tissues	O
.	O

Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
.	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
.	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

PATIENT	O
HISTORY	O
:	O
`	O
The	O
patient	O
is	O
a	O
.	O
vith	O
a	O
history	O
of	O
PSA	O
value	O
of	O
7	O
.	O
3	O
which	O
increased	O
from	O
6	O
.	O
31	O
.	O

The	O
patient	O
also	O
has	O
a	O
.	O
history	O
of	O
.	O
which	O
reveals	O
a	O
Gleason	O
Grade	O
of	O
3	O
+	O
3	O
=	O
6	O
on	O
the	O
right	O
lobe	O
.	O

Patient	O
has	O
a	O
past	O
medical	O
.	O
history	O
of	O
dental	O
.	O

PRE	O
-	O
OP	O
DIAGNOSIS	O
:	O
Prostate	O
cancer	O
.	O

POST	O
-	O
OP	O
DIAGNOSIS	O
:	O
Same	O
.	O

PROCEDURE	O
:	O
Radical	O
prostatectomy	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
PART	O
1	O
:	O
RIGHT	O
PELVIC	O
LYMPH	O
NODES	O
,	O
EXCISION	O
-	O
.	O

ONE	O
BENIGN	O
LYMPH	O
NODE	O
.	O

PART	O
2	O
:	O
LYMPH	O
NODE	O
,	O
LEFT	O
PELVIS	O
,	O
EXCISION	O
-	O
.	O

ONE	O
BENIGN	O
LYMPH	O
NODE	O
.	O

PART	O
3	O
:	O
PROSTATE	O
AND	O
BILATERAL	O
SEMINAL	O
VESICLES	O
,	O
RADICAL	O
PROSTATECTOMY	O
-	O
.	O

A	O
.	O

INVASIVE	O
POORLY	O
DIFFERENTIATED	O
ADENOCARCINOMA	O
,	O
GLEASON	O
SCORE	O
3	O
+	O
4	O
=	O
7	O
WITH	O
A	O
DISTINCT	O
.	O

FOAMY	O
MORPHOLOGY	O
.	O

B	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
PREDOMINANTLY	O
THE	O
RIGHT	O
LOBE	O
AND	O
HAS	O
A	O
GREATEST	O
NODULAR	O
.	O

DIAMETER	O
OF	O
1	B
.	I
8	I
CM	I
.	O

C	O
.	O

THE	O
CARCINOMA	O
INVOLVES	O
15	O
%	O
OF	O
THE	O
EXAMINED	O
PROSTATE	O
VOLUME	O
.	O

D	O
.	O

EXTRACAPSULAR	O
PROSTATIC	O
EXTENSION	O
IS	O
PRESENT	O
IN	O
THE	O
REGIONS	O
OF	O
ANTERIOR	O
RIGHT	O
BASE	O
(	O
SLIDE	O
.	O
3Q	O
)	O
AND	O
POSTERIOR	O
RIGHT	O
BASE	O
(	O
SLIDE	O
3Z	O
)	O
.	O

E	O
.	O

ALL	O
EXAMINED	O
SURGICAL	O
RESECTION	O
MARGINS	O
ARE	O
FREE	O
OF	O
CARCINOMA	O
.	O

F	O
.	O

EXTENSIVE	O
PERINEURAL	O
INVASION	O
IS	O
SEEN	O
.	O

G	O
.	O

MULTIFOCAL	O
HIGH	O
-	O
GRADE	O
PROSTATIC	O
INTRAEPITHELIAL	O
NEOPLASIA	O
(	O
PIN	O
)	O
IS	O
IDENTIFIED	O
.	O

H	O
.	O

BILATERAL	O
SEMINAL	O
VESICLES	O
ARE	O
NOT	O
INVOLVED	O
BY	O
TUMOR	O
.	O

I	O
.	O

NO	O
ANGIOLYMPHATIC	O
INVASION	O
IS	O
IDENTIFIED	O
.	O

J	O
.	O

PATHOLOGIC	O
TNM	O
STAGE	O
:	O
pT3a	O
NO	O
MX	O
.	O

K	O
.	O

TNM	O
HISTOLOGIC	O
GRADE	O
=	O
G3	O
.	O

L	O
.	O

BENIGN	O
PROSTATIC	O
HYPERTROPHY	O
AND	O
CHRONIC	O
MODERATELY	O
ACTIVE	O
PROSTATITIS	O
ARE	O
NOTED	O
.	O

CASE	O
SYNOPSIS	O
:	O
SYNOPTIC	O
DATA	O
-	O
PRIMARY	O
PROSTATE	O
TUMORS	O
.	O

CLINICAL	O
DATA	O
:	O
PSA	O
value	O
:	O
7	O
.	O
3	O
.	O

INVASIVE	O
CA	O
IDENTIFIED	O
?	O
.	O

TUMOR	O
HISTOLOGY	O
:	O
Adenocarcinoma	O
NOS	O
.	O

PRIMARY	O
GLEASON	O
GRADE	O
:	O
3	O
.	O

SECONDARY	O
GLEASON	O
GRADE	O
:	O
4	O
.	O

GLEASON	O
SUM	O
SCORE	O
:	O
7	O
.	O

GLEASON	O
4	O
/	O
5	O
PERCENTAGE	O
:	O
20	O
%	O
.	O

WEIGHT	O
OF	O
PROSTATE	O
:	O
53	O
.	O
47gm	O
.	O

TUMOR	O
SIZE	O
:	O
Maximum	O
dimension	O
:	O
1	B
.	I
8	I
cm	I
.	O

LOBE	O
LATERALITY	O
:	O
Right	O
Lobe	O
.	O

PERCENT	O
OF	O
SPECIMEN	O
INVOLVED	O
BY	O
TUMOR	O
:	O
5	O
25	O
%	O
.	O

MULTIFOCAL	O
DISEASE	O
:	O
HIGH	O
GRADE	O
PIN	O
:	O
Yes	O
NOS	O
.	O

EXTRAPROSTATIC	O
EXTENSION	O
:	O
Yes	O
-	O
Established	O
(	O
>	O
0	O
.	O
8mm	O
)	O
.	O

PERINEURAL	O
INVASION	O
:	O
ANGIOLYMPHATIC	O
INVASION	O
:	O
SEMINAL	O
VESICLE	O
INVASION	O
:	O
SURGICAL	O
MARGIN	O
INVOLVEMENT	O
:	O
All	O
surgical	O
margins	O
free	O
of	O
tumor	O
.	O

LYMPH	O
NODES	O
EXAMINED	O
:	O
2	O
.	O

LYMPH	O
NODES	O
POSITIVE	O
:	O
0	O
.	O

T	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pT3a	O
.	O

N	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pNO	O
.	O

M	O
STAGE	O
,	O
PATHOLOGIC	O
:	O
pMX	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
-	O
4	O
,	O
Poorly	O
differentiated	O
/	O
undifferentiated	O
.	O

FINAL	O
DIAGNOSIS	O
.	O

A	O
.	O

RIGHT	O
OCCIPITAL	O
NEOPLASM	O
,	O
BIOPSY	O
:	O
-	O
-	O
INFILTRATING	O
GLIOMA	O
.	O

B	O
.	O

RIGHT	O
OCCIPITAL	O
NEOPLASM	O
,	O
BIOPSY	O
NUMBER	O
TWO	O
:	O
-	O
-	O
MALIGNANT	O
ASTROCYTOMA	O
.	O

C	O
.	O

SPECIMEN	O
LABELED	O
SECOND	O
PERMANENT	O
CORE	O
:	O
-	O
-	O
MALIGNANT	O
ASTROCYTOMA	O
.	O

D	O
.	O

SPECIMEN	O
LABELED	O
THREE	O
PERMANENT	O
EDGE	O
:	O
-	O
-	O
GLIOBLASTOMA	O
MULTIFORME	O
(	O
WHO	O
GRADE	O
IV	O
)	O
,	O
SMALL	O
CELL	O
VARIANT	O
.	O

Note	O
:	O
Immunohistochemical	O
staining	O
for	O
primitive	O
neuroectodermal	O
differentiation	O
(	O
synaptophysin	O
,	O
neurofilaments	O
)	O
is	O
.	O
negative	O
.	O

E	O
.	O

PERMANENT	O
WHITE	O
MATTER	O
,	O
REMOVAL	O
:	O
CEREBRAL	O
CORTEX	O
AND	O
WHITE	O
MATTER	O
DEMONSTRATING	O
FOCAL	O
HYPERCELLULARITY	O
,	O
CONSISTENT	O
.	O

WITH	O
INFILTRATING	O
GLIOMA	O
.	O

One	O
or	O
more	O
of	O
the	O
reagents	O
used	O
to	O
perform	O
assays	O
on	O
this	O
specimen	O
MAY	O
have	O
contained	O
components	O
considered	O
.	O
to	O
be	O
analyte	O
specific	O
reagents	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O
Food	O
and	O
Drug	O
.	O

Administration	O
.	O

These	O
assays	O
were	O
developed	O
and	O
their	O
performance	O
characteristics	O
determined	O
by	O
the	O
Department	O
.	O
of	O
Pathology	O
at	O
.	O

The	O
assays	O
were	O
performed	O
with	O
appropriate	O
positive	O
and	O
negative	O
.	O
controls	O
.	O

By	O
the	O
signature	O
on	O
this	O
report	O
,	O
the	O
individual	O
or	O
group	O
listed	O
as	O
making	O
the	O
Final	O
Interpretation	O
/	O
Diagnosis	O
certifies	O
that	O
they	O
have	O
reviewed	O
this	O
case	O
.	O

Intraoperative	O
Consult	O
Diagnosis	O
.	O

A	O
.	O

Touch	O
Imprint	O
and	O
Microscopic	O
:	O
Hypercellular	O
tissue	O
.	O

No	O
definite	O
neoplasm	O
identified	O
.	O

B	O
.	O

Touch	O
Imprint	O
and	O
Microscopic	O
:	O
High	O
Grade	O
glial	O
neoplasm	O
.	O

Clinical	O
History	O
:	O
Right	O
occipital	O
neoplasm	O
.	O

Specimens	O
Submitted	O
As	O
:	O
A	O
:	O
RIGHT	O
OCCIPITAL	O
NEOPLASM	O
.	O

B	O
:	O
R	O
OCCIPITAL	O
NEOPLASM	O
.	O

C	O
:	O
2	O
PERM	O
CORE	O
.	O

D	O
:	O
3	O
PERM	O
EDGE	O
.	O

E	O
:	O
PERM	O
WHITE	O
MATTER	O
.	O

Gross	O
Description	O
:	O
A	O
:	O
Received	O
fresh	O
,	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
and	O
"	O
1	O
"	O
,	O
are	O
multiple	O
.	O
irregular	O
fragments	O
of	O
tan	O
-	O
pink	O
,	O
soft	O
tissue	O
,	O
1	O
.	O
4	O
x	O
0	O
.	O
6	O
x	O
0	O
.	O
6	O
cm	O
in	O
aggregate	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
cassette	O
A1	O
for	O
frozen	O
section	O
analysis	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
in	O
toto	O
in	O
cassette	O
A2	O
.	O

B	O
:	O
Received	O
fresh	O
,	O
for	O
intraoperative	O
consultation	O
,	O
labelled	O
with	O
patient	O
'	O
s	O
name	O
and	O
number	O
,	O
are	O
multiple	O
irregular	O
.	O
fragments	O
of	O
tan	O
-	O
pink	O
neural	O
tissue	O
,	O
0	O
.	O
6	O
X	O
0	O
.	O
4	O
x	O
0	O
.	O
3	O
cm	O
in	O
aggregate	O
.	O

Representative	O
sections	O
are	O
submitted	O
in	O
.	O
cassette	O
B1	O
for	O
frozen	O
section	O
and	O
permanent	O
analysis	O
and	O
the	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
entirely	O
in	O
.	O
cassette	O
B2	O
.	O

C	O
:	O
Received	O
fresh	O
,	O
post	O
fixed	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
,	O
and	O
"	O
2	O
"	O
,	O
are	O
two	O
light	O
tan	O
to	O
white	O
-	O
.	O
tan	O
irregular	O
to	O
wedge	O
-	O
shaped	O
soft	O
tissue	O
fragments	O
measuring	O
0	O
.	O
9	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
7	O
cm	O
and	O
1	O
.	O
4	O
X	O
1	O
.	O
1	O
X	O
0	O
.	O
75	O
cm	O
.	O

Both	O
.	O
fragments	O
are	O
bisected	O
.	O

On	O
section	O
,	O
the	O
tissue	O
is	O
light	O
tan	O
throughout	O
.	O

Submitted	O
entirely	O
in	O
two	O
cassettes	O
.	O

D	O
:	O
Received	O
fresh	O
,	O
post	O
fixed	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
,	O
and	O
"	O
3	O
"	O
,	O
are	O
six	O
light	O
tan	O
to	O
brown	O
.	O
irregular	O
to	O
wedge	O
-	O
shaped	O
soft	O
tissue	O
fragments	O
ranging	O
from	O
1	O
x	O
0	O
.	O
5	O
x	O
0	O
.	O
3	O
cm	O
to	O
2	O
.	O
7	O
X	O
1	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

The	O
two	O
largest	O
.	O
fragments	O
are	O
serially	O
sectioned	O
.	O

On	O
section	O
,	O
the	O
tissue	O
is	O
light	O
tan	O
throughout	O
.	O

Submitted	O
entirely	O
in	O
four	O
cassettes	O
.	O

E	O
:	O
Received	O
fresh	O
,	O
post	O
fixed	O
in	O
formalin	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
number	O
,	O
and	O
"	O
4	O
"	O
,	O
are	O
multiple	O
light	O
tan	O
to	O
.	O
white	O
-	O
tan	O
irregular	O
to	O
wedge	O
-	O
shaped	O
soft	O
fragments	O
of	O
brain	O
ranging	O
from	O
flecks	O
to	O
4	O
.	O
2	O
x	O
2	O
.	O
2	O
x	O
1	O
.	O
8	O
cm	O
.	O

One	O
side	O
of	O
the	O
.	O
largest	O
fragment	O
is	O
smooth	O
and	O
glistening	O
.	O

The	O
two	O
largest	O
fragments	O
are	O
serially	O
sectioned	O
.	O

On	O
section	O
,	O
the	O
tissue	O
is	O
light	O
tan	O
to	O
white	O
tan	O
and	O
lobulated	O
.	O

Submitted	O
entirely	O
in	O
14	O
cassettes	O
.	O

Summary	O
of	O
cassettes	O
.	O

D1	O
-	O
D2	O
largest	O
fragment	O
.	O

D3	O
2nd	O
largest	O
fragment	O
.	O

D4	O
remaining	O
tissue	O
.	O

E1	O
-	O
E11	O
largest	O
fragment	O
.	O

E12	O
-	O
E13	O
2nd	O
largest	O
fragment	O
.	O

E14	O
remaining	O
tissue	O
.	O

Additional	O
Copy	O
lo	O
:	O
net	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
ith	O
right	O
3	O
.	O
8	O
cm	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
right	O
;	O
partial	O
nephrectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

SP	O
:	O
Kidney	O
,	O
right	O
;	O
partial	O
nephrectomy	O
.	O

Tumor	O
Type	O
:	O
Renal	O
cell	O
carcinoma	O
-	O
Conventional	O
(	O
clear	O
cell	O
)	O
type	O
.	O

Fuhrman	O
Nuclear	O
Grade	O
:	O
Nuclear	O
grade	O
II	O
/	O
IV	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
diameter	O
is	O
3	B
,	I
4	I
cm	I
,	O
.	O

Local	O
Invasion	O
(	O
for	O
renal	O
cortical	O
types	O
)	O
:	O
Not	O
Identified	O
.	O

Renal	O
Vein	O
Invasion	O
:	O
Not	O
identified	O
.	O

Small	O
vessel	O
anglolymphatic	O
invasion	O
also	O
not	O
identifled	O
.	O

Surgical	O
Margins	O
:	O
Free	O
of	O
tumor	O
.	O

Non	O
-	O
Neoplastic	O
Kidney	O
:	O
Focal	O
hyalinizing	O
glomerulosclerosis	O
and	O
mild	O
arteriosclerosis	O
.	O

Adrenal	O
Gland	O
:	O
Not	O
identified	O
.	O

Lymph	O
Nodes	O
:	O
Not	O
identified	O
.	O

Staging	O
for	O
renal	O
cell	O
carcinoma	O
/	O
oncocytoma	O
:	O
pT1	O
Tumor	O
<	O
=	O
7	O
.	O
0	O
cm	O
in	O
greatest	O
dimension	O
limited	O
to	O
the	O
kidney	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
I	O
HAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

1	O
)	O
.	O

The	O
specimen	O
Is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
labeled	O
"	O
Right	O
renal	O
mass	O
"	O
and	O
consists	O
of	O
a	O
partial	O
.	O
nephrectomy	O
measuring	O
4	O
.	O
5	O
x	O
3	O
.	O
7	O
x	O
2	O
.	O
9	O
cm	O
.	O

The	O
resected	O
margin	O
is	O
pink	O
brown	O
,	O
rough	O
,	O
and	O
grossly	O
unremarkable	O
;	O
and	O
has	O
been	O
.	O
inked	O
black	O
.	O

The	O
capsular	O
surtace	O
Is	O
smooth	O
pink	O
-	O
tan	O
with	O
attached	O
adipose	O
tissue	O
,	O
and	O
hes	O
been	O
inked	O
blue	O
.	O

The	O
specimen	O
.	O

is	O
.	O
sectioned	O
to	O
reveal	O
a	O
centrally	O
located	O
fairly	O
well	O
circumscribed	O
partially	O
cystic	O
and	O
partially	O
subcapsular	O
tumor	O
nodule	O
measuring	O
.	O

3	O
.	O
4	O
x	O
2	O
,	O
5	O
x	O
2	O
.	O
7	O
cm	O
,	O
which	O
is	O
located	O
0	O
,	O
1	O
cm	O
from	O
the	O
nearest	O
resected	O
margin	O
.	O

On	O
cut	O
section	O
,	O
the	O
solid	O
portion	O
of	O
the	O
nodule	O
.	O
consists	O
of	O
yellow	O
homogenous	O
and	O
focally	O
hemorrhagic	O
soft	O
tissue	O
,	O
and	O
the	O
cystic	O
portion	O
is	O
multilocular	O
,	O
with	O
smooth	O
white	O
tan	O
.	O
fibrous	O
septa	O
are	O
noted	O
,	O
The	O
renal	O
capsule	O
and	O
perinephric	O
fat	O
appear	O
grossly	O
uninvolved	O
.	O

The	O
remaining	O
renal	O
parenchyma	O
is	O
.	O
pink	O
brown	O
and	O
grossly	O
unremarkable	O
.	O

Representative	O
sections	O
of	O
the	O
specimen	O
are	O
submitted	O
for	O
frozen	O
section	O
consultation	O
,	O
to	O
.	O

TPS	O
and	O
for	O
permanent	O
section	O
,	O
and	O
a	O
photograph	O
of	O
the	O
cut	O
sections	O
of	O
the	O
nodule	O
has	O
been	O
taken	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
-	O
frozen	O
section	O
control	O
.	O

RST	O
-	O
representative	O
sections	O
tumor	O
with	O
margin	O
and	O
capsule	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Kidney	O
,	O
right	O
;	O
partial	O
nephrectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

5	O
.	O
rst	O
.	O

5	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
RENAL	O
CORTICAL	O
NEOPLASM	O
,	O
MARGIN	O
NEGATIVE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

Provider	O
Status	O
.	O

Observation	O
Date	O
and	O
Time	O
.	O

Result	O
Narrative	O
.	O

(	O
NOTE	O
)	O
.	O

Clinical	O
History	O
.	O

Malignant	O
neoplasm	O
of	O
frontal	O
lobe	O
of	O
brain	O
[	O
191	O
.	O
1	O
]	O
.	O

.	O
Medical	O
History	O
:	O
GERD	O
(	O
gastroesophageal	O
reflux	O
disease	O
)	O
.	O

Optic	O
nerve	O
edema	O
.	O

ADDENDA	O
:	O
Addendum	O
added	O
:	O
Addendum	O
added	O
:	O
Final	O
Pathologic	O
Diagnosis	O
-	O
-	O
.	O

A	O
.	O

Left	O
frontal	O
tumor	O
,	O
biopsy	O
:	O
Slides	O
have	O
been	O
referred	O
to	O
.	O
for	O
review	O
and	O
diagnosis	O
.	O

An	O
.	O
addendum	O
will	O
follow	O
.	O

B	O
.	O

Left	O
frontal	O
tumor	O
,	O
excision	O
:	O
Slides	O
have	O
been	O
referred	O
to	O
.	O
for	O
review	O
and	O
diagnosis	O
.	O

An	O
.	O
addendum	O
will	O
follow	O
.	O

C	O
.	O

Left	O
frontal	O
tumor	O
,	O
excision	O
:	O
Slides	O
have	O
been	O
referred	O
to	O
.	O
for	O
review	O
and	O
diagnosis	O
.	O

An	O
.	O
addendum	O
will	O
follow	O
.	O

Signed	O
_	O
By	O
.	O

Addendum	O
Report	O
-	O
-	O
.	O

Addendum	O
.	O

See	O
below	O
.	O

Since	O
the	O
pathologists	O
of	O
.	O
specialists	O
in	O
.	O
neuropathology	O
and	O
were	O
the	O
locum	O
tenens	O
on	O
this	O
case	O
during	O
my	O
absence	O
,	O
I	O
.	O
offer	O
no	O
professional	O
opinion	O
on	O
this	O
case	O
except	O
to	O
indicate	O
that	O
the	O
.	O
interpretation	O
of	O
the	O
pathologist	O
of	O
.	O
been	O
.	O

faithfully	O
transferred	O
to	O
this	O
addendum	O
.	O

The	O
original	O
consultation	O
report	O
.	O

is	O
on	O
file	O
in	O
Surgical	O
Pathology	O
.	O

The	O
following	O
is	O
the	O
text	O
of	O
their	O
.	O

Report	O
received	O
from	O
:	O
Consult	O
Service	O
.	O

INTERPRETATION	O
AND	O
DIAGNOSIS	O
:	O
1	O
)	O
LT	O
FRONTAL	O
TUMOR	O
.	O

ANAPLASTIC	O
INFILTRATING	O
GLIOMA	O
(	O
WHO	O
.	O
GRADE	O
III	O
)	O
.	O

SEE	O
COMMENT	O
.	O

COMMENT	O
:	O
Histologic	O
sections	O
demonstrate	O
an	O
infiltrating	O
glial	O
neoplasm	O
.	O
with	O
increased	O
mitotic	O
activity	O
(	O
up	O
to	O
5	O
per	O
10	O
high	O
power	O
fields	O
)	O
.	O

Areas	O
.	O
of	O
the	O
tumor	O
demonstrate	O
cells	O
with	O
numerous	O
cytoplasmic	O
processes	O
and	O
.	O
nuclear	O
pleomorphism	O
,	O
while	O
others	O
contain	O
round	O
cells	O
with	O
micronucleoli	O
.	O
and	O
halos	O
.	O
mmunohistochemical	O
stains	O
performed	O
at	O
.	O
demonstrate	O
.	O

strong	O
p53	O
labeling	O
.	O

MIB	O
-	O
1	O
labeling	O
index	O
is	O
moderate	O
.	O

Molecular	O
SNP	O
.	O
array	O
studies	O
are	O
negative	O
for	O
1p	O
/	O
19q	O
loss	O
.	O

The	O
findings	O
support	O
a	O
.	O
diagnosis	O
of	O
anaplastic	O
infiltrating	O
glioma	O
.	O

Given	O
the	O
variable	O
cytologic	O
.	O
features	O
(	O
pleomorphic	O
and	O
round	O
cells	O
)	O
the	O
tumor	O
may	O
be	O
interpreted	O
as	O
an	O
.	O
oligoastrocytoma	O
.	O

Some	O
stains	O
/	O
tests	O
used	O
in	O
	O
rriving	O
at	O
the	O
diagnosis	O
were	O
performed	O
here	O
.	O
using	O
reagents	O
that	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
.	O

Drug	O
Administration	O
These	O
were	O
developed	O
and	O
their	O
performance	O
determined	O
.	O
by	O
thel	O
.	O
ledical	O
Laboratories	O
.	O

Their	O
use	O
does	O
not	O
require	O
FDA	O
.	O
approval	O
.	O

GROSS	O
DESCRIPTION	O
.	O

PART	O
#	O
1	O
:	O
LT	O
FRONTAL	O
TUMOR	O
.	O

Resident	O
Pathologist	O
:	O
NONE	O
ASSIGNED	O
.	O

Received	O
14	O
slides	O
.	O

(	O
AF1	O
,	O
AFTP	O
,	O
AF	O
,	O
B1	O
-	O
B5	O
,	O
C1	O
-	O
C6	O
)	O
from	O
.	O

2	O
/	O
8	O
/	O
12	O
,	O
Received	O
8	O
unstained	O
slides	O
.	O

B4	O
)	O
.	O

2	O
/	O
24	O
/	O
12	O
,	O
Received	O
5	O
additional	O
unstained	O
slides	O
.	O

B4	O
)	O
.	O

End	O
of	O
Report	O
.	O
lectronically	O
Signed	O
Out	O
By	O
.	O

Addendum	O
.	O

Since	O
the	O
pathologists	O
of	O
.	O
are	O
specialists	O
in	O
.	O
neuropathology	O
and	O
were	O
the	O
locum	O
tenens	O
on	O
this	O
case	O
during	O
my	O
absence	O
,	O
.	O
offer	O
no	O
professional	O
opinion	O
on	O
this	O
case	O
except	O
to	O
indicate	O
that	O
the	O
.	O
interpretation	O
of	O
the	O
pathologist	O
of	O
.	O
has	O
been	O
.	O
faithfully	O
transferred	O
to	O
this	O
addendum	O
.	O

The	O
original	O
consultation	O
report	O
.	O

is	O
on	O
file	O
in	O
Surgical	O
Pathology	O
.	O

The	O
following	O
is	O
the	O
text	O
of	O
their	O
.	O

Addendum	O
from	O
:	O
ADDENDUM	O
.	O

Synaptophysin	O
and	O
Neu	O
-	O
N	O
immunostains	O
performed	O
at	O
.	O
highlight	O
.	O

non	O
-	O
neoplastic	O
brain	O
parenchyma	O
.	O

Some	O
stains	O
/	O
tests	O
used	O
in	O
arriving	O
at	O
the	O
diagnosis	O
were	O
performed	O
here	O
.	O
using	O
reagents	O
that	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
Food	O
and	O
.	O

Drug	O
Administration	O
.	O

These	O
were	O
developed	O
and	O
their	O
performance	O
determined	O
.	O
by	O
the	O
.	O

Laboratories	O
.	O

Their	O
use	O
does	O
not	O
require	O
FDA	O
.	O
approval	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
DIAGNOSIS	O
:	O
AF1	O
.	O

Left	O
frontal	O
tumor	O
(	O
Frozen	O
section	O
performed	O
)	O
:	O
Consistent	O
with	O
glial	O
neoplasm	O
,	O
possible	O
oligo	O
.	O

Note	O
:	O
Called	O
to	O
Dr	O
.	O
Examining	O
pathologist	O
:	O
MICROSCOPIC	O
:	O
A	O
microscopic	O
examination	O
was	O
not	O
performed	O
.	O

SPECIMEN	O
(	O
S	O
)	O
RECEIVED	O
:	O
NBX	O
.	O

A	O
:	O
Neuropath	O
,	O
Brain	O
,	O
Bx	O
.	O

B	O
:	O
Neuropath	O
Reg	O
.	O

C	O
:	O
Neuropath	O
Reg	O
.	O

GROSS	O
DESCRIPTION	O
:	O
The	O
specimens	O
are	O
received	O
in	O
two	O
properly	O
labeled	O
containers	O
with	O
the	O
.	O

patient	O
'	O
S	O
name	O
and	O
accession	O
number	O
,	O
one	O
of	O
which	O
is	O
a	O
frozen	O
section	O
.	O

A	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
left	O
frontal	O
tumor	O
"	O
and	O
consists	O
of	O
.	O

a	O
0	B
.	I
7	I
X	I
0	I
.	I
3	I
X	I
0	I
.	I
3	I
cm	I
portion	O
of	O
tissue	O
.	O

A	O
frozen	O
section	O
was	O
performed	O
and	O
.	O
cassette	O
AF1	O
is	O
resubmitted	O
as	O
received	O
.	O

B	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
left	O
frontal	O
tumor	O
"	O
and	O
consists	O
of	O
.	O

a	O
3	B
.	I

9	B
X	I
3	I
.	I
8	I
X	I
2	I
.	I
8	I
cm	I
gray	O
-	O
tan	O
to	O
pink	O
soft	O
tumor	O
with	O
focal	O
areas	O
of	O
.	O
hemorrhage	O
.	O

Summary	O
of	O
Cassettes	O
:	O
B1	O
-	O
5	O
,	O
tumor	O
.	O

C	O
.	O

The	O
specimen	O
is	O
designated	O
"	O
left	O
frontal	O
tumor	O
"	O
and	O
consists	O
of	O
.	O

a	O
5	B
.	I
5	I
X	I
5	I
.	I
0	I
X	I
1	I
.	I

7	B
cm	I
aggregate	O
of	O
extremely	O
soft	O
white	O
-	O
tan	O
to	O
pink	O
-	O
tan	O
,	O
.	O
slightly	O
mucinous	O
soft	O
tissue	O
.	O

The	O
cut	O
surface	O
is	O
pink	O
-	O
tan	O
to	O
white	O
-	O
tan	O
.	O
and	O
gelatinous	O
.	O

RS6	O
.	O

Lab	O
Use	O
Only	O
:	O
Lab	O
Use	O
Only	O
:	O
Gross	O
description	O
by	O
:	O
This	O
result	O
is	O
currently	O
not	O
released	O
to	O
.	O

Patient	O
Care	O
Team	O
.	O

Relationship	O
.	O

Specialty	O
.	O

Notifications	O
.	O

Start	O
.	O

End	O
.	O

PCP	O
-	O
General	O
.	O

Family	O
.	O

Medicine	O
.	O

PROCEDURE	O
.	O

Lung	O
,	O
left	O
lower	O
lobectomy	O
.	O

SPECIMEN	O
:	O
A	O
.	O

L9	O
lymph	O
node	O
.	O

B	O
.	O
left	O
lower	O
lobe	O
lung	O
.	O

C	O
.	O

L10	O
.	O
intralobar	O
.	O

D	O
.	O

L7	O
.	O

HISTORY	O
.	O

Left	O
lower	O
lobe	O
(	O
cancer	O
)	O
(	O
mass	O
)	O
.	O

GROSS	O
.	O

A	O
.	O

Labeled	O
"	O
L9	O
lymph	O
node	O
"	O
is	O
a	O
0	O
.	O
8	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
rubbery	O
yellow	O
.	O
fat	O
which	O
includes	O
a	O
0	O
.	O
3	O
cm	O
in	O
diameter	O
,	O
gray	O
-	O
tan	O
rubbery	O
nodule	O
.	O

B	O
.	O

Labeled	O
"	O
left	O
lower	O
lobe	O
lung	O
"	O
is	O
a	O
rubbery	O
salmon	O
-	O
pink	O
resected	O
.	O
left	O
lower	O
lobe	O
of	O
lung	O
,	O
130	O
grams	O
and	O
13	O
.	O
2	O
x	O
10	O
.	O
8	O
x	O
5	O
cm	O
.	O

A	O
2	B
.	I
9	I
.	I

x	B
.	I

2	B
.	I
4	I
x	I
1	I
.	I
3	I
cm	I
firm	O
tan	O
-	O
gray	O
variegated	O
tumor	O
mass	O
,	O
1	O
.	O
5	O
cm	O
from	O
the	O
.	O
bronchial	O
resection	O
margin	O
,	O
puckers	O
but	O
does	O
not	O
penetrate	O
the	O
.	O
pleura	O
of	O
the	O
superior	O
segment	O
.	O

The	O
pleural	O
surface	O
is	O
inked	O
above	O
.	O
the	O
tumor	O
.	O

Resection	O
margins	O
of	O
bronchus	O
and	O
blood	O
vessels	O
are	O
.	O
grossly	O
unremarkable	O
.	O

Parenchyma	O
away	O
from	O
the	O
tumor	O
is	O
gray	O
and	O
.	O
salmon	O
pink	O
,	O
free	O
of	O
additional	O
nodules	O
.	O

Block	O
1	O
:	O
Frozen	O
section	O
.	O
remnant	O
of	O
bronchial	O
margin	O
.	O

Block	O
2	O
:	O
Resection	O
margins	O
of	O
.	O
vessels	O
.	O

Blocks	O
3	O
-	O
5	O
:	O
Tumor	O
.	O

Block	O
6	O
:	O
Representative	O
lung	O
away	O
from	O
tumor	O
.	O

A	O
.	O
portion	O
of	O
the	O
tumor	O
is	O
submitted	O
for	O
cancer	O
genome	O
study	O
.	O

C	O
.	O

Labeled	O
"	O
L10	O
intralobar	O
"	O
is	O
a	O
1	O
.	O
2	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
3	O
cm	O
rubbery	O
.	O
tan	O
-	O
yellow	O
node	O
,	O
bisected	O
.	O

2	O
/	O
1	O
.	O

D	O
.	O

Labeled	O
"	O
L	O
/	O
7	O
"	O
is	O
a	O
0	O
.	O
6	O
x	O
0	O
.	O
3	O
x	O
0	O
.	O
2	O
cm	O
rubbery	O
gray	O
-	O
black	O
nodule	O
,	O
.	O
bisected	O
.	O

2	O
/	O
1	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
.	O

B	O
.	O

Left	O
lower	O
lobe	O
lung	O
,	O
resection	O
:	O
Bronchial	O
resection	O
margins	O
negative	O
for	O
carcinoma	O
.	O

(	O
Diagnosis	O
to	O
.	O

MICROSCOPIC	O
.	O

A	O
-	O
D	O
.	O

Performed	O
.	O

DIAGNOSIS	O
.	O

A	O
.	O

L9	O
lymph	O
node	O
,	O
excision	O
biopsy	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
.	O

CPT	O
88305	O
.	O

B	O
.	O

Left	O
lower	O
lobe	O
lung	O
,	O
resection	O
:	O
Adenocarcinoma	O
,	O
poorly	O
differentiated	O
(	O
2	B
.	I
9	I
cm	I
)	O
,	O
previously	O
.	O
diagnosed	O
.	O

Intralymphatic	O
tumor	O
invasion	O
.	O

Bronchial	O
and	O
vascular	O
resection	O
margins	O
,	O
free	O
of	O
.	O
malignancy	O
.	O

Tumor	O
-	O
associated	O
scar	O
.	O

Lung	O
parenchyma	O
away	O
from	O
tumor	O
,	O
free	O
of	O
lesion	O
.	O

CPT	O
88309	O
,	O
88331	O
.	O

C	O
.	O

L10	O
intralobular	O
lymph	O
node	O
,	O
excision	O
biopsy	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
.	O

CPT	O
88305	O
.	O

D	O
.	O

L7	O
lymph	O
node	O
,	O
excision	O
biopsy	O
:	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
metastatic	O
carcinoma	O
.	O

CPT	O
88305	O
.	O

SUMMARY	O
OF	O
MALIGNANT	O
NEOPLASM	O
:	O
LUNG	O
.	O

SPECIMEN	O
:	O
lung	O
lobe	O
.	O

PROCEDURE	O
:	O
lobectomy	O
.	O

SPECIMEN	O
INTEGRITY	O
:	O
intact	O
.	O

SPECIMEN	O
LATERALITY	O
.	O
left	O
.	O

TUMOR	O
SITE	O
:	O
lower	O
lobe	O
,	O
superior	O
segment	O
.	O

TUMOR	O
SIZE	O
:	O
2	B
.	I
9	I
cm	I
.	O

TUMOR	O
FOCALITY	O
.	O

Unifocal	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
Poorly	O
differentiated	O
.	O

VISCERAL	O
PLEURA	O
INVASION	O
:	O
visceral	O
pleural	O
not	O
involved	O
.	O

MARGINS	O
:	O
Not	O
involved	O
;	O
1	O
.	O
5	O
cm	O
to	O
closest	O
.	O

(	O
bronchial	O
)	O
margin	O
.	O

TREATMENT	O
EFFECT	O
:	O
Not	O
applicable	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Present	O
.	O

LYMPH	O
NODES	O
:	O
Three	O
of	O
3	O
lymph	O
nodes	O
,	O
negative	O
for	O
.	O
metastasis	O
.	O

OTHER	O
FINDINGS	O
:	O
Tumor	O
-	O
associated	O
scar	O
.	O

PATH	O
TNM	O
(	O
AJCC	O
7th	O
ed	O
.	O
)	O
:	O
pT1b	O
pNO	O
Stage	O
IA	O
.	O

COMMENT	O
.	O

Final	O
diagnosis	O
for	O
specimen	O
B	O
corresponds	O
to	O
that	O
given	O
at	O
the	O
time	O
.	O
of	O
frozen	O
section	O
examination	O
.	O

Completed	O
Action	O
List	O
:	O
Type	O
:	O
Title	O
:	O

Focal	O
Papillary	O
Renal	O
Cell	O
Carcinoma	O
,	O
Type	O
I	O
.	O
Stage	O
:	O
pT1b	O
,	O
pNX	O
,	O
pMX	O
,	O
vo	O
,	O
LO	O
,	O
R1	O
.	O

Grade	O
:	O
GII	O
.	O

ICD	O
-	O
0	O
-	O
Code	O
:	O
8260	O
/	O
3	O
.	O

Diagnosis	O
:	O
1	O
.	O

Chronically	O
fibrosing	O
cholecystitis	O
,	O
with	O
reactive	O
hyperplasia	O
of	O
a	O
local	O
lymph	O
node	O
.	O

2	O
.	O

Tumor	O
-	O
free	O
fatty	O
tissue	O
.	O

3	O
.	O

Resected	O
colon	O
with	O
a	O
centrally	O
ulcerated	O
,	O
moderately	O
differentiated	O
.	O
adenocarcinoma	O
of	O
the	O
colorectal	O
type	O
,	O
located	O
1	O
.	O
5	O
cm	O
from	O
the	O
aboral	O
resection	O
.	O
margin	O
,	O
and	O
with	O
wide	O
infiltration	O
of	O
the	O
pericolic	O
fatty	O
tissue	O
as	O
well	O
as	O
with	O
four	O
.	O
local	O
lymph	O
node	O
metastases	O
.	O

Tumor	O
-	O
free	O
colon	O
resection	O
margins	O
.	O

Tumor	O
-	O
free	O
.	O
mesocolic	O
resection	O
margin	O
.	O

Also	O
diverticulosis	O
coli	O
.	O

Stage	O
of	O
tumor	O
:	O
pT3	O
pN2	O
(	O
4	O
/	O
35	O
)	O
pMX	O
;	O
G2	O
,	O
L1	O
,	O
V0	O
,	O
local	O
R0	O
.	O

Operative	O
Procedure	O
:	O
Nephrectomy	O
.	O

Pre	O
-	O
Operative	O
Diagnosis	O
:	O
Renal	O
mass	O
.	O

A	O
:	O
Left	O
kidney	O
.	O

B	O
:	O
Peri	O
-	O
aortic	O
lymph	O
node	O
.	O

Final	O
Pathologic	O
Diagnosis	O
:	O
A	O
.	O

Kidney	O
,	O
left	O
,	O
nephrectomy	O
:	O
Tumor	O
histologic	O
type	O
:	O
Papillary	O
renal	O
cell	O
carcinoma	O
,	O
type	O
1	O
.	O

(	O
Please	O
,	O
see	O
note	O
)	O
.	O

Sarcomatoid	O
features	O
(	O
%	O
)	O
:	O
0	O
%	O
.	O

Tumor	O
size	O
:	O
5	B
cm	I
(	O
greatest	O
dimension	O
)	O
.	O

Other	O
dimensions	O
:	O
3	B
X	I
2	I
cm	I
.	O

Macroscopic	O
extent	O
of	O
tumor	O
:	O
Tumor	O
limited	O
to	O
the	O
kidney	O
.	O

Focality	O
:	O
Unifocal	O
.	O

Fuhrman	O
grade	O
:	O
1	O
of	O
4	O
.	O

Microscopic	O
extent	O
of	O
tumor	O
:	O
Perinephric	O
fat	O
invasion	O
:	O
Renal	O
sinus	O
invasion	O
:	O
Renal	O
vein	O
involvement	O
:	O
Adrenal	O
gland	O
present	O
:	O
Cancer	O
at	O
resection	O
margin	O
:	O
Pathologic	O
findings	O
in	O
nonneoplastic	O
kidney	O
:	O
Patchy	O
chronic	O
inflammation	O
.	O

Hilar	O
lymph	O
nodes	O
present	O
:	O
Number	O
involved	O
/	O
number	O
present	O
:	O
0	O
/	O
1	O
.	O

Ancillary	O
Studies	O
:	O
Racemase	O
:	O
Positive	O
.	O

Carbonic	O
anhydrase	O
:	O
Positive	O
.	O

TFE3	O
:	O
Negative	O
.	O

Vimentin	O
:	O
Positive	O
.	O

SDHB	O
:	O
Negative	O
.	O

Cytokeratin	O
7	O
:	O
Positive	O
.	O

All	O
controls	O
stained	O
appropriately	O
.	O

Pathologic	O
stage	O
(	O
2010	O
)	O
.	O

pT1b	O
,	O
pNO	O
,	O
pMX	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
periaortic	O
,	O
resection	O
:	O
Fifteen	O
lymph	O
nodes	O
,	O
negative	O
for	O
malignancy	O
(	O
0	O
/	O
15	O
)	O
.	O

The	O
examination	O
of	O
this	O
case	O
material	O
and	O
the	O
preparation	O
of	O
this	O
report	O
were	O
.	O

Note	O
:	O
The	O
tumor	O
is	O
predominantly	O
papillary	O
in	O
architecture	O
with	O
cells	O
that	O
mainly	O
have	O
.	O

an	O
abundant	O
cytoplasm	O
that	O
ranges	O
from	O
completely	O
eosinophilic	O
to	O
clear	O
.	O

Although	O
,	O
the	O
morphologic	O
features	O
in	O
general	O
are	O
in	O
favor	O
of	O
papillary	O
renal	O
.	O
cell	O
carcinoma	O
type	O
I	O
,	O
the	O
cytological	O
features	O
of	O
"	O
clear	O
cells	O
"	O
are	O
concerning	O
.	O
for	O
clear	O
cell	O
papillary	O
renal	O
cell	O
carcinoma	O
.	O

Immunohistochemical	O
studies	O
.	O
showed	O
that	O
the	O
tumor	O
cells	O
are	O
positive	O
for	O
cytokeratin	O
7	O
,	O
racemase	O
,	O
carbonic	O
.	O
anhydrase	O
and	O
vimentin	O
and	O
are	O
negative	O
for	O
TFE3	O
and	O
SDHB	O
.	O

Controls	O
stained	O
.	O
appropriately	O
.	O

The	O
immunohistochemical	O
profile	O
and	O
morphologic	O
features	O
are	O
.	O
consistent	O
with	O
the	O
diagnosis	O
of	O
renal	O
papillary	O
carcinoma	O
type	O
I	O
.	O

Dr	O
.	O
has	O
reviewed	O
the	O
case	O
and	O
.	O
concurs	O
with	O
the	O
diagnosis	O
.	O

Gross	O
Description	O
:	O
Received	O
are	O
two	O
formalin	O
filled	O
containers	O
,	O
each	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
.	O

Part	O
A	O
.	O
Specimen	O
components	O
and	O
dimensions	O
:	O
The	O
specimen	O
is	O
the	O
product	O
of	O
a	O
left	O
.	O
nephrectomy	O
,	O
having	O
aggregate	O
dimensions	O
of	O
15	O
X	O
11	O
x	O
10	O
cm	O
and	O
consists	O
of	O
a	O
.	O
kidney	O
having	O
dimensions	O
of	O
10	O
x	O
7	O
X	O
5	O
cm	O
,	O
ureter	O
with	O
length	O
of	O
5	O
cm	O
.	O

Adrenal	O
.	O
gland	O
is	O
not	O
present	O
.	O

Size	O
,	O
appearance	O
,	O
and	O
location	O
of	O
tumor	O
:	O
5	O
x	O
3	O
x	O
2	O
cm	O
located	O
in	O
the	O
.	O

mid	O
/	O
superior	O
pole	O
,	O
well	O
encapsulated	O
,	O
inside	O
the	O
capsule	O
the	O
tumor	O
is	O
a	O
friable	O
.	O
tissue	O
,	O
yellow	O
tan	O
-	O
to	O
grey	O
tan	O
in	O
color	O
.	O

It	O
is	O
contained	O
within	O
the	O
kidney	O
.	O
parenchyma	O
boundaries	O
.	O

Renal	O
capsule	O
/	O
renal	O
sinus	O
:	O
The	O
renal	O
capsule	O
strips	O
with	O
ease	O
.	O

Renal	O
vein	O
:	O
The	O
renal	O
vein	O
is	O
free	O
of	O
tumor	O
.	O

Lymph	O
nodes	O
(	O
size	O
,	O
number	O
,	O
&	O
location	O
)	O
:	O
Perihilar	O
fibrofatty	O
tissue	O
weighs	O
.	O

100	O
grams	O
,	O
it	O
was	O
placed	O
in	O
a	O
fat	O
clearing	O
agent	O
for	O
30	O
minutes	O
.	O

Serial	O
.	O
sectioning	O
and	O
palpation	O
does	O
not	O
reveal	O
any	O
obvious	O
lymph	O
nodes	O
.	O

Portions	O
of	O
.	O
fibrous	O
fatty	O
tissue	O
with	O
probable	O
lymph	O
nodes	O
are	O
submitted	O
in	O
cassettes	O
A13	O
-	O
14	O
.	O
for	O
microscopic	O
analysis	O
.	O

Other	O
findings	O
:	O
Multiple	O
cortical	O
cysts	O
that	O
measure	O
from	O
0	O
.	O
5	O
cm	O
up	O
to	O
2	O
cm	O
in	O
.	O
greatest	O
dimension	O
.	O

Blocks	O
submitted	O
:	O
A1	O
.	O
ureter	O
and	O
vascular	O
margins	O
;	O
.	O

A2	O
-	O
4	O
.	O
tumor	O
to	O
renal	O
capsule	O
;	O
.	O

A5	O
-	O
6	O
.	O
tumor	O
to	O
renal	O
sinus	O
fat	O
;	O
.	O

A7	O
.	O
tumor	O
to	O
collecting	O
system	O
;	O
.	O

A8	O
tumor	O
;	O
.	O

A9	O
-	O
12	O
representative	O
sections	O
of	O
the	O
cysts	O
;	O
.	O

A13	O
-	O
14	O
Perihilar	O
fibrofatty	O
tissue	O
with	O
possible	O
whole	O
lymph	O
nodes	O
.	O

Part	O
B	O
is	O
additionally	O
labeled	O
"	O
periaortic	O
lymph	O
nodes	O
"	O
and	O
consists	O
of	O
multiple	O
.	O
portions	O
of	O
fibrofatty	O
tissue	O
that	O
measure	O
in	O
aggregate	O
3	O
X	O
3	O
X	O
0	O
.	O
8	O
cm	O
.	O

Sectioning	O
reveals	O
four	O
possible	O
lymph	O
nodes	O
that	O
range	O
from	O
0	O
.	O
5	O
cm	O
up	O
to	O
2	O
cm	O
.	O
in	O
greatest	O
dimension	O
.	O

Blocks	O
submitted	O
:	O
B1	O
-	O
2	O
multiple	O
whole	O
lymph	O
nodes	O
;	O
.	O

B3	O
.	O
one	O
lymph	O
node	O
bisected	O
;	O
.	O

B4	O
.	O
one	O
lymph	O
node	O
bisected	O
;	O
.	O

B5	O
.	O
one	O
lymph	O
node	O
bisected	O
.	O

Microscopic	O
Description	O
:	O
The	O
final	O
diagnosis	O
of	O
each	O
specimen	O
incorporates	O
the	O
microscopic	O
examination	O
.	O
findings	O
.	O

Gender	O
:	O
F	O
.	O

Requisition	O
.	O
case	O
OpenClinica	O
ID	O
Gross	O
.	O

Microscopic	O
.	O

Diagnosis	O
.	O

Comments	O
.	O

Description	O
.	O

Description	O
.	O

Details	O
.	O

Laterality	O
/	O
lo	O
.	O

Date	O
of	O
excision	O
.	O
cation	O
.	O

LUNG	O
TISSUE	O
CHECKLIST	O
.	O

Left	O
-	O
lower	O
.	O

Specimen	O
type	O
:	O
Lobectomy	O
.	O

Tumor	O
site	O
:	O
Lung	O
.	O

Tumor	O
size	O
:	O
2	B
X	I
3	I
X	I
2	I
.	I
5	I
cm	I
.	O

Histologic	O
type	O
:	O
Squamous	O
cell	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Poorly	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Other	O
tumor	O
nodules	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
.	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Sample	O
Type	O
TUMOUR	O
.	O

Sample	O
Preparation	O
.	O

Fresh	O
Frozen	O
.	O

Site	O
of	O
Primary	O
(	O
Event	O
)	O
.	O

Uterine	O
.	O

Site	O
of	O
Tissue	O
.	O
mass	O
on	O
posterior	O
wall	O
.	O

Year	O
of	O
Sample	O
Collection	O
.	O

Age	O
at	O
Sample	O
Collection	O
(	O
yrs	O
)	O
.	O

Sample	O
Comments	O
.	O

Days	O
to	O
Procedure	O
Date	O
.	O

0	O
.	O

Days	O
to	O
Diagnosis	O
.	O

22	O
.	O

Type	O
of	O
Procedure	O
.	O

Surgical	O
resection	O
.	O

Site	O
of	O
Primary	O
(	O
Histology	O
)	O
.	O

Uterus	O
.	O

Bilateral	O
Disease	O
.	O

Tumour	O
Size	O
(	O
cm	O
)	O
.	O

4	B
.	I
2999999999999998	I
.	O

Histology	O
.	O

Endometrioid	O
adenocarcinoma	O
,	O
NOS	O
.	O

Grade	O
/	O
Differentiation	O
.	O

III	O
.	O

Pathological	O
T	O
.	O

T1b	O
.	O

Pathological	O
N	O
.	O
Number	O
of	O
Nodes	O
Sampled	O
.	O

0	O
.	O

Number	O
of	O
Nodes	O
Positive	O
.	O

18	O
.	O

Clinical	O
M	O
.	O

M0	O
.	O

Histology	O
Comments	O
.	O

CONFIDENTIAL	O
.	O

Demographics	O
(	O
for	O
.	O
verification	O
purposes	O
)	O
.	O

Sex	O
:	O
M	O
.	O

Collected	O
Date	O
/	O
Time	O
.	O

Received	O
Date	O
/	O
Time	O
.	O

Specimen	O
Description	O
.	O

A	O
.	O

Liver	O
biopsy	O
at	O
.	O

B	O
.	O

Liver	O
biopsy	O
number	O
2	O
at	O
.	O

C	O
.	O

Liver	O
biopsy	O
number	O
3	O
at	O
.	O

D	O
.	O

Body	O
and	O
tail	O
of	O
pancreas	O
at	O
.	O

Clinical	O
Information	O
.	O

Pancreatitis	O
.	O

Possible	O
pancreatic	O
cancer	O
.	O

Diagnosis	O
.	O

A	O
.	O

Liver	O
,	O
Biopsy	O
:	O
Bile	O
duct	O
hamartoma	O
.	O

Negative	O
for	O
malignancy	O
.	O

B	O
.	O

Liver	O
,	O
Biopsy	O
#	O
2	O
:	O
Benign	O
liver	O
tissue	O
.	O

Negative	O
for	O
malignancy	O
.	O

C	O
.	O

Liver	O
,	O
Biopsy	O
#	O
3	O
:	O
Benign	O
liver	O
tissue	O
.	O

Negative	O
for	O
malignancy	O
.	O

D	O
.	O

Pancreas	O
,	O
Body	O
and	O
Tail	O
,	O
Distal	O
Pancreatectomy	O
:	O
Invasive	O
ductal	O
adenocarcinoma	O
,	O
moderately	O
differentiated	O
with	O
.	O
focal	O
foamy	O
gland	O
pattern	O
,	O
4	B
.	I
5	I
x	I
3	I
.	I
5	I
x	I
3	I
.	I
5	I
cm	I
.	O

Prominent	O
perineural	O
,	O
lymphatic	O
,	O
and	O
venous	O
invasion	O
present	O
.	O

Invasive	O
adenocarcinoma	O
involves	O
retroperitoneal	O
margin	O
and	O
.	O
pancreatic	O
body	O
margin	O
.	O

Thirteen	O
of	O
twenty	O
-	O
one	O
peripancreatic	O
lymph	O
nodes	O
involved	O
by	O
.	O
metastatic	O
adenocarcinoma	O
(	O
13	O
/	O
21	O
)	O
extranodal	O
extension	O
present	O
;	O
.	O
largest	O
tumor	O
deposit	O
1	B
.	I
2	I
cm	I
.	O

Please	O
see	O
comment	O
and	O
synontin	O
report	O
.	O

Verified	O
:	O
Synoptic	O
Report	O
.	O

SPECIMEN	O
:	O
Body	O
of	O
pancreas	O
.	O

Tail	O
of	O
pancreas	O
.	O

PROCEDURE	O
:	O
Partial	O
pancreatectomy	O
,	O
pancreatic	O
tail	O
.	O

TUMOR	O
SITE	O
:	O
Pancreatic	O
tail	O
.	O

TUMOR	O
SIZE	O
:	O
Greatest	O
dimension	O
:	O
4	B
.	I
5	I
.	I

cm	B
.	O

Additional	O
dimensions	O
:	O
3	B
.	I
5	I
x	I
3	I
.	I
5	I
.	I

cm	B
.	O

HISTOLOGIC	O
TYPE	O
:	O
Ductal	O
adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G2	O
:	O
Moderately	O
differentiated	O
.	O

MICROSCOPIC	O
TUMOR	O
EXTENSION	O
:	O
Tumor	O
invades	O
peripancreatic	O
soft	O
tissues	O
.	O

Tumor	O
invades	O
retroperitoneal	O
soft	O
tissue	O
.	O

Tumor	O
invades	O
other	O
adjacent	O
organs	O
or	O
structures	O
.	O
tumor	O
invades	O
wall	O
of	O
splenic	O
vein	O
.	O

MARGINS	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Proximal	O
pancreatic	O
margin	O
.	O

Invasive	O
carcinoma	O
involves	O
posterior	O
retroperitoneal	O
surface	O
of	O
pancreas	O
.	O

TREATMENT	O
EFFECT	O
(	O
applicable	O
to	O
carcinomas	O
treated	O
with	O
neoadjuvant	O
therapy	O
)	O
.	O

No	O
prior	O
treatment	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Present	O
.	O

PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT3	O
:	O
Tumor	O
extends	O
beyond	O
the	O
pancreas	O
but	O
without	O
involvement	O
of	O
the	O
celiac	O
axis	O
or	O
the	O
.	O
superior	O
mesenteric	O
artery	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pN1	O
:	O
Regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
21	O
.	O

Number	O
involved	O
:	O
13	O
.	O

DISTANT	O
METASTASIS	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Pancreatic	O
intraepithelial	O
neoplasia	O
(	O
highest	O
grade	O
:	O
PanIN	O
2	O
.	O

Chronic	O
pancreatitis	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
specimen	O
containers	O
A	O
to	O
D	O
.	O

A11	O
requisitions	O
and	O
specimen	O
containers	O
are	O
.	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

The	O
cassettes	O
and	O
identifiers	O
are	O
.	O
labelled	O
with	O
the	O
Surgical	O
Number	O
.	O

A	O
.	O

The	O
specimen	O
consists	O
of	O
liver	O
tissue	O
,	O
measuring	O
0	O
.	O
3	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
.	O
cassette	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
subsequently	O
placed	O
into	O
formalin	O
.	O

The	O
container	O
.	O

is	O
designated	O
"	O
A	O
:	O
Liver	O
biopsy	O
at	O
.	O

The	O
previously	O
frozen	O
tissue	O
is	O
entirely	O
.	O
resubmitted	O
for	O
permanent	O
sections	O
in	O
cassette	O
AQS1	O
.	O

B	O
.	O

The	O
specimen	O
consists	O
of	O
liver	O
tissue	O
,	O
measuring	O
0	O
.	O
2	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
.	O
cassette	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
subsequently	O
placed	O
into	O
formalin	O
.	O

The	O
container	O
.	O

is	O
designated	O
"	O
B	O
:	O
Liver	O
biopsy	O
number	O
2	O
at	O
.	O

The	O
previously	O
frozen	O
tissue	O
is	O
.	O
entirely	O
resubmitted	O
for	O
permanent	O
sections	O
in	O
cassette	O
BQS1	O
.	O

C	O
.	O

The	O
specimen	O
consists	O
of	O
liver	O
tissue	O
,	O
measuring	O
0	O
.	O
8	O
cm	O
.	O

Submitted	O
in	O
toto	O
in	O
one	O
.	O
cassette	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
subsequently	O
placed	O
into	O
formalin	O
.	O

The	O
container	O
.	O

is	O
designated	O
"	O
C	O
:	O
Liver	O
biopsy	O
number	O
3	O
at	O
.	O

The	O
previously	O
frozen	O
tissue	O
is	O
.	O
entirely	O
submitted	O
for	O
permanent	O
sections	O
in	O
cassette	O
CQS1	O
.	O

D	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
subsequently	O
placed	O
into	O
formalin	O
.	O

The	O
.	O
container	O
is	O
designated	O
"	O
D	O
:	O
Body	O
and	O
tail	O
of	O
pancreas	O
at	O
.	O
and	O
contains	O
a	O
12	O
.	O
0	O
x	O
6	O
.	O
0	O
.	O

x	O
3	O
.	O
5	O
cm	O
portion	O
of	O
pancreatic	O
body	O
and	O
tail	O
.	O

The	O
pancreatic	O
body	O
margin	O
is	O
inked	O
blue	O
,	O
.	O
the	O
distal	O
margin	O
is	O
inked	O
orange	O
,	O
and	O
the	O
radial	O
margin	O
is	O
inked	O
black	O
.	O

The	O
specimen	O
is	O
.	O
bisected	O
longitudinally	O
and	O
is	O
fixed	O
in	O
formalin	O
overnight	O
.	O

Sectioning	O
reveals	O
an	O
ill	O
-	O
.	O
defined	O
,	O
firm	O
,	O
yellow	O
-	O
tan	O
,	O
4	O
.	O
5	O
x	O
3	O
.	O
5	O
x	O
3	O
.	O
5	O
cm	O
mass	O
with	O
a	O
few	O
punctate	O
hemorrhagic	O
areas	O
.	O

The	O
mass	O
is	O
located	O
in	O
the	O
anterior	O
half	O
of	O
the	O
specimen	O
and	O
grossly	O
extends	O
to	O
the	O
.	O
anterior	O
serosa	O
,	O
to	O
within	O
1	O
.	O
0	O
cm	O
of	O
the	O
blue	O
-	O
inked	O
pancreatic	O
body	O
resection	O
margin	O
,	O
and	O
.	O
very	O
close	O
(	O
1	O
-	O
2	O
mm	O
)	O
to	O
the	O
posterior	O
/	O
retroperitoneal	O
margin	O
.	O

The	O
rim	O
of	O
pancreatic	O
.	O
tissue	O
proximal	O
to	O
the	O
mass	O
is	O
soft	O
and	O
tan	O
-	O
colored	O
with	O
a	O
normal	O
lobular	O
configuration	O
.	O

The	O
pancreatic	O
tail	O
tissue	O
distal	O
to	O
the	O
mass	O
(	O
3	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
)	O
is	O
attenuated	O
,	O
faintly	O
.	O
nodular	O
,	O
and	O
atrophic	O
-	O
appearing	O
.	O

The	O
pancreatic	O
duct	O
passes	O
through	O
the	O
central	O
.	O
posterior	O
aspect	O
of	O
the	O
mass	O
,	O
and	O
shows	O
no	O
obvious	O
dilation	O
,	O
stricture	O
,	O
or	O
intraductal	O
.	O
mass	O
.	O

Within	O
the	O
peripancreatic	O
fat	O
superior	O
,	O
inferior	O
and	O
posterior	O
to	O
the	O
mass	O
,	O
there	O
.	O
are	O
multiple	O
vell	O
-	O
circumscribed	O
ovoid	O
,	O
firm	O
,	O
white	O
nodules	O
,	O
consistent	O
with	O
lymph	O
nodes	O
,	O
.	O
many	O
of	O
which	O
appear	O
grossly	O
suspicious	O
for	O
metastatic	O
tumor	O
.	O

Representative	O
sections	O
.	O
are	O
submitted	O
as	O
follows	O
:	O
D1	O
.	O
representative	O
perpendicular	O
section	O
of	O
pancreatic	O
body	O
margin	O
closest	O
to	O
.	O
tumor	O
.	O

D2	O
/	O
3	O
.	O
remainder	O
of	O
pancreatic	O
body	O
margin	O
,	O
shaved	O
and	O
submitted	O
en	O
face	O
.	O

D4	O
.	O
single	O
grossly	O
suspicious	O
lymph	O
node	O
,	O
superior	O
to	O
pancreatic	O
mass	O
,	O
sectioned	O
.	O

D5	O
.	O
additional	O
superior	O
margin	O
with	O
possible	O
lymph	O
nodes	O
.	O

D6	O
.	O
single	O
grossly	O
suspicious	O
lymph	O
node	O
located	O
superior	O
to	O
mass	O
,	O
bisected	O
.	O

D7	O
to	O
9	O
.	O
additional	O
representative	O
sections	O
of	O
superior	O
portion	O
of	O
tumor	O
with	O
.	O
adjacent	O
grossly	O
.	O
positive	O
lymph	O
nodes	O
.	O

D10	O
to	O
12	O
.	O
representative	O
sections	O
of	O
tumor	O
with	O
retroperitoneal	O
margin	O
and	O
grossly	O
.	O
suspicious	O
.	O

retroperitoneal	O
lymph	O
nodes	O
.	O

D13	O
.	O
representative	O
section	O
of	O
atrophic	O
pancreatic	O
tail	O
near	O
retroperitoneum	O
.	O

D14	O
.	O
representative	O
portion	O
of	O
central	O
tumor	O
with	O
large	O
vessel	O
.	O

D15	O
/	O
16	O
.	O
tumor	O
with	O
inferior	O
margin	O
.	O

D17	O
.	O
representative	O
portion	O
of	O
atrophic	O
distal	O
pancreatic	O
tail	O
with	O
distal	O
margin	O
.	O

D18	O
.	O
distal	O
portion	O
of	O
tumor	O
with	O
adjacent	O
possible	O
lymph	O
node	O
.	O

D19	O
.	O
tumor	O
with	O
adjacent	O
anterior	O
serosa	O
.	O

D20	O
.	O
distal	O
peripancreatic	O
fat	O
with	O
three	O
possible	O
lymph	O
nodes	O
(	O
bisected	O
)	O
.	O

D21	O
.	O
two	O
additional	O
possible	O
lymph	O
nodes	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

A	O
.	O

Liver	O
Biopsy	O
:	O
No	O
evidence	O
of	O
carcinoma	O
.	O

B	O
.	O

Liver	O
Biopsy	O
Number	O
2	O
:	O
Negative	O
for	O
malignancy	O
.	O

C	O
.	O

Liver	O
Biopsy	O
Number	O
3	O
:	O
Negative	O
for	O
carcinoma	O
.	O

Pathologist	O
Comment	O
.	O

In	O
case	O
ancillary	O
studies	O
are	O
desired	O
,	O
tumor	O
block	O
information	O
is	O
listed	O
below	O
:	O
Best	O
tumor	O
block	O
:	O
D4	O
.	O

Best	O
normal	O
block	O
:	O
D17	O
.	O

Encounter	O
Number	O
.	O

Patient	O
Location	O
.	O

SLIDE	O
DISPOSITION	O
:	O
DIAGNOSIS	O
:	O
A	O
.	O

Uterus	O
,	O
left	O
and	O
right	O
fallopian	O
tubes	O
and	O
ovaries	O
,	O
hysterectomy	O
.	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
Malignant	O
mixed	O
Mullerian	O
.	O
tumor	O
with	O
eterologous	O
differentiation	O
(	O
60	O
%	O
glandular	O
,	O
40	O
%	O
stromal	O
.	O
differentiation	O
)	O
is	O
identified	O
forming	O
a	O
mass	O
,	O
7	B
.	I
5	I
x	I
7	I
.	I
0	I
x	I
2	I
.	I
0	I
cm	I
,	O
.	O
circumferentially	O
involving	O
the	O
uterine	O
cavity	O
.	O

The	O
tumor	O
invades	O
.	O

2	O
.	O
0	O
cm	O
into	O
the	O
myometrium	O
(	O
total	O
wall	O
thickness	O
2	O
.	O
4	O
cm	O
)	O
.	O

The	O
tumor	O
.	O
does	O
not	O
involve	O
the	O
endocervix	O
.	O

Lymphovascular	O
space	O
invasion	O
is	O
.	O
not	O
identified	O
.	O

The	O
margins	O
are	O
negative	O
for	O
tumor	O
.	O

Bilateral	O
.	O
fallopian	O
tubes	O
display	O
severe	O
epithelial	O
atypia	O
.	O

The	O
ovaries	O
are	O
.	O
unremarkable	O
.	O

Seen	O
in	O
consultation	O
with	O
Dr	O
.	O
B	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
19	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

C	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
15	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

D	O
.	O

Lymph	O
nodes	O
,	O
left	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
14	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

E	O
.	O

Lymph	O
nodes	O
,	O
right	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
2	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O
with	O
available	O
surgical	O
material	O
[	O
AJCC	O
pT1bNO	O
]	O
(	O
7th	O
edition	O
,	O
.	O

AMENDMENTS	O
:	O
(	O
Previous	O
signout	O
Date	O
:	O
Revision	O
Description	O
:	O
Need	O
to	O
add	O
frozen	O
section	O
diagnosis	O
to	O
part	O
.	O

A	O
.	O
original	O
Frozen	O
Sect	O
-	O
Intraop	O
.	O

A	O
.	O

Uterus	O
,	O
left	O
and	O
right	O
fallopian	O
tubes	O
and	O
ovaries	O
,	O
hysterectomy	O
.	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
Malignant	O
mixed	O
Mullerian	O
.	O
tumor	O
with	O
heterologous	O
differentiation	O
invading	O
into	O
the	O
outer	O
half	O
.	O
of	O
myometrium	O
and	O
confined	O
to	O
the	O
uterus	O
.	O

Endocervix	O
shows	O
focal	O
.	O
atypical	O
glands	O
suspicious	O
for	O
adenocarcinoma	O
in	O
situ	O
.	O

HOLDOVER	O
to	O
.	O
evaluate	O
on	O
permanent	O
sections	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
19	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

c	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
15	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
interpretation	O
performed	O
by	O
:	O
D	O
.	O

Lymph	O
nodes	O
,	O
left	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
14	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
.	O
interpretation	O
performed	O
by	O
:	O
E	O
.	O

Lymph	O
nodes	O
,	O
right	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
2	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
.	O
interpretation	O
performed	O
by	O
:	O
Frozen	O
section	O
histologic	O
interpretation	O
performed	O
by	O
:	O
PRELIMINARY	O
FROZEN	O
SECTION	O
CONSULTATION	O
:	O
A	O
.	O

Uterus	O
,	O
left	O
and	O
right	O
fallopian	O
tubes	O
and	O
ovaries	O
,	O
hysterectomy	O
.	O
and	O
bilateral	O
salpingo	O
-	O
oophorectomy	O
:	O
Malignant	O
mixed	O
Mullerian	O
.	O
tumor	O
with	O
heterologous	O
differentiation	O
invading	O
into	O
the	O
outer	O
half	O
.	O
of	O
myometrium	O
and	O
confined	O
to	O
the	O
uterus	O
.	O

Endocervix	O
shows	O
focal	O
.	O
atypical	O
glands	O
suspicious	O
for	O
adenocarcinoma	O
in	O
situ	O
.	O

The	O
.	O
margins	O
are	O
negative	O
for	O
tumor	O
.	O

Bilateral	O
fallopian	O
tubes	O
and	O
.	O
ovaries	O
are	O
unremarkable	O
.	O

HOLDOVER	O
to	O
evaluate	O
on	O
permanent	O
.	O
sections	O
.	O

See	O
comment	O
.	O

B	O
.	O

Lymph	O
nodes	O
,	O
right	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
19	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

c	O
.	O

Lymph	O
nodes	O
,	O
left	O
pelvic	O
,	O
excision	O
:	O
Multiple	O
(	O
15	O
)	O
lymph	O
nodes	O
.	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
interpretation	O
performed	O
by	O
:	O
D	O
.	O

Lymph	O
nodes	O
,	O
left	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
14	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
.	O
interpretation	O
performed	O
by	O
:	O
E	O
.	O

Lymph	O
nodes	O
,	O
right	O
para	O
-	O
aortic	O
,	O
excision	O
:	O
Multiple	O
(	O
2	O
)	O
lymph	O
.	O
nodes	O
are	O
negative	O
for	O
tumor	O
.	O

Frozen	O
section	O
histologic	O
.	O
interpretation	O
performed	O
by	O
:	O
Frozen	O
section	O
histologic	O
interpretation	O
performed	O
by	O
:	O
Comment	O
:	O
Permanent	O
sections	O
revealed	O
severe	O
atypia	O
in	O
.	O
fallopian	O
tubes	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

Received	O
fresh	O
labeled	O
"	O
uterus	O
,	O
left	O
and	O
right	O
fallopian	O
tube	O
.	O
and	O
ovary	O
"	O
is	O
a	O
195	O
.	O
0	O
gram	O
disrupted	O
uterus	O
with	O
attached	O
bilateral	O
.	O
tubes	O
and	O
ovaries	O
.	O

The	O
cervix	O
is	O
nearly	O
detached	O
,	O
4	O
.	O
5	O
cm	O
from	O
the	O
.	O
ectocervical	O
margin	O
.	O

Multiple	O
portions	O
of	O
a	O
polypoid	O
exophytic	O
mass	O
.	O
measuring	O
6	O
.	O
5	O
x	O
6	O
.	O
4	O
x	O
5	O
.	O
0	O
cm	O
in	O
aggregate	O
are	O
present	O
,	O
separately	O
.	O

There	O
is	O
a	O
7	O
.	O
5	O
x	O
7	O
.	O
0	O
x	O
2	O
.	O
0	O
cm	O
exophytic	O
/	O
polypoid	O
,	O
friable	O
mass	O
.	O
circumferentially	O
involving	O
the	O
endometrial	O
cavity	O
,	O
grossly	O
invading	O
.	O

2	O
.	O
0	O
cm	O
.	O

The	O
myometrial	O
thickness	O
is	O
2	O
.	O
4	O
cm	O
.	O

There	O
are	O
no	O
.	O
leiomyomas	O
.	O

There	O
is	O
a	O
2	O
.	O
1	O
x	O
1	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
right	O
ovary	O
with	O
a	O
.	O
smooth	O
outer	O
surface	O
and	O
a	O
cystic	O
cut	O
surface	O
with	O
a	O
6	O
.	O
9	O
x	O
0	O
.	O
4	O
cm	O
.	O
right	O
fallopian	O
tube	O
which	O
is	O
unremarkable	O
.	O

There	O
is	O
a	O
1	O
.	O
9	O
x	O
1	O
.	O
7	O
x	O
.	O

1	O
.	O
3	O
cm	O
left	O
ovary	O
with	O
a	O
smooth	O
surface	O
and	O
a	O
solid	O
cut	O
surface	O
with	O
.	O

a	O
6	O
.	O
8	O
x	O
0	O
.	O
4	O
cm	O
left	O
fallopian	O
tube	O
which	O
is	O
unremarkable	O
.	O

On	O
cut	O
.	O
surface	O
,	O
the	O
left	O
ovary	O
contains	O
a	O
0	O
.	O
7	O
x	O
0	O
.	O
7	O
x	O
0	O
.	O
6	O
cm	O
white	O
yellow	O
.	O
solid	O
nodule	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

B	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
4	O
.	O
9	O
x	O
4	O
.	O
8	O
.	O

x	O
1	O
.	O
4	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

Lymph	O
nodes	O
.	O
submitted	O
.	O

c	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
pelvic	O
lymph	O
nodes	O
"	O
is	O
a	O
4	O
.	O
4	O
x	O
3	O
.	O
3	O
.	O

X	O
1	O
.	O
5	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

Lymph	O
nodes	O
all	O
.	O
submitted	O
.	O

D	O
.	O

Received	O
fresh	O
labeled	O
"	O
left	O
para	O
-	O
aortic	O
lymph	O
nodes	O
"	O
is	O
a	O
3	O
.	O
2	O
x	O
.	O

2	O
.	O
2	O
x	O
1	O
.	O
4	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

Lymph	O
nodes	O
.	O
submitted	O
.	O

E	O
.	O

Received	O
fresh	O
labeled	O
"	O
right	O
para	O
-	O
aortic	O
lymph	O
nodes	O
"	O
is	O
a	O
1	O
.	O
9	O
.	O

x	O
.	O

0	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
aggregate	O
of	O
adipose	O
and	O
lymphatic	O
tissue	O
.	O

Lymph	O
.	O
nodes	O
submitted	O
.	O

OC	O
ID	O
:	O
Gross	O
Description	O
:	O
Lump	O
with	O
the	O
tumour	O
of	O
1	B
.	I
4	I
x	I
1	I
.	I
2	I
cm	I
in	O
size	O
;	O
fatty	O
tissue	O
lymph	O
nodes	O
demonstrate	O
lipomatosis	O
.	O

Microscopic	O
Description	O
:	O
Infiltrating	O
duct	O
carcinoma	O
;	O
G2	O
.	O

Ten	O
dissected	O
lymph	O
nodes	O
demonstrate	O
hyalinosis	O
,	O
sinus	O
histeocytosis	O
,	O
lipomatosis	O
.	O

Diagnosis	O
Details	O
:	O
Tumor	O
Features	O
:	O
Unknown	O
,	O
Tumor	O
Extent	O
:	O
T1	O
tumor	O
size	O
2	B
cm	I
or	O
less	O
,	O
Venous	O
Invasion	O
:	O
Absent	O
,	O
Margins	O
:	O
Absent	O
,	O
Treatment	O
.	O

Effect	O
:	O
Comments	O
:	O
BREAST	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Lumpectomy	O
.	O

Specimen	O
size	O
:	O
Not	O
specified	O
.	O

Tumor	O
site	O
:	O
Upper	O
outer	O
quadrant	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
2x0x1	I
.	I
4	I
cm	I
.	O

Grossly	O
evident	O
lesion	O
:	O
Yes	O
.	O

Histologic	O
type	O
:	O
Infiltrating	O
ductal	O
carcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Not	O
specified	O
.	O

Lymph	O
nodes	O
:	O
0	O
/	O
10	O
positive	O
for	O
metastasis	O
(	O
Axillary	O
0	O
/	O
10	O
)	O
.	O

Extracapsular	O
invasion	O
of	O
the	O
lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Nottingham	O
Histologic	O
Score	O
.	O

Tubule	O
formation	O
:	O
Not	O
specified	O
.	O

Nuclear	O
pleomorphism	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
25x	O
)	O
:	O
Not	O
specified	O
.	O

Mitotic	O
count	O
(	O
40x	O
)	O
:	O
Not	O
specified	O
.	O

Total	O
Nottingham	O
Score	O
:	O
Score	O
cannot	O
be	O
determined	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Laterality	O
:	O
Right	O
,	O
upper	O
outer	O
quadrant	O
.	O

Clinical	O
Information	O
.	O

Obstruction	O
of	O
bile	O
duct	O
.	O

Acute	O
pancreatitis	O
.	O

Diagnosis	O
.	O

A	O
.	O

LIVER	O
CORE	O
BIOPSY	O
:	O
-	O
Liver	O
tissue	O
with	O
features	O
consistent	O
with	O
bile	O
outflow	O
obstruction	O
.	O

-	O
No	O
evidence	O
of	O
malignancy	O
.	O

B	O
.	O

LIVER	O
,	O
WEDGE	O
BIOPSY	O
:	O
-	O
Hyalinized	O
nodule	O
and	O
features	O
of	O
bile	O
outflow	O
obstruction	O
.	O

-	O
No	O
evidence	O
of	O
malignancy	O
.	O

C	O
.	O

COMMON	O
HEPATIC	O
ARTERY	O
LYMPH	O
NODE	O
,	O
BIOPSY	O
:	O
-	O
Three	O
lymph	O
nodes	O
with	O
no	O
evidence	O
of	O
malignancy	O
(	O
0	O
/	O
3	O
)	O
.	O

D	O
.	O

PARTIAL	O
PANCREATICODUODENECTOMY	O
:	O
-	O
Invasive	O
moderately	O
to	O
poorly	O
differentiated	O
ductal	O
adenocarcinoma	O
,	O
size	O
:	O
2	B
.	I
8	I
cm	I
in	O
maximum	O
.	O
diameter	O
,	O
invading	O
into	O
peripancreatic	O
tissue	O
and	O
wall	O
of	O
small	O
bowel	O
,	O
please	O
see	O
staging	O
summary	O
.	O

-	O
Seven	O
of	O
twenty	O
-	O
two	O
lymph	O
nodes	O
positive	O
for	O
metastatic	O
carcinoma	O
(	O
7	O
/	O
22	O
)	O
.	O

-	O
Perineural	O
invasion	O
identified	O
.	O

-	O
Common	O
bile	O
duct	O
,	O
pancreatic	O
duct	O
margin	O
and	O
SMA	O
margin	O
negative	O
for	O
malignancy	O
.	O

-	O
Proximal	O
duodenal	O
margin	O
positive	O
for	O
subserosal	O
ductal	O
adenocarcinoma	O
,	O
distal	O
duodenal	O
margin	O
.	O
negative	O
.	O

E	O
.	O

LYMPH	O
NODE	O
FROM	O
AORTOCAVAL	O
GROOVE	O
,	O
BIOPSY	O
:	O
-	O
Four	O
lymph	O
nodes	O
with	O
no	O
evidence	O
of	O
malignancy	O
(	O
0	O
/	O
5	O
)	O
.	O

Pathology	O
Synoptic	O
.	O

Specimen	O
type	O
:	O
Partial	O
pancreaticoduodenectomy	O
.	O

Tumor	O
location	O
:	O
Head	O
of	O
pancreas	O
.	O

Histologic	O
type	O
:	O
Ductal	O
adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
G2	O
-	O
3	O
.	O

Tumor	O
size	O
and	O
invasion	O
of	O
:	O
Tumor	O
extends	O
beyond	O
the	O
pancreas	O
,	O
but	O
without	O
involvement	O
of	O
.	O
celiac	O
axis	O
or	O
SMA	O
:	O
Yes	O
.	O

Tumor	O
involves	O
celiac	O
axis	O
or	O
SMA	O
:	O
No	O
.	O

Lymphatic	O
invasion	O
:	O
Identified	O
.	O

Large	O
vessel	O
invasion	O
:	O
Not	O
identified	O
.	O

Margins	O
:	O
Common	O
bile	O
duct	O
:	O
Negative	O
.	O

Proximal	O
duodenal	O
:	O
Positive	O
.	O

Distal	O
duodenal	O
margin	O
:	O
Negative	O
.	O

Proximal	O
or	O
distal	O
pancreatic	O
margin	O
:	O
Negative	O
.	O

Peripancreatic	O
soft	O
tissue	O
margin	O
(	O
including	O
retroperitoneal	O
and	O
posterior	O
.	O
pancreatic	O
margin	O
)	O
:	O
Negative	O
.	O

Total	O
regional	O
lymph	O
nodes	O
:	O
30	O
Number	O
positive	O
:	O
7	O
.	O

AJCC	O
Pathologic	O
Stage	O
:	O
pT3	O
N1	O
(	O
AJCC	O
7th	O
edition	O
,	O
2010	O
)	O
.	O

Dictated	O
and	O
authenticated	O
by	O
:	O
Performing	O
Location	O
:	O
Gross	O
Description	O
.	O

A	O
.	O

CORE	O
LIVER	O
BIOPSY	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
name	O
.	O

Description	O
:	O
The	O
specimen	O
consists	O
of	O
two	O
cylinders	O
of	O
tan	O
-	O
brown	O
tissue	O
having	O
lengths	O
of	O
0	O
.	O
7	O
and	O
1	O
.	O
2	O
.	O

cm	O
and	O
diameters	O
of	O
less	O
than	O
0	O
.	O
1	O
cm	O
.	O

The	O
specimen	O
is	O
entirely	O
embedded	O
for	O
a	O
frozen	O
section	O
.	O
diagnosis	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
PERFORMED	O
AT	O
.	O

No	O
evidence	O
.	O
of	O
malignancy	O
.	O

SECTIONS	O
:	O
A1	O
.	O

Frozen	O
section	O
control	O
.	O

B	O
.	O

WEDGE	O
LIVER	O
BIOPSY	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
name	O
.	O

Description	O
:	O
The	O
specimen	O
consists	O
of	O
three	O
pieces	O
of	O
tan	O
-	O
brown	O
tissue	O
ranging	O
from	O
0	O
.	O
5	O
-	O
1	O
.	O
0	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
each	O
of	O
which	O
reveals	O
a	O
white	O
-	O
tan	O
nodule	O
measuring	O
up	O
to	O
0	O
.	O
1	O
cm	O
in	O
greatest	O
.	O
specimen	O
.	O

The	O
specimen	O
is	O
entirely	O
embedded	O
for	O
a	O
frozen	O
section	O
diagnosis	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
PERFORMED	O
AT	O
.	O

No	O
evidence	O
.	O
of	O
malignancy	O
.	O

SECTIONS	O
:	O
B1	O
.	O

Frozen	O
section	O
control	O
.	O

C	O
.	O

COMMON	O
HEPATIC	O
ARTERY	O
LYMPH	O
NODE	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
name	O
.	O

Description	O
:	O
The	O
specimen	O
consists	O
of	O
an	O
irregular	O
piece	O
of	O
yellow	O
-	O
brown	O
tissue	O
measuring	O
3	O
.	O
1	O
cm	O
in	O
.	O
greatest	O
dimension	O
,	O
from	O
which	O
are	O
retrieved	O
three	O
lymph	O
nodes	O
which	O
are	O
submitted	O
in	O
their	O
entirety	O
.	O

SECTIONS	O
:	O
C1	O
.	O

One	O
longitudinally	O
bisected	O
lymph	O
node	O
.	O

C2	O
.	O

One	O
intact	O
lymph	O
node	O
and	O
one	O
inked	O
and	O
longitudinally	O
bisected	O
lymph	O
node	O
.	O

D	O
.	O

PRODUCT	O
OF	O
PARTIAL	O
PANCREATICODUODENECTOMY	O
:	O
Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
name	O
.	O

Specimen	O
received	O
:	O
Product	O
of	O
a	O
partial	O
pancreaticoduodenectomy	O
.	O

Orientation	O
given	O
:	O
Two	O
medium	O
length	O
sutures	O
,	O
one	O
long	O
suture	O
and	O
two	O
long	O
sutures	O
identify	O
the	O
bile	O
.	O
duct	O
,	O
pancreatic	O
neck	O
and	O
SMA	O
margin	O
respectively	O
,	O
per	O
the	O
intraoperative	O
consultation	O
form	O
.	O

Integrity	O
:	O
The	O
pancreatic	O
component	O
is	O
intact	O
;	O
the	O
duodenum	O
is	O
unopened	O
.	O

Size	O
of	O
pancreas	O
:	O
6	O
.	O
5	O
X	O
6	O
.	O
0	O
x	O
3	O
.	O
5	O
cm	O
.	O

Length	O
of	O
duodenum	O
:	O
19	O
.	O
0	O
cm	O
.	O

Ducts	O
:	O
Probe	O
patency	O
cannot	O
be	O
demonstrated	O
between	O
the	O
common	O
bile	O
duct	O
and	O
the	O
ampulla	O
.	O

Ampulla	O
:	O
The	O
ampulla	O
is	O
easily	O
probed	O
from	O
the	O
pancreatic	O
duct	O
.	O

Inking	O
scheme	O
:	O
The	O
anterior	O
and	O
posterior	O
surfaces	O
of	O
the	O
pancreas	O
are	O
inked	O
blue	O
and	O
black	O
.	O
respectively	O
.	O

The	O
margins	O
of	O
the	O
common	O
bile	O
duct	O
and	O
the	O
pancreas	O
are	O
inked	O
purple	O
and	O
green	O
.	O
respectively	O
,	O
after	O
the	O
true	O
pancreatic	O
margin	O
is	O
embedded	O
for	O
a	O
frozen	O
section	O
diagnosis	O
.	O

The	O
concavity	O
.	O
created	O
by	O
the	O
portal	O
vein	O
is	O
inked	O
yellow	O
and	O
the	O
SMA	O
margin	O
is	O
inked	O
orange	O
.	O

Tumor	O
site	O
:	O
Within	O
the	O
head	O
of	O
the	O
pancreas	O
.	O

Tumor	O
size	O
:	O
Tumor	O
is	O
estimated	O
to	O
measure	O
2	B
.	I
8	I
cm	I
in	O
greatest	O
dimension	O
.	O

Tumor	O
description	O
:	O
White	O
-	O
tan	O
,	O
waxy	O
,	O
poorly	O
circumscribed	O
.	O

Invasion	O
of	O
:	O
The	O
tumor	O
surrounds	O
the	O
common	O
bile	O
duct	O
,	O
compressing	O
it	O
to	O
a	O
diameter	O
of	O
less	O
than	O
0	O
.	O
1	O
.	O

cm	O
,	O
having	O
a	O
diameter	O
of	O
1	O
.	O
7	O
cm	O
at	O
its	O
margin	O
of	O
resection	O
.	O

Distance	O
from	O
margins	O
:	O
The	O
tumor	O
appears	O
to	O
most	O
closely	O
approximate	O
the	O
pancreatic	O
margin	O
of	O
.	O
resection	O
by	O
0	O
.	O
5	O
cm	O
,	O
the	O
bile	O
duct	O
margin	O
by	O
3	O
.	O
0	O
cm	O
,	O
the	O
anterior	O
blue	O
ink	O
aspect	O
of	O
the	O
pancreas	O
by	O
.	O
apparently	O
less	O
than	O
0	O
.	O
1	O
cm	O
,	O
the	O
posterior	O
pancreas	O
by	O
1	O
.	O
0	O
cm	O
,	O
the	O
concavity	O
created	O
by	O
the	O
portal	O
vein	O
.	O
by	O
0	O
.	O
5	O
cm	O
and	O
the	O
SMA	O
margin	O
by	O
1	O
.	O
0	O
cm	O
.	O

Remaining	O
specimen	O
:	O
The	O
small	O
intestinal	O
component	O
has	O
stapled	O
margins	O
of	O
resection	O
,	O
scant	O
serosal	O
.	O
adhesions	O
,	O
an	O
average	O
wall	O
thickness	O
of	O
0	O
.	O
3	O
cm	O
and	O
an	O
unremarkable	O
mucosa	O
.	O

Peripheral	O
to	O
the	O
tumor	O
.	O
the	O
pancreas	O
reveals	O
unremarkable	O
cut	O
surfaces	O
,	O
excepting	O
for	O
a	O
1	O
.	O
1	O
cm	O
smooth	O
-	O
walled	O
cyst	O
.	O

Lymph	O
nodes	O
:	O
The	O
lymph	O
nodes	O
retrieved	O
from	O
the	O
specimen	O
are	O
submitted	O
in	O
their	O
entirety	O
.	O

Representative	O
sections	O
are	O
submitted	O
with	O
the	O
pancreatic	O
component	O
being	O
submitted	O
proceeding	O
from	O
.	O
the	O
margin	O
towards	O
head	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
PERFORMED	O
AT	O
.	O

Indicated	O
.	O
margins	O
:	O
All	O
negative	O
for	O
carcinoma	O
.	O

SECTIONS	O
:	O
D1	O
.	O

Frozen	O
section	O
control	O
of	O
common	O
bile	O
duct	O
margin	O
.	O

D2	O
.	O

Frozen	O
section	O
control	O
of	O
pancreatic	O
margin	O
.	O

D3	O
.	O

Frozen	O
section	O
control	O
of	O
SMA	O
margin	O
.	O

D4	O
-	O
5	O
.	O

En	O
face	O
proximal	O
and	O
distal	O
duodenal	O
margins	O
,	O
respectively	O
.	O

D6	O
-	O
7	O
.	O

Longitudinally	O
bisected	O
ampulla	O
.	O

D8	O
-	O
9	O
.	O

Transverse	O
of	O
common	O
bile	O
duct	O
proceeding	O
from	O
margin	O
towards	O
head	O
with	O
adjacent	O
pancreatic	O
.	O
tissue	O
(	O
green	O
ink	O
does	O
not	O
represent	O
a	O
true	O
surgical	O
margin	O
)	O
.	O

D10	O
.	O

Approximation	O
of	O
tumor	O
to	O
blue	O
inked	O
anterior	O
pancreatic	O
surface	O
,	O
duodenal	O
wall	O
and	O
green	O
inked	O
.	O
cut	O
surface	O
of	O
pancreas	O
.	O

D11	O
.	O

Approximation	O
of	O
tumor	O
to	O
concavity	O
created	O
by	O
portal	O
vein	O
including	O
pancreatic	O
cyst	O
and	O
.	O
beginning	O
of	O
stricture	O
of	O
common	O
bile	O
duct	O
.	O

D12	O
.	O

Pancreatic	O
cyst	O
,	O
SMA	O
margin	O
and	O
the	O
posterior	O
surface	O
of	O
pancreas	O
.	O

D13	O
.	O

Compressed	O
bile	O
duct	O
and	O
posterior	O
surface	O
of	O
pancreas	O
.	O

D14	O
.	O

Tumor	O
and	O
anterior	O
surface	O
of	O
pancreas	O
.	O

D15	O
.	O

Pancreas	O
,	O
SMA	O
margin	O
,	O
posterior	O
surface	O
and	O
one	O
bisected	O
lymph	O
node	O
.	O

D16	O
.	O

Pancreatic	O
tissue	O
and	O
adjacent	O
duodenal	O
wall	O
,	O
posterior	O
surface	O
of	O
pancreas	O
and	O
compressed	O
.	O
common	O
bile	O
duct	O
.	O

D17	O
.	O

Tumor	O
,	O
anterior	O
surface	O
of	O
pancreas	O
and	O
pancreatic	O
duct	O
.	O

D18	O
.	O

Two	O
inked	O
and	O
longitudinally	O
bisected	O
lymph	O
nodes	O
retrieved	O
from	O
anterior	O
surface	O
of	O
pancreas	O
.	O

D19	O
-	O
20	O
.	O

Eight	O
intact	O
lymph	O
nodes	O
retrieved	O
from	O
inferior	O
aspect	O
of	O
pancreas	O
with	O
four	O
in	O
each	O
cassette	O
.	O

D21	O
.	O

Three	O
intact	O
lymph	O
nodes	O
retrieved	O
from	O
inferior	O
aspect	O
of	O
pancreas	O
.	O

D22	O
.	O

Two	O
longitudinally	O
bisected	O
lymph	O
nodes	O
retrieved	O
from	O
inferior	O
pancreas	O
with	O
one	O
inked	O
orange	O
.	O

D23	O
.	O

One	O
trisected	O
lymph	O
node	O
retrieved	O
from	O
inferior	O
aspect	O
of	O
pancreas	O
.	O

D24	O
-	O
26	O
.	O

One	O
sectioned	O
lymph	O
node	O
retrieved	O
from	O
anterior	O
pancreas	O
adjacent	O
to	O
common	O
bile	O
duct	O
.	O

E	O
.	O

LYMPH	O
NODE	O
FROM	O
AORTOCAVAL	O
GROOVE	O
.	O

Received	O
in	O
formalin	O
labeled	O
with	O
the	O
patient	O
name	O
.	O

Description	O
:	O
The	O
specimen	O
consists	O
of	O
an	O
ovoid	O
piece	O
of	O
tan	O
tissue	O
having	O
a	O
diameter	O
of	O
2	O
.	O
5	O
cm	O
from	O
.	O
which	O
are	O
retrieved	O
multiple	O
suspected	O
lymph	O
nodes	O
which	O
are	O
submitted	O
in	O
their	O
entirety	O
.	O

SECTIONS	O
:	O
E1	O
.	O

Four	O
intact	O
suspected	O
lymph	O
nodes	O
.	O

E2	O
-	O
3	O
.	O

One	O
longitudinally	O
trisected	O
lymph	O
node	O
.	O

Microscopic	O
Description	O
.	O

A	O
.	O

CORE	O
LIVER	O
BIOPSY	O
:	O
Microscopic	O
examination	O
is	O
performed	O
and	O
supports	O
the	O
diagnosis	O
above	O
.	O

B	O
.	O

WEDGE	O
LIVER	O
BIOPSY	O
:	O
Microscopic	O
examination	O
is	O
performed	O
and	O
supports	O
the	O
diagnosis	O
above	O
.	O

C	O
.	O

COMMON	O
HEPATIC	O
ARTERY	O
LYMPH	O
NODE	O
:	O
Microscopic	O
examination	O
is	O
performed	O
and	O
supports	O
the	O
.	O
diagnosis	O
above	O
.	O

D	O
.	O

PRODUCT	O
OF	O
PARTIAL	O
PANCREATICODUODENECTOMY	O
:	O
Microscopic	O
examination	O
is	O
performed	O
and	O
.	O
supports	O
the	O
diagnosis	O
above	O
.	O

E	O
.	O

LYMPH	O
NODE	O
FROM	O
AORTOCAVAL	O
GROOVE	O
:	O
Microscopic	O
examination	O
is	O
performed	O
and	O
supports	O
.	O
the	O
diagnosis	O
above	O
.	O

Surg	O
Path	O
Non	O
-	O
Chartable	O
Comment	O
.	O

Diagnosis	O
given	O
directly	O
to	O
surgeon	O
over	O
telephone	O
/	O
speaker	O
phone	O
.	O

(	O
parts	O
Aand	O
B	O
)	O
.	O

Tumor	O
QC	O
block	O
on	O
part	O
D	O
.	O
;	O
.	O

SPECIMENS	O
:	O
A	O
.	O

LEFT	O
KIDNEY	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

LEFT	O
KIDNEY	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
CLEAR	O
CELL	O
TYPE	O
,	O
FURHMAN	O
GRADE	O
4	O
,	O
MEASURING	O
6	B
.	I
4	I
-	I
CM	I
,	O
.	O

CONFINED	O
TO	O
RENAL	O
CAPSULE	O
.	O

-	O
URETERAL	O
MARGIN	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

-	O
ADRENAL	O
GLAND	O
,	O
NO	O
TUMOR	O
SEEN	O
.	O

-	O
ONE	O
HILAR	O
LYMPH	O
NODE	O
NEGATIVE	O
FOR	O
CARCINOMA	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
SEE	O
SYNOPTIC	O
REPORT	O
AND	O
SEE	O
NOTE	O
.	O

NOTE	O
:	O
The	O
tumor	O
has	O
solid	O
and	O
papillary	O
architecture	O
.	O

The	O
cells	O
show	O
clear	O
cytoplasm	O
.	O

Part	O
of	O
the	O
tumor	O
.	O
has	O
high	O
grade	O
nuclei	O
(	O
Furhman	O
grade	O
4	O
)	O
.	O

Theimmunoprofileiscompatible	O
with	O
clear	O
cell	O
carcinoma	O
.	O
phenotype	O
.	O

The	O
patient	O
has	O
tumor	O
metastases	O
to	O
the	O
lung	O
.	O

Dr	O
.	O
concurs	O
.	O

SUMMARY	O
OF	O
MMUNOHISTOCHEMISTRYISPECIAL	O
STAINS	O
.	O

Material	O
:	O
Block	O
A4	O
.	O

Population	O
:	O
Tumor	O
Cells	O
.	O

Stain	O
/	O
Marker	O
:	O
Result	O
:	O
Comment	O
:	O
CYTOKERATIN	O
7	O
.	O

Negative	O
.	O

PIN	O
-	O
4	O
HMWCK	O
(	O
CK5	O
&	O
CK14	O
)	O
Negative	O
.	O

PIN	O
-	O
4	O
P504S	O
Positive	O
.	O

PIN	O
-	O
4	O
p63	O
.	O

Negative	O
.	O

CD	O
10	O
.	O

Positive	O
.	O

The	O
interpretation	O
of	O
the	O
above	O
immunohistochemistry	O
stain	O
or	O
stains	O
is	O
guided	O
by	O
published	O
results	O
in	O
.	O
the	O
medical	O
literature	O
,	O
provided	O
package	O
information	O
from	O
the	O
manufacturer	O
and	O
by	O
internal	O
review	O
of	O
.	O
staining	O
performance	O
and	O
assay	O
validation	O
within	O
the	O
.	O

The	O
use	O
of	O
one	O
or	O
more	O
reagents	O
in	O
the	O
above	O
tests	O
is	O
regulated	O
as	O
an	O
analyte	O
.	O
specific	O
reagent	O
(	O
ASR	O
)	O
.	O

These	O
tests	O
were	O
developed	O
and	O
their	O
performance	O
characteristic	O
determined	O
.	O
by	O
the	O
.	O

They	O
have	O
not	O
been	O
.	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
.	O
clearance	O
or	O
approval	O
is	O
not	O
necessary	O
.	O

Special	O
stains	O
and	O
/	O
or	O
immunohistochemical	O
stains	O
were	O
performed	O
with	O
appropriately	O
stained	O
positive	O
.	O

and	O
/	O
or	O
negative	O
controls	O
.	O

SYNOPTIC	O
REPORT	O
-	O
KIDNEY	O
(	O
PARTIAL	O
OR	O
RADICAL	O
)	O
.	O

Specimen	O
Type	O
:	O
Radical	O
nephrectomy	O
.	O

With	O
adrenal	O
gland	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
Site	O
:	O
Not	O
specified	O
.	O

Focality	O
:	O
Unifocal	O
.	O

Tumor	O
Size	O
(	O
largest	O
tumor	O
if	O
multiple	O
)	O
:	O
Greatest	O
dimension	O
:	O
6	O
.	O
4cm	O
.	O

Macroscopic	O
Extent	O
of	O
Tumor	O
:	O
Tumor	O
limited	O
to	O
kidney	O
.	O

WHO	O
CLASSIFICATION	O
.	O

Clear	O
cell	O
renal	O
cell	O
carcinoma	O
8310	O
/	O
3	O
.	O

Histologic	O
Grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
G4	O
:	O
Nuclei	O
bizarre	O
and	O
multilobated	O
,	O
20	O
u	O
or	O
greater	O
,	O
nucleoli	O
prominent	O
,	O
chromatin	O
clumped	O
.	O

Invasion	O
of	O
Vascular	O
/	O
Lymphatic	O
:	O
Absent	O
.	O

Perinephric	O
Tissue	O
Invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Adrenal	O
Gland	O
:	O
Uninvolved	O
by	O
tumor	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
Negative	O
0	O
/	O
1	O
.	O

Additional	O
Findings	O
:	O
None	O
identified	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT	O
1b	O
N	O
0	O
M	O
1	O
.	O

Pathological	O
staging	O
is	O
based	O
on	O
the	O
AJCC	O
Cancer	O
Staging	O
Manual	O
,	O
7th	O
Edition	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

LEFT	O
KIDNEY	O
.	O

Received	O
fresh	O
labeled	O
with	O
patient	O
'	O
s	O
identification	O
and	O
"	O
left	O
kidney	O
"	O
is	O
an	O
intact	O
kidney	O
with	O
attached	O
.	O
perinephric	O
fat	O
weighing	O
322	O
g	O
and	O
measuring	O
12	O
X	O
7	O
x	O
5	O
cm	O
.	O

The	O
adrenal	O
gland	O
is	O
5	O
.	O
2	O
x	O
2	O
.	O
2	O
x	O
0	O
.	O
5	O
cm	O
;	O
it	O
.	O
has	O
a	O
golden	O
orange	O
coloration	O
.	O

The	O
ureter	O
is	O
8	O
.	O
3	O
x	O
0	O
.	O
5	O
cm	O
.	O

On	O
opening	O
,	O
it	O
is	O
smooth	O
and	O
tan	O
in	O
.	O
coloration	O
.	O

There	O
is	O
a	O
hilar	O
lymph	O
node	O
,	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
capsular	O
and	O
perinephric	O
fat	O
are	O
inked	O
.	O
black	O
and	O
the	O
kidney	O
is	O
bisected	O
.	O

There	O
is	O
an	O
orange	O
-	O
tan	O
mass	O
,	O
6	O
.	O
4	O
x	O
6	O
.	O
2	O
x	O
5	O
.	O
2	O
cm	O
which	O
extends	O
to	O
.	O
within	O
0	O
.	O
2	O
cm	O
of	O
the	O
capsule	O
.	O

It	O
is	O
hemorrhagic	O
and	O
fibrotic	O
and	O
pushes	O
on	O
the	O
renal	O
pelvis	O
resulting	O
in	O
its	O
.	O
dilation	O
.	O

Photograph	O
is	O
taken	O
and	O
tissue	O
is	O
procured	O
;	O
representatively	O
submitted	O
:	O
A1	O
:	O
vasculature	O
margins	O
.	O

A2	O
:	O
bisected	O
hilar	O
lymph	O
node	O
.	O

A3	O
-	O
A5	O
:	O
mass	O
and	O
relationship	O
to	O
capsule	O
and	O
perinephric	O
fat	O
.	O

A6	O
-	O
A7	O
:	O
mass	O
in	O
relationship	O
to	O
renal	O
pelvis	O
.	O

A8	O
:	O
mass	O
and	O
relationship	O
to	O
normal	O
-	O
appearing	O
parenchyma	O
.	O

A9	O
:	O
normal	O
-	O
appearing	O
parenchyma	O
.	O

A10	O
:	O
adrenal	O
gland	O
.	O

A11	O
.	O

Ureter	O
margin	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
Given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
None	O
Given	O
.	O

PROCEDURE	O
DATE	O
:	O
RECEIVED	O
DATE	O
:	O
Pre	O
-	O
Op	O
Diagnosis	O
.	O

Right	O
colon	O
cancer	O
.	O

Post	O
-	O
Op	O
Diagnosis	O
.	O

Same	O
as	O
above	O
.	O

Clinical	O
History	O
.	O

Nothing	O
indicated	O
.	O

Gross	O
Description	O
:	O
Received	O
in	O
a	O
single	O
container	O
labeled	O
.	O

-	O
right	O
colon	O
.	O
and	O
terminal	O
ileum	O
"	O
is	O
a	O
23	O
cm	O
previously	O
opened	O
portion	O
of	O
large	O
.	O
bowel	O
including	O
cecum	O
,	O
as	O
well	O
as	O
8	O
cm	O
of	O
attached	O
previously	O
opened	O
.	O
terminal	O
ileum	O
.	O

The	O
specimen	O
is	O
covered	O
by	O
a	O
moderate	O
amount	O
of	O
.	O
pericolic	O
and	O
epiploic	O
adipose	O
tissue	O
in	O
which	O
a	O
8	O
.	O
4	O
x	O
0	O
.	O
8	O
x	O
0	O
.	O
8	O
cm	O
.	O
grossly	O
unremarkable	O
vermiform	O
appendix	O
is	O
identified	O
.	O

The	O
visible	O
.	O
serosa	O
is	O
focally	O
shaggy	O
and	O
tan	O
pink	O
with	O
a	O
few	O
fibrofatty	O
.	O
adhesions	O
.	O

Noted	O
at	O
a	O
point	O
approximately	O
9	O
cm	O
from	O
the	O
distal	O
.	O
margin	O
is	O
a	O
3	O
.	O
3	O
x	O
3	O
.	O
2	O
cm	O
area	O
of	O
indurated	O
umbilication	O
of	O
the	O
.	O
serosa	O
.	O

The	O
specimen	O
has	O
been	O
received	O
after	O
tissue	O
harvest	O
for	O
.	O
genomic	O
study	O
.	O

Within	O
the	O
specimen	O
container	O
are	O
three	O
tissue	O
.	O
cassettes	O
each	O
labeled	O
.	O

The	O
bowel	O
wall	O
is	O
up	O
to	O
.	O

0	O
.	O
6	O
cm	O
edematous	O
and	O
fibrotic	O
.	O

The	O
lumen	O
is	O
lined	O
by	O
tan	O
pink	O
mucosa	O
.	O
with	O
preservation	O
of	O
intestinal	O
folds	O
.	O

In	O
the	O
area	O
corresponding	O
to	O
.	O
the	O
umbilication	O
at	O
a	O
point	O
8	O
.	O
6	O
cm	O
from	O
the	O
distal	O
margin	O
and	O
3	O
.	O
8	O
cm	O
.	O
from	O
the	O
ileocecal	O
valve	O
is	O
a	O
partially	O
sectioned	O
9	O
.	O
2	O
x	O
7	O
.	O
5	O
cm	O
.	O
plaque	O
like	O
finely	O
granular	O
centrally	O
ulcerated	O
tan	O
pink	O
lesion	O
with	O
.	O
raised	O
rolled	O
borders	O
.	O

This	O
has	O
a	O
gritty	O
gray	O
tan	O
fibrotic	O
cut	O
.	O
surface	O
measuring	O
up	O
to	O
3	O
.	O
2	O
cm	O
in	O
thickness	O
.	O

The	O
lesion	O
grossly	O
.	O
extends	O
through	O
the	O
muscularis	O
but	O
is	O
limited	O
by	O
the	O
serosa	O
in	O
the	O
.	O
area	O
away	O
from	O
the	O
pericolic	O
fat	O
.	O

In	O
the	O
area	O
of	O
the	O
pericolic	O
fat	O
.	O
the	O
lesion	O
grossly	O
appears	O
to	O
focally	O
extend	O
through	O
the	O
wall	O
into	O
.	O
the	O
adipose	O
tissue	O
where	O
it	O
is	O
seen	O
at	O
its	O
nearest	O
point	O
.	O
approximately	O
0	O
.	O
9	O
cm	O
from	O
the	O
nearest	O
outer	O
surface	O
margin	O
.	O

The	O
.	O
lesion	O
is	O
noted	O
within	O
0	O
.	O
1	O
cm	O
of	O
the	O
outer	O
surface	O
in	O
the	O
area	O
of	O
.	O
the	O
serosa	O
.	O

Noted	O
scattered	O
along	O
the	O
length	O
of	O
the	O
bowel	O
are	O
a	O
few	O
.	O
additional	O
tan	O
gray	O
polypoid	O
excrescences	O
up	O
to	O
0	O
.	O
8	O
cm	O
which	O
are	O
.	O
unfixed	O
to	O
the	O
underlying	O
muscularis	O
.	O

On	O
sectioning	O
the	O
surrounding	O
.	O
adipose	O
tissue	O
reveals	O
multiple	O
poorly	O
defined	O
fleshy	O
tan	O
pink	O
to	O
.	O
yellow	O
nodules	O
up	O
to	O
1	O
.	O
5	O
cm	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O
labeled	O
as	O
follows	O
:	O
A	O
-	O
proximal	O
margin	O
;	O
B	O
-	O
distal	O
margin	O
;	O
C	O
-	O
G	O
-	O
.	O
representative	O
lesion	O
and	O
surrounding	O
tissue	O
;	O
H	O
-	O
representative	O
.	O
polyps	O
;	O
I	O
-	O
random	O
uninvolved	O
bowel	O
;	O
J	O
-	O
appendix	O
;	O
K	O
-	O
N	O
-	O
individual	O
.	O
pericolic	O
nodules	O
bisected	O
;	O
O	O
-	O
R	O
-	O
whole	O
smaller	O
pericolic	O
nodules	O
.	O

Microscopic	O
Description	O
:	O
The	O
slides	O
labeled	O
.	O
are	O
examined	O
.	O

See	O
diagnosis	O
.	O

Final	O
Diagnosis	O
.	O

Distal	O
ileum	O
,	O
appendix	O
,	O
and	O
right	O
colon	O
(	O
right	O
colectomy	O
)	O
:	O
Tumor	O
characteristics	O
:	O
Tumor	O
site	O
:	O
Cecum	O
.	O

Size	O
:	O
9	B
.	I
2	I
cm	I
in	O
greatest	O
diameter	O
.	O

Macroscopic	O
tumor	O
perforation	O
:	O
Not	O
identified	O
.	O

Histologic	O
type	O
:	O
Adenocarcinoma	O
.	O

Grade	O
:	O
Moderately	O
differentiated	O
.	O

Microscopic	O
tumor	O
extension	O
:	O
Carcinoma	O
extends	O
through	O
muscularis	O
.	O
propria	O
into	O
subserosal	O
adipose	O
tissue	O
.	O

Margin	O
Status	O
:	O
Proximal	O
margin	O
:	O
No	O
carcinoma	O
identified	O
.	O

Distal	O
margin	O
:	O
No	O
carcinoma	O
identified	O
.	O

Circumferential	O
radial	O
/	O
mesenteric	O
margin	O
:	O
No	O
carcinoma	O
.	O
identified	O
.	O

Distance	O
of	O
tumor	O
from	O
closest	O
margin	O
:	O
1	O
mm	O
from	O
the	O
.	O
circumferential	O
radial	O
margin	O
.	O

Treatment	O
effect	O
:	O
Unknown	O
.	O

Lymphovascular	O
space	O
invasion	O
:	O
No	O
unequivocal	O
lymphovascular	O
.	O
space	O
invasion	O
identified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
identified	O
.	O

Presence	O
of	O
mesenteric	O
tumor	O
deposits	O
:	O
Not	O
identified	O
.	O

Lymph	O
Node	O
Status	O
:	O
Total	O
number	O
of	O
lymph	O
nodes	O
examined	O
:	O
32	O
.	O

Total	O
number	O
of	O
lymph	O
nodes	O
containing	O
metastatic	O
carcinoma	O
:	O
Zero	O
(	O
0	O
/	O
32	O
)	O
PAS	O
9	O
.	O

Other	O
findings	O
:	O
Scattered	O
foci	O
of	O
lymphoid	O
aggregates	O
.	O

PAS	O
6	O
.	O

Scattered	O
hyperplastic	O
polyps	O
.	O

PAS	O
4	O
.	O

Appendix	O
:	O
No	O
carcinoma	O
is	O
identified	O
.	O

PAS	O
1	O
SPC	O
-	O
A	O
.	O

Stage	O
:	O
pT3NO	O
.	O

Comments	O
.	O

At	O
the	O
request	O
of	O
the	O
undersigned	O
pathologist	O
,	O
these	O
slides	O
have	O
.	O
been	O
additionally	O
reviewed	O
by	O
Dr	O
.	O
who	O
concurs	O
with	O
the	O
.	O
diagnosis	O
.	O

Hospital	O
No	O
:	O
Date	O
of	O
Birth	O
:	O
Date	O
Received	O
:	O
DIAGNOSIS	O
:	O
A	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
:	O
Ovary	O
and	O
fallopian	O
tube	O
with	O
multiple	O
foci	O
of	O
papillary	O
carcinoma	O
,	O
.	O
predominantly	O
in	O
the	O
lumen	O
of	O
vessels	O
.	O

B	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
:	O
Ovary	O
and	O
fallopian	O
tube	O
with	O
multiple	O
foci	O
of	O
papillary	O
carcinoma	O
,	O
.	O
predominantly	O
in	O
the	O
lumen	O
of	O
vessels	O
.	O

C	O
.	O

UTERUS	O
AND	O
CERVIX	O
:	O
Malignant	O
mixed	O
mullerian	O
tumor	O
of	O
the	O
endometrium	O
infiltrating	O
the	O
entire	O
.	O
thickness	O
of	O
the	O
myometrium	O
with	O
extensive	O
vascular	O
invasion	O
.	O

Cervix	O
:	O
Foci	O
of	O
papillary	O
serous	O
carcinoma	O
within	O
vessels	O
.	O

Leiomyoma	O
with	O
foci	O
of	O
papillary	O
serous	O
carcinoma	O
within	O
vessels	O
.	O

D	O
.	O

RIGHT	O
PARAAORTIC	O
LYMPH	O
NODE	O
:	O
Metastatic	O
papillary	O
serous	O
carcinoma	O
in	O
lymph	O
node	O
extending	O
to	O
perinodal	O
.	O
connective	O
tissue	O
.	O

E	O
.	O

OMENTUM	O
BIOPSY	O
:	O
Adipose	O
tissue	O
,	O
no	O
tumor	O
present	O
.	O

COMMENT	O
:	O
This	O
malignant	O
mixed	O
mullerian	O
tumor	O
is	O
composed	O
of	O
papillary	O
serous	O
.	O
carcinoma	O
,	O
approximately	O
50	O
%	O
,	O
and	O
sarcoma	O
,	O
with	O
extensive	O
areas	O
of	O
.	O
rhabdomyosarcoma	O
,	O
approximately	O
50	O
%	O
.	O

All	O
the	O
foci	O
of	O
tumor	O
in	O
the	O
myometrium	O
,	O
cervix	O
,	O
.	O
fallopian	O
tubes	O
and	O
ovaries	O
consist	O
of	O
only	O
papillary	O
serous	O
carcinoma	O
.	O

SYNOPTIC	O
REPORT	O
:	O
Applies	O
To	O
:	O
A	O
:	O
LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

B	O
:	O
RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

C	O
:	O
UTERUS	O
AND	O
CERVIX	O
.	O

D	O
:	O
RIGHT	O
PERIAORTIC	O
LYMPH	O
NODE	O
.	O

E	O
:	O
OMENTUM	O
BIOPSY	O
.	O

Microscopic	O
.	O

Histologic	O
Type	O
:	O
Malignant	O
mixed	O
mullerian	O
tumor	O
.	O

Tumor	O
Size	O
:	O
Dimensions	O
:	O
12	B
X	I
10	I
X	I
8cm	I
.	O

Myometrial	O
Invasion	O
:	O
Greater	O
than	O
50	O
%	O
myometrial	O
invasion	O
.	O

Patient	O
Case	O
(	O
s	O
)	O
:	O
Copy	O
For	O
.	O

PATIENT	O
NOTIFIED	O
OF	O
RESULTS	O
.	O

DR	O
:	O
NURSE	O
:	O
Involvement	O
of	O
Cervix	O
:	O
Invasion	O
of	O
cervical	O
stromal	O
connective	O
tissue	O
.	O

Margins	O
:	O
Uninvolved	O
by	O
invasive	O
carcinoma	O
.	O

Lymphovascular	O
Invasion	O
:	O
Present	O
.	O

Pathologic	O
Staging	O
(	O
p	O
FTNM	O
)	O
AJCC	O
7th	O
Edition	O
2010	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT3a	O
:	O
Tumor	O
involves	O
serosa	O
and	O
/	O
or	O
adnexa	O
(	O
direct	O
extension	O
or	O
metastasis	O
)	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Cannot	O
be	O
assessed	O
.	O

Number	O
of	O
para	O
-	O
aortic	O
lymph	O
nodes	O
examined	O
:	O
1	O
.	O

Number	O
of	O
para	O
-	O
aortic	O
lymph	O
nodes	O
involved	O
:	O
1	O
.	O

HISTORY	O
:	O
Vaginal	O
discharge	O
.	O

MICROSCOPIC	O
FINDINGS	O
:	O
See	O
diagnosis	O
.	O

GROSS	O
:	O
A	O
.	O

LEFT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
.	O
designated	O
"	O
left	O
tube	O
and	O
ovary	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
an	O
intact	O
adnexa	O
.	O
consisting	O
of	O
a	O
short	O
segment	O
of	O
non	O
-	O
fimbriated	O
fallopian	O
tube	O
measuring	O
2	O
.	O
6	O
cm	O
long	O
and	O
1	O
.	O
2	O
cm	O
in	O
.	O
diameter	O
intimately	O
attached	O
to	O
a	O
2	O
.	O
6	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
6	O
cm	O
ovary	O
.	O

The	O
fallopian	O
tube	O
lumen	O
ranges	O
from	O
pinpoint	O
.	O
to	O
0	O
.	O
4	O
cm	O
in	O
diameter	O
.	O

The	O
cut	O
surface	O
of	O
the	O
ovary	O
is	O
ill	O
-	O
defined	O
mottled	O
and	O
pink	O
-	O
tan	O
to	O
white	O
.	O

The	O
.	O
overlying	O
capsular	O
surface	O
is	O
disrupted	O
and	O
shaggy	O
.	O

There	O
is	O
attached	O
blood	O
clot	O
and	O
fibrous	O
adhesions	O
.	O
on	O
the	O
mesosalpinx	O
of	O
the	O
fallopian	O
tube	O
.	O

Ink	O
key	O
:	O
black	O
-	O
external	O
surface	O
of	O
adnexa	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Slide	O
key	O
:	O
A1	O
-	O
A3	O
.	O

Fallopian	O
tube	O
with	O
attached	O
ovary	O
-	O
1	O
each	O
.	O

B	O
.	O

RIGHT	O
TUBE	O
AND	O
OVARY	O
.	O

Labeled	O
.	O
designated	O
"	O
right	O
tube	O
and	O
ovary	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
an	O
intact	O
adnexa	O
.	O
consisting	O
of	O
a	O
non	O
-	O
fimbriated	O
segment	O
of	O
fallopian	O
tube	O
measuring	O
6	O
.	O
4	O
cm	O
long	O
and	O
average	O
diameter	O
of	O
.	O

1	O
.	O
5	O
cm	O
attached	O
to	O
a	O
2	O
.	O
5	O
X	O
2	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
ovary	O
.	O

The	O
attached	O
mesosalpinx	O
and	O
fibrovascular	O
paraovarian	O
.	O
tissue	O
measures	O
4	O
.	O
5	O
x	O
2	O
.	O
5	O
x	O
1	O
.	O
0	O
cm	O
.	O

The	O
ovary	O
has	O
a	O
mottled	O
pink	O
-	O
tan	O
to	O
white	O
cut	O
surface	O
.	O

The	O
capsule	O
.	O

is	O
shaggy	O
and	O
granular	O
.	O

The	O
ovary	O
has	O
a	O
patent	O
lumen	O
ranging	O
from	O
pinpoint	O
to	O
0	O
.	O
2	O
cm	O
in	O
diameter	O
.	O

The	O
.	O
mesosalpinx	O
has	O
a	O
shaggy	O
surface	O
with	O
attached	O
adhesions	O
.	O

The	O
paraovarian	O
soft	O
tissue	O
is	O
thickened	O
.	O
and	O
edematous	O
.	O

Ink	O
key	O
:	O
black	O
-	O
external	O
surface	O
of	O
adnexa	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Slide	O
key	O
:	O
B1	O
.	O

Fallopian	O
tube	O
cross	O
sections	O
-	O
2	O
.	O

B2	O
,	O
B3	O
.	O

Bisected	O
presumed	O
non	O
-	O
fimbriated	O
distal	O
end	O
of	O
fallopian	O
tube	O
-	O
2	O
.	O

B4	O
.	O

Ovary	O
2	O
.	O

B5	O
.	O

Paraovarian	O
tissue	O
-	O
2	O
.	O

C	O
.	O

UTERUS	O
AND	O
CERVIX	O
FS	O
.	O

Labeled	O
.	O
designated	O
"	O
uterus	O
and	O
cervix	O
FS	O
"	O
,	O
and	O
received	O
fresh	O
for	O
intraoperative	O
.	O
consultation	O
is	O
a	O
1331	O
.	O
5	O
gram	O
total	O
hysterectomy	O
specimen	O
.	O

It	O
measures	O
13	O
.	O
4	O
cm	O
ectocervix	O
to	O
fundus	O
,	O
.	O

14	O
.	O
0	O
cm	O
cornu	O
to	O
cornu	O
,	O
and	O
approximately	O
14	O
.	O
0	O
cm	O
anterior	O
to	O
posterior	O
.	O

The	O
cervical	O
portion	O
of	O
the	O
.	O
uterus	O
is	O
3	O
.	O
0	O
cm	O
long	O
and	O
up	O
to	O
6	O
.	O
7	O
cm	O
in	O
maximum	O
diameter	O
.	O

The	O
endometrial	O
cavity	O
is	O
approximately	O
.	O

12	O
.	O
0	O
cm	O
long	O
and	O
10	O
.	O
0	O
cm	O
wide	O
.	O

The	O
myometrial	O
thickness	O
ranges	O
from	O
1	O
.	O
4	O
to	O
3	O
.	O
5	O
cm	O
.	O

There	O
is	O
a	O
large	O
fungating	O
mass	O
entirely	O
filling	O
the	O
endometrial	O
cavity	O
(	O
12	O
.	O
0	O
X	O
10	O
.	O
0	O
x	O
8	O
.	O
0	O
cm	O
)	O
.	O

It	O
is	O
primarily	O
.	O
based	O
in	O
the	O
uterus	O
with	O
extension	O
into	O
both	O
the	O
anterior	O
and	O
posterior	O
lower	O
uterine	O
segments	O
.	O

The	O
mass	O
.	O

is	O
located	O
4	O
.	O
2	O
cm	O
from	O
the	O
anterior	O
ectocervix	O
and	O
1	O
.	O
6	O
cm	O
from	O
the	O
posterior	O
ectocervix	O
.	O

On	O
the	O
adjacent	O
.	O
myometrium	O
are	O
several	O
separate	O
polypoid	O
masses	O
ranging	O
from	O
1	O
.	O
0	O
to	O
2	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
small	O
portions	O
of	O
intervening	O
myometrium	O
range	O
from	O
smooth	O
to	O
pink	O
-	O
tan	O
with	O
an	O
average	O
thickness	O
.	O
of	O
0	O
.	O
3	O
cm	O
to	O
bulky	O
solid	O
and	O
tan	O
-	O
white	O
with	O
a	O
thickness	O
of	O
0	O
.	O
6	O
cm	O
.	O

The	O
exophytic	O
portions	O
of	O
the	O
mass	O
.	O
range	O
from	O
soft	O
glistening	O
to	O
pink	O
-	O
tan	O
to	O
firm	O
tan	O
-	O
white	O
and	O
whorled	O
.	O

The	O
surface	O
of	O
the	O
exophytic	O
mass	O
is	O
.	O
gray	O
-	O
yellow	O
and	O
necrotic	O
appearing	O
.	O

Approximately	O
20	O
%	O
to	O
30	O
%	O
of	O
the	O
mass	O
is	O
necrotic	O
appearing	O
.	O

The	O
.	O
entire	O
mass	O
is	O
superficial	O
with	O
focal	O
probable	O
invasion	O
.	O

In	O
the	O
fundus	O
of	O
the	O
anterior	O
side	O
there	O
is	O
invasive	O
.	O
to	O
0	O
.	O
4	O
cm	O
out	O
of	O
a	O
total	O
myometrial	O
thickness	O
of	O
1	O
.	O
5	O
cm	O
(	O
less	O
than	O
50	O
%	O
)	O
.	O

In	O
the	O
remaining	O
uterus	O
the	O
mass	O
.	O

is	O
not	O
grossly	O
invasive	O
.	O

Separately	O
received	O
is	O
an	O
aggregate	O
of	O
polypoid	O
necrotic	O
and	O
hemorrhagic	O
mass	O
.	O
measuring	O
11	O
.	O
0	O
x	O
7	O
.	O
0	O
X	O
5	O
.	O
0	O
cm	O
in	O
aggregate	O
.	O

Within	O
the	O
myometrium	O
are	O
approximately	O
20	O
to	O
30	O
subserosal	O
and	O
intramural	O
nodules	O
ranging	O
from	O
0	O
.	O
6	O
to	O
.	O

5	O
.	O
8	O
cm	O
in	O
diameter	O
.	O

All	O
of	O
the	O
nodules	O
have	O
a	O
firm	O
tan	O
-	O
white	O
whorled	O
cut	O
surface	O
.	O

Areas	O
of	O
hemorrhage	O
.	O
necrosis	O
are	O
not	O
identified	O
.	O

In	O
one	O
of	O
the	O
middle	O
-	O
sized	O
subserosal	O
nodules	O
are	O
focal	O
calcifications	O
.	O

The	O
.	O
intervening	O
myometrium	O
is	O
pink	O
-	O
tan	O
and	O
rubbery	O
.	O

On	O
the	O
serosal	O
aspect	O
of	O
the	O
uterine	O
corpus	O
are	O
several	O
.	O
small	O
fibrous	O
adhesions	O
.	O

The	O
endocervical	O
canal	O
is	O
dilated	O
with	O
a	O
flat	O
tan	O
-	O
brown	O
faintly	O
granular	O
mucosal	O
.	O
surface	O
.	O

Ink	O
key	O
:	O
Blue	O
-	O
anterior	O
paracervical	O
tissue	O
and	O
uterine	O
corpus	O
serosa	O
.	O

Black	O
-	O
posterior	O
paracervical	O
soft	O
tissue	O
and	O
uterine	O
corpus	O
serosa	O
.	O

Orange	O
-	O
inferior	O
portion	O
of	O
lower	O
uterine	O
segment	O
sections	O
.	O

A	O
representative	O
section	O
is	O
submitted	O
for	O
frozen	O
section	O
,	O
and	O
further	O
submitted	O
for	O
permanent	O
sections	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Gross	O
photographs	O
are	O
taken	O
.	O

Slide	O
key	O
:	O
C1	O
.	O

Anterior	O
cervix	O
-	O
1	O
.	O

C2	O
.	O

Anterior	O
lower	O
uterine	O
segment	O
with	O
mass	O
-	O
1	O
.	O

C3	O
-	O
C5	O
.	O

Trisected	O
mass	O
anterior	O
side	O
mid	O
corpus	O
-	O
1	O
each	O
.	O

C6	O
,	O
C7	O
.	O

Bisected	O
full	O
thickness	O
section	O
of	O
anterior	O
fundus	O
with	O
soft	O
glistening	O
portion	O
of	O
mass	O
and	O
.	O
probable	O
deepest	O
mass	O
invasion	O
-	O
1	O
each	O
.	O

C8	O
-	O
C10	O
.	O

Additional	O
full	O
thickness	O
trisected	O
anterior	O
fundus	O
with	O
soft	O
glistening	O
portion	O
of	O
mass	O
-	O
1	O
each	O
.	O

C11	O
,	O
C12	O
.	O

Representative	O
sections	O
of	O
separately	O
received	O
tumor	O
-	O
1	O
each	O
.	O

C13	O
.	O

Posterior	O
cervix	O
-	O
1	O
.	O

C14	O
.	O

Posterior	O
lower	O
uterine	O
segment	O
-	O
1	O
.	O

C15	O
,	O
C16	O
.	O

Bisected	O
mid	O
portion	O
of	O
posterior	O
uterine	O
corpus	O
with	O
mass	O
-	O
1	O
each	O
.	O

C17	O
-	O
C19	O
.	O

Posterior	O
fundus	O
trisected	O
full	O
thickness	O
section	O
with	O
solid	O
firm	O
whorled	O
component	O
of	O
mass	O
-	O
1	O
.	O
each	O
.	O

C20	O
.	O

Representative	O
posterior	O
leiomyomata	O
-	O
4	O
.	O

C21	O
.	O

Representative	O
anterior	O
leiomyomata	O
-	O
4	O
.	O

C22	O
.	O

Frozen	O
section	O
remnant	O
-	O
1	O
.	O

D	O
.	O

RIGHT	O
PARAAORTIC	O
LYMPH	O
NODE	O
.	O

Labeled	O
.	O
designated	O
"	O
right	O
paraaortic	O
lymph	O
node	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
3	O
.	O
0	O
x	O
1	O
.	O
4	O
.	O

X	O
0	O
.	O
9	O
cm	O
semifirm	O
candidate	O
lymph	O
node	O
.	O

The	O
cut	O
surface	O
is	O
partially	O
cystic	O
with	O
a	O
solid	O
tan	O
-	O
white	O
tumor	O
.	O
deposit	O
measuring	O
1	O
.	O
3	O
cm	O
in	O
greatest	O
dimension	O
.	O

The	O
candidate	O
node	O
is	O
representatively	O
submitted	O
.	O

D1	O
.	O

4	O
.	O

E	O
.	O

OMENTAL	O
BIOPSY	O
.	O

Labeled	O
.	O
,	O
designated	O
"	O
omental	O
biopsy	O
"	O
,	O
and	O
received	O
in	O
formalin	O
is	O
a	O
portion	O
of	O
finely	O
.	O
lobulated	O
tan	O
-	O
yellow	O
fibroadipose	O
tissue	O
consistent	O
with	O
omentum	O
measuring	O
7	O
.	O
0	O
X	O
4	O
.	O
0	O
x	O
0	O
.	O
6	O
cm	O
.	O

Mass	O
.	O
lesions	O
are	O
not	O
identified	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

E1	O
.	O

Multiple	O
.	O

Gross	O
dictated	O
by	O
.	O

INTRAOPERATIVE	O
CONSULTATION	O
:	O
OPERATIVE	O
CALL	O
.	O

OPERATIVE	O
CONSULT	O
(	O
FROZEN	O
)	O
:	O
FSC	O
.	O

UTERUS	O
AND	O
CERVIX	O
:	O
Uterine	O
cavity	O
filled	O
by	O
polypoid	O
mass	O
of	O
tumor	O
.	O
grossly	O
superficially	O
invasive	O
high	O
-	O
grade	O
malignant	O
tumor	O
.	O

I	O
have	O
personallv	O
examined	O
the	O
specimen	O
,	O
interpreted	O
the	O
results	O
,	O
reviewed	O
the	O
report	O
and	O
signed	O
it	O
electronically	O
.	O

TUTO	O
TC	O
ANT	O
ADDENDUM	O
REPORT	O
.	O

SPECIMEN	O
(	O
S	O
)	O
SUBMITTED	O
/	O
PROCEDURES	O
ORDERED	O
.	O

A	O
.	O

Left	O
brain	O
mass	O
.	O

A	O
.	O

KI	O
-	O
67	O
,	O
Nuclear	O
Antigen	O
,	O
Mibl	O
(	O
	O
.	O

A	O
.	O

Glial	O
Fibrill	O
.	O

Acid	O
Prt	O
.	O

A	O
.	O

1P19q	O
Malignant	O
.	O

Glioma	O
Anaysis	O
(	O
.	O
A	O
.	O
1P19q	O
Malignant	O
Glioma	O
Analysis	O
,	O
add	O
.	O
)	O
x	O
3	O
.	O

A	O
.	O

P53	O
Protein	O
(	O
88342	O
)	O
A	O
.	O

Frozen	O
Section	O
Charge	O
(	O
-	O
.	O

CLINICAL	O
HISTORY	O
:	O
A	O
.	O

CT	O
.	O

A	O
revealed	O
left	O
temporal	O
lobe	O
mass	O
with	O
some	O
associated	O
edema	O
.	O

GROSS	O
DESCRIPTION	O
:	O
Received	O
the	O
following	O
specimen	O
in	O
the	O
Department	O
of	O
.	O

Pathology	O
,	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
hospital	O
#	O
.	O

A	O
.	O

Left	O
brain	O
mass	O
.	O

A	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
,	O
labeled	O
"	O
brain	O
lesion	O
"	O
and	O
consists	O
.	O
of	O
two	O
rectangular	O
pieces	O
of	O
cerebral	O
cortex	O
with	O
underlying	O
subcortical	O
.	O
white	O
matter	O
.	O

Each	O
piece	O
of	O
tissue	O
measures	O
4	O
.	O
2	O
x	O
4	O
.	O
0	O
x	O
1	O
.	O

cm	O
and	O
4	O
.	O

1	O
x	O
.	O

3	O
.	O
0	O
x	O
1	O
.	O
4	O
cm	O
.	O

The	O
meningeal	O
surfaces	O
are	O
smooth	O
and	O
beige	O
-	O
tan	O
,	O
with	O
a	O
.	O
fine	O
reticulated	O
vasculature	O
.	O

The	O
resection	O
margin	O
is	O
cauterized	O
and	O
.	O
focally	O
necrotic	O
.	O

Sectioning	O
reveals	O
a	O
clear	O
demarcation	O
between	O
the	O
.	O
gray	O
and	O
white	O
matter	O
layers	O
.	O

No	O
discrete	O
lesion	O
is	O
identified	O
,	O
however	O
,	O
.	O
there	O
is	O
focal	O
discoloration	O
of	O
the	O
white	O
matter	O
.	O

A	O
representative	O
.	O
section	O
of	O
this	O
discolored	O
white	O
matter	O
is	O
submitted	O
for	O
frozen	O
section	O
.	O

Frozen	O
section	O
diagnosis	O
is	O
"	O
Malignant	O
glioma	O
,	O
per	O
.	O

The	O
.	O
frozen	O
section	O
tissue	O
is	O
submitted	O
for	O
permanent	O
processing	O
in	O
cassette	O
.	O

FSA1	O
.	O

Additional	O
representative	O
sections	O
are	O
submitted	O
in	O
cassettes	O
.	O

A2	O
-	O
A7	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

"	O
Left	O
brain	O
mass	O
"	O
:	O
Glioblastoma	O
multiforme	O
with	O
oligodendroglioma	O
component	O
.	O

(	O
WHO	O
Grade	O
IV	O
)	O
(	O
see	O
comment	O
)	O
.	O

COMMENT	O
:	O
This	O
high	O
grade	O
glioma	O
features	O
areas	O
of	O
high	O
cellularity	O
,	O
.	O
mitoses	O
,	O
vascular	O
endothelial	O
proliferation	O
and	O
necrosis	O
.	O

The	O
areas	O
of	O
.	O
necrosis	O
with	O
apparent	O
pseudopalisading	O
are	O
best	O
represented	O
in	O
slide	O
.	O

"	O
A1	O
"	O
.	O

Additional	O
rather	O
circumscribed	O
foci	O
of	O
high	O
grade	O
.	O
oligodendrogliomatous	O
appearance	O
are	O
also	O
seen	O
.	O

In	O
such	O
areas	O
,	O
the	O
Ki	O
-	O
67	O
.	O
labeling	O
index	O
is	O
20	O
-	O
30	O
%	O
P53	O
is	O
reactive	O
in	O
about	O
20	O
%	O
of	O
tumor	O
cell	O
.	O
nuclei	O
.	O

GFAP	O
is	O
reactive	O
in	O
some	O
tumor	O
cells	O
and	O
in	O
reactive	O
-	O
appearing	O
.	O
astrocytes	O
.	O

These	O
results	O
support	O
the	O
diagnosis	O
.	O

bf	O
these	O
results	O
on	O
.	O

"	O
I	O
,	O
or	O
my	O
qualified	O
designee	O
,	O
have	O
performed	O
the	O
gross	O
examination	O
and	O
.	O
description	O
and	O
I	O
have	O
personally	O
reviewed	O
the	O
gross	O
description	O
and	O
.	O
specimen	O
preparations	O
referenced	O
herein	O
,	O
and	O
have	O
personally	O
issued	O
this	O
.	O
report	O
.	O

"	O
.	O

Resident	O
/	O
Prosector	O
/	O
Pathologist	O
:	O
Note	O
:	O
Test	O
systems	O
have	O
been	O
developed	O
and	O
their	O
performance	O
.	O
characteristics	O
determined	O
by	O
.	O

Some	O
tests	O
.	O
have	O
not	O
been	O
cleared	O
or	O
approved	O
by	O
the	O
US	O
FOOD	O
and	O
Drug	O
Administration	O
.	O

The	O
FDA	O
has	O
determined	O
that	O
such	O
clearance	O
is	O
not	O
necessary	O
.	O

These	O
tests	O
.	O
are	O
used	O
for	O
clinical	O
purposes	O
and	O
should	O
not	O
be	O
regarded	O
as	O
.	O
investigational	O
or	O
for	O
research	O
.	O

This	O
laboratory	O
is	O
certified	O
under	O
the	O
.	O

Clinical	O
Laboratory	O
Improvement	O
Amendments	O
of	O
.	O
as	O
qualified	O
.	O
to	O
perform	O
high	O
complexity	O
clinical	O
laboratory	O
testing	O
.	O

Path	O
	O
logist	O
.	O

CHROMOSOMES	O
1P	O
AND	O
19Q	O
ANALYSIS	O
:	O
FLUORESCENCE	O
IN	O
SITU	O
HYBRIDIZATION	O
(	O
FISH	O
)	O
WAS	O
PERFORMED	O
ON	O
REPRESENTATIVE	O
.	O

PARAFFIN	O
-	O
EMBEDDED	O
TUMOR	O
TISSUE	O
(	O
VYSIS	O
)	O
.	O

IN	O
THIS	O
CASE	O
,	O
NO	O
DELETIONS	O
OF	O
1P	O
OR	O
19Q	O
WERE	O
IDENTIFIED	O
.	O

PLEASE	O
REFER	O
TO	O
UF	O
DIAGNOSTIC	O
REFERENCE	O
LABORATORIES	O
REPORT	O
:	O
FOR	O
.	O

FURTHER	O
DETAILS	O
OF	O
THIS	O
ANALYSIS	O
.	O

REFERENCES	O
:	O

CONFIDENTIAL	O
.	O

Demographics	O
(	O
for	O
.	O
verification	O
purposes	O
)	O
.	O

Sex	O
:	O
F	O
.	O

Collected	O
Date	O
/	O
Time	O
.	O

Received	O
Date	O
/	O
Time	O
.	O

Specimen	O
Description	O
.	O

A	O
:	O
Node	O
8	O
at	O
.	O

B	O
:	O
Periportal	O
lymph	O
node	O
at	O
.	O

C	O
:	O
Proximal	O
bile	O
duct	O
margin	O
at	O
.	O

D	O
:	O
Whipple	O
'	O
s	O
specimen	O
at	O
.	O

Clinical	O
Information	O
.	O

Pancreatic	O
cancer	O
.	O

Diagnosis	O
.	O

A	O
.	O

Node	O
8	O
:	O
Metastatic	O
adenocarcinoma	O
with	O
focal	O
extracapsular	O
extension	O
.	O

B	O
.	O

Periportal	O
Lymph	O
Node	O
:	O
Fibroadipose	O
tissue	O
only	O
.	O

C	O
.	O

Proximal	O
bile	O
duct	O
margin	O
:	O
Inflammatory	O
changes	O
,	O
no	O
neoplasia	O
.	O

D	O
.	O

Whipples	O
specimen	O
:	O
Poorly	O
differentiated	O
ductal	O
carcinoma	O
invasive	O
into	O
duodenum	O
with	O
.	O
perineural	O
,	O
lymphatic	O
and	O
arterial	O
channel	O
invasion	O
,	O
present	O
at	O
the	O
.	O
uncinate	O
resection	O
margin	O
.	O

Four	O
peripancreatic	O
lymph	O
nodes	O
with	O
metastatic	O
adenocarcinoma	O
.	O

Verified	O
:	O
Synoptic	O
Report	O
.	O

HISTOLOGIC	O
TYPE	O
:	O
Ductal	O
adenocarcinoma	O
.	O

HISTOLOGIC	O
GRADE	O
:	O
G3	O
:	O
Poorly	O
differentiated	O
.	O

MICROSCOPIC	O
TUMOR	O
EXTENSION	O
:	O
Tumor	O
invades	O
duodenal	O
wall	O
.	O

MARGINS	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Uncinate	O
process	O
(	O
retroperitoneal	O
)	O
margin	O
(	O
nonperitonealized	O
surface	O
of	O
the	O
uncinate	O
.	O
process	O
)	O
.	O

TREATMENT	O
EFFECT	O
(	O
applicable	O
to	O
carcinomas	O
treated	O
with	O
neoadjuvant	O
therapy	O
)	O
:	O
No	O
prior	O
treatment	O
.	O

LYMPH	O
-	O
VASCULAR	O
INVASION	O
:	O
Present	O
.	O

PERINEURAL	O
INVASION	O
:	O
Present	O
.	O

PRIMARY	O
TUMOR	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
limited	O
to	O
the	O
pancreas	O
,	O
more	O
than	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

REGIONAL	O
LYMPH	O
NODES	O
(	O
pN	O
)	O
:	O
pN1	O
:	O
Regional	O
lymph	O
node	O
metastasis	O
.	O

Number	O
examined	O
:	O
5	O
.	O

Number	O
involved	O
:	O
5	O
.	O

ADDITIONAL	O
PATHOLOGIC	O
FINDINGS	O
:	O
Chronic	O
pancreatitis	O
.	O

Gross	O
Description	O
.	O

Received	O
are	O
specimen	O
containers	O
A	O
to	O
D	O
all	O
requisitions	O
and	O
specimen	O
containers	O
are	O
.	O
labelled	O
with	O
the	O
patient	O
'	O
s	O
name	O
,	O
.	O

The	O
cassettes	O
and	O
.	O
identifiers	O
.	O

are	O
labelled	O
with	O
the	O
Surgical	O
Numper	O
.	O

A	O
:	O
The	O
specimen	O
is	O
received	O
fresh	O
and	O
is	O
subsequently	O
placed	O
into	O
formalin	O
.	O

The	O
.	O
container	O
is	O
designated	O
A	O
node	O
8	O
.	O

The	O
specimen	O
consists	O
of	O
a	O
single	O
possible	O
fragment	O
of	O
.	O
lymph	O
node	O
that	O
measures	O
2	O
.	O
8	O
x	O
1	O
.	O
3	O
x	O
0	O
.	O
6	O
cm	O
with	O
attached	O
adipose	O
tissue	O
.	O

The	O
specimen	O
.	O

is	O
serially	O
sectioned	O
.	O

The	O
possible	O
lymph	O
node	O
is	O
submitted	O
in	O
A1	O
/	O
2	O
and	O
the	O
remaining	O
.	O
adipose	O
tissue	O
is	O
submitted	O
in	O
A3	O
.	O

B	O
:	O
Specimen	O
is	O
received	O
fresh	O
.	O

The	O
container	O
is	O
designated	O
B	O
periportal	O
lymph	O
node	O
.	O

The	O
specimen	O
consists	O
of	O
two	O
irregular	O
portions	O
of	O
fibrofatty	O
tissue	O
measuring	O
in	O
.	O
aggregate	O
4	O
x	O
2	O
.	O
5	O
x	O
0	O
.	O
5	O
cm	O
.	O

One	O
piece	O
is	O
submitted	O
in	O
toto	O
in	O
B1	O
,	O
other	O
piece	O
is	O
bisected	O
.	O
and	O
submitted	O
in	O
toto	O
in	O
B2	O
/	O
3	O
.	O

C	O
:	O
The	O
specimen	O
consists	O
of	O
a	O
ring	O
-	O
shaped	O
piece	O
of	O
duct	O
which	O
measures	O
0	O
.	O
2	O
cm	O
in	O
length	O
.	O
and	O
0	O
.	O
9	O
cm	O
in	O
diameter	O
.	O

Submitted	O
in	O
toto	O
for	O
quick	O
section	O
in	O
one	O
block	O
.	O

Specimen	O
is	O
received	O
fresh	O
.	O

The	O
container	O
is	O
designated	O
C	O
proximal	O
bile	O
duct	O
margin	O
.	O

D	O
:	O
Specimen	O
is	O
received	O
fresh	O
.	O

The	O
container	O
is	O
designated	O
Whipple	O
'	O
s	O
The	O
specimen	O
.	O
consists	O
of	O
a	O
segment	O
of	O
duodenum	O
with	O
attached	O
head	O
of	O
pancreas	O
.	O

The	O
bowel	O
measures	O
.	O
approximately	O
25	O
cm	O
in	O
length	O
with	O
a	O
circumference	O
which	O
ranges	O
from	O
4	O
to	O
6	O
.	O
5	O
cm	O
.	O

The	O
.	O
attached	O
head	O
of	O
pancreas	O
measures	O
6	O
x	O
5	O
x	O
2	O
.	O
5	O
cm	O
.	O

The	O
pancreatic	O
body	O
margin	O
is	O
inked	O
.	O
blue	O
,	O
the	O
mesenteric	O
vessel	O
bed	O
margin	O
inked	O
orange	O
,	O
and	O
the	O
uncinate	O
process	O
inked	O
.	O
black	O
.	O

Sectioning	O
the	O
pancreas	O
reveals	O
a	O
firm	O
light	O
tan	O
ill	O
defined	O
mass	O
near	O
the	O
.	O
uncinate	O
process	O
measuring	O
approximately	O
2	O
.	O
5	O
x	O
2	O
.	O
7	O
x	O
1	O
.	O
5	O
cm	O
.	O

Grossly	O
,	O
the	O
mass	O
comes	O
.	O
within	O
0	O
.	O
1	O
to	O
0	O
.	O
2	O
cm	O
of	O
the	O
black	O
painted	O
uncinate	O
process	O
margin	O
.	O

It	O
is	O
approximately	O
.	O

2	O
.	O
5	O
cm	O
away	O
from	O
the	O
blue	O
painted	O
pancreatic	O
body	O
margin	O
.	O

Grossly	O
,	O
the	O
mass	O
comes	O
within	O
.	O
less	O
than	O
0	O
.	O
1	O
cm	O
of	O
the	O
external	O
smooth	O
mesothelial	O
surface	O
of	O
the	O
pancreas	O
.	O

The	O
bile	O
.	O
duct	O
is	O
identified	O
and	O
upon	O
opening	O
,	O
contains	O
a	O
stent	O
.	O

The	O
bile	O
duct	O
measures	O
7	O
cm	O
in	O
.	O
length	O
and	O
has	O
a	O
circumference	O
of	O
2	O
.	O
5	O
cm	O
at	O
the	O
proximal	O
resection	O
margin	O
.	O

The	O
.	O
circumference	O
as	O
it	O
nears	O
the	O
ampulla	O
is	O
1	O
.	O
5	O
cm	O
.	O

The	O
mucosa	O
of	O
the	O
bile	O
duct	O
is	O
tan	O
and	O
.	O

is	O
hemorrhagic	O
where	O
the	O
stent	O
is	O
found	O
.	O

The	O
mucosal	O
surface	O
surrounding	O
the	O
ampulla	O
is	O
.	O
firm	O
and	O
indurated	O
.	O

Where	O
the	O
mucosa	O
of	O
the	O
ampulla	O
and	O
the	O
duodenum	O
is	O
firm	O
and	O
.	O
indurated	O
,	O
also	O
corresponds	O
to	O
the	O
location	O
of	O
the	O
tumor	O
which	O
is	O
found	O
in	O
the	O
pancreas	O
.	O

Found	O
in	O
the	O
adipose	O
adjacent	O
to	O
the	O
pancreas	O
,	O
are	O
four	O
possible	O
lymph	O
nodes	O
ranging	O
in	O
.	O
size	O
from	O
0	O
.	O
7	O
to	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Sections	O
of	O
the	O
specimen	O
as	O
follows	O
:	O
D1	O
.	O
bile	O
duct	O
margin	O
.	O

D2	O
/	O
3	O
.	O
one	O
section	O
of	O
the	O
mass	O
in	O
the	O
pancreas	O
bisected	O
.	O

These	O
sections	O
also	O
.	O
demonstrate	O
the	O
.	O
black	O
painted	O
uncinate	O
process	O
/	O
retroperitoneal	O
margin	O
,	O
as	O
well	O
as	O
the	O
.	O
indurated	O
duodenal	O
.	O
mucosa	O
.	O

D4	O
/	O
5	O
.	O
one	O
section	O
of	O
the	O
mass	O
in	O
the	O
pancreas	O
bisected	O
.	O

This	O
section	O
also	O
shows	O
.	O
the	O
black	O
.	O
painted	O
uncinate	O
process	O
/	O
retroperitoneal	O
margin	O
,	O
as	O
well	O
as	O
the	O
indurated	O
.	O
duodenal	O
.	O

mucosa	O
.	O
three	O
sections	O
of	O
bile	O
duct	O
and	O
ampulla	O
.	O

D8	O
/	O
9	O
.	O
shave	O
section	O
of	O
pancreatic	O
body	O
margin	O
bisected	O
.	O

D10	O
.	O
section	O
of	O
grossly	O
unremarkable	O
pancreas	O
with	O
identifiable	O
pancreatic	O
duct	O
.	O

Also	O
includes	O
.	O

a	O
section	O
of	O
bile	O
duct	O
where	O
the	O
stent	O
was	O
located	O
.	O

D11	O
/	O
12	O
.	O
two	O
further	O
sections	O
of	O
bile	O
duct	O
where	O
the	O
stent	O
was	O
found	O
.	O

D13	O
/	O
14	O
.	O
proximal	O
resection	O
margin	O
of	O
duodenum	O
?	O

distal	O
portion	O
of	O
stomach	O
bisected	O
.	O

D15	O
.	O
shave	O
section	O
distal	O
margin	O
of	O
duodenum	O
bisected	O
.	O

D16	O
.	O
one	O
possible	O
lymph	O
node	O
bisected	O
.	O

D17	O
.	O
two	O
possible	O
lymph	O
nodes	O
.	O

D18	O
/	O
19	O
.	O
one	O
possible	O
lymph	O
node	O
bisected	O
.	O

Frozen	O
Section	O
Diagnosis	O
.	O

C	O
:	O
Proximal	O
Bile	O
Duct	O
Margin	O
:	O
Low	O
grade	O
dysplasia	O
.	O

Negative	O
for	O
carcinoma	O
.	O

Encounter	O
Number	O
.	O

Patient	O
Location	O
.	O

Facility	O
:	O
Specimen	O
(	O
e	O
)	O
.	O

1	O
.	O

Thyrold	O
:	O
left	O
hemithyroid	O
stitch	O
upper	O
pole	O
.	O

Diagnosis	O
.	O

Papillary	O
carcinoma	O
,	O
follicular	O
variant	O
,	O
3	B
.	I
6	I
cm	I
;	O
mild	O
nodular	O
hyperplasia	O
:	O
Thyroid	O
,	O
left	O
hemithyroidectomy	O
specimen	O
.	O

Synoptic	O
Data	O
.	O

Clinical	O
History	O
:	O
No	O
radiation	O
exposure	O
.	O

Procedure	O
:	O
Left	O
hemithyroidectomy	O
.	O

Fresh	O
.	O

Specimen	O
Integrity	O
:	O
Intact	O
.	O

Specimen	O
Size	O
:	O
Left	O
lobe	O
:	O
4	O
.	O
3	O
cm	O
.	O

3	O
.	O
6	O
cm	O
.	O

2	O
.	O
3	O
cm	O
.	O

Isthmus	O
+	O
/	O
-	O
pyramidal	O
lobe	O
:	O
2	O
.	O
6	O
cm	O
.	O

0	O
.	O
8	O
cm	O
.	O

0	O
.	O
6	O
cm	O
.	O

Specimen	O
Weight	O
:	O
20	O
.	O
1	O
g	O
.	O

Tumor	O
Focality	O
:	O
Unifocal	O
.	O

DOMINANT	O
TUMOR	O
.	O

Tumor	O
Laterality	O
:	O
Left	O
lobe	O
.	O

Tumor	O
Size	O
:	O
Greatest	O
dimension	O
:	O
3	B
.	I
6cm	I
.	O

Additional	O
dimension	O
:	O
3	B
.	I
2	I
cm	I
.	O

Additional	O
dimension	O
:	O
2	B
.	I
1	I
cm	I
.	O

Histologic	O
Type	O
:	O
Papillary	O
carcinoma	O
,	O
.	O
follicular	O
variant	O
per	O
J35	O
,	O
follicular	O
varient	O
=	O
100	O
%	O
.	O

Follicular	O
architecture	O
.	O

Classical	O
cytomorphology	O
.	O

Histologic	O
Grade	O
:	O
Not	O
applicable	O
.	O

Margins	O
:	O
Margins	O
uninvolved	O
by	O
carcinoma	O
.	O

Tumor	O
Capsule	O
:	O
Totally	O
encapsulated	O
.	O

Tumor	O
Capsular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Lymph	O
-	O
Vascular	O
Invasion	O
:	O
Not	O
identified	O
.	O

Perineural	O
Invasion	O
:	O
Not	O
identified	O
.	O

Extrathyroidal	O
Extension	O
:	O
Not	O
identified	O
.	O

TNM	O
Descriptors	O
:	O
Not	O
applicable	O
.	O

Primary	O
Tumor	O
(	O
pT	O
)	O
:	O
pT2	O
:	O
Tumor	O
more	O
than	O
2	O
cm	O
,	O
but	O
not	O
more	O
than	O
4	O
cm	O
,	O
limited	O
to	O
thyroid	O
.	O

Regional	O
Lymph	O
Nodes	O
(	O
pN	O
)	O
:	O
pNX	O
:	O
Regional	O
lymph	O
nodes	O
cannot	O
be	O
assigned	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
examined	O
:	O
0	O
.	O

Number	O
of	O
regional	O
lymph	O
nodes	O
involved	O
:	O
0	O
.	O

Distant	O
Metastasis	O
(	O
pM	O
)	O
:	O
Not	O
applicable	O
.	O

Additional	O
Pathologic	O
Findings	O
:	O
Adenomatoid	O
nodule	O
(	O
s	O
)	O
or	O
Nodular	O
follicular	O
disease	O
.	O

Thyroiditis	O
,	O
palpation	O
.	O

Pathologic	O
Staging	O
is	O
based	O
on	O
AJCC	O
/	O
UICC	O
TNM	O
,	O
7th	O
Edition	O
.	O

Gross	O
Descriation	O
.	O

1	O
.	O

The	O
specimen	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
name	O
and	O
as	O
"	O
left	O
hemithyroid	O
stitch	O
upper	O
pole	O
"	O
,	O
consists	O
of	O
a	O
left	O
hemithyroidectorny	O
.	O
specimen	O
that	O
is	O
oriented	O
with	O
a	O
suture	O
and	O
weighs	O
20	O
.	O
1	O
g	O
.	O

The	O
lobe	O
measures	O
4	O
.	O
3cm	O
SI	O
x	O
3	O
.	O
6	O
cm	O
ML	O
x	O
2	O
.	O
3	O
cm	O
AP	O
and	O
the	O
isthmus	O
.	O
measures	O
2	O
.	O
6	O
SI	O
x	O
0	O
.	O
8	O
cm	O
ML	O
x	O
0	O
.	O
6	O
cm	O
AP	O
.	O

The	O
external	O
surfaces	O
have	O
fibrous	O
adhesions	O
and	O
are	O
painted	O
with	O
blue	O
dye	O
.	O
parathyroid	O
glands	O
or	O
no	O
lymph	O
nodes	O
are	O
identified	O
grossly	O
.	O

The	O
mid	O
superior	O
lobe	O
contains	O
one	O
well	O
delineated	O
nodule	O
that	O
.	O
measures	O
3	O
.	O
6	O
cm	O
SI	O
x	O
3	O
.	O
2	O
cm	O
ML	O
x	O
2	O
.	O
1	O
cm	O
AP	O
.	O

The	O
cut	O
surface	O
of	O
the	O
nodule	O
has	O
a	O
variegated	O
red	O
-	O
brown	O
color	O
and	O
has	O
a	O
soft	O
and	O
.	O
flabby	O
consistency	O
.	O

The	O
remainder	O
of	O
the	O
thyroid	O
tissue	O
is	O
homogenous	O
and	O
grossly	O
unremarkable	O
.	O

Sections	O
of	O
nodule	O
and	O
normal	O
.	O
tissue	O
are	O
stored	O
frozen	O
.	O

The	O
remainder	O
of	O
the	O
specimen	O
is	O
submitted	O
as	O
follows	O
:	O
1A	O
-	O
J	O
.	O
lobe	O
,	O
superior	O
to	O
Inferior	O
.	O

1K	O
.	O
isthmus	O
.	O

Gross	O
.	O

Microscopic	O
Description	O
.	O

Diagnosis	O
Details	O
.	O

Description	O
.	O

In	O
lesser	O
curvature	O
,	O
.	O

Mucosa	O
is	O
ulcerated	O
.	O

Tumor	O
is	O
.	O

Tubular	O
adenocarcinoma	O
,	O
.	O
there	O
is	O
an	O
ulcerated	O
.	O
invasion	O
into	O
serosa	O
.	O

Tumor	O
is	O
.	O
moderately	O
-	O
differentiated	O
,	O
.	O
tumor	O
,	O
with	O
.	O
composed	O
of	O
tubules	O
containing	O
.	O
infiltrating	O
serosa	O
.	O

3x3x1cm	O
in	O
size	O
,	O
.	O
necrosis	O
or	O
trabeculae	O
.	O

Glands	O
are	O
.	O
firm	O
and	O
gray	O
.	O
variability	O
in	O
size	O
and	O
shape	O
.	O

Tumor	O
.	O
surface	O
.	O

cells	O
are	O
moderately	O
straitified	O
.	O

Mitotic	O
index	O
is	O
present	O
.	O

Nuclei	O
are	O
.	O
hyperchromatic	O
and	O
irregularly	O
.	O
enlarged	O
and	O
prominent	O
nucleoli	O
.	O

Stroma	O
is	O
invasion	O
of	O
prominent	O
.	O
lymphocytes	O
.	O

Tumor	O
is	O
necrotic	O
.	O

Comments	O
.	O

STOMACH	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Gastrectomy	O
.	O

Tumor	O
site	O
:	O
Antrum	O
.	O

Tumor	O
size	O
:	O
3	B
X	I
3	I
X	I
1	I
cm	I
.	O

Tumor	O
features	O
:	O
Ulcerated	O
.	O

Histologic	O
type	O
:	O
Tubular	O
adenocarcinoma	O
.	O

Histologic	O
grade	O
:	O
Moderately	O
differentiated	O
.	O

Tumor	O
extent	O
:	O
Serosa	O
(	O
visceral	O
peritoneum	O
)	O
.	O

Lymph	O
nodes	O
:	O
3	O
/	O
10	O
positive	O
for	O
metastasis	O
(	O
Adjacent	O
.	O
lymph	O
node	O
3	O
/	O
10	O
)	O
.	O

Lymphatic	O
invasion	O
:	O
Present	O
.	O

Venous	O
invasion	O
:	O
Not	O
specified	O
.	O

Perineural	O
invasion	O
:	O
Not	O
specified	O
.	O

Margins	O
:	O
Not	O
specified	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Not	O
specified	O
.	O

Comments	O
:	O
None	O
.	O

Laterality	O
:	O
Tumor	O
Features	O
:	O
Pigmented	O
,	O
Tumor	O
Extent	O
:	O
Tumor	O
2	O
.	O
01	O
?	O
4mm	O
.	O
with	O
or	O
without	O
ulceration	O
,	O
Venous	O
Invasion	O
:	O
Absent	O
,	O
Margins	O
:	O
Absent	O
,	O
Treatment	O
Effect	O
:	O
Path	O
Report	O
:	O
SKIN	O
TISSUE	O
CHECKLIST	O
.	O

Specimen	O
type	O
:	O
Excision	O
of	O
skin	O
lesion	O
.	O

Tumor	O
site	O
:	O
Skin	O
,	O
facial	O
.	O

Tumor	O
size	O
:	O
1	B
.	I
5	I
x	I
1	I
x	I
2	I
cm	I
.	O

Tumor	O
features	O
:	O
Pigmented	O
.	O

Satellite	O
nodules	O
:	O
Present	O
.	O

Histologic	O
type	O
:	O
Malignant	O
melanoma	O
.	O

Histologic	O
grade	O
:	O
Lymph	O
nodes	O
:	O
Not	O
specified	O
.	O

Lymphatic	O
invasion	O
:	O
Not	O
specified	O
.	O

Venous	O
invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Uninvolved	O
.	O

Evidence	O
of	O
neo	O
-	O
adjuvant	O
treatment	O
:	O
Not	O
specified	O
.	O

Additional	O
pathologic	O
findings	O
:	O
Breslow	O
thickness	O
is	O
4	O
mm	O
.	O

Comments	O
:	O
None	O
.	O

SPECIMENS	O
:	O
A	O
.	O

TUMOR	O
BED	O
LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

B	O
.	O

LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
.	O

TUMOR	O
BED	O
LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

B	O
.	O

LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

DIAGNOSIS	O
:	O
A	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
TUMOR	O
BED	O
BIOPSY	O
:	O
-	O
NEGATIVE	O
FOR	O
MALIGNANCY	O
.	O

B	O
.	O

KIDNEY	O
,	O
LEFT	O
,	O
PARTIAL	O
NEPHRECTOMY	O
:	O
-	O
RENAL	O
CELL	O
CARCINOMA	O
,	O
PAPILLARY	O
TYPE	O
.	O

-	O
FUHRMAN	O
NUCLEAR	O
GRADE	O
2	O
.	O

-	O
TUMOR	O
SIZE	O
:	O
6	B
.	I
2	I
X	I
6	I
X	I
5	I
.	I
3	I
CM	I
.	O

-	O
SURGICAL	O
MARGIN	O
PSITIVE	O
(	O
FOCAL	O
:	O
1MM	O
)	O
.	O

-	O
NO	O
VASCULAR	O
INVASION	O
IDENTIFIED	O
.	O

-	O
TUMOR	O
LIMITED	O
TO	O
THE	O
KIDNEY	O
.	O

SYNOPTIC	O
REPORT	O
-	O
KIDNEY	O
(	O
PARTIAL	O
OR	O
RADICAL	O
)	O
.	O

Specimens	O
Involved	O
.	O

Specimens	O
:	O
A	O
:	O
TUMOR	O
BED	O
LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

B	O
:	O
LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

Specimen	O
Type	O
:	O
Partial	O
nephrectomy	O
.	O

Without	O
adrenal	O
gland	O
.	O

Laterality	O
:	O
Left	O
.	O

Tumor	O
Site	O
:	O
Not	O
specified	O
.	O

Focality	O
:	O
Unifocal	O
.	O

Tumor	O
Size	O
(	O
largest	O
tumor	O
if	O
multiple	O
)	O
:	O
Greatest	O
dimension	O
:	O
6	O
.	O
2cm	O
.	O

Additional	O
dimensions	O
:	O
6cm	O
X	O
5	O
.	O
3cm	O
.	O

Macroscopic	O
Extent	O
of	O
Tumor	O
:	O
Tumor	O
limited	O
to	O
kidney	O
.	O

WHO	O
CLASSIFICATION	O
.	O

Papillary	O
renal	O
cell	O
carcinoma	O
8260	O
/	O
3	O
.	O

Histologic	O
Grade	O
(	O
Fuhrman	O
Nuclear	O
Grade	O
)	O
:	O
G2	O
:	O
Nuclei	O
slightly	O
irregular	O
,	O
approximately	O
15	O
u	O
;	O
.	O
nucleoli	O
evident	O
.	O

Invasion	O
of	O
Vascular	O
/	O
Lymphatic	O
:	O
Absent	O
.	O

Perinephric	O
Tissue	O
Invasion	O
:	O
Absent	O
.	O

Margins	O
:	O
Margin	O
(	O
s	O
)	O
involved	O
by	O
invasive	O
carcinoma	O
.	O

Include	O
:	O
Renal	O
parenchymal	O
margin	O
(	O
partial	O
nephrectomy	O
only	O
)	O
.	O

Distance	O
:	O
Ocm	O
.	O

Adrenal	O
Gland	O
:	O
Not	O
present	O
.	O

Regional	O
Lymph	O
Nodes	O
:	O
None	O
sampled	O
.	O

Additional	O
Findings	O
:	O
None	O
identified	O
.	O

Pathological	O
Staging	O
(	O
pTNM	O
)	O
:	O
pT	O
1b	O
N	O
X	O
M	O
X	O
.	O

Pathological	O
staging	O
is	O
based	O
on	O
the	O
AJCC	O
Cancer	O
Staging	O
Manual	O
,	O
7th	O
Edition	O
.	O

pMX	O
:	O
Cannot	O
be	O
assessed	O
.	O

GROSS	O
DESCRIPTION	O
:	O
A	O
.	O

TUMOR	O
BED	O
LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
and	O
designated	O
"	O
tumor	O
bed	O
,	O
left	O
partial	O
.	O

nephrectomy	O
"	O
is	O
a	O
fragment	O
of	O
tan	O
fibrous	O
tissue	O
measuring	O
0	O
.	O
3	O
X	O
0	O
.	O
3	O
X	O
0	O
.	O
2	O
cm	O
.	O

Entirely	O
submitted	O
for	O
.	O
frozen	O
section	O
,	O
FSA	O
.	O

B	O
.	O

LEFT	O
PARTIAL	O
NEPHRECTOMY	O
.	O

Received	O
fresh	O
labeled	O
with	O
the	O
patient	O
'	O
s	O
identification	O
and	O
designated	O
"	O
left	O
partial	O
nephrectomy	O
"	O
is	O
an	O
.	O
intact	O
,	O
unoriented	O
,	O
partial	O
nephrectomy	O
specimen	O
,	O
6	O
.	O
5	O
X	O
6	O
X	O
5	O
.	O
3	O
cm	O
,	O
with	O
detached	O
fragment	O
of	O
adipose	O
.	O
tissue	O
,	O
13	O
.	O
2	O
X	O
4	O
.	O
5	O
X	O
2	O
cm	O
,	O
collectively	O
weighing	O
104	O
g	O
.	O

The	O
parenchymal	O
margin	O
inked	O
black	O
,	O
remainder	O
.	O
of	O
kidney	O
specimen	O
inked	O
blue	O
.	O

The	O
kidney	O
is	O
sectioned	O
to	O
show	O
an	O
encapsulated	O
,	O
golden	O
tan	O
,	O
lobulated	O
,	O
.	O
soft	O
friable	O
mass	O
measuring	O
6	O
.	O
2	O
x	O
6	O
X	O
5	O
.	O
3	O
cm	O
,	O
approaching	O
the	O
parenchymal	O
margin	O
at	O
distance	O
of	O
0	O
.	O
3	O
.	O

cm	O
.	O

The	O
fragment	O
of	O
adipose	O
tissue	O
is	O
sectioned	O
to	O
show	O
unremarkable	O
cut	O
surface	O
.	O

Gross	O
photographs	O
.	O
are	O
taken	O
.	O

A	O
portion	O
of	O
the	O
specimen	O
is	O
submitted	O
for	O
tissue	O
procurement	O
,	O
representatively	O
submitted	O
:	O
B1	O
-	O
B5	O
:	O
Representative	O
sections	O
,	O
mass	O
and	O
parenchymal	O
margin	O
.	O

B6	O
-	O
B9	O
:	O
Representative	O
sections	O
,	O
mass	O
.	O

B10	O
:	O
Representative	O
sections	O
,	O
detached	O
fragment	O
adipose	O
tissue	O
.	O

CLINICAL	O
HISTORY	O
:	O
None	O
given	O
.	O

PRE	O
-	O
OPERATIVE	O
DIAGNOSIS	O
:	O
Left	O
renal	O
mass	O
.	O

FROZEN	O
SECTION	O
INTRAOPERATIVE	O
REPORT	O
:	O
FSA	O
:	O
Soft	O
tissue	O
,	O
tumor	O
bed	O
,	O
biopsy	O
:	O
Fibroadipose	O
tissue	O
defer	O
to	O
permanent	O
.	O

Diagnosis	O
called	O
at	O
.	O

Microscopic	O
/	O
Diagnostic	O
Dictation	O
:	O
.	O
,	O
Pathologist	O
,	O
.	O

Final	O
Review	O
:	O
.	O

Pathologist	O
,	O
.	O

Final	O
:	O
Pathologist	O
.	O

DIAGNOSIS	O
.	O

(	O
A	O
)	O
STOMACH	O
,	O
LESSER	O
CURVATURE	O
ULCER	O
SCAR	O
,	O
BIOPSY	O
:	O
Gastric	O
mucosa	O
with	O
focal	O
active	O
inflammation	O
,	O
fibrosis	O
of	O
the	O
lamina	O
propria	O
and	O
foveolar	O
hyperplasia	O
;	O
.	O
negative	O
for	O
carcinoma	O
.	O

(	O
B	O
)	O
DISTAL	O
ESOPHAGEAL	O
TUMOR	O
,	O
BIOPSY	O
:	O
INVASIVE	O
ADENOCARCINOMA	O
,	O
MODERATELY	O
TO	O
POORLY	O
DIFFERENTIATED	O
.	O

COLUMNAR	O
MUCOSA	O
WITH	O
HIGH	O
GRADE	O
DYSPLASIA	O
.	O

Entire	O
report	O
and	O
diagnosis	O
completed	O
by	O
.	O

GROSS	O
DESCRIPTION	O
.	O

(	O
A	O
)	O
ULCER	O
,	O
SCAR	O
,	O
LESSER	O
CURVATURE	O
-	O
Multiple	O
tan	O
-	O
pink	O
irregular	O
fragments	O
of	O
tissue	O
(	O
1	O
.	O
0	O
X	O
0	O
.	O
7	O
x	O
0	O
.	O
2	O
cm	O
in	O
aggregate	O
)	O
.	O

Toto	O
in	O
A	O
.	O

(	O
B	O
)	O
DISTAL	O
ESOPHAGEAL	O
TUMOR	O
-	O
Multiple	O
tan	O
-	O
pink	O
irregular	O
fragments	O
of	O
tissue	O
(	O
1	B
.	I
3	I
X	I
0	I
.	I
7	I
x	I
0	I
.	I
2	I
cm	I
in	O
aggregate	O
)	O
.	O

Toto	O
in	O
B	O
.	O

CLINICAL	O
HISTORY	O
.	O

Esophageal	O
cancer	O
and	O
Barrett	O
esophagus	O
.	O

SNOMED	O
CODES	O
.	O

"	O
Some	O
tests	O
reported	O
here	O
may	O
have	O
been	O
developed	O
and	O
performance	O
characteristics	O
determined	O
by	O
.	O

These	O
tests	O
have	O
not	O
been	O
.	O
specifically	O
cleared	O
or	O
approved	O
by	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
.	O
"	O
.	O

Released	O
by	O
:	O
END	O
OF	O
REPORT	O
-	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Palpable	O
right	O
breast	O
mass	O
with	O
core	O
biopsy	O
showing	O
invasive	O
cancer	O
.	O

Specimens	O
Submitted	O
:	O
2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

2	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
2	O
,	O
right	O
axilla	O
.	O

4	O
:	O
SP	O
:	O
Right	O
breast	O
.	O

5	O
:	O
SP	O
:	O
Sentinel	O
nodes	O
#	O
4	O
and	O
#	O
5	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

6	O
:	O
SP	O
:	O
Non	O
-	O
sentinel	O
nodes	O
right	O
axilla	O
.	O

DIAGNOSIS	O
:	O
1	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
1	O
LEVEL	O
I	O
RIGHT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
ADDITIONAL	O
H	O
/	O
E	O
LEVELS	O
AND	O
CYTOKERATIN	O
(	O
AE1	O
:	O
AE3	O
)	O
IMMUNOSTAINS	O
ARE	O
ALSO	O
.	O

NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
.	O

2	O
)	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
2	O
LEVEL	O
I	O
RIGHT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
ADDITIONAL	O
H	O
/	O
E	O
LEVELS	O
AND	O
CYTOKERATIN	O
(	O
AE1	O
:	O
AE3	O
)	O
IMMUNOSTAINS	O
ARE	O
ALSO	O
.	O

NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
.	O

LYMPH	O
NODE	O
,	O
SENTINEL	O
#	O
3	O
LEVEL	O
II	O
RIGHT	O
AXILLA	O
;	O
BIOPSY	O
:	O
-	O
ONE	O
BENIGN	O
LYMPH	O
NODE	O
(	O
0	O
/	O
1	O
)	O
.	O

-	O
ADDITIONAL	O
H	O
/	O
E	O
LEVELS	O
AND	O
CYTOKERATIN	O
(	O
AE1	O
:	O
AE3	O
)	O
IMMUNOSTAINS	O
ARE	O
ALSO	O
.	O

NEGATIVE	O
FOR	O
METASTATIC	O
TUMOR	O
.	O

4	O
)	O
.	O

BREAST	O
,	O
RIGHT	O
;	O
TOTAL	O
MASTECTOMY	O
:	O
-	O
INVASIVE	O
DUCTAL	O
CARCINOMA	O
,	O
MODERATELY	O
DIFFERENTIATED	O
WITH	O
.	O

SOLID	O
-	O
PAPILLARY	O
GROWTH	O
PATTERN	O
AND	O
MUCINOUS	O
DIFFERENTIATION	O
,	O
MEASURING	O
2	B
.	I
2	I
.	I

CM	B
IN	O
LARGEST	O
DIMENSION	O
MICROSCOPICALLY	O
.	O

FOCAL	O
DUCTAL	O
CARCINOMA	O
IN	O
SITU	O
(	O
DCIS	O
)	O
.	O

SOLID	O
-	O
PAPILLARY	O
,	O
SOLID	O
AND	O
.	O

CRIBRIFORM	O
TYPES	O
WITH	O
LOW	O
TO	O
INTERMEDIATE	O
NUCLEAR	O
GRADE	O
AND	O
MINIMAL	O
.	O

NECROSIS	O
.	O

-	O
NIPPLE	O
,	O
SXIN	O
AND	O
SURGICAL	O
MARGINS	O
ARE	O
NEGATIVE	O
FOR	O
TUMOR	O
.	O

-	O
NO	O
CONVINCING	O
EVIDENCE	O
OF	O
LYMPHOVASCULAR	O
INVASION	O
.	O

-	O
PREVIOUS	O
BIOPSY	O
SITE	O
CHANGES	O
,	O
STROMAL	O
FIBROSIS	O
AND	O
ATROPHY	O
.	O

-	O
IMMUNOHISTOCHEMICAL	O
STAINS	O
WERE	O
PERFORMED	O
ON	O
FORMALIN	O
-	O
FIXED	O
TISSUE	O
.	O

WITH	O
THE	O
FOLLOWING	O
RESULTS	O
FOR	O
INVASIVE	O
CARCINOMA	O
(	O
BLOCK	O
"	O
T3	O
)	O
:	O
rage	O
2	O
or	O
5	O
.	O

ESTROGEN	O
RECEPTOR	O
(	O
6F11	O
,	O
.	O

100	O
%	O
NUCLEAR	O
STAINING	O
.	O

WITH	O
STRONG	O
INTENSITY	O
.	O

PROGESTERONE	O
RECEPTOR	O
(	O
1E2	O
;	O
.	O

5	O
	O
NUCLEAR	O
STAINING	O
.	O

WITH	O
MODERATE	O
INTENSITY	O
.	O

HER	O
-	O
2	O
/	O
NEU	O
(	O
HercepTest	O
;	O
.	O
NEGATIVE	O
(	O
STAINING	O
.	O
INTENSITY	O
OF	O
0	O
)	O
.	O
5	O
)	O
.	O

LYMPH	O
NODES	O
,	O
SENTINEL	O
#	O
4	O
AND	O
#	O
5	O
LEVEL	O
I	O
RIGHT	O
AXILLA	O
;	O
EXCISION	O
:	O
-	O
TWO	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
2	O
)	O
.	O

6	O
)	O
.	O

LYMPH	O
NODES	O
,	O
NON	O
-	O
SENTINEL	O
RIGHT	O
AXILLA	O
;	O
EXCISION	O
:	O
FIVE	O
BENIGN	O
LYMPH	O
NODES	O
(	O
0	O
/	O
5	O
)	O
.	O

I	O
ATTEST	O
THAT	O
THE	O
ABOVE	O
DLAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
.	O

THE	O
SLIDES	O
(	O
AND	O
/	O
OR	O
OTHER	O
MATERIAL	O
)	O
.	O

AND	O
THAT	O
I	O
HAVE	O
REVIEWED	O
AND	O
APPROVED	O
.	O

THIS	O
REPORT	O
.	O

Special	O
Studies	O
:	O
Special	O
Stain	O
.	O

Comment	O
.	O

RECUT	O
.	O

Gross	O
Description	O
:	O
1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
.	O
labeled	O
"	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
one	O
,	O
right	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
single	O
.	O
pink	O
tan	O
firm	O
lymph	O
node	O
measuring	O
1	O
.	O
2	O
cm	O
in	O
greatest	O
dimension	O
.	O

Bisected	O
.	O
and	O
entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

2	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
consultation	O
,	O
.	O
labeled	O
Sentinel	O
node	O
#	O
2	O
,	O
level	O
1	O
,	O
right	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
pink	O
tan	O
.	O
firm	O
lymph	O
node	O
measuring	O
0	O
.	O
5	O
cm	O
.	O

Entirely	O
submitted	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

1	O
.	O

3	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozon	O
section	O
consultation	O
,	O
.	O
labeled	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
2	O
,	O
right	O
axilla	O
"	O
and	O
consists	O
of	O
a	O
single	O
.	O
pink	O
tan	O
firm	O
lymph	O
node	O
measuring	O
0	O
.	O
8	O
cm	O
.	O

Bicected	O
and	O
entirely	O
submitted	O
.	O
for	O
frozen	O
section	O
.	O

Summary	O
of	O
sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

4	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
labeled	O
,	O
"	O
Right	O
breast	O
,	O
stitch	O
marks	O
.	O
axillary	O
tail	O
and	O
consists	O
of	O
a	O
breast	O
measuring	O
25	O
.	O
2	O
x	O
24	O
.	O
6	O
x	O
3	O
.	O
2	O
cm	O
with	O
.	O
overlying	O
ckin	O
ellipse	O
measuring	O
15	O
.	O
1	O
x	O
14	O
.	O
6	O
cm	O
.	O

Situated	O
centrally	O
on	O
the	O
.	O
skin	O
surface	O
is	O
an	O
everted	O
nipple	O
measuring	O
1	O
.	O
1	O
cm	O
and	O
areola	O
measuring	O
4	O
.	O
1	O
.	O

x	O
4	O
.	O
2	O
cm	O
.	O

There	O
is	O
no	O
scar	O
on	O
the	O
skin	O
surface	O
.	O

A	O
suture	O
demarcates	O
the	O
.	O
axillary	O
aspect	O
.	O

The	O
posterior	O
surface	O
of	O
the	O
breast	O
is	O
inked	O
black	O
and	O
the	O
.	O
axillary	O
aspect	O
is	O
inked	O
green	O
.	O

The	O
specimen	O
is	O
serially	O
sectioned	O
to	O
.	O
reveal	O
a	O
2	B
.	I
5	I
x	I
2	I
.	I
2	I
x	I
2	I
.	I
3	I
cm	I
well	O
circunscribed	O
,	O
brown	O
,	O
focally	O
hemorrhagic	O
.	O
mass	O
located	O
at	O
the	O
11	O
o	O
'	O
clock	O
axis	O
(	O
upper	O
outer	O
quadrant	O
)	O
,	O
0	O
.	O
9	O
cm	O
from	O
the	O
.	O
deep	O
margin	O
.	O

A	O
metallic	O
clip	O
is	O
identified	O
adjacent	O
to	O
this	O
lesion	O
.	O

Additionally	O
,	O
a	O
1	O
.	O
7	O
x	O
1	O
.	O
5	O
x	O
1	O
.	O
5	O
cm	O
fibrous	O
area	O
with	O
areas	O
of	O
hemorrhage	O
and	O
.	O
necrosis	O
is	O
present	O
inferior	O
to	O
the	O
2	O
.	O
5	O
em	O
mass	O
in	O
the	O
11	O
o	O
'	O
clock	O
axis	O
in	O
.	O
the	O
retroareolar	O
region	O
.	O

No	O
other	O
masses	O
or	O
lesions	O
are	O
grossly	O
identified	O
.	O

The	O
cut	O
surfaces	O
are	O
composed	O
of	O
60	O
%	O
fatty	O
and	O
40	O
%	O
fibrous	O
ticsue	O
.	O

Sectioning	O
of	O
the	O
axillary	O
aspect	O
reveals	O
no	O
grossly	O
identifiable	O
lymph	O
.	O
nodes	O
.	O

Tissue	O
submitted	O
for	O
TPS	O
.	O

Representative	O
sections	O
are	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
N	O
nipple	O
.	O

NB	O
-	O
nipple	O
base	O
.	O

s	O
skin	O
.	O

D	O
deep	O
margin	O
.	O

T	O
tumor	O
.	O

UIQ	O
-	O
upper	O
inner	O
quadrant	O
.	O

LIQ	O
-	O
lower	O
inner	O
quadrant	O
.	O

UOQ	O
-	O
upper	O
outer	O
quadrant	O
.	O

LOQ	O
-	O
lower	O
outer	O
quadrant	O
.	O

RA	O
-	O
retzoareolar	O
fibrous	O
tissue	O
.	O

5	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
labeled	O
,	O
"	O
Sentinel	O
nodes	O
#	O
4	O
and	O
.	O

5	O
,	O
level	O
1	O
,	O
right	O
axilla	O
"	O
,	O
and	O
consists	O
of	O
two	O
tan	O
lymph	O
nodes	O
measuring	O
2	O
.	O

cm	O
and	O
0	O
.	O
8	O
cm	O
respectively	O
.	O

Both	O
are	O
bisected	O
and	O
entirely	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LLN	O
-	O
larger	O
lymph	O
node	O
(	O
bisected	O
and	O
submitted	O
in	O
two	O
cassettes	O
)	O
.	O

SLN	O
-	O
smaller	O
lymph	O
node	O
.	O

6	O
)	O
.	O

The	O
specimen	O
is	O
received	O
in	O
formalin	O
,	O
labeled	O
"	O
Non	O
-	O
sentinel	O
nodes	O
.	O
right	O
axilla	O
"	O
and	O
consists	O
of	O
multiple	O
pink	O
tan	O
firm	O
lymph	O
nodes	O
ranging	O
.	O
from	O
0	O
.	O
2	O
cm	O
to	O
2	O
.	O
1	O
cm	O
in	O
greatest	O
dimension	O
.	O

All	O
identified	O
lymph	O
nodes	O
are	O
.	O
submitted	O
.	O

Summary	O
of	O
sections	O
:	O
LN	O
-	O
lymph	O
nodes	O
.	O

BLN	O
-	O
bisected	O
lymph	O
node	O
.	O

LLN	O
-	O
largest	O
lymph	O
node	O
bisected	O
and	O
submitted	O
in	O
two	O
cassettes	O
.	O
rage	O
4	O
or	O
5	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
1	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O
site	O
.	O

PCs	O
.	O

1	O
.	O

FSC	O
.	O

1	O
.	O

Part	O
2	O
:	O
SP	O
:	O
Sentincl	O
node	O
#	O
2	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

FSC	O
.	O

1	O
.	O

Part	O
3	O
:	O
SP	O
:	O
Sentinel	O
node	O
#	O
3	O
,	O
level	O
2	O
,	O
right	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

FSC	O
.	O

Part	O
4	O
:	O
SP	O
:	O
Right	O
breast	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

1	O
.	O

1	O
.	O

LIQ	O
.	O

1	O
.	O

1	O
.	O

LOQ	O
.	O

1	O
.	O

1	O
.	O

N	O
.	O

1	O
.	O

1	O
.	O

NB	O
.	O

1	O
.	O

2	O
.	O

RA	O
.	O

2	O
.	O

1	O
.	O

S	O
.	O

6	O
.	O

6	O
.	O

1	O
.	O

UIQ	O
.	O

1	O
.	O

UOQ	O
.	O

1	O
.	O

Part	O
5	O
:	O
SP	O
:	O
Sentincl	O
nodes	O
#	O
4	O
and	O
#	O
5	O
,	O
level	O
1	O
,	O
right	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

LLN	O
.	O

2	O
.	O

1	O
.	O

SLN	O
.	O

1	O
.	O

Part	O
6	O
:	O
SP	O
:	O
Non	O
-	O
sentinel	O
nodes	O
right	O
axilla	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O

BLN	O
.	O

1	O
.	O

2	O
.	O

LLN	O
.	O

2	O
.	O

1	O
.	O

LN	O
.	O

1	O
.	O

Intraopezative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
cample	O
.	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
consultation	O
.	O
ray	O
a	O
or	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTINEL	O
NODE	O
#	O
1	O
,	O
LEVEL	O
1	O
,	O
.	O

RIGHT	O
AXILLA	O
.	O

BENIGN	O
LYMPH	O
NODE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

2	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTINEL	O
NODE	O
#	O
2	O
,	O
LEVEL	O
1	O
.	O

RIGHT	O
AXILLA	O
.	O

RENIGN	O
LYMPH	O
NODE	O
,	O
MAINLY	O
FIBROFATTY	O
WITH	O
SCANTY	O
.	O

LYMPHOID	O
TISSUE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

3	O
)	O
.	O

SECTION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTINEL	O
NODE	O
#	O
3	O
,	O
LEVEL	O
2	O
,	O
.	O

RIGHT	O
AXILLA	O
.	O

BENIGN	O
LYMPH	O
NODE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
tissue	O
sample	O
.	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraopezative	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
.	O

CECTION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTIMET	O
MODE	O
#	O
1	O
,	O
LEVEL	O
1	O
,	O
.	O

RIGHT	O
AXILLA	O
.	O

BENIGN	O
LYMPH	O
NODE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

2	O
)	O
.	O

FROZEM	O
ION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTINEL	O
NODE	O
#	O
2	O
,	O
LEVEL	O
1	O
,	O
.	O

RIGHT	O
AXILLA	O
.	O

:	O
BENIGN	O
LYMPH	O
NODE	O
,	O
MAINLY	O
FIBROFATTY	O
WITH	O
SCANTY	O
.	O

LYMPHOID	O
TISSUE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

3	O
)	O
.	O

FROVEN	O
.	O

ION	O
DIAGNOSIS	O
:	O
SP	O
:	O
SENTINEL	O
NODE	O
#	O
3	O
,	O
LEVEL	O
2	O
,	O
.	O

RIGHT	O
AXILLA	O
.	O

BENIGN	O
LYMPH	O
NODE	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

CLINICAL	O
DETAILS	O
.	O

Left	O
frontal	O
mass	O
.	O

?	O
low	O
grade	O
glioma	O
.	O

?	O
metastasis	O
.	O

?	O
lymphoma	O
.	O

FROZEN	O
SECTION	O
REPORT	O
.	O

SPECIMEN	O
:	O
"	O
LEFT	O
FRONTAL	O
MASS	O
FROZEN	O
SECTION	O
"	O
.	O

REPORT	O
:	O
Glioma	O
.	O

No	O
definite	O
high	O
grade	O
features	O
seen	O
but	O
increased	O
cellularity	O
noted	O
.	O

Await	O
.	O
paraffin	O
sections	O
for	O
further	O
grading	O
.	O

PHONED	O
TO	O
:	O
Ext	O
:	O
TIME	O
:	O
SECTIONED	O
BY	O
:	O
Clinical	O
history	O
:	O
see	O
above	O
.	O

Imaging	O
findings	O
:	O
MRI	O
brain	O
.	O

FIRST	O
SEIZURE	O
PRESENTATION	O
.	O

LEFT	O
FRONTAL	O
NON	O
-	O
ENHANCING	O
CYSTIC	O
LESION	O
ON	O
MRI	O
SCAN	O
DONE	O
IN	O
.	O

(	O
FOR	O
INTRAOPERATIVEMRI	O
)	O
.	O

Initial	O
sequences	O
demonstrate	O
a	O
large	O
intra	O
-	O
axial	O
mass	O
lesion	O
.	O
within	O
the	O
left	O
frontal	O
lobe	O
measuring	O
up	O
to	O
7	O
.	O
5	O
x	O
3	O
.	O

3cm	O
in	O
maxinum	O
axial	O
dimension	O
and	O
with	O
"	O
.	O
partially	O
cystic	O
component	O
superiorly	O
.	O

Following	O
sequences	O
demonstrate	O
resection	O
of	O
a	O
large	O
.	O
component	O
of	O
the	O
lesion	O
without	O
apparent	O
complication	O
.	O

Please	O
see	O
Surgeon	O
'	O
s	O
report	O
for	O
detuils	O
.	O
"	O
.	O

Radiological	O
Size	O
of	O
Lesion	O
:	O
7	O
.	O
5	O
x	O
3	O
.	O
3cm	O
.	O

Contrast	O
enhancement	O
:	O
non	O
enhancing	O
.	O

Current	O
and	O
previous	O
treatment	O
:	O
nil	O
stated	O
.	O

Previous	O
pathology	O
lab	O
number	O
:	O
nil	O
present	O
.	O

Anatomical	O
site	O
:	O
frontal	O
lobe	O
.	O

Intra	O
-	O
axial	O
/	O
extra	O
-	O
axial	O
:	O
intra	O
-	O
axial	O
.	O

Laterality	O
of	O
tumour	O
:	O
left	O
.	O

Specimen	O
type	O
:	O
biopsy	O
.	O

Clinical	O
or	O
differential	O
diagnosis	O
:	O
?	O
low	O
grade	O
glioma	O
.	O

?	O
metastasis	O
.	O

?	O
lymphoma	O
.	O

MACROSCOPIC	O
DESCRIPTION	O
.	O

Two	O
specimens	O
received	O
.	O

1	O
.	O

"	O
LEFT	O
FRONTAL	O
MASS	O
FROZEN	O
SECTION	O
"	O
.	O

There	O
are	O
two	O
reddish	O
tan	O
fragments	O
measuring	O
.	O

5mm	O
and	O
2mm	O
.	O

First	O
half	O
of	O
largest	O
piece	O
bisceted	O
and	O
embedded	O
in	O
block	O
A	O
and	O
two	O
smears	O
made	O
.	O

H	O
+	O
E	O
and	O
tol	O
blue	O
.	O

le	O
frozen	O
section	O
piece	O
has	O
been	O
kept	O
frozen	O
and	O
residual	O
.	O
tissue	O
embedded	O
in	O
block	O
A	O
.	O

Histopathology	O
Report	O
.	O

Temporary	O
Copy	O
.	O

Case	O
:	O
:	O
2	O
.	O

"	O
LEFT	O
FRONTAL	O
MASS	O
HISTOPATHOLOGY	O
"	O
.	O

There	O
is	O
one	O
fragment	O
of	O
pale	O
partially	O
very	O
.	O
soll	O
and	O
haemorrhagie	O
tissue	O
.	O
aggregating	O
to	O
35	O
x	O
20	O
x	O
13mm	O
.	O

All	O
embedded	O
from	O
block	O
A	O
-	O
D	O
.	O

MICROSCOPIC	O
REPORT	O
.	O

Specimen	O
1	O
and	O
2	O
show	O
features	O
of	O
Oligodendroglioma	O
WHO	O
(	O
2007	O
)	O
Grade	O
II	O
.	O

The	O
tumour	O
is	O
infiltrative	O
and	O
is	O
of	O
moderate	O
to	O
dense	O
cellularity	O
.	O

It	O
is	O
composed	O
of	O
mostly	O
round	O
to	O
.	O
oval	O
cells	O
displaying	O
mild	O
nuclear	O
pleomorphism	O
,	O
perinuclear	O
halos	O
and	O
set	O
in	O
a	O
fibrillary	O
.	O
background	O
.	O

Delicate	O
branching	O
vascular	O
network	O
is	O
evident	O
.	O

In	O
some	O
areas	O
,	O
the	O
tumour	O
has	O
a	O
.	O
demarcated	O
pushing	O
edge	O
and	O
the	O
adjacent	O
brain	O
is	O
severely	O
gliotic	O
with	O
many	O
gemistocytic	O
.	O
astrocytes	O
and	O
rosenthal	O
-	O
like	O
fibres	O
are	O
seen	O
(	O
block	O
2D	O
)	O
.	O

There	O
is	O
perivascular	O
lymphocytic	O
cuffing	O
.	O

Therc	O
is	O
adjacent	O
brain	O
cortex	O
and	O
leptomeninges	O
scen	O
in	O
block	O
2A	O
.	O

Perinuclear	O
satellitosis	O
is	O
not	O
a	O
.	O
feature	O
in	O
this	O
biopsy	O
.	O

Mitotic	O
figures	O
are	O
very	O
infrequent	O
with	O
only	O
two	O
isolated	O
mitosis	O
identified	O
in	O
.	O
all	O
tumour	O
blocks	O
.	O

There	O
is	O
no	O
necrosis	O
or	O
endothelial	O
proliferation	O
.	O

Immunohistochemistry	O
was	O
perfonmed	O
:	O
IDH	O
1	O
(	O
R132H	O
)	O
:	O
GFAP	O
:	O
p53	O
:	O
EGFR	O
:	O
Ki	O
-	O
67	O
:	O
Microscopic	O
findings	O
:	O
see	O
above	O
.	O

Histological	O
tumour	O
type	O
:	O
Oligodendroglioma	O
.	O

Histological	O
tumour	O
grade	O
:	O
WHO	O
(	O
2007	O
)	O
grade	O
II	O
.	O

Brain	O
invasion	O
(	O
for	O
meningiomas	O
)	O
:	O
n	O
/	O
a	O
.	O

Artefacts	O
impacting	O
specimen	O
:	O
nil	O
significant	O
.	O

ANCILLARY	O
TEST	O
FINDINGS	O
.	O

Immunohistochemical	O
stains	O
block	O
:	O
2A	O
.	O

Immunohistochemical	O
stains	O
result	O
:	O
IDH	O
1	O
(	O
R132H	O
)	O
:	O
NEGATIVE	O
.	O

Positive	O
antibodies	O
:	O
GFAP	O
(	O
patchy	O
)	O
,	O
EGFR	O
(	O
moderate	O
)	O
.	O

p53	O
(	O
20	O
%	O
nuclei	O
)	O
.	O

Negative	O
antibodies	O
:	O
IDHI	O
(	O
R132H	O
)	O
.	O

Equivocal	O
antibodies	O
:	O
Ki	O
-	O
67	O
labelling	O
index	O
:	O
5	O
%	O
.	O

Molecular	O
pathology	O
testing	O
:	O
FISH	O
for	O
1p	O
/	O
19q	O
and	O
EGFR	O
.	O

IDH	O
sequencing	O
.	O

Research	O
consent	O
:	O
Research	O
block	O
:	O
2B	O
.	O

Dage	O
3of	O
.	O
3	O
.	O

Histopathology	O
Report	O
.	O

Temporary	O
Copy	O
.	O

SUMMARY	O
.	O

Specimen	O
1	O
and	O
2	O
,	O
Left	O
frontal	O
mass	O
:	O
-	O
Oligodendroglioma	O
WHO	O
(	O
2007	O
)	O
grade	O
II	O
.	O

-	O
IDHI	O
(	O
R132H	O
)	O
negative	O
on	O
immunohistochemistry	O
.	O

-	O
Supplementary	O
reports	O
with	O
molecular	O
studies	O
to	O
follow	O
.	O

Histopathology	O
Supplementary	O
.	O

Temporary	O
Copy	O
.	O

Case	O
:	O
:	O
SUPPLEMENTARY	O
REPORT	O
.	O

RPAH	O
GLIOMA	O
FISH	O
RESULTS	O
This	O
case	O
was	O
analysed	O
for	O
1p	O
/	O
199	O
LOH	O
using	O
.	O
dual	O
.	O

colour	O
probe	O
sets	O
.	O

1p36	O
,	O
.	O

1q25	O
and	O
.	O

19q13	O
/	O
19p13	O
.	O

Cut	O
-	O
off	O
values	O
:	O
a	O
1p	O
/	O
lq	O
ratio	O
and	O
.	O

19q	O
/	O
19p	O
ratio	O
of	O
<	O
-	O
0	O
.	O
80	O
is	O
taken	O
as	O
indicating	O
LOH	O
.	O

Sixty	O
cells	O
were	O
formally	O
scored	O
with	O
each	O
.	O
probe	O
pair	O
.	O

The	O
case	O
was	O
also	O
hybridised	O
with	O
.	O

EGFR	O
/	O
Ccp7	O
dual	O
colour	O
FISH	O
probeset	O
to	O
assess	O
EGFR	O
.	O
gene	O
amplification	O
.	O

Chromosome	O
1	O
.	O

Mean	O
copies	O
1p	O
per	O
cell	O
:	O
1	O
.	O
32	O
.	O

Mean	O
copies	O
1q	O
per	O
cell	O
:	O
1	O
.	O
92	O
.	O

1p	O
/	O
lq	O
ratio	O
:	O
0	O
.	O
687	O
.	O

Interpretation	O
:	O
Ip	O
loss	O
detected	O
by	O
FISII	O
.	O

Chromosome	O
19	O
.	O

Mean	O
copies	O
19q	O
per	O
cell	O
:	O
1	O
.	O
08	O
.	O

Mean	O
copies	O
19p	O
per	O
cell	O
:	O
1	O
.	O
87	O
.	O

194	O
/	O
19p	O
ratio	O
:	O
0	O
.	O
58	O
.	O

Interpretation	O
:	O
194	O
loss	O
detected	O
by	O
FISH	O
.	O

EGFR	O
:	O
Not	O
amplified	O
(	O
mean	O
copies	O
EGFR	O
/	O
cell	O
=	O
1	O
.	O
95	O
)	O
.	O

COMMENT	O
:	O
Dual	O
1p	O
/	O
19q	O
loss	O
delected	O
,	O
consistent	O
with	O
oligodendroglial	O
phenotype	O
.	O

No	O
EGFR	O
.	O
anmplification	O
detected	O
.	O

Thuis	O
case	O
was	O
also	O
refererd	O
to	O
.	O
for	O
IDH	O
gene	O
sequencing	O
.	O

They	O
report	O
an	O
IDH2	O
(	O
R172M	O
)	O
mutation	O
(	O
sce	O
seperate	O
report	O
.	O

SUPPLEMENTARY	O
SUMMARY	O
.	O

Specimen	O
1	O
and	O
2	O
.	O

Left	O
frontal	O
mass	O
:	O
-	O
Oligodendroglioma	O
WHO	O
(	O
2007	O
)	O
grade	O
II	O
.	O

-	O
IDH2	O
(	O
R172M	O
)	O
mutation	O
detected	O
by	O
external	O
laboratory	O
.	O

-	O
1p	O
/	O
19q	O
codeletion	O
detected	O
by	O
FISH	O
.	O

-	O
No	O
EGFR	O
amplification	O
.	O

Neuropathology	O
Report	O
.	O

Temporary	O
Copy	O
.	O

CLINICAL	O
HISTORY	O
.	O

Block	O
2B	O
.	O

Oligodendroglioma	O
with	O
1p	O
/	O
19q	O
codeletion	O
but	O
negative	O
on	O
IHC	O
for	O
IDHI	O
.	O

(	O
R132H	O
)	O
.	O

For	O
sequencing	O
please	O
.	O

SPECIMEN	O
DESCRIPTION	O
.	O

1	O
vial	O
of	O
FFPE	O
sections	O
for	O
IDH	O
sequencing	O
.	O

Neuropathology	O
Report	O
.	O

IDH1	O
and	O
IDH2	O
MUTATION	O
STATUS	O
.	O

HISTOLOGICAL	O
ASSESMENT	O
:	O
The	O
sample	O
was	O
review	O
by	O
a	O
pathologist	O
and	O
estimated	O
to	O
contain	O
at	O
least	O
50	O
%	O
tumour	O
cells	O
.	O

METHOD	O
:	O
Codon	O
132	O
of	O
the	O
IDIII	O
gene	O
and	O
codon	O
172	O
of	O
the	O
IDII2	O
gene	O
are	O
amplified	O
and	O
sequenced	O
by	O
pyrosequencing	O
.	O

IDHI	O
:	O
No	O
Mutation	O
Detected	O
.	O

IDH2	O
:	O
MUTATIONDETECTED	O
-	O
R172M	O
.	O

The	O
HGVS	O
nomenclature	O
for	O
this	O
mutation	O
is	O
NM	O
_	O
002168	O
.	O
2	O
(	O
IDI	O
(	O
2	O
)	O
:	O
c	O
.	O
515G	O
>	O
T	O
(	O
p	O
.	O
R172M	O
)	O
.	O

COMMENTS	O
.	O

This	O
result	O
indicates	O
that	O
the	O
tumour	O
harbours	O
the	O
IDH2	O
(	O
p	O
.	O
R172M	O
)	O
mutation	O
.	O

No	O
IDHI	O
codon	O
132	O
mutation	O
was	O
present	O
.	O

Note	O
:	O
All	O
PCR	O
based	O
tests	O
are	O
subject	O
to	O
a	O
low	O
risk	O
of	O
non	O
-	O
amplification	O
of	O
one	O
allele	O
due	O
to	O
primer	O
binding	O
site	O
.	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNP	O
)	O
.	O

This	O
can	O
lead	O
to	O
a	O
false	O
negative	O
result	O
.	O

Sample	O
fixation	O
causes	O
DNA	O
degradation	O
which	O
may	O
result	O
in	O
false	O
negative	O
results	O
due	O
to	O
non	O
-	O
amplification	O
of	O
.	O
one	O
allele	O
(	O
allelic	O
drop	O
out	O
)	O
or	O
false	O
positive	O
results	O
due	O
to	O
trans	O
-	O
lesional	O
nucleotide	O
repair	O
during	O
PCR	O
.	O
amplification	O
.	O

SUMMARY	O
.	O

This	O
result	O
indicates	O
that	O
the	O
tumour	O
harbours	O
the	O
IDH2	O
(	O
p	O
.	O
R172M	O
)	O
mutation	O
.	O

Surgical	O
Histology	O
.	O

Surgical	O
Histology	O
.	O

ADDRESS	O
FOR	O
REPORT	O
:	O
HISTOPATHOLOGY	O
REPORT	O
.	O

CASE	O
HISTORY	O
:	O
?	O
BCC	O
.	O

8mm	O
punch	O
.	O

MACROSCOPIC	O
:	O
8	O
mm	O
punch	O
biopsy	O
.	O

MICROSCOPY	O
:	O
A	O
punch	O
excision	O
of	O
skin	O
showing	O
a	O
benign	O
early	O
trichilemmoma	O
which	O
.	O
appears	O
completely	O
excised	O
.	O

There	O
is	O
no	O
evidence	O
of	O
dysplasia	O
or	O
.	O
malignancy	O
.	O

DIAGNOSIS	O
:	O
8MM	O
PUNCH	O
EXCISION	O
OF	O
SKIN	O
(	O
RIGHT	O
CHEEK	O
)	O
:	O
TRICHILEMMOMA	O
.	O

Surgical	O
Histology	O
.	O

Surgical	O
Histology	O
.	O

ADDRESS	O
FOR	O
REPORT	O
:	O
Report	O
to	O
Cancer	O
Registry	O
.	O

HISTOPATHOLOGY	O
REPORT	O
.	O

CASE	O
HISTORY	O
:	O
Superficial	O
mass	O
for	O
many	O
years	O
.	O

Ulcerated	O
skin	O
over	O
mass	O
.	O

?	O
Fat	O
.	O
necrosis	O
in	O
old	O
lipoma	O
.	O

MACROSCOPIC	O
:	O
One	O
core	O
of	O
tissue	O
,	O
0	O
.	O
9	O
cm	O
,	O
plus	O
frags	O
.	O

MICROSCOPY	O
:	O
A	O
fragmented	O
needle	O
core	O
biopsy	O
of	O
fibrofatty	O
tissue	O
,	O
which	O
includes	O
.	O
parts	O
of	O
a	O
malignant	O
neoplasm	O
.	O

It	O
is	O
composed	O
of	O
pleomorphic	O
large	O
.	O
epithelioid	O
and	O
spindle	O
-	O
cell	O
shaped	O
cells	O
.	O

They	O
have	O
abundant	O
.	O
eosinophilic	O
(	O
sometimes	O
faintly	O
yellowish	O
)	O
cytoplasm	O
and	O
large	O
.	O
eosinophilic	O
nucleoli	O
.	O

Elsewhere	O
,	O
the	O
tissue	O
shows	O
chronic	O
.	O
iibro	O
-	O
inflammatory	O
changes	O
with	O
focal	O
yellowish	O
brown	O
pigment	O
.	O

(	O
probably	O
blood	O
-	O
derived	O
)	O
.	O

There	O
are	O
various	O
possibilities	O
,	O
of	O
which	O
malignant	O
melanoma	O
or	O
.	O
metastatic	O
carcinoma	O
are	O
likely	O
contenders	O
.	O

Are	O
there	O
any	O
clinical	O
.	O
or	O
historical	O
clues	O
?	O
.	O

Please	O
regard	O
this	O
as	O
a	O
provisional	O
and	O
preliminary	O
urgent	O
report	O
.	O

Definitive	O
diagnosis	O
will	O
depend	O
upon	O
immunohistochemical	O
staining	O
.	O

A	O
further	O
report	O
will	O
follow	O
.	O

DIAGNOSIS	O
:	O
CORE	O
BIOPSY	O
OF	O
MASS	O
,	O
RIGHT	O
ARM	O
.	O

SUPPLEMENTARY	O
REPORT	O
:	O
Histochemical	O
and	O
immunohistochemical	O
staining	O
has	O
been	O
undertaken	O
.	O

No	O
definite	O
melanin	O
is	O
recognised	O
within	O
the	O
tumour	O
cells	O
.	O

They	O
are	O
.	O
strongly	O
immunostained	O
in	O
S100	O
protein	O
,	O
melan	O
A	O
,	O
and	O
HMB	O
-	O
45	O
.	O
preparations	O
.	O

They	O
do	O
not	O
stain	O
for	O
keratins	O
.	O

These	O
observations	O
.	O
imply	O
that	O
the	O
tumour	O
is	O
a	O
malignant	O
melanoma	O
.	O

The	O
history	O
provided	O
.	O
seems	O
odd	O
in	O
that	O
context	O
.	O

DIAGNOSIS	O
:	O
CORE	O
BIOPSY	O
OF	O
MASS	O
,	O
RIGHT	O
ARM	O
:	O
MALIGNANT	O
MELANOMA	O
.	O

REPORT	O
DATE	O
:	O
MALIGNANT	O
MELANOMA	O
MINIMUM	O
DATA	O
SET	O
.	O

LAB	O
NUMBER	O
:	O
PRIVATE	O
PATIENT	O
:	O
ADDRESS	O
FOR	O
REPORT	O
:	O
CLINICAL	O
HISTORY	O
:	O
Melanoma	O
right	O
upper	O
arm	O
.	O

MACROSCOPIC	O
:	O
Large	O
disc	O
of	O
skin	O
12	O
x	O
17	O
X	O
3	O
.	O
5	O
cm	O
.	O

Skin	O
sutured	O
centrally	O
with	O
.	O
underlying	O
firm	O
tumour	O
,	O
4	B
cm	I
maximum	O
diameter	O
,	O
which	O
has	O
been	O
.	O
sliced	O
open	O
,	O
disrupted	O
Distance	O
of	O
tumour	O
to	O
margin	O
approximately	O
4	O
.	O

cm	O
,	O
.	O
minimum	O
2	O
.	O
0	O
cm	O
.	O

Deep	O
margin	O
black	O
.	O

Peripheral	O
margin	O
yellow	O
.	O

Closest	O
margin	O
is	O
A	O
and	O
B	O
.	O

A	O
and	O
B	O
continuous	O
.	O

C	O
and	O
D	O
continuous	O
.	O

E	O
and	O
F	O
=	O
random	O
tumour	O
.	O

MICROSCOPIC	O
:	O
Tumour	O
type	O
.	O

Nodular	O
.	O

Growth	O
phase	O
.	O

Vertical	O
.	O

Breslow	O
thickness	O
(	O
mm	O
)	O
.	O

12	O
.	O
00	O
.	O

Mitotic	O
rate	O
(	O
/	O
sq	O
mm	O
)	O
.	O

4	O
.	O

Regression	O
.	O

Absent	O
.	O

Lymphovascular	O
invasion	O
.	O

Absent	O
.	O

Perineural	O
invasion	O
.	O

Absent	O
.	O

Microsatellites	O
.	O

Absent	O
.	O

Coexistent	O
naevus	O
.	O

Absent	O
.	O

Tumour	O
infiltrating	O
lymphocytes	O
.	O

Non	O
-	O
brisk	O
.	O

Completely	O
Excised	O
.	O

Deep	O
margin	O
(	O
mm	O
)	O
.	O

0	O
.	O
3	O
.	O

Circumferential	O
margin	O
(	O
mm	O
)	O
.	O

20	O
.	O
0	O
.	O

Stage	O
.	O

pT4a	O
.	O

COMMENT	O
:	O
Skin	O
sliced	O
open	O
before	O
receipt	O
ulceration	O
can	O
not	O
be	O
.	O
excluded	O
.	O

The	O
possibility	O
of	O
a	O
metastatic	O
lesion	O
should	O
be	O
excluded	O
.	O
clinically	O
.	O

DIAGNOSIS	O
:	O
Skin	O
of	O
Right	O
Arm	O
:	O
Malignant	O
Melanoma	O
.	O

ADDITIONAL	O
REPORT	O
:	O
BRAF	O
immunostain	O
is	O
negative	O
.	O

This	O
case	O
was	O
sent	O
to	O
.	O
for	O
BRAF	O
.	O
testing	O
.	O

BRAF	O
gene	O
analysis	O
using	O
PCR	O
for	O
.	O

Codon	O
600	O
,	O
Exon	O
of	O
BRAF	O
gene	O
showed	O
no	O
evidence	O
of	O
mutation	O
.	O

Surgical	O
Histology	O
.	O

Surgical	O
Histology	O
.	O

Report	O
to	O
Cancer	O
Registry	O
.	O

HISTOPATHOLOGY	O
REPORT	O
.	O

LAB	O
No	O
:	O
Lab	O
No	O
.	O

Hosp	O
No	O
.	O

CASE	O
HISTORY	O
:	O
Prostate	O
chippings	O
.	O

Catheter	O
in	O
-	O
situ	O
for	O
retention	O
.	O

DRE	O
hard	O
prostate	O
.	O

PSA	O
awaited	O
?	O
Ca	O
prostate	O
.	O

MACROSCOPIC	O
:	O
Prostate	O
chips	O
weighing	O
24g	O
.	O

MICROSCOPY	O
:	O
Shows	O
infiltrating	O
adenocarcinoma	O
with	O
more	O
than	O
90	O
%	O
of	O
the	O
prostate	O
.	O
chips	O
.	O

The	O
features	O
are	O
those	O
of	O
Gleason	O
4	O
+	O
4	O
=	O
8	O
with	O
tertiary	O
.	O
pattern	O
5	O
.	O

DIAGNOSIS	O
:	O
PROSTATE	O
CHIPPINGS	O
:	O
INFILTRATING	O
ADENOCARCINOMA	O
IN	O
MORE	O
THAN	O
90	O
%	O
OF	O
.	O

TISSUE	O
.	O

pTlb	O
.	O

Consultant	O
Histopathologist	O
.	O

Consultant	O
Histopathologist	O
.	O

REPORT	O
DATE	O
:	O

Laterality	O
:	O
Tumor	O
consists	O
of	O
papillae	O
having	O
an	O
fine	O
fibrovascular	O
stalk	O
or	O
.	O
colloid	O
folliculae	O
covered	O
by	O
a	O
single	O
to	O
mutiple	O
layers	O
of	O
cuboidal	O
epithelial	O
cells	O
.	O

Tumor	O
invades	O
in	O
.	O
capsule	O
or	O
vessle	O
or	O
begnin	O
tissue	O
or	O
muscle	O
.	O

The	O
cells	O
tend	O
to	O
maintain	O
their	O
polarity	O
.	O

Nuclei	O
are	O
quite	O
.	O
regular	O
and	O
contain	O
finely	O
dispersed	O
chromatin	O
,	O
or	O
intranuclear	O
grooves	O
.	O

Tumor	O
is	O
fibrous	O
.	O

Path	O
Report	O
:	O
Tumor	O
type	O
:	O
Papillary	O
carcinoma	O
.	O

Tumor	O
size	O
:	O
1x0	B
.	I
7x0	I
.	I
7cm	I
.	O

Laterality	O
:	O
left	O
.	O

Tumor	O
focality	O
:	O
Unifocal	O
.	O

Invasion	O
of	O
capsule	O
:	O
Yes	O
.	O

Extrathyroidal	O
extension	O
:	O
No	O
.	O

SPECIMEN	O
(	O
S	O
)	O
:	O
A	O
:	O
Posterior	O
skin	O
.	O

B	O
:	O
Subdermal	O
mass	O
,	O
under	O
flap	O
by	O
external	O
jugular	O
.	O

C	O
:	O
Posterior	O
parotid	O
perifacial	O
node	O
.	O

D	O
:	O
Greature	O
auricular	O
.	O

E	O
:	O
Paratid	O
Superior	O
margin	O
of	O
tumor	O
.	O

F	O
:	O
Right	O
parotidectomy	O
.	O

G	O
:	O
Upper	O
deep	O
margin	O
.	O

H	O
:	O
Lower	O
deep	O
margin	O
.	O

I	O
:	O
Inferior	O
skin	O
margin	O
.	O

J	O
:	O
Anterior	O
skin	O
margin	O
.	O

K	O
:	O
Superior	O
skin	O
margin	O
.	O

L	O
:	O
Ear	O
lobe	O
skin	O
margin	O
.	O

M	O
:	O
Zone	O
3	O
lymph	O
node	O
.	O

N	O
:	O
Neck	O
dissection	O
:	O
Lateral	O
zones	O
2	O
and	O
3	O
.	O

O	O
:	O
Anterior	O
zones	O
2A	O
and	O
3	O
.	O

P	O
:	O
Submandibular	O
gland	O
,	O
right	O
.	O

FINAL	O
DIAGNOSIS	O
:	O
A	O
.	O

Posterior	O
skin	O
,	O
excision	O
:	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
carcinoma	O
.	O

B	O
.	O

Subdermal	O
mass	O
,	O
under	O
flap	O
by	O
external	O
jugular	O
,	O
excision	O
:	O
-	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

C	O
.	O

Posterior	O
parotid	O
perifacial	O
node	O
,	O
excision	O
:	O
-	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

D	O
.	O

Greature	O
auricular	O
,	O
excision	O
:	O
-	O
Fibroconnective	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

E	O
.	O

Paratid	O
superior	O
margin	O
of	O
tumor	O
,	O
excision	O
:	O
-	O
Benign	O
salivary	O
gland	O
tissue	O
.	O

-	O
No	O
evidence	O
of	O
carcinoma	O
.	O

F	O
.	O

Right	O
parotid	O
,	O
right	O
parotidectomy	O
:	O
-	O
Invasive	O
squamous	O
cell	O
carcinoma	O
,	O
poorly	O
differentiated	O
,	O
greater	O
than	O
5	B
.	I
0	I
cm	I
.	O

-	O
Resection	O
margin	O
:	O
Negative	O
for	O
carcinoma	O
.	O

The	O
invasive	O
carcinoma	O
.	O

is	O
0	O
.	O
1	O
cm	O
from	O
the	O
closest	O
resection	O
margin	O
.	O

-	O
No	O
squamous	O
cell	O
carcinoma	O
in	O
situ	O
identified	O
.	O

-	O
Benign	O
salivary	O
glands	O
.	O

-	O
See	O
comment	O
.	O

G	O
.	O

Upper	O
deep	O
margin	O
,	O
excision	O
:	O
-	O
Benign	O
salivary	O
gland	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

H	O
.	O

Lower	O
deep	O
margin	O
,	O
excision	O
:	O
-	O
Benign	O
salivary	O
gland	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

I	O
.	O

Inferior	O
skin	O
margin	O
,	O
excision	O
:	O
-	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
carcinoma	O
.	O

J	O
.	O

Anterior	O
skin	O
margin	O
,	O
excision	O
:	O
-	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
carcinoma	O
.	O

K	O
.	O

Superior	O
skin	O
margin	O
,	O
excision	O
:	O
-	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
carcinoma	O
.	O

L	O
.	O

Ear	O
lobe	O
skin	O
margin	O
,	O
excision	O
:	O
-	O
Squamous	O
mucosa	O
,	O
negative	O
for	O
carcinoma	O
.	O

M	O
.	O

Zone	O
3	O
lymph	O
node	O
,	O
excision	O
:	O
-	O
One	O
lymph	O
node	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
1	O
)	O
.	O

N	O
.	O

Neck	O
dissection	O
:	O
Lateral	O
zones	O
2	O
and	O
3	O
,	O
excision	O
:	O
Thirteen	O
lymph	O
nodes	O
,	O
negative	O
for	O
carcinoma	O
(	O
0	O
/	O
13	O
)	O
.	O

O	O
.	O

Anterior	O
zones	O
2A	O
and	O
3	O
,	O
excision	O
:	O
-	O
One	O
of	O
three	O
lymph	O
nodes	O
with	O
metastatic	O
poorly	O
differentiated	O
.	O
squamous	O
cell	O
carcinoma	O
(	O
0	B
.	I
6	I
cm	I
in	O
length	O
)	O
(	O
1	O
/	O
3	O
)	O
.	O

-	O
Extranodal	O
extension	O
:	O
Absent	O
.	O

P	O
.	O

Submandibular	O
gland	O
,	O
right	O
,	O
excision	O
:	O
-	O
Benign	O
salivary	O
gland	O
tissue	O
,	O
negative	O
for	O
carcinoma	O
.	O

COMMENT	O
:	O
Invasive	O
poorly	O
differentiated	O
squamous	O
cell	O
carcinoma	O
(	O
greater	O
than	O
5	B
.	I
0	I
cm	I
)	O
is	O
.	O
identified	O
in	O
the	O
parotid	O
glands	O
.	O

No	O
squamous	O
cell	O
carcinoma	O
in	O
situ	O
is	O
.	O
seen	O
.	O

The	O
invasive	O
squamous	O
cell	O
carcinoma	O
could	O
be	O
from	O
the	O
overlying	O
.	O
skin	O
,	O
metastatic	O
from	O
other	O
organs	O
or	O
primary	O
tumor	O
from	O
parotid	O
.	O

However	O
,	O
primary	O
parotid	O
squamous	O
cell	O
carcinoma	O
is	O
very	O
uncommon	O
.	O

Correlation	O
with	O
complete	O
clinical	O
information	O
is	O
required	O
.	O

Reviewed	O
CT	O
+	O
PET	O
scen	O
I	O
wk	O
prior	O
.	O

CLINICAL	O
HISTORY	O
:	O
The	O
patient	O
has	O
right	O
parotid	O
cancer	O
.	O

Operative	O
Procedure	O
:	O
Right	O
parotidectomy	O
with	O
radical	O
neck	O
dissection	O
.	O
and	O
margins	O
.	O

Multiple	O
frozen	O
sections	O
.	O

Clinical	O
Diagnosis	O
&	O
History	O
:	O
Right	O
renal	O
mass	O
.	O

Specimens	O
Submitted	O
:	O
1	O
:	O
Right	O
kidney	O
;	O
partial	O
nephrectomy	O
.	O

DIAGNOSIS	O
:	O
1	O
.	O

Right	O
kidney	O
;	O
partial	O
nephrectomy	O
:	O
PAPILLARY	O
RENAL	O
CELL	O
CARCNIOMA	O
,	O
TYPE	O
8	O
,	O
(	O
HIGH	O
GRADE	O
)	O
.	O

TUMOR	O
MEASURES	O
1	B
.	I
3	I
CM	I
.	O

TUMO	O
IS	O
CONFINED	O
WITHIN	O
THE	O
RENAL	O
CAPSULE	O
.	O

-	O
NO	O
INVASION	O
OF	O
THE	O
RENAL	O
VEIN	O
IS	O
IDENTIFIED	O
.	O

-	O
SURGICAL	O
MARGIN	O
IS	O
FREE	O
OF	O
TUMOR	O
(	O
TUMOR	O
IS	O
0	O
.	O
2	O
CM	O
FROM	O
THE	O
RESECTION	O
MARGIN	O
)	O
.	O

-	O
INCIDENTAL	O
PAPILLARY	O
"	O
ADENOMA	O
"	O
(	O
1	O
.	O
0	O
MM	O
)	O
.	O

IATTEST	O
THAT	O
THE	O
ABOVE	O
DIAGNOSIS	O
IS	O
BASED	O
UPON	O
MY	O
PERSONAL	O
EXAMINATION	O
OF	O
THE	O
SLIDES	O
(	O
ANDIOR	O
OTHER	O
MATERIAL	O
)	O
,	O
AND	O
THAT	O
THAVE	O
.	O

REVIEWED	O
AND	O
APPROVED	O
THIS	O
REPORT	O
.	O

1	O
)	O
.	O

The	O
specimen	O
is	O
received	O
fresh	O
for	O
frozen	O
section	O
,	O
labeled	O
"	O
Right	O
Kidney	O
Tumor	O
"	O
.	O

It	O
consists	O
of	O
a	O
piece	O
of	O
renal	O
cortex	O
.	O
measuring	O
4	O
x	O
3	O
.	O
5	O
x	O
1	O
cm	O
.	O

Sectioning	O
of	O
the	O
tissue	O
reveals	O
a	O
well	O
-	O
circumscribed	O
,	O
cystic	O
tumor	O
measuring	O
1	O
.	O
3	O
x	O
0	O
.	O
5	O
x	O
2	O
cm	O
,	O
filled	O
.	O
with	O
gray	O
-	O
tan	O
,	O
soft	O
,	O
cheesy	O
material	O
.	O

The	O
tissue	O
surgical	O
margin	O
is	O
inked	O
black	O
.	O

The	O
tumor	O
is	O
0	O
.	O
2	O
cm	O
away	O
from	O
the	O
surgical	O
.	O
margin	O
.	O

A	O
portion	O
of	O
tissue	O
is	O
submitted	O
for	O
TPS	O
.	O

Photographs	O
are	O
taken	O
.	O

Representative	O
sections	O
are	O
submitted	O
for	O
histologic	O
.	O
examination	O
.	O

Summary	O
of	O
Sections	O
:	O
FSC	O
-	O
frozen	O
section	O
control	O
.	O

T	O
tumor	O
.	O

Summary	O
of	O
Sections	O
:	O
Part	O
1	O
:	O
Right	O
kidnoy	O
;	O
partial	O
nephrectomy	O
.	O

Block	O
.	O

Sect	O
.	O

Site	O
.	O

PCs	O
.	O

1	O
.	O
fsc	O
.	O

1	O
.	O

ss	O
.	O

4	O
.	O

3	O
.	O

3	O
.	O

Intraoperative	O
Consultation	O
:	O
Note	O
:	O
The	O
diagnoses	O
given	O
in	O
this	O
section	O
pertain	O
only	O
to	O
the	O
lissue	O
sample	O
examined	O
at	O
the	O
time	O
of	O
the	O
intraoperative	O
.	O
consultation	O
.	O

1	O
)	O
.	O

FROZEN	O
SECTION	O
DIAGNOSIS	O
:	O
RENAL	O
CORTICAL	O
NEOPLASM	O
;	O
STITCHED	O
MARGIN	O
IS	O
FREE	O
OF	O
TUMOR	O
.	O

PERMANENT	O
DIAGNOSIS	O
:	O
SAME	O
.	O

HISTORY	O
.	O

Left	O
lobe	O
lobectomy	O
upper	O
.	O

MACROSCOPIC	O
.	O

Two	O
specimens	O
submitted	O
.	O

1	O
:	O
The	O
specimen	O
is	O
labelled	O
"	O
left	O
upper	O
lobe	O
"	O
and	O
consists	O
of	O
a	O
left	O
upper	O
lobe	O
of	O
lung	O
measuring	O
220	O
X	O
.	O

90	O
X	O
17	O
mm	O
.	O

A	O
large	O
area	O
of	O
parietal	O
pleural	O
adhesion	O
is	O
noted	O
on	O
the	O
anterolateral	O
surface	O
.	O

Beneath	O
.	O
this	O
a	O
firm	O
mass	O
is	O
palpable	O
within	O
the	O
anterior	O
segment	O
.	O

On	O
sectioning	O
a	O
mass	O
is	O
confirmed	O
within	O
the	O
.	O
lung	O
.	O

The	O
mass	O
measures	O
40	O
X	O
17	O
X	O
32	O
mm	O
and	O
has	O
a	O
cream	O
to	O
tan	O
cut	O
surface	O
with	O
black	O
streaking	O
.	O

The	O
tumour	O
lies	O
adjacent	O
to	O
the	O
area	O
of	O
thickened	O
and	O
adherent	O
pleura	O
.	O

The	O
tumour	O
is	O
over	O
25	O
mm	O
away	O
.	O
from	O
the	O
medial	O
pleural	O
surface	O
and	O
is	O
well	O
clear	O
of	O
the	O
posterior	O
pleural	O
surface	O
.	O

The	O
tumour	O
is	O
at	O
least	O
.	O

40	O
mm	O
away	O
from	O
the	O
bronchial	O
resection	O
margin	O
.	O

The	O
uninvolved	O
lung	O
tissue	O
appears	O
unremarkable	O
.	O

[	O
1A	O
,	O
bronchial	O
resection	O
margin	O
;	O
1B	O
,	O
peribronchial	O
lymph	O
nodes	O
;	O
1C	O
,	O
tumour	O
with	O
adherent	O
lateral	O
.	O
pleura	O
;	O
1D	O
,	O
adjacent	O
medial	O
pleural	O
margin	O
;	O
1E	O
-	O
1F	O
,	O
further	O
sections	O
through	O
tumour	O
;	O
1G	O
,	O
uninvolved	O
.	O
lung	O
]	O
.	O

2	O
:	O
The	O
specimen	O
is	O
labelled	O
"	O
lymph	O
node	O
No	O
.	O
5	O
"	O
and	O
consists	O
of	O
a	O
single	O
fragment	O
of	O
cream	O
fatty	O
tissue	O
.	O
containing	O
grey	O
-	O
black	O
lymph	O
nodes	O
.	O

The	O
specimen	O
measures	O
25	O
X	O
18	O
X	O
7	O
mm	O
.	O

No	O
obvious	O
.	O
involvement	O
by	O
tumour	O
is	O
noted	O
on	O
sectioning	O
.	O

[	O
Bisected	O
and	O
BIT	O
,	O
2A	O
-	O
B	O
]	O
.	O

MICROSCOPIC	O
.	O

1	O
:	O
Sections	O
show	O
a	O
moderately	O
to	O
poorly	O
differentiated	O
adenocarcinoma	O
which	O
invades	O
into	O
the	O
.	O
overlying	O
adherent	O
parietal	O
pleura	O
but	O
appears	O
clear	O
of	O
the	O
soft	O
tissue	O
resection	O
margin	O
.	O

Definite	O
.	O
vascular	O
or	O
lymphatic	O
invasion	O
is	O
not	O
identified	O
.	O

Metastatic	O
adenocarcinoma	O
is	O
present	O
in	O
one	O
of	O
the	O
.	O
peribronchial	O
lymph	O
nodes	O
with	O
transcapsular	O
extension	O
into	O
adjacent	O
hilar	O
fibrofatty	O
tissue	O
and	O
.	O
perineural	O
and	O
intraneural	O
invasion	O
in	O
this	O
region	O
.	O

The	O
bronchial	O
resection	O
margin	O
is	O
clear	O
of	O
.	O
malignancy	O
but	O
shows	O
several	O
foci	O
of	O
squamous	O
metaplasia	O
and	O
low	O
-	O
grade	O
dysplasia	O
.	O

Distant	O
lung	O
.	O
parenchyma	O
shows	O
focal	O
organising	O
pneumonia	O
,	O
congestion	O
and	O
emphysema	O
.	O

2	O
:	O
Sections	O
show	O
partial	O
replacement	O
of	O
the	O
lymph	O
nodes	O
by	O
metastatic	O
carcinoma	O
with	O
transcapsular	O
.	O
extension	O
into	O
the	O
adjacent	O
fibrofatty	O
tissue	O
.	O

SUMMARY	O
.	O

Left	O
upper	O
lobectomy	O
and	O
lymph	O
node	O
No	O
5	O
:	O
Moderately	O
to	O
poorly	O
differentiated	O
adenocarcinoma	O
,	O
40	O
mm	O
in	O
diameter	O
.	O

Invasion	O
of	O
parietal	O
pleura	O
present	O
.	O

No	O
vascular	O
invasion	O
identified	O
.	O

Metastatic	O
adenocarcinoma	O
present	O
in	O
peribronchial	O
and	O
No	O
5	O
lymph	O
nodes	O
.	O

Perineural	O
and	O
intraneural	O
invasion	O
present	O
in	O
hilar	O
soft	O
tissue	O
.	O

Pathological	O
stage	O
T3	O
N2	O
.	O

T	O
-	O
28000	O
M	O
-	O
81403	O
P1	O
-	O
03000	O
.	O

SUPPLEMENTARY	O
REPORT	O
.	O

Elastic	O
stains	O
demonstrate	O
unequivocal	O
vascular	O
invasion	O
by	O
tumour	O
.	O

